Citrus Sinensis ID: 014904

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410------
Protein Sequence
MSSSGGSGSNYSGSEAPLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDASLADLNEGIRPGQSSVYGSYGSSDYDTMQYNEDLKKFRKMALNSQEYSASSEYSRPTSEYGLYPSGSSSEGQNTREMEMGKTKKNSQGFSGSP
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccEEEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEEEEccccEEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHccHHHHHHcccccccEEccccccccccccccccccccccccccccccccccEEcccccccccccHHHHccccccccccccHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHccccccccccccccccccccccccccccccccccHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccEcHHHHHHHHccccHHcccccccccEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHHHcHcHHHEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHHccccEEcccccHHHEEEcccccEEEccccccEEcccccEEccccccccHHHccHHHHHHcEEcHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHHHHcccHHHHccccHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHcccccccccccccccccccccccccccccccccccHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
msssggsgsnysgseaplpppspglslgfskstfTYEELARatdgfsdanllgqggfgyvhrgvlpngkEVAIKQLkagsgqgereFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYefvpnntlefhlhgkgrptmDWLTRLKIALGSAKGLaylhedchpkiiHRDIKAANILLDFKFEAKVADFGLAKiasdvnthvstrvmgtfgylapeyassgklteksdvFSFGVMLLELitgrrpvdsthtfvEDSLVDWARPLLNRaiedgnfdtlvdpklhneynhNEMARMVACAAACVRHSARRRPRMSQIVRALEgdasladlnegirpgqssvygsygssdydtMQYNEDLKKFRKMALNSqeysasseysrptseyglypsgsssegqntrememgktkknsqgfsgsp
Flexible Loop (DISEMBL)
msssggsgsnysgseaplpppsPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKiasdvnthvSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELItgrrpvdsthtfvEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGdasladlnegirpgqssvygsygsSDYDTMQYNEDLKKFRKMALNSQEysasseysrptseyglypsgsssegqntrememgktkknsqgfsgsp
Low Complexity Region (SEG)
MsssggsgsnysgseaplpppspglslgfsKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEmarmvacaaacvrHSARRRPRMSQIVRALEGDASLADLNEGIRPGQssvygsygssdydTMQYNEDLKKFRKMALNSQEYSASSEYSRPTSEYGLYPSGSSSEGQNTREMEMGKTKKNSQGFSGSP
Disordered region (IsUnstruct)
********************************TFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLK********EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRH****************************************************************************************************************
Disordered Region (DISOPRED)
******************************KSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLK*G***GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDASLAD*****************************************************************************************
Disordered Region (DISEMBL)
*******************PPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQL*********EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDASLADLNEGIRPGQSSVYGSYGSSDYDTMQYNEDLKKFRKMAL***************************************************
Disordered Region (DISPRO)
******************************KSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDASL*D*N***************************************************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSSSGGSGSNYSGSEAPLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDASLADLNEGIRPGQSSVYGSYGSSDYDTMQYNEDLKKFRKMALNSQEYSASSEYSRPTSEYGLYPSGSSSEGQNTREMEMGKTKKNSQGFSGSP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	416	2.2.26 [Sep-21-2011]
Q9LV48	652	Proline-rich receptor-lik	yes	no	0.954	0.608	0.829	0.0
Q9LK03	717	Proline-rich receptor-lik	no	no	0.954	0.553	0.714	1e-169
Q9ZNQ8	633	Proline-rich receptor-lik	no	no	0.894	0.587	0.744	1e-165
Q8GX23	670	Proline-rich receptor-lik	no	no	0.939	0.583	0.700	1e-160
Q9C821	509	Proline-rich receptor-lik	no	no	0.908	0.742	0.686	1e-154
Q9XI96	699	Proline-rich receptor-lik	no	no	0.930	0.553	0.740	1e-150
Q9LS95	700	Putative proline-rich rec	no	no	0.865	0.514	0.754	1e-146
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.764	0.619	0.755	1e-146
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.942	0.552	0.587	1e-133
Q9ZUE0	720	Proline-rich receptor-lik	no	no	0.848	0.490	0.613	1e-130

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  700 bits (1807), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/398 (82%), Positives = 367/398 (92%), Gaps = 1/398 (0%)

Query: 18  LPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLK 77
           LPPPSPGL LGFSKSTFTYEEL+RAT+GFS+ANLLGQGGFGYVH+G+LP+GKEVA+KQLK
Sbjct: 252 LPPPSPGLVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLK 311

Query: 78  AGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRP 137
           AGSGQGEREFQAEVEIISRVHH+HLVSL+GY  AG QR+LVYEFVPNN LEFHLHGKGRP
Sbjct: 312 AGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRP 371

Query: 138 TMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD 197
           TM+W TRLKIALGSAKGL+YLHEDC+PKIIHRDIKA+NIL+DFKFEAKVADFGLAKIASD
Sbjct: 372 TMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASD 431

Query: 198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL 257
            NTHVSTRVMGTFGYLAPEYA+SGKLTEKSDVFSFGV+LLELITGRRPVD+ + +V+DSL
Sbjct: 432 TNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSL 491

Query: 258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
           VDWARPLLNRA E+G+F+ L D K+ NEY+  EMARMVACAAACVRHSARRRPRMSQIVR
Sbjct: 492 VDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVR 551

Query: 318 ALEGDASLADLNEGIRPGQSSVYGSY-GSSDYDTMQYNEDLKKFRKMALNSQEYSASSEY 376
           ALEG+ SL+DLNEG+RPG S+VY SY GS+DYDT QYN+D+ KFRKMAL +QEY  + EY
Sbjct: 552 ALEGNVSLSDLNEGMRPGHSNVYSSYGGSTDYDTSQYNDDMIKFRKMALGTQEYGTTGEY 611

Query: 377 SRPTSEYGLYPSGSSSEGQNTREMEMGKTKKNSQGFSG 414
           S PTS+YGLYPSGSSSEGQ TREMEMGK KK  QG+SG
Sbjct: 612 SNPTSDYGLYPSGSSSEGQATREMEMGKIKKTGQGYSG 649

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  596 bits (1537), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 290/406 (71%), Positives = 339/406 (83%), Gaps = 9/406 (2%)

Query: 10  NYSGSEAPLPPPSPGLSLGFS--KSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPN 67
           NYS  ++ LPPPSPGL+LG    + TF YEEL+RAT+GFS+ANLLGQGGFGYV +G+L N
Sbjct: 317 NYS-DQSVLPPPSPGLALGLGIYQGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRN 375

Query: 68  GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL 127
           GKEVA+KQLK GS QGEREFQAEV IISRVHH+HLV+LVGY  A +QR+LVYEFVPNNTL
Sbjct: 376 GKEVAVKQLKEGSSQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTL 435

Query: 128 EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA 187
           EFHLHGKGRPTM+W +RLKIA+GSAKGL+YLHE+C+PKIIHRDIKA+NIL+DFKFEAKVA
Sbjct: 436 EFHLHGKGRPTMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVA 495

Query: 188 DFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
           DFGLAKIASD NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV+LLELITGRRP+D
Sbjct: 496 DFGLAKIASDTNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPID 555

Query: 248 STHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSAR 307
             +   ++SLVDWARPLLN+  E GNF+ +VD KL+NEY+  EMARMVACAAACVR +A 
Sbjct: 556 VNNVHADNSLVDWARPLLNQVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAP 615

Query: 308 RRPRMSQIVRALEGDASLADLNEGIRPGQSSVYGSY-GSSDYDTMQYNEDLKKFRKMALN 366
           RRPRM Q+ R LEG+ S +DLN+GI PG S+VYGS  GS+DYD+ Q NE + KFRK+ L 
Sbjct: 616 RRPRMDQVARVLEGNISPSDLNQGITPGHSNVYGSSGGSTDYDSSQDNEGMNKFRKVGLE 675

Query: 367 SQEYSASSEYSRPTSEYGLYPSGSSSEGQNTREMEMGKTKKNSQGF 412
           +Q+      YS P SEY LYPS SS++GQ T+    G  K+  QG+
Sbjct: 676 TQDL-----YSNPISEYDLYPSWSSTDGQTTQGKATGNIKRPGQGY 716

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZNQ8|PERK4_ARATH Proline-rich receptor-like protein kinase PERK4 OS=Arabidopsis thaliana GN=PERK4 PE=1 SV=1

 Score =  581 bits (1497), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 279/375 (74%), Positives = 322/375 (85%), Gaps = 3/375 (0%)

Query: 1   MSSSGGSGSNYSGSEAP-LPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGY 59
           M +SG   S YSG   P LPPPSP L+LGF+KSTFTY+ELA AT GF+DANLLGQGGFGY
Sbjct: 238 MPTSGEDSSMYSGPSRPVLPPPSPALALGFNKSTFTYQELAAATGGFTDANLLGQGGFGY 297

Query: 60  VHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY 119
           VH+GVLP+GKEVA+K LKAGSGQGEREFQAEV+IISRVHH++LVSLVGY  A  QRMLVY
Sbjct: 298 VHKGVLPSGKEVAVKSLKAGSGQGEREFQAEVDIISRVHHRYLVSLVGYCIADGQRMLVY 357

Query: 120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD 179
           EFVPN TLE+HLHGK  P M++ TRL+IALG+AKGLAYLHEDCHP+IIHRDIK+ANILLD
Sbjct: 358 EFVPNKTLEYHLHGKNLPVMEFSTRLRIALGAAKGLAYLHEDCHPRIIHRDIKSANILLD 417

Query: 180 FKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 239
           F F+A VADFGLAK+ SD NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS+GVMLLEL
Sbjct: 418 FNFDAMVADFGLAKLTSDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSYGVMLLEL 477

Query: 240 ITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAA 299
           ITG+RPVD++ T ++D+LVDWARPL+ RA+EDGNF+ L D +L   YN  EMARMV CAA
Sbjct: 478 ITGKRPVDNSIT-MDDTLVDWARPLMARALEDGNFNELADARLEGNYNPQEMARMVTCAA 536

Query: 300 ACVRHSARRRPRMSQIVRALEGDASLADLNEGIRPGQSSVYGSYG-SSDYDTMQYNEDLK 358
           A +RHS R+RP+MSQIVRALEG+ SL  LNEG++PG S+VYGS G SSDY    YN D+K
Sbjct: 537 ASIRHSGRKRPKMSQIVRALEGEVSLDALNEGVKPGHSNVYGSLGASSDYSQTSYNADMK 596

Query: 359 KFRKMALNSQEYSAS 373
           KFR++AL+SQE+  S
Sbjct: 597 KFRQIALSSQEFPVS 611

Required during abscisic acid (ABA)-mediated activation of Ca(2+) channels. Regulates ABA signaling pathways. Modulates the expression of genes related to cell elongation and ABA signaling during root growth.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1

 Score =  565 bits (1456), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 283/404 (70%), Positives = 332/404 (82%), Gaps = 13/404 (3%)

Query: 9   SNYSGSEAPLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNG 68
           SN +G  A +P P    +LG ++STFTY+EL+ AT+GF+ +NLLGQGGFGYVH+GVLP+G
Sbjct: 277 SNLTGRTA-IPSPQ-AATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSG 334

Query: 69  KEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLE 128
           KEVA+K LK GSGQGEREFQAEV+IISRVHH+HLVSLVGY  +G QR+LVYEF+PNNTLE
Sbjct: 335 KEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLE 394

Query: 129 FHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD 188
           FHLHGKGRP +DW TR+KIALGSA+GLAYLHEDCHP+IIHRDIKAANILLDF FE KVAD
Sbjct: 395 FHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVAD 454

Query: 189 FGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDS 248
           FGLAK++ D  THVSTRVMGTFGYLAPEYASSGKL++KSDVFSFGVMLLELITGR P+D 
Sbjct: 455 FGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLDL 514

Query: 249 THTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARR 308
           T   +EDSLVDWARPL  +A +DG+++ L DP+L   Y+H EM +M +CAAA +RHSARR
Sbjct: 515 TGE-MEDSLVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSARR 573

Query: 309 RPRMSQIVRALEGDASLADLNEGIRPGQSSVYGSYG--SSDYDTMQYNEDLKKFRKMALN 366
           RP+MSQIVRALEGD S+ DL+EG RPGQS+ Y S G  SS+YD   Y  D+KKF+K+AL 
Sbjct: 574 RPKMSQIVRALEGDMSMDDLSEGTRPGQST-YLSPGSVSSEYDASSYTADMKKFKKLALE 632

Query: 367 SQEYSASSEYSRPTSEYGLYPSGSSSEGQNTREMEMGKTKKNSQ 410
           ++EY  SSEY   TSEYGL PS SSSE     EM  G  K+N Q
Sbjct: 633 NKEYQ-SSEYGG-TSEYGLNPSASSSE-----EMNRGSMKRNPQ 669

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1

 Score =  544 bits (1402), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 263/383 (68%), Positives = 316/383 (82%), Gaps = 5/383 (1%)

Query: 31  KSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAE 90
           ++ FTYE+L++AT  FS+ NLLGQGGFGYVHRGVL +G  VAIKQLK+GSGQGEREFQAE
Sbjct: 128 QNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAE 187

Query: 91  VEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
           ++ ISRVHH+HLVSL+GY   G+QR+LVYEFVPN TLEFHLH K RP M+W  R+KIALG
Sbjct: 188 IQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALG 247

Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
           +AKGLAYLHEDC+PK IHRD+KAANIL+D  +EAK+ADFGLA+ + D +THVSTR+MGTF
Sbjct: 248 AAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTF 307

Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED-SLVDWARPLLNRAI 269
           GYLAPEYASSGKLTEKSDVFS GV+LLELITGRRPVD +  F +D S+VDWA+PL+ +A+
Sbjct: 308 GYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQAL 367

Query: 270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDASLADLN 329
            DGNFD LVDP+L N+++ NEM RMVACAAA VRHSA+RRP+MSQIVRA EG+ S+ DL 
Sbjct: 368 NDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNISIDDLT 427

Query: 330 EGIRPGQSSVYGSYGSSDYDTMQYNEDLKKFRKMALNSQEYSASSEYSRPTSEYGLYPSG 389
           EG  PGQS++Y   GSSDY + QY EDLKKF+KMA  S+ +  SSE S  TS+ G  PSG
Sbjct: 428 EGAAPGQSTIYSLDGSSDYSSTQYKEDLKKFKKMAFESKTF-GSSECSGLTSDNGQNPSG 486

Query: 390 SSS--EGQ-NTREMEMGKTKKNS 409
           SSS  EGQ  T+E+E  K  K++
Sbjct: 487 SSSITEGQRTTQEIEPEKNTKDT 509

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XI96|PERK7_ARATH Proline-rich receptor-like protein kinase PERK7 OS=Arabidopsis thaliana GN=PERK7 PE=2 SV=1

 Score =  532 bits (1371), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 291/393 (74%), Positives = 325/393 (82%), Gaps = 6/393 (1%)

Query: 4   SGGSGSNYS-GSEAP-LPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVH 61
           SG   SN+S G  AP LPPP P ++LGF+ STFTYEELA AT GFS   LLGQGGFGYVH
Sbjct: 292 SGEMSSNFSSGPYAPSLPPPHPSVALGFNNSTFTYEELASATQGFSKDRLLGQGGFGYVH 351

Query: 62  RGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT-AGSQRMLVYE 120
           +G+LPNGKE+A+K LKAGSGQGEREFQAEVEIISRVHH+HLVSLVGY + AG QR+LVYE
Sbjct: 352 KGILPNGKEIAVKSLKAGSGQGEREFQAEVEIISRVHHRHLVSLVGYCSNAGGQRLLVYE 411

Query: 121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF 180
           F+PN+TLEFHLHGK    MDW TRLKIALGSAKGLAYLHEDCHPKIIHRDIKA+NILLD 
Sbjct: 412 FLPNDTLEFHLHGKSGTVMDWPTRLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDH 471

Query: 181 KFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 240
            FEAKVADFGLAK++ D NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI
Sbjct: 472 NFEAKVADFGLAKLSQDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 531

Query: 241 TGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAA 300
           TGR PVD +   +EDSLVDWARPL  R  +DG +  LVDP L ++Y   EMARMVACAAA
Sbjct: 532 TGRGPVDLSGD-MEDSLVDWARPLCMRVAQDGEYGELVDPFLEHQYEPYEMARMVACAAA 590

Query: 301 CVRHSARRRPRMSQIVRALEGDASLADLNEGIRPGQSSVYGSYGSSDYDTMQYNEDLKKF 360
            VRHS RRRP+MSQIVR LEGDASL DL++G++P QSS     GSSDY+   Y  +++KF
Sbjct: 591 AVRHSGRRRPKMSQIVRTLEGDASLDDLDDGVKPKQSSSG-GEGSSDYEMGTYGAEMRKF 649

Query: 361 RKMALNSQEYSASSEYSRPTSEYGLYPSGSSSE 393
           RK+ L S++Y ASSEY   TSEYGL PS SSSE
Sbjct: 650 RKVTLESRDYGASSEYGA-TSEYGLDPSSSSSE 681

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LS95|PERK6_ARATH Putative proline-rich receptor-like protein kinase PERK6 OS=Arabidopsis thaliana GN=PERK6 PE=2 SV=2

 Score =  519 bits (1337), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 273/362 (75%), Positives = 312/362 (86%), Gaps = 2/362 (0%)

Query: 26  SLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGER 85
           +LGF+KSTFTY+ELA AT GFS + LLGQGGFGYVH+G+LPNGKE+A+K LKAGSGQGER
Sbjct: 317 ALGFNKSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGER 376

Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL 145
           EFQAEV+IISRVHH+ LVSLVGY  AG QRMLVYEF+PN+TLEFHLHGK    +DW TRL
Sbjct: 377 EFQAEVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRL 436

Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR 205
           KIALGSAKGLAYLHEDCHP+IIHRDIKA+NILLD  FEAKVADFGLAK++ D  THVSTR
Sbjct: 437 KIALGSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTR 496

Query: 206 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLL 265
           +MGTFGYLAPEYASSGKLT++SDVFSFGVMLLEL+TGRRPVD T   +EDSLVDWARP+ 
Sbjct: 497 IMGTFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGE-MEDSLVDWARPIC 555

Query: 266 NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDASL 325
             A +DG++  LVDP+L N+Y  +EMA+MVACAAA VRHSARRRP+MSQIVRALEGDA+L
Sbjct: 556 LNAAQDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEGDATL 615

Query: 326 ADLNEGIRPGQSSVYGSYGSSDYDTMQYNEDLKKFRKMALNSQEYSASSEYSRPTSEYGL 385
            DL+EG + GQSS  G   SSDYD+  Y+ D+KKFRK+AL+S EY ASSEY   TSEYGL
Sbjct: 616 DDLSEGGKAGQSSFLGRGSSSDYDSSTYSADMKKFRKVALDSHEYGASSEYGN-TSEYGL 674

Query: 386 YP 387
            P
Sbjct: 675 DP 676

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  518 bits (1334), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 241/319 (75%), Positives = 285/319 (89%), Gaps = 1/319 (0%)

Query: 21  PSP-GLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAG 79
           P+P GL LG  +STFTY ELARAT+ FS+ANLLG+GGFG+V++G+L NG EVA+KQLK G
Sbjct: 157 PAPIGLVLGIHQSTFTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVG 216

Query: 80  SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTM 139
           S QGE+EFQAEV IIS++HH++LVSLVGY  AG+QR+LVYEFVPNNTLEFHLHGKGRPTM
Sbjct: 217 SAQGEKEFQAEVNIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGRPTM 276

Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
           +W  RLKIA+ S+KGL+YLHE+C+PKIIHRDIKAANIL+DFKFEAKVADFGLAKIA D N
Sbjct: 277 EWSLRLKIAVSSSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALDTN 336

Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
           THVSTRVMGTFGYLAPEYA+SGKLTEKSDV+SFGV+LLELITGRRPVD+ + + +DSLVD
Sbjct: 337 THVSTRVMGTFGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVD 396

Query: 260 WARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL 319
           WARPLL +A+E+ NF+ L D KL+NEY+  EMARMVACAAACVR++ARRRPRM Q+VR L
Sbjct: 397 WARPLLVQALEESNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVL 456

Query: 320 EGDASLADLNEGIRPGQSS 338
           EG+ S +DLN+GI PG S+
Sbjct: 457 EGNISPSDLNQGITPGHSN 475

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  476 bits (1224), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 242/412 (58%), Positives = 296/412 (71%), Gaps = 20/412 (4%)

Query: 2   SSSGGSGSNYSGSEAPLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVH 61
           S  GG G   SGS AP         +G  ++ FTYEEL   T+GFS  N+LG+GGFG V+
Sbjct: 315 SQRGGGGYTRSGS-AP-----DSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVY 368

Query: 62  RGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF 121
           +G L +GK VA+KQLK GSGQG+REF+AEVEIISRVHH+HLVSLVGY  A S+R+L+YE+
Sbjct: 369 KGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEY 428

Query: 122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK 181
           VPN TLE HLHGKGRP ++W  R++IA+GSAKGLAYLHEDCHPKIIHRDIK+ANILLD +
Sbjct: 429 VPNQTLEHHLHGKGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDE 488

Query: 182 FEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           FEA+VADFGLAK+     THVSTRVMGTFGYLAPEYA SGKLT++SDVFSFGV+LLELIT
Sbjct: 489 FEAQVADFGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELIT 548

Query: 242 GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAAC 301
           GR+PVD      E+SLV+WARPLL++AIE G+F  LVD +L   Y  NE+ RM+  AAAC
Sbjct: 549 GRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAAC 608

Query: 302 VRHSARRRPRMSQIVRALEGDASLADLNEGIRPGQSSVYGSYGSSDYDTMQYNEDLKKFR 361
           VRHS  +RPRM Q+VRAL+ +  + D++ G + GQSS         YD+ QYN D  KFR
Sbjct: 609 VRHSGPKRPRMVQVVRALDSEGDMGDISNGNKVGQSSA--------YDSGQYNNDTMKFR 660

Query: 362 KMALNSQEYSASSEYSRPTSEYGLYPSGSSSEGQNTREMEMGKTKKNSQGFS 413
           KMA    + S S  YS      G Y    S +G N    E  + +  ++ F+
Sbjct: 661 KMAFGFDDSSDSGMYS------GDYSVQDSRKGSNGASSEFTRNETENRNFN 706

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2

 Score =  464 bits (1194), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 225/367 (61%), Positives = 278/367 (75%), Gaps = 14/367 (3%)

Query: 27  LGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGERE 86
           LG  ++ F+YEELA  T GF+  N+LG+GGFG V++G L +GK VA+KQLKAGSGQG+RE
Sbjct: 352 LGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDRE 411

Query: 87  FQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK 146
           F+AEVEIISRVHH+HLVSLVGY  +   R+L+YE+V N TLE HLHGKG P ++W  R++
Sbjct: 412 FKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVR 471

Query: 147 IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRV 206
           IA+GSAKGLAYLHEDCHPKIIHRDIK+ANILLD ++EA+VADFGLA++     THVSTRV
Sbjct: 472 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRV 531

Query: 207 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN 266
           MGTFGYLAPEYASSGKLT++SDVFSFGV+LLEL+TGR+PVD T    E+SLV+WARPLL 
Sbjct: 532 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLL 591

Query: 267 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDASLA 326
           +AIE G+   L+D +L   Y  +E+ RM+  AAACVRHS  +RPRM Q+VRAL+ D    
Sbjct: 592 KAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGDSG 651

Query: 327 DLNEGIRPGQSSVYGSYGSSDYDTMQYNEDLKKFRKMALNSQEYSASSEYSRPTSEYGLY 386
           D++ GI+ GQS+         YD+ QYNED+ KFRKMA        S  YS      G Y
Sbjct: 652 DISNGIKIGQSTT--------YDSGQYNEDIMKFRKMAFGGDNSVESGLYS------GNY 697

Query: 387 PSGSSSE 393
            + SSS+
Sbjct: 698 SAKSSSD 704

Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	416
255546475	670	ATP binding protein, putative [Ricinus c	0.961	0.597	0.875	0.0
121308607	665	PERK1-like protein kinase [Nicotiana tab	0.959	0.6	0.857	0.0
356520517	672	PREDICTED: proline-rich receptor-like pr	0.954	0.590	0.850	0.0
356520519	671	PREDICTED: proline-rich receptor-like pr	0.954	0.591	0.850	0.0
351725713	443	putative receptor protein kinase PERK1 [	0.954	0.896	0.842	0.0
359484580	650	PREDICTED: proline-rich receptor-like pr	0.959	0.613	0.862	0.0
297831298	650	hypothetical protein ARALYDRAFT_479967 [	0.954	0.610	0.836	0.0
13447449	647	receptor protein kinase PERK1 [Brassica	0.954	0.613	0.829	0.0
227206330	615	AT3G24550 [Arabidopsis thaliana]	0.954	0.645	0.829	0.0
13877617	652	protein kinase-like protein [Arabidopsis	0.954	0.608	0.829	0.0

>gi|255546475|ref|XP_002514297.1| ATP binding protein, putative [Ricinus communis] gi|223546753|gb|EEF48251.1| ATP binding protein, putative [Ricinus communis]

 Score =  740 bits (1910), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/401 (87%), Positives = 376/401 (93%), Gaps = 1/401 (0%)

Query: 15  EAPLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIK 74
           E PLPPPSPGL+L FSKSTF++EELARATDGFS+ANLLGQGGFGYVHRGVLP+GKEVA+K
Sbjct: 270 ENPLPPPSPGLALSFSKSTFSFEELARATDGFSNANLLGQGGFGYVHRGVLPSGKEVAVK 329

Query: 75  QLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGK 134
           QLKAGSGQGEREFQAE+EIISRVHHKHLVSLVGY   GSQR+LVYEFVPNNTLEFHLHGK
Sbjct: 330 QLKAGSGQGEREFQAEIEIISRVHHKHLVSLVGYCITGSQRLLVYEFVPNNTLEFHLHGK 389

Query: 135 GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI 194
           GRPTMDW TRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 
Sbjct: 390 GRPTMDWPTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKF 449

Query: 195 ASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE 254
           +SD NTHVSTRVMGTFGYLAPEYA+SGKLT+KSDVFSFG+MLLELITGRRPVD+   + +
Sbjct: 450 SSDFNTHVSTRVMGTFGYLAPEYAASGKLTDKSDVFSFGIMLLELITGRRPVDANPAYAD 509

Query: 255 DSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQ 314
           DSLVDWARPLL RA+EDGNFDTL DPKL N+Y+HNEMARMVA AAACVRHSARRRPRMSQ
Sbjct: 510 DSLVDWARPLLTRALEDGNFDTLADPKLQNDYDHNEMARMVASAAACVRHSARRRPRMSQ 569

Query: 315 IVRALEGDASLADLNEGIRPGQSSVYGSYGSSDYDTMQYNEDLKKFRKMALNSQEYSASS 374
           +VRALEGD +L+DLNEGIRPG SS+Y SYGSSDYDT QYNED+KKFRKMAL SQEY ASS
Sbjct: 570 VVRALEGDVALSDLNEGIRPGHSSLY-SYGSSDYDTSQYNEDMKKFRKMALGSQEYGASS 628

Query: 375 EYSRPTSEYGLYPSGSSSEGQNTREMEMGKTKKNSQGFSGS 415
           EYS PTSEYGLYPSGSSSEG NTREMEMGK K+NSQGFSG+
Sbjct: 629 EYSGPTSEYGLYPSGSSSEGHNTREMEMGKMKRNSQGFSGN 669

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|121308607|dbj|BAF43699.1| PERK1-like protein kinase [Nicotiana tabacum]

 Score =  727 bits (1876), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 342/399 (85%), Positives = 372/399 (93%)

Query: 17  PLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQL 76
           PLPPPSPG+ LGFSKSTFTYEEL RATDGFS+ANLLGQGGFGYVHRGVLPNGKEVA+KQL
Sbjct: 260 PLPPPSPGMVLGFSKSTFTYEELVRATDGFSNANLLGQGGFGYVHRGVLPNGKEVAVKQL 319

Query: 77  KAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR 136
           KAGSGQGEREFQAEVEIISRVHHKHLVSLVGY   GSQR+LVYEFVPNNTLEFHLHGKGR
Sbjct: 320 KAGSGQGEREFQAEVEIISRVHHKHLVSLVGYCITGSQRLLVYEFVPNNTLEFHLHGKGR 379

Query: 137 PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
           P +DW  RLKIALGSAKGLAYLHEDC PKIIHRDIKAANIL+DF FEAKVADFGLAK+ S
Sbjct: 380 PPLDWPIRLKIALGSAKGLAYLHEDCQPKIIHRDIKAANILVDFNFEAKVADFGLAKLTS 439

Query: 197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDS 256
           DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS+G+MLLELITGRRPVDS+ T+++DS
Sbjct: 440 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSYGIMLLELITGRRPVDSSQTYMDDS 499

Query: 257 LVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIV 316
           LVDWARP L RA+ED  FD+L+DP+L N+YNHNE+ARMVACAAACVRHSARRRPRMSQ+V
Sbjct: 500 LVDWARPQLTRALEDEKFDSLIDPRLGNDYNHNEVARMVACAAACVRHSARRRPRMSQVV 559

Query: 317 RALEGDASLADLNEGIRPGQSSVYGSYGSSDYDTMQYNEDLKKFRKMALNSQEYSASSEY 376
           RALEGD SL+DLNEGIRPG S+VY S+GSSDYD  QYNED+KKFRKMAL SQEY ++ +Y
Sbjct: 560 RALEGDVSLSDLNEGIRPGHSTVYSSHGSSDYDASQYNEDMKKFRKMALGSQEYGSTGQY 619

Query: 377 SRPTSEYGLYPSGSSSEGQNTREMEMGKTKKNSQGFSGS 415
           S PTSEYGLYPSGSSSEGQ TREMEMG+TKK+S+GFSGS
Sbjct: 620 SNPTSEYGLYPSGSSSEGQPTREMEMGRTKKDSRGFSGS 658

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356520517|ref|XP_003528908.1| PREDICTED: proline-rich receptor-like protein kinase PERK15-like isoform 1 [Glycine max]

 Score =  712 bits (1839), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/401 (85%), Positives = 370/401 (92%), Gaps = 4/401 (0%)

Query: 18  LPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLK 77
           LPPPSPG++LGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRG+LPNGKEVA+KQLK
Sbjct: 272 LPPPSPGIALGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGILPNGKEVAVKQLK 331

Query: 78  AGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRP 137
           AGSGQGEREFQAEVEIISRVHHKHLVSLVGY   GSQR+LVYEFVPNNTLEFHLHG+GRP
Sbjct: 332 AGSGQGEREFQAEVEIISRVHHKHLVSLVGYCITGSQRLLVYEFVPNNTLEFHLHGRGRP 391

Query: 138 TMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD 197
           TMDW TRL+IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK +SD
Sbjct: 392 TMDWPTRLRIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKFSSD 451

Query: 198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL 257
           VNTHVSTRVMGTFGYLAPEYASSGKLT+KSDVFS+GVMLLELITGRRPVD   TF+EDSL
Sbjct: 452 VNTHVSTRVMGTFGYLAPEYASSGKLTDKSDVFSYGVMLLELITGRRPVDKNQTFMEDSL 511

Query: 258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
           VDWARPLL RA+E+ +FD+++DP+L N+Y+ NEMARMVA AAAC+RHSA+RRPRMSQ+VR
Sbjct: 512 VDWARPLLTRALEEDDFDSIIDPRLQNDYDPNEMARMVASAAACIRHSAKRRPRMSQVVR 571

Query: 318 ALEGDASLADLNEGIRPGQSSVYGSYGSSDYDTMQYNEDLKKFRKMALNSQEYSASSEYS 377
           ALEGD SLADLNEGIRPG S++Y S+ SSDYDT QY ED+KKFRKMAL +QEY ASSEYS
Sbjct: 572 ALEGDVSLADLNEGIRPGHSTMYSSHESSDYDTAQYKEDMKKFRKMALGTQEYGASSEYS 631

Query: 378 RPTSEYGLYPSGSSSEGQN---TREMEMGKTKKNSQGFSGS 415
             TSEYGL PSGSSSE Q+   TREMEM K  KNSQGFSGS
Sbjct: 632 AATSEYGLNPSGSSSEAQSRQTTREMEMRKM-KNSQGFSGS 671

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356520519|ref|XP_003528909.1| PREDICTED: proline-rich receptor-like protein kinase PERK15-like isoform 2 [Glycine max]

 Score =  712 bits (1838), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/401 (85%), Positives = 370/401 (92%), Gaps = 4/401 (0%)

Query: 18  LPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLK 77
           LPPPSPG++LGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRG+LPNGKEVA+KQLK
Sbjct: 271 LPPPSPGIALGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGILPNGKEVAVKQLK 330

Query: 78  AGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRP 137
           AGSGQGEREFQAEVEIISRVHHKHLVSLVGY   GSQR+LVYEFVPNNTLEFHLHG+GRP
Sbjct: 331 AGSGQGEREFQAEVEIISRVHHKHLVSLVGYCITGSQRLLVYEFVPNNTLEFHLHGRGRP 390

Query: 138 TMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD 197
           TMDW TRL+IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK +SD
Sbjct: 391 TMDWPTRLRIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKFSSD 450

Query: 198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL 257
           VNTHVSTRVMGTFGYLAPEYASSGKLT+KSDVFS+GVMLLELITGRRPVD   TF+EDSL
Sbjct: 451 VNTHVSTRVMGTFGYLAPEYASSGKLTDKSDVFSYGVMLLELITGRRPVDKNQTFMEDSL 510

Query: 258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
           VDWARPLL RA+E+ +FD+++DP+L N+Y+ NEMARMVA AAAC+RHSA+RRPRMSQ+VR
Sbjct: 511 VDWARPLLTRALEEDDFDSIIDPRLQNDYDPNEMARMVASAAACIRHSAKRRPRMSQVVR 570

Query: 318 ALEGDASLADLNEGIRPGQSSVYGSYGSSDYDTMQYNEDLKKFRKMALNSQEYSASSEYS 377
           ALEGD SLADLNEGIRPG S++Y S+ SSDYDT QY ED+KKFRKMAL +QEY ASSEYS
Sbjct: 571 ALEGDVSLADLNEGIRPGHSTMYSSHESSDYDTAQYKEDMKKFRKMALGTQEYGASSEYS 630

Query: 378 RPTSEYGLYPSGSSSEGQN---TREMEMGKTKKNSQGFSGS 415
             TSEYGL PSGSSSE Q+   TREMEM K  KNSQGFSGS
Sbjct: 631 AATSEYGLNPSGSSSEAQSRQTTREMEMRKM-KNSQGFSGS 670

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351725713|ref|NP_001237102.1| putative receptor protein kinase PERK1 [Glycine max] gi|77403742|dbj|BAE46451.1| putative receptor protein kinase PERK1 [Glycine max] gi|223452349|gb|ACM89502.1| PERK1-like protein kinase [Glycine max]

 Score =  709 bits (1830), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/401 (84%), Positives = 370/401 (92%), Gaps = 4/401 (0%)

Query: 18  LPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLK 77
           LPPPSPG+SLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRG+LPNGKEVA+KQLK
Sbjct: 43  LPPPSPGISLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGILPNGKEVAVKQLK 102

Query: 78  AGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRP 137
           AGSGQGEREFQAEVEIISRVHHKHLVSLVGY   GSQR+LVYEFVPNNTLEFHLHGKGRP
Sbjct: 103 AGSGQGEREFQAEVEIISRVHHKHLVSLVGYCITGSQRLLVYEFVPNNTLEFHLHGKGRP 162

Query: 138 TMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD 197
           TMDW TRL+IALGSAKGLAYLHEDCHPKIIHRDIK+ANILLDFKFEAKVADFGLAK +SD
Sbjct: 163 TMDWPTRLRIALGSAKGLAYLHEDCHPKIIHRDIKSANILLDFKFEAKVADFGLAKFSSD 222

Query: 198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL 257
           VNTHVSTRVMGTFGYLAPEYASSGKLT+KSDVFS+G+MLLELITGRRPVD   T++EDSL
Sbjct: 223 VNTHVSTRVMGTFGYLAPEYASSGKLTDKSDVFSYGIMLLELITGRRPVDKNQTYMEDSL 282

Query: 258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
           VDWARPLL RA+E+ +FD+++DP+L N+Y+ +EMARMVA AAAC+RHSA+RRPRMSQ+VR
Sbjct: 283 VDWARPLLTRALEEDDFDSIIDPRLQNDYDPHEMARMVASAAACIRHSAKRRPRMSQVVR 342

Query: 318 ALEGDASLADLNEGIRPGQSSVYGSYGSSDYDTMQYNEDLKKFRKMALNSQEYSASSEYS 377
           ALEGD SLADLNEGIRPG S++Y S+ SSDYDT QY ED+KKFRKMAL +QEY ASSEYS
Sbjct: 343 ALEGDVSLADLNEGIRPGHSTMYSSHESSDYDTAQYKEDMKKFRKMALGTQEYGASSEYS 402

Query: 378 RPTSEYGLYPSGSSSEGQN---TREMEMGKTKKNSQGFSGS 415
             TSEYGL PSGSSSE Q+   TREMEM K  KN+QGFSGS
Sbjct: 403 AATSEYGLNPSGSSSEAQSRQTTREMEMRKM-KNNQGFSGS 442

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484580|ref|XP_002284430.2| PREDICTED: proline-rich receptor-like protein kinase PERK1-like isoform 2 [Vitis vinifera] gi|297738823|emb|CBI28068.3| unnamed protein product [Vitis vinifera]

 Score =  707 bits (1826), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 346/401 (86%), Positives = 374/401 (93%), Gaps = 2/401 (0%)

Query: 15  EAPLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIK 74
           + PLPPPSP ++LGFSKSTFTYEEL  ATDGFS+ANLLGQGGFGYVHRGVLPNGKEVA+K
Sbjct: 247 DNPLPPPSPSIALGFSKSTFTYEELVMATDGFSNANLLGQGGFGYVHRGVLPNGKEVAVK 306

Query: 75  QLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGK 134
           QLKAGSGQGEREFQAEVEIISRVHHKHLV+L GY   GS R+LVYEFVPNNTLEFHLHGK
Sbjct: 307 QLKAGSGQGEREFQAEVEIISRVHHKHLVTLAGYCITGSHRLLVYEFVPNNTLEFHLHGK 366

Query: 135 GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI 194
           GRPTMDW TRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 
Sbjct: 367 GRPTMDWSTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKF 426

Query: 195 ASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE 254
           +SD NTHVSTRVMGTFGYLAPEYA+SGKL++KSDVFSFGVMLLEL+TGRRPVD+  TF+E
Sbjct: 427 SSDANTHVSTRVMGTFGYLAPEYAASGKLSDKSDVFSFGVMLLELLTGRRPVDANQTFME 486

Query: 255 DSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQ 314
           DSLVDWARPLL RA+EDGNFDTLVDP+L  +YNH+EMARMVACAAACVRHSARRRPRMSQ
Sbjct: 487 DSLVDWARPLLTRALEDGNFDTLVDPRLQKDYNHHEMARMVACAAACVRHSARRRPRMSQ 546

Query: 315 IVRALEGDASLADLNEGIRPGQSSVYGSYGSSDYDTMQYNEDLKKFRKMALNSQEYSASS 374
           IVRALEGDASL+DLNEG+RPGQSS+Y S+GSSDYDT QYNED+ KFRKMAL S++Y  SS
Sbjct: 547 IVRALEGDASLSDLNEGMRPGQSSIYSSHGSSDYDTNQYNEDMIKFRKMALASRDY-GSS 605

Query: 375 EYSRPTSEYGLYPSGSSSEGQ-NTREMEMGKTKKNSQGFSG 414
           EYS PTSEYGLYPSGSSSEGQ  TREMEMGK KK+S+G+SG
Sbjct: 606 EYSGPTSEYGLYPSGSSSEGQRTTREMEMGKMKKDSRGYSG 646

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297831298|ref|XP_002883531.1| hypothetical protein ARALYDRAFT_479967 [Arabidopsis lyrata subsp. lyrata] gi|297329371|gb|EFH59790.1| hypothetical protein ARALYDRAFT_479967 [Arabidopsis lyrata subsp. lyrata]

 Score =  707 bits (1824), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 333/398 (83%), Positives = 369/398 (92%), Gaps = 1/398 (0%)

Query: 18  LPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLK 77
           LPPPSPGL LGFSKSTFTYEEL+RAT+GFS+ANLLGQGGFGYVH+G+LP+GKEVA+KQLK
Sbjct: 250 LPPPSPGLVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLK 309

Query: 78  AGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRP 137
           AGSGQGEREFQAEVEIISRVHH+HLVSL+GY  AG QR+LVYEFVPNN LEFHLHGKGRP
Sbjct: 310 AGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRP 369

Query: 138 TMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD 197
           TM+W TRLKIALGSAKGL+YLHEDC+PKIIHRDIKAANIL+DFKFEAKVADFGLAKIASD
Sbjct: 370 TMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKAANILVDFKFEAKVADFGLAKIASD 429

Query: 198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL 257
            NTHVSTRVMGTFGYLAPEYA+SGKLTEKSDVFSFGV+LLELITGRRPVD+ + +V+DSL
Sbjct: 430 TNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSL 489

Query: 258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
           VDWARPLLNRA E+G+F+ L DPK+ NEY+  EMARMVACAAACVRHSARRRPRMSQIVR
Sbjct: 490 VDWARPLLNRASEEGDFEGLADPKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVR 549

Query: 318 ALEGDASLADLNEGIRPGQSSVYGSY-GSSDYDTMQYNEDLKKFRKMALNSQEYSASSEY 376
           ALEG+ SL+DLNEG+RPG S+VY SY GS+DYDT QYN+D+KKFRKMAL +QEY  + EY
Sbjct: 550 ALEGNVSLSDLNEGMRPGHSNVYSSYGGSTDYDTSQYNDDMKKFRKMALGTQEYGTTGEY 609

Query: 377 SRPTSEYGLYPSGSSSEGQNTREMEMGKTKKNSQGFSG 414
           S PTS+YGLYPSGSSSEGQ TREMEMGK KK  QG+SG
Sbjct: 610 SNPTSDYGLYPSGSSSEGQATREMEMGKIKKTGQGYSG 647

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|13447449|gb|AAK21965.1| receptor protein kinase PERK1 [Brassica napus]

 Score =  701 bits (1808), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/398 (82%), Positives = 369/398 (92%), Gaps = 1/398 (0%)

Query: 18  LPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLK 77
           LPPPSPGL LGFSKSTFTYEELARAT+GFS+ANLLGQGGFGYVH+GVLP+GKEVA+KQLK
Sbjct: 247 LPPPSPGLVLGFSKSTFTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLK 306

Query: 78  AGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRP 137
            GSGQGEREFQAEVEIISRVHH+HLVSLVGY  AG++R+LVYEFVPNN LE HLHG+GRP
Sbjct: 307 VGSGQGEREFQAEVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHGEGRP 366

Query: 138 TMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD 197
           TM+W TRLKIALGSAKGL+YLHEDC+PKIIHRDIKA+NIL+DFKFEAKVADFGLAKIASD
Sbjct: 367 TMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASD 426

Query: 198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL 257
            NTHVSTRVMGTFGYLAPEYA+SGKLTEKSDVFSFGV+LLELITGRRPVD+ + +V+DSL
Sbjct: 427 TNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSL 486

Query: 258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
           VDWARPLLNRA E G+F+ L D K++N Y+  EMARMVACAAACVRHSARRRPRMSQIVR
Sbjct: 487 VDWARPLLNRASEQGDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQIVR 546

Query: 318 ALEGDASLADLNEGIRPGQSSVYGSY-GSSDYDTMQYNEDLKKFRKMALNSQEYSASSEY 376
           ALEG+ SL+DLNEG+RPGQS+VY SY GS+DYD+ QYNED+KKFRKMAL +QEY+A+ EY
Sbjct: 547 ALEGNVSLSDLNEGMRPGQSNVYSSYGGSTDYDSSQYNEDMKKFRKMALGTQEYNATGEY 606

Query: 377 SRPTSEYGLYPSGSSSEGQNTREMEMGKTKKNSQGFSG 414
           S PTS+YGLYPSGSSSEGQ TREMEMGK K+  QG+SG
Sbjct: 607 SNPTSDYGLYPSGSSSEGQTTREMEMGKIKRTGQGYSG 644

Source: Brassica napus

Species: Brassica napus

Genus: Brassica

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|227206330|dbj|BAH57220.1| AT3G24550 [Arabidopsis thaliana]

 Score =  700 bits (1807), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/398 (82%), Positives = 367/398 (92%), Gaps = 1/398 (0%)

Query: 18  LPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLK 77
           LPPPSPGL LGFSKSTFTYEEL+RAT+GFS+ANLLGQGGFGYVH+G+LP+GKEVA+KQLK
Sbjct: 215 LPPPSPGLVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLK 274

Query: 78  AGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRP 137
           AGSGQGEREFQAEVEIISRVHH+HLVSL+GY  AG QR+LVYEFVPNN LEFHLHGKGRP
Sbjct: 275 AGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRP 334

Query: 138 TMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD 197
           TM+W TRLKIALGSAKGL+YLHEDC+PKIIHRDIKA+NIL+DFKFEAKVADFGLAKIASD
Sbjct: 335 TMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASD 394

Query: 198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL 257
            NTHVSTRVMGTFGYLAPEYA+SGKLTEKSDVFSFGV+LLELITGRRPVD+ + +V+DSL
Sbjct: 395 TNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSL 454

Query: 258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
           VDWARPLLNRA E+G+F+ L D K+ NEY+  EMARMVACAAACVRHSARRRPRMSQIVR
Sbjct: 455 VDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVR 514

Query: 318 ALEGDASLADLNEGIRPGQSSVYGSY-GSSDYDTMQYNEDLKKFRKMALNSQEYSASSEY 376
           ALEG+ SL+DLNEG+RPG S+VY SY GS+DYDT QYN+D+ KFRKMAL +QEY  + EY
Sbjct: 515 ALEGNVSLSDLNEGMRPGHSNVYSSYGGSTDYDTSQYNDDMIKFRKMALGTQEYGTTGEY 574

Query: 377 SRPTSEYGLYPSGSSSEGQNTREMEMGKTKKNSQGFSG 414
           S PTS+YGLYPSGSSSEGQ TREMEMGK KK  QG+SG
Sbjct: 575 SNPTSDYGLYPSGSSSEGQATREMEMGKIKKTGQGYSG 612

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|13877617|gb|AAK43886.1|AF370509_1 protein kinase-like protein [Arabidopsis thaliana] gi|30725492|gb|AAP37768.1| At3g24600 [Arabidopsis thaliana]

 Score =  700 bits (1807), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/398 (82%), Positives = 367/398 (92%), Gaps = 1/398 (0%)

Query: 18  LPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLK 77
           LPPPSPGL LGFSKSTFTYEEL+RAT+GFS+ANLLGQGGFGYVH+G+LP+GKEVA+KQLK
Sbjct: 252 LPPPSPGLVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLK 311

Query: 78  AGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRP 137
           AGSGQGEREFQAEVEIISRVHH+HLVSL+GY  AG QR+LVYEFVPNN LEFHLHGKGRP
Sbjct: 312 AGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRP 371

Query: 138 TMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD 197
           TM+W TRLKIALGSAKGL+YLHEDC+PKIIHRDIKA+NIL+DFKFEAKVADFGLAKIASD
Sbjct: 372 TMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASD 431

Query: 198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL 257
            NTHVSTRVMGTFGYLAPEYA+SGKLTEKSDVFSFGV+LLELITGRRPVD+ + +V+DSL
Sbjct: 432 TNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSL 491

Query: 258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
           VDWARPLLNRA E+G+F+ L D K+ NEY+  EMARMVACAAACVRHSARRRPRMSQIVR
Sbjct: 492 VDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVR 551

Query: 318 ALEGDASLADLNEGIRPGQSSVYGSY-GSSDYDTMQYNEDLKKFRKMALNSQEYSASSEY 376
           ALEG+ SL+DLNEG+RPG S+VY SY GS+DYDT QYN+D+ KFRKMAL +QEY  + EY
Sbjct: 552 ALEGNVSLSDLNEGMRPGHSNVYSSYGGSTDYDTSQYNDDMIKFRKMALGTQEYGTTGEY 611

Query: 377 SRPTSEYGLYPSGSSSEGQNTREMEMGKTKKNSQGFSG 414
           S PTS+YGLYPSGSSSEGQ TREMEMGK KK  QG+SG
Sbjct: 612 SNPTSDYGLYPSGSSSEGQATREMEMGKIKKTGQGYSG 649

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	416
UNIPROTKB|Q9ARH1	647	Q9ARH1 "Receptor protein kinas	0.923	0.593	0.766	6.8e-159
TAIR|locus:2091722	652	PERK1 "proline-rich extensin-l	0.923	0.588	0.766	6.8e-159
TAIR|locus:2139474	670	PERK5 "proline-rich extensin-l	0.894	0.555	0.682	6e-135
TAIR|locus:2093999	700	PERK6 "proline-rich extensin-l	0.867	0.515	0.705	5.4e-134
TAIR|locus:2010282	699	PERK7 "proline-rich extensin-l	0.889	0.529	0.686	3.9e-131
TAIR|locus:2046268	633	PERK4 "proline-rich extensin-l	0.822	0.540	0.700	1.2e-127
TAIR|locus:2018209	509	PERK15 "proline-rich extensin-	0.908	0.742	0.639	2.6e-127
TAIR|locus:2026846	710	PERK13 "proline-rich extensin-	0.879	0.515	0.578	5.9e-112
TAIR|locus:2028911	720	PERK12 "proline-rich extensin-	0.831	0.480	0.588	3e-108
TAIR|locus:2159873	681	PERK8 "proline-rich extensin-l	0.831	0.508	0.568	1.2e-106

UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)]

 Score = 1548 (550.0 bits), Expect = 6.8e-159, P = 6.8e-159
 Identities = 295/385 (76%), Positives = 332/385 (86%)

Query:    31 KSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAE 90
             KSTFTYEELARAT+GFS+ANLLGQGGFGYVH+GVLP+GKEVA+KQLK GSGQGEREFQAE
Sbjct:   260 KSTFTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGEREFQAE 319

Query:    91 VEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
             VEIISRVHH+HLVSLVGY  AG++R+LVYEFVPNN LE HLHG+GRPTM+W TRLKIALG
Sbjct:   320 VEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHGEGRPTMEWSTRLKIALG 379

Query:   151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
             SAKGL+YLHEDC+PKIIHRDIKA+NIL+DFKFEAKVADFGLAKIASD NTHVSTRVMGTF
Sbjct:   380 SAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTF 439

Query:   211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE 270
             GYLAPEYA+SGKLTEKSDVFSFGV+LLELITGRRPVD+ + +V+DSLVDWARPLLNRA E
Sbjct:   440 GYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASE 499

Query:   271 DGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRMSQIVRALEGDASLADLNE 330
              G+F+ L D K++N Y+  E             HSARRRPRMSQIVRALEG+ SL+DLNE
Sbjct:   500 QGDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDLNE 559

Query:   331 GIRPGQXXXXXXXXXXXXX-TMQYNEDLKKFRKMALNSQEYSASSEYSRPTSEYGLYPSG 389
             G+RPGQ              + QYNED+KKFRKMAL +QEY+A+ EYS PTS+YGLYPSG
Sbjct:   560 GMRPGQSNVYSSYGGSTDYDSSQYNEDMKKFRKMALGTQEYNATGEYSNPTSDYGLYPSG 619

Query:   390 SSSEGQNTREMEMGKTKKNSQGFSG 414
             SSSEGQ TREMEMGK K+  QG+SG
Sbjct:   620 SSSEGQTTREMEMGKIKRTGQGYSG 644

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005887 "integral to plasma membrane" evidence=IDA

TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1548 (550.0 bits), Expect = 6.8e-159, P = 6.8e-159
 Identities = 295/385 (76%), Positives = 330/385 (85%)

Query:    31 KSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAE 90
             KSTFTYEEL+RAT+GFS+ANLLGQGGFGYVH+G+LP+GKEVA+KQLKAGSGQGEREFQAE
Sbjct:   265 KSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAE 324

Query:    91 VEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
             VEIISRVHH+HLVSL+GY  AG QR+LVYEFVPNN LEFHLHGKGRPTM+W TRLKIALG
Sbjct:   325 VEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALG 384

Query:   151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
             SAKGL+YLHEDC+PKIIHRDIKA+NIL+DFKFEAKVADFGLAKIASD NTHVSTRVMGTF
Sbjct:   385 SAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTF 444

Query:   211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE 270
             GYLAPEYA+SGKLTEKSDVFSFGV+LLELITGRRPVD+ + +V+DSLVDWARPLLNRA E
Sbjct:   445 GYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASE 504

Query:   271 DGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRMSQIVRALEGDASLADLNE 330
             +G+F+ L D K+ NEY+  E             HSARRRPRMSQIVRALEG+ SL+DLNE
Sbjct:   505 EGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDLNE 564

Query:   331 GIRPGQXXXXXXXXXXXXX-TMQYNEDLKKFRKMALNSQEYSASSEYSRPTSEYGLYPSG 389
             G+RPG               T QYN+D+ KFRKMAL +QEY  + EYS PTS+YGLYPSG
Sbjct:   565 GMRPGHSNVYSSYGGSTDYDTSQYNDDMIKFRKMALGTQEYGTTGEYSNPTSDYGLYPSG 624

Query:   390 SSSEGQNTREMEMGKTKKNSQGFSG 414
             SSSEGQ TREMEMGK KK  QG+SG
Sbjct:   625 SSSEGQATREMEMGKIKKTGQGYSG 649

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;ISS;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

GO:0052541 "plant-type cell wall cellulose metabolic process" evidence=RCA

GO:0052546 "cell wall pectin metabolic process" evidence=RCA

TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1322 (470.4 bits), Expect = 6.0e-135, P = 6.0e-135
 Identities = 260/381 (68%), Positives = 300/381 (78%)

Query:    31 KSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAE 90
             +STFTY+EL+ AT+GF+ +NLLGQGGFGYVH+GVLP+GKEVA+K LK GSGQGEREFQAE
Sbjct:   297 QSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLKLGSGQGEREFQAE 356

Query:    91 VEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
             V+IISRVHH+HLVSLVGY  +G QR+LVYEF+PNNTLEFHLHGKGRP +DW TR+KIALG
Sbjct:   357 VDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHGKGRPVLDWPTRVKIALG 416

Query:   151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
             SA+GLAYLHEDCHP+IIHRDIKAANILLDF FE KVADFGLAK++ D  THVSTRVMGTF
Sbjct:   417 SARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLAKLSQDNYTHVSTRVMGTF 476

Query:   211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE 270
             GYLAPEYASSGKL++KSDVFSFGVMLLELITGR P+D T   +EDSLVDWARPL  +A +
Sbjct:   477 GYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLDLTGE-MEDSLVDWARPLCLKAAQ 535

Query:   271 DGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRMSQIVRALEGDASLADLNE 330
             DG+++ L DP+L   Y+H E             HSARRRP+MSQIVRALEGD S+ DL+E
Sbjct:   536 DGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKMSQIVRALEGDMSMDDLSE 595

Query:   331 GIRPGQXXXXX-XXXXXXXXTMQYNEDLKKFRKMALNSQEYSASSEYSRPTSEYGLYPSG 389
             G RPGQ                 Y  D+KKF+K+AL ++EY  SSEY   TSEYGL PS 
Sbjct:   596 GTRPGQSTYLSPGSVSSEYDASSYTADMKKFKKLALENKEYQ-SSEYGG-TSEYGLNPSA 653

Query:   390 SSSEGQNTREMEMGKTKKNSQ 410
             SSSE     EM  G  K+N Q
Sbjct:   654 SSSE-----EMNRGSMKRNPQ 669

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0048610 "cellular process involved in reproduction" evidence=RCA

GO:0048868 "pollen tube development" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1313 (467.3 bits), Expect = 5.4e-134, P = 5.4e-134
 Identities = 256/363 (70%), Positives = 292/363 (80%)

Query:    31 KSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAE 90
             KSTFTY+ELA AT GFS + LLGQGGFGYVH+G+LPNGKE+A+K LKAGSGQGEREFQAE
Sbjct:   322 KSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAE 381

Query:    91 VEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
             V+IISRVHH+ LVSLVGY  AG QRMLVYEF+PN+TLEFHLHGK    +DW TRLKIALG
Sbjct:   382 VDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLKIALG 441

Query:   151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
             SAKGLAYLHEDCHP+IIHRDIKA+NILLD  FEAKVADFGLAK++ D  THVSTR+MGTF
Sbjct:   442 SAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIMGTF 501

Query:   211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE 270
             GYLAPEYASSGKLT++SDVFSFGVMLLEL+TGRRPVD T   +EDSLVDWARP+   A +
Sbjct:   502 GYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGE-MEDSLVDWARPICLNAAQ 560

Query:   271 DGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRMSQIVRALEGDASLADLNE 330
             DG++  LVDP+L N+Y  +E             HSARRRP+MSQIVRALEGDA+L DL+E
Sbjct:   561 DGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEGDATLDDLSE 620

Query:   331 GIRPGQXXXXXXXXXXXXXTMQYNEDLKKFRKMALNSQEYSASSEYSRPTSEYGLYPSGS 390
             G + GQ             +  Y+ D+KKFRK+AL+S EY ASSEY   TSEYGL PS S
Sbjct:   621 GGKAGQSSFLGRGSSSDYDSSTYSADMKKFRKVALDSHEYGASSEYGN-TSEYGLDPSSS 679

Query:   391 SSE 393
             SSE
Sbjct:   680 SSE 682

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 1286 (457.8 bits), Expect = 3.9e-131, P = 3.9e-131
 Identities = 261/380 (68%), Positives = 292/380 (76%)

Query:    32 STFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
             STFTYEELA AT GFS   LLGQGGFGYVH+G+LPNGKE+A+K LKAGSGQGEREFQAEV
Sbjct:   322 STFTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEV 381

Query:    92 EIISRVHHKHLVSLVGYYT-AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
             EIISRVHH+HLVSLVGY + AG QR+LVYEF+PN+TLEFHLHGK    MDW TRLKIALG
Sbjct:   382 EIISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHGKSGTVMDWPTRLKIALG 441

Query:   151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
             SAKGLAYLHEDCHPKIIHRDIKA+NILLD  FEAKVADFGLAK++ D NTHVSTRVMGTF
Sbjct:   442 SAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDNNTHVSTRVMGTF 501

Query:   211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE 270
             GYLAPEYASSGKLTEKSDVFSFGVMLLELITGR PVD +   +EDSLVDWARPL  R  +
Sbjct:   502 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGD-MEDSLVDWARPLCMRVAQ 560

Query:   271 DGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRMSQIVRALEGDASLADLNE 330
             DG +  LVDP L ++Y   E             HS RRRP+MSQIVR LEGDASL DL++
Sbjct:   561 DGEYGELVDPFLEHQYEPYEMARMVACAAAAVRHSGRRRPKMSQIVRTLEGDASLDDLDD 620

Query:   331 GIRPGQXXXXXXXXXXXXXTMQYNEDLKKFRKMALNSQEYSASSEYSRPTSEYGLYPSGS 390
             G++P Q                Y  +++KFRK+ L S++Y ASSEY   TSEYGL PS S
Sbjct:   621 GVKPKQSSSGGEGSSDYEMGT-YGAEMRKFRKVTLESRDYGASSEYGA-TSEYGLDPSSS 678

Query:   391 SSEGQNTREMEMG-KTKKNS 409
             SSE     EM +G  T K +
Sbjct:   679 SSE-----EMHIGGSTSKTT 693

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2046268 PERK4 "proline-rich extensin-like receptor kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1253 (446.1 bits), Expect = 1.2e-127, P = 1.2e-127
 Identities = 241/344 (70%), Positives = 280/344 (81%)

Query:    31 KSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAE 90
             KSTFTY+ELA AT GF+DANLLGQGGFGYVH+GVLP+GKEVA+K LKAGSGQGEREFQAE
Sbjct:   269 KSTFTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGEREFQAE 328

Query:    91 VEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
             V+IISRVHH++LVSLVGY  A  QRMLVYEFVPN TLE+HLHGK  P M++ TRL+IALG
Sbjct:   329 VDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTRLRIALG 388

Query:   151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
             +AKGLAYLHEDCHP+IIHRDIK+ANILLDF F+A VADFGLAK+ SD NTHVSTRVMGTF
Sbjct:   389 AAKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVSTRVMGTF 448

Query:   211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE 270
             GYLAPEYASSGKLTEKSDVFS+GVMLLELITG+RPVD++ T ++D+LVDWARPL+ RA+E
Sbjct:   449 GYLAPEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSIT-MDDTLVDWARPLMARALE 507

Query:   271 DGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRMSQIVRALEGDASLADLNE 330
             DGNF+ L D +L   YN  E             HS R+RP+MSQIVRALEG+ SL  LNE
Sbjct:   508 DGNFNELADARLEGNYNPQEMARMVTCAAASIRHSGRKRPKMSQIVRALEGEVSLDALNE 567

Query:   331 GIRPGQXXXXXXXXXXXXXTM-QYNEDLKKFRKMALNSQEYSAS 373
             G++PG              +   YN D+KKFR++AL+SQE+  S
Sbjct:   568 GVKPGHSNVYGSLGASSDYSQTSYNADMKKFRQIALSSQEFPVS 611

GO:0004672 "protein kinase activity" evidence=IEA;ISS;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=IMP

GO:0009845 "seed germination" evidence=IMP

GO:0019722 "calcium-mediated signaling" evidence=IMP

GO:0048364 "root development" evidence=IMP

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2018209 PERK15 "proline-rich extensin-like receptor kinase 15" [Arabidopsis thaliana (taxid:3702)]

 Score = 1250 (445.1 bits), Expect = 2.6e-127, P = 2.6e-127
 Identities = 245/383 (63%), Positives = 296/383 (77%)

Query:    31 KSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAE 90
             ++ FTYE+L++AT  FS+ NLLGQGGFGYVHRGVL +G  VAIKQLK+GSGQGEREFQAE
Sbjct:   128 QNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAE 187

Query:    91 VEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
             ++ ISRVHH+HLVSL+GY   G+QR+LVYEFVPN TLEFHLH K RP M+W  R+KIALG
Sbjct:   188 IQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALG 247

Query:   151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
             +AKGLAYLHEDC+PK IHRD+KAANIL+D  +EAK+ADFGLA+ + D +THVSTR+MGTF
Sbjct:   248 AAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTF 307

Query:   211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED-SLVDWARPLLNRAI 269
             GYLAPEYASSGKLTEKSDVFS GV+LLELITGRRPVD +  F +D S+VDWA+PL+ +A+
Sbjct:   308 GYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQAL 367

Query:   270 EDGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRMSQIVRALEGDASLADLN 329
              DGNFD LVDP+L N+++ NE             HSA+RRP+MSQIVRA EG+ S+ DL 
Sbjct:   368 NDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNISIDDLT 427

Query:   330 EGIRPGQXXXXXXXXXXXXXTMQYNEDLKKFRKMALNSQEYSASSEYSRPTSEYGLYPSG 389
             EG  PGQ             + QY EDLKKF+KMA  S+ +  SSE S  TS+ G  PSG
Sbjct:   428 EGAAPGQSTIYSLDGSSDYSSTQYKEDLKKFKKMAFESKTFG-SSECSGLTSDNGQNPSG 486

Query:   390 SSS--EGQNT-REMEMGKTKKNS 409
             SSS  EGQ T +E+E  K  K++
Sbjct:   487 SSSITEGQRTTQEIEPEKNTKDT 509

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1105 (394.0 bits), Expect = 5.9e-112, P = 5.9e-112
 Identities = 220/380 (57%), Positives = 268/380 (70%)

Query:    34 FTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEI 93
             FTYEEL   T+GFS  N+LG+GGFG V++G L +GK VA+KQLK GSGQG+REF+AEVEI
Sbjct:   341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400

Query:    94 ISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAK 153
             ISRVHH+HLVSLVGY  A S+R+L+YE+VPN TLE HLHGKGRP ++W  R++IA+GSAK
Sbjct:   401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAK 460

Query:   154 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL 213
             GLAYLHEDCHPKIIHRDIK+ANILLD +FEA+VADFGLAK+     THVSTRVMGTFGYL
Sbjct:   461 GLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGYL 520

Query:   214 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN 273
             APEYA SGKLT++SDVFSFGV+LLELITGR+PVD      E+SLV+WARPLL++AIE G+
Sbjct:   521 APEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGD 580

Query:   274 FDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRMSQIVRALEGDASLADLNEGIR 333
             F  LVD +L   Y  NE             HS  +RPRM Q+VRAL+ +  + D++ G +
Sbjct:   581 FSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISNGNK 640

Query:   334 PGQXXXXXXXXXXXXXTMQYNEDLKKFRKMALNSQEYSASSEYSRPTSEYGLYPSGSSSE 393
              GQ               QYN D  KFRKMA    + S S  YS      G Y    S +
Sbjct:   641 VGQSSAYDSG--------QYNNDTMKFRKMAFGFDDSSDSGMYS------GDYSVQDSRK 686

Query:   394 GQNTREMEMGKTKKNSQGFS 413
             G N    E  + +  ++ F+
Sbjct:   687 GSNGASSEFTRNETENRNFN 706

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=ISS

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 1070 (381.7 bits), Expect = 3.0e-108, P = 3.0e-108
 Identities = 212/360 (58%), Positives = 259/360 (71%)

Query:    34 FTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEI 93
             F+YEELA  T GF+  N+LG+GGFG V++G L +GK VA+KQLKAGSGQG+REF+AEVEI
Sbjct:   359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418

Query:    94 ISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAK 153
             ISRVHH+HLVSLVGY  +   R+L+YE+V N TLE HLHGKG P ++W  R++IA+GSAK
Sbjct:   419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAK 478

Query:   154 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL 213
             GLAYLHEDCHPKIIHRDIK+ANILLD ++EA+VADFGLA++     THVSTRVMGTFGYL
Sbjct:   479 GLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGYL 538

Query:   214 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN 273
             APEYASSGKLT++SDVFSFGV+LLEL+TGR+PVD T    E+SLV+WARPLL +AIE G+
Sbjct:   539 APEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETGD 598

Query:   274 FDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRMSQIVRALEGDASLADLNEGIR 333
                L+D +L   Y  +E             HS  +RPRM Q+VRAL+ D    D++ GI+
Sbjct:   599 LSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGDSGDISNGIK 658

Query:   334 PGQXXXXXXXXXXXXXTMQYNEDLKKFRKMALNSQEYSASSEYSRPTSEYGLYPSGSSSE 393
              GQ               QYNED+ KFRKMA        S  YS      G Y + SSS+
Sbjct:   659 IGQSTTYDSG--------QYNEDIMKFRKMAFGGDNSVESGLYS------GNYSAKSSSD 704

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0032502 "developmental process" evidence=IMP

GO:0048610 "cellular process involved in reproduction" evidence=RCA

GO:0048868 "pollen tube development" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1055 (376.4 bits), Expect = 1.2e-106, P = 1.2e-106
 Identities = 203/357 (56%), Positives = 267/357 (74%)

Query:    31 KSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAE 90
             +S F+Y+EL++ T GFS+ NLLG+GGFG V++GVL +G+EVA+KQLK G  QGEREF+AE
Sbjct:   324 RSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAE 383

Query:    91 VEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
             VEIISRVHH+HLV+LVGY  +   R+LVY++VPNNTL +HLH  GRP M W TR+++A G
Sbjct:   384 VEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAG 443

Query:   151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS--DVNTHVSTRVMG 208
             +A+G+AYLHEDCHP+IIHRDIK++NILLD  FEA VADFGLAKIA   D+NTHVSTRVMG
Sbjct:   444 AARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMG 503

Query:   209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRA 268
             TFGY+APEYA+SGKL+EK+DV+S+GV+LLELITGR+PVD++    ++SLV+WARPLL +A
Sbjct:   504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQA 563

Query:   269 IEDGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRMSQIVRALEGDASLADL 328
             IE+  FD LVDP+L   +   E             HSA +RP+MSQ+VRAL+      D+
Sbjct:   564 IENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATDI 623

Query:   329 NEGIRPGQXXXXXXXXXXXXXTMQYNEDLKKFRKMALNSQEYSASS-EYSRPTSEYG 384
               G+RPGQ             + Q +  ++ F++MA  SQ+YS+   + S+  S +G
Sbjct:   624 TNGMRPGQSQVFD--------SRQQSAQIRMFQRMAFGSQDYSSDFFDRSQSHSSWG 672

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005199 "structural constituent of cell wall" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9LV48	PERK1_ARATH	2, ., 7, ., 1, 1, ., 1	0.8291	0.9543	0.6088	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh2_kg.3__2668__AT3G24550.1 annotation not avaliable (650 aa) (Arabidopsis lyrata)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	416
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-52
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-50
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-50
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-49
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-48
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-48
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-45
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-43
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-40
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-33
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-33
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-32
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-32
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-31
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-31
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-31
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-30
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-29
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-28
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-28
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-28
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-28
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-28
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-26
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-26
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-26
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-25
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-25
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-25
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-24
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-23
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-23
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-23
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-23
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-23
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-22
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-21
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-21
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-21
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-21
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-21
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-21
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-21
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-20
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-20
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-19
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-19
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-18
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-18
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-18
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-17
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-17
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-17
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-17
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-16
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-15
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-14
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-14
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-14
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-13
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	7e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.002
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.003

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  173 bits (441), Expect = 4e-52
 Identities = 72/192 (37%), Positives = 106/192 (55%), Gaps = 9/192 (4%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+GGFG V+       GK+VAIK +K        E    E+EI+ +++H ++V L G +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
              +   LV E+    +L+  L  +    +     L+I L   +GL YLH   +  IIHR
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHS--N-GIIHR 116

Query: 170 DIKAANILLDFK-FEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-YASSGKLTEKS 227
           D+K  NILLD    + K+ADFGL+K+ +   + + T V GT  Y+APE     G  +EKS
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKS 175

Query: 228 DVFSFGVMLLEL 239
           D++S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  170 bits (433), Expect = 2e-50
 Identities = 91/278 (32%), Positives = 134/278 (48%), Gaps = 36/278 (12%)

Query: 52  LGQGGFGYVHRGVL-----PNGKEVAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSL 105
           LG+G FG V++G L         +VA+K LK G+ + ER EF  E  I+ ++ H ++V L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRP-TMDWLTRLKIALGSAKGLAYLHEDCHP 164
           +G  T G    +V E++P   L   L   G   T+  L  L++AL  AKG+ YL      
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDL--LQMALQIAKGMEYLESK--- 121

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
             +HRD+ A N L+      K++DFGL++ I  D              ++APE    GK 
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKF 181

Query: 224 TEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL 282
           T KSDV+SFGV+L E+ T G +P      +   S  +    +L   +EDG    L  P  
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEQP------YPGMSNEE----VLEL-LEDGY--RLPRP-- 226

Query: 283 HNEYNHNEMAR-MVACAAACVRHSARRRPRMSQIVRAL 319
             E   +E+   M+ C A    +    RP  S++V  L
Sbjct: 227 --ENCPDELYELMLQCWA----YDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  168 bits (429), Expect = 7e-50
 Identities = 67/202 (33%), Positives = 98/202 (48%), Gaps = 9/202 (4%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLV 103
           +     LG+G FG V+       GK VAIK +K    + +RE    E++I+ ++ H ++V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            L   +    +  LV E+     L   L  +GR + D              L YLH    
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEA--RFYLRQILSALEYLHSK-- 116

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
             I+HRD+K  NILLD     K+ADFGLA+        ++T V GT  Y+APE       
Sbjct: 117 -GIVHRDLKPENILLDEDGHVKLADFGLARQLDP-GEKLTTFV-GTPEYMAPEVLLGKGY 173

Query: 224 TEKSDVFSFGVMLLELITGRRP 245
            +  D++S GV+L EL+TG+ P
Sbjct: 174 GKAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  168 bits (429), Expect = 1e-49
 Identities = 83/293 (28%), Positives = 127/293 (43%), Gaps = 53/293 (18%)

Query: 50  NLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
             LG+G FG V++G L        EVA+K LK  + + ER +F  E  ++ ++ H ++V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGK-------GRPTMDWLTRLKIALGSAKGLAY 157
           L+G  T      LV E++    L  +L           + T+     L  A+  AKG+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST-------RVMGTF 210
           L      K +HRD+ A N L+      K++DFGL++   D + +          R     
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----- 172

Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD--STHTFVEDSLVDWARPLLNR 267
            ++APE    G  T KSDV+SFGV+L E+ T G  P    S    +E             
Sbjct: 173 -WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE------------- 218

Query: 268 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
            +  G    L  P    EY  +E+  ++     C +     RP  S++V  LE
Sbjct: 219 YLRKGYR--LPKP----EYCPDELYELMLS---CWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  165 bits (421), Expect = 1e-48
 Identities = 81/276 (29%), Positives = 124/276 (44%), Gaps = 32/276 (11%)

Query: 52  LGQGGFGYVHRGVL-----PNGKEVAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG V++G L         EVA+K LK   S Q   EF  E  I+ ++ H ++V L
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 106 VGYYTAGSQRMLVYEFVPN-NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           +G  T     M+V E++P  + L++ L       +     L  AL  A+G+ YL      
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDY-LRKNRPKELSLSDLLSFALQIARGMEYLESK--- 122

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
             IHRD+ A N L+      K++DFGL++   D + +          ++APE    GK T
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFT 182

Query: 225 EKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLH 283
            KSDV+SFGV+L E+ T G  P      +   S  +    +L   ++ G       P   
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEP------YPGMSNAE----VLEY-LKKGYRLPK--P--- 226

Query: 284 NEYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL 319
                 E+ +++     C       RP  S++V  L
Sbjct: 227 -PNCPPELYKLMLQ---CWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  165 bits (419), Expect = 2e-48
 Identities = 71/201 (35%), Positives = 105/201 (52%), Gaps = 11/201 (5%)

Query: 52  LGQGGFGYVHRGVL--PNGK---EVAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSL 105
           LG+G FG V++G L    GK   EVA+K LK  + + +  EF  E  I+ ++ H ++V L
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G  T      +V E++    L  +L  K RP +     L  AL  A+G+ YL       
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK---N 122

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
            IHRD+ A N L+      K++DFGL++   D + +          ++APE    GK T 
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTS 182

Query: 226 KSDVFSFGVMLLELIT-GRRP 245
           KSDV+SFGV+L E+ T G +P
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQP 203

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  155 bits (395), Expect = 7e-45
 Identities = 74/199 (37%), Positives = 104/199 (52%), Gaps = 12/199 (6%)

Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLK---AGSGQGEREFQAEVEIISRVHHKHLVSLVG 107
           LG G FG V++      GK VA+K LK     S + ++  + E+ I+ R+ H ++V L+ 
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPNIVRLID 65

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
            +       LV E+     L  +L   G   +      KIAL   +GL YLH +    II
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSN---GII 120

Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-YASSGKLTEK 226
           HRD+K  NILLD     K+ADFGLAK     ++ ++T V GT  Y+APE          K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPK 179

Query: 227 SDVFSFGVMLLELITGRRP 245
            DV+S GV+L EL+TG+ P
Sbjct: 180 VDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  151 bits (384), Expect = 3e-43
 Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 21/207 (10%)

Query: 50  NLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGE--REFQAEVEIISRVHHKHLVSLV 106
            LLG+G FG V+  +    G+ +A+K ++      E     + E+ I+S + H ++V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 107 GYYTAGSQRML-VY-EFVPNNTLEFHLHGKGR---PTMDWLTR--LKIALGSAKGLAYLH 159
           G      +  L ++ E+V   +L   L   G+   P +   TR  L+       GLAYLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE-------GLAYLH 118

Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAPEYA 218
            +    I+HRDIK ANIL+D     K+ADFG AK   D+ T   T  + GT  ++APE  
Sbjct: 119 SN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175

Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
              +    +D++S G  ++E+ TG+ P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  142 bits (361), Expect = 5e-40
 Identities = 72/204 (35%), Positives = 106/204 (51%), Gaps = 13/204 (6%)

Query: 46  FSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           F     +G+GGFG V++      GKEVAIK +K  S + + +   E++I+ +  H ++V 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA---LGSAKGLAYLHED 161
             G Y    +  +V EF    +L+  L    +     LT  +IA       KGL YLH +
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT----LTESQIAYVCKELLKGLEYLHSN 117

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
               IIHRDIKAANILL    E K+ DFGL+   SD  T     ++GT  ++APE  +  
Sbjct: 118 ---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD--TKARNTMVGTPYWMAPEVINGK 172

Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
               K+D++S G+  +EL  G+ P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  125 bits (315), Expect = 3e-33
 Identities = 72/197 (36%), Positives = 105/197 (53%), Gaps = 6/197 (3%)

Query: 46  FSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           F+    LG G FG V  G+  N   VAIK LK+     +++FQ EV+ + R+ HKHL+SL
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
               + G    ++ E +   +L   L       +   + + +A   A+G+AYL E     
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
            IHRD+ A NIL+      KVADFGLA+ I  DV      ++   + + APE AS G  +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFS 182

Query: 225 EKSDVFSFGVMLLELIT 241
            KSDV+SFG++L E+ T
Sbjct: 183 TKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  123 bits (311), Expect = 9e-33
 Identities = 69/198 (34%), Positives = 105/198 (53%), Gaps = 14/198 (7%)

Query: 51  LLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
            +G+G FG V  G    G++VA+K LK  S   +  F AE  +++ + H +LV L+G   
Sbjct: 13  TIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
            G+   +V E++   +L  +L  +GR  +    +L  AL   +G+ YL E      +HRD
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127

Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASSGKLTEKSD 228
           + A N+L+     AKV+DFGLAK AS        +  G     + APE     K + KSD
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEAS------QGQDSGKLPVKWTAPEALREKKFSTKSD 181

Query: 229 VFSFGVMLLELIT-GRRP 245
           V+SFG++L E+ + GR P
Sbjct: 182 VWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  123 bits (311), Expect = 1e-32
 Identities = 74/277 (26%), Positives = 127/277 (45%), Gaps = 41/277 (14%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLK-AGSGQGEREF-QAEVEIISRVHHKHLVSLV 106
             +G+G FG V+      +GK   +K++  +   + ERE    EV+I+ +++H +++   
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLH---GKGRPT-----MDWLTRLKIALGSAKGLAYL 158
             +    +  +V E+     L   +     +G+P      +DW  +L         L YL
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKYL 119

Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           H     KI+HRDIK  NI L      K+ DFG++K+ S       T V GT  YL+PE  
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELC 175

Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV 278
            +     KSD++S G +L EL T + P      F  ++L       L   I  G +    
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHP------FEGENL-----LELALKILKGQY---- 220

Query: 279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQI 315
            P + ++Y+ +E+  +V   ++ ++     RP ++QI
Sbjct: 221 -PPIPSQYS-SELRNLV---SSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  122 bits (307), Expect = 4e-32
 Identities = 65/197 (32%), Positives = 98/197 (49%), Gaps = 9/197 (4%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G+  N   VA+K LK G+   + +F AE +I+ ++ H  L+ L    T 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                +V E +   +L  +L G     +     + +A   A G+AYL    +   IHRD+
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY---IHRDL 129

Query: 172 KAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
            A N+L+      KVADFGLA++            +      + APE A   + + KSDV
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFSIKSDV 187

Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L E++T GR P
Sbjct: 188 WSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  121 bits (306), Expect = 7e-32
 Identities = 88/283 (31%), Positives = 133/283 (46%), Gaps = 41/283 (14%)

Query: 50  NLLGQGGFGYVHRGVL--PNGKE--VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
            ++G G FG V RG L  P  KE  VAIK LKAGS   +R +F  E  I+ +  H +++ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHL-HGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           L G  T     M++ E++ N +L+  L    G+ T      + +  G A G+ YL E  +
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT--VGQLVGMLRGIASGMKYLSEMNY 127

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR-----VMGTFGYLAPEYA 218
              +HRD+ A NIL++     KV+DFGL++   D     +T+     +  T    APE  
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAI 180

Query: 219 SSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL 277
           +  K T  SDV+SFG+++ E+++ G RP             D +   + +A+EDG    L
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERPYW-----------DMSNQDVIKAVEDGY--RL 227

Query: 278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
             P       +  M         C +     RP  SQIV  L+
Sbjct: 228 PPPMDCPSALYQLM-------LDCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  118 bits (299), Expect = 6e-31
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 11/200 (5%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLK-AGSGQGE-REFQAEVEIISRVHHKHLVSLV 106
           +L+G+G FG V++G+ L  G  VAIKQ+      +   +    E++++  + H ++V  +
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGR-PTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           G         ++ E+  N +L   +   G  P       +   L   +GLAYLHE     
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL---QGLAYLHEQ---G 119

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           +IHRDIKAANIL       K+ADFG+A   +DV +     V+GT  ++APE       + 
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDV-SKDDASVVGTPYWMAPEVIEMSGAST 178

Query: 226 KSDVFSFGVMLLELITGRRP 245
            SD++S G  ++EL+TG  P
Sbjct: 179 ASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  121 bits (304), Expect = 6e-31
 Identities = 69/212 (32%), Positives = 97/212 (45%), Gaps = 19/212 (8%)

Query: 51  LLGQGGFGYVHRGVLPNGKEVAIKQLK---AGSGQGEREFQAEVEIISRV-HHKHLVSLV 106
            LG+G FG V+       K VA+K L        +    F  E++I++ + H  ++V L 
Sbjct: 7   KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHL-HGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
            ++       LV E+V   +LE  L     +  +     L I       L YLH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121

Query: 166 IIHRDIKAANILLDFK-FEAKVADFGLAKIASDVNTHVSTR-----VMGTFGYLAPEYAS 219
           IIHRDIK  NILLD      K+ DFGLAK+  D  +  S        +GT GY+APE   
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 220 SGKL---TEKSDVFSFGVMLLELITGRRPVDS 248
              L   +  SD++S G+ L EL+TG  P + 
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213

Length = 384

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  118 bits (298), Expect = 6e-31
 Identities = 71/202 (35%), Positives = 109/202 (53%), Gaps = 14/202 (6%)

Query: 52  LGQGGFGYVHRGV--LPNGKE--VAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG G FG V +GV  + +GKE  VA+K LK      G++EF  E  +++++ H  +V L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
           G    G   MLV E  P   L  +L  K R  +      ++A   A G+AYL E  H   
Sbjct: 63  GV-CKGEPLMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYL-ESKH--F 116

Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASSGKLT 224
           +HRD+ A N+LL  + +AK++DFG+++     + +      G +   + APE  + GK +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176

Query: 225 EKSDVFSFGVMLLELIT-GRRP 245
            KSDV+S+GV L E  + G +P
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  119 bits (299), Expect = 8e-31
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 13/205 (6%)

Query: 52  LGQGGFGYVHRGV-LPNGK----EVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSL 105
           LG G FG V++GV +P G+     VAIK L+  +  +  +E   E  +++ V H H+V L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G     SQ  L+ + +P   L  ++    +  +     L   +  AKG++YL E    +
Sbjct: 75  LGI-CLSSQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQIAKGMSYLEEK---R 129

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
           ++HRD+ A N+L+      K+ DFGLAK +  D   + +        ++A E       T
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT 189

Query: 225 EKSDVFSFGVMLLELIT-GRRPVDS 248
            KSDV+S+GV + EL+T G +P + 
Sbjct: 190 HKSDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  117 bits (296), Expect = 2e-30
 Identities = 68/197 (34%), Positives = 99/197 (50%), Gaps = 9/197 (4%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K LK G+   E  F  E +I+ ++ H  LV L    + 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                +V E++   +L   L       +     + +A   A+G+AYL        IHRD+
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDL 129

Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASSGKLTEKSDV 229
            A NIL+      K+ADFGLA++  D     + R    F   + APE A+ G+ T KSDV
Sbjct: 130 AARNILVGENLVCKIADFGLARLIED--DEYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187

Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L E++T GR P
Sbjct: 188 WSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  118 bits (297), Expect = 2e-30
 Identities = 66/207 (31%), Positives = 100/207 (48%), Gaps = 16/207 (7%)

Query: 50  NLLGQGGFGYVHRGVLPN-----GKEVAIKQLKA-GSGQGEREFQAEVEIISRVHHKHLV 103
             LG+G FG V            G++VA+K L   G  Q   +F+ E+EI+  + H+++V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 104 SLVGYYTAGSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
              G       R   L+ E++P+ +L  +L  + R  ++    L  +    KG+ YL   
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQ 128

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS---DVNTHVSTRVMGTFGYLAPEYA 218
              + IHRD+ A NIL++ +   K++DFGLAK+     D            F Y APE  
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184

Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
            + K +  SDV+SFGV L EL T   P
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDP 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  114 bits (288), Expect = 2e-29
 Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 17/201 (8%)

Query: 52  LGQGGFGYVHRGVL-PNGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVG-Y 108
           LGQG  G V++    P GK  A+K++      +  ++   E++ +      ++V   G +
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           Y  G    +V E++   +L   L  K      P + ++ R +I     KGL YLH   H 
Sbjct: 69  YKEGEIS-IVLEYMDGGSLA-DLLKKVGKIPEPVLAYIAR-QIL----KGLDYLHTKRH- 120

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
            IIHRDIK +N+L++ K E K+ADFG++K+  +     +T V GT  Y++PE       +
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYS 178

Query: 225 EKSDVFSFGVMLLELITGRRP 245
             +D++S G+ LLE   G+ P
Sbjct: 179 YAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 1e-28
 Identities = 72/207 (34%), Positives = 101/207 (48%), Gaps = 22/207 (10%)

Query: 52  LGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHHKHLVS 104
           LG+G FG V     +     GK  A+K LK       +E +    E  I+SR++H  +V 
Sbjct: 1   LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57

Query: 105 LVGYYTAGSQRML--VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYLHED 161
           L  +Y   ++  L  V E+ P   L  HL  +GR + +   R   A +  A  L YLH  
Sbjct: 58  L--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER-ARFYAAEIVLA--LEYLHSL 112

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
               II+RD+K  NILLD     K+ DFGLAK  S   +  +T   GT  YLAPE     
Sbjct: 113 ---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGK 168

Query: 222 KLTEKSDVFSFGVMLLELITGRRPVDS 248
              +  D +S GV+L E++TG+ P  +
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPPFYA 195

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  111 bits (279), Expect = 3e-28
 Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 8/207 (3%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG V  G     ++VAIK ++ G+   E +F  E +++ ++ H  LV L G  T 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
            S   LV+EF+ +  L  +L  + R      T L + L   +G+AYL       +IHRD+
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126

Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
            A N L+      KV+DFG+ +   D     ST       + +PE  S  K + KSDV+S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 232 FGVMLLELIT-GRRPVD--STHTFVED 255
           FGV++ E+ + G+ P +  S    VE 
Sbjct: 187 FGVLMWEVFSEGKTPYENRSNSEVVET 213

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  111 bits (279), Expect = 3e-28
 Identities = 82/279 (29%), Positives = 133/279 (47%), Gaps = 35/279 (12%)

Query: 46  FSDANLLGQGGFGYVHRGVLPNGKEV-AIKQ--LKAGSGQGEREFQAEVEIISRVHHKHL 102
           F   N +G+G FG V + V    K V A+KQ  L   + +   E   E  +++++   ++
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG-KGRPTMD---WLTRLKIALGSAKGLAYL 158
           +     +    +  +V E+  N  L   L   +GRP  +   W   ++I LG    LA+L
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHL 117

Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           H     KI+HRDIK+ N+ LD     K+ D G+AK+ SD NT+ +  ++GT  YL+PE  
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLSPELC 173

Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV 278
                 EKSDV++ GV+L E  TG+ P D+ +   + +L+          I  G F    
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALI--------LKIIRGVF---- 218

Query: 279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
            P +   Y+     ++      C+    R+RP   Q++R
Sbjct: 219 -PPVSQMYS----QQLAQLIDQCLTKDYRQRPDTFQLLR 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  111 bits (279), Expect = 5e-28
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 30/218 (13%)

Query: 52  LGQGGFGYVHRGVLPNGKE------VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVS 104
           LG+G FG V  G   + +       VA+K LK  +    R+ F+ E E+++   H+++V 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHL--HG-------KGRPTMDWLTR---LKIALGSA 152
             G  T G   ++V+E++ +  L   L  HG            M  LT    L+IA+  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT--- 209
            G+ YL        +HRD+   N L+ +    K+ DFG+++   DV T    RV G    
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGGHTML 186

Query: 210 -FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
              ++ PE     K T +SDV+SFGV+L E+ T G++P
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  110 bits (277), Expect = 6e-28
 Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 26/205 (12%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
            LG+G +G V++ +    G+ VAIK +        +E   E+ I+ +    ++V   G Y
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL--QEIIKEISILKQCDSPYIVKYYGSY 67

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKG------RPTMDWLTRLKIAL---GSAKGLAYLHE 160
              +   +V E+           G G      + T   LT  +IA     + KGL YLH 
Sbjct: 68  FKNTDLWIVMEYC----------GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117

Query: 161 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS 220
           +   K IHRDIKA NILL+ + +AK+ADFG++   +D     +T V+GT  ++APE    
Sbjct: 118 N---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQE 173

Query: 221 GKLTEKSDVFSFGVMLLELITGRRP 245
                K+D++S G+  +E+  G+ P
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  110 bits (277), Expect = 8e-28
 Identities = 68/208 (32%), Positives = 101/208 (48%), Gaps = 20/208 (9%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE--REFQAEVEIISRVHHKHLVSLV 106
           N +G G FG V+  V L  G+ +A+K+++      +  +E   E++++  + H +LV   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63

Query: 107 GYYTAGSQRMLVY---EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            YY     R  VY   E+    TLE  L          +    + L   +GLAYLH    
Sbjct: 64  -YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSH-- 118

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRV---MGTFGYLAPEYASS 220
             I+HRDIK ANI LD     K+ DFG A    +  T +   V    GT  Y+APE  + 
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 221 GKLTEK---SDVFSFGVMLLELITGRRP 245
           GK       +D++S G ++LE+ TG+RP
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 4e-26
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 8/198 (4%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG VH G      +VAIK ++ G+   E +F  E +++ ++ H +LV L G  T 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 112 GSQRMLVYEFVPNNTLEFHLHG-KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                +V E++ N  L  +L   KG+   +WL  L +     + + YL  +     IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---FIHRD 125

Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KV+DFGLA+   D     S        +  PE     + + KSDV+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185

Query: 231 SFGVMLLELIT-GRRPVD 247
           SFGV++ E+ + G+ P +
Sbjct: 186 SFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  105 bits (262), Expect = 7e-26
 Identities = 71/198 (35%), Positives = 103/198 (52%), Gaps = 12/198 (6%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K LK G+   E  F  E +I+ ++ H  LV L   Y  
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQL---YAV 69

Query: 112 GSQR--MLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
            S+    +V E++   +L +F   G+GR  +     + +A   A G+AY+        IH
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIER---MNYIH 125

Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 228
           RD+++ANIL+      K+ADFGLA++  D              + APE A  G+ T KSD
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 229 VFSFGVMLLELIT-GRRP 245
           V+SFG++L EL+T GR P
Sbjct: 186 VWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  105 bits (263), Expect = 9e-26
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 27/210 (12%)

Query: 52  LGQGGFGYVHRGVLPN------GKEVAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
           LGQG FG V+ G+            VAIK +   +   ER EF  E  ++   +  H+V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW------LTRLKI---ALGSAKGL 155
           L+G  + G   ++V E +    L+ +L  + RP  +        T  K    A   A G+
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH----VSTRVMGTFG 211
           AYL      K +HRD+ A N ++      K+ DFG+ +   D+          + +    
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR---DIYETDYYRKGGKGLLPVR 186

Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           ++APE    G  T KSDV+SFGV+L E+ T
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  104 bits (260), Expect = 2e-25
 Identities = 69/197 (35%), Positives = 101/197 (51%), Gaps = 10/197 (5%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VAIK LK GS   E  F AE  ++ ++ H  LV L    T 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N +L   L       +     + +A   A+G+A++    +   IHRD+
Sbjct: 73  -EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRDL 128

Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASSGKLTEKSDV 229
           +AANIL+      K+ADFGLA++  D     + R    F   + APE  + G  T KSDV
Sbjct: 129 RAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186

Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L E++T GR P
Sbjct: 187 WSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  108 bits (271), Expect = 3e-25
 Identities = 76/295 (25%), Positives = 139/295 (47%), Gaps = 27/295 (9%)

Query: 29  FSKSTFTYEELARATDGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF 87
            SKS  T  ++  +     + N++ +G  G  ++G  + NG +  +K++   +     E 
Sbjct: 679 VSKS-ITINDILSSL---KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEI 734

Query: 88  QAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKI 147
                 + ++ H ++V L+G   +     L++E++    L   L       + W  R KI
Sbjct: 735 AD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKI 785

Query: 148 ALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM 207
           A+G AK L +LH  C P ++  ++    I++D K E  +       + +D    +S+   
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS--- 842

Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNR 267
               Y+APE   +  +TEKSD++ FG++L+EL+TG+ P D+    V  S+V+WAR     
Sbjct: 843 ---AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWAR----Y 894

Query: 268 AIEDGNFDTLVDP--KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
              D + D  +DP  +     N NE+  ++  A  C       RP  + +++ LE
Sbjct: 895 CYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  103 bits (258), Expect = 4e-25
 Identities = 68/201 (33%), Positives = 104/201 (51%), Gaps = 15/201 (7%)

Query: 51  LLGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
            LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V  
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 106 VGY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            G  Y+AG + + LV E++P  +L  +L  K R  +D    L  A    KG+ YL     
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSK-- 127

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASS 220
            + +HRD+   NIL++ +   K+ DFGL K+      +   R  G    F Y APE  + 
Sbjct: 128 -RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTE 185

Query: 221 GKLTEKSDVFSFGVMLLELIT 241
            K +  SDV+SFGV+L EL T
Sbjct: 186 SKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  102 bits (257), Expect = 4e-25
 Identities = 68/213 (31%), Positives = 106/213 (49%), Gaps = 20/213 (9%)

Query: 44  DGFSDANLLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGER-EFQAEVEIISRVH 98
           D       LG G  G V    HR   P GK +A+K ++    +  + +   E++I+ + +
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHR---PTGKIMAVKTIRLEINEAIQKQILRELDILHKCN 57

Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
             ++V   G +       +  E++   +L+      +GR     L   KIA+   KGL Y
Sbjct: 58  SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG--KIAVAVLKGLTY 115

Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAP 215
           LHE  H KIIHRD+K +NIL++ + + K+ DFG++   + S   T V     GT  Y+AP
Sbjct: 116 LHEK-H-KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAP 168

Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPVDS 248
           E       + KSD++S G+ L+EL TGR P   
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  101 bits (253), Expect = 1e-24
 Identities = 71/197 (36%), Positives = 100/197 (50%), Gaps = 10/197 (5%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 69

Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + +A   A G+AY+        +HR
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126

Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 187 WSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  100 bits (252), Expect = 2e-24
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 30/210 (14%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE-----REFQAEVEIISRVHHKHLVS 104
           LLG G FG V+ G+ L +G   A+K++             ++ + E+ ++S++ H ++V 
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL---KIALGSAKGLAYLHED 161
            +G         +  E VP  +L   L  K     + + RL   +I LG    L YLH+ 
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLYTRQILLG----LEYLHDR 121

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-----GTFGYLAPE 216
                +HRDIK ANIL+D     K+ADFG+AK        V          G+  ++APE
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGSPYWMAPE 171

Query: 217 Y-ASSGKLTEKSDVFSFGVMLLELITGRRP 245
             A  G     +D++S G  +LE+ TG+ P
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 99.7 bits (248), Expect = 7e-24
 Identities = 68/203 (33%), Positives = 108/203 (53%), Gaps = 12/203 (5%)

Query: 51  LLGQGGFGYVHRGVL--PNGKE--VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSL 105
           ++G G FG V RG+L  P  KE  VAIK LK G  + +R +F +E  I+ +  H +++ L
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
            G  T     M++ E++ N  L+ +L             + +  G A G+ YL +  +  
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNY-- 128

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFG--YLAPEYASSGKL 223
            +HRD+ A NIL++   E KV+DFGL+++  D      T   G     + APE  +  K 
Sbjct: 129 -VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187

Query: 224 TEKSDVFSFGVMLLELIT-GRRP 245
           T  SDV+SFG+++ E+++ G RP
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 99.3 bits (247), Expect = 9e-24
 Identities = 68/196 (34%), Positives = 106/196 (54%), Gaps = 14/196 (7%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +G+G FG V +G    G++VA+K +K   + Q    F  E  +++++HHK+LV L+G   
Sbjct: 14  IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVIL 69

Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 +V E +    L   L  +GR  +  +  L+ +L  A+G+ YL      K++HRD
Sbjct: 70  HNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD 125

Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A NIL+     AKV+DFGLA++ S    +    V  T    APE     K + KSDV+
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSDVW 181

Query: 231 SFGVMLLELIT-GRRP 245
           S+GV+L E+ + GR P
Sbjct: 182 SYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 98.6 bits (245), Expect = 2e-23
 Identities = 74/198 (37%), Positives = 103/198 (52%), Gaps = 12/198 (6%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G      +VAIK LK G+   E  F  E +I+ ++ H  LV L   Y  
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPL---YAV 69

Query: 112 GSQR--MLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
            S+    +V EF+   +L +F   G G+  +     + +A   A G+AY+        IH
Sbjct: 70  VSEEPIYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAYIER---MNYIH 125

Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 228
           RD++AANIL+      K+ADFGLA++  D              + APE A  G+ T KSD
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 229 VFSFGVMLLELIT-GRRP 245
           V+SFG++L EL+T GR P
Sbjct: 186 VWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 97.8 bits (244), Expect = 2e-23
 Identities = 65/205 (31%), Positives = 88/205 (42%), Gaps = 16/205 (7%)

Query: 51  LLGQGGFGYVHRG--VLPNGK--EVAIKQLKAGSGQG-EREFQAEVEIISRVHHKHLVSL 105
            LG G FG V RG      GK   VA+K LK+        +F  E  I+  + H++L+ L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
            G        M+V E  P  +L   L           T    A+  A G+ YL      +
Sbjct: 62  YGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---R 117

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST----RVMGTFGYLAPEYASSG 221
            IHRD+ A NILL    + K+ DFGL +       H       +V   F + APE   + 
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRTR 175

Query: 222 KLTEKSDVFSFGVMLLELIT-GRRP 245
             +  SDV+ FGV L E+ T G  P
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 98.4 bits (246), Expect = 3e-23
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 29/207 (14%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE---FQA--EVEIISRVHHKHLVSL 105
           +G+G +G V++      G+ VA+K+++    + E+E     A  E++++ ++ H ++V L
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63

Query: 106 VGYYT--AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
               T        +V+E++ ++        + + T   +      L   +GL YLH    
Sbjct: 64  KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL--LEGLQYLH---S 118

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE------- 216
             I+HRDIK +NIL++     K+ADFGLA+  +  N+   T  + T  Y  PE       
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR 178

Query: 217 YASSGKLTEKSDVFSFGVMLLELITGR 243
           Y        + D++S G +L EL  G+
Sbjct: 179 Y------GPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 97.6 bits (243), Expect = 4e-23
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 9/208 (4%)

Query: 50  NLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGY 108
           + LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
            T      ++ EF+    L  +L    R  ++ +  L +A   +  + YL +      IH
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 127

Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 228
           RD+ A N L+      KVADFGL+++ +               + APE  +  K + KSD
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187

Query: 229 VFSFGVMLLELIT-GRRP---VDSTHTF 252
           V++FGV+L E+ T G  P   +D +  +
Sbjct: 188 VWAFGVLLWEIATYGMSPYPGIDLSQVY 215

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 97.7 bits (244), Expect = 4e-23
 Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 11/197 (5%)

Query: 52  LGQGGFGYVHR-GVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHHKHLVSLVGY 108
           +G+G  G V +      G+ VA+K++     +G    QA  E++ +    H ++V L+  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
           +  GS  +LV E++P+  L   L  + RP  +   +        KG+AY+H +    I+H
Sbjct: 68  FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMHAN---GIMH 122

Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE--YASSGKLTEK 226
           RD+K AN+L+      K+ADFGLA++ S+    + +  + T  Y APE  Y +  K    
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR-KYDPG 181

Query: 227 SDVFSFGVMLLELITGR 243
            D+++ G +  EL+ G 
Sbjct: 182 VDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 97.0 bits (242), Expect = 5e-23
 Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 19/208 (9%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +G G +G V++   +  G+ VAIK +K   G      Q E+ ++    H ++V+  G Y 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIAL---GSAKGLAYLHEDCHPKII 167
              +  +V E+    +L+        P    L+ L+IA     + KGLAYLHE      I
Sbjct: 71  RRDKLWIVMEYCGGGSLQDIYQVTRGP----LSELQIAYVCRETLKGLAYLHET---GKI 123

Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYLAPEYA---SSGK 222
           HRDIK ANILL    + K+ADFG   +++ +   ++ R   +GT  ++APE A     G 
Sbjct: 124 HRDIKGANILLTEDGDVKLADFG---VSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGG 180

Query: 223 LTEKSDVFSFGVMLLELITGRRPVDSTH 250
              K D+++ G+  +EL   + P+   H
Sbjct: 181 YDGKCDIWALGITAIELAELQPPMFDLH 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 97.5 bits (243), Expect = 6e-23
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 31/213 (14%)

Query: 52  LGQGGFGYVHRG--VLPNGKE----VAIKQLK-AGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG+G FG V++G    PN +     VAIK LK     + ++EF+ E E++S + H ++V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 105 LVGYYTAGSQRMLVYEFVPNNTL-EFHL-------------HGKGRPTMDWLTRLKIALG 150
           L+G  T      +++E++ +  L EF +                 + ++D    L IA+ 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT- 209
            A G+ YL        +HRD+ A N L+      K++DFGL++   D+ +    RV    
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADYYRVQSKS 186

Query: 210 ---FGYLAPEYASSGKLTEKSDVFSFGVMLLEL 239
                ++ PE    GK T +SD++SFGV+L E+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 97.5 bits (243), Expect = 6e-23
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 18/211 (8%)

Query: 44  DGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQLKAGSGQG-EREFQAEVEIISRVHHKH 101
           +   + + LG+G  G V +  L N   + A+K +        +++   E+EI       +
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 102 LVSLVGYYTAGSQRML--VYEFVPNNTLEFHLHGK-----GRPTMDWLTRLKIALGSAKG 154
           +V   G +   S   +    E+    +L+  ++ K     GR     L   KIA    KG
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKKVKKRGGRIGEKVL--GKIAESVLKG 117

Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           L+YLH     KIIHRDIK +NILL  K + K+ DFG++     VN+   T   GT  Y+A
Sbjct: 118 LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL--VNSLAGTFT-GTSFYMA 171

Query: 215 PEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           PE       +  SDV+S G+ LLE+   R P
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 96.8 bits (241), Expect = 8e-23
 Identities = 58/212 (27%), Positives = 108/212 (50%), Gaps = 25/212 (11%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQ----------AEVEIISRVHH 99
           L+G+G +G V+  + +  G+ +A+KQ++  +    R             +E+E +  + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLE--FHLHGKGRPTM-DWLTRLKIALGSAKGLA 156
            ++V  +G+ T      +  E+VP  ++      +G+    +  + T   +     +GLA
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-----EGLA 122

Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAP 215
           YLH      I+HRD+KA N+L+D     K++DFG++K + D+  +     M G+  ++AP
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179

Query: 216 EYASSGK--LTEKSDVFSFGVMLLELITGRRP 245
           E   S     + K D++S G ++LE+  GRRP
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 96.5 bits (240), Expect = 9e-23
 Identities = 70/206 (33%), Positives = 113/206 (54%), Gaps = 16/206 (7%)

Query: 51  LLGQGGFGYVHRGVL--PNGKE--VAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVSL 105
           ++G G FG V RG L  P  +E  VAIK LK+G + +  R+F +E  I+ +  H +++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 106 VGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
            G  T     M++ EF+ N  L+ F     G+ T+  L  + +  G A G+ YL E  + 
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL--VGMLRGIAAGMKYLSEMNY- 127

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS-TRVMG---TFGYLAPEYASS 220
             +HRD+ A NIL++     KV+DFGL++   D  +  + T  +G      + APE  + 
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 221 GKLTEKSDVFSFGVMLLELIT-GRRP 245
            K T  SDV+S+G+++ E+++ G RP
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 96.0 bits (239), Expect = 1e-22
 Identities = 58/194 (29%), Positives = 96/194 (49%), Gaps = 6/194 (3%)

Query: 51  LLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
            +G+G FG V++GVL    EVA+K  ++      +  F  E EI+ +  H ++V L+G  
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
                  +V E VP  +L   L  K    +     L+++L +A G+ YL        IHR
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117

Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT-FGYLAPEYASSGKLTEKSD 228
           D+ A N L+      K++DFG+++        VS  +      + APE  + G+ T +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177

Query: 229 VFSFGVMLLELITG 242
           V+S+G++L E  + 
Sbjct: 178 VWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 64/233 (27%), Positives = 99/233 (42%), Gaps = 47/233 (20%)

Query: 46  FSDANLLGQGGFGYVHRGVL-PNGKEVAIKQL---------KAGSGQGEREFQAEVEIIS 95
           F    ++G+G F  V         KE AIK L         K    + E+E      +++
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKE------VLT 56

Query: 96  RV-HHKHLVSLVGYYTAGSQRML--VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGS 151
           R+  H  ++ L  YYT   +  L  V E+ PN  L  ++   G       TR   A +  
Sbjct: 57  RLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRFYAAEILL 113

Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM---- 207
           A  L YLH      IIHRD+K  NILLD     K+ DFG AK+    ++  S +      
Sbjct: 114 A--LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168

Query: 208 ---------------GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
                          GT  Y++PE  +     + SD+++ G ++ +++TG+ P
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 21/213 (9%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREF-QAEVEIISRVHHKHLV 103
           F+    +G+G FG V++ +     + VAIK +     + E E  Q E++ +S+    ++ 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA------LGSAKGLAY 157
              G +  GS+  ++ E+    +    L   G+     L    IA      L    GL Y
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSC-LDLLKPGK-----LDETYIAFILREVL---LGLEY 113

Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
           LHE+     IHRDIKAANILL  + + K+ADFG++   +   +  +T V GT  ++APE 
Sbjct: 114 LHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEV 169

Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
                  EK+D++S G+  +EL  G  P+   H
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 95.0 bits (237), Expect = 4e-22
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 17/206 (8%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           + +   +G+G  G V++      GKEVAIK+++      E     E+ I+    H ++V 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVD 79

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA---LGSAKGLAYLHED 161
               Y  G +  +V E++   +L   +          +   +IA       +GL YLH  
Sbjct: 80  YYDSYLVGDELWVVMEYMDGGSLTDII----TQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYLAPEYAS 219
               +IHRDIK+ NILL      K+ADFG    A+ +    S R  V+GT  ++APE   
Sbjct: 136 ---NVIHRDIKSDNILLSKDGSVKLADFG---FAAQLTKEKSKRNSVVGTPYWMAPEVIK 189

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRP 245
                 K D++S G+M +E+  G  P
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 94.9 bits (237), Expect = 6e-22
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 46/219 (21%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE---FQA--EVEIISRVHHKHLV 103
             LG+G +  V++      G+ VAIK++K G  +  ++   F A  E++++  + H +++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA----------K 153
            L+  +   S   LV+EF+  + LE  +  K            I L  A          +
Sbjct: 66  GLLDVFGHKSNINLVFEFMETD-LEKVIKDK-----------SIVLTPADIKSYMLMTLR 113

Query: 154 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL 213
           GL YLH +    I+HRD+K  N+L+      K+ADFGLA+     N  ++ +V+ T  Y 
Sbjct: 114 GLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYR 169

Query: 214 APE-------YASSGKLTEKSDVFSFGVMLLELITGRRP 245
           APE       Y          D++S G +  EL+  R P
Sbjct: 170 APELLFGARHYGVG------VDMWSVGCIFAELLL-RVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 93.8 bits (233), Expect = 9e-22
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 26/213 (12%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQ--LKAGSGQGERE-------FQAEVEIISRVHHK 100
           L+G G FG V+ G+   +G+ +A+KQ  L + S   +            E+ ++  + H+
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG---RPTMDWLTRLKIALGSAKGLAY 157
           ++V  +G         +  E+VP  ++   L+  G      +    R  +     KGL Y
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-----KGLNY 121

Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-----IASDVNTHVSTRVMGTFGY 212
           LH      IIHRDIK ANIL+D K   K++DFG++K       S         + G+  +
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           +APE       T K+D++S G +++E++TG+ P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 93.6 bits (233), Expect = 1e-21
 Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 16/204 (7%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSLVGYY 109
           +G G    V+  + LPN ++VAIK++     Q    E + EV+ +S+ +H ++V     +
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 110 TAGSQRMLVYEFVPNNTL----EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
             G +  LV  ++   +L    +      G       T LK  L   KGL YLH +    
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL---KGLEYLHSNGQ-- 123

Query: 166 IIHRDIKAANILLDFKFEAKVADFGL-AKIASDVNTHVSTR--VMGTFGYLAPEYASSGK 222
            IHRDIKA NILL      K+ADFG+ A +A   +     R   +GT  ++APE      
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182

Query: 223 -LTEKSDVFSFGVMLLELITGRRP 245
               K+D++SFG+  +EL TG  P
Sbjct: 183 GYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 93.9 bits (233), Expect = 1e-21
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 17/210 (8%)

Query: 51  LLGQGGFGYVHRGV-LPNGKE----VAIKQLKAGSGQGEREFQAEVE---IISRVHHKHL 102
           LLG G FG VH+G+ +P G      VAIK ++  SG+  + FQ   +    +  + H ++
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDHMLAMGSLDHAYI 71

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           V L+G    G+   LV +  P  +L  H+  + R ++D    L   +  AKG+ YL E  
Sbjct: 72  VRLLGI-CPGASLQLVTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLEEHR 129

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIA-SDVNTHVSTRVMGTFGYLAPEYASSG 221
              ++HR++ A NILL      ++ADFG+A +   D   +  +       ++A E    G
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 222 KLTEKSDVFSFGVMLLELIT-GRRPVDSTH 250
           + T +SDV+S+GV + E+++ G  P     
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 93.2 bits (231), Expect = 1e-21
 Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 5/195 (2%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G   N  +VA+K LK G+    + F  E  ++  + H  LV L    T 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++   +L   L       +     +  +   A+G+AY+    +   IHRD+
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY---IHRDL 129

Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AAN+L+      K+ADFGLA++  D              + APE  + G  T KSDV+S
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189

Query: 232 FGVMLLELIT-GRRP 245
           FG++L E++T G+ P
Sbjct: 190 FGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 71/214 (33%), Positives = 101/214 (47%), Gaps = 32/214 (14%)

Query: 46  FSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHHK 100
           F+D   +G G FG V+  R V    + VAIK++     Q   ++Q    EV  + ++ H 
Sbjct: 17  FTDLREIGHGSFGAVYFARDVR-TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75

Query: 101 HLVSLVGYYTAGSQRMLVYEFV---PNNTLEFHLHGKGRPTMDWLTRLKIA---LGSAKG 154
           + +   G Y       LV E+     ++ LE H           L  ++IA    G+ +G
Sbjct: 76  NTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP--------LQEVEIAAICHGALQG 127

Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LAYLH       IHRDIKA NILL      K+ADFG A + S  N+ V     GT  ++A
Sbjct: 128 LAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMA 179

Query: 215 PEY---ASSGKLTEKSDVFSFGVMLLELITGRRP 245
           PE       G+   K DV+S G+  +EL   R+P
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIEL-AERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 93.0 bits (231), Expect = 1e-21
 Identities = 69/204 (33%), Positives = 111/204 (54%), Gaps = 14/204 (6%)

Query: 51  LLGQGGFGYVHRGVL--PNGKE--VAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVSL 105
           ++G G FG V  G L  P  +E  VAIK LKAG + +  R+F +E  I+ +  H +++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 106 VGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
            G  T     M+V E++ N +L+ F     G+ T+  L  + +  G A G+ YL +  + 
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL--VGMLRGIASGMKYLSDMGY- 127

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFG--YLAPEYASSGK 222
             +HRD+ A NIL++     KV+DFGL+++  D      T   G     + APE  +  K
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 223 LTEKSDVFSFGVMLLELIT-GRRP 245
            T  SDV+S+G+++ E+++ G RP
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 93.4 bits (232), Expect = 1e-21
 Identities = 73/219 (33%), Positives = 106/219 (48%), Gaps = 29/219 (13%)

Query: 50  NLLGQGGFGYVHRG----VLPNGKE---VAIKQLKAGSGQGER-EFQAEVEIISRVHHKH 101
           N LG G FG V+ G    +L  G     VA+K L+ G+   E+ EF  E  ++S  +H +
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGK-----GRPTMDWLTRLKIALGSAKGLA 156
           +V L+G       + ++ E +    L  +L        G P +     L I L  AKG  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-----KVADFGLAKIASDVNTHVSTRVMGT-- 209
           YL E  H   IHRD+ A N L+  K        K+ DFGLA+   D+      R  G   
Sbjct: 121 YL-EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---DIYKSDYYRKEGEGL 174

Query: 210 --FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
               ++APE    GK T +SDV+SFGV++ E++T G++P
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 18/211 (8%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQ---GEREF---QAEVEIISRVHHKHLV 103
            +LG+G +G V+ G+   G+ +A+KQ++  +      E+E+   Q EV+++  + H ++V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR-PTMDWLTRLKIALGSAKGLAYLHEDC 162
             +G     +   +  EFVP  ++   L+  G  P   +    K  L    G+AYLH +C
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL---DGVAYLHNNC 122

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-----GTFGYLAPEY 217
              ++HRDIK  N++L      K+ DFG A+  + V  H +   M     GT  ++APE 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRPVDS 248
            +      KSD++S G  + E+ TG+ P+ S
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLAS 210

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 92.7 bits (230), Expect = 2e-21
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 12/196 (6%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G+G FG V  G    G +VA+K +K  +    + F AE  +++++ H +LV L+G    
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 112 GSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
               + +V E++   +L  +L  +GR  +     LK +L   + + YL  +     +HRD
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRD 127

Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N+L+     AKV+DFGL K AS         V  T    APE     K + KSDV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVW 183

Query: 231 SFGVMLLELIT-GRRP 245
           SFG++L E+ + GR P
Sbjct: 184 SFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 92.2 bits (229), Expect = 2e-21
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 11/203 (5%)

Query: 51  LLGQGGFGYVH--RGVLPNGKEVAIKQLKA-GSGQGERE-FQAEVEIISRVHHKHLVSLV 106
           ++G+G FG VH  R    + K V IKQ+      + ER   Q E +++  + H +++   
Sbjct: 7   VVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
             +      M+V E+ P  TL  ++  +    +D  T L   +     L ++H      I
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LI 122

Query: 167 IHRDIKAANILLD-FKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           +HRD+K  NILLD  K   K+ DFG++KI S   +   T V+GT  Y++PE        +
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYT-VVGTPCYISPELCEGKPYNQ 180

Query: 226 KSDVFSFGVMLLELITGRRPVDS 248
           KSD+++ G +L EL + +R  ++
Sbjct: 181 KSDIWALGCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 92.2 bits (229), Expect = 3e-21
 Identities = 72/211 (34%), Positives = 104/211 (49%), Gaps = 33/211 (15%)

Query: 50  NLLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVS 104
            ++G+G FG V+ G L   +G+++  A+K L   +   E E F  E  I+    H +++S
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGL 155
           L+G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+
Sbjct: 61  LLGI-------CLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL--IGFGLQVAKGM 111

Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD-----VNTHVSTRVMGTF 210
            YL      K +HRD+ A N +LD  F  KVADFGLA+   D     V+ H   ++    
Sbjct: 112 EYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL--PV 166

Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            ++A E   + K T KSDV+SFGV+L EL+T
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 91.9 bits (228), Expect = 3e-21
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 14/201 (6%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VAIK +K GS   E EF  E +++ ++ H+ LV L G  T 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 112 GSQRMLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                +V E++ N  L  +L     R     L  L++     +G+AYL      + IHRD
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL--LEMCKDVCEGMAYLESK---QFIHRD 125

Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT---FGYLAPEYASSGKLTEKS 227
           + A N L+D +   KV+DFGL++   D + + S+  +G+     +  PE     K + KS
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLD-DEYTSS--VGSKFPVRWSPPEVLLYSKFSSKS 182

Query: 228 DVFSFGVMLLELIT-GRRPVD 247
           DV++FGV++ E+ + G+ P +
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.8 bits (228), Expect = 4e-21
 Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGEREFQA---EVEIISRVHHKHLVS 104
           LLGQG FG V+    +  G+E+A+KQ+     S + ++E  A   E++++  + H+ +V 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
             G         +  E++P  +++  L   G    + +TR K      +G+ YLH +   
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTR-KYTRQILEGVEYLHSN--- 123

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAPEYASSGK 222
            I+HRDIK ANIL D     K+ DFG +K    + +  +    V GT  +++PE  S   
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183

Query: 223 LTEKSDVFSFGVMLLELITGRRP 245
              K+DV+S G  ++E++T + P
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 92.2 bits (229), Expect = 4e-21
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 13/200 (6%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQG-EREFQAEVEIISRVHHKHLVSLVGYY 109
           LG G  G V +   +P G  +A K +  G+     ++   E++I+      ++VS  G +
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
              +   +  EF+   +L+      G   ++ L   KIA+   +GL YL+      I+HR
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG--KIAVAVVEGLTYLYNVHR--IMHR 128

Query: 170 DIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS 227
           DIK +NIL++ + + K+ DFG++   I S  +T V     GT  Y++PE    GK T KS
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYTVKS 183

Query: 228 DVFSFGVMLLELITGRRPVD 247
           DV+S G+ ++EL  G+ P  
Sbjct: 184 DVWSLGISIIELALGKFPFA 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 92.1 bits (229), Expect = 4e-21
 Identities = 74/215 (34%), Positives = 102/215 (47%), Gaps = 24/215 (11%)

Query: 50  NLLGQGGFG------YVHRGVLPNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHL 102
             LG G FG      Y  R       +VA+K L ++ S Q E +F  E  I+S+ +H+++
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRP------TMDWLTRLKIALGSAKGL 155
           V L+G       R ++ E +    L+ F    + RP      TM  L  L  A   AKG 
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL--LFCARDVAKGC 129

Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAK-IASDVNTHVSTRVMGTFG 211
            YL E+     IHRDI A N LL  K     AK+ADFG+A+ I          R M    
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186

Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
           ++ PE    G  T K+DV+SFGV+L E+ + G  P
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 91.7 bits (227), Expect = 5e-21
 Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 9/207 (4%)

Query: 46  FSDANLLGQGGFGYVHRGVLPNGKEV-AIKQLKAGSGQGERE-FQAEVEIISRVHHKHLV 103
           F+    +G+G FG V +G+    ++V AIK +     + E E  Q E+ ++S+    ++ 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
              G Y  G++  ++ E++   +    L           T LK  L   KGL YLH +  
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE-- 120

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
            K IHRDIKAAN+LL  + + K+ADFG+A   +D     +T V GT  ++APE       
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAY 178

Query: 224 TEKSDVFSFGVMLLELITGRRPVDSTH 250
             K+D++S G+  +EL  G  P    H
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMH 205

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 91.4 bits (227), Expect = 6e-21
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)

Query: 45  GFSDANLLGQGGFGYVHR-GVLPNGKEVAIKQLKAGS-GQGEREFQA-EVEIISRVHHKH 101
            F     LG+G +G V++   L + +  A+K++  GS  Q ERE    E+ I++ V+H +
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHL---HGKGRP---TMDWLTRLKIALGSAKGL 155
           ++S    +  G++  +V E+ P   L   +     K +       W    +I +   +GL
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGL 116

Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
             LHE    KI+HRD+K+ANILL      K+ D G++K+         T  +GT  Y+AP
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKT-QIGTPHYMAP 170

Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           E       + KSD++S G +L E+ T   P
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 91.4 bits (228), Expect = 6e-21
 Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 30/206 (14%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA----EVEIISRVHHKHLVSLV 106
           LG+G +G V++      G+ VA+K+++      E    +    E+ ++  + H ++V L+
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK-IALGSAKGLAYLHEDCHPK 165
                  +  LV+E+   + L+ +L  +  P +     +K I     +GLAY H   H +
Sbjct: 65  DVIHTERKLYLVFEYCDMD-LKKYLDKRPGP-LS-PNLIKSIMYQLLRGLAYCHS--H-R 118

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPE-------Y 217
           I+HRD+K  NIL++     K+ADFGLA+     + T+ +  V+ T  Y APE       Y
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPEILLGSKHY 176

Query: 218 ASSGKLTEKSDVFSFGVMLLELITGR 243
           +++       D++S G +  E+ITG+
Sbjct: 177 STA------VDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 91.1 bits (226), Expect = 9e-21
 Identities = 68/209 (32%), Positives = 99/209 (47%), Gaps = 34/209 (16%)

Query: 52  LGQGGFGYVHRGVL-PN----GKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
           LG+G FG V      P     G+ VA+K LK   GQ     ++ E+ I+  ++H+++V  
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 106 VGYYTAGSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS--------AKGL 155
            G  +    +   L+ E+VP  +L            D+L + K+ L           +G+
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSL-----------RDYLPKHKLNLAQLLLFAQQICEGM 120

Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGY 212
           AYLH       IHRD+ A N+LLD     K+ DFGLAK   + + +   R  G    F Y
Sbjct: 121 AYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 177

Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            A E     K +  SDV+SFGV L EL+T
Sbjct: 178 -AVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 23/211 (10%)

Query: 45  GFSDANLLGQGGFGYV----HRGVLPNGKEVAIKQL---KAGSGQGEREFQAEVEIISRV 97
            F    ++G+G FG V     R      K  A+K +   K       R    E  I+  +
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKR---DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL 57

Query: 98  HHKHLVSLVGYYT-AGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKG 154
           +H  LV+L  +Y+    + M LV + +    L +HL  K + + +   +  I  +  A  
Sbjct: 58  NHPFLVNL--WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-QVKFWICEIVLA-- 112

Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           L YLH      IIHRDIK  NILLD +    + DF +A   +     ++T   GT GY+A
Sbjct: 113 LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP--DTLTTSTSGTPGYMA 167

Query: 215 PEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           PE       +   D +S GV   E + G+RP
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 90.1 bits (223), Expect = 2e-20
 Identities = 68/216 (31%), Positives = 103/216 (47%), Gaps = 26/216 (12%)

Query: 52  LGQGGFGYVH----RGVLPNGKE--VAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG V       +LP   +  VA+K LK  S    ++FQ E E+++ + H+H+V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR--------------LKIALGS 151
            G  T G   ++V+E++ +  L   L   G P    L                L IA   
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHG-PDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTF 210
           A G+ YL    H   +HRD+   N L+      K+ DFG+++ I S     V  R M   
Sbjct: 132 ASGMVYL-ASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
            ++ PE     K T +SD++SFGV+L E+ T G++P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 89.2 bits (222), Expect = 3e-20
 Identities = 72/273 (26%), Positives = 111/273 (40%), Gaps = 75/273 (27%)

Query: 36  YEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQ---AEV 91
           YE L            +G+G FG V +     +GK +  K++  G+   E+E Q   +EV
Sbjct: 2   YEVLET----------IGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEKQQLVSEV 50

Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHG-------KGRPTM 139
            I+  + H ++V    YY     R        +N       E+   G       K +   
Sbjct: 51  NILRELKHPNIV---RYY----DR----IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER 99

Query: 140 D-------W--LTRLKIALGSAKGLAYLHEDCH------PKIIHRDIKAANILLDFKFEA 184
                   W  LT+L +AL           +CH        ++HRD+K ANI LD     
Sbjct: 100 KYIEEEFIWRILTQLLLAL----------YECHNRSDPGNTVLHRDLKPANIFLDANNNV 149

Query: 185 KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRR 244
           K+ DFGLAKI    ++   T V GT  Y++PE  +     EKSD++S G ++ EL     
Sbjct: 150 KLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208

Query: 245 PVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL 277
           P  +    ++          L   I++G F  +
Sbjct: 209 PFTAR-NQLQ----------LASKIKEGKFRRI 230

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 89.7 bits (222), Expect = 3e-20
 Identities = 67/208 (32%), Positives = 107/208 (51%), Gaps = 11/208 (5%)

Query: 46  FSDANLLGQGGFGYVHRGVLPNGKEV-AIKQLKAGSGQGERE-FQAEVEIISRVHHKHLV 103
           F+    +G+G FG V++G+    KEV AIK +     + E E  Q E+ ++S+    ++ 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWL-TRLKIALGSAKGLAYLHEDC 162
              G Y  G++  ++ E++   +    L   G     ++ T L+  L   KGL YLH + 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGS-ALDLLKPGPLEETYIATILREIL---KGLDYLHSE- 120

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK 222
             + IHRDIKAAN+LL  + + K+ADFG+A   +D     +T V GT  ++APE      
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 177

Query: 223 LTEKSDVFSFGVMLLELITGRRPVDSTH 250
              K+D++S G+  +EL  G  P    H
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLH 205

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 89.5 bits (223), Expect = 3e-20
 Identities = 66/205 (32%), Positives = 88/205 (42%), Gaps = 27/205 (13%)

Query: 52  LGQGGFGYVHRGVL-PNGKEVAIKQLKAG----SGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG G FG V       +GK  A+K L         Q E     E  I+  + H  LV+L 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVL-NEKRILQSIRHPFLVNLY 67

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL---KIALGSAKGLAYLHEDCH 163
           G +   S   LV E+VP   L  HL   GR       R    ++ L     L YLH    
Sbjct: 68  GSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV-ARFYAAQVVL----ALEYLH---S 119

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM---GTFGYLAPEYASS 220
             I++RD+K  N+LLD     K+ DFG AK        V  R     GT  YLAPE   S
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAK-------RVKGRTYTLCGTPEYLAPEIILS 172

Query: 221 GKLTEKSDVFSFGVMLLELITGRRP 245
               +  D ++ G+++ E++ G  P
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 89.0 bits (221), Expect = 4e-20
 Identities = 70/277 (25%), Positives = 125/277 (45%), Gaps = 45/277 (16%)

Query: 52  LGQGGFGYVHRGVLPNGKE----VAIKQ--LKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG      L    E    V  K+  L   S +  R+   E+ I+S + H ++++ 
Sbjct: 8   LGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64

Query: 106 VGYYTAGSQRMLVYEFVPNNTL-EFHLHGKG-----RPTMDWLTRLKIALGSAKGLAYLH 159
             ++   +  ++  E+    TL +  +  KG        + +L      + SA  ++Y+H
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL----FQIVSA--VSYIH 118

Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
           +     I+HRDIK  NI L      K+ DFG++KI     +   T V+GT  Y++PE   
Sbjct: 119 KA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQ 174

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD 279
             K   KSD+++ G +L EL+T +R  D+T+              L   I  GN+  +V 
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----------LNLVVKIVQGNYTPVVS 223

Query: 280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIV 316
                 Y+ +E+  +V    + ++    +RP   +++
Sbjct: 224 V-----YS-SELISLV---HSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 89.0 bits (221), Expect = 4e-20
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 19/209 (9%)

Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G FG V++      G   A K ++  S +   +F  E++I+S   H ++V L   Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS---AKGLAYLHEDCHPKII 167
             ++  ++ EF     L+  +    R     LT  +I        + L +LH     K+I
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERG----LTEPQIRYVCRQMLEALNFLHSH---KVI 125

Query: 168 HRDIKAANILLDFKFEAKVADFGL-AKIASDVNTHVSTRVMGTFGYLAPEYA-----SSG 221
           HRD+KA NILL    + K+ADFG+ AK  S +    +   +GT  ++APE          
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDN 183

Query: 222 KLTEKSDVFSFGVMLLELITGRRPVDSTH 250
               K+D++S G+ L+EL     P    +
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHELN 212

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 88.7 bits (220), Expect = 5e-20
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 9/212 (4%)

Query: 52  LGQGGFGYVHR-GVLPNGKEVAIKQL---KAGSGQGEREFQAEVEIISRVHHKHLVSLVG 107
           LG+GGFG V    V   GK  A K+L   +    +GE+    E +I+ +V  + +VSL  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
            +       LV   +    L++H++  G P       +  A     GL +LH+    +I+
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIV 117

Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS 227
           +RD+K  N+LLD     +++D GLA         +  R  GT GY+APE           
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRA-GTPGYMAPEVLQGEVYDFSV 175

Query: 228 DVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
           D F+ G  L E+I GR P       VE   + 
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 88.6 bits (220), Expect = 6e-20
 Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 11/201 (5%)

Query: 51  LLGQGGFGYVHRGV--LPNGKE--VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
            +G+G FG V++GV   P  ++  VA+K  K  +    RE F  E  I+ +  H H+V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G  T  +   +V E  P   L  +L    + ++D  + +  +   +  LAYL      +
Sbjct: 73  IGVITE-NPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLESK---R 127

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
            +HRDI A N+L+      K+ DFGL++   D + + +++      ++APE  +  + T 
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187

Query: 226 KSDVFSFGVMLLE-LITGRRP 245
            SDV+ FGV + E L+ G +P
Sbjct: 188 ASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 87.6 bits (217), Expect = 1e-19
 Identities = 76/270 (28%), Positives = 119/270 (44%), Gaps = 28/270 (10%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG VH G      +VAIK +  G+   E +F  E +++ ++ H  LV L G  T 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 112 GSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                +V EF+ N  L  +L  + G+ + D L  L +     +G+ YL  +     IHRD
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SFIHRD 125

Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KV+DFG+ +   D     S+       +  PE  +  K + KSDV+
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185

Query: 231 SFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHN 289
           SFGV++ E+ T G+ P +    +            +   I  G    L  PKL +   + 
Sbjct: 186 SFGVLMWEVFTEGKMPFEKKSNYE-----------VVEMISRGF--RLYRPKLASMTVYE 232

Query: 290 EMARMVACAAACVRHSARRRPRMSQIVRAL 319
            M         C       RP  ++++RA+
Sbjct: 233 VMYS-------CWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 67/214 (31%), Positives = 112/214 (52%), Gaps = 23/214 (10%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEV----AIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVS 104
           +LG G FG V++G+ +P G+ V    AIK L   +G +   EF  E  I++ + H HLV 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGK-----GRPTMDWLTRLKIALGSAKGLAYLH 159
           L+G   + + + LV + +P+  L  ++H        +  ++W  ++      AKG+ YL 
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126

Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPEYA 218
           E    +++HRD+ A N+L+      K+ DFGLA+ +  D   + +        ++A E  
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 219 SSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHT 251
              K T +SDV+S+GV + EL+T G +P D   T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 27/206 (13%)

Query: 51  LLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGE--REFQAEVEIISRVHHKHLVSLVG 107
           ++G+G +G V +      G+ VAIK+ K      +  +    EV+++ ++ H+++V+L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPT-MDWLTRLKIALGSAKGLAYLHEDCHPKI 166
            +    +  LV+E+V    LE     +  P  +             + +AY H      I
Sbjct: 68  AFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCHSH---NI 121

Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKI-----ASDVNTHVSTRVMGTFGYLAPE----Y 217
           IHRDIK  NIL+      K+ DFG A+      AS +  +V+TR      Y APE     
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR-----WYRAPELLVGD 176

Query: 218 ASSGKLTEKSDVFSFGVMLLELITGR 243
            + GK     DV++ G ++ EL+ G 
Sbjct: 177 TNYGK---PVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 86.2 bits (213), Expect = 3e-19
 Identities = 61/190 (32%), Positives = 97/190 (51%), Gaps = 7/190 (3%)

Query: 51  LLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLVGYY 109
           LLG+G FG V +G L +   VA+K  K    Q  + +F +E  I+ +  H ++V L+G  
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH-EDCHPKIIH 168
           T      +V E VP       L  K +  +     +K AL +A G+AYL  ++C    IH
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNC----IH 116

Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 228
           RD+ A N L+      K++DFG+++   D     S        + APE  + G+ + +SD
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 229 VFSFGVMLLE 238
           V+S+G++L E
Sbjct: 177 VWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 87.5 bits (216), Expect = 3e-19
 Identities = 72/212 (33%), Positives = 104/212 (49%), Gaps = 25/212 (11%)

Query: 46  FSDANLLGQGGFG--YVHRGVLPNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHHK 100
           F+D   +G G FG  Y  R V  N + VAIK++     Q   ++Q    EV+ + R+ H 
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85

Query: 101 HLVSLVGYYTAGSQRMLVYEFV---PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           + +   G Y       LV E+     ++ LE H     +  +  +    I  G+ +GLAY
Sbjct: 86  NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH-----KKPLQEVEIAAITHGALQGLAY 140

Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
           LH      +IHRDIKA NILL    + K+ADFG A IAS  N+ V     GT  ++APE 
Sbjct: 141 LHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEV 192

Query: 218 ---ASSGKLTEKSDVFSFGVMLLELITGRRPV 246
                 G+   K DV+S G+  +EL   + P+
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 88.0 bits (218), Expect = 3e-19
 Identities = 71/242 (29%), Positives = 110/242 (45%), Gaps = 28/242 (11%)

Query: 17  PLPPPSPGLSLGFSKSTFTYEELARATDGFSD---ANLLGQGGFGYV----HRGVLPNGK 69
           PLPPPS   S   S S         A    S+    N +G G  G V    HR   P G+
Sbjct: 46  PLPPPSSSSSSSSSSSASGSA--PSAAKSLSELERVNRIGSGAGGTVYKVIHR---PTGR 100

Query: 70  EVAIKQLKAGSGQG-EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLE 128
             A+K +         R+   E+EI+  V+H ++V     +    +  ++ EF+   +LE
Sbjct: 101 LYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE 160

Query: 129 FHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD 188
                 G    D      +A     G+AYLH      I+HRDIK +N+L++     K+AD
Sbjct: 161 ------GTHIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIAD 211

Query: 189 FGLAKIASDVNTHVSTRVMGTFGYLAPEYASS----GKLTEKS-DVFSFGVMLLELITGR 243
           FG+++I +      ++ V GT  Y++PE  ++    G     + D++S GV +LE   GR
Sbjct: 212 FGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Query: 244 RP 245
            P
Sbjct: 271 FP 272

Length = 353

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 85.4 bits (212), Expect = 8e-19
 Identities = 56/189 (29%), Positives = 86/189 (45%), Gaps = 17/189 (8%)

Query: 68  GKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPN 124
           G   AIK +K      + +      E +I+S+    ++V L   +       LV E++P 
Sbjct: 18  GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77

Query: 125 NTLEFHLHGKGRPTMD-WLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE 183
             L   L   G  ++D  + R+ IA      L YLH +    IIHRD+K  NIL+D    
Sbjct: 78  GDLASLLENVG--SLDEDVARIYIA-EIVLALEYLHSN---GIIHRDLKPDNILIDSNGH 131

Query: 184 AKVADFGLAK-------IASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVML 236
            K+ DFGL+K       I  + +     R++GT  Y+APE       ++  D +S G +L
Sbjct: 132 LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCIL 191

Query: 237 LELITGRRP 245
            E + G  P
Sbjct: 192 YEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 19/205 (9%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
           +LG+G +G V+    L     +AIK++     +  +    E+ + S + H+++V  +G  
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRP------TMDWLTRLKIALGSAKGLAYLHEDCH 163
           +      +  E VP  +L   L  K  P      T+ + T+  +     +GL YLH++  
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHDN-- 127

Query: 164 PKIIHRDIKAANILLD-FKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK 222
            +I+HRDIK  N+L++ +    K++DFG +K  + +N    T   GT  Y+APE    G 
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGP 185

Query: 223 --LTEKSDVFSFGVMLLELITGRRP 245
                 +D++S G  ++E+ TG+ P
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 9/204 (4%)

Query: 46  FSDANLLGQGGFGYVHR-GVLPNGKEVAIKQL---KAGSGQGEREFQAEVEIISRVHHKH 101
           F    +LG+GGFG V    V   GK  A K+L   +    +GE     E +I+ +V+ + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
           +VSL   Y       LV   +    L+FH++  G    +    +  A     GL  LH++
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
              +I++RD+K  NILLD     +++D GLA    +  T +  RV GT GY+APE   + 
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE 176

Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
           + T   D ++ G +L E+I G+ P
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 6/195 (3%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V         +VA+K +K GS   E  F AE  ++  + H  LV L    T 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ EF+   +L   L             +  +   A+G+A++ +  +   IHRD+
Sbjct: 73  -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRDL 128

Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV+S
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 188

Query: 232 FGVMLLELIT-GRRP 245
           FG++L+E++T GR P
Sbjct: 189 FGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 85.0 bits (210), Expect = 1e-18
 Identities = 67/204 (32%), Positives = 100/204 (49%), Gaps = 9/204 (4%)

Query: 46  FSDANLLGQGGFGYVHR-GVLPNGKEVAIKQL---KAGSGQGEREFQAEVEIISRVHHKH 101
           F    +LG+GGFG V    V   GK  A K+L   +    +GE     E  I+ +V+ + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
           +VSL   Y       LV   +    L+FH++  G P  D    +  A     GL  L  +
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
              +I++RD+K  NILLD +   +++D GLA    +  T V  RV GT GY+APE  ++ 
Sbjct: 122 ---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINNE 176

Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
           K T   D +  G ++ E+I G+ P
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 13/201 (6%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRVHH---KHLVSL 105
           L+G+G +G V+RG  +P G+ VA+K +   +   +  + Q EV ++S++      ++   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
            G Y  G +  ++ E+    ++   +  K  P  +    + I       L Y+H+     
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAEKYISV-IIREVLVALKYIHKV---G 121

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           +IHRDIKAANIL+      K+ DFG+A + +  ++  ST V GT  ++APE  + GK  +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYD 180

Query: 226 -KSDVFSFGVMLLELITGRRP 245
            K+D++S G+ + E+ TG  P
Sbjct: 181 TKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 23/211 (10%)

Query: 46  FSDANLLGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGEREFQ---AEVEIISRVHHKH 101
           F   + +G G FG V+     +  E VA+K++     Q   ++Q    EV+ + ++ H +
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 102 LVSLVGYYTAGSQRMLVYEFV---PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
            +   G Y       LV E+     ++ LE H     +  +  +    I  G+ +GLAYL
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVH-----KKPLQEVEIAAITHGALQGLAYL 137

Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY- 217
           H      +IHRDIKA NILL    + K+ADFG A  +S  N+ V     GT  ++APE  
Sbjct: 138 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVI 189

Query: 218 --ASSGKLTEKSDVFSFGVMLLELITGRRPV 246
                G+   K DV+S G+  +EL   + P+
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 84.2 bits (208), Expect = 2e-18
 Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 12/201 (5%)

Query: 52  LGQGGFGYVHRGVLPNGK---EVAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLVG 107
           LG G FG V +GV    K   +VAIK LK  + +  R E   E EI+ ++ + ++V ++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
              A +  MLV E      L   L GK +  +     +++    + G+ YL        +
Sbjct: 63  VCEAEAL-MLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFV 117

Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASSGKLTE 225
           HRD+ A N+LL  +  AK++DFGL+K     +++   R  G +   + APE  +  K + 
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 226 KSDVFSFGVMLLELIT-GRRP 245
           +SDV+S+G+ + E  + G++P
Sbjct: 178 RSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 24/214 (11%)

Query: 52  LGQGGFGYVHRG----VLPNGKE--VAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG V       + P   +  VA+K LK  S    ++F  E E+++ + H+H+V  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHL--HG-------KGRPTMDWLTR---LKIALGSAK 153
            G    G   ++V+E++ +  L   L  HG       +G    + LT+   L IA   A 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE-LTQSQMLHIAQQIAA 131

Query: 154 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGY 212
           G+ YL        +HRD+   N L+      K+ DFG+++ + S     V    M    +
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188

Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
           + PE     K T +SDV+S GV+L E+ T G++P
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 84.1 bits (208), Expect = 3e-18
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 14/200 (7%)

Query: 52  LGQGGFGYVHRGVLPN-GKE-----VAIKQLKAGSGQGERE-FQAEVEIISRV-HHKHLV 103
           LG G FG V         K      VA+K LK  +   ERE   +E++I+S + +H+++V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL-HEDC 162
           +L+G  T G   +++ E+     L   L  K    +     L  +   AKG+A+L  ++C
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC 162

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPEYASSG 221
               IHRD+ A N+LL      K+ DFGLA+ I +D N  V         ++APE   + 
Sbjct: 163 ----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC 218

Query: 222 KLTEKSDVFSFGVMLLELIT 241
             T +SDV+S+G++L E+ +
Sbjct: 219 VYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 9/204 (4%)

Query: 46  FSDANLLGQGGFGYVHR-GVLPNGKEVAIKQL---KAGSGQGEREFQAEVEIISRVHHKH 101
           F    +LG+GGFG V    V   GK  A K+L   +    +GE     E +I+ +V+ + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
           +VSL   Y       LV   +    L+FH++  G P  D    +  A     GL  LH +
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
              +I++RD+K  NILLD     +++D GLA    +    +  RV GT GY+APE   + 
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE-GETIRGRV-GTVGYMAPEVVKNE 176

Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
           + T   D +  G ++ E+I G+ P
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 86.8 bits (215), Expect = 4e-18
 Identities = 58/192 (30%), Positives = 94/192 (48%), Gaps = 18/192 (9%)

Query: 68  GKEVAIKQLKAGSGQGERE---FQAEVEIISRVHHKHLVSLVGYYTAGSQRML-VYEFVP 123
           G EVAIK L+  + + E +   F+ E  + +R++H ++V+L+    A    +  V+E+VP
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL---DF 180
             TL   L   G   +      ++ L     LA  H      I+HRD+K  NI++     
Sbjct: 63  GRTLREVLAADG--ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGV 117

Query: 181 KFEAKVADFGLAKIASDVNTHVSTR------VMGTFGYLAPEYASSGKLTEKSDVFSFGV 234
           +  AKV DFG+  +   V             V+GT  Y APE      +T  SD++++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177

Query: 235 MLLELITGRRPV 246
           + LE +TG+R V
Sbjct: 178 IFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 65/211 (30%), Positives = 109/211 (51%), Gaps = 15/211 (7%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKE----VAIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++    VAIK+L+ A S +  +E   E  +++ V +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
            H+  L+G     S   L+ + +P   L ++    K      +L  L   +  AKG+ YL
Sbjct: 69  PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQIAKGMNYL 125

Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPEY 217
            E    +++HRD+ A N+L+      K+ DFGLAK + +D   + +        ++A E 
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182

Query: 218 ASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
                 T +SDV+S+GV + EL+T G +P D
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 83.1 bits (205), Expect = 6e-18
 Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 18/202 (8%)

Query: 52  LGQGGFGYVH------RGVLPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVS 104
           LG+G FG V        G    G++VA+K LK  SG     + + E+EI+  ++H+++V 
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 105 LVGYYT--AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
             G  T   G+   L+ EF+P+ +L+ +L  + +  ++   +LK A+   KG+ YL    
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGSR- 128

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST---RVMGTFGYLAPEYAS 219
             + +HRD+ A N+L++ + + K+ DFGL K       + +         F Y APE   
Sbjct: 129 --QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLI 185

Query: 220 SGKLTEKSDVFSFGVMLLELIT 241
             K    SDV+SFGV L EL+T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 83.2 bits (206), Expect = 6e-18
 Identities = 78/301 (25%), Positives = 126/301 (41%), Gaps = 64/301 (21%)

Query: 34  FTYEELARATDGFSDANLLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGE-REFQ 88
           FT E+L        D   +G+G FG V    H+   P+G  +A+K++++   + E +   
Sbjct: 1   FTAEDL-------KDLGEIGRGAFGTVNKMLHK---PSGTIMAVKRIRSTVDEKEQKRLL 50

Query: 89  AEVEIISRVHHKHLVSLVGYYTA----GSQRM----------LVYEFVPNNTLEFHLHGK 134
            +++++ R        +V +Y A    G   +            Y++V       +   K
Sbjct: 51  MDLDVVMR--SSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYV-------YEVLK 101

Query: 135 GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI 194
                + L   KIA+ + K L YL E+   KIIHRD+K +NILLD     K+ DFG++  
Sbjct: 102 SVIPEEILG--KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGIS-- 155

Query: 195 ASDVNTHVSTRVMGTFGYLAPE-YASSG--KLTEKSDVFSFGVMLLELITGRRPVDSTHT 251
              V++   TR  G   Y+APE    S       +SDV+S G+ L E+ TG+ P    ++
Sbjct: 156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS 215

Query: 252 -FVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP 310
            F + + V    P                P L N          V     C+     +RP
Sbjct: 216 VFDQLTQVVKGDP----------------PILSNSEEREFSPSFVNFINLCLIKDESKRP 259

Query: 311 R 311
           +
Sbjct: 260 K 260

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 83.1 bits (205), Expect = 8e-18
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 25/216 (11%)

Query: 52  LGQGGFGYVHRG----VLPNGKE--VAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG V       + P   +  VA+K LK  +    ++FQ E E+++ + H+H+V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWL--------------TRLKIALGS 151
            G    G   ++V+E++ +  L   L   G   M  +                L IA   
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTF 210
           A G+ YL        +HRD+   N L+      K+ DFG+++ + S     V    M   
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
            ++ PE     K T +SDV+SFGV+L E+ T G++P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 82.7 bits (204), Expect = 8e-18
 Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 26/217 (11%)

Query: 52  LGQGGFGYVHRG--VLP---NGKEVAIKQLK-AGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+  FG +++G   LP   + + VAIK LK   + Q   EFQ E  +++ +HH ++V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 106 VGYYTAGSQRMLVYEFVPNNTL-EFHL--------------HGKGRPTMDWLTRLKIALG 150
           +G  T      +++E++    L EF +               G  + ++D    L IA+ 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGT 209
            A G+ YL        +H+D+ A NIL+  +   K++D GL++ I S     V  + +  
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
             ++ PE    GK +  SD++SFGV+L E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 82.6 bits (204), Expect = 8e-18
 Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 18/207 (8%)

Query: 51  LLGQGGFG--YVHRGVLPNGKEVAIKQLK---AGSGQGEREFQA---EVEIISRVHHKHL 102
            LG G F   Y  R V   G  +A+KQ+      S + E   +A   E+ +++R++H H+
Sbjct: 7   QLGTGAFSSCYQARDVK-TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           + ++G     S   L  E++   ++   L   G    + +  +       +GL+YLHE+ 
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-AFKEAVI-INYTEQLLRGLSYLHEN- 122

Query: 163 HPKIIHRDIKAANILLDFKFE-AKVADFGLA-KIASDVN--THVSTRVMGTFGYLAPEYA 218
             +IIHRD+K AN+L+D   +  ++ADFG A ++A+          +++GT  ++APE  
Sbjct: 123 --QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
              +     DV+S G +++E+ T + P
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 82.4 bits (203), Expect = 9e-18
 Identities = 66/207 (31%), Positives = 100/207 (48%), Gaps = 9/207 (4%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLV 103
           F+    +G+G FG V +G+     K VAIK +     + E E  Q E+ ++S+    ++ 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
              G Y   ++  ++ E++   +    L           T L+  L   KGL YLH +  
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSE-- 120

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
            K IHRDIKAAN+LL    E K+ADFG+A   +D     +T V GT  ++APE       
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178

Query: 224 TEKSDVFSFGVMLLELITGRRPVDSTH 250
             K+D++S G+  +EL  G  P    H
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELH 205

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 66/212 (31%), Positives = 99/212 (46%), Gaps = 25/212 (11%)

Query: 46  FSDANLLGQGGFG--YVHRGVLPNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHHK 100
           FSD   +G G FG  Y  R V  + + VAIK++     Q   ++Q    EV  + ++ H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNS-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75

Query: 101 HLVSLVGYYTAGSQRMLVYEFV---PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           + +   G Y       LV E+     ++ LE H     +  +  +    +  G+ +GLAY
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAY 130

Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
           LH      +IHRD+KA NILL      K+ DFG A I +  N  V     GT  ++APE 
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEV 182

Query: 218 ---ASSGKLTEKSDVFSFGVMLLELITGRRPV 246
                 G+   K DV+S G+  +EL   + P+
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 9/218 (4%)

Query: 46  FSDANLLGQGGFGYVHR-GVLPNGKEVAIKQL---KAGSGQGEREFQAEVEIISRVHHKH 101
           F    +LG+GGFG V    V   GK  A K+L   +    +GE     E +I+ +V+ + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
           +V+L   Y       LV   +    L+FH++  G P  +    L  A     GL  LH +
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
                ++RD+K  NILLD     +++D GLA +       +  RV GT GY+APE  ++ 
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRV-GTVGYMAPEVLNNQ 176

Query: 222 KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
           + T   D +  G ++ E+I G+ P       V+   VD
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 23/208 (11%)

Query: 52  LGQGGFGYVH----RGVLPNGKE--VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
           LGQG FG V+    +GV+ +  E  VAIK +   +   ER EF  E  ++   +  H+V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLH----------GKGRPTMDWLTRLKIALGSAKG 154
           L+G  + G   +++ E +    L+ +L            +  P++  +  +++A   A G
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM--IQMAGEIADG 131

Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH-VSTRVMGTFGYL 213
           +AYL+ +   K +HRD+ A N ++   F  K+ DFG+ +   + + +    + +    ++
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT 241
           +PE    G  T  SDV+SFGV+L E+ T
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 28/228 (12%)

Query: 42  ATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HH 99
            T  F    ++G+G +G V++      G+ VAIK +       E E + E  I+ +  +H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYSNH 62

Query: 100 KHLVSLVGYY------TAGSQRMLVYEFVPNNT---LEFHLHGKGRP-TMDWLTRLKIAL 149
            ++ +  G +          Q  LV E     +   L   L  KG+    +W+    I  
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILR 120

Query: 150 GSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VM 207
            + +GLAYLHE+   K+IHRDIK  NILL    E K+ DFG+   ++ +++ +  R   +
Sbjct: 121 ETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV---SAQLDSTLGRRNTFI 174

Query: 208 GTFGYLAPEY-ASSGKLTE----KSDVFSFGVMLLELITGRRPVDSTH 250
           GT  ++APE  A   +       +SDV+S G+  +EL  G+ P+   H
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 80.9 bits (199), Expect = 3e-17
 Identities = 64/205 (31%), Positives = 109/205 (53%), Gaps = 15/205 (7%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLK--AGSGQGEREFQA---EVEIISRVHHKHLVS 104
           LLGQG FG V+    +  G+E+A KQ++    S +  +E  A   E++++  + H+ +V 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 105 LVGYYTAGSQRMLV--YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
             G     +++ L    E++P  +++  L   G  T + +TR K      +G++YLH + 
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALT-ESVTR-KYTRQILEGMSYLHSN- 125

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTR-VMGTFGYLAPEYASS 220
              I+HRDIK ANIL D     K+ DFG +K + +   +    R V GT  +++PE  S 
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183

Query: 221 GKLTEKSDVFSFGVMLLELITGRRP 245
                K+DV+S G  ++E++T + P
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 43/224 (19%)

Query: 52  LGQGGFGYVHR----GVLPNGKE--VAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVS 104
           +GQG FG V +    G+LP      VA+K LK   S   + +FQ E  +++   H ++V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 105 LVGYYTAGSQRMLVYEFV--------------------PNNTLEFHLHGKGRPTMDWLTR 144
           L+G    G    L++E++                     ++T      G     +    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KIAS------D 197
           L IA   A G+AYL E    K +HRD+   N L+      K+ADFGL+  I S       
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            N  +  R M       PE     + T +SDV+++GV+L E+ +
Sbjct: 190 ENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 80.7 bits (199), Expect = 4e-17
 Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 38/279 (13%)

Query: 51  LLGQGGFGYVHRGVL--PNGKE--VAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVSL 105
           +LG G FG + RG L  P+ +E  VAI  L+AG S +  R F AE   + +  H ++V L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 106 VGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
            G  T G+  M+V E++ N  L+ F    +G+     L  + +  G A G+ YL E  + 
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL--MGMLPGLASGMKYLSEMGY- 128

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL--APEYASSGK 222
             +H+ + A  +L++     K++ F   ++  D +  + T + G    L  APE      
Sbjct: 129 --VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184

Query: 223 LTEKSDVFSFGVMLLELIT-GRRPV-DSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP 280
            +  SDV+SFG+++ E+++ G RP  D +    +D +         +A+EDG    L  P
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVI---------KAVEDGF--RLPAP 230

Query: 281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL 319
           +      H  M         C +     RPR SQI   L
Sbjct: 231 RNCPNLLHQLMLD-------CWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 81.3 bits (201), Expect = 4e-17
 Identities = 63/207 (30%), Positives = 92/207 (44%), Gaps = 26/207 (12%)

Query: 52  LGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREFQAEV------EIISRVHHKH 101
           LG+G FG V    ++     G+  AIK LK G      E ++ +      E  +   H  
Sbjct: 7   LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAK---GLAYL 158
           LV+L   +        V E+     L  H+H       D  +  +    +A    GL YL
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIH------TDVFSEPRAVFYAACVVLGLQYL 117

Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           HE+   KI++RD+K  N+LLD +   K+ADFGL K         ST   GT  +LAPE  
Sbjct: 118 HEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPEVL 173

Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
           +    T   D +  GV++ E++ G  P
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 80.3 bits (198), Expect = 6e-17
 Identities = 57/196 (29%), Positives = 102/196 (52%), Gaps = 14/196 (7%)

Query: 52  LGQGGFGYVHRG-VLPNGKEVAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
           LG G  G V++   L   + +A+K +    + + +++  +E+EI+ +    +++   G +
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
              ++  +  EF+   +L+ +     +     L R  IA+   KGL YL      KI+HR
Sbjct: 69  FVENRISICTEFMDGGSLDVY----RKIPEHVLGR--IAVAVVKGLTYLWS---LKILHR 119

Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D+K +N+L++ + + K+ DFG++     VN+   T V GT  Y+APE  S  +    SDV
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVST--QLVNSIAKTYV-GTNAYMAPERISGEQYGIHSDV 176

Query: 230 FSFGVMLLELITGRRP 245
           +S G+  +EL  GR P
Sbjct: 177 WSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 20/201 (9%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHHKHLVSLVGY 108
           +G+G +G V++      G+ VAIK++K           A  E++++  ++H +++ L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
           +       LV+EF+  +  +  +  + R   + L +        +GLA+ H      I+H
Sbjct: 67  FRHKGDLYLVFEFMDTDLYKL-IKDRQRGLPESLIK-SYLYQLLQGLAFCHSH---GILH 121

Query: 169 RDIKAANILLDFKFEAKVADFGLAKIA---SDVNTH-VSTRVMGTFGYLAPE--YASSGK 222
           RD+K  N+L++ +   K+ADFGLA+         TH V TR      Y APE      G 
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKG- 175

Query: 223 LTEKSDVFSFGVMLLELITGR 243
            +   D++S G +  EL++ R
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.4 bits (198), Expect = 6e-17
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 37/222 (16%)

Query: 52  LGQGGFGYVHRGV------LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVS 104
           LG+G FG V +              VA+K LK  +   E R+  +E  ++ +V+H H++ 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHL-----------------------HGKGRP-TMD 140
           L G  +     +L+ E+    +L   L                       +   R  TM 
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 141 WLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT 200
            L  +  A   ++G+ YL E    K++HRD+ A N+L+    + K++DFGL++   + ++
Sbjct: 128 DL--ISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182

Query: 201 HVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           +V  ++      ++A E       T +SDV+SFGV+L E++T
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 34/218 (15%)

Query: 51  LLGQGGFGYVHRGV---LPNGKE---VAIKQLKAGSGQGE-REFQAEVEIISRV-HHKHL 102
            LG+G FG V +     L N  E   VA+K LK  + + +  +  +E+E++  +  HK++
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGK-----------GRPTMDWLTRLKI---A 148
           ++L+G  T      +V E+  +  L   L  +            RP  + LT+  +   A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
              A+G+ +L      K IHRD+ A N+L+      K+ADFGLA+    ++ +  T    
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT---- 191

Query: 209 TFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT 241
           T G L     APE       T +SDV+SFGV+L E+ T
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 30/214 (14%)

Query: 50  NLLGQGGFGYVHRGVLP---NGKEVAIKQLKA-GSGQGEREFQAEVEIISRV-HHKHLVS 104
           +++G+G FG V R ++         AIK LK   S    R+F  E+E++ ++ HH ++++
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 105 LVGYYTAGSQRMLVYEFVP-NNTLEF--------------HLHGKGRPTMDWLTRLKIAL 149
           L+G         +  E+ P  N L+F                HG    T+     L+ A 
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAS-TLTSQQLLQFAS 126

Query: 150 GSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
             A G+ YL E    + IHRD+ A N+L+     +K+ADFGL++   +V      + MG 
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-GEEVYV---KKTMGR 179

Query: 210 FG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
               ++A E  +    T KSDV+SFGV+L E+++
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 41/103 (39%), Positives = 63/103 (61%), Gaps = 9/103 (8%)

Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVS 203
           KI++   +GL YL E  H KI+HRD+K +NIL++ + E K+ DFG++   I S  N+ V 
Sbjct: 103 KISIAVLRGLTYLREK-H-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 160

Query: 204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
           TR      Y++PE       T +SD++S G+ L+E+  GR P+
Sbjct: 161 TR-----SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 78.2 bits (192), Expect = 2e-16
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 17/206 (8%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLK--AGSGQGEREFQA---EVEIISRVHHKHLVS 104
           LLGQG FG V+       G+E+A+KQ++    S +  +E  A   E++++  + H+ +V 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 105 LVGYYTAGSQRML--VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
             G      +R L    E +P  +++  L   G  T + +TR K      +G++YLH + 
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTEN-VTR-KYTRQILEGVSYLHSN- 125

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV---NTHVSTRVMGTFGYLAPEYAS 219
              I+HRDIK ANIL D     K+ DFG +K    +    T + + V GT  +++PE  S
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPEVIS 182

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRP 245
                 K+D++S G  ++E++T + P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 78.2 bits (192), Expect = 2e-16
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 30/214 (14%)

Query: 50  NLLGQGGFGYVHRGVLPNG---KEVAIKQLKAGSGQGE-REFQAEVEIISRV-HHKHLVS 104
           +++G+G FG V +  +       + AIK++K  + + + R+F  E+E++ ++ HH ++++
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 105 LVGYYTAGSQRMLVYEFVP-NNTLEF--------------HLHGKGRPTMDWLTRLKIAL 149
           L+G         L  E+ P  N L+F                +     T+     L  A 
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS-TLSSQQLLHFAA 119

Query: 150 GSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
             A+G+ YL +    + IHRD+ A NIL+   + AK+ADFGL++   +V      + MG 
Sbjct: 120 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYV---KKTMGR 172

Query: 210 FG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
               ++A E  +    T  SDV+S+GV+L E+++
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 13/200 (6%)

Query: 52  LGQGGFGYV------HRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+GGFG V      + G +   K++  K+LK  SG  E+    E EI+ +V+   +V+L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSG--EKMALLEKEILEKVNSPFIVNL 58

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
              + + +   LV   +    L++H++  G   ++    +  +     G+ +LH      
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MD 115

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           I++RD+K  N+LLD +   +++D GLA    D  T   T+  GT GY+APE       + 
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSY 173

Query: 226 KSDVFSFGVMLLELITGRRP 245
             D F+ G  + E++ GR P
Sbjct: 174 PVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 78.0 bits (193), Expect = 3e-16
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 48/215 (22%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA--------EVEIISRV-HHKH 101
           LG G FG V+       G+ VAIK++K       ++F +        EV+ + ++  H +
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA---LGSAKGLAYL 158
           +V L   +    +   V+E++  N  +     KG+P     +   I        +GLA++
Sbjct: 60  IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKP----FSESVIRSIIYQILQGLAHI 115

Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IAS--DVNTHVSTRVMGTFGYLAP 215
           H+  H    HRD+K  N+L+      K+ADFGLA+ I S      +VSTR      Y AP
Sbjct: 116 HK--H-GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAP 167

Query: 216 E-------YASSGKLTEKSDVFSFGVMLLELITGR 243
           E       Y+S        D+++ G ++ EL T R
Sbjct: 168 EILLRSTSYSS------PVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 21/199 (10%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G FG V++      G   A K ++  S +   ++  E+EI++  +H ++V L+G + 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 111 AGSQRMLVYEFVPNNTLEFHL----HGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
              +  ++ EF P   ++  +     G   P +  + R  +     + L YLH     KI
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLHSM---KI 131

Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTE 225
           IHRD+KA N+LL    + K+ADFG++  A +V T       +GT  ++APE      + +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 226 -----KSDVFSFGVMLLEL 239
                K+D++S G+ L+E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 30/217 (13%)

Query: 52  LGQGGFGYVHR----------GVLPNGKE-----VAIKQLKAGSGQGER-EFQAEVEIIS 95
           LG+G FG VH           G      +     VA+K L+A   +  R +F  E++I+S
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 96  RVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHL----------HGKGRPTMDWLTRL 145
           R+ + +++ L+G   +     ++ E++ N  L   L          H    P++     L
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVST 204
            +A+  A G+ YL        +HRD+   N L+   +  K+ADFG+++ + S     +  
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           R +    ++A E    GK T  SDV++FGV L E+ T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 78.2 bits (192), Expect = 4e-16
 Identities = 55/181 (30%), Positives = 93/181 (51%), Gaps = 11/181 (6%)

Query: 67  NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT 126
            GK+VA+K++     Q       EV I+   HH+++V +   Y  G +  +V EF+    
Sbjct: 46  TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105

Query: 127 L-EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAK 185
           L +   H +    M+      + L   + L+YLH      +IHRDIK+ +ILL      K
Sbjct: 106 LTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIK 158

Query: 186 VADFGL-AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRR 244
           ++DFG  A+++ +V    S  ++GT  ++APE  S      + D++S G+M++E+I G  
Sbjct: 159 LSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216

Query: 245 P 245
           P
Sbjct: 217 P 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 25/209 (11%)

Query: 52  LGQGGFGYVHRGVLPN------GKEVAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
           LGQG FG V+ G   +         VA+K +   +   ER EF  E  ++      H+V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHL--------HGKGRPTMDWLTRLKIALGSAKGLA 156
           L+G  + G   ++V E + +  L+ +L        +  GRP       +++A   A G+A
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT----FGY 212
           YL+     K +HRD+ A N ++   F  K+ DFG+ +   D+      R  G       +
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR---DIYETDYYRKGGKGLLPVRW 187

Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           +APE    G  T  SD++SFGV+L E+ +
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 58/232 (25%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-F----QAEVEIISRVHHKHLVSL 105
           LG+G FG V++   +  G+ VA+K++   +   E++ F      E++I+ ++ H ++V L
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHN---EKDGFPITALREIKILKKLKHPNVVPL 72

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKG-----RPTMDW-LT------RLKIALGSAK 153
           +          +  E             +G      P MD  L+       +K+     K
Sbjct: 73  ID---------MAVERPDK-----SKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK 118

Query: 154 --------GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI----------A 195
                   G+ YLHE+    I+HRDIKAANIL+D +   K+ADFGLA+            
Sbjct: 119 CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 196 SDVNTHVSTRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLELITGRRPV 246
               T   T ++ T  Y  PE      + T   D++  G +  E+ T RRP+
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPI 226

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 78.2 bits (193), Expect = 5e-16
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 26/211 (12%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA-------EVEIISRV 97
           F   N +G+G +G V+R     +G+ VA+K+++      + E          E+ ++  +
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM-----DNERDGIPISSLREITLLLNL 63

Query: 98  HHKHLVSLVGYYTAGSQR---MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK-IALGSAK 153
            H ++V L      G       LV E+   + L   L     P  +  +++K + L   +
Sbjct: 64  RHPNIVELK-EVVVGKHLDSIFLVMEYCEQD-LASLLDNMPTPFSE--SQVKCLMLQLLR 119

Query: 154 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL 213
           GL YLHE+    IIHRD+K +N+LL  K   K+ADFGLA+        ++ +V+ T  Y 
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYR 175

Query: 214 APEYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           APE        T   D+++ G +L EL+  +
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.7 bits (191), Expect = 6e-16
 Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 28/213 (13%)

Query: 50  NLLGQGGFGYVHRGVLPNG---KEVAIKQLKAGSGQGE-REFQAEVEIISRV-HHKHLVS 104
           +++G+G FG V +  +       + AIK++K  + + + R+F  E+E++ ++ HH ++++
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 105 LVGYYTAGSQRMLVYEFVPNNTL--------------EFHLHGKGRPTMDWLTRLKIALG 150
           L+G         L  E+ P+  L               F +      T+     L  A  
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
            A+G+ YL +    + IHRD+ A NIL+   + AK+ADFGL++   +V      + MG  
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYV---KKTMGRL 185

Query: 211 G--YLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
              ++A E  +    T  SDV+S+GV+L E+++
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 77.3 bits (190), Expect = 7e-16
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 26/204 (12%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA-EVEIISRVHHKHLVSLVGYY 109
           +GQG  G V+  + +  G+EVAIKQ+     Q ++E    E+ ++    H ++V+ +  Y
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA--------KGLAYLHED 161
             G +  +V E++   +L            D +T   +  G          + L +LH +
Sbjct: 86  LVGDELWVVMEYLAGGSL-----------TDVVTETCMDEGQIAAVCRECLQALEFLHSN 134

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
              ++IHRDIK+ NILL      K+ DFG     +   +  ST V GT  ++APE  +  
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 190

Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
               K D++S G+M +E++ G  P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (188), Expect = 8e-16
 Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 17/206 (8%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQL--KAGSGQGEREFQA---EVEIISRVHHKHLVS 104
           LLG+G FG V+       G+E+A+KQ+     S +  +E  A   E++++  + H  +V 
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 105 LVGYYTAGSQRML--VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
             G      ++ L    E++P  +++  L   G  T + +TR +      +G++YLH + 
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTEN-VTR-RYTRQILQGVSYLHSN- 125

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV---NTHVSTRVMGTFGYLAPEYAS 219
              I+HRDIK ANIL D     K+ DFG +K    +    T + + V GT  +++PE  S
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEVIS 182

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRP 245
                 K+DV+S    ++E++T + P
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 77.4 bits (191), Expect = 8e-16
 Identities = 63/204 (30%), Positives = 92/204 (45%), Gaps = 15/204 (7%)

Query: 51  LLGQGGFGYVHRGVLPNGKEV-AIKQLKAGSGQGEREF---QAEVEIISRV-HHKHLVSL 105
           +LG+G FG V    L    E+ A+K LK      + +      E  +++    H  L  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
              +    +   V E+V    L FH+   GR   D       A     GL +LHE     
Sbjct: 62  HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHER---G 116

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
           II+RD+K  N+LLD +   K+ADFG+ K  I   V T   +   GT  Y+APE  S    
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEILSYQPY 173

Query: 224 TEKSDVFSFGVMLLELITGRRPVD 247
               D ++ GV+L E++ G+ P +
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 58/197 (29%), Positives = 105/197 (53%), Gaps = 11/197 (5%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA-EVEIISRVHHKHLVSLVGYY 109
           LG+G +  V++G     G+ VA+K++   + +G       E+ ++  + H+++V L    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 110 TAGSQRMLVYEFVPNNTLEF-HLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
              ++ MLV+E++  +  ++   HG     +D  T         KG+A+ HE+   +++H
Sbjct: 68  HTENKLMLVFEYMDKDLKKYMDTHGVRGA-LDPNTVKSFTYQLLKGIAFCHEN---RVLH 123

Query: 169 RDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS 227
           RD+K  N+L++ + E K+ADFGLA+     VNT  +  V  T  Y AP+     +    S
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTYSTS 181

Query: 228 -DVFSFGVMLLELITGR 243
            D++S G ++ E+ITGR
Sbjct: 182 IDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 62/211 (29%), Positives = 108/211 (51%), Gaps = 23/211 (10%)

Query: 51  LLGQGGFGYVHRGV-LPNGKE----VAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVS 104
           +LG G FG V++G+ +P+G+     VAIK L+   S +  +E   E  +++ V   ++  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHL-HGKGR----PTMDWLTRLKIALGSAKGLAYLH 159
           L+G     S   LV + +P   L  ++   K R      ++W  ++      AKG++YL 
Sbjct: 74  LLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126

Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS-DVNTHVSTRVMGTFGYLAPEYA 218
           E    +++HRD+ A N+L+      K+ DFGLA++   D   + +        ++A E  
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183

Query: 219 SSGKLTEKSDVFSFGVMLLELIT-GRRPVDS 248
              + T +SDV+S+GV + EL+T G +P D 
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 52/180 (28%), Positives = 91/180 (50%), Gaps = 11/180 (6%)

Query: 68  GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL 127
           G++VA+K++     Q       EV I+    H ++V +   Y  G +  +V EF+    L
Sbjct: 44  GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103

Query: 128 -EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV 186
            +   H +    M+      + L   K L++LH      +IHRDIK+ +ILL      K+
Sbjct: 104 TDIVTHTR----MNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKL 156

Query: 187 ADFGL-AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           +DFG  A+++ +V    S  ++GT  ++APE  S      + D++S G+M++E++ G  P
Sbjct: 157 SDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 14/202 (6%)

Query: 52  LGQGGFGYVHRGVL---PNGKEVAIKQLKAGSGQG--EREFQAEVEIISRVHHKHLVSLV 106
           LG G FG V +G+     + K VA+K LK  +     + E   E  ++ ++ + ++V ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
           G   A S  MLV E      L   L      T   +T L   +  + G+ YL E      
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNITELVHQV--SMGMKYLEET---NF 116

Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASSGKLT 224
           +HRD+ A N+LL  +  AK++DFGL+K       +   +  G +   + APE  +  K +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 225 EKSDVFSFGVMLLELIT-GRRP 245
            KSDV+SFGV++ E  + G++P
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 28/216 (12%)

Query: 52  LGQGGFGYV----HRGVLPNGKEVAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G +G V    H    P G  +A+K+++A  + Q ++    +++I  R         V
Sbjct: 9   LGRGAYGVVDKMRHV---PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS--VDCPYTV 63

Query: 107 GYYTAGSQRMLVYEF--VPNNTLE-----FHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
            +Y A  +   V+    V + +L+      +  G   P  D L   KIA+   K L YLH
Sbjct: 64  TFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPE-DILG--KIAVSIVKALEYLH 120

Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY-- 217
                 +IHRD+K +N+L++   + K+ DFG++     V++   T   G   Y+APE   
Sbjct: 121 SKL--SVIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSVAKTIDAGCKPYMAPERIN 176

Query: 218 --ASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHT 251
              +      KSDV+S G+ ++EL TGR P DS  T
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT 212

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 14/198 (7%)

Query: 52  LGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +G+G  G V    V  +GK VA+K++     Q       EV I+    H+++V +   Y 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 111 AGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            G +  +V EF+    L +   H +    M+      + L   K L+ LH      +IHR
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQ---GVIHR 140

Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYLAPEYASSGKLTEKS 227
           DIK+ +ILL      K++DFG     + V+  V  R  ++GT  ++APE  S      + 
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFC---AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197

Query: 228 DVFSFGVMLLELITGRRP 245
           D++S G+M++E++ G  P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 75.9 bits (186), Expect = 2e-15
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 8/195 (4%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +GQG  G V   + +  G+EVAIKQ+       +     E+ ++  + + ++V+ +  + 
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
            G +  +V E++   +L   +       MD      +     + L +LH +   ++IHRD
Sbjct: 87  VGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHAN---QVIHRD 140

Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           IK+ N+LL      K+ DFG     +   +  ST V GT  ++APE  +      K D++
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199

Query: 231 SFGVMLLELITGRRP 245
           S G+M +E++ G  P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 60/229 (26%), Positives = 92/229 (40%), Gaps = 47/229 (20%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA--------------EVEII 94
             LG+G +G V +      GK VAIK++K      +                   E++I+
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK------IA 148
           + + H++++ LV  Y  G    LV +          +    +  +D   RL       I 
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDI---------MASDLKKVVDRKIRLTESQVKCIL 125

Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK---------IASDVN 199
           L    GL  LH+      +HRD+  ANI ++ K   K+ADFGLA+           S   
Sbjct: 126 LQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182

Query: 200 THVSTRVMG----TFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 243
           T      M     T  Y APE    + K     D++S G +  EL+TG+
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 8/195 (4%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +GQG  G V+  + +  G+EVAIKQ+       +     E+ ++    + ++V+ +  Y 
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
            G +  +V E++   +L   +       MD      +     + L +LH +   ++IHRD
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSN---QVIHRD 140

Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           IK+ NILL      K+ DFG     +   +  ST V GT  ++APE  +      K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199

Query: 231 SFGVMLLELITGRRP 245
           S G+M +E++ G  P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 73.5 bits (180), Expect = 7e-15
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 23/198 (11%)

Query: 52  LGQGGFGYVHRGVL-PNGKEVAIK--------QLKAGSGQGEREFQAEVEIISRVHHKHL 102
           +G+G FG V  G L  +   VA+K         LKA       +F  E  I+ +  H ++
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-------KFLQEARILKQYSHPNI 55

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           V L+G  T      +V E V        L  +G P +     +++   +A G+ YL    
Sbjct: 56  VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH 114

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASS 220
               IHRD+ A N L+  K   K++DFG+++   D   + ST  M      + APE  + 
Sbjct: 115 ---CIHRDLAARNCLVTEKNVLKISDFGMSREEED-GVYASTGGMKQIPVKWTAPEALNY 170

Query: 221 GKLTEKSDVFSFGVMLLE 238
           G+ + +SDV+SFG++L E
Sbjct: 171 GRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 74.1 bits (182), Expect = 7e-15
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 16/226 (7%)

Query: 52  LGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQA---EVEIISRVHHKHLVSLVG 107
           LG+GGFG V    +   GK  A K+L     +  + ++    E  I+++VH + +VSL  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHG--KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
            +   +   LV   +    L +H++   +  P                GL +LH+    +
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           II+RD+K  N+LLD     +++D GLA    D  +  +    GT G++APE     +   
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYDF 176

Query: 226 KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIED 271
             D F+ GV L E+I  R P  +    VE+      + L  R + D
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVEN------KELKQRILND 216

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 74.3 bits (182), Expect = 8e-15
 Identities = 52/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)

Query: 67  NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT 126
           +G++VA+K +     Q       EV I+    H+++V +   Y  G +  ++ EF+    
Sbjct: 45  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104

Query: 127 LEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV 186
           L   +  + R   + +  +  ++  A  L YLH      +IHRDIK+ +ILL      K+
Sbjct: 105 LT-DIVSQTRLNEEQIATVCESVLQA--LCYLHSQ---GVIHRDIKSDSILLTLDGRVKL 158

Query: 187 ADFGL-AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           +DFG  A+I+ DV    S  ++GT  ++APE  S      + D++S G+M++E++ G  P
Sbjct: 159 SDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 74.2 bits (182), Expect = 9e-15
 Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 32/217 (14%)

Query: 52  LGQGGFGYVHR----GVLPNGKE----VAIKQLK-AGSGQGEREFQAEVEIISRV-HHKH 101
           LG+G FG V R    G+  +  +    VA+K LK   + +   +  +E+E++  +  HK+
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW---LTRL-----------KI 147
           +++L+G  T      ++ E+     L   L  +  P  D+   +T++             
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 148 ALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST--- 204
           A   A+G+ YL      + IHRD+ A N+L+      K+ADFGLA+   D++ +  T   
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           R+     ++APE       T +SDV+SFG+++ E+ T
Sbjct: 197 RL--PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 23/200 (11%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAI----KQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVG 107
           LG G FG V++      KE  +    K +   S +   ++  E++I++   H ++V L+ 
Sbjct: 13  LGDGAFGKVYKA---QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
            +   +   ++ EF     ++  +    RP  +   R+ +   + + L YLHE+   KII
Sbjct: 70  AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHEN---KII 125

Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR---VMGTFGYLAPEYASSGKLT 224
           HRD+KA NIL     + K+ADFG+    S  NT    R    +GT  ++APE        
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGV----SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181

Query: 225 E-----KSDVFSFGVMLLEL 239
           +     K+DV+S G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 22/209 (10%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +G G +G V++   L  G+  A+K +K   G      Q E+ ++    H ++V+  G Y 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 111 AGSQRMLVYEFVPNNTLE--FHLHGKGRPTMDWLTRLKIAL---GSAKGLAYLHEDCHPK 165
           +  +  +  E+    +L+  +H+ G        L+ L+IA     + +GLAYLH      
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTGP-------LSELQIAYVCRETLQGLAYLHSKGK-- 127

Query: 166 IIHRDIKAANILLDFKFEAKVADFGL-AKIASDVNTHVSTRVMGTFGYLAPEYAS---SG 221
            +HRDIK ANILL    + K+ADFG+ AKI + +    S   +GT  ++APE A+   +G
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVEKNG 184

Query: 222 KLTEKSDVFSFGVMLLELITGRRPVDSTH 250
              +  D+++ G+  +EL   + P+   H
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 26/209 (12%)

Query: 51  LLGQGGFGYVH--RGVL--PNGKEVAIKQLKAG----SGQGEREFQAEVEIISRVHHKHL 102
           +LG+GG+G V   R V     GK  A+K LK      + +     +AE  I+  V H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----WLTRLKIALGSAKGLAYL 158
           V L+  +  G +  L+ E++    L  HL  +G    D    +L+ + +AL       +L
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE------HL 116

Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAPE 216
           H      II+RD+K  NILLD +   K+ DFGL K  I     TH      GT  Y+APE
Sbjct: 117 H---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPE 170

Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
                   +  D +S G ++ +++TG  P
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 53/196 (27%), Positives = 97/196 (49%), Gaps = 10/196 (5%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +GQG  G V+  + +  G+EVAI+Q+       +     E+ ++    + ++V+ +  Y 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
            G +  +V E++   +L   +       MD      +     + L +LH +   ++IHRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141

Query: 171 IKAANILLDFKFEAKVADFGL-AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           IK+ NILL      K+ DFG  A+I  + +    + ++GT  ++APE  +      K D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDI 199

Query: 230 FSFGVMLLELITGRRP 245
           +S G+M +E+I G  P
Sbjct: 200 WSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 21/211 (9%)

Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV 97
           D F   + LG G  G V +      G++   K + ++   A   Q  RE Q    ++   
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60

Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +  ++V   G + +  +  +  E +   +L+  L    R   + L ++ IA+   +GLAY
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAY 118

Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAP 215
           L E    +I+HRD+K +NIL++ + E K+ DFG++   I S  N+ V TR      Y++P
Sbjct: 119 LREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 171

Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
           E       + +SD++S G+ L+EL  GR P+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 70/216 (32%), Positives = 96/216 (44%), Gaps = 18/216 (8%)

Query: 51  LLGQGGFGYVHRGVLPNGKEV-AIKQLKAGSGQGEREFQAEVEIISRV-----HHKHLVS 104
           +LG+G FG V    L    E  AIK LK      + + +  + +  RV      H  L  
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTM-VERRVLALAWEHPFLTH 60

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKI-ALGSAKGLAYLHEDCH 163
           L   +        V E++    L FH+   GR       R +  A     GL +LH+   
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD---EARARFYAAEIICGLQFLHKK-- 115

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
             II+RD+K  N+LLD     K+ADFG+ K   +     ST   GT  Y+APE     K 
Sbjct: 116 -GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQKY 173

Query: 224 TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
            E  D +SFGV+L E++ G+ P    H   ED L D
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPF---HGEDEDELFD 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 61/222 (27%), Positives = 110/222 (49%), Gaps = 26/222 (11%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLV 103
           F    L+G G +G V++G  +  G+  AIK +   +G  E E + E+ ++ +  HH+++ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 66

Query: 104 SLVGYYTAGS------QRMLVYEFVPNNTLEFHLHGKGRPTM--DWLTRLKIALGSAKGL 155
           +  G +   +      Q  LV EF    ++   +      T+  +W+    I     +GL
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124

Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYL 213
           ++LH+    K+IHRDIK  N+LL    E K+ DFG   +++ ++  V  R   +GT  ++
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTPYWM 178

Query: 214 APEYASSGKLTE-----KSDVFSFGVMLLELITGRRPVDSTH 250
           APE  +  +  +     KSD++S G+  +E+  G  P+   H
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 59/218 (27%), Positives = 89/218 (40%), Gaps = 35/218 (16%)

Query: 52  LGQGGFGYVHRGVLPNGKEVA---IKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLVG 107
           +G G FG V  G    G   A   +K+L+A +   E+  F  EV+    ++H +++  +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHL-----HGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
                   +LV EF P   L+ +L             D L R+  A   A GL +LH+  
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQA- 119

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLA-------KIASDVNTHVSTRVMGTFGYLAP 215
               IH D+   N  L      K+ D+GLA          +     V  R      +LAP
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WLAP 171

Query: 216 EYASS-------GKLTEKSDVFSFGVMLLELIT-GRRP 245
           E              T+KS+++S GV + EL T   +P
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 72.2 bits (177), Expect = 3e-14
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 27/219 (12%)

Query: 51  LLGQGGFGYVHRGVLPNG-------KEVAIKQLKAGSGQGERE-----FQAEVEII-SRV 97
            LG G FG V++    N        KE+ +     G  + ER+       +EV II  ++
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG----KGRPTMD--WLTRLKIALGS 151
            H ++V     +    +  +V + +    L  H +     K R T +  W   +++ L  
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125

Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
              L YLH++   +I+HRD+   NI+L    +  + DFGLAK      + + T V+GT  
Sbjct: 126 ---LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-ESKL-TSVVGTIL 178

Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
           Y  PE   +    EK+DV++FG +L ++ T + P  ST+
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 61/203 (30%), Positives = 85/203 (41%), Gaps = 21/203 (10%)

Query: 52  LGQGGFGYVHR-GVLPNGKEVAIKQLKAG---SGQGEREFQAEVEIISRVHHKHLVSLVG 107
           LG GGFG V    V    +  A+K +K         +    +E EI+   +H  +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 108 YYTAGSQRMLVY---EFVPNNTLEFHLHGKGRPTMD-WLTRLKIALGSAKGLAYLHEDCH 163
            +     +  +Y   E+     L   L  +G    D +  R  IA        YLH    
Sbjct: 61  TF---KDKKYIYMLMEYCLGGELWTILRDRGL--FDEYTARFYIA-CVVLAFEYLHNR-- 112

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGK 222
             II+RD+K  N+LLD     K+ DFG AK       T       GT  Y+APE   +  
Sbjct: 113 -GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKG 168

Query: 223 LTEKSDVFSFGVMLLELITGRRP 245
                D +S G++L EL+TGR P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 46/282 (16%)

Query: 51  LLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHHKHLVS 104
           L+G+G +G V    H+     G+ VAIK+          +  A  E+ ++ ++ H++LV+
Sbjct: 8   LVGEGSYGMVMKCKHK---ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVN 64

Query: 105 LVGYYTAGSQRMLVYEFVPN---NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
           L+  +    +  LV+EFV +   + LE + +G     +D     K      +G+ + H  
Sbjct: 65  LIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSH 119

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IAS--DVNT-HVSTRVMGTFGYLAPEY 217
               IIHRDIK  NIL+      K+ DFG A+ +A+  +V T +V+TR      Y APE 
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPEL 171

Query: 218 -ASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIED-GNFD 275
                K     D+++ G ++ E++TG  P+     F  DS +D     L   I+  GN  
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTG-EPL-----FPGDSDID----QLYHIIKCLGNL- 220

Query: 276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRR-PRMSQIV 316
               P+    +  N +   +            +R P++S +V
Sbjct: 221 ---IPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLV 259

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)

Query: 44  DGFSDANLLGQGGFGYV----HR--GVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV 97
           D F   + LG G  G V    H+  G++   K + ++   A   Q  RE Q    ++   
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60

Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +  ++V   G + +  +  +  E +   +L+  L   GR     L ++ IA+   KGL Y
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTY 118

Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAP 215
           L E    KI+HRD+K +NIL++ + E K+ DFG++   I S  N+ V TR      Y++P
Sbjct: 119 LREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 171

Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
           E       + +SD++S G+ L+E+  GR P+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 71.5 bits (175), Expect = 4e-14
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 22/208 (10%)

Query: 52  LGQGGFG--YVHRGVLPNGKEVAIKQ--LKAGSGQGEREFQAEVEIISRVHHKHLVSLVG 107
           +G+G FG  Y+ +    + +   IK+  L     + +   + EV +++++ H ++V+   
Sbjct: 8   IGEGSFGKIYLAKAKSDS-EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHL---HG---KGRPTMDWLTRLKIALGSAKGLAYLHED 161
            +    +  +V E+     L   +    G        + W   ++I+LG    L ++H+ 
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISLG----LKHIHDR 120

Query: 162 CHPKIIHRDIKAANILLDFK-FEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS 220
              KI+HRDIK+ NI L      AK+ DFG+A+  +D +  ++   +GT  YL+PE   +
Sbjct: 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYTCVGTPYYLSPEICQN 176

Query: 221 GKLTEKSDVFSFGVMLLELITGRRPVDS 248
                K+D++S G +L EL T + P + 
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEG 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 72.0 bits (177), Expect = 4e-14
 Identities = 41/110 (37%), Positives = 56/110 (50%), Gaps = 8/110 (7%)

Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR 205
           K+ +   K L YL E  H  +IHRD+K +NILLD     K+ DFG++    D      TR
Sbjct: 118 KMTVAIVKALHYLKEK-H-GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TR 173

Query: 206 VMGTFGYLAPEYASSGKLTEK----SDVFSFGVMLLELITGRRPVDSTHT 251
             G   Y+APE         K    +DV+S G+ L+EL TG+ P  +  T
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 58/207 (28%), Positives = 106/207 (51%), Gaps = 22/207 (10%)

Query: 52  LGQGGFGYVHRGVL--PNGKEVAIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSLVGY 108
           LG+G +G V++ VL  P G  +A+K+++    + +  +   E++I+ +    ++V   G 
Sbjct: 9   LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPT--MDWLTRLKIALGSAKGLAYLHEDCHPKI 166
           +       +  E++   +L+  L+  G  T  +      +I     KGL +L E+ +  I
Sbjct: 68  FFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--I 124

Query: 167 IHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
           IHRD+K  N+L++   + K+ DFG++   +AS   T++     G   Y+APE   SG   
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPN 179

Query: 225 E------KSDVFSFGVMLLELITGRRP 245
           +      +SDV+S G+ +LE+  GR P
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 71.8 bits (176), Expect = 4e-14
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 21/213 (9%)

Query: 51  LLGQGGFGYVHRGVL--PNGK--EVAIKQLKA-GSGQGE-REFQAEVEIISRVHHKHLVS 104
           +LG+G FG V  G L   +G   +VA+K +K       E  EF +E   +    H +++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 105 LVGYYTAGSQR------MLVYEFVPNNTLEFHLH----GKGRPTMDWLTRLKIALGSAKG 154
           L+G     S        M++  F+ +  L   L     G     +   T LK  +  A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT-FGYL 213
           + YL        IHRD+ A N +L       VADFGL+K     + +   R+      ++
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
           A E  +    T KSDV++FGV + E+ T G+ P
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 64/282 (22%), Positives = 122/282 (43%), Gaps = 33/282 (11%)

Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVH 98
              F     +G+G F  V++ + L +G+ VA+K+++       +  Q    E++++ ++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEF---HLHGKGRPTMDWLTRLKIALGSAKGL 155
           H +++  +  +   ++  +V E      L     H   + R  +   T  K  +     L
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWKYFVQLCSAL 119

Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
            ++H     +I+HRDIK AN+ +      K+ D GL +  S   T   + V GT  Y++P
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175

Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED--SLVDWARPLLNRAIEDGN 273
           E         KSD++S G +L E+   + P      F  D  +L       L + IE  +
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP------FYGDKMNLYS-----LCKKIEKCD 224

Query: 274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQI 315
           +     P L  ++   E+  +V   + C+     +RP +S +
Sbjct: 225 Y-----PPLPADHYSEELRDLV---SRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 73.4 bits (180), Expect = 5e-14
 Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 24/223 (10%)

Query: 163 HPK-IIHRDIKAANILLDFKFEAKVADFGLAKI-ASDVNTHVSTRVMGTFGYLAPEYASS 220
           H K +IHRDIK+ANILL      K+ DFG +K+ A+ V+  V     GT  Y+APE    
Sbjct: 160 HSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR 219

Query: 221 GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP 280
              ++K+D+FS GV+L EL+T +RP D  +             ++++ +  G +D L   
Sbjct: 220 KPYSKKADMFSLGVLLYELLTLKRPFDGENM----------EEVMHKTLA-GRYDPLPPS 268

Query: 281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDASLADLNEGIRPGQSSVY 340
                    EM  +V    A +    +RRP  S+++        ++ L E I   Q    
Sbjct: 269 I------SPEMQEIV---TALLSSDPKRRPSSSKLLNMPICKLFISGLLE-IVQTQPGFS 318

Query: 341 GSYGSS-DYDTMQYNEDLKKFRKMALNSQEYSASSEYSRPTSE 382
           G    +      Q  + L+  R+  +   E S S+  S    E
Sbjct: 319 GPLRDTISRQIQQTKQLLQVERRRIVRQMEESLSTAASTTILE 361

Length = 496

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.9 bits (176), Expect = 6e-14
 Identities = 67/218 (30%), Positives = 98/218 (44%), Gaps = 16/218 (7%)

Query: 51  LLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRV-----HHKHLVS 104
           +LG+G FG V    L   G+  A+K LK      + + +  + +  RV      +  L  
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTM-VEKRVLALAWENPFLTH 60

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L   +        V EF+    L FH+  KGR   D       A     GL +LH     
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSK--- 115

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
            II+RD+K  N++LD     K+ADFG+ K  +    + ++   GT  Y+APE     K T
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCK-ENVFGDNRASTFCGTPDYIAPEILQGLKYT 174

Query: 225 EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR 262
              D +SFGV+L E++ G+ P    H   ED L +  R
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPF---HGDDEDELFESIR 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 26/203 (12%)

Query: 52  LGQGGFGYV----HRGVLPNGKEVAIKQL--KAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           +G+G +G V    HR    +GK+  IK+L  +  S +  +  + E +++S++ H ++V+ 
Sbjct: 8   VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 106 VGYYTAGS-QRMLVYEFVPNNTLEFHL-HGKG-----RPTMDWLTRLKIALGSAKGLAYL 158
              +        +V  F     L   L   KG        ++W  ++ +AL       YL
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QYL 118

Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           HE     I+HRD+K  N+ L      KV D G+A++  +     ST ++GT  Y++PE  
Sbjct: 119 HEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELF 174

Query: 219 SSGKLTEKSDVFSFGVMLLELIT 241
           S+     KSDV++ G  + E+ T
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 71.4 bits (176), Expect = 9e-14
 Identities = 58/233 (24%), Positives = 97/233 (41%), Gaps = 73/233 (31%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA---------EVEIISRVHH 99
             +G G +G V   V    G++VAIK++          F           E++++  + H
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRH 58

Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH------------LHG---KGRPTMDWLTR 144
           ++++ L          + +    P +  +F+            LH      +P    LT 
Sbjct: 59  ENIIGL----------LDI--LRPPSPEDFNDVYIVTELMETDLHKVIKSPQP----LTD 102

Query: 145 LKI------ALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA--- 195
             I       L   +GL YLH      +IHRD+K +NIL++   + K+ DFGLA+     
Sbjct: 103 DHIQYFLYQIL---RGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156

Query: 196 ----SDVNTHVSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 243
                 +  +V TR      Y APE   SS + T+  D++S G +  EL+T +
Sbjct: 157 EDEKGFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 52/193 (26%), Positives = 85/193 (44%), Gaps = 27/193 (13%)

Query: 71  VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLVG-------------YYTAG--SQ 114
           VA+K L+  +    R +F  EV+I+SR+   ++  L+G             Y   G  +Q
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAA 174
            +  +    +             ++ + T L +A   A G+ YL        +HRD+   
Sbjct: 109 FLQKHVAETSGLAC------NSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATR 159

Query: 175 NILLDFKFEAKVADFGLAKIA-SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFG 233
           N L+   +  K+ADFG+++   S     V  R      ++A E    GK T KSDV++FG
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFG 219

Query: 234 VMLLELIT-GRRP 245
           V L E++T  R  
Sbjct: 220 VTLWEILTLCREQ 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 67/207 (32%), Positives = 92/207 (44%), Gaps = 27/207 (13%)

Query: 50  NLLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHHKHL 102
             LG G FG V    H+G    G+  AIK LK       ++ Q    E  I+  + H  +
Sbjct: 24  ETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----WLTRLKIALGSAKGLAYL 158
           V+++  +   ++   + EFV    L  HL   GR   D    +   L +A        YL
Sbjct: 81  VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAF------EYL 134

Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           H      II+RD+K  N+LLD K   KV DFG AK   D     +  + GT  YLAPE  
Sbjct: 135 HSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD----RTFTLCGTPEYLAPEVI 187

Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
            S    +  D ++ GV+L E I G  P
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 36/219 (16%)

Query: 52  LGQGGFGYV--------HRGVLPNGKEVAIKQLKA-GSGQGEREFQAEVEIISRV-HHKH 101
           LG+G FG V         +        VA+K LK   + +   +  +E+E++  +  HK+
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW-----------LT---RLKI 147
           +++L+G  T      ++ E+     L  +L  +  P MD+           LT    +  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 148 ALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM 207
           A   A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+   +++ +  T   
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT--- 193

Query: 208 GTFG-----YLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            T G     ++APE       T +SDV+SFGV+L E+ T
Sbjct: 194 -TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 36/219 (16%)

Query: 52  LGQGGFGYVHRGVL-------PNG-KEVAIKQLKAGSGQGE-REFQAEVEIISRV-HHKH 101
           LG+G FG V            PN   +VA+K LK+ + + +  +  +E+E++  +  HK+
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR--------------LKI 147
           +++L+G  T      ++ E+     L  +L  +  P M++                 +  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 148 ALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM 207
           A   A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+   D++ H+     
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR---DIH-HIDYYKK 198

Query: 208 GTFG-----YLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            T G     ++APE       T +SDV+SFGV+L E+ T
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 59/214 (27%), Positives = 108/214 (50%), Gaps = 22/214 (10%)

Query: 41  RATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-FQA----EVEII 94
           R+ D +   N + +G +G V+R      G+ VA+K+LK      E+E F      E+ I+
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLREINIL 58

Query: 95  SRVHHKHLVSL----VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
            ++ H ++V++    VG  +   +  +V E+V ++        K       +  L + L 
Sbjct: 59  LKLQHPNIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLL 116

Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
           S  G+A+LH++    I+HRD+K +N+LL+ +   K+ DFGLA+          T+++ T 
Sbjct: 117 S--GVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS-PLKPYTQLVVTL 170

Query: 211 GYLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 243
            Y APE    + + +   D++S G +  EL+T +
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 20/205 (9%)

Query: 51  LLGQGGFGYVH--RGVLP--NGKEVAIKQLKAGSGQGEREFQAEVE--IISRVHHKHLVS 104
           +LGQG FG V   R +     G+  A+K LK  + +     + ++E  I++ V+H  +V 
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----WLTRLKIALGSAKGLAYLHE 160
           L   +    +  L+ +F+    L   L  +   T +    +L  L +AL     L     
Sbjct: 63  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---- 118

Query: 161 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS 220
                II+RD+K  NILLD +   K+ DFGL+K + D +   +    GT  Y+APE  + 
Sbjct: 119 -----IIYRDLKPENILLDEEGHIKLTDFGLSKESID-HEKKAYSFCGTVEYMAPEVVNR 172

Query: 221 GKLTEKSDVFSFGVMLLELITGRRP 245
              T+ +D +SFGV++ E++TG  P
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 62/222 (27%), Positives = 109/222 (49%), Gaps = 26/222 (11%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLV 103
           F    ++G G +G V++G  +  G+  AIK +     + E E + E+ ++ +  HH+++ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76

Query: 104 SLVGYYTAGS------QRMLVYEFVPNNTL-EFHLHGKGRP-TMDWLTRLKIALGSAKGL 155
           +  G +   S      Q  LV EF    ++ +   + KG     DW+    I     +GL
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134

Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYL 213
           A+LH     K+IHRDIK  N+LL    E K+ DFG   +++ ++  V  R   +GT  ++
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTPYWM 188

Query: 214 APEYASSGKLTE-----KSDVFSFGVMLLELITGRRPVDSTH 250
           APE  +  +  +     +SD++S G+  +E+  G  P+   H
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 52/198 (26%), Positives = 83/198 (41%), Gaps = 17/198 (8%)

Query: 54  QGGFG--YVHRGVLPNGKEVAIKQLKAGSGQGERE---FQAEVEII-SRVHHKHLVSLVG 107
           +G FG  Y+ +     G   AIK LK      + +    +AE  I+  +    ++  L  
Sbjct: 6   KGAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
            + +     LV E++        +   G    DW    +       G+  LH+     II
Sbjct: 65  SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQR---GII 119

Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS 227
           HRDIK  N+L+D     K+ DFGL++         + + +GT  YLAPE        + S
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKKFVGTPDYLAPETILGVGDDKMS 174

Query: 228 DVFSFGVMLLELITGRRP 245
           D +S G ++ E + G  P
Sbjct: 175 DWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 41/226 (18%)

Query: 52  LGQGGFGYVHRGVLPNGKE-----------------VAIKQLKAGSGQGER-EFQAEVEI 93
           LG+G FG VH   + N ++                 VA+K L+  + +  R +F  EV+I
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 94  ISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLH--------GKGR--------- 136
           +SR+   +++ L+G         ++ E++ N  L   L           G          
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 137 PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--I 194
           P + + + L +AL  A G+ YL        +HRD+   N L+      K+ADFG+++   
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 195 ASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 240
           A D    +  R +    ++A E    GK T  SDV++FGV L E++
Sbjct: 190 AGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 36/219 (16%)

Query: 52  LGQGGFGYVHRG-VLPNGKE-------VAIKQLKAGSGQGE-REFQAEVEIISRV-HHKH 101
           LG+G FG V     L   K+       VA+K LK  + + +  +  +E+E++  +  HK+
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW---LTRL-----------KI 147
           +++L+G  T      ++ E+     L  +L  +  P M++   + R+             
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 148 ALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM 207
               A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+  ++++ +  T   
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT--- 196

Query: 208 GTFG-----YLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            T G     ++APE       T +SDV+SFGV++ E+ T
Sbjct: 197 -TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 26/217 (11%)

Query: 46  FSDANL-----LGQGGFGYVHRGVLPN----GKE--VAIKQLKAGSGQG-EREFQAEVEI 93
           F  +NL     LG+G FG V           G E  V +K L+    +  + EF+ E+++
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 94  ISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL-EFHLHGKGR------PTMDWLTRLK 146
             ++ HK++V L+G         ++ E+     L +F    K +      P +    ++ 
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121

Query: 147 IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVST 204
           +    A G+ +L      + +HRD+ A N L+  + E KV+   L+K    S+     + 
Sbjct: 122 LCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178

Query: 205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            +     +LAPE       + KSDV+SFGV++ E+ T
Sbjct: 179 LI--PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 66/285 (23%), Positives = 125/285 (43%), Gaps = 59/285 (20%)

Query: 52  LGQGGFGYVHRGVL----PNGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSL 105
           +G+G FG   + +L     +GK+  IK++     S +   E + EV ++S + H ++V  
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHG-KG-----RPTMDWLTRLKIALGSAKGLAYLH 159
              +       +V ++     L   ++  +G        +DW  ++ +AL       ++H
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVH 118

Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
           +    KI+HRDIK+ NI L      K+ DFG+A++ +     ++   +GT  YL+PE   
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-TVELARTCIGTPYYLSPEICE 174

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV- 278
           +     KSD+++ G +L E+ T                       L  A E GN   LV 
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCT-----------------------LKHAFEAGNMKNLVL 211

Query: 279 ------DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
                  P + + Y++ ++  +V   +   + + R RP ++ I+ 
Sbjct: 212 KIIRGSYPPVSSHYSY-DLRNLV---SQLFKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 22/209 (10%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +G G +G V++   +  G+  AIK +K   G+     Q E+ ++    H ++V+  G Y 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 111 AGSQRMLVYEFVPNNTLE--FHLHGKGRPTMDWLTRLKIALGSA---KGLAYLHEDCHPK 165
              +  +  EF    +L+  +H+ G        L+  +IA  S    +GL YLH      
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYHVTGP-------LSESQIAYVSRETLQGLYYLHSKGK-- 127

Query: 166 IIHRDIKAANILLDFKFEAKVADFGL-AKIASDVNTHVSTRVMGTFGYLAPEYAS---SG 221
            +HRDIK ANILL      K+ADFG+ A+I + +    S   +GT  ++APE A+    G
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVERKG 184

Query: 222 KLTEKSDVFSFGVMLLELITGRRPVDSTH 250
              +  D+++ G+  +EL   + P+   H
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 62/235 (26%), Positives = 110/235 (46%), Gaps = 50/235 (21%)

Query: 41  RATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-FQA----EVEII 94
           R  D F     +G+G +G V++      G+ VA+K+++      E+E F      E++I+
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL---DNEKEGFPITAIREIKIL 60

Query: 95  SRVHHKHLVSLVGYYTAGSQRM----------LVYEFVPNNTL-----------EFHLHG 133
            +++H+++V+L    T     +          LV+E++ ++ +           E H+  
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120

Query: 134 KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLA 192
             +  ++             GL Y    CH K  +HRDIK +NILL+ K + K+ADFGLA
Sbjct: 121 FMKQLLE-------------GLNY----CHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163

Query: 193 KIASDVNTHVSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGRRPV 246
           ++ +   +   T  + T  Y  PE      +     DV+S G +L EL T ++P+
Sbjct: 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.4 bits (167), Expect = 5e-13
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 21/218 (9%)

Query: 46  FSDANLLGQGGFGYVHRGVLP----NGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHH 99
           F+   +LG+G FG V    L     + ++VA+K LKA   S     EF  E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 100 KHLVSLVG--YYTAGSQR----MLVYEFVPNNTLEFHLH----GKGRPTMDWLTRLKIAL 149
            +++ L+G    +    R    M++  F+ +  L   L     G+   T+   T ++  +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 150 GSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVMG 208
             A G+ YL        IHRD+ A N +L+      VADFGL+ KI S            
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
              +LA E  +    T  SDV++FGV + E++T G+ P
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 8e-13
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 40/216 (18%)

Query: 53  GQGGFGYVHRGVLPN---GKEVAIKQLKAGSGQGEREFQA---EVEIISRVHHKHLVSLV 106
           G+G +G V++    N   GKE AIK+ K    Q     Q+   E+ ++  + H+++VSLV
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 107 GYYTAGSQRM--LVYEFVPNNTLE---FHLHGKGR---PTMDWLTRLKIALGSA-KGLAY 157
             +   + +   L++++  ++  +   FH   K     P+M     +K  L     G+ Y
Sbjct: 69  EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM-----VKSLLWQILNGVHY 123

Query: 158 LHEDCHPKIIHRDIKAANILL----DFKFEAKVADFGLAKI-------ASDVNTHVSTRV 206
           LH +    ++HRD+K ANIL+      +   K+ D GLA++        +D++      V
Sbjct: 124 LHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD-----PV 175

Query: 207 MGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELIT 241
           + T  Y APE     +  T+  D+++ G +  EL+T
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 9e-13
 Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 52/233 (22%)

Query: 36  YEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLK-AGSGQGE-----REFQ 88
           YEEL            +G+G +G V++   L  G+ VA+K+++   S +G      RE  
Sbjct: 1   YEEL----------AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI- 49

Query: 89  AEVEIISRVHHKHLVSL----VGYYTAGSQRM-LVYEFVPNNTLEFHLH----GKGRPTM 139
           A ++ +    H ++V L     G  T    ++ LV+E V  +   +       G    T+
Sbjct: 50  ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETI 109

Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
             L R  +     +G+ +LH   H +I+HRD+K  NIL+    + K+ADFGLA+I S   
Sbjct: 110 KDLMRQLL-----RGVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF-- 159

Query: 200 THVS-TRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             ++ T V+ T  Y APE      YA+        D++S G +  EL   RRP
Sbjct: 160 -EMALTSVVVTLWYRAPEVLLQSSYATP------VDMWSVGCIFAELFR-RRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 68/236 (28%), Positives = 109/236 (46%), Gaps = 19/236 (8%)

Query: 29  FSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREF 87
           ++ S    E L   TD +     +G+G +G V++     +G   A+K L   S   E E 
Sbjct: 7   YNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EI 65

Query: 88  QAEVEIISRV-HHKHLVSLVG-YYTA----GSQRMLVYEFVPNNTLEFHLHG--KGRPTM 139
           +AE  I+  + +H ++V   G +Y A    G Q  LV E     ++   + G       +
Sbjct: 66  EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL 125

Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
           D      I  G+  GL +LH +   +IIHRD+K  NILL  +   K+ DFG++   +   
Sbjct: 126 DEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182

Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKS-----DVFSFGVMLLELITGRRPVDSTH 250
              +T V GT  ++APE  +  +  + S     DV+S G+  +EL  G  P+   H
Sbjct: 183 LRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 35/217 (16%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHL 102
           + + + +G+G +G V      P G +VAIK++     Q   +R  + E++I+ R  H+++
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHENI 65

Query: 103 VSLVGYYTAGS-QRM----LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA------LGS 151
           + ++      S +      +V E +  +     L+   +     L+   I       L  
Sbjct: 66  IGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQH--LSNDHIQYFLYQIL-- 116

Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM---- 207
            +GL Y+H      ++HRD+K +N+LL+   + K+ DFGLA+IA     H  T  +    
Sbjct: 117 -RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD--PEHDHTGFLTEYV 170

Query: 208 GTFGYLAPEYASSGKLTEKS-DVFSFGVMLLELITGR 243
            T  Y APE   + K   K+ D++S G +L E+++ R
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 61/225 (27%), Positives = 110/225 (48%), Gaps = 40/225 (17%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHHKHLVSLVGY 108
           +G+G +G V++G     G+ VA+K+++  S +      A  E+ ++  + H ++V L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGL------AYLHED- 161
               S+  L++EF+               +MD L +   +L   + +      +YL++  
Sbjct: 68  LMQESRLYLIFEFL---------------SMD-LKKYLDSLPKGQYMDAELVKSYLYQIL 111

Query: 162 -----CHP-KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
                CH  +++HRD+K  N+L+D K   K+ADFGLA+ A  +   V T  + T  Y AP
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVVTLWYRAP 170

Query: 216 E-YASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
           E    S + +   D++S G +  E+ T ++P+     F  DS +D
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL-----FHGDSEID 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 19/202 (9%)

Query: 51  LLGQGGFGYVHRGVLPNGKE-VAIKQLKAG---SGQGEREFQAEVEIISRVHHKHLVSLV 106
            +G G FG VH       +   A+K +        + E+    E  ++  V H  ++ L 
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL- 66

Query: 107 GYYTAGSQRML--VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
            ++T   QR L  + E+VP   L  +L   GR +    T L  A      L YLH     
Sbjct: 67  -FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS--TGLFYASEIVCALEYLHSK--- 120

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAPEYASSGKL 223
           +I++RD+K  NILLD +   K+ DFG AK   D      T  + GT  YLAPE   S   
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTPEYLAPEVIQSKGH 175

Query: 224 TEKSDVFSFGVMLLELITGRRP 245
            +  D ++ G+++ E++ G  P
Sbjct: 176 NKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 70/238 (29%), Positives = 98/238 (41%), Gaps = 21/238 (8%)

Query: 51  LLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQ---AEVEIISRV-HHKHLVSL 105
           +LG+G FG V    L    +  AIK LK      + + +    E  ++S    H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
              +        V E++    L FH+    +   D       A     GL +LH      
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSK---G 116

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
           I++RD+K  NILLD     K+ADFG+ K  +  D  T       GT  Y+APE     K 
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAPEILLGQKY 173

Query: 224 TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR---PLLNRAIEDGNFDTLV 278
               D +SFGV+L E++ G+ P    H   E+ L    R   P   R +     D LV
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPF---HGHDEEELFQSIRMDNPCYPRWLTREAKDILV 228

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 12/199 (6%)

Query: 52  LGQGGFGYVHRGVLPNGKEV-AIKQLKAGSGQGEREFQ---AEVEIISRVHHKHLVSLVG 107
           +G+G FG V +    + + + A+K ++        E     AE  ++++V+   +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAK-GLAYLHEDCHPKI 166
            + +  +  LV  F+    L  HL  +GR     L+R +         L  LH+     +
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFD---LSRARFYTAELLCALENLHK---FNV 114

Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEK 226
           I+RD+K  NILLD++    + DFGL K+ +  +   +    GT  YLAPE       T+ 
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173

Query: 227 SDVFSFGVMLLELITGRRP 245
            D ++ GV+L E++TG  P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 18/203 (8%)

Query: 51  LLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHHKHLV 103
           LLG+G FG V   +L      GK  A+K LK      + E      E  ++    H  L 
Sbjct: 2   LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           +L   +    +   V E+     L FHL  +   + D        + SA  L YLH    
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LGYLHSC-- 114

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAPEYASSGK 222
             +++RD+K  N++LD     K+ DFGL K    ++   + +   GT  YLAPE      
Sbjct: 115 -DVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 171

Query: 223 LTEKSDVFSFGVMLLELITGRRP 245
                D +  GV++ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 16/215 (7%)

Query: 51  LLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQA---EVEIISRVH-HKHLVSL 105
           +LG+G FG V    L  +G+  A+K LK      + + +    E  I+S    H  L  L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
              +    +   V EFV    L FH+    R            + SA  L +LH+     
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--LMFLHDK---G 116

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAPEYASSGKLT 224
           II+RD+K  N+LLD +   K+ADFG+ K    +    +T    GT  Y+APE        
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174

Query: 225 EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
              D ++ GV+L E++ G  P ++ +   ED L +
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 60/231 (25%)

Query: 36  YEELARATDGFSDANLLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREFQA-- 89
           YE+L++          +G+G +G V    +R     G+ VAIK+      + E +     
Sbjct: 3   YEKLSK----------IGEGSYGVVFKCRNR---ETGQIVAIKKFV----ESEDDPVIKK 45

Query: 90  ----EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPN---NTLEFHLHGKGRPTMDWL 142
               E+ ++ ++ H +LV+L+  +    +  LV+E+  +   N LE +  G     +   
Sbjct: 46  IALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-----VPEH 100

Query: 143 TRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS----DV 198
              KI   + + + + H+      IHRD+K  NIL+  + + K+ DFG A+I +    D 
Sbjct: 101 LIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157

Query: 199 NTHVSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELITG 242
             +V+TR      Y APE       Y          DV++ G +  EL+TG
Sbjct: 158 TDYVATR-----WYRAPELLVGDTQYGPP------VDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 65.6 bits (160), Expect = 5e-12
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 18/206 (8%)

Query: 52  LGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREFQ----AEVEIISRVHHK-HL 102
           LG G +G V      G    GK  A+K LK  +   + +       E +++  V     L
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS-AKGLAYLHED 161
           V+L   +   ++  L+ ++V    L  HL+ +   T      +++ +      L +LH+ 
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIAEIVLALDHLHQ- 123

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
               II+RDIK  NILLD +    + DFGL+K         +    GT  Y+APE    G
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181

Query: 222 KLTEKS--DVFSFGVMLLELITGRRP 245
                   D +S GV+  EL+TG  P
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 9/168 (5%)

Query: 76  LKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG 135
           +KAG   G      E  I+  ++H  ++ L G +T      L+   +P    + + +   
Sbjct: 122 IKAGQRGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAA 175

Query: 136 RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA 195
           +  +     L I     + + YLHE+   +IIHRDIKA NI ++   +  + DFG A   
Sbjct: 176 KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFP 232

Query: 196 SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 243
            D+N +      GT    APE  +        D++S G++L E+ T  
Sbjct: 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 65.8 bits (161), Expect = 7e-12
 Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 55/227 (24%)

Query: 44  DGFSDANLLGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGEREFQA---------EVEI 93
           D + + + +G G +G V           VAIK+L        R FQ+         E+ +
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRL 67

Query: 94  ISRVHHKHLVSLVGYYTAGSQRM------LVYEFVP---NNTLEFHLHGKGRPTMDWLTR 144
           +  + H++++ L+  +T  S         LV   +    NN ++       + + D +  
Sbjct: 68  LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ-----KLSDDHIQF 122

Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT-HVS 203
           L   +   +GL Y+H      IIHRD+K +NI ++   E K+ DFGLA+   D  T +V+
Sbjct: 123 LVYQI--LRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVA 177

Query: 204 TRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELITGR 243
           TR      Y APE       Y       +  D++S G ++ EL+TG+
Sbjct: 178 TR-----WYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 65.1 bits (159), Expect = 8e-12
 Identities = 50/223 (22%), Positives = 105/223 (47%), Gaps = 29/223 (13%)

Query: 39  LARATDGFSDANLLGQGGFGYVHRGVL-----PNGKEVAIKQLKAGSGQGERE-FQAEVE 92
           +A + D  + ++LL +G FG +  G+L        +EV +K +K  + + +      E  
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60

Query: 93  IISRVHHKHLVSLVGYYTAGSQR-MLVYEFVPNNTLEFHL----HGKGRPTMDWLTRLKI 147
           ++  + H++++ ++       +   ++Y ++    L+  L     G+        T+  +
Sbjct: 61  LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 148 ALGS--AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVS 203
            +    A G++YLH+     +IH+DI A N ++D + + K+ D  L++     D +    
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC--- 174

Query: 204 TRVMGT-----FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
              +G        ++A E   + + +  SDV+SFGV+L EL+T
Sbjct: 175 ---LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 64.8 bits (158), Expect = 8e-12
 Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 33/209 (15%)

Query: 52  LGQGGFGYVHRGVLPN---------GKE--VAIKQLKAGSGQGEREFQAEVEIISRVHHK 100
           LGQG F  +++GVL           G+E  V +K L +   +    F     ++S++ HK
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-HRDSLAFFETASLMSQLSHK 61

Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLAYLH 159
           HLV L G      + ++V E+V    L+  LH  K   ++ W   L +A   A  L YL 
Sbjct: 62  HLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLE 118

Query: 160 EDCHPKIIHRDIKAANILL-------DFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +    K++H ++   NIL+        +    K++D G+          V         +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIPW 170

Query: 213 LAPEYASSG--KLTEKSDVFSFGVMLLEL 239
           +APE   +G   LT  +D +SFG  LLE+
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 65.6 bits (160), Expect = 9e-12
 Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 12/149 (8%)

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLH--GKGRPTMDWLTRLKIALGSAKGLAYLH 159
           L  L   +    +   V E+V    L +H+   GK +         +IA+G    L +LH
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG----LFFLH 118

Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAPEYA 218
                 II+RD+K  N++LD +   K+ADFG+ K   ++    +TR   GT  Y+APE  
Sbjct: 119 SK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEII 173

Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRPVD 247
           +     +  D ++FGV+L E++ G+ P D
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 56/209 (26%), Positives = 103/209 (49%), Gaps = 22/209 (10%)

Query: 43  TDGFSDANLLGQGGFGYV--HRGVLPNGKEVAIKQLK---AGSGQGEREFQAEVEIISRV 97
           T+ + D   +G G FG V   R  L  G+ VAIK++    +     +R ++ E++++  +
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQL-TGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHL 66

Query: 98  HHKHLVSLVGYYTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLA 156
            H++++SL   + +  + +  V E +     + H     RP      +        +GL 
Sbjct: 67  RHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQY-FLYQILRGLK 122

Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA-SDVNTHVSTRVMGTFGYLAP 215
           Y+H      ++HRD+K +NIL++   + K+ DFGLA+I    +  +VSTR      Y AP
Sbjct: 123 YVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAP 174

Query: 216 EYASS-GKLTEKSDVFSFGVMLLELITGR 243
           E   +  K   + D++S G +  E++ G+
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)

Query: 44  DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHHK 100
           D +     LG+G +  V++G    NGK VA+K ++    +G   F A  E  ++  + H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHA 63

Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHE 160
           ++V L           LV+E+V  +  ++     G    + +      L   +GL+Y+H+
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQL--LRGLSYIHQ 121

Query: 161 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-YAS 219
                I+HRD+K  N+L+    E K+ADFGLA+ A  V +H  +  + T  Y  P+    
Sbjct: 122 R---YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLG 177

Query: 220 SGKLTEKSDVFSFGVMLLELITG 242
           S + +   D++  G + +E+I G
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 64.9 bits (159), Expect = 1e-11
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 18/101 (17%)

Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTH--------VS 203
           K L Y+H      +IHRD+K +NILL+     K+ADFGLA+ ++              V+
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 204 TRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 243
           TR      Y APE    S + T+  D++S G +L E++ G+
Sbjct: 175 TR-----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 32/220 (14%)

Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQLK-AGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG+  FG V++G L         + VAIK LK    G    EF+ E  + SR+ H ++V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG--------------RPTMDWLTRLKIALG 150
           L+G  T      +++ +  ++ L   L  +               + T++    + I   
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT- 209
            A G+ +L       ++H+D+   N+L+  K   K++D GL +   +V      ++MG  
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFR---EVYAADYYKLMGNS 186

Query: 210 ---FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
                +++PE    GK +  SD++S+GV+L E+ + G +P
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 43/134 (32%), Positives = 70/134 (52%), Gaps = 12/134 (8%)

Query: 117 LVYEFVPNNTLEFHLH--GKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAA 174
            V E+V    L +H+   GK +         +I++G    L +LH      II+RD+K  
Sbjct: 78  FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFFLHRR---GIIYRDLKLD 130

Query: 175 NILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAPEYASSGKLTEKSDVFSFG 233
           N++LD +   K+ADFG+ K    +   V+TR   GT  Y+APE  +     +  D +++G
Sbjct: 131 NVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYG 188

Query: 234 VMLLELITGRRPVD 247
           V+L E++ G+ P D
Sbjct: 189 VLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 20/207 (9%)

Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQA--EVEIISRVH---HKHLVSL 105
           +G G +G V++   P+ G  VA+K ++  + +         EV ++ R+    H ++V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 106 VGY-YTAGSQR----MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHE 160
           +    T+ + R     LV+E V +  L  +L     P +   T   +     +GL +LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 161 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS-TRVMGTFGYLAPEYAS 219
           +C   I+HRD+K  NIL+    + K+ADFGLA+I S     ++ T V+ T  Y APE   
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPEVLL 180

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRPV 246
                   D++S G +  E+   R+P+
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 24/206 (11%)

Query: 51  LLGQGGFGYVHRGVL----PNGKEVAIKQLK-AGSGQGEREFQAEVEIISRVHHKHLVSL 105
           ++G+G FG   R +L     + ++ A+K+++   S     + + E  +++++ H ++V+ 
Sbjct: 7   VVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHL---HGKGRP---TMDWLTRLKIALGSAKGLAYLH 159
              + A     +V E+     L   +    GK  P    + W  ++ +      G+ ++H
Sbjct: 64  KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH 117

Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
           E    +++HRDIK+ NI L    + K+ DFG A++ +    +  T V GT  Y+ PE   
Sbjct: 118 EK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWE 173

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRP 245
           +     KSD++S G +L EL T + P
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 37/93 (39%), Positives = 51/93 (54%), Gaps = 7/93 (7%)

Query: 154 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL 213
           GL ++H      +++RD+K ANILLD     +++D GLA   S    H S   +GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162

Query: 214 APEYASSGKLTEKS-DVFSFGVMLLELITGRRP 245
           APE    G   + S D FS G ML +L+ G  P
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 18/216 (8%)

Query: 51  LLGQGGFGYVHRGVLPNGKEV-AIKQLKAGSGQGEREFQ---AEVEIIS-RVHHKHLVSL 105
           +LG+G FG V    L    EV AIK LK      + +      E  I++    H  L +L
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
              +    +   V E+V    L F +  + R   +  +R   A      L +LH      
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDLMFQIQ-RSRKFDEPRSRF-YAAEVTLALMFLHRH---G 116

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
           +I+RD+K  NILLD +   K+ADFG+ K  I + V T   T   GT  Y+APE     + 
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQELEY 173

Query: 224 TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
               D ++ GV++ E++ G+ P ++ +   ED L +
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 37/217 (17%)

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASD-VNTHVSTRVMGTFGYLAPEYASSGKL 223
           K++HRD+K+ANI L      K+ DFG +K  SD V+  V++   GT  YLAPE     + 
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248

Query: 224 TEKSDVFSFGVMLLELITGRRPV-----------------DSTHTFVEDSLVDWARPLLN 266
           ++K+D++S GV+L EL+T  RP                  D     V   +     PLL+
Sbjct: 249 SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLS 308

Query: 267 RAIEDGNFDTLVDPKLH---NEYNHNEMARMVA-CAAACVRHSARRRPR-MSQIVRALEG 321
           +           +P L     +  H E  + VA      VRHS    P    +I+R L+ 
Sbjct: 309 K-----------NPALRPTTQQLLHTEFLKYVANLFQDIVRHSETISPHDREEILRQLQE 357

Query: 322 DASLADLNEGIRPGQSSVYGSYGSSDYDTMQYNEDLK 358
               A     IR G  +   ++G   Y   +Y+ D++
Sbjct: 358 SGERAPPPSSIRYGVVTSDVTHGGYLY---KYSSDMR 391

Length = 478

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 29/218 (13%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHHKHL 102
           F     +G+G +G V++      G+ VA+K+++  +        A  E+ ++  ++H ++
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAK--------G 154
           V L+      ++  LV+EF         LH   +  MD      I L   K        G
Sbjct: 62  VKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112

Query: 155 LAYLHEDCHP-KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL 213
           LA+    CH  +++HRD+K  N+L++ +   K+ADFGLA+ A  V     T  + T  Y 
Sbjct: 113 LAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYR 167

Query: 214 APEYASSGKL-TEKSDVFSFGVMLLELITGRR--PVDS 248
           APE     K  +   D++S G +  E++T R   P DS
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 63/213 (29%)

Query: 35  TYEELARATDGFSDANLLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREFQA- 89
            YE+LA+          +GQG FG V    H+      + VA+K++       E E +  
Sbjct: 13  KYEKLAK----------IGQGTFGEVFKARHK---KTKQIVALKKVLM-----ENEKEGF 54

Query: 90  ------EVEIISRVHHKHLVSLV--------GYYTAGSQRMLVYEF--------VPNNTL 127
                 E++I+  + H+++V+L+         Y        LV+EF        + N  +
Sbjct: 55  PITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV 114

Query: 128 EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA 187
           +F L  + +  M  L           GL Y+H +   KI+HRD+KAANIL+      K+A
Sbjct: 115 KFTL-SEIKKVMKMLL---------NGLYYIHRN---KILHRDMKAANILITKDGILKLA 161

Query: 188 DFGLAKIAS----DVNTHVSTRVMGTFGYLAPE 216
           DFGLA+  S          + RV+ T  Y  PE
Sbjct: 162 DFGLARAFSLSKNSKPNRYTNRVV-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 69/262 (26%), Positives = 103/262 (39%), Gaps = 57/262 (21%)

Query: 44  DGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQLKAG----SGQGEREFQAEVEIISRVH 98
           D F    ++G+G FG V      +  +V A+K L+        Q     +AE +I++   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59

Query: 99  HKHLVSLVGYYTAGSQRML--VYEFVPNNTLEFHLHGKGRPTMDW----LTRLKIALGSA 152
              +V L  YY+   +  L  V E++P   L   L  K     +     +  L +AL S 
Sbjct: 60  SPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117

Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-----------------IA 195
             L +         IHRDIK  NIL+D     K+ADFGL K                 + 
Sbjct: 118 HKLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168

Query: 196 SDVNTHVSTR-----------VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRR 244
              N  V  R            +GT  Y+APE         + D +S GV+L E++ G  
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228

Query: 245 PVDSTHTFVEDSLVDWARPLLN 266
           P      F  D+L +    ++N
Sbjct: 229 P------FYSDTLQETYNKIIN 244

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 9/171 (5%)

Query: 76  LKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG 135
           +KA +G        E++I+  + H+ +++L+  Y   S   +V   +P    +   +   
Sbjct: 124 VKAVTGGKTPG--REIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDR 178

Query: 136 RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KI 194
              +     + I     + LAYLH      IIHRD+K  NI LD    A + DFG A K+
Sbjct: 179 SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235

Query: 195 ASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
            +  +T       GT    +PE  +      K+D++S G++L E+      
Sbjct: 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 9/195 (4%)

Query: 52  LGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +  V +G        VA+K+++    +G       EV ++  + H ++V+L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
                  LV+E++ ++  ++  +     +M  +      L   +GL+Y H     KI+HR
Sbjct: 73  HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQL--LRGLSYCH---KRKILHR 127

Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-YASSGKLTEKSD 228
           D+K  N+L++ K E K+ADFGLA+ A  V T   +  + T  Y  P+    S + +   D
Sbjct: 128 DLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186

Query: 229 VFSFGVMLLELITGR 243
           ++  G +L E+ TGR
Sbjct: 187 MWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 63.6 bits (154), Expect = 3e-11
 Identities = 65/203 (32%), Positives = 90/203 (44%), Gaps = 18/203 (8%)

Query: 51  LLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHHKHLV 103
           LLG+G FG V   +L     +GK  A+K LK      + E      E  ++    H  L 
Sbjct: 2   LLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           SL   +    +   V E+V    L FHL  + R   +  TR   A      L YLH    
Sbjct: 59  SLKYSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGA-EIVSALDYLHSG-- 114

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIA-SDVNTHVSTRVMGTFGYLAPEYASSGK 222
            KI++RD+K  N++LD     K+ DFGL K   +D  T  +    GT  YLAPE      
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDND 171

Query: 223 LTEKSDVFSFGVMLLELITGRRP 245
                D +  GV++ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 61/200 (30%), Positives = 87/200 (43%), Gaps = 11/200 (5%)

Query: 51  LLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGERE---FQAEVEIISR-VHHKHLVSL 105
           ++G+G FG V       +GK  A+K L+       +E     AE  ++ + V H  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
              +    +   V +FV    L FHL  + R   +   R   A   A  L YLH      
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAA-EIASALGYLHS---IN 116

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           I++RD+K  NILLD +    + DFGL K      +  +T   GT  YLAPE         
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 226 KSDVFSFGVMLLELITGRRP 245
             D +  G +L E++ G  P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)

Query: 51  LLGQGGFGYVHRGVLPN-GKEVAIKQL---KAGSGQGEREFQAE---VEIISRVHHKHLV 103
           ++G+GGFG V+     + GK  A+K L   +    QGE     E   + ++S      +V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHL--HGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
            +   +    +   + + +    L +HL  HG            +I LG    L ++H  
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG----LEHMHNR 116

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
               +++RD+K ANILLD     +++D GLA   S    H S   +GT GY+APE    G
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKG 170

Query: 222 KLTEKS-DVFSFGVMLLELITGRRP 245
              + S D FS G ML +L+ G  P
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 20/211 (9%)

Query: 52  LGQGGFGYVHRGVLPNGK---EVAIKQLK-AGSGQGERE-FQAEVEIISRVHHKHLVSLV 106
           LG+G FG V  G L       +VA+K +K A   + E E F +E   +    H +++ L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 107 GYYTAGSQR------MLVYEFVPNNTLE-FHLHGKGRPTMDWL---TRLKIALGSAKGLA 156
           G      +       +++  F+ +  L  F L+ +      +L     +K     A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT-FGYLAP 215
           YL        IHRD+ A N +L+      VADFGL+K   + + +   R+      ++A 
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
           E  +    T KSDV+SFGV + E+ T G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 63.0 bits (153), Expect = 5e-11
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 31/218 (14%)

Query: 52  LGQGGFGYVH----RGVLPNGKE-------------VAIKQLKAGSGQGER-EFQAEVEI 93
           LG+G FG VH     G+     +             VA+K L+  + +  R +F  E++I
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 94  ISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHL---------HGKGRPTMDWLTR 144
           +SR+   +++ L+          ++ E++ N  L   L               T+ + T 
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVS 203
           + +A   A G+ YL        +HRD+   N L+   +  K+ADFG+++ + S     + 
Sbjct: 133 IFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            R +    +++ E    GK T  SDV++FGV L E++T
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)

Query: 52  LGQGGFGYVHRGVLPNG---KEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVG 107
           +G G FG V  G + +G    +V +K+L+  +  Q + +F  E +    + H +L+  +G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRP---TMDWLTRLKIALGSAKGLAYLHEDCHP 164
             T  +  +LV EF P   L+ +L    +    T D  T  ++A   A GL +LH++   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPEYASS--G 221
             IH D+   N LL      K+ D+GL+      + +V   ++     ++APE      G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 222 KL-----TEKSDVFSFGVMLLELIT-GRRP 245
            L     T++S+V+S GV + EL   G +P
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 62.4 bits (152), Expect = 7e-11
 Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 38/223 (17%)

Query: 52  LGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHHKHLVSLVGY 108
           LG+G +  V++G     G+ VA+K+++    +G   F A  E  ++  + H ++V+L   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHDI 71

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW------LTRLKIALGS-AKGLAYLHED 161
                   LV+E++  +  ++         MD       +  +++ L    +GLAY H  
Sbjct: 72  IHTKKTLTLVFEYLDTDLKQY---------MDDCGGGLSMHNVRLFLFQLLRGLAYCH-- 120

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAP------ 215
              +++HRD+K  N+L+  + E K+ADFGLA+ A  V +   +  + T  Y  P      
Sbjct: 121 -QRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRPPDVLLGS 178

Query: 216 -EYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL 257
            EY++S       D++  G +  E+ TG RP+    T VED L
Sbjct: 179 TEYSTS------LDMWGVGCIFYEMATG-RPLFPGSTDVEDQL 214

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 62.7 bits (153), Expect = 7e-11
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 34/214 (15%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQ---GEREFQAEVEIISRVHHKHLVSLVG 107
           +G G +G V   +   +GK+VAIK++          +R  + E++I+    H +++++  
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAIRD 71

Query: 108 YYTA----GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR--LKIALGSAKGLAYLHED 161
                        +V + + ++ L   +H    P  +   R  L   L   +GL Y+H  
Sbjct: 72  ILRPPGADFKDVYVVMDLMESD-LHHIIHSDQ-PLTEEHIRYFLYQLL---RGLKYIHSA 126

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT--------HVSTRVMGTFGYL 213
               +IHRD+K +N+L++   E ++ DFG+A+  S   T        +V+TR      Y 
Sbjct: 127 N---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR-----WYR 178

Query: 214 APEYA-SSGKLTEKSDVFSFGVMLLELITGRRPV 246
           APE   S  + T   D++S G +  E++ GRR +
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 29/204 (14%)

Query: 52  LGQGGFGYVHRGVLPNGKEVA------IKQLKAGSGQGEREFQAEVE--IISRVHHKHLV 103
           LG+G FG V+  ++ + K VA      +K++  G        QA  E  ++S++ H  +V
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLH-----GKGRP---TMDWLTRLKIALGSAKGL 155
                +       ++ E+     L+  L      GK        +W  +L +      G+
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GV 119

Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
            Y+H+    +I+HRD+KA NI L      K+ DFG++++    +  ++T   GT  Y++P
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMG-SCDLATTFTGTPYYMSP 174

Query: 216 EYASSGKLTEKSDVFSFGVMLLEL 239
           E         KSD++S G +L E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 66/236 (27%), Positives = 103/236 (43%), Gaps = 21/236 (8%)

Query: 30  SKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVL--PNGKEVAIKQLKAGSGQGEREF 87
           S  T  ++     +D +     +G+G +G V + VL   NG + A+K L       E E 
Sbjct: 4   SGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDE-EI 61

Query: 88  QAEVEIISRVH-HKHLVSLVGYY-----TAGSQRMLVYEFVPNNTLEFHLHG--KGRPTM 139
           +AE  I+  +  H ++V   G Y       G Q  LV E     ++   + G  K    M
Sbjct: 62  EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121

Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
           +      I   +  GL +LH +   K IHRD+K  NILL  +   K+ DFG++   +   
Sbjct: 122 EEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178

Query: 200 THVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
              +T V GT  ++APE  +           + DV+S G+  +EL  G  P+   H
Sbjct: 179 LRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 64/240 (26%), Positives = 96/240 (40%), Gaps = 34/240 (14%)

Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE---FQAEVEIISRVHH 99
             F   +L+G+G FG V        G   A+K +K      +     F+ E +I+S  + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD------WLTRLKIALGSAK 153
             +  L   +       LV E+ P   L   L  +     D      +L  L +A+ S  
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119

Query: 154 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGY 212
            + Y         +HRDIK  N+L+D     K+ADFG A      N  V S   +GT  Y
Sbjct: 120 QMGY---------VHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDY 169

Query: 213 LAPEYASSGKLTEKS------DVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN 266
           +APE  ++     K       D +S GV+  E+I GR P      F E +       ++N
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP------FHEGTSAKTYNNIMN 223

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 42/182 (23%), Positives = 70/182 (38%), Gaps = 33/182 (18%)

Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GL YLH     +IIHRD+K  NI ++   +  + D G A+    V       + GT   
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVET 222

Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELI------------TGRRPVDSTHTFVEDSLVDW 260
            APE  +  K   K+D++S G++L E++            T    V S H+     L+  
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS----HLLKI 278

Query: 261 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
              L    +    F      +L   +            A+  R    R P   ++   ++
Sbjct: 279 ISTL---KVHPEEFPRDPGSRLVRGFIE---------YASLERQPYTRYPCFQRVNLPID 326

Query: 321 GD 322
           G+
Sbjct: 327 GE 328

Length = 357

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 39/219 (17%)

Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA---------EVEI 93
           D + D   +G G +G V   +    G +VAIK+L        R FQ+         E+ +
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-------YRPFQSELFAKRAYRELRL 67

Query: 94  ISRVHHKHLVSLVGYYTAGSQR------MLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLK 146
           +  + H++++ L+  +T            LV  F+  +  +   H K     + +L    
Sbjct: 68  LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM 127

Query: 147 IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA-SDVNTHVSTR 205
           +     KGL Y+H      IIHRD+K  N+ ++   E K+ DFGLA+   S++  +V TR
Sbjct: 128 L-----KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR 179

Query: 206 VMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 243
                 Y APE   +    T+  D++S G ++ E++TG+
Sbjct: 180 -----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 12/200 (6%)

Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLK---AGSGQGEREFQAEVEIISRVHHKHLVSLVG 107
           +G+G +G V +       E VA+K+++      G      + E+ ++  + HK++V L  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
              +  +  LV+E+   +  ++     G    + +      L   KGLA+ H      ++
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL--LKGLAFCHSH---NVL 121

Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS 227
           HRD+K  N+L++   E K+ADFGLA+         S  V+ T  Y  P+     KL   S
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTS 180

Query: 228 -DVFSFGVMLLELITGRRPV 246
            D++S G +  EL    RP+
Sbjct: 181 IDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 59/270 (21%), Positives = 117/270 (43%), Gaps = 27/270 (10%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLK---AGSGQGEREFQAEVEIISRVHHKHLVSLVG 107
           +G+G F  V+R   L + K VA+K+++       +  ++   E++++ +++H +++  + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 108 YYTAGSQRMLVYEFVPNNTLE--FHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
            +   ++  +V E      L        K +  +   T  K  +     + ++H     +
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---R 126

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           ++HRDIK AN+ +      K+ D GL +  S   T   + V GT  Y++PE         
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNF 185

Query: 226 KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNE 285
           KSD++S G +L E+   + P      F  D +  ++   L + IE  ++  L  P  H  
Sbjct: 186 KSDIWSLGCLLYEMAALQSP------FYGDKMNLFS---LCQKIEQCDYPPL--PTEHYS 234

Query: 286 YNHNEMARMVACAAACVRHSARRRPRMSQI 315
               E+  M      C+     +RP +  +
Sbjct: 235 EKLRELVSM------CIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 49/152 (32%), Positives = 71/152 (46%), Gaps = 12/152 (7%)

Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL---KIALGSAKGL 155
           H  LV L   +   S+   V EFV    L FH+  + R   +   R    +I+L     L
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ-RQRKLPEEHARFYSAEISLA----L 109

Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
            +LHE     II+RD+K  N+LLD +   K+ D+G+ K         ST   GT  Y+AP
Sbjct: 110 NFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYIAP 165

Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
           E           D ++ GV++ E++ GR P D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 65/208 (31%), Positives = 92/208 (44%), Gaps = 17/208 (8%)

Query: 52  LGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGERE---FQAEVEI-ISRVHHKHLV 103
           +G+G FG V    H+    +GK  A+K L+  +   ++E     AE  + +  V H  LV
Sbjct: 3   IGKGSFGKVLLAKHK---ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            L   +    +   V ++V    L FHL  + R   +   R   A   A  L YLH    
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGELFFHLQ-RERSFPEPRARF-YAAEIASALGYLHS--- 114

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
             II+RD+K  NILLD +    + DFGL K   + +   ST   GT  YLAPE       
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLRKQPY 173

Query: 224 TEKSDVFSFGVMLLELITGRRPVDSTHT 251
               D +  G +L E++ G  P  S  T
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDT 201

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 17/209 (8%)

Query: 51  LLGQGGFGYV----HRGVLPNGKEVAIKQLKAGS---GQGEREFQAEVEIISR-VHHKHL 102
           ++G+G FG V    H+      K  A+K L+  +    + E+   +E  ++ + V H  L
Sbjct: 2   VIGKGSFGKVLLARHKA---EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           V L   +    +   V +++    L +HL  + R  ++   R   A   A  L YLH   
Sbjct: 59  VGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARF-YAAEIASALGYLHS-- 114

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK 222
              I++RD+K  NILLD +    + DFGL K   + N   ST   GT  YLAPE      
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQP 172

Query: 223 LTEKSDVFSFGVMLLELITGRRPVDSTHT 251
                D +  G +L E++ G  P  S +T
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNT 201

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 23/205 (11%)

Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGEREFQ---AEVEIISRVHHKHLVSLVG 107
           +GQGG+G V      +  E VA+K++K        E +    E +I++    + LV L+ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKG----RPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            +       L  E+VP       L+  G         ++  +  A+ +   L Y      
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY------ 122

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPEYASSGK 222
              IHRD+K  N L+D     K+ DFGL+K I +  N+     V+G+  Y+APE      
Sbjct: 123 ---IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVLRGKG 174

Query: 223 LTEKSDVFSFGVMLLELITGRRPVD 247
                D +S G ML E + G  P  
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFS 199

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 6/150 (4%)

Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +H  LV L   +   S+   V E+V    L FH+  + R   +   R   A  S   L Y
Sbjct: 54  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISL-ALNY 111

Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
           LHE     II+RD+K  N+LLD +   K+ D+G+ K         ++   GT  Y+APE 
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCGTPNYIAPEI 167

Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
                     D ++ GV++ E++ GR P D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 58/218 (26%), Positives = 107/218 (49%), Gaps = 27/218 (12%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA-------EVEIISRVHHKHLV 103
           +G+G +G V++      G+ VA+K+++      E E +        E+ ++  ++H ++V
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRL-----ETEDEGVPSTAIREISLLKELNHPNIV 61

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            L+    + ++  LV+EF+ +  L+ ++       +D            +G+AY    CH
Sbjct: 62  RLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY----CH 116

Query: 164 P-KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK 222
             +++HRD+K  N+L+D +   K+ADFGLA+ A  V     T  + T  Y APE     +
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEILLGSR 175

Query: 223 LTEKS-DVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
                 D++S G +  E++  RRP+     F  DS +D
Sbjct: 176 QYSTPVDIWSIGCIFAEMVN-RRPL-----FPGDSEID 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 34/95 (35%), Positives = 56/95 (58%), Gaps = 6/95 (6%)

Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GL Y+H      ++HRD+K +N+LL+   + K+ DFGLA+  S+    ++  V+ T  Y
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174

Query: 213 LAPE-YASSGKLTEKSDVFSFGVMLLELITGRRPV 246
            APE   +  + T   DV+S G +  EL+ GR+P+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 47/146 (32%), Positives = 68/146 (46%), Gaps = 6/146 (4%)

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
           LV L   +   S+  LV E+V    L FH+  + R   +   R   A      L +LHE 
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ-RQRKLPEEHARF-YAAEICIALNFLHER 115

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
               II+RD+K  N+LLD     K+ D+G+ K         ST   GT  Y+APE     
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRGE 171

Query: 222 KLTEKSDVFSFGVMLLELITGRRPVD 247
           +     D ++ GV++ E++ GR P D
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.5 bits (144), Expect = 5e-10
 Identities = 67/282 (23%), Positives = 122/282 (43%), Gaps = 41/282 (14%)

Query: 52  LGQGGFGYVHRGVLPNGK--------EVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
           LGQG F  + +G+             EV +K L          F     ++S++ HKHLV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
              G    G + ++V E+V   +L+ +L  K +  ++   +L++A   A  L +L +   
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAWALHFLEDK-- 119

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASD--VNTHVSTRVMGT--FGYLAPEYAS 219
             + H ++ A N+LL  + + K  +    K+ SD  ++  V  + +      ++ PE   
Sbjct: 120 -GLTHGNVCAKNVLLIREEDRKTGNPPFIKL-SDPGISITVLPKEILLERIPWVPPECIE 177

Query: 220 SGK-LTEKSDVFSFGVMLLELITG-RRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL 277
           + + L+  +D +SFG  L E+ +G  +P+         S +D  + L     ED +   L
Sbjct: 178 NPQNLSLAADKWSFGTTLWEIFSGGDKPL---------SALDSQKKLQ--FYEDRH--QL 224

Query: 278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL 319
             PK        E+A ++     C+ +    RP    I+R L
Sbjct: 225 PAPKW------TELANLI---NQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 44/203 (21%), Positives = 92/203 (45%), Gaps = 28/203 (13%)

Query: 59  YVHRGVLPNGKEVAIKQLKA---GSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQR 115
            +++G+  N KEV I+  K    G        + E++ + R+   +++ + G+       
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 116 M----LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
           +    L+ E+     L   L  +    + + T+L +A+   KGL  L++  +    ++++
Sbjct: 94  LPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNL 149

Query: 172 KAANILLDFKFEAKVADFGLAKIAS-----DVNTHVSTRVMGTFGYLAPEYASS--GKLT 224
            + + L+   ++ K+   GL KI S     +VN  V         Y + +  +    + T
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV---------YFSYKMLNDIFSEYT 200

Query: 225 EKSDVFSFGVMLLELITGRRPVD 247
            K D++S GV+L E+ TG+ P +
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFE 223

Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 59.3 bits (143), Expect = 6e-10
 Identities = 59/270 (21%), Positives = 121/270 (44%), Gaps = 27/270 (10%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKA---GSGQGEREFQAEVEIISRVHHKHLVSLVG 107
           +G+G F  V+R   L +G  VA+K+++       +   +   E++++ +++H +++    
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLH--GKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
            +   ++  +V E      L   +    K +  +   T  K  +     L ++H     +
Sbjct: 70  SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---R 126

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           ++HRDIK AN+ +      K+ D GL +  S   T   + V GT  Y++PE         
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNF 185

Query: 226 KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNE 285
           KSD++S G +L E+   + P      F  D +  ++   L + IE  ++     P L ++
Sbjct: 186 KSDIWSLGCLLYEMAALQSP------FYGDKMNLYS---LCKKIEQCDY-----PPLPSD 231

Query: 286 YNHNEMARMVACAAACVRHSARRRPRMSQI 315
           +   E+ ++V     C+     +RP ++ +
Sbjct: 232 HYSEELRQLV---NMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)

Query: 46  FSDANLLGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGEREFQA--EVEIISRVHHKHL 102
           F    ++G+G +G V +      KE VAIK+ K      E +     E++++  +  +++
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEF-HLHGKGRP---TMDWLTRLKIALGSAKGLAYL 158
           V L   +    +  LV+E+V  N LE       G P      ++ +L       K + + 
Sbjct: 63  VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL------IKAIHWC 116

Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           H++    I+HRDIK  N+L+      K+ DFG A+  S+ +    T  + T  Y +PE  
Sbjct: 117 HKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173

Query: 219 SSGKLTEKSDVFSFGVMLLELITGR 243
                 +  D++S G +L EL  G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 60.6 bits (147), Expect = 7e-10
 Identities = 55/230 (23%), Positives = 101/230 (43%), Gaps = 43/230 (18%)

Query: 51  LLGQGGFGYVHRGVLPN-GKEVAIKQLK---AGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           L+G+GG G V+    P   + VA+K+++   + +   ++ F  E +I + + H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV- 67

Query: 107 GYYTAGSQRMLVY---EFVPNNTLEFHLHGKGRPTMDWLTR-----------LKIALGSA 152
             Y+  S    VY    ++   TL+  L  K     + L++           L I     
Sbjct: 68  --YSICSDGDPVYYTMPYIEGYTLKSLL--KSVWQKESLSKELAEKTSVGAFLSIFHKIC 123

Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK---------IASDVNTHVS 203
             + Y+H      ++HRD+K  NILL    E  + D+G A          +  DV+    
Sbjct: 124 ATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 204 T--------RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
                    +++GT  Y+APE       +E +D+++ GV+L +++T   P
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 59.2 bits (143), Expect = 8e-10
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 25/203 (12%)

Query: 52  LGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHHKHLVSLVGY 108
           LG+G +  V++G+   NG+ VA+K +   + +G   F A  E  ++  + H ++V L   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDI 71

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKG-------RPTMDWLTRLKIALGSAKGLAYLHED 161
                    V+E++  +  ++ +   G       R  M  L R         GLAY+H  
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR---------GLAYIH-- 120

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-YASS 220
               I+HRD+K  N+L+ +  E K+ADFGLA+  S  +   S+ V+ T  Y  P+    +
Sbjct: 121 -GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGA 178

Query: 221 GKLTEKSDVFSFGVMLLELITGR 243
              +   D++  G + +E++ G+
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 59.2 bits (143), Expect = 9e-10
 Identities = 42/132 (31%), Positives = 68/132 (51%), Gaps = 8/132 (6%)

Query: 117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANI 176
            V E+V    L + +   GR        +  A   A GL +LH      II+RD+K  N+
Sbjct: 78  FVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNV 132

Query: 177 LLDFKFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAPEYASSGKLTEKSDVFSFGVM 235
           +LD +   K+ADFG+ K   ++   V+T+   GT  Y+APE  +     +  D ++FGV+
Sbjct: 133 MLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 190

Query: 236 LLELITGRRPVD 247
           L E++ G+ P +
Sbjct: 191 LYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 37/104 (35%), Positives = 59/104 (56%), Gaps = 7/104 (6%)

Query: 145 LKIALGSAKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHV 202
           L+ +   A+G+ +L  ++C    IHRD+ A N+LL     AK+ DFGLA+ I +D N  V
Sbjct: 215 LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270

Query: 203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
                    ++APE       T +SDV+S+G++L E+ + G+ P
Sbjct: 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)

Query: 52  LGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVH---HKHLVS 104
           +G+G +G V   R +   G+ VA+K+++  +G+         EV ++  +    H ++V 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 105 LVGYYTAG-----SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
           L    T       ++  LV+E V +  L  +L     P +   T   +     +GL +LH
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
                +++HRD+K  NIL+    + K+ADFGLA+I S       T V+ T  Y APE   
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEVLL 182

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRPV 246
                   D++S G +  E+   R+P+
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 13/210 (6%)

Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +  V +G     +  VA+K+++    +G       EV ++  + H ++V+L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA-KGLAYLHEDCHPKIIH 168
                  LV+E++ +  L+ ++   G   +  +  +KI L    +GLAY H     K++H
Sbjct: 74  HTDKSLTLVFEYL-DKDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLH 127

Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-YASSGKLTEKS 227
           RD+K  N+L++ + E K+ADFGLA+ A  V T   +  + T  Y  P+    S + + + 
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186

Query: 228 DVFSFGVMLLELITGRRPVDSTHTFVEDSL 257
           D++  G +  E+ +G RP+    T VED L
Sbjct: 187 DMWGVGCIFFEMASG-RPLFPGST-VEDEL 214

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 58/248 (23%), Positives = 105/248 (42%), Gaps = 51/248 (20%)

Query: 44  DGFSDANLLGQGGFGYVHRGVLPNGKEV----------AIKQLKAGSGQGEREF--QAEV 91
           D F    ++G+G FG V    + + + +           +K+ +    + ER      + 
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 92  EIISRVHH-----KHLVSLVGYYTAGSQRMLVYEF---VPNNTLEFHLHGKGRPTMDWLT 143
           + I+ +H+      +L  ++ YY  G    L+ +F   +P +   F           ++ 
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-----------YIA 109

Query: 144 RLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS 203
            + +A+ S   L Y         +HRDIK  N+LLD     ++ADFG     +   T  S
Sbjct: 110 EMVLAIHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160

Query: 204 TRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV 258
           +  +GT  Y++PE   +     GK   + D +S GV + E++ G  P      F  +SLV
Sbjct: 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP------FYAESLV 214

Query: 259 DWARPLLN 266
           +    ++N
Sbjct: 215 ETYGKIMN 222

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 39/105 (37%), Positives = 58/105 (55%), Gaps = 12/105 (11%)

Query: 152 AKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGT 209
           AKG+++L  ++C    IHRD+ A NILL      K+ DFGLA+ I +D N  V       
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT------GRRPVDS 248
             ++APE   +   T +SDV+S+G++L E+ +         PVDS
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 53/196 (27%), Positives = 97/196 (49%), Gaps = 11/196 (5%)

Query: 52  LGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +  V++G        VA+K+++    +G       EV ++  + H ++V+L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA-KGLAYLHEDCHPKIIH 168
                  LV+E++ +  L+ +L   G      +  +K+ L    +GL Y H     K++H
Sbjct: 74  HTEKSLTLVFEYL-DKDLKQYLDDCGNSIN--MHNVKLFLFQLLRGLNYCHRR---KVLH 127

Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-YASSGKLTEKS 227
           RD+K  N+L++ + E K+ADFGLA+ A  + T   +  + T  Y  P+    S   + + 
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI 186

Query: 228 DVFSFGVMLLELITGR 243
           D++  G +  E+ TGR
Sbjct: 187 DMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 62/248 (25%), Positives = 106/248 (42%), Gaps = 51/248 (20%)

Query: 44  DGFSDANLLGQGGFGYVHRGVLPNGKEV----------AIKQLKAGSGQGEREF--QAEV 91
           + F    ++G+G FG V    L N  +V           +K+ +    + ER+     + 
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 92  EIISRVHH-----KHLVSLVGYYTAGSQRMLVYEF---VPNNTLEFHLHGKGRPTMDWLT 143
           + I+ +H+      +L  ++ YY  G    L+ +F   +P +   F           +L 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-----------YLA 109

Query: 144 RLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS 203
            + IA+ S   L Y         +HRDIK  NIL+D     ++ADFG      +  T  S
Sbjct: 110 EMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160

Query: 204 TRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV 258
           +  +GT  Y++PE   +     GK   + D +S GV + E++ G  P      F  +SLV
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP------FYAESLV 214

Query: 259 DWARPLLN 266
           +    ++N
Sbjct: 215 ETYGKIMN 222

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 18/212 (8%)

Query: 46  FSDANLLGQGGFGYVH--RGVLPN--GKEVAIKQLKAGS----GQGEREFQAEVEIISRV 97
           F    +LG G +G V   R V  +  GK  A+K LK  +     +     + E +++  +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 98  HHK-HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS-AKGL 155
                LV+L   +   ++  L+ +++    L  HL  + R        ++I  G     L
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ---EVQIYSGEIVLAL 118

Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
            +LH+     II+RDIK  NILLD      + DFGL+K   +     +    GT  Y+AP
Sbjct: 119 EHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175

Query: 216 EYASSGKLTEKS--DVFSFGVMLLELITGRRP 245
           +    G        D +S GV++ EL+TG  P
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 16/208 (7%)

Query: 44  DGFSDANLLGQGGFGYVHRGVLPNGK--EVAIKQLKAGSGQGEREFQ---AEVEIISRVH 98
           + F+    LG G FG V      N     VAIK+ +      +++     +E +I++ ++
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
           H   V+L G +   S   LV EFV        L    R   D      +    A  +  +
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND------VGCFYAAQIVLI 143

Query: 159 HEDCHP-KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
            E      I++RD+K  N+LLD     K+ DFG AK+   V+T   T + GT  Y+APE 
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV---VDTRTYT-LCGTPEYIAPEI 199

Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +    + +D ++ G+ + E++ G  P
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 6/93 (6%)

Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS-DVNTHVSTRVMGTFG 211
           +GL YLH      I+HRDIK  N+L++     K+ DFGLA++   D + H++  V+  + 
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169

Query: 212 YLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 243
           Y APE    S   T   D++S G +  EL+  R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 18/203 (8%)

Query: 51  LLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHHKHLV 103
           LLG+G FG V   +L      G+  A+K L+      + E      E  ++    H  L 
Sbjct: 2   LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           +L   +    +   V E+     L FHL  +   T +        + SA  L YLH    
Sbjct: 59  ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLHSR-- 114

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAPEYASSGK 222
             +++RDIK  N++LD     K+ DFGL K    ++   + +   GT  YLAPE      
Sbjct: 115 -DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 171

Query: 223 LTEKSDVFSFGVMLLELITGRRP 245
                D +  GV++ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 48/149 (32%), Positives = 72/149 (48%), Gaps = 15/149 (10%)

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----WLTRLKIALGSAKGLAY 157
           +V L   +   S   LV +++    L +HL  +GR + D    ++  L +AL       +
Sbjct: 58  IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLAL------EH 111

Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
           LH+     I++RD+K  NILLD      + DFGL+K     N   +T   GT  YLAPE 
Sbjct: 112 LHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEV 167

Query: 218 ASSGK-LTEKSDVFSFGVMLLELITGRRP 245
               K  T+  D +S GV++ E+  G  P
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 7/95 (7%)

Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA-SDVNTHVS-TRVMGTF 210
           + L Y+H      + HRD+K  NIL +   + K+ DFGLA++A +D  T +  T  + T 
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 211 GYLAPEYASS--GKLTEKSDVFSFGVMLLELITGR 243
            Y APE   S   K T   D++S G +  E++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 38/208 (18%)

Query: 52  LGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGE-----REFQAEVEIISRV-HHKHLVS 104
           +G+G F  V +      GK  AIK +K      E     RE QA    + R+  H +++ 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQA----LRRLSPHPNILR 62

Query: 105 LVGY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRP-----TMDWLTRLKIALGSAKGLAY 157
           L+   +   + R+ LV+E +  N  E  + G+ RP        ++ +L       K L +
Sbjct: 63  LIEVLFDRKTGRLALVFELMDMNLYEL-IKGRKRPLPEKRVKSYMYQL------LKSLDH 115

Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASD--VNTHVSTRVMGTFGYLA 214
           +H      I HRDIK  NIL+      K+ADFG  + I S      ++STR      Y A
Sbjct: 116 MH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-----WYRA 166

Query: 215 PE-YASSGKLTEKSDVFSFGVMLLELIT 241
           PE   + G    K D+++ G +  E+++
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 17/206 (8%)

Query: 51  LLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGERE---FQAEVEIISR-VHHKHL 102
           ++G+G FG V     +    +G   A+K L+  +   ++E     AE  ++ + + H  L
Sbjct: 2   VIGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFL 58

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           V L   +    +   V ++V    L FHL  + R  ++   R   A   A  + YLH   
Sbjct: 59  VGLHYSFQTAEKLYFVLDYVNGGELFFHLQ-RERCFLEPRARF-YAAEVASAIGYLHSL- 115

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK 222
              II+RD+K  NILLD +    + DFGL K   +     ST   GT  YLAPE      
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEP 172

Query: 223 LTEKSDVFSFGVMLLELITGRRPVDS 248
                D +  G +L E++ G  P  S
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYS 198

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 38/211 (18%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEV---------EIISRVHHK 100
            +G G +G V   +    G++VAIK+L        R FQ+E+          ++  + H+
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKL-------SRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 101 HLVSLVGYYTAGSQR------MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKG 154
           +++ L+  +T+           LV  ++  +  +   H      + +L    +      G
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML-----CG 129

Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA-SDVNTHVSTRVMGTFGYL 213
           L Y+H      IIHRD+K  N+ ++   E K+ DFGLA+ A +++  +V TR      Y 
Sbjct: 130 LKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYR 181

Query: 214 APEYASSG-KLTEKSDVFSFGVMLLELITGR 243
           APE   +     +  D++S G ++ E++TG+
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 38/97 (39%), Positives = 55/97 (56%), Gaps = 8/97 (8%)

Query: 154 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD---VNTHVSTRVMGTF 210
           GL Y+H      ++HRD+K  N+L++   E K+ DFGLA+  S+    N    T  + T 
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 211 GYLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPV 246
            Y APE   S +   K+ DV+S G +L EL+ GR+PV
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 23/221 (10%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGY 108
           N++G G FG V+  + +   ++VAIK++        RE      I+  ++H +++ L  Y
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDY 127

Query: 109 YTAGSQRM--------LVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLAYLH 159
           Y     +         +V EF+P    ++  H  +    +        +    + LAY+H
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187

Query: 160 EDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
                 I HRD+K  N+L+D      K+ DFG AK  + +    S   + +  Y APE  
Sbjct: 188 SKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLLAGQRSVSYICSRFYRAPELM 242

Query: 219 -SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV 258
             +   T   D++S G ++ E+I G  P+ S  + V D LV
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMILG-YPIFSGQSSV-DQLV 281

Length = 440

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 37/97 (38%), Positives = 49/97 (50%), Gaps = 12/97 (12%)

Query: 167 IHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVMGTFGYLAPEYASS----G 221
           IHRD+K  N+LLD     K+ADFG   K+ ++      T V GT  Y++PE   S    G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDG 222

Query: 222 KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV 258
               + D +S GV L E++ G  P      F  DSLV
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP------FYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 15/202 (7%)

Query: 51  LLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHHKHLV 103
           LLG+G FG V   +L      G+  A+K LK      + E      E  ++    H  L 
Sbjct: 2   LLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           +L   +    +   V E+     L FHL  +   + D        + SA  L YLH +  
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLHSE-- 114

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
             +++RD+K  N++LD     K+ DFGL K        + T   GT  YLAPE       
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDY 173

Query: 224 TEKSDVFSFGVMLLELITGRRP 245
               D +  GV++ E++ GR P
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 53/208 (25%), Positives = 105/208 (50%), Gaps = 23/208 (11%)

Query: 52  LGQGGFGYVHRGVLPNGK---EVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGY 108
           +G+G +G+V++    +GK   E A+KQ++ G+G      + E+ ++  + H ++++L   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACR-EIALLRELKHPNVIALQKV 66

Query: 109 YTAGSQRM--LVYEFVPNN---TLEFHLHGKGRPTMDWLTRLKIA---LGSAKGLAYLHE 160
           + + S R   L++++  ++    ++FH   K       L R  +         G+ YLH 
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 161 DCHPKIIHRDIKAANILL----DFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLA 214
           +    ++HRD+K ANIL+      +   K+AD G A++ +     ++    V+ TF Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 215 PEYASSGK-LTEKSDVFSFGVMLLELIT 241
           PE     +  T+  D+++ G +  EL+T
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 26/187 (13%)

Query: 68  GKEVAIKQLK---AGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLV 118
           G  VA+K+L          +R ++ E+ ++  V+HK+++SL+  +T            LV
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104

Query: 119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL 178
            E +  N  +          M +L    +      G+ +LH      IIHRD+K +NI++
Sbjct: 105 MELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVV 156

Query: 179 DFKFEAKVADFGLAKIASD---VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVM 235
                 K+ DFGLA+ A     +  +V TR      Y APE        E  D++S G +
Sbjct: 157 KSDCTLKILDFGLARTACTNFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCI 211

Query: 236 LLELITG 242
           + EL+ G
Sbjct: 212 MGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 45/235 (19%)

Query: 33  TFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREF 87
           TF  +EL +      + + + + +G G +G V        G  VA+K+L        R F
Sbjct: 2   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPF 54

Query: 88  QA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG--- 135
           Q+         E+ ++  + H++++ L+  +T         E   +  L  HL G     
Sbjct: 55  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNN 110

Query: 136 -----RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG 190
                + T D +  L   +   +GL Y+H      IIHRD+K +N+ ++   E K+ DFG
Sbjct: 111 IVKCQKLTDDHVQFLIYQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 165

Query: 191 LAKIASDVNT-HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 243
           LA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 166 LARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 34/91 (37%), Positives = 48/91 (52%), Gaps = 4/91 (4%)

Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTF 210
           A+G+ +L      K IHRD+ A NILL      K+ DFGLA+ I  D +           
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239

Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            ++APE       T +SDV+SFGV+L E+ +
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 30/220 (13%)

Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGEREFQA-------EVEIISRVHHKHLV 103
           +G+G +G V++       E +A+K+++      E+E +        E+ ++  + H ++V
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRL-----EQEDEGVPSTAIREISLLKEMQHGNIV 64

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL-KIALGSA-KGLAYLHED 161
            L     +  +  LV+E++    L+   H    P      RL K  L    +G+AY H  
Sbjct: 65  RLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121

Query: 162 CHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-YAS 219
              +++HRD+K  N+L+D +  A K+ADFGLA+ A  +     T  + T  Y APE    
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVVTLWYRAPEILLG 177

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
           S   +   D++S G +  E++  ++P+     F  DS +D
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVN-QKPL-----FPGDSEID 211

Length = 294

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 53.7 bits (130), Expect = 4e-08
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 25/156 (16%)

Query: 98  HHKHLVSLVGYYTAGSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGL 155
            + + + L  YY+  + +  +L+ +++ +  L   L  +G+ +     + KI     + L
Sbjct: 67  DNPNFIKL--YYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEA-EVK-KIIRQLVEAL 122

Query: 156 AYLHEDCHPKIIHRDIKAANILLD-FKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
             LH+  H  IIH DIK  N+L D  K    + D+GL KI    + +      GT  Y +
Sbjct: 123 NDLHK--H-NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFS 174

Query: 215 PEYASSGKLTEKSDVFSF-----GVMLLELITGRRP 245
           PE     K+   +   SF     GV+  EL+TG+ P
Sbjct: 175 PE-----KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 32/93 (34%), Positives = 47/93 (50%), Gaps = 11/93 (11%)

Query: 154 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD---VNTHVSTRVMGTF 210
           G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A     +  +V TR     
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182

Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 243
            Y APE        E  D++S G ++ E+I G 
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 54/208 (25%), Positives = 107/208 (51%), Gaps = 23/208 (11%)

Query: 52  LGQGGFGYVHRGVLPNGKE---VAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGY 108
           +G+G +G+V++    +GK+    A+KQ++ G+G      + E+ ++  + H +++SL   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACR-EIALLRELKHPNVISLQKV 66

Query: 109 YTAGSQRM--LVYEFVPNN---TLEFHLHGKGRPTMDWLTR--LKIALGSA-KGLAYLHE 160
           + + + R   L++++  ++    ++FH   K       L R  +K  L     G+ YLH 
Sbjct: 67  FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126

Query: 161 DCHPKIIHRDIKAANILL----DFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLA 214
           +    ++HRD+K ANIL+      +   K+AD G A++ +     ++    V+ TF Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 215 PEYASSGK-LTEKSDVFSFGVMLLELIT 241
           PE     +  T+  D+++ G +  EL+T
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 55/206 (26%), Positives = 82/206 (39%), Gaps = 50/206 (24%)

Query: 62  RGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF 121
           R VL NG    I  L          FQ E          +L  ++ YY  G    L+ +F
Sbjct: 52  RDVLVNGDRRWITNLHYA-------FQDE---------NNLYLVMDYYVGGDLLTLLSKF 95

Query: 122 ---VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL 178
              +P +   F           +L  + +A+ S   L Y         +HRDIK  N+LL
Sbjct: 96  EDRLPEDMARF-----------YLAEMVLAIDSVHQLGY---------VHRDIKPDNVLL 135

Query: 179 DFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFG 233
           D     ++ADFG         T  S   +GT  Y++PE   +     G+   + D +S G
Sbjct: 136 DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLG 195

Query: 234 VMLLELITGRRPVDSTHTFVEDSLVD 259
           V + E++ G  P      F  +SLV+
Sbjct: 196 VCMYEMLYGETP------FYAESLVE 215

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 43/142 (30%), Positives = 62/142 (43%), Gaps = 20/142 (14%)

Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----WLTRLKI------ALGSAKGLAYLHE 160
           AG   +L   F P         G   P  +    W + L +      +   A+G+ +L  
Sbjct: 139 AGQASVLFSRFQP------STSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192

Query: 161 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPEYAS 219
               K IHRD+ A NILL      K+ DFGLA+ I  D +            ++APE   
Sbjct: 193 R---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIF 249

Query: 220 SGKLTEKSDVFSFGVMLLELIT 241
               T +SDV+SFGV+L E+ +
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 17/212 (8%)

Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHHK 100
           D +     +G+G +G V++      GK VA+K+ +    +      A  E+ ++  +   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 101 -HLVSL-----VGYYTAGSQRMLVYEFVPNNTLEF-HLHGKGRPT-MDWLTRLKIALGSA 152
            ++V L     V          LV+E++ ++  +F   +G+G    +   T         
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120

Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLD-FKFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           KG+A+ H+     ++HRD+K  N+L+D  K   K+AD GL + A  +     T  + T  
Sbjct: 121 KGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKSYTHEIVTLW 176

Query: 212 YLAPE-YASSGKLTEKSDVFSFGVMLLELITG 242
           Y APE    S   +   D++S G +  E+   
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 37/101 (36%), Positives = 50/101 (49%), Gaps = 5/101 (4%)

Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTF 210
           AKG+ +L      K IHRD+ A NILL      K+ DFGLA+ I  D +           
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245

Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTH 250
            ++APE       T +SDV+SFGV+L E+ + G  P     
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 34/221 (15%)

Query: 46  FSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           + D   LG G  G V   V  +  K VA+K++     Q  +    E++II R+ H ++V 
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA------------ 152
           +  Y   G     + E V + T E +     +  M+  T L   L               
Sbjct: 67  V--YEVLGPSGSDLTEDVGSLT-ELNSVYIVQEYME--TDLANVLEQGPLSEEHARLFMY 121

Query: 153 ---KGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAKIASDVNTHVS----- 203
              +GL Y+H      ++HRD+K AN+ ++ +    K+ DFGLA+I   V+ H S     
Sbjct: 122 QLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARI---VDPHYSHKGYL 175

Query: 204 TRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           +  + T  Y +P    S    T+  D+++ G +  E++TG+
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 65/247 (26%), Positives = 108/247 (43%), Gaps = 37/247 (14%)

Query: 26  SLGFSKSTFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AG 79
           S+    STFT   L R    + +   +G G  G V   +  VL   + VAIK+L      
Sbjct: 5   SVEVGDSTFTV--LKR----YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQN 56

Query: 80  SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHG 133
               +R ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +     
Sbjct: 57  QTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME 115

Query: 134 KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 193
                M +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+
Sbjct: 116 LDHERMSYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167

Query: 194 IASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI------TGRRPVD 247
            A    + + T  + T  Y APE        E  D++S G ++ E++       GR  +D
Sbjct: 168 TAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225

Query: 248 STHTFVE 254
             +  +E
Sbjct: 226 QWNKVIE 232

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 48/219 (21%), Positives = 84/219 (38%), Gaps = 32/219 (14%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQ--LKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
                  ++ +   P    VA+K+  L + S +  +  Q E+    ++ H +++  V  +
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 110 TAGSQRMLVYEFVP----NNTLEFHLHGKGRPTMDWLTRLKIAL---GSAKGLAYLHEDC 162
              S+  +V   +      + L+ H         + L  L IA         L Y+H   
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLLKTHF-------PEGLPELAIAFILKDVLNALDYIH--- 118

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFG--------YLA 214
               IHR +KA++ILL    +  ++  GL    S +      RV+  F         +L+
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176

Query: 215 PE--YASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHT 251
           PE    +     EKSD++S G+   EL  G  P      
Sbjct: 177 PEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA 215

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 29/208 (13%)

Query: 52  LGQGGFGYVHRGVL---PNGKEVAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLVG 107
           +G G FG V    +        V +K+LKA +   E+ EF  + +    + H +++  +G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHL--HGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
                   +LV+E+     L+ +L      R     L   ++A   A G+ ++H+     
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLA-------KIASDVNTHVSTRVMGTFGYLAPEYA 218
            +H D+   N  L      KV D+G+         I ++ +  V  R      +LAPE  
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR------WLAPELV 173

Query: 219 SS--GKL-----TEKSDVFSFGVMLLEL 239
               G L     T+ S+V++ GV L EL
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 37/98 (37%), Positives = 48/98 (48%), Gaps = 12/98 (12%)

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVMGTFGYLAPEYASS---- 220
           +IHRD+K  N+LLD     K+ADFG   K+         T V GT  Y++PE   S    
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGD 221

Query: 221 GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV 258
           G    + D +S GV L E++ G  P      F  DSLV
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTP------FYADSLV 253

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 70/273 (25%), Positives = 110/273 (40%), Gaps = 70/273 (25%)

Query: 44  DGFSDANLLGQGGFGYVHRGVLP--NGKEVAIKQLKAGSGQGERE----FQAEVEIISRV 97
           D F    ++G+G FG V R V     G   A+K+L+  S   E+E     +AE +I++  
Sbjct: 1   DDFESIKVIGRGAFGEV-RLVQKKDTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILAEA 58

Query: 98  HHKHLVSLVGYYTAGSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKI-----ALG 150
            +  +V L  YY+   +    L+ E++P   +   L  K   T +  TR  I     A+ 
Sbjct: 59  DNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-ETRFYIAETILAID 115

Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--------------IAS 196
           S   L Y         IHRDIK  N+LLD K   K++DFGL                  +
Sbjct: 116 SIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 197 DVNTHVST------------------RVM-----GTFGYLAPEYASSGKLTEKSDVFSFG 233
             +  +                    R +     GT  Y+APE        ++ D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226

Query: 234 VMLLELITGRRPVDSTHTFVEDSLVDWARPLLN 266
           V++ E++ G  P      F  D+  +  R ++N
Sbjct: 227 VIMYEMLVGYPP------FCSDNPQETYRKIIN 253

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 38/105 (36%), Positives = 51/105 (48%), Gaps = 12/105 (11%)

Query: 167 IHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVMGTFGYLAPEYASS----G 221
           IHRD+K  N+LLD     K+ADFG   K+  +      T V GT  Y++PE   S    G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 222

Query: 222 KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN 266
               + D +S GV L E++ G  P      F  DSLV     ++N
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP------FYADSLVGTYSKIMN 261

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 50.3 bits (120), Expect = 8e-07
 Identities = 30/81 (37%), Positives = 43/81 (53%), Gaps = 1/81 (1%)

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA-SSGKLT 224
           I++RDIK  NILLD +    + DFGL+K         +    GT  Y+APE     G   
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185

Query: 225 EKSDVFSFGVMLLELITGRRP 245
           +  D +S G+++ EL+TG  P
Sbjct: 186 KAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 10/93 (10%)

Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT-HVSTRVMGTFG 211
           +GL Y+H      IIHRD+K +N+ ++   E ++ DFGLA+ A D  T +V+TR      
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180

Query: 212 YLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 243
           Y APE   +     +  D++S G ++ EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 6/107 (5%)

Query: 137 PTMDWLTRLKIALGSAKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-I 194
           P + ++  +  +   A G+ +L  ++C    +HRD+ A N+L+      K+ DFGLA+ I
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDI 289

Query: 195 ASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
             D N            ++APE   +   T  SDV+SFG++L E+ T
Sbjct: 290 MRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 51/189 (26%), Positives = 85/189 (44%), Gaps = 30/189 (15%)

Query: 69  KEVAIKQLK---AGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML-------- 117
           + VAIK+L          +R ++ E+ ++  V+HK+++ L+  +T   Q+ L        
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTP--QKSLEEFQDVYI 106

Query: 118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANIL 177
           V E +  N  +          M +L    +      G+ +LH      IIHRD+K +NI+
Sbjct: 107 VMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIV 158

Query: 178 LDFKFEAKVADFGLAKIASD---VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 234
           +      K+ DFGLA+ A     +  +V TR      Y APE        E  D++S G 
Sbjct: 159 VKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGC 213

Query: 235 MLLELITGR 243
           ++ E+I G 
Sbjct: 214 IMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 33/200 (16%)

Query: 66  PNGKEVAIKQ--LKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP 123
           P G+ V +++  L+A + +     Q E+ +    +H ++V     + A ++  +V  F+ 
Sbjct: 23  PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82

Query: 124 NNTLEFHLHGKGRPT-----MDWLTRLKIA---LGSAKGLAYLHEDCHPKIIHRDIKAAN 175
                   +G  +       MD ++ L IA    G  K L Y+H   H   +HR +KA++
Sbjct: 83  --------YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASH 131

Query: 176 ILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFG--------YLAPEYASSG--KLTE 225
           IL+    + KV   GL    S +N     RV+  F         +L+PE           
Sbjct: 132 ILI--SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA 189

Query: 226 KSDVFSFGVMLLELITGRRP 245
           KSD++S G+   EL  G  P
Sbjct: 190 KSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 52/182 (28%), Positives = 83/182 (45%), Gaps = 26/182 (14%)

Query: 87  FQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLH-GKGRPTMDWLTRL 145
           F     ++S+V H HL  + G    GS+ ++V EFV +  L+  L   KGR  + W  ++
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120

Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA-------KVADFGLAKIASDV 198
            +A   A  L+YL ED    ++H ++ A NILL     A       K++D G++  A   
Sbjct: 121 TVAQQLASALSYL-ED--KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR 177

Query: 199 NTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLEL-------ITGRRPVDSTH 250
              V         ++APE    G  L+  +D +SFG  LLE+       +  R P +   
Sbjct: 178 EERVE-----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232

Query: 251 TF 252
            +
Sbjct: 233 FY 234

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 17/197 (8%)

Query: 66  PNGKEVAIK--QLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP 123
           P G  V ++   L+  + +  +  Q EV +     H ++++    +T GS   ++  F+ 
Sbjct: 23  PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82

Query: 124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE 183
             +    L       M       I  G+ +GL YLH++ +   IHR+IKA++IL+    +
Sbjct: 83  YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY---IHRNIKASHILI--SGD 137

Query: 184 AKVADFGLAKIASDVNTHVSTRVMGTFG--------YLAPEYASSG--KLTEKSDVFSFG 233
             V+  GL+ + S V      +V+  F         +L+PE           KSD++S G
Sbjct: 138 GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVG 197

Query: 234 VMLLELITGRRPVDSTH 250
           +   EL TGR P     
Sbjct: 198 ITACELATGRVPFQDML 214

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.9 bits (114), Expect = 5e-06
 Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 31/224 (13%)

Query: 44  DGFSDANLLGQGGFGYVHRGVLPNGKEV----AIKQLKAGS----GQGEREFQAEVEIIS 95
           + F    L+  G +G V+   L   KE     A+K++   +     Q ++ F  E +I++
Sbjct: 1   EDFETIKLISNGAYGAVY---LVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILT 56

Query: 96  RVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGL 155
              +  +VS+   +       +V E+V        L   G   +D + R+  A  +   L
Sbjct: 57  FAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD-MARMYFA-ETVLAL 114

Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--------------ASDVNTH 201
            YLH   +  I+HRD+K  N+L+      K+ DFGL+KI                D    
Sbjct: 115 EYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171

Query: 202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           +  +V GT  Y+APE        +  D ++ G++L E + G  P
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 6/92 (6%)

Query: 152 AKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGT 209
           A+G+ +L  ++C    +HRD+ A N+LL      K+ DFGLA+ I  D N          
Sbjct: 247 ARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
             ++APE       T  SDV+S+G++L E+ +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 44/185 (23%), Positives = 77/185 (41%), Gaps = 31/185 (16%)

Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----WLTRLKIALGSAKGLA 156
           ++V L  Y  +     LV +      L  H+        +    W   + +AL +     
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100

Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG-LAKIASDVNTHVSTRVMGTFGYLAP 215
            LH +    I+ RD+   NILLD +   ++  F   +++    +      +     Y AP
Sbjct: 101 -LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151

Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPVDS------THTFVEDSLVDW----ARPLL 265
           E     + TE  D +S G +L EL+TG+  V+       THT +  ++ +W    AR LL
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTL--NIPEWVSEEARSLL 209

Query: 266 NRAIE 270
            + ++
Sbjct: 210 QQLLQ 214

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 26/207 (12%)

Query: 52  LGQGGFGYVHRGVLPN---------GKEVAIKQLKAGSGQGERE----FQAEVEIISRVH 98
           LG+G    ++ G+L             E  IK +        R+    F     ++ +V 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRP-TMDWLTRLKIALGSAKGLAY 157
           HKH+V L G      + ++V EFV    L+  +H K    T  W  + K+A   A  L+Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120

Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD--VNTHVSTR--VMGTFGYL 213
           L ED    ++H ++   NILL    E    + G     SD  +   V +R   +    ++
Sbjct: 121 L-ED--KDLVHGNVCTKNILL--AREGIDGECGPFIKLSDPGIPITVLSRQECVERIPWI 175

Query: 214 APEYASSGK-LTEKSDVFSFGVMLLEL 239
           APE     K L+  +D +SFG  L E+
Sbjct: 176 APECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 58/246 (23%), Positives = 94/246 (38%), Gaps = 55/246 (22%)

Query: 44  DGFSDANLLGQGGFGYVHRGVLP--NGKEVAIKQLKAGSGQGERE----FQAEVEIISRV 97
           D F    ++G+G FG V R V     G   A+K L+  +   E+E     +AE +I+   
Sbjct: 1   DDFESLKVIGRGAFGEV-RLVQKKDTGHIYAMKILRK-ADMLEKEQVAHIRAERDILVEA 58

Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG----RPTMDWLTRLKIALGSAK 153
               +V +   +       L+ EF+P   +   L  K       T  ++    +A+ +  
Sbjct: 59  DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH 118

Query: 154 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL---------------------- 191
            L +         IHRDIK  N+LLD K   K++DFGL                      
Sbjct: 119 QLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169

Query: 192 ------------AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 239
                       A+        ++   +GT  Y+APE        +  D +S GV++ E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 240 ITGRRP 245
           + G  P
Sbjct: 230 LIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 44.7 bits (105), Expect = 6e-05
 Identities = 54/244 (22%), Positives = 92/244 (37%), Gaps = 51/244 (20%)

Query: 44  DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGERE----FQAEVEIISRVHH 99
           + F    ++G+G FG V      +   V   ++   +   E+E     +AE +I+     
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----WLTRLKIALGSAKGL 155
             +V +   +       L+ EF+P   +   L  K   T +    ++    +A+ S   L
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-----------------KIASDV 198
            +         IHRDIK  N+LLD K   K++DFGL                   + SD 
Sbjct: 121 GF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171

Query: 199 N-----------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
                               ++   +GT  Y+APE        +  D +S GV++ E++ 
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231

Query: 242 GRRP 245
           G  P
Sbjct: 232 GYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 44/184 (23%), Positives = 85/184 (46%), Gaps = 18/184 (9%)

Query: 66  PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL--------VGYYTAGSQRML 117
           P  + +  K++KAGS +   + + E+  + R++H++++ +          Y         
Sbjct: 190 PKCERLIAKRVKAGS-RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFD 248

Query: 118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANIL 177
           +Y F+ +   ++    K RP +   TR  I       + Y+H+    K+IHRDIK  NI 
Sbjct: 249 LYSFMYDEAFDW----KDRP-LLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299

Query: 178 LDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLL 237
           L+   +  + DFG A              +GT    +PE  +     E +D++S G++LL
Sbjct: 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILL 359

Query: 238 ELIT 241
           ++++
Sbjct: 360 DMLS 363

Length = 501

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 44/194 (22%), Positives = 70/194 (36%), Gaps = 47/194 (24%)

Query: 88  QAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKI 147
             E EI++ + H  L +L   +   +   LV ++ P    E     + +P       L  
Sbjct: 49  LTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGG--ELFRLLQRQPG----KCLSE 102

Query: 148 ALGSAK--------GLAYLHEDCHPKIIHRDIKAANILL-----------DFKFEAKVAD 188
               A+         L YLH      I++RD+K  NILL           D   ++ V  
Sbjct: 103 E--VARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157

Query: 189 ----FGLAKIASDVNTH----------VSTRVM---GTFGYLAPEYASSGKLTEKSDVFS 231
                 L K +   + +           S R     GT  Y+APE  S        D ++
Sbjct: 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWT 217

Query: 232 FGVMLLELITGRRP 245
            G++L E++ G  P
Sbjct: 218 LGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 38/145 (26%), Positives = 55/145 (37%), Gaps = 47/145 (32%)

Query: 167 IHRDIKAANILLDFKFEAKVADFGL--------------------------AKIASDV-N 199
           IHRDIK  NIL+D     K+ DFGL                          + +  DV N
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 200 THVSTRVM-------------------GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 240
                R+                    GT  Y+APE       T+  D +S GV+L E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 241 TGRRP-VDSTHTFVEDSLVDWARPL 264
            G+ P +  T T  +  +++W   L
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTL 267

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 50/157 (31%), Positives = 75/157 (47%), Gaps = 17/157 (10%)

Query: 44  DGFSDANLLGQGGFGYVHRGV--LPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVH 98
           + F    ++G+G FG V R V     GK  A+K L       + +    +AE ++++   
Sbjct: 1   EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59

Query: 99  HKHLVSLVGYYT-AGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLA 156
              +VSL  YY+   +Q + L+ EF+P   L   L      + D +TR  +A      LA
Sbjct: 60  SPWVVSL--YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-VTRFYMA---ECVLA 113

Query: 157 YLHEDCHP-KIIHRDIKAANILLDFKFEAKVADFGLA 192
              E  H    IHRDIK  NIL+D     K++DFGL+
Sbjct: 114 I--EAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.8 bits (98), Expect = 6e-04
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 13/147 (8%)

Query: 54  QGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGE---REFQAEVEIISRVHHKHLVSLVGYY 109
           +G FG V+ G    N K  A+K +K      +    + QAE + ++      +V L  YY
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL--YY 71

Query: 110 T--AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
           +  + +   LV E++    ++  LH  G    D    +K     A  L YLH   H  II
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHR--H-GII 126

Query: 168 HRDIKAANILLDFKFEAKVADFGLAKI 194
           HRD+K  N+L+  +   K+ DFGL+K+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 41.3 bits (97), Expect = 6e-04
 Identities = 35/141 (24%), Positives = 52/141 (36%), Gaps = 43/141 (30%)

Query: 167 IHRDIKAANILLDFKFEAKVADFGL------------------------------AKIAS 196
           IHRDIK  NIL+D     K+ DFGL                              ++I  
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 197 DVNTHVSTRVM------------GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRR 244
                +  R              GT  Y+APE       T+  D +S GV+L E++ G+ 
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 245 P-VDSTHTFVEDSLVDWARPL 264
           P +  T    +  +++W   L
Sbjct: 243 PFLADTPAETQLKVINWETTL 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 16/155 (10%)

Query: 90  EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP--NNTLEFHLHGKGRPTMDWLTRLKI 147
           E  ++ R+ H  +++L+     G    LV   +P   + L  +L  + RP    L   ++
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRP----LGLAQV 262

Query: 148 ALGSAKGLA---YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV-NTHVS 203
              + + L+   Y+H +    IIHRDIK  N+L++   +  + DFG A  A    +T   
Sbjct: 263 TAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319

Query: 204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLE 238
             + GT    APE  +    T   D++S G+++ E
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 28/78 (35%), Positives = 43/78 (55%), Gaps = 8/78 (10%)

Query: 52  LGQGGFGYVHR------GVLPNGKEVAIKQLKAGSGQGERE-FQAEVEIISRV-HHKHLV 103
           LG G FG V        G   N   VA+K LKA +   ERE   +E++I+S +  HK++V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105

Query: 104 SLVGYYTAGSQRMLVYEF 121
           +L+G  T G   +++ E+
Sbjct: 106 NLLGACTHGGPVLVITEY 123

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	416
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.98
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.98
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.84
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.82
PRK10345	210	hypothetical protein; Provisional	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
smart00090	237	RIO RIO-like kinase.	99.77
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.67
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.55
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.51
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.36
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.35
KOG1243	690	consensus Protein kinase [General function predict	99.35
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.33
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.26
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
KOG3087	229	consensus Serine/threonine protein kinase [General	99.25
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.23
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.13
COG4248	637	Uncharacterized protein with protein kinase and he	99.11
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.08
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.05
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.01
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.95
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.91
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.84
PRK09902	216	hypothetical protein; Provisional	98.78
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.77
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.73
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.64
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.54
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.44
PF01636	239	APH: Phosphotransferase enzyme family This family	98.42
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.33
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.26
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.22
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.19
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.17
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.1
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.08
PLN02876	822	acyl-CoA dehydrogenase	98.06
PRK10593	297	hypothetical protein; Provisional	98.06
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.0
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.99
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.91
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.82
PRK05231	319	homoserine kinase; Provisional	97.72
KOG2270	520	consensus Serine/threonine protein kinase involved	97.63
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.6
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.58
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.57
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.54
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.31
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.31
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.15
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.95
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.93
PRK11768	325	serine/threonine protein kinase; Provisional	96.87
COG2334	331	Putative homoserine kinase type II (protein kinase	96.84
PLN02236	344	choline kinase	96.67
PRK12396	409	5-methylribose kinase; Reviewed	96.53
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.52
PRK06148	1013	hypothetical protein; Provisional	96.48
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.42
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.36
PLN02756	418	S-methyl-5-thioribose kinase	96.33
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.03
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.02
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.92
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.2
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.03
PTZ00384	383	choline kinase; Provisional	94.57
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.3
PTZ00296	442	choline kinase; Provisional	93.91

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-63  Score=491.51  Aligned_cols=290  Identities=59%  Similarity=0.999  Sum_probs=260.1

Q ss_pred             CccccCHHHHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEE
Q 014904           30 SKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY  109 (416)
Q Consensus        30 ~~~~f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  109 (416)
                      ....|+|+||.+||++|+..++||+||||.||+|.+.+|+.||||++.....+..++|..|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56789999999999999999999999999999999999999999988876544256799999999999999999999999


Q ss_pred             EeCC-eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEee
Q 014904          110 TAGS-QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD  188 (416)
Q Consensus       110 ~~~~-~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~D  188 (416)
                      .+.+ +++|||||+++|+|.++|+......++|.+|++||.++|+||+|||+.|.+.|||||||++|||||.++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9988 599999999999999999976544789999999999999999999999999999999999999999999999999


Q ss_pred             cccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHh
Q 014904          189 FGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRA  268 (416)
Q Consensus       189 FGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~  268 (416)
                      ||+++.......+..+...||+||+||||+..+.+++|+|||||||+|+||+||+++++...+..+..+++|+++.+   
T Consensus       221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~---  297 (361)
T KOG1187|consen  221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL---  297 (361)
T ss_pred             ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH---
Confidence            99997665422222222289999999999999999999999999999999999999999877667778999997665   


Q ss_pred             hhcCCcccccCcccc-CcCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          269 IEDGNFDTLVDPKLH-NEYNH-NEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       269 ~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                       .++.+.+++||++. ..++. .++.++..++.+|++.+|.+||+|.||+++|+...
T Consensus       298 -~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  298 -EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             -HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence             46699999999988 66665 68999999999999999999999999999996543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-48  Score=381.80  Aligned_cols=256  Identities=34%  Similarity=0.543  Sum_probs=211.5

Q ss_pred             CCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCccc--HHHHHHHHHHHHhcCCCcccceEEEEEeCC-eEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQG--EREFQAEVEIISRVHHKHLVSLVGYYTAGS-QRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~  121 (416)
                      .+...+.||.|+||+||+|.+.....||||++.......  .+.|.+|+.++.+++|||||+++|+|.+.. ..++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            344455699999999999999554449999998654333  458999999999999999999999999987 79999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeecccCCcEEECCCC-ceEEeecccceeccCCC
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK-IIHRDIKAANILLDFKF-EAKVADFGLAKIASDVN  199 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~-iiHrDIkp~NILl~~~~-~~kl~DFGla~~~~~~~  199 (416)
                      +++|+|..+++......+++..++.|+.+||+||.|||+.   + |||||||+.||||+.++ .+||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            9999999999885445799999999999999999999999   7 99999999999999997 99999999998765432


Q ss_pred             cceeecccccccccChhhhc--cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          200 THVSTRVMGTFGYLAPEYAS--SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~--~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                       ...+...||+.|||||++.  ...++.|+|||||||+||||+||+.||....+ ..  +   +...    ...+     
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~--~---~~~v----~~~~-----  262 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQ--V---ASAV----VVGG-----  262 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HH--H---HHHH----HhcC-----
Confidence             2223368999999999999  56899999999999999999999999987554 11  0   1000    1111     


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                          .....+..+...+..++.+||+.+|..||++.+|+..|+...
T Consensus       263 ----~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~  304 (362)
T KOG0192|consen  263 ----LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM  304 (362)
T ss_pred             ----CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence                122223336678999999999999999999999999998543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-46  Score=354.63  Aligned_cols=252  Identities=29%  Similarity=0.430  Sum_probs=211.5

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCC-eEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGS-QRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~  121 (416)
                      +....+.||+|..|+|||+.++ +++-+|+|++.... ....+++.+|++++...+||+||.++|.|.... ...++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4455789999999999999964 68999999995443 334578999999999999999999999999988 59999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHE-DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |.+|+|+.++...+  .+++...-+|+.++++||.|||+ .   +||||||||+||||+..|++||||||.++.+.+.  
T Consensus       160 MDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             cCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            99999999997654  58999999999999999999996 5   9999999999999999999999999999877653  


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                       ....++||..|||||.+.+..|+.++||||||++++|+.+|+.|+....    .....|+.  +..++-++....+.+ 
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~----~~~~~~~~--Ll~~Iv~~ppP~lP~-  304 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN----PPYLDIFE--LLCAIVDEPPPRLPE-  304 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC----CCCCCHHH--HHHHHhcCCCCCCCc-
Confidence             5567899999999999999999999999999999999999999997651    22233432  223344444333222 


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                          .   ....++..++..||++||.+||++.|+++.
T Consensus       305 ----~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  305 ----G---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             ----c---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                1   245689999999999999999999998854

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=372.08  Aligned_cols=253  Identities=31%  Similarity=0.441  Sum_probs=218.5

Q ss_pred             CcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCC
Q 014904           47 SDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT  126 (416)
Q Consensus        47 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~s  126 (416)
                      ...+.||+|-||.||.|.+.....||+|.++... .....|.+|+.+++.|+|+|||+++++|..+..++|||||++.|+
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs  287 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS  287 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence            3467899999999999999777799999999764 445689999999999999999999999999889999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeecc
Q 014904          127 LEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRV  206 (416)
Q Consensus       127 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  206 (416)
                      |.++|+...+..+...+.+.++.|||+|++||+++   ++|||||.++||||+++..+||+|||||+...+.........
T Consensus       288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~  364 (468)
T KOG0197|consen  288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG  364 (468)
T ss_pred             HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence            99999986666899999999999999999999999   999999999999999999999999999996666555555545


Q ss_pred             cccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCc
Q 014904          207 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNE  285 (416)
Q Consensus       207 ~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~  285 (416)
                      .-+..|.|||.+..++++.|||||||||+||||+| |+.|+.....           .-+.+.++.|         .+-.
T Consensus       365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----------~ev~~~le~G---------yRlp  424 (468)
T KOG0197|consen  365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----------EEVLELLERG---------YRLP  424 (468)
T ss_pred             CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----------HHHHHHHhcc---------CcCC
Confidence            56778999999999999999999999999999999 9998776543           1122233333         2334


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          286 YNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       286 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      .+..++..+.+++..||+.+|++|||+..+...|+...
T Consensus       425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            45567889999999999999999999999999988543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-45  Score=364.76  Aligned_cols=248  Identities=23%  Similarity=0.367  Sum_probs=211.1

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      .+|...++||+|||+.||.+.. .+|+.||+|++.+...   .....+.+|++|.+.|+|||||+++++|++..+.|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688999999999999999996 8899999999976432   23457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      |+|.+++|..++.  .+..+++.++..+..||+.||.|||+.   +|||||||..|+||+++.++||+|||||..+....
T Consensus        98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            9999999999986  445799999999999999999999999   99999999999999999999999999999887543


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                      . .....+|||-|+|||++.....+..+||||+|||+|-||.|++||+...-.+          .+. .++..++     
T Consensus       173 E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke----------ty~-~Ik~~~Y-----  235 (592)
T KOG0575|consen  173 E-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE----------TYN-KIKLNEY-----  235 (592)
T ss_pred             c-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH----------HHH-HHHhcCc-----
Confidence            2 2345789999999999998889999999999999999999999998754211          111 1122221     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                           .++........+|+.++|+.+|.+||++.+|+..
T Consensus       236 -----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  236 -----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                 1222344567899999999999999999999954

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-45  Score=351.67  Aligned_cols=254  Identities=26%  Similarity=0.383  Sum_probs=207.5

Q ss_pred             hhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCccc-------HHHHHHHHHHHHhcCCCcccceEEEEEeCC
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQG-------EREFQAEVEIISRVHHKHLVSLVGYYTAGS  113 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  113 (416)
                      ..+.|.+.+.||+|+||.|-+|. ..+|+.||||++++.....       ....++|+++|++|+|||||++++++....
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            34567888899999999999999 5689999999997642211       234579999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC---CceEEeecc
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK---FEAKVADFG  190 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~---~~~kl~DFG  190 (416)
                      ..|+|+||+.||.|.+.+-.++  .+.+.....++.|++.||.|||+.   ||+||||||+|||+..+   ..+||+|||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence            9999999999999999987765  466667788999999999999999   99999999999999776   679999999


Q ss_pred             cceeccCCCcceeecccccccccChhhhccCC---CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHH
Q 014904          191 LAKIASDVNTHVSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNR  267 (416)
Q Consensus       191 la~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~---~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~  267 (416)
                      +|+..+.  .......+||+.|+|||++.++.   +..|+|+||+|||||-+|+|.+||......          +.+.+
T Consensus       325 lAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~----------~sl~e  392 (475)
T KOG0615|consen  325 LAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD----------PSLKE  392 (475)
T ss_pred             hhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC----------ccHHH
Confidence            9998873  33445689999999999997764   345889999999999999999999765431          11223


Q ss_pred             hhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          268 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       268 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ++..|.+...      ........++..+++.+||..||++||++.|+++.
T Consensus       393 QI~~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  393 QILKGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             HHhcCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            3444543221      12233456788999999999999999999998754

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3e-44  Score=343.61  Aligned_cols=203  Identities=29%  Similarity=0.452  Sum_probs=182.1

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ...+|.....||.|.|++||+|.+ .++.+||||.+....  ....+-+..|+.+|+.++|||||.+++++..++..+||
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            457888889999999999999995 468999999997663  22234578899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC------CceEEeecccc
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK------FEAKVADFGLA  192 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~------~~~kl~DFGla  192 (416)
                      ||||.||+|.++++..+  .++..+...++.|+|.||++||+.   +||||||||+||||+..      -.+||+|||+|
T Consensus        88 MEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999998876  589999999999999999999999   99999999999999765      45899999999


Q ss_pred             eeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCc
Q 014904          193 KIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHT  251 (416)
Q Consensus       193 ~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~  251 (416)
                      +.+..  .......+|++-|||||++..++|+.|+|+||+|++||+|++|+.||+....
T Consensus       163 R~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  163 RFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             hhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            98874  3444668999999999999999999999999999999999999999986554

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.7e-46  Score=339.30  Aligned_cols=257  Identities=24%  Similarity=0.386  Sum_probs=213.4

Q ss_pred             CCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEE-EEEeCCe-EEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVG-YYTAGSQ-RMLV  118 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lV  118 (416)
                      .+|.+.+.||.|.||.||++. +.+|..+|.|.++-...  .....+..|+.+|++|+|||||+.++ .+.++.. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            457788999999999999999 77999999999985432  33456889999999999999999998 5665555 8999


Q ss_pred             EEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeecccCCcEEECCCCceEEeecccceec
Q 014904          119 YEFVPNNTLEFHLHG--KGRPTMDWLTRLKIALGSAKGLAYLHEDCHP-KIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~-~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ||++..|+|..+++.  +.+..+++.++|+++.|++.||.++|..... -|+||||||.||+|+.+|.+||+||||++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999863  3455799999999999999999999994211 3899999999999999999999999999988


Q ss_pred             cCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ....+ .....+|||-||+||.+...+|+.||||||+||++|||+.-+.||...+-           -.+.+.+++|++.
T Consensus       179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~-----------~~L~~KI~qgd~~  246 (375)
T KOG0591|consen  179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL-----------LSLCKKIEQGDYP  246 (375)
T ss_pred             cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH-----------HHHHHHHHcCCCC
Confidence            76443 34568899999999999999999999999999999999999999987532           2245567788765


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      .+.|        .--...+..++..|+..||+.||+...+|..+.
T Consensus       247 ~~p~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  247 PLPD--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             CCcH--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            4432        223457899999999999999998655555443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=9e-44  Score=337.30  Aligned_cols=243  Identities=27%  Similarity=0.359  Sum_probs=204.0

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCccc---HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQG---EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .+.|.+.++||+|+||.||.+.. .+++.+|+|++++.....   .+...+|..||..++||.||+++-.|.+...+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            46899999999999999999994 568999999998764333   35678999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      +||+.||.|..+|+..+  .+++..+...+.+|+.||.|||+.   +||||||||+|||||.+|.++|+||||++.....
T Consensus       104 ld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            99999999999998776  488888899999999999999999   9999999999999999999999999999865443


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      .. ....++||+.|||||++.+..++..+|.||||+++|||++|.+||...+.      ..+...     +..+..    
T Consensus       179 ~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~-----I~~~k~----  242 (357)
T KOG0598|consen  179 GD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDK-----ILKGKL----  242 (357)
T ss_pred             CC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHH-----HhcCcC----
Confidence            22 23348999999999999999999999999999999999999999987553      222221     222220    


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCC
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPR  311 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt  311 (416)
                           ...+.-......+++...+..+|++|-.
T Consensus       243 -----~~~p~~ls~~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  243 -----PLPPGYLSEEARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             -----CCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence                 1111113347889999999999999964

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.1e-43  Score=345.51  Aligned_cols=258  Identities=28%  Similarity=0.421  Sum_probs=204.7

Q ss_pred             hCCCCcCceecccCcEEEEEEEe------CCCcEEEEEEeecCCcc-cHHHHHHHHHHHHhc-CCCcccceEEEEEeC-C
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL------PNGKEVAIKQLKAGSGQ-GEREFQAEVEIISRV-HHKHLVSLVGYYTAG-S  113 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  113 (416)
                      .++|.+.++||+|+||.||+|.+      .+++.||||+++..... ....+..|+.++..+ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46899999999999999999974      23568999999754332 235688999999999 899999999998764 4


Q ss_pred             eEEEEEEecCCCCHHHHhhcCC----------------------------------------------------------
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKG----------------------------------------------------------  135 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~----------------------------------------------------------  135 (416)
                      ..++||||+++++|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            5889999999999999886432                                                          


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce-eecccccccc
Q 014904          136 --RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGY  212 (416)
Q Consensus       136 --~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y  212 (416)
                        ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++......... .....++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              12478889999999999999999998   99999999999999999999999999998654322221 2234567889


Q ss_pred             cChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHH
Q 014904          213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEM  291 (416)
Q Consensus       213 laPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  291 (416)
                      +|||++.+..++.++|||||||+||||++ |+.||......  ..        +...+..+....         .+....
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~--------~~~~~~~~~~~~---------~~~~~~  303 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EE--------FCQRLKDGTRMR---------APENAT  303 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HH--------HHHHHhcCCCCC---------CCCCCC
Confidence            99999999999999999999999999997 99999764321  11        111122222111         112234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          292 ARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       292 ~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      ..+.+++.+||+.+|.+||++.||++.|+..
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            5788999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.7e-42  Score=331.13  Aligned_cols=256  Identities=21%  Similarity=0.334  Sum_probs=204.7

Q ss_pred             ccCHHHHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCccc---HHHHHHHHHHHHhcCCCcccceEEEE
Q 014904           33 TFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQG---EREFQAEVEIISRVHHKHLVSLVGYY  109 (416)
Q Consensus        33 ~f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~  109 (416)
                      .++++++     .......||+|+++.||+|.. +|+.||||+++......   .+.|.+|+.++.+++||||+++++++
T Consensus        14 ~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~   87 (283)
T PHA02988         14 CIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI   87 (283)
T ss_pred             ecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence            4455665     333346899999999999998 78999999998654333   35678999999999999999999998


Q ss_pred             Ee----CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceE
Q 014904          110 TA----GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAK  185 (416)
Q Consensus       110 ~~----~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~k  185 (416)
                      .+    ....++||||+++++|.+++....  .+++...+.++.+++.||.|||+..  +++||||||+|||++.++.+|
T Consensus        88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~k  163 (283)
T PHA02988         88 IDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLK  163 (283)
T ss_pred             EecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEE
Confidence            77    456899999999999999997643  6899999999999999999999843  788999999999999999999


Q ss_pred             EeecccceeccCCCcceeecccccccccChhhhcc--CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH
Q 014904          186 VADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP  263 (416)
Q Consensus       186 l~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~--~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~  263 (416)
                      |+|||+++......    ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.....   ..+..    
T Consensus       164 l~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~~----  232 (283)
T PHA02988        164 IICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIYD----  232 (283)
T ss_pred             EcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHHH----
Confidence            99999988654322    22467899999999976  6899999999999999999999999976432   11111    


Q ss_pred             HhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          264 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       264 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                          .+..+...    +.    .+......+.+++.+||+.+|++||++.||++.|+-
T Consensus       233 ----~i~~~~~~----~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        233 ----LIINKNNS----LK----LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             ----HHHhcCCC----CC----CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence                11111111    11    122344578999999999999999999999999873

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=327.75  Aligned_cols=262  Identities=24%  Similarity=0.352  Sum_probs=215.1

Q ss_pred             hCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcccH-HHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .+.|.+...||.|.-++||+|. .+.+..||||++....-... ..++.|+..++.++||||++.+..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4688999999999999999999 77899999999986544433 788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+.+|++.+++...-...+++..+..|..++++||.|||++   |.||||||+.||||+.+|.+||+|||.+....+...
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            99999999999876555699999999999999999999999   999999999999999999999999999765544333


Q ss_pred             cee---ecccccccccChhhhcc--CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          201 HVS---TRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       201 ~~~---~~~~gt~~YlaPE~~~~--~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ...   ....||+.|||||++..  ..|+.|+||||||++..||.+|..||....+..          .+...+ +|...
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk----------vLl~tL-qn~pp  250 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK----------VLLLTL-QNDPP  250 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH----------HHHHHh-cCCCC
Confidence            222   34689999999999643  369999999999999999999999999876521          111112 33333


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .+....+..+.+......+..++..||+.||.+||+++++++.
T Consensus       251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            2222222222222333578899999999999999999999853

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-43  Score=356.69  Aligned_cols=312  Identities=28%  Similarity=0.405  Sum_probs=256.4

Q ss_pred             ccccCHHHHHHhhCCCC---------cCceecccCcEEEEEEEeCC----CcEEEEEEeecCCccc-HHHHHHHHHHHHh
Q 014904           31 KSTFTYEELARATDGFS---------DANLLGQGGFGYVHRGVLPN----GKEVAIKQLKAGSGQG-EREFQAEVEIISR   96 (416)
Q Consensus        31 ~~~f~~~el~~~t~~f~---------~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~-~~~~~~E~~~l~~   96 (416)
                      -..||||+--.|.+.|.         +.++||.|.||.|++|.++.    ...||||.|+...... +++|+.|+.|+.+
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ  686 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ  686 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence            34588988888877764         46799999999999999753    3579999999876443 4689999999999


Q ss_pred             cCCCcccceEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcE
Q 014904           97 VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANI  176 (416)
Q Consensus        97 l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NI  176 (416)
                      ..||||++|.|+.......++|.|||+||+|+.+|+.+.+ .+++.+...++.+||.|+.||-+.   ++|||||.++||
T Consensus       687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNI  762 (996)
T KOG0196|consen  687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNI  762 (996)
T ss_pred             CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhe
Confidence            9999999999999999999999999999999999998876 499999999999999999999999   999999999999


Q ss_pred             EECCCCceEEeecccceeccCCCcceeec--ccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccc
Q 014904          177 LLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFV  253 (416)
Q Consensus       177 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~--~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~  253 (416)
                      ||+.|..+||+||||++.+.+......+.  -.-...|.|||.+...++|.+|||||||||+||.++ |.+|+.....  
T Consensus       763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--  840 (996)
T KOG0196|consen  763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--  840 (996)
T ss_pred             eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--
Confidence            99999999999999999886654222222  233568999999999999999999999999999999 9999876443  


Q ss_pred             chhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccCcccccC---
Q 014904          254 EDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDASLADLNE---  330 (416)
Q Consensus       254 ~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~~~~~~~~---  330 (416)
                               .-+.+++++|         ++-..+.+++..|.+|++.||+++-.+||++.|||..|+..+.-++..+   
T Consensus       841 ---------QdVIkaIe~g---------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~  902 (996)
T KOG0196|consen  841 ---------QDVIKAIEQG---------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIA  902 (996)
T ss_pred             ---------HHHHHHHHhc---------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccC
Confidence                     2233444443         2334566788999999999999999999999999999987654433221   


Q ss_pred             CCCCCCCcccCCCCCCCCCcccCHHHHHHHHHHhcc
Q 014904          331 GIRPGQSSVYGSYGSSDYDTMQYNEDLKKFRKMALN  366 (416)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (416)
                      +..++.+......+.+++..+....||.+.+||.--
T Consensus       903 ~~~~r~s~~lld~~~~~~~~f~sv~~WL~aIkm~rY  938 (996)
T KOG0196|consen  903 PESPRPSQPLLDRSGSDFTPFRSVGDWLEAIKMGRY  938 (996)
T ss_pred             CCCCCCcccccCCCCCCCcccCCHHHHHHHhhhhHH
Confidence            223444444455566788888889999999999543

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=8e-42  Score=323.31  Aligned_cols=254  Identities=27%  Similarity=0.444  Sum_probs=209.7

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      ++|++.++||+|+||.||+|...+++.||+|.+.... .....+..|+.++++++|+||+++++++......++|+||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            5788999999999999999998888899999987543 235678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      +++|.+++.......+++..++.++.+++.||+|||+.   +++||||||+||+++.++.++|+|||++...........
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  161 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR  161 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence            99999999765555789999999999999999999998   999999999999999999999999999987654332222


Q ss_pred             ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      ....++..|+|||++..+.++.++|||||||++|+|++ |+.||.....   .....+        +..+. .   .+ .
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~--------~~~~~-~---~~-~  225 (261)
T cd05072         162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSA--------LQRGY-R---MP-R  225 (261)
T ss_pred             CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHH--------HHcCC-C---CC-C
Confidence            33446778999999998899999999999999999998 9999865332   111111        11111 0   01 1


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                          ....+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus       226 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         226 ----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                11233568899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=321.72  Aligned_cols=256  Identities=28%  Similarity=0.435  Sum_probs=209.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ..++|++.+.||+|++|.||+|...+++.||||.++... ....++.+|+.++++++|+||+++++++......++||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            346799999999999999999998778899999987544 3456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.+++.......+++..+..++.+++.||.+||+.   +++||||||+||+++.++.++|+|||+++........
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999999765545789999999999999999999999   9999999999999999999999999999876533222


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                      .......+..|+|||++.+..++.++||||||++++||++ |+.||.....   ..+.        ..+..+ ..     
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~--------~~~~~~-~~-----  222 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVL--------QQVDQG-YR-----  222 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHH--------HHHHcC-CC-----
Confidence            1111223457999999998899999999999999999999 9999875432   1111        111111 10     


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                         ...+......+.+++.+|++.+|.+||++.+|++.|+.
T Consensus       223 ---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 ---MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ---CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence               01112234578999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.1e-41  Score=325.78  Aligned_cols=251  Identities=27%  Similarity=0.420  Sum_probs=203.1

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .|+..+.||+|+||.||+|.. .+++.||||++.....   .....+.+|+.++.+++|+||+++++++.+....++|+|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            477889999999999999995 5799999999875432   223467889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|..++.......+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            99999999888655444689999999999999999999999   999999999999999999999999999987543222


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                        .....||..|+|||++.+..++.++|||||||++|||++|+.||...........       +...+....       
T Consensus       158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~-------~~~~~~~~~-------  221 (285)
T cd05631         158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE-------VDRRVKEDQ-------  221 (285)
T ss_pred             --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH-------HHHHhhccc-------
Confidence              2345789999999999999999999999999999999999999986543111100       001111110       


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPR-----MSQIVR  317 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evv~  317 (416)
                         ..++......+.+++.+||+.+|.+||+     +.++++
T Consensus       222 ---~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         222 ---EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ---ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence               1122223457889999999999999997     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-41  Score=324.14  Aligned_cols=255  Identities=26%  Similarity=0.383  Sum_probs=205.9

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC----CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP----NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      .++|++.++||+|+||.||+|++.    .+..||+|.++.... .....|.+|+.++.+++||||+++++++..+...++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            357889999999999999999853    367899999986532 223568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+++++|.+++..... .+++..++.++.+++.||+|||+.   +++||||||+|||++.++.++++|||.+.....
T Consensus        84 v~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEG-QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            9999999999999876432 689999999999999999999999   999999999999999999999999998765432


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      ..........++..|+|||++.++.++.++|||||||++||+++ |+.||......   .+        ...+.++... 
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~--------~~~~~~~~~~-  227 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DV--------IKAVEDGFRL-  227 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HH--------HHHHHCCCCC-
Confidence            22111122345678999999999999999999999999999875 99999764321   11        1112222110 


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                              ..+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       228 --------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         228 --------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence                    1122345578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-43  Score=338.18  Aligned_cols=268  Identities=24%  Similarity=0.307  Sum_probs=212.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcC-CCcccceEEEEEeCC-eEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSG-QGEREFQAEVEIISRVH-HKHLVSLVGYYTAGS-QRML  117 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l  117 (416)
                      .-++|...++||.|.||.||+|+ ..+|..||||+++.... +.+..=++|+..|++++ ||||+++.+.+.+.. .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            44688999999999999999999 56799999999986543 33334468999999998 999999999998877 9999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||| ..+|.+++... +..++...+..|+.||++||+|+|++   |+.|||+||+|||+..+..+||+|||+|+....
T Consensus        88 VfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence            99999 56899998877 55899999999999999999999999   999999999999999899999999999997654


Q ss_pred             CCcceeecccccccccChhhh-ccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhh----------hhhhHH-h
Q 014904          198 VNTHVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV----------DWARPL-L  265 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~-~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~----------~~~~~~-~  265 (416)
                      ...  .+.++.|..|+|||++ ..+.|+.+.|||++||+++||.+-++.|.+.++.++...+          .|..-. +
T Consensus       163 kpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  163 KPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             CCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            333  3667889999999986 5678999999999999999999999999887654332211          121100 0


Q ss_pred             HHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          266 NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       266 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ..++ +=.+.+..--.+..-. .+...+.++++.+|+++||.+|||+.|.++.
T Consensus       241 a~~m-nf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  241 ASAM-NFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHh-ccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            0000 1111111111121112 2366789999999999999999999999976

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.7e-42  Score=317.61  Aligned_cols=268  Identities=21%  Similarity=0.285  Sum_probs=210.4

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      +.|....++|+|.||.|||+.++ +|+.||||++....  ..-.+-.++|+.+|++++|+|+|.+++.|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45778889999999999999954 69999999997543  2223457899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      ||+..-|..+-+...  .++.....+++.|+++|+.|||++   ++|||||||+||||+.++.+||||||+|+.+.. ..
T Consensus        82 ~~dhTvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg  155 (396)
T KOG0593|consen   82 YCDHTVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG  155 (396)
T ss_pred             ecchHHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence            998776665543332  488889999999999999999999   999999999999999999999999999998875 33


Q ss_pred             ceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhh-h---hHHhHHhhh-cCCc
Q 014904          201 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDW-A---RPLLNRAIE-DGNF  274 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~-~---~~~~~~~~~-~~~~  274 (416)
                      ..-+.++-|..|.|||++.+ -+|...+|||++||++.||++|.+.|..........++.- .   .|..+..+. +..|
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            34466788999999999987 6899999999999999999999999988765443332211 1   111222222 2233


Q ss_pred             ccccCccccC-----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          275 DTLVDPKLHN-----EYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       275 ~~~~d~~l~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..+.-|....     .-......-+++++..|++.||.+|++-+|++.
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            3322222211     111233457889999999999999999999884

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.2e-41  Score=321.86  Aligned_cols=269  Identities=21%  Similarity=0.279  Sum_probs=205.2

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ++|.+.+.||+|+||.||+|... +++.||||+++....  .....+.+|+.+++.++|+||+++++++......++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999964 688999999975432  223567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |++++.+..+....  ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          81 YVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            99998777655432  3589999999999999999999999   999999999999999999999999999987654333


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhh-hhhhHH----hHHhhhcCCcc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV-DWARPL----LNRAIEDGNFD  275 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~-~~~~~~----~~~~~~~~~~~  275 (416)
                      .......|++.|+|||++.+..++.++|||||||++|||++|+.||............ ....+.    +........+.
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            3334467899999999999889999999999999999999999999764432111111 100000    00000111111


Q ss_pred             cccCccccC------cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          276 TLVDPKLHN------EYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       276 ~~~d~~l~~------~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ....+....      .+.......+.+++.+||+.+|++||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111111110      111123456899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=331.02  Aligned_cols=255  Identities=27%  Similarity=0.426  Sum_probs=206.2

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCC--eEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGS--QRMLVY  119 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~  119 (416)
                      ..++...+.||+|.||.||++... +|...|||.+...+....+.+.+|+.+|++++|||||+.+|......  .+++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            456778899999999999999964 48999999988764333556899999999999999999999854433  689999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC-CCceEEeecccceeccC-
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF-KFEAKVADFGLAKIASD-  197 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~-~~~~kl~DFGla~~~~~-  197 (416)
                      ||+++|+|.+++...+. .++...+.....|+++||+|||++   +||||||||+||||+. ++.+||+|||+++.... 
T Consensus        96 Ey~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             eccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999999999988776 799999999999999999999999   9999999999999999 79999999999987663 


Q ss_pred             -CCcceeecccccccccChhhhccCC-CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          198 -VNTHVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       198 -~~~~~~~~~~gt~~YlaPE~~~~~~-~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                       ........+.||+.|||||++..+. ...++|||||||+++||+||++||....     ....+..    .....+.  
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~----~ig~~~~--  240 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALL----LIGREDS--  240 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHH----HHhccCC--
Confidence             2222234478999999999999643 3459999999999999999999987531     1111111    1111111  


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL  319 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L  319 (416)
                         -|    .++........+++.+|+..+|++|||+.++++.-
T Consensus       241 ---~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  241 ---LP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ---CC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence               12    33334556788999999999999999999999764

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=334.47  Aligned_cols=253  Identities=26%  Similarity=0.370  Sum_probs=211.5

Q ss_pred             HHhhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcc---cHHHHHHHHHHHHhc-CCCcccceEEEEEeCCe
Q 014904           40 ARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQ---GEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        40 ~~~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  114 (416)
                      .+-.++|...+.||+|.|++|++|+ ..++++||||++.+...-   .......|-++|.+| .||.|++|+--|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            5566799999999999999999999 567999999999754322   223466788999999 89999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      +|+|+||+++|.|.++|...+  .|+.......+.+|+.||+|||+.   |||||||||+|||||.|+.+||+|||.|+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence            999999999999999998776  588888899999999999999999   999999999999999999999999999997


Q ss_pred             ccCCCcc----------ee--ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh
Q 014904          195 ASDVNTH----------VS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR  262 (416)
Q Consensus       195 ~~~~~~~----------~~--~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~  262 (416)
                      +......          ..  ..++||..|.+||++..+..+..+|+|+|||+||+||.|.+||...++.          
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----------  293 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----------  293 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----------
Confidence            6543221          11  3489999999999999999999999999999999999999999886641          


Q ss_pred             HHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          263 PLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       263 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                       +..+.+..      ++-.    ++...++...+|+.+.|..+|.+|++..||-+.
T Consensus       294 -liFqkI~~------l~y~----fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  294 -LIFQKIQA------LDYE----FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -HHHHHHHH------hccc----CCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence             11111111      1112    223333678899999999999999999998876

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.1e-41  Score=324.66  Aligned_cols=261  Identities=25%  Similarity=0.391  Sum_probs=203.5

Q ss_pred             CCCCcCceecccCcEEEEEEEeCC-----------------CcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccce
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPN-----------------GKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSL  105 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l  105 (416)
                      ++|.+.+.||+|+||.||++.+.+                 +..||+|++...... ...+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578899999999999999998532                 346999998764322 33578999999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCCHHHHhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 014904          106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKG-----------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH  168 (416)
Q Consensus       106 ~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH  168 (416)
                      ++++.+....++||||+++++|.+++....                 ...++|..++.++.|++.||.|||+.   +|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            999999999999999999999999885421                 12478899999999999999999999   9999


Q ss_pred             ecccCCcEEECCCCceEEeecccceeccCCCc-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh--CCCC
Q 014904          169 RDIKAANILLDFKFEAKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT--GRRP  245 (416)
Q Consensus       169 rDIkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt--G~~p  245 (416)
                      |||||+|||++.++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986543322 12233456889999999998999999999999999999997  4556


Q ss_pred             CCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          246 VDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       246 f~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      |.....   .....++...+.    ......  ..    ..+..++..+.+++.+||+.+|.+||+|.+|++.|+
T Consensus       242 ~~~~~~---~~~~~~~~~~~~----~~~~~~--~~----~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTD---EQVIENAGEFFR----DQGRQV--YL----FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCH---HHHHHHHHHHhh----hccccc--cc----cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            654321   222222222111    110000  00    011123457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-41  Score=333.40  Aligned_cols=251  Identities=27%  Similarity=0.398  Sum_probs=209.2

Q ss_pred             HHHhhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecC----Cc-ccHHHHHHHHHHHHhcC-CCcccceEEEEEe
Q 014904           39 LARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAG----SG-QGEREFQAEVEIISRVH-HKHLVSLVGYYTA  111 (416)
Q Consensus        39 l~~~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  111 (416)
                      .....++|...+.||+|.||+|+.|. ..++..||+|++...    .. .....+.+|+.++++++ ||||+++++++..
T Consensus        12 ~~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t   91 (370)
T KOG0583|consen   12 LQLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT   91 (370)
T ss_pred             cccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence            34567899999999999999999998 457899999977653    11 22346678999999998 9999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC-CceEEeecc
Q 014904          112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFG  190 (416)
Q Consensus       112 ~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~-~~~kl~DFG  190 (416)
                      ....++||||+.+|.|.+.+...+  .+.+....+++.|++.|++|||+.   +|+||||||+|||++.+ +++||+|||
T Consensus        92 ~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   92 PTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             CCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            999999999999999999998744  588899999999999999999999   99999999999999999 999999999


Q ss_pred             cceeccCCCcceeecccccccccChhhhccCC-CC-chhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHh
Q 014904          191 LAKIASDVNTHVSTRVMGTFGYLAPEYASSGK-LT-EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRA  268 (416)
Q Consensus       191 la~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~-~t-~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~  268 (416)
                      ++.... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||+....           +.+...
T Consensus       167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----------~~l~~k  234 (370)
T KOG0583|consen  167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----------PNLYRK  234 (370)
T ss_pred             cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----------HHHHHH
Confidence            999874 2233445678999999999999876 75 799999999999999999999987443           111122


Q ss_pred             hhcCCcccccCccccCcCCHHH-HHHHHHHHHHhhccCCCCCCCHHHHH
Q 014904          269 IEDGNFDTLVDPKLHNEYNHNE-MARMVACAAACVRHSARRRPRMSQIV  316 (416)
Q Consensus       269 ~~~~~~~~~~d~~l~~~~~~~~-~~~l~~l~~~cl~~~p~~RPt~~evv  316 (416)
                      +..+.+.          ++... ...+..++.+|+..+|.+|+++.+|+
T Consensus       235 i~~~~~~----------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  235 IRKGEFK----------IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             HhcCCcc----------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            3333321          11111 45789999999999999999999999

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.8e-41  Score=320.42  Aligned_cols=254  Identities=28%  Similarity=0.399  Sum_probs=207.9

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      .+|...+.||+|+||.||+|... .++.||+|+++... ....++.+|+.++.+++|+||+++++++......++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45788899999999999999954 58899999987543 33467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++++|.+++.......+++..++.++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++..........
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            999999999766555789999999999999999999998   99999999999999999999999999998765432222


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                      .....++..|+|||++.+..++.++|||||||++|||++ |..||.....   .   ++.     ..+..+.        
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~---~~~-----~~~~~~~--------  222 (263)
T cd05052         162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---S---QVY-----ELLEKGY--------  222 (263)
T ss_pred             cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---H---HHH-----HHHHCCC--------
Confidence            222334678999999999999999999999999999998 9999865432   1   111     1111111        


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                       ....+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       223 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         223 -RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence             011122234578999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.4e-42  Score=358.37  Aligned_cols=257  Identities=27%  Similarity=0.451  Sum_probs=216.5

Q ss_pred             CCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      .+....+.||+|.||.||+|...      +.+.||||.|+..... ...+|++|++++..++|||||+++|.|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            44555678999999999999943      3468999999976554 6679999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCce
Q 014904          117 LVYEFVPNNTLEFHLHGKG------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA  184 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~  184 (416)
                      +|+||+..|+|..+|....            ...|+..+.+.||.|||.|+.||-+.   .+|||||..+|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence            9999999999999996421            12388999999999999999999999   99999999999999999999


Q ss_pred             EEeeccccee-ccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhh
Q 014904          185 KVADFGLAKI-ASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWAR  262 (416)
Q Consensus       185 kl~DFGla~~-~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~  262 (416)
                      ||+||||++- +..+..+.....+-...||+||.+..+++|.+||||||||||||+++ |+.|+.....   +.      
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~E------  713 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---QE------  713 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---HH------
Confidence            9999999984 33333333334556789999999999999999999999999999999 9999876443   11      


Q ss_pred             HHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          263 PLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       263 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                        +.+.+.+|.+         -..+.+++.++..|+..||+.+|.+||+++||-..|....
T Consensus       714 --VIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  714 --VIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             --HHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence              2223344543         3466778889999999999999999999999999998543

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.5e-41  Score=339.88  Aligned_cols=256  Identities=27%  Similarity=0.420  Sum_probs=204.1

Q ss_pred             CCCCcCceecccCcEEEEEEEe------CCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL------PNGKEVAIKQLKAGSG-QGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  115 (416)
                      ++|++.+.||+|+||.||+|.+      .++..||||+++.... .....+.+|+.++..+ +||||++++++|..+...
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4788899999999999999973      2456899999975432 2345688999999999 899999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCC------------------------------------------------------------
Q 014904          116 MLVYEFVPNNTLEFHLHGKG------------------------------------------------------------  135 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~------------------------------------------------------------  135 (416)
                      ++||||+++|+|.+++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999998886432                                                            


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          136 -------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       136 -------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                                   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                         12478899999999999999999998   99999999999999999999999999998654432211


Q ss_pred             -eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          203 -STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       203 -~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                       .....++..|+|||++.+..++.++|||||||++|||++ |..||.....  ...+..+        +..+...  ..+
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--~~~~~~~--------~~~~~~~--~~~  339 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSKFYKM--------IKEGYRM--LSP  339 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--hHHHHHH--------HHhCccC--CCC
Confidence             122345678999999999999999999999999999998 8888865432  1122211        1222110  011


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                             ...+..+.+++.+||+.+|++||+|.||++.|+.
T Consensus       340 -------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         340 -------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             -------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                   1123478899999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.6e-41  Score=318.14  Aligned_cols=252  Identities=29%  Similarity=0.440  Sum_probs=205.5

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      +.|.+.+.||+|+||.||++.+.++..+|+|.+.... .....+..|+.++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4688889999999999999998888899999887443 335678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      +++|.++++.... .+++..++.++.+++.||.|||+.   +|+|+||||+||+++.++.+||+|||+++..........
T Consensus        83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05114          83 NGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS  158 (256)
T ss_pred             CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence            9999999875433 589999999999999999999999   999999999999999999999999999876543222222


Q ss_pred             ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      ....++..|+|||++.+..++.++||||||+++|||++ |+.||.....   .....+        +..+..  ...+. 
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~--------i~~~~~--~~~~~-  224 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEM--------ISRGFR--LYRPK-  224 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH--------HHCCCC--CCCCC-
Confidence            22345678999999998899999999999999999999 8999865432   111111        112211  11111 


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                            .....+.+++.+||+.+|.+||++.+|++.|.
T Consensus       225 ------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         225 ------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  12347899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2e-41  Score=320.34  Aligned_cols=257  Identities=31%  Similarity=0.476  Sum_probs=213.5

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ....+|...++||.|+||.||+|...+++.+++|++..........+..|+.+++.++|+||+++++++......++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34567889999999999999999987899999999987665556688999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|.+++.......+++..++.++.+++.||.|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999999876555789999999999999999999998   999999999999999999999999999976644322


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                      . .....++..|+|||++.++.++.++||||||+++++|++ |+.||.....   .....+.        ..+ ..    
T Consensus       160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~--------~~~-~~----  222 (261)
T cd05148         160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQI--------TAG-YR----  222 (261)
T ss_pred             c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHH--------HhC-Cc----
Confidence            2 223345778999999998899999999999999999999 8999865432   1111111        111 00    


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                          ...+..++..+.+++.+|++.+|.+||++.++++.|+.
T Consensus       223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         223 ----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence                11122334578899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-41  Score=322.98  Aligned_cols=249  Identities=31%  Similarity=0.547  Sum_probs=196.1

Q ss_pred             cCceecccCcEEEEEEEeC-----CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           48 DANLLGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        48 ~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +.+.||.|.||.||+|.+.     .+..|+||.++..... ...+|.+|+.++++++||||++++|+|......++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999975     3678999999764332 357899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC-c
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN-T  200 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~-~  200 (416)
                      +++++|.+++.......+++..++.|+.|+++||.|||+.   +++|++|+++||+++.++.+||+|||++....... .
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            9999999999887555799999999999999999999999   99999999999999999999999999998763222 2


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                      ...........|+|||++....++.++||||||+++|||++ |+.||.....   ..+.        ..+.++...    
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~--------~~~~~~~~~----  224 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEII--------EKLKQGQRL----  224 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHH--------HHHHTTEET----
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc---cccc--------ccccccccc----
Confidence            22233456788999999999899999999999999999999 7788765432   1111        111122111    


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL  319 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L  319 (416)
                           ..+...+..+..++..||..+|++||+|.+|++.|
T Consensus       225 -----~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 -----PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                 11122345788999999999999999999999987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-41  Score=329.60  Aligned_cols=252  Identities=25%  Similarity=0.344  Sum_probs=205.2

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.+.||+|+||.||+|... +++.||||+++...   ......+..|+.++..++|+||+++++++......++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47899999999999999999965 58999999997542   223356888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....  
T Consensus        81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            9999999999997544  588999999999999999999999   999999999999999999999999999976543  


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc-hhhhhhhhHHhHHhhhcCCccccc
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE-DSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+..|.          ..   +.
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------~~---~~  218 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK----------ET---LQ  218 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc----------cc---cc
Confidence              22345799999999999999999999999999999999999999976543111 0111110          00   00


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .+.. ..........+.+++.+||+.+|.+||++.+|++.
T Consensus       219 ~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         219 RPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            1111 00011234578899999999999999999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.2e-41  Score=306.58  Aligned_cols=268  Identities=25%  Similarity=0.372  Sum_probs=211.7

Q ss_pred             CCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCccc--HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQG--EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .+|...++||+|.||.||+|. ..+|+.||||+++.....+  .....+|+..|+.++|+||+.++++|.+.+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            578888999999999999999 5689999999998764432  3467899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |++ .+|+..+..+.. .+.-..+..++.++++||+|||..   .|+||||||.|+|++.+|.+||+|||+|+.+...+.
T Consensus        82 fm~-tdLe~vIkd~~i-~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNI-ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             ecc-ccHHHHhccccc-ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            994 689998876654 688889999999999999999999   899999999999999999999999999999876655


Q ss_pred             ceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhh--------hHHhHHhhhc
Q 014904          201 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA--------RPLLNRAIED  271 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~--------~~~~~~~~~~  271 (416)
                      ..... +-|..|.|||++.+. .|+...||||.||++.||+-|.+-|.+....++.+.+--+        ||-+...-.-
T Consensus       157 ~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  157 IQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             ccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            44433 568999999998765 6999999999999999999998888776653332222100        0111000000


Q ss_pred             CCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          272 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       272 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ..+.....+.+.. .-..+.....+++..++..||.+|.+++|++++
T Consensus       236 ~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  236 VKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1111122222222 333455667999999999999999999999865

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.3e-41  Score=320.07  Aligned_cols=255  Identities=29%  Similarity=0.485  Sum_probs=207.2

Q ss_pred             CCCCcCceecccCcEEEEEEEeCC-C-----cEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPN-G-----KEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~-g-----~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      ++|++.+.||+|+||.||+|.... +     +.||+|.++.... .....|.+|+.++.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            478889999999999999998533 2     5799999875432 23356899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC
Q 014904          117 LVYEFVPNNTLEFHLHGKGR--------------PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF  182 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~  182 (416)
                      +++||+++++|.+++.....              ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            99999999999999865321              3588999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccceeccCCCc-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhh
Q 014904          183 EAKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDW  260 (416)
Q Consensus       183 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~  260 (416)
                      .++|+|||+++....... .......+++.|+|||++.++.++.++|||||||++|||++ |..||.....   ..+.. 
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~~-  237 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVIE-  237 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH-
Confidence            999999999976533222 22233456888999999998999999999999999999998 9999876443   11111 


Q ss_pred             hhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          261 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                             .+..+...         ..+...+..+.+++.+||+.+|.+||++.||++.|+.
T Consensus       238 -------~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 -------MIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -------HHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                   11222211         1123345689999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.6e-41  Score=337.07  Aligned_cols=256  Identities=27%  Similarity=0.397  Sum_probs=202.8

Q ss_pred             CCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  115 (416)
                      ++|.+.+.||+|+||.||+|...      ++..||||+++..... ....+.+|+.+++.+ +|+||++++++|......
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            47889999999999999998842      2357999999754332 234688999999999 899999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCC------------------------------------------------------------
Q 014904          116 MLVYEFVPNNTLEFHLHGKG------------------------------------------------------------  135 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~------------------------------------------------------------  135 (416)
                      ++||||+++++|.++++...                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999999885421                                                            


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc-eeecc
Q 014904          136 --------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH-VSTRV  206 (416)
Q Consensus       136 --------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~  206 (416)
                              ...+++..+++|+.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++........ .....
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                    12478889999999999999999998   9999999999999999999999999999765432221 11223


Q ss_pred             cccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCc
Q 014904          207 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNE  285 (416)
Q Consensus       207 ~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~  285 (416)
                      .++..|+|||++.+..++.++|||||||++|||++ |+.||.......  .        +...+..+.  ....      
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~--------~~~~~~~~~--~~~~------  336 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K--------FYKMVKRGY--QMSR------  336 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H--------HHHHHHccc--CccC------
Confidence            45678999999998999999999999999999998 999987543211  1        111111111  0001      


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          286 YNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       286 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                       +...+..+.+++.+||+.+|.+||++.+|+++|+.
T Consensus       337 -~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         337 -PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             -CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence             11123578899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-41  Score=322.74  Aligned_cols=245  Identities=25%  Similarity=0.334  Sum_probs=201.3

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.+.||+|+||.||+|... +++.||||++.....   .....+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47889999999999999999964 689999999875322   22356888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++....  .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  155 (291)
T cd05612          81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT  155 (291)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence            9999999999987544  588999999999999999999999   99999999999999999999999999987654321


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                          ....||+.|+|||++.+..++.++|||||||++|+|++|+.||......   .+.        ..+..+..     
T Consensus       156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~--------~~i~~~~~-----  215 (291)
T cd05612         156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIY--------EKILAGKL-----  215 (291)
T ss_pred             ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH--------HHHHhCCc-----
Confidence                2356899999999999888999999999999999999999999764321   111        11112211     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPR-----MSQIVRA  318 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evv~~  318 (416)
                           .++......+.+++.+||+.||.+||+     +.++++.
T Consensus       216 -----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 -----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                 111122346889999999999999995     7776643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.4e-40  Score=327.02  Aligned_cols=265  Identities=23%  Similarity=0.336  Sum_probs=205.2

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      -++|.+.+.||+|+||.||++... ++..+|+|++..... .....+.+|+.++..++|+||+++++++..+...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            478999999999999999999954 688999999876432 233578999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|.+++....  .+++..+..++.+++.||.|||+.+  +|+||||||+|||++.++.+||+|||++....... 
T Consensus        84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            999999999997543  5889999999999999999999863  69999999999999999999999999987654321 


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc------
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF------  274 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~------  274 (416)
                        .....|++.|+|||++.+..++.++|||||||++|||++|+.||......   .+........... ..+..      
T Consensus       159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~  232 (331)
T cd06649         159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK---ELEAIFGRPVVDG-EEGEPHSISPR  232 (331)
T ss_pred             --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhccccccc-ccCCccccCcc
Confidence              23356899999999999989999999999999999999999999654321   1111100000000 00000      


Q ss_pred             -------------------------ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          275 -------------------------DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       275 -------------------------~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                                               ..++...............+.+++.+||+.+|++||++.||++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                     00000000000011234578999999999999999999999865

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.4e-40  Score=314.78  Aligned_cols=254  Identities=28%  Similarity=0.447  Sum_probs=207.4

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      .++|++.+.||+|+||.||+|...++..+|+|.+..... ....+.+|+.++++++|+|++++++++.. ...++||||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence            357889999999999999999988888999999976543 34678999999999999999999998854 5678999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++++|.++++......+++..++.++.+++.||.|||+.   +++||||||+||+++.++.++|+|||++..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            999999999765555689999999999999999999999   99999999999999999999999999998765433222


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                      .....++..|+|||++.+..++.++||||||+++++|++ |+.||.....   ....++        +..+.        
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~--------~~~~~--------  220 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQ--------VERGY--------  220 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH--------HHcCC--------
Confidence            223345678999999998899999999999999999999 8889865332   111111        11111        


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                       ....+......+.+++.+|++.+|.+||++.++++.|+.
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         221 -RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             011122334578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.8e-40  Score=329.10  Aligned_cols=248  Identities=26%  Similarity=0.405  Sum_probs=195.1

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ++|...+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.+++.++|+||+++++++......++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            4566778999999999999995 46899999999754322 235788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +.+++|....      ...+..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus       154 ~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-  223 (353)
T PLN00034        154 MDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-  223 (353)
T ss_pred             CCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence            9999986432      356777889999999999999999   999999999999999999999999999987643221 


Q ss_pred             eeecccccccccChhhhcc-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          202 VSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~-----~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      ......||..|+|||++..     ...+.++|||||||++|||++|+.||.....      .+|.....  .+..+..  
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~------~~~~~~~~--~~~~~~~--  293 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ------GDWASLMC--AICMSQP--  293 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------ccHHHHHH--HHhccCC--
Confidence            1234579999999998743     2345699999999999999999999974322      12211111  0111110  


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                             ..........+.+++.+||+.+|++||++.||++.
T Consensus       294 -------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        294 -------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   11122334578999999999999999999999975

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-40  Score=327.73  Aligned_cols=246  Identities=27%  Similarity=0.356  Sum_probs=201.9

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .++|.+.+.||+|+||.||+|... +++.||||+++...   ......+.+|+.++.+++||||+++++++.+....++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            367889999999999999999964 68999999997532   12235688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+++++|.+++....  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        97 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999999987654  578889999999999999999999   9999999999999999999999999999876432


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      .    ....||+.|+|||++.+..++.++|||||||++|||++|+.||......      .     ....+..+.+.   
T Consensus       172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~-----~~~~i~~~~~~---  233 (329)
T PTZ00263        172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------R-----IYEKILAGRLK---  233 (329)
T ss_pred             c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------H-----HHHHHhcCCcC---
Confidence            2    2357899999999999999999999999999999999999999754321      0     01112222211   


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPR-----MSQIVRA  318 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evv~~  318 (416)
                         +    +......+.+++.+||+.||.+||+     +.+++..
T Consensus       234 ---~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        234 ---F----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ---C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               1    1112346789999999999999996     5666543

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=314.64  Aligned_cols=251  Identities=26%  Similarity=0.401  Sum_probs=204.2

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      .+|++.+.||+|+||.||+|.+.++..+|+|++..... ....+.+|+.++++++|+||+++++++......++|+||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            35788899999999999999987778899999875432 34578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      +++|.+++..... .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++...+......
T Consensus        83 ~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          83 NGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            9999999875443 689999999999999999999999   999999999999999999999999999886543322222


Q ss_pred             ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      ....++..|+|||++.+..++.++||||||+++|+|++ |+.||......   ....        .+..+.     ..  
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~--------~~~~~~-----~~--  220 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVE--------SVSAGY-----RL--  220 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHH--------HHHcCC-----cC--
Confidence            22234457999999998999999999999999999999 89998754321   1111        111111     00  


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL  319 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L  319 (416)
                        ..+...+..+.+++.+||+.+|++||+|.||++.|
T Consensus       221 --~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         221 --YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence              11112345799999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.4e-40  Score=326.13  Aligned_cols=242  Identities=24%  Similarity=0.330  Sum_probs=197.1

Q ss_pred             ceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCC
Q 014904           50 NLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNN  125 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~  125 (416)
                      ++||+|+||.||++.. .+|+.||||+++....   .....+..|+.++.+++||||+++++++......++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999995 4789999999975421   22346778999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeec
Q 014904          126 TLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR  205 (416)
Q Consensus       126 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  205 (416)
                      +|..++....  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~  154 (323)
T cd05571          81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT  154 (323)
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccc
Confidence            9998886543  589999999999999999999999   999999999999999999999999999875432221 2234


Q ss_pred             ccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCc
Q 014904          206 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNE  285 (416)
Q Consensus       206 ~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~  285 (416)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+.        ..+..+..      .    
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~--------~~~~~~~~------~----  213 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLF--------ELILMEEI------R----  213 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHH--------HHHHcCCC------C----
Confidence            5799999999999999999999999999999999999999975432   1111        11111111      1    


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014904          286 YNHNEMARMVACAAACVRHSARRRP-----RMSQIVRA  318 (416)
Q Consensus       286 ~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~~  318 (416)
                      ++......+.+++.+||+.+|++||     ++.++++.
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            1122345688999999999999999     78888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-41  Score=335.35  Aligned_cols=265  Identities=27%  Similarity=0.452  Sum_probs=211.8

Q ss_pred             HHHHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccH--HHHHHHHHHHHhcCCCcccceEEEEEeCC
Q 014904           36 YEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGE--REFQAEVEIISRVHHKHLVSLVGYYTAGS  113 (416)
Q Consensus        36 ~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~  113 (416)
                      .++...-.+.+.+...||+|.||+||+|.+..  .||||+|+......+  +.|+.||..+++.+|.||+-+.|||....
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            34444555667778899999999999999743  599999997755443  57999999999999999999999999987


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      . .+|..+|+|.+|+.+||-... .|+..+.+.||.|+|+|+.|||.+   +|||||||..||+|.+++.|||+||||+.
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             e-eeeehhccCchhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccccee
Confidence            7 899999999999999986653 689999999999999999999999   99999999999999999999999999986


Q ss_pred             eccCC-CcceeecccccccccChhhhcc---CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhh
Q 014904          194 IASDV-NTHVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAI  269 (416)
Q Consensus       194 ~~~~~-~~~~~~~~~gt~~YlaPE~~~~---~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~  269 (416)
                      .-..- .........|...|||||++..   .+|+..+||||||+|+|||+||..||.....  +..+..         .
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dqIifm---------V  605 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQIIFM---------V  605 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hheEEE---------e
Confidence            43221 1112233457788999999964   4789999999999999999999999983221  211111         1


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      ..|.  -..|..   ....++++.|.+|+..||..++++||.+.+|+..|+...
T Consensus       606 GrG~--l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  606 GRGY--LMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             cccc--cCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence            1121  111111   123456778999999999999999999999999887543

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.6e-40  Score=314.42  Aligned_cols=254  Identities=29%  Similarity=0.436  Sum_probs=208.5

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      .+.|.+.++||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++|+|++++++++. ....++|+||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            467888999999999999999988899999999876543 3467899999999999999999999875 45689999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++++|.+++.......+++..++.++.+++.||+|||+.   +++|+||||+||+++.++.++|+|||++..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence            999999998766556799999999999999999999998   99999999999999999999999999998765333222


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                      .....++..|+|||++..+.++.++||||||++++||++ |+.||.....   ..+.        ..+..+...      
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~--------~~~~~~~~~------  222 (260)
T cd05067         160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVI--------QNLERGYRM------  222 (260)
T ss_pred             ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHH--------HHHHcCCCC------
Confidence            233456788999999998899999999999999999999 9999975432   1111        111111100      


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                         ..+...+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus       223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 ---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence               1111233579999999999999999999999999973

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-41  Score=329.42  Aligned_cols=269  Identities=23%  Similarity=0.313  Sum_probs=207.2

Q ss_pred             hCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCccc--HHHHHHHHHHHHhcCCCcccceEEEEEeC--CeEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQG--EREFQAEVEIISRVHHKHLVSLVGYYTAG--SQRML  117 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  117 (416)
                      .+.|..+++||+|.||.||+|. +.+|+.||+|++.......  ..-..+|+.||++|+||||++|.+...+.  ..+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3567778899999999999999 6689999999998765332  24567899999999999999999998876  68999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      |+|||+. +|.-++.. ..-.|+..++.-++.|++.||+|||..   +|+|||||.+|||||++|.+||+|||||+++..
T Consensus       196 VFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             EEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            9999965 55555543 334689999999999999999999999   999999999999999999999999999998887


Q ss_pred             CCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhh-hhhhHHhHHhhhcCCcc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV-DWARPLLNRAIEDGNFD  275 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~  275 (416)
                      ......+..+-|..|.|||++.+. .|+.+.|+||.||||.||++|++.|....+..+...+ ......-...+....+.
T Consensus       271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence            766656667789999999999875 6999999999999999999999999887654332222 00000000000000000


Q ss_pred             --cccCc------cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          276 --TLVDP------KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       276 --~~~d~------~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                        ....+      .+.+. -.......++|+..+|..||.+|.|+.++++
T Consensus       351 ~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence              11111      11111 1123356789999999999999999998874

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-40  Score=314.72  Aligned_cols=252  Identities=29%  Similarity=0.440  Sum_probs=205.4

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      ++|.+.+.||+|+||.||+|...++..+|||.+.... .....|.+|+.++.+++||||+++++++......++||||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4578889999999999999998777789999987543 334678999999999999999999999999888999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      +++|.+++..... .+++..++.++.+++.||+|||+.   +++|+||||.||+++.++.+||+|||+++..........
T Consensus        83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            9999999876443 689999999999999999999999   999999999999999999999999999886644322222


Q ss_pred             ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      ....++..|++||++.+..++.++|||||||++|+|++ |+.||.....   .....        .+..+....      
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~--------~~~~~~~~~------  221 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVE--------KVSQGLRLY------  221 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHH--------HHhcCCCCC------
Confidence            22345678999999998899999999999999999999 9999875432   11111        111221110      


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                         .+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus       222 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 ---RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence               01112357899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-40  Score=317.76  Aligned_cols=255  Identities=26%  Similarity=0.476  Sum_probs=208.2

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCC------CcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPN------GKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  115 (416)
                      .++|.+.+.||+|+||.||+|...+      ++.||||+++..... ....+.+|+.+++.++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            4568889999999999999998633      478999999765443 346899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc
Q 014904          116 MLVYEFVPNNTLEFHLHGKG------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE  183 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~  183 (416)
                      ++||||+++++|.+++...+            ...+++..+..++.+++.||.|||+.   +++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence            99999999999999997542            23578999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccceeccCCCc-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhh
Q 014904          184 AKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWA  261 (416)
Q Consensus       184 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~  261 (416)
                      +||+|||+++....... .......+++.|+|||++.++.++.++|||||||++|||++ |+.||.....   ....++ 
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~-  236 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIEC-  236 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH-
Confidence            99999999875432221 12233456788999999999999999999999999999999 9999865432   112211 


Q ss_pred             hHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          262 RPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       262 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                             +..+....         .+......+.+++.+||+.+|++||++.||++.|+
T Consensus       237 -------~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 -------ITQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -------HHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                   12222211         11123457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-41  Score=332.93  Aligned_cols=250  Identities=24%  Similarity=0.403  Sum_probs=214.2

Q ss_pred             CCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           44 DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      ..|.....||+|.-|.||.|. ..+++.||||++.......++-+.+|+.+++..+|+|||++++.+..++.+|.||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            367788899999999999999 5678999999998877666677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++|+|.+.+...   .+++.++..|+.++++||+|||..   +|+|||||..|||++.++.+||+|||++..+.......
T Consensus       353 ~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR  426 (550)
T KOG0578|consen  353 EGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR  426 (550)
T ss_pred             CCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence            999999998654   499999999999999999999999   99999999999999999999999999988776655543


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                       ...+||+-|||||++....|.+|.||||||++++||+-|.+||-...+.....++          ..+|.      |. 
T Consensus       427 -~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI----------a~ng~------P~-  488 (550)
T KOG0578|consen  427 -STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----------ATNGT------PK-  488 (550)
T ss_pred             -ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH----------hhcCC------CC-
Confidence             4467999999999999999999999999999999999999999765542221111          11222      11 


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                       ...+......+.+++.+||+.|+++||++.|+|+.
T Consensus       489 -lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  489 -LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             -cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence             12233455689999999999999999999999964

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.3e-40  Score=316.43  Aligned_cols=269  Identities=22%  Similarity=0.308  Sum_probs=201.8

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .++|...++||+|+||.||+|... +++.||+|+++.... .....+.+|+.++++++|+||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            367999999999999999999954 689999999875432 223467899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++ +|..++...+. .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~~~~-~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          84 YLDS-DLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCCc-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            9975 88887765432 578999999999999999999999   999999999999999999999999999976543222


Q ss_pred             ceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhh-hhhh----HHhHHhhhcCCc
Q 014904          201 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV-DWAR----PLLNRAIEDGNF  274 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~-~~~~----~~~~~~~~~~~~  274 (416)
                      . .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||............ ....    ..+........+
T Consensus       159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         159 T-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             c-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            1 233467999999999865 46899999999999999999999999765432111110 0000    000000011111


Q ss_pred             ccccCccccCcC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          275 DTLVDPKLHNEY----NHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       275 ~~~~d~~l~~~~----~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .....+......    .......+.+++.+|++.+|.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            111112111100    0112346789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.4e-40  Score=313.19  Aligned_cols=254  Identities=30%  Similarity=0.436  Sum_probs=206.7

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      .++|.+.+.||+|+||.||+|.+.+...||+|+++... .....+.+|+.++++++|+||+++++++.. ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            35789999999999999999998777789999998543 234678999999999999999999998754 5678999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++++|.+++.......+++..++.++.++++||+|||+.   +++|+||||+||+++.++.++|+|||.++.........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            999999999765444689999999999999999999999   99999999999999999999999999998665433222


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                      .....++..|+|||+..++.++.++||||||+++|||++ |+.||......   .+       . ..+..+..       
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~-------~-~~~~~~~~-------  221 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV-------L-DQVERGYR-------  221 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HH-------H-HHHhcCCC-------
Confidence            223446778999999998999999999999999999999 88888654321   11       1 11111110       


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                        .......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       222 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         222 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             --CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence              01122345678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-40  Score=313.40  Aligned_cols=255  Identities=30%  Similarity=0.470  Sum_probs=206.7

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCC----CcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPN----GKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      .++|++.+.||+|+||.||+|.+..    ...||||+++.... .....|..|+.++++++|+||+++++++......++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3678999999999999999999642    45799999875432 233578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+++++|.+++..... .+++..++.++.+++.||+|||+.   +|+|+||||+||+++.++.++|+|||+++....
T Consensus        83 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          83 ITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            9999999999999876443 689999999999999999999998   999999999999999999999999999987753


Q ss_pred             CCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          198 VNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       198 ~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ..... .....++..|+|||++.+..++.++||||||+++++|++ |+.||.....   ..+.        ..+..+...
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~--------~~~~~~~~~  227 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVI--------KAVEDGYRL  227 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHH--------HHHHcCCCC
Confidence            22221 222345678999999998899999999999999999998 9999865322   1111        112221100


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                          +     .+...+..+.+++.+|++.+|++||++.||++.|+.
T Consensus       228 ----~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         228 ----P-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             ----C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                0     112234578999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.8e-40  Score=323.93  Aligned_cols=254  Identities=26%  Similarity=0.425  Sum_probs=202.9

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCc----EEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGK----EVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      .+|+..+.||+|+||.||+|.+. +++    .||||+++.... ....++..|+.+++.++|+||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46999999999999999999853 343    489999875432 3346788999999999999999999999875 5679


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      |++|+++++|.+++..... .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence            9999999999999876543 588999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCccee-ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          198 VNTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       198 ~~~~~~-~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||.....   ..+.        ..+..+.. 
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~---~~~~--------~~~~~~~~-  229 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEIS--------SILEKGER-  229 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHH--------HHHhCCCC-
Confidence            333222 22334678999999999999999999999999999998 9999875432   1111        11112211 


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                       +..+       ..+...+..++.+||+.+|.+||++.+|+..|...
T Consensus       230 -~~~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         230 -LPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             -CCCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             1111       12234688999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-40  Score=311.21  Aligned_cols=256  Identities=29%  Similarity=0.447  Sum_probs=210.4

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ..++|.+.+.||+|+||.||+|...+++.+|||.+.... ....++.+|+.++++++|+||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            357899999999999999999998888899999988544 3456789999999999999999999999998899999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.+++.......+++..+..++.+++.||.|||+.   +++|+||||+||+++.++.+||+|||+++........
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            9999999999876655799999999999999999999999   9999999999999999999999999999876542222


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                      ......++..|+|||.+.+..++.++||||||+++++|++ |+.||.....   ....+.        +..+ +.     
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~--------~~~~-~~-----  222 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQ--------VERG-YR-----  222 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH--------HHcC-CC-----
Confidence            2222334678999999998899999999999999999999 9999865432   111111        1111 10     


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                         ...+...+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus       223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 ---MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence               00111224578999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.6e-40  Score=330.23  Aligned_cols=259  Identities=22%  Similarity=0.277  Sum_probs=198.1

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      .++|.+.+.||+|+||.||++.. .+++.||+|....      ..+.+|+.++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            36799999999999999999995 5689999997542      3567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +. ++|..++....  .+++..++.|+.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       165 ~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        165 YK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             CC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            85 67777775443  588999999999999999999999   9999999999999999999999999999765433333


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc-----hhhhhhhh--------------
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE-----DSLVDWAR--------------  262 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~-----~~l~~~~~--------------  262 (416)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||........     ..+.....              
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            33446799999999999999999999999999999999999988754322111     01100000              


Q ss_pred             ----HHhHHhhhcCCcccccCccccCcC--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          263 ----PLLNRAIEDGNFDTLVDPKLHNEY--NHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       263 ----~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                          ..+.... ...   ...+.....+  ....+..+.+++.+||+.+|++||++.|+++
T Consensus       319 ~~~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        319 ANLDEIYIGLA-KKS---SRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHH-hcc---CCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                0000000 000   0000000000  0123457889999999999999999999985

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.7e-40  Score=333.21  Aligned_cols=258  Identities=24%  Similarity=0.382  Sum_probs=205.8

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcC-CCcccceEEEEEeCCe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVH-HKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  114 (416)
                      .++|.+.++||+|+||.||+|+..      .+..||||+++..... ....+..|+.+++++. ||||++++++|.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            568999999999999999999852      2347999999754332 2357889999999996 9999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCC-----------------------------------------------------------
Q 014904          115 RMLVYEFVPNNTLEFHLHGKG-----------------------------------------------------------  135 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~-----------------------------------------------------------  135 (416)
                      .+|||||+++++|.++++...                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999998886421                                                           


Q ss_pred             -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC
Q 014904          136 -----------------------------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF  180 (416)
Q Consensus       136 -----------------------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~  180 (416)
                                                         ...+++..++.++.|+++||.|||+.   +|+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence                                               12478888999999999999999998   9999999999999999


Q ss_pred             CCceEEeecccceeccCCCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhh
Q 014904          181 KFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLV  258 (416)
Q Consensus       181 ~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~  258 (416)
                      ++.+||+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.....  +..+.
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~--~~~~~  350 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV--DSTFY  350 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch--hHHHH
Confidence            9999999999998664432221 223456788999999998999999999999999999997 9999865322  11111


Q ss_pred             hhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          259 DWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                              ..+..+..     +    ..+......+.+++.+||+.+|++||++.+|+++|+..
T Consensus       351 --------~~~~~~~~-----~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         351 --------NKIKSGYR-----M----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             --------HHHhcCCC-----C----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence                    11112210     0    11123346789999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1e-39  Score=313.92  Aligned_cols=268  Identities=22%  Similarity=0.302  Sum_probs=197.4

Q ss_pred             CCCCcCceecccCcEEEEEEEe-C-CCcEEEEEEeecCCcc--cHHHHHHHHHHHHhc---CCCcccceEEEEEe-----
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-P-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRV---HHKHLVSLVGYYTA-----  111 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----  111 (416)
                      ++|.+.+.||+|+||.||+|.. . +++.||||+++.....  ....+.+|+.+++.+   +||||++++++|..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            4789999999999999999985 3 4688999998754322  223566777777766   69999999999852     


Q ss_pred             CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       112 ~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                      ....++|+||+. ++|..++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999996 5888888765555689999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch-hhhhhhhHHhHHhh-
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED-SLVDWARPLLNRAI-  269 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~-~l~~~~~~~~~~~~-  269 (416)
                      ++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .+.+.......... 
T Consensus       157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            9866433  2223457899999999999889999999999999999999999999865432111 01110000000000 


Q ss_pred             hcCCc-ccccCcccc---CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          270 EDGNF-DTLVDPKLH---NEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       270 ~~~~~-~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..-.+ .....+...   ..........+.+++.+||+.+|++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00000 000000000   0011122346789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=305.56  Aligned_cols=236  Identities=28%  Similarity=0.375  Sum_probs=202.2

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHH---HHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGER---EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.....||.|.||+|+++.. .+|..+|+|++++......+   ...+|..+|+.+.||.++++.+.|.+....++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            4788889999999999999995 46899999999876544333   4668999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||++||.|..+++..+  .++......+|.+|+.||+|||..   .|++||+||+|||||.+|.+||+|||.|+...+. 
T Consensus       124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            9999999999998766  489999999999999999999999   9999999999999999999999999999987653 


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                         ....+||+.|+|||.+.+..+..++|.|+|||++|||+.|.+||...++.          ... +.+..+++     
T Consensus       198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~----------~iY-~KI~~~~v-----  258 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI----------QIY-EKILEGKV-----  258 (355)
T ss_pred             ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH----------HHH-HHHHhCcc-----
Confidence               34578999999999999999999999999999999999999999887651          111 12223332     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCC
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRR  309 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R  309 (416)
                           .++.-....+.+|+...++.|-.+|
T Consensus       259 -----~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 -----KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -----cCCcccCHHHHHHHHHHHhhhhHhh
Confidence                 2333334478889999999999988

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.2e-40  Score=315.64  Aligned_cols=256  Identities=25%  Similarity=0.425  Sum_probs=209.1

Q ss_pred             CCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ++|.+.+.||+|+||.||+|...      ++..+++|.+..........+.+|+.++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46888899999999999999842      356799999876665555679999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc
Q 014904          118 VYEFVPNNTLEFHLHGKG--------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE  183 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~  183 (416)
                      ||||+++++|.+++....              ...+++..++.++.+++.||+|||+.   +|+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            999999999999986532              12489999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccceeccCCCc-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhh
Q 014904          184 AKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWA  261 (416)
Q Consensus       184 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~  261 (416)
                      ++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||......   ...   
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~---  235 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVI---  235 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---
Confidence            99999999976543221 12233556788999999998999999999999999999999 99998664431   111   


Q ss_pred             hHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          262 RPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       262 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                           ..+..+.....         ....+..+.+++.+||+.+|.+||++.+|+++|+..
T Consensus       236 -----~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         236 -----ECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             -----HHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence                 11222322211         112345788999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.6e-40  Score=338.04  Aligned_cols=250  Identities=22%  Similarity=0.305  Sum_probs=204.3

Q ss_pred             CCCcCceecccCcEEEEEEEeC-C-CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-N-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      .|.+.++||+|+||.||+|... + ++.||+|.+..........+..|+.+++.++||||+++++++......+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4889999999999999999843 3 6788888876555444456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          123 PNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       123 ~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      ++++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++.......
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887542  234688999999999999999999998   999999999999999999999999999987654322


Q ss_pred             -ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          201 -HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       201 -~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                       .......||++|+|||++.+..++.++|||||||++|||++|+.||.....      .+.    + ..+..+....   
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~----~-~~~~~~~~~~---  290 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REI----M-QQVLYGKYDP---  290 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHH----H-HHHHhCCCCC---
Confidence             223446799999999999999999999999999999999999999975432      111    1 1111222211   


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                            .+......+.+++.+||+.+|++||++.+++.
T Consensus       291 ------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 ------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                  11123357899999999999999999999874

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.3e-40  Score=316.45  Aligned_cols=256  Identities=24%  Similarity=0.434  Sum_probs=204.8

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      ++++|+..+.||+|+||.||+|.+.      .+..||||++..... ....++.+|+.+++.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            5788999999999999999999853      356799999864332 233568899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEE
Q 014904          115 RMLVYEFVPNNTLEFHLHGKG--------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV  186 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl  186 (416)
                      .++|+||+++++|.+++....        ...+++..++.++.+++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986432        12467889999999999999999998   9999999999999999999999


Q ss_pred             eecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHH
Q 014904          187 ADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPL  264 (416)
Q Consensus       187 ~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~  264 (416)
                      +|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ |..||.....   .....     
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~-----  232 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLR-----  232 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH-----
Confidence            999998755432221 1122345788999999998899999999999999999999 7888865432   11111     


Q ss_pred             hHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          265 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       265 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                         ....+....         .+...+..+.+++.+|++.+|++||++.|+++.|+
T Consensus       233 ---~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         233 ---FVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             ---HHHcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence               111222111         11123457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.6e-40  Score=307.98  Aligned_cols=247  Identities=28%  Similarity=0.421  Sum_probs=200.8

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEeecCCccc-HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCHH
Q 014904           50 NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQG-EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLE  128 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL~  128 (416)
                      ++||+|+||.||+|...+++.+|+|++....... ...+.+|+.++..++|+||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4699999999999998889999999987654332 346889999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeecccc
Q 014904          129 FHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG  208 (416)
Q Consensus       129 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g  208 (416)
                      .++.... ..+++..++.++.+++.+|.|||+.   +++|+||||+||+++.++.+||+|||++...............+
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            9886543 3589999999999999999999998   99999999999999999999999999987544322222222344


Q ss_pred             cccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCC
Q 014904          209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYN  287 (416)
Q Consensus       209 t~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  287 (416)
                      +..|+|||++.++.++.++||||||+++|++++ |+.||......   ...        ..+..+...         ..+
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~--------~~~~~~~~~---------~~~  216 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAR--------EQVEKGYRM---------SCP  216 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHH--------HHHHcCCCC---------CCC
Confidence            678999999999999999999999999999999 99998654321   111        111111110         111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          288 HNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       288 ~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      ...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            223467899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.8e-40  Score=315.98  Aligned_cols=255  Identities=27%  Similarity=0.463  Sum_probs=204.4

Q ss_pred             CCCCcCceecccCcEEEEEEEe-----CCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-----PNGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      +.|++.+.||+|+||.||+|..     ..++.+++|.++.... +....+.+|+.++++++|+||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4678889999999999999984     2467899999975432 333578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC
Q 014904          118 VYEFVPNNTLEFHLHGKG---------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF  182 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~  182 (416)
                      ||||+++++|.+++....               ...+++...+.++.+++.||.|||+.   +++||||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            999999999999885321               23578999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccceeccCCCc-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhh
Q 014904          183 EAKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDW  260 (416)
Q Consensus       183 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~  260 (416)
                      .+||+|||+++....... .......++..|+|||++.++.++.++|||||||+++||++ |..||.....   ..+.+ 
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~-  237 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIE-  237 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHH-
Confidence            999999999976533221 22233446778999999998899999999999999999999 9989865432   11111 


Q ss_pred             hhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          261 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                             .+..+...         ..+......+.+++.+|++.+|.+||++.+|++.|.+
T Consensus       238 -------~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 -------MVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -------HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                   11111111         1112234578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-41  Score=330.63  Aligned_cols=251  Identities=25%  Similarity=0.318  Sum_probs=204.4

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.+.||+|+||.||+|... +++.||||+++...   ......+..|+.++..++|+||+++++++.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999964 68999999997542   123456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|..++...  ..+++..+..++.|++.||+|||+.   +|+||||||+||||+.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999999765  3689999999999999999999998   99999999999999999999999999998665433


Q ss_pred             ----------------------------cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCc
Q 014904          200 ----------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHT  251 (416)
Q Consensus       200 ----------------------------~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~  251 (416)
                                                  ........||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                        1122345799999999999999999999999999999999999999976542


Q ss_pred             ccc-hhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 014904          252 FVE-DSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR-MSQIVRA  318 (416)
Q Consensus       252 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~evv~~  318 (416)
                      ... ..+..|.          ..+.   -|.. .    .....+.+++..|++ +|.+||+ +.++++.
T Consensus       236 ~~~~~~i~~~~----------~~~~---~p~~-~----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         236 QETYNKIINWK----------ESLR---FPPD-P----PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHHHHhccC----------Cccc---CCCC-C----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            110 0011110          1110   0100 0    134578889999997 9999999 9999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.1e-40  Score=322.34  Aligned_cols=242  Identities=26%  Similarity=0.331  Sum_probs=196.8

Q ss_pred             ceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCC
Q 014904           50 NLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNN  125 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~  125 (416)
                      ++||+|+||.||++.. .+++.||||++....   ......+..|+.+++.++||||+++++++......++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999995 468999999997542   222356788999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeec
Q 014904          126 TLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR  205 (416)
Q Consensus       126 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  205 (416)
                      +|..++....  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus        81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~  154 (328)
T cd05593          81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKT  154 (328)
T ss_pred             CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cccc
Confidence            9998886543  589999999999999999999999   999999999999999999999999999875432221 2234


Q ss_pred             ccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCc
Q 014904          206 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNE  285 (416)
Q Consensus       206 ~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~  285 (416)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||......   .+.        ..+..+.      ..+   
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~--------~~~~~~~------~~~---  214 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF--------ELILMED------IKF---  214 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHH--------HHhccCC------ccC---
Confidence            67999999999999889999999999999999999999999754321   111        1111111      111   


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014904          286 YNHNEMARMVACAAACVRHSARRRP-----RMSQIVRA  318 (416)
Q Consensus       286 ~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~~  318 (416)
                       +......+.+++.+||+.+|++||     ++.|+++.
T Consensus       215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 -PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             -CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence             112335688999999999999997     88888754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.1e-40  Score=309.83  Aligned_cols=253  Identities=30%  Similarity=0.438  Sum_probs=205.8

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      ++|.+...||+|++|.||+|.+..+..+|+|.+.... .....+.+|+.++++++|+|++++++++.. ...++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            5688899999999999999998777789999887543 334678899999999999999999998754 56789999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      +++|.++++......+++..+..++.+++.||.|||+.   +++|+||||+||++++++.++|+|||++...........
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence            99999999765555689999999999999999999998   999999999999999999999999999987644322222


Q ss_pred             ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      ....++..|+|||+..++.++.++|||||||++|||++ |+.||.....   .....+        +..+. .    +  
T Consensus       161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~--------~~~~~-~----~--  222 (260)
T cd05069         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQ--------VERGY-R----M--  222 (260)
T ss_pred             CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH--------HHcCC-C----C--
Confidence            23346778999999998999999999999999999999 8999875432   111111        11111 0    0  


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                        ..+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 --PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              1112334678999999999999999999999999973

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-40  Score=320.77  Aligned_cols=242  Identities=23%  Similarity=0.315  Sum_probs=195.3

Q ss_pred             ecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCH
Q 014904           52 LGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL  127 (416)
Q Consensus        52 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL  127 (416)
                      ||+|+||.||+|... +++.||+|+++...   ......+..|+.++.+++||||+++++++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999964 68899999987532   22335678899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeeccc
Q 014904          128 EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM  207 (416)
Q Consensus       128 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  207 (416)
                      ..++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~  154 (312)
T cd05585          81 FHHLQREG--RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC  154 (312)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence            99987544  589999999999999999999999   99999999999999999999999999987543322 2233467


Q ss_pred             ccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCC
Q 014904          208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYN  287 (416)
Q Consensus       208 gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  287 (416)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||.....      .......     ..+..          .++
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~-----~~~~~----------~~~  213 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKI-----LQEPL----------RFP  213 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHH-----HcCCC----------CCC
Confidence            99999999999999999999999999999999999999975432      1111111     11111          112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          288 HNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       288 ~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      ......+.+++.+||+.+|.+||++..+.+.|+
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            223356889999999999999987554444443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7.1e-40  Score=308.34  Aligned_cols=250  Identities=28%  Similarity=0.430  Sum_probs=207.1

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +|...+.||+|++|.||+|... +++.|++|.+....  ......+..|+.++++++|+||+++++++......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999954 68999999987542  23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.+++.......+++..++.++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||+++........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999999999876455799999999999999999999998   9999999999999999999999999998876543322


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                       .....|+..|+|||++.+..++.++||||||+++++|++|+.||.....   .....        .+..+.+..     
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~--------~~~~~~~~~-----  220 (256)
T cd08529         158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALIL--------KIIRGVFPP-----  220 (256)
T ss_pred             -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHH--------HHHcCCCCC-----
Confidence             2335688999999999999999999999999999999999999976542   11111        111222211     


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                          ........+.+++.+||+.+|++||++.+|++.
T Consensus       221 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         221 ----VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ----CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                111234578999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.8e-40  Score=321.76  Aligned_cols=242  Identities=23%  Similarity=0.329  Sum_probs=195.9

Q ss_pred             ceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCC
Q 014904           50 NLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNN  125 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~  125 (416)
                      ++||+|+||.||++.. .+|+.||+|+++...   ......+..|+.++..++||||+++++++......++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999995 478999999997542   122346778999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeec
Q 014904          126 TLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR  205 (416)
Q Consensus       126 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  205 (416)
                      +|..++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~  154 (323)
T cd05595          81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT  154 (323)
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cccc
Confidence            9998886543  589999999999999999999999   999999999999999999999999999875322211 1233


Q ss_pred             ccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCc
Q 014904          206 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNE  285 (416)
Q Consensus       206 ~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~  285 (416)
                      ..||+.|+|||++.++.++.++|||||||++|||++|+.||......   .+.        ..+..+..      .    
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~--------~~~~~~~~------~----  213 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLF--------ELILMEEI------R----  213 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHH--------HHHhcCCC------C----
Confidence            57999999999999999999999999999999999999999754321   111        11111111      1    


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014904          286 YNHNEMARMVACAAACVRHSARRRP-----RMSQIVRA  318 (416)
Q Consensus       286 ~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~~  318 (416)
                      ++......+.+++.+||+.+|.+||     ++.++++.
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            1122335688999999999999998     78887753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=330.44  Aligned_cols=240  Identities=30%  Similarity=0.489  Sum_probs=204.5

Q ss_pred             CcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCC
Q 014904           47 SDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT  126 (416)
Q Consensus        47 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~s  126 (416)
                      ..++-||.|..|.||+|.+ .++.||||+++.-.       ..++.-|++|+|+||+.+.|+|....-+|||||||..|.
T Consensus       127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            4467799999999999998 56889999886322       246777999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeecc
Q 014904          127 LEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRV  206 (416)
Q Consensus       127 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  206 (416)
                      |..+|....  .+.-.....|..+||.|+.|||.+   +|||||||.-||||..+..+||+|||-++...+..+.+  .+
T Consensus       199 L~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkM--SF  271 (904)
T KOG4721|consen  199 LYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKM--SF  271 (904)
T ss_pred             HHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhh--hh
Confidence            999997544  577788889999999999999999   99999999999999999999999999999887764443  37


Q ss_pred             cccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcC
Q 014904          207 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEY  286 (416)
Q Consensus       207 ~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  286 (416)
                      .||..|||||++.+.+.++|+|||||||||||||||.-|+..-    +.+.+-|-         -|      .-.+.-..
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV----dssAIIwG---------VG------sNsL~Lpv  332 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV----DSSAIIWG---------VG------SNSLHLPV  332 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc----chheeEEe---------cc------CCcccccC
Confidence            8999999999999999999999999999999999999998653    22333331         11      11233445


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          287 NHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       287 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      +..++..+.-|++.||+..|+.||++++|+..|+
T Consensus       333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            5667788999999999999999999999999986

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.2e-40  Score=325.63  Aligned_cols=257  Identities=27%  Similarity=0.416  Sum_probs=203.4

Q ss_pred             CCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCccc-HHHHHHHHHHHHhc-CCCcccceEEEEEe-CCe
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSGQG-EREFQAEVEIISRV-HHKHLVSLVGYYTA-GSQ  114 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~  114 (416)
                      ++|.+.++||+|+||.||+|...      +++.||+|+++...... ...+..|+.++.++ +|+||++++++|.. +..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            57999999999999999999732      34789999987543322 34677899999999 89999999998865 456


Q ss_pred             EEEEEEecCCCCHHHHhhcCCC----------------------------------------------------------
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGR----------------------------------------------------------  136 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~----------------------------------------------------------  136 (416)
                      .++|+||+++++|.+++.....                                                          
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            8899999999999988854221                                                          


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce-eecccccccccC
Q 014904          137 -PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLA  214 (416)
Q Consensus       137 -~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Yla  214 (416)
                       ..++|..+..++.|++.||+|||+.   +|+||||||.|||++.++.++|+|||+++......... .....++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence             2589999999999999999999998   99999999999999999999999999998654332222 223456778999


Q ss_pred             hhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHH
Q 014904          215 PEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMAR  293 (416)
Q Consensus       215 PE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  293 (416)
                      ||++.+..++.++|||||||+|+||++ |+.||......  +.+        ...+..+....         .+......
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~--------~~~~~~~~~~~---------~~~~~~~~  304 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEF--------CRRLKEGTRMR---------APEYATPE  304 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHH--------HHHHhccCCCC---------CCccCCHH
Confidence            999999999999999999999999998 99998754321  111        11122221111         11123357


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          294 MVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       294 l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      +.+++.+||+.+|++||++.||++.|+..
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            89999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.9e-40  Score=331.32  Aligned_cols=257  Identities=22%  Similarity=0.273  Sum_probs=203.6

Q ss_pred             HHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           39 LARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        39 l~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      +....++|.+.++||+|+||.||++.. .+++.||+|++....   ......+..|+.+++.++||||+++++++.+...
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            334567899999999999999999995 468999999997432   2223457789999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      .++||||+++++|..++...   .++...+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            99999999999999988653   477888889999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCcceeecccccccccChhhhccC----CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh
Q 014904          195 ASDVNTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       195 ~~~~~~~~~~~~~gt~~YlaPE~~~~~----~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~  270 (416)
                      .............||+.|+|||++.+.    .++.++|||||||++|||++|+.||......      .    .+.. +.
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~----~~~~-i~  260 (370)
T cd05596         192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------G----TYSK-IM  260 (370)
T ss_pred             ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------H----HHHH-HH
Confidence            654333223346799999999998653    4789999999999999999999999764421      0    0111 11


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARR--RPRMSQIVRA  318 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evv~~  318 (416)
                      .+.. .+.   +..  .......+.+++.+||+.+|.+  ||++.++++.
T Consensus       261 ~~~~-~~~---~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         261 DHKN-SLT---FPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             cCCC-cCC---CCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            1110 000   000  1122457888999999999988  9999999865

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.7e-40  Score=323.34  Aligned_cols=246  Identities=24%  Similarity=0.299  Sum_probs=201.3

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCC--CcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPN--GKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~--g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      .++|.+.+.||+|+||.||+|....  +..||+|++....   ......+..|+.++..++||||+++++++.+....++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4579999999999999999998543  3689999986432   2223467889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+++++|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       109 v~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            999999999999997554  588999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      .    .....||+.|+|||++.+..++.++|||||||++|||++|+.||......           .....+..+...  
T Consensus       184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----------~~~~~i~~~~~~--  246 (340)
T PTZ00426        184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-----------LIYQKILEGIIY--  246 (340)
T ss_pred             C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-----------HHHHHHhcCCCC--
Confidence            2    12357999999999999888999999999999999999999999765431           011111122210  


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRP-----RMSQIVRA  318 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~~  318 (416)
                              ++......+.+++.+|++.+|.+|+     ++.++++.
T Consensus       247 --------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        247 --------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                    1112234578899999999999995     78887754

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=353.51  Aligned_cols=256  Identities=31%  Similarity=0.477  Sum_probs=211.9

Q ss_pred             CCCcCceecccCcEEEEEEEeC--CCc----EEEEEEeecC-CcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP--NGK----EVAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~--~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      +....+.||+|.||.||.|...  +|.    .||||.++.. +.+...+|..|..+++.++|||||+++|+|.+....++
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            3445678999999999999953  343    4999999865 44556789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccc
Q 014904          118 VYEFVPNNTLEFHLHGKG-----RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA  192 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~-----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla  192 (416)
                      ++|||.+|+|..+|+...     ...+.....+.++++||+|+.||+++   ++|||||.++|+||+....+||+|||+|
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchh
Confidence            999999999999998651     24689999999999999999999999   9999999999999999999999999999


Q ss_pred             e-eccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhh
Q 014904          193 K-IASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       193 ~-~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~  270 (416)
                      + .+...........+-...|||||.+..+.++.|+|||||||+|||++| |..|+......          .++...++
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~----------~v~~~~~~  919 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF----------EVLLDVLE  919 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH----------HHHHHHHh
Confidence            9 333322222233344678999999999999999999999999999999 99999775541          22222344


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      .|.   +       ..+..++..+.+++..||+.+|++||++..|++.+....
T Consensus       920 ggR---L-------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  920 GGR---L-------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             CCc---c-------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence            552   2       234456678899999999999999999999999876543

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.1e-40  Score=311.58  Aligned_cols=254  Identities=25%  Similarity=0.391  Sum_probs=203.3

Q ss_pred             HHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEEEEeC-----
Q 014904           40 ARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYYTAG-----  112 (416)
Q Consensus        40 ~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----  112 (416)
                      ..+++.|...+.||+|+||.||+|.. .+++.||+|++.... .....+..|+.++.++ +|+||+++++++...     
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            45778899999999999999999995 468899999987543 3446788999999998 799999999998753     


Q ss_pred             -CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          113 -SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       113 -~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                       ...++||||+++++|.+++.......+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence             4689999999999999998865555789999999999999999999998   999999999999999999999999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhc-----cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhH
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN  266 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~-----~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~  266 (416)
                      +........ ......|+..|+|||++.     ...++.++|||||||++|||++|+.||.......     .+..    
T Consensus       158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~~----  227 (272)
T cd06637         158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALFL----  227 (272)
T ss_pred             ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHHH----
Confidence            886543222 223467899999999986     3458889999999999999999999996533211     1000    


Q ss_pred             HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          267 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       267 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                        ..........        ....+..+.+++.+||+.+|.+||++.+|++
T Consensus       228 --~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         228 --IPRNPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             --HhcCCCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence              0011111111        1123356889999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8e-40  Score=315.01  Aligned_cols=255  Identities=26%  Similarity=0.418  Sum_probs=203.8

Q ss_pred             CCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      +|.+.+.||+|+||.||+|...      ....+++|.+...... ....+..|+.+++.++||||++++++|......++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4788899999999999999852      2357899988755432 23578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCc
Q 014904          118 VYEFVPNNTLEFHLHGK----------------------GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAAN  175 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~----------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~N  175 (416)
                      |+||+.+++|.+++...                      ....+++..++.++.+++.||.|||+.   +|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            99999999999987532                      113578999999999999999999998   99999999999


Q ss_pred             EEECCCCceEEeecccceeccCCCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccc
Q 014904          176 ILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFV  253 (416)
Q Consensus       176 ILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~  253 (416)
                      ||+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||++++||++ |+.||....+  
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--  235 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--  235 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            999999999999999998654333221 122345778999999988899999999999999999999 9999865432  


Q ss_pred             chhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          254 EDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       254 ~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                       ..+..+        +..+.         ....+......+.+++.+|++.+|++||++.+|++.|+..
T Consensus       236 -~~~~~~--------~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         236 -ERLFNL--------LKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             -HHHHHH--------HhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence             112111        11111         0111122335788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1e-39  Score=320.74  Aligned_cols=252  Identities=24%  Similarity=0.292  Sum_probs=199.5

Q ss_pred             CCCcCceecccCcEEEEEEEe----CCCcEEEEEEeecCC----cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGS----GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  115 (416)
                      +|.+.+.||+|+||.||++..    .+++.||+|++....    ......+..|+.++.++ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478899999999999999885    357899999987532    12234577899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++||||+++++|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            99999999999999886543  588999999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ............||+.|+|||++.+. .++.++|||||||++|||++|+.||...........  .     ...+...  
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~--~-----~~~~~~~--  226 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE--V-----SRRILKC--  226 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH--H-----HHHHhcC--
Confidence            44333333446799999999999765 478999999999999999999999975432111111  0     0111111  


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP-----RMSQIVRA  318 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~~  318 (416)
                          ++.+..    .....+.+++.+||+.+|++||     ++.++++.
T Consensus       227 ----~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         227 ----DPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ----CCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                111212    2234678999999999999999     66676653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.8e-40  Score=321.10  Aligned_cols=267  Identities=20%  Similarity=0.330  Sum_probs=196.9

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeC-----CeEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAG-----SQRM  116 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  116 (416)
                      +|.+.++||+|+||.||+|.. .+++.||||++....  ......+.+|+.++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            588889999999999999995 468999999987432  22335688999999999999999999988643     2479


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +||||+. ++|..++....  .+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999995 67888876543  589999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCc--ceeecccccccccChhhhcc--CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhh-hhhh---HHhHHh
Q 014904          197 DVNT--HVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV-DWAR---PLLNRA  268 (416)
Q Consensus       197 ~~~~--~~~~~~~gt~~YlaPE~~~~--~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~-~~~~---~~~~~~  268 (416)
                      ....  .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+ +...   +.....
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2221  11234578999999999875  67899999999999999999999999764421110000 0000   000000


Q ss_pred             hhcCCccccc---Cc----cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          269 IEDGNFDTLV---DP----KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       269 ~~~~~~~~~~---d~----~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      +........+   .+    .+...+ ......+.+++.+||+.+|++||++.||++.
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000000000   00    000000 0123467899999999999999999999964

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.3e-39  Score=317.76  Aligned_cols=201  Identities=26%  Similarity=0.432  Sum_probs=175.7

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .++|++.+.||+|+||.||++.+. +++.+|+|++..... .....+.+|+.++..++|+||++++++|......++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999965 688899998875432 233568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|.+++....  .+++.....++.+++.||.|||+.+  +|+|+||||+|||++.++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            999999999987543  5889999999999999999999753  6999999999999999999999999998755332  


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCC
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH  250 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~  250 (416)
                       ......|+..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence             1233568999999999998899999999999999999999999997543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=307.53  Aligned_cols=251  Identities=24%  Similarity=0.404  Sum_probs=203.0

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc-----cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ-----GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ++|.+.+.||+|++|.||+|.. .+++.+|+|.+......     ....+.+|+.++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5799999999999999999995 46899999998754321     12467889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      |+||+++++|.+++....  .+++..+..++.+++.||.|||+.   +|+|+||+|+||+++.++.++|+|||+++....
T Consensus        82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            999999999999887543  588899999999999999999999   999999999999999999999999999876543


Q ss_pred             CCccee--ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          198 VNTHVS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       198 ~~~~~~--~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ......  ....++..|+|||++.+..++.++||||||+++|||++|+.||.......  ...        .......  
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~--------~~~~~~~--  224 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--AIF--------KIATQPT--  224 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--HHH--------HHhccCC--
Confidence            222111  23567889999999999889999999999999999999999986543211  000        0000100  


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                             ....+......+.+++.+||+.+|.+||++.+|++.
T Consensus       225 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         225 -------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                   011222234568899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.4e-40  Score=315.09  Aligned_cols=257  Identities=25%  Similarity=0.412  Sum_probs=207.7

Q ss_pred             CCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+..........+..|++++.+++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            57889999999999999999842      345689999876554445678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEE
Q 014904          118 VYEFVPNNTLEFHLHGKG-----------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV  186 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl  186 (416)
                      |+||+++++|.+++....           ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence            999999999999986432           12589999999999999999999998   9999999999999999999999


Q ss_pred             eecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHH
Q 014904          187 ADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPL  264 (416)
Q Consensus       187 ~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~  264 (416)
                      +|||+++........ ......++..|+|||++.+..++.++|||||||++++|++ |..||.....   ...       
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~-------  231 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEV-------  231 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHH-------
Confidence            999999765432221 1223446778999999998899999999999999999999 8999865442   111       


Q ss_pred             hHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          265 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       265 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                       ...+..+.....     ...    ....+.+++.+||+.+|.+||++.+|+..|+...
T Consensus       232 -~~~i~~~~~~~~-----~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         232 -IECITQGRVLQR-----PRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             -HHHHHcCCcCCC-----CCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence             111222322111     111    2346899999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.7e-40  Score=327.36  Aligned_cols=246  Identities=27%  Similarity=0.414  Sum_probs=211.2

Q ss_pred             CCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ++|.+.+.||+|.||+||||. ..+.+.||+|.+.+....  +.+.+.+|++|++.++||||+.+++.|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            578889999999999999999 457899999998765332  23568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+.| +|..+|...+  .+++.....|+.+++.||.|||+.   +|+|||+||+|||++.++.+|+||||+|+.... ++
T Consensus        82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT  154 (808)
T ss_pred             hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence            9977 9999997665  599999999999999999999999   999999999999999999999999999997655 66


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                      .+.+.+.||+-|||||++.++.|+..+|+|||||+|||+.+|++||....      +...+..     +..       ||
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~-----I~~-------d~  216 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKS-----ILK-------DP  216 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHH-----Hhc-------CC
Confidence            77788999999999999999999999999999999999999999986532      2222221     111       12


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .   .++......+..++...+..||..|-+-.+++.
T Consensus       217 v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  217 V---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             C---CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            1   123355668899999999999999999999874

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8.6e-40  Score=307.81  Aligned_cols=247  Identities=26%  Similarity=0.397  Sum_probs=197.3

Q ss_pred             ceecccCcEEEEEEEe-CCCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCH
Q 014904           50 NLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL  127 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL  127 (416)
                      +.||+|+||.||+|.+ .+++.+|+|.+.... ......+.+|+.++++++|+||++++++|......++|+||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4699999999999996 478999999876443 23345789999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee-ecc
Q 014904          128 EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS-TRV  206 (416)
Q Consensus       128 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~~  206 (416)
                      .+++.... ..+++..++.++.|++.||.|||+.   +++||||||.||+++.++.+||+|||++....+...... ...
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            99987543 3589999999999999999999999   999999999999999999999999999875443211110 111


Q ss_pred             cccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCc
Q 014904          207 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNE  285 (416)
Q Consensus       207 ~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~  285 (416)
                      ..+..|+|||++.++.++.++||||||+++|||++ |..||......   ..        ...+..+.         ...
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~--------~~~~~~~~---------~~~  216 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QT--------REAIEQGV---------RLP  216 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HH--------HHHHHcCC---------CCC
Confidence            23457999999999999999999999999999998 88888653321   11        01111111         011


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          286 YNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       286 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      .+...+..+.+++.+|++.+|++||++.+|+++|.
T Consensus       217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            12223457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.5e-40  Score=326.49  Aligned_cols=253  Identities=23%  Similarity=0.263  Sum_probs=203.5

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.+.||+|+||.||++.. .+|+.||||+++....   .....+..|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4789999999999999999995 4789999999985432   23356889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++..... .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRYED-QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            99999999999976532 689999999999999999999999   99999999999999999999999999998765544


Q ss_pred             cceeecccccccccChhhhc------cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          200 THVSTRVMGTFGYLAPEYAS------SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~------~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      ........||+.|+|||++.      ...++.++|||||||++|||++|+.||......      ....    .......
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~----~i~~~~~  226 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYN----NIMNFQR  226 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHH----HHHcCCC
Confidence            43344467999999999986      456789999999999999999999999764321      1111    1111111


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ...+.+       .......+.+++..|++ +|.+||++.+++..
T Consensus       227 ~~~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         227 FLKFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             ccCCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            111110       11223567889999998 99999999998753

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.6e-39  Score=315.19  Aligned_cols=268  Identities=22%  Similarity=0.312  Sum_probs=198.3

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ..++|.+.+.||+|+||.||+|... +++.||||++...... ....+.+|+.+++.++||||+++++++......++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            3578999999999999999999964 6899999998754322 2346778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+. ++|.+++.... ..++...+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          83 EYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             ECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            9996 56666665433 2588889999999999999999999   99999999999999999999999999987543322


Q ss_pred             cceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHH--------h--
Q 014904          200 THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNR--------A--  268 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~--------~--  268 (416)
                       .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+..... .+..        .  
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~  234 (303)
T cd07869         158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ-DQLERIFL-VLGTPNEDTWPGVHS  234 (303)
T ss_pred             -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHH-HhCCCChhhccchhh
Confidence             12233568999999999865 458899999999999999999999997643211 11110000 0000        0  


Q ss_pred             ---hhcCCcccccCccccCcCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          269 ---IEDGNFDTLVDPKLHNEYN-HNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       269 ---~~~~~~~~~~d~~l~~~~~-~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                         .....+.......+...++ ......+.+++.+||+.+|++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence               0000000000000000000 001245778999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.9e-40  Score=316.93  Aligned_cols=256  Identities=27%  Similarity=0.395  Sum_probs=206.0

Q ss_pred             CCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSG-QGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  115 (416)
                      ++|.+.+.||+|+||.||+|...      .+..||||+++.... .....+.+|+.+++++ +|+||+++++++......
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            57999999999999999999742      345799999875532 2235688999999999 799999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++|+||+++++|..+++......+++.+++.++.+++.||.|||+.   +|+|+||||+|||++.++.++|+|||+++..
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            9999999999999999765544589999999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          196 SDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       196 ~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      ...... ......++..|+|||++.++.++.++|||||||++|||++ |+.||.....  ...+..        .+..+.
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--~~~~~~--------~~~~~~  261 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--DSKFYK--------LIKEGY  261 (302)
T ss_pred             cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--hHHHHH--------HHHcCC
Confidence            443221 1222345778999999999999999999999999999998 9999865432  111111        111111


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                      .         ...+......+.+++.+|+..+|++||++.||++.|+.
T Consensus       262 ~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         262 R---------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             c---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            0         00111223578999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.3e-39  Score=308.37  Aligned_cols=254  Identities=28%  Similarity=0.449  Sum_probs=207.9

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      .++|.+.+.||+|+||.||++...++..+|+|.+.... .....+.+|+.++++++|+||+++++++.. ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            46889999999999999999998778889999887543 234578899999999999999999999887 7789999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++++|.+++.......+++..++.++.+++.||.|||+.   +++|+||||+||+++.++.+||+|||++..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  159 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence            999999999775555789999999999999999999998   99999999999999999999999999998665433222


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                      .....++..|+|||++..+.++.++|||||||+++++++ |+.||.....   ..+.        ..+..+....     
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~--------~~~~~~~~~~-----  223 (260)
T cd05073         160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVI--------RALERGYRMP-----  223 (260)
T ss_pred             ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHH--------HHHhCCCCCC-----
Confidence            223446678999999998899999999999999999999 8999875432   1111        1122221110     


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                          ........+.+++.+|++.+|++||++.+|++.|+.
T Consensus       224 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 ----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                111233578899999999999999999999999973

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.6e-39  Score=318.59  Aligned_cols=244  Identities=27%  Similarity=0.410  Sum_probs=194.4

Q ss_pred             CCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHH---HhcCCCcccceEEEEEeCCeEEEE
Q 014904           46 FSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEII---SRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      |++.++||+|+||.||+|.. .+++.||||+++...   ......+..|..++   ..++||||+++++++......++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            67789999999999999995 468999999997542   12234566666655   566899999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+++++|...+...   .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            9999999999888643   589999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      .. ......|++.|+|||++.+..++.++|||||||++|||++|+.||......      +..     ..+..+..    
T Consensus       155 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~-----~~i~~~~~----  218 (324)
T cd05589         155 GD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVF-----DSIVNDEV----  218 (324)
T ss_pred             CC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHH-----HHHHhCCC----
Confidence            22 223467999999999999999999999999999999999999999765421      111     11111111    


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPR-----MSQIVR  317 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evv~  317 (416)
                        .    ++......+.+++.+||+.+|.+||+     +.++++
T Consensus       219 --~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 --R----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             --C----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence              1    11223456789999999999999994     555554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.6e-40  Score=328.62  Aligned_cols=258  Identities=21%  Similarity=0.271  Sum_probs=201.6

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCC
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGS  113 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  113 (416)
                      ++....++|.+.+.||+|+||.||++... +++.+|+|++....   ......+.+|+.+++.++||||+++++++.++.
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            34445678999999999999999999964 68899999986432   222346788999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ..++||||+++++|.+++...   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccce
Confidence            999999999999999998643   478889999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCcceeecccccccccChhhhccC----CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhh
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAI  269 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~~~----~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~  269 (416)
                      ..............||+.|+|||++.+.    .++.++|||||||++|||++|+.||......      .    .+....
T Consensus       191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~----~~~~i~  260 (370)
T cd05621         191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------G----TYSKIM  260 (370)
T ss_pred             ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------H----HHHHHH
Confidence            7654333233456799999999998653    3789999999999999999999999764321      0    011111


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARR--RPRMSQIVRA  318 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evv~~  318 (416)
                      .......     +..  .......+..++..|++.++.+  ||++.|+++.
T Consensus       261 ~~~~~~~-----~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         261 DHKNSLN-----FPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             hCCcccC-----CCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            1110000     000  1122346778888898755544  8899998875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-39  Score=306.92  Aligned_cols=250  Identities=31%  Similarity=0.474  Sum_probs=207.7

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      .++|.+.+.||+|+||.||+|.. .|+.||||.++.... ...++.+|+.+++.++|+||+++++++......++|+||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            35788899999999999999997 478999999986544 4567899999999999999999999999989999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++.......  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            999999999766555799999999999999999999999   999999999999999999999999999986633222  


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                        ....+..|+|||++.++.++.++||||||++++||++ |+.||.....   ..+.        ..+..+..       
T Consensus       158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~--------~~~~~~~~-------  217 (256)
T cd05039         158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVV--------PHVEKGYR-------  217 (256)
T ss_pred             --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHH--------HHHhcCCC-------
Confidence              2335678999999998899999999999999999998 9999865432   1111        11111110       


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                        ...+...+..+.+++.+|++.+|++||++.+|+++|+.
T Consensus       218 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         218 --MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             --CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence              01112234678999999999999999999999999963

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-41  Score=334.17  Aligned_cols=255  Identities=29%  Similarity=0.454  Sum_probs=205.3

Q ss_pred             CCCcCceecccCcEEEEEEEeCC--C--cE-EEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLPN--G--KE-VAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~~--g--~~-vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      +-...++||+|.||.||+|.+..  +  .. ||||..+...   .....+|.+|++++++++|||||+++|++.....++
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            33445899999999999999543  2  23 8999998532   344568999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +|||+|.||+|.++|..... .++..+++.++.++|.||+|||+.   ++|||||.++|+|+..++.+||+|||+++...
T Consensus       238 ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            99999999999999987765 699999999999999999999999   99999999999999999999999999987554


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ...... ....-+..|+|||.+..+.++.++|||||||++||+++ |..|+......   .+.        ..+....+.
T Consensus       314 ~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~--------~kI~~~~~r  381 (474)
T KOG0194|consen  314 QYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVK--------AKIVKNGYR  381 (474)
T ss_pred             ceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHH--------HHHHhcCcc
Confidence            111111 11234678999999999999999999999999999999 88898765431   111        112111111


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                              -..+...+..+..++.+|+..+|++||+|.+|.+.|+...
T Consensus       382 --------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~  421 (474)
T KOG0194|consen  382 --------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE  421 (474)
T ss_pred             --------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence                    1122244567788888999999999999999999998543

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-40  Score=327.93  Aligned_cols=252  Identities=24%  Similarity=0.318  Sum_probs=199.1

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.++||+|+||.||+|.. .+++.||||++....   ......+..|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4789999999999999999995 468999999997532   122345788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++...+  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            9999999999987654  589999999999999999999999   99999999999999999999999999987543211


Q ss_pred             cc-------------------------------------eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhC
Q 014904          200 TH-------------------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG  242 (416)
Q Consensus       200 ~~-------------------------------------~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG  242 (416)
                      ..                                     .....+||+.|+|||++....++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            00                                     01124699999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 014904          243 RRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR---MSQIVRA  318 (416)
Q Consensus       243 ~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt---~~evv~~  318 (416)
                      +.||........          ..... .... .+..+   .  .......+.+++.+|+. +|.+|++   +.|+++.
T Consensus       236 ~~Pf~~~~~~~~----------~~~i~-~~~~-~~~~~---~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         236 YPPFCSDNPQET----------YRKII-NWKE-TLQFP---D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCHHHH----------HHHHH-cCCC-ccCCC---C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            999976543110          00000 1000 00001   0  00123467788888986 8999998   8777753

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=9.2e-40  Score=312.51  Aligned_cols=256  Identities=29%  Similarity=0.443  Sum_probs=203.7

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      .+++|.+.+.||+|++|.||+|.+.      .+..||+|.+..... .....|..|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            4578999999999999999999964      356889998865432 234568899999999999999999999999889


Q ss_pred             EEEEEEecCCCCHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC---ceEE
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGR-----PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF---EAKV  186 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~-----~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~---~~kl  186 (416)
                      .++|+||+++++|.+++.....     ..+++..++.++.+++.||+|||+.   +++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999875432     2589999999999999999999999   999999999999998754   5899


Q ss_pred             eecccceeccCCCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHH
Q 014904          187 ADFGLAKIASDVNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPL  264 (416)
Q Consensus       187 ~DFGla~~~~~~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~  264 (416)
                      +|||+++......... ......+..|+|||++.++.++.++|||||||++|||++ |+.||......   .+..     
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~-----  232 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVME-----  232 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH-----
Confidence            9999998653322111 122334568999999999999999999999999999997 99998754321   1111     


Q ss_pred             hHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          265 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       265 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                         .+..+.         ....+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus       233 ---~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         233 ---FVTGGG---------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ---HHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence               111111         01112223457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.1e-39  Score=317.71  Aligned_cols=242  Identities=26%  Similarity=0.381  Sum_probs=195.8

Q ss_pred             ceecccCcEEEEEEEe----CCCcEEEEEEeecCC----cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           50 NLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGS----GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ++||+|+||.||++..    .+++.||||+++...    ......+..|+.+++.++||||+++++++..+...++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6899999999999985    357899999997532    12234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|..++...+  .+.+..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (323)
T cd05584          82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-  155 (323)
T ss_pred             CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence            99999999886544  578888889999999999999999   999999999999999999999999999875433222 


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......      ..    + ..+..+..       
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~----~-~~~~~~~~-------  217 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KT----I-DKILKGKL-------  217 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HH----H-HHHHcCCC-------
Confidence            223457999999999999888999999999999999999999999764421      11    1 11112221       


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRP-----RMSQIVRA  318 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~~  318 (416)
                         ..+......+.+++.+||+.+|++||     ++.++++.
T Consensus       218 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         218 ---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence               11112234688999999999999999     77777653

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.9e-39  Score=306.59  Aligned_cols=258  Identities=20%  Similarity=0.338  Sum_probs=207.9

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.+.||+|+||.||+|.. .+++.||||.++....   .....+.+|+.+++.++||||+++++++......++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5799999999999999999995 4789999998865322   22346889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          120 EFVPNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       120 e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||+++++|..++...  ....++...++.++.++++||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            999999999888532  234588999999999999999999998   999999999999999999999999999887654


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      .... .....|++.|+|||++.+..++.++||||||+++|||++|+.||.....    ....+..     .+.....   
T Consensus       159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~-----~~~~~~~---  225 (267)
T cd08228         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQ-----KIEQCDY---  225 (267)
T ss_pred             hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHH-----HHhcCCC---
Confidence            3221 1234688899999999988899999999999999999999999865332    1111111     1111111   


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                        +.   .........+.+++.+||+.+|++||++.+|++.|+..
T Consensus       226 --~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         226 --PP---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             --CC---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence              11   11123346789999999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.7e-39  Score=306.27  Aligned_cols=251  Identities=30%  Similarity=0.486  Sum_probs=204.9

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      .+|+..+.||+|+||.||+|.+.+++.+|+|.+..... ....|.+|+.++++++|+|++++++++......++|+||+.
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46788899999999999999987788999999875433 34578999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      +++|.+++..... .+++..++.++.+++.+|+|||+.   +++|+||||+||+++.++.++|+|||+++..........
T Consensus        83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          83 HGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            9999999875443 588999999999999999999998   999999999999999999999999999876543322222


Q ss_pred             ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      ....++.+|+|||++.++.++.++||||||+++|||++ |+.||.....   ..+.        ..+..+.  ....+..
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~--------~~~~~~~--~~~~~~~  225 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVV--------ETINAGF--RLYKPRL  225 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHH--------HHHhCCC--CCCCCCC
Confidence            22335678999999998999999999999999999998 9999875432   1111        1111111  1111211


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL  319 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L  319 (416)
                             ....+.+++.+||+.+|++||++.+|++.|
T Consensus       226 -------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         226 -------ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                   235789999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3e-39  Score=306.51  Aligned_cols=257  Identities=21%  Similarity=0.352  Sum_probs=208.0

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc---cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ---GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.+.||+|+||.||+|.. .+++.+|||.+......   ...++..|+.+++.++|+||+++++++......++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            5788899999999999999994 57899999988754322   2347889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          120 EFVPNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       120 e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||+++++|.+++...  ....+++..++.++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988632  234689999999999999999999999   999999999999999999999999999876644


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      .... .....|+..|+|||++.+..++.++||||||+++|+|++|..||.....    ....+.     ..+.....   
T Consensus       159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~-----~~~~~~~~---  225 (267)
T cd08229         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLC-----KKIEQCDY---  225 (267)
T ss_pred             CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHh-----hhhhcCCC---
Confidence            3322 2235688999999999988999999999999999999999999865332    111111     11111111   


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                        +..   ........+.+++.+|++.+|++||+|.+|+++|+.
T Consensus       226 --~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         226 --PPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             --CCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence              111   112244578899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.7e-39  Score=311.42  Aligned_cols=254  Identities=26%  Similarity=0.434  Sum_probs=201.0

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCc----EEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGK----EVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ++|.+.+.||+|+||.||+|.+ .+++    .+++|.+...... ...++..|+.++.++.|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            4678889999999999999995 3454    4777777543322 23567788889999999999999998864 55788


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      |+||+++++|.+++..... .+++..++.|+.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++....
T Consensus        86 i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            9999999999999975443 689999999999999999999998   899999999999999999999999999987643


Q ss_pred             CCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          198 VNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       198 ~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      .... ......++..|+|||++.++.++.++|||||||++|||++ |+.||......   .+.        ..+..+...
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~--------~~~~~~~~~  230 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EVP--------DLLEKGERL  230 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH--------HHHHCCCcC
Confidence            3222 2234567789999999999999999999999999999998 99998764331   111        112222211


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                        ..+..       +...+..++.+|+..+|.+||++.|+++.|...
T Consensus       231 --~~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         231 --AQPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             --CCCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence              11111       224577899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-39  Score=311.46  Aligned_cols=252  Identities=27%  Similarity=0.398  Sum_probs=202.8

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      +|+..++||+|+||.||++.. .+++.||||++.....   .....+.+|+.++++++|+||+++++.+..+...++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            478889999999999999995 4689999999975432   223457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|..++.......+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            99999999888765545689999999999999999999999   999999999999999999999999999986543222


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                      .  ....|++.|+|||++.+..++.++|||||||++|||++|+.||.......   ....    +...+..+.       
T Consensus       158 ~--~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~----~~~~~~~~~-------  221 (285)
T cd05605         158 I--RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREE----VERRVKEDQ-------  221 (285)
T ss_pred             c--ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHH----HHHHhhhcc-------
Confidence            1  23468999999999998899999999999999999999999997643211   0000    001111111       


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRP-----RMSQIVRA  318 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~~  318 (416)
                         ..++......+.+++.+||+.||.+||     ++.++++.
T Consensus       222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence               112223345788999999999999999     77777654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-39  Score=336.88  Aligned_cols=259  Identities=24%  Similarity=0.328  Sum_probs=208.4

Q ss_pred             HHHHHhhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCC
Q 014904           37 EELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGS  113 (416)
Q Consensus        37 ~el~~~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  113 (416)
                      +++....++|.+.++||+|+||+||+|. ..+|+.||||++.....  .....+.+|+.++..++|+|+++++..+....
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            4556677899999999999999999999 45799999999875432  33356888999999999999999988765432


Q ss_pred             --------eEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc
Q 014904          114 --------QRMLVYEFVPNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE  183 (416)
Q Consensus       114 --------~~~lV~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~  183 (416)
                              ..++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGL  181 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCC
Confidence                    368999999999999988643  234689999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccceeccCCCc-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh
Q 014904          184 AKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR  262 (416)
Q Consensus       184 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~  262 (416)
                      +||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      .++..
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~  255 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMH  255 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHH
Confidence            99999999987643322 223346799999999999999999999999999999999999999975432      11111


Q ss_pred             HHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          263 PLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       263 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                           ....+....         .+......+.+++.+||+.+|.+||++.++++.
T Consensus       256 -----~~~~~~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        256 -----KTLAGRYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -----HHhcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                 111222211         122234578999999999999999999999864

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-39  Score=311.22  Aligned_cols=264  Identities=26%  Similarity=0.362  Sum_probs=202.8

Q ss_pred             CCCCcCceecccCcEEEEEEEe-----CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEe--CCeEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-----PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA--GSQRM  116 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  116 (416)
                      .+|++.+.||+|+||.||++..     .+++.||+|++........+.|..|+.++++++|+||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            5788899999999999999974     2578999999886655555688999999999999999999998754  34689


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +|+||+++++|.+++.... ..+++..++.++.+++.||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            9999999999999986543 2589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCccee--ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhh------hhhhHHhHHh
Q 014904          197 DVNTHVS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV------DWARPLLNRA  268 (416)
Q Consensus       197 ~~~~~~~--~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~------~~~~~~~~~~  268 (416)
                      .......  ....++..|+|||++.+..++.++|||||||+++||++|..++..........+.      .....+ ...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  238 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL-IEL  238 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH-HHH
Confidence            4332211  1122345699999999889999999999999999999988775432210000000      000000 011


Q ss_pred             hhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          269 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       269 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                      +..+.         ........+..+.+++.+||+.+|++||+|.||++.|+.
T Consensus       239 ~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         239 LKNNG---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HhcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            11110         001112234579999999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.8e-39  Score=305.98  Aligned_cols=255  Identities=25%  Similarity=0.396  Sum_probs=204.0

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++.+++|+||+++++++......++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35799999999999999999995 57889999999865544456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.++++...  .+++..+..++.|++.||.|||+.   +|+||||||.||+++.++.++|+|||++........ 
T Consensus        88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06646          88 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-  161 (267)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence            99999999886543  589999999999999999999998   999999999999999999999999999986543221 


Q ss_pred             eeecccccccccChhhhc---cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          202 VSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~---~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      ......|++.|+|||.+.   ...++.++|||||||+++||++|+.||....+...  ...+         ....+   .
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~~---------~~~~~---~  227 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLM---------SKSNF---Q  227 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--heee---------ecCCC---C
Confidence            112346889999999874   34578899999999999999999999864432111  0000         01111   1


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL  319 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L  319 (416)
                      .+....  .......+.+++.+||+.+|++||++.+|++.|
T Consensus       228 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         228 PPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            111111  112345788999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.3e-39  Score=312.03  Aligned_cols=254  Identities=27%  Similarity=0.418  Sum_probs=205.1

Q ss_pred             CCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ++|....+||+|+||.||++...      ++..+|+|.++.........+.+|+.++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            56788899999999999999732      356899999886655555689999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCce
Q 014904          118 VYEFVPNNTLEFHLHGKGR-------------PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA  184 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~  184 (416)
                      |+||+++++|.+++.....             ..+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence            9999999999999865421             3588999999999999999999998   99999999999999999999


Q ss_pred             EEeecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhh
Q 014904          185 KVADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWAR  262 (416)
Q Consensus       185 kl~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~  262 (416)
                      ||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.......   ..    
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~----  234 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AI----  234 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HH----
Confidence            99999998755432211 1223345788999999999999999999999999999998 899986543211   11    


Q ss_pred             HHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          263 PLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       263 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                          .....+...         ..+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       235 ----~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         235 ----ECITQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ----HHHHcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                111111110         111123356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.7e-39  Score=304.02  Aligned_cols=259  Identities=20%  Similarity=0.363  Sum_probs=210.5

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      +++|.+.+.||+|+||.||+|... +|+.||+|.++....   .....+..|+.++++++|+|++++++++......++|
T Consensus         1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            368999999999999999999965 799999999874322   2245788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          119 YEFVPNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      |||+++++|..++...  ....+++..++.++.+++.||+|||+.   +|+|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            9999999999988642  234689999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      ..... .....++..|+|||++.+..++.++|||||||++|+|++|+.||.....    .+.++.     ..+..+....
T Consensus       158 ~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~-----~~~~~~~~~~  227 (267)
T cd08224         158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLC-----KKIEKCDYPP  227 (267)
T ss_pred             CCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHH-----hhhhcCCCCC
Confidence            33222 2334688899999999988899999999999999999999999865431    111111     1112222211


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      +.        .......+.+++.+|+..+|++||++.+|+++|...
T Consensus       228 ~~--------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         228 LP--------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CC--------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            11        113345788999999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.5e-39  Score=306.67  Aligned_cols=257  Identities=23%  Similarity=0.369  Sum_probs=206.2

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      |++.+++++....+||+|+||.||+|.. .++..|++|.+........+.+.+|+.++++++|+||+++++++..+...+
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            4566788898889999999999999995 467889999988766556678999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC-CCceEEeecccce
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTM--DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF-KFEAKVADFGLAK  193 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l--~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~-~~~~kl~DFGla~  193 (416)
                      +|+||+++++|..++..... .+  ++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.++|+|||++.
T Consensus        82 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            99999999999999875432 34  7888899999999999999998   9999999999999976 6789999999987


Q ss_pred             eccCCCcceeecccccccccChhhhccCC--CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhc
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIED  271 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~~~~--~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~  271 (416)
                      ........ .....|+..|+|||++.+..  ++.++||||||+++|+|++|+.||......   ....|....      .
T Consensus       158 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---~~~~~~~~~------~  227 (268)
T cd06624         158 RLAGINPC-TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---QAAMFKVGM------F  227 (268)
T ss_pred             ecccCCCc-cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---hhhHhhhhh------h
Confidence            65432221 22345789999999987654  789999999999999999999998653221   111111000      0


Q ss_pred             CCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          272 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       272 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      +         .....+......+..++.+||+.+|.+||++.||++
T Consensus       228 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         228 K---------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             c---------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            0         011122233457889999999999999999999985

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.2e-40  Score=315.37  Aligned_cols=258  Identities=27%  Similarity=0.411  Sum_probs=206.2

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhc-CCCcccceEEEEEeCC
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSG-QGEREFQAEVEIISRV-HHKHLVSLVGYYTAGS  113 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  113 (416)
                      ..++|+..+.||+|+||.||++...      ....+|+|.+..... ....++.+|+.++.++ +|+||+++++++..+.
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            4567888999999999999999853      236899999875432 2335688999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC
Q 014904          114 QRMLVYEFVPNNTLEFHLHGK--------------GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD  179 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~  179 (416)
                      ..++||||+++++|..+++..              ....+++..++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence            999999999999999998642              234689999999999999999999998   999999999999999


Q ss_pred             CCCceEEeecccceeccCCCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhh
Q 014904          180 FKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSL  257 (416)
Q Consensus       180 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l  257 (416)
                      .++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......   .+
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~  243 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---EL  243 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---HH
Confidence            99999999999998664432211 122345678999999998899999999999999999998 99998654321   11


Q ss_pred             hhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                              ...+..+..         ...+......+.+++.+|++.+|++||++.||++.|+..
T Consensus       244 --------~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         244 --------FKLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             --------HHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence                    111111110         111223345788999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.5e-40  Score=313.30  Aligned_cols=255  Identities=24%  Similarity=0.384  Sum_probs=203.8

Q ss_pred             CCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCccc-HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSGQG-EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      ..|.+.+.||+|+||.||+|...      .++.||||+++...... ...+.+|+.++..++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            34777889999999999999853      25789999997543222 356889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC
Q 014904          117 LVYEFVPNNTLEFHLHGK--------------GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF  182 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~  182 (416)
                      +++||+++++|..++...              ....+++..++.++.|++.||.|||+.   +|+||||||.||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence            999999999999988532              123588899999999999999999998   999999999999999999


Q ss_pred             ceEEeecccceeccCCCc-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhh
Q 014904          183 EAKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDW  260 (416)
Q Consensus       183 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~  260 (416)
                      .+||+|||+++....... .......+++.|+|||++.++.++.++||||||+++|||++ |..||.....   ..+.  
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~--  236 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVI--  236 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH--
Confidence            999999999876543222 12233456789999999998899999999999999999998 8888865432   1111  


Q ss_pred             hhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          261 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                            ..+..+...         .++...+..+.+++..|++.+|.+||++.+|+..|+.
T Consensus       237 ------~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 ------EMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ------HHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                  111222211         1122344578999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.9e-39  Score=310.81  Aligned_cols=247  Identities=24%  Similarity=0.339  Sum_probs=197.2

Q ss_pred             ecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCH
Q 014904           52 LGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL  127 (416)
Q Consensus        52 LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL  127 (416)
                      ||+|+||.||++.. .+|+.||+|++.....   .....+..|++++.+++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999995 4689999999864321   1233456799999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeeccc
Q 014904          128 EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM  207 (416)
Q Consensus       128 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  207 (416)
                      ..++.......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence            9888766655789999999999999999999998   99999999999999999999999999987664422  223456


Q ss_pred             ccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCC
Q 014904          208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYN  287 (416)
Q Consensus       208 gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  287 (416)
                      |+..|+|||++.+..++.++|||||||++|||++|+.||........  ...+...     ...+....      .   .
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~-----~~~~~~~~------~---~  219 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRR-----TLEDEVKF------E---H  219 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHH-----hhcccccc------c---c
Confidence            89999999999988999999999999999999999999975432111  1111111     11111100      0   0


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014904          288 HNEMARMVACAAACVRHSARRRPRMSQIVRAL  319 (416)
Q Consensus       288 ~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L  319 (416)
                      ......+.+++.+||+.+|++||++.|+++.+
T Consensus       220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            11234688999999999999999998877544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.3e-39  Score=319.33  Aligned_cols=242  Identities=23%  Similarity=0.317  Sum_probs=195.8

Q ss_pred             ceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCC
Q 014904           50 NLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNN  125 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~  125 (416)
                      ++||+|+||.||++.. .+|+.||+|+++....   .....+..|+.++..++||||+++++++......++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999995 5789999999975422   22346778999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          126 TLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHE-DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       126 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      +|..++....  .+++..+..++.|++.||.|||+ .   +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus        81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~  154 (325)
T cd05594          81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MK  154 (325)
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-cc
Confidence            9998886543  58999999999999999999997 6   8999999999999999999999999998754322222 23


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccC
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHN  284 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~  284 (416)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+.        ..+..+..      .+..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~--------~~i~~~~~------~~p~  217 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF--------ELILMEEI------RFPR  217 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHH--------HHHhcCCC------CCCC
Confidence            357999999999999999999999999999999999999999754321   111        11111111      1111


Q ss_pred             cCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014904          285 EYNHNEMARMVACAAACVRHSARRRP-----RMSQIVRA  318 (416)
Q Consensus       285 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~~  318 (416)
                          .....+.+++.+||+.+|++|+     ++.++++.
T Consensus       218 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         218 ----TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             ----CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence                2234688999999999999996     89988854

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.9e-39  Score=305.47  Aligned_cols=245  Identities=27%  Similarity=0.413  Sum_probs=197.0

Q ss_pred             eecccCcEEEEEEEe---CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCC
Q 014904           51 LLGQGGFGYVHRGVL---PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNN  125 (416)
Q Consensus        51 ~LG~G~~g~Vy~~~~---~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~  125 (416)
                      .||+|+||.||+|.+   .+++.+|+|+++....  ....++..|+.++..+.|+||+++++++.. ...++|+||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999974   3578999999875432  224578899999999999999999998864 5678999999999


Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee--
Q 014904          126 TLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--  203 (416)
Q Consensus       126 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~--  203 (416)
                      +|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||.||+++.++.+||+|||+++..........  
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            9999986543  588999999999999999999998   999999999999999999999999999986654333211  


Q ss_pred             ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      ....++..|+|||.+....++.++|||||||++|||++ |+.||.....   ..+.        ..+..+...       
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~--------~~i~~~~~~-------  217 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVT--------QMIESGERM-------  217 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHH--------HHHHCCCCC-------
Confidence            12234578999999988889999999999999999998 9999976432   1111        112222211       


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                        ..+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus       218 --~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         218 --ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             --CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence              1122234578899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.4e-39  Score=311.37  Aligned_cols=251  Identities=23%  Similarity=0.384  Sum_probs=205.8

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ..+|...+.||+|+||.||+|+. .+++.|++|.+..........+..|+.+++.++|+|++++++++..+...++|+||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            35888899999999999999995 57899999999876655566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|..++...   .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.........
T Consensus        99 ~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654          99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             cCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            9999999998643   478999999999999999999999   9999999999999999999999999998765432221


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                       .....+++.|+|||++.+..++.++|||||||++|+|++|+.||....+.  ..+..+        ...+. ..+    
T Consensus       173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~~--------~~~~~-~~~----  236 (296)
T cd06654         173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLI--------ATNGT-PEL----  236 (296)
T ss_pred             -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHHH--------hcCCC-CCC----
Confidence             22346889999999999888999999999999999999999999764431  111111        00111 000    


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                         ..+......+.+++.+||..+|++||++.+|++.
T Consensus       237 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         237 ---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ---CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence               1122234568899999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.5e-39  Score=307.43  Aligned_cols=256  Identities=30%  Similarity=0.500  Sum_probs=204.9

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CC---cEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NG---KEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      +++|...+.||+|+||.||+|.+. ++   ..+++|.++... ......+..|+.++.+++|+|++++++++......++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            457888999999999999999964 33   379999987553 2234578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+++++|..++..+. ..+++..++.++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999999987543 3689999999999999999999999   999999999999999999999999999876644


Q ss_pred             CCcceee--cccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          198 VNTHVST--RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       198 ~~~~~~~--~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      .......  ....+..|+|||++.++.++.++|||||||++|||++ |+.||.....   ..+.        ..+..+. 
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~--------~~i~~~~-  227 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVM--------KAINDGF-  227 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHH--------HHHhcCC-
Confidence            3222211  1223457999999998899999999999999999998 9999865432   1111        1111111 


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                       ..  +     ........+.+++.+|++.+|++||++.+|++.|++.
T Consensus       228 -~~--~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 -RL--P-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -CC--C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             00  1     1112345788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-40  Score=323.64  Aligned_cols=264  Identities=27%  Similarity=0.405  Sum_probs=218.1

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccH-HHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      .....+.++||+|-||.|+++....+..||||.++....... ++|..|+.+|.+++||||+.|+|.|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            345677899999999999999997889999999998765554 7899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee-ccCCCc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI-ASDVNT  200 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~-~~~~~~  200 (416)
                      +++|+|.+++....-+.+.-.....|+.|||.|++||.+.   ++|||||.++|+|++.++++||+|||+++. +.....
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999999877555556667788999999999999998   999999999999999999999999999984 444444


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh--CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT--GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt--G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      +...+.+-+..|+|+|.+..++++.+||||+|||++||+++  ..+||...   .++..++-+..++    .++....  
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l---t~e~vven~~~~~----~~~~~~~--  764 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL---TDEQVVENAGEFF----RDQGRQV--  764 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh---hHHHHHHhhhhhc----CCCCcce--
Confidence            55566677889999999999999999999999999999976  66777543   2334444333222    1111111  


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                          ....+.-++..+.+++..||+.+-.+||++.+|...|..+
T Consensus       765 ----~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  765 ----VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ----eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                1122344667888999999999999999999999998754

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.2e-39  Score=326.73  Aligned_cols=251  Identities=22%  Similarity=0.304  Sum_probs=196.2

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .|...+.||+|+||+||+|.. .+++.||||++.....   .....+..|+.++.+++|+||+++++++.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            588899999999999999994 5688999999975432   223468899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC-
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN-  199 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~-  199 (416)
                      |+++++|.+++....  .+++.....++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++.+.... 
T Consensus        82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            999999999987544  588888899999999999999998   99999999999999999999999999975331100 


Q ss_pred             ---------------------------------------------cceeecccccccccChhhhccCCCCchhhhHhHHH
Q 014904          200 ---------------------------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV  234 (416)
Q Consensus       200 ---------------------------------------------~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGv  234 (416)
                                                                   ........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                         00112357999999999999889999999999999


Q ss_pred             HHHHHHhCCCCCCCCCcccc-hhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHH--hhccCCCCCCC
Q 014904          235 MLLELITGRRPVDSTHTFVE-DSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAA--CVRHSARRRPR  311 (416)
Q Consensus       235 vL~elltG~~pf~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--cl~~~p~~RPt  311 (416)
                      ++|||++|+.||........ ..+..|          ...+      ....  .......+.+++.+  |+..++..||+
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~----------~~~~------~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~  298 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVINW----------ENTL------HIPP--QVKLSPEAVDLITKLCCSAEERLGRNG  298 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHcc----------cccc------CCCC--CCCCCHHHHHHHHHHccCcccccCCCC
Confidence            99999999999976543111 011111          0110      0000  01122356667766  55666667999


Q ss_pred             HHHHHHH
Q 014904          312 MSQIVRA  318 (416)
Q Consensus       312 ~~evv~~  318 (416)
                      +.+|+..
T Consensus       299 ~~~~l~h  305 (381)
T cd05626         299 ADDIKAH  305 (381)
T ss_pred             HHHHhcC
Confidence            9999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.5e-39  Score=302.24  Aligned_cols=249  Identities=27%  Similarity=0.401  Sum_probs=205.6

Q ss_pred             CCCCcCceecccCcEEEEEEEeCC-CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      ++|...+.||+|+||.||+|...+ ++.+++|.+.....  ..++.+|++++++++|+||+++++++......++|+||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            689999999999999999999654 88999999875533  568999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++++|.+++.... ..+++..++.++.+++.||.|||+.   +++|+||+|.||+++.++.++|+|||++........ .
T Consensus        81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (256)
T cd06612          81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K  155 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence            9999999986544 3689999999999999999999999   999999999999999999999999999887654332 2


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      .....++..|+|||++.+..++.++||||||+++|+|++|+.||....+...  ...         ......     +. 
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~---------~~~~~~-----~~-  218 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFM---------IPNKPP-----PT-  218 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhh---------hccCCC-----CC-
Confidence            2335688999999999988999999999999999999999999976433110  000         000000     00 


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                       ...+......+.+++.+|++.+|.+||++.||++
T Consensus       219 -~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         219 -LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence             1112223457899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.3e-39  Score=309.46  Aligned_cols=268  Identities=26%  Similarity=0.367  Sum_probs=204.2

Q ss_pred             CCC-CcCceecccCcEEEEEEEe-----CCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeC--Ce
Q 014904           44 DGF-SDANLLGQGGFGYVHRGVL-----PNGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAG--SQ  114 (416)
Q Consensus        44 ~~f-~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  114 (416)
                      ++| ...+.||+|+||.||++..     .+++.||+|.++.... .....+.+|+.+++.++|+||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            445 8889999999999988652     3578999999876532 3346788999999999999999999998753  46


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      .++||||+++++|.+++...   .+++..++.++.+++.||.|||+.   +|+||||||+||+++.++.++|+|||+++.
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence            88999999999999998654   489999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCcce--eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcC
Q 014904          195 ASDVNTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDG  272 (416)
Q Consensus       195 ~~~~~~~~--~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~  272 (416)
                      ........  .....++..|+|||++....++.++||||||++++||++|+.|+....... ..+..+....    ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~----~~~~  231 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQ----MTVV  231 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccc----cchh
Confidence            65432211  122335667999999998899999999999999999999999986543211 1111111000    0000


Q ss_pred             CcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          273 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       273 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      .+..+++.......+...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            11111111111122333456899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-39  Score=302.68  Aligned_cols=247  Identities=28%  Similarity=0.428  Sum_probs=200.9

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCHH
Q 014904           50 NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLE  128 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL~  128 (416)
                      ++||+|+||.||++...+++.|++|++...... ....+..|+.++++++|+||+++++++......++|+||+.+++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999767999999998865443 4467899999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee-eccc
Q 014904          129 FHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS-TRVM  207 (416)
Q Consensus       129 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~~~  207 (416)
                      +++..... .+++..++.++.+++.+|.|||+.   +++||||||+||+++.++.+||+|||+++.......... ....
T Consensus        81 ~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          81 TFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            99875433 588999999999999999999999   999999999999999999999999999986543222111 1123


Q ss_pred             ccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcC
Q 014904          208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEY  286 (416)
Q Consensus       208 gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  286 (416)
                      ++..|+|||++.++.++.++|||||||+++||++ |..||......   ...        ..+..+.  .+       ..
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~--------~~~~~~~--~~-------~~  216 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTR--------ERIESGY--RM-------PA  216 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHH--------HHHhcCC--CC-------CC
Confidence            4667999999998899999999999999999999 88888654321   111        1111111  00       11


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          287 NHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       287 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      +...+..+.+++.+|++.+|.+||++.||++.|+
T Consensus       217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            1223457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=321.41  Aligned_cols=250  Identities=26%  Similarity=0.402  Sum_probs=210.4

Q ss_pred             hCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ...|+..++||+|.||.||+|. ...++.||+|++...... ...+++.|+.+|..++++||.+.++.+..+..++++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            3467788999999999999999 567999999999865443 34688999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+.+|++.+.+....  .+.+.....|+.+++.||.|||..   +.+|||||+.|||+..+|.+||+|||++-.......
T Consensus        92 y~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             HhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            999999999997554  457778888999999999999999   999999999999999999999999999987765444


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                      .. ..++||+-|||||++....|+.|+||||||++.+||.+|.+|+....+..-.                    -++-.
T Consensus       167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl--------------------flIpk  225 (467)
T KOG0201|consen  167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL--------------------FLIPK  225 (467)
T ss_pred             cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE--------------------EeccC
Confidence            43 6689999999999999889999999999999999999999999876651110                    11111


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .-...+......-+.+++..||+.+|+.||++.++++.
T Consensus       226 ~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  226 SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            11222223344578999999999999999999999853

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-39  Score=306.25  Aligned_cols=255  Identities=26%  Similarity=0.445  Sum_probs=206.0

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCC------CcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPN------GKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  115 (416)
                      .++|.+.+.||+|+||.||+|....      +..||+|.+..... .....+.+|+.++..++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4678899999999999999999642      46899999875432 3335788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEe
Q 014904          116 MLVYEFVPNNTLEFHLHGKG--------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA  187 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~  187 (416)
                      ++|+||+++++|..++....        ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence            99999999999999986432        22478999999999999999999998   99999999999999999999999


Q ss_pred             ecccceeccCCCc-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHh
Q 014904          188 DFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLL  265 (416)
Q Consensus       188 DFGla~~~~~~~~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~  265 (416)
                      |||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |+.||.....   ..+..      
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~------  232 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLK------  232 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHH------
Confidence            9999876543322 12233456789999999998899999999999999999998 9999865432   11111      


Q ss_pred             HHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          266 NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       266 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                        .+..+....         .+......+.+++.+||+.+|++||++.+|++.|+
T Consensus       233 --~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         233 --FVIDGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             --HHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence              111222111         11122467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.8e-39  Score=309.28  Aligned_cols=258  Identities=24%  Similarity=0.396  Sum_probs=207.4

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCC-----CcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEe-CCe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPN-----GKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTA-GSQ  114 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  114 (416)
                      ..++|.+.++||+|+||.||+|.+..     +..|++|+++.... .....+..|+.+++.++|+||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35789999999999999999999755     78899999875432 224568899999999999999999999876 567


Q ss_pred             EEEEEEecCCCCHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEee
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGR------PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD  188 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~D  188 (416)
                      .+++++|+++++|..++.....      ..+++..++.++.+++.||+|||+.   +++|+||||+||+++.++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            8999999999999999865321      4689999999999999999999998   999999999999999999999999


Q ss_pred             cccceeccCCCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhH
Q 014904          189 FGLAKIASDVNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLN  266 (416)
Q Consensus       189 FGla~~~~~~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~  266 (416)
                      ||+++.......+. .....++..|+|||++.+..++.++||||||+++||+++ |+.||....+   ..+..+      
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~------  231 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAY------  231 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHH------
Confidence            99998654333222 223446778999999998889999999999999999999 9999976433   112221      


Q ss_pred             HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          267 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       267 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                        +..+..  +   ..    ....+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       232 --~~~~~~--~---~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         232 --LKDGYR--L---AQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             --HHcCCC--C---CC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence              112110  0   01    112345789999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.9e-39  Score=318.66  Aligned_cols=202  Identities=26%  Similarity=0.373  Sum_probs=175.4

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|...+.||+|+||+||++.. .+++.||||++.....   .....+..|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4789999999999999999995 4689999999975322   22246788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            9999999999997654  589999999999999999999999   99999999999999999999999999987543211


Q ss_pred             c----------------------------------ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCC
Q 014904          200 T----------------------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP  245 (416)
Q Consensus       200 ~----------------------------------~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~p  245 (416)
                      .                                  .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            0                                  011235799999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 014904          246 VDSTH  250 (416)
Q Consensus       246 f~~~~  250 (416)
                      |....
T Consensus       236 f~~~~  240 (363)
T cd05628         236 FCSET  240 (363)
T ss_pred             CCCCC
Confidence            97644

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.7e-39  Score=315.58  Aligned_cols=242  Identities=26%  Similarity=0.367  Sum_probs=194.4

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ++||+|+||.||+|... +++.||||+++...   ......+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999964 57899999997542   22234567888888866 799999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      ++|...+....  .+++..+..++.+++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~  154 (321)
T cd05591          81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT  154 (321)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence            99998886543  588999999999999999999999   999999999999999999999999999875433222 223


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccC
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHN  284 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~  284 (416)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+.        ..+..+..   .      
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~~--------~~i~~~~~---~------  214 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLF--------ESILHDDV---L------  214 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHHH--------HHHHcCCC---C------
Confidence            45799999999999988999999999999999999999999976543   1111        11112211   1      


Q ss_pred             cCCHHHHHHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 014904          285 EYNHNEMARMVACAAACVRHSARRRP-------RMSQIVRA  318 (416)
Q Consensus       285 ~~~~~~~~~l~~l~~~cl~~~p~~RP-------t~~evv~~  318 (416)
                       ++......+.+++.+||+.+|++||       ++.++++.
T Consensus       215 -~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         215 -YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence             1111234688999999999999999       66777643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4e-39  Score=304.16  Aligned_cols=248  Identities=29%  Similarity=0.438  Sum_probs=202.5

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEE-eCCeEEEEEEec
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT-AGSQRMLVYEFV  122 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~  122 (416)
                      ++|.+.+.||+|+||.||++.. .|+.+|+|.++...  ....+.+|+.++++++|+|++++++++. .+...++|+||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            4788899999999999999987 47889999987543  2457889999999999999999999764 456789999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++++|.+++.......+++..++.++.+++.||+|||+.   +++||||||+||+++.++.+||+|||+++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            999999999876655689999999999999999999998   99999999999999999999999999987544322   


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                       ....++..|+|||++.+..++.++||||||+++|+|++ |+.||.....   ..+..+        +..+...      
T Consensus       157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~--------~~~~~~~------  218 (256)
T cd05082         157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR--------VEKGYKM------  218 (256)
T ss_pred             -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH--------HhcCCCC------
Confidence             22345678999999998899999999999999999998 9999864322   111111        1111111      


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                         ......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       219 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         219 ---DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence               1112234578899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.5e-39  Score=313.86  Aligned_cols=240  Identities=28%  Similarity=0.422  Sum_probs=190.7

Q ss_pred             ceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ++||+|+||.||+|.. .+++.||||+++...   ......+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999995 468899999997542   12223455666676654 899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      ++|..++....  .+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS  154 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence            99999887544  588899999999999999999998   99999999999999999999999999997653322 2233


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccC
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHN  284 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~  284 (416)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+       +.. +....      +.   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~-------~~~-i~~~~------~~---  214 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DEL-------FDS-ILNDR------PH---  214 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHH-------HHH-HHcCC------CC---
Confidence            46799999999999988999999999999999999999999976442   111       111 11111      11   


Q ss_pred             cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 014904          285 EYNHNEMARMVACAAACVRHSARRRPRMSQIV  316 (416)
Q Consensus       285 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv  316 (416)
                       ++......+.+++.+||+.+|.+||++.+.+
T Consensus       215 -~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l  245 (316)
T cd05592         215 -FPRWISKEAKDCLSKLFERDPTKRLGVDGDI  245 (316)
T ss_pred             -CCCCCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence             1122334678899999999999999986433

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.4e-39  Score=315.64  Aligned_cols=248  Identities=23%  Similarity=0.341  Sum_probs=195.8

Q ss_pred             ceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ++||+|+||.||++.. .+++.||||+++....   .....+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999995 4688999999985422   2234578899999888 799999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      ++|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS  154 (329)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence            99998886543  589999999999999999999999   99999999999999999999999999987432211 1223


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccc--chhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFV--EDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||+......  .....++...    .+..+..      .+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~----~~~~~~~------~~  224 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ----VILEKQI------RI  224 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH----HHHcCCC------CC
Confidence            4679999999999999999999999999999999999999997532211  1122222221    1112211      11


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCC------HHHHHH
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPR------MSQIVR  317 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt------~~evv~  317 (416)
                          +......+.+++.+||+.+|.+||+      +.++++
T Consensus       225 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         225 ----PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             ----CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence                1122346889999999999999997      556653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-39  Score=311.24  Aligned_cols=261  Identities=24%  Similarity=0.388  Sum_probs=201.7

Q ss_pred             CCCCcCceecccCcEEEEEEEeCC---------------CcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPN---------------GKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVG  107 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~---------------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~  107 (416)
                      ++|.+.+.||+|+||.||++....               ...||+|++..... .....|.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            689999999999999999988532               23589999875432 23356889999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCCHHHHhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEE
Q 014904          108 YYTAGSQRMLVYEFVPNNTLEFHLHGKG----------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANIL  177 (416)
Q Consensus       108 ~~~~~~~~~lV~e~~~~~sL~~~l~~~~----------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NIL  177 (416)
                      ++......++||||+++++|.+++....          ...+++..++.++.+++.||+|||+.   +++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence            9999999999999999999999886432          12478999999999999999999999   9999999999999


Q ss_pred             ECCCCceEEeecccceeccCCCc-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh--CCCCCCCCCcccc
Q 014904          178 LDFKFEAKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT--GRRPVDSTHTFVE  254 (416)
Q Consensus       178 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt--G~~pf~~~~~~~~  254 (416)
                      ++.++.+||+|||++........ .......++..|+|||++.++.++.++|||||||++++|++  +..||.....   
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~---  238 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD---  238 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence            99999999999999876543221 12233455778999999999999999999999999999998  5566654332   


Q ss_pred             hhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          255 DSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       255 ~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      ............   ..+.....       ..+...+..+.+++.+|++.+|++||+|.+|++.|.
T Consensus       239 ~~~~~~~~~~~~---~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 EQVIENTGEFFR---NQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHHHhhh---hccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            111111111100   00000000       011123358999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=326.63  Aligned_cols=251  Identities=23%  Similarity=0.325  Sum_probs=196.3

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.+.||+|+||.||++.. .+++.||||++....   ......+..|+.++.+++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4789999999999999999994 578999999986532   122346788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|..++....  .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+....
T Consensus        81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            9999999999986543  588889999999999999999999   99999999999999999999999999986322100


Q ss_pred             c------------c----------------------------------eeecccccccccChhhhccCCCCchhhhHhHH
Q 014904          200 T------------H----------------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFG  233 (416)
Q Consensus       200 ~------------~----------------------------------~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlG  233 (416)
                      .            .                                  ......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            0            0                                  00124699999999999988999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCcccc-hhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCC---
Q 014904          234 VMLLELITGRRPVDSTHTFVE-DSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRR---  309 (416)
Q Consensus       234 vvL~elltG~~pf~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R---  309 (416)
                      |++|||++|+.||........ ..+..|.          ..+ .+  |   ..  ......+.+++.+|++ +|.+|   
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~----------~~~-~~--p---~~--~~~s~~~~dli~~lL~-~~~~r~~r  296 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKIINWR----------ETL-YF--P---DD--IHLSVEAEDLIRRLIT-NAENRLGR  296 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHHccC----------Ccc-CC--C---CC--CCCCHHHHHHHHHHhc-CHhhcCCC
Confidence            999999999999976443110 0111110          000 00  1   00  0123467889999997 66665   


Q ss_pred             CCHHHHHHH
Q 014904          310 PRMSQIVRA  318 (416)
Q Consensus       310 Pt~~evv~~  318 (416)
                      +++.|+++.
T Consensus       297 ~~~~~~l~h  305 (377)
T cd05629         297 GGAHEIKSH  305 (377)
T ss_pred             CCHHHHhcC
Confidence            588888865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-38  Score=323.13  Aligned_cols=261  Identities=21%  Similarity=0.260  Sum_probs=195.4

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      .+|.+.+.||+|+||.||+|.+. .++.||||....      ..+.+|+.++++++|+|||++++++..+...++|+|++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            36999999999999999999965 578999996432      24578999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc-
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH-  201 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~-  201 (416)
                      . ++|..++..... .++|..++.|+.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++........ 
T Consensus       243 ~-~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        243 R-SDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             C-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            5 677777754332 699999999999999999999999   9999999999999999999999999999876433222 


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccc-----chhhhhhhhHHhHHhhhcCCccc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFV-----EDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~-----~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      ......||..|+|||++.+..++.++|||||||+||||++|..++.......     ...+........   .....+..
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~---~~~~~~~~  394 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQ---VHVDEFPQ  394 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhc---cccccCCC
Confidence            2234679999999999999999999999999999999999887653322110     111111111000   00000000


Q ss_pred             cc----------------Ccccc-CcCC--HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          277 LV----------------DPKLH-NEYN--HNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       277 ~~----------------d~~l~-~~~~--~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ..                .+... ..+.  ......+.+|+.+||+.||.+||++.||++.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00                00000 0000  0112357789999999999999999999864

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-40  Score=298.05  Aligned_cols=250  Identities=26%  Similarity=0.369  Sum_probs=211.1

Q ss_pred             hhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      +.++|.+.+.||+|.||.||.|. .+++..||+|++.+..   .+..+++.+|++|-+.|+||||++++++|.+....||
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            34689999999999999999999 5578899999987542   3345789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ++||.++|.+...|.......++......++.|+|.||.|+|..   ++|||||||+|+|++.++..||+|||.+-..+ 
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            99999999999999877666789999999999999999999999   99999999999999999999999999986544 


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                        .......+||+.|++||...+...+.++|+|++||+.||+|.|.+||.....   .....-        +..      
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---~etYkr--------I~k------  236 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---SETYKR--------IRK------  236 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---HHHHHH--------HHH------
Confidence              2223457899999999999999999999999999999999999999986542   111111        100      


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                          ..-.++........+++..|+..+|.+|.+..||+..
T Consensus       237 ----~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  237 ----VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ----ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                1112223445578899999999999999999999864

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.7e-39  Score=314.62  Aligned_cols=241  Identities=26%  Similarity=0.369  Sum_probs=194.0

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCC-CcccceEEEEEeCCeEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHH-KHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~  119 (416)
                      +|.+.+.||+|+||.||+|... +++.||||++....   ......+..|..++..+.| ++|+++++++......++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999954 57899999997532   2233567789999999976 56888999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|..++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            9999999999886544  588999999999999999999999   99999999999999999999999999987532222


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                      . ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+.        ..+.....     
T Consensus       156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~--------~~i~~~~~-----  218 (324)
T cd05587         156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELF--------QSIMEHNV-----  218 (324)
T ss_pred             C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHH--------HHHHcCCC-----
Confidence            1 22345799999999999999999999999999999999999999976442   1111        11111111     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRM  312 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  312 (416)
                       .    ++......+.+++.+||+.+|.+|++.
T Consensus       219 -~----~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 -S----YPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -C----CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence             1    111223468899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.5e-39  Score=330.99  Aligned_cols=272  Identities=20%  Similarity=0.290  Sum_probs=197.4

Q ss_pred             HHHHHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCC------CcccceEEE
Q 014904           36 YEELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHH------KHLVSLVGY  108 (416)
Q Consensus        36 ~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~  108 (416)
                      .+++...+++|.+.++||+|+||+||+|.+ ..++.||||+++... ...+.+..|+.++..++|      .++++++++
T Consensus       121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            456666789999999999999999999995 468899999997432 223456667777777754      458888888


Q ss_pred             EEeC-CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC-----
Q 014904          109 YTAG-SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-----  182 (416)
Q Consensus       109 ~~~~-~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~-----  182 (416)
                      +... .+.++||+++ +++|.+++...+  .+++..+..|+.|++.||.|||..+  +||||||||+|||++.++     
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccc
Confidence            8764 5788999987 778888776543  5899999999999999999999733  899999999999998765     


Q ss_pred             -----------ceEEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCc
Q 014904          183 -----------EAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHT  251 (416)
Q Consensus       183 -----------~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~  251 (416)
                                 .+||+|||++.....    ......||+.|+|||++.+..++.++|||||||+||||++|+.||+....
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                       499999998754322    22346799999999999999999999999999999999999999987553


Q ss_pred             ccchhhhh---------hhhHH----hHHhh-hcCCcccccCcccc----C-c--CCHHHHHHHHHHHHHhhccCCCCCC
Q 014904          252 FVEDSLVD---------WARPL----LNRAI-EDGNFDTLVDPKLH----N-E--YNHNEMARMVACAAACVRHSARRRP  310 (416)
Q Consensus       252 ~~~~~l~~---------~~~~~----~~~~~-~~~~~~~~~d~~l~----~-~--~~~~~~~~l~~l~~~cl~~~p~~RP  310 (416)
                      .....++.         |....    ..... ..+.+....++...    . .  ........+.+|+.+||+.||.+||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            22111111         11000    00000 01111111111100    0 0  0001124578999999999999999


Q ss_pred             CHHHHHH
Q 014904          311 RMSQIVR  317 (416)
Q Consensus       311 t~~evv~  317 (416)
                      ++.|+++
T Consensus       431 ta~e~L~  437 (467)
T PTZ00284        431 NARQMTT  437 (467)
T ss_pred             CHHHHhc
Confidence            9999986

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.5e-39  Score=315.68  Aligned_cols=243  Identities=23%  Similarity=0.338  Sum_probs=192.0

Q ss_pred             ceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ++||+|+||.||+|.. .+++.||+|+++....   .....+..|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4799999999999995 4688999999986422   2234577888888776 799999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      ++|..++....  .+++..+..++.+++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~  154 (329)
T cd05618          81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS  154 (329)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccc
Confidence            99998886543  589999999999999999999999   999999999999999999999999999875432221 123


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcc--cchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTF--VEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~--~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......  .......+...    .+..+..        
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~----~i~~~~~--------  222 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ----VILEKQI--------  222 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH----HHhcCCC--------
Confidence            467999999999999999999999999999999999999999642211  11111222211    1111111        


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRM  312 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  312 (416)
                        ..+......+.+++.+||+.+|.+||+.
T Consensus       223 --~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         223 --RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             --CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence              1122234567899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=326.41  Aligned_cols=244  Identities=28%  Similarity=0.396  Sum_probs=204.4

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCccc---HHHHHHHHHHHHhcC-CCcccceEEEEEeCCeE
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQG---EREFQAEVEIISRVH-HKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  115 (416)
                      -..++|.+..+||+|.||+|+++..+ +++.+|||++++.....   .+..+.|..|+.... ||.+++++.+|....++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34578999999999999999999954 68899999999875433   345778999988885 99999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++||||+.||++..+.+.   ..++...+..++..++.||.|||++   +||+||||.+|||||.+|.+||+|||+++-.
T Consensus       445 ~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999995444432   2699999999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ..... .+.+++||+.|+|||++.+..|+..+|.|+|||+|||||.|..||...++   +.+.        ..+...   
T Consensus       519 m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE---ee~F--------dsI~~d---  583 (694)
T KOG0694|consen  519 MGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE---EEVF--------DSIVND---  583 (694)
T ss_pred             CCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHH--------HHHhcC---
Confidence            43222 44668999999999999999999999999999999999999999987654   1111        111111   


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRM  312 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  312 (416)
                             ...|+.....+.+.++.++|..+|++|.-+
T Consensus       584 -------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 -------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -------CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                   123555566788999999999999999977

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.7e-40  Score=312.28  Aligned_cols=250  Identities=24%  Similarity=0.407  Sum_probs=218.3

Q ss_pred             hhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcccH---HHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE---REFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ...+|.+.+.||+|.||.|-+|. +..|+.||||.+++....++   ..+.+|++|++.|+||||+.++.+|++.+...|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            45689999999999999999999 57899999999987655544   457789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||..+|.|.+++...+  .|+......++.||..|+.|||.+   +++|||||.+|||||.|+++||+||||+.++.+
T Consensus       131 vMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            999999999999997665  599999999999999999999999   999999999999999999999999999998876


Q ss_pred             CCcceeecccccccccChhhhccCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~-t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      ..  ..+.++|++-|.+||++.+.+| .+.+|-|||||+||-|+.|..||+..+-           ..+.+++..|.+.+
T Consensus       206 ~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----------k~lvrQIs~GaYrE  272 (668)
T KOG0611|consen  206 KK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----------KRLVRQISRGAYRE  272 (668)
T ss_pred             cc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----------HHHHHHhhcccccC
Confidence            43  3466899999999999998887 4799999999999999999999998653           23445566777655


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      --.|           ....-|++|||..+|++|.|+.+|...+-
T Consensus       273 P~~P-----------SdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  273 PETP-----------SDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             CCCC-----------chHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence            3222           24567999999999999999999998863

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-38  Score=300.40  Aligned_cols=250  Identities=21%  Similarity=0.340  Sum_probs=205.2

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      +|.+.+.||+|+||.||++... +++.+|+|.++... ......+..|+.+++.++|+||+++++++..+...++|+||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999954 68999999986533 233457888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++++|..++.......++....+.++.+++.||.|||+.   +|+|+||||+||+++.++.++|+|||++........ .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence            999999988755445688999999999999999999999   999999999999999999999999999976644322 2


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      .....|+..|+|||++.+..++.++||||||+++++|++|+.||......      ..     ...+..+....+     
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~-----~~~~~~~~~~~~-----  220 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NL-----ILKVCQGSYKPL-----  220 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HH-----HHHHhcCCCCCC-----
Confidence            23456889999999999889999999999999999999999999764321      00     011122322211     


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                          +......+.+++.+||+.+|++||++.+|+..
T Consensus       221 ----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 ----PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ----CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                11233468899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.2e-39  Score=312.22  Aligned_cols=254  Identities=28%  Similarity=0.430  Sum_probs=200.4

Q ss_pred             CCCCcCceecccCcEEEEEEEeCC-Cc--EEEEEEeecCC-cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPN-GK--EVAIKQLKAGS-GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ++|++.++||+|+||.||+|...+ +.  .+++|.++... ....+.+..|+.++.++ +||||+++++++......++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578999999999999999999643 33  47888887432 23345788999999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCce
Q 014904          119 YEFVPNNTLEFHLHGKG--------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA  184 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~  184 (416)
                      +||+++++|.++++...              ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            99999999999986532              12588999999999999999999998   99999999999999999999


Q ss_pred             EEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhH
Q 014904          185 KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARP  263 (416)
Q Consensus       185 kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~  263 (416)
                      ||+|||++........  ......+..|+|||++.+..++.++|||||||++|||++ |+.||.....   ..+.     
T Consensus       159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~~-----  228 (297)
T cd05089         159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AELY-----  228 (297)
T ss_pred             EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH-----
Confidence            9999999864322111  111223567999999998899999999999999999998 9999865432   1111     


Q ss_pred             HhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          264 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       264 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                         ..+..+.     .+    ..+......+.+++.+|++.+|.+||++.+|++.|+..
T Consensus       229 ---~~~~~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  275 (297)
T cd05089         229 ---EKLPQGY-----RM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM  275 (297)
T ss_pred             ---HHHhcCC-----CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               1111111     01    11112335688999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.3e-39  Score=314.55  Aligned_cols=237  Identities=28%  Similarity=0.381  Sum_probs=191.6

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ++||+|+||.||+|... +++.||||+++...   ......+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 68899999987532   22234567788888876 699999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      ++|..++....  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS  154 (320)
T ss_pred             chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence            99998887554  588999999999999999999999   99999999999999999999999999987543222 2223


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccC
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHN  284 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~  284 (416)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+.        ..+..+...         
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~--------~~i~~~~~~---------  214 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---DDLF--------EAILNDEVV---------  214 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHH--------HHHhcCCCC---------
Confidence            46799999999999988999999999999999999999999976442   1111        111122110         


Q ss_pred             cCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 014904          285 EYNHNEMARMVACAAACVRHSARRRPRMS  313 (416)
Q Consensus       285 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~  313 (416)
                       .+......+.+++.+||+.+|.+||++.
T Consensus       215 -~~~~~~~~~~~li~~~L~~dP~~R~~~~  242 (320)
T cd05590         215 -YPTWLSQDAVDILKAFMTKNPTMRLGSL  242 (320)
T ss_pred             -CCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence             1112234688999999999999999983

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.9e-39  Score=307.03  Aligned_cols=245  Identities=26%  Similarity=0.375  Sum_probs=194.9

Q ss_pred             ecccCcEEEEEEEe-CCCcEEEEEEeecCCcc---cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCH
Q 014904           52 LGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ---GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL  127 (416)
Q Consensus        52 LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL  127 (416)
                      ||+|+||.||++.. .+++.||||++......   ....+..|+.+++.++|+||+++.+++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999995 47899999998754322   224567899999999999999999999999999999999999999


Q ss_pred             HHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeec
Q 014904          128 EFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR  205 (416)
Q Consensus       128 ~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  205 (416)
                      ..++...  ....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++......... ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence            8887532  234689999999999999999999999   9999999999999999999999999999766443222 233


Q ss_pred             ccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCc
Q 014904          206 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNE  285 (416)
Q Consensus       206 ~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~  285 (416)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ...    . ..+..+.          ..
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~----~-~~~~~~~----------~~  219 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KEL----K-QRILNDS----------VT  219 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHH----H-HhhcccC----------CC
Confidence            57899999999999999999999999999999999999999764321110  000    0 0000110          11


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014904          286 YNHNEMARMVACAAACVRHSARRRP-----RMSQIVR  317 (416)
Q Consensus       286 ~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~  317 (416)
                      ++......+.+++.+||+.+|++||     ++.++++
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            2223445788999999999999999     5666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.8e-39  Score=307.48  Aligned_cols=251  Identities=26%  Similarity=0.390  Sum_probs=200.8

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc---cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ---GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .|+..++||+|+||+||+|.. .+++.+|+|++......   ....+.+|+.++++++|+|++.+.+++..+...++|+|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            367788999999999999995 57899999999754322   22457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|..++.......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            99999999888765555799999999999999999999999   999999999999999999999999999876543222


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                        .....|+..|+|||++.+..++.++|||||||++|+|++|+.||........  ...+.     .....+.      .
T Consensus       158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~-----~~~~~~~------~  222 (285)
T cd05632         158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVD-----RRVLETE------E  222 (285)
T ss_pred             --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-----Hhhhccc------c
Confidence              1335789999999999988999999999999999999999999976432111  11110     1111111      0


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPR-----MSQIVR  317 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evv~  317 (416)
                          .+.......+.+++..|++.+|++||+     +.+++.
T Consensus       223 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         223 ----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                111222346789999999999999999     555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.2e-38  Score=308.40  Aligned_cols=250  Identities=23%  Similarity=0.374  Sum_probs=205.8

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ..+|.+.+.||+|+||.||+|.. .+++.||+|.+..........+..|+.+++.++|+||+++++++..+...++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36899999999999999999995 57999999999876555556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|..++...   .+++..+..++.+++.||.|||+.   +++||||||+|||++.++.++|+|||++.........
T Consensus        98 ~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             cCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            9999999998643   588999999999999999999998   9999999999999999999999999998765433222


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                       .....+++.|+|||++.+..++.++|||||||++|+|++|+.||....+...  +...        ...+ ...     
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~~~--------~~~~-~~~-----  234 (297)
T cd06656         172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLI--------ATNG-TPE-----  234 (297)
T ss_pred             -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--eeee--------ccCC-CCC-----
Confidence             2335688999999999988999999999999999999999999976443111  0000        0001 000     


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                        ...+......+.+++.+||+.+|++||++.+|++
T Consensus       235 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         235 --LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0111223356788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1e-38  Score=307.60  Aligned_cols=262  Identities=26%  Similarity=0.392  Sum_probs=205.4

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCC-----------------CcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccc
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPN-----------------GKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVS  104 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~  104 (416)
                      ..+|.+.+.||+|+||.||+|....                 +..||+|++..... .....+.+|+.++.+++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4689999999999999999998542                 24689999876532 23457889999999999999999


Q ss_pred             eEEEEEeCCeEEEEEEecCCCCHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCc
Q 014904          105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG---------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAAN  175 (416)
Q Consensus       105 l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~---------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~N  175 (416)
                      +++++..+...++|+||+++++|..++....         ...+++..++.++.+++.||+|||+.   +|+|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            9999999999999999999999999986543         12589999999999999999999998   99999999999


Q ss_pred             EEECCCCceEEeecccceeccCCCc-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh--CCCCCCCCCcc
Q 014904          176 ILLDFKFEAKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT--GRRPVDSTHTF  252 (416)
Q Consensus       176 ILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt--G~~pf~~~~~~  252 (416)
                      |+++.++.++|+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++  +..||..... 
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence            9999999999999999876543222 22334567789999999998899999999999999999998  6677754321 


Q ss_pred             cchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          253 VEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       253 ~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                        .....++...    .........      ...+...+..+.+++.+|++.+|.+||++.||++.|+
T Consensus       240 --~~~~~~~~~~----~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 --QQVIENAGHF----FRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             --HHHHHHHHhc----ccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence              1111111110    001110000      1111223357999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.6e-39  Score=303.46  Aligned_cols=248  Identities=28%  Similarity=0.413  Sum_probs=201.0

Q ss_pred             ceecccCcEEEEEEEeCC--C--cEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVLPN--G--KEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~--g--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ++||+|++|.||+|.+.+  +  ..||||.+..... ...+.+..|+.++++++|+||+++++++.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999643  3  3689999987665 445688999999999999999999999988 889999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce--
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV--  202 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~--  202 (416)
                      ++|..++.......+++...+.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++.........  
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            9999999765434689999999999999999999999   99999999999999999999999999998765433221  


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                      .....++.+|+|||++.+..++.++|||||||++|||++ |+.||......   .+...       ....+.  ...   
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~-------~~~~~~--~~~---  221 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKK-------IDKEGE--RLE---  221 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH-------HHhcCC--cCC---
Confidence            123457889999999998899999999999999999999 99998654321   11110       000111  110   


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                          .+...+..+.+++.+|++.+|.+||++.+|++.|.
T Consensus       222 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 ----RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                11123457899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2e-39  Score=324.10  Aligned_cols=261  Identities=22%  Similarity=0.271  Sum_probs=205.2

Q ss_pred             HHHHHHhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEe
Q 014904           36 YEELARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTA  111 (416)
Q Consensus        36 ~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  111 (416)
                      ..++....++|.+.+.||+|+||.||++... +++.+|+|++....   ......+.+|+.++..++||||+++++.+.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4566677799999999999999999999964 68899999986422   1223457789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       112 ~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                      +...++||||+++++|..++...   .++...+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            99999999999999999998653   478888899999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccC----CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHH
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNR  267 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~----~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~  267 (416)
                      ++..............||+.|+|||++...    .++.++|||||||++|||++|+.||......      ..    +..
T Consensus       189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~----~~~  258 (371)
T cd05622         189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GT----YSK  258 (371)
T ss_pred             eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HH----HHH
Confidence            987654433333456799999999998653    3789999999999999999999999764431      11    111


Q ss_pred             hhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHh
Q 014904          268 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARR--RPRMSQIVRAL  319 (416)
Q Consensus       268 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evv~~L  319 (416)
                      .........+.+       .......+.+++.+|+..++.+  ||++.+|++..
T Consensus       259 i~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         259 IMNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HHcCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            111111111111       1123456788999999854443  77888888754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.6e-39  Score=305.83  Aligned_cols=254  Identities=30%  Similarity=0.472  Sum_probs=204.9

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-C---CcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-N---GKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~---g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .+|.+.+.||+|+||.||+|.+. +   +..+|+|.++..... ....+..|+.++.+++||||+++++++..+...++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57888999999999999999853 2   347999998754322 235788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+++++|.+++..... .+++.+++.++.+++.||+|||+.   +++||||||+|||++.++.++|+|||++......
T Consensus        84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          84 TEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            999999999999976543 589999999999999999999999   9999999999999999999999999999876544


Q ss_pred             Ccceeec--ccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          199 NTHVSTR--VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       199 ~~~~~~~--~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      .....+.  ..++..|+|||++.++.++.++||||||++++|+++ |+.||......   ....        .+.++.  
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~--------~~~~~~--  226 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIK--------AIEEGY--  226 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHH--------HHhCCC--
Confidence            3322221  223567999999998899999999999999999887 99998654321   1111        111211  


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                      ..       ......+..+.+++.+|++.+|.+||+|.+|++.|+.
T Consensus       227 ~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         227 RL-------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             cC-------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence            00       0112234578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.8e-39  Score=313.96  Aligned_cols=241  Identities=26%  Similarity=0.357  Sum_probs=194.7

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---ccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG---QGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      +|.+.+.||+|+||.||+|... +++.||||+++....   .....+..|..++..+ +|++|+++++++......++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999954 578999999985422   2223466778888777 5899999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|...+....  .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            9999999998886554  588999999999999999999999   99999999999999999999999999987543222


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                      . ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+..        .+..+..     
T Consensus       156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~--------~i~~~~~-----  218 (323)
T cd05616         156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQ--------SIMEHNV-----  218 (323)
T ss_pred             C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHH--------HHHhCCC-----
Confidence            1 22346799999999999999999999999999999999999999976442   11111        1111111     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRM  312 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  312 (416)
                           .++......+.+++.+|++.+|.+|++.
T Consensus       219 -----~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 -----AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -----CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                 1122234578899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3e-39  Score=325.61  Aligned_cols=258  Identities=25%  Similarity=0.395  Sum_probs=204.8

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCccc-HHHHHHHHHHHHhcC-CCcccceEEEEEeCCe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSGQG-EREFQAEVEIISRVH-HKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  114 (416)
                      .++|.+.++||+|+||.||+|.+.      .++.||||+++...... ...+..|+.++.++. ||||++++++|.....
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            346778899999999999999853      34689999998643332 346889999999997 9999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCCC----------------------------------------------------------
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGR----------------------------------------------------------  136 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~----------------------------------------------------------  136 (416)
                      .++|+||+++++|.++++....                                                          
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            9999999999999999864321                                                          


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE
Q 014904          137 --------------------------------------PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL  178 (416)
Q Consensus       137 --------------------------------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl  178 (416)
                                                            ..+++...+.++.+++.||.|||+.   +++||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence                                                  2467888899999999999999998   99999999999999


Q ss_pred             CCCCceEEeecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchh
Q 014904          179 DFKFEAKVADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDS  256 (416)
Q Consensus       179 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~  256 (416)
                      +.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||......  +.
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~--~~  350 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN--EQ  350 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch--HH
Confidence            99999999999999865432221 1123456788999999998899999999999999999998 88998654321  11


Q ss_pred             hhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          257 LVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       257 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      +        ...+..+.  ..       ..+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus       351 ~--------~~~~~~~~--~~-------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         351 F--------YNAIKRGY--RM-------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             H--------HHHHHcCC--CC-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1        11111111  00       11112345789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7e-39  Score=320.01  Aligned_cols=267  Identities=20%  Similarity=0.246  Sum_probs=200.0

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCC-----eEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGS-----QRM  116 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  116 (416)
                      +|++.++||+|+||.||++.. .+++.||||++....  ....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999995 478999999986532  223457889999999999999999999998766     789


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +|+||+. ++|...+....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999996 56777665433  589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhh----------hh--hH
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD----------WA--RP  263 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~----------~~--~~  263 (416)
                      ...........+++.|+|||++.+. .++.++|||||||+++||++|+.||....+......+.          +.  ..
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            4333333445688999999998764 47999999999999999999999998655321111100          00  00


Q ss_pred             HhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          264 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       264 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .....+...... .................+.+++.+||+.||++||++.|+++.
T Consensus       235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         235 GARAHILRGPHK-PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHhCCCC-CCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            000000000000 000000001111224578899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.3e-39  Score=306.93  Aligned_cols=254  Identities=29%  Similarity=0.478  Sum_probs=202.8

Q ss_pred             CCCCcCceecccCcEEEEEEEeCC-C---cEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPN-G---KEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~-g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      +.|++.+.||+|+||.||+|.+.. +   ..||||.++... .....+|..|+.+++.++||||+++++++..+...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457788999999999999999643 3   369999987543 23345799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      +||+++++|.+++..... .+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++.....
T Consensus        84 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          84 TEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            999999999999876533 689999999999999999999998   9999999999999999999999999998765433


Q ss_pred             Cccee-ec-cc--ccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          199 NTHVS-TR-VM--GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       199 ~~~~~-~~-~~--gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      ..... .. ..  .+..|+|||++.++.++.++|||||||++||+++ |..||.....   .....+.        ... 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i--------~~~-  227 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAI--------EQD-  227 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHH--------HcC-
Confidence            22111 11 11  2457999999999999999999999999999987 9999875432   1222221        111 


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                      . .+       ..+...+..+.+++..||+.+|.+||++.+|+..|+.
T Consensus       228 ~-~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         228 Y-RL-------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             C-cC-------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            0 00       0111234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-39  Score=304.33  Aligned_cols=253  Identities=26%  Similarity=0.392  Sum_probs=200.9

Q ss_pred             CCcCceecccCcEEEEEEEeCC----CcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCe-----
Q 014904           46 FSDANLLGQGGFGYVHRGVLPN----GKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ-----  114 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  114 (416)
                      |.+.++||+|+||.||+|.+..    +..||||+++....  .....+..|+.+++.++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999999542    36899999875432  223578899999999999999999999876554     


Q ss_pred             -EEEEEEecCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeec
Q 014904          115 -RMLVYEFVPNNTLEFHLHGK----GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF  189 (416)
Q Consensus       115 -~~lV~e~~~~~sL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DF  189 (416)
                       .++|+||+++++|..++...    ....+++...+.++.|++.||.|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             79999999999999888542    223689999999999999999999998   9999999999999999999999999


Q ss_pred             ccceeccCCCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHH
Q 014904          190 GLAKIASDVNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNR  267 (416)
Q Consensus       190 Gla~~~~~~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~  267 (416)
                      |+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.....   ..+.+        
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~--------  226 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYD--------  226 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHH--------
Confidence            9998654433221 122335678999999988899999999999999999999 8888865332   11111        


Q ss_pred             hhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          268 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       268 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                      .+..+....         .+...+..+.+++.+|++.+|.+||++.||++.|+.
T Consensus       227 ~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         227 YLRHGNRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             HHHcCCCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            112222111         122344578999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-38  Score=314.43  Aligned_cols=192  Identities=24%  Similarity=0.352  Sum_probs=164.2

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ...+|.+.+.||+|+||.||+|... +++.||+|+....      ....|+.++++++|+||+++++++......++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999964 5788999975432      23568999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      ++. ++|..++.... ..+++..++.|+.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       138 ~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  212 (357)
T PHA03209        138 HYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA  212 (357)
T ss_pred             ccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence            995 57777765433 3689999999999999999999999   999999999999999999999999999875432211


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCC
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPV  246 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf  246 (416)
                        .....||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus       213 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        213 --FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             --cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence              23356899999999999999999999999999999999966554

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.8e-39  Score=306.64  Aligned_cols=256  Identities=26%  Similarity=0.408  Sum_probs=203.7

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCc----EEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGK----EVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      .++|...++||+|+||.||+|.+ .+++    .||+|+++.... ....++..|+.++..++|+||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            35788899999999999999984 4554    489999875433 3345788999999999999999999999764 567


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      ++++|+++++|.+++.... ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            9999999999999987543 2589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCccee-ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          197 DVNTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       197 ~~~~~~~-~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ....... ....+++.|+|||...+..++.++|||||||++|||++ |..||.....   ..+..+        +..+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~--------~~~~~~  229 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDL--------LEKGER  229 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH--------HHCCCc
Confidence            4332211 12234678999999998899999999999999999998 8999865432   222222        112211


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      ..         .+......+.+++.+||+.+|++||++.++++.|+...
T Consensus       230 ~~---------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         230 LP---------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             CC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            11         11123457889999999999999999999999997543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.8e-39  Score=313.12  Aligned_cols=256  Identities=27%  Similarity=0.411  Sum_probs=203.8

Q ss_pred             CCCCcCceecccCcEEEEEEEeC--------CCcEEEEEEeecCC-cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCC
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP--------NGKEVAIKQLKAGS-GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGS  113 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  113 (416)
                      ++|.+.+.||+|+||.||++...        +...+|+|.++... .....++..|+.++..+ +|+||+++++++....
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            67999999999999999999842        23579999998643 22335688899999999 7999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGR--------------PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD  179 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~  179 (416)
                      ..++|+||+++++|.+++.....              ..+++..++.++.|++.||+|||+.   +++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence            99999999999999999975321              2589999999999999999999998   999999999999999


Q ss_pred             CCCceEEeecccceeccCCCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhh
Q 014904          180 FKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSL  257 (416)
Q Consensus       180 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l  257 (416)
                      .++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.....   ..+
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---~~~  251 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EEL  251 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHH
Confidence            99999999999987654322111 112234568999999998899999999999999999998 8888865432   111


Q ss_pred             hhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      .        ..+..+..         ...+......+.+++.+|++.+|.+||+|.+|++.|+..
T Consensus       252 ~--------~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         252 F--------KLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             H--------HHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            1        11112211         111223345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-38  Score=355.17  Aligned_cols=261  Identities=28%  Similarity=0.543  Sum_probs=215.7

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ...|...++||+|+||.||+|.. .++..||||++.......    ..|+.++++++|||||+++++|.+....++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            34677888999999999999996 578999999987543222    3468889999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.++++     .++|..+.+|+.++|+||+|||..|.++|+||||||+||+++.++.+++. |+.+......   
T Consensus       765 ~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---  835 (968)
T PLN00113        765 IEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---  835 (968)
T ss_pred             CCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence            99999999995     38999999999999999999998777899999999999999999888875 6665433221   


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                        ....+|+.|+|||++.+..++.|+|||||||++|||+||+.||+.... ....+++|++...    .......++|+.
T Consensus       836 --~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~~~  908 (968)
T PLN00113        836 --TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCY----SDCHLDMWIDPS  908 (968)
T ss_pred             --CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhc----CccchhheeCcc
Confidence              223678999999999999999999999999999999999999965432 3456777775432    233445566666


Q ss_pred             ccC--cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          282 LHN--EYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       282 l~~--~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      +..  ..+..++.++.+++.+||+.+|++||+|.||++.|+...
T Consensus       909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  952 (968)
T PLN00113        909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS  952 (968)
T ss_pred             ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence            643  345567788999999999999999999999999998653

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4e-39  Score=310.00  Aligned_cols=259  Identities=26%  Similarity=0.454  Sum_probs=205.3

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCC
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGS  113 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  113 (416)
                      ..+++|.+.+.||+|+||.||+|...      .+..||+|.+..... .....+.+|+.++++++|+||+++++++....
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35678999999999999999999743      245899998864432 22346788999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceE
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKG--------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAK  185 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~k  185 (416)
                      ..++||||+++++|.+++....        ...+.+..+..++.+++.||.|||+.   +|+||||||+||+++.++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999996422        23467788899999999999999999   999999999999999999999


Q ss_pred             EeecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhH
Q 014904          186 VADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARP  263 (416)
Q Consensus       186 l~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~  263 (416)
                      |+|||+++........ ......++..|+|||++.++.++.++|||||||+++||++ |..||.....   ....+    
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~~----  232 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVLK----  232 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----
Confidence            9999998754332221 1122345778999999999999999999999999999999 7888865432   11111    


Q ss_pred             HhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          264 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       264 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                          .+..+....         .+......+.+++.+|++.+|++||++.++++.|+..
T Consensus       233 ----~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         233 ----FVMDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             ----HHHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                111221111         1112245799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-39  Score=300.83  Aligned_cols=248  Identities=30%  Similarity=0.467  Sum_probs=204.2

Q ss_pred             ceecccCcEEEEEEEeCC----CcEEEEEEeecCCccc-HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVLPN----GKEVAIKQLKAGSGQG-EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ++||+|+||.||+|....    +..|++|.+....... ...+..|+.++..++|+|++++++++......++|+||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999643    8899999998654433 56889999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          125 NTLEFHLHGKG-------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       125 ~sL~~~l~~~~-------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ++|.+++....       ...+++..++.++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999997652       24699999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCc-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          198 VNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       198 ~~~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ... .......++..|+|||.+....++.++||||||+++++|++ |+.||.....   ..+.        ..+..+.. 
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~--------~~~~~~~~-  225 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVL--------EYLRKGYR-  225 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHH--------HHHHcCCC-
Confidence            332 12233457889999999998899999999999999999999 6999876532   1111        11112111 


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                              ...+......+.+++.+|++.+|.+||++.|+++.|+
T Consensus       226 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 --------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                    1112223567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.5e-39  Score=312.01  Aligned_cols=258  Identities=26%  Similarity=0.398  Sum_probs=205.8

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC--------CCcEEEEEEeecCC-cccHHHHHHHHHHHHhc-CCCcccceEEEEEeC
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP--------NGKEVAIKQLKAGS-GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAG  112 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  112 (416)
                      .++|.+.+.||+|+||.||+|...        ++..||+|.+.... ......+..|+.+++.+ +|+||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467888899999999999999731        24579999987543 23346788999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE
Q 014904          113 SQRMLVYEFVPNNTLEFHLHGKG--------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL  178 (416)
Q Consensus       113 ~~~~lV~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl  178 (416)
                      ...++||||+++++|..++....              ...+++..++.++.|++.||.|||+.   +++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence            99999999999999999987532              13578899999999999999999999   99999999999999


Q ss_pred             CCCCceEEeecccceeccCCCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchh
Q 014904          179 DFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDS  256 (416)
Q Consensus       179 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~  256 (416)
                      +.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.....     
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----  245 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----  245 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence            999999999999998765433222 122345678999999998899999999999999999998 7888865432     


Q ss_pred             hhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          257 LVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       257 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                       .++..     .+..+...         ..+...+..+..++.+||+.+|.+||+|.||++.|+...
T Consensus       246 -~~~~~-----~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         246 -EELFK-----LLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             -HHHHH-----HHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence             11111     11111110         111234467889999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-38  Score=311.93  Aligned_cols=241  Identities=27%  Similarity=0.392  Sum_probs=194.8

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ++||+|+||.||+|... +++.||||+++...   ......+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 58899999998542   22234567888888887 799999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      ++|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (318)
T cd05570          81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS  154 (318)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence            99998887554  589999999999999999999999   999999999999999999999999999875322221 223


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccC
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHN  284 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~  284 (416)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ..+.        ..+..+..      .   
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~--------~~i~~~~~------~---  214 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELF--------QSILEDEV------R---  214 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHH--------HHHHcCCC------C---
Confidence            35689999999999999999999999999999999999999975432   1111        11111111      1   


Q ss_pred             cCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 014904          285 EYNHNEMARMVACAAACVRHSARRRPRM-----SQIVR  317 (416)
Q Consensus       285 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~-----~evv~  317 (416)
                       ++......+.+++.+||+.+|.+||++     .++++
T Consensus       215 -~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         215 -YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             -CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence             111233578899999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-39  Score=334.06  Aligned_cols=270  Identities=24%  Similarity=0.316  Sum_probs=215.1

Q ss_pred             CCCCCCCCccccCHHHHHHhhCCCCcCceecccCcEEEEEEEeCCC-cEEEEEEeecCCcccHHHHHHHHHHHHhcC-CC
Q 014904           23 PGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNG-KEVAIKQLKAGSGQGEREFQAEVEIISRVH-HK  100 (416)
Q Consensus        23 ~~~~~~~~~~~f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~  100 (416)
                      +....++-..+|+..     ..++++.+.|.+|||+.||+|.+..+ ..||+|++-..+....+.+.+|++++++|. |+
T Consensus        21 ~~~~~~~~G~~~~Vg-----~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~   95 (738)
T KOG1989|consen   21 PQSENYFVGQTFTVG-----SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHK   95 (738)
T ss_pred             cccccCCCceEEEEC-----CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCC
Confidence            333444444555443     45778889999999999999996555 999999998877777788999999999997 99


Q ss_pred             cccceEEE-EEe------CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccC
Q 014904          101 HLVSLVGY-YTA------GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKA  173 (416)
Q Consensus       101 niv~l~~~-~~~------~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp  173 (416)
                      |||.+++. ...      .-..+|.||||+++.|-+++.......|++.++++|+.++++|+++||.. .+.|||||||-
T Consensus        96 nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKi  174 (738)
T KOG1989|consen   96 NIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKI  174 (738)
T ss_pred             ceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhh
Confidence            99999993 221      23578999999999999999755544699999999999999999999985 67799999999


Q ss_pred             CcEEECCCCceEEeecccceeccCCCccee--------ecccccccccChhhh---ccCCCCchhhhHhHHHHHHHHHhC
Q 014904          174 ANILLDFKFEAKVADFGLAKIASDVNTHVS--------TRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVMLLELITG  242 (416)
Q Consensus       174 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~--------~~~~gt~~YlaPE~~---~~~~~t~ksDV~SlGvvL~elltG  242 (416)
                      +||||..++..||||||.+.-.........        -...-|+.|+|||.+   .+..+++|+|||+|||+||-|+..
T Consensus       175 ENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~  254 (738)
T KOG1989|consen  175 ENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYF  254 (738)
T ss_pred             hheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHh
Confidence            999999999999999999864322211100        012458999999976   567899999999999999999999


Q ss_pred             CCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          243 RRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       243 ~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                      ..||+....               -++.+|++        .-........+|..||+.||+.+|++||++.||+..+-.
T Consensus       255 t~PFe~sg~---------------laIlng~Y--------~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  255 TTPFEESGK---------------LAILNGNY--------SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             CCCcCcCcc---------------eeEEeccc--------cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence            999987533               12223333        222234567899999999999999999999999988753

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-39  Score=316.45  Aligned_cols=238  Identities=26%  Similarity=0.317  Sum_probs=193.9

Q ss_pred             ceecccCcEEEEEEEe----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           50 NLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      +.||+|+||.||++..    .+|+.||+|++.....  .....+..|+.++.+++||||+++++++......++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999874    3588999999975432  223456789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      +++|..++....  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus        82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~  155 (318)
T cd05582          82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KA  155 (318)
T ss_pred             CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ce
Confidence            999999886543  589999999999999999999999   999999999999999999999999999876543322 22


Q ss_pred             ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcccc
Q 014904          204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLH  283 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~  283 (416)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......   ...        ..+..+..         
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~--------~~i~~~~~---------  215 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETM--------TMILKAKL---------  215 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHH--------HHHHcCCC---------
Confidence            3467999999999999888999999999999999999999999764321   111        11111111         


Q ss_pred             CcCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 014904          284 NEYNHNEMARMVACAAACVRHSARRRPRMSQ  314 (416)
Q Consensus       284 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~e  314 (416)
                       ..+......+.+++.+||+.+|++||++.+
T Consensus       216 -~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 -GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence             111122346789999999999999999766

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.2e-39  Score=321.09  Aligned_cols=245  Identities=24%  Similarity=0.305  Sum_probs=200.9

Q ss_pred             hCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcccH---HHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE---REFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .++|..+.+||+|+||.||+|. ..+|..+|+|++++......   ...+.|-.+|....++.||+++-.|.+...+|||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            4689999999999999999999 45799999999997654433   3577899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC-
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD-  197 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~-  197 (416)
                      |||++||++..+|...+  .|+.......+.+++.||.-||+.   |+|||||||+|+|||..|.+||+||||+.-+.. 
T Consensus       220 MEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            99999999999998766  688888889999999999999999   999999999999999999999999999742110 


Q ss_pred             ----------------------CCc----ce-------------------eecccccccccChhhhccCCCCchhhhHhH
Q 014904          198 ----------------------VNT----HV-------------------STRVMGTFGYLAPEYASSGKLTEKSDVFSF  232 (416)
Q Consensus       198 ----------------------~~~----~~-------------------~~~~~gt~~YlaPE~~~~~~~t~ksDV~Sl  232 (416)
                                            ...    ..                   ....+|||-|+|||++.+..|+..+|.|||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                  000    00                   012479999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCccc-chhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCC
Q 014904          233 GVMLLELITGRRPVDSTHTFV-EDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR  311 (416)
Q Consensus       233 GvvL~elltG~~pf~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt  311 (416)
                      |||+||||.|.+||....+.. =..++.|-.-+.             -|.     ......+..+||.+|+. ||++|--
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-------------fP~-----~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-------------FPE-----EVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-------------CCC-----cCcccHHHHHHHHHHhc-CHHHhcC
Confidence            999999999999998876532 234444432111             010     01122577899999999 9999986

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-38  Score=305.57  Aligned_cols=265  Identities=26%  Similarity=0.394  Sum_probs=208.7

Q ss_pred             ccccCHHHHHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEE
Q 014904           31 KSTFTYEELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGY  108 (416)
Q Consensus        31 ~~~f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  108 (416)
                      ..++.++.+..++++|.+.+.||+|+||.||++.. .+++.+|+|++.... .....+..|+.++..+ +|+||++++++
T Consensus         5 ~~~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~   83 (286)
T cd06638           5 GKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGM   83 (286)
T ss_pred             CceEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeee
Confidence            34567788899999999999999999999999995 468899999886533 2235688899999999 69999999998


Q ss_pred             EE-----eCCeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC
Q 014904          109 YT-----AGSQRMLVYEFVPNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK  181 (416)
Q Consensus       109 ~~-----~~~~~~lV~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~  181 (416)
                      +.     .+...++||||+++++|.+++...  ....+++..+..++.+++.||.|||+.   +|+||||||+||+++.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~  160 (286)
T cd06638          84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTE  160 (286)
T ss_pred             eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCC
Confidence            84     345789999999999999887532  234688999999999999999999998   99999999999999999


Q ss_pred             CceEEeecccceeccCCCcceeecccccccccChhhhcc-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchh
Q 014904          182 FEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDS  256 (416)
Q Consensus       182 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~-----~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~  256 (416)
                      +.+||+|||+++....... ......|++.|+|||++..     ..++.++|||||||++|||++|+.||.......  .
T Consensus       161 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~  237 (286)
T cd06638         161 GGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--A  237 (286)
T ss_pred             CCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--H
Confidence            9999999999886643222 2233468999999999853     457899999999999999999999987543211  1


Q ss_pred             hhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          257 LVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       257 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      +..         ...+....+.++.       .....+..++.+||+.+|++||++.||++.
T Consensus       238 ~~~---------~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         238 LFK---------IPRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             Hhh---------ccccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            100         0011111111111       122468899999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.6e-38  Score=298.22  Aligned_cols=251  Identities=22%  Similarity=0.367  Sum_probs=207.5

Q ss_pred             CCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +|+..++||+|+||.||.+. ..+++.+++|.+....  .....++.+|+.++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            58889999999999999988 4568999999987543  33345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.+++.......+++..+..++.+++.+|.|||+.   +++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999765445789999999999999999999998   999999999999999999999999999987654332 


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                      ......+++.|+|||++.+..++.++||||||++++||++|+.||......      +..     ..+..+.+...    
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~-----~~~~~~~~~~~----  221 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLV-----VKIVQGNYTPV----  221 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHH-----HHHHcCCCCCC----
Confidence            223456899999999998888999999999999999999999999764321      111     11112322211    


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL  319 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L  319 (416)
                           .......+.+++.+|++.+|.+||++.++++.+
T Consensus       222 -----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         222 -----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             -----ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                 122345788999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=9.2e-39  Score=302.63  Aligned_cols=246  Identities=27%  Similarity=0.425  Sum_probs=196.1

Q ss_pred             eecccCcEEEEEEEeC---CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCC
Q 014904           51 LLGQGGFGYVHRGVLP---NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT  126 (416)
Q Consensus        51 ~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~s  126 (416)
                      .||+|+||.||+|.+.   .+..||+|++...... ....+.+|+.++++++|+||+++++++.. ...++|+||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999853   3557999998765432 23568899999999999999999998864 57899999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeec-
Q 014904          127 LEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR-  205 (416)
Q Consensus       127 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~-  205 (416)
                      |.+++.... ..+++..++.++.+++.||.|||+.   +++||||||+||+++.++.+||+|||++............. 
T Consensus        81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            999987543 3689999999999999999999998   99999999999999999999999999998654433322211 


Q ss_pred             -ccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcccc
Q 014904          206 -VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLH  283 (416)
Q Consensus       206 -~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~  283 (416)
                       ..++..|+|||++.+..++.++|||||||++|||++ |+.||......   .+.        ..+..+..         
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~--------~~~~~~~~---------  216 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVM--------SFIEQGKR---------  216 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHH--------HHHHCCCC---------
Confidence             223578999999998889999999999999999997 99998754321   111        11122211         


Q ss_pred             CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          284 NEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       284 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                      ...+..+...+.+++.+||..+|++||++.+|.+.|+.
T Consensus       217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            11222345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1e-38  Score=303.56  Aligned_cols=253  Identities=24%  Similarity=0.357  Sum_probs=197.7

Q ss_pred             CCcCceecccCcEEEEEEEeCC-Cc--EEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeC------Ce
Q 014904           46 FSDANLLGQGGFGYVHRGVLPN-GK--EVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAG------SQ  114 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~~-g~--~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  114 (416)
                      |.+.++||+|+||.||+|.+.. ++  .+|+|.++...  ......+..|+.+++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4567899999999999999654 33  68999887542  23345788999999999999999999988542      24


Q ss_pred             EEEEEEecCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecc
Q 014904          115 RMLVYEFVPNNTLEFHLHGK----GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG  190 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFG  190 (416)
                      .++|+||+++++|..++...    ....+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999887421    223589999999999999999999998   99999999999999999999999999


Q ss_pred             cceeccCCCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHh
Q 014904          191 LAKIASDVNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRA  268 (416)
Q Consensus       191 la~~~~~~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~  268 (416)
                      +++......... .....+++.|++||++.+..++.++||||||+++|||++ |+.||.....   ..+.        ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~--------~~  226 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIY--------DY  226 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH--------HH
Confidence            998764332211 122345778999999999999999999999999999999 8888865332   1111        11


Q ss_pred             hhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          269 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       269 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                      +..+....         .+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       227 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         227 LRQGNRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             HHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            22222111         111234568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.4e-38  Score=309.39  Aligned_cols=268  Identities=21%  Similarity=0.317  Sum_probs=199.6

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ++|.+.+.||+|+||.||+|... +++.||+|+++..... ....+.+|+.++++++|+||+++++++......++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            67999999999999999999954 6789999998754322 234677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++ +|..++..... .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus        86 ~~~-~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  160 (309)
T cd07872          86 LDK-DLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT  160 (309)
T ss_pred             CCC-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence            975 77777654432 588999999999999999999998   9999999999999999999999999998765432221


Q ss_pred             eeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh--H---HhHHhhhcCCcc
Q 014904          202 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR--P---LLNRAIEDGNFD  275 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~--~---~~~~~~~~~~~~  275 (416)
                       .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||................  +   .+........+.
T Consensus       161 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         161 -YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             -cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence             223467899999998865 468999999999999999999999997654321111110000  0   000000000000


Q ss_pred             cccCccccC----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          276 TLVDPKLHN----EYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       276 ~~~d~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ....+....    .........+.+++.+||+.+|.+||++.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000011000    001123346789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.8e-38  Score=310.23  Aligned_cols=240  Identities=28%  Similarity=0.375  Sum_probs=191.7

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      +.||+|+||.||+|... +++.||||+++...   ......+..|..++... +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 57899999997542   12234566677788764 899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      ++|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (316)
T cd05619          81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTC  154 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-cee
Confidence            99999986543  588999999999999999999999   999999999999999999999999999875432222 223


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccC
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHN  284 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~  284 (416)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+..        .+..+.      +..  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~--------~i~~~~------~~~--  215 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQ--------SIRMDN------PCY--  215 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHH--------HHHhCC------CCC--
Confidence            45799999999999988999999999999999999999999976432   11111        111111      111  


Q ss_pred             cCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 014904          285 EYNHNEMARMVACAAACVRHSARRRPRMS-QIV  316 (416)
Q Consensus       285 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-evv  316 (416)
                        +......+.+++.+||+.+|.+||++. ++.
T Consensus       216 --~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         216 --PRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             --CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence              111234678999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.9e-39  Score=302.23  Aligned_cols=247  Identities=30%  Similarity=0.499  Sum_probs=201.7

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      ++|.+.+.||+|+||.||++.. +++.||+|+++...  ....+.+|+.++++++|+|++++++++... ..++|+||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4688899999999999999985 67889999987532  235788999999999999999999998765 4789999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      +++|..++.......+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......    
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----  154 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----  154 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence            99999999866555689999999999999999999998   99999999999999999999999999987643321    


Q ss_pred             ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      .....+..|+|||++.++.++.++||||||++++||++ |+.||......      ++.     ..+..+..   .    
T Consensus       155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~-----~~~~~~~~---~----  216 (254)
T cd05083         155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVK-----ECVEKGYR---M----  216 (254)
T ss_pred             CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHH-----HHHhCCCC---C----
Confidence            12234568999999998899999999999999999998 99998654321      111     11112210   0    


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                        ......+..+.+++.+|++.+|++||++.+|+..|+.
T Consensus       217 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 --EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             --CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence              1112234578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.3e-38  Score=311.35  Aligned_cols=240  Identities=28%  Similarity=0.396  Sum_probs=191.8

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ++||+|+||.||+|... +|+.||||+++...   ......+..|..++... +|+||+++++++.+....++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999964 68899999997532   12234566777777754 899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      ++|..++....  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS  154 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence            99998886543  588999999999999999999999   99999999999999999999999999987432211 1233


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccC
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHN  284 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~  284 (416)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+.        +.+..+.      +.+..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~--------~~~~~~~------~~~~~  217 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELF--------ESIRVDT------PHYPR  217 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHH--------HHHHhCC------CCCCC
Confidence            46799999999999999999999999999999999999999975432   1111        1111111      11111


Q ss_pred             cCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 014904          285 EYNHNEMARMVACAAACVRHSARRRPRMS-QIV  316 (416)
Q Consensus       285 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-evv  316 (416)
                          .....+.+++.+||+.+|++||++. +++
T Consensus       218 ----~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         218 ----WITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ----CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                1234678899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=303.62  Aligned_cols=248  Identities=26%  Similarity=0.394  Sum_probs=204.4

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ++|...+.||.|++|.||+|... +++.||+|.+.... ......+..|+.+++.++|+|++++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            47888999999999999999954 68999999987553 23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.+++...   .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+++....... 
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  153 (274)
T cd06609          81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-  153 (274)
T ss_pred             eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence            9999999998754   689999999999999999999998   999999999999999999999999999987654322 


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                      ......+++.|+|||++.+..++.++||||||+++|+|++|+.||....+..      .    . ..+..+....+.   
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~----~-~~~~~~~~~~~~---  219 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------V----L-FLIPKNNPPSLE---  219 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------H----H-HHhhhcCCCCCc---
Confidence            2233568889999999999899999999999999999999999997544210      0    0 011111111111   


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                        ..   .....+.+++.+||..+|++||++.+|++
T Consensus       220 --~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         220 --GN---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             --cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              11   13346888999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.7e-39  Score=324.12  Aligned_cols=202  Identities=25%  Similarity=0.315  Sum_probs=173.2

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .|...++||+|+||.||+|.. .+++.||||++.....   .....+.+|+.++++++|+||+++++.+.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588999999999999999995 5688999999875422   223468889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC-
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN-  199 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~-  199 (416)
                      |+++++|..++...+  .++......++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+.... 
T Consensus        82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            999999999987553  578888899999999999999999   99999999999999999999999999975321000 


Q ss_pred             ---------------------------------------------cceeecccccccccChhhhccCCCCchhhhHhHHH
Q 014904          200 ---------------------------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV  234 (416)
Q Consensus       200 ---------------------------------------------~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGv  234 (416)
                                                                   ........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                         00112357999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCc
Q 014904          235 MLLELITGRRPVDSTHT  251 (416)
Q Consensus       235 vL~elltG~~pf~~~~~  251 (416)
                      +||||++|+.||....+
T Consensus       237 il~elltG~~Pf~~~~~  253 (382)
T cd05625         237 ILYEMLVGQPPFLAQTP  253 (382)
T ss_pred             HHHHHHhCCCCCCCCCH
Confidence            99999999999976543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.9e-38  Score=299.77  Aligned_cols=252  Identities=25%  Similarity=0.358  Sum_probs=193.7

Q ss_pred             ceecccCcEEEEEEEeCC---CcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCC
Q 014904           50 NLLGQGGFGYVHRGVLPN---GKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNN  125 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~---g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~  125 (416)
                      +.||+|+||.||+|...+   +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998543   46799998876543 23357888999999999999999999999989999999999999


Q ss_pred             CHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          126 TLEFHLHGKG---RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       126 sL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      +|.+++....   ....++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986432   23467788889999999999999999   99999999999999999999999999987544332221


Q ss_pred             -eecccccccccChhhhccC-------CCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          203 -STRVMGTFGYLAPEYASSG-------KLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       203 -~~~~~gt~~YlaPE~~~~~-------~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                       .....++..|+|||++...       .++.++||||||+++|||++ |+.||......   ....+        ...+.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~--------~~~~~  226 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---QVLTY--------TVREQ  226 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---HHHHH--------Hhhcc
Confidence             2234578889999998542       35789999999999999997 99999654321   11111        01111


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      ...+.++.+...    ....+.+++..|+ .+|++||++.||++.|.
T Consensus       227 ~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         227 QLKLPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCCCCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            122223332222    2235777889998 68999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.1e-39  Score=311.98  Aligned_cols=255  Identities=27%  Similarity=0.435  Sum_probs=200.3

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCc--EEEEEEeecCC-cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGK--EVAIKQLKAGS-GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  117 (416)
                      .++|.+.+.||+|+||.||+|.+. ++.  .+++|.++... ......+.+|+.++.++ +|+||+++++++......++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357888999999999999999964 454  45777766433 23345788999999999 89999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc
Q 014904          118 VYEFVPNNTLEFHLHGKG--------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE  183 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~  183 (416)
                      |+||+++++|.++++...              ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence            999999999999987432              23588999999999999999999998   9999999999999999999


Q ss_pred             eEEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhh
Q 014904          184 AKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWAR  262 (416)
Q Consensus       184 ~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~  262 (416)
                      +||+|||+++.......  .....++..|+|||++.+..++.++|||||||+++||+| |..||.....   ....+   
T Consensus       163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~---  234 (303)
T cd05088         163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYE---  234 (303)
T ss_pred             EEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHHHH---
Confidence            99999999864321111  111234667999999988889999999999999999998 9999865432   11111   


Q ss_pred             HHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          263 PLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       263 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                           .+..+.         ....+......+.+++.+|++.+|++||++.+++..|+..
T Consensus       235 -----~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         235 -----KLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             -----HHhcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                 111110         0011112334688999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.1e-39  Score=307.50  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=205.4

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      ..++|...+.||+|+||.||+|...      ++..||+|++.... .....++.+|+.++++++|+||+++++++..+..
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            3578999999999999999999853      46789999987543 2334678899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCC
Q 014904          115 RMLVYEFVPNNTLEFHLHGKG--------------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAA  174 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~  174 (416)
                      .++|+||+++++|..++....                    ...+++..++.++.+++.||+|||+.   +++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence            999999999999999986321                    12478899999999999999999998   9999999999


Q ss_pred             cEEECCCCceEEeecccceeccCCCc-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcc
Q 014904          175 NILLDFKFEAKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF  252 (416)
Q Consensus       175 NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~  252 (416)
                      ||+++.++.++|+|||++........ ........+..|+|||++.+..++.++|||||||++|||++ |..||..... 
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-  238 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-  238 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence            99999999999999999875432221 11222345678999999998999999999999999999998 8888864332 


Q ss_pred             cchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          253 VEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       253 ~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                        ..+.        ..+..+....         .+...+..+.+++.+|++.+|.+||++.||++.|+
T Consensus       239 --~~~~--------~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         239 --EEVI--------YYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             --HHHH--------HHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence              1111        1122232211         11223457899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=301.18  Aligned_cols=247  Identities=29%  Similarity=0.471  Sum_probs=198.4

Q ss_pred             ceecccCcEEEEEEEeC-C---CcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVLP-N---GKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~-~---g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ++||+|+||.||+|... .   +..+|+|.+...... ...++..|+.+++++.|+||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999842 2   268999998865543 3457899999999999999999999876 4568999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      ++|.+++....  .+++..++.++.|++.||+|||..   +++|+||||+|||++.++.+||+|||+++...........
T Consensus        80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            99999997654  689999999999999999999998   9999999999999999999999999999866543332211


Q ss_pred             --cccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          205 --RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       205 --~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                        ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....   ..+..+        +..+..  .    
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~--------~~~~~~--~----  217 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAM--------LESGER--L----  217 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHH--------HHcCCc--C----
Confidence              1223467999999999999999999999999999998 9999875432   122222        112211  0    


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                         ..+...+..+.+++.+|+..+|++||++.+|++.|++.
T Consensus       218 ---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         218 ---PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence               11122345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=311.39  Aligned_cols=255  Identities=20%  Similarity=0.240  Sum_probs=197.0

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.+.||+|+||.||++.. .+++.||||++....   ......+.+|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4789999999999999999995 468999999997422   122345888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|..++.... ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            9999999999986533 2588999999999999999999999   99999999999999999999999999987665443


Q ss_pred             cceeecccccccccChhhhcc-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          200 THVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~-----~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ........||+.|+|||++..     +.++.++|||||||++|||++|+.||.....      .+.....    ......
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i----~~~~~~  226 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKI----MNHKEH  226 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHH----HcCCCc
Confidence            333344579999999999863     4578899999999999999999999975432      1111111    111111


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCC--CCCCCHHHHHHH
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSA--RRRPRMSQIVRA  318 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p--~~RPt~~evv~~  318 (416)
                      ..+  +....    .....+.+++.+|++.++  ..||++.++++.
T Consensus       227 ~~~--~~~~~----~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         227 FQF--PPDVT----DVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ccC--CCccC----CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            111  10011    123456777777765433  347888888866

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.9e-39  Score=320.38  Aligned_cols=251  Identities=22%  Similarity=0.284  Sum_probs=195.8

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ..|.+.+.||+|+||.||+|.. .+++.||||++.....   .....+.+|+.++.+++|+||+++++.+.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3689999999999999999995 4689999999864321   22346788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC-
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV-  198 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~-  198 (416)
                      ||+++++|.+++...+  .++......++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+... 
T Consensus        81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            9999999999997654  578888889999999999999999   9999999999999999999999999997532100 


Q ss_pred             -----------------------------------------CcceeecccccccccChhhhccCCCCchhhhHhHHHHHH
Q 014904          199 -----------------------------------------NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLL  237 (416)
Q Consensus       199 -----------------------------------------~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~  237 (416)
                                                               .........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                     000012357999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCcccch-hhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCC---CHH
Q 014904          238 ELITGRRPVDSTHTFVED-SLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP---RMS  313 (416)
Q Consensus       238 elltG~~pf~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP---t~~  313 (416)
                      ||++|+.||....+.... .+..|.          ..   +..+. ..    .....+.+++.+|+ .+|.+|+   ++.
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~~~~----------~~---~~~~~-~~----~~s~~~~~li~~l~-~~p~~R~~~~t~~  296 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVINWE----------TT---LHIPS-QA----KLSREASDLILRLC-CGAEDRLGKNGAD  296 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHhccC----------cc---ccCCC-CC----CCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence            999999999765431110 011110          00   00010 11    12335666777765 4999999   788


Q ss_pred             HHHHH
Q 014904          314 QIVRA  318 (416)
Q Consensus       314 evv~~  318 (416)
                      |++..
T Consensus       297 ell~h  301 (376)
T cd05598         297 EIKAH  301 (376)
T ss_pred             HHhCC
Confidence            88755

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.4e-38  Score=307.98  Aligned_cols=261  Identities=24%  Similarity=0.375  Sum_probs=202.1

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ++|.+.+.||+|+||.||++.. .++..+|+|.+..... ....++.+|++++.+++||||++++++|..+...++|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            4789999999999999999995 4688899998875422 2235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.+++....  .+++..+..++.|+++||.|||+.+  +++|+||||.|||++.++.+||+|||++.......  
T Consensus        81 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          81 MDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            99999999997653  5889999999999999999999743  89999999999999999999999999987553321  


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc-------
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF-------  274 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~-------  274 (416)
                       .....|+..|+|||++.+..++.++|||||||++++|++|+.||......   .+..+....... ......       
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~  229 (308)
T cd06615         155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSE-GEAKESHRPVSGH  229 (308)
T ss_pred             -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCcccc-ccccCCcccccCC
Confidence             23356889999999998888999999999999999999999998654321   111111000000 000000       


Q ss_pred             ----------cc----c---cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          275 ----------DT----L---VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       275 ----------~~----~---~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                                .+    +   ..+.+..   ......+.+++.+||+.+|++||++.+|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      00    0   0011100   0123468899999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.9e-38  Score=305.30  Aligned_cols=250  Identities=26%  Similarity=0.408  Sum_probs=201.2

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc---cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ---GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .|+..++||+|+||.||++.. .+++.||||.+......   ....+..|+.++.+++|+|++.+++.+......++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            377788999999999999995 46899999998754322   22457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            99999999988765555689999999999999999999998   999999999999999999999999999876543222


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc-hhhhhhhhHHhHHhhhcCCcccccC
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE-DSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                      .  ....|+..|+|||++.+..++.++|||||||++|+|++|+.||........ .....    ..    ...       
T Consensus       158 ~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~----~~----~~~-------  220 (285)
T cd05630         158 I--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----LV----KEV-------  220 (285)
T ss_pred             c--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh----hh----hhh-------
Confidence            1  234689999999999999999999999999999999999999976432111 01100    00    000       


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPR-----MSQIVR  317 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evv~  317 (416)
                         ...+.......+.+++..||+.+|++||+     +.|+++
T Consensus       221 ---~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         221 ---QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ---hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence               00111122346789999999999999999     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9.6e-39  Score=303.94  Aligned_cols=254  Identities=26%  Similarity=0.400  Sum_probs=204.1

Q ss_pred             CCCCcCceecccCcEEEEEEEeCC----CcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPN----GKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ++|.+.++||+|+||.||+|...+    ...|+||...... ....+.+.+|+.++++++|+||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            468888999999999999999543    2468999887654 3344678999999999999999999999876 457899


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      +||+++++|.+++..... .+++..++.++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||+++.....
T Consensus        85 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          85 MELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            999999999999975433 589999999999999999999998   9999999999999999999999999999876554


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      .........++..|+|||++....++.++||||||++++||++ |+.||......   ....+        +..+...  
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~--------~~~~~~~--  227 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGR--------IENGERL--  227 (270)
T ss_pred             cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH--------HHcCCcC--
Confidence            3332233345568999999988889999999999999999997 99999765421   11111        1122111  


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                         .    .+...+..+.+++.+|+..+|.+||++.++++.|+..
T Consensus       228 ---~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         228 ---P----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             ---C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               1    1122345789999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.1e-38  Score=296.10  Aligned_cols=251  Identities=30%  Similarity=0.460  Sum_probs=204.4

Q ss_pred             CCcCceecccCcEEEEEEEeCC-----CcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           46 FSDANLLGQGGFGYVHRGVLPN-----GKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      |.+.+.||.|+||.||++....     +..||+|++...... ....+..|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567899999999999999653     488999999765433 4568899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++.......+++..+..++.|++.||++||+.   +++|+||||+||+++.++.++|+|||+++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999999765543389999999999999999999999   99999999999999999999999999998765543


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      ........+++.|+|||.+.+..++.++||||||+++++|++ |+.||.....   ..+..        ....+....  
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~--------~~~~~~~~~--  224 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLE--------YLKKGYRLP--  224 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH--------HHhcCCCCC--
Confidence            322222336789999999988889999999999999999999 7888765322   11111        111221111  


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL  319 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L  319 (416)
                             ........+.+++.+|++.+|++||++.|+++.|
T Consensus       225 -------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 -------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                   1112345788999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.7e-38  Score=311.95  Aligned_cols=244  Identities=23%  Similarity=0.316  Sum_probs=193.6

Q ss_pred             ceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ++||+|+||.||+|.. .+++.||+|+++....   .....+..|+.++.++ +|+||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999995 4678999999986432   2234578899999888 699999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      ++|..++....  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (327)
T cd05617          81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTS  154 (327)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-cee
Confidence            99998886543  589999999999999999999999   999999999999999999999999999875332221 223


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccC
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHN  284 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~  284 (416)
                      ...||+.|+|||++.+..++.++|||||||+||||++|+.||............++....    +.....          
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~----------  220 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV----ILEKPI----------  220 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH----HHhCCC----------
Confidence            467999999999999999999999999999999999999999754332222222222111    111111          


Q ss_pred             cCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 014904          285 EYNHNEMARMVACAAACVRHSARRRPRMS  313 (416)
Q Consensus       285 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~  313 (416)
                      ..+......+.+++.+||+.+|.+|+++.
T Consensus       221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         221 RIPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            11122234678999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.5e-39  Score=315.26  Aligned_cols=239  Identities=26%  Similarity=0.359  Sum_probs=190.0

Q ss_pred             ceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHH-HHHhcCCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVE-IISRVHHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ++||+|+||.||+|.. .+|+.||||++.....   ....++..|.. +++.++||||+++++++......++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999996 4789999999975321   12234445544 56789999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      ++|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (323)
T cd05575          81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS  154 (323)
T ss_pred             CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence            99998887543  588999999999999999999999   99999999999999999999999999987543222 2223


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccC
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHN  284 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~  284 (416)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....      .+...     .+..+..      .+..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~-----~i~~~~~------~~~~  217 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYD-----NILNKPL------RLKP  217 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHH-----HHHcCCC------CCCC
Confidence            45799999999999999999999999999999999999999976432      11111     1111111      1111


Q ss_pred             cCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 014904          285 EYNHNEMARMVACAAACVRHSARRRPRMSQI  315 (416)
Q Consensus       285 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev  315 (416)
                          .....+.+++.+||+.+|.+||++.+.
T Consensus       218 ----~~~~~~~~li~~~l~~~p~~R~~~~~~  244 (323)
T cd05575         218 ----NISVSARHLLEGLLQKDRTKRLGAKDD  244 (323)
T ss_pred             ----CCCHHHHHHHHHHhhcCHHhCCCCCCC
Confidence                224568899999999999999998633

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.5e-38  Score=304.66  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=199.0

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ++|...++||+|+||.||+|.. .+++.||+|++.... ......+..|+.++.+++||||+++++++......++|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            4678889999999999999994 578999999987543 23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|..+.      .+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.++|+|||++.......  
T Consensus        81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence            9999997552      478888999999999999999999   99999999999999999999999999997654321  


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch-hhhhhhhHHhHHhhhcCCcccccCc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED-SLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                       .....|+..|+|||++.+..++.++||||||+++|+|++|+.||......... ....+.     ..+.....     +
T Consensus       150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~-----~  218 (279)
T cd06619         150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL-----QCIVDEDP-----P  218 (279)
T ss_pred             -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH-----HHHhccCC-----C
Confidence             22357899999999999889999999999999999999999999753321110 000111     11111111     1


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .+.   .......+.+++.+|++.+|++||++.|+++.
T Consensus       219 ~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         219 VLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            110   11123468899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.9e-38  Score=299.08  Aligned_cols=252  Identities=29%  Similarity=0.483  Sum_probs=200.7

Q ss_pred             CCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHH--HHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           46 FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGER--EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      |++.+.||+|+||+||++... +++.+|+|++.........  ....|+.++.+++|+||+++++++.+....++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567789999999999999965 4678999999876544332  3456999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      .+++|..++...  ..+++..++.++.|+++||.+||+.   +|+|+||||+||+++.++.++|+|||.+..... ....
T Consensus        81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNEN  154 (260)
T ss_dssp             TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSE
T ss_pred             cccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cccc
Confidence            999999999722  3689999999999999999999999   999999999999999999999999999976422 2223


Q ss_pred             eecccccccccChhhhc-cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          203 STRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~-~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                      .....++..|+|||++. +..++.++||||||+++++|++|+.||.............   .........        ..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~~~~~--------~~  223 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKRPLPS--------SS  223 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHTHHHH--------HT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hcccccccc--------cc
Confidence            34567899999999998 8889999999999999999999999998752211111111   111000000        00


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .   ........+.+++..||+.+|++||++.++++
T Consensus       224 ~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 Q---QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             T---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             c---ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0   00001268999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.7e-38  Score=304.82  Aligned_cols=264  Identities=23%  Similarity=0.306  Sum_probs=196.0

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc--cHHHHHHHHHHHHhc---CCCcccceEEEEEe-----CC
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRV---HHKHLVSLVGYYTA-----GS  113 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  113 (416)
                      +|.+.+.||+|+||.||+|... +++.||+|.++.....  ....+..|+.++.++   +|+||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888899999999999999954 6899999998754322  123456677777665   69999999998864     34


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ..++|+||+.+ +|..++.......+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57999999975 788888765555689999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH---hHHh--
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL---LNRA--  268 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~---~~~~--  268 (416)
                      .......  .....||..|+|||++.+..++.++|||||||++++|++|++||......  +.+.......   ....  
T Consensus       157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH--HHHHHHHHHhCCCChhhCc
Confidence            6643221  23356899999999999889999999999999999999999999764331  1111111000   0000  


Q ss_pred             ----hhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          269 ----IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       269 ----~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                          .....+... .+.............+.+++.+||+.||++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPR-GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCC-CCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                000000000 000000111123456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.2e-38  Score=306.10  Aligned_cols=261  Identities=24%  Similarity=0.395  Sum_probs=202.4

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-----------------CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccce
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-----------------NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSL  105 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-----------------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l  105 (416)
                      ++|++.+.||+|+||.||++...                 ++..+|+|++..... .....+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            57999999999999999998532                 244689999875432 234578999999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCCHHHHhhcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcE
Q 014904          106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANI  176 (416)
Q Consensus       106 ~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~---------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NI  176 (416)
                      ++++......++||||+++++|..++.....         ..+++.+++.++.+++.||+|||+.   +++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            9999999999999999999999999875421         2477889999999999999999999   999999999999


Q ss_pred             EECCCCceEEeecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh--CCCCCCCCCccc
Q 014904          177 LLDFKFEAKVADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT--GRRPVDSTHTFV  253 (416)
Q Consensus       177 Ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt--G~~pf~~~~~~~  253 (416)
                      |++.++.++|+|||+++........ ......++..|++||+...+.++.++|||||||++|||++  |..||.....  
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~--  239 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD--  239 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence            9999999999999998765332221 1223445678999999988999999999999999999998  6677754332  


Q ss_pred             chhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          254 EDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       254 ~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                       ...+........   ..+.  ....+     .+..++..+.+++.+||+.+|.+||+|.+|++.|+
T Consensus       240 -~~~~~~~~~~~~---~~~~--~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         240 -EQVIENTGEFFR---DQGR--QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             -HHHHHHHHHHHh---hccc--cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence             111111111110   0000  00001     11123467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.4e-38  Score=307.94  Aligned_cols=250  Identities=21%  Similarity=0.367  Sum_probs=205.4

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      .+|+..+.||.|++|.||+|.. .+++.|++|.+..........+.+|+.+++.++|+|++++++++......++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            3699999999999999999994 578999999997665555667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++++|..++...   .+++..++.++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||++......... 
T Consensus        99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-  171 (296)
T cd06655          99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-  171 (296)
T ss_pred             CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence            999999988643   589999999999999999999999   9999999999999999999999999998765433221 


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      .....++..|+|||.+.+..++.++|||||||++|+|++|+.||....+....  ..+         .......+.    
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~--~~~---------~~~~~~~~~----  236 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YLI---------ATNGTPELQ----  236 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHH---------HhcCCcccC----
Confidence            22346888999999999888999999999999999999999999765431111  000         011111110    


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                         .+......+.+++.+||+.+|.+||++.+|+..
T Consensus       237 ---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         237 ---NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ---CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence               111233468889999999999999999999843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-38  Score=304.83  Aligned_cols=266  Identities=25%  Similarity=0.373  Sum_probs=206.6

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-----CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEe--CCeE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTA--GSQR  115 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  115 (416)
                      +.|...+.||+|+||.||+|.+.     +++.+|||+++..... ....|..|+.+++.+.|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999853     3689999999865443 35689999999999999999999999987  5678


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++|+||+++++|.+++..... .+++..++.++.+++.||+|||+.   +++|+||||.||+++.++.++|+|||++...
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            999999999999999976543 589999999999999999999998   9999999999999999999999999999876


Q ss_pred             cCCCcce--eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhh----hhhhhHHhHHhh
Q 014904          196 SDVNTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL----VDWARPLLNRAI  269 (416)
Q Consensus       196 ~~~~~~~--~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l----~~~~~~~~~~~~  269 (416)
                      .......  .....++..|++||++.+..++.++||||||++++||++|+.|+..........+    ..+....+...+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            5332211  1123445679999999988999999999999999999999999865322110000    000011111111


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      ..+.         ....+..++..+.+++.+|++.+|.+||+|.||+++|+..
T Consensus       240 ~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         240 KEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111         1111222346799999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-38  Score=324.59  Aligned_cols=265  Identities=22%  Similarity=0.341  Sum_probs=194.5

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeC--------
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAG--------  112 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  112 (416)
                      ..++|.+.++||+|+||.||+|.. .+++.||||++....    ....+|+.+++.++|+||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            456899999999999999999995 468999999886432    2345799999999999999999887432        


Q ss_pred             CeEEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC-ceEEeec
Q 014904          113 SQRMLVYEFVPNNTLEFHLHG--KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADF  189 (416)
Q Consensus       113 ~~~~lV~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~-~~kl~DF  189 (416)
                      ...++||||+++ +|..++..  .....+++..+..++.|++.||+|||+.   +|+||||||+||||+.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence            246799999975 56555532  2334689999999999999999999999   999999999999998664 6999999


Q ss_pred             ccceeccCCCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh----HH
Q 014904          190 GLAKIASDVNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR----PL  264 (416)
Q Consensus       190 Gla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~----~~  264 (416)
                      |+++.......  .....||+.|+|||++.+. .++.++|||||||+||||++|+.||......  +.+.....    +.
T Consensus       216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~p~  291 (440)
T PTZ00036        216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRIIQVLGTPT  291 (440)
T ss_pred             ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCC
Confidence            99986643222  2235689999999998754 6899999999999999999999999765431  11111110    00


Q ss_pred             hHHhh-hcCCcccc-----cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          265 LNRAI-EDGNFDTL-----VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       265 ~~~~~-~~~~~~~~-----~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ..... ....+..+     ....+...++......+.+|+.+||+.+|.+||++.|+++.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            00000 00111111     11111111222234578999999999999999999998843

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.3e-38  Score=298.50  Aligned_cols=250  Identities=22%  Similarity=0.368  Sum_probs=203.0

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEe-CCeEEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTA-GSQRMLVYE  120 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e  120 (416)
                      +|.+.+.||+|++|.||++... +++.||+|++.....  ...+.+..|+.++++++|+|++++++.+.. ....++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5888999999999999999954 578999999875432  234568899999999999999999988764 446899999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|.+++.......+++.+++.++.+++.||++||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999998765445689999999999999999999999   999999999999999999999999999987644322


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                       ......+++.|+|||++.+..++.++||||||+++++|++|+.||.....      ..+...     +..+...     
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~-----~~~~~~~-----  220 (257)
T cd08223         158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYR-----IIEGKLP-----  220 (257)
T ss_pred             -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHH-----HHhcCCC-----
Confidence             22345688999999999999999999999999999999999999875432      111111     1122211     


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                          ..+......+.+++.+|++.+|++||++.++++.
T Consensus       221 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         221 ----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                1122344578999999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.9e-39  Score=314.75  Aligned_cols=255  Identities=19%  Similarity=0.253  Sum_probs=197.7

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.+.||+|+||.||++... +++.||+|++....   ......+.+|..++..++|+||+++++++.+....++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57899999999999999999954 68899999987532   122345788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|..++..... .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        81 Ey~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            99999999999976432 588999999999999999999999   99999999999999999999999999998765443


Q ss_pred             cceeecccccccccChhhhcc-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          200 THVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~-----~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ........||++|+|||++.+     +.++.++|||||||+||||++|+.||......      +...    ... ....
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~----~i~-~~~~  225 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYG----KIM-NHEE  225 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHH----HHH-cCCC
Confidence            333344679999999999875     56889999999999999999999999754321      1110    101 1100


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARR--RPRMSQIVRA  318 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evv~~  318 (416)
                       .+   .+... .......+.+++.+|++..+++  |+++.++++.
T Consensus       226 -~~---~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         226 -RF---QFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             -cc---cCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence             00   00000 0123456788888888865544  4577777654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-38  Score=303.59  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=206.2

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .++|++.+.||+|+||.||++.. .+++.||+|++.... ......+..|++++..++|+||+++++++......++|+|
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            35788889999999999999995 468999999887543 2334678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|..++...+  .+++..+..++.+++.+|.|||+..  +++||||||+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          84 FMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             cCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            999999999887543  5899999999999999999999743  79999999999999999999999999986543221 


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc-----hhhhhhhhHHhHHhhhcCCcc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE-----DSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~-----~~l~~~~~~~~~~~~~~~~~~  275 (416)
                        .....|+..|+|||++.++.++.++|||||||++|+|++|+.||.......+     ..+.++.....     ...  
T Consensus       159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~--  229 (284)
T cd06620         159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-----QEP--  229 (284)
T ss_pred             --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-----hcc--
Confidence              1235689999999999888999999999999999999999999986543211     11222221111     111  


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL  319 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L  319 (416)
                         .+.+..   ...+..+.+++.+|++.+|.+||++.||++..
T Consensus       230 ---~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 ---PPRLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             ---CCCCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence               011111   12345788999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-38  Score=308.31  Aligned_cols=252  Identities=23%  Similarity=0.285  Sum_probs=202.9

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc---cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ---GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|...+.||+|++|.||+|... +++.||+|.+......   ..+.+..|+.++.+++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47889999999999999999965 5899999999865433   3356889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+.+++|.+++.......+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999998765555789999999999999999999998   99999999999999999999999999987543221


Q ss_pred             cc----------------------------eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCc
Q 014904          200 TH----------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHT  251 (416)
Q Consensus       200 ~~----------------------------~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~  251 (416)
                      ..                            ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            11                            11134688999999999988999999999999999999999999975442


Q ss_pred             ccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 014904          252 FVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR----MSQIVR  317 (416)
Q Consensus       252 ~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt----~~evv~  317 (416)
                      .  ..+        .... .....      .  .........+.+++.+|++.+|++||+    +.|++.
T Consensus       238 ~--~~~--------~~~~-~~~~~------~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 D--ETF--------SNIL-KKEVT------F--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             H--HHH--------HHHh-cCCcc------C--CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            1  111        0111 11110      0  011114568999999999999999999    555544

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-38  Score=297.81  Aligned_cols=254  Identities=27%  Similarity=0.415  Sum_probs=207.1

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      .++|...+.||.|+||.||+|.. .+++.+++|++..........+..|+.++++++|+||+++++++......++||||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            36788999999999999999996 46789999999876655567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|..++.... ..++...+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++........ 
T Consensus        82 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          82 CGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            99999999887542 3588999999999999999999998   999999999999999999999999999876543221 


Q ss_pred             eeecccccccccChhhhccC---CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          202 VSTRVMGTFGYLAPEYASSG---KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~---~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      ......++..|+|||.+.+.   .++.++||||||+++++|++|+.||....+..  ....         .....+.   
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~---------~~~~~~~---  222 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFL---------ISKSNFP---  222 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH---------HHhccCC---
Confidence            12335688899999999776   88999999999999999999999997644311  1110         0111110   


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .+.+  .........+.+++.+||+.+|.+||++.+|+.
T Consensus       223 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         223 PPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             Cccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1111  112234567899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.7e-38  Score=299.93  Aligned_cols=248  Identities=25%  Similarity=0.459  Sum_probs=200.5

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCccc---------HHHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQG---------EREFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      +|.+...||+|++|.||+|.. .+++.+|+|.+.......         ...+..|+.++++++|+||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            477889999999999999995 468899999887543221         1357889999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      .++|+||+++++|..++....  .+++..+..++.+++.||.|||+.   +++||||+|+||+++.++.++|+|||+++.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            999999999999999997543  588899999999999999999998   999999999999999999999999999886


Q ss_pred             ccCCCcc-----eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhh
Q 014904          195 ASDVNTH-----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAI  269 (416)
Q Consensus       195 ~~~~~~~-----~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~  269 (416)
                      .......     ......|+..|+|||++.+..++.++|||||||++|+|++|+.||......  ..+        .. .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~--------~~-~  224 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAI--------FK-I  224 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHH--------HH-H
Confidence            6532111     112245888999999999889999999999999999999999999754321  000        00 0


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ...     ..+.    .+......+.+++.+||+.+|.+||++.||++
T Consensus       225 ~~~-----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 GEN-----ASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             hcc-----CCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            011     1111    12233457889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.4e-38  Score=300.84  Aligned_cols=253  Identities=25%  Similarity=0.395  Sum_probs=201.8

Q ss_pred             CCCcCceecccCcEEEEEEEeCC--CcEEEEEEeecCCc----------ccHHHHHHHHHHHHh-cCCCcccceEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVLPN--GKEVAIKQLKAGSG----------QGEREFQAEVEIISR-VHHKHLVSLVGYYTA  111 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~~--g~~vavK~l~~~~~----------~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  111 (416)
                      +|.+.+.||+|+||.||+|.+..  ++.+|+|.+.....          ....++..|+.++.+ ++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999654  78899998864321          112356678887765 799999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeec
Q 014904          112 GSQRMLVYEFVPNNTLEFHLHG--KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF  189 (416)
Q Consensus       112 ~~~~~lV~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DF  189 (416)
                      +...++||||+++++|.+++..  .....+++..++.++.+++.||.|||+..  +++|+||+|.||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999988743  22346899999999999999999999632  7999999999999999999999999


Q ss_pred             ccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhh
Q 014904          190 GLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAI  269 (416)
Q Consensus       190 Gla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~  269 (416)
                      |++.......  ......|+..|+|||++.++.++.++||||||+++|+|++|+.||......      ...     ..+
T Consensus       159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~-----~~~  225 (269)
T cd08528         159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLA-----TKI  225 (269)
T ss_pred             cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHH-----HHH
Confidence            9998765433  223456899999999999889999999999999999999999998654321      111     111


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      ..+......    .    ......+.+++.+|++.+|++||++.||..+|+
T Consensus       226 ~~~~~~~~~----~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         226 VEAVYEPLP----E----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hhccCCcCC----c----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            122221111    1    112356889999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5e-38  Score=296.21  Aligned_cols=238  Identities=27%  Similarity=0.431  Sum_probs=191.0

Q ss_pred             ceecccCcEEEEEEEeCCCc-----------EEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           50 NLLGQGGFGYVHRGVLPNGK-----------EVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...|.+|+.+++.++|+||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999975432           5788887654433 5688999999999999999999999988 778999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC-------ceEEeeccc
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-------EAKVADFGL  191 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~-------~~kl~DFGl  191 (416)
                      +||+++++|..++..... .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999976543 689999999999999999999998   999999999999999887       799999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccC--CCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHh
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRA  268 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~--~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~  268 (416)
                      +.....     .....++..|+|||++...  .++.++|||||||++|+|++ |..||.......   ...+.       
T Consensus       155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~-------  219 (259)
T cd05037         155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFY-------  219 (259)
T ss_pred             cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHH-------
Confidence            876543     1223467789999999876  78999999999999999999 577775543211   11110       


Q ss_pred             hhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          269 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       269 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                       .....  ...+         ....+.+++.+||..+|.+||++.+|++.|+
T Consensus       220 -~~~~~--~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         220 -QDQHR--LPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -hcCCC--CCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             01110  0000         1157889999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.3e-38  Score=312.06  Aligned_cols=267  Identities=23%  Similarity=0.311  Sum_probs=198.4

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCC----
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGS----  113 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  113 (416)
                      ...++|.+.+.||+|+||.||++.. .+|+.||||++....  ......+.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            3568999999999999999999995 468999999997542  233456789999999999999999999986543    


Q ss_pred             --eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          114 --QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       114 --~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                        ..++||||+.+ +|...++.    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence              57999999975 45555542    478888999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch------------hhhh
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED------------SLVD  259 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~------------~l~~  259 (416)
                      ++......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........            .+..
T Consensus       170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence            97543321  223357899999999999999999999999999999999999999765321100            0000


Q ss_pred             hhhHHhHHhhhc-CCc-----ccc----cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          260 WARPLLNRAIED-GNF-----DTL----VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       260 ~~~~~~~~~~~~-~~~-----~~~----~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .....+...... ..+     .++    ..+.. ..........+.+++.+||+.+|++||++.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSE-SERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccc-cccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000011000000 000     000    00000 00111123567899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-38  Score=314.90  Aligned_cols=258  Identities=29%  Similarity=0.427  Sum_probs=201.1

Q ss_pred             hCCCCcCceecccCcEEEEEEEe------CCCcEEEEEEeecCCcc-cHHHHHHHHHHHHhc-CCCcccceEEEEEe-CC
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL------PNGKEVAIKQLKAGSGQ-GEREFQAEVEIISRV-HHKHLVSLVGYYTA-GS  113 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  113 (416)
                      .++|++.++||+|+||.||+|..      .+++.||||+++..... ....+..|+.++.++ +|+||++++++|.. +.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35899999999999999999973      35789999999754332 234688899999999 78999999998865 45


Q ss_pred             eEEEEEEecCCCCHHHHhhcCC----------------------------------------------------------
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKG----------------------------------------------------------  135 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~----------------------------------------------------------  135 (416)
                      ..++|+||+++++|.++++...                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999886432                                                          


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc-eeeccc
Q 014904          136 -------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH-VSTRVM  207 (416)
Q Consensus       136 -------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~  207 (416)
                             ...+++..+..++.|+++||+|||+.   +|+||||||.|||++.++.+||+|||++......... ......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   12368888999999999999999999   9999999999999999999999999998765332221 112234


Q ss_pred             ccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcC
Q 014904          208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEY  286 (416)
Q Consensus       208 gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  286 (416)
                      ++..|+|||++.+..++.++||||||+++|+|++ |..||......  ..        +...+..+.....  +   .  
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~--------~~~~~~~~~~~~~--~---~--  305 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EE--------FCRRLKEGTRMRA--P---D--  305 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HH--------HHHHHhccCCCCC--C---C--
Confidence            5678999999998899999999999999999997 89998653321  01        1111222221110  1   1  


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          287 NHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       287 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                        .....+.+++..||+.+|.+||++.||++.|+..
T Consensus       306 --~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         306 --YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             --CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              1124688999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.8e-38  Score=302.70  Aligned_cols=255  Identities=24%  Similarity=0.410  Sum_probs=204.5

Q ss_pred             CCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      .+|.+...||+|+||.||+|...      +.+.|++|.+...... ....+..|+.++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888999999999999999953      3467999988754433 3457899999999999999999999999989999


Q ss_pred             EEEEecCCCCHHHHhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeec
Q 014904          117 LVYEFVPNNTLEFHLHGKGR-------PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF  189 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~-------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DF  189 (416)
                      +|+||+++++|.+++.....       ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999975441       2589999999999999999999998   9999999999999999999999999


Q ss_pred             ccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHh
Q 014904          190 GLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRA  268 (416)
Q Consensus       190 Gla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~  268 (416)
                      |++...............++..|+|||.+.+..++.++||||||+++++|++ |..||.....   ..++.        .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~--------~  230 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLN--------R  230 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHH--------H
Confidence            9987543322222223456778999999988889999999999999999999 7888854322   11111        1


Q ss_pred             hhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          269 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       269 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      ...+....        ......+..+.+++.+|++.+|.+||++.|++..|.
T Consensus       231 ~~~~~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         231 LQAGKLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHcCCcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            11222111        011123357899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-38  Score=303.79  Aligned_cols=239  Identities=25%  Similarity=0.366  Sum_probs=188.6

Q ss_pred             eecccCcEEEEEEEeCC-------------------------CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccce
Q 014904           51 LLGQGGFGYVHRGVLPN-------------------------GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL  105 (416)
Q Consensus        51 ~LG~G~~g~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l  105 (416)
                      +||+|+||.||+|.+..                         ...|++|++..........|.+|+.+++.++|+||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998421                         13589998876544444678889999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC---
Q 014904          106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF---  182 (416)
Q Consensus       106 ~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~---  182 (416)
                      +++|......++||||+++++|..++.... ..+++..++.++.|+++||+|||+.   +|+||||||+|||++..+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence            999999999999999999999999886543 3688999999999999999999998   999999999999997643   


Q ss_pred             ----ceEEeecccceeccCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHH-hCCCCCCCCCcccchh
Q 014904          183 ----EAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELI-TGRRPVDSTHTFVEDS  256 (416)
Q Consensus       183 ----~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~ell-tG~~pf~~~~~~~~~~  256 (416)
                          .+|++|||++......     ....++..|+|||++.+ ..++.++|||||||++|||+ +|+.||....+..   
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---  229 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---  229 (274)
T ss_pred             CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---
Confidence                3799999987644322     12346788999998865 56899999999999999995 6999987543311   


Q ss_pred             hhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          257 LVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       257 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      ...+.        ...       ......    ....+.+++.+||+.+|.+||++.+|++.|.
T Consensus       230 ~~~~~--------~~~-------~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 KERFY--------EKK-------HRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHH--------Hhc-------cCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            11110        000       001111    1236889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.9e-38  Score=312.42  Aligned_cols=268  Identities=22%  Similarity=0.284  Sum_probs=199.8

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeC-----
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAG-----  112 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  112 (416)
                      ...++|...+.||+|+||.||++.. ..++.||||++.....  .....+.+|+.+++.++|+||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            4668999999999999999999995 4689999999875432  2235677899999999999999999988643     


Q ss_pred             -CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          113 -SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       113 -~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                       ...++||||+++ ++...+..    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence             357999999965 56555543    478899999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhh-h-----------h
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL-V-----------D  259 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l-~-----------~  259 (416)
                      ++......  ......||..|+|||++.+..++.++|||||||++|+|++|+.||........... .           .
T Consensus       166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            98654321  22345789999999999988999999999999999999999999976542111000 0           0


Q ss_pred             hhhHHhHHhhhc-CCcccccCccc--------cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          260 WARPLLNRAIED-GNFDTLVDPKL--------HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       260 ~~~~~~~~~~~~-~~~~~~~d~~l--------~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ...+.+....+. ..+..+..+..        ...........+.+++.+||+.+|++||++.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            000111111110 01111110100        001111223567899999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1e-38  Score=313.05  Aligned_cols=243  Identities=26%  Similarity=0.343  Sum_probs=191.7

Q ss_pred             ceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHH-HHHhcCCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVE-IISRVHHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ++||+|+||.||+|.. .+|+.||||++....   ......+..|.. +++.++||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999995 478999999997532   122234555554 56778999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      ++|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~  154 (325)
T cd05604          81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTT  154 (325)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Ccc
Confidence            99998886543  589999999999999999999999   999999999999999999999999999875322211 223


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccC
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHN  284 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~  284 (416)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......      +    .+ ..+..+..      .+  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~----~~-~~~~~~~~------~~--  215 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------E----MY-DNILHKPL------VL--  215 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------H----HH-HHHHcCCc------cC--
Confidence            467999999999999999999999999999999999999999764321      1    11 11111111      01  


Q ss_pred             cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014904          285 EYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL  319 (416)
Q Consensus       285 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L  319 (416)
                        .......+.+++.+|++.+|.+||++.+.++.+
T Consensus       216 --~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i  248 (325)
T cd05604         216 --RPGASLTAWSILEELLEKDRQRRLGAKEDFLEI  248 (325)
T ss_pred             --CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence              111234678899999999999999987555443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.3e-38  Score=299.86  Aligned_cols=240  Identities=24%  Similarity=0.386  Sum_probs=190.1

Q ss_pred             ceecccCcEEEEEEEeCC-------------CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           50 NLLGQGGFGYVHRGVLPN-------------GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      +.||+|+||.||+|.+..             ...|++|++..........|.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2358899887654444457888999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc-------eEEeec
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE-------AKVADF  189 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~-------~kl~DF  189 (416)
                      +|+||+++++|..++..... .+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.       ++++||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEecccCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            99999999999988875433 589999999999999999999999   9999999999999987654       899999


Q ss_pred             ccceeccCCCcceeecccccccccChhhhc-cCCCCchhhhHhHHHHHHHHH-hCCCCCCCCCcccchhhhhhhhHHhHH
Q 014904          190 GLAKIASDVNTHVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELI-TGRRPVDSTHTFVEDSLVDWARPLLNR  267 (416)
Q Consensus       190 Gla~~~~~~~~~~~~~~~gt~~YlaPE~~~-~~~~t~ksDV~SlGvvL~ell-tG~~pf~~~~~~~~~~l~~~~~~~~~~  267 (416)
                      |++......     ....++..|+|||++. +..++.++|||||||++|||+ +|+.||........    .        
T Consensus       157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~--------  219 (262)
T cd05077         157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----E--------  219 (262)
T ss_pred             CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----H--------
Confidence            998654322     1245788999999986 467899999999999999998 48888764322100    0        


Q ss_pred             hhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          268 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       268 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      ....+.+. ...         .....+.+++.+||+.+|++||++.+|++.|+
T Consensus       220 ~~~~~~~~-~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         220 RFYEGQCM-LVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HHHhcCcc-CCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            00111111 111         11346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-38  Score=301.81  Aligned_cols=248  Identities=28%  Similarity=0.443  Sum_probs=194.3

Q ss_pred             ceecccCcEEEEEEEeCC-Cc--EEEEEEeecCC-cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVLPN-GK--EVAIKQLKAGS-GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~-g~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ++||+|+||.||+|.+.+ +.  .+++|.++... ......+..|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            469999999999999643 43  46888887433 23345788999999999 899999999999999999999999999


Q ss_pred             CCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecc
Q 014904          125 NTLEFHLHGKG--------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG  190 (416)
Q Consensus       125 ~sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFG  190 (416)
                      ++|.+++....              ...+++..++.++.+++.||+|||+.   +++||||||+||+++.++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            99999986432              12478999999999999999999998   99999999999999999999999999


Q ss_pred             cceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhh
Q 014904          191 LAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAI  269 (416)
Q Consensus       191 la~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~  269 (416)
                      ++........  ......+..|+|||++....++.++|||||||+++||++ |+.||.....   ..+.        ..+
T Consensus       158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~--------~~~  224 (270)
T cd05047         158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELY--------EKL  224 (270)
T ss_pred             Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHH--------HHH
Confidence            9863221111  111223567999999988899999999999999999997 9999865332   1111        111


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      ..+..         ...+......+.+++.+|++.+|.+||++.+|+..|+..
T Consensus       225 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         225 PQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             hCCCC---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            11110         011112334688999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.3e-38  Score=303.91  Aligned_cols=265  Identities=27%  Similarity=0.394  Sum_probs=203.7

Q ss_pred             CCCCcCceecccCcEEEEEEEe-----CCCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeC--CeE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-----PNGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAG--SQR  115 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  115 (416)
                      +.|.+.+.||+|+||.||++..     .++..||+|.++... ......+.+|+.++++++|+|++++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578889999999999999973     357899999987553 23345789999999999999999999998875  568


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++||||+++++|..++..... .+++..++.++.+++.||+|||+.   +++||||||+||+++.++.++|+|||+++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence            999999999999999865432 589999999999999999999999   9999999999999999999999999999866


Q ss_pred             cCCCcc--eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch----hhhhhhhHHhHHhh
Q 014904          196 SDVNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED----SLVDWARPLLNRAI  269 (416)
Q Consensus       196 ~~~~~~--~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~----~l~~~~~~~~~~~~  269 (416)
                      ......  ......++..|+|||++.+..++.++|||||||++|||++++.|..........    .-..+........+
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            543321  112345677899999999889999999999999999999988765321110000    00000001111111


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                      ..+...         ......+..+.+++.+|++.+|.+||++.+|++.|+.
T Consensus       240 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         240 EEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            222111         1112234689999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.3e-38  Score=304.32  Aligned_cols=247  Identities=26%  Similarity=0.417  Sum_probs=201.2

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      .|+..+.||+|+||.||+|.+ .+++.||+|.+..... .....+..|+.++++++|+||+++++++......++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            466778899999999999985 4678999999875432 23357889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++++|..++...   .+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........ .
T Consensus        85 ~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06642          85 GGGSALDLLKPG---PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence            999999988642   588999999999999999999998   999999999999999999999999999876544322 1


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      .....++..|+|||++.+..++.++|||||||+++||++|+.||....+..   ...        .+..+.     .+  
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~--------~~~~~~-----~~--  219 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLF--------LIPKNS-----PP--  219 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHh--------hhhcCC-----CC--
Confidence            223467889999999998899999999999999999999999986543211   000        011111     11  


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                        .........+.+++.+|++.+|.+||+|.+|++.
T Consensus       220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         220 --TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence              1222344578899999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-39  Score=321.53  Aligned_cols=252  Identities=28%  Similarity=0.394  Sum_probs=213.4

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc---cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ---GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      +-|...+-||.|+-|.|-+|++ .+|+..|||++.+....   ....+..|+-|++.+.|||++++++.+++..++|||.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4577888999999999999995 58999999999765221   1245778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++|-|.+++..++  .++.....+.+.||+.|+.|||..   +|+|||+||+|+|||..+++||+|||+|.+-..  
T Consensus        92 Eyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP--  164 (786)
T ss_pred             EecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence            9999999999998777  488888999999999999999999   999999999999999999999999999976543  


Q ss_pred             cceeecccccccccChhhhccCCCC-chhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t-~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      .......+|.+.|.+||++.+.+|. .++||||.||+||.||||+.||+..+.          +.++ ..+..|.|+   
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi----------r~LL-lKV~~G~f~---  230 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI----------RVLL-LKVQRGVFE---  230 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH----------HHHH-HHHHcCccc---
Confidence            3344567899999999999998875 799999999999999999999985442          1222 233455543   


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hcccc
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA--LEGDA  323 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~--L~~~~  323 (416)
                             .+.+...+..+|+.+|+..||++|-|+.||++.  |.+-.
T Consensus       231 -------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  231 -------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             -------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence                   344556688999999999999999999999986  44433

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=9.2e-38  Score=300.95  Aligned_cols=251  Identities=24%  Similarity=0.361  Sum_probs=201.9

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      +.|++.+.||+|+||.||+|... +++.+++|.+..........+..|+.+++.++|+|++++++++..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            57889999999999999999964 58999999998766555667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++++|..++..... .+++..++.++.|++.+|.|||+.   +++||||||+||+++.++.++|+|||++........ .
T Consensus        92 ~~~~l~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-~  166 (292)
T cd06644          92 PGGAVDAIMLELDR-GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-R  166 (292)
T ss_pred             CCCcHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc-c
Confidence            99999888765433 589999999999999999999998   999999999999999999999999999875433221 1


Q ss_pred             eecccccccccChhhhc-----cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          203 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~-----~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      .....++..|+|||++.     ...++.++|||||||++|||++|+.||......  ..+..         +.......+
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~---------~~~~~~~~~  235 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLK---------IAKSEPPTL  235 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHHHH---------HhcCCCccC
Confidence            23356788999999984     345788999999999999999999998654321  11111         111111111


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .       .+......+.+++.+||+.+|++||++.+|++
T Consensus       236 ~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         236 S-------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             C-------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1       11223346889999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.7e-38  Score=309.00  Aligned_cols=242  Identities=25%  Similarity=0.365  Sum_probs=194.2

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHHhcC-CCcccceEEEEEeCCeEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  119 (416)
                      +|...++||+|+||.||+|.. .+|+.||||++....   ......+..|..++..+. |++|+++++++......++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            477889999999999999995 468999999997532   122345778888888885 577888999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|..++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            9999999999886544  589999999999999999999999   99999999999999999999999999987543222


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                      . ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+..        .+..+..     
T Consensus       156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~--------~i~~~~~-----  218 (323)
T cd05615         156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQ--------SIMEHNV-----  218 (323)
T ss_pred             c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHH--------HHHhCCC-----
Confidence            1 22335689999999999988999999999999999999999999976542   11111        1111111     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMS  313 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~  313 (416)
                           .++......+.+++.+|++.+|.+|++..
T Consensus       219 -----~~p~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         219 -----SYPKSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             -----CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence                 11122334678899999999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.3e-38  Score=299.20  Aligned_cols=250  Identities=26%  Similarity=0.448  Sum_probs=201.1

Q ss_pred             CCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcc------cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQ------GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      +|...+.||+|+||.||+|...+++.+|||.+......      ....+.+|++++++++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            47888999999999999999888999999998754221      124588899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      +||+++++|.+++....  .+++..+..++.|++.||+|||+.   +|+|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            99999999999996543  578999999999999999999998   9999999999999999999999999998754321


Q ss_pred             C-----cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          199 N-----THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       199 ~-----~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      .     ........|+..|+|||++.+..++.++|||||||++++|++|+.||........  .       .......+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~-------~~~~~~~~~  226 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--M-------FYIGAHRGL  226 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--H-------HHhhhccCC
Confidence            1     1112235689999999999988899999999999999999999999975432110  0       000000011


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                           .+.+..    .....+.+++.+||+.+|.+||++.+|++
T Consensus       227 -----~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 -----MPRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -----CCCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 111111    23456889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.7e-38  Score=300.23  Aligned_cols=250  Identities=23%  Similarity=0.359  Sum_probs=199.4

Q ss_pred             CCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           46 FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      |++.+.||+|+||.||+|... ++..+++|.+..........+..|+.+++.++|+|++++++++..+...++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            566788999999999999964 5788899998765544556788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      ++|..++.... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........ ...
T Consensus        87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~  161 (282)
T cd06643          87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD  161 (282)
T ss_pred             CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-ccc
Confidence            99998876533 3689999999999999999999999   999999999999999999999999999876543221 223


Q ss_pred             cccccccccChhhhc-----cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          205 RVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~-----~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                      ...++..|+|||++.     +..++.++|||||||++|+|++|+.||......  .....         +..+....+..
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~---------~~~~~~~~~~~  230 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLK---------IAKSEPPTLAQ  230 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHH---------HhhcCCCCCCC
Confidence            356899999999984     345788999999999999999999998654321  11111         01111111111


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                             +......+.+++.+||+.+|.+||++.+|++.
T Consensus       231 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         231 -------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   11223578899999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-38  Score=313.26  Aligned_cols=255  Identities=20%  Similarity=0.255  Sum_probs=197.1

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.++||+|+||.||++... +++.+|+|++....   ......+..|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47889999999999999999964 57889999986422   122235788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++..... .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        81 ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             eccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            99999999999975332 589999999999999999999999   99999999999999999999999999987654433


Q ss_pred             cceeecccccccccChhhhc-----cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          200 THVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~-----~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ........||+.|+|||++.     .+.++.++|||||||++|||++|+.||.....      .+....     +.... 
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~-----i~~~~-  224 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGK-----IMNHK-  224 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHH-----HhCCC-
Confidence            33334467999999999986     34688999999999999999999999975432      111111     11111 


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARR--RPRMSQIVRA  318 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evv~~  318 (416)
                      ..+.-|..    .......+.+++.+|+..++.+  |+++.|+++.
T Consensus       225 ~~~~~p~~----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         225 ERFQFPAQ----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ccccCCCc----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            00000111    1123356777888877654443  6788888755

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.9e-38  Score=299.13  Aligned_cols=248  Identities=26%  Similarity=0.406  Sum_probs=204.6

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ..|+..+.||.|+||.||+|... +++.||+|++.... ......+..|+.+++++.|+||+++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35777889999999999999964 68899999987543 23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.+++...   .+++.....++.+++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........ 
T Consensus        84 ~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06640          84 LGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence            9999999988643   588889999999999999999998   999999999999999999999999999976644322 


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                      ......++..|+|||++.+..++.++|||||||++|||++|..||....+...   .        ..+..+         
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~--------~~~~~~---------  216 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV---L--------FLIPKN---------  216 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---h--------hhhhcC---------
Confidence            22335678899999999988999999999999999999999999875433110   0        000111         


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .........+..+.+++.+||+.+|++||++.+|+..
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            1122334456778999999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.9e-38  Score=311.15  Aligned_cols=244  Identities=25%  Similarity=0.327  Sum_probs=191.7

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---ccHHHHHHHH-HHHHhcCCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG---QGEREFQAEV-EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      +.||+|+||.||+|... +++.||+|++.....   .....+..|. .+++.++|+||+++++++......++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999954 678899999875321   2223444444 456788999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      ++|..++....  .+.......++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~  154 (325)
T cd05602          81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTS  154 (325)
T ss_pred             CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccc
Confidence            99999987543  477888888999999999999999   999999999999999999999999999875432222 223


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccC
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHN  284 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~  284 (416)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......   ....        .+.....          
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~--------~i~~~~~----------  213 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYD--------NILNKPL----------  213 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHH--------HHHhCCc----------
Confidence            467999999999999999999999999999999999999999754321   1111        1111111          


Q ss_pred             cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          285 EYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       285 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      .........+.+++.+|++.+|.+||++.+.+..+.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~  249 (325)
T cd05602         214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK  249 (325)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence            011123346889999999999999999886554443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.6e-38  Score=300.21  Aligned_cols=253  Identities=25%  Similarity=0.393  Sum_probs=202.6

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|+++.........+.+|+.+++.++||||+++++++......++|+||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            45788889999999999999995 46899999999866544445688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.+++...+  .+++...+.++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||++........ 
T Consensus        88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06645          88 CGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-  161 (267)
T ss_pred             cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence            99999999986554  589999999999999999999999   999999999999999999999999999876543221 


Q ss_pred             eeecccccccccChhhhc---cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          202 VSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~---~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      ......|+..|+|||++.   .+.++.++|||||||++|+|++|+.||....+......           .....+.   
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~-----------~~~~~~~---  227 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-----------MTKSNFQ---  227 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh-----------hhccCCC---
Confidence            123356899999999974   45688999999999999999999999865443111000           0011111   


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .+.....  ......+.+++.+|++.+|++||++.+|++
T Consensus       228 ~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         228 PPKLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CCccccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            1111110  012346789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-39  Score=312.18  Aligned_cols=261  Identities=23%  Similarity=0.340  Sum_probs=205.6

Q ss_pred             CHHHHHHhhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCc--------------ccHHHHHHHHHHHHhcCC
Q 014904           35 TYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSG--------------QGEREFQAEVEIISRVHH   99 (416)
Q Consensus        35 ~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~h   99 (416)
                      .-.+-.+..|+|.+...||+|.||.|-+|. ..+++.||||++.+...              ...+..++|+.|+++++|
T Consensus        88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H  167 (576)
T KOG0585|consen   88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH  167 (576)
T ss_pred             cCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence            334556678899999999999999999999 45799999999964311              112468899999999999


Q ss_pred             CcccceEEEEEe--CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEE
Q 014904          100 KHLVSLVGYYTA--GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANIL  177 (416)
Q Consensus       100 ~niv~l~~~~~~--~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NIL  177 (416)
                      +|||+|+++..+  .+..|||+|||..|.+...=  .....+...+.++++.+++.||.|||.+   +||||||||+|+|
T Consensus       168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLL  242 (576)
T KOG0585|consen  168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLL  242 (576)
T ss_pred             cCeeEEEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheE
Confidence            999999999865  56799999999988774321  1222389999999999999999999999   9999999999999


Q ss_pred             ECCCCceEEeecccceeccCCCc----ceeecccccccccChhhhccCC----CCchhhhHhHHHHHHHHHhCCCCCCCC
Q 014904          178 LDFKFEAKVADFGLAKIASDVNT----HVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVMLLELITGRRPVDST  249 (416)
Q Consensus       178 l~~~~~~kl~DFGla~~~~~~~~----~~~~~~~gt~~YlaPE~~~~~~----~t~ksDV~SlGvvL~elltG~~pf~~~  249 (416)
                      |+.+|.+||+|||.+..+.....    .......||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||-..
T Consensus       243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence            99999999999999986632211    1123368999999999987743    457899999999999999999999654


Q ss_pred             CcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014904          250 HTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL  319 (416)
Q Consensus       250 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L  319 (416)
                      ..      .+.+             +.++...+.-....++-+.+.+|++++|++||++|-+..+|....
T Consensus       323 ~~------~~l~-------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  323 FE------LELF-------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             hH------HHHH-------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            32      1111             122222222222234556889999999999999999999998775

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.9e-38  Score=295.30  Aligned_cols=249  Identities=21%  Similarity=0.354  Sum_probs=204.8

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +|+..+.||+|+||.||++.. .+|+.||+|.+....  .....++.+|+.++++++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            588899999999999999995 468999999987542  22335788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.+++.......+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            9999999998765444689999999999999999999998   9999999999999999999999999999866443221


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                       .....|+..|+|||++.++.++.++|||||||++++|++|+.||.....      .+...    .. ..+....     
T Consensus       158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~----~~-~~~~~~~-----  220 (256)
T cd08218         158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVL----KI-IRGSYPP-----  220 (256)
T ss_pred             -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHH----HH-hcCCCCC-----
Confidence             2234688899999999988999999999999999999999999875432      11111    11 1222111     


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                          .+......+.+++.+|++.+|.+||+|.+|++
T Consensus       221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 ----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                11223457899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4e-38  Score=296.45  Aligned_cols=247  Identities=24%  Similarity=0.412  Sum_probs=202.0

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-----ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG-----QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      +|+..+.||+|++|.||+|+.. +++.|++|.+.....     +..+.+..|+.+++.++|+||+++++++..+...++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            5778899999999999999965 789999999875431     2335788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      +||+++++|.+++....  .+++..+..++.+++.||+|||+.   +++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            99999999999987553  588999999999999999999999   9999999999999999999999999998765443


Q ss_pred             CcceeecccccccccChhhhccCC-CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~-~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      .  ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||......  ..+.        .......... 
T Consensus       156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~~--------~~~~~~~~~~-  222 (258)
T cd06632         156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVF--------KIGRSKELPP-  222 (258)
T ss_pred             c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHHH--------HHHhcccCCC-
Confidence            3  223456889999999997776 899999999999999999999999764321  1111        1111111111 


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                              .+......+.+++.+||+.+|.+||++.++++
T Consensus       223 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 --------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             --------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                    11123356788999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-37  Score=293.32  Aligned_cols=248  Identities=27%  Similarity=0.426  Sum_probs=203.4

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +|...+.||+|+||.||++.. .+++.+|||.+....  ......+..|+.++++++|+|++++++.+......++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            588899999999999999995 468899999987543  22345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC-CceEEeecccceeccCCCc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~-~~~kl~DFGla~~~~~~~~  200 (416)
                      +++++|.+++.......+++..++.++.+++.+|.|||+.   +++|+||+|+||+++.+ +.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            9999999999876555689999999999999999999998   99999999999999855 4589999999987654322


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                        .....++..|+|||.+.+..++.++||||||+++++|++|+.||......   ....        .+..+....+   
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~--------~~~~~~~~~~---  221 (256)
T cd08220         158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVL--------KIMSGTFAPI---  221 (256)
T ss_pred             --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHH--------HHHhcCCCCC---
Confidence              22356889999999999888999999999999999999999998764421   1111        1111221111   


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                            +......+.+++.+||+.+|.+||++.|+++
T Consensus       222 ------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         222 ------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                  1123457889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8.3e-38  Score=306.66  Aligned_cols=265  Identities=18%  Similarity=0.281  Sum_probs=194.6

Q ss_pred             cCceeccc--CcEEEEEEEe-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           48 DANLLGQG--GFGYVHRGVL-PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        48 ~~~~LG~G--~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      +.++||+|  +|++||++.. .+|+.||||++.....  .....+++|+.+++.++||||+++++++..+...++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  7899999994 5789999999975432  22346778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc-
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH-  201 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~-  201 (416)
                      ++++|.+++.......+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.++++||+........... 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999998654444689999999999999999999998   9999999999999999999999999865432211110 


Q ss_pred             -----eeecccccccccChhhhcc--CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhH--------
Q 014904          202 -----VSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN--------  266 (416)
Q Consensus       202 -----~~~~~~gt~~YlaPE~~~~--~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~--------  266 (416)
                           ......++..|+|||++.+  ..++.++|||||||+++||++|+.||......  ..........+.        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh--HHHHHHhcCCccccccccch
Confidence                 0112346778999999976  35899999999999999999999999753221  000000000000        


Q ss_pred             --Hhh--------hcCCccccc-----Cc----cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          267 --RAI--------EDGNFDTLV-----DP----KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       267 --~~~--------~~~~~~~~~-----d~----~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                        ..+        .+..+....     .+    .............+.+++.+||+.||++||++.||++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence              000        000000000     00    0000112223457889999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.1e-38  Score=337.40  Aligned_cols=258  Identities=21%  Similarity=0.314  Sum_probs=202.9

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc---cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ---GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.++||+|+||.||+|... +++.||||++......   ...+|.+|+.++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            68999999999999999999954 6899999999754322   2357889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecc
Q 014904          120 EFVPNNTLEFHLHGKG---------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG  190 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~---------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFG  190 (416)
                      ||+++++|.+++....         ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999886321         12456788899999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCCc-----------------ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccc
Q 014904          191 LAKIASDVNT-----------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFV  253 (416)
Q Consensus       191 la~~~~~~~~-----------------~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~  253 (416)
                      +++.......                 .......||+.|+|||++.+..++.++|||||||+++||+||+.||...... 
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence            9986521110                 0112357999999999999999999999999999999999999999763321 


Q ss_pred             chhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHhccc
Q 014904          254 EDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP-RMSQIVRALEGD  322 (416)
Q Consensus       254 ~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~evv~~L~~~  322 (416)
                        .+. +          ..   .+.++... ......+..+.+++.+|++.+|++|| ++.++++.|+..
T Consensus       238 --ki~-~----------~~---~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        238 --KIS-Y----------RD---VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             --hhh-h----------hh---hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              000 0          00   00111000 00112335688999999999999996 667777777643

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.2e-38  Score=308.87  Aligned_cols=256  Identities=26%  Similarity=0.424  Sum_probs=202.9

Q ss_pred             CCCCcCceecccCcEEEEEEEeC--------CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhc-CCCcccceEEEEEeCC
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP--------NGKEVAIKQLKAGSG-QGEREFQAEVEIISRV-HHKHLVSLVGYYTAGS  113 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  113 (416)
                      ++|.+.+.||+|+||.||++...        ....+|+|.++.... .....+..|+.+++++ +|+||++++++|....
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            57888999999999999999742        245789999875432 2335688999999999 6999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKG--------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD  179 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~  179 (416)
                      ..++|+||+++++|..++....              ...+++..+..++.|++.||.|||+.   +++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence            9999999999999999986532              13589999999999999999999998   999999999999999


Q ss_pred             CCCceEEeecccceeccCCCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhh
Q 014904          180 FKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSL  257 (416)
Q Consensus       180 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l  257 (416)
                      .++.+||+|||+++......... .....++..|+|||++.++.++.++|||||||++|||++ |+.||.....   ..+
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~  245 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EEL  245 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence            99999999999998654322211 111234567999999998899999999999999999999 8888865432   111


Q ss_pred             hhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      .        ..+..+...         ..+......+.+++.+|++.+|++||++.+|++.|...
T Consensus       246 ~--------~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         246 F--------KLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             H--------HHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            1        111122110         11222345788999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.7e-38  Score=302.78  Aligned_cols=260  Identities=25%  Similarity=0.399  Sum_probs=206.2

Q ss_pred             cCHHHHHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEEEEe
Q 014904           34 FTYEELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYYTA  111 (416)
Q Consensus        34 f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  111 (416)
                      .++.++..+.+.|++.+.||+|+||.||+|.. .+++.+|+|++.... .....+..|+.++.++ +|+||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            36677777889999999999999999999995 568899999986543 2335688899999998 79999999999853


Q ss_pred             ------CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceE
Q 014904          112 ------GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAK  185 (416)
Q Consensus       112 ------~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~k  185 (416)
                            ....++||||+++++|.+++.......+++..++.++.|++.||+|||+.   +|+|+||+|+||+++.++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence                  46789999999999999998765545688999999999999999999999   999999999999999999999


Q ss_pred             EeecccceeccCCCcceeecccccccccChhhhc-----cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhh
Q 014904          186 VADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDW  260 (416)
Q Consensus       186 l~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~-----~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~  260 (416)
                      |+|||++......... .....|++.|+|||.+.     ...++.++|||||||++|||++|+.||....+......   
T Consensus       162 l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~---  237 (282)
T cd06636         162 LVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL---  237 (282)
T ss_pred             EeeCcchhhhhccccC-CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh---
Confidence            9999998755332221 23356899999999875     34688899999999999999999999965432111000   


Q ss_pred             hhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          261 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                             . ...     ..+...   .......+.+++.+||+.+|.+||++.||++
T Consensus       238 -------~-~~~-----~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 -------I-PRN-----PPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -------H-hhC-----CCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                   0 000     011111   1123457899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-37  Score=297.62  Aligned_cols=266  Identities=21%  Similarity=0.326  Sum_probs=202.9

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ++|+....||+|+||.||+|... +++.||+|++....  ....+.+.+|+.++++++|+|++++++++......++|+|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            47889999999999999999965 68999999986442  2223567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|..++....  .+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            999998888775433  589999999999999999999998   999999999999999999999999999987654332


Q ss_pred             ceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh---HHhHH---hhhcCC
Q 014904          201 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR---PLLNR---AIEDGN  273 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~---~~~~~---~~~~~~  273 (416)
                       ......++..|+|||++.+ ..++.++||||||+++++|++|+.||.......  .+..+..   .....   ......
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChHHhhhccccc
Confidence             1223457889999999876 468899999999999999999999997654321  1111110   00000   000011


Q ss_pred             -cccccCccccCcCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          274 -FDTLVDPKLHNEYN-----HNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       274 -~~~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                       +..+..+......+     ......+.+++.+||+.+|++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence             01111111111111     122457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-38  Score=300.24  Aligned_cols=253  Identities=25%  Similarity=0.370  Sum_probs=204.5

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +++|.+.+.||+|+||.||+|.. .+++.+|+|++..........+..|+.++++++|+|++++++++......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            46789999999999999999996 46899999999866555556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|..++..... .+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++.........
T Consensus        84 ~~~~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          84 CDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             cCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence            999999999875433 689999999999999999999999   9999999999999999999999999998765432222


Q ss_pred             eeecccccccccChhhhc-----cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          202 VSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~-----~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                       .....+++.|+|||++.     ...++.++||||||+++|+|++|+.||......  ..+..         +..+....
T Consensus       160 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~---------~~~~~~~~  227 (280)
T cd06611         160 -RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLK---------ILKSEPPT  227 (280)
T ss_pred             -cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHH---------HhcCCCCC
Confidence             23356899999999975     345788999999999999999999999764321  11111         11221111


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      +..       +......+.+++.+||+.+|.+||++.+|++.
T Consensus       228 ~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         228 LDQ-------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             cCC-------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            111       11223467889999999999999999999754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.7e-38  Score=309.31  Aligned_cols=237  Identities=25%  Similarity=0.343  Sum_probs=188.1

Q ss_pred             ceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHH-HHHhcCCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVE-IISRVHHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ++||+|+||.||+|.. .+++.||+|++.....   .....+..|.. +++.++||||+++++++.+....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999996 4688999999875322   12234455544 67889999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      ++|..++....  .++......++.|++.||.|||+.   +|+||||||+||+|+.++.+||+|||+++....... ...
T Consensus        81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (321)
T cd05603          81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTS  154 (321)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-ccc
Confidence            99988886543  578888899999999999999998   999999999999999999999999999875322221 223


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccC
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHN  284 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~  284 (416)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ....     ..+..+..          
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~-----~~i~~~~~----------  213 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMY-----DNILHKPL----------  213 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHH-----HHHhcCCC----------
Confidence            46799999999999988999999999999999999999999976432      1111     11111111          


Q ss_pred             cCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 014904          285 EYNHNEMARMVACAAACVRHSARRRPRMS  313 (416)
Q Consensus       285 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~  313 (416)
                      ..+......+.+++.+||+.+|.+||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            11222345788999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.9e-39  Score=317.24  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=214.1

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCccc--HHHHHHHHHHHHhcCCCcccceEEEEEeCCe-EEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQG--EREFQAEVEIISRVHHKHLVSLVGYYTAGSQ-RMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~  119 (416)
                      ++|...++||+|.||.++...++ +++.+|+|++.......  ++....|+.++++++|||||...+.+++++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999998854 67899999998654333  3457889999999999999999999998888 99999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      +|++||++.+.+....+..++...+++++.|++.|+.|||+.   +|+|||||+.|||++.+..+||.|||+|+......
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            999999999999877777899999999999999999999988   99999999999999999999999999999887654


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                      . ....+.||+-|+.||.+.+.+|..|+|||||||++|||++-+++|...+.   ..       ++.+ +-.+.    . 
T Consensus       161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---~~-------Li~k-i~~~~----~-  223 (426)
T KOG0589|consen  161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---SE-------LILK-INRGL----Y-  223 (426)
T ss_pred             h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---HH-------HHHH-Hhhcc----C-
Confidence            2 34458899999999999999999999999999999999999999987653   11       1111 11111    1 


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                          ...+......+..++..|++.+|+.||++.+++..
T Consensus       224 ----~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  224 ----SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ----CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                12333455688999999999999999999999976

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.9e-38  Score=301.32  Aligned_cols=248  Identities=29%  Similarity=0.484  Sum_probs=197.4

Q ss_pred             ceecccCcEEEEEEEeCC-------CcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           50 NLLGQGGFGYVHRGVLPN-------GKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +.||+|+||.||+|...+       ++.+|||.+..... .....+.+|+.+++.++||||+++++++......++|+||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999999642       25799998865432 3345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC-----ceEEeeccc
Q 014904          122 VPNNTLEFHLHGK-----GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-----EAKVADFGL  191 (416)
Q Consensus       122 ~~~~sL~~~l~~~-----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~-----~~kl~DFGl  191 (416)
                      +++++|.+++...     ....+++..++.++.+++.||.|||+.   +++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998643     223578999999999999999999998   999999999999999887     899999999


Q ss_pred             ceeccCCCc-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhh
Q 014904          192 AKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAI  269 (416)
Q Consensus       192 a~~~~~~~~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~  269 (416)
                      ++....... .......++..|+|||++.++.++.++|||||||++|||++ |+.||.....   ......        +
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~--------~  226 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQH--------V  226 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHH--------H
Confidence            875533221 11223345788999999999999999999999999999998 9999865432   111111        1


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      ..+..         ...+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       227 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         227 TAGGR---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             hcCCc---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            11110         0112233467889999999999999999999999986

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.3e-39  Score=318.49  Aligned_cols=203  Identities=26%  Similarity=0.384  Sum_probs=175.5

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|...+.||+|+||.||++... +++.||||++....   ......+..|+.++..++|+||+++++.+.+....++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999954 68999999997532   222356788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            9999999999987544  588999999999999999999999   99999999999999999999999999987442211


Q ss_pred             c----------------------------------ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCC
Q 014904          200 T----------------------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP  245 (416)
Q Consensus       200 ~----------------------------------~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~p  245 (416)
                      .                                  .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            0                                  011235799999999999999999999999999999999999999


Q ss_pred             CCCCCc
Q 014904          246 VDSTHT  251 (416)
Q Consensus       246 f~~~~~  251 (416)
                      |....+
T Consensus       236 f~~~~~  241 (360)
T cd05627         236 FCSETP  241 (360)
T ss_pred             CCCCCH
Confidence            976543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-38  Score=300.92  Aligned_cols=254  Identities=28%  Similarity=0.424  Sum_probs=203.9

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCc----EEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGK----EVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      .+|.+.+.||+|+||.||+|.+. +|.    .+|+|.+..... ....++.+|+.++.+++|+||++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            57888899999999999999954 333    589998876543 234578899999999999999999999987 78899


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      |+||+++++|.+++..... .+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++....
T Consensus        86 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            9999999999999976543 589999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCccee-ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          198 VNTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       198 ~~~~~~-~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ...... ....++..|+|||.+....++.++||||||++++||++ |+.||.....   ..+..        .+..+.. 
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~--------~~~~~~~-  229 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VEIPD--------LLEKGER-  229 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HHHHH--------HHhCCCC-
Confidence            333221 11224567999999988899999999999999999999 9999876432   11111        1112211 


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                       ...       +..+...+..++.+||..+|.+||++.++++.|+..
T Consensus       230 -~~~-------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         230 -LPQ-------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             -CCC-------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence             111       111234688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.1e-37  Score=294.51  Aligned_cols=251  Identities=24%  Similarity=0.335  Sum_probs=190.2

Q ss_pred             eecccCcEEEEEEEeCC---CcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCC
Q 014904           51 LLGQGGFGYVHRGVLPN---GKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT  126 (416)
Q Consensus        51 ~LG~G~~g~Vy~~~~~~---g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~s  126 (416)
                      .||+|+||.||+|...+   ...+|+|.+..... .....+.+|+.+++.++|+||++++++|......++||||+++++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997533   35688887764432 223568899999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc-e
Q 014904          127 LEFHLHGKGR---PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH-V  202 (416)
Q Consensus       127 L~~~l~~~~~---~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~  202 (416)
                      |.+++.....   ...++...+.++.|++.||+|||+.   +|+||||||.|||++.++.+||+|||++......... .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999875432   2356788899999999999999999   9999999999999999999999999998654322211 1


Q ss_pred             eecccccccccChhhhcc-------CCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          203 STRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~-------~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |+.||......  +.        +...+..+ .
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~--------~~~~~~~~-~  227 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QV--------LKQVVREQ-D  227 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HH--------HHHHhhcc-C
Confidence            123346778999998743       356889999999999999999 78888654321  11        11111111 1


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      ..+.++.+...    ....+..++..|+ .+|++||++.+|++.|.
T Consensus       228 ~~~~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         228 IKLPKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ccCCCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            22333333322    2345667788888 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.4e-37  Score=296.19  Aligned_cols=252  Identities=23%  Similarity=0.366  Sum_probs=190.8

Q ss_pred             ceecccCcEEEEEEEeCCC---cEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCC
Q 014904           50 NLLGQGGFGYVHRGVLPNG---KEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNN  125 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~g---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~  125 (416)
                      +.||+|+||.||+|...++   ..+++|.++.... .....+.+|+.+++.++||||+++++.|......++||||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999985443   3566777665432 33467899999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC-Ccce
Q 014904          126 TLEFHLHGKG--RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV-NTHV  202 (416)
Q Consensus       126 sL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~-~~~~  202 (416)
                      +|..+++...  ...+++...+.++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++...... ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999987542  23467778889999999999999998   9999999999999999999999999997643211 1112


Q ss_pred             eecccccccccChhhhcc-------CCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          203 STRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~-------~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||.....   ..   .    +...+ .+..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~---~----~~~~~-~~~~  226 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---RE---V----LNHVI-KDQQ  226 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HH---H----HHHHH-hhcc
Confidence            233567889999998743       245789999999999999997 5667754332   11   1    11111 1222


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      ..+.++.+...++    ..+.+++..|+ .+|++||++.+|++.|-
T Consensus       227 ~~~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         227 VKLFKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cccCCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2344444443333    46777888899 67999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.4e-38  Score=299.36  Aligned_cols=265  Identities=22%  Similarity=0.295  Sum_probs=198.2

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +|.+.+.||+|++|.||+|... +++.||||+++....  .....+.+|+.++.+++|+||+++++++.++...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999964 689999999875432  2235788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          122 VPNNTLEFHLHGKG-RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       122 ~~~~sL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      +. ++|..++.... ...+++..++.++.|+++||.|||+.   +++|+||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 57877776433 24689999999999999999999999   99999999999999999999999999987654322 


Q ss_pred             ceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHh---HHh----hhcC
Q 014904          201 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLL---NRA----IEDG  272 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~---~~~----~~~~  272 (416)
                      .......+++.|+|||++.+. .++.++|||||||++++|+||+.||......  ..+........   ...    ....
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhcchhhH
Confidence            122334578899999988654 5789999999999999999999999765431  11111100000   000    0000


Q ss_pred             C----cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          273 N----FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       273 ~----~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      +    +.......+. .........+.+++.+||+.+|.+||++.+|++
T Consensus       234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         234 DYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0    0000000000 001113356789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.7e-38  Score=302.63  Aligned_cols=263  Identities=26%  Similarity=0.395  Sum_probs=208.5

Q ss_pred             cccCHHHHHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEEE
Q 014904           32 STFTYEELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYY  109 (416)
Q Consensus        32 ~~f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  109 (416)
                      ..|+++++..++++|.+.+.||+|+||.||++.. .+++.+|+|++..... ....+.+|+.++.++ +|+|++++++++
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~   88 (291)
T cd06639          10 SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMF   88 (291)
T ss_pred             hhhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence            3477789999999999999999999999999995 5688999999875432 235678899999999 899999999998


Q ss_pred             EeC-----CeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC
Q 014904          110 TAG-----SQRMLVYEFVPNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF  182 (416)
Q Consensus       110 ~~~-----~~~~lV~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~  182 (416)
                      ...     ...++|+||+++++|.++++..  ....+++..++.++.+++.||.|||+.   +++|+||||+||+++.++
T Consensus        89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~  165 (291)
T cd06639          89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG  165 (291)
T ss_pred             EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence            753     3589999999999999988632  233689999999999999999999998   999999999999999999


Q ss_pred             ceEEeecccceeccCCCcceeecccccccccChhhhccCC-----CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhh
Q 014904          183 EAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK-----LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL  257 (416)
Q Consensus       183 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~-----~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l  257 (416)
                      .+||+|||++......... .....|+..|+|||++....     ++.++|||||||++|||++|+.||......  ..+
T Consensus       166 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~  242 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTL  242 (291)
T ss_pred             CEEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHH
Confidence            9999999998765432221 22346889999999986443     689999999999999999999998754321  111


Q ss_pred             hhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..+         ..+....+.++       ......+.+++.+|++.+|++||++.||++
T Consensus       243 ~~~---------~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         243 FKI---------PRNPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHH---------hcCCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            111         11111111111       122346899999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.9e-38  Score=302.67  Aligned_cols=268  Identities=24%  Similarity=0.384  Sum_probs=202.4

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ++|+..++||+|+||.||+|... +++.||+|++......  ....+.+|+++++.++|+||+++++++..+...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            47888999999999999999965 5899999998654322  23568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |++++.|..+.....  .+++..++.++.++++||+|||+.   +++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-  154 (286)
T cd07846          81 FVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  154 (286)
T ss_pred             cCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence            999999988775443  489999999999999999999998   99999999999999999999999999988664433 


Q ss_pred             ceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc-hhhhhhhhHHhHH---hhhcCC-c
Q 014904          201 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE-DSLVDWARPLLNR---AIEDGN-F  274 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~-~~l~~~~~~~~~~---~~~~~~-~  274 (416)
                      .......++..|+|||++.+ ..++.++||||||++++||++|+.||........ ..+..+...+...   ...... .
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence            22233567899999999875 4578899999999999999999999875432111 0111111000000   000000 0


Q ss_pred             ccccCccccCc-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          275 DTLVDPKLHNE-----YNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       275 ~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .....+.....     ........+.+++.+||+.+|++||++.+|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00001111000     01123467899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.4e-37  Score=309.65  Aligned_cols=268  Identities=22%  Similarity=0.285  Sum_probs=199.2

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeC-----
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAG-----  112 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  112 (416)
                      ...++|.+.+.||+|+||.||++.. ..++.||||++....  ......+.+|+.+++.++|+||+++++++...     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            3568999999999999999999995 468899999997542  22335678899999999999999999987543     


Q ss_pred             -CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          113 -SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       113 -~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                       ...++||||+++ +|...+..    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence             357999999965 66666643    478889999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhh------------h
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV------------D  259 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~------------~  259 (416)
                      ++......  ......||..|+|||++.+..++.++|||||||++|+|++|+.||...........+            .
T Consensus       173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            98654322  223356899999999999999999999999999999999999999765432110000            0


Q ss_pred             hhhHHhHHhhhcC-Ccccc----cCccc----cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          260 WARPLLNRAIEDG-NFDTL----VDPKL----HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       260 ~~~~~~~~~~~~~-~~~~~----~d~~l----~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ...+.+.....+. .+...    ..+..    ....+......+.+++.+|++.||.+||++.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000000111100 00000    00000    001111123467899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.2e-37  Score=292.92  Aligned_cols=255  Identities=26%  Similarity=0.412  Sum_probs=206.2

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ++|++.+.||.|+||+||+|.. .++..+++|++..... .....+.+|+.+++.++|+|++++++.+..+...++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4789999999999999999995 4688999999875432 2446789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          122 VPNNTLEFHLHGKGR-PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      +++++|.+++..... ..+++.....++.|++.||++||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999975432 4689999999999999999999998   999999999999999999999999999876654332


Q ss_pred             c---eeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          201 H---VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       201 ~---~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      .   ......|+..|+|||++... .++.++|||||||++++|++|+.||......  ..+..        ... ..   
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~--------~~~-~~---  223 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLML--------TLQ-ND---  223 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHH--------Hhc-CC---
Confidence            2   22345689999999999877 7899999999999999999999999765431  11111        111 11   


Q ss_pred             ccCccccCcC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          277 LVDPKLHNEY-NHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       277 ~~d~~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                        .+.+.... .......+.+++.+|++.+|++||++.+|++
T Consensus       224 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         224 --PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             --CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence              11111111 1233467889999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.2e-38  Score=297.14  Aligned_cols=249  Identities=27%  Similarity=0.377  Sum_probs=192.8

Q ss_pred             ceecccCcEEEEEEEeC----CCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEE-eCCeEEEEEEecC
Q 014904           50 NLLGQGGFGYVHRGVLP----NGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYT-AGSQRMLVYEFVP  123 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~~  123 (416)
                      ++||+|+||.||+|.+.    ....+|+|.+.... ......+.+|+.+++.++||||+++++++. .+...++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    24579999886432 233457889999999999999999999876 4556889999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc--
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH--  201 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~--  201 (416)
                      +++|..++..... .+.+..++.++.+++.||+|||+.   +++||||||+|||++.++.+||+|||+++........  
T Consensus        81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            9999999975433 467888899999999999999998   9999999999999999999999999998755332111  


Q ss_pred             -eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhC-CCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          202 -VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG-RRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       202 -~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG-~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                       ......++..|+|||++.+..++.++|||||||++|||++| ..||.....   ..+..        .+..+..     
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~--------~~~~~~~-----  220 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITV--------YLLQGRR-----  220 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH--------HHhcCCC-----
Confidence             11234567789999999888999999999999999999995 555644322   11111        1112211     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      +..    +...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       221 ~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         221 LLQ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             CCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            000    111235788999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=9.9e-38  Score=296.51  Aligned_cols=249  Identities=26%  Similarity=0.424  Sum_probs=195.2

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-----ccHHHHHHHHHHHHhcCCCcccceEEEEEe--CCeE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG-----QGEREFQAEVEIISRVHHKHLVSLVGYYTA--GSQR  115 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  115 (416)
                      .+|...++||+|+||.||+|.. .+++.|++|++.....     .....+.+|+.++++++|+||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4789999999999999999995 4689999999875422     122457889999999999999999999875  3678


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++|+||+++++|.+++....  .+++...+.++.|++.||+|||+.   +|+|+||+|+||+++.++.+||+|||+++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            89999999999999987544  488999999999999999999998   9999999999999999999999999998754


Q ss_pred             cCCCcc--eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          196 SDVNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       196 ~~~~~~--~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      ......  ......++..|+|||++.+..++.++|||||||++|||++|+.||.......     .     +....... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~-----~~~~~~~~-  225 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----A-----IFKIATQP-  225 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----H-----HHHHhcCC-
Confidence            321111  1123468899999999998889999999999999999999999997543210     0     00000011 


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                          ..+.+    +......+..++ +|+..+|++||+|.||++
T Consensus       226 ----~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 ----TNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ----CCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                11111    222233455555 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.5e-38  Score=295.52  Aligned_cols=251  Identities=27%  Similarity=0.451  Sum_probs=203.2

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +|...+.||+|+||.||+|.. .+++.|++|.++.....  ..+.+..|+.++++++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            588889999999999999995 47899999999866543  456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.+++....  .+++..+..|+.+++.||.|||+.   +++|+||+|.||+++.++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            99999999997643  478899999999999999999999   9999999999999999999999999998876544332


Q ss_pred             eee---cccccccccChhhhccCC---CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          202 VST---RVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       202 ~~~---~~~gt~~YlaPE~~~~~~---~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ...   ...++..|+|||++.+..   .+.++||||||+++++|++|+.||.....       .|....   .+..+.. 
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-------~~~~~~---~~~~~~~-  224 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-------EFQIMF---HVGAGHK-  224 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-------hHHHHH---HHhcCCC-
Confidence            222   356788999999998766   88999999999999999999999975431       111000   0111111 


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                          +.+...  ......+.+++.+||+.+|.+||++.+++.
T Consensus       225 ----~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 ----PPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ----CCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                111111  112456789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-39  Score=289.55  Aligned_cols=264  Identities=22%  Similarity=0.311  Sum_probs=210.4

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCC---
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGS---  113 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  113 (416)
                      .+...-++|++.++||+|||+.||++. ..+++-+|+|++...+.++.+..++|++..++++|||++++++++..+.   
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            344456799999999999999999999 6789999999999888777788999999999999999999998875433   


Q ss_pred             --eEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeec
Q 014904          114 --QRMLVYEFVPNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF  189 (416)
Q Consensus       114 --~~~lV~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DF  189 (416)
                        ..||+++|...|+|.+.+...  ++..+++.+.+.|+.++++||.+||+. .+.+.||||||.|||+.+.+.++|.||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence              489999999999999888643  334799999999999999999999998 234999999999999999999999999


Q ss_pred             ccceeccCCC--ccee------ecccccccccChhhhc---cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhh
Q 014904          190 GLAKIASDVN--THVS------TRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV  258 (416)
Q Consensus       190 Gla~~~~~~~--~~~~------~~~~gt~~YlaPE~~~---~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~  258 (416)
                      |.+....-.-  .+..      ..-..|..|.|||++.   +..+++++|||||||+||+|+.|..||+..-.       
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-------  246 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-------  246 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-------
Confidence            9987542110  0000      1124688999999984   45689999999999999999999999975322       


Q ss_pred             hhhhHHhHHhhhcCCccc--ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          259 DWARPLLNRAIEDGNFDT--LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~--~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                                  .|.--.  +..+.+...-.....+.+.+++.+|++.||.+||++.+++..++.
T Consensus       247 ------------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  247 ------------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             ------------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence                        121111  112222211122255789999999999999999999999998864

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.3e-37  Score=301.41  Aligned_cols=269  Identities=20%  Similarity=0.309  Sum_probs=200.4

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .++|.+.+.||+|+||.||+|... +++.||+|.++.... .....+..|+.+++.++|+||+++++++......++|+|
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            367899999999999999999954 688999999875432 223467789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |++ ++|..++..... .+++..+..++.|+++||.|||+.   +|+|+||||+||+++.++.+||+|||++........
T Consensus        85 ~~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          85 YLD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             ccc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            997 578877765433 588999999999999999999999   999999999999999999999999999876443222


Q ss_pred             ceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhh-hhhhh----HHhHHhhhcCCc
Q 014904          201 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL-VDWAR----PLLNRAIEDGNF  274 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l-~~~~~----~~~~~~~~~~~~  274 (416)
                      . .....+++.|+|||++.+. .++.++|||||||++|||++|+.||........... .....    ..+........+
T Consensus       160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         160 T-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             c-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence            1 1234578899999998654 578999999999999999999999976543111000 00000    000000111111


Q ss_pred             ccccCccccCc----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          275 DTLVDPKLHNE----YNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       275 ~~~~d~~l~~~----~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .....+.....    ........+.+++.+||+.+|.+||++.||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11111111111    11122346789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.9e-38  Score=300.28  Aligned_cols=240  Identities=23%  Similarity=0.382  Sum_probs=190.4

Q ss_pred             ceecccCcEEEEEEEeCC--------CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           50 NLLGQGGFGYVHRGVLPN--------GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +.||+|+||.||+|....        ...+++|.+..........+.+|+.+++.++|||++++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998532        234888887654444446788999999999999999999999998999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc--------eEEeecccce
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE--------AKVADFGLAK  193 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~--------~kl~DFGla~  193 (416)
                      +++++|..++..... .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.        ++++|||++.
T Consensus        81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999976543 689999999999999999999999   9999999999999987765        5899999886


Q ss_pred             eccCCCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCC-CCCCCCCcccchhhhhhhhHHhHHhhhc
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGR-RPVDSTHTFVEDSLVDWARPLLNRAIED  271 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~-~pf~~~~~~~~~~l~~~~~~~~~~~~~~  271 (416)
                      .....     ....++..|+|||++.+. .++.++|||||||++|||++|. .|+........   ..        ... 
T Consensus       157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~--------~~~-  219 (258)
T cd05078         157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQ--------FYE-  219 (258)
T ss_pred             ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HH--------HHH-
Confidence            54321     224578899999999864 5799999999999999999985 55544322110   00        000 


Q ss_pred             CCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          272 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       272 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      ..          ...+......+.+++.+||+.+|++||++.+|++.|+
T Consensus       220 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 DR----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             cc----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00          0111122346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.6e-38  Score=305.14  Aligned_cols=255  Identities=29%  Similarity=0.462  Sum_probs=201.0

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCc----EEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGK----EVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      .++|...+.||+|+||.||+|.+ .+|.    .+|+|.+...... ...++.+|+.+++.++|+||++++++|... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            35678889999999999999985 3444    4788888754332 234688999999999999999999999764 467


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +|+||+++++|.+++..... .+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+++...
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eeehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence            89999999999999875432 588999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          197 DVNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       197 ~~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ...... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.....   ..+.++        +..+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~--------~~~~~~  229 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDL--------LEKGER  229 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH--------HHCCCC
Confidence            433221 122345778999999998899999999999999999998 8999865322   112221        111111


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                        ...       +......+..++..|+..+|++||++.+|++.|+..
T Consensus       230 --~~~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         230 --LPQ-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             --CCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              111       111234688999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-38  Score=300.07  Aligned_cols=269  Identities=23%  Similarity=0.353  Sum_probs=205.4

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ++|+..+.||+|+||.||+|.+. +++.||||+++...  ......+.+|+.++++++|+||+++++++..+...++|+|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            47889999999999999999965 58899999987542  2234578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |++++.+..++....  .+++..++.++.+++.||.|||+.   +++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          81 YVERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             cCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            999877776664432  489999999999999999999999   999999999999999999999999999987665444


Q ss_pred             ceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhh-hhhhhHHhH----HhhhcCCc
Q 014904          201 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL-VDWARPLLN----RAIEDGNF  274 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l-~~~~~~~~~----~~~~~~~~  274 (416)
                      .......++..|+|||++.+. .++.++||||||+++|+|++|+.||........... ..+......    .......+
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            333456788999999999888 889999999999999999999999975432111000 000000000    00001111


Q ss_pred             cc--ccCcc----ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          275 DT--LVDPK----LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       275 ~~--~~d~~----l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..  +.+..    +...++......+.+++.+||..+|++||++.+|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00  00000    001122223567999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.1e-37  Score=301.88  Aligned_cols=196  Identities=22%  Similarity=0.355  Sum_probs=160.7

Q ss_pred             CceecccCcEEEEEEEeC---CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEe--CCeEEEEEEecC
Q 014904           49 ANLLGQGGFGYVHRGVLP---NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA--GSQRMLVYEFVP  123 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~  123 (416)
                      ..+||+|+||.||+|...   +++.||+|++.....  ...+.+|+.++++++||||+++++++..  +...++|+||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            358999999999999954   468899999875432  3457889999999999999999998864  456899999985


Q ss_pred             CCCHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE----CCCCceEEeecccc
Q 014904          124 NNTLEFHLHGK-------GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL----DFKFEAKVADFGLA  192 (416)
Q Consensus       124 ~~sL~~~l~~~-------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl----~~~~~~kl~DFGla  192 (416)
                      + +|..++...       ....+++..+..++.|++.||.|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4 676666421       122588999999999999999999999   99999999999999    45678999999999


Q ss_pred             eeccCCCcc--eeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCC
Q 014904          193 KIASDVNTH--VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTH  250 (416)
Q Consensus       193 ~~~~~~~~~--~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~  250 (416)
                      +........  ......||+.|+|||++.+. .++.++|||||||+++||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            876543221  12346789999999998764 58999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-38  Score=297.67  Aligned_cols=254  Identities=28%  Similarity=0.424  Sum_probs=202.9

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEEEEeCC-----
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGS-----  113 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  113 (416)
                      .++++|.+.+.||+|++|.||+|... +++.+++|++..... ....+..|+.+++++ .|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            46799999999999999999999964 678999999876543 346789999999999 7999999999997644     


Q ss_pred             -eEEEEEEecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecc
Q 014904          114 -QRMLVYEFVPNNTLEFHLHGKG--RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG  190 (416)
Q Consensus       114 -~~~lV~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFG  190 (416)
                       ..++||||+++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999886533  34689999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCCcceeecccccccccChhhhcc-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHh
Q 014904          191 LAKIASDVNTHVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLL  265 (416)
Q Consensus       191 la~~~~~~~~~~~~~~~gt~~YlaPE~~~~-----~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~  265 (416)
                      ++......... .....|+..|+|||++..     ..++.++|||||||++++|++|+.||......  ..+.       
T Consensus       159 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~-------  228 (275)
T cd06608         159 VSAQLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALF-------  228 (275)
T ss_pred             cceecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHH-------
Confidence            98765433222 233568999999998753     34778999999999999999999999653321  1111       


Q ss_pred             HHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          266 NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       266 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                       . +..+....+       ..+......+.+++.+||..+|++||++.+|++
T Consensus       229 -~-~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         229 -K-IPRNPPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -H-hhccCCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             1 111111111       111224457889999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-37  Score=313.50  Aligned_cols=263  Identities=21%  Similarity=0.249  Sum_probs=198.5

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC---CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP---NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ..+|.+.+.||+|+||.||++...   .+..||||.+...     ..+.+|+.++++++|+||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999843   3578999988643     24568999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      |++. ++|..++...  ..+++..++.|+.|++.||.|||+.   +|+||||||+|||++.++.++|+|||+++......
T Consensus       166 e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        166 PKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             hhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            9985 5777777433  3689999999999999999999999   99999999999999999999999999997655432


Q ss_pred             cc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccc-chhhhhhhhHH-------------
Q 014904          200 TH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFV-EDSLVDWARPL-------------  264 (416)
Q Consensus       200 ~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~-~~~l~~~~~~~-------------  264 (416)
                      .. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+......+             
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence            22 2234679999999999999999999999999999999999999997654321 11111111000             


Q ss_pred             -hHHhhhcCCcccccCcccc--CcC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          265 -LNRAIEDGNFDTLVDPKLH--NEY-NHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       265 -~~~~~~~~~~~~~~d~~l~--~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                       +...+..  +.....+...  ... .......+..++.+||+.+|++||++.|++..
T Consensus       320 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        320 NLCKHFKQ--YAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hHHHHHHh--hcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence             0000000  0000000000  000 00123467789999999999999999999865

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.2e-38  Score=308.45  Aligned_cols=257  Identities=26%  Similarity=0.393  Sum_probs=203.7

Q ss_pred             CCCCcCceecccCcEEEEEEEeC--------CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhc-CCCcccceEEEEEeCC
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP--------NGKEVAIKQLKAGSG-QGEREFQAEVEIISRV-HHKHLVSLVGYYTAGS  113 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  113 (416)
                      .+|.+.+.||+|+||.||+|...        ....||+|.++.... ....++..|+.++.++ +|+||++++++|....
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46889999999999999999742        123689998875432 2345788999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKG--------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD  179 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~  179 (416)
                      ..++|+||+++++|.+++....              ...++|..++.++.|++.||+|||+.   +|+||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence            9999999999999999986432              23588999999999999999999998   999999999999999


Q ss_pred             CCCceEEeecccceeccCCCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhh
Q 014904          180 FKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSL  257 (416)
Q Consensus       180 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l  257 (416)
                      .++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.....      
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------  242 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------  242 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------
Confidence            99999999999998654432221 122334567999999999999999999999999999999 8888865432      


Q ss_pred             hhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      .++..     .+..+...         ..+......+.+++.+|++.+|.+||+|.||++.|+...
T Consensus       243 ~~~~~-----~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         243 EELFK-----LLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HHHHH-----HHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            11111     11111111         111123457889999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-37  Score=295.66  Aligned_cols=254  Identities=24%  Similarity=0.431  Sum_probs=199.9

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc----------cHHHHHHHHHHHHhcCCCcccceEEEEEeCC
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ----------GEREFQAEVEIISRVHHKHLVSLVGYYTAGS  113 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  113 (416)
                      +|...+.||+|+||.||+|.. .+|+.+|+|.++.....          ..+.+..|+.+++.++|+|++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467789999999999999984 46899999988642111          0135778999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ..++|+||+++++|.+++...+  .+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            9999999999999999987653  589999999999999999999998   99999999999999999999999999987


Q ss_pred             eccCCCcce-eecccccccccChhhhccCC--CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh
Q 014904          194 IASDVNTHV-STRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       194 ~~~~~~~~~-~~~~~gt~~YlaPE~~~~~~--~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~  270 (416)
                      ......... .....|+..|+|||++....  ++.++||||||+++++|++|..||.....     ...+.     .. .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~-----~~-~  225 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAMF-----KL-G  225 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHHH-----Hh-h
Confidence            654322221 23356889999999987654  78999999999999999999999864332     11110     00 0


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .....    +.............+.+++.+|++.+|.+||++.+|++.
T Consensus       226 ~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         226 NKRSA----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ccccC----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11111    111111212234678899999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.6e-37  Score=290.93  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=208.3

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ++|.+.++||+|++|.||+|... +++.|+||++..... .....+..|+.++.+++|+|++++++++......++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            47889999999999999999965 599999999886654 3346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHE-DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      +++++|.+++...  ..+++..++.++.++++||+|||+ .   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999999999754  368999999999999999999999 8   999999999999999999999999999987654332


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                      . .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..........+..+        +..+..     +
T Consensus       156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--------~~~~~~-----~  221 (264)
T cd06623         156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA--------ICDGPP-----P  221 (264)
T ss_pred             c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH--------HhcCCC-----C
Confidence            2 2345688999999999999999999999999999999999999976542111111111        111111     1


Q ss_pred             cccCcCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          281 KLHNEYNHN-EMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       281 ~l~~~~~~~-~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .    .+.. .+..+.+++.+|+..+|.+||++.+|++.
T Consensus       222 ~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         222 S----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             C----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1    1122 44689999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.2e-37  Score=293.89  Aligned_cols=253  Identities=23%  Similarity=0.365  Sum_probs=203.2

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEe--CCeEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTA--GSQRMLVY  119 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~  119 (416)
                      +|.+.+.||.|+||.||++.. .+++.+|+|.+.....  .....+..|+.+++.++|+||+++++++..  +...++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            478889999999999999994 5688999999875432  233568889999999999999999998764  45679999


Q ss_pred             EecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          120 EFVPNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDC--HPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       120 e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ||+++++|..++...  ....+++..++.++.+++.||.|||..+  ..+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998643  2346899999999999999999999332  239999999999999999999999999999876


Q ss_pred             cCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ...... .....++..|+|||++.+..++.++||||||+++++|++|+.||.....   ..+.        +.+..+.+.
T Consensus       161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~--------~~~~~~~~~  228 (265)
T cd08217         161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLA--------SKIKEGKFR  228 (265)
T ss_pred             cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHH--------HHHhcCCCC
Confidence            543321 2335689999999999988999999999999999999999999976442   1111        112222221


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                               ..+......+.+++.+|++.+|.+||++.+|++.
T Consensus       229 ---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 ---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                     1222344678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.2e-37  Score=299.77  Aligned_cols=249  Identities=22%  Similarity=0.341  Sum_probs=201.2

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      .|.....||+|+||.||+|.. .+++.||+|++..........+.+|+.++..++|||++++++++..+...++|+||++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            344456799999999999995 4689999999976554555678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      +++|..++...   .+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++......... .
T Consensus       102 ~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~  174 (297)
T cd06659         102 GGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-R  174 (297)
T ss_pred             CCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-c
Confidence            99999887542   589999999999999999999999   9999999999999999999999999998755432221 2


Q ss_pred             ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcccc
Q 014904          204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLH  283 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~  283 (416)
                      ....|+..|+|||++.+..++.++|||||||+++||++|+.||....+..  .+. .        +.........     
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~-~--------~~~~~~~~~~-----  238 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMK-R--------LRDSPPPKLK-----  238 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH-H--------HhccCCCCcc-----
Confidence            33568999999999998899999999999999999999999997543211  111 0        1111110000     


Q ss_pred             CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          284 NEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       284 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                        ........+.+++.+|++.+|.+||++.+|++.
T Consensus       239 --~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         239 --NAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             --ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence              011123468899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-37  Score=297.31  Aligned_cols=253  Identities=25%  Similarity=0.393  Sum_probs=201.1

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ++|++.+.||+|+||.||++... +++.||+|.++.... .....+.+|+.++.+++|+||+++++++......++|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46888999999999999999965 789999999875422 2235788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          122 VPNNTLEFHLHGKG-RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       122 ~~~~sL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      +++++|..++.... ...+++..+..++.+++.||.|||+.+  +|+|+||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            99999998886532 236899999999999999999999743  89999999999999999999999999987653322 


Q ss_pred             ceeecccccccccChhhhccCC------CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGK------LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~------~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                        .....++..|+|||++.+..      ++.++|||||||++|+|++|+.||.....   .....   . + ..+..+..
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~---~-~-~~~~~~~~  227 (286)
T cd06622         158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFA---Q-L-SAIVDGDP  227 (286)
T ss_pred             --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHH---H-H-HHHhhcCC
Confidence              22345788999999986543      48899999999999999999999965322   11100   0 0 01111111


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                               ...+......+.+++.+|++.+|.+||++.+++..
T Consensus       228 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         228 ---------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             ---------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence                     11222345678899999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-37  Score=307.00  Aligned_cols=267  Identities=20%  Similarity=0.322  Sum_probs=199.0

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeC--
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAG--  112 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  112 (416)
                      ......++|...+.||+|+||.||+|.. .+++.||||++.....  .....+.+|+.++++++|+||+++++++...  
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878           9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            4556788999999999999999999995 5688999999875422  2234677899999999999999999887543  


Q ss_pred             ----CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEee
Q 014904          113 ----SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD  188 (416)
Q Consensus       113 ----~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~D  188 (416)
                          ...+++++++ +++|..++...   .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D  161 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD  161 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence                3568999987 78888877532   589999999999999999999999   999999999999999999999999


Q ss_pred             cccceeccCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh-----
Q 014904          189 FGLAKIASDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR-----  262 (416)
Q Consensus       189 FGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~-----  262 (416)
                      ||+++......    ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......  +.+..+..     
T Consensus       162 fg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~  235 (343)
T cd07878         162 FGLARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVVGTP  235 (343)
T ss_pred             CccceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCC
Confidence            99998654322    23568999999999876 56899999999999999999999999764321  11111100     


Q ss_pred             -HHhHHhhhcCC-------cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          263 -PLLNRAIEDGN-------FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       263 -~~~~~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                       +.....+....       +.......+...+ ......+.+++.+|++.+|.+||++.|++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CHHHHHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             00000000000       0000000000000 0112357899999999999999999999854

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.3e-37  Score=296.26  Aligned_cols=266  Identities=21%  Similarity=0.300  Sum_probs=203.2

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +|.+.+.||+|++|.||+|.. .+|+.||||++.....  .....+..|+.++++++|+||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            578889999999999999995 4789999999986542  2235788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      + +++|.+++.... ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.........
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            9 999999886544 3699999999999999999999999   9999999999999999999999999999876544322


Q ss_pred             eeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhH--------HhhhcC
Q 014904          202 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN--------RAIEDG  272 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~--------~~~~~~  272 (416)
                      ......|+..|+|||++.+. .++.++||||||++++||++|+++|......   ....+....+.        ...+..
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcc
Confidence            23345689999999998654 4689999999999999999998887654321   11111110000        000000


Q ss_pred             CcccccCcccc----CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          273 NFDTLVDPKLH----NEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       273 ~~~~~~d~~l~----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      +...+..+...    .....+....+.+++.+|++.+|++||++.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00000000000    01111234688999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8.7e-38  Score=299.32  Aligned_cols=266  Identities=19%  Similarity=0.253  Sum_probs=196.1

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +|...+.||+|+||.||+|.. .+|+.+|+|+++.....  ....+.+|+.++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            578889999999999999996 46899999998754222  224677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +.+ +|..++.... ..+++..++.++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  155 (284)
T cd07839          81 CDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC  155 (284)
T ss_pred             CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence            975 6776665433 2589999999999999999999999   9999999999999999999999999998765432221


Q ss_pred             eeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhh----------hhhHHhHHhhh
Q 014904          202 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD----------WARPLLNRAIE  270 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~----------~~~~~~~~~~~  270 (416)
                       .....++..|+|||++.+. .++.++|||||||++|+|++|+.|+...... ...+..          +..+.+.....
T Consensus       156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-HHHHHHHHHHhCCCChHHhHHhhhccc
Confidence             2234578899999998765 4789999999999999999999986543321 111100          00000000000


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ...+...................+.+++.+||+.+|.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00000000000000111123457889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.1e-37  Score=293.97  Aligned_cols=249  Identities=24%  Similarity=0.360  Sum_probs=196.3

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-----ccHHHHHHHHHHHHhcCCCcccceEEEEEeC--CeE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG-----QGEREFQAEVEIISRVHHKHLVSLVGYYTAG--SQR  115 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  115 (416)
                      ++|.+.++||+|+||.||+|.. .+++.||||++.....     .....+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5788999999999999999995 4689999998864321     1124678899999999999999999998763  467


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++|+||+++++|.+++....  .+++...+.++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            89999999999999986543  478888999999999999999999   9999999999999999999999999998754


Q ss_pred             cCCCcc--eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          196 SDVNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       196 ~~~~~~--~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      ......  ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.......     .     +....... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~-----~~~~~~~~-  225 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----A-----IFKIATQP-  225 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----H-----HHHHhcCC-
Confidence            322111  1123568899999999988889999999999999999999999986532210     0     00000000 


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                              .....+......+..++.+|+. +|++||++.+|++
T Consensus       226 --------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         226 --------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             --------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                    0111233444567888888985 8999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.4e-37  Score=298.82  Aligned_cols=251  Identities=23%  Similarity=0.392  Sum_probs=205.5

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      .++|.+.+.||+|+||.||++.. .+++.||+|.+..........+.+|+.+++.++|||++++++++......++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            37899999999999999999995 46889999998765544456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|..++...   .+++..+..++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||++.........
T Consensus        98 ~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             CCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            9999999998653   478999999999999999999999   9999999999999999999999999998765443322


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                       .....+++.|+|||++..+.++.++|||||||++|+|++|+.||........  +..+        ...+.      +.
T Consensus       172 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~~--------~~~~~------~~  234 (293)
T cd06647         172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLI--------ATNGT------PE  234 (293)
T ss_pred             -cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eeeh--------hcCCC------CC
Confidence             2234688899999999888899999999999999999999999976543111  0000        00000      00


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                        ..........+.+++.+||+.+|++||++.+++..
T Consensus       235 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         235 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              01112234568899999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3e-37  Score=300.43  Aligned_cols=195  Identities=23%  Similarity=0.358  Sum_probs=159.7

Q ss_pred             ceecccCcEEEEEEEeC---CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEe--CCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVLP---NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA--GSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~  124 (416)
                      .+||+|+||.||+|...   ++..||+|.+.....  ...+.+|+.++++++||||+++++++..  ....++|+||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            58999999999999964   457899999875432  3467889999999999999999999854  5678999999865


Q ss_pred             CCHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE----CCCCceEEeecccce
Q 014904          125 NTLEFHLHGK-------GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL----DFKFEAKVADFGLAK  193 (416)
Q Consensus       125 ~sL~~~l~~~-------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl----~~~~~~kl~DFGla~  193 (416)
                       +|.+++...       ....+++..+..++.|++.||.|||+.   +|+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             666555321       123588999999999999999999999   99999999999999    566789999999998


Q ss_pred             eccCCCcc--eeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCC
Q 014904          194 IASDVNTH--VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTH  250 (416)
Q Consensus       194 ~~~~~~~~--~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~  250 (416)
                      ........  ......||+.|+|||++.+. .++.++|||||||++|||+||+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            76543221  12335789999999998764 58999999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-37  Score=294.67  Aligned_cols=248  Identities=25%  Similarity=0.455  Sum_probs=201.0

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC-cccHHHHHHHHHHHHhcC---CCcccceEEEEEeCCeEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS-GQGEREFQAEVEIISRVH---HKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~  119 (416)
                      .|+..+.||+|+||.||+|.+ .+++.||+|.+.... .....++.+|+.++++++   |+|++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            577889999999999999995 578999999987543 233457889999999997   999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++...   .+++...+.++.+++.||.|||+.   +|+|+||+|+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            999999999988653   689999999999999999999999   99999999999999999999999999998765443


Q ss_pred             cceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          200 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      .. .....|+..|+|||++.++ .++.++|||||||++|+|++|+.||.......   ...+        +....     
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~--------~~~~~-----  218 (277)
T cd06917         156 SK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR---AMML--------IPKSK-----  218 (277)
T ss_pred             cc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh---hhhc--------cccCC-----
Confidence            22 2335689999999998765 46899999999999999999999997543211   0000        00111     


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .+.+...   ..+..+.+++.+||+.+|.+||++.++++.
T Consensus       219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            1111111   134578899999999999999999999863

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=306.20  Aligned_cols=252  Identities=27%  Similarity=0.347  Sum_probs=213.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCccc---HHHHHHHHHHHHhcC-CCcccceEEEEEeCCeEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQG---EREFQAEVEIISRVH-HKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  116 (416)
                      ....|.+.+.||+|.||.||+++.+ +|+.+|+|++.+.....   ...+.+|+.+|+++. |||||.+.+.+++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            4567888899999999999999965 49999999998765433   357899999999998 999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC----CceEEeecccc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK----FEAKVADFGLA  192 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~----~~~kl~DFGla  192 (416)
                      +|||++.||.|.+.+...   .++......++.+++.++.|||+.   +|+||||||+|+|+...    +.+|++|||++
T Consensus       113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            999999999999998766   389999999999999999999998   99999999999999543    47999999999


Q ss_pred             eeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcC
Q 014904          193 KIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDG  272 (416)
Q Consensus       193 ~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~  272 (416)
                      .....  .......+||+.|+|||++....++..+||||+||++|.|++|..||........           ...+..+
T Consensus       187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-----------~~~i~~~  253 (382)
T KOG0032|consen  187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-----------FLAILRG  253 (382)
T ss_pred             eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-----------HHHHHcC
Confidence            98876  4445668999999999999999999999999999999999999999987654211           1123344


Q ss_pred             CcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          273 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       273 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ++      .....+-........+++..|+..||.+|+++.++++.
T Consensus       254 ~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  254 DF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            44      12222333445678899999999999999999999983

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.2e-37  Score=293.03  Aligned_cols=253  Identities=26%  Similarity=0.422  Sum_probs=204.6

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ++|...+.||+|++|.||++.+. +++.+|+|++..... ....++.+|++++++++|+||+++++++......++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            46788899999999999999965 689999999876543 3345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHE-DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      +++++|.+++.... ..++......++.+++.||+|||+ .   +++|+||||+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            99999999987543 368899999999999999999999 7   999999999999999999999999999875543222


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                      .   ...++..|+|||++.+..++.++||||||+++++|++|+.||...... .....+.....     ..+..     +
T Consensus       157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~-----~~~~~-----~  222 (265)
T cd06605         157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYI-----VNEPP-----P  222 (265)
T ss_pred             h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHH-----hcCCC-----C
Confidence            2   166889999999999889999999999999999999999999764321 11122221111     11111     1


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .+...   .....+.+++.+|+..+|++||++.+++.
T Consensus       223 ~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         223 RLPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCChh---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            11111   13456889999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4e-37  Score=298.66  Aligned_cols=256  Identities=20%  Similarity=0.269  Sum_probs=203.7

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|...+.||+|+||.||++... .++.|++|.+.....   .....+.+|+.+++.++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47889999999999999999954 578999999876532   22346789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|..++....  .+++..+..++.+++.||.|||+.   +++||||||.||+++.++.+||+|||+++......
T Consensus        81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            9999999999996553  589999999999999999999998   99999999999999999999999999986421110


Q ss_pred             c--------------ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHh
Q 014904          200 T--------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLL  265 (416)
Q Consensus       200 ~--------------~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~  265 (416)
                      .              .......++..|+|||++....++.++|||||||++|||++|+.||......      ++..   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~---  226 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFG---  226 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH---
Confidence            0              0112245788999999998889999999999999999999999999754321      1111   


Q ss_pred             HHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          266 NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       266 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                        ....+...   .+...    ......+.+++.+||+.+|++||++.++.+.|+..
T Consensus       227 --~~~~~~~~---~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         227 --QVISDDIE---WPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             --HHHhcccC---CCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence              11111111   11111    12345689999999999999999988888887753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.3e-37  Score=296.72  Aligned_cols=266  Identities=23%  Similarity=0.280  Sum_probs=201.9

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc-----cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ-----GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      +|...+.||+|++|.||+|... +++.||||++......     ....+..|+.++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999954 6899999999865432     234567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+ +++|..++.... ..+++..++.++.|+++||.|||+.   +|+|+||+|+||+++.++.++|+|||+++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 899999997654 3689999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH---hHHh-hhcCC
Q 014904          199 NTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL---LNRA-IEDGN  273 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~---~~~~-~~~~~  273 (416)
                      ... .....+++.|+|||++.+ ..++.++|||||||+++||++|..+|.......  .+.......   .... .....
T Consensus       156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhhhhccc
Confidence            322 223456788999999855 467899999999999999999988876544311  111110000   0000 00000


Q ss_pred             cccccCccccCc-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          274 FDTLVDPKLHNE-----YNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       274 ~~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ............     ........+.+++.+||+.+|++||++.||++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            000000000001     112234678899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.2e-37  Score=299.08  Aligned_cols=245  Identities=25%  Similarity=0.400  Sum_probs=198.4

Q ss_pred             CceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCH
Q 014904           49 ANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL  127 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL  127 (416)
                      ...||+|+||.||++.. .+++.||||.+..........+..|+.+++.++|+||+++++.+..+...++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            45699999999999995 46889999998765545556788999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeeccc
Q 014904          128 EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM  207 (416)
Q Consensus       128 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  207 (416)
                      ..++...   .+++..++.++.+++.||.|||+.   +|+||||||+||+++.++.++|+|||++......... .....
T Consensus       107 ~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~  179 (292)
T cd06658         107 TDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLV  179 (292)
T ss_pred             HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cceee
Confidence            9988543   488999999999999999999999   9999999999999999999999999998755432222 23356


Q ss_pred             ccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCC
Q 014904          208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYN  287 (416)
Q Consensus       208 gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  287 (416)
                      |+..|+|||++.+..++.++|||||||+++||++|+.||........  +.         .+...     ..+.+..  .
T Consensus       180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~---------~~~~~-----~~~~~~~--~  241 (292)
T cd06658         180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--MR---------RIRDN-----LPPRVKD--S  241 (292)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH---------HHHhc-----CCCcccc--c
Confidence            89999999999888899999999999999999999999875433110  00         01110     0111111  1


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          288 HNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       288 ~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ......+..++.+|++.+|.+||++.+|++.
T Consensus       242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1123467889999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-38  Score=310.52  Aligned_cols=252  Identities=27%  Similarity=0.419  Sum_probs=213.5

Q ss_pred             CCcCceecccCcEEEEEEEeC---CC--cEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           46 FSDANLLGQGGFGYVHRGVLP---NG--KEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~---~g--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ....++||.|-||.||+|+..   .|  -.||||..+.+. ....+.|+.|..+++.++||||++++|+|.+ ...|+||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence            344678999999999999942   23  368999998754 4445689999999999999999999999987 4689999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      |.++-|.|..+|+.+.. .++..+....+.|++.||+|||+.   ++|||||..+|||+.....+||+|||+++...+..
T Consensus       470 EL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             ecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            99999999999986654 688899999999999999999999   99999999999999999999999999999988876


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      .....+..-+..|||||-+.-..++.+||||.|||.+||+++ |.+||..-....           +...+++|+     
T Consensus       546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-----------VI~~iEnGe-----  609 (974)
T KOG4257|consen  546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-----------VIGHIENGE-----  609 (974)
T ss_pred             hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----------eEEEecCCC-----
Confidence            666666666788999999999999999999999999999998 999997633200           111233443     


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                          +..++.+|+..+..++.+||..+|.+||++.||...|...
T Consensus       610 ----RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  610 ----RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             ----CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence                2345667788999999999999999999999999999754

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.5e-37  Score=296.82  Aligned_cols=256  Identities=24%  Similarity=0.374  Sum_probs=209.8

Q ss_pred             HHHhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           39 LARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        39 l~~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ....++.|...+.||+|++|.||+|.+. +++.+++|++..... ....+..|++++++++|+|++++++++......++
T Consensus        14 ~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          14 EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             CCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            3457788999999999999999999975 689999999986554 45678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      |+||+++++|.+++.... ..+++..++.++.+++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        93 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          93 VMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            999999999999998654 3699999999999999999999998   999999999999999999999999999865543


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      ... ......++..|++||++.+..++.++|||||||++|+|++|+.||....+..  ....         +.......+
T Consensus       169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~~~---------~~~~~~~~~  236 (286)
T cd06614         169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--ALFL---------ITTKGIPPL  236 (286)
T ss_pred             chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHHH---------HHhcCCCCC
Confidence            221 1233467889999999988889999999999999999999999987544311  0100         111111111


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .+       .......+.+++.+|++.+|.+||++.+|++.
T Consensus       237 ~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         237 KN-------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             cc-------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            11       11133578899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.1e-36  Score=284.39  Aligned_cols=249  Identities=31%  Similarity=0.474  Sum_probs=205.8

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      .|...+.||+|++|.||++... +++.+++|++..........+.+|+.++++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3778899999999999999965 689999999987655455789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      +++|.+++.... ..+++..+..++.+++.||.+||+.   +++|+||+|+||+++.++.++|+|||.+........  .
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  154 (253)
T cd05122          81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R  154 (253)
T ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence            999999987653 3689999999999999999999998   999999999999999999999999999877654332  2


Q ss_pred             ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcccc
Q 014904          204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLH  283 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~  283 (416)
                      ....++..|++||++.+..++.++||||||+++++|++|+.||.......  .+.        . ........+.++   
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~--------~-~~~~~~~~~~~~---  220 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--ALF--------K-IATNGPPGLRNP---  220 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH--HHH--------H-HHhcCCCCcCcc---
Confidence            34578899999999998889999999999999999999999987643210  000        0 011111111111   


Q ss_pred             CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          284 NEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       284 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                          ......+.+++.+|++.+|.+||++.+|++
T Consensus       221 ----~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         221 ----EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ----cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                111457899999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.4e-37  Score=290.26  Aligned_cols=249  Identities=23%  Similarity=0.385  Sum_probs=203.1

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +|...+.||+|+||.||+|... +|..+|+|.+....  ......+.+|+.+++.++|+|++++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5788899999999999999954 68899999987542  22345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC-ceEEeecccceeccCCCc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKIASDVNT  200 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~-~~kl~DFGla~~~~~~~~  200 (416)
                      +++++|.+++.......+++..+..++.+++.||.|||+.   +++|+||||+||+++.++ .+||+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            9999999998765555689999999999999999999998   999999999999998885 469999999886654322


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                       ......|++.|+|||++.+..++.++||||||++++||++|+.||.....      .++....     ..+....+   
T Consensus       158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~-----~~~~~~~~---  222 (257)
T cd08225         158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKI-----CQGYFAPI---  222 (257)
T ss_pred             -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH-----hcccCCCC---
Confidence             22335689999999999888999999999999999999999999865432      1111111     11211111   


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                            .......+.+++.+|++.+|++||++.+|++
T Consensus       223 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         223 ------SPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                  1122346889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.6e-37  Score=293.65  Aligned_cols=248  Identities=24%  Similarity=0.361  Sum_probs=202.2

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      .|...++||+|++|.||++.. .+++.+++|++..........+.+|+.+++.++|+|++++++++......++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            466678999999999999995 4688999999876554445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      +++|.+++...   .+++..+..++.+++.||+|||+.   +|+||||+|+||+++.++.++|+|||++........ ..
T Consensus       100 ~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~  172 (285)
T cd06648         100 GGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR  172 (285)
T ss_pred             CCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence            99999998762   589999999999999999999999   999999999999999999999999998875543222 12


Q ss_pred             ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcccc
Q 014904          204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLH  283 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~  283 (416)
                      ....|++.|+|||++.+..++.++|||||||++++|++|+.||....+.      .+..     .+..+....+..    
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~-----~~~~~~~~~~~~----  237 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMK-----RIRDNLPPKLKN----  237 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHH-----HHHhcCCCCCcc----
Confidence            3356899999999998888999999999999999999999998754331      1111     111111111111    


Q ss_pred             CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          284 NEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       284 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                         .......+.+++.+||+.+|++||++.++++
T Consensus       238 ---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         238 ---LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ---cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence               1113357899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-37  Score=320.53  Aligned_cols=272  Identities=18%  Similarity=0.223  Sum_probs=190.0

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEeCC--CcEEEEE------------------EeecCCcccHHHHHHHHHHHHhcCCC
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVLPN--GKEVAIK------------------QLKAGSGQGEREFQAEVEIISRVHHK  100 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~~~--g~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~h~  100 (416)
                      ...++|.+.+.||+|+||.||++.+..  +...++|                  .+.. .......+.+|+.++.+++|+
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence            356799999999999999999987432  2222222                  1111 111234678999999999999


Q ss_pred             cccceEEEEEeCCeEEEEEEecCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEE
Q 014904          101 HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG---RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANIL  177 (416)
Q Consensus       101 niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NIL  177 (416)
                      ||+++++++......++|++++.. .|..++....   ...........|+.|++.||.|||+.   +||||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence            999999999999999999999854 5555553321   11234556778999999999999999   9999999999999


Q ss_pred             ECCCCceEEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCC-CCCCCcccchh
Q 014904          178 LDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP-VDSTHTFVEDS  256 (416)
Q Consensus       178 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~p-f~~~~~~~~~~  256 (416)
                      |+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+ +..........
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            99999999999999987765444434456799999999999999999999999999999999998754 44332222222


Q ss_pred             hhhhhhHH-------------hHHhhhcCCcccccCccccCcC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          257 LVDWARPL-------------LNRAIEDGNFDTLVDPKLHNEY-NHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       257 l~~~~~~~-------------~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      +.+....+             +...+....+..... .+.... .......+.+++.+||+.||.+||++.|++..
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGH-SVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCcc-chhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            22211100             000000000000000 000000 00122356778999999999999999999864

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.4e-38  Score=293.41  Aligned_cols=268  Identities=22%  Similarity=0.259  Sum_probs=203.3

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccH--HHHHHHHHHHHhcCCCcccceEEEEEe--CCeEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGE--REFQAEVEIISRVHHKHLVSLVGYYTA--GSQRML  117 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  117 (416)
                      .++|.++|.|++|.||.||+|.+ .+++.||+|+++.......  -.-++|+.+|.+.+|||||.+..+...  -+..|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            35677889999999999999994 5789999999986542211  135789999999999999999988764  346899


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      |||||+ .+|..+++.-. +.+...+...+..|+++||+|||..   -|+|||||++|+|++..|.+||+|||+|+.+..
T Consensus       155 VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  155 VMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             eHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999994 57888887655 3688888899999999999999999   899999999999999999999999999999877


Q ss_pred             CCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH--hHHhhhcC--
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL--LNRAIEDG--  272 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~--~~~~~~~~--  272 (416)
                      ... ..+..+-|..|.|||++.+. .|+...|+||+||++.||+++++.|.+.....+...  .+.-+  -.+.+..|  
T Consensus       230 p~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~--If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  230 PLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK--IFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             Ccc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH--HHHHhCCCccccCCCcc
Confidence            533 33556679999999999876 589999999999999999999999988665333221  11100  00000001  


Q ss_pred             --------CcccccCccccCcCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          273 --------NFDTLVDPKLHNEYNHN-EMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       273 --------~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                              .+..-.--.+...+... ..+.-++|+...+..||.+|-|+.|.++.
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence                    00000001111222221 23566789999999999999999987753

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.1e-37  Score=296.66  Aligned_cols=265  Identities=20%  Similarity=0.301  Sum_probs=199.3

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +|+..+.||.|++|.||+|... +++.||||++.....  .....+..|++++++++|+||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            5888999999999999999954 689999999875432  2235788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +. ++|..++.......+++..++.++.+++.||+|||+.   +++|+||+|+||+++.++.+||+|||+++........
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            95 5788888765555789999999999999999999998   9999999999999999999999999998765432221


Q ss_pred             eeecccccccccChhhhccCC-CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh----------HHhHHh-h
Q 014904          202 VSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR----------PLLNRA-I  269 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~-~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~----------~~~~~~-~  269 (416)
                       .....++..|+|||++.+.. ++.++|||||||++|||+||+.||......  ..+.....          +.+... .
T Consensus       157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHHHH
Confidence             22345688999999887644 688999999999999999999999754321  11111110          000000 0


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ....+.......+. .........+.+++.+|++.+|.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00001111000000 000112346788999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.3e-37  Score=290.46  Aligned_cols=252  Identities=23%  Similarity=0.397  Sum_probs=201.9

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc------cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ------GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      +|+..++||+|++|.||+|.. .+++.||+|++......      ....+..|+.++++++|+||+++++++.+....++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            578889999999999999994 67899999998753311      23568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC-ceEEeecccceecc
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKIAS  196 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~-~~kl~DFGla~~~~  196 (416)
                      |+||+++++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||+|.||+++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            999999999999987543  588999999999999999999999   999999999999998775 59999999987665


Q ss_pred             CCCcc---eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          197 DVNTH---VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       197 ~~~~~---~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      .....   ......|+..|+|||++.+..++.++||||||+++++|++|+.||.............       . .... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~-~~~~-  226 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF-------K-IASA-  226 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH-------H-Hhcc-
Confidence            43211   1223568899999999988889999999999999999999999996543211111100       0 0000 


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                             ......+......+.+++.+|++.+|.+||++.+++.
T Consensus       227 -------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         227 -------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                   0011223334467889999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.8e-37  Score=296.32  Aligned_cols=270  Identities=20%  Similarity=0.326  Sum_probs=197.8

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCccc-HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQG-EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++++|.+.+.||+|+||.||+|.. .+++.||+|++....... ...+.+|+.+++.++|+||+++++++..+...++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            678999999999999999999995 468999999987543222 346778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+. +++...+.... ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+++......
T Consensus        83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9996 56665554332 2578888899999999999999999   99999999999999999999999999987543322


Q ss_pred             cceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh---H--HhHHhhh-cC
Q 014904          200 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR---P--LLNRAIE-DG  272 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~---~--~~~~~~~-~~  272 (416)
                      .. .....+++.|+|||++.+. .++.++|||||||++++|++|+.||.......+.....|..   +  .....+. .-
T Consensus       158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         158 QT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             CC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence            11 1224578899999998754 57899999999999999999999997654321111111110   0  0000000 00


Q ss_pred             Ccc-ccc---Cc-cccCcC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          273 NFD-TLV---DP-KLHNEY-NHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       273 ~~~-~~~---d~-~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .+. ...   .+ .+.... .......+.+++.+|++.+|.+||++.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000 000   00 000000 0011356788999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.4e-37  Score=287.08  Aligned_cols=250  Identities=27%  Similarity=0.417  Sum_probs=206.5

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeC--CeEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAG--SQRMLVY  119 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~  119 (416)
                      +|...+.||+|++|.||+|... +++.|++|++.....  .....+.+|+.++++++|+||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999965 689999999876543  3346789999999999999999999999988  8899999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++....  .+++..++.++.+++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999999987654  689999999999999999999998   99999999999999999999999999998776543


Q ss_pred             cc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          200 TH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       200 ~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      .. ......++..|+|||++.....+.++||||||+++++|++|+.||......   .      .........+.     
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~------~~~~~~~~~~~-----  221 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---M------AALYKIGSSGE-----  221 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---H------HHHHhccccCC-----
Confidence            21 123356889999999999888999999999999999999999999765410   0      00001000011     


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                          ....+......+.+++.+|++.+|.+||++.+++.
T Consensus       222 ----~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 ----PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ----CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                11122233568999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.3e-37  Score=294.02  Aligned_cols=247  Identities=28%  Similarity=0.419  Sum_probs=201.4

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      -|+..+.||.|+||.||+|.. .+++.||||++..... .....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            467788999999999999985 4688999999865432 22356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++++|..++...   .+++..+..++.+++.++.+||+.   +++|+||+|.||+++.++.++|+|||++........ .
T Consensus        85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06641          85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence            999999988643   589999999999999999999998   999999999999999999999999999876544222 1


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      .....++..|+|||++.+..++.++|||||||++++|++|..||......      .+..     .+..+..     +. 
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~-----~~~~~~~-----~~-  220 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLF-----LIPKNNP-----PT-  220 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHH-----HHhcCCC-----CC-
Confidence            23346788999999999888999999999999999999999998653321      0100     0111111     11 


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                         ........+.+++.+|++.+|.+||++.++++.
T Consensus       221 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 ---LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ---CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence               122234568899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-37  Score=296.10  Aligned_cols=268  Identities=20%  Similarity=0.324  Sum_probs=198.0

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .++|...+.||+|++|.||+|... +++.||||.+...... ....+.+|+.++++++|+||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            478999999999999999999965 6899999998754322 22456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+.+ +|.+++..... .+++.....++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        84 ~~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          84 YLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             cCCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            9975 88888865543 688999999999999999999999   999999999999999999999999999875432111


Q ss_pred             ceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh-------HHhHHhhhcC
Q 014904          201 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR-------PLLNRAIEDG  272 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~-------~~~~~~~~~~  272 (416)
                       ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.......+ .+.....       ..+.......
T Consensus       159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED-QLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHHHHHhcCCCChhhhhhhhhcc
Confidence             1122346888999999875 4589999999999999999999999965432111 1100000       0000000000


Q ss_pred             Cccc-----ccCccccCcCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          273 NFDT-----LVDPKLHNEYN-HNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       273 ~~~~-----~~d~~l~~~~~-~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ....     .....+..... ......+.+++.+|++.+|++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0000     00000000000 011256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=316.78  Aligned_cols=262  Identities=27%  Similarity=0.378  Sum_probs=219.4

Q ss_pred             HHHHHhhCCCCcCceecccCcEEEEEEEeCC-CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeE
Q 014904           37 EELARATDGFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        37 ~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  115 (416)
                      ++.+--..+....++||-|-||.||.|+|+. .-.||||.|+.+. ...++|+.|+.+++.++|||+|+|+|+|......
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            4444455566778899999999999999864 5679999998644 4467999999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      |||.|||..|+|.++|+..++..++-...+.+|.||+.|+.||...   ++|||||.++|+|+.++..+||+||||+++.
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            9999999999999999988888888889999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ............-...|.|||-+....++.|+|||+|||+||||.| |-.|+...+      +.+.     -..++.|  
T Consensus       416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSqV-----Y~LLEkg--  482 (1157)
T KOG4278|consen  416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQV-----YGLLEKG--  482 (1157)
T ss_pred             cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHHH-----HHHHhcc--
Confidence            6544333333445678999999999999999999999999999999 877765432      1111     1122222  


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                             ++-+-+..|+..+..|+++||+++|.+||++.||-+.||-.
T Consensus       483 -------yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  483 -------YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             -------ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence                   23334556778999999999999999999999999998753

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.1e-37  Score=295.64  Aligned_cols=243  Identities=27%  Similarity=0.358  Sum_probs=200.4

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.+.||+|+||.||++... +++.+|+|++.....   .....+..|+.++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47889999999999999999954 689999999875422   22356889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||+|.||+++.++.+||+|||++...... 
T Consensus        81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            9999999999987653  589999999999999999999998   9999999999999999999999999998876543 


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                         .....+++.|+|||.+.+...+.++||||||+++++|++|+.||.....   ..       .. ..+..+..     
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~-------~~-~~~~~~~~-----  215 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQ-------IY-EKILEGKV-----  215 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HH-------HH-HHHhcCCc-----
Confidence               2335689999999999888899999999999999999999999975442   00       11 11112211     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRP-----RMSQIV  316 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv  316 (416)
                       .    .+......+.+++.+||+.+|.+||     ++.|++
T Consensus       216 -~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         216 -R----FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             -c----CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence             1    1112245788999999999999999     555555

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.7e-37  Score=295.96  Aligned_cols=269  Identities=20%  Similarity=0.281  Sum_probs=202.1

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCccc--HHHHHHHHHHHHhcCCCcccceEEEEEeC--CeEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQG--EREFQAEVEIISRVHHKHLVSLVGYYTAG--SQRML  117 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  117 (416)
                      .++|...+.||+|+||.||+|... +++.+|+|.++......  ...+.+|+.++.+++||||+++++++...  ...++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            357899999999999999999965 68899999997543221  23567899999999999999999999877  88999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      |+||+.+ +|..++..... .+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        84 v~e~~~~-~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             EehhcCc-CHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            9999974 88888865443 689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch-hhhh---------hhhHHhH
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED-SLVD---------WARPLLN  266 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~-~l~~---------~~~~~~~  266 (416)
                      .... .....+++.|+|||++.+. .++.++||||||+++++|++|+.||......... .+..         |......
T Consensus       159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         159 PLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             Cccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            3222 1234578899999998754 4689999999999999999999999764431110 0100         1000000


Q ss_pred             HhhhcCCcccccCccccCcCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          267 RAIEDGNFDTLVDPKLHNEYNHN-EMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       267 ~~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ...............+...++.. ....+.+++..||+.+|++||++.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            00000111111111122222222 3556889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-37  Score=295.37  Aligned_cols=253  Identities=23%  Similarity=0.270  Sum_probs=207.5

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCccc---HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQG---EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      +.|+..+.||+|.-|+||++.+. ++..+|+|++.+.....   ..+.+.|-+||+.++||.+++|+..+..+...||||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            46778899999999999999965 46899999998664333   346778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC--
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD--  197 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~--  197 (416)
                      |||+||+|..+++.+....++...+...+.+++.||+|||-.   |||.|||||+||||.++|.+-|+||.|+..+.-  
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            999999999999998888999999999999999999999999   999999999999999999999999998642210  


Q ss_pred             -------------------------------CCc----------------------ceeecccccccccChhhhccCCCC
Q 014904          198 -------------------------------VNT----------------------HVSTRVMGTFGYLAPEYASSGKLT  224 (416)
Q Consensus       198 -------------------------------~~~----------------------~~~~~~~gt~~YlaPE~~~~~~~t  224 (416)
                                                     ...                      ..+..++||-.|+|||++.+..-+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                           000                      111236799999999999999999


Q ss_pred             chhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhcc
Q 014904          225 EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRH  304 (416)
Q Consensus       225 ~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~  304 (416)
                      .++|+|+|||+|||||.|..||.+...  ...+..                 ++-..+.-.-....+..+.+||++.|.+
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~--~~Tl~N-----------------Iv~~~l~Fp~~~~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNN--KETLRN-----------------IVGQPLKFPEEPEVSSAAKDLIRKLLVK  374 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCc--hhhHHH-----------------HhcCCCcCCCCCcchhHHHHHHHHHhcc
Confidence            999999999999999999999988664  112211                 1111111111124556788999999999


Q ss_pred             CCCCCCC----HHHHHHH
Q 014904          305 SARRRPR----MSQIVRA  318 (416)
Q Consensus       305 ~p~~RPt----~~evv~~  318 (416)
                      ||.+|-.    +.||-+.
T Consensus       375 dP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  375 DPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             ChhhhhccccchHHhhcC
Confidence            9999998    7776643

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-36  Score=292.03  Aligned_cols=258  Identities=26%  Similarity=0.328  Sum_probs=202.1

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEe--CCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTA--GSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~  119 (416)
                      ++|...+.||.|++|.||++.. .+++.+|+|.+..... ....++.+|++++++++|+||++++++|..  ....++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4788899999999999999996 4689999999875433 334678999999999999999999999865  34689999


Q ss_pred             EecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          120 EFVPNNTLEFHLHG--KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       120 e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||+++++|.+++..  .....+++.....++.+++.||+|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999887753  2233588999999999999999999998   999999999999999999999999999865433


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCc--ccchhhhhhhhHHhHHhhhcCCcc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHT--FVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~--~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ...   ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....  .....+..|..        .....
T Consensus       158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~  226 (287)
T cd06621         158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV--------NMPNP  226 (287)
T ss_pred             ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh--------cCCch
Confidence            221   234578899999999999999999999999999999999999986532  11112222211        11111


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .+.+. ..  ........+.+++.+||+.+|.+||++.||++.
T Consensus       227 ~~~~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         227 ELKDE-PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             hhccC-CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            11110 00  011234678999999999999999999998863

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.9e-37  Score=293.74  Aligned_cols=254  Identities=26%  Similarity=0.396  Sum_probs=198.2

Q ss_pred             CCcCceecccCcEEEEEEEeC----CCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCC------
Q 014904           46 FSDANLLGQGGFGYVHRGVLP----NGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGS------  113 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  113 (416)
                      |.+.++||+|+||.||+|.+.    +++.||||++....  ....+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999853    36899999987543  223457889999999999999999999886532      


Q ss_pred             eEEEEEEecCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeec
Q 014904          114 QRMLVYEFVPNNTLEFHLHGK----GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF  189 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DF  189 (416)
                      ..+++++|+.+++|..++...    ....+++...+.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            247889999999998877432    122578999999999999999999998   9999999999999999999999999


Q ss_pred             ccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHH
Q 014904          190 GLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNR  267 (416)
Q Consensus       190 Gla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~  267 (416)
                      |+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||.....   ..+..+       
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~-------  227 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNY-------  227 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHH-------
Confidence            998865432211 1122345678999999998889999999999999999999 8888865432   112111       


Q ss_pred             hhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          268 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       268 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                       +..+..  +   .    .+......+.+++.+|++.+|.+||++.+|++.|+..
T Consensus       228 -~~~~~~--~---~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         228 -LIKGNR--L---K----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -HHcCCc--C---C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             111110  0   0    0112345799999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.4e-37  Score=294.88  Aligned_cols=251  Identities=25%  Similarity=0.382  Sum_probs=193.9

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-ccHHHHHHHHHH-HHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG-QGEREFQAEVEI-ISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ++|++.+.||+|+||.||++... +|+.||+|+++.... ....++..|+.+ ++.++|+||+++++++..+...++|+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47889999999999999999964 699999999876432 233455566665 566789999999999999999999999


Q ss_pred             ecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          121 FVPNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       121 ~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |++ ++|..++...  ....+++..++.++.|++.||.|||+.+  +++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            996 6777776532  2346899999999999999999999864  8999999999999999999999999998865432


Q ss_pred             CcceeecccccccccChhhhcc----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASS----GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~----~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ..  .....++..|+|||++.+    ..++.++||||||+++|+|++|+.||...... ...+.        ... .+..
T Consensus       158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~--------~~~-~~~~  225 (283)
T cd06617         158 VA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLK--------QVV-EEPS  225 (283)
T ss_pred             cc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHH--------HHH-hcCC
Confidence            21  233568899999998864    44688999999999999999999998643210 01111        111 1111


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..+..        ......+.+++.+||..+|.+||++.+|++
T Consensus       226 ~~~~~--------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 PQLPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCCc--------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11111        112357889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.8e-37  Score=293.86  Aligned_cols=268  Identities=22%  Similarity=0.290  Sum_probs=202.4

Q ss_pred             hCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCc-ccceEEEEEeCC-----
Q 014904           43 TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKH-LVSLVGYYTAGS-----  113 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-----  113 (416)
                      ...|...++||+|.||+||+|. ..+|+.||+|++......  ......+|+.++++++|+| ||++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            3456667789999999999999 557899999999866542  2245678999999999999 999999998877     


Q ss_pred             -eEEEEEEecCCCCHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecc
Q 014904          114 -QRMLVYEFVPNNTLEFHLHGKGR--PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG  190 (416)
Q Consensus       114 -~~~lV~e~~~~~sL~~~l~~~~~--~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFG  190 (416)
                       ..++|+||+ ...|..++.....  ..++-..+..++.|+++||+|||++   +|+||||||+||||+.+|.+||+|||
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence             789999999 5688888876543  3577788999999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh-------
Q 014904          191 LAKIASDVNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR-------  262 (416)
Q Consensus       191 la~~~~~~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~-------  262 (416)
                      +|+...-.... .+..++|..|.|||++.+. .|+...||||+||++.||++++..|.......+  +...++       
T Consensus       166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q--l~~If~~lGtP~e  242 (323)
T KOG0594|consen  166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ--LFRIFRLLGTPNE  242 (323)
T ss_pred             hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH--HHHHHHHcCCCCc
Confidence            99965522221 3446789999999999877 799999999999999999999999987665221  111111       


Q ss_pred             ---HHhHHhhhcC--CcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          263 ---PLLNRAIEDG--NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       263 ---~~~~~~~~~~--~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                         |.+.. +.+.  .+.....+......-........+++.+|++.+|.+|.++...++.
T Consensus       243 ~~Wp~v~~-~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  243 KDWPGVSS-LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccc-cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence               00000 0000  0000000000000001112478899999999999999999999875

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.3e-37  Score=330.87  Aligned_cols=260  Identities=21%  Similarity=0.324  Sum_probs=201.1

Q ss_pred             HHHHHHhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEe-
Q 014904           36 YEELARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTA-  111 (416)
Q Consensus        36 ~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  111 (416)
                      |.+.....++|.+.+.||+|+||+||+|... +++.||+|++.....  .....|..|+.++.+++|||||+++++|.. 
T Consensus         5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de   84 (1021)
T PTZ00266          5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK   84 (1021)
T ss_pred             ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence            3344456689999999999999999999954 578899999875432  223578899999999999999999998865 


Q ss_pred             -CCeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeeeecccCCcEEECCC---
Q 014904          112 -GSQRMLVYEFVPNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDCH----PKIIHRDIKAANILLDFK---  181 (416)
Q Consensus       112 -~~~~~lV~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~----~~iiHrDIkp~NILl~~~---  181 (416)
                       ....+|||||+++++|..+|...  ....+++..++.|+.||+.||+|||..+.    .+||||||||+||||+.+   
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence             45689999999999999988642  12369999999999999999999998531    259999999999999642   


Q ss_pred             --------------CceEEeecccceeccCCCcceeecccccccccChhhhcc--CCCCchhhhHhHHHHHHHHHhCCCC
Q 014904          182 --------------FEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRP  245 (416)
Q Consensus       182 --------------~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~--~~~t~ksDV~SlGvvL~elltG~~p  245 (416)
                                    ..+||+|||++.......  ......||+.|+|||++.+  ..++.++|||||||+||||++|+.|
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                          348999999998654322  2234579999999999854  4589999999999999999999999


Q ss_pred             CCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          246 VDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       246 f~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      |.....     ...+.     ..+..+.       .+..   ......+.+|+..||+.+|.+||++.|++.
T Consensus       243 F~~~~~-----~~qli-----~~lk~~p-------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        243 FHKANN-----FSQLI-----SELKRGP-------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCcCCc-----HHHHH-----HHHhcCC-------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            975432     11111     1111111       1100   112356889999999999999999999984

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=305.18  Aligned_cols=236  Identities=25%  Similarity=0.302  Sum_probs=184.2

Q ss_pred             ecccCcEEEEEEEe-CCCcEEEEEEeecCCccc---HHHHHHHHHHHHhc---CCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           52 LGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQG---EREFQAEVEIISRV---HHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        52 LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ||+|+||.||+|.. .+++.||||++.......   ...+..|..++.+.   +||||+++++++......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999995 468999999986432211   22344566666655   699999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      ++|..++....  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~  154 (330)
T cd05586          81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTN  154 (330)
T ss_pred             ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Ccc
Confidence            99998887544  589999999999999999999999   999999999999999999999999999875432221 223


Q ss_pred             cccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcccc
Q 014904          205 RVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLH  283 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~  283 (416)
                      ...||+.|+|||++.+. .++.++|||||||++|+|++|+.||......   .+        ...+..+... +..    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~~--------~~~i~~~~~~-~~~----  218 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---QM--------YRNIAFGKVR-FPK----  218 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---HH--------HHHHHcCCCC-CCC----
Confidence            46799999999998765 4899999999999999999999999764321   01        1111222211 100    


Q ss_pred             CcCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 014904          284 NEYNHNEMARMVACAAACVRHSARRRPRMS  313 (416)
Q Consensus       284 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~  313 (416)
                      .    .....+.+++.+||+.+|.+||++.
T Consensus       219 ~----~~~~~~~~li~~~L~~~P~~R~~~~  244 (330)
T cd05586         219 N----VLSDEGRQFVKGLLNRNPQHRLGAH  244 (330)
T ss_pred             c----cCCHHHHHHHHHHcCCCHHHCCCCC
Confidence            0    1234678899999999999999543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.7e-36  Score=300.58  Aligned_cols=268  Identities=22%  Similarity=0.299  Sum_probs=200.6

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeC-----
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAG-----  112 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  112 (416)
                      ...++|...+.||+|+||.||+|.. .+++.||||++....  ......+..|+.++++++|+||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            3568999999999999999999995 478999999986432  22334677899999999999999999988643     


Q ss_pred             -CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          113 -SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       113 -~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                       ...++|+||+.+ +|...+...    ++...+..++.|++.||+|||..   +|+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence             357999999964 777776532    78889999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch------------hhhh
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED------------SLVD  259 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~------------~l~~  259 (416)
                      ++.......  .....++..|+|||++.+..++.++|||||||++++|++|+.||...+.....            .+..
T Consensus       165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         165 ARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             ceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            987644222  23346789999999999999999999999999999999999999764421100            0000


Q ss_pred             hhhHHhHHhhhcC------CcccccC----ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          260 WARPLLNRAIEDG------NFDTLVD----PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       260 ~~~~~~~~~~~~~------~~~~~~d----~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .............      .+.++..    +.............+.+++.+||+.+|++||++.|++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000000001000      0111111    111111122345678899999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4e-38  Score=298.37  Aligned_cols=264  Identities=25%  Similarity=0.382  Sum_probs=200.4

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCC-----eEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGS-----QRM  116 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  116 (416)
                      +-.|...+++|.|.||.||+|+. .+++.||||+......    .-..|+.+++.+.|||||+++-+|....     ...
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            34567789999999999999994 4579999999875442    2346899999999999999998886522     346


Q ss_pred             EEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC-CceEEeecccce
Q 014904          117 LVYEFVPNNTLEFHLHG--KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAK  193 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~-~~~kl~DFGla~  193 (416)
                      ||+||++. +|...++.  ..+..++...+.-+..|+++||+|||..   +|+||||||+|+|+|.+ |.+||||||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            89999975 67666653  1234677778888999999999999998   99999999999999977 899999999999


Q ss_pred             eccCCCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH---hHHhh
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL---LNRAI  269 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~---~~~~~  269 (416)
                      .........  ....|.-|+|||++.+. .|+.+.||||.|||+.||+-|++.|.+...  .+.++..+.-+   -.+.+
T Consensus       175 ~L~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  175 VLVKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTPTREDI  250 (364)
T ss_pred             eeccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCCCHHHH
Confidence            887655543  35678889999999875 699999999999999999999999987554  33333332111   00001


Q ss_pred             h--cCCcccccCcccc-----CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          270 E--DGNFDTLVDPKLH-----NEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       270 ~--~~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .  +.+..+...|.+.     .-+......+.++++.++++.+|.+|.++.|++..
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            1  1122222223222     22344556789999999999999999999998843

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-37  Score=292.38  Aligned_cols=264  Identities=20%  Similarity=0.296  Sum_probs=199.2

Q ss_pred             CCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           46 FSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      |+..+.||.|++|.||+|.. .+|+.||+|++.....  .....+.+|++++++++|+|++++++++.++...++|+||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            67788999999999999995 4799999999875432  22356888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      . ++|..++.......+++..++.++.++++||+|||+.   +++|+||+|+||+++.++.++|+|||+++........ 
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-  155 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-  155 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence            5 6898888765545689999999999999999999998   9999999999999999999999999998755432211 


Q ss_pred             eecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH----------HhHHhhh-
Q 014904          203 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP----------LLNRAIE-  270 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~----------~~~~~~~-  270 (416)
                      .....++..|+|||++.+. .++.++||||||+++|+|++|+.||......  ..+.+....          ....... 
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            1223568899999988664 5789999999999999999999999765431  111111110          0000000 


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ...+........ ..........+.+++.+|++.+|.+||++.||++
T Consensus       234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000000000000 0111223357889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.2e-37  Score=295.38  Aligned_cols=254  Identities=26%  Similarity=0.439  Sum_probs=195.5

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcC-CCcccceEEEEEeCCeEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG-QGEREFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +|...+.||+|+||.||++.. .+++.+|+|++..... .....+..|+.++.++. |+||+++++++......++|+||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            455567899999999999995 4689999999875432 33457889999999996 99999999999999999999999


Q ss_pred             cCCCCHHHH---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          122 VPNNTLEFH---LHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       122 ~~~~sL~~~---l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      +.. ++..+   +.......+++.....++.+++.||+|||+.+  +++||||||+||+++.++.+||+|||++......
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 44433   33333346899999999999999999999743  8999999999999999999999999998765432


Q ss_pred             CcceeecccccccccChhhhccC---CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSG---KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~---~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ...  ....|++.|+|||++.+.   .++.++|||||||++|+|++|+.||.....     ...-    +.+ ...+.  
T Consensus       162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~----~~~-~~~~~--  227 (288)
T cd06616         162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQ----LTQ-VVKGD--  227 (288)
T ss_pred             Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHH----Hhh-hcCCC--
Confidence            222  234688999999998776   689999999999999999999999865431     1100    000 01111  


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                         .+.+...........+.+++.+|++.+|.+||++.+|++.
T Consensus       228 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 ---PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             ---CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               1122222222345678999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8e-37  Score=296.81  Aligned_cols=247  Identities=28%  Similarity=0.408  Sum_probs=197.1

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc---cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ---GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ...|...+.||+|+||.||+|... +++.||+|++......   ....+.+|+.+++.++|||+++++++|.+....++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356888999999999999999964 6899999998754322   224688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      +||+. +++.+++.... ..+++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|||++......
T Consensus        94 ~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          94 MEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            99997 56666654333 2589999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CcceeecccccccccChhhhc---cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          199 NTHVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~---~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                           ....++..|+|||++.   .+.++.++||||||+++|||++|+.||........          .. .+..+.. 
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~----------~~-~~~~~~~-  231 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------LY-HIAQNDS-  231 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH----------HH-HHhcCCC-
Confidence                 2346788999999874   45688999999999999999999999865432110          00 0111111 


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                          +.+   ........+.+++.+||+.+|.+||++.+|+..
T Consensus       232 ----~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 ----PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ----CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                111   111234578999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-37  Score=292.61  Aligned_cols=267  Identities=21%  Similarity=0.289  Sum_probs=199.2

Q ss_pred             CCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeC--CeEEEEEE
Q 014904           46 FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAG--SQRMLVYE  120 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e  120 (416)
                      |.+.+.||+|++|.||+|... +++.+|+|++....  ......+.+|+.++++++|+|++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            667889999999999999965 58999999998653  22235688999999999999999999999987  88999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++ +|..++.... ..+++..++.++.++++||+|||+.   +++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            9975 7887776543 3689999999999999999999998   999999999999999999999999999987655433


Q ss_pred             ceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch-hhhhhhhHHhHHhh---------
Q 014904          201 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED-SLVDWARPLLNRAI---------  269 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~-~l~~~~~~~~~~~~---------  269 (416)
                      .......++..|+|||.+.+ ..++.++||||||++++||++|+.||......... .+.+..........         
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence            22233456888999998764 46799999999999999999999999765431110 00000000000000         


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ............+...+...+...+.+++.+|++.+|.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            000000000000001111112567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.6e-36  Score=283.27  Aligned_cols=249  Identities=24%  Similarity=0.400  Sum_probs=206.5

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +|...+.||.|+||.||++... +++.+++|++.....  .....+..|+++++.++|+|++++++.+..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999964 689999999986543  3446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          122 VPNNTLEFHLHGKG--RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       122 ~~~~sL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      +++++|..++....  ...+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999987642  34799999999999999999999999   99999999999999999999999999998765543


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                       .......|++.|+|||.+.+..++.++||||||+++++|++|+.||.....      .+    .. .....+....+  
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~----~~-~~~~~~~~~~~--  223 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LE----LA-LKILKGQYPPI--  223 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HH----HH-HHHhcCCCCCC--
Confidence             223345788999999999988999999999999999999999999865432      01    11 11112222111  


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                             +......+.+++.+||..+|++||++.++++
T Consensus       224 -------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 -------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                   1123457889999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3e-37  Score=311.18  Aligned_cols=199  Identities=28%  Similarity=0.368  Sum_probs=174.3

Q ss_pred             CCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-C-----CcccceEEEEEeCCeEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-H-----KHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  117 (416)
                      +|.+.++||+|.||.|-+|+ ..+++.||||+++... .-.++-+.|+.+|..|+ |     -|+|++++||...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            67889999999999999999 5679999999998643 22356678999999997 4     489999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC--CceEEeecccceec
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK--FEAKVADFGLAKIA  195 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~--~~~kl~DFGla~~~  195 (416)
                      |+|.+ ..+|.++|..+.-..++......|+.||+.||..||+.   +|||+||||+||||.+-  ..+||+|||.++..
T Consensus       266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99988 78999999877766799999999999999999999999   99999999999999654  46999999999876


Q ss_pred             cCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcc
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTF  252 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~  252 (416)
                      ...-    ...+.+.-|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.++.
T Consensus       342 ~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~  394 (586)
T KOG0667|consen  342 SQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY  394 (586)
T ss_pred             CCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence            5422    2466788899999999999999999999999999999999888876653

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=294.72  Aligned_cols=269  Identities=21%  Similarity=0.286  Sum_probs=197.3

Q ss_pred             CCCcCceecccCcEEEEEEEeC---CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeC--CeEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP---NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAG--SQRM  116 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  116 (416)
                      +|.+.+.||+|+||.||+|...   +++.||+|.+....   ......+.+|+.++..++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            5788899999999999999964   47999999998643   22235678899999999999999999999988  8899


Q ss_pred             EEEEecCCCCHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC----CCceEEeec
Q 014904          117 LVYEFVPNNTLEFHLHGK---GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF----KFEAKVADF  189 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~----~~~~kl~DF  189 (416)
                      +|+||+++ +|..++...   ....++...++.++.|++.||.|||+.   +|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 555555322   223688999999999999999999999   9999999999999999    899999999


Q ss_pred             ccceeccCCCcc--eeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccc-------chhhhh
Q 014904          190 GLAKIASDVNTH--VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFV-------EDSLVD  259 (416)
Q Consensus       190 Gla~~~~~~~~~--~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~-------~~~l~~  259 (416)
                      |++.........  ......+++.|+|||++.+. .++.++|||||||++++|++|+.||.......       ...+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            999866443221  12335678999999988764 57999999999999999999999997654322       011111


Q ss_pred             hhhHH-------hHHhhhcCCcccccCccccCcCC---------H--HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          260 WARPL-------LNRAIEDGNFDTLVDPKLHNEYN---------H--NEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       260 ~~~~~-------~~~~~~~~~~~~~~d~~l~~~~~---------~--~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ++..+       .....+...+..+.+......++         .  .....+.+++.+|++.+|++||++.||++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11000       00000000111100000001111         0  22346889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=294.02  Aligned_cols=273  Identities=20%  Similarity=0.310  Sum_probs=209.6

Q ss_pred             HHHHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEee--cCCcccHHHHHHHHHHHHhcCCCcccceEEEEEe--
Q 014904           37 EELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLK--AGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA--  111 (416)
Q Consensus        37 ~el~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  111 (416)
                      .+...+...|...+.||+|.+|.|+.+.. .+|+.||||++.  .......++..+|+.+|++++|+||+.+++.+..  
T Consensus        15 ~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~   94 (359)
T KOG0660|consen   15 GELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS   94 (359)
T ss_pred             eeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence            35666778888899999999999999994 579999999987  3344445678899999999999999999998865  


Q ss_pred             ---CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEee
Q 014904          112 ---GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD  188 (416)
Q Consensus       112 ---~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~D  188 (416)
                         -...|+|+|++ +.+|...++...  .++......++.|+++||.|+|+.   +++||||||+|+|++.+..+||+|
T Consensus        95 ~~~f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~D  168 (359)
T KOG0660|consen   95 RDKFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICD  168 (359)
T ss_pred             ccccceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecc
Confidence               45679999999 778888886553  489999999999999999999999   999999999999999999999999


Q ss_pred             cccceeccCCC-cceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh----
Q 014904          189 FGLAKIASDVN-THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR----  262 (416)
Q Consensus       189 FGla~~~~~~~-~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~----  262 (416)
                      ||+|+...... ....+..+-|..|.|||++.+ ..|+...||||.||+|.||++|++.|.+.+...+..++.-.-    
T Consensus       169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS  248 (359)
T ss_pred             ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence            99999875431 112255677999999998754 579999999999999999999999998766543333221110    


Q ss_pred             ---------HHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          263 ---------PLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       263 ---------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                               ......+..  +.......+...++ +.....++|+.+||..||.+|+|+.|.++.
T Consensus       249 ~e~l~~i~s~~ar~yi~s--lp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKS--LPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHHHhccHHHHHHHHh--CCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                     001111110  00000000111111 233467899999999999999999998864

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=313.58  Aligned_cols=247  Identities=27%  Similarity=0.408  Sum_probs=207.6

Q ss_pred             cCceecccCcEEEEEEEeC--CCc--EEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           48 DANLLGQGGFGYVHRGVLP--NGK--EVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        48 ~~~~LG~G~~g~Vy~~~~~--~g~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      ..++||+|.||.|++|.|.  +|+  .||||.++..... ....|.+|+.++.+|+|+|+++|+|+..+ ....+|+|.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            4678999999999999975  343  6899999877654 45689999999999999999999999998 6788999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      +.|+|.+.|+...+..|-......++.|||.|+.||..+   ++|||||.++|+||-..-.+||+||||.+.+.....+.
T Consensus       193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            999999999986666788999999999999999999999   99999999999999998899999999999877655443


Q ss_pred             e--ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          203 S--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       203 ~--~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                      .  ....-.+.|+|||.+..++++.+||||+|||+||||+| |..||..-..           ..+.+.         +|
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------~qIL~~---------iD  329 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------IQILKN---------ID  329 (1039)
T ss_pred             EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------HHHHHh---------cc
Confidence            2  22344678999999999999999999999999999999 8888876443           111111         22


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ..-.-.-+..+.+++.++++.||.++|.+||++..|++.
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            222233455688899999999999999999999999844

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.1e-37  Score=288.54  Aligned_cols=247  Identities=25%  Similarity=0.324  Sum_probs=202.5

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      +|.+.+.||+|+||.||+|... +++.||+|++.....   ...+.+.+|+.++++++||||+++++++..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5888999999999999999965 689999999975432   234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+.+++|..++...  ..+++..+..++.++++||.|||+.   +++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999999998765  3689999999999999999999998   99999999999999999999999999987665432 


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                       ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......    ..+..    ......        
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~----~~~~~~--------  217 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIR----AKQETA--------  217 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHH----HHhccc--------
Confidence             1233568889999999998889999999999999999999999998654321    11111    111100        


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCH--HHHH
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRM--SQIV  316 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~--~evv  316 (416)
                        ....+......+.+++.+||+.+|.+||++  .|++
T Consensus       218 --~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         218 --DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             --cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence              011122234678899999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=9e-37  Score=286.90  Aligned_cols=247  Identities=25%  Similarity=0.397  Sum_probs=204.3

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +|++.+.||+|++|.||++.. .+++.+|+|.+.....  ....++..|+.+++.++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            588899999999999999984 4788999999876432  2235678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          122 VPNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       122 ~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      +++++|..++...  ....+++..++.++.+++.||+|||+.   +++|+||+|.||+++.++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999988652  234689999999999999999999999   9999999999999999999999999999876554 


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                        ......++..|++||++.+..++.++|+||||+++++|++|+.||......   .        +......+.+..   
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~--------~~~~~~~~~~~~---  220 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---D--------LRYKVQRGKYPP---  220 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H--------HHHHHhcCCCCC---
Confidence              222345788999999999889999999999999999999999999765431   1        111112222221   


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                            .+......+.+++.+|++.+|++||++.++++
T Consensus       221 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         221 ------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                  12244567999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2e-36  Score=295.54  Aligned_cols=247  Identities=28%  Similarity=0.414  Sum_probs=196.3

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCccc---HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQG---EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .|...+.||+|+||.||+|.. .+++.+|+|++.......   ...+..|+.++++++|+|++++++++..+...++|+|
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            477788999999999999995 468999999987543322   2468889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+.+ +|.+.+.... ..+++..+..++.+++.||.|||+.   +|+||||+|+||+++.++.++|+|||++......  
T Consensus       106 ~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         106 YCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             CCCC-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            9975 6666664333 3589999999999999999999999   9999999999999999999999999998754432  


Q ss_pred             ceeecccccccccChhhhc---cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          201 HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~---~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                         ....|++.|+|||++.   .+.++.++|||||||++|||++|+.||......  ..+..+        . .+.... 
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~--------~-~~~~~~-  243 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHI--------A-QNESPT-  243 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHH--------H-hccCCC-
Confidence               2346888999999973   457899999999999999999999998654321  111111        1 111100 


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                          .   ........+.+++.+|++.+|.+||++.+|++.+-
T Consensus       244 ----~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         244 ----L---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             ----C---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence                0   11123356889999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.9e-36  Score=298.16  Aligned_cols=267  Identities=22%  Similarity=0.351  Sum_probs=199.7

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecC--CcccHHHHHHHHHHHHhc-CCCcccceEEEEEe--CCeE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAG--SGQGEREFQAEVEIISRV-HHKHLVSLVGYYTA--GSQR  115 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--~~~~  115 (416)
                      ..++|.+.+.||+|+||.||+|... +++.+|||++...  .......+..|+.++.++ +|+||++++++|..  ....
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            5678999999999999999999965 6889999988543  222334677899999999 99999999999865  3468


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++|+||+. ++|..++...   .+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||++...
T Consensus        85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            99999997 5888887654   688999999999999999999998   9999999999999999999999999999865


Q ss_pred             cCCCcc----eeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhh-h----------
Q 014904          196 SDVNTH----VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV-D----------  259 (416)
Q Consensus       196 ~~~~~~----~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~-~----------  259 (416)
                      ......    ......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||............ .          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            443321    2234568999999998765 45789999999999999999999999764432111100 0          


Q ss_pred             --hhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          260 --WARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       260 --~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                        +..+.....+.  ........... .........+.+++.+|++.+|.+||++.++++.
T Consensus       238 ~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLD--SLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhh--hcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence              00000000000  00000000000 1111134678999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7.6e-37  Score=288.32  Aligned_cols=246  Identities=24%  Similarity=0.368  Sum_probs=199.4

Q ss_pred             ecccCcEEEEEEEeC-CCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCH
Q 014904           52 LGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL  127 (416)
Q Consensus        52 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL  127 (416)
                      ||.|+||.||++... +|+.+++|++.....   .....+.+|+.++.+++|+||+++++.+..+...++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999975 499999999876543   2345788999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc-------
Q 014904          128 EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT-------  200 (416)
Q Consensus       128 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~-------  200 (416)
                      ..++....  .+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........       
T Consensus        81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99997654  689999999999999999999998   999999999999999999999999999875433211       


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                      .......++..|++||++.....+.++||||||+++++|++|+.||.....   ....        ..+..+....   +
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~--------~~~~~~~~~~---~  221 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---EEIF--------QNILNGKIEW---P  221 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHH--------HHHhcCCcCC---C
Confidence            122335678899999999888899999999999999999999999976442   1111        1111121110   0


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                         ...  .....+.+++.+|++.+|.+||++.+|.+.|+-
T Consensus       222 ---~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         222 ---EDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             ---ccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence               000  124678999999999999999999888877764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.1e-36  Score=288.08  Aligned_cols=241  Identities=27%  Similarity=0.390  Sum_probs=192.6

Q ss_pred             ecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCH
Q 014904           52 LGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL  127 (416)
Q Consensus        52 LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL  127 (416)
                      ||+|+||+||++.. .+|+.||+|.+....   ......+..|+.++++++|||++++++++......++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999984 468999999987532   12234567899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeeccc
Q 014904          128 EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM  207 (416)
Q Consensus       128 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  207 (416)
                      .+++.......+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence            9999766555789999999999999999999998   99999999999999999999999999987654321  122345


Q ss_pred             ccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCC
Q 014904          208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYN  287 (416)
Q Consensus       208 gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  287 (416)
                      ++..|+|||++.++.++.++|||||||++++|++|+.||...........       +    ......      .....+
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~----~~~~~~------~~~~~~  218 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE-------L----KRRTLE------MAVEYP  218 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH-------H----Hhcccc------ccccCC
Confidence            78899999999888899999999999999999999999976543111000       0    011000      001112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHH
Q 014904          288 HNEMARMVACAAACVRHSARRRPRMSQ  314 (416)
Q Consensus       288 ~~~~~~l~~l~~~cl~~~p~~RPt~~e  314 (416)
                      ......+.+++.+||+.+|.+||+..+
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         219 DKFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             ccCCHHHHHHHHHHccCChhHccCCCc
Confidence            223457889999999999999995444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.3e-36  Score=287.66  Aligned_cols=261  Identities=21%  Similarity=0.237  Sum_probs=194.6

Q ss_pred             CCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcC-CCcccceEEEEEeC--CeEEEEEE
Q 014904           46 FSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG-QGEREFQAEVEIISRVH-HKHLVSLVGYYTAG--SQRMLVYE  120 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e  120 (416)
                      |.+.+.||+|+||.||+|.. .+++.||+|+++.... ........|+.++.++. |+|++++++++.+.  ...++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            66788999999999999995 4689999999875432 22234457888888885 99999999999987  88999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+.+ +|.+.+.... ..+++..++.++.|++.||.|||+.   +++||||+|+||+++. +.+||+|||+++.......
T Consensus        81 ~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          81 LMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             cCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            9975 6776665433 3689999999999999999999999   9999999999999999 9999999999986643322


Q ss_pred             ceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHh-------HHhhhcC
Q 014904          201 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLL-------NRAIEDG  272 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~-------~~~~~~~  272 (416)
                      .  ....++..|+|||++.. +.++.++|||||||++|||++|..||......   ..+.+....+       .......
T Consensus       155 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07831         155 Y--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFRKS  229 (282)
T ss_pred             c--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhccc
Confidence            2  23467889999997654 56789999999999999999999999765431   1122211110       0000011


Q ss_pred             CcccccCccccC----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          273 NFDTLVDPKLHN----EYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       273 ~~~~~~d~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .......+....    .........+.+++.+||+.+|++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            111111111000    011234578999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.2e-36  Score=288.25  Aligned_cols=267  Identities=22%  Similarity=0.335  Sum_probs=199.3

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      +|+..+.||+|++|.||+|... +|+.||||+++..... ....+.+|+.++++++|+||+++++++......++|+||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999964 6899999999765432 2356778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          123 PNNTLEFHLHGKG-RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       123 ~~~sL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      ++ +|.+++.... ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.........
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            85 7777775443 34689999999999999999999998   9999999999999999999999999998755332211


Q ss_pred             eeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch-hhhhhhh-HH--hHHhhhc-----
Q 014904          202 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED-SLVDWAR-PL--LNRAIED-----  271 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~-~l~~~~~-~~--~~~~~~~-----  271 (416)
                       .....++..|++||++.+. .++.++|||||||++|+|++|+.||......... .+.+... +.  ....+..     
T Consensus       157 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         157 -FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             -cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence             1224568899999998654 5789999999999999999999999764431110 0111100 00  0000000     


Q ss_pred             CCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          272 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       272 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..+....+... ..........+.+++.+|++.+|.+||++.||++
T Consensus       236 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         236 PTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000000000 1111223457889999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.2e-36  Score=290.26  Aligned_cols=267  Identities=19%  Similarity=0.272  Sum_probs=197.1

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ++|...+.||+|++|.||+|... +|+.||+|++.....  .....+..|+.++++++|+||+++++++......++|+|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57899999999999999999964 689999999865432  223568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC-CCceEEeecccceeccCCC
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~-~~~~kl~DFGla~~~~~~~  199 (416)
                      |++ ++|..++.......+++.....++.+++.||+|||+.   +++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 4777777554444578888899999999999999999   9999999999999985 5679999999997654322


Q ss_pred             cceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchh-hhhhhhHHhHHhhhcCCcccc
Q 014904          200 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDS-LVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      . ......+++.|+|||++.+. .++.++|||||||++|+|+||+.||.......... ...+........+ . .+..+
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~  234 (294)
T PLN00009        158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW-P-GVTSL  234 (294)
T ss_pred             c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc-c-ccccc
Confidence            1 12234578899999998664 57899999999999999999999997644311100 0000000000000 0 00000


Q ss_pred             cC-----ccccC----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          278 VD-----PKLHN----EYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       278 ~d-----~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .+     +....    .........+.+++.+|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00     00000    011123356889999999999999999999986

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-36  Score=286.12  Aligned_cols=265  Identities=20%  Similarity=0.277  Sum_probs=201.4

Q ss_pred             CCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           46 FSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      |...+.||+|++|.||+|.. .+++.+++|++......  ....+..|+.++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            56778999999999999995 47899999998755432  3457888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++ +|..++.... ..+++..++.++.+++.||.|||+.   +|+|+||||+||+++.++.++|+|||.+....... ..
T Consensus        81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP  154 (283)
T ss_pred             CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence            75 7777776543 3689999999999999999999999   99999999999999999999999999998765543 12


Q ss_pred             eecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhh-h-------hhhHHhHHhhhcCC
Q 014904          203 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV-D-------WARPLLNRAIEDGN  273 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~-~-------~~~~~~~~~~~~~~  273 (416)
                      .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||............ .       +.++.+........
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            2335678899999998876 7899999999999999999999999765432111000 0       00000000000000


Q ss_pred             --cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          274 --FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       274 --~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                        +....+... ..........+.+++.+||+.+|.+||++.+++.
T Consensus       235 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         235 FSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence              000000000 1112234568899999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.2e-36  Score=291.05  Aligned_cols=269  Identities=23%  Similarity=0.289  Sum_probs=199.8

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCC----
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGS----  113 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  113 (416)
                      .+.++|.+.+.||+|+||.||+|... +++.||+|+++....  .....+.+|+.++++++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            46789999999999999999999965 589999999975432  22346778999999999999999999987654    


Q ss_pred             ------eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEe
Q 014904          114 ------QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA  187 (416)
Q Consensus       114 ------~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~  187 (416)
                            ..++|+||+++ .+...+... ...+++..++.++.|++.||+|||+.   +|+|+||||+||+++.++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence                  78999999976 666666544 23689999999999999999999999   99999999999999999999999


Q ss_pred             ecccceeccCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH--
Q 014904          188 DFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL--  264 (416)
Q Consensus       188 DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~--  264 (416)
                      |||++...............++..|+|||.+.+ ..++.++|||||||+++||++|+.||.......  .+.......  
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~~~~~~~~~  236 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLELISRLCGS  236 (302)
T ss_pred             cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCC
Confidence            999998765443322233456788999998865 357899999999999999999999997544311  111110000  


Q ss_pred             -hH---HhhhcCCc------ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          265 -LN---RAIEDGNF------DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       265 -~~---~~~~~~~~------~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                       ..   ..+.....      .......+...+. ..+..+.+++..||+.+|.+||++.+|++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             00   00000000      0000000101111 12457899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6.6e-36  Score=287.85  Aligned_cols=262  Identities=20%  Similarity=0.276  Sum_probs=194.8

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcC-CCcccceEEEEEeCCe-----
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVH-HKHLVSLVGYYTAGSQ-----  114 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  114 (416)
                      ++|+..+.||+|+||.||+|.. .+++.||||++......  ....+.+|+.+++.+. |+||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4789999999999999999995 46899999998654322  2356888999999995 6999999999887655     


Q ss_pred             EEEEEEecCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC-CCceEEeecc
Q 014904          115 RMLVYEFVPNNTLEFHLHGKG---RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF-KFEAKVADFG  190 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~-~~~~kl~DFG  190 (416)
                      .++||||+++ +|..++....   ...+++..++.++.|++.||.|||+.   +|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 7877775432   23689999999999999999999999   9999999999999998 8899999999


Q ss_pred             cceeccCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhh
Q 014904          191 LAKIASDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAI  269 (416)
Q Consensus       191 la~~~~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~  269 (416)
                      +++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||........  +...    . ..+
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~----~-~~~  228 (295)
T cd07837         157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHI----F-KLL  228 (295)
T ss_pred             cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHH----H-HHh
Confidence            98765332111 122356888999998865 4579999999999999999999999976433111  1100    0 000


Q ss_pred             hcCC---cccc---cC----cccc----CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          270 EDGN---FDTL---VD----PKLH----NEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       270 ~~~~---~~~~---~d----~~l~----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ....   +...   .+    +...    ..........+.+++.+||+.+|.+||++.|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000   0000   00    0000    0001123456889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.6e-36  Score=285.67  Aligned_cols=242  Identities=26%  Similarity=0.329  Sum_probs=195.8

Q ss_pred             ecccCcEEEEEEEeC-CCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCH
Q 014904           52 LGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL  127 (416)
Q Consensus        52 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL  127 (416)
                      ||.|++|.||++... +++.+|+|++.....   .....+..|+.++++++|+||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999964 589999999875432   2335788999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeeccc
Q 014904          128 EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM  207 (416)
Q Consensus       128 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  207 (416)
                      .+++....  .+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~  153 (262)
T cd05572          81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC  153 (262)
T ss_pred             HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence            99997643  489999999999999999999998   99999999999999999999999999998765432  223356


Q ss_pred             ccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCC
Q 014904          208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYN  287 (416)
Q Consensus       208 gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  287 (416)
                      ++..|++||++.+..++.++|+||||+++|+|++|..||.......    .++..     .+..+.        ....++
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~-----~~~~~~--------~~~~~~  216 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYN-----DILKGN--------GKLEFP  216 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHH-----HHhccC--------CCCCCC
Confidence            8899999999988889999999999999999999999997654210    11111     111110        011122


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014904          288 HNEMARMVACAAACVRHSARRRPR-----MSQIVR  317 (416)
Q Consensus       288 ~~~~~~l~~l~~~cl~~~p~~RPt-----~~evv~  317 (416)
                      ......+..++.+||+.+|++||+     +.|+++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            222567899999999999999999     555554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-36  Score=281.59  Aligned_cols=247  Identities=27%  Similarity=0.430  Sum_probs=204.2

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +|.+.+.||+|++|.||++... +++.|++|.+.....  .....+.+|++++++++|+|++++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            5788899999999999999954 678999999986654  3345789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.+++...  ..+++..+..++.+++.||.+||+.   +|+|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            9999999998755  3689999999999999999999999   9999999999999999999999999999876654332


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                       .....++..|+|||++.+..++.++|||+||+++++|++|+.||......    ...|      .. ......      
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~~------~~-~~~~~~------  217 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AALF------RI-VQDDHP------  217 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHHH------HH-hccCCC------
Confidence             23356889999999998888899999999999999999999998754320    1111      00 111111      


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                         ..+......+.+++.+|+..+|++||++.+++.
T Consensus       218 ---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 ---PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ---CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence               111223457889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=284.69  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=204.5

Q ss_pred             hhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecC--CcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .++.|++-+.||+|.|+.|+++. .++|+.+|+|++...  +..+-+++.+|+.|...|+|||||++.+........++|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            45788888999999999999998 567999999988643  333557889999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC---CCceEEeecccceec
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFGLAKIA  195 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~---~~~~kl~DFGla~~~  195 (416)
                      +|++.|+.|..-|-..  ...++...-..+.||+++|.|+|..   +|||||+||.|++|..   ..-+||+|||+|...
T Consensus        89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999997555432  2566777778899999999999999   9999999999999943   345899999999987


Q ss_pred             cCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      .+  ........|||+|||||++...+++..+|||+-||+||-||.|+.||.....           ..+-+.+..|.++
T Consensus       164 ~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-----------~rlye~I~~g~yd  230 (355)
T KOG0033|consen  164 ND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----------HRLYEQIKAGAYD  230 (355)
T ss_pred             CC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-----------HHHHHHHhccccC
Confidence            73  3333446899999999999999999999999999999999999999987432           1122334455543


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                        +++...    ....+...+|+++||..||.+|-|+.|.+.
T Consensus       231 --~~~~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  231 --YPSPEW----DTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             --CCCccc----CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence              122222    223346788999999999999999998764

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.7e-37  Score=280.86  Aligned_cols=254  Identities=25%  Similarity=0.392  Sum_probs=208.5

Q ss_pred             HHhhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCc----ccH----HHHHHHHHHHHhc-CCCcccceEEEE
Q 014904           40 ARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSG----QGE----REFQAEVEIISRV-HHKHLVSLVGYY  109 (416)
Q Consensus        40 ~~~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~----~~~----~~~~~E~~~l~~l-~h~niv~l~~~~  109 (416)
                      ....+.|...+.||.|..+.|-+++ .++|+++|+|++.....    ...    +.-..|+.||+++ -||+|+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            3445678888999999999999988 45789999999864321    112    2345799999999 599999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeec
Q 014904          110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF  189 (416)
Q Consensus       110 ~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DF  189 (416)
                      ..+...++|+|.++.|.|.++|...-  .++.....+|+.|+.+|++|||..   .||||||||+|||+|+|.++||+||
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence            99999999999999999999997654  689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccCCCcceeecccccccccChhhhc------cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH
Q 014904          190 GLAKIASDVNTHVSTRVMGTFGYLAPEYAS------SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP  263 (416)
Q Consensus       190 Gla~~~~~~~~~~~~~~~gt~~YlaPE~~~------~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~  263 (416)
                      |+++.+....  .....+|||||+|||.+.      ...|+...|+|+.||++|-||.|.+||.....           -
T Consensus       168 GFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----------m  234 (411)
T KOG0599|consen  168 GFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----------M  234 (411)
T ss_pred             ceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----------H
Confidence            9999876533  335689999999999873      34688899999999999999999999965322           1


Q ss_pred             HhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          264 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       264 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ++.+.+.+|.+. +-.|.+     .+......+|+.+||+.||.+|-|+.|++.
T Consensus       235 lMLR~ImeGkyq-F~speW-----adis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  235 LMLRMIMEGKYQ-FRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHHHhcccc-cCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            233445566653 222222     234557889999999999999999999885

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.8e-36  Score=289.33  Aligned_cols=271  Identities=22%  Similarity=0.271  Sum_probs=195.4

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEeCC-----
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTAGS-----  113 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  113 (416)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||.+......  ....+.+|+.++++++||||++++++|....     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            345799999999999999999995 46899999998754322  2235678999999999999999999987643     


Q ss_pred             ---eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecc
Q 014904          114 ---QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG  190 (416)
Q Consensus       114 ---~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFG  190 (416)
                         ..++|+||+.+ +|...+.... ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence               45999999965 7777765443 3589999999999999999999999   99999999999999999999999999


Q ss_pred             cceeccCCCcc---eeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh----
Q 014904          191 LAKIASDVNTH---VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR----  262 (416)
Q Consensus       191 la~~~~~~~~~---~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~----  262 (416)
                      ++.........   ......++..|+|||++.+. .++.++||||||++++||++|+.||................    
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99765432221   11234678899999998664 47889999999999999999999997654322111111100    


Q ss_pred             HHhHHhhhc-CCcccccCcc-----ccCcC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          263 PLLNRAIED-GNFDTLVDPK-----LHNEY-NHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       263 ~~~~~~~~~-~~~~~~~d~~-----l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      +.+...... ..+..+..+.     ..... +......+.+++.+||+.+|.+||++.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            000000000 0000000000     00000 0001235678999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-37  Score=278.45  Aligned_cols=249  Identities=26%  Similarity=0.440  Sum_probs=196.4

Q ss_pred             CcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC-cccHHHHHHHHHHHHhcC-CCcccceEEEEEeCCeEEEEEEecC
Q 014904           47 SDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS-GQGEREFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        47 ~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      ..+..||.|..|.||++.. .+|..+|||...... ....++++..++++..-+ +|+||+.+|||..+...++.||.+ 
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-  173 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-  173 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence            3456799999999999995 568999999987654 344467888888877775 899999999999999999999987 


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      ...++.++..-.. ++++..+=++...+++||.||.+++  +|||||+||+|||+|..|++|+||||++-..-+...+  
T Consensus       174 s~C~ekLlkrik~-piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh--  248 (391)
T KOG0983|consen  174 STCAEKLLKRIKG-PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH--  248 (391)
T ss_pred             HHHHHHHHHHhcC-CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence            5566666654333 5888888899999999999999886  9999999999999999999999999999776654433  


Q ss_pred             ecccccccccChhhhc---cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          204 TRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~---~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                      ++..|.+.|||||-+.   ..+|+.++||||||+.|+||.||+.||..... +-+.+.        ..+ +...     |
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-dFe~lt--------kvl-n~eP-----P  313 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-DFEVLT--------KVL-NEEP-----P  313 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-cHHHHH--------HHH-hcCC-----C
Confidence            5567999999999884   34789999999999999999999999987543 111111        111 1111     3


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .+....  .....+.+++..||+.|+.+||...++++.
T Consensus       314 ~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  314 LLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            332221  144688999999999999999999998753

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-36  Score=287.89  Aligned_cols=266  Identities=21%  Similarity=0.262  Sum_probs=198.6

Q ss_pred             CCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcC-CCcccceEEEEEeCCeEEEEEEec
Q 014904           46 FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      |.+.+.||+|++|.||+|... +++.|+||++..... .......+|+..+.+++ |+|++++++++..+...++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            667889999999999999965 578999999875432 22334567899999999 999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                       +++|.+.+.......+++..++.++.|++.+|.|||+.   +++|+||+|.||+++.++.++|+|||++......... 
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-  155 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc-
Confidence             78898888766545789999999999999999999998   9999999999999999999999999999866443221 


Q ss_pred             eecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch-hhhhhhhH----HhHHhh-hcCCcc
Q 014904          203 STRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED-SLVDWARP----LLNRAI-EDGNFD  275 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~-~l~~~~~~----~~~~~~-~~~~~~  275 (416)
                       ....++..|+|||++.. ..++.++||||||++++||++|+.||......... ....+...    .+.... ......
T Consensus       156 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         156 -TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             -CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence             23457889999998754 45799999999999999999999999765431110 00000000    000000 000111


Q ss_pred             cccCcccc---CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          276 TLVDPKLH---NEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       276 ~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..+.....   ..........+..++.+|++.+|++||++.||+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000000   0001112467899999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-36  Score=283.53  Aligned_cols=249  Identities=23%  Similarity=0.359  Sum_probs=197.2

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC-----cccHHHHHHHHHHHHhcCCCcccceEEEEEeC--CeE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS-----GQGEREFQAEVEIISRVHHKHLVSLVGYYTAG--SQR  115 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  115 (416)
                      .+|.+.++||+|+||.||+|.. .+++.||+|.+....     ......+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5789999999999999999995 468999999875321     12235788999999999999999999998764  468


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++|+||+++++|.+++....  .+++.....++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            89999999999999987543  478889999999999999999999   9999999999999999999999999999765


Q ss_pred             cCCCc--ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          196 SDVNT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       196 ~~~~~--~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      .....  .......++..|+|||++.+..++.++|||||||++++|++|+.||.......  ..        .+..... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~--------~~~~~~~-  225 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AI--------FKIATQP-  225 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HH--------HHHHcCC-
Confidence            32111  11123568999999999998889999999999999999999999996532210  00        1111011 


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                              .....+......+.+++..|++ ++.+||+..++++
T Consensus       226 --------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         226 --------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                    1111223344578999999999 4799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-36  Score=297.02  Aligned_cols=267  Identities=22%  Similarity=0.349  Sum_probs=197.4

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeC-----Ce
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAG-----SQ  114 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  114 (416)
                      .+++|.+.++||+|+||.||+|.. .+|+.||||+++.... .....+..|+.++++++|+||+++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            468999999999999999999994 5789999999875332 2335678899999999999999999987654     35


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      .++|+||+.+ +|..++...   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        83 ~~lv~e~~~~-~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          83 VYIVQELMET-DLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEEehhccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence            7999999965 777766443   589999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCCcce--eecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhH-----
Q 014904          195 ASDVNTHV--STRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN-----  266 (416)
Q Consensus       195 ~~~~~~~~--~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~-----  266 (416)
                      ........  .....|+..|+|||++.+ ..++.++|||||||++++|++|+.||.......  .+..+ ...+.     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~~-~~~~~~~~~~  232 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNLI-LGVLGTPSQE  232 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH-HHHcCCCCHH
Confidence            54322221  133568999999998755 468999999999999999999999996543211  01000 00000     


Q ss_pred             --HhhhcCC----ccccc-Ccccc-CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          267 --RAIEDGN----FDTLV-DPKLH-NEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       267 --~~~~~~~----~~~~~-d~~l~-~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                        ..+....    +..+. .+... ..........+.+++.+||+.+|++||++.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0000000    00000 00000 00001124568899999999999999999999976

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1e-35  Score=285.40  Aligned_cols=242  Identities=24%  Similarity=0.327  Sum_probs=188.0

Q ss_pred             eecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHh---cCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           51 LLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISR---VHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        51 ~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      +||+|+||.||++.. .+++.+|+|.+.....   .....+..|..++..   .+|+|++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999995 4689999999875432   112234455444443   479999999999999899999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      +++|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++........   
T Consensus        81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---  152 (279)
T cd05633          81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---  152 (279)
T ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---
Confidence            999998886544  589999999999999999999999   999999999999999999999999999875543222   


Q ss_pred             ecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          204 TRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      ....|+..|+|||.+.+ ..++.++|||||||++++|++|+.||..........+...        ..      ....  
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--------~~------~~~~--  216 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--------TL------TVNV--  216 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH--------hh------cCCc--
Confidence            23468999999999874 4589999999999999999999999975433111111100        00      0011  


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRP-----RMSQIVRA  318 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~~  318 (416)
                        ..+......+.+++.+||+.+|.+||     ++.|+++.
T Consensus       217 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         217 --ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             --CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence              12223345788999999999999999     58888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.4e-35  Score=286.66  Aligned_cols=244  Identities=25%  Similarity=0.378  Sum_probs=197.5

Q ss_pred             CceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCH
Q 014904           49 ANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL  127 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL  127 (416)
                      ..+||+|+||.||++.. .+++.||||++..........+..|+.+++.++|+|++++++++......++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            35799999999999996 57899999998755544556788999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeeccc
Q 014904          128 EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM  207 (416)
Q Consensus       128 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  207 (416)
                      .+++...   .+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........ ......
T Consensus       105 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~  177 (292)
T cd06657         105 TDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV  177 (292)
T ss_pred             HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence            9887532   478999999999999999999999   999999999999999999999999999876543222 123356


Q ss_pred             ccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCC
Q 014904          208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYN  287 (416)
Q Consensus       208 gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  287 (416)
                      |++.|+|||++.+..++.++|||||||++++|++|..||.......   .....        ..+.     .+.+..  .
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~~~--------~~~~-----~~~~~~--~  239 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMI--------RDNL-----PPKLKN--L  239 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH--------HhhC-----CcccCC--c
Confidence            8899999999988889999999999999999999999987543211   11110        0110     011100  0


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          288 HNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       288 ~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ......+.+++.+||+.+|.+||++.+|++
T Consensus       240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            112346788999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-35  Score=282.44  Aligned_cols=263  Identities=22%  Similarity=0.305  Sum_probs=197.0

Q ss_pred             CCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCccc--HHHHHHHHHHHHhc---CCCcccceEEEEEeCCe-----
Q 014904           46 FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQG--EREFQAEVEIISRV---HHKHLVSLVGYYTAGSQ-----  114 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  114 (416)
                      |++.+.||+|+||.||+|... +++.||+|+++......  ...+.+|+.++.++   +|+|++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            677889999999999999975 48999999997543221  23566788877766   59999999999988776     


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      .+++|||+.+ +|.+++.......+++..++.++.+++.||.|||+.   +++|+||+|+||+++.++.+||+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999975 788888665444689999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhH---Hhhh-
Q 014904          195 ASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN---RAIE-  270 (416)
Q Consensus       195 ~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~---~~~~-  270 (416)
                      .......  ....++..|+|||++.+..++.++|||||||++++|++|+.||.....  .+.+..+......   .... 
T Consensus       157 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         157 YSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE--ADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh--HHHHHHHHHHcCCCChHhcCC
Confidence            6443221  223578899999999999999999999999999999999999876443  1111111110000   0000 


Q ss_pred             -----cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          271 -----DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       271 -----~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                           ...+........ ..........+.+++.+||+.+|.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             Ccccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                 000000000000 1111223467789999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.9e-36  Score=295.55  Aligned_cols=278  Identities=21%  Similarity=0.336  Sum_probs=202.7

Q ss_pred             cCHHHHHHhh----CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceE
Q 014904           34 FTYEELARAT----DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLV  106 (416)
Q Consensus        34 f~~~el~~~t----~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~  106 (416)
                      |+.+|+.+++    ++|...+.||+|+||.||+|.. .+|+.||||++....  ......+..|+.+++.++|+||++++
T Consensus         1 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~   80 (342)
T cd07879           1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL   80 (342)
T ss_pred             CchhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchh
Confidence            5566777665    8999999999999999999995 468999999987532  12234678999999999999999999


Q ss_pred             EEEEeC------CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC
Q 014904          107 GYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF  180 (416)
Q Consensus       107 ~~~~~~------~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~  180 (416)
                      +++...      ...++|+||+.. +|..++.    ..+++..+..++.|++.||+|||+.   +++||||||+||+++.
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~  152 (342)
T cd07879          81 DVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNE  152 (342)
T ss_pred             heecccccCCCCceEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC
Confidence            998754      346899999964 6666542    2588999999999999999999999   9999999999999999


Q ss_pred             CCceEEeecccceeccCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhh
Q 014904          181 KFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD  259 (416)
Q Consensus       181 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~  259 (416)
                      ++.+||+|||+++......    ....++..|+|||.+.+ ..++.++|||||||+++||++|+.||.............
T Consensus       153 ~~~~kL~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~  228 (342)
T cd07879         153 DCELKILDFGLARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL  228 (342)
T ss_pred             CCCEEEeeCCCCcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999987643221    23467889999999876 468999999999999999999999997654211111000


Q ss_pred             hh----hHHhHHhhhcCCcccccC--ccc-cCcC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hcccc
Q 014904          260 WA----RPLLNRAIEDGNFDTLVD--PKL-HNEY---NHNEMARMVACAAACVRHSARRRPRMSQIVRA--LEGDA  323 (416)
Q Consensus       260 ~~----~~~~~~~~~~~~~~~~~d--~~l-~~~~---~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~--L~~~~  323 (416)
                      +.    .+.+...+........+.  +.. ....   .......+.+++.+||+.+|.+||++.+++..  +++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         229 KVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            00    000001111100000000  000 0000   01123468899999999999999999999954  65543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.3e-35  Score=286.93  Aligned_cols=258  Identities=18%  Similarity=0.205  Sum_probs=185.1

Q ss_pred             CCCCcCceecccCcEEEEEEEeCC----CcEEEEEEeecCCcccHH-----------HHHHHHHHHHhcCCCcccceEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPN----GKEVAIKQLKAGSGQGER-----------EFQAEVEIISRVHHKHLVSLVGY  108 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~-----------~~~~E~~~l~~l~h~niv~l~~~  108 (416)
                      ++|.+.++||+|+||.||+|...+    +..+|+|+..........           ....++..+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            689999999999999999999644    456666654332221111           11223344556789999999998


Q ss_pred             EEeCC----eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCce
Q 014904          109 YTAGS----QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA  184 (416)
Q Consensus       109 ~~~~~----~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~  184 (416)
                      +....    ..+++++++. .++.+.+....  ..++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence            76543    3467777764 35555554322  357888899999999999999999   99999999999999999999


Q ss_pred             EEeecccceeccCCCcce------eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhh
Q 014904          185 KVADFGLAKIASDVNTHV------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV  258 (416)
Q Consensus       185 kl~DFGla~~~~~~~~~~------~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~  258 (416)
                      +|+|||+++.+.......      .....||+.|+|||++.+..++.++|||||||+++||++|+.||......  ..++
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~--~~~~  243 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN--GNLI  243 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc--hHHH
Confidence            999999998664322111      12246999999999999999999999999999999999999999765321  1111


Q ss_pred             hhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          259 DWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      .-...-+...+..+..        .   ....+..+.+++..|++.+|++||++.+|++.|+
T Consensus       244 ~~~~~~~~~~~~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKCDFIKRLHEGKI--------K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHHHHHHHhhhhhh--------c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            1111001111111111        0   0112467889999999999999999999998874

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.3e-35  Score=291.16  Aligned_cols=264  Identities=20%  Similarity=0.279  Sum_probs=194.6

Q ss_pred             ceeccc--CcEEEEEEEe-CCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQG--GFGYVHRGVL-PNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G--~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ..||.|  +|++||++.+ .+|+.||||++......  ..+.+.+|+.+++.++|+||++++++|..+...++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456766  8999999996 47999999998754322  235688899999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce--
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV--  202 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~--  202 (416)
                      ++|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999998765545689999999999999999999998   99999999999999999999999998653322111110  


Q ss_pred             ----eecccccccccChhhhccC--CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH------------H
Q 014904          203 ----STRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP------------L  264 (416)
Q Consensus       203 ----~~~~~gt~~YlaPE~~~~~--~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~------------~  264 (416)
                          .....++..|+|||++.+.  .++.++|||||||++++|++|+.||......  ..+......            .
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccch
Confidence                0112345679999999764  4789999999999999999999999754321  111100000            0


Q ss_pred             -----------h-----HHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          265 -----------L-----NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       265 -----------~-----~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                                 .     ......+....+.+..+...........+.+++.+||+.+|++||++.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                       0     00000000001111222222233456788999999999999999999999854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.3e-35  Score=288.81  Aligned_cols=263  Identities=18%  Similarity=0.254  Sum_probs=192.5

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEeecC--CcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCH
Q 014904           50 NLLGQGGFGYVHRGVLPNGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL  127 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL  127 (416)
                      +.+|.|+++.|+++.. +++.||||+++..  .......+..|+.++++++|+||+++++++......+++|||+++++|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3344555555555555 7899999999765  233346789999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc------c
Q 014904          128 EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT------H  201 (416)
Q Consensus       128 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~------~  201 (416)
                      .+++.......+++.....++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||.+........      .
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            9999765444688999999999999999999999   999999999999999999999999999875432211      1


Q ss_pred             eeecccccccccChhhhccC--CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh-------cC
Q 014904          202 VSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE-------DG  272 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~--~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~-------~~  272 (416)
                      ......++..|+|||++...  .++.++|||||||++|||++|+.||.......  .+.+-........+.       ..
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcC
Confidence            11234577889999998753  58899999999999999999999997643211  111000000000000       00


Q ss_pred             Cccc----ccCcc----ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          273 NFDT----LVDPK----LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       273 ~~~~----~~d~~----l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ....    ..++.    ............+.+++.+||+.+|++||++.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            0000    01111    1111223344678899999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.9e-36  Score=289.05  Aligned_cols=253  Identities=25%  Similarity=0.421  Sum_probs=195.2

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCC-CcEEEEEEeecCCc-ccHHHHHHHHHHHHhcC-CCcccceEEEEEeCCeEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSG-QGEREFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  119 (416)
                      .++|.+.+.||+|+||.||+|.+.+ ++.||||+++.... ....++..|+.++.+.. |+||++++++|..+...++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            4678889999999999999999754 89999999975432 23345667777777775 999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+. +++..++..... .+++..+..++.+++.||+|||+.+  +|+||||+|+||+++.++.+||+|||++.......
T Consensus        94 e~~~-~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMS-TCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccC-cCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9985 467766654333 6899999999999999999999733  89999999999999999999999999987654322


Q ss_pred             cceeecccccccccChhhhccCC----CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          200 THVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~----~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ..  ....++..|+|||++.+..    ++.++||||||+++|+|++|+.||...... .+.+.        ..+. +...
T Consensus       170 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~--------~~~~-~~~~  237 (296)
T cd06618         170 AK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLT--------KILQ-EEPP  237 (296)
T ss_pred             cc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHH--------HHhc-CCCC
Confidence            22  2345788999999987553    889999999999999999999998653220 11111        1111 1111


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .+..       .......+.+++.+||+.+|.+||++.+|++.
T Consensus       238 ~~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         238 SLPP-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1100       01233578999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.5e-35  Score=286.42  Aligned_cols=269  Identities=23%  Similarity=0.287  Sum_probs=197.2

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCccc--HHHHHHHHHHHHhcCCCcccceEEEEEeC--CeEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQG--EREFQAEVEIISRVHHKHLVSLVGYYTAG--SQRML  117 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  117 (416)
                      .++|.+.+.||+|+||.||+|.. .+|+.||+|+++......  ...+.+|+.++.+++|+||+++++++...  ...++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            46899999999999999999996 468999999987543221  23466899999999999999999998764  56899


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      |+||+.+ +|..++.... ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            9999965 7877776433 3689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchh-hhhhhh-------HHhHHh
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDS-LVDWAR-------PLLNRA  268 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~-l~~~~~-------~~~~~~  268 (416)
                      .... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +.++..       +.+...
T Consensus       161 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         161 PAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             ccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            3221 122345788999999865 457999999999999999999999997654321111 001000       000000


Q ss_pred             hhcCCcccccCcccc--CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          269 IEDGNFDTLVDPKLH--NEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       269 ~~~~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      -..+.+. +......  ..........+.+++.+|++.||++||++.||++.
T Consensus       240 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         240 PLVGKFT-LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             ccccccc-ccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000000 0000000  00001124567889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=280.06  Aligned_cols=244  Identities=22%  Similarity=0.252  Sum_probs=191.5

Q ss_pred             ceecccCcEEEEEEEe-CCCcEEEEEEeecCCccc---HHHHHHHHHH-HHhcCCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQG---EREFQAEVEI-ISRVHHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      +.||+|+||.||+|.. .+++.||||++.......   ...+..|..+ ....+|+|++++++++..+...++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5689999999999995 468999999987543221   2234445444 4455899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      ++|..++....  .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+++....     ..
T Consensus        82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~  151 (260)
T cd05611          82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK  151 (260)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence            99999997543  588899999999999999999998   999999999999999999999999999876443     22


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccC
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHN  284 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~  284 (416)
                      ...++..|+|||.+.+..++.++||||||+++++|++|..||......   ..   .     ..+..+...      ...
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~---~-----~~~~~~~~~------~~~  214 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AV---F-----DNILSRRIN------WPE  214 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HH---H-----HHHHhcccC------CCC
Confidence            346888999999998888999999999999999999999999754321   11   1     011111111      011


Q ss_pred             cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          285 EYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       285 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      .........+.+++.+||+.+|++||++.++.+.|.
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            111123467899999999999999998877766665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.4e-36  Score=287.81  Aligned_cols=248  Identities=24%  Similarity=0.371  Sum_probs=202.9

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcC-CCcccceEEEEEeCCeEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV  118 (416)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....   ......+..|+.++.+++ |+||+++++++..+...++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47889999999999999999964 78999999987532   222356888999999998 99999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      ||++++++|.+++....  .+++..++.|+.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            99999999999997654  699999999999999999999998   9999999999999999999999999998865443


Q ss_pred             Cc-------------------ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhh
Q 014904          199 NT-------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD  259 (416)
Q Consensus       199 ~~-------------------~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~  259 (416)
                      ..                   .......++..|+|||.+....++.++||||||++++++++|+.||......   ..  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~--  230 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LT--  230 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HH--
Confidence            32                   1223356789999999998888999999999999999999999999765421   00  


Q ss_pred             hhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 014904          260 WARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRM----SQIVR  317 (416)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~----~evv~  317 (416)
                           +... ...          ...++......+.+++.+||+.+|.+||++    .++++
T Consensus       231 -----~~~~-~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         231 -----FQKI-LKL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             -----HHHH-Hhc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                 0010 011          011222235678999999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.4e-36  Score=294.68  Aligned_cols=271  Identities=19%  Similarity=0.292  Sum_probs=200.4

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEe----CCe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTA----GSQ  114 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~  114 (416)
                      +.++|.+.+.||+|+||.||+|.. .+|+.||+|++.....  .....+..|+.++++++|+||+++++++..    ...
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            347899999999999999999995 4699999999875422  234567789999999999999999988753    456


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      .++|+||+. ++|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            899999995 58888886543  489999999999999999999998   999999999999999999999999999976


Q ss_pred             ccCCCcc---eeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhh----hHHhH
Q 014904          195 ASDVNTH---VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA----RPLLN  266 (416)
Q Consensus       195 ~~~~~~~---~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~----~~~~~  266 (416)
                      .......   ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.............-.    .+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            5433221   1233578899999999865 46899999999999999999999999764431111000000    00000


Q ss_pred             HhhhcCCcccccC---cccc---CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          267 RAIEDGNFDTLVD---PKLH---NEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       267 ~~~~~~~~~~~~d---~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ............+   ....   ..........+.+++.+||+.+|++||++.+++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0000000000000   0000   00112235679999999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.1e-35  Score=283.99  Aligned_cols=244  Identities=25%  Similarity=0.337  Sum_probs=193.8

Q ss_pred             CCCcCceecccCcEEEEEEEe----CCCcEEEEEEeecCCc----ccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSG----QGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  115 (416)
                      +|++.+.||+|+||.||++..    .+|+.||+|+++....    ...+.+..|+.++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999985    3689999999975432    2235678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++|+||+++++|.+++....  .+++.....++.|++.||.|||+.   +++||||+|+|||++.++.+||+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            99999999999999987543  588899999999999999999998   9999999999999999999999999999876


Q ss_pred             cCCCcceeecccccccccChhhhccC--CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~--~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      ............|+..|+|||++..+  .++.++||||||+++|+|++|+.||......  .....+....     ....
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~-----~~~~  228 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRI-----LKSE  228 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHh-----hccC
Confidence            54333223345689999999998753  4688999999999999999999998653221  1111111111     0110


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCC
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP  310 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP  310 (416)
                            +    .++......+.+++.+|++.+|.+||
T Consensus       229 ------~----~~~~~~~~~~~~ll~~~l~~~p~~R~  255 (290)
T cd05613         229 ------P----PYPQEMSALAKDIIQRLLMKDPKKRL  255 (290)
T ss_pred             ------C----CCCccCCHHHHHHHHHHhcCCHHHhc
Confidence                  1    11222345788999999999999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-37  Score=300.77  Aligned_cols=253  Identities=22%  Similarity=0.377  Sum_probs=205.1

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeec--CCcccHHHHHHHHHHHHhcC-CCcccceEEEEEeCCeEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKA--GSGQGEREFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV  118 (416)
                      .-..|++.++||.||.+.||++...+.+.+|+|++..  .+.+...-|..|+..|.+|+ |.+|++|++|-..++.+|+|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            3457899999999999999999988888899987753  34455567999999999995 99999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      ||+- ..+|..+|..+......| .+..+..|++.|+.++|+.   +|||.||||.|+|+- .|.+||+|||+|......
T Consensus       439 mE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             eecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence            9965 789999998777655556 6678899999999999999   999999999999994 568999999999987766


Q ss_pred             Ccce-eecccccccccChhhhccC-----------CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhH
Q 014904          199 NTHV-STRVMGTFGYLAPEYASSG-----------KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN  266 (416)
Q Consensus       199 ~~~~-~~~~~gt~~YlaPE~~~~~-----------~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~  266 (416)
                      .+.+ ....+||+.||+||.+...           +++.+||||||||+||+|+.|+.||.....       .|+     
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~a-----  580 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIA-----  580 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHH-----
Confidence            5554 3557899999999988322           367899999999999999999999975321       222     


Q ss_pred             HhhhcCCcccccCccccCcCCHHH-HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          267 RAIEDGNFDTLVDPKLHNEYNHNE-MARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       267 ~~~~~~~~~~~~d~~l~~~~~~~~-~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                            .+..+.||....+|+.-- ...++++++.||..||.+||+..++|+.
T Consensus       581 ------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  581 ------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                  223455554444443211 1239999999999999999999999864

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.8e-35  Score=284.23  Aligned_cols=256  Identities=25%  Similarity=0.289  Sum_probs=202.1

Q ss_pred             CCCcCceecccCcEEEEEEEe----CCCcEEEEEEeecCCc----ccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSG----QGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  115 (416)
                      +|.+.+.||+|++|.||++..    .+++.||||+++....    .....+..|+.++.++ +|+||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477889999999999999984    2578899999875322    2234678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++||||+++++|..++....  .+++.....++.|++++|.|||+.   +++|+||+|.||+++.++.++|+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            99999999999998886543  588999999999999999999998   9999999999999999999999999998765


Q ss_pred             cCCCcceeecccccccccChhhhccCC--CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~~--~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      ............|+..|+|||++.+..  .+.++||||||+++++|++|..||.......  ....+..     ......
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~-----~~~~~~  228 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISR-----RILKSK  228 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHH-----HHHccC
Confidence            443333233356899999999987765  7899999999999999999999986432211  1111111     111111


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                            +..    +......+.+++.+||+.+|++||++.++.+.|+..
T Consensus       229 ------~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         229 ------PPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             ------CCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence                  111    112234678899999999999999999999888753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-37  Score=303.69  Aligned_cols=245  Identities=29%  Similarity=0.432  Sum_probs=199.9

Q ss_pred             CCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcc---cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQ---GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .|..++-||.|.||.||.|. ..+.+.||||+..-.-.+   ...++..||..|.+++|||++...|++......|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            46667789999999999999 457889999998744333   34578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      || -|+-.+++.-... ++....+..|+.+.+.||+|||+.   +.||||||+.||||++.|.|||+|||.|.+....  
T Consensus       107 YC-lGSAsDlleVhkK-plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--  179 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--  179 (948)
T ss_pred             HH-hccHHHHHHHHhc-cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence            99 4566666653332 688889999999999999999999   9999999999999999999999999999876543  


Q ss_pred             ceeecccccccccChhhhc---cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          201 HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~---~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                         ..++|||-|||||++.   .|.|+-|+||||||++..||.-.++|....+..  ..|..         +..++-   
T Consensus       180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM--SALYH---------IAQNes---  242 (948)
T KOG0577|consen  180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYH---------IAQNES---  242 (948)
T ss_pred             ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH--HHHHH---------HHhcCC---
Confidence               3478999999999974   578999999999999999999999997654431  11111         112222   


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                        |.+.   ..+....+..++..||+.-|.+||+..++++.
T Consensus       243 --PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  243 --PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             --CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence              2222   23455679999999999999999999998753

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-35  Score=293.15  Aligned_cols=274  Identities=20%  Similarity=0.284  Sum_probs=203.9

Q ss_pred             ccCHHHHHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEE
Q 014904           33 TFTYEELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYY  109 (416)
Q Consensus        33 ~f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~  109 (416)
                      .....++..++++|.+.+.||+|+||.||+|.. .+++.||+|+++...  ......+.+|+.++.+++|+||+++++++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            456678899999999999999999999999994 578999999987542  22235678899999999999999999988


Q ss_pred             EeC------CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc
Q 014904          110 TAG------SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE  183 (416)
Q Consensus       110 ~~~------~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~  183 (416)
                      ...      ...+++++++ +++|..++...   .+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence            643      3467888876 78898887643   489999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccceeccCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch-hhhhhh
Q 014904          184 AKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED-SLVDWA  261 (416)
Q Consensus       184 ~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~-~l~~~~  261 (416)
                      +||+|||+++.....    .....++..|+|||++.+ ..++.++|||||||++++|++|+.||......... .+..+.
T Consensus       159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (345)
T cd07877         159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  234 (345)
T ss_pred             EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999998765332    123467889999999866 46889999999999999999999999654331110 000000


Q ss_pred             ---hHHhHHhhhcC-------CcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          262 ---RPLLNRAIEDG-------NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       262 ---~~~~~~~~~~~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                         .+.+...+...       .+......... .........+.+++.+|++.+|.+||++.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         235 GTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence               00000000000       00000000000 0001123468899999999999999999988854

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=305.65  Aligned_cols=244  Identities=26%  Similarity=0.427  Sum_probs=204.6

Q ss_pred             eecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCHHH
Q 014904           51 LLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEF  129 (416)
Q Consensus        51 ~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL~~  129 (416)
                      +||+|.||+||.|.+. +...+|||.+...+.....-+.+|+.+.++++|+|||+.+|.|.+++..-+.||.++||+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            7999999999999954 566899999876665555678999999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC-CCCceEEeecccceeccCCCcceeecc
Q 014904          130 HLHGKGRPTM--DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD-FKFEAKVADFGLAKIASDVNTHVSTRV  206 (416)
Q Consensus       130 ~l~~~~~~~l--~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~  206 (416)
                      +|..+=+ ++  ++.+.-....||++||.|||+.   .|||||||-.||||+ -.|.+||+|||-++.+..-+.. +..+
T Consensus       662 LLrskWG-PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~-TETF  736 (1226)
T KOG4279|consen  662 LLRSKWG-PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC-TETF  736 (1226)
T ss_pred             HHHhccC-CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc-cccc
Confidence            9986533 34  6778888999999999999999   999999999999995 5688999999999887654443 4557


Q ss_pred             cccccccChhhhccCC--CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccC
Q 014904          207 MGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHN  284 (416)
Q Consensus       207 ~gt~~YlaPE~~~~~~--~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~  284 (416)
                      -||..|||||++..|+  |..++|||||||++.||.|||+||-.....   .      .   ....-|.++      ...
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---q------A---AMFkVGmyK------vHP  798 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---Q------A---AMFKVGMYK------VHP  798 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---h------H---hhhhhccee------cCC
Confidence            8999999999998774  889999999999999999999999643220   0      0   112234332      345


Q ss_pred             cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          285 EYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       285 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..+.+..++...++++|+.++|.+||++.+++.
T Consensus       799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            566777889999999999999999999999884

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-35  Score=291.90  Aligned_cols=273  Identities=18%  Similarity=0.277  Sum_probs=201.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeC-----C
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAG-----S  113 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  113 (416)
                      +.++|.+.+.||+|+||+||+|.. .+++.||||.+....  ......+..|+.+++.++|+||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            467899999999999999999995 568999999987532  22335677899999999999999999988654     3


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ..++|+||+. ++|..++....  .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            4799999996 67888776543  589999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchh-hhhhhhHHhH---Hh
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDS-LVDWARPLLN---RA  268 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~-l~~~~~~~~~---~~  268 (416)
                      ...... .......++..|+|||.+.. ..++.++|||||||++++|++|+.||.......... +.........   ..
T Consensus       157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            664432 22233567889999998865 468999999999999999999999997543211100 0000000000   00


Q ss_pred             hhcCCc-------ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hccc
Q 014904          269 IEDGNF-------DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA--LEGD  322 (416)
Q Consensus       269 ~~~~~~-------~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~--L~~~  322 (416)
                      +..+..       ....++.... ........+.+++.+||+.+|++||++.++++.  |+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            000000       0000111110 111244678999999999999999999999976  5543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.1e-35  Score=286.78  Aligned_cols=244  Identities=27%  Similarity=0.410  Sum_probs=192.9

Q ss_pred             CCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc---cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           46 FSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ---GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      |...+.||+|+||.||+|.. .+++.|++|++......   ....+..|+.+++.++|+|++++++++.+....++|+||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66677899999999999995 46899999998754332   224678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +.+ ++.+++.... ..+++..++.++.+++.||.|||+.   +++|+||+|+||+++.++.+||+|||++......   
T Consensus       103 ~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---  174 (313)
T cd06633         103 CLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---  174 (313)
T ss_pred             CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence            964 6666665433 3589999999999999999999998   9999999999999999999999999998643321   


Q ss_pred             eeecccccccccChhhhc---cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          202 VSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~---~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                        ....|+..|+|||++.   .+.++.++|||||||++|+|++|+.||........   ..       . ...+......
T Consensus       175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~---~~-------~-~~~~~~~~~~  241 (313)
T cd06633         175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LY-------H-IAQNDSPTLQ  241 (313)
T ss_pred             --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HH-------H-HHhcCCCCCC
Confidence              2356889999999984   46688999999999999999999999866432111   10       0 0111111111


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .        ......+.+++.+||+.+|.+||++.++++.
T Consensus       242 ~--------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         242 S--------NEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             c--------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1        1122458889999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.6e-35  Score=288.06  Aligned_cols=249  Identities=26%  Similarity=0.392  Sum_probs=196.3

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ..+.|...+.||+|+||.||+|... +++.+|+|.+.....   ....++..|+.+++.++|+|++++++++......++
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            3445777889999999999999954 678999999864322   223467889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      |+||+. +++.+.+.... ..+++..+..++.+++.||.|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        93 v~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          93 VMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            999996 57776665433 3588999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCcceeecccccccccChhhhc---cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~---~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      .     ....+++.|+|||++.   .+.++.++|||||||++|+|++|+.||......  ..+..+         ..+..
T Consensus       168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~---------~~~~~  231 (308)
T cd06634         168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHI---------AQNES  231 (308)
T ss_pred             c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHHH---------hhcCC
Confidence            2     2346788999999974   356889999999999999999999998653321  011111         11111


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL  319 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L  319 (416)
                           +..   ........+.+++.+||+.+|++||++.+|++..
T Consensus       232 -----~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         232 -----PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             -----CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence                 111   0112345688999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-35  Score=290.99  Aligned_cols=268  Identities=20%  Similarity=0.288  Sum_probs=202.1

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCC-----eEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGS-----QRM  116 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  116 (416)
                      +|.+.+.||+|++|.||+|... +++.||||++....  ....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999964 58999999987643  333457889999999999999999999988765     789


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +|+||+. ++|..++....  .+++..++.++.+++.||++||+.   +|+|+||||.|||++.++.++|+|||++....
T Consensus        81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999997 47888886544  699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCc--ceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchh-hhhhhhHHhHHhh---
Q 014904          197 DVNT--HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDS-LVDWARPLLNRAI---  269 (416)
Q Consensus       197 ~~~~--~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~-l~~~~~~~~~~~~---  269 (416)
                      ....  .......++..|+|||++.+. .++.++||||||+++++|++|+.||.......... +..+........+   
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            5431  112335678899999999887 89999999999999999999999997654311100 0000000000000   


Q ss_pred             hcCCcccccC---ccc---cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          270 EDGNFDTLVD---PKL---HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       270 ~~~~~~~~~d---~~l---~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ........+.   ...   ...........+.+++.+||+.+|.+||++.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0000000000   000   000111234678899999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.7e-35  Score=286.74  Aligned_cols=270  Identities=21%  Similarity=0.244  Sum_probs=194.6

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEeC-------
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTAG-------  112 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  112 (416)
                      +++|.+.++||+|+||.||+|... +++.+|||++......  ....+.+|++++++++|+||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            689999999999999999999954 6899999998654322  124567899999999999999999987543       


Q ss_pred             -CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          113 -SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       113 -~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                       ...++|+||+.+ ++...+.... ..+++..+..++.|+++||+|||+.   +|+|+||||+||+++.++.++|+|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence             346999999965 5666655432 3699999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCcc----------eeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhh-h
Q 014904          192 AKIASDVNTH----------VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV-D  259 (416)
Q Consensus       192 a~~~~~~~~~----------~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~-~  259 (416)
                      +.........          ..+...+++.|+|||++.+. .++.++|||||||+++||++|+.||............ .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            8755432211          11235678899999988654 5899999999999999999999999764432111110 0


Q ss_pred             hhhHHhHHhhh-cCCccc----ccCccccCc---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          260 WARPLLNRAIE-DGNFDT----LVDPKLHNE---YNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       260 ~~~~~~~~~~~-~~~~~~----~~d~~l~~~---~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ........... ......    .........   ........+.+++.+|++.+|.+||++.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            00000000000 000000    000000000   00112256889999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4e-35  Score=279.54  Aligned_cols=251  Identities=22%  Similarity=0.270  Sum_probs=196.1

Q ss_pred             CHHHHHHhhCCCCcCcee--cccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEEEE
Q 014904           35 TYEELARATDGFSDANLL--GQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYYT  110 (416)
Q Consensus        35 ~~~el~~~t~~f~~~~~L--G~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  110 (416)
                      +..++....++|.+.+.+  |+|+||.||++.. .++..+|+|.+.......     .|+.....+ +|+|++++++++.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEe
Confidence            345566667888888877  9999999999995 568899999987543221     122222222 7999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC-ceEEeec
Q 014904          111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADF  189 (416)
Q Consensus       111 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~-~~kl~DF  189 (416)
                      .....++||||+++++|..++....  .+++..+..++.|+++||.|||+.   +++||||||+||+++.++ .++|+||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence            9999999999999999999997654  689999999999999999999999   999999999999999998 9999999


Q ss_pred             ccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhh
Q 014904          190 GLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAI  269 (416)
Q Consensus       190 Gla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~  269 (416)
                      |+++......     ...++..|+|||++.+..++.++||||||+++++|++|+.||..... .......|...     .
T Consensus       155 g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~-----~  223 (267)
T PHA03390        155 GLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKR-----Q  223 (267)
T ss_pred             ccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHh-----h
Confidence            9987654321     24578999999999988999999999999999999999999975432 11112222110     0


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR-MSQIVR  317 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~evv~  317 (416)
                       ...          ..........+.+++.+||+.+|.+||+ +.|+++
T Consensus       224 -~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        224 -QKK----------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -ccc----------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence             000          0111134457899999999999999995 688873

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.2e-35  Score=281.72  Aligned_cols=241  Identities=25%  Similarity=0.360  Sum_probs=187.6

Q ss_pred             eecccCcEEEEEEEe-CCCcEEEEEEeecCCcc---cHHHHHHHHHH---HHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           51 LLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ---GEREFQAEVEI---ISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        51 ~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      +||+|+||.||+|.. .+++.||+|.+......   ....+..|..+   +....|+||+.+++++......++|+||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999995 46899999998754322   12233444443   444579999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      +++|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........   
T Consensus        81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---  152 (278)
T cd05606          81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---  152 (278)
T ss_pred             CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence            999998886543  699999999999999999999998   999999999999999999999999999875543222   


Q ss_pred             ecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          204 TRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      ....|+..|+|||++.++ .++.++|||||||++++|++|+.||........... .       .....      ..+.+
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~-------~~~~~------~~~~~  218 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-D-------RMTLT------MAVEL  218 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-H-------HHhhc------cCCCC
Confidence            234689999999999755 689999999999999999999999976532111110 0       00000      11111


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRP-----RMSQIVR  317 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~  317 (416)
                          +......+.+++.+|+..+|.+||     ++.++++
T Consensus       219 ----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 ----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                222345789999999999999999     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.8e-35  Score=288.29  Aligned_cols=270  Identities=20%  Similarity=0.298  Sum_probs=200.3

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEe-CC
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTA-GS  113 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  113 (416)
                      ++..++++|...+.||.|+||.||+|.. .+++.||||++....  ......+..|+.++..++||||+++++++.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            4566899999999999999999999994 478999999886432  2234567889999999999999999999875 56


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ..++|+||+ +++|..++...   .+++.....++.|+++||.|||+.   +|+||||+|.||+++.++.++|+|||++.
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            789999998 56888887643   478888889999999999999999   99999999999999999999999999987


Q ss_pred             eccCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc-hhhhhhhhHHhHHhh--
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE-DSLVDWARPLLNRAI--  269 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~-~~l~~~~~~~~~~~~--  269 (416)
                      ......    ....++..|+|||++.+ ..++.++||||||+++++|++|+.||........ ..+.++......+..  
T Consensus       157 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         157 IQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             ccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            543211    22457888999998866 5689999999999999999999999976443111 011111100000000  


Q ss_pred             -hcCCcccc-cCccccCcCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          270 -EDGNFDTL-VDPKLHNEYN-----HNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       270 -~~~~~~~~-~d~~l~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                       ..++...+ ..-......+     ......+.+++.+|++.+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             00000000 0000001111     1123678899999999999999999998755

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.4e-35  Score=287.94  Aligned_cols=269  Identities=22%  Similarity=0.319  Sum_probs=199.9

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCC-
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGS-  113 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  113 (416)
                      +++...++|.+.+.||+|+||.||+|. ..+++.||||++.....  .....+..|+.++++++|+||+++++++.... 
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880           9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            567788999999999999999999999 45789999999864322  22346889999999999999999999987543 


Q ss_pred             -----eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEee
Q 014904          114 -----QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD  188 (416)
Q Consensus       114 -----~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~D  188 (416)
                           ..++|+||+ +++|..++...   .+++..++.++.|+++||.|||+.   +|+||||||+||+++.++.++|+|
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence                 458999998 77888887542   589999999999999999999998   999999999999999999999999


Q ss_pred             cccceeccCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch-hhhhhh---hH
Q 014904          189 FGLAKIASDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED-SLVDWA---RP  263 (416)
Q Consensus       189 FGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~-~l~~~~---~~  263 (416)
                      ||++.......    ....+++.|+|||++.+ ..++.++|||||||++++|++|+.||......... .+....   ..
T Consensus       162 fg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07880         162 FGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK  237 (343)
T ss_pred             cccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            99987654322    23457889999999876 45889999999999999999999999764321100 000000   00


Q ss_pred             HhHHhhhcCCcccccC--cccc----CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          264 LLNRAIEDGNFDTLVD--PKLH----NEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       264 ~~~~~~~~~~~~~~~d--~~l~----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .+...+..........  +...    ..........+.+++.+|++.+|.+||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000000000000  0000    0011122346889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.8e-35  Score=292.16  Aligned_cols=269  Identities=20%  Similarity=0.280  Sum_probs=196.0

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeC---------
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAG---------  112 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  112 (416)
                      ..+|.+.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+++++.++|+||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            47899999999999999999995 46899999999876655567788999999999999999999776543         


Q ss_pred             -----CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC-CCceEE
Q 014904          113 -----SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF-KFEAKV  186 (416)
Q Consensus       113 -----~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~-~~~~kl  186 (416)
                           ...++|+||++ ++|..++...   .+++.....++.|++.||.|||+.   +|+||||||+||+++. ++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence                 35789999997 5787777532   588999999999999999999998   9999999999999974 567899


Q ss_pred             eecccceeccCCCcce--eecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH
Q 014904          187 ADFGLAKIASDVNTHV--STRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP  263 (416)
Q Consensus       187 ~DFGla~~~~~~~~~~--~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~  263 (416)
                      +|||+++.........  .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||....+...........+
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999998654322221  122457889999998754 4688999999999999999999999976543211111000000


Q ss_pred             HhH----HhhhcCCcccccCccccCc-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          264 LLN----RAIEDGNFDTLVDPKLHNE-----YNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       264 ~~~----~~~~~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ...    ..........+........     ........+.+++.+||+.+|++||++.||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            000    0000000000000000000     001123568899999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.8e-35  Score=279.64  Aligned_cols=248  Identities=22%  Similarity=0.325  Sum_probs=195.9

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC-----cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS-----GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      +|.+.+.||+|+||.||++... .+..+++|+++...     .....++..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5888899999999999999854 34556666665322     12234567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          119 YEFVPNNTLEFHLHG--KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +||+++++|..++..  .....+++..++.++.|++.||.|||+.   +++|+||+|+||+++. +.++|+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988864  2234689999999999999999999998   9999999999999975 569999999987764


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      .... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....      .....     ....+..  
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~-----~~~~~~~--  222 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVL-----RIVEGPT--  222 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHH-----HHHcCCC--
Confidence            4322 22335688899999999888899999999999999999999999864332      11111     1111111  


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                         +.    .+......+.+++.+|++.+|++||++.||++
T Consensus       223 ---~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         223 ---PS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ---CC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence               11    12234457889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=290.14  Aligned_cols=251  Identities=20%  Similarity=0.277  Sum_probs=210.6

Q ss_pred             HhhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcccH--HHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE--REFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ++.+-|...+.||+|-|..|-+|. .-+|..||||++.+......  ..+..|+..++.++|||||+++++......+||
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence            355678888999999999999999 46899999999987654433  468899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC-CCCceEEeecccceecc
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD-FKFEAKVADFGLAKIAS  196 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~-~~~~~kl~DFGla~~~~  196 (416)
                      |+|.-.+|.|.++|..... .+.+....+.+.||+.|+.|||+.   .+|||||||+||.+- +-|-+||.|||++..+.
T Consensus        95 iLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            9999999999999965543 588888899999999999999999   899999999999875 45889999999997665


Q ss_pred             CCCcceeecccccccccChhhhccCCCC-chhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t-~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ..  ...+..+|...|-|||++.+..|+ +++|||||||+||-|++|+.||...+.                   ...+.
T Consensus       171 PG--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND-------------------SETLT  229 (864)
T KOG4717|consen  171 PG--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND-------------------SETLT  229 (864)
T ss_pred             Cc--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc-------------------hhhhh
Confidence            43  233557899999999999988775 689999999999999999999987554                   11222


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .++|-++  ..+.-...++.+||..||..+|.+|.+..||+..
T Consensus       230 mImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  230 MIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             hhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            3344333  2344556788999999999999999999999854

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=284.17  Aligned_cols=249  Identities=27%  Similarity=0.385  Sum_probs=208.5

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      -|.++.+||+|.||.||+|++ ..|+.+|||++....  +..++..|+.|+.+...+++|+.+|.+.....+|+|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            366778999999999999995 479999999987543  34688899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      -|++.+.++... +++....+..|+...++||.|||..   +-||||||+.||||+.+|.+||+|||.|-.+.+.... .
T Consensus       112 AGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-R  186 (502)
T KOG0574|consen  112 AGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-R  186 (502)
T ss_pred             CCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-h
Confidence            999999997654 4799999999999999999999999   8899999999999999999999999999877664433 3


Q ss_pred             ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcccc
Q 014904          204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLH  283 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~  283 (416)
                      ..+.||+-|||||++..-.|+.++||||||++..||..|++|+....+....-.           +-......       
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-----------IPT~PPPT-------  248 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-----------IPTKPPPT-------  248 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-----------ccCCCCCC-------
Confidence            458899999999999998999999999999999999999999987665111000           00111111       


Q ss_pred             CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          284 NEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       284 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      -.-+.....++-++++.||-..|++|-|+.++++.
T Consensus       249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            11223345689999999999999999999998754

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=291.25  Aligned_cols=255  Identities=28%  Similarity=0.378  Sum_probs=211.9

Q ss_pred             HHHHHhh-CCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEe
Q 014904           37 EELARAT-DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTA  111 (416)
Q Consensus        37 ~el~~~t-~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  111 (416)
                      -|....| +.|+..++||+||||.||-+. ..+|+.+|.|.+.+..   .+++...++|-.||.+++.+.||.+--.++.
T Consensus       177 lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT  256 (591)
T KOG0986|consen  177 LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET  256 (591)
T ss_pred             HHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence            4444444 468889999999999999988 4579999999987543   3444567889999999999999999988999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       112 ~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                      .+.+|||+..|.||+|..+|...+++.++.......+.+|+.||.+||+.   +||.||+||+|||||+.|+++|+|+||
T Consensus       257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGL  333 (591)
T KOG0986|consen  257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGL  333 (591)
T ss_pred             CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccce
Confidence            99999999999999999999988888999999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhc
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIED  271 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~  271 (416)
                      |.-+.+...+..  .+||.||||||++.++.|+...|.|||||+||||+.|+.||......     +.|-  -+.+.+.+
T Consensus       334 Avei~~g~~~~~--rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-----vk~e--Evdrr~~~  404 (591)
T KOG0986|consen  334 AVEIPEGKPIRG--RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-----VKRE--EVDRRTLE  404 (591)
T ss_pred             EEecCCCCcccc--ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-----hhHH--HHHHHHhc
Confidence            998877555433  37999999999999999999999999999999999999999765432     2220  01111111


Q ss_pred             CCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 014904          272 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMS  313 (416)
Q Consensus       272 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~  313 (416)
                                -..+++....+....+....|+.||.+|.--+
T Consensus       405 ----------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  405 ----------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             ----------chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence                      11345555566788899999999999997443

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-35  Score=279.56  Aligned_cols=265  Identities=21%  Similarity=0.296  Sum_probs=199.5

Q ss_pred             CCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           46 FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      |+..+.||+|++|.||+|+.. +++.+|+|++....  ......+..|+.++++++|+|++++++++......++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999965 58999999998653  222356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      + ++|.+++.... ..+++..++.++.+++.||.|||+.   +|+||||+|+||+++.++.++|+|||++......... 
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-  154 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-  154 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-
Confidence            7 58999887653 3589999999999999999999999   9999999999999999999999999998766443221 


Q ss_pred             eecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch-hhhhhhh-------HHhHHh-hhcC
Q 014904          203 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED-SLVDWAR-------PLLNRA-IEDG  272 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~-~l~~~~~-------~~~~~~-~~~~  272 (416)
                      .....++..|+|||++.+. .++.++|||||||+++||++|+.||......... .+.....       +.+... ....
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            1223457789999998776 7899999999999999999999999764421110 0000000       000000 0001


Q ss_pred             CcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          273 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       273 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .+............ ......+.+++.+||+.+|++||++.+|+.
T Consensus       235 ~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         235 TFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            11111110010001 112457899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.5e-34  Score=284.26  Aligned_cols=270  Identities=23%  Similarity=0.279  Sum_probs=197.4

Q ss_pred             hhCCCCc-CceecccCcEEEEEEEeC-CCcEEEEEEeecCCccc--------------HHHHHHHHHHHHhcCCCcccce
Q 014904           42 ATDGFSD-ANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQG--------------EREFQAEVEIISRVHHKHLVSL  105 (416)
Q Consensus        42 ~t~~f~~-~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l  105 (416)
                      ..++|.. .+.||+|+||.||+|... +++.||||+++......              ...+.+|+.++++++|+||+++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            4467765 467999999999999954 68999999987543221              1247789999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceE
Q 014904          106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAK  185 (416)
Q Consensus       106 ~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~k  185 (416)
                      ++++......++||||+. ++|..++....  .+++.....++.|++.||.|||+.   +|+|+||+|+||+++.++.++
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             eEEEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence            999999999999999996 58888876433  588999999999999999999998   999999999999999999999


Q ss_pred             EeecccceeccCCC-------------cceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCc
Q 014904          186 VADFGLAKIASDVN-------------THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHT  251 (416)
Q Consensus       186 l~DFGla~~~~~~~-------------~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~  251 (416)
                      |+|||++.......             ........++..|+|||++.+. .++.++|||||||++++|++|+.||.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999997654111             1111123468889999998764 478999999999999999999999976543


Q ss_pred             ccch-hhhhhhhHHhH----HhhhcC---CcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          252 FVED-SLVDWARPLLN----RAIEDG---NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       252 ~~~~-~l~~~~~~~~~----~~~~~~---~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .... .+.........    ......   .+.....+... .........+.+++.+|++.+|++||++.||+..
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            1110 01110000000    000000   00000000000 0011224568899999999999999999999964

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=300.84  Aligned_cols=250  Identities=24%  Similarity=0.392  Sum_probs=205.4

Q ss_pred             CCCcCceecccCcEEEEEEEeCC-CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           45 GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      .|.++.-||-|.||.||+|+.++ +---|-|++...+.....+|.-|++||....||+||+|++.|...+.++++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            45667789999999999999654 33456677777676667789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      ||.++.++-.-++ .|+..++..++.+++.||.|||+.   +|||||||+.|||++.+|.++|+|||.+..... .....
T Consensus       113 GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkR  187 (1187)
T KOG0579|consen  113 GGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKR  187 (1187)
T ss_pred             CchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhhh
Confidence            9999988876655 799999999999999999999999   999999999999999999999999999743221 12233


Q ss_pred             ecccccccccChhhh-----ccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          204 TRVMGTFGYLAPEYA-----SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~-----~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      ..++||+-|||||+.     ...+|+.++||||||++|.||..+.+|-..-++  ...+.         .+...+...++
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--MRVll---------KiaKSePPTLl  256 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLL---------KIAKSEPPTLL  256 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--HHHHH---------HHhhcCCCccc
Confidence            558999999999986     356899999999999999999999999665443  11111         22344555565


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .|.-+       ...+.+++..||..+|+.||++.++++
T Consensus       257 qPS~W-------s~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  257 QPSHW-------SRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             Ccchh-------hhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            55432       347889999999999999999999874

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.3e-34  Score=281.77  Aligned_cols=264  Identities=21%  Similarity=0.261  Sum_probs=192.1

Q ss_pred             CCCcCceecccCcEEEEEEEeC-C--CcEEEEEEeecCC--cccHHHHHHHHHHHHhc-CCCcccceEEEEEeC----Ce
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-N--GKEVAIKQLKAGS--GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAG----SQ  114 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~--g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  114 (416)
                      +|.+.+.||+|+||.||++... .  ++.||+|++....  ......+..|+.++.++ +|+||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            5788899999999999999954 4  7899999987432  12235678899999999 599999999976432    45


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      .+++++++. ++|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            788888885 68888875433  589999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCcc---eeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCccc-------------chhh
Q 014904          195 ASDVNTH---VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFV-------------EDSL  257 (416)
Q Consensus       195 ~~~~~~~---~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~-------------~~~l  257 (416)
                      .......   ......|+..|+|||++.+ ..++.++|||||||++++|++|+.||.......             ...+
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            5432221   1133568999999998865 468999999999999999999999997644210             0111


Q ss_pred             hhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..+..+.........  .......+ ..........+.+++.+|++.+|++||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         235 SRIGSPKAQNYIRSL--PNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HhhhhhhHHHHHHhc--cccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111111000000000  00000000 0001112357889999999999999999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-35  Score=293.27  Aligned_cols=250  Identities=25%  Similarity=0.340  Sum_probs=209.1

Q ss_pred             HHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccH--HHHHHHHHHHHhcCCCcccceEEEEEeCCeE
Q 014904           39 LARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGE--REFQAEVEIISRVHHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        39 l~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  115 (416)
                      ...-+..|.+...||+|.|+.|.+|.+ .++..||||.+.+......  ..+.+|++++..++|||||+++.+.+....+
T Consensus        51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l  130 (596)
T KOG0586|consen   51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL  130 (596)
T ss_pred             ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence            344567899999999999999999994 5799999999987644332  4578999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      |+||||+.++.+.+++...++  +.......++.|+..|++|||++   .|||||||++||||+.+.++||+|||++..+
T Consensus       131 ylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             EEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceee
Confidence            999999999999999988775  44577888999999999999999   8999999999999999999999999999987


Q ss_pred             cCCCcceeecccccccccChhhhccCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~~~-t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ..  .......+|++.|.|||++.+.++ .+.+|+||+|++||-|++|..||+.....                      
T Consensus       206 ~~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk----------------------  261 (596)
T KOG0586|consen  206 DY--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK----------------------  261 (596)
T ss_pred             cc--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc----------------------
Confidence            63  444566899999999999998765 58999999999999999999999865431                      


Q ss_pred             ccccCccccCcCC--HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          275 DTLVDPKLHNEYN--HNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       275 ~~~~d~~l~~~~~--~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                       .+-++.+...+-  --....+.+++++++-.+|.+|+++.+|.+.
T Consensus       262 -~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  262 -ELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             -cccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence             111111111111  1122356789999999999999999999865

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-35  Score=291.28  Aligned_cols=270  Identities=20%  Similarity=0.311  Sum_probs=200.0

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      .+..+.++|.+.+.||+|++|.||+|... +++.||||++....  ......+..|+.+++.++|+|++++++++.....
T Consensus         9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07851           9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS   88 (343)
T ss_pred             ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence            34456789999999999999999999964 68899999987532  2223567789999999999999999988765544


Q ss_pred             ------EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEee
Q 014904          115 ------RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD  188 (416)
Q Consensus       115 ------~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~D  188 (416)
                            .++|+||+ +++|.+++...   .+++..++.++.++++||.|||+.   +|+||||||+||+++.++.++|+|
T Consensus        89 ~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d  161 (343)
T cd07851          89 LEDFQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD  161 (343)
T ss_pred             ccccccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence                  89999998 67898888652   589999999999999999999998   999999999999999999999999


Q ss_pred             cccceeccCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch-hhhhhh---hH
Q 014904          189 FGLAKIASDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED-SLVDWA---RP  263 (416)
Q Consensus       189 FGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~-~l~~~~---~~  263 (416)
                      ||++......    .....++..|+|||.+.+ ..++.++|||||||++++|++|+.||......... .+.+..   .+
T Consensus       162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  237 (343)
T cd07851         162 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE  237 (343)
T ss_pred             cccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence            9998765432    223467889999999865 36789999999999999999999999754431100 000000   00


Q ss_pred             HhHHhhhcCCcccccCc---cccCc---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          264 LLNRAIEDGNFDTLVDP---KLHNE---YNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       264 ~~~~~~~~~~~~~~~d~---~l~~~---~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .+...+.......++..   .....   ........+.+++.+|++.+|.+||++.+|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            00000000000000000   00000   001124678999999999999999999998753

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=270.59  Aligned_cols=236  Identities=29%  Similarity=0.349  Sum_probs=194.0

Q ss_pred             ecccCcEEEEEEEeC-CCcEEEEEEeecCCcc---cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCH
Q 014904           52 LGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ---GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL  127 (416)
Q Consensus        52 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL  127 (416)
                      ||+|+||.||++... +++.+|+|++......   ....+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999964 5899999998765432   335788999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeeccc
Q 014904          128 EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM  207 (416)
Q Consensus       128 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  207 (416)
                      .+++....  .+++.....++.|++.||.|||+.   +++|+||+|.||+++.++.++|+|||++....... .......
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC  154 (250)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence            99987554  589999999999999999999998   99999999999999999999999999998765432 1223456


Q ss_pred             ccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCC
Q 014904          208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYN  287 (416)
Q Consensus       208 gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  287 (416)
                      ++..|++||...+...+.++|+||||+++++|++|+.||.....   ..+..       . +..+.          ..++
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~-------~-~~~~~----------~~~~  213 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYE-------K-ILKDP----------LRFP  213 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH-------H-HhcCC----------CCCC
Confidence            88899999999888899999999999999999999999975432   11111       1 11111          1112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHH
Q 014904          288 HNEMARMVACAAACVRHSARRRPRMSQ  314 (416)
Q Consensus       288 ~~~~~~l~~l~~~cl~~~p~~RPt~~e  314 (416)
                      ......+.+++.+||..+|++||++.+
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            222457889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.6e-34  Score=305.99  Aligned_cols=146  Identities=29%  Similarity=0.368  Sum_probs=131.5

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCccc---HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQG---EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .++|.+.++||+|+||.||+|... +++.||||+++......   ...+..|+.++..++|+||+++++++......+||
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            468999999999999999999965 68999999997543222   35688899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      |||+.+++|..++....  .+++..++.|+.|++.||.|||..   +||||||||+||||+.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999987543  588889999999999999999998   99999999999999999999999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-35  Score=282.96  Aligned_cols=271  Identities=29%  Similarity=0.443  Sum_probs=200.1

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhc--CCCcccceEEEEEeCC----eEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV--HHKHLVSLVGYYTAGS----QRML  117 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~l  117 (416)
                      ......++||+|+||.||||.+ +++.||||++..   +....|++|-+|.+..  +|+||+++++.-..+.    .++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            3455677899999999999998 559999999975   4445788888887765  8999999999877665    8899


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC------HPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~------~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                      |++|.+.|+|.++|..+   .++|....+|+.-+++||+|||+.-      .|.|+|||||.+||||.+|+++.|+|||+
T Consensus       286 Vt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             EeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            99999999999999776   6999999999999999999999753      45799999999999999999999999999


Q ss_pred             ceeccCCCcc-eeecccccccccChhhhccC-CCC-----chhhhHhHHHHHHHHHhCCCCCCCCCcccchhh--hhhh-
Q 014904          192 AKIASDVNTH-VSTRVMGTFGYLAPEYASSG-KLT-----EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL--VDWA-  261 (416)
Q Consensus       192 a~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~-~~t-----~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l--~~~~-  261 (416)
                      |..+...... .....+||..|||||++.+. .+.     .+.||||+|.|||||++....++.... .+..+  ..-+ 
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~v-p~Yqlpfe~evG  441 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPV-PEYQLPFEAEVG  441 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCC-CcccCchhHHhc
Confidence            9877643322 12236899999999999764 233     368999999999999998777643111 11000  0000 


Q ss_pred             -hHHhHHhhhcCCcccccCccccCcC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          262 -RPLLNRAIEDGNFDTLVDPKLHNEY-NHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       262 -~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                       .|.+.+. .+-...+-..|.+...+ ....+.-+.+.+..||.+||+.|-|+.=|-+.+....
T Consensus       442 ~hPt~e~m-q~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  442 NHPTLEEM-QELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             CCCCHHHH-HHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence             0000000 00000001112222111 1245677889999999999999999998887776543

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-35  Score=295.01  Aligned_cols=271  Identities=25%  Similarity=0.363  Sum_probs=205.9

Q ss_pred             CCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeC------CeEEE
Q 014904           46 FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAG------SQRML  117 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  117 (416)
                      +...+.||+|+||.||+|. ..+|+.||||.++..... ..+....|++++++++|+|||+++++=+..      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            3445789999999999999 568999999999875433 335677899999999999999999876543      45789


Q ss_pred             EEEecCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC--CCc--eEEeecccc
Q 014904          118 VYEFVPNNTLEFHLHGKGR-PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF--KFE--AKVADFGLA  192 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~--~~~--~kl~DFGla  192 (416)
                      |||||.+|+|...+....+ ..|+....+.+...++.||.|||+.   +|+||||||.||++-.  +|+  .||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999976533 4699999999999999999999998   9999999999999942  233  699999999


Q ss_pred             eeccCCCcceeecccccccccChhhhc-cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH------Hh
Q 014904          193 KIASDVNTHVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP------LL  265 (416)
Q Consensus       193 ~~~~~~~~~~~~~~~gt~~YlaPE~~~-~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~------~~  265 (416)
                      +-..++.  ..+.++||..|++||++. .+.|+..+|.|||||++|+++||..||-.........-+.|..-      ..
T Consensus       172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            9887654  556789999999999998 48999999999999999999999999976544222112222210      00


Q ss_pred             H--HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHhcc
Q 014904          266 N--RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP--RMSQIVRALEG  321 (416)
Q Consensus       266 ~--~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP--t~~evv~~L~~  321 (416)
                      .  ..-++|.+..--.-............++-..+..+|..++++|-  ...++...+.+
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~d  309 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDD  309 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHH
Confidence            0  01112222211111112334455567788888899999999999  66666655554

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-35  Score=296.95  Aligned_cols=253  Identities=27%  Similarity=0.408  Sum_probs=209.1

Q ss_pred             CCcCceecccCcEEEEEEEe-CCC----cEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           46 FSDANLLGQGGFGYVHRGVL-PNG----KEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~-~~g----~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++...+||+|.||+||+|.+ +.|    -+||+|++..... +...+++.|+-++.+|+|||+++|+++|.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34467899999999999994 554    3789998876543 44578999999999999999999999998765 88999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      +|++.|+|.++++.... .+--...+.|..|||+|+.|||++   +++||||.++||||..-..+||.|||+++......
T Consensus       777 q~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            99999999999986543 688889999999999999999999   99999999999999999999999999999887665


Q ss_pred             cceeec-ccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          200 THVSTR-VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       200 ~~~~~~-~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      ...... ..-.+.|||-|.+...+++.++|||||||++|||+| |..|++....   +.        +...++.|+    
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~---~e--------I~dlle~ge----  917 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA---EE--------IPDLLEKGE----  917 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH---HH--------hhHHHhccc----
Confidence            554322 233567999999999999999999999999999999 9999877543   11        122233343    


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                           +-..++.+...+..++.+||..|+..||+++++...+...+
T Consensus       918 -----RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  918 -----RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             -----cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence                 12234456678899999999999999999999999887654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.2e-34  Score=306.90  Aligned_cols=255  Identities=26%  Similarity=0.424  Sum_probs=193.9

Q ss_pred             HHhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeC-----
Q 014904           40 ARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAG-----  112 (416)
Q Consensus        40 ~~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  112 (416)
                      ..-.++|....+||+||||.|||+..+ ||+.||||++.... ......+.+|+.+|++|+|||+|+.+..+.+.     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            456678899999999999999999954 89999999997653 22235788999999999999999876532100     


Q ss_pred             --------------------------------------------------------------------------------
Q 014904          113 --------------------------------------------------------------------------------  112 (416)
Q Consensus       113 --------------------------------------------------------------------------------  112 (416)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 014904          113 ----------------------------------SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL  158 (416)
Q Consensus       113 ----------------------------------~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~L  158 (416)
                                                        ..+|+-||||+..+|.++++.+... -.....++++.+|++||+|+
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHH
Confidence                                              1246778888888888888765321 13567789999999999999


Q ss_pred             HhcCCCCeeeecccCCcEEECCCCceEEeecccceecc------C-----------CCcceeecccccccccChhhhccC
Q 014904          159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS------D-----------VNTHVSTRVMGTFGYLAPEYASSG  221 (416)
Q Consensus       159 H~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~------~-----------~~~~~~~~~~gt~~YlaPE~~~~~  221 (416)
                      |+.   +||||||||.||+||.+..|||+|||+|+...      +           .+....+..+||.-|+|||++.+.
T Consensus       714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            999   99999999999999999999999999998611      0           011123457899999999999654


Q ss_pred             ---CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHH
Q 014904          222 ---KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACA  298 (416)
Q Consensus       222 ---~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~  298 (416)
                         +|+.|+|+|||||||+||+.   ||...-.          +......++.|.+..-      ..+..+.+..-..++
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME----------Ra~iL~~LR~g~iP~~------~~f~~~~~~~e~slI  851 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSME----------RASILTNLRKGSIPEP------ADFFDPEHPEEASLI  851 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHH----------HHHHHHhcccCCCCCC------cccccccchHHHHHH
Confidence               59999999999999999995   4654221          1112223344443321      234445566678999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 014904          299 AACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       299 ~~cl~~~p~~RPt~~evv~  317 (416)
                      .+++++||.+|||+.|++.
T Consensus       852 ~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  852 RWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHhcCCCccCCCHHHHhh
Confidence            9999999999999999874

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-35  Score=295.06  Aligned_cols=242  Identities=24%  Similarity=0.406  Sum_probs=194.4

Q ss_pred             CcCceecccCcEEEEEEEe-CCCcEEEEEEeecC----CcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCe--EEEEE
Q 014904           47 SDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAG----SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ--RMLVY  119 (416)
Q Consensus        47 ~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV~  119 (416)
                      +...+||+|.|.+||+|.+ .+|-+||--.++..    +.....+|..|+.+|+.|+|+||++++.++.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            3456899999999999995 46888876655432    22333679999999999999999999999987555  78999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC-CceEEeecccceeccCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAKIASDV  198 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~-~~~kl~DFGla~~~~~~  198 (416)
                      |.+..|+|..++...+  .++......|+.||++||.|||.+ .|+|||||||-.||+|+.+ |.|||+|+|||.+....
T Consensus       123 EL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999999999997765  478889999999999999999997 7889999999999999876 89999999999876543


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCC----c
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN----F  274 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~----~  274 (416)
                      .   ...++|||.|||||.+. ..|++.+||||||+.++||+|+..|+.-=..         ...++.+. ..|.    +
T Consensus       200 ~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n---------~AQIYKKV-~SGiKP~sl  265 (632)
T KOG0584|consen  200 H---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN---------PAQIYKKV-TSGIKPAAL  265 (632)
T ss_pred             c---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC---------HHHHHHHH-HcCCCHHHh
Confidence            2   23489999999999998 7899999999999999999999999853211         01111111 1221    1


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ..+-|            .++.++|.+|+.. ..+||++.|+|..
T Consensus       266 ~kV~d------------Pevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  266 SKVKD------------PEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             hccCC------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            22222            3688999999999 9999999999954

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-34  Score=300.25  Aligned_cols=257  Identities=26%  Similarity=0.421  Sum_probs=207.8

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC----C----CcEEEEEEeecCCcc-cHHHHHHHHHHHHhc-CCCcccceEEEEEeC
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP----N----GKEVAIKQLKAGSGQ-GEREFQAEVEIISRV-HHKHLVSLVGYYTAG  112 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~----~----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  112 (416)
                      .++..+.+.||+|.||.|++|...    .    ...||||.++..... ..+.+..|+.+++.+ +|+||+.++|+|...
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            344456669999999999999842    1    457999999865443 446789999999999 699999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhcCC------------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE
Q 014904          113 SQRMLVYEFVPNNTLEFHLHGKG------------R--PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL  178 (416)
Q Consensus       113 ~~~~lV~e~~~~~sL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl  178 (416)
                      ...++|.||+..|+|..++..+.            .  ..++....+.++.|||.|++||++.   ++|||||.++|||+
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLI  451 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEe
Confidence            99999999999999999997665            0  1388899999999999999999999   99999999999999


Q ss_pred             CCCCceEEeecccceeccCCCcceeecccc--cccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccch
Q 014904          179 DFKFEAKVADFGLAKIASDVNTHVSTRVMG--TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVED  255 (416)
Q Consensus       179 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~  255 (416)
                      ..+..+||+|||+++...+........-.|  ...|||||.+....++.|||||||||+||||+| |..|+.....  ..
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~~  529 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--TE  529 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--HH
Confidence            999999999999999655544433222222  456999999999999999999999999999999 8888865221  11


Q ss_pred             hhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          256 SLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       256 ~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                      .+.        +.++.|.-         ...+..+..++..+++.||+.+|++||++.++++.|+.
T Consensus       530 ~l~--------~~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  530 ELL--------EFLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             HHH--------HHHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            222        23344431         12233445688899999999999999999999999987

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=315.30  Aligned_cols=257  Identities=28%  Similarity=0.423  Sum_probs=205.3

Q ss_pred             HHHhhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCccc--HHHHHHHHHHHHhcCCCcccceEEEEEeCCeE
Q 014904           39 LARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQG--EREFQAEVEIISRVHHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        39 l~~~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  115 (416)
                      +...+-++...+.||.|.||.||-|+ ..+|.-.|+|-++.+....  -..+.+|..++..++|||+|+.+|+=.+....
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            34455677788899999999999999 5678899999887654432  24678899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      +|.||||.+|+|.++++..+  ..++.....+..|++.|++|||+.   +||||||||.||+|+.+|.+|++|||.|...
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence            99999999999999997543  355666667788999999999999   9999999999999999999999999999876


Q ss_pred             cCCCcce---eecccccccccChhhhccCC---CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhh
Q 014904          196 SDVNTHV---STRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAI  269 (416)
Q Consensus       196 ~~~~~~~---~~~~~gt~~YlaPE~~~~~~---~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~  269 (416)
                      .......   ....+||+.|||||++.+.+   -.-+.||||||||++||+||++||...+.       +|+.   +-..
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aI---My~V 1454 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAI---MYHV 1454 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHH---HhHH
Confidence            5543221   23468999999999997543   34689999999999999999999976443       2332   1122


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL  319 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L  319 (416)
                      ..|.-     |.    .+......=.+++.+||+.||.+|.++.|+++.=
T Consensus      1455 ~~gh~-----Pq----~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1455 AAGHK-----PQ----IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             hccCC-----CC----CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence            23332     22    2333455667899999999999999998887653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.7e-33  Score=260.66  Aligned_cols=238  Identities=28%  Similarity=0.336  Sum_probs=195.2

Q ss_pred             CcEEEEEEEeC-CCcEEEEEEeecCCccc-HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCHHHHhhc
Q 014904           56 GFGYVHRGVLP-NGKEVAIKQLKAGSGQG-EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG  133 (416)
Q Consensus        56 ~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~  133 (416)
                      +||.||+|+.. +|+.+|+|++....... ...+.+|+..+++++|+|++++++++......++|+||+++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999975 58999999998765544 57899999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeeccccccccc
Q 014904          134 KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL  213 (416)
Q Consensus       134 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Yl  213 (416)
                      ...  +++..++.++.+++++|.+||+.   +++|+||+|.||+++.++.++|+|||.+.......  ......++..|+
T Consensus        81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~  153 (244)
T smart00220       81 RGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM  153 (244)
T ss_pred             ccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence            443  88999999999999999999999   99999999999999999999999999998765432  223456888999


Q ss_pred             ChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHH
Q 014904          214 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMAR  293 (416)
Q Consensus       214 aPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  293 (416)
                      +||.+....++.++|||+||+++++|++|+.||.....  ...+.++        +..+.....       .........
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~--------~~~~~~~~~-------~~~~~~~~~  216 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKK--------IGKPKPPFP-------PPEWKISPE  216 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHH--------HhccCCCCc-------cccccCCHH
Confidence            99999988899999999999999999999999876321  1112111        111111110       000003357


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 014904          294 MVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       294 l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      +..++.+|+..+|++||++.++++
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhh
Confidence            899999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-34  Score=265.85  Aligned_cols=267  Identities=23%  Similarity=0.388  Sum_probs=212.1

Q ss_pred             CHHHHHHhhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-CCcccceEEEEEeC
Q 014904           35 TYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-HKHLVSLVGYYTAG  112 (416)
Q Consensus        35 ~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  112 (416)
                      +++|+.+.|+     ++||+|.++.|--++ +.+|.++|||++.+.......+..+|++++.+.+ |+||++++++|+++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            5789988884     679999999999998 7899999999999887777888999999999995 99999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc---eEEeec
Q 014904          113 SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADF  189 (416)
Q Consensus       113 ~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~---~kl~DF  189 (416)
                      ...|||||.+.||.|..+|+...  .+++..+..+..+|+.||.+||..   +|.|||+||+|||......   +||+||
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDF  223 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecc
Confidence            99999999999999999997654  689999999999999999999999   9999999999999976554   799999


Q ss_pred             ccceeccCCC------cceeecccccccccChhhhc-----cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcc----cc
Q 014904          190 GLAKIASDVN------THVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTF----VE  254 (416)
Q Consensus       190 Gla~~~~~~~------~~~~~~~~gt~~YlaPE~~~-----~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~----~~  254 (416)
                      .|..-....+      +......+|+..|||||+..     .-.|+.+.|.|||||+||-||+|.+||......    ..
T Consensus       224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr  303 (463)
T KOG0607|consen  224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR  303 (463)
T ss_pred             ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence            9865322111      11123467899999999862     236889999999999999999999999765431    11


Q ss_pred             hhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          255 DSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       255 ~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..........+.+.+.+|.+. +.|..+     ........+++...+..++.+|-++.+++.
T Consensus       304 Ge~Cr~CQ~~LFesIQEGkYe-FPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  304 GEVCRVCQNKLFESIQEGKYE-FPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCccHHHHHHHHHHHhccCCc-CChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            111222234444556666653 222211     223345667888888899999999998886

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-35  Score=270.71  Aligned_cols=249  Identities=25%  Similarity=0.334  Sum_probs=201.2

Q ss_pred             hCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcccHHH---HHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE---FQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      -++|..+++||+|.||.|.++. ..+++.+|+|++++.-.-.+.+   -+.|-.+|...+||.+..+.-.|...+.+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            3589999999999999999999 4579999999998764433333   45688899999999999999899999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+.||.|..+|....  .++..........|+.||.|||+.   +||.||||.+|.|||++|.+||+|||+.+.--..
T Consensus       247 MeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            99999999998886543  688888888999999999999999   9999999999999999999999999998743221


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                       ......++||+.|+|||++....|...+|.|.+|||+|||++||.||...+..   .|.        +.+-.++     
T Consensus       322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLF--------eLIl~ed-----  384 (516)
T KOG0690|consen  322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLF--------ELILMED-----  384 (516)
T ss_pred             -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHH--------HHHHhhh-----
Confidence             22335589999999999999999999999999999999999999999765431   111        1111111     


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRP-----RMSQIVRA  318 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~~  318 (416)
                           ..++.....+...|+...|..||.+|.     .+.||.+.
T Consensus       385 -----~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  385 -----LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             -----ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence                 123333344677888899999999997     45566543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.2e-33  Score=262.73  Aligned_cols=220  Identities=21%  Similarity=0.199  Sum_probs=176.5

Q ss_pred             cCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCHHHHhhc
Q 014904           55 GGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG  133 (416)
Q Consensus        55 G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~  133 (416)
                      |.++.||++.. .+++.+|+|++....     .+..|...+....||||+++++++.+....++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            88999999995 578999999997543     233445555566799999999999999999999999999999998865


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeeccccccccc
Q 014904          134 KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL  213 (416)
Q Consensus       134 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Yl  213 (416)
                      ..  .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++++|||.+......    .....++..|+
T Consensus        79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~  149 (237)
T cd05576          79 FL--NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC  149 (237)
T ss_pred             hc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence            43  489999999999999999999998   9999999999999999999999999987654432    12234577899


Q ss_pred             ChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHH
Q 014904          214 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMAR  293 (416)
Q Consensus       214 aPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  293 (416)
                      |||++.+..++.++||||||++++||++|+.|+.......                  .....+       ..+......
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------------~~~~~~-------~~~~~~~~~  204 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------------NTHTTL-------NIPEWVSEE  204 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------------cccccc-------CCcccCCHH
Confidence            9999988889999999999999999999998875432100                  000000       111122356


Q ss_pred             HHHHHHHhhccCCCCCCCHH
Q 014904          294 MVACAAACVRHSARRRPRMS  313 (416)
Q Consensus       294 l~~l~~~cl~~~p~~RPt~~  313 (416)
                      +.+++.+|++.+|.+||++.
T Consensus       205 ~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHHHccCCHHHhcCCC
Confidence            88999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-33  Score=269.27  Aligned_cols=267  Identities=25%  Similarity=0.371  Sum_probs=203.1

Q ss_pred             HHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhc--CCCcccceEEEEEeC----C
Q 014904           40 ARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV--HHKHLVSLVGYYTAG----S  113 (416)
Q Consensus        40 ~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~  113 (416)
                      ..+.+.....+.||+|.||.||+|.+ -|..||||++...   +++.+.+|.+|...+  +|+||+.+++....+    .
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             HhhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            34566778889999999999999999 6789999999753   345677788887764  999999999987654    3


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeeeecccCCcEEECCCCceEEee
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHE-----DCHPKIIHRDIKAANILLDFKFEAKVAD  188 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-----~~~~~iiHrDIkp~NILl~~~~~~kl~D  188 (416)
                      +++||.+|.+.|+|.++|...   +++....++++..+|.||++||-     +..|.|.|||||+.||||.+++.+-|+|
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence            789999999999999999764   69999999999999999999995     3567899999999999999999999999


Q ss_pred             cccceeccCCCcce---eecccccccccChhhhccCC----CC--chhhhHhHHHHHHHHHhCC----------CCCCCC
Q 014904          189 FGLAKIASDVNTHV---STRVMGTFGYLAPEYASSGK----LT--EKSDVFSFGVMLLELITGR----------RPVDST  249 (416)
Q Consensus       189 FGla~~~~~~~~~~---~~~~~gt~~YlaPE~~~~~~----~t--~ksDV~SlGvvL~elltG~----------~pf~~~  249 (416)
                      +|||-........+   ....+||-.|||||++...-    +.  ..+||||||.|+||+.-..          .||..-
T Consensus       360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~  439 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV  439 (513)
T ss_pred             ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence            99997665443322   24468999999999985421    11  3699999999999997532          333321


Q ss_pred             CcccchhhhhhhhHHhHHhhhcCCcccccCccccCcC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          250 HTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEY-NHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       250 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      -+ .+.++.+..         +=-..+-+.|.+...+ +..++..|.++++.||..+|..|-|+-.|-+.|....
T Consensus       440 Vp-~DPs~eeMr---------kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  440 VP-SDPSFEEMR---------KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CC-CCCCHHHHh---------cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            11 111111111         1111122334443333 3467788999999999999999999999988886543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-34  Score=285.17  Aligned_cols=258  Identities=24%  Similarity=0.269  Sum_probs=202.9

Q ss_pred             CCCCCCCccccCHHHH---HHhhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-C
Q 014904           24 GLSLGFSKSTFTYEEL---ARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-H   98 (416)
Q Consensus        24 ~~~~~~~~~~f~~~el---~~~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~   98 (416)
                      ....|++..-++..+=   ...+..|.....||.|.|+.|..+. ..+++..+||++....    .+-.+|+.++.+. +
T Consensus       299 ~if~g~sfva~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~  374 (612)
T KOG0603|consen  299 TIFSGPSFVAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRD  374 (612)
T ss_pred             chhcCCCccChHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcC
Confidence            3444555444433322   1246778888889999999999999 5678999999998652    2345677776666 7


Q ss_pred             CCcccceEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE
Q 014904           99 HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL  178 (416)
Q Consensus        99 h~niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl  178 (416)
                      |+||+++.+.+.++.+.++|||.+.++-+.+.+..+..  +. ..+..|+.+++.|+.|||++   ++|||||||+|||+
T Consensus       375 h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~  448 (612)
T KOG0603|consen  375 HPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILL  448 (612)
T ss_pred             CCcceeecceecCCceeeeeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheee
Confidence            99999999999999999999999999988877765532  22 67778999999999999999   99999999999999


Q ss_pred             -CCCCceEEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhh
Q 014904          179 -DFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL  257 (416)
Q Consensus       179 -~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l  257 (416)
                       +..++++|+|||.++.....    ....+-|..|.|||++....+++++||||||++||+||+|+.||......  .. 
T Consensus       449 ~~~~g~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e-  521 (612)
T KOG0603|consen  449 DGSAGHLRLTYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE-  521 (612)
T ss_pred             cCCCCcEEEEEechhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH-
Confidence             58899999999999876654    12234588999999999889999999999999999999999999876542  11 


Q ss_pred             hhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                             +...+..+.+            .........+|+.+||+.+|.+||+|.++..
T Consensus       522 -------i~~~i~~~~~------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  522 -------IHTRIQMPKF------------SECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -------HHHhhcCCcc------------ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                   1122222222            2344567889999999999999999999874

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=277.76  Aligned_cols=256  Identities=27%  Similarity=0.426  Sum_probs=197.3

Q ss_pred             hCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcccH-------HHHHHHHHHHHhcCCCcccceEEEEE-eCC
Q 014904           43 TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE-------REFQAEVEIISRVHHKHLVSLVGYYT-AGS  113 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~-~~~  113 (416)
                      .++|-.+++||+|||+.||+|. +...+.||||+-..+..+..       +...+|..|.+.|.||.||++++|+. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            4577788999999999999999 55688999998766544432       12457999999999999999999986 556


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC---CCceEEeecc
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFG  190 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~---~~~~kl~DFG  190 (416)
                      ..|-|+|||+|.+|+.+|....  .++...+..|+.||+.||.||.+. .++|||-||||.||||-+   -|.+||.|||
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            7899999999999999996554  689999999999999999999987 567999999999999954   4779999999


Q ss_pred             cceeccCCCc------ceeecccccccccChhhhccC----CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhh
Q 014904          191 LAKIASDVNT------HVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDW  260 (416)
Q Consensus       191 la~~~~~~~~------~~~~~~~gt~~YlaPE~~~~~----~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~  260 (416)
                      |+++..+...      .......||..|++||.+.-+    +++.|+||||.||++|.+|.|++||.....  ...+.+ 
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILq-  695 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQ-  695 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHh-
Confidence            9998754322      233446899999999998654    588999999999999999999999987653  111111 


Q ss_pred             hhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 014904          261 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIV  316 (416)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv  316 (416)
                                .+.+-..-.-.+  ...+.......+++++||+..-++|-...++.
T Consensus       696 ----------eNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  696 ----------ENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             ----------hhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                      111100000000  01112234677899999999999997766554

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-33  Score=258.58  Aligned_cols=255  Identities=24%  Similarity=0.342  Sum_probs=204.8

Q ss_pred             HhhCCCCcCc-eecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEEEEe----CC
Q 014904           41 RATDGFSDAN-LLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYYTA----GS  113 (416)
Q Consensus        41 ~~t~~f~~~~-~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~  113 (416)
                      .+|++|++.. +||-|-.|.|-.+.+ .+++.+|+|+|...     ....+||++.-+. .|+|||.+++++.+    ..
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            4678887754 899999999999985 47899999998632     2446788876665 59999999999865    33


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC---CCceEEeecc
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFG  190 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~---~~~~kl~DFG  190 (416)
                      .+++|||+++||.|...++..+...+++.++..|+.+|+.|+.|||+.   +|.||||||+|+|...   |..+||+|||
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence            568999999999999999999888999999999999999999999999   9999999999999964   4558999999


Q ss_pred             cceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh
Q 014904          191 LAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       191 la~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~  270 (416)
                      +|+.......  ....+-|+-|.|||++...+|+...|+||+||++|-||+|.+||.......       ..|-+...+.
T Consensus       210 FAK~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-------ispgMk~rI~  280 (400)
T KOG0604|consen  210 FAKETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------ISPGMKRRIR  280 (400)
T ss_pred             cccccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-------CChhHHhHhh
Confidence            9987654222  234667999999999999999999999999999999999999997655311       1123334455


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .|.+. +.+|.+     ....+...++++.+|+.+|.+|-|+.|++..
T Consensus       281 ~gqy~-FP~pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  281 TGQYE-FPEPEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ccCcc-CCChhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            55542 222222     2345667889999999999999999999854

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-33  Score=284.91  Aligned_cols=262  Identities=25%  Similarity=0.409  Sum_probs=216.0

Q ss_pred             cCHHHHHHhhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEEEEe
Q 014904           34 FTYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYYTA  111 (416)
Q Consensus        34 f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  111 (416)
                      ..++.+.--++-|.+.+.||+|.+|.||++. .++++-.|||++.... ....++..|..||+.. +|||++.++|++..
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            4455555667789999999999999999999 5678999999887654 4446788899999998 69999999999864


Q ss_pred             -----CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEE
Q 014904          112 -----GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV  186 (416)
Q Consensus       112 -----~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl  186 (416)
                           ++++|||||||.+|+..+++....+..+.|..+..|++.++.||.+||..   .+||||||-.|||++.++.+||
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence                 67899999999999999999876666899999999999999999999999   9999999999999999999999


Q ss_pred             eecccceeccCCCcceeecccccccccChhhhcc-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhh
Q 014904          187 ADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA  261 (416)
Q Consensus       187 ~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~-----~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~  261 (416)
                      +|||++...... -.......||+.|||||++.-     ..|+.++|+||||++..||--|.+|+....+.         
T Consensus       165 vDFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---------  234 (953)
T KOG0587|consen  165 VDFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---------  234 (953)
T ss_pred             eeeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---------
Confidence            999998766542 233345789999999999842     34778999999999999999999998776651         


Q ss_pred             hHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          262 RPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       262 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      +.+         |...-+|...-.-+....+.+.+++..||..|.++||++.++++.
T Consensus       235 raL---------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  235 RAL---------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             hhh---------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            111         111122333333455677899999999999999999999998853

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-35  Score=265.00  Aligned_cols=252  Identities=25%  Similarity=0.370  Sum_probs=196.7

Q ss_pred             cCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           48 DANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG-QGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        48 ~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      .+..||.|.||+|+|-.+ +.|+..|||+++.... .+..+|+.|+++..+- +.||||+++|.+...+..|+.||.+ .
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d  146 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-D  146 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-h
Confidence            356799999999999884 5799999999987654 3345788888877665 6899999999999999999999998 5


Q ss_pred             CCHHHHh---hcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          125 NTLEFHL---HGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       125 ~sL~~~l---~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      .+|+.+-   +......+++...-.|....+.||.||-+..  +||||||||+||||+..|.+||||||+.-.+.+.  .
T Consensus       147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--i  222 (361)
T KOG1006|consen  147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--I  222 (361)
T ss_pred             hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH--H
Confidence            5665443   3333346888888899999999999999875  8999999999999999999999999998655432  2


Q ss_pred             eeecccccccccChhhhcc--CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          202 VSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~--~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                      ..+.-.|...|||||-+..  ..++.+|||||||++|+|+.||+.|+.....     ..+-.     ..+-.|+...+..
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql-----~~Vv~gdpp~l~~  292 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQL-----CQVVIGDPPILLF  292 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHH-----HHHHcCCCCeecC
Confidence            2344578899999998843  2489999999999999999999999876543     11111     1123566555444


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      +.-.-    .....|+.++..|+..+-.+||...++.+.
T Consensus       293 ~~~~~----~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  293 DKECV----HYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ccccc----ccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            33222    234578999999999999999999988753

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.5e-32  Score=287.54  Aligned_cols=268  Identities=21%  Similarity=0.248  Sum_probs=175.9

Q ss_pred             cCHHHHHH------hhCCCCcCceecccCcEEEEEEEeC-C----CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcc
Q 014904           34 FTYEELAR------ATDGFSDANLLGQGGFGYVHRGVLP-N----GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHL  102 (416)
Q Consensus        34 f~~~el~~------~t~~f~~~~~LG~G~~g~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni  102 (416)
                      |....+..      ..++|.+.++||+|+||.||+|.+. +    +..||||++......  +.+..+  .+.+..+.++
T Consensus       116 ~~l~~l~~~~~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~  191 (566)
T PLN03225        116 FVLAPLEGLFRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSC  191 (566)
T ss_pred             eeechhhhccCCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhH
Confidence            34445555      6789999999999999999999964 4    689999987643211  111111  1222222222


Q ss_pred             cceEEE------EEeCCeEEEEEEecCCCCHHHHhhcCCCC------------------CCCHHHHHHHHHHHHHHHHHH
Q 014904          103 VSLVGY------YTAGSQRMLVYEFVPNNTLEFHLHGKGRP------------------TMDWLTRLKIALGSAKGLAYL  158 (416)
Q Consensus       103 v~l~~~------~~~~~~~~lV~e~~~~~sL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~aL~~L  158 (416)
                      +.++..      +..+...++|+||+.+++|.+++......                  ......+..|+.|++.||.||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yL  271 (566)
T PLN03225        192 ADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGL  271 (566)
T ss_pred             HHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHH
Confidence            222111      24567789999999999999988754311                  112334567999999999999


Q ss_pred             HhcCCCCeeeecccCCcEEECC-CCceEEeecccceeccCCCcceeecccccccccChhhhccC----------------
Q 014904          159 HEDCHPKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG----------------  221 (416)
Q Consensus       159 H~~~~~~iiHrDIkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~----------------  221 (416)
                      |+.   +|+||||||+|||++. ++.+||+|||+++..............+++.|+|||.+...                
T Consensus       272 H~~---gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~s  348 (566)
T PLN03225        272 HST---GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS  348 (566)
T ss_pred             HHC---CEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCcccccccccc
Confidence            999   9999999999999986 57899999999986654444444567889999999965321                


Q ss_pred             ------CCCchhhhHhHHHHHHHHHhCCCCCCCCCcc-------cchhhhhhhhHHhHHhhhcCCcccccCccccCcCC-
Q 014904          222 ------KLTEKSDVFSFGVMLLELITGRRPVDSTHTF-------VEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYN-  287 (416)
Q Consensus       222 ------~~t~ksDV~SlGvvL~elltG~~pf~~~~~~-------~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~-  287 (416)
                            .++.++|||||||+||||+++..+++.....       ....+..|....     ...     ..+.+...+. 
T Consensus       349 p~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-----~~~-----~~~~~~~~~~~  418 (566)
T PLN03225        349 PVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLV-----EPR-----ASPDLRRGFEV  418 (566)
T ss_pred             chhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhh-----ccc-----cchhhhhhhhh
Confidence                  2456779999999999999977664321100       001112221110     000     0000000000 


Q ss_pred             -HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          288 -HNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       288 -~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                       ........+|+.+||+.||++||++.|+++.
T Consensus       419 ~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        419 LDLDGGAGWELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             ccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence             0011234589999999999999999999974

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.8e-32  Score=277.37  Aligned_cols=259  Identities=22%  Similarity=0.316  Sum_probs=182.6

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-----------------CCCcEEEEEEeecCCcccHHH--------------HHHH
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-----------------PNGKEVAIKQLKAGSGQGERE--------------FQAE   90 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~--------------~~~E   90 (416)
                      ..++|.+.++||+|+||.||+|.+                 .+++.||||++.........+              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467999999999999999999974                 235689999987543322222              3346


Q ss_pred             HHHHHhcCCCcc-----cceEEEEEe--------CCeEEEEEEecCCCCHHHHhhcCCC---------------------
Q 014904           91 VEIISRVHHKHL-----VSLVGYYTA--------GSQRMLVYEFVPNNTLEFHLHGKGR---------------------  136 (416)
Q Consensus        91 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~~sL~~~l~~~~~---------------------  136 (416)
                      +.++.+++|.++     ++++++|..        ....+|||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     677787753        3568999999999999999875321                     


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeecccccccccCh
Q 014904          137 -PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAP  215 (416)
Q Consensus       137 -~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaP  215 (416)
                       ..++|..+..|+.+++.+|.|||+.   +|+||||||+|||++.++.+||+|||++...............+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence             1346788899999999999999999   999999999999999999999999999975543222212223458899999


Q ss_pred             hhhccCCC----------------------CchhhhHhHHHHHHHHHhCCC-CCCCCCccc------chhhhhhhhHHhH
Q 014904          216 EYASSGKL----------------------TEKSDVFSFGVMLLELITGRR-PVDSTHTFV------EDSLVDWARPLLN  266 (416)
Q Consensus       216 E~~~~~~~----------------------t~ksDV~SlGvvL~elltG~~-pf~~~~~~~------~~~l~~~~~~~~~  266 (416)
                      |.+.....                      ..+.||||+||++++|++|.. ||.....+.      ...+..|.     
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r-----  454 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR-----  454 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-----
Confidence            98754321                      235799999999999999875 665322111      11112221     


Q ss_pred             HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCC---CCCCCHHHHHH
Q 014904          267 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSA---RRRPRMSQIVR  317 (416)
Q Consensus       267 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p---~~RPt~~evv~  317 (416)
                       ....+.++    -.    ..........+++.++|..+|   .+|+++.|+++
T Consensus       455 -~~~~~~~~----~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        455 -MYKGQKYD----FS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             -hhcccCCC----cc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence             11111111    00    111223567889999998765   78999999985

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=295.65  Aligned_cols=280  Identities=25%  Similarity=0.292  Sum_probs=217.9

Q ss_pred             HHHHHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEe
Q 014904           36 YEELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTA  111 (416)
Q Consensus        36 ~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  111 (416)
                      ..++.-..++|.++++||+|+||.|..+.. .+++.||+|++++-.   ...-.-|..|-+++..-+.+=|++++-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            356666778999999999999999999995 468999999998632   2223468899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       112 ~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                      ..++|+||||++||+|-.++...+  .++...+.+.+..++.||.-||+.   |+|||||||.|||||..|.+||+|||.
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence            999999999999999999997766  588888899999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhcc-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhH
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN  266 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~-----~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~  266 (416)
                      +-.....+.-.+...+|||-|.+||++..     +.|...+|.||+||++||||.|..||..      +++++-...++.
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~KIm~  295 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGKIMN  295 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHHHhc
Confidence            87777666666777899999999999842     5789999999999999999999999864      455554443332


Q ss_pred             HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH--hccccCcccccCCCCCCCCcc
Q 014904          267 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR---MSQIVRA--LEGDASLADLNEGIRPGQSSV  339 (416)
Q Consensus       267 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt---~~evv~~--L~~~~~~~~~~~~~~~~~~~~  339 (416)
                      .    .+.-.+.+     +  ........+||.+.+. +|+.|-.   +.++-..  ++|+ ....+.+...|.-..+
T Consensus       296 h----k~~l~FP~-----~--~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~-~W~~iR~~~pP~vPev  360 (1317)
T KOG0612|consen  296 H----KESLSFPD-----E--TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI-DWDNIRESVPPVVPEV  360 (1317)
T ss_pred             h----hhhcCCCc-----c--cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC-ChhhhhhcCCCCCCcC
Confidence            2    11111111     0  1244566777776654 4566666   7777654  3432 2334444444443333

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-33  Score=271.97  Aligned_cols=244  Identities=24%  Similarity=0.383  Sum_probs=197.0

Q ss_pred             CceecccCcEEEEEEEe-CCCcEEEEEEeecC--CcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCC
Q 014904           49 ANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNN  125 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~  125 (416)
                      .++||.|-||+||-|++ ++|+.||||++.+-  ....+..+.+|+.||..++||.||.+-.-|+..+..++|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            46899999999999994 68999999999753  3344578999999999999999999999999999999999999766


Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC---CceEEeecccceeccCCCcce
Q 014904          126 TLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK---FEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       126 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~---~~~kl~DFGla~~~~~~~~~~  202 (416)
                      -|+-+|... ...++...-..++.||+.||.|||.+   +|+|+||||+||||...   -++||||||.|++.++..-  
T Consensus       649 MLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--  722 (888)
T KOG4236|consen  649 MLEMILSSE-KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--  722 (888)
T ss_pred             HHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence            666655433 23688888889999999999999999   99999999999999654   4589999999999876433  


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      ...++||+.|+|||++.+..|...-|+||.||++|--|+|..||.......             .++.+-.|  +.    
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn-------------dQIQNAaF--My----  783 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN-------------DQIQNAAF--MY----  783 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh-------------HHhhcccc--cc----
Confidence            345899999999999999999999999999999999999999997644311             11222111  11    


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..+.-.+.....++++...|+..-++|-+...-+.
T Consensus       784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            11222234457788999999999999988877653

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-32  Score=263.49  Aligned_cols=241  Identities=28%  Similarity=0.374  Sum_probs=194.9

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-cc-H-HHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG-QG-E-REFQAEVEIISRV-HHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~-~-~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  117 (416)
                      ...|..+.+||+|.||.|.+|..+ +.+-+|||+|++.-. |+ . +--..|-.+|... +-|.++++..+|..-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            457888999999999999999954 567899999987532 11 1 1124566777776 46889999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+.||.|-.+++.-++  +.+..+...|..||-||-+||+.   +||.||||..|||||.+|.+||+|||+.+.---
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence            9999999999999987664  77778889999999999999999   999999999999999999999999999874221


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      . ...+..++||+.|+|||++...+|...+|.|||||+|||||.|++||+..+.   +.+        .+++.+.+    
T Consensus       503 ~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE---~el--------F~aI~ehn----  566 (683)
T KOG0696|consen  503 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DEL--------FQAIMEHN----  566 (683)
T ss_pred             C-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH---HHH--------HHHHHHcc----
Confidence            1 1223458999999999999999999999999999999999999999998654   111        12222211    


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCC
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRP  310 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP  310 (416)
                            ..|+.....+.+++....+...|.+|.
T Consensus       567 ------vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 ------VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ------CcCcccccHHHHHHHHHHhhcCCcccc
Confidence                  235555667788899999999999995

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.98  E-value=2.2e-32  Score=253.64  Aligned_cols=209  Identities=25%  Similarity=0.363  Sum_probs=172.2

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEEeCC-----CcEEEEEEeecCCcc-cH-HHHHHHHHHHHhcCCCcccceEEEEE
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGVLPN-----GKEVAIKQLKAGSGQ-GE-REFQAEVEIISRVHHKHLVSLVGYYT  110 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~-~~-~~~~~E~~~l~~l~h~niv~l~~~~~  110 (416)
                      |-......|.....||+|.+|.||+|+-.+     .+.+|+|+++..... +. ....+|+.+++.++|+|++.++.++.
T Consensus        18 ~rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl   97 (438)
T KOG0666|consen   18 ERVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL   97 (438)
T ss_pred             hhHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence            333556689999999999999999997332     247999999865322 22 34678999999999999999999988


Q ss_pred             e-CCeEEEEEEecCCCCHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC----C
Q 014904          111 A-GSQRMLVYEFVPNNTLEFHLHGK---GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK----F  182 (416)
Q Consensus       111 ~-~~~~~lV~e~~~~~sL~~~l~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~----~  182 (416)
                      . +...+|++||.+. +|..+|+-.   ....++-.....|+.||+.|+.|||+.   =|+||||||.||||..+    |
T Consensus        98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG  173 (438)
T KOG0666|consen   98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERG  173 (438)
T ss_pred             ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccC
Confidence            7 7889999999965 555555422   224788899999999999999999999   69999999999999888    8


Q ss_pred             ceEEeecccceeccCCCcce--eecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCC
Q 014904          183 EAKVADFGLAKIASDVNTHV--STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTH  250 (416)
Q Consensus       183 ~~kl~DFGla~~~~~~~~~~--~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~  250 (416)
                      .+||+|||+++++.+.-...  ...++-|+.|.|||++.+. .||.+.|||+.||++.||||-.+.|....
T Consensus       174 ~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  174 RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             eeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence            99999999999887654433  3457789999999999876 59999999999999999999999887543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.98  E-value=6.6e-33  Score=263.56  Aligned_cols=267  Identities=20%  Similarity=0.299  Sum_probs=203.6

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCC--C----cccceEEEEEeCCe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHH--K----HLVSLVGYYTAGSQ  114 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~~~  114 (416)
                      .+++|.+..++|+|.||.|-.+++ ..+..||||+++.-.. -.+..+-|+++|.++.+  |    -+|++.++|.-.++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            489999999999999999999994 4578999999985332 12345678999999942  3    26778888999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC---------------
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD---------------  179 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~---------------  179 (416)
                      .|+|+|.+ |.++.+++..++-.+++...+..|+.|+++++++||+.   +++|.||||+|||+-               
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999977 77999999888877899999999999999999999999   999999999999993               


Q ss_pred             -----CCCceEEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc
Q 014904          180 -----FKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE  254 (416)
Q Consensus       180 -----~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~  254 (416)
                           ++..++|+|||.|.......    ..++.|..|.|||++.+-.++..+||||+||+|+||.||...|......+.
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH  317 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH  317 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence                 13458999999998765433    336679999999999999999999999999999999999999987663221


Q ss_pred             hhhhhhh----hH-HhHH-----hhhcCCcc-----------cccCcc----ccCcCCHHHHHHHHHHHHHhhccCCCCC
Q 014904          255 DSLVDWA----RP-LLNR-----AIEDGNFD-----------TLVDPK----LHNEYNHNEMARMVACAAACVRHSARRR  309 (416)
Q Consensus       255 ~~l~~~~----~~-~~~~-----~~~~~~~~-----------~~~d~~----l~~~~~~~~~~~l~~l~~~cl~~~p~~R  309 (416)
                      ..+.+-+    .. ++.+     ....|.++           ...++-    ..-.....+..+|++|+..||..||.+|
T Consensus       318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R  397 (415)
T KOG0671|consen  318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR  397 (415)
T ss_pred             HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence            1111110    01 1111     11111111           000000    0011234466789999999999999999


Q ss_pred             CCHHHHHH
Q 014904          310 PRMSQIVR  317 (416)
Q Consensus       310 Pt~~evv~  317 (416)
                      +|+.|++.
T Consensus       398 iTl~EAL~  405 (415)
T KOG0671|consen  398 ITLREALS  405 (415)
T ss_pred             ccHHHHhc
Confidence            99999875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.7e-31  Score=254.99  Aligned_cols=267  Identities=22%  Similarity=0.323  Sum_probs=204.1

Q ss_pred             CCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-----C---CcccceEEEEEe---
Q 014904           44 DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-----H---KHLVSLVGYYTA---  111 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~---  111 (416)
                      ++|.+.++||-|-|++||+++ ..+.+.||+|+.+... .-.+....|+.+|++++     |   .+||+|++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            578889999999999999999 4567899999988532 22234678999999984     2   479999999964   


Q ss_pred             -CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC-----------
Q 014904          112 -GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD-----------  179 (416)
Q Consensus       112 -~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~-----------  179 (416)
                       +.+.|+|+|++ |.+|..+|....-..++......|+.|++.||.|||+.|  +|||.||||+|||+-           
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~  233 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAR  233 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhh
Confidence             67899999998 778888887776668999999999999999999999999  999999999999993           


Q ss_pred             --------------------------------------------------------------------------------
Q 014904          180 --------------------------------------------------------------------------------  179 (416)
Q Consensus       180 --------------------------------------------------------------------------------  179 (416)
                                                                                                      
T Consensus       234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~  313 (590)
T KOG1290|consen  234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE  313 (590)
T ss_pred             hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence                                                                                            


Q ss_pred             -----------------------CC----------------------------------------------------Cce
Q 014904          180 -----------------------FK----------------------------------------------------FEA  184 (416)
Q Consensus       180 -----------------------~~----------------------------------------------------~~~  184 (416)
                                             .+                                                    -.+
T Consensus       314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v  393 (590)
T KOG1290|consen  314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV  393 (590)
T ss_pred             cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence                                   00                                                    026


Q ss_pred             EEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCc----ccchhhhhh
Q 014904          185 KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHT----FVEDSLVDW  260 (416)
Q Consensus       185 kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~----~~~~~l~~~  260 (416)
                      ||+|||-|++....    .+.-+.|..|+|||++.+..|+..+||||++|++|||+||-..|+....    ..++.+...
T Consensus       394 KIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i  469 (590)
T KOG1290|consen  394 KIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI  469 (590)
T ss_pred             EEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence            77788877765432    2334578899999999999999999999999999999999999976432    234444333


Q ss_pred             hhH---HhHHhhhcCCc-ccccCcc----------c---------cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          261 ARP---LLNRAIEDGNF-DTLVDPK----------L---------HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       261 ~~~---~~~~~~~~~~~-~~~~d~~----------l---------~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..-   +-...+..|.+ +++.+.+          .         .=.++.++..++.+++.-||+.+|++||++.+.++
T Consensus       470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK  549 (590)
T ss_pred             HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence            211   11111122221 1222221          1         11366788899999999999999999999999885


Q ss_pred             H
Q 014904          318 A  318 (416)
Q Consensus       318 ~  318 (416)
                      .
T Consensus       550 h  550 (590)
T KOG1290|consen  550 H  550 (590)
T ss_pred             C
Confidence            3

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=231.58  Aligned_cols=264  Identities=23%  Similarity=0.318  Sum_probs=199.4

Q ss_pred             CCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCccc--HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQG--EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +|...++||+|.+|+||+|. ..+++.||+|.++..+..+  .....+|+-+|+.+.|+|||++++....+...-||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            56677899999999999999 4568899999988654332  35678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      | ...|..+...-++ .++......++.|+++||.++|++   ++.|||+||+|.||+.||+.|++|||+++.++-.-..
T Consensus        83 c-dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             h-hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            9 4566666654333 688899999999999999999999   9999999999999999999999999999977654333


Q ss_pred             eeecccccccccChhhhccCC-CCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhc--CCcccc
Q 014904          202 VSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIED--GNFDTL  277 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~-~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~--~~~~~~  277 (416)
                      .+.. +-|..|.+|.++.+.+ |+...|+||-||++.|+.. |++.|...+  .++.+...++.+-.. .++  ..+..+
T Consensus       158 ysae-vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d--vddqlkrif~~lg~p-~ed~wps~t~l  233 (292)
T KOG0662|consen  158 YSAE-VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTP-TEDQWPSMTKL  233 (292)
T ss_pred             eece-eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc--HHHHHHHHHHHhCCC-ccccCCccccC
Confidence            3333 4589999999998865 7899999999999999998 666666654  355555544322110 000  112334


Q ss_pred             cCccccCcCCH-----HHHH----HHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          278 VDPKLHNEYNH-----NEMA----RMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       278 ~d~~l~~~~~~-----~~~~----~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .|-....-++.     +...    .=.+++...+.-+|..|-++.+.++
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            44443333332     1222    2246777778888888888877654

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=253.96  Aligned_cols=262  Identities=24%  Similarity=0.328  Sum_probs=211.9

Q ss_pred             HHHHHhhCCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEE
Q 014904           37 EELARATDGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYY  109 (416)
Q Consensus        37 ~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~  109 (416)
                      .||..-..+++...++-+|.||.||.|++.      +.+.|.||.++....+ .-..++.|.-++..+.|||+..+.+.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            455666678888899999999999999754      2456778887754332 234678899999999999999999998


Q ss_pred             Ee-CCeEEEEEEecCCCCHHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC
Q 014904          110 TA-GSQRMLVYEFVPNNTLEFHLHG------KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF  182 (416)
Q Consensus       110 ~~-~~~~~lV~e~~~~~sL~~~l~~------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~  182 (416)
                      .+ ...++.+|.+..-++|..++..      +..+.++..+...++.|++.|++|||..   ++||.||.++|++||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhe
Confidence            75 5668899999999999999872      2234678888899999999999999999   999999999999999999


Q ss_pred             ceEEeecccceeccCCCccee-ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhh
Q 014904          183 EAKVADFGLAKIASDVNTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDW  260 (416)
Q Consensus       183 ~~kl~DFGla~~~~~~~~~~~-~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~  260 (416)
                      ++||+|-.+++-+.....+.. ..-..+..||+||.+.+..++.++|||||||+||||+| |+.|+..-++++...    
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~----  509 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH----  509 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH----
Confidence            999999999986554444433 33345678999999999999999999999999999999 999987766643322    


Q ss_pred             hhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          261 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                             .+.+|-  +       -.-+-+++.+++.++.-||+..|++||++.|++.-|.+
T Consensus       510 -------ylkdGy--R-------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  510 -------YLKDGY--R-------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             -------HHhccc--e-------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence                   223332  1       12234677899999999999999999999999998864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.4e-29  Score=228.23  Aligned_cols=211  Identities=35%  Similarity=0.540  Sum_probs=185.0

Q ss_pred             ecccCcEEEEEEEeCC-CcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCHHH
Q 014904           52 LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEF  129 (416)
Q Consensus        52 LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL~~  129 (416)
                      ||+|.+|.||++...+ ++.+++|++...... ....+.+|+..+..+.|++++++++++......++|+|++++++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 899999999865543 34678999999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC-CCceEEeecccceeccCCCcceeecccc
Q 014904          130 HLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMG  208 (416)
Q Consensus       130 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~g  208 (416)
                      ++.... ..+++..++.++.+++++|.+||+.   +++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~  155 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG  155 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence            987543 3589999999999999999999999   9999999999999999 89999999999987654332 1233557


Q ss_pred             cccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCC
Q 014904          209 TFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYN  287 (416)
Q Consensus       209 t~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  287 (416)
                      ...|++||.+... ..+.++|+|+||+++++|                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            8899999999877 888999999999999999                                                


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014904          288 HNEMARMVACAAACVRHSARRRPRMSQIVRAL  319 (416)
Q Consensus       288 ~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L  319 (416)
                          ..+.+++..|++.+|.+||++.++++.|
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                3678899999999999999999998754

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1e-30  Score=260.91  Aligned_cols=210  Identities=24%  Similarity=0.358  Sum_probs=176.8

Q ss_pred             CCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcccH---HHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE---REFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      -|..++.||-|.||.|.++. .++...+|.|.|.+.+...+   ...++|-+||..-..+-||+|+-.|.+++.+|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            57778899999999999998 55678899999987654333   346789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce-------
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-------  193 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~-------  193 (416)
                      |++||++-.+|-..+  .+++..+.+.+.++..|+++.|..   |+|||||||.|||||.+|.+||.||||..       
T Consensus       710 YIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             ccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccc
Confidence            999999998887655  588888888899999999999999   99999999999999999999999999963       


Q ss_pred             --eccCCCcce---------------------------------eecccccccccChhhhccCCCCchhhhHhHHHHHHH
Q 014904          194 --IASDVNTHV---------------------------------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLE  238 (416)
Q Consensus       194 --~~~~~~~~~---------------------------------~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~e  238 (416)
                        .+.. +.|.                                 ....+||+.|+|||++....++..+|.||.||+|||
T Consensus       785 skYYq~-gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  785 SKYYQE-GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             cccccC-CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence              2221 1110                                 012469999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCccc-chhhhhh
Q 014904          239 LITGRRPVDSTHTFV-EDSLVDW  260 (416)
Q Consensus       239 lltG~~pf~~~~~~~-~~~l~~~  260 (416)
                      |+.|+.||-...+.. ...++.|
T Consensus       864 m~~g~~pf~~~tp~~tq~kv~nw  886 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQYKVINW  886 (1034)
T ss_pred             HhhCCCCccCCCCCcceeeeeeh
Confidence            999999997766543 3344455

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-32  Score=265.90  Aligned_cols=243  Identities=24%  Similarity=0.324  Sum_probs=199.0

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCc-EEEEEEeecCCccc---HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGK-EVAIKQLKAGSGQG---EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~-~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ..++..+-.||-||||.|-+....... .+|+|++++....+   .+.+..|-.|+...+.+.||+++--|.+....|++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            345556667999999999998864433 38999887653322   34567889999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      ||-|-||.|...|...+  .++..+...++..+++|++|||+.   +||.|||||+|.+||.+|-+||.|||+|+.....
T Consensus       499 mEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            99999999999997766  588888889999999999999999   9999999999999999999999999999987653


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      .  .+..++||+.|.|||++.+..-+.++|.|+||++++|||+|++||...++..-.+++          + .| ++.  
T Consensus       574 ~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I----------L-kG-id~--  637 (732)
T KOG0614|consen  574 R--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI----------L-KG-IDK--  637 (732)
T ss_pred             C--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH----------H-hh-hhh--
Confidence            3  345589999999999999999999999999999999999999999987763322221          1 11 111  


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCC
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPR  311 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt  311 (416)
                           .+++........+++++..+.+|.+|.-
T Consensus       638 -----i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  638 -----IEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             -----hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence                 1233344456788999999999999975

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=8.2e-31  Score=230.89  Aligned_cols=229  Identities=26%  Similarity=0.401  Sum_probs=179.4

Q ss_pred             CCCCCCCCCCCCC-CccccCHHHHHHhhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCC-cccHHHHHHHHHH
Q 014904           17 PLPPPSPGLSLGF-SKSTFTYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGS-GQGEREFQAEVEI   93 (416)
Q Consensus        17 ~~~~~~~~~~~~~-~~~~f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~   93 (416)
                      |.+.+.|+..+.. .........+....+.......||+|++|.|-+-. ..+|+..|+|.+...- .+..++++.|+++
T Consensus        18 P~~~~tpp~~Ld~~a~i~I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi   97 (282)
T KOG0984|consen   18 PAPRETPPRNLDSRALIYIGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDI   97 (282)
T ss_pred             CCcCCCCCcccCCCceEEEecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhh
Confidence            3333444443332 33344444456666777778889999999998888 4689999999997643 3444678889998


Q ss_pred             HHhc-CCCcccceEEEEEeCCeEEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeec
Q 014904           94 ISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG--KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD  170 (416)
Q Consensus        94 l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrD  170 (416)
                      ..+. .+|.+|.++|........++.||.+ ..+|+.+-..  +.+..+++...=+||..+.+||.|||++.  .+||||
T Consensus        98 ~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRD  174 (282)
T KOG0984|consen   98 IMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRD  174 (282)
T ss_pred             hccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhcc
Confidence            8776 6999999999988889999999988 5567655432  22347899999999999999999999986  899999


Q ss_pred             ccCCcEEECCCCceEEeecccceeccCCCcceeecccccccccChhhhcc----CCCCchhhhHhHHHHHHHHHhCCCCC
Q 014904          171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS----GKLTEKSDVFSFGVMLLELITGRRPV  246 (416)
Q Consensus       171 Ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~----~~~t~ksDV~SlGvvL~elltG~~pf  246 (416)
                      +||+||||+.+|++|+||||++-.+.+.-.  .+...|.-.|+|||.+..    ..|+.|+||||||+.+.||.++|.|+
T Consensus       175 vKPsNiLIn~~GqVKiCDFGIsG~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY  252 (282)
T KOG0984|consen  175 VKPSNILINYDGQVKICDFGISGYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPY  252 (282)
T ss_pred             CCcceEEEccCCcEEEcccccceeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccc
Confidence            999999999999999999999987654322  233457888999998743    36899999999999999999999998


Q ss_pred             CCCC
Q 014904          247 DSTH  250 (416)
Q Consensus       247 ~~~~  250 (416)
                      +...
T Consensus       253 ~~w~  256 (282)
T KOG0984|consen  253 ESWG  256 (282)
T ss_pred             cccC
Confidence            7644

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=273.51  Aligned_cols=243  Identities=26%  Similarity=0.394  Sum_probs=187.8

Q ss_pred             CCcCceecccCcE-EEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEEEecC
Q 014904           46 FSDANLLGQGGFG-YVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        46 f~~~~~LG~G~~g-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      |...+++|.|..| .||+|.. .|++||||.+-...   ....++|+..|..- .|||||+.++.-.+....|++.|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            4555678999987 6899998 67899999986433   23567899999988 5999999998888889999999999 


Q ss_pred             CCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC---C--CceEEeecccceecc
Q 014904          124 NNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF---K--FEAKVADFGLAKIAS  196 (416)
Q Consensus       124 ~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~---~--~~~kl~DFGla~~~~  196 (416)
                      ..+|.+++...  ......-...+.+..|+++||++||+.   +||||||||+||||+.   +  ..++|+|||+++...
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            67999999774  111222245567889999999999997   9999999999999976   2  568999999999876


Q ss_pred             CCCccee--ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhC-CCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          197 DVNTHVS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG-RRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       197 ~~~~~~~--~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG-~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      .......  ....||-||.|||.+....-+.++||||||||+|..++| ..||+..-.. +.++            ..|+
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~NI------------l~~~  729 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QANI------------LTGN  729 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhhh------------hcCc
Confidence            6554433  346899999999999998888999999999999999995 9999864321 1111            1122


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIV  316 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv  316 (416)
                      +.-.   .+.  ...++  ...+||.+|++++|..||++.+|+
T Consensus       730 ~~L~---~L~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  730 YTLV---HLE--PLPDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             ccee---eec--cCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            1110   011  11111  677899999999999999999998

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.4e-31  Score=242.05  Aligned_cols=265  Identities=25%  Similarity=0.362  Sum_probs=190.0

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc-c-HHHHHHHHHHHHhcCCCcccceEEEEEe--------CC
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ-G-EREFQAEVEIISRVHHKHLVSLVGYYTA--------GS  113 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~  113 (416)
                      .|....+||+|.||.||+|.. .+|+.||+|+.-..... + .....+|+.+|..+.|+|++.+++.|..        ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            455567899999999999995 45788899876432211 1 1345789999999999999999998854        23


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ..+||+++|+. +|.-+|.. ....++..++.+++.++..||.|+|+.   .|+|||+|+.|+||+.++.+||+|||+++
T Consensus        98 t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence            57999999954 55555532 234688899999999999999999999   99999999999999999999999999997


Q ss_pred             eccCCCcce---eecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhh--------h
Q 014904          194 IASDVNTHV---STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDW--------A  261 (416)
Q Consensus       194 ~~~~~~~~~---~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~--------~  261 (416)
                      .+.......   .+..+-|..|++||.+.+. .++++.|||.-||++.||+|+.+-+..+...-...++.-        +
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            654322221   2334569999999998764 699999999999999999999998887654333222211        1


Q ss_pred             hHH-----hHHhhh-----cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          262 RPL-----LNRAIE-----DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       262 ~~~-----~~~~~~-----~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ||-     +.+.++     .|.+..+.+ ++.. +-  --...++++..++..||.+|+.+++++..
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n-~~kp-~~--kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKN-RLKP-YV--KDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhh-hccc-cc--CChhHHHHHHHHhccCcccCcchHhhhch
Confidence            110     011111     111111100 0000 00  01256789999999999999999998854

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=5e-29  Score=228.94  Aligned_cols=199  Identities=33%  Similarity=0.444  Sum_probs=174.3

Q ss_pred             CCcCceecccCcEEEEEEEeCC-CcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           46 FSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      |...+.||+|++|.||++...+ ++.+++|.+...... ....+.+|++.+.+++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5677899999999999999764 899999999876544 45688899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      +++|.+++..... .+++.....++.+++.+|.+||+.   +++|+||++.||+++.++.++|+|||.+...........
T Consensus        81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            9999999876542 288999999999999999999999   999999999999999999999999999987765431122


Q ss_pred             ecccccccccChhhh-ccCCCCchhhhHhHHHHHHHHHhCCCCCCC
Q 014904          204 TRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGRRPVDS  248 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~-~~~~~t~ksDV~SlGvvL~elltG~~pf~~  248 (416)
                      ....++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            335678889999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.1e-30  Score=238.90  Aligned_cols=247  Identities=22%  Similarity=0.323  Sum_probs=193.9

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  118 (416)
                      +.|..+.+||+|.|.+|-.+.+ ++.+.+|+|++++.-   ..+....+.|-.+..+- +||.+|-+..+|.....+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            5799999999999999999995 568899999998642   23334556676666665 799999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      .||++||.|-.+++...  .++.+.+......|+.||.|||+.   +||.||||..|||||..|.+||.|+|+.+.--..
T Consensus       330 ieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            99999999988886554  589999999999999999999999   9999999999999999999999999998743322


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCc-ccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHT-FVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                       ...+..++||+.|.|||++.+..|....|.|+|||+++||+.||.||+--.- ..+.+-.++...+    +-+..+   
T Consensus       405 -gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv----ilekqi---  476 (593)
T KOG0695|consen  405 -GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV----ILEKQI---  476 (593)
T ss_pred             -CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH----Hhhhcc---
Confidence             2233458999999999999999999999999999999999999999975221 1122222222221    111111   


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCC
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRP  310 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP  310 (416)
                             ..+....-+...+++.-|+.||.+|.
T Consensus       477 -------riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  477 -------RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -------cccceeehhhHHHHHHhhcCCcHHhc
Confidence                   12222333556778888999999885

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=1.1e-29  Score=226.85  Aligned_cols=269  Identities=21%  Similarity=0.331  Sum_probs=202.1

Q ss_pred             ccCHHHH---HHhhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-CCcccceEE
Q 014904           33 TFTYEEL---ARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-HKHLVSLVG  107 (416)
Q Consensus        33 ~f~~~el---~~~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~  107 (416)
                      -+.||..   +..+++|++.+++|+|.++.||.|. ..+++.++||++++-   ..+.+.+|+.||..|. ||||+++++
T Consensus        24 YWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~D  100 (338)
T KOG0668|consen   24 YWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLD  100 (338)
T ss_pred             hcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhh
Confidence            3445443   3356789999999999999999999 567899999999864   3568899999999997 999999999


Q ss_pred             EEEe--CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC-Cce
Q 014904          108 YYTA--GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEA  184 (416)
Q Consensus       108 ~~~~--~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~-~~~  184 (416)
                      ...+  ...+.||+||+.+.....+..     .++...+...+.++++||.|||+.   ||.|||+||.|++||.. -.+
T Consensus       101 iV~Dp~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkL  172 (338)
T KOG0668|consen  101 IVKDPESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKL  172 (338)
T ss_pred             hhcCccccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhcee
Confidence            9876  456789999999888776653     477777888999999999999999   99999999999999975 458


Q ss_pred             EEeecccceeccCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH
Q 014904          185 KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP  263 (416)
Q Consensus       185 kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~  263 (416)
                      +|+|+|+|.++...... .- .+.+.-|--||++-. ..++..-|+|||||+|..|+..+.||..... .-+.|+..+.-
T Consensus       173 rlIDWGLAEFYHp~~eY-nV-RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakV  249 (338)
T KOG0668|consen  173 RLIDWGLAEFYHPGKEY-NV-RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKV  249 (338)
T ss_pred             eeeecchHhhcCCCcee-ee-eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHH
Confidence            99999999887654332 11 223455778998754 5689999999999999999999999865443 34566665532


Q ss_pred             Hh----HHhhhcCCcccccCccccC-----------cC----CH-HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          264 LL----NRAIEDGNFDTLVDPKLHN-----------EY----NH-NEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       264 ~~----~~~~~~~~~~~~~d~~l~~-----------~~----~~-~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      +-    ...+..-.  --+||.+..           .+    +. -...+.++++.+.|+.|-.+|||+.|.+.
T Consensus       250 LGt~el~~Yl~KY~--i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  250 LGTDELYAYLNKYQ--IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             hChHHHHHHHHHHc--cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            21    11111111  113332211           00    01 11257889999999999999999999764

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.2e-29  Score=229.03  Aligned_cols=268  Identities=21%  Similarity=0.298  Sum_probs=191.7

Q ss_pred             CcCceecccCcEEEEEEEeC-CCcEEEEEEeecC--CcccHHHHHHHHHHHHhcCCCcccceEEEEEeCC-----eEEEE
Q 014904           47 SDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGS-----QRMLV  118 (416)
Q Consensus        47 ~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lV  118 (416)
                      ...+.||.|.||.||..+++ +|+.||+|++...  +...-+.+.+|+.+|...+|.|++..+++..-..     ..|+|
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            44678999999999999964 7999999998643  2233467888999999999999999887764432     24566


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      .|.+ ..+|..++-.  ...++-....-+..||++||.|||+.   +|.||||||.|.|++.|-.+||||||+++.....
T Consensus       136 TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  136 TELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence            6665 3455555432  23577777788899999999999999   9999999999999999999999999999976654


Q ss_pred             CcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh--HHh--HHhhhcCC
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR--PLL--NRAIEDGN  273 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~--~~~--~~~~~~~~  273 (416)
                      .....+..+-|.-|.|||++.+. .|+.+.||||.||++.||+..|-.|....+.....++.-..  |.+  ++...+|.
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            44434444568889999999875 69999999999999999999999998877755444332210  000  01111111


Q ss_pred             cccccC-----ccccCcC---C-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          274 FDTLVD-----PKLHNEY---N-HNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       274 ~~~~~d-----~~l~~~~---~-~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      -..++.     |.+..-|   . ...-..-+.+...++..+|++|-+..+.+..+.
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            111111     1111101   1 112235567888899999999999888876653

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=244.02  Aligned_cols=198  Identities=24%  Similarity=0.362  Sum_probs=168.4

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHH--------HHHHHHHHHHhcC---CCcccceEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGER--------EFQAEVEIISRVH---HKHLVSLVGYY  109 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~--------~~~~E~~~l~~l~---h~niv~l~~~~  109 (416)
                      ....|...+.||+|.||.|+.|+++ +..+|+||.+.+.......        ..-.|+.||..++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            3456888999999999999999965 5778999998765432111        2446999999997   99999999999


Q ss_pred             EeCCeEEEEEEec-CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEee
Q 014904          110 TAGSQRMLVYEFV-PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD  188 (416)
Q Consensus       110 ~~~~~~~lV~e~~-~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~D  188 (416)
                      ++++..||++|.. ++..|.++|..+.  .+++.....|+.|++-|+++||++   +|||||||-+||.++.+|-+||+|
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence            9999999999965 4567888887665  599999999999999999999999   999999999999999999999999


Q ss_pred             cccceeccCCCcceeecccccccccChhhhccCCC-CchhhhHhHHHHHHHHHhCCCCCC
Q 014904          189 FGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVD  247 (416)
Q Consensus       189 FGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~-t~ksDV~SlGvvL~elltG~~pf~  247 (416)
                      ||.+.+...   .....++||.+|.|||++.+.+| ...-|||+||++||.++....||.
T Consensus       714 fgsaa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  714 FGSAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ccchhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999876543   23355789999999999998876 567899999999999998887764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=3e-28  Score=238.86  Aligned_cols=269  Identities=23%  Similarity=0.262  Sum_probs=201.4

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC------CCcccceEEEEEeCC
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH------HKHLVSLVGYYTAGS  113 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~  113 (416)
                      ..-.+|.+....|+|-|++|-.|.. ..|+.||||++..+.... +.=+.|++||++|+      --|+++++-.|...+
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            3456888888999999999999995 458899999998754332 23467999999995      358999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC-CceEEeeccc
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGR-PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGL  191 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~-~~~kl~DFGl  191 (416)
                      ++|||+|-+ ..+|.++|...+. ..|........+.|+.-||..|-..   +|+|.||||.||||++. ..+||||||.
T Consensus       508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcc
Confidence            999999987 6789999876543 3578888899999999999999887   99999999999999876 4579999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcc-cchhhhhhhhHHhHHhhh
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTF-VEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~-~~~~l~~~~~~~~~~~~~  270 (416)
                      |-...+...   +.+.-+.-|.|||++.+-.|+...|+||.||.||||.||+-.|.+...- +-.-..+.-.++-.+.+.
T Consensus       584 A~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  584 ASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             ccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            987665432   2234456799999999999999999999999999999999999764331 111111111112222222


Q ss_pred             cCCcc-----c----------------------ccCc------cc--cCcCC---HHHHHHHHHHHHHhhccCCCCCCCH
Q 014904          271 DGNFD-----T----------------------LVDP------KL--HNEYN---HNEMARMVACAAACVRHSARRRPRM  312 (416)
Q Consensus       271 ~~~~~-----~----------------------~~d~------~l--~~~~~---~~~~~~l~~l~~~cl~~~p~~RPt~  312 (416)
                      .|.|.     .                      .+.|      .+  ...++   ......|.+|+..|+..||++|-+.
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence            22221     1                      0111      00  01123   3345678899999999999999999


Q ss_pred             HHHHH
Q 014904          313 SQIVR  317 (416)
Q Consensus       313 ~evv~  317 (416)
                      .|.|.
T Consensus       741 nqAL~  745 (752)
T KOG0670|consen  741 NQALK  745 (752)
T ss_pred             HHHhc
Confidence            98774

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-27  Score=217.37  Aligned_cols=263  Identities=19%  Similarity=0.352  Sum_probs=194.9

Q ss_pred             cCHHHHHH--hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEE-
Q 014904           34 FTYEELAR--ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGY-  108 (416)
Q Consensus        34 f~~~el~~--~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-  108 (416)
                      ++.+||.+  ..+.|.+.+.||+|.||.+-++.+. ..+.+|+|-+.... ...++|.+|..---.| .|.||+.-++. 
T Consensus        12 I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~va   90 (378)
T KOG1345|consen   12 IPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVA   90 (378)
T ss_pred             cccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHH
Confidence            34444443  4578999999999999999999964 67889999876433 3457888888765555 58999988765 


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC--CCCceEE
Q 014904          109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD--FKFEAKV  186 (416)
Q Consensus       109 ~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~--~~~~~kl  186 (416)
                      |...+..++++||++.|+|..-+...+   +.+....+++.|++.||.|+|+.   ++||||||.+||||-  +...+||
T Consensus        91 Fqt~d~YvF~qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKl  164 (378)
T KOG1345|consen   91 FQTSDAYVFVQEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKL  164 (378)
T ss_pred             hhcCceEEEeeccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEe
Confidence            566678889999999999998886543   67778889999999999999999   999999999999993  2347999


Q ss_pred             eecccceeccCCCcceeecccccccccChhhhccC-----CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhh
Q 014904          187 ADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA  261 (416)
Q Consensus       187 ~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~-----~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~  261 (416)
                      ||||+.+..+..    ...+.-+..|.+||.....     +..+.+|||.||++++.+|||+.||... ...+...++|.
T Consensus       165 cDFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~  239 (378)
T KOG1345|consen  165 CDFGLTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWE  239 (378)
T ss_pred             eecccccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHH
Confidence            999998754321    1223345569999987432     3567899999999999999999999843 34666777764


Q ss_pred             hHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          262 RPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       262 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                      .-      ..+..     +++...+.. ...++..+.++-+.+++++|=...++-++-.
T Consensus       240 ~w------~~rk~-----~~~P~~F~~-fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  240 QW------LKRKN-----PALPKKFNP-FSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             HH------hcccC-----ccCchhhcc-cCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence            32      12221     122222221 2346777888899999999966666665543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=2.7e-27  Score=220.80  Aligned_cols=260  Identities=23%  Similarity=0.326  Sum_probs=196.9

Q ss_pred             hCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecC--CcccHHHHHHHHHHHHhcCCCcccceEEEEEeCC------
Q 014904           43 TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGS------  113 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  113 (416)
                      ..+|.....+|.|.- .|-.+. .-.+++||+|++...  .....++..+|+.++..++|+||++++.++.-..      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            468888889999988 555555 336899999998643  2344467788999999999999999999986433      


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ..|+|||++ ..+|...++.    .++=.+...|..|++.|+.|||+.   +|+||||||+||++..+..+||.|||+|+
T Consensus        95 e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhc
Confidence            468999999 6788888773    366678889999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhh------------
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA------------  261 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~------------  261 (416)
                      .....  ...+..+.|.-|.|||++.+..+.+.+||||+||++.||++|+-.|.+..     .+-+|.            
T Consensus       167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPDPS  239 (369)
T ss_pred             ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCCHH
Confidence            65432  34566788999999999998889999999999999999999999887432     333332            


Q ss_pred             -----hHHhHHhhhc------CCc-ccccCccccCcC--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          262 -----RPLLNRAIED------GNF-DTLVDPKLHNEY--NHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       262 -----~~~~~~~~~~------~~~-~~~~d~~l~~~~--~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                           .+......+.      -.+ ..+.|..+....  +.-......+++.+||-.+|++|-++.++++.
T Consensus       240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                 1111111110      001 112222222111  12233456789999999999999999999975

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=9e-27  Score=224.40  Aligned_cols=268  Identities=23%  Similarity=0.325  Sum_probs=196.6

Q ss_pred             HHHhhCCCCcCceecccCcEEEEEEEeC----CCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-CCcccceEEEEEeCC
Q 014904           39 LARATDGFSDANLLGQGGFGYVHRGVLP----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-HKHLVSLVGYYTAGS  113 (416)
Q Consensus        39 l~~~t~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  113 (416)
                      +....+.|..+++||+|.|++||++++.    ..+.||+|.+...+  ....+.+|+++|..+. +.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3345568899999999999999999943    46789999987543  3357899999999995 999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC-CceEEeecccc
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLA  192 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~-~~~kl~DFGla  192 (416)
                      +.++|+||++.....++...     ++...+...+..+++||+++|..   |||||||||+|+|.+.. +.-.|+|||+|
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence            99999999999999888864     66788889999999999999999   99999999999999754 56799999998


Q ss_pred             eeccCC---------------------------------C----------cceeecccccccccChhhhcc-CCCCchhh
Q 014904          193 KIASDV---------------------------------N----------THVSTRVMGTFGYLAPEYASS-GKLTEKSD  228 (416)
Q Consensus       193 ~~~~~~---------------------------------~----------~~~~~~~~gt~~YlaPE~~~~-~~~t~ksD  228 (416)
                      ......                                 .          ........||+||.|||++.. +..+.++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            721100                                 0          000112469999999999865 46789999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh---H-HhH-HhhhcCC------------------ccccc-Ccc---
Q 014904          229 VFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR---P-LLN-RAIEDGN------------------FDTLV-DPK---  281 (416)
Q Consensus       229 V~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~---~-~~~-~~~~~~~------------------~~~~~-d~~---  281 (416)
                      |||-||+++-+++++.||...... -+.+.+.+.   + .+. -+...|.                  +..+. ..-   
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd-~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDD-ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             eeeccceeehhhccccccccCccc-cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            999999999999999998764431 122222110   0 000 0111111                  11110 000   


Q ss_pred             ----cc-CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          282 ----LH-NEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       282 ----l~-~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                          .. .....-.+..+.+++.+|+..||.+|-++.+.|+
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                00 0111112347889999999999999999998874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=9.7e-28  Score=241.32  Aligned_cols=254  Identities=24%  Similarity=0.413  Sum_probs=204.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      -.++|.....+|.|.+|.|||+.+ ..++..|||+++......-.-++.|+-+++..+|+|||.+++.+......+++||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            356899999999999999999994 5789999999998777777788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      ||.+|+|.+.-+..+  .++..++..++...++||+|||..   +=+|||||-.|||+++.+.+|++|||.+-.+... .
T Consensus        93 ycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i  166 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-I  166 (829)
T ss_pred             ecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh-h
Confidence            999999998877554  689999999999999999999999   8899999999999999999999999998655432 2


Q ss_pred             ceeecccccccccChhhh---ccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          201 HVSTRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~---~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      .....+.||+-|+|||+.   ..+.|..++|||++|+...|+---++|...-.+.  +.+      .+   .....++. 
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r~l------~L---mTkS~~qp-  234 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--RAL------FL---MTKSGFQP-  234 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--HHH------HH---hhccCCCC-
Confidence            223558899999999987   4567999999999999999998877774433321  111      00   11111111 


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                        |.+..  .....+.+..+++.|+..+|.+||++..++.
T Consensus       235 --p~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  235 --PTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             --CcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence              11111  1223456889999999999999999987663

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1.5e-27  Score=260.30  Aligned_cols=195  Identities=15%  Similarity=0.226  Sum_probs=139.3

Q ss_pred             hcCC-CcccceEEEE-------EeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 014904           96 RVHH-KHLVSLVGYY-------TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII  167 (416)
Q Consensus        96 ~l~h-~niv~l~~~~-------~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ii  167 (416)
                      .++| .||++++++|       .+....++++|+. +++|.++|.... ..+++..++.++.||++||+|||+.   +|+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQ---GIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            4555 5888888877       3334567788877 669999997543 3699999999999999999999998   999


Q ss_pred             eecccCCcEEECC-------------------CCceEEeecccceeccCCC---------------cceeeccccccccc
Q 014904          168 HRDIKAANILLDF-------------------KFEAKVADFGLAKIASDVN---------------THVSTRVMGTFGYL  213 (416)
Q Consensus       168 HrDIkp~NILl~~-------------------~~~~kl~DFGla~~~~~~~---------------~~~~~~~~gt~~Yl  213 (416)
                      ||||||+||||+.                   ++.+|++|||+++......               .......+||+.|+
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999954                   4456666666665321100               00011246888999


Q ss_pred             ChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHH
Q 014904          214 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMAR  293 (416)
Q Consensus       214 aPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  293 (416)
                      |||++.+..++.++|||||||+||||++|..|+.....    .+..    +     ...    ...+..     ......
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~----~-----~~~----~~~~~~-----~~~~~~  240 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSS----L-----RHR----VLPPQI-----LLNWPK  240 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHH----H-----HHh----hcChhh-----hhcCHH
Confidence            99999999999999999999999999998887642110    0000    0     000    011111     011234


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 014904          294 MVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       294 l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ...++.+||+.+|.+||+|.||++
T Consensus       241 ~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        241 EASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHHHhCCCChhhCcChHHHhh
Confidence            567888999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=7e-26  Score=201.81  Aligned_cols=166  Identities=20%  Similarity=0.243  Sum_probs=125.7

Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      |+|.+++...+ ..+++..++.|+.|+++||.|||+.   +      ||+|||++.++.+|+  ||+++......     
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----
Confidence            67888887543 3699999999999999999999998   5      999999999999999  99998765422     


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccC
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHN  284 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~  284 (416)
                       ..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+..+..         +....  ++.. .
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~---------~~~~~--~~~~-~  129 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-SAILEILLN---------GMPAD--DPRD-R  129 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-cHHHHHHHH---------HhccC--Cccc-c
Confidence             25899999999999999999999999999999999999998654321 111111111         00000  0000 0


Q ss_pred             cCCHHHHH--HHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          285 EYNHNEMA--RMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       285 ~~~~~~~~--~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                      ........  .+.+++.+|++.+|.+||++.|+++.+..
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            01112222  68999999999999999999999998863

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=5.4e-24  Score=208.79  Aligned_cols=262  Identities=21%  Similarity=0.229  Sum_probs=198.1

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEeCCC--cEEEEEEeecCCcccHHHHHHHHHHHHhcCC----CcccceEEEE-EeCC
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVLPNG--KEVAIKQLKAGSGQGEREFQAEVEIISRVHH----KHLVSLVGYY-TAGS  113 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~  113 (416)
                      ..+ +|.+.++||+|+||.||++.....  ..+|+|............+..|+.++..+..    +++..+++.. ....
T Consensus        16 ~~~-~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~   94 (322)
T KOG1164|consen   16 VNT-RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED   94 (322)
T ss_pred             ccc-ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence            344 899999999999999999996553  5789888776543333377889999998873    6889999988 4777


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC-----CceEEee
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK-----FEAKVAD  188 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~-----~~~kl~D  188 (416)
                      ..++||+.+ |.+|.++........++..+.+.|+.|++.+|.+||+.   +++||||||.|+++...     -.+.|.|
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            889999977 99999988655556799999999999999999999999   99999999999999765     3589999


Q ss_pred             cccce--eccCCCcc--e-----eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhh
Q 014904          189 FGLAK--IASDVNTH--V-----STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD  259 (416)
Q Consensus       189 FGla~--~~~~~~~~--~-----~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~  259 (416)
                      ||+++  .+......  .     .....||..|.++..+.+...+.+.|+||++.++.|++.|..||.............
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            99998  33222211  1     123559999999999999999999999999999999999999986644322211110


Q ss_pred             hhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          260 WARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      -           .........     .....+..+..+...+-..+...+|....+...|....
T Consensus       251 ~-----------~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~  298 (322)
T KOG1164|consen  251 K-----------DPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF  298 (322)
T ss_pred             H-----------Hhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence            0           000001110     11112345566666666699999999999999987543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=2.3e-24  Score=212.82  Aligned_cols=164  Identities=20%  Similarity=0.208  Sum_probs=128.7

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC--CCcEEEEEEeecCC-----cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP--NGKEVAIKQLKAGS-----GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      +.++|...+.||+|+||.||+|.+.  +++.+|||++....     ....+.|.+|+.++.+++|+|++..+..   ...
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~   92 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK   92 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence            5578999999999999999999854  57788999875331     1123568999999999999999863322   245


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecc-cCCcEEECCCCceEEeecccce
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI-KAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDI-kp~NILl~~~~~~kl~DFGla~  193 (416)
                      .+|||||+++++|... ..     ..   ...++.+++++|.|||+.   +|+|||| ||+|||++.++.+||+|||+++
T Consensus        93 ~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         93 DGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             cEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            7999999999999632 11     11   135788999999999999   9999999 9999999999999999999998


Q ss_pred             eccCCCcce-------eecccccccccChhhhcc
Q 014904          194 IASDVNTHV-------STRVMGTFGYLAPEYASS  220 (416)
Q Consensus       194 ~~~~~~~~~-------~~~~~gt~~YlaPE~~~~  220 (416)
                      .+.......       .+..++++.|+|||++.-
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            765433211       135678999999998843

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=3e-22  Score=190.88  Aligned_cols=259  Identities=28%  Similarity=0.367  Sum_probs=199.3

Q ss_pred             CCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcc---cHHHHHHHHHHHHhcCCC-cccceEEEEEeCCeEEEEEEe
Q 014904           46 FSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQ---GEREFQAEVEIISRVHHK-HLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~  121 (416)
                      |.....||.|+|+.||++...  ..+++|.+......   ....+.+|+.++..+.|+ +++++.+++......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999976  78899998765433   256789999999999988 799999999877778999999


Q ss_pred             cCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC-ceEEeecccceeccCCC
Q 014904          122 VPNNTLEFHLHGKGR-PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKIASDVN  199 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~-~~kl~DFGla~~~~~~~  199 (416)
                      +.++++..++..... ..+.......++.+++.++.|+|+.   +++||||||+||+++... .++++|||+++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966654432 2588889999999999999999999   899999999999999988 79999999998665443


Q ss_pred             cc-----eeecccccccccChhhhcc---CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcc-cchhhhhhhhHHhHHhhh
Q 014904          200 TH-----VSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDSTHTF-VEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       200 ~~-----~~~~~~gt~~YlaPE~~~~---~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~-~~~~l~~~~~~~~~~~~~  270 (416)
                      ..     ......|+..|++||.+.+   .......|+|++|++++++++|..||...... ........        +.
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~--------~~  228 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI--------IL  228 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH--------HH
Confidence            32     2355789999999999987   57899999999999999999999997654421 00111111        11


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ..... .................+.+++..|+..+|..|.++.+....
T Consensus       229 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         229 ELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             hcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            11100 000011111112233578889999999999999999987764

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.3e-24  Score=198.89  Aligned_cols=247  Identities=19%  Similarity=0.283  Sum_probs=193.7

Q ss_pred             cCceecccCcEEEEEEEeCCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCC
Q 014904           48 DANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNN  125 (416)
Q Consensus        48 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~  125 (416)
                      ...+|.+.-.|..|+|.+.. ..+++|+++....  ...++|..|.-.|+...||||..+++.|....++.++..|++.+
T Consensus       194 l~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            34567888899999999954 5567788875432  23368999999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee-eecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          126 TLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII-HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       126 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ii-HrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      +|..++|+......+-.+..+++.++|+|++|||+..  +++ ---+....++||++.+++|.- +-+++...     ..
T Consensus       273 slynvlhe~t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarism-ad~kfsfq-----e~  344 (448)
T KOG0195|consen  273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQ-----EV  344 (448)
T ss_pred             HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheec-ccceeeee-----cc
Confidence            9999999988877888999999999999999999974  444 346899999999998887752 22221111     11


Q ss_pred             cccccccccChhhhccCCCC---chhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          205 RVMGTFGYLAPEYASSGKLT---EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t---~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                      ..+-.+.|++||.++..+-+   ..+|+|||.++||||.|...||....+.+-  -.                 .+.-..
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec--gm-----------------kialeg  405 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC--GM-----------------KIALEG  405 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh--hh-----------------hhhhcc
Confidence            12346889999999876543   579999999999999999999987655111  00                 111123


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      ++...++.....|.+++.-|++.||.+||.+..|+-.||..
T Consensus       406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            44455666777899999999999999999999999999864

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=4.5e-22  Score=186.79  Aligned_cols=203  Identities=23%  Similarity=0.319  Sum_probs=175.6

Q ss_pred             hhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-CCcccceEEEEEeCCeEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  119 (416)
                      .--+|++.++||+|.||.++.|+ +-+++.||||.-...+  ..-++..|....+.|. .++|..++-|..++.+-.||+
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            34589999999999999999999 6789999999754332  2247888999999885 799999999888999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC-----CCceEEeeccccee
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF-----KFEAKVADFGLAKI  194 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~-----~~~~kl~DFGla~~  194 (416)
                      |.+ |.+|+++..-.++ .++..+.+.||.|++.-++|+|++   .+|.|||||+|+||..     ...+.|+|||+|+.
T Consensus       104 dLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            988 9999999876665 699999999999999999999999   9999999999999953     34589999999998


Q ss_pred             ccCCCccee------ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCc
Q 014904          195 ASDVNTHVS------TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHT  251 (416)
Q Consensus       195 ~~~~~~~~~------~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~  251 (416)
                      +-+..++..      ...-||..||+--.+.+...+.+.|+-|||-|++..|-|..||..-..
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            877655432      236799999999999999999999999999999999999999987543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=2.2e-22  Score=185.87  Aligned_cols=177  Identities=13%  Similarity=0.153  Sum_probs=137.3

Q ss_pred             HHHHHH--hhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHH---------HHHHHHHHHhcCCCcccc
Q 014904           36 YEELAR--ATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGERE---------FQAEVEIISRVHHKHLVS  104 (416)
Q Consensus        36 ~~el~~--~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~h~niv~  104 (416)
                      |.||..  ..++|+..++||.|+||.||+... ++..+|||++........+.         +.+|+..+.+++|++|..
T Consensus        21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~   99 (232)
T PRK10359         21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS   99 (232)
T ss_pred             HHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence            444443  468999999999999999999665 67789999998654333322         678999999999999999


Q ss_pred             eEEEEEeC--------CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcE
Q 014904          105 LVGYYTAG--------SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANI  176 (416)
Q Consensus       105 l~~~~~~~--------~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NI  176 (416)
                      +..++...        ...+|||||++|.+|.++..      ++.    ....+++.+|..||+.   +++||||||+||
T Consensus       100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Ni  166 (232)
T PRK10359        100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNF  166 (232)
T ss_pred             ceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHE
Confidence            99886532        35789999999999987732      222    2456899999999999   999999999999


Q ss_pred             EECCCCceEEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHH
Q 014904          177 LLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI  240 (416)
Q Consensus       177 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ell  240 (416)
                      +++.++ ++|+|||...........             -.++....+..++|+|+|||.+..+.
T Consensus       167 li~~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEeCCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999988 999999987654321111             01444455668999999999987665

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=2.4e-23  Score=219.53  Aligned_cols=251  Identities=23%  Similarity=0.234  Sum_probs=184.4

Q ss_pred             CCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCc-ccHHHHHHHHHH--HHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSG-QGEREFQAEVEI--ISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      +|...+.||.+.|=+|.+|.+..|. |+||++-+... -..+.|.++++-  ...++|||.+.+.-........|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            7788899999999999999998887 99999876553 233444443333  4556899999988777777778899999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce--eccCCC
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVN  199 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~--~~~~~~  199 (416)
                      +. .+|.+.+.  .++.+...+...|+.|++.||..+|..   +|+|||||.+||||+.-+-+.|+||..-+  ++++++
T Consensus       103 vk-hnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  103 VK-HNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             Hh-hhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            95 46777773  456788899999999999999999999   99999999999999999999999998765  233333


Q ss_pred             cceeecc----cccccccChhhhccC-----------CCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhH
Q 014904          200 THVSTRV----MGTFGYLAPEYASSG-----------KLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARP  263 (416)
Q Consensus       200 ~~~~~~~----~gt~~YlaPE~~~~~-----------~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~  263 (416)
                      ....+-+    ..-..|+|||-+...           .++++.||||+||+++||++ |+++|..++-.           
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~-----------  245 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL-----------  245 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH-----------
Confidence            3222211    223469999987431           26789999999999999999 78888654321           


Q ss_pred             HhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          264 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       264 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                          +.+.|+ ......-+.. .   +-..+..+++.|++.+|.+|-++.+.++.-.|.
T Consensus       246 ----aYr~~~-~~~~e~~Le~-I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  246 ----AYRSGN-ADDPEQLLEK-I---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             ----hHhccC-ccCHHHHHHh-C---cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence                111221 0000000000 0   012577899999999999999999999886553

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=2e-22  Score=181.78  Aligned_cols=258  Identities=21%  Similarity=0.287  Sum_probs=195.3

Q ss_pred             hhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCC-CcccceEEEEEeCCeEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHH-KHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~  119 (416)
                      ..+.|.++++||.|.||.+|.|. ..+|.+||||+-+.....  -++..|..+...+++ ..|..+..|..+...-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            35789999999999999999999 678999999987654322  367889999999975 78888889999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC---CceEEeecccceecc
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK---FEAKVADFGLAKIAS  196 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~---~~~kl~DFGla~~~~  196 (416)
                      +.+ |.+|+++..-..+ .++..+.+-++-|++.-++|+|..   ++|||||||+|+|+.-+   ..+.++|||+++.+-
T Consensus        91 dLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             ecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            987 9999998864443 688999999999999999999999   89999999999999644   568999999999776


Q ss_pred             CCCc--cee----ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh
Q 014904          197 DVNT--HVS----TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       197 ~~~~--~~~----~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~  270 (416)
                      +..+  |+.    ....||..|.+--.+.+-..+.+.|+-|+|.+|..+.-|..||............+-+   .     
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI---~-----  237 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI---S-----  237 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH---H-----
Confidence            5443  222    3367999999988888778889999999999999999999999875543222222111   0     


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL  319 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L  319 (416)
                      +...... -..+...+    +.++...+.-|=..--++-|...-+-+.+
T Consensus       238 EkK~s~~-ie~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  238 EKKMSTP-IEVLCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             HhhcCCC-HHHHhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence            0000000 01122222    33566666777777777888655444333

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=1.2e-21  Score=177.55  Aligned_cols=140  Identities=16%  Similarity=0.146  Sum_probs=109.5

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEeecCCcc--c-------HH-----------------HHHHHHHHHHhcCCCcc
Q 014904           49 ANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQ--G-------ER-----------------EFQAEVEIISRVHHKHL  102 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~-------~~-----------------~~~~E~~~l~~l~h~ni  102 (416)
                      ...||+|+||.||+|...+|+.||||+++.....  .       ..                 ....|+.++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999879999999999764321  1       01                 12349999999988877


Q ss_pred             cceEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeecccCCcEEECCC
Q 014904          103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL-HEDCHPKIIHRDIKAANILLDFK  181 (416)
Q Consensus       103 v~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~iiHrDIkp~NILl~~~  181 (416)
                      .....+...  ..+|||||++++++...+...  ..+++.....++.|++.+|.+| |+.   +|+||||||+|||++ +
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence            544433222  238999999988776543222  2588899999999999999999 687   999999999999998 4


Q ss_pred             CceEEeecccceecc
Q 014904          182 FEAKVADFGLAKIAS  196 (416)
Q Consensus       182 ~~~kl~DFGla~~~~  196 (416)
                      +.++|+|||++....
T Consensus       154 ~~v~LiDFG~a~~~~  168 (190)
T cd05147         154 GKLYIIDVSQSVEHD  168 (190)
T ss_pred             CcEEEEEccccccCC
Confidence            789999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=2.7e-22  Score=210.28  Aligned_cols=253  Identities=21%  Similarity=0.247  Sum_probs=186.9

Q ss_pred             CcCceecccCcEEEEEEEe-CCCcEEEEEEeecC--CcccHH----HHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           47 SDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAG--SGQGER----EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        47 ~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~----~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ...+++|.|.+|.|+.... ...+..+.|.+...  .....+    .+..|+-+-..++|+|++..+..+.+......+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4567899999998877773 23444444443311  111111    2556888888899999988777776666666669


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      |||++ +|..++...+  .+....+..+..|++.|+.|+|..   +|.|||+|++|+++..++.+||+|||.+..+.-..
T Consensus       401 E~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            99999 8888886653  477778888999999999999999   99999999999999999999999999987654332


Q ss_pred             ---cceeecccccccccChhhhccCCCCc-hhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          200 ---THVSTRVMGTFGYLAPEYASSGKLTE-KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       200 ---~~~~~~~~gt~~YlaPE~~~~~~~t~-ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                         .+.....+|+..|+|||.+....|.+ ..||||.|+++..|++|+.||...........            ......
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~------------~~~~~~  542 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK------------TNNYSD  542 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh------------hhcccc
Confidence               25566788999999999999888876 68999999999999999999987654222110            000111


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      +.....-........+.+...++.++|+.+|.+|-+|.+|++
T Consensus       543 ~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  543 QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            111111112223445678889999999999999999999985

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=1.9e-20  Score=169.75  Aligned_cols=140  Identities=16%  Similarity=0.117  Sum_probs=112.0

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEeecCCccc--------------------------HHHHHHHHHHHHhcCCCcc
Q 014904           49 ANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQG--------------------------EREFQAEVEIISRVHHKHL  102 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni  102 (416)
                      ...||+|++|.||+|.+.+|+.||||+++......                          ...+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46899999999999997789999999998653210                          1124578999999999988


Q ss_pred             cceEEEEEeCCeEEEEEEecCCCCHHHH-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeecccCCcEEECC
Q 014904          103 VSLVGYYTAGSQRMLVYEFVPNNTLEFH-LHGKGRPTMDWLTRLKIALGSAKGLAYLHE-DCHPKIIHRDIKAANILLDF  180 (416)
Q Consensus       103 v~l~~~~~~~~~~~lV~e~~~~~sL~~~-l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiHrDIkp~NILl~~  180 (416)
                      .....+....  .+|||||++++++... +..   ..++......++.+++.++.+||. .   +|+||||||.|||++ 
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence            6555444332  4899999998855433 322   246778889999999999999999 7   999999999999998 


Q ss_pred             CCceEEeecccceeccC
Q 014904          181 KFEAKVADFGLAKIASD  197 (416)
Q Consensus       181 ~~~~kl~DFGla~~~~~  197 (416)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            88999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=4.7e-20  Score=167.34  Aligned_cols=188  Identities=16%  Similarity=0.090  Sum_probs=143.1

Q ss_pred             CCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccH----HHHHHHHHHHHhcC-CCcccceEEEEEeCCeEEEEEE
Q 014904           46 FSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGE----REFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~----~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      +.....|+.|+||+||.+.. .+.+++.+.+........    ..+.+|+.+|.++. |+++++++++    ...+++||
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            34567899999999997766 677888787775443222    25789999999995 5889999886    34689999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecc-cCCcEEECCCCceEEeecccceeccCCC
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI-KAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDI-kp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      |+.|.+|...+..         ....++.+++.+|.++|+.   +|+|||| ||.|||++.++.++|+|||++.......
T Consensus        79 yI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         79 YLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             eecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            9999998754321         1134678899999999999   9999999 7999999999999999999998655433


Q ss_pred             cc----e--------eecccccccccChhhhccC-CCC-chhhhHhHHHHHHHHHhCCCCCCCCC
Q 014904          200 TH----V--------STRVMGTFGYLAPEYASSG-KLT-EKSDVFSFGVMLLELITGRRPVDSTH  250 (416)
Q Consensus       200 ~~----~--------~~~~~gt~~YlaPE~~~~~-~~t-~ksDV~SlGvvL~elltG~~pf~~~~  250 (416)
                      ..    .        ..-...++.|++|+...-- ..+ ...+.++-|..+|.++|++.+.....
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            21    0        1113468889999865322 223 57899999999999999998876544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.83  E-value=5.9e-20  Score=174.66  Aligned_cols=232  Identities=19%  Similarity=0.276  Sum_probs=150.9

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCC----------CcccceEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHH----------KHLVSLVGYYT  110 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~  110 (416)
                      .+.....||.|+++.||.+++. +|+++|||++.....   ...+.+++|.-.+..+.+          -.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3445678999999999999965 599999999864432   223466666655555322          12222222221


Q ss_pred             ---------eCC--------eEEEEEEecCCCCHHHHhhc---C--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 014904          111 ---------AGS--------QRMLVYEFVPNNTLEFHLHG---K--GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH  168 (416)
Q Consensus       111 ---------~~~--------~~~lV~e~~~~~sL~~~l~~---~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH  168 (416)
                               ...        ..+++|+-+ -++|..++..   .  ....+....++.+..|+++.+++||..   +++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence                     111        236677766 5677766532   1  122355677788889999999999999   9999


Q ss_pred             ecccCCcEEECCCCceEEeecccceeccCCCcceeecccccccccChhhhcc--------CCCCchhhhHhHHHHHHHHH
Q 014904          169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS--------GKLTEKSDVFSFGVMLLELI  240 (416)
Q Consensus       169 rDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~--------~~~t~ksDV~SlGvvL~ell  240 (416)
                      +||+|+|++++.+|.++|+||+.....+.....    ...+..|.+||....        -.++.+.|.|+||+++|.|+
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999999887665432211    345677999997643        25789999999999999999


Q ss_pred             hCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCC
Q 014904          241 TGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRR  309 (416)
Q Consensus       241 tG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R  309 (416)
                      +++.||+...+...   ..|                     .-..+. +.++.+..|+..+|+.+|++|
T Consensus       245 C~~lPf~~~~~~~~---~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEAD---PEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGST---SGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCcccc---ccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999987643111   111                     112345 667789999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=1.6e-19  Score=193.78  Aligned_cols=250  Identities=20%  Similarity=0.226  Sum_probs=184.6

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC---CCcccceEEEEEeCCe
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH---HKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~  114 (416)
                      ++..--..|.+.+.||+|+||.||+|...+|+.||+|+-++...++   |.-=.+++.||+   -+.|..+...+.-.+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            4444556788899999999999999998889999999999888773   222234444454   2344555555555667


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC-------CCceEEe
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF-------KFEAKVA  187 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~-------~~~~kl~  187 (416)
                      .+||+||.+-|+|.+++.  ....++|...+.++.++++.+.+||..   +|||+||||+|+||..       +.-++|+
T Consensus       769 S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             ceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence            789999999999999997  445799999999999999999999999   9999999999999943       3458999


Q ss_pred             ecccce---eccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH
Q 014904          188 DFGLAK---IASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL  264 (416)
Q Consensus       188 DFGla~---~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~  264 (416)
                      |||.+-   ++.+.  .....+++|-++-.+|...+..|+...|.|.|+.+++-||.|+..=                  
T Consensus       844 DfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------  903 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------  903 (974)
T ss_pred             ecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------
Confidence            999975   33333  2345578899999999999999999999999999999999986531                  


Q ss_pred             hHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          265 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       265 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                          ..+|.. ..++.++..-+..+...+   +...+|+.+-..=|...++...|++..
T Consensus       904 ----~~~g~~-~~~~~~~~Ry~~~~~W~~---~F~~lLN~~~~~~p~l~~lr~~~~~~~  954 (974)
T KOG1166|consen  904 ----VKNGSS-WMVKTNFPRYWKRDMWNK---FFDLLLNPDCDTLPNLQELRTELEEVL  954 (974)
T ss_pred             ----hcCCcc-eeccccchhhhhHHHHHH---HHHHHhCcCcccchhHHHHHHHHHHHH
Confidence                112222 222332222223333333   444445566666777777777777643

>PRK10345 hypothetical protein; Provisional

Probab=99.80  E-value=1e-18  Score=160.45  Aligned_cols=137  Identities=20%  Similarity=0.253  Sum_probs=107.3

Q ss_pred             CCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-----CCCcccceEEEEEeCC---e-EE
Q 014904           46 FSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-----HHKHLVSLVGYYTAGS---Q-RM  116 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~  116 (416)
                      .....+||+|+||.||.  ++.....+||++........+.+.+|+.+++.+     .||||+++++++.++.   . ..
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34567999999999996  443333479988765444567899999999999     5799999999998863   3 34


Q ss_pred             EEEEe--cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeeecccCCcEEECC----CCceEEee-
Q 014904          117 LVYEF--VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGL-AYLHEDCHPKIIHRDIKAANILLDF----KFEAKVAD-  188 (416)
Q Consensus       117 lV~e~--~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL-~~LH~~~~~~iiHrDIkp~NILl~~----~~~~kl~D-  188 (416)
                      +|+||  +++++|.+++...   .++..  ..++.+++.++ +|||+.   +|+||||||+|||++.    ++.++|+| 
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            78999  5679999999653   25544  35577888777 999999   9999999999999974    34799999 


Q ss_pred             cccc
Q 014904          189 FGLA  192 (416)
Q Consensus       189 FGla  192 (416)
                      ||..
T Consensus       154 ~G~~  157 (210)
T PRK10345        154 IGES  157 (210)
T ss_pred             CCCc
Confidence            5543

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=4.3e-19  Score=178.98  Aligned_cols=214  Identities=23%  Similarity=0.422  Sum_probs=163.0

Q ss_pred             HHhcCCCcccceEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-eeeccc
Q 014904           94 ISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI-IHRDIK  172 (416)
Q Consensus        94 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i-iHrDIk  172 (416)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... ...++|.....++.++++||.|||..   .| .|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence            35678999999999999999999999999999999999763 34799999999999999999999987   44 999999


Q ss_pred             CCcEEECCCCceEEeecccceeccCC-CcceeecccccccccChhhhccC-------CCCchhhhHhHHHHHHHHHhCCC
Q 014904          173 AANILLDFKFEAKVADFGLAKIASDV-NTHVSTRVMGTFGYLAPEYASSG-------KLTEKSDVFSFGVMLLELITGRR  244 (416)
Q Consensus       173 p~NILl~~~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~YlaPE~~~~~-------~~t~ksDV~SlGvvL~elltG~~  244 (416)
                      ..|+++|..+.+||+|||+.....+. .........-..-|.|||.+...       ..+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998766431 00111112234569999998653       15778999999999999999999


Q ss_pred             CCCCCCcccc-hhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          245 PVDSTHTFVE-DSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       245 pf~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      ||+......+ +.++.+        ++. .......|.+....  +....+..++..||..+|.+||++.+|-..++..
T Consensus       157 ~~~~~~~~~~~~eii~~--------~~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILR--------VKK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             ccccccccCChHHHHHH--------HHh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            9987443222 222222        122 11122233332111  3334799999999999999999999999888743

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=3.1e-18  Score=157.28  Aligned_cols=134  Identities=22%  Similarity=0.323  Sum_probs=114.8

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEeecCCccc--------HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           50 NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQG--------EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ++||+|++|.||+|.. .|..++||+........        ...+..|+.++..+.|+++.....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999998 67789999876433211        13577899999999999998888888777888999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      ++|.+|.+++....     + .+..++.+++.+|.+||+.   +++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999886432     2 7889999999999999999   999999999999999 78899999999865

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=2.7e-18  Score=161.03  Aligned_cols=142  Identities=15%  Similarity=0.144  Sum_probs=111.5

Q ss_pred             CCCcCceecccCcEEEEEEE--eCCCcEEEEEEeecCCcc------------------------cHHHHHHHHHHHHhcC
Q 014904           45 GFSDANLLGQGGFGYVHRGV--LPNGKEVAIKQLKAGSGQ------------------------GEREFQAEVEIISRVH   98 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~   98 (416)
                      .|.+.+.||+|+||.||+|.  ..+|+.||||++......                        ....+..|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998  568999999998754211                        0123568999999997


Q ss_pred             CCc--ccceEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeecccCCc
Q 014904           99 HKH--LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK-IIHRDIKAAN  175 (416)
Q Consensus        99 h~n--iv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~-iiHrDIkp~N  175 (416)
                      +.+  +.+++++    ...++||||+++.+|...+....  .+.......++.+++.+|.+||+.   + |+||||||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence            633  3344443    23579999999988876543222  355566778999999999999999   8 9999999999


Q ss_pred             EEECCCCceEEeecccceecc
Q 014904          176 ILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       176 ILl~~~~~~kl~DFGla~~~~  196 (416)
                      |+++ ++.++|+|||.+....
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccC
Confidence            9999 8899999999987543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.77  E-value=9.8e-20  Score=184.03  Aligned_cols=225  Identities=28%  Similarity=0.318  Sum_probs=175.7

Q ss_pred             eecccCcEEEEEEE----eCCCcEEEEEEeecCCcccH--HHHHHHHHHHHhcC-CCcccceEEEEEeCCeEEEEEEecC
Q 014904           51 LLGQGGFGYVHRGV----LPNGKEVAIKQLKAGSGQGE--REFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        51 ~LG~G~~g~Vy~~~----~~~g~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      .+|+|.||.|++..    ...|+.+|+|++++......  .....|-.++..++ ||.+|++.-.+......+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999765    33578899999876532211  13456778888887 9999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      ++.|...+...  ..++..........++-+++++|+.   +|+|||+|++||+++.+|.+++.|||+.+..-+....  
T Consensus        81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--  153 (612)
T KOG0603|consen   81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--  153 (612)
T ss_pred             cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence            99887766443  3566777777788899999999999   9999999999999999999999999999876543332  


Q ss_pred             ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcccc
Q 014904          204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLH  283 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~  283 (416)
                         +||..|+|||++.  .....+|.||||++.+||+||..||...          -...++               +..
T Consensus       154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----------~~~~Il---------------~~~  203 (612)
T KOG0603|consen  154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----------TMKRIL---------------KAE  203 (612)
T ss_pred             ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----------HHHHHh---------------hhc
Confidence               7999999999998  4578999999999999999999999760          000010               111


Q ss_pred             CcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 014904          284 NEYNHNEMARMVACAAACVRHSARRRPRM  312 (416)
Q Consensus       284 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  312 (416)
                      ...+.+.......++..++..+|..|--.
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            23344455566777788888888888755

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=6.5e-18  Score=176.75  Aligned_cols=148  Identities=19%  Similarity=0.263  Sum_probs=120.6

Q ss_pred             ccCHHHHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCC-c-------ccHHHHHHHHHHHHhcCCCcccc
Q 014904           33 TFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGS-G-------QGEREFQAEVEIISRVHHKHLVS  104 (416)
Q Consensus        33 ~f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~-~-------~~~~~~~~E~~~l~~l~h~niv~  104 (416)
                      .+++.........|...++||+|+||.||+|.+.... +++|+..... .       .....+..|+.++..++|++++.
T Consensus       322 ~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~  400 (535)
T PRK09605        322 EVTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT  400 (535)
T ss_pred             eeeeccccccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCe
Confidence            3556666667777888999999999999999975443 4444432211 1       11245789999999999999999


Q ss_pred             eEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCce
Q 014904          105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA  184 (416)
Q Consensus       105 l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~  184 (416)
                      ...++......++||||+++++|.+++.          .+..++.+++++|.+||+.   +++||||||+|||+ .++.+
T Consensus       401 p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~  466 (535)
T PRK09605        401 PVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRL  466 (535)
T ss_pred             eEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcE
Confidence            8888888778899999999999998875          3567899999999999999   99999999999999 67799


Q ss_pred             EEeecccceec
Q 014904          185 KVADFGLAKIA  195 (416)
Q Consensus       185 kl~DFGla~~~  195 (416)
                      +|+|||+++..
T Consensus       467 ~liDFGla~~~  477 (535)
T PRK09605        467 YLIDFGLGKYS  477 (535)
T ss_pred             EEEeCcccccC
Confidence            99999998753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=7.4e-18  Score=153.38  Aligned_cols=131  Identities=21%  Similarity=0.317  Sum_probs=108.9

Q ss_pred             eecccCcEEEEEEEeCCCcEEEEEEeecCCcc--------cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           51 LLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQ--------GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        51 ~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      +||+|+||.||+|.+ ++..+++|+.......        ...++.+|+.++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999995 6788999986643211        1245778999999999988776666666777789999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      +|++|.+++.....         .++.+++.+|.+||+.   +++|+|++|.||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999988754311         7899999999999999   999999999999999 789999999998653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=8.4e-18  Score=153.33  Aligned_cols=146  Identities=18%  Similarity=0.146  Sum_probs=114.5

Q ss_pred             HHHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcc----------------------cHHHHHHHHHHH
Q 014904           37 EELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQ----------------------GEREFQAEVEII   94 (416)
Q Consensus        37 ~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~----------------------~~~~~~~E~~~l   94 (416)
                      .++.+.-..|.+.+.||+|+||.||++...+|+.||||++......                      ....+..|..++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            4555555568889999999999999999888999999987643210                      011356788899


Q ss_pred             HhcCCCc--ccceEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccc
Q 014904           95 SRVHHKH--LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIK  172 (416)
Q Consensus        95 ~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIk  172 (416)
                      ..+.|.+  +..+++.    ...++||||+++++|..+...        .....++.+++.++.++|+.   +|+|||||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~  152 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLS  152 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence            9988774  4444432    345899999999998765431        23457888999999999998   99999999


Q ss_pred             CCcEEECCCCceEEeecccceeccC
Q 014904          173 AANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       173 p~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      |.||+++.++.++|+|||++.....
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.71  E-value=3.2e-18  Score=170.13  Aligned_cols=171  Identities=24%  Similarity=0.357  Sum_probs=129.1

Q ss_pred             eEEEEEEecCCCCHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccc
Q 014904          114 QRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA  192 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla  192 (416)
                      .+++.|++|.-.+|++||... .....++...+.++.|++.|+.|   +   +.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999743 34467889999999999999999   5   8999999999999999999999999998


Q ss_pred             eeccCCC-----cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhH
Q 014904          193 KIASDVN-----THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLN  266 (416)
Q Consensus       193 ~~~~~~~-----~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~  266 (416)
                      .......     ....+...||..|++||.+.+..|+.|+|||+||++|+||+. =...|....              ..
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~--------------t~  469 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA--------------TL  469 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH--------------hh
Confidence            7554433     222355689999999999999999999999999999999997 222221111              11


Q ss_pred             HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 014904          267 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMS  313 (416)
Q Consensus       267 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~  313 (416)
                      .-+++|.+.    |....+++     .-..++.+++...|.+||++.
T Consensus       470 ~d~r~g~ip----~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  470 TDIRDGIIP----PEFLQDYP-----EEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             hhhhcCCCC----hHHhhcCc-----HHHHHHHHhcCCCcccCchHH
Confidence            112233322    11112222     235788999999999999443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=4.4e-16  Score=133.49  Aligned_cols=135  Identities=20%  Similarity=0.131  Sum_probs=115.2

Q ss_pred             cCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCC--CcccceEEEEEeCCeEEEEEEecCCC
Q 014904           48 DANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHH--KHLVSLVGYYTAGSQRMLVYEFVPNN  125 (416)
Q Consensus        48 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~~  125 (416)
                      +.+.||+|.++.||++...+ +.+++|.......  ...+..|+.++..++|  .++++++.++...+..++++||+++.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999854 7899999875443  4578899999999976  58899999888888899999999888


Q ss_pred             CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          126 TLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       126 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      .+..+         +......++.+++++|++||.....+++|+|++|.||+++..+.++++|||.+..
T Consensus        79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543         5567778899999999999987555799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.68  E-value=4.1e-16  Score=149.98  Aligned_cols=196  Identities=21%  Similarity=0.248  Sum_probs=136.4

Q ss_pred             CCCcccceEEEEEe---------------------------CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 014904           98 HHKHLVSLVGYYTA---------------------------GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG  150 (416)
Q Consensus        98 ~h~niv~l~~~~~~---------------------------~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~  150 (416)
                      +|||||+++++|.+                           ...+|+||.-. ..+|..++-..   ..+...+.-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence            59999999887744                           23567888765 45777777544   3555566778899


Q ss_pred             HHHHHHHHHhcCCCCeeeecccCCcEEE--CCCC--ceEEeecccceeccCCCcce---e--ecccccccccChhhhccC
Q 014904          151 SAKGLAYLHEDCHPKIIHRDIKAANILL--DFKF--EAKVADFGLAKIASDVNTHV---S--TRVMGTFGYLAPEYASSG  221 (416)
Q Consensus       151 ia~aL~~LH~~~~~~iiHrDIkp~NILl--~~~~--~~kl~DFGla~~~~~~~~~~---~--~~~~gt~~YlaPE~~~~~  221 (416)
                      +++|+.|||++   +|.|||+|.+||||  |++.  .+.|+|||++.-.....-..   +  -..-|....+|||++...
T Consensus       350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            99999999999   99999999999999  3333  36899999875332211111   1  113466778999998543


Q ss_pred             C-----C-CchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHH
Q 014904          222 K-----L-TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMV  295 (416)
Q Consensus       222 ~-----~-t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  295 (416)
                      +     + =.|+|.|+.|.+.||+++.+.||..... .-.              +...+++---|.+..    .++..+.
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L--------------~~r~Yqe~qLPalp~----~vpp~~r  487 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLL--------------DTRTYQESQLPALPS----RVPPVAR  487 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccch-hee--------------chhhhhhhhCCCCcc----cCChHHH
Confidence            2     1 2589999999999999999999976322 111              111222222233333    3445788


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHh
Q 014904          296 ACAAACVRHSARRRPRMSQIVRAL  319 (416)
Q Consensus       296 ~l~~~cl~~~p~~RPt~~evv~~L  319 (416)
                      +++...++.+|.+|++..-....|
T Consensus       488 qlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  488 QLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHHHhcCCccccCCccHHHhHH
Confidence            899999999999999887665555

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.67  E-value=5.2e-16  Score=139.70  Aligned_cols=137  Identities=18%  Similarity=0.198  Sum_probs=99.0

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEeecCCcccH--HH----------------------HHHHHHHHHhcCCCc--c
Q 014904           49 ANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGE--RE----------------------FQAEVEIISRVHHKH--L  102 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~--~~----------------------~~~E~~~l~~l~h~n--i  102 (416)
                      .+.||+|+||.||+|...+++.||||++........  ..                      ...|...+.++.+.+  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            468999999999999987899999999875432111  11                      135666666665443  3


Q ss_pred             cceEEEEEeCCeEEEEEEecCCCCHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeecccCCcEEECC
Q 014904          103 VSLVGYYTAGSQRMLVYEFVPNNTLEF-HLHGKGRPTMDWLTRLKIALGSAKGLAYLHE-DCHPKIIHRDIKAANILLDF  180 (416)
Q Consensus       103 v~l~~~~~~~~~~~lV~e~~~~~sL~~-~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiHrDIkp~NILl~~  180 (416)
                      .+++++    ...++||||++++.+.. .+....   .. .....++.+++.++.++|. .   +|+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence            444433    24689999999854321 111110   11 5667899999999999999 7   999999999999999 


Q ss_pred             CCceEEeecccceeccC
Q 014904          181 KFEAKVADFGLAKIASD  197 (416)
Q Consensus       181 ~~~~kl~DFGla~~~~~  197 (416)
                      ++.++|+|||.+.....
T Consensus       150 ~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CCcEEEEECcccccccC
Confidence            88999999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=9.1e-17  Score=170.13  Aligned_cols=210  Identities=22%  Similarity=0.292  Sum_probs=143.5

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      -.+|..+++|..|.+|.||...++ ..+++|+|+ +++..    -+++   ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----ilRn---ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----ILRN---ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----hhhc---cccccCCccee------------------
Confidence            468999999999999999999865 478888843 32211    0111   33333444433                  


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC---
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV---  198 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~---  198 (416)
                         |+-...+...+  .++..        ++.+++|||..   +|+|||+||.|.+|+.=|.+|+.|||+.+.....   
T Consensus       136 ---gDc~tllk~~g--~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG--PLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ---chhhhhcccCC--CCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence               22233333222  23322        27789999999   9999999999999999999999999998743211   


Q ss_pred             ---------Ccc--eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHH
Q 014904          199 ---------NTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNR  267 (416)
Q Consensus       199 ---------~~~--~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~  267 (416)
                               .++  ....++||+.|.|||++....|...+|+|++|+++||.+-|+.||+...+.   .|..-+   +..
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe---elfg~v---isd  273 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQV---ISD  273 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH---HHHhhh---hhh
Confidence                     011  123478999999999999999999999999999999999999999887551   111111   100


Q ss_pred             hhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 014904          268 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRM  312 (416)
Q Consensus       268 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  312 (416)
                         +..+         .+-+...+.+..+++...|+.+|..|--.
T Consensus       274 ---~i~w---------pE~dea~p~Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  274 ---DIEW---------PEEDEALPPEAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             ---hccc---------cccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence               0111         11122233567889999999999999733

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=4.4e-15  Score=139.49  Aligned_cols=136  Identities=19%  Similarity=0.229  Sum_probs=105.8

Q ss_pred             Cceec-ccCcEEEEEEEeCCCcEEEEEEeecCC-------------cccHHHHHHHHHHHHhcCCCcc--cceEEEEEeC
Q 014904           49 ANLLG-QGGFGYVHRGVLPNGKEVAIKQLKAGS-------------GQGEREFQAEVEIISRVHHKHL--VSLVGYYTAG  112 (416)
Q Consensus        49 ~~~LG-~G~~g~Vy~~~~~~g~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  112 (416)
                      ...|| .||.|+||+.... +..++||.+....             ......+.+|+.++.++.|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35688 8999999999884 6789999885321             1223467889999999998885  6677765432


Q ss_pred             C----eEEEEEEecCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEe
Q 014904          113 S----QRMLVYEFVPN-NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA  187 (416)
Q Consensus       113 ~----~~~lV~e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~  187 (416)
                      .    ..++|+|++++ .+|.+++...   .++..    .+.+++.+|.+||+.   +|+||||||.|||++.++.++|+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence            2    23599999997 6898887542   34433    356899999999999   99999999999999998899999


Q ss_pred             ecccceec
Q 014904          188 DFGLAKIA  195 (416)
Q Consensus       188 DFGla~~~  195 (416)
                      |||.+...
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99988653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=4.3e-16  Score=163.65  Aligned_cols=254  Identities=20%  Similarity=0.275  Sum_probs=185.1

Q ss_pred             CCCcCceecccCcEEEEEEEeCC--CcEEEEEEeecCC--cccHHHHHHHHHHHHhcC-CCcccceEEEEEeCCeEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLPN--GKEVAIKQLKAGS--GQGEREFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~~--g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  119 (416)
                      .|...+.||+|.|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++.+++...+....+++.
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            45555669999999998887533  3455666555433  111233445777777776 999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeeecccCCcEEECCCC-ceEEeecccceeccC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH-EDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKIASD  197 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH-~~~~~~iiHrDIkp~NILl~~~~-~~kl~DFGla~~~~~  197 (416)
                      ++..++.+...+........+-...-....|+..++.|+| ..   ++.|+||||+|.+++..+ ..+++|||+|..+..
T Consensus       101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            9999999988873222223444555678899999999999 76   899999999999999999 999999999987766


Q ss_pred             -CC-cceeecccc-cccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          198 -VN-THVSTRVMG-TFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       198 -~~-~~~~~~~~g-t~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                       .+ ........| ++.|.|||...+ ....+..|+||.|+++.-+++|..|++...... .....|...       .+.
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~-------~~~  249 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSN-------KGR  249 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeeccc-------ccc
Confidence             22 333345678 999999999887 456789999999999999999999987755422 222222210       000


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      +        .............++..+++..+|..|.+.+++..
T Consensus       250 ~--------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  250 F--------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             c--------ccCccccCChhhhhcccccccCCchhccccccccc
Confidence            0        01111223345677888888899999998887653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.51  E-value=7.3e-14  Score=142.26  Aligned_cols=144  Identities=25%  Similarity=0.295  Sum_probs=100.9

Q ss_pred             CCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCccc----------------------------------------H
Q 014904           45 GFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQG----------------------------------------E   84 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~----------------------------------------~   84 (416)
                      .|. .+.||.|++|.||+|++.+|+.||||+..+.....                                        +
T Consensus       119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E  197 (437)
T TIGR01982       119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE  197 (437)
T ss_pred             hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence            444 36899999999999999999999999987542110                                        0


Q ss_pred             HHHHHHHHHHHhcC-----CCcccceEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHH
Q 014904           85 REFQAEVEIISRVH-----HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAK-GLAYL  158 (416)
Q Consensus        85 ~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~-aL~~L  158 (416)
                      -+|..|+..+.++.     ++++.-..-|....+..+|||||++|.+|.++...... ..   .+..++..++. .+..+
T Consensus       198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQV  273 (437)
T ss_pred             HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHH
Confidence            02444555555552     23332222222234557899999999999887643211 12   23456666665 46788


Q ss_pred             HhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       159 H~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      |..   +++|+|+||.||+++.++.++++|||++....
T Consensus       274 ~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       274 LRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            888   99999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.37  E-value=2.3e-12  Score=113.74  Aligned_cols=130  Identities=19%  Similarity=0.095  Sum_probs=96.5

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCccc-ceEEEEEeCCeEEEEEEecCCCCH
Q 014904           49 ANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV-SLVGYYTAGSQRMLVYEFVPNNTL  127 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~~sL  127 (416)
                      .+.|+.|.++.||++... ++.+++|+...... ....+..|+.++..+.+.+++ +++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            457889999999999874 77899999765432 123467899999998765554 455443  3345799999999887


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          128 EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC--HPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       128 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ....       .   ....++.+++++|+.||...  ...++|+|++|.||+++ ++.++++||+.+.
T Consensus        79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            5430       1   11245678999999999983  22369999999999998 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.36  E-value=1.4e-12  Score=132.34  Aligned_cols=246  Identities=22%  Similarity=0.268  Sum_probs=177.7

Q ss_pred             CCCcCceecc--cCcEEEEEEEe---CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEE
Q 014904           45 GFSDANLLGQ--GGFGYVHRGVL---PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        45 ~f~~~~~LG~--G~~g~Vy~~~~---~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  116 (416)
                      .|.....+|.  |.+|.||.+..   .++..+|+|.-+...  .+....=.+|+.....+ .|+|.++....+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4566778999  99999999885   357889999854332  22222334567666677 4999999888899999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeeecccCCcEEECCC-CceEEeeccc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAK----GLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGL  191 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~----aL~~LH~~~~~~iiHrDIkp~NILl~~~-~~~kl~DFGl  191 (416)
                      +-.|.+ +.+|..+.+.... .++....+.+..+...    ||.++|..   .++|-|+||.||++..+ ..++++|||+
T Consensus       195 iqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcce
Confidence            999988 5788888776543 4666666777777777    99999999   99999999999999999 8899999999


Q ss_pred             ceeccCCCcc----eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHH
Q 014904          192 AKIASDVNTH----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNR  267 (416)
Q Consensus       192 a~~~~~~~~~----~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~  267 (416)
                      .....+.+-.    ...+..|...|++||... +-++.+.|||+||.++++..++-........      ..|..     
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~-----  337 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQ-----  337 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC------CCccc-----
Confidence            9877665422    223446788899999876 5789999999999999999997765433210      11221     


Q ss_pred             hhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 014904          268 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIV  316 (416)
Q Consensus       268 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv  316 (416)
                       ++.+.        +..++-..-...+...+..+++.++..|++...+.
T Consensus       338 -~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  338 -LRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             -ccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence             11111        11111111123445588899999999999877655

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=7e-13  Score=125.23  Aligned_cols=203  Identities=20%  Similarity=0.303  Sum_probs=139.1

Q ss_pred             HHHHHHHhcCCCcccceEEEEEeC-----CeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 014904           89 AEVEIISRVHHKHLVSLVGYYTAG-----SQRMLVYEFVPNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHED  161 (416)
Q Consensus        89 ~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~  161 (416)
                      .-+.-|-++.|.|||+++.|+.+.     ....++.||+..+++..+|+..  ....+......+|+.||..||.|||. 
T Consensus       116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-  194 (458)
T KOG1266|consen  116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-  194 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-
Confidence            344556677899999999998653     3468999999999999999743  33457777778899999999999998 


Q ss_pred             CCCCeeeecccCCcEEECCCCceEEeecccceeccCC-C---cceeecccccccccChhhhccCCCCchhhhHhHHHHHH
Q 014904          162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV-N---THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLL  237 (416)
Q Consensus       162 ~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~-~---~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~  237 (416)
                      |.|.|+|+++.-+.|++..++-+|+.- +........ +   .....+-.+-++|.+||+=..-+.+-.+|||+||.-.+
T Consensus       195 ~~PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl  273 (458)
T KOG1266|consen  195 CDPPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL  273 (458)
T ss_pred             cCCccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence            688999999999999999998888742 221111100 0   00111234678999999987778889999999999999


Q ss_pred             HHHhCCCCC-CCCC-cccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 014904          238 ELITGRRPV-DSTH-TFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQI  315 (416)
Q Consensus       238 elltG~~pf-~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev  315 (416)
                      ||.-+.--- .... ...+..+..             .+..+-++            +-..++..|++..|..||+|+++
T Consensus       274 emailEiq~tnseS~~~~ee~ia~-------------~i~~len~------------lqr~~i~kcl~~eP~~rp~ar~l  328 (458)
T KOG1266|consen  274 EMAILEIQSTNSESKVEVEENIAN-------------VIIGLENG------------LQRGSITKCLEGEPNGRPDARLL  328 (458)
T ss_pred             HHHHheeccCCCcceeehhhhhhh-------------heeeccCc------------cccCcCcccccCCCCCCcchhhh
Confidence            998764321 1100 001111100             00000000            12346678999999999999998


Q ss_pred             HHH
Q 014904          316 VRA  318 (416)
Q Consensus       316 v~~  318 (416)
                      +..
T Consensus       329 lfH  331 (458)
T KOG1266|consen  329 LFH  331 (458)
T ss_pred             hcC
Confidence            743

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.35  E-value=3.4e-11  Score=123.53  Aligned_cols=166  Identities=20%  Similarity=0.263  Sum_probs=128.8

Q ss_pred             eCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHH
Q 014904           65 LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR  144 (416)
Q Consensus        65 ~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~  144 (416)
                      ..++.+|.|...+...........+-+..|+.++||||++++..+......|||+|-+  ..|...+...+     -...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~v  106 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEEV  106 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHHH
Confidence            4578899999988766533345778889999999999999999999999999999987  46666665433     4455


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeecccccccccChhhhccCCCC
Q 014904          145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT  224 (416)
Q Consensus       145 ~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t  224 (416)
                      ...+.||+.||.+||+.|  +++|++|.-..|+|+..|+.||++|.++......+. ......--..|..|+.+....  
T Consensus       107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--  181 (690)
T ss_pred             HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence            667889999999999888  999999999999999999999999998765443322 111112233467777553222  


Q ss_pred             chhhhHhHHHHHHHHHhC
Q 014904          225 EKSDVFSFGVMLLELITG  242 (416)
Q Consensus       225 ~ksDV~SlGvvL~elltG  242 (416)
                      -..|.|.||++++|++.|
T Consensus       182 ~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cchhhhhHHHHHHHHhCc
Confidence            456999999999999998

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.33  E-value=3.2e-12  Score=132.19  Aligned_cols=146  Identities=20%  Similarity=0.246  Sum_probs=96.1

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCC-CcEEEEEEeecCCccc----------------------------------H--
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQG----------------------------------E--   84 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~----------------------------------~--   84 (416)
                      ....|.. +.||.|.+|.||+|++++ |+.||||++.+.-...                                  .  
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3456776 789999999999999877 9999999997542110                                  0  


Q ss_pred             ----HHHHHHHHHHHhcC----CCcccceEEEEEe-CCeEEEEEEecCCCCHHHHh--hcCCCCCCCHHHHHHHHHHHHH
Q 014904           85 ----REFQAEVEIISRVH----HKHLVSLVGYYTA-GSQRMLVYEFVPNNTLEFHL--HGKGRPTMDWLTRLKIALGSAK  153 (416)
Q Consensus        85 ----~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~e~~~~~sL~~~l--~~~~~~~l~~~~~~~i~~~ia~  153 (416)
                          -+|..|+..+.+++    +.+.+.+-..+.+ .+..+|||||+.|+.+.++.  ...+   .+...   ++...+.
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d~~~---la~~~v~  270 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TDMKL---LAERGVE  270 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CCHHH---HHHHHHH
Confidence                12444555555552    3333433333322 45678999999999997642  2221   22111   2221111


Q ss_pred             -HHHHHHhcCCCCeeeecccCCcEEECCCC----ceEEeecccceeccC
Q 014904          154 -GLAYLHEDCHPKIIHRDIKAANILLDFKF----EAKVADFGLAKIASD  197 (416)
Q Consensus       154 -aL~~LH~~~~~~iiHrDIkp~NILl~~~~----~~kl~DFGla~~~~~  197 (416)
                       -+..+...   +++|+|+||.||+++.++    .++++|||++.....
T Consensus       271 ~~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        271 VFFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence             12334455   999999999999999888    999999999876643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.26  E-value=1.1e-10  Score=105.74  Aligned_cols=137  Identities=15%  Similarity=0.149  Sum_probs=98.0

Q ss_pred             CceecccCcEEEEEEEeCC-------CcEEEEEEeecCCc---------------------cc-HHHHH----HHHHHHH
Q 014904           49 ANLLGQGGFGYVHRGVLPN-------GKEVAIKQLKAGSG---------------------QG-EREFQ----AEVEIIS   95 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~---------------------~~-~~~~~----~E~~~l~   95 (416)
                      ...||.|.-+.||.|...+       +..+|||+.+....                     .. ...+.    .|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999998543       47999999863210                     00 11233    7999999


Q ss_pred             hcCC--CcccceEEEEEeCCeEEEEEEecCCCCHH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeecc
Q 014904           96 RVHH--KHLVSLVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPTMDWLTRLKIALGSAKGLAYL-HEDCHPKIIHRDI  171 (416)
Q Consensus        96 ~l~h--~niv~l~~~~~~~~~~~lV~e~~~~~sL~-~~l~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~iiHrDI  171 (416)
                      ++..  -++..++.+    ...+|||||+.+..+. ..+...   .++......+..+++.+|..| |+.   +|||+||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL  151 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL  151 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            9864  345556654    4567999999765332 222211   244455667788999999999 777   9999999


Q ss_pred             cCCcEEECCCCceEEeecccceecc
Q 014904          172 KAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       172 kp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      ++.|||++ ++.+.|+|||.+-...
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999996 4689999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=5.6e-11  Score=109.26  Aligned_cols=143  Identities=20%  Similarity=0.233  Sum_probs=110.6

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCC--cccceEEEEEeCC---eEEEEEEec
Q 014904           49 ANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHK--HLVSLVGYYTAGS---QRMLVYEFV  122 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lV~e~~  122 (416)
                      .+.|+.|..+.||++...+|+.+++|+...... .....+..|+.++..+.+.  ++.+++.++....   ..++||||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            357899999999999987778999999765432 1345788999999999764  4577787776542   568999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC----------------------------------------  162 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~----------------------------------------  162 (416)
                      ++.++...+..   ..++...+..++.+++++|..||+..                                        
T Consensus        83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            99988766532   24677777888888888888888521                                        


Q ss_pred             -------------CCCeeeecccCCcEEECC--CCceEEeeccccee
Q 014904          163 -------------HPKIIHRDIKAANILLDF--KFEAKVADFGLAKI  194 (416)
Q Consensus       163 -------------~~~iiHrDIkp~NILl~~--~~~~kl~DFGla~~  194 (416)
                                   ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245799999999999998  56689999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.25  E-value=1.2e-10  Score=102.52  Aligned_cols=144  Identities=19%  Similarity=0.255  Sum_probs=107.7

Q ss_pred             cCceecccCcEEEEEEEeCCCcEEEEEEeecCCc--------ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           48 DANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSG--------QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        48 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ...+|-||.-++|+++.+ .|+..+||.--....        -..++.++|+.+|.+++--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            567899999999999998 567777775432211        12356788999999987667665555676666677999


Q ss_pred             EecCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc---eEEeecccceec
Q 014904          120 EFVPN-NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIA  195 (416)
Q Consensus       120 e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~---~kl~DFGla~~~  195 (416)
                      ||+++ .++.+++.........-.....++..+-+.|..||..   .|||+||..+||+|..++.   +.++|||++...
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            99987 4777777654433333334467888888999999999   9999999999999965543   589999998643

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.23  E-value=1.9e-10  Score=101.60  Aligned_cols=131  Identities=19%  Similarity=0.270  Sum_probs=102.2

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEeecCCccc--------HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           50 NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQG--------EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      .+|.+|.-+.+|.+.+. |..+++|.-.+.....        ..+-..|+.+|.+++--.|...+-|..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46889999999999764 3446777544332221        13456799999999877777667677777888899999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      ++|..|.+.+...         +..++..+-.-+.-||..   +|+|+||.++||++..+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888654         245667777778899999   999999999999997764 99999999864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.13  E-value=4.4e-11  Score=121.42  Aligned_cols=250  Identities=21%  Similarity=0.207  Sum_probs=178.7

Q ss_pred             HHHhhCCCCcCceecccCcEEEEEEEe--CCCcEEEEEEeecCCcccHHHH--HHHHHHHHhc-CCCcccceEEEEEeCC
Q 014904           39 LARATDGFSDANLLGQGGFGYVHRGVL--PNGKEVAIKQLKAGSGQGEREF--QAEVEIISRV-HHKHLVSLVGYYTAGS  113 (416)
Q Consensus        39 l~~~t~~f~~~~~LG~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~--~~E~~~l~~l-~h~niv~l~~~~~~~~  113 (416)
                      ..-.+.+|..+..||.|.|+.|++...  .++..+++|.+.........++  ..|+-+...+ .|.+++..+..+....
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            445567899999999999999998773  4678899998876654443332  3466665555 5888888877777777


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC-CceEEeecccc
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLA  192 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~-~~~kl~DFGla  192 (416)
                      +.++--||+.++++...+.  ....++...++++..+++.++.++|+.   .++|+|+||+||++..+ +..++.|||++
T Consensus       340 ~~~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             cccCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence            8888899999998876662  223577778899999999999999998   99999999999999886 78899999998


Q ss_pred             eeccCCCcceeeccccccccc--ChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh
Q 014904          193 KIASDVNTHVSTRVMGTFGYL--APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       193 ~~~~~~~~~~~~~~~gt~~Yl--aPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~  270 (416)
                      ..+.-.    .......-++.  +++......+..+.|+|+||.-+.+.+++...-        .+.+.|..      +.
T Consensus       415 t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls--------~~~~~~~~------i~  476 (524)
T KOG0601|consen  415 TRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS--------ESGVQSLT------IR  476 (524)
T ss_pred             ccccee----cccccccccccccchhhccccccccccccccccccccccccCcccC--------ccccccee------ee
Confidence            632111    11112222333  555556667889999999999999999876532        12222321      11


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                      .|.+     +.+    + .....+..++..++..++..||.+.++....+-
T Consensus       477 ~~~~-----p~~----~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  477 SGDT-----PNL----P-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             cccc-----cCC----C-chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            2221     111    1 122567778888999999999999888766553

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.11  E-value=3.2e-09  Score=103.95  Aligned_cols=257  Identities=19%  Similarity=0.199  Sum_probs=162.0

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEE------E-EeCCeEEEEEE
Q 014904           49 ANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGY------Y-TAGSQRMLVYE  120 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~-~~~~~~~lV~e  120 (416)
                      ...||+||.+.+|-.-.- +. .+-|++.........+.   +..|... .||-+-.-+.+      . ..+...-+.|.
T Consensus        16 gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CccccCCccceeeecchh-hc-hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            456999999999863321 12 34577765443322222   2223333 45543321111      1 11223567788


Q ss_pred             ecCCCCH-HHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          121 FVPNNTL-EFHLHG----KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       121 ~~~~~sL-~~~l~~----~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      .+++..- ..+..-    ..-+...|...++++..+|.+.+.||+.   |.+-+|++++|+|+.+++.+.|.|-...++.
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence            8876532 222211    1224578999999999999999999999   9999999999999999999999997666555


Q ss_pred             cCCCcceeecccccccccChhhhc-----cCCCCchhhhHhHHHHHHHHHhC-CCCCCCCCcccchhhhhhhhHHhHHhh
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITG-RRPVDSTHTFVEDSLVDWARPLLNRAI  269 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~-----~~~~t~ksDV~SlGvvL~elltG-~~pf~~~~~~~~~~l~~~~~~~~~~~~  269 (416)
                      .+  .......+|...|++||.-.     +..-+...|.|.|||++++||.| +.||.......+      +..-+...+
T Consensus       168 ~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~------ap~p~E~~I  239 (637)
T COG4248         168 AN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD------APNPLETDI  239 (637)
T ss_pred             cC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC------CCCcchhhh
Confidence            33  33335567899999999754     33567889999999999999996 999976432111      111122223


Q ss_pred             hcCCcccccCccc-----cCcCCH-HHHHHHHHHHHHhhcc--CCCCCCCHHHHHHHhcc
Q 014904          270 EDGNFDTLVDPKL-----HNEYNH-NEMARMVACAAACVRH--SARRRPRMSQIVRALEG  321 (416)
Q Consensus       270 ~~~~~~~~~d~~l-----~~~~~~-~~~~~l~~l~~~cl~~--~p~~RPt~~evv~~L~~  321 (416)
                      ..|.|..-.|...     ....+- -.+..+..+..+|+..  ++.-||++.-++..|..
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence            3444433322211     111121 2235677777788754  36789999999988864

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.08  E-value=3.3e-09  Score=101.10  Aligned_cols=141  Identities=18%  Similarity=0.101  Sum_probs=103.4

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEeecCCcc-----------cHHHHHHHHHHHHhcCCCccc--ceEEEEEe-----
Q 014904           50 NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQ-----------GEREFQAEVEIISRVHHKHLV--SLVGYYTA-----  111 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv--~l~~~~~~-----  111 (416)
                      +.+-.-....|.+..+ +|+.+.||........           ....+.+|+..+.++...+|.  .++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444455777666 7789999977543211           011477899999999655554  45666653     


Q ss_pred             CCeEEEEEEecCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC-------CCc
Q 014904          112 GSQRMLVYEFVPNN-TLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF-------KFE  183 (416)
Q Consensus       112 ~~~~~lV~e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~-------~~~  183 (416)
                      ....+||+|++++. +|.+++........+...+..++.+++..+..||+.   +|+|+|+++.|||++.       +..
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence            23578999999986 898887543223455667778999999999999999   9999999999999975       467


Q ss_pred             eEEeeccccee
Q 014904          184 AKVADFGLAKI  194 (416)
Q Consensus       184 ~kl~DFGla~~  194 (416)
                      +.|+||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.05  E-value=4.4e-11  Score=127.61  Aligned_cols=248  Identities=19%  Similarity=0.235  Sum_probs=166.7

Q ss_pred             hhCCCCcCceecccCcEEEEEEE-eCCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ..+.|.+.+-+-.|.++.++.+. -..|.-.+.|+......   ...+....+-.++...++|-++...--+.-....+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            34667777788889999998877 33454445554432211   111223333334444455666655544445667889


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      |++|+.++.|...++..+.  .+..........+..+++|||..   .+.|+|++|.|+++..++..++.||+.......
T Consensus       882 ~~~~~~~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGC--LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             hhHHhccCCchhhhhcCCC--cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence            9999999999999987652  33333344455677889999998   799999999999999999999999984321110


Q ss_pred             C------------------------------CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCC
Q 014904          198 V------------------------------NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD  247 (416)
Q Consensus       198 ~------------------------------~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~  247 (416)
                      .                              +......+.||+.|++||...+..-...+|+|++|+.++|.++|..||.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence            0                              0011223679999999999999999999999999999999999999998


Q ss_pred             CCCcccchhhhhhhhHHhHHhhhcCCcccccCcccc-CcCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 014904          248 STHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLH-NEYNHNEMARMVACAAACVRHSARRRPRMS  313 (416)
Q Consensus       248 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~  313 (416)
                      ...+.                   ..++.++..... ...+.....+...++...+..++.+|-.|.
T Consensus      1037 a~tpq-------------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQ-------------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchh-------------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            76541                   111112211111 112233345677788888889999887766

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.01  E-value=5.1e-09  Score=94.48  Aligned_cols=126  Identities=22%  Similarity=0.268  Sum_probs=81.9

Q ss_pred             EEEEEEeCCCcEEEEEEeecCCcc----------------------c----HHHHHHHHHHHHhcCCCc--ccceEEEEE
Q 014904           59 YVHRGVLPNGKEVAIKQLKAGSGQ----------------------G----EREFQAEVEIISRVHHKH--LVSLVGYYT  110 (416)
Q Consensus        59 ~Vy~~~~~~g~~vavK~l~~~~~~----------------------~----~~~~~~E~~~l~~l~h~n--iv~l~~~~~  110 (416)
                      .||.|...+|..+|||+.+.....                      .    ....+.|+..|.++..-+  +.+++.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            489999999999999998642110                      0    124678999999998764  4555544  


Q ss_pred             eCCeEEEEEEecC--CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeeecccCCcEEECCCCceEEe
Q 014904          111 AGSQRMLVYEFVP--NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY-LHEDCHPKIIHRDIKAANILLDFKFEAKVA  187 (416)
Q Consensus       111 ~~~~~~lV~e~~~--~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~-LH~~~~~~iiHrDIkp~NILl~~~~~~kl~  187 (416)
                      .  ..+|||||+.  +..+..+....    ++......++.+++..+.. +|..   +|+|+|+.+.|||++.+ .+.|+
T Consensus        79 ~--~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   79 N--RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             E--TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred             e--CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence            2  3469999998  65555443322    1122344566777775555 4676   99999999999999887 99999


Q ss_pred             ecccceecc
Q 014904          188 DFGLAKIAS  196 (416)
Q Consensus       188 DFGla~~~~  196 (416)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.95  E-value=3.2e-08  Score=99.26  Aligned_cols=167  Identities=18%  Similarity=0.249  Sum_probs=128.1

Q ss_pred             EEEEEEE-eCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEE----eCCeEEEEEEecCCC-CHHHHh
Q 014904           58 GYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT----AGSQRMLVYEFVPNN-TLEFHL  131 (416)
Q Consensus        58 g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lV~e~~~~~-sL~~~l  131 (416)
                      .+.||++ .-+|..|++|++.....+.....-.-+++++++.|.|+|++.+++.    .+..++|||+|.++. +|.+.-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            5889999 4589999999995544443334455688999999999999988876    356789999999864 555443


Q ss_pred             hcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          132 HGK-------------GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       132 ~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      ...             .+...++...|.++.|+.-||.++|+.   |+..+-|.+.+||++.+.+++|+..|...+...+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            221             112467889999999999999999999   9999999999999999999999988887665443


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCC
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP  245 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~p  245 (416)
                      ..               |-+..   -.+-|.=-||.+++.|.||+..
T Consensus       447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            21               11111   2367888999999999999654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.91  E-value=9.2e-09  Score=96.06  Aligned_cols=134  Identities=19%  Similarity=0.200  Sum_probs=97.0

Q ss_pred             CCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcc----------------------cHHHHHHHHHHHHhcCCC--c
Q 014904           46 FSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQ----------------------GEREFQAEVEIISRVHHK--H  101 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~----------------------~~~~~~~E~~~l~~l~h~--n  101 (416)
                      ..+.+.||.|.-+.||.|..++|.++|||.-+.....                      .....++|+++|.+|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            3556899999999999999999999999987533211                      112356799999999755  5


Q ss_pred             ccceEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC
Q 014904          102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK  181 (416)
Q Consensus       102 iv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~  181 (416)
                      +.+.+++    +...+|||++.+-.|...-       ++....-.|+..|++-+..+-..   +|||+|+++-||+++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d  238 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence            6666543    4456999999887665432       12223334444555555555555   99999999999999999


Q ss_pred             CceEEeecccce
Q 014904          182 FEAKVADFGLAK  193 (416)
Q Consensus       182 ~~~kl~DFGla~  193 (416)
                      |.+.++||--+.
T Consensus       239 g~~~vIDwPQ~v  250 (304)
T COG0478         239 GDIVVIDWPQAV  250 (304)
T ss_pred             CCEEEEeCcccc
Confidence            999999997654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.84  E-value=7.8e-10  Score=114.09  Aligned_cols=152  Identities=22%  Similarity=0.343  Sum_probs=107.2

Q ss_pred             HHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc--------eeecccccccccChhhhc
Q 014904          148 ALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH--------VSTRVMGTFGYLAPEYAS  219 (416)
Q Consensus       148 ~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~--------~~~~~~gt~~YlaPE~~~  219 (416)
                      +.+++.|+.++|...  ++||++|.|++|.++.++..||+.|+.+.........        ..-...-...|+|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            344558999999886  9999999999999999999999999987544332111        111122345699999999


Q ss_pred             cCCCCchhhhHhHHHHHHHHHhCCCC-CCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHH
Q 014904          220 SGKLTEKSDVFSFGVMLLELITGRRP-VDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACA  298 (416)
Q Consensus       220 ~~~~t~ksDV~SlGvvL~elltG~~p-f~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~  298 (416)
                      .-..+.++|+|||||+++.+..|..+ +........                 +.+....+..-...+..+.+.++.+.+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----------------~~~~~~~~~~~~~~~s~~~p~el~~~l  245 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----------------YSFSRNLLNAGAFGYSNNLPSELRESL  245 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcch-----------------hhhhhcccccccccccccCcHHHHHHH
Confidence            88889999999999999999955544 443322111                 111111111112233456677899999


Q ss_pred             HHhhccCCCCCCCHHHHHHH
Q 014904          299 AACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       299 ~~cl~~~p~~RPt~~evv~~  318 (416)
                      .+.+..++.-||++.++...
T Consensus       246 ~k~l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  246 KKLLNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             HHHhcCCcccCcchhhhhcc
Confidence            99999999999988887654

>PRK09902 hypothetical protein; Provisional

Probab=98.78  E-value=2.6e-07  Score=84.31  Aligned_cols=154  Identities=14%  Similarity=0.124  Sum_probs=117.0

Q ss_pred             CHHHHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCC------cccHHHHHHHHHHHHhcCCCc--ccceE
Q 014904           35 TYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGS------GQGEREFQAEVEIISRVHHKH--LVSLV  106 (416)
Q Consensus        35 ~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~n--iv~l~  106 (416)
                      +++.++.....+-..---|.||.+-|+.-.. +|+.+-+|+-...-      +.+...|.+|+..|.++..-+  +.+++
T Consensus         9 ~f~~~w~~~~~wve~pN~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv   87 (216)
T PRK09902          9 EFNHWWATEGDWVEEPNYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV   87 (216)
T ss_pred             hHHHHHhCCCceecCCCcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc
Confidence            5677777777776666668899999999776 44578888865221      335568999999999996433  44444


Q ss_pred             EEEEe-----CCeEEEEEEecCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC
Q 014904          107 GYYTA-----GSQRMLVYEFVPN-NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF  180 (416)
Q Consensus       107 ~~~~~-----~~~~~lV~e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~  180 (416)
                       ++..     ..+.+||+|-+.+ .+|.+++........+...+..+..++++.|+-||+.   ++.|+|+.+.||+++.
T Consensus        88 -f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~  163 (216)
T PRK09902         88 -FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKT  163 (216)
T ss_pred             -eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecC
Confidence             3321     2346899997754 5888888665544567788889999999999999999   9999999999999986


Q ss_pred             CCc--eEEeecccce
Q 014904          181 KFE--AKVADFGLAK  193 (416)
Q Consensus       181 ~~~--~kl~DFGla~  193 (416)
                      ++.  ++++||.-++
T Consensus       164 ~g~~~v~lIDlEk~r  178 (216)
T PRK09902        164 EGKAEAGFLDLEKSR  178 (216)
T ss_pred             CCCeeEEEEEhhccc
Confidence            666  9999998765

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.77  E-value=1.1e-07  Score=87.36  Aligned_cols=134  Identities=21%  Similarity=0.155  Sum_probs=97.6

Q ss_pred             cEEEEEEEe----CCCcEEEEEEeecCC-------cccHHHHHHHHHHHHhcCCCc--ccceEEEEEeC----CeEEEEE
Q 014904           57 FGYVHRGVL----PNGKEVAIKQLKAGS-------GQGEREFQAEVEIISRVHHKH--LVSLVGYYTAG----SQRMLVY  119 (416)
Q Consensus        57 ~g~Vy~~~~----~~g~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~----~~~~lV~  119 (416)
                      -+.+|.++.    ..++.+.+|.+....       ........+|...+.++...+  ...++++....    ...+||+
T Consensus        17 R~~~~~~~~~~~~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lit   96 (206)
T PF06293_consen   17 RRGGWFGVQRVVDLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLIT   96 (206)
T ss_pred             CceEEEEEEccccccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEE
Confidence            344455443    235566666543211       123346788999988886544  45667776652    2458999


Q ss_pred             EecCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC---ceEEeecccceec
Q 014904          120 EFVPNN-TLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF---EAKVADFGLAKIA  195 (416)
Q Consensus       120 e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~---~~kl~DFGla~~~  195 (416)
                      |++++. +|.+++.....  ++......++.+++..++-||+.   +|+|+|+++.|||++.+.   .+.++||+.++..
T Consensus        97 e~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen   97 EALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             EeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999884 79988875332  55567788999999999999999   999999999999999887   8999999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.73  E-value=5.5e-08  Score=100.37  Aligned_cols=146  Identities=23%  Similarity=0.301  Sum_probs=96.7

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCccc----------------------------------------
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQG----------------------------------------   83 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~----------------------------------------   83 (416)
                      ..|.. +.|+.+.-|.||+|++++|+.||||+..++-...                                        
T Consensus       126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            34443 6899999999999999999999999996532210                                        


Q ss_pred             HHHHHHHHHHHHhcC-----CCcccceEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHH-HHH
Q 014904           84 EREFQAEVEIISRVH-----HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKG-LAY  157 (416)
Q Consensus        84 ~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~a-L~~  157 (416)
                      +-++..|..-+.+++     .+++.-..-|..-.+...|+|||++|..+.+....+. ..++...   |+..++++ +..
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q  280 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQ  280 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHH
Confidence            112444555555542     2333322223334567789999999999988743222 1344333   33333322 333


Q ss_pred             HHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       158 LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      +=..   +++|.|.+|.||+++.++.+.+.|||+.....+
T Consensus       281 ~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         281 LLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            3345   899999999999999999999999999865543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.64  E-value=5.7e-07  Score=83.38  Aligned_cols=154  Identities=19%  Similarity=0.210  Sum_probs=105.5

Q ss_pred             ccCHHHHHHhhCCCCcCceec---ccCcEEEEEEEeCCCcEEEEEEeecCCccc-------------------HH-----
Q 014904           33 TFTYEELARATDGFSDANLLG---QGGFGYVHRGVLPNGKEVAIKQLKAGSGQG-------------------ER-----   85 (416)
Q Consensus        33 ~f~~~el~~~t~~f~~~~~LG---~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-------------------~~-----   85 (416)
                      ..|++.|..+.++..+..+.|   .|.-+.||+|...++..+|||+++......                   .+     
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            356778888888888777655   677789999998889999999997532211                   11     


Q ss_pred             HHHHHHHHHHhcC--CCcccceEEEEEeCCeEEEEEEecCCCCH-HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 014904           86 EFQAEVEIISRVH--HKHLVSLVGYYTAGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC  162 (416)
Q Consensus        86 ~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~~sL-~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~  162 (416)
                      ....|+.-|.++.  +-.+.+.+.+..    -.|||||+....+ .-.|..-   .+.......+..++++.+.-|-..+
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhc
Confidence            2345777777774  334445554443    3599999965421 1111111   2222245566777777777777744


Q ss_pred             CCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       163 ~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                        ++||+||+.-|||+. ++.+.|+||+-+-...
T Consensus       187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence              999999999999998 7899999999876543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.54  E-value=1.8e-06  Score=80.38  Aligned_cols=138  Identities=17%  Similarity=0.173  Sum_probs=87.1

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCc--ccceEEEEEeCCeEEEEEEecCCCC-
Q 014904           50 NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKH--LVSLVGYYTAGSQRMLVYEFVPNNT-  126 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~~s-  126 (416)
                      .+||+|.-+.||+.   .+..+++|......  ......+|.+++..+..-+  +.+++.++.......+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999983   24567889876533  3345788999999997544  4678888888788889999999863 


Q ss_pred             HHHH---------------------hhcCCCCCCCHHHHHHHHH-----------HHHH-HHHHHHhc-CCCCeeeeccc
Q 014904          127 LEFH---------------------LHGKGRPTMDWLTRLKIAL-----------GSAK-GLAYLHED-CHPKIIHRDIK  172 (416)
Q Consensus       127 L~~~---------------------l~~~~~~~l~~~~~~~i~~-----------~ia~-aL~~LH~~-~~~~iiHrDIk  172 (416)
                      +...                     +|.-.........+..-..           .+.. ...+|... ..+.++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            2111                     1211101111111110000           0111 12222211 13457899999


Q ss_pred             CCcEEECCCCceEEeecccce
Q 014904          173 AANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       173 p~NILl~~~~~~kl~DFGla~  193 (416)
                      |.||++++++ +.|+||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999887 9999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.44  E-value=3.2e-06  Score=77.50  Aligned_cols=137  Identities=15%  Similarity=0.211  Sum_probs=92.0

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHH---------HHHHHHHhcCCC---cccceEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQ---------AEVEIISRVHHK---HLVSLVGYYT  110 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~---------~E~~~l~~l~h~---niv~l~~~~~  110 (416)
                      .++|...+++-......|.+-.. +|+.+++|..+......++.|.         +.+..+.++...   .++.++...+
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            46778778888777777877666 6788999998765433333332         233333334322   2233222222


Q ss_pred             e-----CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceE
Q 014904          111 A-----GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAK  185 (416)
Q Consensus       111 ~-----~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~k  185 (416)
                      .     ....+|||||++|..|.+...      ++.    .++..++.++..||+.   |+.|+|++|.|++++++ .++
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~  174 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIR  174 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEE
Confidence            1     234578999999988866532      222    2455677889999999   99999999999999865 599


Q ss_pred             Eeeccccee
Q 014904          186 VADFGLAKI  194 (416)
Q Consensus       186 l~DFGla~~  194 (416)
                      ++||+..+.
T Consensus       175 iID~~~k~~  183 (229)
T PF06176_consen  175 IIDTQGKRM  183 (229)
T ss_pred             EEECccccc
Confidence            999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.42  E-value=3e-06  Score=78.09  Aligned_cols=143  Identities=18%  Similarity=0.194  Sum_probs=86.7

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCC--cccceEEEEEe---CCeEEEEEEecC
Q 014904           49 ANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHK--HLVSLVGYYTA---GSQRMLVYEFVP  123 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lV~e~~~  123 (416)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+..|+.++..+...  .+.+++.++..   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4678999999999999877 68999997654  3456788899999888543  35677765533   345789999999


Q ss_pred             CCCHHH----------------Hh---hcC--CCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 014904          124 NNTLEF----------------HL---HGK--GRPTMDWLTR---------LKI------------ALGSAK-GLAYLHE  160 (416)
Q Consensus       124 ~~sL~~----------------~l---~~~--~~~~l~~~~~---------~~i------------~~~ia~-aL~~LH~  160 (416)
                      +..+..                .+   +..  ....+.+...         ...            ...+.+ .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988777                11   111  1111111110         000            111222 3444443


Q ss_pred             c----CCCCeeeecccCCcEEEC-CCCceEEeeccccee
Q 014904          161 D----CHPKIIHRDIKAANILLD-FKFEAKVADFGLAKI  194 (416)
Q Consensus       161 ~----~~~~iiHrDIkp~NILl~-~~~~~kl~DFGla~~  194 (416)
                      .    ....++|+|+.+.|||++ .++.+-|+||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2    234699999999999999 566667999987653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.33  E-value=7.9e-06  Score=76.69  Aligned_cols=138  Identities=19%  Similarity=0.129  Sum_probs=85.1

Q ss_pred             ecccCc-EEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-CCcccceEEEEEeCCeEEEEEEecCCCCHHH
Q 014904           52 LGQGGF-GYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEF  129 (416)
Q Consensus        52 LG~G~~-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~~sL~~  129 (416)
                      |-.|.. ..||+.... +..++||+.....   ...+..|+.++..+. +--+.++++++...+..++||++++|.++..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444555 689998764 4678888876443   335678899888884 3445577887777667899999999987764


Q ss_pred             Hh-------------------hcCCC--CCCC--HHHHHHHHH--------------------HHHHHHHHHHhc----C
Q 014904          130 HL-------------------HGKGR--PTMD--WLTRLKIAL--------------------GSAKGLAYLHED----C  162 (416)
Q Consensus       130 ~l-------------------~~~~~--~~l~--~~~~~~i~~--------------------~ia~aL~~LH~~----~  162 (416)
                      ..                   |....  ..+.  +..++....                    .+...+..|-..    .
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            32                   11110  0111  001110000                    011112222111    1


Q ss_pred             CCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          163 HPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       163 ~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      .+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            3468999999999999998778899998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.26  E-value=4.3e-06  Score=86.34  Aligned_cols=144  Identities=23%  Similarity=0.266  Sum_probs=92.7

Q ss_pred             CCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCccc-------------------------------------HHHH
Q 014904           45 GFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQG-------------------------------------EREF   87 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-------------------------------------~~~~   87 (416)
                      .|. .+.|+....|.||+|++++|+.||||+-++.-...                                     +=+|
T Consensus       163 ~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF  241 (538)
T KOG1235|consen  163 EFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF  241 (538)
T ss_pred             hcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence            444 35789999999999999999999999986532210                                     0124


Q ss_pred             HHHHHHHHhc----CCCc------ccceEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 014904           88 QAEVEIISRV----HHKH------LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY  157 (416)
Q Consensus        88 ~~E~~~l~~l----~h~n------iv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~  157 (416)
                      ..|+.-..+.    .|-+      |.+++.  .-.....|+|||++|..+.++-.-... .++-..   |+..+.++  |
T Consensus       242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~---i~~~l~~~--~  313 (538)
T KOG1235|consen  242 TKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHD---ILNKLVEA--Y  313 (538)
T ss_pred             HHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc-CCCHHH---HHHHHHHH--H
Confidence            4455444443    3444      233332  223568899999999888765432211 244443   33333332  3


Q ss_pred             HHhcCCCCeeeecccCCcEEECC----CCceEEeecccceeccC
Q 014904          158 LHEDCHPKIIHRDIKAANILLDF----KFEAKVADFGLAKIASD  197 (416)
Q Consensus       158 LH~~~~~~iiHrDIkp~NILl~~----~~~~kl~DFGla~~~~~  197 (416)
                      ++..-..|++|+|-+|.||+++.    ++++.+.|||+......
T Consensus       314 ~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  314 LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            33333338999999999999983    67899999999876543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.22  E-value=3.7e-05  Score=70.00  Aligned_cols=134  Identities=21%  Similarity=0.299  Sum_probs=96.0

Q ss_pred             CcCceecccCcEEEEEEEeCCCcEEEEEEeecCC----------------cccHHHHHHHHHHHHhcC------CCcccc
Q 014904           47 SDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGS----------------GQGEREFQAEVEIISRVH------HKHLVS  104 (416)
Q Consensus        47 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~  104 (416)
                      +...+||+|+.-.||.  ++++....||+.....                ....++..+|+.-...+.      +.+|.+
T Consensus         4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            3456899999999986  6777788999998665                112345566666555554      789999


Q ss_pred             eEEEEEeCCeEEEEEEecCC------CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE
Q 014904          105 LVGYYTAGSQRMLVYEFVPN------NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL  178 (416)
Q Consensus       105 l~~~~~~~~~~~lV~e~~~~------~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl  178 (416)
                      ++|+...+.-..+|+|.+.+      .+|.+++...   .++. .   +...+-+-..||-+.   .|+.+|++|.||++
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVV  151 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEE
Confidence            99999999999999998753      3677777543   2443 2   333344456677777   89999999999999


Q ss_pred             CCCC----ceEEee-cccc
Q 014904          179 DFKF----EAKVAD-FGLA  192 (416)
Q Consensus       179 ~~~~----~~kl~D-FGla  192 (416)
                      ..+.    .+.|+| ||..
T Consensus       152 ~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             EecCCCceEEEEEeCCCCc
Confidence            5432    477777 4543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.19  E-value=2.9e-05  Score=70.44  Aligned_cols=137  Identities=26%  Similarity=0.388  Sum_probs=97.3

Q ss_pred             CCCCccccCHHHHHHhhCCCCcCceecccCc-EEEEEEEeCCCcEEEEEEeecC---Cc------c------------cH
Q 014904           27 LGFSKSTFTYEELARATDGFSDANLLGQGGF-GYVHRGVLPNGKEVAIKQLKAG---SG------Q------------GE   84 (416)
Q Consensus        27 ~~~~~~~f~~~el~~~t~~f~~~~~LG~G~~-g~Vy~~~~~~g~~vavK~l~~~---~~------~------------~~   84 (416)
                      .|+....|+.     -+..++..+.||.|.. |.||++.. +|+.+|+|+++.-   ..      .            -.
T Consensus        25 ~gPKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~   98 (207)
T PF13095_consen   25 PGPKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYA   98 (207)
T ss_pred             CCCCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhc
Confidence            4556666776     2388999999999999 99999998 6789999994321   00      0            01


Q ss_pred             HHHHHHHHHHHhcC---CCcc--cceEEEEEeC------------------CeEEEEEEecCCCCHHHHhhcCCCCCCCH
Q 014904           85 REFQAEVEIISRVH---HKHL--VSLVGYYTAG------------------SQRMLVYEFVPNNTLEFHLHGKGRPTMDW  141 (416)
Q Consensus        85 ~~~~~E~~~l~~l~---h~ni--v~l~~~~~~~------------------~~~~lV~e~~~~~sL~~~l~~~~~~~l~~  141 (416)
                      ..|.+|.....+|+   +.++  |+++||..-.                  ....||.||++...           .+..
T Consensus        99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~  167 (207)
T PF13095_consen   99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI  167 (207)
T ss_pred             ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch
Confidence            24778988888884   4466  8999987322                  12367888776543           1222


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccc
Q 014904          142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA  192 (416)
Q Consensus       142 ~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla  192 (416)
                          .-+.++.+-|..+|..   +|+-+|+++.|..   +  -||+|||.+
T Consensus       168 ----~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  168 ----RDIPQMLRDLKILHKL---GIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             ----hHHHHHHHHHHHHHHC---CeeeccCcccccc---C--CEEEecccC
Confidence                2345666677789998   9999999999986   2  489999864

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.17  E-value=9.7e-06  Score=73.29  Aligned_cols=104  Identities=18%  Similarity=0.119  Sum_probs=80.9

Q ss_pred             HHHHHHHHhcCC-CcccceEEEEEeCCeEEEEEEecCCCCHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 014904           88 QAEVEIISRVHH-KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG-KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK  165 (416)
Q Consensus        88 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~  165 (416)
                      +.|.-++..+++ +++.+++|+|-+    ++|.|++..+++...-.. ..-...+|..|.+||.++++.+.+|+......
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458888888876 699999999943    578899986655321000 00114689999999999999999999865446


Q ss_pred             eeeecccCCcEEECCCCceEEeecccceec
Q 014904          166 IIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       166 iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      +.-.|++++|+-+++++++|++|...+-..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.10  E-value=3.2e-05  Score=68.24  Aligned_cols=130  Identities=21%  Similarity=0.203  Sum_probs=91.6

Q ss_pred             CCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCccc-ceEEEEEeCCeEEEEEEecCC
Q 014904           46 FSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV-SLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      -...+.|++|.+|.||+|.+ .|.++|+|+-..++.  ...+..|+++|..+.--++. +++.|..+    .+.|||+.|
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G   96 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG   96 (201)
T ss_pred             hhhhhhhhcccccEEEEeec-cCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence            34567899999999999998 456899998776543  35788999999999876664 45554433    255999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccc-CCcEEECCCCceEEeeccccee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIK-AANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIk-p~NILl~~~~~~kl~DFGla~~  194 (416)
                      -.|..+....     +-    +-...+++.-.-|-..   +|-|+.|. |..++|-.+..+.|+||.-|..
T Consensus        97 ~~L~~~~~~~-----~r----k~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          97 RPLGKLEIGG-----DR----KHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cchhhhhhcc-----cH----HHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            8887765432     11    2234455554445555   89999887 4555554555999999998863

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.08  E-value=2.4e-05  Score=73.12  Aligned_cols=73  Identities=16%  Similarity=0.235  Sum_probs=47.2

Q ss_pred             CceecccCcE-EEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCC---cccceEEEEEeC---CeEEEEEEe
Q 014904           49 ANLLGQGGFG-YVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHK---HLVSLVGYYTAG---SQRMLVYEF  121 (416)
Q Consensus        49 ~~~LG~G~~g-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lV~e~  121 (416)
                      ++.|+.||.. .||+.    +..+++|.....  .....+..|..++..+...   .+.++++.....   ...++||++
T Consensus         2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            3567878877 48874    345788875542  2345788999999988632   234444443322   235889999


Q ss_pred             cCCCCH
Q 014904          122 VPNNTL  127 (416)
Q Consensus       122 ~~~~sL  127 (416)
                      ++|.++
T Consensus        76 i~G~~l   81 (235)
T cd05155          76 LEGETA   81 (235)
T ss_pred             ecCCCC
Confidence            998766

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=98.06  E-value=7.3e-05  Score=82.57  Aligned_cols=146  Identities=15%  Similarity=0.234  Sum_probs=92.6

Q ss_pred             CceecccCcEEEEEEEeCCC---cEEEEEEeecCCc-ccHHHHHHHHHHHHhcC-CCcc--cceEEEEEeC---CeEEEE
Q 014904           49 ANLLGQGGFGYVHRGVLPNG---KEVAIKQLKAGSG-QGEREFQAEVEIISRVH-HKHL--VSLVGYYTAG---SQRMLV  118 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~~g---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lV  118 (416)
                      ...|+.|.+..+|+....++   ..+++|+...... .....+.+|+.+++.+. |.++  .+++.+|.+.   ...++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56788898999999876554   4678887654322 23457889999999995 6665  7788888764   467899


Q ss_pred             EEecCCCCHHH-----------------------HhhcCCC---------CCCCHH--HHHHHH---------------H
Q 014904          119 YEFVPNNTLEF-----------------------HLHGKGR---------PTMDWL--TRLKIA---------------L  149 (416)
Q Consensus       119 ~e~~~~~sL~~-----------------------~l~~~~~---------~~l~~~--~~~~i~---------------~  149 (416)
                      |||++|..+.+                       .||.-..         ....+.  +...+.               -
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            99998864321                       1122110         011111  111110               1


Q ss_pred             HHHHHHHHHHhcCC--------CCeeeecccCCcEEECCC-Cc-eEEeeccccee
Q 014904          150 GSAKGLAYLHEDCH--------PKIIHRDIKAANILLDFK-FE-AKVADFGLAKI  194 (416)
Q Consensus       150 ~ia~aL~~LH~~~~--------~~iiHrDIkp~NILl~~~-~~-~kl~DFGla~~  194 (416)
                      .+...+.+|.....        +.+||+|+++.|||++.+ .. +-|.||.++..
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence            23345667755332        359999999999999853 34 57899988754

>PRK10593 hypothetical protein; Provisional

Probab=98.06  E-value=0.00012  Score=71.02  Aligned_cols=78  Identities=12%  Similarity=0.052  Sum_probs=57.8

Q ss_pred             CcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCC---CcccceEEEEEe---CCeEEEEEE
Q 014904           47 SDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHH---KHLVSLVGYYTA---GSQRMLVYE  120 (416)
Q Consensus        47 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lV~e  120 (416)
                      ...+.||.|..+.||+....++ .+++|..+..  .....+..|...|+.+.-   -.+.+++++|..   .+..+||||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3455799999999999886555 4677775431  123578899999999953   367888988864   356899999


Q ss_pred             ecCCCCH
Q 014904          121 FVPNNTL  127 (416)
Q Consensus       121 ~~~~~sL  127 (416)
                      ++++.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.00  E-value=5.2e-07  Score=92.78  Aligned_cols=194  Identities=17%  Similarity=0.158  Sum_probs=135.0

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCc-ccceEEEEEeCCeEE
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKH-LVSLVGYYTAGSQRM  116 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~  116 (416)
                      .++..+.-+...+-++++.++.++|..-...+....+.+...     ....-++++|.+++||| .+..++-+......+
T Consensus       236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~  310 (829)
T KOG0576|consen  236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLW  310 (829)
T ss_pred             cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccc
Confidence            344444455555667889999999887433344444444322     34456889999999999 566666666677888


Q ss_pred             EEEEecCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          117 LVYEFVPNN-TLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       117 lV~e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++++++..+ +...... .....+...+...+...-++++++||+.   .=+|+|    ||+..+ +..+..||+.+..+
T Consensus       311 i~~~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L  381 (829)
T KOG0576|consen  311 IPMRICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQL  381 (829)
T ss_pred             hhhhhhcCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCccc
Confidence            999998776 2211110 0011234445556777788899999987   458888    887765 57899999998776


Q ss_pred             cCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCC
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD  247 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~  247 (416)
                      ....  ......+|+.++|||+...+.+..+.|+|++|+-..++--|-.|-.
T Consensus       382 ~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  382 TRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             Cccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            6543  2344678999999999999999999999999987666766666643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.99  E-value=4.5e-05  Score=73.70  Aligned_cols=153  Identities=18%  Similarity=0.158  Sum_probs=91.3

Q ss_pred             HHHHHhhCCCCc-----CceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCc--ccceEEE-
Q 014904           37 EELARATDGFSD-----ANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKH--LVSLVGY-  108 (416)
Q Consensus        37 ~el~~~t~~f~~-----~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-  108 (416)
                      ++|...-++|.+     .+.|..|-...+|+....+ ..+++|+...   .....+..|+.++..+.+.+  +.+++.. 
T Consensus         2 ~~l~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~   77 (296)
T cd05153           2 EELASFLADYDLGELLSFEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADR   77 (296)
T ss_pred             HHHHHHHHHcCCCchhheecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCC
Confidence            345555555543     4456667778999987644 4688898764   23456777888888885433  3444331 


Q ss_pred             -----EEeCCeEEEEEEecCCCCHHH----H----------hhcC----CC-----CCCCHHHHHH----------HHHH
Q 014904          109 -----YTAGSQRMLVYEFVPNNTLEF----H----------LHGK----GR-----PTMDWLTRLK----------IALG  150 (416)
Q Consensus       109 -----~~~~~~~~lV~e~~~~~sL~~----~----------l~~~----~~-----~~l~~~~~~~----------i~~~  150 (416)
                           ....+..++|++|++|..+..    .          +|..    ..     ....|.....          ....
T Consensus        78 ~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  157 (296)
T cd05153          78 DGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRAL  157 (296)
T ss_pred             CCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHH
Confidence                 123456689999999876421    0          1110    00     1123332211          1112


Q ss_pred             HHHHHHHHHh----cCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          151 SAKGLAYLHE----DCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       151 ia~aL~~LH~----~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      +..++.++..    .....++|+|+.|.||+++.+..+.|+||+.+.
T Consensus       158 ~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         158 LADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             HHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            3344555543    223479999999999999988777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.91  E-value=0.00016  Score=67.25  Aligned_cols=73  Identities=18%  Similarity=0.213  Sum_probs=47.5

Q ss_pred             ceecccCcEEEEEEEeCC--CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcc-cceEEEEEeCCeEEEEEEecCCCC
Q 014904           50 NLLGQGGFGYVHRGVLPN--GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVYEFVPNNT  126 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~~s  126 (416)
                      +.|..|-...+|+....+  ++.|++|+....... .-....|+.++..+...++ .+++..+.    ..+||||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            456667777999988764  678999987643221 1123468888888854444 44444332    237999999876


Q ss_pred             H
Q 014904          127 L  127 (416)
Q Consensus       127 L  127 (416)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.82  E-value=0.00012  Score=69.28  Aligned_cols=136  Identities=15%  Similarity=0.113  Sum_probs=77.9

Q ss_pred             ecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcc-cceEEEEEeCCeEEEEEEecCCCCHHHH
Q 014904           52 LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVYEFVPNNTLEFH  130 (416)
Q Consensus        52 LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~~sL~~~  130 (416)
                      +..|-...+|+... +++.+++|........-.-....|..+++.+...++ .+++..+.    .++|+||++|..+...
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            44566678898874 567888997654322211134678889998865444 34444432    3689999998765321


Q ss_pred             -----------------hhcCC--CCCCCHHHHH-HHHH---------HHHHHHHHHHhc-----CCCCeeeecccCCcE
Q 014904          131 -----------------LHGKG--RPTMDWLTRL-KIAL---------GSAKGLAYLHED-----CHPKIIHRDIKAANI  176 (416)
Q Consensus       131 -----------------l~~~~--~~~l~~~~~~-~i~~---------~ia~aL~~LH~~-----~~~~iiHrDIkp~NI  176 (416)
                                       +|...  ...++...+. ....         .+...+..+-..     ..+.++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             12211  1122222111 1100         111112222211     133589999999999


Q ss_pred             EECCCCceEEeecccce
Q 014904          177 LLDFKFEAKVADFGLAK  193 (416)
Q Consensus       177 Ll~~~~~~kl~DFGla~  193 (416)
                      +++.++ +.|+||..+.
T Consensus       159 l~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEeCCC-CEEEeccccC
Confidence            999876 7899998775

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.72  E-value=0.00099  Score=65.10  Aligned_cols=157  Identities=15%  Similarity=0.141  Sum_probs=88.6

Q ss_pred             ccCHHHHHHhhCCCCc-----CceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCc--ccce
Q 014904           33 TFTYEELARATDGFSD-----ANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKH--LVSL  105 (416)
Q Consensus        33 ~f~~~el~~~t~~f~~-----~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l  105 (416)
                      ..+-+++......|.+     .+.|..|....+|+....+| .+++|+...   .....+..|+.++..+...+  +.++
T Consensus         6 ~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~   81 (319)
T PRK05231          6 DVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAP   81 (319)
T ss_pred             cCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcc
Confidence            4566777777777755     24455666678999887555 688898762   12334455666666664222  3333


Q ss_pred             EE------EEEeCCeEEEEEEecCCCCHH-----------HH---hhcCCC---------CCCCH-HHHHHH--------
Q 014904          106 VG------YYTAGSQRMLVYEFVPNNTLE-----------FH---LHGKGR---------PTMDW-LTRLKI--------  147 (416)
Q Consensus       106 ~~------~~~~~~~~~lV~e~~~~~sL~-----------~~---l~~~~~---------~~l~~-~~~~~i--------  147 (416)
                      +.      +....+..+++++|++|..+.           ..   +|....         ..+.| ...+.-        
T Consensus        82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (319)
T PRK05231         82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE  161 (319)
T ss_pred             eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence            32      122355678999999887431           11   111110         01112 111110        


Q ss_pred             ----H-HHHHHHHHHHHhc----CCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          148 ----A-LGSAKGLAYLHED----CHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       148 ----~-~~ia~aL~~LH~~----~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                          . ..+...+..+...    ...++||+|+++.||+++.+...-|+||+.+.
T Consensus       162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                1 1111122333211    34579999999999999876556899999864

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.63  E-value=0.00048  Score=67.50  Aligned_cols=136  Identities=15%  Similarity=0.181  Sum_probs=95.9

Q ss_pred             eecccCcEEEEEEEeCCCcEEEEEEeecCCc---------c------------c-----HHHHHHHHHHHHhcCCCcccc
Q 014904           51 LLGQGGFGYVHRGVLPNGKEVAIKQLKAGSG---------Q------------G-----EREFQAEVEIISRVHHKHLVS  104 (416)
Q Consensus        51 ~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~---------~------------~-----~~~~~~E~~~l~~l~h~niv~  104 (416)
                      .|..|.-+.||.++..+|..+|||+++..-.         .            .     ......|+.-|.+++.-.|.-
T Consensus       151 CiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~  230 (520)
T KOG2270|consen  151 CISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC  230 (520)
T ss_pred             ccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            5667889999999998999999999863100         0            0     112446888888887666543


Q ss_pred             eEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCce
Q 014904          105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA  184 (416)
Q Consensus       105 l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~  184 (416)
                      .--+...  ...|||+|+....+..-.-  ....++...+..+-.+++.-+.-|.+.|  ++||.||.--|+|+ .+|.+
T Consensus       231 PePIlLk--~hVLVM~FlGrdgw~aPkL--Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hdG~l  303 (520)
T KOG2270|consen  231 PEPILLK--NHVLVMEFLGRDGWAAPKL--KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HDGKL  303 (520)
T ss_pred             CCceeee--cceEeeeeccCCCCcCccc--ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-ECCEE
Confidence            3333332  3469999996443322111  1124666677778888888899999999  99999999999999 56689


Q ss_pred             EEeecccce
Q 014904          185 KVADFGLAK  193 (416)
Q Consensus       185 kl~DFGla~  193 (416)
                      .|+|-+-+-
T Consensus       304 yiIDVSQSV  312 (520)
T KOG2270|consen  304 YIIDVSQSV  312 (520)
T ss_pred             EEEEccccc
Confidence            999987654

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.60  E-value=0.0014  Score=63.77  Aligned_cols=158  Identities=18%  Similarity=0.189  Sum_probs=92.2

Q ss_pred             ccCHHHHHHhhCCCCc-----CceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCc--ccce
Q 014904           33 TFTYEELARATDGFSD-----ANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKH--LVSL  105 (416)
Q Consensus        33 ~f~~~el~~~t~~f~~-----~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l  105 (416)
                      +.+-++|...-..|.+     ...|+.|-...+|+....+| .+++|+.....  ...++..|+.++..|...+  +.++
T Consensus         6 ~~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~   82 (307)
T TIGR00938         6 SVSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKP   82 (307)
T ss_pred             cCCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            4455777777667755     34566666678999876555 57888875432  2345566777777774322  3344


Q ss_pred             EEEE------EeCCeEEEEEEecCCCCHH-----------H---HhhcCCC------C----CCCHHHHHH---------
Q 014904          106 VGYY------TAGSQRMLVYEFVPNNTLE-----------F---HLHGKGR------P----TMDWLTRLK---------  146 (416)
Q Consensus       106 ~~~~------~~~~~~~lV~e~~~~~sL~-----------~---~l~~~~~------~----~l~~~~~~~---------  146 (416)
                      +...      ...+..++|++|++|..+.           .   .+|....      .    .-.|.....         
T Consensus        83 i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l  162 (307)
T TIGR00938        83 VKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQL  162 (307)
T ss_pred             ccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhccccc
Confidence            3321      2245678999999885431           1   1121100      0    011221110         


Q ss_pred             ---HHHHHHHHHHHHHh----cCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          147 ---IALGSAKGLAYLHE----DCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       147 ---i~~~ia~aL~~LH~----~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                         ....+.+.++++..    ....+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       163 EAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence               01123334555543    234589999999999999988767899998763

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.58  E-value=0.00052  Score=66.52  Aligned_cols=138  Identities=24%  Similarity=0.300  Sum_probs=81.4

Q ss_pred             eecccCcEEEEEEEeCC-------CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcc-cceEEEEEeCCeEEEEEEec
Q 014904           51 LLGQGGFGYVHRGVLPN-------GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        51 ~LG~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~  122 (416)
                      .|..|--..||+....+       ++.+++|+...... .......|+.++..+...++ .++++++..    .+|++|+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            44445556889888654       57899999765432 22345778888888864444 355655542    3689999


Q ss_pred             CCCCHHHH-----------------hhcCCCC-------CCC--HHHHHH--------------------------HHHH
Q 014904          123 PNNTLEFH-----------------LHGKGRP-------TMD--WLTRLK--------------------------IALG  150 (416)
Q Consensus       123 ~~~sL~~~-----------------l~~~~~~-------~l~--~~~~~~--------------------------i~~~  150 (416)
                      +|..+...                 +|.....       ..+  |.....                          +...
T Consensus        80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (302)
T cd05156          80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED  159 (302)
T ss_pred             CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence            88765321                 1211111       011  111111                          0111


Q ss_pred             HHHHHHHHHh------cCCCCeeeecccCCcEEECCC----CceEEeecccce
Q 014904          151 SAKGLAYLHE------DCHPKIIHRDIKAANILLDFK----FEAKVADFGLAK  193 (416)
Q Consensus       151 ia~aL~~LH~------~~~~~iiHrDIkp~NILl~~~----~~~kl~DFGla~  193 (416)
                      +...+..|-.      .....++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            2222334432      245578999999999999885    789999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.57  E-value=0.00042  Score=76.26  Aligned_cols=196  Identities=19%  Similarity=0.198  Sum_probs=134.5

Q ss_pred             HHHHHHHHHhcCCCcccceEEEEEeCCeEE----EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 014904           87 FQAEVEIISRVHHKHLVSLVGYYTAGSQRM----LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC  162 (416)
Q Consensus        87 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~  162 (416)
                      ...|+..+....|+|++.++.|.......-    +..+++..-++...++..+  ..+..+.+.+..++.+||+|+|+. 
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~-  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSL-  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHh-
Confidence            345777888889999999999876543332    3346777777777776554  477788888999999999999998 


Q ss_pred             CCCeeeecccCC---cEEECCCCceEEe--ecccceeccCCCcceeecccccccccChhhhccCCCC--chhhhHhHHHH
Q 014904          163 HPKIIHRDIKAA---NILLDFKFEAKVA--DFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT--EKSDVFSFGVM  235 (416)
Q Consensus       163 ~~~iiHrDIkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t--~ksDV~SlGvv  235 (416)
                        ...|.-+..+   +.-++.++.+.+.  ||+..+...+......  ..-+..+.++|........  ...|+|++|.+
T Consensus       306 --~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  306 --SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             --ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHHH
Confidence              6666655555   5555666677777  8888877665433322  2234557788877655444  44799999999


Q ss_pred             HHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 014904          236 LLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQI  315 (416)
Q Consensus       236 L~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev  315 (416)
                      +..+..|..+-.....                          +..-+....    ...+.....+|+..++++|+.+.++
T Consensus       382 ~~~~~~~~~i~~~~~~--------------------------~~~~l~~~~----~~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSAV--------------------------PVSLLDVLS----TSELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HhhhhhcCcccccccc--------------------------hhhhhcccc----chhhhhhhhhhcchhhhhccchhhh
Confidence            9999987665322110                          000000111    1146677789999999999999999


Q ss_pred             HHHh
Q 014904          316 VRAL  319 (416)
Q Consensus       316 v~~L  319 (416)
                      +...
T Consensus       432 l~~~  435 (1351)
T KOG1035|consen  432 LTHP  435 (1351)
T ss_pred             hhch
Confidence            9764

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.54  E-value=8.7e-05  Score=71.47  Aligned_cols=145  Identities=18%  Similarity=0.151  Sum_probs=98.9

Q ss_pred             ccCHHHHHHhhCC---CCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcc-----c-----------------HHHH
Q 014904           33 TFTYEELARATDG---FSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQ-----G-----------------EREF   87 (416)
Q Consensus        33 ~f~~~el~~~t~~---f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-----~-----------------~~~~   87 (416)
                      -+.|--|....++   ++..+.||-|.-+.||.+...+|++.++|.-......     .                 .-..
T Consensus        78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa  157 (465)
T KOG2268|consen   78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA  157 (465)
T ss_pred             cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence            3556666666664   4678999999999999999999999999975322110     0                 0123


Q ss_pred             HHHHHHHHhcCCCc--ccceEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 014904           88 QAEVEIISRVHHKH--LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK  165 (416)
Q Consensus        88 ~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~  165 (416)
                      ..|+..++.+....  +.+.+++    +..++|||++.+..|...-+-.     +..++   ...+..-+--|-..   |
T Consensus       158 ~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-----d~~~l---y~~lm~~Iv~la~~---G  222 (465)
T KOG2268|consen  158 TKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-----DPPTL---YDDLMGLIVRLANH---G  222 (465)
T ss_pred             HHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC-----ChHHH---HHHHHHHHHHHHHc---C
Confidence            45777788875432  3344443    4557999999998887654322     22222   22233334445566   9


Q ss_pred             eeeecccCCcEEECCCCceEEeecccc
Q 014904          166 IIHRDIKAANILLDFKFEAKVADFGLA  192 (416)
Q Consensus       166 iiHrDIkp~NILl~~~~~~kl~DFGla  192 (416)
                      +||+|++--||+|+++..++++||--.
T Consensus       223 lIHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  223 LIHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             ceecccchheeEEecCCCEEEeechHh
Confidence            999999999999999999999999654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.31  E-value=0.0018  Score=62.11  Aligned_cols=31  Identities=26%  Similarity=0.465  Sum_probs=25.5

Q ss_pred             CCeeeecccCCcEEECCCCc-eEEeeccccee
Q 014904          164 PKIIHRDIKAANILLDFKFE-AKVADFGLAKI  194 (416)
Q Consensus       164 ~~iiHrDIkp~NILl~~~~~-~kl~DFGla~~  194 (416)
                      +.++|+|+++.|||++.++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 46999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.31  E-value=0.0076  Score=60.76  Aligned_cols=75  Identities=20%  Similarity=0.184  Sum_probs=53.5

Q ss_pred             CceecccCcEEEEEEEeCCC-cEEEEEEeecC-----C--cccHHHHHHHHHHHHhcC---CCcccceEEEEEeCCeEEE
Q 014904           49 ANLLGQGGFGYVHRGVLPNG-KEVAIKQLKAG-----S--GQGEREFQAEVEIISRVH---HKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~~g-~~vavK~l~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  117 (416)
                      .+.||-|.+..||+....+| +.++||+-.+.     .  .....++..|.+.|..+.   -.++.+++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            35789999999999998777 58999985422     1  123456777888888863   2356667766  3355789


Q ss_pred             EEEecCCC
Q 014904          118 VYEFVPNN  125 (416)
Q Consensus       118 V~e~~~~~  125 (416)
                      |||++++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99999864

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.15  E-value=0.0064  Score=59.33  Aligned_cols=141  Identities=19%  Similarity=0.312  Sum_probs=82.3

Q ss_pred             ccCcE-EEEEEEeCCCcEEEEEEee-cCCcccHHHHHHHHHHHHhcCC--CcccceEEEEEeCC--eEEEEEEecCCCCH
Q 014904           54 QGGFG-YVHRGVLPNGKEVAIKQLK-AGSGQGEREFQAEVEIISRVHH--KHLVSLVGYYTAGS--QRMLVYEFVPNNTL  127 (416)
Q Consensus        54 ~G~~g-~Vy~~~~~~g~~vavK~l~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lV~e~~~~~sL  127 (416)
                      .||++ .+|.... ++++++++.-. ...........+|..+++.+.-  --+...+++|.++.  ..+.||+|++|..+
T Consensus        34 ~~G~sn~t~~~~~-~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~  112 (321)
T COG3173          34 SGGWSNDTFRLGD-TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVV  112 (321)
T ss_pred             cCCcccceEEEec-CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceec
Confidence            44555 3333333 38889988221 1122333566788888888753  34456677887766  67999999988322


Q ss_pred             HH------------------Hh---hcC--------C-------CCCCCHHHHHHHHH--------HHHHHHHHHHhcC-
Q 014904          128 EF------------------HL---HGK--------G-------RPTMDWLTRLKIAL--------GSAKGLAYLHEDC-  162 (416)
Q Consensus       128 ~~------------------~l---~~~--------~-------~~~l~~~~~~~i~~--------~ia~aL~~LH~~~-  162 (416)
                      ..                  .|   |.-        +       ++...|...+..+.        ....-..||+... 
T Consensus       113 ~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p  192 (321)
T COG3173         113 WSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRP  192 (321)
T ss_pred             cCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCC
Confidence            11                  11   100        0       00111222221111        1223345555442 


Q ss_pred             ----CCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          163 ----HPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       163 ----~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                          .+.++|+|+++.||+++.+.-+-|+||+++.+-
T Consensus       193 ~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         193 PWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             CcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                346999999999999999888999999998654

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.95  E-value=0.013  Score=56.86  Aligned_cols=64  Identities=6%  Similarity=0.088  Sum_probs=39.9

Q ss_pred             EEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCc--ccceEEE------EEeCCeEEEEEEecCCCCH
Q 014904           59 YVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKH--LVSLVGY------YTAGSQRMLVYEFVPNNTL  127 (416)
Q Consensus        59 ~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~e~~~~~sL  127 (416)
                      .||+....+| .+++|++...    ...+..|+..+..|...+  +++++..      ...++..++|++|++|..+
T Consensus        11 ~v~~v~t~~g-~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~   82 (313)
T TIGR02906        11 NVYKVETDSG-NKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC   82 (313)
T ss_pred             cEEEEEeCCC-CeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence            5888886555 5888987521    234556777777774333  3333321      2235678999999998554

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.93  E-value=0.0059  Score=58.95  Aligned_cols=139  Identities=19%  Similarity=0.227  Sum_probs=74.1

Q ss_pred             cCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC---CCcccceEEEEEeCCeEEEEEEecCC
Q 014904           48 DANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH---HKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        48 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ..+.|+-|....+|+.. .+++.+.||+-..   .....|..|++-|+.|.   --.+.+++++....+..+||+||++.
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            34578888889999877 5778899998762   22347888999888884   34577889888877778999999976


Q ss_pred             CCH--------H---HHhhc-CCCC-------------------CCCHHH-----HHHHHHHHH-----------HHHHH
Q 014904          125 NTL--------E---FHLHG-KGRP-------------------TMDWLT-----RLKIALGSA-----------KGLAY  157 (416)
Q Consensus       125 ~sL--------~---~~l~~-~~~~-------------------~l~~~~-----~~~i~~~ia-----------~aL~~  157 (416)
                      +..        .   ..+|. ....                   .-+|..     |+....+.+           +.+..
T Consensus        97 ~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~  176 (288)
T PF03881_consen   97 GSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVER  176 (288)
T ss_dssp             ----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHH
Confidence            611        1   11233 1110                   123322     112112111           11222


Q ss_pred             HHhc-----CCCCeeeecccCCcEEECCCCceEEeecc
Q 014904          158 LHED-----CHPKIIHRDIKAANILLDFKFEAKVADFG  190 (416)
Q Consensus       158 LH~~-----~~~~iiHrDIkp~NILl~~~~~~kl~DFG  190 (416)
                      +.+.     ..|-++|+||-+.|++++.++.+.|+|-.
T Consensus       177 ~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa  214 (288)
T PF03881_consen  177 LPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA  214 (288)
T ss_dssp             HHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred             HHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence            2221     24569999999999999999989998854

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.87  E-value=0.065  Score=52.69  Aligned_cols=95  Identities=13%  Similarity=0.058  Sum_probs=58.8

Q ss_pred             ccccCHHHHHHhhCCCCcC---c-eecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCc--ccc
Q 014904           31 KSTFTYEELARATDGFSDA---N-LLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKH--LVS  104 (416)
Q Consensus        31 ~~~f~~~el~~~t~~f~~~---~-~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~  104 (416)
                      ...++-+.+..+...+-+.   + ..-.+.-..||+....+++.+++|+..... ....++..|+..+..+....  ++.
T Consensus         8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~   86 (325)
T PRK11768          8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVA   86 (325)
T ss_pred             CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCC
Confidence            4456666776666655332   1 122345568999988788899999886433 34567778888887774221  222


Q ss_pred             eE---E--EEEeCCeEEEEEEecCCCC
Q 014904          105 LV---G--YYTAGSQRMLVYEFVPNNT  126 (416)
Q Consensus       105 l~---~--~~~~~~~~~lV~e~~~~~s  126 (416)
                      .+   |  +...++..+.|+++++|..
T Consensus        87 p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         87 PLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             CccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            11   1  1233467788999998764

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.84  E-value=0.013  Score=57.62  Aligned_cols=156  Identities=23%  Similarity=0.340  Sum_probs=92.1

Q ss_pred             cCHHHHHHhhCCCCc-----CceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcc------
Q 014904           34 FTYEELARATDGFSD-----ANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHL------  102 (416)
Q Consensus        34 f~~~el~~~t~~f~~-----~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni------  102 (416)
                      ++-.++..+...|..     ...|.+ .-..||+....+|+. ++|+....  ....++..|...+..+.-.++      
T Consensus        11 ~~~~~~~~~l~~~~~g~~~~~~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl   86 (331)
T COG2334          11 LTSDEAAAALEAYHYGLDGSLRGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPL   86 (331)
T ss_pred             cChHHHHHHHHhcCcCcccccccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            344555666555543     223444 556799999877776 89988765  455677788888888743222      


Q ss_pred             cceEE----EEEeCCeEEEEEEecCCCCHHH-----H----------hhc--CC----C----CCCCHHH----------
Q 014904          103 VSLVG----YYTAGSQRMLVYEFVPNNTLEF-----H----------LHG--KG----R----PTMDWLT----------  143 (416)
Q Consensus       103 v~l~~----~~~~~~~~~lV~e~~~~~sL~~-----~----------l~~--~~----~----~~l~~~~----------  143 (416)
                      ..+=|    ........+-|++|++|..+..     .          +|.  .+    +    ....|..          
T Consensus        87 ~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~  166 (331)
T COG2334          87 PSLDGELLEALSGGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLD  166 (331)
T ss_pred             cCCCcchhhhccCCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhc
Confidence            11111    1111237788999999987762     1          111  11    1    1233431          


Q ss_pred             ---HHHHHHHHHHHHHHHHhc----CCCC---eeeecccCCcEEECCCCc-eEEeecccce
Q 014904          144 ---RLKIALGSAKGLAYLHED----CHPK---IIHRDIKAANILLDFKFE-AKVADFGLAK  193 (416)
Q Consensus       144 ---~~~i~~~ia~aL~~LH~~----~~~~---iiHrDIkp~NILl~~~~~-~kl~DFGla~  193 (416)
                         ......++...+..+.+.    ....   +||+|+.|.||+++.+.. +-++||+-+.
T Consensus       167 ~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         167 LVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             ccCchhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               011223333444444432    2223   899999999999999875 8999999764

>PLN02236 choline kinase

Probab=96.67  E-value=0.028  Score=55.69  Aligned_cols=138  Identities=19%  Similarity=0.229  Sum_probs=80.2

Q ss_pred             eecccCcEEEEEEEeCC-----CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCccc-ceEEEEEeCCeEEEEEEecCC
Q 014904           51 LLGQGGFGYVHRGVLPN-----GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV-SLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        51 ~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      .|-.|---.+|+....+     ++.|++|+......... .-..|..++..+...++. ++++.+..+    .|++|+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            34335556899987532     36899998865432221 236788888888655554 566666433    58999987


Q ss_pred             CCHHHH-----------------hhcCC---CC-CCCHHHHHHHHH-----------------HHHHHHHHHHh-----c
Q 014904          125 NTLEFH-----------------LHGKG---RP-TMDWLTRLKIAL-----------------GSAKGLAYLHE-----D  161 (416)
Q Consensus       125 ~sL~~~-----------------l~~~~---~~-~l~~~~~~~i~~-----------------~ia~aL~~LH~-----~  161 (416)
                      .++...                 +|...   .. ...|....++..                 .+...+..|.+     .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            766311                 12211   11 112332222221                 11222222322     1


Q ss_pred             CCCCeeeecccCCcEEECC-CCceEEeecccce
Q 014904          162 CHPKIIHRDIKAANILLDF-KFEAKVADFGLAK  193 (416)
Q Consensus       162 ~~~~iiHrDIkp~NILl~~-~~~~kl~DFGla~  193 (416)
                      ....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            2336899999999999986 4679999998764

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.53  E-value=0.032  Score=56.00  Aligned_cols=74  Identities=15%  Similarity=0.186  Sum_probs=49.1

Q ss_pred             CceecccCcEEEEEEEeCC-CcEEEEEEeecCC------cccHHHHHHHHHHHHhcC--CCc-ccceEEEEEeCCeEEEE
Q 014904           49 ANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGS------GQGEREFQAEVEIISRVH--HKH-LVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~lV  118 (416)
                      .+.||-|--..||++.+.+ ++.|+||+-...-      .....+..-|.++|+...  .|. +.+++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            3578999999999999753 5789999864321      222356667888888763  454 4445543  33456688


Q ss_pred             EEecCC
Q 014904          119 YEFVPN  124 (416)
Q Consensus       119 ~e~~~~  124 (416)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888754

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.52  E-value=0.044  Score=53.37  Aligned_cols=32  Identities=16%  Similarity=0.250  Sum_probs=28.3

Q ss_pred             CCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       163 ~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      ..+++|+|+.+.|||++.++.+.|+||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            44799999999999999998999999988754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK06148 hypothetical protein; Provisional

Probab=96.48  E-value=0.034  Score=62.89  Aligned_cols=158  Identities=18%  Similarity=0.190  Sum_probs=85.8

Q ss_pred             cCHHHHHHh-hCCCCc---CceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC--CCcc--cce
Q 014904           34 FTYEELARA-TDGFSD---ANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH--HKHL--VSL  105 (416)
Q Consensus        34 f~~~el~~~-t~~f~~---~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--h~ni--v~l  105 (416)
                      ++-+++... .+.|-+   ...|+ |..-.+|+....+|+.+++|+......  ...+..|...+..|.  ++.+  .++
T Consensus        11 ~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~   87 (1013)
T PRK06148         11 FTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRL   87 (1013)
T ss_pred             CCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCee
Confidence            444454333 334443   24554 456788998887888999999986532  234445555665552  2222  222


Q ss_pred             EE--------EEEe-CC--eEEEEEEecCCCCHHHH-----------------hhc----CC----CCCCCHHH------
Q 014904          106 VG--------YYTA-GS--QRMLVYEFVPNNTLEFH-----------------LHG----KG----RPTMDWLT------  143 (416)
Q Consensus       106 ~~--------~~~~-~~--~~~lV~e~~~~~sL~~~-----------------l~~----~~----~~~l~~~~------  143 (416)
                      +-        .+.. ..  ..+.+++|++|..+...                 ++.    ..    ...+.|..      
T Consensus        88 i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l  167 (1013)
T PRK06148         88 IPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRA  167 (1013)
T ss_pred             eecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhh
Confidence            21        1111 12  46778999999877541                 110    10    11233321      


Q ss_pred             -----------HHHHHHHHHHHHHH----HHhcCCCCeeeecccCCcEEECCCC--ceE-Eeeccccee
Q 014904          144 -----------RLKIALGSAKGLAY----LHEDCHPKIIHRDIKAANILLDFKF--EAK-VADFGLAKI  194 (416)
Q Consensus       144 -----------~~~i~~~ia~aL~~----LH~~~~~~iiHrDIkp~NILl~~~~--~~k-l~DFGla~~  194 (416)
                                 ...++..++..+.-    .-......+||+|+++.|||++.+.  .+. |+|||.+..
T Consensus       168 ~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        168 RDRLHFIDDPEDRALVERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             hhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence                       11222222222211    1122344799999999999999875  554 999998753

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.42  E-value=0.0088  Score=54.78  Aligned_cols=121  Identities=21%  Similarity=0.267  Sum_probs=60.2

Q ss_pred             CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcc-cceEEEEEeCCeEEEEEEecCCCCHHH-------H---------
Q 014904           68 GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVYEFVPNNTLEF-------H---------  130 (416)
Q Consensus        68 g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~~sL~~-------~---------  130 (416)
                      ++.|+||+..... ...-.-..|..+++.+..-++ .++++++.++    +|++|+.+..|..       .         
T Consensus         2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence            4678999988663 222345678888888865444 4566655332    5779997665421       0         


Q ss_pred             -hhc-----CCCCCCCHHHHHHH----------------------HHHHHHHHHHHHh----c-CCCCeeeecccCCcEE
Q 014904          131 -LHG-----KGRPTMDWLTRLKI----------------------ALGSAKGLAYLHE----D-CHPKIIHRDIKAANIL  177 (416)
Q Consensus       131 -l~~-----~~~~~l~~~~~~~i----------------------~~~ia~aL~~LH~----~-~~~~iiHrDIkp~NIL  177 (416)
                       +|.     ......-|.....+                      ...+.+-+..+.+    . ...-++|+|+.+.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence             010     00111112222222                      0112222222222    1 1125789999999999


Q ss_pred             E-CCCCceEEeecccce
Q 014904          178 L-DFKFEAKVADFGLAK  193 (416)
Q Consensus       178 l-~~~~~~kl~DFGla~  193 (416)
                      + +.++.++++||..+.
T Consensus       157 ~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             ETSSSSCEEE--GTT-E
T ss_pred             eccCCCeEEEecHHHHh
Confidence            9 888999999998875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.36  E-value=0.017  Score=53.15  Aligned_cols=152  Identities=17%  Similarity=0.183  Sum_probs=91.3

Q ss_pred             cCcEEEEEEEeCCCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCHHHHhhc
Q 014904           55 GGFGYVHRGVLPNGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG  133 (416)
Q Consensus        55 G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~  133 (416)
                      +|-++.-++...-| +..+|++..-... ...-|..+.+++.+++  .|+++..-  ++....++.|.|.-...      
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            44445444443333 4566666543333 3456778888888875  45555522  34456688888743211      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeeccccccccc
Q 014904          134 KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL  213 (416)
Q Consensus       134 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Yl  213 (416)
                           +.    ..++..=+++|.-.|+. +.+.+|+|..|+||+-|..|.+||.|-+..-  ..           +.-|.
T Consensus       142 -----~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~-----------~V~~v  198 (308)
T PF07387_consen  142 -----NF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--EN-----------QVNMV  198 (308)
T ss_pred             -----ch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh--hh-----------eeeEE
Confidence                 11    12222224678888964 4589999999999999999999999966421  10           11122


Q ss_pred             ChhhhccCCCCchhhhHhHHHHHHHHHhCC
Q 014904          214 APEYASSGKLTEKSDVFSFGVMLLELITGR  243 (416)
Q Consensus       214 aPE~~~~~~~t~ksDV~SlGvvL~elltG~  243 (416)
                      --||   ...|.++.+-+|=.-++++....
T Consensus       199 N~~Y---~~lT~~aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  199 NIEY---ESLTQEAEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             eeec---cccChHHHHHHHHHHHHHHHHHH
Confidence            2122   34577888888777777777643

The function of this family is unknown.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.33  E-value=0.063  Score=54.22  Aligned_cols=73  Identities=12%  Similarity=0.130  Sum_probs=49.1

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEeecCCc-------ccHHHHHHHHHHHHhcC---CCcccceEEEEEeCCeEEEE
Q 014904           49 ANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSG-------QGEREFQAEVEIISRVH---HKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV  118 (416)
                      .+.||-|....||+.... ++.++||+-.....       ....+-..|+..|..+.   -.++.+++.++.+  ..++|
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence            457898999999998864 56799998652211       12223344566666653   2477788888874  46789


Q ss_pred             EEecCC
Q 014904          119 YEFVPN  124 (416)
Q Consensus       119 ~e~~~~  124 (416)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.03  E-value=0.0012  Score=74.72  Aligned_cols=159  Identities=13%  Similarity=0.035  Sum_probs=108.3

Q ss_pred             HHHHHHHHHhcCCCcccceEEEEE--eCCeEEEEEEecCCCCHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcC
Q 014904           87 FQAEVEIISRVHHKHLVSLVGYYT--AGSQRMLVYEFVPNNTLEFHLHGKGR--PTMDWLTRLKIALGSAKGLAYLHEDC  162 (416)
Q Consensus        87 ~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lV~e~~~~~sL~~~l~~~~~--~~l~~~~~~~i~~~ia~aL~~LH~~~  162 (416)
                      ...|.+.++...|++++....-..  +....+.+++++.+|.+...|-....  +.+...-......+......-+|...
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            344555566667888776554433  23445788899999999888864322  23333332222233344455555443


Q ss_pred             C--CCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHH
Q 014904          163 H--PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI  240 (416)
Q Consensus       163 ~--~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ell  240 (416)
                      +  .--+|+++|+.|.+|..+..+|+.++|+.+....... ......+++-|+.|+....-+++.++|+|..|+.+|++.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence            1  2368999999999999999999999999984433222 223456777899999998889999999999999999888


Q ss_pred             hCCCCC
Q 014904          241 TGRRPV  246 (416)
Q Consensus       241 tG~~pf  246 (416)
                      -|..+|
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            776554

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.02  E-value=0.073  Score=52.43  Aligned_cols=138  Identities=16%  Similarity=0.211  Sum_probs=77.0

Q ss_pred             eecccCcEEEEEEEeCC----CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcc-cceEEEEEeCCeEEEEEEecCCC
Q 014904           51 LLGQGGFGYVHRGVLPN----GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVYEFVPNN  125 (416)
Q Consensus        51 ~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~~  125 (416)
                      .|-.|=--.+|+....+    +..|++|+........ -.-.+|..+++.+..-++ .++++++..+    +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence            34334445788876533    2479999876543221 123578888888876555 4566665322    589999876


Q ss_pred             CHHH-----------------HhhcCC---CCCC-CHHHHHHHHHH----------------------HHHHHHHHHhc-
Q 014904          126 TLEF-----------------HLHGKG---RPTM-DWLTRLKIALG----------------------SAKGLAYLHED-  161 (416)
Q Consensus       126 sL~~-----------------~l~~~~---~~~l-~~~~~~~i~~~----------------------ia~aL~~LH~~-  161 (416)
                      .|..                 .+|...   .... -|.....+..+                      +..-+..+... 
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            6521                 012211   1111 23322222111                      11122222221 


Q ss_pred             ----CCCCeeeecccCCcEEECC-CCceEEeecccce
Q 014904          162 ----CHPKIIHRDIKAANILLDF-KFEAKVADFGLAK  193 (416)
Q Consensus       162 ----~~~~iiHrDIkp~NILl~~-~~~~kl~DFGla~  193 (416)
                          ...-++|.|+.+.|||+++ ++.++++||..+-
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence                1224799999999999974 5689999998763

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.92  E-value=0.13  Score=51.17  Aligned_cols=72  Identities=15%  Similarity=0.111  Sum_probs=47.2

Q ss_pred             eecccCcEEEEEEEeCCC-cEEEEEEeecCC-------cccHHHHHHHHHHHHhcC--CCc-ccceEEEEEeCCeEEEEE
Q 014904           51 LLGQGGFGYVHRGVLPNG-KEVAIKQLKAGS-------GQGEREFQAEVEIISRVH--HKH-LVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        51 ~LG~G~~g~Vy~~~~~~g-~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~lV~  119 (416)
                      .||-|-...||++..++| +.|+||+-.+.-       .....+..-|...|....  .|. +.+++.  .+.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            378888999999998655 689999864221       222345556777777663  354 344443  3445567999


Q ss_pred             EecCC
Q 014904          120 EFVPN  124 (416)
Q Consensus       120 e~~~~  124 (416)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99865

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.20  E-value=0.053  Score=53.49  Aligned_cols=102  Identities=16%  Similarity=0.176  Sum_probs=69.9

Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ..++++++- |+++...      ....|.+.+.|+.+.+..++-+...-  .+-|||+.-.||||+ +|++-|+||-+++
T Consensus       300 y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         300 YLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             EEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeee
Confidence            445666654 4444321      24578899999999998888888764  788999999999999 9999999999998


Q ss_pred             eccCCCcceeecccccccccChhhhccCCCCchhhhHhH
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSF  232 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~Sl  232 (416)
                      +-...+.- .     .-..--|-.+. |.-+..=+||-+
T Consensus       370 l~~~q~~i-s-----y~rldhp~lF~-G~dd~QFeIYrl  401 (488)
T COG5072         370 LSYSQGII-S-----YNRLDHPDLFN-GVDDYQFEIYRL  401 (488)
T ss_pred             cccCCcee-e-----ccccCchhhhc-CccceeeeHHHH
Confidence            54332221 1     11233455555 444666777763

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.03  E-value=0.52  Score=43.87  Aligned_cols=170  Identities=19%  Similarity=0.293  Sum_probs=98.9

Q ss_pred             EEEEEEE-e-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCC---CcccceEEEEEeCCeEEEEEEecCCCCHH----
Q 014904           58 GYVHRGV-L-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHH---KHLVSLVGYYTAGSQRMLVYEFVPNNTLE----  128 (416)
Q Consensus        58 g~Vy~~~-~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lV~e~~~~~sL~----  128 (416)
                      |.|..|. + ....++.||+-.   ......|.+|+.-|..+.-   -.+.+++.......+.+||+||++-+.+.    
T Consensus        27 G~inea~~v~dg~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d~~~~  103 (286)
T COG3001          27 GDINEAWRLRDGTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLDAHSA  103 (286)
T ss_pred             ccccceeEeecCCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCCchhH
Confidence            4455555 2 245778888643   2334578888888877743   55677888888889999999999876554    


Q ss_pred             -------HHhhcCCC----------------CCCCHH---------HHHHHHHHHH--------------HHHHHHHhcC
Q 014904          129 -------FHLHGKGR----------------PTMDWL---------TRLKIALGSA--------------KGLAYLHEDC  162 (416)
Q Consensus       129 -------~~l~~~~~----------------~~l~~~---------~~~~i~~~ia--------------~aL~~LH~~~  162 (416)
                             ..||..+.                .+-.|.         +|+.+..++|              ..+..+=...
T Consensus       104 ~~~GqqLA~LH~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~~~~~v~elL~~h  183 (286)
T COG3001         104 FILGQQLARLHQWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDAIVEKIQELLADH  183 (286)
T ss_pred             HHHHHHHHHHHhhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHHHHHHHHHHHhcC
Confidence                   11221110                112222         2333333332              2333333333


Q ss_pred             --CCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee-ecccccccccChhhhcc--------CCCCchhhhHh
Q 014904          163 --HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS-TRVMGTFGYLAPEYASS--------GKLTEKSDVFS  231 (416)
Q Consensus       163 --~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~~~gt~~YlaPE~~~~--------~~~t~ksDV~S  231 (416)
                        .|..+|+||-..|+++..+| +.+.|  -|+..++...... +.+.|.   .+||...+        ..+.++.++|.
T Consensus       184 qpqPsLlHGDLW~gN~a~~~~G-Pv~fD--PA~y~GDrE~Dlam~elFgg---fp~efy~gY~sv~PL~~G~~eRk~iYq  257 (286)
T COG3001         184 QPQPSLLHGDLWSGNCAFGKDG-PVIFD--PACYWGDRECDLAMLELFGG---FPPEFYDGYQSVSPLPAGYLERKPIYQ  257 (286)
T ss_pred             CCCcceeecccccccccccCCC-Ceeec--cccccCCcccceehhhhhcC---CcHHHHHhhhccCCCCCchHHHhHHHH
Confidence              46799999999999999998 77766  3445554444332 222233   45665432        23456777777


Q ss_pred             HHHHH
Q 014904          232 FGVML  236 (416)
Q Consensus       232 lGvvL  236 (416)
                      |=.+|
T Consensus       258 LY~ll  262 (286)
T COG3001         258 LYHLL  262 (286)
T ss_pred             HHHHH
Confidence            54443

>PTZ00384 choline kinase; Provisional

Probab=94.57  E-value=0.34  Score=48.81  Aligned_cols=73  Identities=18%  Similarity=0.253  Sum_probs=43.4

Q ss_pred             eecccCcEEEEEEEeCCC--cE-----EEEEEeecCCcccHHHHHHHHHHHHhcCCCccc-ceEEEEEeCCeEEEEEEec
Q 014904           51 LLGQGGFGYVHRGVLPNG--KE-----VAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV-SLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        51 ~LG~G~~g~Vy~~~~~~g--~~-----vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~  122 (416)
                      .|..|--..+|++...++  ..     |.++......... -.-..|+.+++.+...++. ++++.+..    ++|+||+
T Consensus        57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efI  131 (383)
T PTZ00384         57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLV-IDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWV  131 (383)
T ss_pred             EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceE-eccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEe
Confidence            444466678999875443  22     4444332211111 1235688999999766554 56665543    4899999


Q ss_pred             CCCCHH
Q 014904          123 PNNTLE  128 (416)
Q Consensus       123 ~~~sL~  128 (416)
                      +|..|.
T Consensus       132 eGr~l~  137 (383)
T PTZ00384        132 EGNTMG  137 (383)
T ss_pred             ccccCC
Confidence            987764

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.30  E-value=0.16  Score=50.96  Aligned_cols=63  Identities=17%  Similarity=0.152  Sum_probs=44.7

Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK  181 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~  181 (416)
                      ...||-+|..|.++..++..+.   .+...+.+++.-.+.||..+-.-.  +++|.|+.|.||++..+
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRFN  381 (565)
T ss_pred             cceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEec
Confidence            3467778999999999887664   344555666666666655443322  79999999999999543

>PTZ00296 choline kinase; Provisional

Probab=93.91  E-value=0.61  Score=47.88  Aligned_cols=72  Identities=11%  Similarity=0.108  Sum_probs=43.3

Q ss_pred             eecccCcEEEEEEEeCC---------CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCccc-ceEEEEEeCCeEEEEEE
Q 014904           51 LLGQGGFGYVHRGVLPN---------GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV-SLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        51 ~LG~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e  120 (416)
                      .|..|=--.+|+....+         ++.|++|+.......-. .-..|..++..+...+|- ++++.+.    -..|.+
T Consensus       112 ~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~e  186 (442)
T PTZ00296        112 QILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRIEE  186 (442)
T ss_pred             EecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEEEE
Confidence            33334445778777542         46788888765432211 235688888888655554 5565543    236899


Q ss_pred             ecCCCCH
Q 014904          121 FVPNNTL  127 (416)
Q Consensus       121 ~~~~~sL  127 (416)
                      |++|..|
T Consensus       187 fi~g~~l  193 (442)
T PTZ00296        187 WLYGDPL  193 (442)
T ss_pred             eeCCccC
Confidence            9988744

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	416
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-69
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-68
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-47
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-47
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-42
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-42
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-42
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-40
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-28
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-28
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-27
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-26
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-26
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-23
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-23
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-23
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-23
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-22
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-22
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-22
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-21
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-21
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-21
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-21
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-21
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-21
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-21
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-21
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-21
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-21
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-20
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-20
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-20
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-20
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		9e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-19
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-19
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-19
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-19
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-19
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-19
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-19
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-19
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-18
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-18
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-18
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-18
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-18
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-18
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-18
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-18
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-18
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-18
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-18
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-18
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-18
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-17
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-17
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-17
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-17
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-17
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-17
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-17
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-17
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-17
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-17
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-17
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-17
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-17
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-17
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-17
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-17
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-17
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-17
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-17
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-17
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-17
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-16
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-16
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-16
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-16
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-16
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-16
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-16
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-16
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-16
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-16
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-16
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-16
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-16
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-16
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-16
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-16
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-16
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-16
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-16
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-15
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-15
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-15
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-15
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-15
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-15
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		7e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-15
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-14
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-14
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-14
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-14
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-14
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-14
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-14
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		8e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-13
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-13
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		7e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		8e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		9e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		9e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		7e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		9e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-12
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-11
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-11
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		8e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-08
3soa_A	444	Full-Length Human Camkii Length = 444		4e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		8e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		8e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		9e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		8e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		8e-06
3gni_B	389	Structure Of Strad And Mo25 Length = 389		9e-06
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  258 bits (658), Expect = 6e-69,   Method: Compositional matrix adjust.
 Identities = 138/294 (46%), Positives = 187/294 (63%), Gaps = 9/294 (3%)
Query: 34  FTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQG-EREFQAEVE 92
           F+  EL  A+D FS+ N+LG+GGFG V++G L +G  VA+K+LK    QG E +FQ EVE
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 93  IISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGK--GRPTMDWLTRLKIALG 150
           +IS   H++L+ L G+    ++R+LVY ++ N ++   L  +   +P +DW  R +IALG
Sbjct: 88  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 147
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
           SA+GLAYLH+ C PKIIHRD+KAANILLD +FEA V DFGLAK+    + HV   V GT 
Sbjct: 148 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTI 207
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDS--LVDWARPLLNRA 268
           G++APEY S+GK +EK+DVF +GVMLLELITG+R  D      +D   L+DW + LL   
Sbjct: 208 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL--- 264
Query: 269 IEDGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRMSQIVRALEGD 322
            ++   + LVD  L   Y   E              S   RP+MS++VR LEGD
Sbjct: 265 -KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  254 bits (650), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 136/294 (46%), Positives = 185/294 (62%), Gaps = 9/294 (3%)
Query: 34  FTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQG-EREFQAEVE 92
           F+  EL  A+D F + N+LG+GGFG V++G L +G  VA+K+LK    QG E +FQ EVE
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 93  IISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGK--GRPTMDWLTRLKIALG 150
           +IS   H++L+ L G+    ++R+LVY ++ N ++   L  +   +P +DW  R +IALG
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
           SA+GLAYLH+ C PKIIHRD+KAANILLD +FEA V DFGLAK+    + HV   V G  
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXI 199
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDS--LVDWARPLLNRA 268
           G++APEY S+GK +EK+DVF +GVMLLELITG+R  D      +D   L+DW + LL   
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL--- 256
Query: 269 IEDGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRMSQIVRALEGD 322
            ++   + LVD  L   Y   E              S   RP+MS++VR LEGD
Sbjct: 257 -KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 110/286 (38%), Positives = 165/286 (57%), Gaps = 10/286 (3%)
Query: 38  ELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV 97
           +L  AT+ F    L+G G FG V++GVL +G +VA+K+    S QG  EF+ E+E +S  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPT--MDWLTRLKIALGSAKGL 155
            H HLVSL+G+    ++ +L+Y+++ N  L+ HL+G   PT  M W  RL+I +G+A+GL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLA 214
            YLH      IIHRD+K+ NILLD  F  K+ DFG++K  ++++ TH+   V GT GY+ 
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 215 PEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF 274
           PEY   G+LTEKSDV+SFGV+L E++  R  +  +      +L +WA    N    +G  
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN----NGQL 265
Query: 275 DTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRMSQIVRALE 320
           + +VDP L ++                   S+  RP M  ++  LE
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  186 bits (471), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 110/286 (38%), Positives = 164/286 (57%), Gaps = 10/286 (3%)
Query: 38  ELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV 97
           +L  AT+ F    L+G G FG V++GVL +G +VA+K+    S QG  EF+ E+E +S  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPT--MDWLTRLKIALGSAKGL 155
            H HLVSL+G+    ++ +L+Y+++ N  L+ HL+G   PT  M W  RL+I +G+A+GL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV-NTHVSTRVMGTFGYLA 214
            YLH      IIHRD+K+ NILLD  F  K+ DFG++K  +++  TH+   V GT GY+ 
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYID 209
Query: 215 PEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF 274
           PEY   G+LTEKSDV+SFGV+L E++  R  +  +      +L +WA    N    +G  
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN----NGQL 265
Query: 275 DTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRMSQIVRALE 320
           + +VDP L ++                   S+  RP M  ++  LE
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 94/227 (41%), Positives = 146/227 (64%), Gaps = 17/227 (7%)
Query: 33  TFTYEELARATDGFSD------ANLLGQGGFGYVHRGVLPNGKEVAIKQLKA----GSGQ 82
           +F++ EL   T+ F +       N +G+GGFG V++G + N   VA+K+L A     + +
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 83  GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG-KGRPTMDW 141
            +++F  E++++++  H++LV L+G+ + G    LVY ++PN +L   L    G P + W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD-VNT 200
             R KIA G+A G+ +LHE+ H   IHRDIK+ANILLD  F AK++DFGLA+ +     T
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
            + +R++GT  Y+APE A  G++T KSD++SFGV+LLE+ITG   VD
Sbjct: 190 VMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 94/227 (41%), Positives = 145/227 (63%), Gaps = 17/227 (7%)
Query: 33  TFTYEELARATDGFSD------ANLLGQGGFGYVHRGVLPNGKEVAIKQLKA----GSGQ 82
           +F++ EL   T+ F +       N +G+GGFG V++G + N   VA+K+L A     + +
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 83  GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG-KGRPTMDW 141
            +++F  E++++++  H++LV L+G+ + G    LVY ++PN +L   L    G P + W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD-VNT 200
             R KIA G+A G+ +LHE+ H   IHRDIK+ANILLD  F AK++DFGLA+ +     T
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
            +  R++GT  Y+APE A  G++T KSD++SFGV+LLE+ITG   VD
Sbjct: 190 VMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  168 bits (425), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 94/227 (41%), Positives = 144/227 (63%), Gaps = 17/227 (7%)
Query: 33  TFTYEELARATDGFSD------ANLLGQGGFGYVHRGVLPNGKEVAIKQLKA----GSGQ 82
           +F++ EL   T+ F +       N +G+GGFG V++G + N   VA+K+L A     + +
Sbjct: 8   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 66
Query: 83  GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG-KGRPTMDW 141
            +++F  E++++++  H++LV L+G+ + G    LVY ++PN +L   L    G P + W
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 126
Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH 201
             R KIA G+A G+ +LHE+ H   IHRDIK+ANILLD  F AK++DFGLA+ +      
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 202 V-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
           V   R++GT  Y+APE A  G++T KSD++SFGV+LLE+ITG   VD
Sbjct: 184 VMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 229

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 94/227 (41%), Positives = 141/227 (62%), Gaps = 17/227 (7%)
Query: 33  TFTYEELARATDGFSD------ANLLGQGGFGYVHRGVLPNGKEVAIKQLKA----GSGQ 82
           +F++ EL   T+ F +       N  G+GGFG V++G + N   VA+K+L A     + +
Sbjct: 5   SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 63
Query: 83  GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG-KGRPTMDW 141
            +++F  E+++ ++  H++LV L+G+ + G    LVY + PN +L   L    G P + W
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSW 123
Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH 201
             R KIA G+A G+ +LHE+ H   IHRDIK+ANILLD  F AK++DFGLA+ +      
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 202 V-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
           V  +R++GT  Y APE A  G++T KSD++SFGV+LLE+ITG   VD
Sbjct: 181 VXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 226

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/206 (38%), Positives = 114/206 (55%), Gaps = 9/206 (4%)
Query: 46  FSDANL---LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGER--EFQAEVEIISRVHHK 100
           + D N+   +G G FG VHR    +G +VA+K L       ER  EF  EV I+ R+ H 
Sbjct: 36  WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG-RPTMDWLTRLKIALGSAKGLAYLH 159
           ++V  +G  T      +V E++   +L   LH  G R  +D   RL +A   AKG+ YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
              +P I+HRD+K+ N+L+D K+  KV DFGL+++ +      S    GT  ++APE   
Sbjct: 155 NR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLX-SKXAAGTPEWMAPEVLR 212
Query: 220 SGKLTEKSDVFSFGVMLLELITGRRP 245
                EKSDV+SFGV+L EL T ++P
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/207 (38%), Positives = 119/207 (57%), Gaps = 11/207 (5%)
Query: 46  FSDANL---LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGER--EFQAEVEIISRVHHK 100
           + D N+   +G G FG VHR    +G +VA+K L       ER  EF  EV I+ R+ H 
Sbjct: 36  WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG-RPTMDWLTRLKIALGSAKGLAYLH 159
           ++V  +G  T      +V E++   +L   LH  G R  +D   RL +A   AKG+ YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR-VMGTFGYLAPEYA 218
              +P I+HR++K+ N+L+D K+  KV DFGL+++ +  +T +S++   GT  ++APE  
Sbjct: 155 NR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVL 211
Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
                 EKSDV+SFGV+L EL T ++P
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 82/211 (38%), Positives = 117/211 (55%), Gaps = 23/211 (10%)
Query: 52  LGQGGFGYVHRGVLPNGKEV-AIKQLKAGSGQGE-------REFQAEVEIISRVHHKHLV 103
           +G+GGFG VH+G L   K V AIK L  G  +GE       +EFQ EV I+S ++H ++V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            L G       RM V EFVP   L   L  K  P + W  +L++ L  A G+ Y+ ++ +
Sbjct: 87  KLYGL-MHNPPRM-VMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYM-QNQN 142
Query: 164 PKIIHRDIKAANILLDFKFE-----AKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY- 217
           P I+HRD+++ NI L    E     AKVADFGL    S  + H  + ++G F ++APE  
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL----SQQSVHSVSGLLGNFQWMAPETI 198
Query: 218 -ASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
            A     TEK+D +SF ++L  ++TG  P D
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/211 (38%), Positives = 116/211 (54%), Gaps = 23/211 (10%)
Query: 52  LGQGGFGYVHRGVLPNGKEV-AIKQLKAGSGQGE-------REFQAEVEIISRVHHKHLV 103
           +G+GGFG VH+G L   K V AIK L  G  +GE       +EFQ EV I+S ++H ++V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            L G       RM V EFVP   L   L  K  P + W  +L++ L  A G+ Y+ ++ +
Sbjct: 87  KLYGL-MHNPPRM-VMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYM-QNQN 142
Query: 164 PKIIHRDIKAANILLDFKFE-----AKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY- 217
           P I+HRD+++ NI L    E     AKVADFG     S  + H  + ++G F ++APE  
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG----TSQQSVHSVSGLLGNFQWMAPETI 198
Query: 218 -ASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
            A     TEK+D +SF ++L  ++TG  P D
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/211 (38%), Positives = 116/211 (54%), Gaps = 23/211 (10%)
Query: 52  LGQGGFGYVHRGVLPNGKEV-AIKQLKAGSGQGE-------REFQAEVEIISRVHHKHLV 103
           +G+GGFG VH+G L   K V AIK L  G  +GE       +EFQ EV I+S ++H ++V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            L G       RM V EFVP   L   L  K  P + W  +L++ L  A G+ Y+ ++ +
Sbjct: 87  KLYGL-MHNPPRM-VMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYM-QNQN 142
Query: 164 PKIIHRDIKAANILLDFKFE-----AKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY- 217
           P I+HRD+++ NI L    E     AKVADF L    S  + H  + ++G F ++APE  
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSL----SQQSVHSVSGLLGNFQWMAPETI 198
Query: 218 -ASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
            A     TEK+D +SF ++L  ++TG  P D
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/207 (35%), Positives = 107/207 (51%), Gaps = 8/207 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG VH G   N  +VAIK +K GS   E +F  E E++ ++ H  LV L G    
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
            +   LV+EF+ +  L  +L  + R      T L + L   +G+AYL E C   +IHRD+
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 149
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
            A N L+      KV+DFG+ +   D     ST       + +PE  S  + + KSDV+S
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 232 FGVMLLELIT-GRRPVD--STHTFVED 255
           FGV++ E+ + G+ P +  S    VED
Sbjct: 210 FGVLMWEVFSEGKIPYENRSNSEVVED 236

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 107/207 (51%), Gaps = 8/207 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG VH G   N  +VAIK ++ G+   E +F  E E++ ++ H  LV L G    
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
            +   LV+EF+ +  L  +L  + R      T L + L   +G+AYL E C   +IHRD+
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 132
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
            A N L+      KV+DFG+ +   D     ST       + +PE  S  + + KSDV+S
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 232 FGVMLLELIT-GRRPVD--STHTFVED 255
           FGV++ E+ + G+ P +  S    VED
Sbjct: 193 FGVLMWEVFSEGKIPYENRSNSEVVED 219

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 107/207 (51%), Gaps = 8/207 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG VH G   N  +VAIK ++ G+   E +F  E E++ ++ H  LV L G    
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
            +   LV+EF+ +  L  +L  + R      T L + L   +G+AYL E C   +IHRD+
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 129
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
            A N L+      KV+DFG+ +   D     ST       + +PE  S  + + KSDV+S
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 232 FGVMLLELIT-GRRPVD--STHTFVED 255
           FGV++ E+ + G+ P +  S    VED
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEVVED 216

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 107/207 (51%), Gaps = 8/207 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG VH G   N  +VAIK ++ G+   E +F  E E++ ++ H  LV L G    
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
            +   LV+EF+ +  L  +L  + R      T L + L   +G+AYL E C   +IHRD+
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 127
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
            A N L+      KV+DFG+ +   D     ST       + +PE  S  + + KSDV+S
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 232 FGVMLLELIT-GRRPVD--STHTFVED 255
           FGV++ E+ + G+ P +  S    VED
Sbjct: 188 FGVLMWEVFSEGKIPYENRSNSEVVED 214

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 106/207 (51%), Gaps = 8/207 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG VH G   N  +VAIK ++ G+   E +F  E E++ ++ H  LV L G    
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
            +   LV EF+ +  L  +L  + R      T L + L   +G+AYL E C   +IHRD+
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 130
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
            A N L+      KV+DFG+ +   D     ST       + +PE  S  + + KSDV+S
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 232 FGVMLLELIT-GRRPVD--STHTFVED 255
           FGV++ E+ + G+ P +  S    VED
Sbjct: 191 FGVLMWEVFSEGKIPYENRSNSEVVED 217

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/199 (35%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 51  LLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           ++G+G FG V +      K+VAIKQ+++ S +  + F  E+  +SRV+H ++V L G   
Sbjct: 16  VVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYG--A 70
Query: 111 AGSQRMLVYEFVPNNTLEFHLHG-KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
             +   LV E+    +L   LHG +  P       +   L  ++G+AYLH      +IHR
Sbjct: 71  CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 130
Query: 170 DIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 228
           D+K  N+LL       K+ DFG    A D+ TH+ T   G+  ++APE       +EK D
Sbjct: 131 DLKPPNLLLVAGGTVLKICDFG---TACDIQTHM-TNNKGSAAWMAPEVFEGSNYSEKCD 186
Query: 229 VFSFGVMLLELITGRRPVD 247
           VFS+G++L E+IT R+P D
Sbjct: 187 VFSWGIILWEVITRRKPFD 205

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/199 (35%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 51  LLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           ++G+G FG V +      K+VAIKQ+++ S +  + F  E+  +SRV+H ++V L G   
Sbjct: 15  VVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYG--A 69
Query: 111 AGSQRMLVYEFVPNNTLEFHLHG-KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
             +   LV E+    +L   LHG +  P       +   L  ++G+AYLH      +IHR
Sbjct: 70  CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 170 DIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 228
           D+K  N+LL       K+ DFG    A D+ TH+ T   G+  ++APE       +EK D
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFG---TACDIQTHM-TNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 229 VFSFGVMLLELITGRRPVD 247
           VFS+G++L E+IT R+P D
Sbjct: 186 VFSWGIILWEVITRRKPFD 204

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 106/207 (51%), Gaps = 8/207 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG VH G   N  +VAIK ++ G+   E +F  E E++ ++ H  LV L G    
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
            +   LV+EF+ +  L  +L  + R      T L + L   +G+AYL E     +IHRD+
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ASVIHRDL 129
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
            A N L+      KV+DFG+ +   D     ST       + +PE  S  + + KSDV+S
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 232 FGVMLLELIT-GRRPVD--STHTFVED 255
           FGV++ E+ + G+ P +  S    VED
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEVVED 216

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 71
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + +A   A G+AY+    +   +HR
Sbjct: 72  VSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHR 128
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 188
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 189 WSFGILLTELTTKGRVP 205

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 247
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + +A   A G+AY+        +HR
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 365 WSFGILLTELTTKGRVP 381

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 247
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + +A   A G+AY+        +HR
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 365 WSFGILLTELTTKGRVP 381

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 330
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + +A   A G+AY+    +   +HR
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHR 387
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 448 WSFGILLTELTTKGRVP 464

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKIRHEKLVQL---YAV 81
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + +A   A G+AY+    +   +HR
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHR 138
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 199 WSFGILLTELTTKGRVP 215

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 81
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + +A   A G+AY+    +   +HR
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHR 138
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 199 WSFGILLTELTTKGRVP 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 74
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + +A   A G+AY+    +   +HR
Sbjct: 75  VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHR 131
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 191
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 192 WSFGILLTELTTKGRVP 208

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 247
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + +A   A G+AY+        +HR
Sbjct: 248 VSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 365 WSFGILLTELTTKGRVP 381

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 81
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + +A   A G+AY+    +   +HR
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHR 138
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 199 WSFGILLTELTTKGRVP 215

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 81
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + +A   A G+AY+    +   +HR
Sbjct: 82  VSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHR 138
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 199 WSFGILLTELTTKGRVP 215

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 72
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + +A   A G+AY+    +   +HR
Sbjct: 73  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHR 129
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 190 WSFGILLTELTTKGRVP 206

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 99/195 (50%), Gaps = 6/195 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VAIK LK G+   E  F  E +I+ ++ H  LV L    + 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
               ++       + L+F   G+GR  +     + +A   A G+AY+    +   IHRD+
Sbjct: 76  EPIYIVTEYMNKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIERMNY---IHRDL 131
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           ++ANIL+      K+ADFGLA++  D              + APE A  G+ T KSDV+S
Sbjct: 132 RSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 191
Query: 232 FGVMLLELIT-GRRP 245
           FG++L EL+T GR P
Sbjct: 192 FGILLTELVTKGRVP 206

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 81
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++    L   L G+    +     + +A   A G+AY+    +   +HR
Sbjct: 82  VSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHR 138
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 199 WSFGILLTELTTKGRVP 215

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 70
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + +A   A G+AY+    +   +HR
Sbjct: 71  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHR 127
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 188 WSFGILLTELTTKGRVP 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 81
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + +A   A G+AY+    +   +HR
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHR 138
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 199 WSFGILLTELTTKGRVP 215

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 81
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++    L   L G+    +     + +A   A G+AY+    +   +HR
Sbjct: 82  VSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHR 138
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 199 WSFGILLTELTTKGRVP 215

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 6/195 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K LK GS   +  F AE  ++ ++ H+ LV L    T 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N +L   L       +     L +A   A+G+A++ E  +   IHRD+
Sbjct: 86  -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDL 141
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV+S
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 232 FGVMLLELIT-GRRP 245
           FG++L E++T GR P
Sbjct: 202 FGILLTEIVTHGRIP 216

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 6/195 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K LK GS   +  F AE  ++ ++ H+ LV L    T 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N +L   L       +     L +A   A+G+A++ E  +   IHRD+
Sbjct: 88  -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDL 143
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV+S
Sbjct: 144 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 203
Query: 232 FGVMLLELIT-GRRP 245
           FG++L E++T GR P
Sbjct: 204 FGILLTEIVTHGRIP 218

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 6/195 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K LK GS   +  F AE  ++ ++ H+ LV L    T 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N +L   L       +     L +A   A+G+A++ E  +   IHRD+
Sbjct: 82  -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDL 137
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV+S
Sbjct: 138 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 197
Query: 232 FGVMLLELIT-GRRP 245
           FG++L E++T GR P
Sbjct: 198 FGILLTEIVTHGRIP 212

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 78
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + ++   A G+AY+    +   +HR
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY---VHR 135
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 196 WSFGILLTELTTKGRVP 212

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 6/195 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K LK GS   +  F AE  ++ ++ H+ LV L    T 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N +L   L       +     L +A   A+G+A++ E  +   IHRD+
Sbjct: 80  -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDL 135
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 232 FGVMLLELIT-GRRP 245
           FG++L E++T GR P
Sbjct: 196 FGILLTEIVTHGRIP 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 6/195 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K LK GS   +  F AE  ++ ++ H+ LV L    T 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N +L   L       +     L +A   A+G+A++ E  +   IHRD+
Sbjct: 81  -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDL 136
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV+S
Sbjct: 137 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 196
Query: 232 FGVMLLELIT-GRRP 245
           FG++L E++T GR P
Sbjct: 197 FGILLTEIVTHGRIP 211

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 6/195 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K LK GS   +  F AE  ++ ++ H+ LV L    T 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N +L   L       +     L +A   A+G+A++ E  +   IHRD+
Sbjct: 80  -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDL 135
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 232 FGVMLLELIT-GRRP 245
           FG++L E++T GR P
Sbjct: 196 FGILLTEIVTHGRIP 210

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 6/195 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K LK GS   +  F AE  ++ ++ H+ LV L    T 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N +L   L       +     L +A   A+G+A++ E  +   IHRD+
Sbjct: 89  -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDL 144
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV+S
Sbjct: 145 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 204
Query: 232 FGVMLLELIT-GRRP 245
           FG++L E++T GR P
Sbjct: 205 FGILLTEIVTHGRIP 219

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 78
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + ++   A G+AY+    +   +HR
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY---VHR 135
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 196 WSFGILLTELTTKGRVP 212

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 81
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + +A   A G+AY+    +   +HR
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHR 138
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D+ AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 199 WSFGILLTELTTKGRVP 215

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 70/197 (35%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L   Y  
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE-AFLQEAQVMKKLRHEKLVQL---YAV 248
Query: 112 GSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            S+    +V E++   +L   L G+    +     + +A   A G+AY+        +HR
Sbjct: 249 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGL ++  D              + APE A  G+ T KSDV
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 366 WSFGILLTELTTKGRVP 382

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 6/195 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K LK GS   +  F AE  ++ ++ H+ LV L    T 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N +L   L       +     L +A   A+G+A++ E  +   IHRD+
Sbjct: 90  -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDL 145
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV+S
Sbjct: 146 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 205
Query: 232 FGVMLLELIT-GRRP 245
           FG++L E++T GR P
Sbjct: 206 FGILLTEIVTHGRIP 220

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 6/195 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K LK GS   +  F AE  ++ ++ H+ LV L    T 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N +L   L       +     L +A   A+G+A++ E  +   IHRD+
Sbjct: 85  -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDL 140
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV+S
Sbjct: 141 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 200
Query: 232 FGVMLLELIT-GRRP 245
           FG++L E++T GR P
Sbjct: 201 FGILLTEIVTHGRIP 215

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 6/195 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K LK GS   +  F AE  ++ ++ H+ LV L    T 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N +L   L       +     L +A   A+G+A++ E  +   IHRD+
Sbjct: 86  -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDL 141
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV+S
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 232 FGVMLLELIT-GRRP 245
           FG++L E++T GR P
Sbjct: 202 FGILLTEIVTHGRIP 216

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 6/195 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K LK GS   +  F AE  ++ ++ H+ LV L    T 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N +L   L       +     L +A   A+G+A++ E  +   IHRD+
Sbjct: 80  -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDL 135
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 232 FGVMLLELIT-GRRP 245
           FG++L E++T GR P
Sbjct: 196 FGILLTEIVTHGRIP 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 6/195 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K LK GS   +  F AE  ++ ++ H+ LV L    T 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N +L   L       +     L +A   A+G+A++ E  +   IHRD+
Sbjct: 75  -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDL 130
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV+S
Sbjct: 131 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 190
Query: 232 FGVMLLELIT-GRRP 245
           FG++L E++T GR P
Sbjct: 191 FGILLTEIVTHGRIP 205

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 29/212 (13%)
Query: 51  LLGQGGFGYVHRGVLPNGKEVAIKQLKAGS----GQGEREFQAEVEIISRVHHKHLVSLV 106
           ++G GGFG V+R     G EVA+K  +        Q     + E ++ + + H ++++L 
Sbjct: 14  IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPT---MDWLTRLKIALGSAKGLAYLHEDCH 163
           G         LV EF     L   L GK  P    ++W      A+  A+G+ YLH++  
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNYLHDEAI 126
Query: 164 PKIIHRDIKAANILLDFKFE--------AKVADFGLAKIASDVNTHVSTRV--MGTFGYL 213
             IIHRD+K++NIL+  K E         K+ DFGLA+       H +T++   G + ++
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWM 181
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           APE   +   ++ SDV+S+GV+L EL+TG  P
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 120/229 (52%), Gaps = 23/229 (10%)
Query: 35  TYEELARATDGFS---DAN------LLGQGGFGYVHRG--VLPNGKEVA--IKQLKAGSG 81
           TYE+  RA   F+   DA+      ++G G FG V  G   LP  ++VA  IK LK G  
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 82  QGER-EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG-KGRPTM 139
           + +R +F  E  I+ +  H ++V L G  T G   M+V EF+ N  L+  L    G+ T+
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV 144
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
             +  + +  G A G+ YL +  +   +HRD+ A NIL++     KV+DFGL+++  D  
Sbjct: 145 --IQLVGMLRGIAAGMRYLADMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDP 199
Query: 200 THVSTRVMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
             V T   G     + APE     K T  SDV+S+G+++ E+++ G RP
Sbjct: 200 EAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 9/198 (4%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG V++G       V +  + A + Q  + F+ EV ++ +  H +++  +GY TA
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
             Q  +V ++   ++L  HLH       + +  + IA  +A+G+ YLH      IIHRD+
Sbjct: 76  -PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDL 130
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYA---SSGKLTEKS 227
           K+ NI L      K+ DFGLA + S  + +H   ++ G+  ++APE          + +S
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 228 DVFSFGVMLLELITGRRP 245
           DV++FG++L EL+TG+ P
Sbjct: 191 DVYAFGIVLYELMTGQLP 208

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 106/198 (53%), Gaps = 9/198 (4%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG V++G       V +  + A + Q  + F+ EV ++ +  H +++  +GY T 
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
             Q  +V ++   ++L  HLH       +    + IA  +A+G+ YLH      IIHRD+
Sbjct: 80  -PQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDL 134
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYA---SSGKLTEKS 227
           K+ NI L      K+ DFGLA + S  + +H   ++ G+  ++APE      S   + +S
Sbjct: 135 KSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 194
Query: 228 DVFSFGVMLLELITGRRP 245
           DV++FG++L EL+TG+ P
Sbjct: 195 DVYAFGIVLYELMTGQLP 212

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 99/195 (50%), Gaps = 6/195 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G  G V  G      +VA+K LK GS   +  F AE  ++ ++ H+ LV L    T 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N +L   L       +     L +A   A+G+A++ E  +   IHRD+
Sbjct: 80  -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDL 135
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 232 FGVMLLELIT-GRRP 245
           FG++L E++T GR P
Sbjct: 196 FGILLTEIVTHGRIP 210

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 115/224 (51%), Gaps = 14/224 (6%)
Query: 32  STFTYEELARATDG--FSDANLLGQGGFGYVHRG--VLPNGKE--VAIKQLKAGSGQGER 85
           ST T  E A+  D    S   ++G G FG V  G   LP+ KE  VAIK LK G  + +R
Sbjct: 19  STQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 78
Query: 86  -EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR 144
            +F  E  I+ +  H +++ L G  T     M+V E++ N +L+  L  K       +  
Sbjct: 79  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQL 137
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST 204
           + +  G A G+ YL +  +   +HRD+ A NIL++     KV+DFGL+++  D      T
Sbjct: 138 VGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 194
Query: 205 RVMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
              G     + +PE  +  K T  SDV+S+G++L E+++ G RP
Sbjct: 195 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 115/224 (51%), Gaps = 14/224 (6%)
Query: 32  STFTYEELARATDG--FSDANLLGQGGFGYVHRG--VLPNGKE--VAIKQLKAGSGQGER 85
           ST T  E A+  D    S   ++G G FG V  G   LP+ KE  VAIK LK G  + +R
Sbjct: 2   STQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 61
Query: 86  -EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR 144
            +F  E  I+ +  H +++ L G  T     M+V E++ N +L+  L  K       +  
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQL 120
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST 204
           + +  G A G+ YL +  +   +HRD+ A NIL++     KV+DFGL+++  D      T
Sbjct: 121 VGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 205 RVMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
              G     + +PE  +  K T  SDV+S+G++L E+++ G RP
Sbjct: 178 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/230 (32%), Positives = 122/230 (53%), Gaps = 23/230 (10%)
Query: 34  FTYEELARATDGFS---DAN------LLGQGGFGYVHRGVL--PNGKE--VAIKQLKAG- 79
           FT+E+  +A   F+   DA+      ++G G FG V  G L  P  +E  VAIK LKAG 
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 80  SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPT 138
           + +  R+F +E  I+ +  H +++ L G  T     M++ E++ N +L+ F     GR T
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 139 MDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV 198
           +  L  +   +GS  G+ YL +      +HRD+ A NIL++     KV+DFG++++  D 
Sbjct: 130 VIQLVGMLRGIGS--GMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184
Query: 199 NTHVSTRVMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
                T   G     + APE  +  K T  SDV+S+G+++ E+++ G RP
Sbjct: 185 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 114/223 (51%), Gaps = 14/223 (6%)
Query: 33  TFTYEELARATDG--FSDANLLGQGGFGYVHRG--VLPNGKE--VAIKQLKAGSGQGER- 85
           T T  E A+  D    S   ++G G FG V  G   LP+ KE  VAIK LK G  + +R 
Sbjct: 32  TQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL 145
           +F  E  I+ +  H +++ L G  T     M+V E++ N +L+  L  K       +  +
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLV 150
Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR 205
            +  G A G+ YL +  +   +HRD+ A NIL++     KV+DFGLA++  D      T 
Sbjct: 151 GMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTT 207
Query: 206 VMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
             G     + +PE  +  K T  SDV+S+G++L E+++ G RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 100/195 (51%), Gaps = 6/195 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K LK GS   +  F AE  ++ ++ H+ LV L    T 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N +L   L       +     L +A   A+G+A++ E  +   IHR++
Sbjct: 76  -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRNL 131
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV+S
Sbjct: 132 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 191
Query: 232 FGVMLLELIT-GRRP 245
           FG++L E++T GR P
Sbjct: 192 FGILLTEIVTHGRIP 206

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 106/198 (53%), Gaps = 9/198 (4%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG V++G       V +  + A + Q  + F+ EV ++ +  H +++  +GY TA
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
             Q  +V ++   ++L  HLH       +    + IA  +A+G+ YLH      IIHRD+
Sbjct: 92  -PQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDL 146
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPE---YASSGKLTEKS 227
           K+ NI L      K+ DFGLA   S  + +H   ++ G+  ++APE      S   + +S
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 206
Query: 228 DVFSFGVMLLELITGRRP 245
           DV++FG++L EL+TG+ P
Sbjct: 207 DVYAFGIVLYELMTGQLP 224

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 106/198 (53%), Gaps = 9/198 (4%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG V++G       V +  + A + Q  + F+ EV ++ +  H +++  +GY T 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
             Q  +V ++   ++L  HLH       + +  + IA  +A+G+ YLH      IIHRD+
Sbjct: 104 -PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDL 158
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYA---SSGKLTEKS 227
           K+ NI L      K+ DFGLA + S  + +H   ++ G+  ++APE          + +S
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 218
Query: 228 DVFSFGVMLLELITGRRP 245
           DV++FG++L EL+TG+ P
Sbjct: 219 DVYAFGIVLYELMTGQLP 236

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 106/198 (53%), Gaps = 9/198 (4%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG V++G       V +  + A + Q  + F+ EV ++ +  H +++  +GY T 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
             Q  +V ++   ++L  HLH       + +  + IA  +A+G+ YLH      IIHRD+
Sbjct: 81  -PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDL 135
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYA---SSGKLTEKS 227
           K+ NI L      K+ DFGLA + S  + +H   ++ G+  ++APE          + +S
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 195
Query: 228 DVFSFGVMLLELITGRRP 245
           DV++FG++L EL+TG+ P
Sbjct: 196 DVYAFGIVLYELMTGQLP 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 106/198 (53%), Gaps = 9/198 (4%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG V++G       V +  + A + Q  + F+ EV ++ +  H +++  +GY T 
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
             Q  +V ++   ++L  HLH       + +  + IA  +A+G+ YLH      IIHRD+
Sbjct: 103 -PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDL 157
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYA---SSGKLTEKS 227
           K+ NI L      K+ DFGLA + S  + +H   ++ G+  ++APE          + +S
Sbjct: 158 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 217
Query: 228 DVFSFGVMLLELITGRRP 245
           DV++FG++L EL+TG+ P
Sbjct: 218 DVYAFGIVLYELMTGQLP 235

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 106/198 (53%), Gaps = 9/198 (4%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG V++G       V +  + A + Q  + F+ EV ++ +  H +++  +GY T 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
             Q  +V ++   ++L  HLH       + +  + IA  +A+G+ YLH      IIHRD+
Sbjct: 81  -PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDL 135
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYA---SSGKLTEKS 227
           K+ NI L      K+ DFGLA + S  + +H   ++ G+  ++APE          + +S
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 195
Query: 228 DVFSFGVMLLELITGRRP 245
           DV++FG++L EL+TG+ P
Sbjct: 196 DVYAFGIVLYELMTGQLP 213

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 114/223 (51%), Gaps = 14/223 (6%)
Query: 33  TFTYEELARATDG--FSDANLLGQGGFGYVHRG--VLPNGKE--VAIKQLKAGSGQGER- 85
           T T  E A+  D    S   ++G G FG V  G   LP+ KE  VAIK LK G  + +R 
Sbjct: 32  TQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL 145
           +F  E  I+ +  H +++ L G  T     M+V E++ N +L+  L  K       +  +
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLV 150
Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR 205
            +  G A G+ YL +  +   +HRD+ A NIL++     KV+DFGL+++  D      T 
Sbjct: 151 GMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 206 VMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
             G     + +PE  +  K T  SDV+S+G++L E+++ G RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 114/223 (51%), Gaps = 14/223 (6%)
Query: 33  TFTYEELARATDG--FSDANLLGQGGFGYVHRG--VLPNGKE--VAIKQLKAGSGQGER- 85
           T T  E A+  D    S   ++G G FG V  G   LP+ KE  VAIK LK G  + +R 
Sbjct: 32  TQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL 145
           +F  E  I+ +  H +++ L G  T     M+V E++ N +L+  L  K       +  +
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLV 150
Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR 205
            +  G A G+ YL +  +   +HRD+ A NIL++     KV+DFGL+++  D      T 
Sbjct: 151 GMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 206 VMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
             G     + +PE  +  K T  SDV+S+G++L E+++ G RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 106/198 (53%), Gaps = 9/198 (4%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG V++G       V +  + A + Q  + F+ EV ++ +  H +++  +GY T 
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
             Q  +V ++   ++L  HLH       + +  + IA  +A+G+ YLH      IIHRD+
Sbjct: 78  -PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDL 132
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYA---SSGKLTEKS 227
           K+ NI L      K+ DFGLA + S  + +H   ++ G+  ++APE          + +S
Sbjct: 133 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 192
Query: 228 DVFSFGVMLLELITGRRP 245
           DV++FG++L EL+TG+ P
Sbjct: 193 DVYAFGIVLYELMTGQLP 210

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 114/223 (51%), Gaps = 14/223 (6%)
Query: 33  TFTYEELARATDG--FSDANLLGQGGFGYVHRG--VLPNGKE--VAIKQLKAGSGQGER- 85
           T T  E A+  D    S   ++G G FG V  G   LP+ KE  VAIK LK G  + +R 
Sbjct: 32  TQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL 145
           +F  E  I+ +  H +++ L G  T     M+V E++ N +L+  L  K       +  +
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLV 150
Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR 205
            +  G A G+ YL +  +   +HRD+ A NIL++     KV+DFGL+++  D      T 
Sbjct: 151 GMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 206 VMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
             G     + +PE  +  K T  SDV+S+G++L E+++ G RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 114/223 (51%), Gaps = 14/223 (6%)
Query: 33  TFTYEELARATDG--FSDANLLGQGGFGYVHRG--VLPNGKE--VAIKQLKAGSGQGER- 85
           T T  E A+  D    S   ++G G FG V  G   LP+ KE  VAIK LK G  + +R 
Sbjct: 32  TQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL 145
           +F  E  I+ +  H +++ L G  T     M+V E++ N +L+  L  K       +  +
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLV 150
Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR 205
            +  G A G+ YL +  +   +HRD+ A NIL++     KV+DFGL+++  D      T 
Sbjct: 151 GMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 206 VMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
             G     + +PE  +  K T  SDV+S+G++L E+++ G RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 106/198 (53%), Gaps = 9/198 (4%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG V++G       V +  + A + Q  + F+ EV ++ +  H +++  +GY T 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
             Q  +V ++   ++L  HLH       + +  + IA  +A+G+ YLH      IIHRD+
Sbjct: 76  -PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDL 130
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYA---SSGKLTEKS 227
           K+ NI L      K+ DFGLA + S  + +H   ++ G+  ++APE          + +S
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 228 DVFSFGVMLLELITGRRP 245
           DV++FG++L EL+TG+ P
Sbjct: 191 DVYAFGIVLYELMTGQLP 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 111/204 (54%), Gaps = 14/204 (6%)
Query: 51  LLGQGGFGYVHRGVL--PNGKE--VAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVSL 105
           ++G G FG V  G L  P  +E  VAIK LKAG + +  R+F +E  I+ +  H +++ L
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 106 VGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
            G  T     M++ E++ N +L+ F     GR T+  L  +   +GS  G+ YL +  + 
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGS--GMKYLSDMSY- 137
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFG--YLAPEYASSGK 222
             +HRD+ A NIL++     KV+DFG++++  D      T   G     + APE  +  K
Sbjct: 138 --VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 223 LTEKSDVFSFGVMLLELIT-GRRP 245
            T  SDV+S+G+++ E+++ G RP
Sbjct: 196 FTSASDVWSYGIVMWEVMSYGERP 219

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 114/223 (51%), Gaps = 14/223 (6%)
Query: 33  TFTYEELARATDG--FSDANLLGQGGFGYVHRG--VLPNGKE--VAIKQLKAGSGQGER- 85
           T T  E A+  D    S   ++G G FG V  G   LP+ KE  VAIK LK G  + +R 
Sbjct: 30  TQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 89
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL 145
           +F  E  I+ +  H +++ L G  T     M+V E++ N +L+  L  K       +  +
Sbjct: 90  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLV 148
Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR 205
            +  G A G+ YL +  +   +HRD+ A NIL++     KV+DFGL+++  D      T 
Sbjct: 149 GMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 205
Query: 206 VMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
             G     + +PE  +  K T  SDV+S+G++L E+++ G RP
Sbjct: 206 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 114/224 (50%), Gaps = 14/224 (6%)
Query: 32  STFTYEELARATDG--FSDANLLGQGGFGYVHRG--VLPNGKE--VAIKQLKAGSGQGER 85
           ST T  E A+  D    S   ++G G FG V  G   LP+ KE  VAIK LK G  + +R
Sbjct: 2   STQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 61
Query: 86  -EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR 144
            +F  E  I+ +  H +++ L G  T     M+V E + N +L+  L  K       +  
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR-KHDAQFTVIQL 120
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST 204
           + +  G A G+ YL +  +   +HRD+ A NIL++     KV+DFGL+++  D      T
Sbjct: 121 VGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 205 RVMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
              G     + +PE  +  K T  SDV+S+G++L E+++ G RP
Sbjct: 178 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 109/204 (53%), Gaps = 13/204 (6%)
Query: 51  LLGQGGFGYVHRGVL--PNGKE---VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
           ++G G FG V++G+L   +GK+   VAIK LKAG  + +R +F  E  I+ +  H +++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L G  +     M++ E++ N  L+  L  K       L  + +  G A G+ YL    + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFG--YLAPEYASSGK 222
             +HRD+ A NIL++     KV+DFGL+++  D      T   G     + APE  S  K
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 223 LTEKSDVFSFGVMLLELIT-GRRP 245
            T  SDV+SFG+++ E++T G RP
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERP 250

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 111/204 (54%), Gaps = 14/204 (6%)
Query: 51  LLGQGGFGYVHRGVL--PNGKE--VAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVSL 105
           ++G G FG V  G L  P  +E  VAIK LKAG + +  R+F +E  I+ +  H +++ L
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 106 VGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
            G  T     M++ E++ N +L+ F     GR T+  L  +   +GS  G+ YL +  + 
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGS--GMKYLSDMSY- 131
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFG--YLAPEYASSGK 222
             +HRD+ A NIL++     KV+DFG++++  D      T   G     + APE  +  K
Sbjct: 132 --VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 223 LTEKSDVFSFGVMLLELIT-GRRP 245
            T  SDV+S+G+++ E+++ G RP
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 113/223 (50%), Gaps = 14/223 (6%)
Query: 33  TFTYEELARATDG--FSDANLLGQGGFGYVHRG--VLPNGKE--VAIKQLKAGSGQGER- 85
           T T  E A+  D    S   ++G G FG V  G   LP+ KE  VAIK LK G  + +R 
Sbjct: 32  TQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL 145
           +F  E  I+ +  H +++ L G  T     M+V E++ N +L+  L  K       +  +
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLV 150
Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR 205
            +  G A G+ YL +      +HRD+ A NIL++     KV+DFGL+++  D      T 
Sbjct: 151 GMLRGIASGMKYLSD---MGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 206 VMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
             G     + +PE  +  K T  SDV+S+G++L E+++ G RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 113/223 (50%), Gaps = 14/223 (6%)
Query: 33  TFTYEELARATDG--FSDANLLGQGGFGYVHRG--VLPNGKE--VAIKQLKAGSGQGER- 85
           T T  E A+  D    S   ++G G FG V  G   LP+ KE  VAIK LK G  + +R 
Sbjct: 32  TQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL 145
           +F  E  I+ +  H +++ L G  T     M+V E++ N +L+  L  K       +  +
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLV 150
Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR 205
            +  G A G+ YL +  +   +HRD+ A NIL++     KV+DFGL ++  D      T 
Sbjct: 151 GMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT 207
Query: 206 VMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
             G     + +PE  +  K T  SDV+S+G++L E+++ G RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG V++G       V +  + A + Q  + F+ EV ++ +  H +++  +GY T 
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
             Q  +V ++   ++L  HLH       +    + IA  +A+G+ YLH      IIHRD+
Sbjct: 92  -PQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDL 146
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPE---YASSGKLTEKS 227
           K+ NI L      K+ DFGLA   S  + +H   ++ G+  ++APE      S   + +S
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 206
Query: 228 DVFSFGVMLLELITGRRP 245
           DV++FG++L EL+TG+ P
Sbjct: 207 DVYAFGIVLYELMTGQLP 224

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 121/232 (52%), Gaps = 25/232 (10%)
Query: 34  FTYEELARATDGFSDA---------NLLGQGGFGYVHRG--VLPNGKE--VAIKQLKAGS 80
           FT+E+   A   F+            ++G G FG V  G   LP  +E  VAIK LK+G 
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 81  GQGER-EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPT 138
            + +R +F +E  I+ +  H +++ L G  T  +  M++ EF+ N +L+ F     G+ T
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 139 MDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASD 197
           +  +  + +  G A G+ YL +  +   +HRD+ A NIL++     KV+DFGL++ +  D
Sbjct: 134 V--IQLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 188
Query: 198 VNTHVSTRVMG---TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
            +    T  +G      + APE     K T  SDV+S+G+++ E+++ G RP
Sbjct: 189 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/200 (35%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G  VA+KQL+      +R+FQ E++I+  +H   +V   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y  G Q + LV E++P+  L   L  + R  +D    L  +    KG+ YL      
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR--- 133
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + +HRD+ A NIL++ +   K+ADFGLAK+      +   R  G    F Y APE  S  
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-APESLSDN 192
Query: 222 KLTEKSDVFSFGVMLLELIT 241
             + +SDV+SFGV+L EL T
Sbjct: 193 IFSRQSDVWSFGVVLYELFT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/200 (35%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G  VA+KQL+      +R+FQ E++I+  +H   +V   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y  G Q + LV E++P+  L   L  + R  +D    L  +    KG+ YL      
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR--- 146
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + +HRD+ A NIL++ +   K+ADFGLAK+      +   R  G    F Y APE  S  
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-APESLSDN 205
Query: 222 KLTEKSDVFSFGVMLLELIT 241
             + +SDV+SFGV+L EL T
Sbjct: 206 IFSRQSDVWSFGVVLYELFT 225

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 113/223 (50%), Gaps = 14/223 (6%)
Query: 33  TFTYEELARATDG--FSDANLLGQGGFGYVHRG--VLPNGKE--VAIKQLKAGSGQGER- 85
           T T  E A+  D    S   ++G G FG V  G   LP+ KE  VAIK LK G  + +R 
Sbjct: 32  TQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL 145
           +F  E  I+ +  H +++ L G  T     M+V E + N +L+  L  K       +  +
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR-KHDAQFTVIQLV 150
Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR 205
            +  G A G+ YL +  +   +HRD+ A NIL++     KV+DFGL+++  D      T 
Sbjct: 151 GMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 206 VMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
             G     + +PE  +  K T  SDV+S+G++L E+++ G RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/200 (35%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G  VA+KQL+      +R+FQ E++I+  +H   +V   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y  G Q + LV E++P+  L   L  + R  +D    L  +    KG+ YL      
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR--- 134
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + +HRD+ A NIL++ +   K+ADFGLAK+      +   R  G    F Y APE  S  
Sbjct: 135 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-APESLSDN 193
Query: 222 KLTEKSDVFSFGVMLLELIT 241
             + +SDV+SFGV+L EL T
Sbjct: 194 IFSRQSDVWSFGVVLYELFT 213

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 51  LLGQGGFGYVHRGVL--PNGKE--VAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVSL 105
           ++G G FG V RG L  P  KE  VAIK LK G + +  REF +E  I+ +  H +++ L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
            G  T     M++ EF+ N  L+  L    G+ T+  +  + +  G A G+ YL E  + 
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYLAEMSY- 139
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMG---TFGYLAPEYASS 220
             +HRD+ A NIL++     KV+DFGL++ +  + +    T  +G      + APE  + 
Sbjct: 140 --VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 221 GKLTEKSDVFSFGVMLLELIT-GRRP 245
            K T  SD +S+G+++ E+++ G RP
Sbjct: 198 RKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 112/206 (54%), Gaps = 16/206 (7%)
Query: 51  LLGQGGFGYVHRGVL--PNGKE--VAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVSL 105
           ++G G FG V RG L  P  KE  VAIK LK G + +  REF +E  I+ +  H +++ L
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
            G  T     M++ EF+ N  L+  L    G+ T+  +  + +  G A G+ YL E  + 
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYLAEMSY- 137
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS-TRVMG---TFGYLAPEYASS 220
             +HRD+ A NIL++     KV+DFGL++   + ++  + T  +G      + APE  + 
Sbjct: 138 --VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 221 GKLTEKSDVFSFGVMLLELIT-GRRP 245
            K T  SD +S+G+++ E+++ G RP
Sbjct: 196 RKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G   N  +VA+K LK G+    + F  E  ++  + H  LV L    T 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 112 GSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRL-KIALGSAKGLAYLHEDCHPKIIHR 169
                ++ E++   +L +F    +G   +  L +L   +   A+G+AY+    +   IHR
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVL--LPKLIDFSAQIAEGMAYIERKNY---IHR 134
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AAN+L+      K+ADFGLA++  D              + APE  + G  T KSDV
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L E++T G+ P
Sbjct: 195 WSFGILLYEIVTYGKIP 211

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG V++G       V +  + A + Q  + F+ EV ++ +  H +++  +GY T 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
             Q  +V ++   ++L  HLH       + +  + IA  +A+G+ YLH      IIHRD+
Sbjct: 104 -PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDL 158
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYA---SSGKLTEKS 227
           K+ NI L      K+ DFGLA   S  + +H   ++ G+  ++APE          + +S
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 218
Query: 228 DVFSFGVMLLELITGRRP 245
           DV++FG++L EL+TG+ P
Sbjct: 219 DVYAFGIVLYELMTGQLP 236

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y+AG + + L+ EF+P  +L  +L  K +  +D +  L+      KG+ YL      
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 136
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + IHRD+   NIL++ +   K+ DFGL K+          +  G    F Y APE  +  
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 195
Query: 222 KLTEKSDVFSFGVMLLELIT 241
           K +  SDV+SFGV+L EL T
Sbjct: 196 KFSVASDVWSFGVVLYELFT 215

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 114/230 (49%), Gaps = 25/230 (10%)
Query: 35  TYEELARATDGFSDA---------NLLGQGGFGYVHRGVL--PNGKEV--AIKQLKAG-S 80
           TYEE  RA   F+            ++G G  G V  G L  P  ++V  AIK LKAG +
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 81  GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHL--HGKGRPT 138
            +  R+F +E  I+ +  H +++ L G  T G   M+V E++ N +L+  L  H      
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 139 MDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV 198
           M  +  L+   G   G+ YL +  +   +HRD+ A N+L+D     KV+DFGL+++  D 
Sbjct: 151 MQLVGMLR---GVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
Query: 199 NTHVSTRVMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
                T   G     + APE  +    +  SDV+SFGV++ E++  G RP
Sbjct: 205 PDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG V++G       V +  + A + Q  + F+ EV ++ +  H +++  +GY T 
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
             Q  +V ++   ++L  HLH       + +  + IA  +A+G+ YLH      IIHRD+
Sbjct: 96  -PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDL 150
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYA---SSGKLTEKS 227
           K+ NI L      K+ DFGLA   S  + +H   ++ G+  ++APE          + +S
Sbjct: 151 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 210
Query: 228 DVFSFGVMLLELITGRRP 245
           DV++FG++L EL+TG+ P
Sbjct: 211 DVYAFGIVLYELMTGQLP 228

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 112/223 (50%), Gaps = 14/223 (6%)
Query: 33  TFTYEELARATDG--FSDANLLGQGGFGYVHRG--VLPNGKE--VAIKQLKAGSGQGER- 85
           T T  E A+  D    S   ++G G FG V  G   LP+ KE  VAIK LK G  + +R 
Sbjct: 32  TQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL 145
           +F  E  I+ +  H +++ L G  T     M+V E + N +L+  L  K       +  +
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR-KHDAQFTVIQLV 150
Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR 205
            +  G A G+ YL +      +HRD+ A NIL++     KV+DFGL+++  D      T 
Sbjct: 151 GMLRGIASGMKYLSD---MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 206 VMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
             G     + +PE  +  K T  SDV+S+G++L E+++ G RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG V++G       V +  + A + Q  + F+ EV ++ +  H +++  +GY T 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
             Q  +V ++   ++L  HLH       + +  + IA  +A+G+ YLH      IIHRD+
Sbjct: 76  -PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDL 130
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYA---SSGKLTEKS 227
           K+ NI L      K+ DFGLA   S  + +H   ++ G+  ++APE          + +S
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 228 DVFSFGVMLLELITGRRP 245
           DV++FG++L EL+TG+ P
Sbjct: 191 DVYAFGIVLYELMTGQLP 208

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G   N  +VA+K LK G+    + F  E  ++  + H  LV L    T 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 112 GSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRL-KIALGSAKGLAYLHEDCHPKIIHR 169
                ++ EF+   +L +F    +G   +  L +L   +   A+G+AY+    +   IHR
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVL--LPKLIDFSAQIAEGMAYIERKNY---IHR 133
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AAN+L+      K+ADFGLA++  D              + APE  + G  T KS+V
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L E++T G+ P
Sbjct: 194 WSFGILLYEIVTYGKIP 210

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/211 (35%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
           LG+G FG V            G+ VA+K LK G G   R  +Q E+EI+  ++H+H+V  
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 106 VGYYTAGSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            G      ++   LV E+VP  +L  +L    R  +     L  A    +G+AYLH    
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLHAQ-- 131
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASS 220
              IHR + A N+LLD     K+ DFGLAK   + + +   R  G    F Y APE    
Sbjct: 132 -HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKE 189
Query: 221 GKLTEKSDVFSFGVMLLELITGRRPVDSTHT 251
            K    SDV+SFGV L EL+T      S HT
Sbjct: 190 CKFYYASDVWSFGVTLYELLTYCDSNQSPHT 220

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/211 (35%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
           LG+G FG V            G+ VA+K LK G G   R  +Q E+EI+  ++H+H+V  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 106 VGYYTAGSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            G      ++   LV E+VP  +L  +L    R  +     L  A    +G+AYLH    
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLHAQ-- 130
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASS 220
              IHR + A N+LLD     K+ DFGLAK   + + +   R  G    F Y APE    
Sbjct: 131 -HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKE 188
Query: 221 GKLTEKSDVFSFGVMLLELITGRRPVDSTHT 251
            K    SDV+SFGV L EL+T      S HT
Sbjct: 189 CKFYYASDVWSFGVTLYELLTYCDSNQSPHT 219

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 114/230 (49%), Gaps = 25/230 (10%)
Query: 35  TYEELARATDGFSDA---------NLLGQGGFGYVHRGVL--PNGKEV--AIKQLKAG-S 80
           TYEE  RA   F+            ++G G  G V  G L  P  ++V  AIK LKAG +
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 81  GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHL--HGKGRPT 138
            +  R+F +E  I+ +  H +++ L G  T G   M+V E++ N +L+  L  H      
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 139 MDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV 198
           M  +  L+   G   G+ YL +  +   +HRD+ A N+L+D     KV+DFGL+++  D 
Sbjct: 151 MQLVGMLR---GVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
Query: 199 NTHVSTRVMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
                T   G     + APE  +    +  SDV+SFGV++ E++  G RP
Sbjct: 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 6/195 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V         +VA+K +K GS   E  F AE  ++  + H  LV L    T 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ EF+   +L   L             +  +   A+G+A++ +  +   IHRD+
Sbjct: 255 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRDL 310
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV+S
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 370
Query: 232 FGVMLLELIT-GRRP 245
           FG++L+E++T GR P
Sbjct: 371 FGILLMEIVTYGRIP 385

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 113/229 (49%), Gaps = 21/229 (9%)
Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER---EFQAEVEIISRVH 98
           +D +    +LG GG   VH    L + ++VA+K L+A   +       F+ E +  + ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 99  HKHLVSLV----GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKG 154
           H  +V++         AG    +V E+V   TL   +H +G   M     +++   + + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 128
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV--STRVMGTFGY 212
           L + H++    IIHRD+K ANIL+      KV DFG+A+  +D    V  +  V+GT  Y
Sbjct: 129 LNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQY 185
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA 261
           L+PE A    +  +SDV+S G +L E++TG  P      F  DS V  A
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP------FTGDSPVSVA 228

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y+AG + + L+ E++P  +L  +L  K +  +D +  L+      KG+ YL      
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 136
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + IHRD+   NIL++ +   K+ DFGL K+          +  G    F Y APE  +  
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 195
Query: 222 KLTEKSDVFSFGVMLLELIT 241
           K +  SDV+SFGV+L EL T
Sbjct: 196 KFSVASDVWSFGVVLYELFT 215

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V         +VA+K +K GS   E  F AE  ++  + H  LV L    T 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 112 GSQRMLVYEFVPNNTLEFHL---HGKGRPTMDWLTRL-KIALGSAKGLAYLHEDCHPKII 167
                ++ EF+   +L   L    G  +P    L +L   +   A+G+A++ +  +   I
Sbjct: 82  -EPIYIITEFMAKGSLLDFLKSDEGSKQP----LPKLIDFSAQIAEGMAFIEQRNY---I 133
Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS 227
           HRD++AANIL+      K+ADFGLA++  D              + APE  + G  T KS
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 193
Query: 228 DVFSFGVMLLELIT-GRRP 245
           DV+SFG++L+E++T GR P
Sbjct: 194 DVWSFGILLMEIVTYGRIP 212

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 111/236 (47%), Gaps = 20/236 (8%)
Query: 39  LARATDGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQL------KAGSGQGEREFQAEV 91
           +    + F   NLLG+G F  V+R   +  G EVAIK +      KAG  Q     Q EV
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ---RVQNEV 62
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS 151
           +I  ++ H  ++ L  Y+   +   LV E   N  +  +L  + +P  +   R       
Sbjct: 63  KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQI 121
Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVMGTF 210
             G+ YLH      I+HRD+  +N+LL      K+ADFGLA ++      H +  + GT 
Sbjct: 122 ITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTP 176
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDS---THTFVEDSLVDWARP 263
            Y++PE A+      +SDV+S G M   L+ GR P D+    +T  +  L D+  P
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP 232

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y+AG + + L+ E++P  +L  +L  K +  +D +  L+      KG+ YL      
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 138
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + IHRD+   NIL++ +   K+ DFGL K+          +  G    F Y APE  +  
Sbjct: 139 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 197
Query: 222 KLTEKSDVFSFGVMLLELIT 241
           K +  SDV+SFGV+L EL T
Sbjct: 198 KFSVASDVWSFGVVLYELFT 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y+AG + + L+ E++P  +L  +L  K +  +D +  L+      KG+ YL      
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 140
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + IHRD+   NIL++ +   K+ DFGL K+          +  G    F Y APE  +  
Sbjct: 141 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 199
Query: 222 KLTEKSDVFSFGVMLLELIT 241
           K +  SDV+SFGV+L EL T
Sbjct: 200 KFSVASDVWSFGVVLYELFT 219

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y+AG + + L+ E++P  +L  +L  K +  +D +  L+      KG+ YL      
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 133
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + IHRD+   NIL++ +   K+ DFGL K+          +  G    F Y APE  +  
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 192
Query: 222 KLTEKSDVFSFGVMLLELIT 241
           K +  SDV+SFGV+L EL T
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y+AG + + L+ E++P  +L  +L  K +  +D +  L+      KG+ YL      
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 137
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + IHRD+   NIL++ +   K+ DFGL K+          +  G    F Y APE  +  
Sbjct: 138 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 196
Query: 222 KLTEKSDVFSFGVMLLELIT 241
           K +  SDV+SFGV+L EL T
Sbjct: 197 KFSVASDVWSFGVVLYELFT 216

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y+AG + + L+ E++P  +L  +L  K +  +D +  L+      KG+ YL      
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 132
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + IHRD+   NIL++ +   K+ DFGL K+          +  G    F Y APE  +  
Sbjct: 133 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 191
Query: 222 KLTEKSDVFSFGVMLLELIT 241
           K +  SDV+SFGV+L EL T
Sbjct: 192 KFSVASDVWSFGVVLYELFT 211

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y+AG + + L+ E++P  +L  +L  K +  +D +  L+      KG+ YL      
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 133
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + IHRD+   NIL++ +   K+ DFGL K+          +  G    F Y APE  +  
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-APESLTES 192
Query: 222 KLTEKSDVFSFGVMLLELIT 241
           K +  SDV+SFGV+L EL T
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y+AG + + L+ E++P  +L  +L  K +  +D +  L+      KG+ YL      
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 164
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + IHRD+   NIL++ +   K+ DFGL K+          +  G    F Y APE  +  
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 223
Query: 222 KLTEKSDVFSFGVMLLELIT 241
           K +  SDV+SFGV+L EL T
Sbjct: 224 KFSVASDVWSFGVVLYELFT 243

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y+AG + + L+ E++P  +L  +L  K +  +D +  L+      KG+ YL      
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 139
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + IHRD+   NIL++ +   K+ DFGL K+          +  G    F Y APE  +  
Sbjct: 140 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 198
Query: 222 KLTEKSDVFSFGVMLLELIT 241
           K +  SDV+SFGV+L EL T
Sbjct: 199 KFSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y+AG + + L+ E++P  +L  +L  K +  +D +  L+      KG+ YL      
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 133
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + IHRD+   NIL++ +   K+ DFGL K+          +  G    F Y APE  +  
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 192
Query: 222 KLTEKSDVFSFGVMLLELIT 241
           K +  SDV+SFGV+L EL T
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y+AG + + L+ E++P  +L  +L  K +  +D +  L+      KG+ YL      
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 131
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + IHRD+   NIL++ +   K+ DFGL K+          +  G    F Y APE  +  
Sbjct: 132 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 190
Query: 222 KLTEKSDVFSFGVMLLELIT 241
           K +  SDV+SFGV+L EL T
Sbjct: 191 KFSVASDVWSFGVVLYELFT 210

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y+AG + + L+ E++P  +L  +L  K +  +D +  L+      KG+ YL      
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 151
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + IHRD+   NIL++ +   K+ DFGL K+          +  G    F Y APE  +  
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 210
Query: 222 KLTEKSDVFSFGVMLLELIT 241
           K +  SDV+SFGV+L EL T
Sbjct: 211 KFSVASDVWSFGVVLYELFT 230

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 117/229 (51%), Gaps = 23/229 (10%)
Query: 35  TYEELARATDGFSDA---------NLLGQGGFGYVHRG--VLPNGKE--VAIKQLKAGSG 81
           TYE+  +A   F+            ++G G FG V  G   LP  +E  VAIK LK G  
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 82  QGER-EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPTM 139
           + +R +F  E  I+ +  H +++ L G  T     M+V E++ N +L+ F     G+ T+
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV 123
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
             +  + +  G + G+ YL +  +   +HRD+ A NIL++     KV+DFGL+++  D  
Sbjct: 124 --IQLVGMLRGISAGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 178
Query: 200 THVSTRVMGTFG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
               T   G     + APE  +  K T  SDV+S+G+++ E+++ G RP
Sbjct: 179 EAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K +K GS   E EF  E + + ++ H  LV   G  + 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 112 GSQRMLVYEFVPNNTLEFHL--HGKG-RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
                +V E++ N  L  +L  HGKG  P+      L++     +G+A+L      + IH
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPS----QLLEMCYDVCEGMAFLESH---QFIH 127
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 228
           RD+ A N L+D     KV+DFG+ +   D     S        + APE     K + KSD
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 229 VFSFGVMLLELIT-GRRPVD 247
           V++FG+++ E+ + G+ P D
Sbjct: 188 VWAFGILMWEVFSLGKMPYD 207

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y+AG + + L+ E++P  +L  +L  K +  +D +  L+      KG+ YL      
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 151
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + IHRD+   NIL++ +   K+ DFGL K+          +  G    F Y APE  +  
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 210
Query: 222 KLTEKSDVFSFGVMLLELIT 241
           K +  SDV+SFGV+L EL T
Sbjct: 211 KFSVASDVWSFGVVLYELFT 230

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y+AG + + L+ E++P  +L  +L  K +  +D +  L+      KG+ YL      
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 134
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + IHR++   NIL++ +   K+ DFGL K+      +   +  G    F Y APE  +  
Sbjct: 135 RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-APESLTES 193
Query: 222 KLTEKSDVFSFGVMLLELIT 241
           K +  SDV+SFGV+L EL T
Sbjct: 194 KFSVASDVWSFGVVLYELFT 213

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 113/229 (49%), Gaps = 21/229 (9%)
Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER---EFQAEVEIISRVH 98
           +D +    +LG GG   VH    L + ++VA+K L+A   +       F+ E +  + ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 99  HKHLVSLV----GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKG 154
           H  +V++         AG    +V E+V   TL   +H +G   M     +++   + + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 128
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGY 212
           L + H++    IIHRD+K ANI++      KV DFG+A+  +D    V+    V+GT  Y
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA 261
           L+PE A    +  +SDV+S G +L E++TG  P      F  DS V  A
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP------FTGDSPVSVA 228

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL- 105
           LG+G FG V            G  VA+KQL+      +R+FQ E++I+  +H   +V   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 106 -VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
            V Y     +  LV E++P+  L   L  + R  +D    L  +    KG+ YL      
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR--- 130
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + +HRD+ A NIL++ +   K+ADFGLAK+          R  G    F Y APE  S  
Sbjct: 131 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWY-APESLSDN 189
Query: 222 KLTEKSDVFSFGVMLLELIT 241
             + +SDV+SFGV+L EL T
Sbjct: 190 IFSRQSDVWSFGVVLYELFT 209

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 112/216 (51%), Gaps = 23/216 (10%)
Query: 49  ANLLGQGGFGYVHRGV-LPNGK----EVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHL 102
             +LG G FG V++G+ +P G+     VAIK L   +G +   EF  E  I++ + H HL
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGK-----GRPTMDWLTRLKIALGSAKGLAY 157
           V L+G   + + + LV + +P+  L  ++H        +  ++W  ++      AKG+ Y
Sbjct: 80  VRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMY 132
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS-DVNTHVSTRVMGTFGYLAPE 216
           L E    +++HRD+ A N+L+      K+ DFGLA++   D   + +        ++A E
Sbjct: 133 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 189
Query: 217 YASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHT 251
                K T +SDV+S+GV + EL+T G +P D   T
Sbjct: 190 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 225

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 15/213 (7%)
Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER---EFQAEVEIISRVH 98
           +D +    +LG GG   VH    L + ++VA+K L+A   +       F+ E +  + ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 99  HKHLVSLV----GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKG 154
           H  +V++         AG    +V E+V   TL   +H +G   M     +++   + + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 128
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGY 212
           L + H++    IIHRD+K ANI++      KV DFG+A+  +D    V+    V+GT  Y
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           L+PE A    +  +SDV+S G +L E++TG  P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 112/206 (54%), Gaps = 16/206 (7%)
Query: 51  LLGQGGFGYVHRG--VLPNGKE--VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSL 105
           ++G G FG V  G   LP  +E  VAIK LK+G  + +R +F +E  I+ +  H +++ L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 106 VGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
            G  T  +  M++ EF+ N +L+ F     G+ T+  +  + +  G A G+ YL +  + 
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYLADMNY- 130
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMG---TFGYLAPEYASS 220
             +HR + A NIL++     KV+DFGL++ +  D +    T  +G      + APE    
Sbjct: 131 --VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 221 GKLTEKSDVFSFGVMLLELIT-GRRP 245
            K T  SDV+S+G+++ E+++ G RP
Sbjct: 189 RKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 107 GY-YTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G  Y+AG + + L+ E++P  +L  +L       +D +  L+      KG+ YL      
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAE-RIDHIKLLQYTSQICKGMEYLGTK--- 136
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASSG 221
           + IHRD+   NIL++ +   K+ DFGL K+          +  G    F Y APE  +  
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 195
Query: 222 KLTEKSDVFSFGVMLLELIT 241
           K +  SDV+SFGV+L EL T
Sbjct: 196 KFSVASDVWSFGVVLYELFT 215

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 100/223 (44%), Gaps = 13/223 (5%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQLKAGSGQGE---REFQAEVEIISRV 97
             D F     LG+G FG V+       K + A+K L     + E    + + E+EI S +
Sbjct: 12  TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
            H +++ +  Y+    +  L+ EF P   L   L   GR   D           A  L Y
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHY 129
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
            HE    K+IHRDIK  N+L+ +K E K+ADFG +  A  +       + GT  YL PE 
Sbjct: 130 CHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRXMCGTLDYLPPEM 183
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRPVDS-THTFVEDSLVD 259
                  EK D++  GV+  E + G  P DS +HT     +V+
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN 226

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 112/216 (51%), Gaps = 23/216 (10%)
Query: 49  ANLLGQGGFGYVHRGV-LPNGK----EVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHL 102
             +LG G FG V++G+ +P G+     VAIK L   +G +   EF  E  I++ + H HL
Sbjct: 43  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGK-----GRPTMDWLTRLKIALGSAKGLAY 157
           V L+G   + + + LV + +P+  L  ++H        +  ++W  ++      AKG+ Y
Sbjct: 103 VRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMY 155
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS-DVNTHVSTRVMGTFGYLAPE 216
           L E    +++HRD+ A N+L+      K+ DFGLA++   D   + +        ++A E
Sbjct: 156 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 212
Query: 217 YASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHT 251
                K T +SDV+S+GV + EL+T G +P D   T
Sbjct: 213 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 248

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 110/236 (46%), Gaps = 29/236 (12%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 88
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 143
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
            A  L+Y H     ++IHRDIK  N+LL    E K+ADFG +  A        T + GT 
Sbjct: 144 -ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTL 196
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
            YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 252

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 100/223 (44%), Gaps = 13/223 (5%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQLKAGSGQGE---REFQAEVEIISRV 97
             D F     LG+G FG V+       K + A+K L     + E    + + E+EI S +
Sbjct: 13  TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 72
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
            H +++ +  Y+    +  L+ EF P   L   L   GR   D           A  L Y
Sbjct: 73  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHY 130
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
            HE    K+IHRDIK  N+L+ +K E K+ADFG +  A  +       + GT  YL PE 
Sbjct: 131 CHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRXMCGTLDYLPPEM 184
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRPVDS-THTFVEDSLVD 259
                  EK D++  GV+  E + G  P DS +HT     +V+
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN 227

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 111/237 (46%), Gaps = 31/237 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 79
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 80  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 134
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +  A        T + GT
Sbjct: 135 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGT 186
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
             YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 187 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 243

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 52  LGQGGFG--YVHRGVLPNGKEVAIKQLKAGSGQGE---REFQAEVEIISRVHHKHLVSLV 106
           LG GG    Y+    + N K VAIK +     + E   + F+ EV   S++ H+++VS++
Sbjct: 19  LGGGGMSTVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
                     LV E++   TL  ++   G  ++D  T +        G+ + H+    +I
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVD--TAINFTNQILDGIKHAHD---MRI 132
Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEK 226
           +HRDIK  NIL+D     K+ DFG+AK  S+ +   +  V+GT  Y +PE A      E 
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 227 SDVFSFGVMLLELITGRRP 245
           +D++S G++L E++ G  P
Sbjct: 193 TDIYSIGIVLYEMLVGEPP 211

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 106/220 (48%), Gaps = 30/220 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+     N K + A+K L      KAG    E + + EVEI 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 62
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 63  SHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 117
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMG 208
            A  L+Y H     K+IHRDIK  N+LL    E K+ADFG +     V+   S R  + G
Sbjct: 118 -ANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRAALCG 168
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDS 248
           T  YL PE        EK D++S GV+  E + G+ P ++
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 110/236 (46%), Gaps = 29/236 (12%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 62
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 117
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
            A  L+Y H     ++IHRDIK  N+LL    E K+ADFG +  A        T + GT 
Sbjct: 118 -ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTELCGTL 170
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
            YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/201 (35%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
           LG+G FG V            G+ VA+K LKA +G   R  ++ E++I+  ++H+H++  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 106 VGYYT-AGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            G    AG+  + LV E+VP  +L  +L    R ++     L  A    +G+AYLH    
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQ-- 153
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASS 220
              IHRD+ A N+LLD     K+ DFGLAK   + +     R  G    F Y APE    
Sbjct: 154 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APECLKE 211
Query: 221 GKLTEKSDVFSFGVMLLELIT 241
            K    SDV+SFGV L EL+T
Sbjct: 212 YKFYYASDVWSFGVTLYELLT 232

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 111/237 (46%), Gaps = 31/237 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 67
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 122
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +  A        T + GT
Sbjct: 123 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGT 174
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
             YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 175 LDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 231

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 114/231 (49%), Gaps = 25/231 (10%)
Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER---EFQAEVEIISRVH 98
           +D +    +LG GG   VH    L   ++VA+K L+A   +       F+ E +  + ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 99  HKHLVSLVGYYT------AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA 152
           H  +V++  Y T      AG    +V E+V   TL   +H +G   M     +++   + 
Sbjct: 71  HPAIVAV--YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADAC 126
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTF 210
           + L + H++    IIHRD+K ANI++      KV DFG+A+  +D    V+    V+GT 
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA 261
            YL+PE A    +  +SDV+S G +L E++TG  P      F  DS V  A
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP------FTGDSPVSVA 228

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 51  LLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           ++G+G FG V+ G L   +GK++  A+K L   +  GE  +F  E  I+    H +++SL
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLA 156
           +G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+ 
Sbjct: 96  LGI-------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMK 146
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD---VNTHVSTRVMGTFGYL 213
           YL      K +HRD+ A N +LD KF  KVADFGLA+   D    + H  T       ++
Sbjct: 147 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWM 203
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF 252
           A E   + K T KSDV+SFGV+L EL+T G  P    +TF
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 243

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 51  LLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           ++G+G FG V+ G L   +GK++  A+K L   +  GE  +F  E  I+    H +++SL
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLA 156
           +G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+ 
Sbjct: 115 LGI-------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMK 165
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD---VNTHVSTRVMGTFGYL 213
           YL      K +HRD+ A N +LD KF  KVADFGLA+   D    + H  T       ++
Sbjct: 166 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 222
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF 252
           A E   + K T KSDV+SFGV+L EL+T G  P    +TF
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 262

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 111/237 (46%), Gaps = 31/237 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 65
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 120
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +  A        T + GT
Sbjct: 121 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGT 172
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
             YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 229

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 51  LLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           ++G+G FG V+ G L   +GK++  A+K L   +  GE  +F  E  I+    H +++SL
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLA 156
           +G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+ 
Sbjct: 97  LGI-------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMK 147
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD---VNTHVSTRVMGTFGYL 213
           YL      K +HRD+ A N +LD KF  KVADFGLA+   D    + H  T       ++
Sbjct: 148 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF 252
           A E   + K T KSDV+SFGV+L EL+T G  P    +TF
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 244

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 110/236 (46%), Gaps = 29/236 (12%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 62
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 117
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
            A  L+Y H     ++IHRDIK  N+LL    E K+ADFG +  A        T + GT 
Sbjct: 118 -ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTL 170
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
            YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 107/201 (53%), Gaps = 16/201 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           LG+G FG V            G++VA+K LK  SG     + + E+EI+  ++H+++V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 106 VGYYT--AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            G  T   G+   L+ EF+P+ +L+ +L  K +  ++   +LK A+   KG+ YL     
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLGSR-- 145
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAK-IASD--VNTHVSTRVMGTFGYLAPEYASS 220
            + +HRD+ A N+L++ + + K+ DFGL K I +D    T    R    F Y APE    
Sbjct: 146 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQ 203
Query: 221 GKLTEKSDVFSFGVMLLELIT 241
            K    SDV+SFGV L EL+T
Sbjct: 204 SKFYIASDVWSFGVTLHELLT 224

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 111/237 (46%), Gaps = 31/237 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 67
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 122
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +  A        T + GT
Sbjct: 123 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGT 174
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
             YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 231

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 51  LLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           ++G+G FG V+ G L   +GK++  A+K L   +  GE  +F  E  I+    H +++SL
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLA 156
           +G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+ 
Sbjct: 89  LGI-------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMK 139
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD---VNTHVSTRVMGTFGYL 213
           YL      K +HRD+ A N +LD KF  KVADFGLA+   D    + H  T       ++
Sbjct: 140 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 196
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF 252
           A E   + K T KSDV+SFGV+L EL+T G  P    +TF
Sbjct: 197 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 236

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 51  LLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           ++G+G FG V+ G L   +GK++  A+K L   +  GE  +F  E  I+    H +++SL
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLA 156
           +G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+ 
Sbjct: 116 LGI-------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMK 166
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD---VNTHVSTRVMGTFGYL 213
           YL      K +HRD+ A N +LD KF  KVADFGLA+   D    + H  T       ++
Sbjct: 167 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 223
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF 252
           A E   + K T KSDV+SFGV+L EL+T G  P    +TF
Sbjct: 224 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 263

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 107/201 (53%), Gaps = 16/201 (7%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           LG+G FG V            G++VA+K LK  SG     + + E+EI+  ++H+++V  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 106 VGYYT--AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            G  T   G+   L+ EF+P+ +L+ +L  K +  ++   +LK A+   KG+ YL     
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLGSR-- 133
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAK-IASD--VNTHVSTRVMGTFGYLAPEYASS 220
            + +HRD+ A N+L++ + + K+ DFGL K I +D    T    R    F Y APE    
Sbjct: 134 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQ 191
Query: 221 GKLTEKSDVFSFGVMLLELIT 241
            K    SDV+SFGV L EL+T
Sbjct: 192 SKFYIASDVWSFGVTLHELLT 212

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER---EFQAEVEIISRVH 98
           +D +    +LG GG   VH    L   ++VA+K L+A   +       F+ E +  + ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 99  HKHLVSLV----GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKG 154
           H  +V++         AG    +V E+V   TL   +H +G   M     +++   + + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 128
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGY 212
           L + H++    IIHRD+K ANI++      KV DFG+A+  +D    V+    V+GT  Y
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA 261
           L+PE A    +  +SDV+S G +L E++TG  P      F  DS V  A
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP------FTGDSPVSVA 228

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
           LG+G FG V            G+ VA+K LKA  G   R  ++ E++I+  ++H+H++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 106 VGYYTAGSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            G      ++   LV E+VP  +L  +L    R ++     L  A    +G+AYLH    
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHSQ-- 136
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASS 220
              IHR++ A N+LLD     K+ DFGLAK   + + +   R  G    F Y APE    
Sbjct: 137 -HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKE 194
Query: 221 GKLTEKSDVFSFGVMLLELIT 241
            K    SDV+SFGV L EL+T
Sbjct: 195 YKFYYASDVWSFGVTLYELLT 215

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 44  DGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEIISR 96
           + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI S 
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGV---EHQLRREVEIQSH 68
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALGSA 152
           + H +++ L GY+   ++  L+ E+ P  T+   L    R     T  ++T L      A
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL------A 122
Query: 153 KGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
             L+Y    CH K +IHRDIK  N+LL    E K+ADFG +  A        T + GT  
Sbjct: 123 NALSY----CHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR---RTTLCGTLD 175
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE 254
           YL PE        EK D++S GV+  E + G  P ++ HT+ E
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEA-HTYQE 217

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 111/237 (46%), Gaps = 31/237 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 63
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 118
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +  A        T + GT
Sbjct: 119 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGT 170
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
             YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 227

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 51  LLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           ++G+G FG V+ G L   +GK++  A+K L   +  GE  +F  E  I+    H +++SL
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLA 156
           +G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+ 
Sbjct: 92  LGI-------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMK 142
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD---VNTHVSTRVMGTFGYL 213
           YL      K +HRD+ A N +LD KF  KVADFGLA+   D    + H  T       ++
Sbjct: 143 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF 252
           A E   + K T KSDV+SFGV+L EL+T G  P    +TF
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 239

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 111/237 (46%), Gaps = 31/237 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 67
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 122
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +  A        T + GT
Sbjct: 123 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGT 174
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
             YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 231

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 112/238 (47%), Gaps = 33/238 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 88
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 143
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMG 208
            A  L+Y H     ++IHRDIK  N+LL    E K+ADFG +     V+   S R  + G
Sbjct: 144 -ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRDDLCG 194
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
           T  YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 252

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 111/237 (46%), Gaps = 31/237 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 63
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 118
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +  A        T + GT
Sbjct: 119 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR---RTTLSGT 170
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
             YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 227

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 51  LLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           ++G+G FG V+ G L   +GK++  A+K L   +  GE  +F  E  I+    H +++SL
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLA 156
           +G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+ 
Sbjct: 94  LGI-------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMK 144
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD---VNTHVSTRVMGTFGYL 213
           YL      K +HRD+ A N +LD KF  KVADFGLA+   D    + H  T       ++
Sbjct: 145 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 201
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF 252
           A E   + K T KSDV+SFGV+L EL+T G  P    +TF
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
           LG+G FG V            G+ VA+K LKA  G   R  ++ E++I+  ++H+H++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 106 VGYYTAGSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            G      ++   LV E+VP  +L  +L    R ++     L  A    +G+AYLH    
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQ-- 136
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG---TFGYLAPEYASS 220
              IHR++ A N+LLD     K+ DFGLAK   + + +   R  G    F Y APE    
Sbjct: 137 -HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKE 194
Query: 221 GKLTEKSDVFSFGVMLLELIT 241
            K    SDV+SFGV L EL+T
Sbjct: 195 YKFYYASDVWSFGVTLYELLT 215

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V         +VA+K +K GS   E  F AE  ++  + H  LV L    T 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ EF+   +L   L             +  +   A+G+A++ +  +   IHRD+
Sbjct: 249 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRDL 304
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
           +AANIL+      K+ADFGLA++ +               + APE  + G  T KSDV+S
Sbjct: 305 RAANILVSASLVCKIADFGLARVGAKF----------PIKWTAPEAINFGSFTIKSDVWS 354
Query: 232 FGVMLLELIT-GRRP 245
           FG++L+E++T GR P
Sbjct: 355 FGILLMEIVTYGRIP 369

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 51  LLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           ++G+G FG V+ G L   +GK++  A+K L   +  GE  +F  E  I+    H +++SL
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLA 156
           +G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+ 
Sbjct: 95  LGI-------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMK 145
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD---VNTHVSTRVMGTFGYL 213
           YL      K +HRD+ A N +LD KF  KVADFGLA+   D    + H  T       ++
Sbjct: 146 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 202
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF 252
           A E   + K T KSDV+SFGV+L EL+T G  P    +TF
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 242

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 111/237 (46%), Gaps = 31/237 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 62
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 117
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +  A        T + GT
Sbjct: 118 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGT 169
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
             YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 111/237 (46%), Gaps = 31/237 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 62
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 117
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +  A        T + GT
Sbjct: 118 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTXLCGT 169
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
             YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 51  LLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           ++G+G FG V+ G L   +GK++  A+K L   +  GE  +F  E  I+    H +++SL
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLA 156
           +G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+ 
Sbjct: 96  LGI-------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMK 146
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD---VNTHVSTRVMGTFGYL 213
           YL      K +HRD+ A N +LD KF  KVADFGLA+   D    + H  T       ++
Sbjct: 147 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 203
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF 252
           A E   + K T KSDV+SFGV+L EL+T G  P    +TF
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 243

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 111/237 (46%), Gaps = 31/237 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 62
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 117
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +  A        T + GT
Sbjct: 118 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGT 169
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
             YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 51  LLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           ++G+G FG V+ G L   +GK++  A+K L   +  GE  +F  E  I+    H +++SL
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLA 156
           +G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+ 
Sbjct: 97  LGI-------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMK 147
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD---VNTHVSTRVMGTFGYL 213
           YL      K +HRD+ A N +LD KF  KVADFGLA+   D    + H  T       ++
Sbjct: 148 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF 252
           A E   + K T KSDV+SFGV+L EL+T G  P    +TF
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 244

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 105/200 (52%), Gaps = 13/200 (6%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGER--EFQAEVEIISRVHHKHLVSLVGYY 109
           +G G FG V++G      +VA+K LK      E+   F+ EV ++ +  H +++  +GY 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
           T  +   +V ++   ++L  HLH +          + IA  +A+G+ YLH      IIHR
Sbjct: 102 TKDN-LAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHR 156
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYA---SSGKLTE 225
           D+K+ NI L      K+ DFGLA + S  + +    +  G+  ++APE      +   + 
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 226 KSDVFSFGVMLLELITGRRP 245
           +SDV+S+G++L EL+TG  P
Sbjct: 217 QSDVYSYGIVLYELMTGELP 236

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 111/237 (46%), Gaps = 31/237 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 65
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 120
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +  A        T + GT
Sbjct: 121 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGT 172
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
             YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 229

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 104/219 (47%), Gaps = 28/219 (12%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 61
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 62  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 116
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +  A        T + GT
Sbjct: 117 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGT 168
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDS 248
             YL PE        EK D++S GV+  E + G+ P ++
Sbjct: 169 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 207

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 111/237 (46%), Gaps = 31/237 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 66
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 121
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +  A        T + GT
Sbjct: 122 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGT 173
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
             YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 230

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 52  LGQGGFGYVH----RGVLPNGKE--VAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG V       +LP   +  VA+K LK  S    ++FQ E E+++ + H+H+V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLT--------------RLKIALGS 151
            G  T G   ++V+E++ +  L   L   G P    L                L +A   
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHG-PDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTF 210
           A G+ YL    H   +HRD+   N L+      K+ DFG+++ I S     V  R M   
Sbjct: 145 AAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
            ++ PE     K T +SDV+SFGV+L E+ T G++P
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 52  LGQGGFGYVH----RGVLPNGKE--VAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG V       +LP   +  VA+K LK  S    ++FQ E E+++ + H+H+V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLT--------------RLKIALGS 151
            G  T G   ++V+E++ +  L   L   G P    L                L +A   
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHG-PDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTF 210
           A G+ YL    H   +HRD+   N L+      K+ DFG+++ I S     V  R M   
Sbjct: 168 AAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
            ++ PE     K T +SDV+SFGV+L E+ T G++P
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 103/211 (48%), Gaps = 27/211 (12%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG GGFGYV R +  + G++VAIKQ +       RE +  E++I+ +++H ++VS     
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS-AREV 81
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKG------------LAY 157
             G Q++   +  P   +E+   G  R    +L + +   G  +G            L Y
Sbjct: 82  PDGLQKLAPNDL-PLLAMEYCEGGDLR---KYLNQFENCCGLKEGPIRTLLSDISSALRY 137
Query: 158 LHEDCHPKIIHRDIKAANILLD---FKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LHE+   +IIHRD+K  NI+L     +   K+ D G AK        + T  +GT  YLA
Sbjct: 138 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGTLQYLA 192
Query: 215 PEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           PE     K T   D +SFG +  E ITG RP
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 103/211 (48%), Gaps = 27/211 (12%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG GGFGYV R +  + G++VAIKQ +       RE +  E++I+ +++H ++VS     
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS-AREV 80
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKG------------LAY 157
             G Q++   +  P   +E+   G  R    +L + +   G  +G            L Y
Sbjct: 81  PDGLQKLAPNDL-PLLAMEYCEGGDLR---KYLNQFENCCGLKEGPIRTLLSDISSALRY 136
Query: 158 LHEDCHPKIIHRDIKAANILLD---FKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LHE+   +IIHRD+K  NI+L     +   K+ D G AK        + T  +GT  YLA
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGTLQYLA 191
Query: 215 PEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           PE     K T   D +SFG +  E ITG RP
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 52  LGQGGFGYVH----RGVLPNGKE--VAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG V       +LP   +  VA+K LK  S    ++FQ E E+++ + H+H+V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLT--------------RLKIALGS 151
            G  T G   ++V+E++ +  L   L   G P    L                L +A   
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHG-PDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTF 210
           A G+ YL    H   +HRD+   N L+      K+ DFG+++ I S     V  R M   
Sbjct: 139 AAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
            ++ PE     K T +SDV+SFGV+L E+ T G++P
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 110/237 (46%), Gaps = 31/237 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 67
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P   +   L    +     T  ++T L     
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL----- 122
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +  A        T + GT
Sbjct: 123 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGT 174
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
             YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 231

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 114/231 (49%), Gaps = 25/231 (10%)
Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER---EFQAEVEIISRVH 98
           +D +    +LG GG   VH    L   ++VA+K L+A   +       F+ E +  + ++
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 99  HKHLVSLVGYYT------AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA 152
           H  +V++  Y T      AG    +V E+V   TL   +H +G   M     +++   + 
Sbjct: 88  HPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADAC 143
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTF 210
           + L + H++    IIHRD+K ANI++      KV DFG+A+  +D    V+    V+GT 
Sbjct: 144 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA 261
            YL+PE A    +  +SDV+S G +L E++TG  P      F  DS V  A
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP------FTGDSPVSVA 245

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/239 (31%), Positives = 113/239 (47%), Gaps = 35/239 (14%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 64
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 119
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VM 207
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +     V+   S R  + 
Sbjct: 120 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLC 169
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
           GT  YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 228

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 9/214 (4%)
Query: 39  LARATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQLK-AGSGQGEREFQAEVEIISR 96
           +A   + F+    +G+G FG V +G+    ++V AIK +    +     + Q E+ ++S+
Sbjct: 18  IADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ 77
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLA 156
               ++    G Y  GS+  ++ E++   +    L           T LK  L   KGL 
Sbjct: 78  CDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLD 134
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE 216
           YLH +   K IHRDIKAAN+LL  + + K+ADFG+A   +D     +T V GT  ++APE
Sbjct: 135 YLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE 190
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
                    K+D++S G+  +EL  G  P    H
Sbjct: 191 VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 224

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/239 (31%), Positives = 113/239 (47%), Gaps = 35/239 (14%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 63
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 118
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VM 207
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +     V+   S R  + 
Sbjct: 119 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRDTLC 168
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
           GT  YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 227

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 112/238 (47%), Gaps = 33/238 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 65
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 120
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMG 208
            A  L+Y H     ++IHRDIK  N+LL    E K+ADFG +     V+   S R  + G
Sbjct: 121 -ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRAALCG 171
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
           T  YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 229

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 104/219 (47%), Gaps = 28/219 (12%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 59
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 60  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 114
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +  A        T + GT
Sbjct: 115 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGT 166
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDS 248
             YL PE        EK D++S GV+  E + G+ P ++
Sbjct: 167 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 205

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 31/237 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 64
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 119
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
            A  L+Y    CH K +IHRDIK  N+LL    E K+A+FG +  A        T + GT
Sbjct: 120 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGT 171
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
             YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 228

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/225 (33%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 44  DGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEIISR 96
           + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI S 
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGV---EHQLRREVEIQSH 68
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALGSA 152
           + H +++ L GY+   ++  L+ E+ P  T+   L    R     T  ++T L      A
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL------A 122
Query: 153 KGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGT 209
             L+Y    CH K +IHRDIK  N+LL    E K+ADFG +     V+   S R  + GT
Sbjct: 123 NALSY----CHSKRVIHRDIKPENLLLGSNGELKIADFGWS-----VHAPSSRRDTLCGT 173
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE 254
             YL PE        EK D++S GV+  E + G  P ++ HT+ E
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEA-HTYQE 217

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/220 (35%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 51  LLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           ++G+G FG V+ G L   +GK++  A+K L   +  GE  +F  E  I+    H +++SL
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLA 156
           +G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+ 
Sbjct: 156 LGI-------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMK 206
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV---NTHVSTRVMGTFGYL 213
           +L      K +HRD+ A N +LD KF  KVADFGLA+   D    + H  T       ++
Sbjct: 207 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF 252
           A E   + K T KSDV+SFGV+L EL+T G  P    +TF
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 31/237 (13%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 65
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 120
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
            A  L+Y    CH K +IHRDIK  N+LL    E K+A+FG +  A        T + GT
Sbjct: 121 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGT 172
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
             YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 229

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/239 (31%), Positives = 113/239 (47%), Gaps = 35/239 (14%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 65
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 120
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VM 207
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +     V+   S R  + 
Sbjct: 121 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLC 170
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
           GT  YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 229

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 32/221 (14%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 65
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 120
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VM 207
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +     V+   S R  + 
Sbjct: 121 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRDDLC 170
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDS 248
           GT  YL PE        EK D++S GV+  E + G+ P ++
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/239 (31%), Positives = 113/239 (47%), Gaps = 35/239 (14%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 62
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 117
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VM 207
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +     V+   S R  + 
Sbjct: 118 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLC 167
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
           GT  YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/239 (31%), Positives = 113/239 (47%), Gaps = 35/239 (14%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 62
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P  T+   L    +     T  ++T L     
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----- 117
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VM 207
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +     V+   S R  + 
Sbjct: 118 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRAALC 167
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
           GT  YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/220 (35%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 51  LLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           ++G+G FG V+ G L   +GK++  A+K L   +  GE  +F  E  I+    H +++SL
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLA 156
           +G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+ 
Sbjct: 97  LGI-------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMK 147
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV---NTHVSTRVMGTFGYL 213
           +L      K +HRD+ A N +LD KF  KVADFGLA+   D    + H  T       ++
Sbjct: 148 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF 252
           A E   + K T KSDV+SFGV+L EL+T G  P    +TF
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 244

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/220 (35%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 51  LLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           ++G+G FG V+ G L   +GK++  A+K L   +  GE  +F  E  I+    H +++SL
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLA 156
           +G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+ 
Sbjct: 95  LGI-------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMK 145
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV---NTHVSTRVMGTFGYL 213
           +L      K +HRD+ A N +LD KF  KVADFGLA+   D    + H  T       ++
Sbjct: 146 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 202
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF 252
           A E   + K T KSDV+SFGV+L EL+T G  P    +TF
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 242

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/220 (35%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 51  LLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           ++G+G FG V+ G L   +GK++  A+K L   +  GE  +F  E  I+    H +++SL
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLA 156
           +G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+ 
Sbjct: 98  LGI-------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMK 148
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV---NTHVSTRVMGTFGYL 213
           +L      K +HRD+ A N +LD KF  KVADFGLA+   D    + H  T       ++
Sbjct: 149 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 205
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF 252
           A E   + K T KSDV+SFGV+L EL+T G  P    +TF
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 245

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/220 (35%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 51  LLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           ++G+G FG V+ G L   +GK++  A+K L   +  GE  +F  E  I+    H +++SL
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLA 156
           +G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+ 
Sbjct: 97  LGI-------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMK 147
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV---NTHVSTRVMGTFGYL 213
           +L      K +HRD+ A N +LD KF  KVADFGLA+   D    + H  T       ++
Sbjct: 148 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF 252
           A E   + K T KSDV+SFGV+L EL+T G  P    +TF
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 244

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/220 (35%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 51  LLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           ++G+G FG V+ G L   +GK++  A+K L   +  GE  +F  E  I+    H +++SL
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLA 156
           +G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+ 
Sbjct: 102 LGI-------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMK 152
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV---NTHVSTRVMGTFGYL 213
           +L      K +HRD+ A N +LD KF  KVADFGLA+   D    + H  T       ++
Sbjct: 153 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 209
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF 252
           A E   + K T KSDV+SFGV+L EL+T G  P    +TF
Sbjct: 210 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 249

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/220 (35%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 51  LLGQGGFGYVHRGVL--PNGKEV--AIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSL 105
           ++G+G FG V+ G L   +GK++  A+K L   +  GE  +F  E  I+    H +++SL
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---------PTMDWLTRLKIALGSAKGLA 156
           +G         L  E  P   L +  HG  R         PT+  L  +   L  AKG+ 
Sbjct: 98  LGI-------CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMK 148
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV---NTHVSTRVMGTFGYL 213
           +L      K +HRD+ A N +LD KF  KVADFGLA+   D    + H  T       ++
Sbjct: 149 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWM 205
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF 252
           A E   + K T KSDV+SFGV+L EL+T G  P    +TF
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 245

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V+ G +      P+  +VA+K L +  S Q E +F  E  IIS+++H+++V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPT----MDWLTRLKIALGSAKGLAYLH 159
            +G       R ++ E +    L+ F    + RP+    +  L  L +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAP 215
           E+     IHRDI A N LL      +VA  G   +A D+      R     M    ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT 241
           E    G  T K+D +SFGV+L E+ +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/239 (31%), Positives = 112/239 (46%), Gaps = 35/239 (14%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL------KAGSGQGEREFQAEVEII 94
           A + F     LG+G FG V+       K + A+K L      KAG    E + + EVEI 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---EHQLRREVEIQ 67
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
           S + H +++ L GY+   ++  L+ E+ P   +   L    +     T  ++T L     
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL----- 122
Query: 151 SAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VM 207
            A  L+Y    CH K +IHRDIK  N+LL    E K+ADFG +     V+   S R  + 
Sbjct: 123 -ANALSY----CHSKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLX 172
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST---HTFVEDSLVDWARP 263
           GT  YL PE        EK D++S GV+  E + G+ P ++     T+   S V++  P
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 231

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 48  DANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           D  +LG+G +G V+ G  L N   +AIK++     +  +    E+ +   + HK++V  +
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA-KGLAYLHEDCHPK 165
           G ++      +  E VP  +L   L  K  P  D    +        +GL YLH++   +
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 142
Query: 166 IIHRDIKAANILLD-FKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK-- 222
           I+HRDIK  N+L++ +    K++DFG +K  + +N    T   GT  Y+APE    G   
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRG 201
Query: 223 LTEKSDVFSFGVMLLELITGRRP 245
             + +D++S G  ++E+ TG+ P
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPP 224

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 16/198 (8%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G+G FG V  G    G +VA+K +K  +    + F AE  +++++ H +LV L+G    
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 112 GSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
               + +V E++   +L  +L  +GR  +     LK +L   + + YL  +     +HRD
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 314
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASSGKLTEKSD 228
           + A N+L+     AKV+DFGL K AS      ST+  G     + APE     K + KSD
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFSTKSD 368
Query: 229 VFSFGVMLLELIT-GRRP 245
           V+SFG++L E+ + GR P
Sbjct: 369 VWSFGILLWEIYSFGRVP 386

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V+ G +      P+  +VA+K L +  S Q E +F  E  IIS+++H+++V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPT----MDWLTRLKIALGSAKGLAYLH 159
            +G       R ++ E +    L+ F    + RP+    +  L  L +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAP 215
           E+     IHRDI A N LL      +VA  G   +A D+      R     M    ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT 241
           E    G  T K+D +SFGV+L E+ +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 16/198 (8%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G+G FG V  G    G +VA+K +K  +    + F AE  +++++ H +LV L+G    
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 112 GSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
               + +V E++   +L  +L  +GR  +     LK +L   + + YL  +     +HRD
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 142
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASSGKLTEKSD 228
           + A N+L+     AKV+DFGL K AS      ST+  G     + APE     K + KSD
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFSTKSD 196
Query: 229 VFSFGVMLLELIT-GRRP 245
           V+SFG++L E+ + GR P
Sbjct: 197 VWSFGILLWEIYSFGRVP 214

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V+ G +      P+  +VA+K L +  S Q E +F  E  IIS+ +H+++V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPT----MDWLTRLKIALGSAKGLAYLH 159
            +G       R ++ E +    L+ F    + RP+    +  L  L +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAP 215
           E+     IHRDI A N LL      +VA  G   +A D+      R     M    ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT 241
           E    G  T K+D +SFGV+L E+ +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V+ G +      P+  +VA+K L +  S Q E +F  E  IIS+ +H+++V 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPT----MDWLTRLKIALGSAKGLAYLH 159
            +G       R ++ E +    L+ F    + RP+    +  L  L +A   A G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAP 215
           E+     IHRDI A N LL      +VA  G   +A D+      R     M    ++ P
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT 241
           E    G  T K+D +SFGV+L E+ +
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 16/198 (8%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G+G FG V  G    G +VA+K +K  +    + F AE  +++++ H +LV L+G    
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 112 GSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
               + +V E++   +L  +L  +GR  +     LK +L   + + YL  +     +HRD
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 127
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASSGKLTEKSD 228
           + A N+L+     AKV+DFGL K AS      ST+  G     + APE     K + KSD
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 229 VFSFGVMLLELIT-GRRP 245
           V+SFG++L E+ + GR P
Sbjct: 182 VWSFGILLWEIYSFGRVP 199

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 114/226 (50%), Gaps = 21/226 (9%)
Query: 33  TFTYEELARATDGFSDANLLGQGGFGYVH----RGVLPNGKE--VAIKQLKAGSGQGER- 85
            F  +E   A +  + +  LGQG FG V+    +GV+ +  E  VAIK +   +   ER 
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----- 140
           EF  E  ++   +  H+V L+G  + G   +++ E +    L+ +L    RP M+     
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVL 123
Query: 141 ---WLTRL-KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
               L+++ ++A   A G+AYL+ +   K +HRD+ A N ++   F  K+ DFG+ +   
Sbjct: 124 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 180
Query: 197 DVNTHVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           + + +    + +    +++PE    G  T  SDV+SFGV+L E+ T
Sbjct: 181 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V+ G +      P+  +VA+K L +  S Q E +F  E  IIS+ +H+++V 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPT----MDWLTRLKIALGSAKGLAYLH 159
            +G       R ++ E +    L+ F    + RP+    +  L  L +A   A G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAP 215
           E+     IHRDI A N LL      +VA  G   +A D+      R     M    ++ P
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT 241
           E    G  T K+D +SFGV+L E+ +
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V+ G +      P+  +VA+K L +  S Q E +F  E  IIS+ +H+++V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPT----MDWLTRLKIALGSAKGLAYLH 159
            +G       R ++ E +    L+ F    + RP+    +  L  L +A   A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAP 215
           E+     IHRDI A N LL      +VA  G   +A D+      R     M    ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT 241
           E    G  T K+D +SFGV+L E+ +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V+ G +      P+  +VA+K L +  S Q E +F  E  IIS+ +H+++V 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPT----MDWLTRLKIALGSAKGLAYLH 159
            +G       R ++ E +    L+ F    + RP+    +  L  L +A   A G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAP 215
           E+     IHRDI A N LL      +VA  G   +A D+      R     M    ++ P
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT 241
           E    G  T K+D +SFGV+L E+ +
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 16/201 (7%)
Query: 50  NLLGQGGFGYVHRGV-LPNGKE----VAIKQLKAGSGQGEREFQAEVE---IISRVHHKH 101
            +LG G FG VH+GV +P G+     V IK ++  SG+  + FQA  +    I  + H H
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAH 94
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
           +V L+G    GS   LV +++P  +L  H+  + R  +     L   +  AKG+ YL E 
Sbjct: 95  IVRLLGL-CPGSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEH 152
Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPEYASS 220
               ++HR++ A N+LL    + +VADFG+A  +  D    + +       ++A E    
Sbjct: 153 ---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 209
Query: 221 GKLTEKSDVFSFGVMLLELIT 241
           GK T +SDV+S+GV + EL+T
Sbjct: 210 GKYTHQSDVWSYGVTVWELMT 230

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V+ G +      P+  +VA+K L +  S Q E +F  E  IIS+ +H+++V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPT----MDWLTRLKIALGSAKGLAYLH 159
            +G       R ++ E +    L+ F    + RP+    +  L  L +A   A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAP 215
           E+     IHRDI A N LL      +VA  G   +A D+      R     M    ++ P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT 241
           E    G  T K+D +SFGV+L E+ +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 48  DANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           D  +LG+G +G V+ G  L N   +AIK++     +  +    E+ +   + HK++V  +
Sbjct: 12  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 71
Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA-KGLAYLHEDCHPK 165
           G ++      +  E VP  +L   L  K  P  D    +        +GL YLH++   +
Sbjct: 72  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 128
Query: 166 IIHRDIKAANILLD-FKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK-- 222
           I+HRDIK  N+L++ +    K++DFG +K  + +N    T   GT  Y+APE    G   
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRG 187
Query: 223 LTEKSDVFSFGVMLLELITGRRP 245
             + +D++S G  ++E+ TG+ P
Sbjct: 188 YGKAADIWSLGCTIIEMATGKPP 210

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V+ G +      P+  +VA+K L +  S Q E +F  E  IIS+ +H+++V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPT----MDWLTRLKIALGSAKGLAYLH 159
            +G       R ++ E +    L+ F    + RP+    +  L  L +A   A G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAP 215
           E+     IHRDI A N LL      +VA  G   +A D+      R     M    ++ P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT 241
           E    G  T K+D +SFGV+L E+ +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V+ G +      P+  +VA+K L +  S Q E +F  E  IIS+ +H+++V 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPT----MDWLTRLKIALGSAKGLAYLH 159
            +G       R ++ E +    L+ F    + RP+    +  L  L +A   A G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAP 215
           E+     IHRDI A N LL      +VA  G   +A D+      R     M    ++ P
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT 241
           E    G  T K+D +SFGV+L E+ +
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V+ G +      P+  +VA+K L +  S Q E +F  E  IIS+ +H+++V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPT----MDWLTRLKIALGSAKGLAYLH 159
            +G       R ++ E +    L+ F    + RP+    +  L  L +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAP 215
           E+     IHRDI A N LL      +VA  G   +A D+      R     M    ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT 241
           E    G  T K+D +SFGV+L E+ +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 25/229 (10%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYVHRG----VLPNGKE--VAIKQLKAGSGQGER 85
           S F  +E   + +  +    LGQG FG V+ G    ++    E  VA+K +   +   ER
Sbjct: 5   SVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER 64
Query: 86  -EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHL--------HGKGR 136
            EF  E  ++      H+V L+G  + G   ++V E + +  L+ +L        +  GR
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 137 PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
           P       +++A   A G+AYL+     K +HRD+ A N ++   F  K+ DFG+ +   
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--- 178
Query: 197 DVNTHVSTRVMG----TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           D+      R  G       ++APE    G  T  SD++SFGV+L E+ +
Sbjct: 179 DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 25/229 (10%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYVHRG----VLPNGKE--VAIKQLKAGSGQGER 85
           S F  +E   + +  +    LGQG FG V+ G    ++    E  VA+K +   +   ER
Sbjct: 2   SVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER 61
Query: 86  -EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHL--------HGKGR 136
            EF  E  ++      H+V L+G  + G   ++V E + +  L+ +L        +  GR
Sbjct: 62  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 121
Query: 137 PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
           P       +++A   A G+AYL+     K +HRD+ A N ++   F  K+ DFG+ +   
Sbjct: 122 PPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--- 175
Query: 197 DVNTHVSTRVMG----TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           D+      R  G       ++APE    G  T  SD++SFGV+L E+ +
Sbjct: 176 DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 9/206 (4%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G FG V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  +  +  L +A   +  + YL +      IHRD
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 134
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 231 SFGVMLLELIT-GRRP---VDSTHTF 252
           +FGV+L E+ T G  P   +D +  +
Sbjct: 195 AFGVLLWEIATYGMSPYPGIDPSQVY 220

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 113/229 (49%), Gaps = 27/229 (11%)
Query: 33  TFTYEELARATDGFSDANLLGQGGFGYVH----RGVLPNGKE--VAIKQLKAGSGQGER- 85
            +  +E   A +  + +  LGQG FG V+    +GV+ +  E  VAIK +   +   ER 
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 67
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----- 140
           EF  E  ++   +  H+V L+G  + G   +++ E +    L+ +L    RP M+     
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVL 126
Query: 141 ---WLTRL-KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
               L+++ ++A   A G+AYL+ +   K +HRD+ A N ++   F  K+ DFG+ +   
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--- 180
Query: 197 DVNTHVSTRVMGT----FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           D+      R  G       +++PE    G  T  SDV+SFGV+L E+ T
Sbjct: 181 DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V+ G +      P+  +VA+K L +  S Q E +F  E  IIS+ +H+++V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPT----MDWLTRLKIALGSAKGLAYLH 159
            +G       R ++ E +    L+ F    + RP+    +  L  L +A   A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAP 215
           E+     IHRDI A N LL      +VA  G   +A D+      R     M    ++ P
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT 241
           E    G  T K+D +SFGV+L E+ +
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 16/201 (7%)
Query: 50  NLLGQGGFGYVHRGV-LPNGKE----VAIKQLKAGSGQGEREFQAEVE---IISRVHHKH 101
            +LG G FG VH+GV +P G+     V IK ++  SG+  + FQA  +    I  + H H
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAH 76
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
           +V L+G    GS   LV +++P  +L  H+  + R  +     L   +  AKG+ YL E 
Sbjct: 77  IVRLLGL-CPGSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPEYASS 220
               ++HR++ A N+LL    + +VADFG+A  +  D    + +       ++A E    
Sbjct: 135 ---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 221 GKLTEKSDVFSFGVMLLELIT 241
           GK T +SDV+S+GV + EL+T
Sbjct: 192 GKYTHQSDVWSYGVTVWELMT 212

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V+ G +      P+  +VA+K L +  S Q E +F  E  IIS+ +H+++V 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPT----MDWLTRLKIALGSAKGLAYLH 159
            +G       R ++ E +    L+ F    + RP+    +  L  L +A   A G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAP 215
           E+     IHRDI A N LL      +VA  G   +A D+      R     M    ++ P
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT 241
           E    G  T K+D +SFGV+L E+ +
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 24/214 (11%)
Query: 52  LGQGGFGYVHRG----VLPNGKE--VAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG V       + P   +  VA+K LK  S    ++F  E E+++ + H+H+V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 106 VGYYTAGSQRMLVYEFVP----NNTLEFH-----LHGKGRPTMDWLTR---LKIALGSAK 153
            G    G   ++V+E++     N  L  H     L  +G P  + LT+   L IA   A 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTE-LTQSQMLHIAQQIAA 139
Query: 154 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGY 212
           G+ YL        +HRD+   N L+      K+ DFG+++ + S     V    M    +
Sbjct: 140 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
           + PE     K T +SDV+S GV+L E+ T G++P
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG+G +G V++ +    G+ VAIKQ+   S    +E   E+ I+ +    H+V   G Y 
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIAL---GSAKGLAYLHEDCHPKII 167
             +   +V E+    ++   +  + +     LT  +IA     + KGL YLH     + I
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKT----LTEDEIATILQSTLKGLEYLH---FMRKI 147
Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS 227
           HRDIKA NILL+ +  AK+ADFG+A   +D        V+GT  ++APE          +
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK-RNXVIGTPFWMAPEVIQEIGYNCVA 206
Query: 228 DVFSFGVMLLELITGRRPVDSTH 250
           D++S G+  +E+  G+ P    H
Sbjct: 207 DIWSLGITAIEMAEGKPPYADIH 229

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 93/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  ++ +  L +A   +  + YL +      IHRD
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 137
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 197
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 198 AFGVLLWEIAT 208

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 112/225 (49%), Gaps = 27/225 (12%)
Query: 37  EELARATDGFSDANLLGQGGFGYVH----RGVLPNGKE--VAIKQLKAGSGQGER-EFQA 89
           +E   A +  + +  LGQG FG V+    +GV+ +  E  VAIK +   +   ER EF  
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 90  EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD--------W 141
           E  ++   +  H+V L+G  + G   +++ E +    L+ +L    RP M+         
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVLAPPS 121
Query: 142 LTRL-KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT 200
           L+++ ++A   A G+AYL+ +   K +HRD+ A N ++   F  K+ DFG+ +   D+  
Sbjct: 122 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---DIXE 175
Query: 201 HVSTRVMG----TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
               R  G       +++PE    G  T  SDV+SFGV+L E+ T
Sbjct: 176 TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 114/226 (50%), Gaps = 21/226 (9%)
Query: 33  TFTYEELARATDGFSDANLLGQGGFGYVH----RGVLPNGKE--VAIKQLKAGSGQGER- 85
            +  +E   A +  + +  LGQG FG V+    +GV+ +  E  VAIK +   +   ER 
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----- 140
           EF  E  ++   +  H+V L+G  + G   +++ E +    L+ +L    RP M+     
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVL 132
Query: 141 ---WLTRL-KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
               L+++ ++A   A G+AYL+ +   K +HRD+ A N ++   F  K+ DFG+ +   
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 197 DVNTHVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           + + +    + +    +++PE    G  T  SDV+SFGV+L E+ T
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 93/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  ++ +  L +A   +  + YL +      IHRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 141
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 202 AFGVLLWEIAT 212

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 93/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  ++ +  L +A   +  + YL +      IHRD
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 137
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVW 197
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 198 AFGVLLWEIAT 208

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 51  LLGQGGFGYVHRGVLPNGK----EVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
           +LG+G FG V+ GV  N K     VA+K  K       +E F +E  I+  + H H+V L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHE-DCHP 164
           +G         ++ E  P   L  +L  + + ++  LT +  +L   K +AYL   +C  
Sbjct: 75  IGI-IEEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESINC-- 130
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
             +HRDI   NIL+      K+ DFGL++   D + + ++       +++PE  +  + T
Sbjct: 131 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 225 EKSDVFSFGVMLLELIT-GRRP 245
             SDV+ F V + E+++ G++P
Sbjct: 189 TASDVWMFAVCMWEILSFGKQP 210

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 93/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  ++ +  L +A   +  + YL +      IHRD
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 141
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 202 AFGVLLWEIAT 212

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 16/198 (8%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G+G FG V  G    G +VA+K +K  +    + F AE  +++++ H +LV L+G    
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 112 GSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
               + +V E++   +L  +L  +GR  +     LK +L   + + YL  +     +HRD
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 133
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASSGKLTEKSD 228
           + A N+L+     AKV+DFGL K AS      ST+  G     + APE       + KSD
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREAAFSTKSD 187
Query: 229 VFSFGVMLLELIT-GRRP 245
           V+SFG++L E+ + GR P
Sbjct: 188 VWSFGILLWEIYSFGRVP 205

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 25/229 (10%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYVHRG----VLPNGKE--VAIKQLKAGSGQGER 85
           S F  +E   + +  +    LGQG FG V+ G    ++    E  VA+K +   +   ER
Sbjct: 5   SVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER 64
Query: 86  -EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHL--------HGKGR 136
            EF  E  ++      H+V L+G  + G   ++V E + +  L+ +L        +  GR
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 137 PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
           P       +++A   A G+AYL+     K +HRD+ A N ++   F  K+ DFG+ +   
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--- 178
Query: 197 DVNTHVSTRVMG----TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           D+      R  G       ++APE    G  T  SD++SFGV+L E+ +
Sbjct: 179 DIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 114/226 (50%), Gaps = 21/226 (9%)
Query: 33  TFTYEELARATDGFSDANLLGQGGFGYVH----RGVLPNGKE--VAIKQLKAGSGQGER- 85
            +  +E   A +  + +  LGQG FG V+    +GV+ +  E  VAIK +   +   ER 
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----- 140
           EF  E  ++   +  H+V L+G  + G   +++ E +    L+ +L    RP M+     
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVL 125
Query: 141 ---WLTRL-KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
               L+++ ++A   A G+AYL+ +   K +HRD+ A N ++   F  K+ DFG+ +   
Sbjct: 126 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 182
Query: 197 DVNTHVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           + + +    + +    +++PE    G  T  SDV+SFGV+L E+ T
Sbjct: 183 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 108/226 (47%), Gaps = 19/226 (8%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYVHRG----VLPNGKE--VAIKQLKAGSGQGER 85
           S F  +E   + +  +    LGQG FG V+ G    ++    E  VA+K +   +   ER
Sbjct: 5   SVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER 64
Query: 86  -EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHL--------HGKGR 136
            EF  E  ++      H+V L+G  + G   ++V E + +  L+ +L        +  GR
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 137 PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
           P       +++A   A G+AYL+     K +HRD+ A N ++   F  K+ DFG+ +   
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 181
Query: 197 DVNTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           + + +    + +    ++APE    G  T  SD++SFGV+L E+ +
Sbjct: 182 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 51  LLGQGGFGYVHRGVLPNGK----EVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
           +LG+G FG V+ GV  N K     VA+K  K       +E F +E  I+  + H H+V L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHE-DCHP 164
           +G         ++ E  P   L  +L  + + ++  LT +  +L   K +AYL   +C  
Sbjct: 91  IGI-IEEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESINC-- 146
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
             +HRDI   NIL+      K+ DFGL++   D + + ++       +++PE  +  + T
Sbjct: 147 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 204
Query: 225 EKSDVFSFGVMLLELIT-GRRP 245
             SDV+ F V + E+++ G++P
Sbjct: 205 TASDVWMFAVCMWEILSFGKQP 226

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 114/226 (50%), Gaps = 21/226 (9%)
Query: 33  TFTYEELARATDGFSDANLLGQGGFGYVH----RGVLPNGKE--VAIKQLKAGSGQGER- 85
            +  +E   A +  + +  LGQG FG V+    +GV+ +  E  VAIK +   +   ER 
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 67
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----- 140
           EF  E  ++   +  H+V L+G  + G   +++ E +    L+ +L    RP M+     
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVL 126
Query: 141 ---WLTRL-KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
               L+++ ++A   A G+AYL+ +   K +HRD+ A N ++   F  K+ DFG+ +   
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 183
Query: 197 DVNTHVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           + + +    + +    +++PE    G  T  SDV+SFGV+L E+ T
Sbjct: 184 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V+ G +      P+  +VA+K L +  S Q E +F  E  IIS+ +H+++V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPT----MDWLTRLKIALGSAKGLAYLH 159
            +G       R ++ E +    L+ F    + RP+    +  L  L +A   A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAP 215
           E+     IHRDI A N LL      +VA  G   +A D+      R     M    ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT 241
           E    G  T K+D +SFGV+L E+ +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 93/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  ++ +  L +A   +  + YL +      IHRD
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 138
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 199 AFGVLLWEIAT 209

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 107/201 (53%), Gaps = 12/201 (5%)
Query: 52  LGQGGFGYVHRGVLPNGK---EVAIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSLVG 107
           LG G FG V +GV    K   +VAIK LK G+ + +  E   E +I+ ++ + ++V L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
              A +  MLV E      L   L GK R  +      ++    + G+ YL E      +
Sbjct: 78  VCQAEAL-MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFV 132
Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASSGKLTE 225
           HRD+ A N+LL  +  AK++DFGL+K     +++ + R  G +   + APE  +  K + 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 226 KSDVFSFGVMLLELIT-GRRP 245
           +SDV+S+GV + E ++ G++P
Sbjct: 193 RSDVWSYGVTMWEALSYGQKP 213

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 93/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  ++ +  L +A   +  + YL +      IHRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 141
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 202 AFGVLLWEIAT 212

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 51  LLGQGGFGYVHRGVLPNGK----EVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
           +LG+G FG V+ GV  N K     VA+K  K       +E F +E  I+  + H H+V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHE-DCHP 164
           +G         ++ E  P   L  +L  + + ++  LT +  +L   K +AYL   +C  
Sbjct: 79  IGI-IEEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESINC-- 134
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
             +HRDI   NIL+      K+ DFGL++   D + + ++       +++PE  +  + T
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 225 EKSDVFSFGVMLLELIT-GRRP 245
             SDV+ F V + E+++ G++P
Sbjct: 193 TASDVWMFAVCMWEILSFGKQP 214

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 114/226 (50%), Gaps = 21/226 (9%)
Query: 33  TFTYEELARATDGFSDANLLGQGGFGYVH----RGVLPNGKE--VAIKQLKAGSGQGER- 85
            +  +E   A +  + +  LGQG FG V+    +GV+ +  E  VAIK +   +   ER 
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----- 140
           EF  E  ++   +  H+V L+G  + G   +++ E +    L+ +L    RP M+     
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVL 125
Query: 141 ---WLTRL-KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
               L+++ ++A   A G+AYL+ +   K +HRD+ A N ++   F  K+ DFG+ +   
Sbjct: 126 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 182
Query: 197 DVNTHVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           + + +    + +    +++PE    G  T  SDV+SFGV+L E+ T
Sbjct: 183 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 52  LGQGGFGYVHRG----VLPNGKE--VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
           LGQG FG V+ G    ++    E  VA+K +   +   ER EF  E  ++      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHL--------HGKGRPTMDWLTRLKIALGSAKGLA 156
           L+G  + G   ++V E + +  L+ +L        +  GRP       +++A   A G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG----TFGY 212
           YL+     K +HRD+ A N ++   F  K+ DFG+ +   D+      R  G       +
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR---DIXETDXXRKGGKGLLPVRW 198
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           +APE    G  T  SD++SFGV+L E+ +
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 9/206 (4%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  +  +  L +A   +  + YL +      IHRD
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 134
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 231 SFGVMLLELIT-GRRP---VDSTHTF 252
           +FGV+L E+ T G  P   +D +  +
Sbjct: 195 AFGVLLWEIATYGMSPYPGIDPSQVY 220

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 93/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  ++ +  L +A   +  + YL +      IHRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 141
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 202 AFGVLLWEIAT 212

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 113/222 (50%), Gaps = 21/222 (9%)
Query: 37  EELARATDGFSDANLLGQGGFGYVH----RGVLPNGKE--VAIKQLKAGSGQGER-EFQA 89
           +E   A +  + +  LGQG FG V+    +GV+ +  E  VAIK +   +   ER EF  
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 90  EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD--------W 141
           E  ++   +  H+V L+G  + G   +++ E +    L+ +L    RP M+         
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVLAPPS 123
Query: 142 LTRL-KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT 200
           L+++ ++A   A G+AYL+ +   K +HRD+ A N ++   F  K+ DFG+ +   + + 
Sbjct: 124 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 180
Query: 201 HVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           +    + +    +++PE    G  T  SDV+SFGV+L E+ T
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 33  TFTYEELARATDGFSDANLLGQGGFGYVH----RGVLPNGKE--VAIKQLKAGSGQGER- 85
            +  +E   A +  + +  LGQG FG V+    +GV+ +  E  VAIK +   +   ER 
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTM------ 139
           EF  E  ++   +  H+V L+G  + G   +++ E +    L+ +L    RP M      
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPAMANNPVL 132
Query: 140 ---DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
                   +++A   A G+AYL+ +   K +HRD+ A N ++   F  K+ DFG+ +   
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 197 DVNTHVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           + + +    + +    +++PE    G  T  SDV+SFGV+L E+ T
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 93/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  ++ +  L +A   +  + YL +      IHRD
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 140
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 200
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 201 AFGVLLWEIAT 211

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 93/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  ++ +  L +A   +  + YL +      IHRD
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 138
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 199 AFGVLLWEIAT 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 93/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  ++ +  L +A   +  + YL +      IHRD
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 149
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 150 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 209
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 210 AFGVLLWEIAT 220

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 93/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  ++ +  L +A   +  + YL +      IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 93/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  ++ +  L +A   +  + YL +      IHRD
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 138
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 199 AFGVLLWEIAT 209

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 114/226 (50%), Gaps = 21/226 (9%)
Query: 33  TFTYEELARATDGFSDANLLGQGGFGYVH----RGVLPNGKE--VAIKQLKAGSGQGER- 85
            +  +E   A +  + +  LGQG FG V+    +GV+ +  E  VAIK +   +   ER 
Sbjct: 36  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 95
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----- 140
           EF  E  ++   +  H+V L+G  + G   +++ E +    L+ +L    RP M+     
Sbjct: 96  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVL 154
Query: 141 ---WLTRL-KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
               L+++ ++A   A G+AYL+ +   K +HRD+ A N ++   F  K+ DFG+ +   
Sbjct: 155 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 211
Query: 197 DVNTHVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           + + +    + +    +++PE    G  T  SDV+SFGV+L E+ T
Sbjct: 212 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 51  LLGQGGFG----YVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           +LG+G FG      HR     G+ + +K+L     + +R F  EV+++  + H +++  +
Sbjct: 17  VLGKGCFGQAIKVTHRE---TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----WLTRLKIALGSAKGLAYLHEDC 162
           G      +   + E++   TL   +      +MD    W  R+  A   A G+AYLH   
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIK-----SMDSQYPWSQRVSFAKDIASGMAYLHSM- 127
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS-------------TRVMGT 209
              IIHRD+ + N L+       VADFGLA++  D  T                  V+G 
Sbjct: 128 --NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELI 240
             ++APE  +     EK DVFSFG++L E+I
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 93/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  ++ +  L +A   +  + YL +      IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 102/215 (47%), Gaps = 31/215 (14%)
Query: 46  FSDANLLGQGGFG--YVHRGVLPNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHHK 100
           FSD   +G G FG  Y  R V  N + VAIK++     Q   ++Q    EV  + ++ H 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 101 HLVSLVGYYTAGSQRMLVYEFV---PNNTLEFHLHGKGRPTMDWLTRLKIAL---GSAKG 154
           + +   G Y       LV E+     ++ LE H     +P    L  ++IA    G+ +G
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKP----LQEVEIAAVTHGALQG 166
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LAYLH      +IHRD+KA NILL      K+ DFG A I +  N  V     GT  ++A
Sbjct: 167 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMA 218
Query: 215 PEY---ASSGKLTEKSDVFSFGVMLLELITGRRPV 246
           PE       G+   K DV+S G+  +EL   + P+
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 92/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  +  +  L +A   +  + YL +      IHRD
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 92/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  +  +  L +A   +  + YL +      IHRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 141
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 202 AFGVLLWEIAT 212

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 33  TFTYEELARATDGFSDANLLGQGGFGYVH----RGVLPNGKE--VAIKQLKAGSGQGER- 85
            +  +E   A +  + +  LGQG FG V+    +GV+ +  E  VAIK +   +   ER 
Sbjct: 4   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 63
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTM------ 139
           EF  E  ++   +  H+V L+G  + G   +++ E +    L+ +L    RP M      
Sbjct: 64  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPAMANNPVL 122
Query: 140 ---DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
                   +++A   A G+AYL+ +   K +HRD+ A N ++   F  K+ DFG+ +   
Sbjct: 123 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 179
Query: 197 DVNTHVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           + + +    + +    +++PE    G  T  SDV+SFGV+L E+ T
Sbjct: 180 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 92/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  +  +  L +A   +  + YL +      IHRD
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 92/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  +  +  L +A   +  + YL +      IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 92/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  +  +  L +A   +  + YL +      IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 102/215 (47%), Gaps = 31/215 (14%)
Query: 46  FSDANLLGQGGFG--YVHRGVLPNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHHK 100
           FSD   +G G FG  Y  R V  N + VAIK++     Q   ++Q    EV  + ++ H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 101 HLVSLVGYYTAGSQRMLVYEFV---PNNTLEFHLHGKGRPTMDWLTRLKIAL---GSAKG 154
           + +   G Y       LV E+     ++ LE H     +P    L  ++IA    G+ +G
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKP----LQEVEIAAVTHGALQG 127
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LAYLH      +IHRD+KA NILL      K+ DFG A I +  N  V     GT  ++A
Sbjct: 128 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMA 179
Query: 215 PEY---ASSGKLTEKSDVFSFGVMLLELITGRRPV 246
           PE       G+   K DV+S G+  +EL   + P+
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 52  LGQGGFGYVHRG----VLPNGKE--VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
           LGQG FG V+ G    ++    E  VA+K +   +   ER EF  E  ++      H+V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHL--------HGKGRPTMDWLTRLKIALGSAKGLA 156
           L+G  + G   ++V E + +  L+ +L        +  GRP       +++A   A G+A
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS-TRVMGTFGYLAP 215
           YL+     K +HRD+ A N ++   F  K+ DFG+ +   + + +    + +    ++AP
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT 241
           E    G  T  SD++SFGV+L E+ +
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 9/206 (4%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  +  +  L +A   +  + YL +      IHRD
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 134
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 231 SFGVMLLELIT-GRRP---VDSTHTF 252
           +FGV+L E+ T G  P   +D +  +
Sbjct: 195 AFGVLLWEIATYGMSPYPGIDPSQVY 220

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 113/226 (50%), Gaps = 21/226 (9%)
Query: 33  TFTYEELARATDGFSDANLLGQGGFGYVH----RGVLPNGKE--VAIKQLKAGSGQGER- 85
            +  +E   A +  + +  LGQG FG V+    +GV+ +  E  VAIK +   +   ER 
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 60
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----- 140
           EF  E  ++   +  H+V L+G  + G   +++ E +    L+ +L    RP M+     
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVL 119
Query: 141 ---WLTRL-KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
               L+++ ++A   A G+AYL+ +   K +HRD+ A N  +   F  K+ DFG+ +   
Sbjct: 120 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIY 176
Query: 197 DVNTHVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           + + +    + +    +++PE    G  T  SDV+SFGV+L E+ T
Sbjct: 177 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 6/196 (3%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 +V E++P   L  +L    R  +  +  L +A   +  + YL +      IHRD
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKK---NFIHRD 155
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +    + KSDV+
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVW 215
Query: 231 SFGVMLLELIT-GRRP 245
           +FGV+L E+ T G  P
Sbjct: 216 AFGVLLWEIATYGMSP 231

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 52  LGQGGFGYVHRGVLPNGKE------VAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG V      N         VA+K LK  +    ++FQ E E+++ + H+H+V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWL--------------TRLKIALGS 151
            G    G   ++V+E++ +  L   L   G   M  +                L IA   
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTF 210
           A G+ YL        +HRD+   N L+      K+ DFG+++ + S     V    M   
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
            ++ PE     K T +SDV+SFGV+L E+ T G++P
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  ++ +  L +A   +  + YL +      IHR+
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRN 382
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 442
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 443 AFGVLLWEIAT 453

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 107/201 (53%), Gaps = 12/201 (5%)
Query: 52  LGQGGFGYVHRGVLPNGK---EVAIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSLVG 107
           LG G FG V +GV    K   +VAIK LK G+ + +  E   E +I+ ++ + ++V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
              A +  MLV E      L   L GK R  +      ++    + G+ YL E      +
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFV 458
Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFG--YLAPEYASSGKLTE 225
           HR++ A N+LL  +  AK++DFGL+K     +++ + R  G +   + APE  +  K + 
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 226 KSDVFSFGVMLLELIT-GRRP 245
           +SDV+S+GV + E ++ G++P
Sbjct: 519 RSDVWSYGVTMWEALSYGQKP 539

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 92/191 (48%), Gaps = 5/191 (2%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  +  +  L +A   +  + YL +      IHR+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRN 343
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           + A N L+      KVADFGL+++ +               + APE  +  K + KSDV+
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 403
Query: 231 SFGVMLLELIT 241
           +FGV+L E+ T
Sbjct: 404 AFGVLLWEIAT 414

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 9/204 (4%)
Query: 46  FSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQ---GEREFQAEVEIISRVHHKH 101
           F    +LG+GGFG V    V   GK  A K+L+    +   GE     E +I+ +V+ + 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
           +VSL   Y       LV   +    L+FH++  G+        +  A     GL  LH +
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
              +I++RD+K  NILLD     +++D GLA    +  T +  RV GT GY+APE   + 
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE 360
Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
           + T   D ++ G +L E+I G+ P
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 9/204 (4%)
Query: 46  FSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQ---GEREFQAEVEIISRVHHKH 101
           F    +LG+GGFG V    V   GK  A K+L+    +   GE     E +I+ +V+ + 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
           +VSL   Y       LV   +    L+FH++  G+        +  A     GL  LH +
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
              +I++RD+K  NILLD     +++D GLA    +  T +  RV GT GY+APE   + 
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE 360
Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
           + T   D ++ G +L E+I G+ P
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 104/215 (48%), Gaps = 33/215 (15%)
Query: 50  NLLGQGGFGYVHRGVL----PNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVS 104
            ++G+G FG V+ G       N  + AIK L +    Q    F  E  ++  ++H ++++
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHG---------KGRPTMDWLTRLKIALGSAKGL 155
           L+G        ML  E +P+  L +  HG         +  PT+  L  +   L  A+G+
Sbjct: 87  LIGI-------MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL--ISFGLQVARGM 137
Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD-----VNTHVSTRVMGTF 210
            YL E    K +HRD+ A N +LD  F  KVADFGLA+   D     V  H   R+    
Sbjct: 138 EYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL--PV 192
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
            + A E   + + T KSDV+SFGV+L EL+T   P
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 6/197 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VAIK +K GS   E EF  E +++  + H+ LV L G  T 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N  L  +L  + R        L++     + + YL      + +HRD+
Sbjct: 91  QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 146
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
            A N L++ +   KV+DFGL++   D     S        +  PE     K + KSD+++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 232 FGVMLLELIT-GRRPVD 247
           FGV++ E+ + G+ P +
Sbjct: 207 FGVLMWEIYSLGKMPYE 223

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 52  LGQGGFGYVHRG----VLPNGKE--VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
           LGQG FG V+ G    ++    E  VA+K +   +   ER EF  E  ++      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHL--------HGKGRPTMDWLTRLKIALGSAKGLA 156
           L+G  + G   ++V E + +  L+ +L        +  GRP       +++A   A G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST-RVMGTFGYLAP 215
           YL+     K +HR++ A N ++   F  K+ DFG+ +   + + +    + +    ++AP
Sbjct: 145 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT 241
           E    G  T  SD++SFGV+L E+ +
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 6/197 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VAIK +K GS   E EF  E +++  + H+ LV L G  T 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N  L  +L  + R        L++     + + YL      + +HRD+
Sbjct: 91  QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 146
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
            A N L++ +   KV+DFGL++   D     S        +  PE     K + KSD+++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 232 FGVMLLELIT-GRRPVD 247
           FGV++ E+ + G+ P +
Sbjct: 207 FGVLMWEIYSLGKMPYE 223

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 52  LGQGGFGYVHRG----VLPNGKE--VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
           LGQG FG V+ G    ++    E  VA+K +   +   ER EF  E  ++      H+V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHL--------HGKGRPTMDWLTRLKIALGSAKGLA 156
           L+G  + G   ++V E + +  L+ +L        +  GRP       +++A   A G+A
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST-RVMGTFGYLAP 215
           YL+     K +HR++ A N ++   F  K+ DFG+ +   + + +    + +    ++AP
Sbjct: 146 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 216 EYASSGKLTEKSDVFSFGVMLLELIT 241
           E    G  T  SD++SFGV+L E+ +
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 6/197 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VAIK +K GS   E EF  E +++  + H+ LV L G  T 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N  L  +L  + R        L++     + + YL      + +HRD+
Sbjct: 82  QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 137
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
            A N L++ +   KV+DFGL++   D     S        +  PE     K + KSD+++
Sbjct: 138 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 197
Query: 232 FGVMLLELIT-GRRPVD 247
           FGV++ E+ + G+ P +
Sbjct: 198 FGVLMWEIYSLGKMPYE 214

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 6/197 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VAIK +K GS   E EF  E +++  + H+ LV L G  T 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N  L  +L  + R        L++     + + YL      + +HRD+
Sbjct: 75  QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 130
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
            A N L++ +   KV+DFGL++   D     S        +  PE     K + KSD+++
Sbjct: 131 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 190
Query: 232 FGVMLLELIT-GRRPVD 247
           FGV++ E+ + G+ P +
Sbjct: 191 FGVLMWEIYSLGKMPYE 207

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 6/197 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VAIK +K GS   E EF  E +++  + H+ LV L G  T 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N  L  +L  + R        L++     + + YL      + +HRD+
Sbjct: 76  QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 131
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
            A N L++ +   KV+DFGL++   D     S        +  PE     K + KSD+++
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 232 FGVMLLELIT-GRRPVD 247
           FGV++ E+ + G+ P +
Sbjct: 192 FGVLMWEIYSLGKMPYE 208

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 6/197 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VAIK +K GS   E EF  E +++  + H+ LV L G  T 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N  L  +L  + R        L++     + + YL      + +HRD+
Sbjct: 71  QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 126
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
            A N L++ +   KV+DFGL++   D     S        +  PE     K + KSD+++
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 186
Query: 232 FGVMLLELIT-GRRPVD 247
           FGV++ E+ + G+ P +
Sbjct: 187 FGVLMWEIYSLGKMPYE 203

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 24/209 (11%)
Query: 52  LGQGGFG-YVHRGVLPNGKE-----VAIKQLKAGSGQGERE-FQAEVEIISRV-HHKHLV 103
           LG G FG  V       GKE     VA+K LK+ +   E+E   +E++I+S +  H+++V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGK---------GRPTMDWLTRLKIALGSAKG 154
           +L+G  T G   +++ E+     L   L  K         GRP ++    L  +   A+G
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP-LELRDLLHFSSQVAQG 172
Query: 155 LAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGY 212
           +A+L  ++C    IHRD+ A N+LL     AK+ DFGLA+ I +D N  V         +
Sbjct: 173 MAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 228
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           +APE       T +SDV+S+G++L E+ +
Sbjct: 229 MAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 46  FSDANLLGQGGFGYVHRGVLPNGKEV-AIKQLK-AGSGQGEREFQAEVEIISRVHHKHLV 103
           F+  + +G+G FG V++G+  + KEV AIK +    +     + Q E+ ++S+    ++ 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 104 SLVGYYTAGSQRMLVYEFVPN-NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
              G Y   ++  ++ E++   + L+    G    T    T L+  L   KGL YLH + 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYI-ATILREIL---KGLDYLHSE- 135
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK 222
             + IHRDIKAAN+LL  + + K+ADFG+A   +D     +  V GT  ++APE      
Sbjct: 136 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSA 192
Query: 223 LTEKSDVFSFGVMLLELITGRRPVDSTH 250
              K+D++S G+  +EL  G  P    H
Sbjct: 193 YDFKADIWSLGITAIELAKGEPPNSDLH 220

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 24/209 (11%)
Query: 52  LGQGGFG-YVHRGVLPNGKE-----VAIKQLKAGSGQGERE-FQAEVEIISRV-HHKHLV 103
           LG G FG  V       GKE     VA+K LK+ +   E+E   +E++I+S +  H+++V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGK---------GRPTMDWLTRLKIALGSAKG 154
           +L+G  T G   +++ E+     L   L  K         GRP ++    L  +   A+G
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP-LELRDLLHFSSQVAQG 164
Query: 155 LAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGY 212
           +A+L  ++C    IHRD+ A N+LL     AK+ DFGLA+ I +D N  V         +
Sbjct: 165 MAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 220
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           +APE       T +SDV+S+G++L E+ +
Sbjct: 221 MAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           F +  L+G GGFG V +     +GK   IK++K  + + ERE +A    ++++ H ++V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKA----LAKLDHVNIVH 68
Query: 105 LVGYY----------TAGSQR------MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA 148
             G +          +  S R       +  EF    TLE  +  +    +D +  L++ 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
               KG+ Y+H     K+I+RD+K +NI L    + K+ DFGL  + S  N     R  G
Sbjct: 129 EQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGL--VTSLKNDGKRXRSKG 183
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 240
           T  Y++PE  SS    ++ D+++ G++L EL+
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 9/207 (4%)
Query: 46  FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLK-AGSGQGEREFQAEVEIISRVHHKHLV 103
           F+    +G+G FG V +G+     K VAIK +    +     + Q E+ ++S+    ++ 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
              G Y   ++  ++ E++   +    L           T L+  L   KGL YLH +  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSE-- 123
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
            K IHRDIKAAN+LL    E K+ADFG+A   +D     +T V GT  ++APE       
Sbjct: 124 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 181
Query: 224 TEKSDVFSFGVMLLELITGRRPVDSTH 250
             K+D++S G+  +EL  G  P    H
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSELH 208

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 9/207 (4%)
Query: 46  FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLK-AGSGQGEREFQAEVEIISRVHHKHLV 103
           F+    +G+G FG V +G+     K VAIK +    +     + Q E+ ++S+    ++ 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
              G Y   ++  ++ E++   +    L           T L+  L   KGL YLH +  
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSE-- 143
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
            K IHRDIKAAN+LL    E K+ADFG+A   +D     +T V GT  ++APE       
Sbjct: 144 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 201
Query: 224 TEKSDVFSFGVMLLELITGRRPVDSTH 250
             K+D++S G+  +EL  G  P    H
Sbjct: 202 DSKADIWSLGITAIELARGEPPHSELH 228

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV 97
           D F   + LG G  G V +      G++   K + ++   A   Q  RE Q    ++   
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 64
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +  ++V   G + +  +  +  E +   +L+  L   GR     L ++ IA+   KGL Y
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTY 122
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
           L E  H KI+HRD+K +NIL++ + E K+ DFG   ++  +   ++   +GT  Y++PE 
Sbjct: 123 LREK-H-KIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDEMANEFVGTRSYMSPER 177
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTF-VEDSLVDWARPLLNRAIEDGNFDT 276
                 + +SD++S G+ L+E+  GR P      F + D +V+   P L  A+    F  
Sbjct: 178 LQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQD 237
Query: 277 LVDPKL 282
            V+  L
Sbjct: 238 FVNKCL 243

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 6/197 (3%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VAIK +K GS   E EF  E +++  + H+ LV L G  T 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N  L  +L  + R        L++     + + YL      + +HRD+
Sbjct: 76  QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 131
Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 231
            A N L++ +   KV+DFGL++   D     S        +  PE     K + KSD+++
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 232 FGVMLLELIT-GRRPVD 247
           FGV++ E+ + G+ P +
Sbjct: 192 FGVLMWEIYSLGKMPYE 208

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 39/225 (17%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           F +  L+G GGFG V +     +GK   I+++K  + + ERE +A    ++++ H ++V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKA----LAKLDHVNIVH 69
Query: 105 LVGYY-----------------------TAGSQR------MLVYEFVPNNTLEFHLHGKG 135
             G +                       +  S R       +  EF    TLE  +  + 
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 136 RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA 195
              +D +  L++     KG+ Y+H     K+IHRD+K +NI L    + K+ DFGL  + 
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGL--VT 184
Query: 196 SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 240
           S  N    TR  GT  Y++PE  SS    ++ D+++ G++L EL+
Sbjct: 185 SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +GQG  G V+  + +  G+EVAI+Q+       +     E+ ++    + ++V+ +  Y 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
            G +  +V E++   +L   +       MD      +     + L +LH +   ++IHRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           IK+ NILL      K+ DFG     +   +  ST V GT  ++APE  +      K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 200
Query: 231 SFGVMLLELITGRRP 245
           S G+M +E+I G  P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 52  LGQGGFGYVHR----GV--LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRV-HHKHLV 103
           LG+G FG V      G+      + VA+K LK G+   E R   +E++I+  + HH ++V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 104 SLVGYYT-AGSQRMLVYEFVPNNTLEFHLHGKGRPTM----------DWLTRLKIALGS- 151
           +L+G  T  G   M++ EF     L  +L  K    +          D+LT   +   S 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 152 --AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMG 208
             AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +         
Sbjct: 156 QVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
              ++APE       T +SDV+SFGV+L E+ +
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 14/198 (7%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +G+G  G V      + GK+VA+K++     Q       EV I+   HH ++V +   Y 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 111 AGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            G +  +V EF+    L +   H +    M+      + L   + L+YLH      +IHR
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQ---GVIHR 165
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYLAPEYASSGKLTEKS 227
           DIK+ +ILL      K++DFG     + V+  V  R  ++GT  ++APE  S      + 
Sbjct: 166 DIKSDSILLTSDGRIKLSDFGF---CAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 228 DVFSFGVMLLELITGRRP 245
           D++S G+M++E+I G  P
Sbjct: 223 DIWSLGIMVIEMIDGEPP 240

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 51  LLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
            +G+G FG VH+G+  + +     VAIK  K  +    RE F  E   + +  H H+V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G  T      ++ E      L   L  + + ++D  + +  A   +  LAYL      +
Sbjct: 74  IGVITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
            +HRDI A N+L+      K+ DFGL++   D   + +++      ++APE  +  + T 
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 226 KSDVFSFGVMLLELIT-GRRP 245
            SDV+ FGV + E++  G +P
Sbjct: 189 ASDVWMFGVCMWEILMHGVKP 209

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 51  LLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
            +G+G FG VH+G+  + +     VAIK  K  +    RE F  E   + +  H H+V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G  T      ++ E      L   L  + + ++D  + +  A   +  LAYL      +
Sbjct: 77  IGVITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
            +HRDI A N+L+      K+ DFGL++   D   + +++      ++APE  +  + T 
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 226 KSDVFSFGVMLLELIT-GRRP 245
            SDV+ FGV + E++  G +P
Sbjct: 192 ASDVWMFGVCMWEILMHGVKP 212

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 51  LLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
            +G+G FG VH+G+  + +     VAIK  K  +    RE F  E   + +  H H+V L
Sbjct: 19  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 78
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G  T      ++ E      L   L  + + ++D  + +  A   +  LAYL      +
Sbjct: 79  IGVITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---R 133
Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
            +HRDI A N+L+      K+ DFGL++   D   + +++      ++APE  +  + T 
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 193
Query: 226 KSDVFSFGVMLLELIT-GRRP 245
            SDV+ FGV + E++  G +P
Sbjct: 194 ASDVWMFGVCMWEILMHGVKP 214

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 51  LLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
            +G+G FG VH+G+  + +     VAIK  K  +    RE F  E   + +  H H+V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G  T      ++ E      L   L  + + ++D  + +  A   +  LAYL      +
Sbjct: 77  IGVITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
            +HRDI A N+L+      K+ DFGL++   D   + +++      ++APE  +  + T 
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 226 KSDVFSFGVMLLELIT-GRRP 245
            SDV+ FGV + E++  G +P
Sbjct: 192 ASDVWMFGVCMWEILMHGVKP 212

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 51  LLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
            +G+G FG VH+G+  + +     VAIK  K  +    RE F  E   + +  H H+V L
Sbjct: 45  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 104
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G  T      ++ E      L   L  + + ++D  + +  A   +  LAYL      +
Sbjct: 105 IGVITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
            +HRDI A N+L+      K+ DFGL++   D   + +++      ++APE  +  + T 
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 219
Query: 226 KSDVFSFGVMLLELIT-GRRP 245
            SDV+ FGV + E++  G +P
Sbjct: 220 ASDVWMFGVCMWEILMHGVKP 240

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 111/221 (50%), Gaps = 20/221 (9%)
Query: 34  FTYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE-REFQAEV 91
           FT E+L        D   +G+G +G V++ V  P+G+ +A+K++++   + E ++   ++
Sbjct: 19  FTAEDL-------KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL 71
Query: 92  EIISRVHH-KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH--LHGKGRPTMDWLTRLKIA 148
           +++ R     ++V   G         +  E +  +  +F+  ++      +      KI 
Sbjct: 72  DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L + K L +L E+   KIIHRDIK +NILLD     K+ DFG++     V++   TR  G
Sbjct: 132 LATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVDSIAKTRDAG 187
Query: 209 TFGYLAPEY----ASSGKLTEKSDVFSFGVMLLELITGRRP 245
              Y+APE     AS      +SDV+S G+ L EL TGR P
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 52  LGQGGFGYVHR----GV--LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRV-HHKHLV 103
           LG+G FG V      G+      + VA+K LK G+   E R   +E++I+  + HH ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 104 SLVGYYT-AGSQRMLVYEFVPNNTLEFHLHGKGRPTM-----------DWLTRLKIALGS 151
           +L+G  T  G   M++ EF     L  +L  K    +           D+LT   +   S
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 152 ---AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVM 207
              AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +        
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
               ++APE       T +SDV+SFGV+L E+ +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 51  LLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
            +G+G FG VH+G+  + +     VAIK  K  +    RE F  E   + +  H H+V L
Sbjct: 20  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 79
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G  T      ++ E      L   L  + + ++D  + +  A   +  LAYL      +
Sbjct: 80  IGVITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
            +HRDI A N+L+      K+ DFGL++   D   + +++      ++APE  +  + T 
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 194
Query: 226 KSDVFSFGVMLLELIT-GRRP 245
            SDV+ FGV + E++  G +P
Sbjct: 195 ASDVWMFGVCMWEILMHGVKP 215

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 52  LGQGGFGYVHR----GV--LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRV-HHKHLV 103
           LG+G FG V      G+      + VA+K LK G+   E R   +E++I+  + HH ++V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 104 SLVGYYT-AGSQRMLVYEFVPNNTLEFHLHGKGRPTM---------DWLTR---LKIALG 150
           +L+G  T  G   M++ EF     L  +L  K    +         D+LT    +  +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGT 209
            AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +          
Sbjct: 157 VAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
             ++APE       T +SDV+SFGV+L E+ +
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 81  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 133
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 134 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 189
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 131
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 187
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 51  LLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
            +G+G FG VH+G+  + +     VAIK  K  +    RE F  E   + +  H H+V L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G  T      ++ E      L   L  + + ++D  + +  A   +  LAYL      +
Sbjct: 82  IGVITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
            +HRDI A N+L+      K+ DFGL++   D   + +++      ++APE  +  + T 
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 196
Query: 226 KSDVFSFGVMLLELIT-GRRP 245
            SDV+ FGV + E++  G +P
Sbjct: 197 ASDVWMFGVCMWEILMHGVKP 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 78  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 130
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 131 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 186
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 51  LLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
            +G+G FG VH+G+  + +     VAIK  K  +    RE F  E   + +  H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G  T      ++ E      L   L  + + ++D  + +  A   +  LAYL      +
Sbjct: 457 IGVITENPV-WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
            +HRDI A N+L+      K+ DFGL++   D   + +++      ++APE  +  + T 
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 226 KSDVFSFGVMLLELIT-GRRP 245
            SDV+ FGV + E++  G +P
Sbjct: 572 ASDVWMFGVCMWEILMHGVKP 592

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 51  LLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
            +G+G FG VH+G+  + +     VAIK  K  +    RE F  E   + +  H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G  T      ++ E      L   L  + + ++D  + +  A   +  LAYL      +
Sbjct: 457 IGVITENPV-WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
            +HRDI A N+L+      K+ DFGL++   D   + +++      ++APE  +  + T 
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 226 KSDVFSFGVMLLELIT-GRRP 245
            SDV+ FGV + E++  G +P
Sbjct: 572 ASDVWMFGVCMWEILMHGVKP 592

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 77  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 129
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 185
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 80  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 132
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 188
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 52  LGQGGFGYVHR----GV--LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRV-HHKHLV 103
           LG+G FG V      G+      + VA+K LK G+   E R   +E++I+  + HH ++V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 104 SLVGYYT-AGSQRMLVYEFVPNNTLEFHLHGKGRPTM-----------DWLTR---LKIA 148
           +L+G  T  G   M++ EF     L  +L  K    +           D+LT    +  +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVM 207
              AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +        
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
               ++APE       T +SDV+SFGV+L E+ +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     S   L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 102 PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 154
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 155 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 210
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 87  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 139
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 140 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 195
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 51  LLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
            +G+G FG VH+G+  + +     VAIK  K  +    RE F  E   + +  H H+V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G  T      ++ E      L   L  + + ++D  + +  A   +  LAYL      +
Sbjct: 77  IGVITENPV-WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
            +HRDI A N+L+      K+ DFGL++   D   + +++      ++APE  +  + T 
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 226 KSDVFSFGVMLLELIT-GRRP 245
            SDV+ FGV + E++  G +P
Sbjct: 192 ASDVWMFGVCMWEILMHGVKP 212

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 52  LGQGGFGYVHR----GV--LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRV-HHKHLV 103
           LG+G FG V      G+      + VA+K LK G+   E R   +E++I+  + HH ++V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 104 SLVGYYT-AGSQRMLVYEFVPNNTLEFHLHGKGRPTM-----------DWLTRLKIALGS 151
           +L+G  T  G   M++ EF     L  +L  K    +           D+LT   +   S
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 152 ---AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVM 207
              AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +        
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
               ++APE       T +SDV+SFGV+L E+ +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 79  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 131
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 187
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 52  LGQGGFG-YVHRGVLPNGKE-----VAIKQLKAGSGQGERE-FQAEVEIISRV-HHKHLV 103
           LG G FG  V       GKE     VA+K LK+ +   E+E   +E++I+S +  H+++V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR------------PTMDWLTRLKIALGS 151
           +L+G  T G   +++ E+     L   L  K R             T+     L  +   
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 152 AKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGT 209
           A+G+A+L  ++C    IHRD+ A N+LL     AK+ DFGLA+ I +D N  V       
Sbjct: 174 AQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
             ++APE       T +SDV+S+G++L E+ +
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 132
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 188
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 52  LGQGGFGYVHR----GV--LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRV-HHKHLV 103
           LG+G FG V      G+      + VA+K LK G+   E R   +E++I+  + HH ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 104 SLVGYYT-AGSQRMLVYEFVPNNTLEFHLHGKGRPTM-----------DWLTR---LKIA 148
           +L+G  T  G   M++ EF     L  +L  K    +           D+LT    +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVM 207
              AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +        
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
               ++APE       T +SDV+SFGV+L E+ +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 132
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 188
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 83  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 135
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 136 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 191
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 136
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 192
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 52  LGQGGFGYVHR----GV--LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRV-HHKHLV 103
           LG+G FG V      G+      + VA+K LK G+   E R   +E++I+  + HH ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 104 SLVGYYT-AGSQRMLVYEFVPNNTLEFHLHGKGRPTM-------DWLTRLKIALGS---A 152
           +L+G  T  G   M++ EF     L  +L  K    +       D+LT   +   S   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFG 211
           KG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +            
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           ++APE       T +SDV+SFGV+L E+ +
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 132
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 188
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 9/207 (4%)
Query: 46  FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLK-AGSGQGEREFQAEVEIISRVHHKHLV 103
           F+    +G+G FG V +G+     K VAIK +    +     + Q E+ ++S+    ++ 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
              G Y   ++  ++ E++   +    L           T L+  L   KGL YLH +  
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSE-- 138
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
            K IHRDIKAAN+LL    E K+ADFG+A   +D     +  V GT  ++APE       
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAY 196
Query: 224 TEKSDVFSFGVMLLELITGRRPVDSTH 250
             K+D++S G+  +EL  G  P    H
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELH 223

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     S   L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 77  PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 129
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 185
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 104/231 (45%), Gaps = 25/231 (10%)
Query: 52  LGQGGFGYVHRGVLP-NGKEVAIKQL---KAGSGQGEREFQAEVEIISRVHHKHLVSLVG 107
           LG G FG V  G     G +VA+K L   K  S     + + E++ +    H H++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
             +  S   +V E+V    L  ++   GR  +D     ++      G+ Y H      ++
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRH---MVV 138
Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT--E 225
           HRD+K  N+LLD    AK+ADFGL+ + SD          G+  Y APE   SG+L    
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRXSCGSPNYAAPE-VISGRLYAGP 195
Query: 226 KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT 276
           + D++S GV+L  L+ G  P D  H            P L + I DG F T
Sbjct: 196 EVDIWSSGVILYALLCGTLPFDDDHV-----------PTLFKKICDGIFYT 235

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 51  LLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
            +G+G FG VH+G+  + +     VAIK  K  +    RE F  E   + +  H H+V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G  T      ++ E      L   L  + + ++D  + +  A   +  LAYL      +
Sbjct: 77  IGVITENPV-WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
            +HRDI A N+L+      K+ DFGL++   D     +++      ++APE  +  + T 
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTS 191
Query: 226 KSDVFSFGVMLLELIT-GRRP 245
            SDV+ FGV + E++  G +P
Sbjct: 192 ASDVWMFGVCMWEILMHGVKP 212

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 52  LGQGGFG-YVHRGVLPNGKE-----VAIKQLKAGSGQGERE-FQAEVEIISRV-HHKHLV 103
           LG G FG  V       GKE     VA+K LK+ +   E+E   +E++I+S +  H+++V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR--------------LKIAL 149
           +L+G  T G   +++ E+     L   L  K  P +++                 L  + 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 150 GSAKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVM 207
             A+G+A+L  ++C    IHRD+ A N+LL     AK+ DFGLA+ I +D N  V     
Sbjct: 174 QVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 229
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
               ++APE       T +SDV+S+G++L E+ +
Sbjct: 230 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 78  PHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AKG 130
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 131 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 186
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     S   L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 71  PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 123
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 124 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 179
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 129
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 185
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 52  LGQGGFGYVHR----GV--LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRV-HHKHLV 103
           LG+G FG V      G+      + VA+K LK G+   E R   +E++I+  + HH ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 104 SLVGYYT-AGSQRMLVYEFVPNNTLEFHLHGKGRPTM-----------DWLTR---LKIA 148
           +L+G  T  G   M++ EF     L  +L  K    +           D+LT    +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVM 207
              AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +        
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
               ++APE       T +SDV+SFGV+L E+ +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 9/207 (4%)
Query: 46  FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLK-AGSGQGEREFQAEVEIISRVHHKHLV 103
           F+    +G+G FG V +G+     K VAIK +    +     + Q E+ ++S+    ++ 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
              G Y   ++  ++ E++   +    L           T L+  L   KGL YLH +  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSE-- 123
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
            K IHRDIKAAN+LL    E K+ADFG+A   +D     +  V GT  ++APE       
Sbjct: 124 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAY 181
Query: 224 TEKSDVFSFGVMLLELITGRRPVDSTH 250
             K+D++S G+  +EL  G  P    H
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSELH 208

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 52  LGQGGFGYVHR----GV--LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRV-HHKHLV 103
           LG+G FG V      G+      + VA+K LK G+   E R   +E++I+  + HH ++V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 104 SLVGYYT-AGSQRMLVYEFVPNNTLEFHLHGKGRPTM-----------DWLTRLKIALGS 151
           +L+G  T  G   M++ EF     L  +L  K    +           D+LT   +   S
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 152 ---AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVM 207
              AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +        
Sbjct: 157 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
               ++APE       T +SDV+SFGV+L E+ +
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV 97
           D F   + LG G  G V +      G++   K + ++   A   Q  RE Q    ++   
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 123
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +  ++V   G + +  +  +  E +   +L+  L   GR     L ++ IA+   KGL Y
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTY 181
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAP 215
           L E  H KI+HRD+K +NIL++ + E K+ DFG++   I S  N+ V TR      Y++P
Sbjct: 182 LREK-H-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 234
Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
           E       + +SD++S G+ L+E+  GR P+
Sbjct: 235 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 13/210 (6%)
Query: 46  FSDANLLGQGGFGYVHR-GVLPNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHHKH 101
           F     LG G FG VH      NG+  A+K LK       ++ +    E  ++S V H  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
           ++ + G +    Q  ++ +++    L F L  K +   + + +   A      L YLH  
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGEL-FSLLRKSQRFPNPVAKF-YAAEVCLALEYLHSK 125
Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
               II+RD+K  NILLD     K+ DFG AK   D    V+  + GT  Y+APE  S+ 
Sbjct: 126 ---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTPDYIAPEVVSTK 178
Query: 222 KLTEKSDVFSFGVMLLELITGRRPVDSTHT 251
              +  D +SFG+++ E++ G  P   ++T
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     S   L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 77  PHVCRLLGI-CLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AKG 129
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 185
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 52  LGQGGFGYVHR----GV--LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRV-HHKHLV 103
           LG+G FG V      G+      + VA+K LK G+   E R   +E++I+  + HH ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 104 SLVGYYT-AGSQRMLVYEFVPNNTLEFHLHGKGRPTM-------DWLTR---LKIALGSA 152
           +L+G  T  G   M++ EF     L  +L  K    +       D+LT    +  +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFG 211
           KG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +            
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           ++APE       T +SDV+SFGV+L E+ +
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 52  LGQGGFGYVHR----GV--LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRV-HHKHLV 103
           LG+G FG V      G+      + VA+K LK G+   E R   +E++I+  + HH ++V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 104 SLVGYYT-AGSQRMLVYEFVPNNTLEFHLHGKGRPTM-----------DWLTR---LKIA 148
           +L+G  T  G   M++ EF     L  +L  K    +           D+LT    +  +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVM 207
              AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +        
Sbjct: 192 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
               ++APE       T +SDV+SFGV+L E+ +
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV 97
           D F   + LG G  G V +      G++   K + ++   A   Q  RE Q    ++   
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 80
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +  ++V   G + +  +  +  E +   +L+  L   GR     L ++ IA+   KGL Y
Sbjct: 81  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTY 138
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAP 215
           L E    KI+HRD+K +NIL++ + E K+ DFG++   I S  N+ V TR      Y++P
Sbjct: 139 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 191
Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPVDS 248
           E       + +SD++S G+ L+E+  GR P+ S
Sbjct: 192 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGS 224

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +GQG  G V+  + +  G+EVAI+Q+       +     E+ ++    + ++V+ +  Y 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
            G +  +V E++   +L   +       MD      +     + L +LH +   ++IHRD
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 142
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYLAPEYASSGKLTEKSD 228
           IK+ NILL      K+ DFG     + +    S R  ++GT  ++APE  +      K D
Sbjct: 143 IKSDNILLGMDGSVKLTDFGF---CAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVD 199
Query: 229 VFSFGVMLLELITGRRP 245
           ++S G+M +E+I G  P
Sbjct: 200 IWSLGIMAIEMIEGEPP 216

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +GQG  G V+  + +  G+EVAI+Q+       +     E+ ++    + ++V+ +  Y 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
            G +  +V E++   +L   +       MD      +     + L +LH +   ++IHRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYLAPEYASSGKLTEKSD 228
           IK+ NILL      K+ DFG     + +    S R  ++GT  ++APE  +      K D
Sbjct: 142 IKSDNILLGMDGSVKLTDFGF---CAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 229 VFSFGVMLLELITGRRP 245
           ++S G+M +E+I G  P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +GQG  G V+  + +  G+EVAI+Q+       +     E+ ++    + ++V+ +  Y 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
            G +  +V E++   +L   +       MD      +     + L +LH +   ++IHRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYLAPEYASSGKLTEKSD 228
           IK+ NILL      K+ DFG     + +    S R  ++GT  ++APE  +      K D
Sbjct: 142 IKSDNILLGMDGSVKLTDFGF---CAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 229 VFSFGVMLLELITGRRP 245
           ++S G+M +E+I G  P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +GQG  G V+  + +  G+EVAI+Q+       +     E+ ++    + ++V+ +  Y 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
            G +  +V E++   +L   +       MD      +     + L +LH +   ++IHR+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRN 142
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 230
           IK+ NILL      K+ DFG     +   +  ST V GT  ++APE  +      K D++
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 201
Query: 231 SFGVMLLELITGRRP 245
           S G+M +E+I G  P
Sbjct: 202 SLGIMAIEMIEGEPP 216

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 52  LGQGGFGYVHR----GV--LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRV-HHKHLV 103
           LG+G FG V      G+      + VA+K LK G+   E R   +E++I+  + HH ++V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 104 SLVGYYT-AGSQRMLVYEFVPNNTLEFHLHGKGRPTM-----------DWLTR---LKIA 148
           +L+G  T  G   M++ EF     L  +L  K    +           D+LT    +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVM 207
              AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +        
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
               ++APE       T +SDV+SFGV+L E+ +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 52  LGQGGFGYVHR----GV--LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISRV-HHKHLV 103
           LG+G FG V      G+      + VA+K LK G+   E R   +E++I+  + HH ++V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 104 SLVGYYT-AGSQRMLVYEFVPNNTLEFHLHGKGRPTM-----------DWLTRLKIALGS 151
           +L+G  T  G   M++ EF     L  +L  K    +           D+LT   +   S
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 152 ---AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVM 207
              AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +        
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
               ++APE       T +SDV+SFGV+L E+ +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV 97
           D F   + LG G  G V +      G++   K + ++   A   Q  RE Q    ++   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +  ++V   G + +  +  +  E +   +L+  L   GR     L ++ IA+   KGL Y
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTY 119
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAP 215
           L E  H KI+HRD+K +NIL++ + E K+ DFG++   I S  N+ V TR      Y++P
Sbjct: 120 LREK-H-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 172
Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
           E       + +SD++S G+ L+E+  GR P+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G FG V++      G   A K ++  S +   ++  E+EI++   H ++V L+G Y 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 111 AGSQRMLVYEFVPNNTLEFHL----HGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
              +  ++ EF P   ++  +     G   P +  + R  +     + L +LH     +I
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML-----EALNFLHSK---RI 138
Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTE 225
           IHRD+KA N+L+  + + ++ADFG++  A ++ T       +GT  ++APE      + +
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 226 -----KSDVFSFGVMLLELITGRRP 245
                K+D++S G+ L+E+     P
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 105/212 (49%), Gaps = 26/212 (12%)
Query: 52  LGQGGFG-YVHRGVLPNGKE-----VAIKQLKAGSGQGERE-FQAEVEIISRV-HHKHLV 103
           LG G FG  V       GKE     VA+K LK+ +   E+E   +E++I+S +  H+++V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR------------PTMDWLTRLKIALGS 151
           +L+G  T G   +++ E+     L   L  K R             T      L  +   
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 152 AKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGT 209
           A+G+A+L  ++C    IHRD+ A N+LL     AK+ DFGLA+ I +D N  V       
Sbjct: 174 AQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
             ++APE       T +SDV+S+G++L E+ +
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV 97
           D F   + LG G  G V +      G++   K + ++   A   Q  RE Q    ++   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +  ++V   G + +  +  +  E +   +L+  L   GR     L ++ IA+   KGL Y
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTY 119
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAP 215
           L E  H KI+HRD+K +NIL++ + E K+ DFG++   I S  N+ V TR      Y++P
Sbjct: 120 LREK-H-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 172
Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
           E       + +SD++S G+ L+E+  GR P+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV 97
           D F   + LG G  G V +      G++   K + ++   A   Q  RE Q    ++   
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 88
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +  ++V   G + +  +  +  E +   +L+  L   GR     L ++ IA+   KGL Y
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTY 146
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAP 215
           L E  H KI+HRD+K +NIL++ + E K+ DFG++   I S  N+ V TR      Y++P
Sbjct: 147 LREK-H-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 199
Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
           E       + +SD++S G+ L+E+  GR P+
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV 97
           D F   + LG G  G V +      G++   K + ++   A   Q  RE Q    ++   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +  ++V   G + +  +  +  E +   +L+  L   GR     L ++ IA+   KGL Y
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTY 119
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAP 215
           L E  H KI+HRD+K +NIL++ + E K+ DFG++   I S  N+ V TR      Y++P
Sbjct: 120 LREK-H-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 172
Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
           E       + +SD++S G+ L+E+  GR P+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV 97
           D F   + LG G  G V +      G++   K + ++   A   Q  RE Q    ++   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +  ++V   G + +  +  +  E +   +L+  L   GR     L ++ IA+   KGL Y
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTY 119
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAP 215
           L E  H KI+HRD+K +NIL++ + E K+ DFG++   I S  N+ V TR      Y++P
Sbjct: 120 LREK-H-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 172
Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
           E       + +SD++S G+ L+E+  GR P+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 46/231 (19%)
Query: 52  LGQGGFGYVHR----GVLPNGK--EVAIKQLKA-GSGQGEREFQAEVEIISRVHHKHLVS 104
           +G+G FG V +    G+LP      VA+K LK   S   + +FQ E  +++   + ++V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 105 LVGYYTAGSQRMLVYEFVPNNTL-EF---------------------HLHGKGRPTMDWL 142
           L+G    G    L++E++    L EF                      +   G P +   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 143 TRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-------IA 195
            +L IA   A G+AYL E    K +HRD+   N L+      K+ADFGL++         
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 196 SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
           +D N  +  R      ++ PE     + T +SDV+++GV+L E+ + G +P
Sbjct: 232 ADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV 97
           D F   + LG G  G V +      G++   K + ++   A   Q  RE Q    ++   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +  ++V   G + +  +  +  E +   +L+  L   GR     L ++ IA+   KGL Y
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTY 119
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAP 215
           L E  H KI+HRD+K +NIL++ + E K+ DFG++   I S  N+ V TR      Y++P
Sbjct: 120 LREK-H-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 172
Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
           E       + +SD++S G+ L+E+  GR P+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G FG V++      G   A K ++  S +   ++  E+EI++   H ++V L+G Y 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 111 AGSQRMLVYEFVPNNTLEFHL----HGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
              +  ++ EF P   ++  +     G   P +  + R  +     + L +LH     +I
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML-----EALNFLHSK---RI 130
Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTE 225
           IHRD+KA N+L+  + + ++ADFG++  A ++ T       +GT  ++APE      + +
Sbjct: 131 IHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 226 -----KSDVFSFGVMLLELITGRRP 245
                K+D++S G+ L+E+     P
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 111/212 (52%), Gaps = 23/212 (10%)
Query: 49  ANLLGQGGFGYVHRGV-LPNGKEV----AIKQLKAG-SGQGEREFQAEVEIISRVHHKHL 102
             +LG G FG V++G+ +P+G+ V    AIK L+   S +  +E   E  +++ V   ++
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 81
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHL-HGKGR----PTMDWLTRLKIALGSAKGLAY 157
             L+G     + + LV + +P   L  H+   +GR      ++W  ++      AKG++Y
Sbjct: 82  SRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI------AKGMSY 134
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS-DVNTHVSTRVMGTFGYLAPE 216
           L ED   +++HRD+ A N+L+      K+ DFGLA++   D   + +        ++A E
Sbjct: 135 L-EDV--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 217 YASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
                + T +SDV+S+GV + EL+T G +P D
Sbjct: 192 SILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 44  DGFSDANLLGQGGFGYV----HR--GVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV 97
           D F   + LG G  G V    HR  G++   K + ++   A   Q  RE Q    ++   
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 71
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +  ++V   G + +  +  +  E +   +L+  L    R   + L ++ IA+   +GLAY
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAY 129
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAP 215
           L E  H +I+HRD+K +NIL++ + E K+ DFG++   I S  N+ V TR      Y+AP
Sbjct: 130 LREK-H-QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMAP 182
Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
           E       + +SD++S G+ L+EL  GR P+
Sbjct: 183 ERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 111/216 (51%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      A+G
Sbjct: 74  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AEG 126
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 127 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 182
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA-EVEIISRVHH 99
           ++  F     LG G +  V++G+    G  VA+K++K  S +G       E+ ++  + H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGK---GRPTMDWLTRLK-IALGSAKGL 155
           +++V L       ++  LV+EF+ +N L+ ++  +     P    L  +K       +GL
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLA 214
           A+ HE+   KI+HRD+K  N+L++ + + K+ DFGLA+     VNT  S  V  T  Y A
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRA 176
Query: 215 PEYASSGKLTEKS-DVFSFGVMLLELITGR 243
           P+     +    S D++S G +L E+ITG+
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +L  G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 84  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 136
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 192
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 110/222 (49%), Gaps = 26/222 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLV 103
           F    L+G G +G V++G  +  G+  AIK +   +G  E E + E+ ++ +  HH+++ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 104 SLVGYYTAGS------QRMLVYEFVPNNTLEFHLHGKGRPTM--DWLTRLKIALGSAKGL 155
           +  G +   +      Q  LV EF    ++   +      T+  +W+    I     +GL
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 142
Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYL 213
           ++LH+    K+IHRDIK  N+LL    E K+ DFG   +++ ++  V  R   +GT  ++
Sbjct: 143 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTPYWM 196
Query: 214 APEYASSGKLTE-----KSDVFSFGVMLLELITGRRPVDSTH 250
           APE  +  +  +     KSD++S G+  +E+  G  P+   H
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 131
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFG AK+  A +   H     +    +
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKW 187
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AI +L+ A S +  +E   E  +++ V +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 111 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 163
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 164 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 219
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 220 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGER-EFQAEVEIISRVHHKH 101
           D +    ++G G    V      P  ++VAIK++     Q    E   E++ +S+ HH +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 102 LVSLVGYYTAGSQRMLVYEFVPN-NTLEF--HLHGKGR---PTMDWLTRLKIALGSAKGL 155
           +VS    +    +  LV + +   + L+   H+  KG      +D  T   I     +GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS---DVNTH-VSTRVMGTFG 211
            YLH++     IHRD+KA NILL      ++ADFG++   +   D+  + V    +GT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 212 YLAPEYASSGKLTE-KSDVFSFGVMLLELITGRRP 245
           ++APE     +  + K+D++SFG+  +EL TG  P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +L  G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 129
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 185
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 131
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFG AK+  A +   H     +    +
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKW 187
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +L  G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 136
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFGLAK+  A +   H     +    +
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKW 192
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     S   L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 81  PHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 133
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFG AK+  A +   H     +    +
Sbjct: 134 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKW 189
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 79  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 131
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFG AK+  A +   H     +    +
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKW 187
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 43  TDGFSDANLLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQGE---REFQAEVEIIS 95
            D F     LG+G FG V+   L   K+    VA+K L     + E    + + E+EI +
Sbjct: 22  IDDFEIGRPLGKGKFGNVY---LAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQA 78
Query: 96  RVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGL 155
            +HH +++ L  Y+    +  L+ E+ P   L   L      T D      I    A  L
Sbjct: 79  HLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC--TFDEQRTATIMEELADAL 136
Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
            Y H     K+IHRDIK  N+LL  K E K+ADFG +  A  +       + GT  YL P
Sbjct: 137 MYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKT---MCGTLDYLPP 190
Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPVDST 249
           E        EK D++  GV+  EL+ G  P +S 
Sbjct: 191 EMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESA 224

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 129
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFG AK+  A +   H     +    +
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKW 185
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 51  LLGQGGFGYVHR----GVLPNGK--EVAIKQLKAGSGQGERE-FQAEVEIISRV-HHKHL 102
           +LG G FG V      G+   G   +VA+K LK  +   ERE   +E+++++++  H+++
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRP---------------------TMDW 141
           V+L+G  T      L++E+     L  +L  K                         + +
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNT 200
              L  A   AKG+ +L        +HRD+ A N+L+      K+ DFGLA+ I SD N 
Sbjct: 172 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            V         ++APE    G  T KSDV+S+G++L E+ +
Sbjct: 229 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 52  LGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +G+G  G V    V  +GK VA+K++     Q       EV I+    H+++V +   Y 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 111 AGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            G +  +V EF+    L +   H +    M+      + L   + L+ LH      +IHR
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ---GVIHR 271
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYLAPEYASSGKLTEKS 227
           DIK+ +ILL      K++DFG     + V+  V  R  ++GT  ++APE  S      + 
Sbjct: 272 DIKSDSILLTHDGRVKLSDFGF---CAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 328
Query: 228 DVFSFGVMLLELITGRRP 245
           D++S G+M++E++ G  P
Sbjct: 329 DIWSLGIMVIEMVDGEPP 346

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEV----AIKQLK-AGSGQGEREFQAEVEIISRVHH 99
           F    +LG G FG V++G+ +P G++V    AIK+L+ A S +  +E   E  +++ V +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMDWLTRLKIALGSAKG 154
            H+  L+G     + + L+ + +P   L     E   +   +  ++W  ++      AKG
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 136
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI--ASDVNTHVSTRVMGTFGY 212
           + YL +    +++HRD+ A N+L+      K+ DFG AK+  A +   H     +    +
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKW 192
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 247
           +A E       T +SDV+S+GV + EL+T G +P D
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGER-EFQAEVEIISRVHHKH 101
           D +    ++G G    V      P  ++VAIK++     Q    E   E++ +S+ HH +
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 102 LVSLVGYYTAGSQRMLVYEFVPN-NTLEF--HLHGKGR---PTMDWLTRLKIALGSAKGL 155
           +VS    +    +  LV + +   + L+   H+  KG      +D  T   I     +GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS---DVNTH-VSTRVMGTFG 211
            YLH++     IHRD+KA NILL      ++ADFG++   +   D+  + V    +GT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 212 YLAPEYASSGKLTE-KSDVFSFGVMLLELITGRRP 245
           ++APE     +  + K+D++SFG+  +EL TG  P
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 52  LGQGGFGYVHRGVL--PNGK--EVAIKQLKA---GSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V RG    P+GK   VA+K LK       +   +F  EV  +  + H++L+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHG-KGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           L G       +M V E  P  +L   L   +G   +  L+R  + +  A+G+ YL     
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLESK-- 134
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH--VSTRVMGTFGYLAPEYASSG 221
            + IHRD+ A N+LL  +   K+ DFGL +     + H  +       F + APE   + 
Sbjct: 135 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 222 KLTEKSDVFSFGVMLLELIT-GRRP 245
             +  SD + FGV L E+ T G+ P
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 29/209 (13%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAI----KQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVG 107
           LG G FG V++      KE ++    K +   S +   ++  E++I++   H ++V L+ 
Sbjct: 45  LGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAK---GLAYLHEDCHP 164
            +   +   ++ EF     ++  +    RP    LT  +I +   +    L YLH++   
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERP----LTESQIQVVCKQTLDALNYLHDN--- 154
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR---VMGTFGYLAPEYASSG 221
           KIIHRD+KA NIL     + K+ADFG+    S  NT    R    +GT  ++APE     
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRTIQRRDSFIGTPYWMAPEVVMCE 210
Query: 222 KLTE-----KSDVFSFGVMLLELITGRRP 245
              +     K+DV+S G+ L+E+     P
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 52  LGQGGFGYVHRGVL--PNGK--EVAIKQLKA---GSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V RG    P+GK   VA+K LK       +   +F  EV  +  + H++L+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHG-KGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           L G       +M V E  P  +L   L   +G   +  L+R  + +  A+G+ YL     
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLESK-- 140
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH--VSTRVMGTFGYLAPEYASSG 221
            + IHRD+ A N+LL  +   K+ DFGL +     + H  +       F + APE   + 
Sbjct: 141 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 222 KLTEKSDVFSFGVMLLELIT-GRRP 245
             +  SD + FGV L E+ T G+ P
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 52  LGQGGFGYVHRGVL--PNGK--EVAIKQLKA---GSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V RG    P+GK   VA+K LK       +   +F  EV  +  + H++L+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHG-KGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           L G       +M V E  P  +L   L   +G   +  L+R  + +  A+G+ YL     
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGMGYLESK-- 140
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH--VSTRVMGTFGYLAPEYASSG 221
            + IHRD+ A N+LL  +   K+ DFGL +     + H  +       F + APE   + 
Sbjct: 141 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 222 KLTEKSDVFSFGVMLLELIT-GRRP 245
             +  SD + FGV L E+ T G+ P
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 50  NLLGQGGFGYVHRGVLPNG---KEVAIKQLKA-GSGQGEREFQAEVEIISRV-HHKHLVS 104
           +++G+G FG V +  +       + AIK++K   S    R+F  E+E++ ++ HH ++++
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 105 LVGYYTAGSQRMLVYEFVPNNTL--------------EFHLHGKGRPTMDWLTRLKIALG 150
           L+G         L  E+ P+  L               F +      T+     L  A  
Sbjct: 81  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
            A+G+ YL +    + IHRD+ A NIL+   + AK+ADFGL++   +V      + MG  
Sbjct: 141 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYV---KKTMGRL 193
Query: 211 G--YLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
              ++A E  +    T  SDV+S+GV+L E+++
Sbjct: 194 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 37/222 (16%)
Query: 52  LGQGGFG-YVHRGVLPNGKE-----VAIKQLKAGSGQGERE-FQAEVEIISRV-HHKHLV 103
           LG G FG  V       GKE     VA+K LK+ +   E+E   +E++I+S +  H+++V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGK----------------------GRPTMDW 141
           +L+G  T G   +++ E+     L   L  K                      GRP ++ 
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP-LEL 157
Query: 142 LTRLKIALGSAKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVN 199
              L  +   A+G+A+L  ++C    IHRD+ A N+LL     AK+ DFGLA+ I +D N
Sbjct: 158 RDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 213
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
             V         ++APE       T +SDV+S+G++L E+ +
Sbjct: 214 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIK----QLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V         ++VA+K    QL   S    R  + E+  +  + H H++ L 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKLY 75
Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
              T  +  ++V E+      ++ +  K R T D   R    +  A  + Y H     KI
Sbjct: 76  DVITTPTDIVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICA--IEYCHRH---KI 129
Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT-- 224
           +HRD+K  N+LLD     K+ADFGL+ I +D N   ++   G+  Y APE   +GKL   
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VINGKLYAG 186
Query: 225 EKSDVFSFGVMLLELITGRRPVD 247
            + DV+S G++L  ++ GR P D
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 29/209 (13%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAI----KQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVG 107
           LG G FG V++      KE ++    K +   S +   ++  E++I++   H ++V L+ 
Sbjct: 45  LGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAK---GLAYLHEDCHP 164
            +   +   ++ EF     ++  +    RP    LT  +I +   +    L YLH++   
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERP----LTESQIQVVCKQTLDALNYLHDN--- 154
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR---VMGTFGYLAPEYASSG 221
           KIIHRD+KA NIL     + K+ADFG+    S  NT    R    +GT  ++APE     
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRXIQRRDXFIGTPYWMAPEVVMCE 210
Query: 222 KLTE-----KSDVFSFGVMLLELITGRRP 245
              +     K+DV+S G+ L+E+     P
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 50  NLLGQGGFGYVHRGVLPNG---KEVAIKQLKA-GSGQGEREFQAEVEIISRV-HHKHLVS 104
           +++G+G FG V +  +       + AIK++K   S    R+F  E+E++ ++ HH ++++
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 105 LVGYYTAGSQRMLVYEFVPNNTL--------------EFHLHGKGRPTMDWLTRLKIALG 150
           L+G         L  E+ P+  L               F +      T+     L  A  
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
            A+G+ YL +    + IHRD+ A NIL+   + AK+ADFGL++   +V      + MG  
Sbjct: 151 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVK---KTMGRL 203
Query: 211 G--YLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
              ++A E  +    T  SDV+S+GV+L E+++
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 52  LGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +G+G  G V    V  +GK VA+K++     Q       EV I+    H+++V +   Y 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 111 AGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            G +  +V EF+    L +   H +    M+      + L   + L+ LH      +IHR
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ---GVIHR 194
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYLAPEYASSGKLTEKS 227
           DIK+ +ILL      K++DFG     + V+  V  R  ++GT  ++APE  S      + 
Sbjct: 195 DIKSDSILLTHDGRVKLSDFGF---CAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 251
Query: 228 DVFSFGVMLLELITGRRP 245
           D++S G+M++E++ G  P
Sbjct: 252 DIWSLGIMVIEMVDGEPP 269

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 29/209 (13%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAI----KQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVG 107
           LG G FG V++      KE ++    K +   S +   ++  E++I++   H ++V L+ 
Sbjct: 45  LGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAK---GLAYLHEDCHP 164
            +   +   ++ EF     ++  +    RP    LT  +I +   +    L YLH++   
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERP----LTESQIQVVCKQTLDALNYLHDN--- 154
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR---VMGTFGYLAPEYASSG 221
           KIIHRD+KA NIL     + K+ADFG+    S  NT    R    +GT  ++APE     
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRXIQRRDSFIGTPYWMAPEVVMCE 210
Query: 222 KLTE-----KSDVFSFGVMLLELITGRRP 245
              +     K+DV+S G+ L+E+     P
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 52  LGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +G+G  G V    V  +GK VA+K++     Q       EV I+    H+++V +   Y 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 111 AGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            G +  +V EF+    L +   H +    M+      + L   + L+ LH      +IHR
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ---GVIHR 151
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYLAPEYASSGKLTEKS 227
           DIK+ +ILL      K++DFG     + V+  V  R  ++GT  ++APE  S      + 
Sbjct: 152 DIKSDSILLTHDGRVKLSDFGF---CAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 208
Query: 228 DVFSFGVMLLELITGRRP 245
           D++S G+M++E++ G  P
Sbjct: 209 DIWSLGIMVIEMVDGEPP 226

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 52  LGQGGFGYVHRGVL--PNGK--EVAIKQLKA---GSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V RG    P+GK   VA+K LK       +   +F  EV  +  + H++L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHG-KGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           L G       +M V E  P  +L   L   +G   +  L+R   A+  A+G+ YL     
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESK-- 130
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH--VSTRVMGTFGYLAPEYASSG 221
            + IHRD+ A N+LL  +   K+ DFGL +     + H  +       F + APE   + 
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 222 KLTEKSDVFSFGVMLLELIT-GRRP 245
             +  SD + FGV L E+ T G+ P
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 52  LGQGGFGYVHRGVL--PNGK--EVAIKQLKA---GSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V RG    P+GK   VA+K LK       +   +F  EV  +  + H++L+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHG-KGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           L G       +M V E  P  +L   L   +G   +  L+R   A+  A+G+ YL     
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESK-- 134
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH--VSTRVMGTFGYLAPEYASSG 221
            + IHRD+ A N+LL  +   K+ DFGL +     + H  +       F + APE   + 
Sbjct: 135 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 222 KLTEKSDVFSFGVMLLELIT-GRRP 245
             +  SD + FGV L E+ T G+ P
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 52  LGQGGFGYVHRGVL--PNGK--EVAIKQLKA---GSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V RG    P+GK   VA+K LK       +   +F  EV  +  + H++L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHG-KGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           L G       +M V E  P  +L   L   +G   +  L+R   A+  A+G+ YL     
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESK-- 130
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH--VSTRVMGTFGYLAPEYASSG 221
            + IHRD+ A N+LL  +   K+ DFGL +     + H  +       F + APE   + 
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 222 KLTEKSDVFSFGVMLLELIT-GRRP 245
             +  SD + FGV L E+ T G+ P
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 52  LGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +G+G  G V    V  +GK VA+K++     Q       EV I+    H+++V +   Y 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 111 AGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            G +  +V EF+    L +   H +    M+      + L   + L+ LH      +IHR
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ---GVIHR 149
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYLAPEYASSGKLTEKS 227
           DIK+ +ILL      K++DFG     + V+  V  R  ++GT  ++APE  S      + 
Sbjct: 150 DIKSDSILLTHDGRVKLSDFGF---CAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 206
Query: 228 DVFSFGVMLLELITGRRP 245
           D++S G+M++E++ G  P
Sbjct: 207 DIWSLGIMVIEMVDGEPP 224

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 52  LGQGGFGYVHRGVL--PNGK--EVAIKQLKA---GSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V RG    P+GK   VA+K LK       +   +F  EV  +  + H++L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHG-KGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           L G       +M V E  P  +L   L   +G   +  L+R   A+  A+G+ YL     
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESK-- 130
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH--VSTRVMGTFGYLAPEYASSG 221
            + IHRD+ A N+LL  +   K+ DFGL +     + H  +       F + APE   + 
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 222 KLTEKSDVFSFGVMLLELIT-GRRP 245
             +  SD + FGV L E+ T G+ P
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 52  LGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +G+G  G V    V  +GK VA+K++     Q       EV I+    H+++V +   Y 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 111 AGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            G +  +V EF+    L +   H +    M+      + L   + L+ LH      +IHR
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ---GVIHR 140
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYLAPEYASSGKLTEKS 227
           DIK+ +ILL      K++DFG     + V+  V  R  ++GT  ++APE  S      + 
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGF---CAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 197
Query: 228 DVFSFGVMLLELITGRRP 245
           D++S G+M++E++ G  P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 52  LGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +G+G  G V    V  +GK VA+K++     Q       EV I+    H+++V +   Y 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 111 AGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            G +  +V EF+    L +   H +    M+      + L   + L+ LH      +IHR
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ---GVIHR 144
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYLAPEYASSGKLTEKS 227
           DIK+ +ILL      K++DFG     + V+  V  R  ++GT  ++APE  S      + 
Sbjct: 145 DIKSDSILLTHDGRVKLSDFGF---CAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 201
Query: 228 DVFSFGVMLLELITGRRP 245
           D++S G+M++E++ G  P
Sbjct: 202 DIWSLGIMVIEMVDGEPP 219

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 104/196 (53%), Gaps = 11/196 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHHKHLVSLVGYY 109
           +G+G +G V++     G+ VA+K+++  +        A  E+ ++  +HH ++VSL+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA-KGLAYLHEDCHPKIIH 168
            +     LV+EF+  + L+  L        D  +++KI L    +G+A+ H+    +I+H
Sbjct: 89  HSERCLTLVFEFMEKD-LKKVLDENKTGLQD--SQIKIYLYQLLRGVAHCHQH---RILH 142
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-YASSGKLTEKS 227
           RD+K  N+L++     K+ADFGLA+ A  +     T  + T  Y AP+    S K +   
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSV 201
Query: 228 DVFSFGVMLLELITGR 243
           D++S G +  E+ITG+
Sbjct: 202 DIWSIGCIFAEMITGK 217

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 44  DGFSDANLLGQGGFGYVH--RGVL--PNGKEVAIKQLKAG----SGQGEREFQAEVEIIS 95
           + F    +LG+GG+G V   R V     GK  A+K LK      + +     +AE  I+ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 96  RVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----WLTRLKIALGS 151
            V H  +V L+  +  G +  L+ E++    L   L  +G    D    +L  + +ALG 
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG- 135
Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
                +LH+     II+RD+K  NI+L+ +   K+ DFGL K +    T V+    GT  
Sbjct: 136 -----HLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTIE 186
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           Y+APE           D +S G ++ +++TG  P
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 89/180 (49%), Gaps = 9/180 (5%)
Query: 67  NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT 126
           +G++VA+K +     Q       EV I+    H ++V +   Y  G +  ++ EF+    
Sbjct: 69  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128
Query: 127 LEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV 186
           L   +  + R   + +    +     + LAYLH      +IHRDIK+ +ILL      K+
Sbjct: 129 LT-DIVSQVRLNEEQIA--TVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKL 182
Query: 187 ADFGL-AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           +DFG  A+I+ DV       ++GT  ++APE  S      + D++S G+M++E++ G  P
Sbjct: 183 SDFGFCAQISKDVPKR--KXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 104/196 (53%), Gaps = 11/196 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHHKHLVSLVGYY 109
           +G+G +G V++     G+ VA+K+++  +        A  E+ ++  +HH ++VSL+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA-KGLAYLHEDCHPKIIH 168
            +     LV+EF+  + L+  L        D  +++KI L    +G+A+ H+    +I+H
Sbjct: 89  HSERCLTLVFEFMEKD-LKKVLDENKTGLQD--SQIKIYLYQLLRGVAHCHQH---RILH 142
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-YASSGKLTEKS 227
           RD+K  N+L++     K+ADFGLA+ A  +     T  + T  Y AP+    S K +   
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSV 201
Query: 228 DVFSFGVMLLELITGR 243
           D++S G +  E+ITG+
Sbjct: 202 DIWSIGCIFAEMITGK 217

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 44  DGFSDANLLGQGGFGYVH--RGVL--PNGKEVAIKQLKAG----SGQGEREFQAEVEIIS 95
           + F    +LG+GG+G V   R V     GK  A+K LK      + +     +AE  I+ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 96  RVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----WLTRLKIALGS 151
            V H  +V L+  +  G +  L+ E++    L   L  +G    D    +L  + +ALG 
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG- 135
Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
                +LH+     II+RD+K  NI+L+ +   K+ DFGL K +    T V+    GT  
Sbjct: 136 -----HLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTIE 186
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           Y+APE           D +S G ++ +++TG  P
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 18/224 (8%)
Query: 43  TDGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREFQA---EVEIISRV- 97
            D F    +LG+G FG V    V   G   A+K LK      + + +    E  I+S   
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +H  L  L   +    +   V EFV    L FH+    R   D       A      L +
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMF 139
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAP 215
           LH+     II+RD+K  N+LLD +   K+ADFG+ K  I + V T       GT  Y+AP
Sbjct: 140 LHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT---ATFCGTPDYIAP 193
Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
           E           D ++ GV+L E++ G  P ++ +   ED L +
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFE 234

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 50  NLLGQGGFGYVHRGVLPNG---KEVAIKQLKA-GSGQGEREFQAEVEIISRV-HHKHLVS 104
           +++G+G FG V +  +       + AIK++K   S    R+F  E+E++ ++ HH ++++
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 105 LVGYYTAGSQRMLVYEFVPNNTL--------------EFHLHGKGRPTMDWLTRLKIALG 150
           L+G         L  E+ P+  L               F +      T+     L  A  
Sbjct: 88  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
            A+G+ YL +    + IHR++ A NIL+   + AK+ADFGL++   +V      + MG  
Sbjct: 148 VARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR-GQEVYVK---KTMGRL 200
Query: 211 G--YLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
              ++A E  +    T  SDV+S+GV+L E+++
Sbjct: 201 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 121/257 (47%), Gaps = 55/257 (21%)
Query: 51  LLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKH------LVS 104
            +G+G +G V RG L +G+ VA+K     S + E+ +  E EI + V  +H      + S
Sbjct: 15  CVGKGRYGEVWRG-LWHGESVAVKIF---SSRDEQSWFRETEIYNTVLLRHDNILGFIAS 70
Query: 105 LVGYYTAGSQRMLV---------YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGL 155
            +    + +Q  L+         Y+F+   TLE HL             L++A+ +A GL
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHL------------ALRLAVSAACGL 118
Query: 156 AYLHEDC-----HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV----STRV 206
           A+LH +       P I HRD K+ N+L+    +  +AD GLA + S  + ++    + RV
Sbjct: 119 AHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV 178
Query: 207 MGTFGYLAPEYASSGKLTEK------SDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDW 260
            GT  Y+APE       T+       +D+++FG++L E+   RR      T V   + D+
Sbjct: 179 -GTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARR------TIVNGIVEDY 229
Query: 261 ARPLLNRAIEDGNFDTL 277
             P  +    D +F+ +
Sbjct: 230 RPPFYDVVPNDPSFEDM 246

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 34/218 (15%)
Query: 52  LGQGGFGYVHRGVL----------PNG-KEVAIKQLKAGSGQGE-REFQAEVEIISRV-H 98
           LG+G FG V   VL          PN   +VA+K LK+ + + +  +  +E+E++  +  
Sbjct: 21  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-------------- 144
           HK++++L+G  T      ++ E+     L  +L  +  P +++                 
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH-VS 203
           +  A   A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+    ++ +  +
Sbjct: 138 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           T       ++APE       T +SDV+SFGV+L E+ T
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 30/231 (12%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG V        G++VA+K      L     QG  E   E+  +  + H H++ L
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 79
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
                +  + ++V E+  N   ++ +    R  M      +        + Y H     K
Sbjct: 80  YDVIKSKDEIIMVIEYAGNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRH---K 133
Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           I+HRD+K  N+LLD     K+ADFGL+ I +D N   ++   G+  Y APE   SGKL  
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VISGKLYA 190
Query: 226 --KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF 274
             + DV+S GV+L  ++  R P D           D + P+L + I +G +
Sbjct: 191 GPEVDVWSCGVILYVMLCRRLPFD-----------DESIPVLFKNISNGVY 230

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 30/231 (12%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG V        G++VA+K      L     QG  E   E+  +  + H H++ L
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 78
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
                +  + ++V E+  N   ++ +    R  M      +        + Y H     K
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRH---K 132
Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT- 224
           I+HRD+K  N+LLD     K+ADFGL+ I +D N   ++   G+  Y APE   SGKL  
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VISGKLYA 189
Query: 225 -EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF 274
             + DV+S GV+L  ++  R P D           D + P+L + I +G +
Sbjct: 190 GPEVDVWSCGVILYVMLCRRLPFD-----------DESIPVLFKNISNGVY 229

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 52  LGQGGFGYVHRGVL----------PNG-KEVAIKQLKAGSGQGE-REFQAEVEIISRV-H 98
           LG+G FG V   VL          PN   +VA+K LK+ + + +  +  +E+E++  +  
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-------------- 144
           HK++++L+G  T      ++ E+     L  +L  +  P +++                 
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST 204
           +  A   A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+    ++ +  T
Sbjct: 153 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 205 ---RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
              R+     ++APE       T +SDV+SFGV+L E+ T
Sbjct: 210 TNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 30/231 (12%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG V        G++VA+K      L     QG  E   E+  +  + H H++ L
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 69
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
                +  + ++V E+  N   ++ +    R  M      +        + Y H     K
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRH---K 123
Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT- 224
           I+HRD+K  N+LLD     K+ADFGL+ I +D N   ++   G+  Y APE   SGKL  
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VISGKLYA 180
Query: 225 -EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF 274
             + DV+S GV+L  ++  R P D           D + P+L + I +G +
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLPFD-----------DESIPVLFKNISNGVY 220

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG G FG V +G            V I + +A     + E  AE  ++ ++ + ++V ++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 107 GYYTAGSQRMLVYEFVP----NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           G   A S  MLV E       N  L+ + H K +  ++ + ++ +      G+ YL E  
Sbjct: 93  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM------GMKYLEES- 144
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASS 220
               +HRD+ A N+LL  +  AK++DFGL+K       +   +  G +   + APE  + 
Sbjct: 145 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 202
Query: 221 GKLTEKSDVFSFGVMLLELIT-GRRP 245
            K + KSDV+SFGV++ E  + G++P
Sbjct: 203 YKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG G FG V +G            V I + +A     + E  AE  ++ ++ + ++V ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 107 GYYTAGSQRMLVYEFVP----NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           G   A S  MLV E       N  L+ + H K +  ++ + ++ +      G+ YL E  
Sbjct: 95  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM------GMKYLEES- 146
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASS 220
               +HRD+ A N+LL  +  AK++DFGL+K       +   +  G +   + APE  + 
Sbjct: 147 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 221 GKLTEKSDVFSFGVMLLELIT-GRRP 245
            K + KSDV+SFGV++ E  + G++P
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG G FG V +G            V I + +A     + E  AE  ++ ++ + ++V ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 107 GYYTAGSQRMLVYEFVP----NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           G   A S  MLV E       N  L+ + H K +  ++ + ++ +      G+ YL E  
Sbjct: 95  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM------GMKYLEES- 146
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASS 220
               +HRD+ A N+LL  +  AK++DFGL+K       +   +  G +   + APE  + 
Sbjct: 147 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 221 GKLTEKSDVFSFGVMLLELIT-GRRP 245
            K + KSDV+SFGV++ E  + G++P
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 14/211 (6%)
Query: 52  LGQGGFGYVHRGVL-PNGKEVAIKQLK-AGSGQGEREFQAEVEIISRVHH-KHLVSLVGY 108
           +G G  G V +      G  +A+KQ++ +G+ +  +    +++++ + H   ++V   G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
           +   +   +  E +     +     +G      L ++ +A+   K L YL E     +IH
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAI--VKALYYLKE--KHGVIH 148
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE--- 225
           RD+K +NILLD + + K+ DFG++     V+     R  G   Y+APE       T+   
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGIS--GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 226 --KSDVFSFGVMLLELITGRRPVDSTHTFVE 254
             ++DV+S G+ L+EL TG+ P  +  T  E
Sbjct: 207 DIRADVWSLGISLVELATGQFPYKNCKTDFE 237

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 30/231 (12%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG V        G++VA+K      L     QG  E   E+  +  + H H++ L
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 73
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
                +  + ++V E+  N   ++ +    R  M      +        + Y H     K
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRH---K 127
Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT- 224
           I+HRD+K  N+LLD     K+ADFGL+ I +D N   ++   G+  Y APE   SGKL  
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VISGKLYA 184
Query: 225 -EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF 274
             + DV+S GV+L  ++  R P D           D + P+L + I +G +
Sbjct: 185 GPEVDVWSCGVILYVMLCRRLPFD-----------DESIPVLFKNISNGVY 224

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 110/234 (47%), Gaps = 29/234 (12%)
Query: 31  KSTFTYEELARATDGFSDANLL-------GQGGFGYVHRGVLP-----NGKEVAIKQLKA 78
           +S F   E  R  + + D  LL       G G FG V +G            V I + +A
Sbjct: 349 ESPFADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA 408
Query: 79  GSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP----NNTLEFHLHGK 134
                + E  AE  ++ ++ + ++V ++G   A S  MLV E       N  L+ + H K
Sbjct: 409 NDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVK 467
Query: 135 GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI 194
            +  ++ + ++ +      G+ YL E      +HRD+ A N+LL  +  AK++DFGL+K 
Sbjct: 468 DKNIIELVHQVSM------GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 518
Query: 195 ASDVNTHVSTRVMGTF--GYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
                 +   +  G +   + APE  +  K + KSDV+SFGV++ E  + G++P
Sbjct: 519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 103/229 (44%), Gaps = 25/229 (10%)
Query: 52  LGQGGFGYVHRGVLP-NGKEVAIKQL---KAGSGQGEREFQAEVEIISRVHHKHLVSLVG 107
           LG G FG V  G     G +VA+K L   K  S     + + E++ +    H H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
             +  +   +V E+V    L  ++   GR       RL   + SA    + H      ++
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH-----MVV 133
Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT--E 225
           HRD+K  N+LLD    AK+ADFGL+ + SD    + T   G+  Y APE   SG+L    
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC-GSPNYAAPE-VISGRLYAGP 190
Query: 226 KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF 274
           + D++S GV+L  L+ G  P D  H            P L + I  G F
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHV-----------PTLFKKIRGGVF 228

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG G FG V +G            V I + +A     + E  AE  ++ ++ + ++V ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 107 GYYTAGSQRMLVYEFVP----NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           G   A S  MLV E       N  L+ + H K +  ++ + ++ +      G+ YL E  
Sbjct: 85  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM------GMKYLEES- 136
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASS 220
               +HRD+ A N+LL  +  AK++DFGL+K       +   +  G +   + APE  + 
Sbjct: 137 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 221 GKLTEKSDVFSFGVMLLELIT-GRRP 245
            K + KSDV+SFGV++ E  + G++P
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG G FG V +G            V I + +A     + E  AE  ++ ++ + ++V ++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 107 GYYTAGSQRMLVYEFVP----NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           G   A S  MLV E       N  L+ + H K +  ++ + ++ +      G+ YL E  
Sbjct: 73  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM------GMKYLEES- 124
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASS 220
               +HRD+ A N+LL  +  AK++DFGL+K       +   +  G +   + APE  + 
Sbjct: 125 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 182
Query: 221 GKLTEKSDVFSFGVMLLELIT-GRRP 245
            K + KSDV+SFGV++ E  + G++P
Sbjct: 183 YKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG G FG V +G            V I + +A     + E  AE  ++ ++ + ++V ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 107 GYYTAGSQRMLVYEFVP----NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           G   A S  MLV E       N  L+ + H K +  ++ + ++ +      G+ YL E  
Sbjct: 79  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM------GMKYLEES- 130
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTH-VSTRVMGTFGYLAPEYASS 220
               +HRD+ A N+LL  +  AK++DFGL+K + +D N +   T       + APE  + 
Sbjct: 131 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINY 188
Query: 221 GKLTEKSDVFSFGVMLLELIT-GRRP 245
            K + KSDV+SFGV++ E  + G++P
Sbjct: 189 YKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 51  LLGQGGFGYVHRGVLPNGKEV-----AIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
            LG+GGF         + KEV       K L     Q E+    E+ I   + H+H+V  
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 82
Query: 106 VGYYTAGSQRMLVYEFVPNNTL-EFHLHGKG--RPTMDWLTRLKIALGSAKGLAYLHEDC 162
            G++       +V E     +L E H   K    P   +  R +I LG      YLH + 
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHRN- 136
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK 222
             ++IHRD+K  N+ L+   E K+ DFGLA    + +      + GT  Y+APE  S   
Sbjct: 137 --RVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKTLCGTPNYIAPEVLSKKG 193
Query: 223 LTEKSDVFSFGVMLLELITGRRPVDST 249
            + + DV+S G ++  L+ G+ P +++
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 51  LLGQGGFGYVHRGVLPNGKEV-----AIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
            LG+GGF         + KEV       K L     Q E+    E+ I   + H+H+V  
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 86
Query: 106 VGYYTAGSQRMLVYEFVPNNTL-EFHLHGKG--RPTMDWLTRLKIALGSAKGLAYLHEDC 162
            G++       +V E     +L E H   K    P   +  R +I LG      YLH + 
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHRN- 140
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK 222
             ++IHRD+K  N+ L+   E K+ DFGLA    + +      + GT  Y+APE  S   
Sbjct: 141 --RVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKTLCGTPNYIAPEVLSKKG 197
Query: 223 LTEKSDVFSFGVMLLELITGRRPVDST 249
            + + DV+S G ++  L+ G+ P +++
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPFETS 224

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 107/225 (47%), Gaps = 32/225 (14%)
Query: 44  DGFSDANLLGQGGFGYV--------HRGVLPNGKEVAIKQLKAGSGQGE-REFQAEVEII 94
           D  +    LG+G FG V         +        VA+K LK  + + +  +  +E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 95  SRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW---LTRL----- 145
             +  HK++++L+G  T      ++ E+     L  +L  +  P M++   + R+     
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 146 ------KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
                       A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+  ++++
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 200 THVST---RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            + +T   R+     ++APE       T +SDV+SFGV++ E+ T
Sbjct: 212 YYKNTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 51  LLGQGGFGYVHRGVLPNGKEV-----AIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
            LG+GGF         + KEV       K L     Q E+    E+ I   + H+H+V  
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 82
Query: 106 VGYYTAGSQRMLVYEFVPNNTL-EFHLHGKG--RPTMDWLTRLKIALGSAKGLAYLHEDC 162
            G++       +V E     +L E H   K    P   +  R +I LG      YLH + 
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHRN- 136
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK 222
             ++IHRD+K  N+ L+   E K+ DFGLA    + +      + GT  Y+APE  S   
Sbjct: 137 --RVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKTLCGTPNYIAPEVLSKKG 193
Query: 223 LTEKSDVFSFGVMLLELITGRRPVDST 249
            + + DV+S G ++  L+ G+ P +++
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG G FG V +G            V I + +A     + E  AE  ++ ++ + ++V ++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 107 GYYTAGSQRMLVYEFVP----NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           G   A S  MLV E       N  L+ + H K +  ++ + ++ +      G+ YL E  
Sbjct: 75  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM------GMKYLEES- 126
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASS 220
               +HRD+ A N+LL  +  AK++DFGL+K       +   +  G +   + APE  + 
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 221 GKLTEKSDVFSFGVMLLELIT-GRRP 245
            K + KSDV+SFGV++ E  + G++P
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 32/225 (14%)
Query: 44  DGFSDANLLGQGGFGYV--------HRGVLPNGKEVAIKQLKAGSGQGE-REFQAEVEII 94
           D  +    LG+G FG V         +        VA+K LK  + + +  +  +E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 95  SRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW---LTRL----- 145
             +  HK++++L+G  T      ++ E+     L  +L  +  P M++   + R+     
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 146 ------KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
                       A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+  ++++
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 200 THVST---RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            +  T   R+     ++APE       T +SDV+SFGV++ E+ T
Sbjct: 212 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG G FG V +G            V I + +A     + E  AE  ++ ++ + ++V ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 107 GYYTAGSQRMLVYEFVP----NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           G   A S  MLV E       N  L+ + H K +  ++ + ++ +      G+ YL E  
Sbjct: 79  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM------GMKYLEES- 130
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASS 220
               +HRD+ A N+LL  +  AK++DFGL+K       +   +  G +   + APE  + 
Sbjct: 131 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 188
Query: 221 GKLTEKSDVFSFGVMLLELIT-GRRP 245
            K + KSDV+SFGV++ E  + G++P
Sbjct: 189 YKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 32/225 (14%)
Query: 44  DGFSDANLLGQGGFGYV--------HRGVLPNGKEVAIKQLKAGSGQGE-REFQAEVEII 94
           D  +    LG+G FG V         +        VA+K LK  + + +  +  +E+E++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 95  SRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW---LTRLK---- 146
             +  HK++++L+G  T      ++ E+     L  +L  +  P M++   + R+     
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 147 -------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
                       A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+  ++++
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 200 THVST---RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            +  T   R+     ++APE       T +SDV+SFGV++ E+ T
Sbjct: 258 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 111/229 (48%), Gaps = 36/229 (15%)
Query: 52  LGQGGFGYVHR----GVLPN--GKEVAIKQLKAGSGQGERE-FQAEVEIISRV-HHKHLV 103
           LG G FG V      G++ +     VA+K LK  +   ERE   +E++++S + +H ++V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 104 SLVGYYTAGSQRMLVYEFVP-NNTLEF-------HLHGKGRPTM--------DWLTRLKI 147
           +L+G  T G   +++ E+    + L F        +  K  P +        D    L  
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 148 ALGSAKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTR 205
           +   AKG+A+L  ++C    IHRD+ A NILL      K+ DFGLA+ I +D N  V   
Sbjct: 167 SYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 222
Query: 206 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT------GRRPVDS 248
                 ++APE   +   T +SDV+S+G+ L EL +         PVDS
Sbjct: 223 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 271

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG G FG V +G            V I + +A     + E  AE  ++ ++ + ++V ++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 107 GYYTAGSQRMLVYEFVP----NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           G   A S  MLV E       N  L+ + H K +  ++ + ++ +      G+ YL E  
Sbjct: 438 GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM------GMKYLEES- 489
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASS 220
               +HRD+ A N+LL  +  AK++DFGL+K       +   +  G +   + APE  + 
Sbjct: 490 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 547
Query: 221 GKLTEKSDVFSFGVMLLELIT-GRRP 245
            K + KSDV+SFGV++ E  + G++P
Sbjct: 548 YKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 34/218 (15%)
Query: 52  LGQGGFGYVHRGVL----------PNG-KEVAIKQLKAGSGQGE-REFQAEVEIISRV-H 98
           LG+G FG V   VL          PN   +VA+K LK+ + + +  +  +E+E++  +  
Sbjct: 25  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-------------- 144
           HK++++L+G  T      ++ E+     L  +L  +  P +++                 
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH-VS 203
           +  A   A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+    ++ +  +
Sbjct: 142 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 198
Query: 204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           T       ++APE       T +SDV+SFGV+L E+ T
Sbjct: 199 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
            +++  ++G G FG V +  L    EVAIK++     Q +R    E++I+  V H ++V 
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL----QDKRFKNRELQIMRIVKHPNVVD 96
Query: 105 LVG-YYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLAY 157
           L   +Y+ G ++      LV E+VP        H  K + TM  L          + LAY
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAPE 216
           +H      I HRDIK  N+LLD      K+ DFG AKI      +VS   + +  Y APE
Sbjct: 157 IHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX--ICSRYYRAPE 211
Query: 217 YA-SSGKLTEKSDVFSFGVMLLELITGR 243
               +   T   D++S G ++ EL+ G+
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 30/216 (13%)
Query: 52  LGQGGFGYVHR----GVLPN--GKEVAIKQLKAGSGQGERE-FQAEVEIISRV-HHKHLV 103
           LG G FG V      G++ +     VA+K LK  +   ERE   +E++++S + +H ++V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 104 SLVGYYTAGSQRMLVYEFVP-NNTLEF-------HLHGKGRPTM--------DWLTRLKI 147
           +L+G  T G   +++ E+    + L F        +  K  P +        D    L  
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 148 ALGSAKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTR 205
           +   AKG+A+L  ++C    IHRD+ A NILL      K+ DFGLA+ I +D N  V   
Sbjct: 151 SYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 206 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
                 ++APE   +   T +SDV+S+G+ L EL +
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 50  NLLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQG-EREFQAEVEIISRVHHKHLVS 104
           ++LG G F  V   +L   K     VAIK +   + +G E   + E+ ++ ++ H ++V+
Sbjct: 24  DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L   Y +G    L+ + V    L   +  KG  T    +RL   +  A  + YLH+    
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLHD---L 135
Query: 165 KIIHRDIKAANIL---LDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
            I+HRD+K  N+L   LD   +  ++DFGL+K+  D  + +ST   GT GY+APE  +  
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLST-ACGTPGYVAPEVLAQK 193
Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
             ++  D +S GV+   L+ G  P
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 34/218 (15%)
Query: 52  LGQGGFGYVHRGVL----------PNG-KEVAIKQLKAGSGQGE-REFQAEVEIISRV-H 98
           LG+G FG V   VL          PN   +VA+K LK+ + + +  +  +E+E++  +  
Sbjct: 29  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-------------- 144
           HK++++L+G  T      ++ E+     L  +L  +  P +++                 
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH-VS 203
           +  A   A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+    ++ +  +
Sbjct: 146 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 202
Query: 204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           T       ++APE       T +SDV+SFGV+L E+ T
Sbjct: 203 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 14/206 (6%)
Query: 52  LGQGGFGYVHRGVLP-NGKEVAIKQL---KAGSGQGEREFQAEVEIISRVHHKHLVSLVG 107
           LG G FG V  G     G +VA+K L   K  S     + + E++ +    H H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
             +  +   +V E+V    L  ++   GR       RL   + SA    + H      ++
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH-----MVV 133
Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT--E 225
           HRD+K  N+LLD    AK+ADFGL+ + SD      +   G+  Y APE   SG+L    
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS--CGSPNYAAPE-VISGRLYAGP 190
Query: 226 KSDVFSFGVMLLELITGRRPVDSTHT 251
           + D++S GV+L  L+ G  P D  H 
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHV 216

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 51  LLGQGGFGYVHRGVLPNGKEV-----AIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
            LG+GGF         + KEV       K L     Q E+    E+ I   + H+H+V  
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 104
Query: 106 VGYYTAGSQRMLVYEFVPNNTL-EFHLHGKG--RPTMDWLTRLKIALGSAKGLAYLHEDC 162
            G++       +V E     +L E H   K    P   +  R +I LG      YLH + 
Sbjct: 105 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHRN- 158
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK 222
             ++IHRD+K  N+ L+   E K+ DFGLA    + +      + GT  Y+APE  S   
Sbjct: 159 --RVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKVLCGTPNYIAPEVLSKKG 215
Query: 223 LTEKSDVFSFGVMLLELITGRRPVDST 249
            + + DV+S G ++  L+ G+ P +++
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPFETS 242

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 111/229 (48%), Gaps = 36/229 (15%)
Query: 52  LGQGGFGYVHR----GVLPN--GKEVAIKQLKAGSGQGERE-FQAEVEIISRV-HHKHLV 103
           LG G FG V      G++ +     VA+K LK  +   ERE   +E++++S + +H ++V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 104 SLVGYYTAGSQRMLVYEFVP-NNTLEF-------HLHGKGRPTM--------DWLTRLKI 147
           +L+G  T G   +++ E+    + L F        +  K  P +        D    L  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 148 ALGSAKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTR 205
           +   AKG+A+L  ++C    IHRD+ A NILL      K+ DFGLA+ I +D N  V   
Sbjct: 174 SYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 229
Query: 206 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT------GRRPVDS 248
                 ++APE   +   T +SDV+S+G+ L EL +         PVDS
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 278

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 34/218 (15%)
Query: 52  LGQGGFGYVHRGVL----------PNG-KEVAIKQLKAGSGQGE-REFQAEVEIISRV-H 98
           LG+G FG V   VL          PN   +VA+K LK+ + + +  +  +E+E++  +  
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-------------- 144
           HK++++L+G  T      ++ E+     L  +L  +  P +++                 
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH-VS 203
           +  A   A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+    ++ +  +
Sbjct: 153 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           T       ++APE       T +SDV+SFGV+L E+ T
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 34/218 (15%)
Query: 52  LGQGGFGYVHRGVL----------PNG-KEVAIKQLKAGSGQGE-REFQAEVEIISRV-H 98
           LG+G FG V   VL          PN   +VA+K LK+ + + +  +  +E+E++  +  
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-------------- 144
           HK++++L+G  T      ++ E+     L  +L  +  P +++                 
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH-VS 203
           +  A   A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+    ++ +  +
Sbjct: 153 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           T       ++APE       T +SDV+SFGV+L E+ T
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 111/229 (48%), Gaps = 36/229 (15%)
Query: 52  LGQGGFGYVHR----GVLPN--GKEVAIKQLKAGSGQGERE-FQAEVEIISRV-HHKHLV 103
           LG G FG V      G++ +     VA+K LK  +   ERE   +E++++S + +H ++V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 104 SLVGYYTAGSQRMLVYEFVP-NNTLEF-------HLHGKGRPTM--------DWLTRLKI 147
           +L+G  T G   +++ E+    + L F        +  K  P +        D    L  
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 148 ALGSAKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTR 205
           +   AKG+A+L  ++C    IHRD+ A NILL      K+ DFGLA+ I +D N  V   
Sbjct: 169 SYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 224
Query: 206 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT------GRRPVDS 248
                 ++APE   +   T +SDV+S+G+ L EL +         PVDS
Sbjct: 225 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 273

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 107/222 (48%), Gaps = 42/222 (18%)
Query: 52  LGQGGFGYVHRGVL----------PNG-KEVAIKQLKAGSGQGE-REFQAEVEIISRV-H 98
           LG+G FG V   VL          PN   +VA+K LK+ + + +  +  +E+E++  +  
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW--------------LTR 144
           HK++++L+G  T      ++ E+     L  +L  +  P +++                 
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST 204
           +  A   A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+   D++ H+  
Sbjct: 153 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR---DIH-HIDX 205
Query: 205 RVMGTFG-----YLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
               T G     ++APE       T +SDV+SFGV+L E+ T
Sbjct: 206 XKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 51  LLGQGGFGYVHRGVLPNGKEV-----AIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
            LG+GGF         + KEV       K L     Q E+    E+ I   + H+H+V  
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 106
Query: 106 VGYYTAGSQRMLVYEFVPNNTL-EFHLHGKG--RPTMDWLTRLKIALGSAKGLAYLHEDC 162
            G++       +V E     +L E H   K    P   +  R +I LG      YLH + 
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHRN- 160
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK 222
             ++IHRD+K  N+ L+   E K+ DFGLA    + +      + GT  Y+APE  S   
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKVLCGTPNYIAPEVLSKKG 217
Query: 223 LTEKSDVFSFGVMLLELITGRRPVDST 249
            + + DV+S G ++  L+ G+ P +++
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETS 244

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 34/218 (15%)
Query: 52  LGQGGFGYVHRGVL----------PNG-KEVAIKQLKAGSGQGE-REFQAEVEIISRV-H 98
           LG+G FG V   VL          PN   +VA+K LK+ + + +  +  +E+E++  +  
Sbjct: 28  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-------------- 144
           HK++++L+G  T      ++ E+     L  +L  +  P +++                 
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH-VS 203
           +  A   A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+    ++ +  +
Sbjct: 145 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 201
Query: 204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           T       ++APE       T +SDV+SFGV+L E+ T
Sbjct: 202 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 92/190 (48%), Gaps = 7/190 (3%)
Query: 52  LGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLVGYY 109
           +G+G FG V  G L  +   VA+K  +       + +F  E  I+ +  H ++V L+G  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
           T      +V E V        L  +G   +   T L++   +A G+ YL   C    IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHR 237
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT-FGYLAPEYASSGKLTEKSD 228
           D+ A N L+  K   K++DFG+++  +D     S  +      + APE  + G+ + +SD
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 229 VFSFGVMLLE 238
           V+SFG++L E
Sbjct: 298 VWSFGILLWE 307

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 32/225 (14%)
Query: 44  DGFSDANLLGQGGFGYV--------HRGVLPNGKEVAIKQLKAGSGQGE-REFQAEVEII 94
           D  +    LG+G FG V         +        VA+K LK  + + +  +  +E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 95  SRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW---LTRL----- 145
             +  HK++++L+G  T      ++ E+     L  +L  +  P M++   + R+     
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 146 ------KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
                       A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+  ++++
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 200 THVST---RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            +  T   R+     ++APE       T +SDV+SFGV++ E+ T
Sbjct: 212 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 32/225 (14%)
Query: 44  DGFSDANLLGQGGFGYV--------HRGVLPNGKEVAIKQLKAGSGQGE-REFQAEVEII 94
           D  +    LG+G FG V         +        VA+K LK  + + +  +  +E+E++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 95  SRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW---LTRL----- 145
             +  HK++++L+G  T      ++ E+     L  +L  +  P M++   + R+     
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 146 ------KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
                       A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+  ++++
Sbjct: 142 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 200 THVST---RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            +  T   R+     ++APE       T +SDV+SFGV++ E+ T
Sbjct: 199 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 51  LLGQGGFGYVHRGVLPNGKEV-----AIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
            LG+GGF         + KEV       K L     Q E+    E+ I   + H+H+V  
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 80
Query: 106 VGYYTAGSQRMLVYEFVPNNTL-EFHLHGKG--RPTMDWLTRLKIALGSAKGLAYLHEDC 162
            G++       +V E     +L E H   K    P   +  R +I LG      YLH + 
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----YLHRN- 134
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK 222
             ++IHRD+K  N+ L+   E K+ DFGLA    + +      + GT  Y+APE  S   
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 223 LTEKSDVFSFGVMLLELITGRRPVDST 249
            + + DV+S G ++  L+ G+ P +++
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETS 218

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 111/229 (48%), Gaps = 36/229 (15%)
Query: 52  LGQGGFGYVHR----GVLPN--GKEVAIKQLKAGSGQGERE-FQAEVEIISRV-HHKHLV 103
           LG G FG V      G++ +     VA+K LK  +   ERE   +E++++S + +H ++V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 104 SLVGYYTAGSQRMLVYEFVP-NNTLEF-------HLHGKGRPTM--------DWLTRLKI 147
           +L+G  T G   +++ E+    + L F        +  K  P +        D    L  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 148 ALGSAKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTR 205
           +   AKG+A+L  ++C    IHRD+ A NILL      K+ DFGLA+ I +D N  V   
Sbjct: 174 SYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGN 229
Query: 206 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT------GRRPVDS 248
                 ++APE   +   T +SDV+S+G+ L EL +         PVDS
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 278

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 32/225 (14%)
Query: 44  DGFSDANLLGQGGFGYV--------HRGVLPNGKEVAIKQLKAGSGQGE-REFQAEVEII 94
           D  +    LG+G FG V         +        VA+K LK  + + +  +  +E+E++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 95  SRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW---LTRL----- 145
             +  HK++++L+G  T      ++ E+     L  +L  +  P M++   + R+     
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 146 ------KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
                       A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+  ++++
Sbjct: 147 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 200 THVST---RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            +  T   R+     ++APE       T +SDV+SFGV++ E+ T
Sbjct: 204 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 10/218 (4%)
Query: 44  DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHH 99
           D F D  +LG+GGFG V    +   GK  A K+L     +  + +Q    E +I+++VH 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG--KGRPTMDWLTRLKIALGSAKGLAY 157
           + +VSL   +   +   LV   +    + +H++   +  P       +        GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
           LH+     II+RD+K  N+LLD     +++D GLA +        +    GT G++APE 
Sbjct: 305 LHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTKTKGYAGTPGFMAPEL 360
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED 255
               +     D F+ GV L E+I  R P  +    VE+
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 44  DGFSDANLLGQGGFGYV--------HRGVLPNGKEVAIKQLKAGSGQGE-REFQAEVEII 94
           D  +    LG+G FG V         +        VA+K LK  + + +  +  +E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 95  SRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW---LTRL----- 145
             +  HK++++L+G  T      ++ E+     L  +L  +  P M++   + R+     
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 146 ------KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
                       A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+  ++++
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 200 -THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
               +T       ++APE       T +SDV+SFGV++ E+ T
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 32/225 (14%)
Query: 44  DGFSDANLLGQGGFGYV--------HRGVLPNGKEVAIKQLKAGSGQGE-REFQAEVEII 94
           D  +    LG+G FG V         +        VA+K LK  + + +  +  +E+E++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 95  SRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW---LTRL----- 145
             +  HK++++L+G  T      ++ E+     L  +L  +  P M++   + R+     
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 146 ------KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
                       A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+  ++++
Sbjct: 144 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 200 THVST---RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            +  T   R+     ++APE       T +SDV+SFGV++ E+ T
Sbjct: 201 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 10/218 (4%)
Query: 44  DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHH 99
           D F D  +LG+GGFG V    +   GK  A K+L     +  + +Q    E +I+++VH 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG--KGRPTMDWLTRLKIALGSAKGLAY 157
           + +VSL   +   +   LV   +    + +H++   +  P       +        GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
           LH+     II+RD+K  N+LLD     +++D GLA +        +    GT G++APE 
Sbjct: 305 LHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTKTKGYAGTPGFMAPEL 360
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED 255
               +     D F+ GV L E+I  R P  +    VE+
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 10/218 (4%)
Query: 44  DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHH 99
           D F D  +LG+GGFG V    +   GK  A K+L     +  + +Q    E +I+++VH 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG--KGRPTMDWLTRLKIALGSAKGLAY 157
           + +VSL   +   +   LV   +    + +H++   +  P       +        GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
           LH+     II+RD+K  N+LLD     +++D GLA +        +    GT G++APE 
Sbjct: 305 LHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTKTKGYAGTPGFMAPEL 360
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED 255
               +     D F+ GV L E+I  R P  +    VE+
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 50  NLLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQG-EREFQAEVEIISRVHHKHLVS 104
           ++LG G F  V   +L   K     VAIK +   + +G E   + E+ ++ ++ H ++V+
Sbjct: 24  DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L   Y +G    L+ + V    L   +  KG  T    +RL   +  A  + YLH+    
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLHD---L 135
Query: 165 KIIHRDIKAANIL---LDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
            I+HRD+K  N+L   LD   +  ++DFGL+K+  D  + +ST   GT GY+APE  +  
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLST-ACGTPGYVAPEVLAQK 193
Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
             ++  D +S GV+   L+ G  P
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 34/218 (15%)
Query: 52  LGQGGFGYVHRGVL----------PNG-KEVAIKQLKAGSGQGE-REFQAEVEIISRV-H 98
           LG+G FG V   VL          PN   +VA+K LK+ + + +  +  +E+E++  +  
Sbjct: 77  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-------------- 144
           HK++++L+G  T      ++ E+     L  +L  +  P +++                 
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH-VS 203
           +  A   A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+    ++ +  +
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
           T       ++APE       T +SDV+SFGV+L E+ T
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 46  FSDANLLGQGGFGYVHRGVLPNGKEV----AIKQLKAGSGQGEREFQAEVE--IISRVHH 99
           F    +LGQG FG V      +G +     A+K LK  + +     + ++E  I+  V+H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----WLTRLKIALGSAKGL 155
             +V L   +    +  L+ +F+    L   L  +   T +    +L  L +AL     L
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
                     II+RD+K  NILLD +   K+ DFGL+K + D +   +    GT  Y+AP
Sbjct: 146 G---------IIYRDLKPENILLDEEGHIKLTDFGLSKESID-HEKKAYSFCGTVEYMAP 195
Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           E  +    T+ +D +SFGV++ E++TG  P
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 50  NLLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQG-EREFQAEVEIISRVHHKHLVS 104
           ++LG G F  V   +L   K     VAIK +   + +G E   + E+ ++ ++ H ++V+
Sbjct: 24  DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L   Y +G    L+ + V    L   +  KG  T    +RL   +  A  + YLH+    
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLHD---L 135
Query: 165 KIIHRDIKAANIL---LDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
            I+HRD+K  N+L   LD   +  ++DFGL+K+  D  + +ST   GT GY+APE  +  
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLST-ACGTPGYVAPEVLAQK 193
Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
             ++  D +S GV+   L+ G  P
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 50  NLLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQG-EREFQAEVEIISRVHHKHLVS 104
           ++LG G F  V   +L   K     VAIK +   + +G E   + E+ ++ ++ H ++V+
Sbjct: 24  DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L   Y +G    L+ + V    L   +  KG  T    +RL   +  A  + YLH+    
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLHD---L 135
Query: 165 KIIHRDIKAANIL---LDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
            I+HRD+K  N+L   LD   +  ++DFGL+K+  D  + +ST   GT GY+APE  +  
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLST-ACGTPGYVAPEVLAQK 193
Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
             ++  D +S GV+   L+ G  P
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 10/218 (4%)
Query: 44  DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHH 99
           D F D  +LG+GGFG V    +   GK  A K+L     +  + +Q    E +I+++VH 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG--KGRPTMDWLTRLKIALGSAKGLAY 157
           + +VSL   +   +   LV   +    + +H++   +  P       +        GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
           LH+     II+RD+K  N+LLD     +++D GLA +        +    GT G++APE 
Sbjct: 305 LHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTKTKGYAGTPGFMAPEL 360
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED 255
               +     D F+ GV L E+I  R P  +    VE+
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 92/190 (48%), Gaps = 7/190 (3%)
Query: 52  LGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLVGYY 109
           +G+G FG V  G L  +   VA+K  +       + +F  E  I+ +  H ++V L+G  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
           T      +V E V        L  +G   +   T L++   +A G+ YL   C    IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHR 237
Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT-FGYLAPEYASSGKLTEKSD 228
           D+ A N L+  K   K++DFG+++  +D     S  +      + APE  + G+ + +SD
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 229 VFSFGVMLLE 238
           V+SFG++L E
Sbjct: 298 VWSFGILLWE 307

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 14/207 (6%)
Query: 46  FSDANLLGQGGFG---YVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVE--IISRVHH 99
           F    +LGQG FG    V +   P+ G   A+K LK  + +     + ++E  I++ V+H
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS-AKGLAYL 158
             +V L   +    +  L+ +F+    L   L    +  M     +K  L   A GL +L
Sbjct: 90  PFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALGLDHL 146
Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           H      II+RD+K  NILLD +   K+ DFGL+K A D +   +    GT  Y+APE  
Sbjct: 147 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAID-HEKKAYSFCGTVEYMAPEVV 202
Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
           +    +  +D +S+GV++ E++TG  P
Sbjct: 203 NRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 32/225 (14%)
Query: 44  DGFSDANLLGQGGFGYV--------HRGVLPNGKEVAIKQLKAGSGQGE-REFQAEVEII 94
           D  +    LG+G FG V         +        VA+K LK  + + +  +  +E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 95  SRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW---LTRL----- 145
             +  HK++++L+G  T      ++ E+     L  +L  +  P M++   + R+     
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 146 ------KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
                       A+G+ YL      K IHRD+ A N+L+      ++ADFGLA+  ++++
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 200 THVST---RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            +  T   R+     ++APE       T +SDV+SFGV++ E+ T
Sbjct: 212 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 32/225 (14%)
Query: 44  DGFSDANLLGQGGFGYV--------HRGVLPNGKEVAIKQLKAGSGQGE-REFQAEVEII 94
           D  +    LG+G FG V         +        VA+K LK  + + +  +  +E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 95  SRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW---LTRL----- 145
             +  HK+++ L+G  T      ++ E+     L  +L  +  P M++   + R+     
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 146 ------KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
                       A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+  ++++
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 200 THVST---RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            +  T   R+     ++APE       T +SDV+SFGV++ E+ T
Sbjct: 212 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 46  FSDANLLGQGGFGYVHRGVLPNGKEV----AIKQLKAGSGQGEREFQAEVE--IISRVHH 99
           F    +LGQG FG V      +G +     A+K LK  + +     + ++E  I+  V+H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----WLTRLKIALGSAKGL 155
             +V L   +    +  L+ +F+    L   L  +   T +    +L  L +AL     L
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
                     II+RD+K  NILLD +   K+ DFGL+K + D +   +    GT  Y+AP
Sbjct: 146 G---------IIYRDLKPENILLDEEGHIKLTDFGLSKESID-HEKKAYSFCGTVEYMAP 195
Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           E  +    T+ +D +SFGV++ E++TG  P
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 46  FSDANLLGQGGFGYVHRGVLPNGKEV----AIKQLKAGSGQGEREFQAEVE--IISRVHH 99
           F    +LGQG FG V      +G +     A+K LK  + +     + ++E  I+  V+H
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 86
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD----WLTRLKIALGSAKGL 155
             +V L   +    +  L+ +F+    L   L  +   T +    +L  L +AL     L
Sbjct: 87  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 146
Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
                     II+RD+K  NILLD +   K+ DFGL+K + D +   +    GT  Y+AP
Sbjct: 147 G---------IIYRDLKPENILLDEEGHIKLTDFGLSKESID-HEKKAYSFCGTVEYMAP 196
Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           E  +    T+ +D +SFGV++ E++TG  P
Sbjct: 197 EVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 52  LGQGGFGYVH--RGVLPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           +G+G F  V   R +L  GKEVA+K     QL + S Q   +   EV I+  ++H ++V 
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVLNHPNIVK 77
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L           LV E+     +  +L   GR       + K A    + +    + CH 
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGR------MKEKEARAKFRQIVSAVQYCHQ 131
Query: 165 K-IIHRDIKAANILLDFKFEAKVADFGLAK---IASDVNTHVSTRVMGTFGYLAPEYASS 220
           K I+HRD+KA N+LLD     K+ADFG +      + ++T       G+  Y APE    
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC-----GSPPYAAPELFQG 186
Query: 221 GKLT-EKSDVFSFGVMLLELITGRRPVD 247
            K    + DV+S GV+L  L++G  P D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 52  LGQGGFGYVH--RGVLPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           +G+G F  V   R +L  GKEVA+K     QL + S Q   +   EV I+  ++H ++V 
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVLNHPNIVK 77
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L           LV E+     +  +L   GR       + K A    + +    + CH 
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGR------MKEKEARAKFRQIVSAVQYCHQ 131
Query: 165 K-IIHRDIKAANILLDFKFEAKVADFGLAK---IASDVNTHVSTRVMGTFGYLAPEYASS 220
           K I+HRD+KA N+LLD     K+ADFG +      + ++T       G+  Y APE    
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC-----GSPPYAAPELFQG 186
Query: 221 GKLT-EKSDVFSFGVMLLELITGRRPVD 247
            K    + DV+S GV+L  L++G  P D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 44  DGFSDANLLGQGGFGYV--------HRGVLPNGKEVAIKQLKAGSGQGE-REFQAEVEII 94
           D  +    LG+G FG V         +        VA+K LK  + + +  +  +E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 95  SRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD------------- 140
             +  HK++++L+G  T      ++ E+     L  +L  +  P M+             
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 141 -WLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +   +      A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+  ++++
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 200 -THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
               +T       ++APE       T +SDV+SFGV++ E+ T
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++  G     RE Q    I+ ++ H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ----IMRKLDHCNIV 76
Query: 104 SL-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++      LV ++VP        H  + + T+  +          + LA
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAP 191
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           E    +   T   DV+S G +L EL+ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++  G     RE Q    I+ ++ H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ----IMRKLDHCNIV 76
Query: 104 SL-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++      LV ++VP        H  + + T+  +          + LA
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAP 191
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           E    +   T   DV+S G +L EL+ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 20/218 (9%)
Query: 41  RATDGFSDANLLGQGGFGYVHRGVLPNGKEV-----AIKQLKAGSGQGEREFQAEVEIIS 95
           R    +     LG+GGF   +     + KEV       K +     Q E+    E+ I  
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHK 97
Query: 96  RVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL-EFHLHGKG--RPTMDWLTRLKIALGSA 152
            + + H+V   G++       +V E     +L E H   K    P   +  R  I     
Sbjct: 98  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI----- 152
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVMGTFG 211
           +G+ YLH +   ++IHRD+K  N+ L+   + K+ DFGLA KI  D        + GT  
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPN 207
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST 249
           Y+APE       + + D++S G +L  L+ G+ P +++
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 20/218 (9%)
Query: 41  RATDGFSDANLLGQGGFGYVHRGVLPNGKEV-----AIKQLKAGSGQGEREFQAEVEIIS 95
           R    +     LG+GGF   +     + KEV       K +     Q E+    E+ I  
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHK 97
Query: 96  RVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL-EFHLHGKG--RPTMDWLTRLKIALGSA 152
            + + H+V   G++       +V E     +L E H   K    P   +  R  I     
Sbjct: 98  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI----- 152
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVMGTFG 211
           +G+ YLH +   ++IHRD+K  N+ L+   + K+ DFGLA KI  D     +  + GT  
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPN 207
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST 249
           Y+APE       + + D++S G +L  L+ G+ P +++
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++  G     RE Q    I+ ++ H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ----IMRKLDHCNIV 76
Query: 104 SL-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++      LV ++VP        H  + + T+  +          + LA
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAP 191
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           E    +   T   DV+S G +L EL+ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 20/218 (9%)
Query: 41  RATDGFSDANLLGQGGFGYVHRGVLPNGKEV-----AIKQLKAGSGQGEREFQAEVEIIS 95
           R    +     LG+GGF   +     + KEV       K +     Q E+    E+ I  
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHK 81
Query: 96  RVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL-EFHLHGKG--RPTMDWLTRLKIALGSA 152
            + + H+V   G++       +V E     +L E H   K    P   +  R  I     
Sbjct: 82  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI----- 136
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVMGTFG 211
           +G+ YLH +   ++IHRD+K  N+ L+   + K+ DFGLA KI  D        + GT  
Sbjct: 137 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPN 191
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST 249
           Y+APE       + + D++S G +L  L+ G+ P +++
Sbjct: 192 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 105/225 (46%), Gaps = 32/225 (14%)
Query: 44  DGFSDANLLGQGGFGYV--------HRGVLPNGKEVAIKQLKAGSGQGE-REFQAEVEII 94
           D  +    LG+G FG V         +        VA+K LK  + + +  +  +E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 95  SRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW---LTRL----- 145
             +  HK++++L+G  T      ++  +     L  +L  +  P M++   + R+     
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 146 ------KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
                       A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+  ++++
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 200 THVST---RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            +  T   R+     ++APE       T +SDV+SFGV++ E+ T
Sbjct: 212 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 29/209 (13%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G+G FG V RG    G+EVA+K     S + ER +  E EI   V  +H  +++G+  A
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRH-ENILGFIAA 104
Query: 112 -------GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC-- 162
                   +Q  LV ++  + +L  +L+   R T+     +K+AL +A GLA+LH +   
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 163 ---HPKIIHRDIKAANILLDFKFEAKVADFGLA---KIASDVNTHVSTRVMGTFGYLAPE 216
               P I HRD+K+ NIL+       +AD GLA     A+D         +GT  Y+APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 217 YASSG------KLTEKSDVFSFGVMLLEL 239
                      +  +++D+++ G++  E+
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 52  LGQGGFGYVH--RGVLPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           +G+G F  V   R +L  GKEVA++     QL + S Q   +   EV I+  ++H ++V 
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVRIIDKTQLNSSSLQ---KLFREVRIMKVLNHPNIVK 77
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L           LV E+     +  +L   GR       + K A    + +    + CH 
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGR------MKEKEARAKFRQIVSAVQYCHQ 131
Query: 165 K-IIHRDIKAANILLDFKFEAKVADFGLAK---IASDVNTHVSTRVMGTFGYLAPEYASS 220
           K I+HRD+KA N+LLD     K+ADFG +      + ++T       G+  Y APE    
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC-----GSPPYAAPELFQG 186
Query: 221 GKLT-EKSDVFSFGVMLLELITGRRPVD 247
            K    + DV+S GV+L  L++G  P D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 20/218 (9%)
Query: 41  RATDGFSDANLLGQGGFGYVHRGVLPNGKEV-----AIKQLKAGSGQGEREFQAEVEIIS 95
           R    +     LG+GGF   +     + KEV       K +     Q E+    E+ I  
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHK 97
Query: 96  RVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL-EFHLHGKG--RPTMDWLTRLKIALGSA 152
            + + H+V   G++       +V E     +L E H   K    P   +  R  I     
Sbjct: 98  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI----- 152
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVMGTFG 211
           +G+ YLH +   ++IHRD+K  N+ L+   + K+ DFGLA KI  D        + GT  
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPN 207
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST 249
           Y+APE       + + D++S G +L  L+ G+ P +++
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 52  LGQGGFGYVH--RGVLPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           +G+G F  V   R +L  GKEVA+K     QL + S Q   +   EV I+  ++H ++V 
Sbjct: 15  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVLNHPNIVK 70
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L           LV E+     +  +L   G     W+   K A    + +    + CH 
Sbjct: 71  LFEVIETEKTLYLVMEYASGGEVFDYLVAHG-----WMKE-KEARAKFRQIVSAVQYCHQ 124
Query: 165 K-IIHRDIKAANILLDFKFEAKVADFGLAK---IASDVNTHVSTRVMGTFGYLAPEYASS 220
           K I+HRD+KA N+LLD     K+ADFG +      + ++T       G+  Y APE    
Sbjct: 125 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC-----GSPPYAAPELFQG 179
Query: 221 GKLT-EKSDVFSFGVMLLELITGRRPVD 247
            K    + DV+S GV+L  L++G  P D
Sbjct: 180 KKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 52  LGQGGFGYVH--RGVLPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           +G+G F  V   R VL  G+EVA+K     QL   S Q   +   EV I+  ++H ++V 
Sbjct: 23  IGKGNFAKVKLARHVL-TGREVAVKIIDKTQLNPTSLQ---KLFREVRIMKILNHPNIVK 78
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L           LV E+     +  +L   GR       + K A    + +    + CH 
Sbjct: 79  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGR------MKEKEARAKFRQIVSAVQYCHQ 132
Query: 165 K-IIHRDIKAANILLDFKFEAKVADFGLAK---IASDVNTHVSTRVMGTFGYLAPEYASS 220
           K I+HRD+KA N+LLD     K+ADFG +    + + ++T       G+  Y APE    
Sbjct: 133 KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC-----GSPPYAAPELFQG 187
Query: 221 GKLT-EKSDVFSFGVMLLELITGRRPVD 247
            K    + DV+S GV+L  L++G  P D
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 29/209 (13%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G+G FG V RG    G+EVA+K     S + ER +  E EI   V  +H  +++G+  A
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRH-ENILGFIAA 71
Query: 112 -------GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC-- 162
                   +Q  LV ++  + +L  +L+   R T+     +K+AL +A GLA+LH +   
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 128
Query: 163 ---HPKIIHRDIKAANILLDFKFEAKVADFGLA---KIASDVNTHVSTRVMGTFGYLAPE 216
               P I HRD+K+ NIL+       +AD GLA     A+D         +GT  Y+APE
Sbjct: 129 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 188
Query: 217 YASSG------KLTEKSDVFSFGVMLLEL 239
                      +  +++D+++ G++  E+
Sbjct: 189 VLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 52  LGQGGFGYVH--RGVLPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           +G+G F  V   R +L  GKEVA++     QL + S Q   +   EV I+  ++H ++V 
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVRIIDKTQLNSSSLQ---KLFREVRIMKVLNHPNIVK 77
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L           LV E+     +  +L   GR       + K A    + +    + CH 
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGR------MKEKEARAKFRQIVSAVQYCHQ 131
Query: 165 K-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
           K I+HRD+KA N+LLD     K+ADFG +   +  N        G+  Y APE     K 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDEFCGSPPYAAPELFQGKKY 189
Query: 224 T-EKSDVFSFGVMLLELITGRRPVD 247
              + DV+S GV+L  L++G  P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 29/209 (13%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G+G FG V RG    G+EVA+K     S + ER +  E EI   V  +H  +++G+  A
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRH-ENILGFIAA 91
Query: 112 -------GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC-- 162
                   +Q  LV ++  + +L  +L+   R T+     +K+AL +A GLA+LH +   
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 148
Query: 163 ---HPKIIHRDIKAANILLDFKFEAKVADFGLA---KIASDVNTHVSTRVMGTFGYLAPE 216
               P I HRD+K+ NIL+       +AD GLA     A+D         +GT  Y+APE
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 208
Query: 217 YASSG------KLTEKSDVFSFGVMLLEL 239
                      +  +++D+++ G++  E+
Sbjct: 209 VLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 52  LGQGGFGYVH--RGVLPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           +G+G F  V   R +L  GKEVA+K     QL + S Q   +   EV I+  ++H ++V 
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVLNHPNIVK 77
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L           LV E+     +  +L   GR       + K A    + +    + CH 
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGR------MKEKEARAKFRQIVSAVQYCHQ 131
Query: 165 K-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
           K I+HRD+KA N+LLD     K+ADFG +   +  N   +    G   Y APE     K 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA--FCGAPPYAAPELFQGKKY 189
Query: 224 T-EKSDVFSFGVMLLELITGRRPVD 247
              + DV+S GV+L  L++G  P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 29/209 (13%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G+G FG V RG    G+EVA+K     S + ER +  E EI   V  +H  +++G+  A
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRH-ENILGFIAA 66
Query: 112 -------GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC-- 162
                   +Q  LV ++  + +L  +L+   R T+     +K+AL +A GLA+LH +   
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 123
Query: 163 ---HPKIIHRDIKAANILLDFKFEAKVADFGLA---KIASDVNTHVSTRVMGTFGYLAPE 216
               P I HRD+K+ NIL+       +AD GLA     A+D         +GT  Y+APE
Sbjct: 124 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 183
Query: 217 YASSG------KLTEKSDVFSFGVMLLEL 239
                      +  +++D+++ G++  E+
Sbjct: 184 VLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 97/202 (48%), Gaps = 25/202 (12%)
Query: 52  LGQGGFGYVHRGVL----PNGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSL 105
           +G+G FG   + +L     +G++  IK++     S +   E + EV +++ + H ++V  
Sbjct: 32  IGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKG------RPTMDWLTRLKIALGSAKGLAYLH 159
              +       +V ++     L   ++ +          +DW  ++ +AL       ++H
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL------KHVH 142
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
           +    KI+HRDIK+ NI L      ++ DFG+A++ +     ++   +GT  YL+PE   
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-TVELARACIGTPYYLSPEICE 198
Query: 220 SGKLTEKSDVFSFGVMLLELIT 241
           +     KSD+++ G +L EL T
Sbjct: 199 NKPYNNKSDIWALGCVLYELCT 220

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE--REFQAEVEIISRVHHKHLVSLVG 107
           +LG+G FG V +       +E A+K +   S + +       EVE++ ++ H +++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
                S   +V E      L   +  + R +     R+   + S  G+ Y+H+     I+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS--GITYMHK---HNIV 143
Query: 168 HRDIKAANILLDFK---FEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
           HRD+K  NILL+ K    + K+ DFGL+      NT +  R+ GT  Y+APE    G   
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRI-GTAYYIAPE-VLRGTYD 200
Query: 225 EKSDVFSFGVMLLELITGRRP 245
           EK DV+S GV+L  L++G  P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 104 SL-VGYYTAGSQRMLVY-----EFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++ +VY     ++VP        H  + + T+  +          + LA
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAP 191
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           E    +   T   DV+S G +L EL+ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 105/225 (46%), Gaps = 32/225 (14%)
Query: 44  DGFSDANLLGQGGFGYV--------HRGVLPNGKEVAIKQLKAGSGQGE-REFQAEVEII 94
           D  +    LG+G FG V         +        VA+K LK  + + +  +  +E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 95  SRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW---LTRL----- 145
             +  HK++++L+G  T      ++  +     L  +L  +  P M++   + R+     
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 146 ------KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
                       A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+  ++++
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 200 THVST---RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            +  T   R+     ++APE       T +SDV+SFGV++ E+ T
Sbjct: 212 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 29/209 (13%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G+G FG V RG    G+EVA+K     S + ER +  E EI   V  +H  +++G+  A
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRH-ENILGFIAA 68
Query: 112 -------GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC-- 162
                   +Q  LV ++  + +L  +L+   R T+     +K+AL +A GLA+LH +   
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 125
Query: 163 ---HPKIIHRDIKAANILLDFKFEAKVADFGLA---KIASDVNTHVSTRVMGTFGYLAPE 216
               P I HRD+K+ NIL+       +AD GLA     A+D         +GT  Y+APE
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 185
Query: 217 YASSG------KLTEKSDVFSFGVMLLEL 239
                      +  +++D+++ G++  E+
Sbjct: 186 VLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 29/209 (13%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G+G FG V RG    G+EVA+K     S + ER +  E EI   V  +H  +++G+  A
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRH-ENILGFIAA 65
Query: 112 -------GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC-- 162
                   +Q  LV ++  + +L  +L+   R T+     +K+AL +A GLA+LH +   
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 163 ---HPKIIHRDIKAANILLDFKFEAKVADFGLA---KIASDVNTHVSTRVMGTFGYLAPE 216
               P I HRD+K+ NIL+       +AD GLA     A+D         +GT  Y+APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 217 YASSG------KLTEKSDVFSFGVMLLEL 239
                      +  +++D+++ G++  E+
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 36/211 (17%)
Query: 53  GQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISR--VHHKHLVSLVGYYT 110
            +G FG V +  L N + VA+K       Q ++ +Q E E+ S   + H++++  +G   
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPI---QDKQSWQNEYEVYSLPGMKHENILQFIGAEK 88
Query: 111 AGS----QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC---- 162
            G+       L+  F    +L   L       + W     IA   A+GLAYLHED     
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 163 ---HPKIIHRDIKAANILLDFKFEAKVADFGLA------KIASDVNTHVSTRVMGTFGYL 213
               P I HRDIK+ N+LL     A +ADFGLA      K A D +  V TR      Y+
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR-----RYM 200
Query: 214 APEYASSGKLTEKS-----DVFSFGVMLLEL 239
           APE        ++      D+++ G++L EL
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 35/221 (15%)
Query: 52  LGQGGFGYVHRGVLPNGK------EVAIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVS 104
           LG+G FG V +    + K       VA+K LK  +   E R+  +E  ++ +V+H H++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLH-----GKG--------------RPTMDWLTR- 144
           L G  +     +L+ E+    +L   L      G G               P    LT  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 145 --LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV 202
             +  A   ++G+ YL E    K++HRD+ A NIL+    + K++DFGL++   + +++V
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 203 STRVMGTF--GYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
             R  G     ++A E       T +SDV+SFGV+L E++T
Sbjct: 208 K-RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 101/220 (45%), Gaps = 37/220 (16%)
Query: 53  GQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISR--VHHKHLVSLVGYYT 110
            +G FG V +  L N   VA+K       Q ++ +Q+E EI S   + H++L+  +    
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPL---QDKQSWQSEREIFSTPGMKHENLLQFIAAEK 79
Query: 111 AGS----QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED---CH 163
            GS    +  L+  F    +L  +L G     + W     +A   ++GL+YLHED   C 
Sbjct: 80  RGSNLEVELWLITAFHDKGSLTDYLKGN---IITWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 164 -----PKIIHRDIKAANILLDFKFEAKVADFGLA------KIASDVNTHVSTRVMGTFGY 212
                P I HRD K+ N+LL     A +ADFGLA      K   D +  V TR      Y
Sbjct: 137 GEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTR-----RY 191
Query: 213 LAPEYASSGKLTEKS-----DVFSFGVMLLELITGRRPVD 247
           +APE        ++      D+++ G++L EL++  +  D
Sbjct: 192 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 25/225 (11%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 110
Query: 104 SL-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++      LV ++VP        H  + + T+  +          + LA
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 171 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAP 225
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
           E    +   T   DV+S G +L EL+ G +P+     F  DS VD
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-----FPGDSGVD 264

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 111/227 (48%), Gaps = 35/227 (15%)
Query: 51  LLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
            +G+G +G V RG    G+ VA+K     S + E+ +  E E+ + V  +H  +++G+  
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRH-ENILGFIA 69
Query: 111 A-------GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC- 162
           +        +Q  L+  +    +L  +L      T+D ++ L+I L  A GLA+LH +  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 163 ----HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST----RVMGTFGYLA 214
                P I HRD+K+ NIL+    +  +AD GLA + S     +      RV GT  Y+A
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMA 185
Query: 215 PEYASSGKLTE------KSDVFSFGVMLLELITGRRPVDSTHTFVED 255
           PE        +      + D+++FG++L E+   RR V  ++  VED
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV--SNGIVED 228

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 52  LGQGGFGYVH--RGVLPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           +G+G F  V   R +L  G+EVAIK     QL   S Q   +   EV I+  ++H ++V 
Sbjct: 20  IGKGNFAKVKLARHIL-TGREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILNHPNIVK 75
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L           L+ E+     +  +L   GR       + K A    + +    + CH 
Sbjct: 76  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGR------MKEKEARSKFRQIVSAVQYCHQ 129
Query: 165 K-IIHRDIKAANILLDFKFEAKVADFGLAK---IASDVNTHVSTRVMGTFGYLAPEYASS 220
           K I+HRD+KA N+LLD     K+ADFG +    +   ++T       G+  Y APE    
Sbjct: 130 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC-----GSPPYAAPELFQG 184
Query: 221 GKLT-EKSDVFSFGVMLLELITGRRPVD 247
            K    + DV+S GV+L  L++G  P D
Sbjct: 185 KKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 111/227 (48%), Gaps = 35/227 (15%)
Query: 51  LLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
            +G+G +G V RG    G+ VA+K     S + E+ +  E E+ + V  +H  +++G+  
Sbjct: 44  CVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRH-ENILGFIA 98
Query: 111 A-------GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC- 162
           +        +Q  L+  +    +L  +L      T+D ++ L+I L  A GLA+LH +  
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIF 155
Query: 163 ----HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST----RVMGTFGYLA 214
                P I HRD+K+ NIL+    +  +AD GLA + S     +      RV GT  Y+A
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMA 214
Query: 215 PEYASSGKLTE------KSDVFSFGVMLLELITGRRPVDSTHTFVED 255
           PE        +      + D+++FG++L E+   RR V  ++  VED
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV--SNGIVED 257

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 25/225 (11%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 110
Query: 104 SL-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++      LV ++VP        H  + + T+  +          + LA
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 171 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAP 225
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
           E    +   T   DV+S G +L EL+ G +P+     F  DS VD
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-----FPGDSGVD 264

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 13/216 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRV 97
           D +    ++G+G F  V R +    G++ A+K     +  +  G    + + E  I   +
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
            H H+V L+  Y++     +V+EF+    L F +    R    ++    +A    + +  
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSEAVASHYMRQILE 141
Query: 158 LHEDCHP-KIIHRDIKAANILLDFK---FEAKVADFGLAKIASDVNTHVSTRVMGTFGYL 213
               CH   IIHRD+K  N+LL  K      K+ DFG+A    +       RV GT  ++
Sbjct: 142 ALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRV-GTPHFM 200
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST 249
           APE        +  DV+  GV+L  L++G  P   T
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 25/224 (11%)
Query: 46  FSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V 
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 113
Query: 105 L-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLAY 157
           L   +Y++G ++      LV ++VP        H  + + T+  +          + LAY
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAPE 216
           +H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y APE
Sbjct: 174 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAPE 228
Query: 217 YA-SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
               +   T   DV+S G +L EL+ G +P+     F  DS VD
Sbjct: 229 LIFGATDYTSSIDVWSAGCVLAELLLG-QPI-----FPGDSGVD 266

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 25/224 (11%)
Query: 46  FSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 115
Query: 105 L-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLAY 157
           L   +Y++G ++      LV ++VP        H  + + T+  +          + LAY
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAPE 216
           +H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y APE
Sbjct: 176 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAPE 230
Query: 217 YA-SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
               +   T   DV+S G +L EL+ G +P+     F  DS VD
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELLLG-QPI-----FPGDSGVD 268

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 111/227 (48%), Gaps = 35/227 (15%)
Query: 51  LLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
            +G+G +G V RG    G+ VA+K     S + E+ +  E E+ + V  +H  +++G+  
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRH-ENILGFIA 69
Query: 111 A-------GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC- 162
           +        +Q  L+  +    +L  +L      T+D ++ L+I L  A GLA+LH +  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 163 ----HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST----RVMGTFGYLA 214
                P I HRD+K+ NIL+    +  +AD GLA + S     +      RV GT  Y+A
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMA 185
Query: 215 PEYASSGKLTE------KSDVFSFGVMLLELITGRRPVDSTHTFVED 255
           PE        +      + D+++FG++L E+   RR V  ++  VED
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV--SNGIVED 228

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 25/224 (11%)
Query: 46  FSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V 
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 156
Query: 105 L-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLAY 157
           L   +Y++G ++      LV ++VP        H  + + T+  +          + LAY
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAPE 216
           +H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y APE
Sbjct: 217 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAPE 271
Query: 217 YA-SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
               +   T   DV+S G +L EL+ G +P+     F  DS VD
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAELLLG-QPI-----FPGDSGVD 309

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 25/225 (11%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 104
Query: 104 SL-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++      LV ++VP        H  + + T+  +          + LA
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 165 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAP 219
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
           E    +   T   DV+S G +L EL+ G +P+     F  DS VD
Sbjct: 220 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-----FPGDSGVD 258

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 84
Query: 104 SL-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++      LV ++VP        H  + + T+  +          + LA
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 145 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAP 199
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           E    +   T   DV+S G +L EL+ G+
Sbjct: 200 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 88
Query: 104 SL-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++      LV ++VP        H  + + T+  +          + LA
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 149 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAP 203
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           E    +   T   DV+S G +L EL+ G+
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 14/206 (6%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE--REFQAEVEIISRVHHKHL 102
           ++   +LG+G FG V +       +E A+K +   S + +       EVE++ ++ H ++
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           + L       S   +V E      L   +  + R +     R+   + S  G+ Y+H+  
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS--GITYMHKH- 140
Query: 163 HPKIIHRDIKAANILLDFK---FEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
              I+HRD+K  NILL+ K    + K+ DFGL+      NT +  R+ GT  Y+APE   
Sbjct: 141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRI-GTAYYIAPE-VL 195
Query: 220 SGKLTEKSDVFSFGVMLLELITGRRP 245
            G   EK DV+S GV+L  L++G  P
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 52  LGQGGFGYVHR-GVLPNGKEVAIKQLKAGS-GQGERE-FQAEVEIISRVHHKHLVSLVGY 108
           +G G +G   +     +GK +  K+L  GS  + E++   +EV ++  + H ++V    Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR---Y 70
Query: 109 YTAGSQRM-----LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           Y     R      +V E+     L   +  KG     +L   +  L     L    ++CH
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLA-SVITKGTKERQYLDE-EFVLRVMTQLTLALKECH 128
Query: 164 PK------IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
            +      ++HRD+K AN+ LD K   K+ DFGLA+I +  +T  +   +GT  Y++PE 
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKTFVGTPYYMSPEQ 187
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRP 245
            +     EKSD++S G +L EL     P
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 106/209 (50%), Gaps = 14/209 (6%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAG-SGQGEREFQAEVEIISR-VHHKHLVSLVGY 108
           LG+G +G V +   +P+G+ +A+K+++A  + Q ++    +++I  R V     V+  G 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 109 YTAGSQRMLVYEFVPNNTLEFH--LHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
                   +  E +  +  +F+  +  KG+ T+      KIA+   K L +LH      +
Sbjct: 119 LFREGDVWICMELMDTSLDKFYKQVIDKGQ-TIPEDILGKIAVSIVKALEHLHSKLS--V 175
Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA----SSGK 222
           IHRD+K +N+L++   + K+ DFG++     V++   T   G   Y+APE      +   
Sbjct: 176 IHRDVKPSNVLINALGQVKMCDFGISGYL--VDSVAKTIDAGCKPYMAPERINPELNQKG 233
Query: 223 LTEKSDVFSFGVMLLELITGRRPVDSTHT 251
            + KSD++S G+ ++EL   R P DS  T
Sbjct: 234 YSVKSDIWSLGITMIELAILRFPYDSWGT 262

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 14/206 (6%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE--REFQAEVEIISRVHHKHL 102
           ++   +LG+G FG V +       +E A+K +   S + +       EVE++ ++ H ++
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           + L       S   +V E      L   +  + R +     R+   + S  G+ Y+H+  
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS--GITYMHKH- 140
Query: 163 HPKIIHRDIKAANILLDFK---FEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
              I+HRD+K  NILL+ K    + K+ DFGL+      NT +  R+ GT  Y+APE   
Sbjct: 141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRI-GTAYYIAPE-VL 195
Query: 220 SGKLTEKSDVFSFGVMLLELITGRRP 245
            G   EK DV+S GV+L  L++G  P
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 95
Query: 104 SL-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++      LV ++VP        H  + + T+  +          + LA
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 156 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAP 210
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           E    +   T   DV+S G +L EL+ G+
Sbjct: 211 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 88
Query: 104 SL-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++      LV ++VP        H  + + T+  +          + LA
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 149 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAP 203
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           E    +   T   DV+S G +L EL+ G+
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 52  LGQGGFGYVHR-GVLPNGKEVAIKQLKAGS-GQGERE-FQAEVEIISRVHHKHLVSLVGY 108
           +G G +G   +     +GK +  K+L  GS  + E++   +EV ++  + H ++V    Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR---Y 70
Query: 109 YTAGSQRM-----LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           Y     R      +V E+     L   +  KG     +L   +  L     L    ++CH
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLA-SVITKGTKERQYLDE-EFVLRVMTQLTLALKECH 128
Query: 164 PK------IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
            +      ++HRD+K AN+ LD K   K+ DFGLA+I +  +T  +   +GT  Y++PE 
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYYMSPEQ 187
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRP 245
            +     EKSD++S G +L EL     P
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 25/225 (11%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 81
Query: 104 SL-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++      LV ++VP        H  + + T+  +          + LA
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 141
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 142 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAP 196
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
           E    +   T   DV+S G +L EL+ G +P+     F  DS VD
Sbjct: 197 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-----FPGDSGVD 235

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 80
Query: 104 SL-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++      LV ++VP        H  + + T+  +          + LA
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 141 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAP 195
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           E    +   T   DV+S G +L EL+ G+
Sbjct: 196 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 46  FSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHK 100
           +++ + +G+G +G V   +  V  N   VAIK++     Q   +R  + E++I+ R  H+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 81
Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +++ +     A +   +   ++  + +E   + L      + D +      +   +GL Y
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKY 139
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAP 215
           +H      ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y AP
Sbjct: 140 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 216 EYASSGK-LTEKSDVFSFGVMLLELITGR 243
           E   + K  T+  D++S G +L E+++ R
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 35/221 (15%)
Query: 52  LGQGGFGYVHRGVLPNGK------EVAIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVS 104
           LG+G FG V +    + K       VA+K LK  +   E R+  +E  ++ +V+H H++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLH-----GKG--------------RPTMDWLTR- 144
           L G  +     +L+ E+    +L   L      G G               P    LT  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 145 --LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV 202
             +  A   ++G+ YL E    K++HRD+ A NIL+    + K++DFGL++   + ++ V
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 203 STRVMGTF--GYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
             R  G     ++A E       T +SDV+SFGV+L E++T
Sbjct: 208 K-RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 46  FSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHK 100
           +++ + +G+G +G V   +  V  N   VAIK++     Q   +R  + E++I+ R  H+
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 89
Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +++ +     A +   +   ++  + +E   + L      + D +      +   +GL Y
Sbjct: 90  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKY 147
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAP 215
           +H      ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y AP
Sbjct: 148 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 204
Query: 216 EYASSGK-LTEKSDVFSFGVMLLELITGR 243
           E   + K  T+  D++S G +L E+++ R
Sbjct: 205 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 46  FSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHK 100
           +++ + +G+G +G V   +  V  N   VAIK++     Q   +R  + E++I+ R  H+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 81
Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +++ +     A +   +   ++  + +E   + L      + D +      +   +GL Y
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKY 139
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAP 215
           +H      ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y AP
Sbjct: 140 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 216 EYASSGK-LTEKSDVFSFGVMLLELITGR 243
           E   + K  T+  D++S G +L E+++ R
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 104 SL-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++      LV ++VP        H  + + T+  +          + LA
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAP 191
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           E    +   T   DV+S G +L EL+ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 46  FSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHK 100
           +++ + +G+G +G V   +  V  N   VAIK++     Q   +R  + E++I+ R  H+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 83
Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +++ +     A +   +   ++  + +E   + L      + D +      +   +GL Y
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKY 141
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAP 215
           +H      ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y AP
Sbjct: 142 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 216 EYASSGK-LTEKSDVFSFGVMLLELITGR 243
           E   + K  T+  D++S G +L E+++ R
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAG-SGQGEREFQAEVEIISR-VHHKHLVSLVGY 108
           LG+G +G V +   +P+G+ +A+K+++A  + Q ++    +++I  R V     V+  G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 109 YTAGSQRMLVYEFVPNNTLEFH--LHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
                   +  E +  +  +F+  +  KG+ T+      KIA+   K L +LH      +
Sbjct: 75  LFREGDVWICMELMDTSLDKFYKQVIDKGQ-TIPEDILGKIAVSIVKALEHLHSKL--SV 131
Query: 167 IHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVMGTFGYLAPEYA----SSG 221
           IHRD+K +N+L++   + K+ DFG++  +  DV   +     G   Y+APE      +  
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPERINPELNQK 188
Query: 222 KLTEKSDVFSFGVMLLELITGRRPVDSTHT 251
             + KSD++S G+ ++EL   R P DS  T
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGT 218

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 89
Query: 104 SL-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++      LV ++VP        H  + + T+  +          + LA
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 150 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAP 204
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           E    +   T   DV+S G +L EL+ G+
Sbjct: 205 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 127
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 15/215 (6%)
Query: 38  ELARATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQLKAGSGQGEREFQA---EVEI 93
           ++    + F    +LG+G FG V         +  AIK LK      + + +    E  +
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 94  ISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA 152
           +S    H  L  +   +        V E++    L +H+    +  +   T    A    
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--YAAEII 129
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTF 210
            GL +LH      I++RD+K  NILLD     K+ADFG+ K  +  D  T+      GT 
Sbjct: 130 LGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN---EFCGTP 183
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
            Y+APE     K     D +SFGV+L E++ G+ P
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 104 SL-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++      LV ++VP        H  + + T+  +          + LA
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAP 191
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           E    +   T   DV+S G +L EL+ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 46  FSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHK 100
           +++ + +G+G +G V   +  V  N   VAIK++     Q   +R  + E++I+ R  H+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 81
Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +++ +     A +   +   ++  + +E   + L      + D +      +   +GL Y
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKY 139
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAP 215
           +H      ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y AP
Sbjct: 140 IHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 216 EYASSGK-LTEKSDVFSFGVMLLELITGR 243
           E   + K  T+  D++S G +L E+++ R
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 77
Query: 104 SL-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++      LV ++VP        H  + + T+  +          + LA
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 138 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYYRAP 192
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           E    +   T   DV+S G +L EL+ G+
Sbjct: 193 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 46  FSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHK 100
           +++ + +G+G +G V   +  V  N   VAIK++     Q   +R  + E++I+ R  H+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 101
Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +++ +     A +   +   ++  + +E   + L      + D +      +   +GL Y
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKY 159
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAP 215
           +H      ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y AP
Sbjct: 160 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 216 EYASSGK-LTEKSDVFSFGVMLLELITGR 243
           E   + K  T+  D++S G +L E+++ R
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHL 102
           +++ + +G+G +G V       N   VAIK++     Q   +R  + E++I+ R  H+++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRP---TMDWLTRLKIALGSAKGLAYLH 159
           + +     A +   +   ++  + +E  L+   +    + D +      +   +GL Y+H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQI--LRGLKYIH 145
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAPEY 217
                 ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y APE 
Sbjct: 146 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 218 ASSGK-LTEKSDVFSFGVMLLELITGR 243
             + K  T+  D++S G +L E+++ R
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I + ++H+++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 128
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 46  FSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHK 100
           +++ + +G+G +G V   +  V  N   VAIK++     Q   +R  + E++I+ R  H+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 81
Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +++ +     A +   +   ++  + +E   + L      + D +      +   +GL Y
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKY 139
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAP 215
           +H      ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y AP
Sbjct: 140 IHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 216 EYASSGK-LTEKSDVFSFGVMLLELITGR 243
           E   + K  T+  D++S G +L E+++ R
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHL 102
           +++ + +G+G +G V       N   VAIK++     Q   +R  + E++I+ R  H+++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 81
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
           + +     A +   +   ++  + +E   + L      + D +      +   +GL Y+H
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKYIH 139
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAPEY 217
                 ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y APE 
Sbjct: 140 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 218 ASSGK-LTEKSDVFSFGVMLLELITGR 243
             + K  T+  D++S G +L E+++ R
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHL 102
           +++ + +G+G +G V       N   VAIK++     Q   +R  + E++I+ R  H+++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 81
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
           + +     A +   +   ++  + +E   + L      + D +      +   +GL Y+H
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKYIH 139
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAPEY 217
                 ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y APE 
Sbjct: 140 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 218 ASSGK-LTEKSDVFSFGVMLLELITGR 243
             + K  T+  D++S G +L E+++ R
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------L 114
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V     T  + T  Y
Sbjct: 115 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWY 170
Query: 213 LAPEYASSGKLTEKS-DVFSFGVMLLELITGR 243
            APE     K    + D++S G +  E++T R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 52  LGQGGFGYVH--RGVLPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           +G+G F  V   R +L  GKEVA+K     QL + S Q   +   EV I   ++H ++V 
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQ---KLFREVRIXKVLNHPNIVK 77
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L           LV E+     +  +L   GR       + K A    + +    + CH 
Sbjct: 78  LFEVIETEKTLYLVXEYASGGEVFDYLVAHGR------XKEKEARAKFRQIVSAVQYCHQ 131
Query: 165 K-IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
           K I+HRD+KA N+LLD     K+ADFG +   +  N   +    G   Y APE     K 
Sbjct: 132 KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA--FCGAPPYAAPELFQGKKY 189
Query: 224 T-EKSDVFSFGVMLLELITGRRPVD 247
              + DV+S GV+L  L++G  P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHL 102
           +++ + +G+G +G V       N   VAIK++     Q   +R  + E++I+ R  H+++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 88
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
           + +     A +   +   ++  + +E   + L      + D +      +   +GL Y+H
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKYIH 146
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAPEY 217
                 ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y APE 
Sbjct: 147 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 203
Query: 218 ASSGK-LTEKSDVFSFGVMLLELITGR 243
             + K  T+  D++S G +L E+++ R
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHL 102
           +++ + +G+G +G V       N   VAIK++     Q   +R  + E++I+ R  H+++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 89
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
           + +     A +   +   ++  + +E   + L      + D +      +   +GL Y+H
Sbjct: 90  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKYIH 147
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAPEY 217
                 ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y APE 
Sbjct: 148 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 204
Query: 218 ASSGK-LTEKSDVFSFGVMLLELITGR 243
             + K  T+  D++S G +L E+++ R
Sbjct: 205 MLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHL 102
           +++ + +G+G +G V       N   VAIK++     Q   +R  + E++I+ R  H+++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 80
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
           + +     A +   +   ++  + +E   + L      + D +      +   +GL Y+H
Sbjct: 81  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKYIH 138
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAPEY 217
                 ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y APE 
Sbjct: 139 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 195
Query: 218 ASSGK-LTEKSDVFSFGVMLLELITGR 243
             + K  T+  D++S G +L E+++ R
Sbjct: 196 MLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHL 102
           +++ + +G+G +G V       N   VAIK++     Q   +R  + E++I+ R  H+++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
           + +     A +   +   ++  + +E   + L      + D +      +   +GL Y+H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKYIH 145
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAPEY 217
                 ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y APE 
Sbjct: 146 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 218 ASSGK-LTEKSDVFSFGVMLLELITGR 243
             + K  T+  D++S G +L E+++ R
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 128
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 227 SDVFSFGVMLLELITGRRPVD 247
            DV+S G++L  ++ G  P D
Sbjct: 189 VDVWSCGIVLTAMLAGELPWD 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 127
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 227 SDVFSFGVMLLELITGRRPVD 247
            DV+S G++L  ++ G  P D
Sbjct: 188 VDVWSCGIVLTAMLAGELPWD 208

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 44  DGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHH 99
           + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  ++H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSAKG 154
            ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       +G
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------LQG 114
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V     T  + T  Y A
Sbjct: 115 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 170
Query: 215 PEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           PE     K  +   D++S G +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 45  GFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
            ++D  ++G G FG V++  L + G+ VAIK++     Q +R    E++I+ ++ H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 104 SL-VGYYTAGSQR-----MLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLA 156
            L   +Y++G ++      LV ++VP        H  + + T+  +          + LA
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           Y+H      I HRDIK  N+LLD      K+ DFG AK       +VS   + +  Y AP
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAP 191
Query: 216 EYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           E    +   T   DV+S G +L EL+ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 127
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 44  DGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHH 99
           + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  ++H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSAKG 154
            ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       +G
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------LQG 115
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V     T  + T  Y A
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 171
Query: 215 PEYASSGKLTEKS-DVFSFGVMLLELITGR 243
           PE     K    + D++S G +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 44  DGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHH 99
           + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  ++H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSAKG 154
            ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       +G
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------LQG 114
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V     T  + T  Y A
Sbjct: 115 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 170
Query: 215 PEYASSGKLTEKS-DVFSFGVMLLELITGR 243
           PE     K    + D++S G +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 44  DGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHH 99
           + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  ++H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSAKG 154
            ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       +G
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------LQG 119
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V     T  + T  Y A
Sbjct: 120 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 175
Query: 215 PEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           PE     K  +   D++S G +  E++T R
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 44  DGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHH 99
           + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  ++H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSAKG 154
            ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       +G
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------LQG 122
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V     T  + T  Y A
Sbjct: 123 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 178
Query: 215 PEYASSGKLTEKS-DVFSFGVMLLELITGR 243
           PE     K    + D++S G +  E++T R
Sbjct: 179 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 128
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 128
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 128
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHL 102
           +++ + +G+G +G V       N   VAIK++     Q   +R  + E++I+ R  H+++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
           + +     A +   +   ++  + +E   + L      + D +      +   +GL Y+H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKYIH 145
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAPEY 217
                 ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y APE 
Sbjct: 146 S---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 218 ASSGK-LTEKSDVFSFGVMLLELITGR 243
             + K  T+  D++S G +L E+++ R
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 128
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 188
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 73  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 126
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQ 208

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 44  DGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHH 99
           + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  ++H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSAKG 154
            ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       +G
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------LQG 115
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V     T  + T  Y A
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 171
Query: 215 PEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           PE     K  +   D++S G +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 127
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 19/220 (8%)
Query: 39  LARATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISR 96
           L RA   +     +G+G +G V   R +   G+ VA+K+++  +G+         E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 97  VH-----HKHLVSLVGYYTAG-----SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK 146
            H     H ++V L    T       ++  LV+E V +  L  +L     P +   T   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 147 IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRV 206
           +     +GL +LH     +++HRD+K  NIL+    + K+ADFGLA+I S       T V
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSV 179
Query: 207 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
           + T  Y APE           D++S G +  E+   R+P+
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 14/216 (6%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G FG VHR V    G+    K +       +   + E+ I++++HH  L++L   + 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
              + +L+ EF+    L F         M     +     + +GL ++HE     I+H D
Sbjct: 119 DKYEMVLILEFLSGGEL-FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLD 174
Query: 171 IKAANILLDFK--FEAKVADFGLA-KIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS 227
           IK  NI+ + K     K+ DFGLA K+  D    V+T    T  + APE      +   +
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYT 231
Query: 228 DVFSFGVMLLELITGRRPV---DSTHTFVEDSLVDW 260
           D+++ GV+   L++G  P    D   T       DW
Sbjct: 232 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 267

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 127
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 127
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 128
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 127
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 127
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 44  DGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHH 99
           + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  ++H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSAKG 154
            ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       +G
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------LQG 122
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V     T  + T  Y A
Sbjct: 123 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 178
Query: 215 PEYASSGKLTEKS-DVFSFGVMLLELITGR 243
           PE     K    + D++S G +  E++T R
Sbjct: 179 PEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQG--EREFQAEVEIISRVHHKHL 102
           +++ + +G+G +G V       N   VAIK++     Q   +R  + E++I+ R  H+++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR-EIKILLRFRHENI 87
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
           + +     A +   +   ++  + +E   + L      + D +      +   +GL Y+H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKYIH 145
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAPEY 217
                 ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y APE 
Sbjct: 146 S---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 218 ASSGK-LTEKSDVFSFGVMLLELITGR 243
             + K  T+  D++S G +L E+++ R
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 128
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 44  DGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHH 99
           + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  ++H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSAKG 154
            ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       +G
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------LQG 115
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V     T  + T  Y A
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 171
Query: 215 PEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           PE     K  +   D++S G +  E++T R
Sbjct: 172 PEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 16/206 (7%)
Query: 46  FSDANLLGQGGFG--YVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
           F    +LG G F   ++ +  L  GK  A+K +K      +   + E+ ++ ++ H+++V
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPT-MDWLTRLKIALGSAKGLAYLHEDC 162
           +L   Y + +   LV + V    L   +  +G  T  D    ++  L + K   YLHE+ 
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVK---YLHEN- 125
Query: 163 HPKIIHRDIKAANILL---DFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
              I+HRD+K  N+L    +   +  + DFGL+K+  +    + +   GT GY+APE  +
Sbjct: 126 --GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMSTACGTPGYVAPEVLA 180
Query: 220 SGKLTEKSDVFSFGVMLLELITGRRP 245
               ++  D +S GV+   L+ G  P
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 102/207 (49%), Gaps = 15/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVLPNGK-EVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHL 102
           ++    +G+G +G V        K  VAIK++     Q   +R  + E++I+ R  H+++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHENV 103
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
           + +     A +   +   ++  + +E   + L    + + D +      +   +GL Y+H
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQI--LRGLKYIH 161
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAPEY 217
                 ++HRD+K +N+L++   + K+ DFGLA+IA   + H    T  + T  Y APE 
Sbjct: 162 S---ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI 218
Query: 218 ASSGK-LTEKSDVFSFGVMLLELITGR 243
             + K  T+  D++S G +L E+++ R
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 127
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 127
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G +G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 127
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 89/211 (42%), Gaps = 25/211 (11%)
Query: 52  LGQGGFGYVHRGVLPNG-KEVAIKQLKAGSGQGER-------------EFQAEVEIISRV 97
           LG G +G V      NG  E AIK +K       R             E   E+ ++  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
            H +++ L   +       LV EF     L   +    R   D      I      G+ Y
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICY 161
Query: 158 LHEDCHPKIIHRDIKAANILLDFK---FEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LH+     I+HRDIK  NILL+ K      K+ DFGL+   S  +  +  R +GT  Y+A
Sbjct: 162 LHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK-DYKLRDR-LGTAYYIA 216
Query: 215 PEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           PE     K  EK DV+S GV++  L+ G  P
Sbjct: 217 PEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 15/215 (6%)
Query: 38  ELARATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQLKAGSGQGEREFQA---EVEI 93
           ++    + F    +LG+G FG V         +  AIK LK      + + +    E  +
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 94  ISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA 152
           +S    H  L  +   +        V E++    L +H+    +  +   T    A    
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--YAAEII 128
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTF 210
            GL +LH      I++RD+K  NILLD     K+ADFG+ K  +  D  T+      GT 
Sbjct: 129 LGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC---GTP 182
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
            Y+APE     K     D +SFGV+L E++ G+ P
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 46  FSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHK 100
           +++ + +G+G +G V   +  V  N   VAIK++     Q   +R  + E++I+ R  H+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 81
Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRP---TMDWLTRLKIALGSAKGLAY 157
           +++ +     A +   +   ++  + +E  L+   +    + D +      +   +GL Y
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKY 139
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAP 215
           +H      ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y AP
Sbjct: 140 IHS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 216 EYASSGK-LTEKSDVFSFGVMLLELITGR 243
           E   + K  T+  D++S G +L E+++ R
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHL 102
           +++ + +G+G +G V       N   VAI+++     Q   +R  + E++I+ R  H+++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
           + +     A +   +   ++  + +E   + L      + D +      +   +GL Y+H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKYIH 145
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAPEY 217
                 ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y APE 
Sbjct: 146 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 218 ASSGK-LTEKSDVFSFGVMLLELITGR 243
             + K  T+  D++S G +L E+++ R
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 44  DGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQL---KAGSGQGEREFQAEVEIISRVHH 99
           D F     +G+G FG V      + K++ A+K +   K       R    E++I+  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHL----HGKGRPTMDWLTRLKIALGSAKGL 155
             LV+L   +       +V + +    L +HL    H K      ++  L +AL      
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD----- 129
Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
            YL      +IIHRD+K  NILLD      + DF +A +     T ++T + GT  Y+AP
Sbjct: 130 -YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-ETQITT-MAGTKPYMAP 183
Query: 216 EYASSGK---LTEKSDVFSFGVMLLELITGRRP 245
           E  SS K    +   D +S GV   EL+ GRRP
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 19/220 (8%)
Query: 39  LARATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISR 96
           L RA   +     +G+G +G V   R +   G+ VA+K+++  +G+         E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 97  VH-----HKHLVSLVGYYTAG-----SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK 146
            H     H ++V L    T       ++  LV+E V +  L  +L     P +   T   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 147 IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRV 206
           +     +GL +LH     +++HRD+K  NIL+    + K+ADFGLA+I S       T V
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSV 179
Query: 207 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
           + T  Y APE           D++S G +  E+   R+P+
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 19/220 (8%)
Query: 39  LARATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISR 96
           L RA   +     +G+G +G V   R +   G+ VA+K+++  +G+         E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 97  VH-----HKHLVSLVGYYTAG-----SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK 146
            H     H ++V L    T       ++  LV+E V +  L  +L     P +   T   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 147 IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRV 206
           +     +GL +LH     +++HRD+K  NIL+    + K+ADFGLA+I S       T V
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSV 179
Query: 207 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
           + T  Y APE           D++S G +  E+   R+P+
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 52  LGQGGFGYVHR-GVLPNGKEVAIKQLKAGS-GQGERE-FQAEVEIISRVHHKHLVSLVGY 108
           +G G +G   +     +GK +  K+L  GS  + E++   +EV ++  + H ++V    Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR---Y 70
Query: 109 YTAGSQRM-----LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           Y     R      +V E+     L   +  KG     +L   +  L     L    ++CH
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLA-SVITKGTKERQYLDE-EFVLRVMTQLTLALKECH 128
Query: 164 PK------IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
            +      ++HRD+K AN+ LD K   K+ DFGLA+I +  +   +   +GT  Y++PE 
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DEDFAKEFVGTPYYMSPEQ 187
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRP 245
            +     EKSD++S G +L EL     P
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQA--EVEIISRVH 98
           AT  +     +G G +G V++   P +G  VA+K ++  +G+         EV ++ R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 99  ---HKHLVSLVGYY-TAGSQR----MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
              H ++V L+    T+ + R     LV+E V +  L  +L     P +   T   +   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
             +GL +LH +C   I+HRD+K  NIL+      K+ADFGLA+I S         V+ T 
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALAPVVVTL 175
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
            Y APE           D++S G +  E+   R+P+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 11/198 (5%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G FG VHR      G   A K +       +   + E++ +S + H  LV+L   + 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
             ++ +++YEF+    L F         M     ++      KGL ++HE+ +   +H D
Sbjct: 119 DDNEMVMIYEFMSGGEL-FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY---VHLD 174
Query: 171 IKAANILLDFKF--EAKVADFGL-AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS 227
           +K  NI+   K   E K+ DFGL A +    +  V+T   GT  + APE A    +   +
Sbjct: 175 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYT 231
Query: 228 DVFSFGVMLLELITGRRP 245
           D++S GV+   L++G  P
Sbjct: 232 DMWSVGVLSYILLSGLSP 249

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 44  DGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHH 99
           + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  ++H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSAKG 154
            ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       +G
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------LQG 115
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           L++ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V     T  + T  Y A
Sbjct: 116 LSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 171
Query: 215 PEYASSGKLTEKS-DVFSFGVMLLELITGR 243
           PE     K    + D++S G +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQA--EVEIISRVH 98
           AT  +     +G G +G V++   P +G  VA+K ++  +G+         EV ++ R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 99  ---HKHLVSLVGYY-TAGSQR----MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
              H ++V L+    T+ + R     LV+E V +  L  +L     P +   T   +   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
             +GL +LH +C   I+HRD+K  NIL+      K+ADFGLA+I S         V+ T 
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALDPVVVTL 175
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
            Y APE           D++S G +  E+   R+P+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 52  LGQGGFGYVH--RGVLPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           +G+G F  V   R +L  G+EVAIK     QL   S Q   +   EV I+  ++H ++V 
Sbjct: 23  IGKGNFAKVKLARHIL-TGREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILNHPNIVK 78
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L           L+ E+     +  +L   GR       + K A    + +    + CH 
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGR------MKEKEARSKFRQIVSAVQYCHQ 132
Query: 165 K-IIHRDIKAANILLDFKFEAKVADFGLAK---IASDVNTHVSTRVMGTFGYLAPEYASS 220
           K I+HRD+KA N+LLD     K+ADFG +    +   ++        G   Y APE    
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-----GAPPYAAPELFQG 187
Query: 221 GKLT-EKSDVFSFGVMLLELITGRRPVD 247
            K    + DV+S GV+L  L++G  P D
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-HKHLVSLVGY 108
           +L +GGF +V+    + +G+E A+K+L +   +  R    EV  + ++  H ++V     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 109 YTAGSQR--------MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHE 160
            + G +         +L+ E      +EF    + R  +   T LKI   + + + ++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 161 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS---DVNTHVSTRVM--------GT 209
              P IIHRD+K  N+LL  +   K+ DFG A   S   D +     R +         T
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 210 FGYLAPEYA---SSGKLTEKSDVFSFGVMLLELITGRRPVD 247
             Y  PE     S+  + EK D+++ G +L  L   + P +
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 27/213 (12%)
Query: 44  DGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHH 99
           + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  ++H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW--LTRLKIALGSA----- 152
            ++V L+      ++  LV+E         H+H   +  MD   LT + + L  +     
Sbjct: 61  PNIVKLLDVIHTENKLYLVFE---------HVHQDLKTFMDASALTGIPLPLIKSYLFQL 111
Query: 153 -KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
            +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V     T  + T  
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLW 167
Query: 212 YLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           Y APE     K  +   D++S G +  E++T R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 11/198 (5%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G FG VHR      G   A K +       +   + E++ +S + H  LV+L   + 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
             ++ +++YEF+    L F         M     ++      KGL ++HE+ +   +H D
Sbjct: 225 DDNEMVMIYEFMSGGEL-FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY---VHLD 280
Query: 171 IKAANILLDFKF--EAKVADFGL-AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS 227
           +K  NI+   K   E K+ DFGL A +    +  V+T   GT  + APE A    +   +
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYT 337
Query: 228 DVFSFGVMLLELITGRRP 245
           D++S GV+   L++G  P
Sbjct: 338 DMWSVGVLSYILLSGLSP 355

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 35/221 (15%)
Query: 52  LGQGGFGYVHRGVLPNGK------EVAIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVS 104
           LG+G FG V +    + K       VA+K LK  +   E R+  +E  ++ +V+H H++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLH-----GKG--------------RPTMDWLTR- 144
           L G  +     +L+ E+    +L   L      G G               P    LT  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 145 --LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV 202
             +  A   ++G+ YL E     ++HRD+ A NIL+    + K++DFGL++   + ++ V
Sbjct: 151 DLISFAWQISQGMQYLAEM---SLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 203 STRVMGTF--GYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
             R  G     ++A E       T +SDV+SFGV+L E++T
Sbjct: 208 K-RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 99/199 (49%), Gaps = 19/199 (9%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQA-------EVEIISRVHHKHLVS 104
           +G+G +G V++     G+  A+K+++      E+E +        E+ I+  + H ++V 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL-----EKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L        + +LV+E +  +  +     +G   ++ +T     L    G+AY H+    
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR--- 119
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-YASSGKL 223
           +++HRD+K  N+L++ + E K+ADFGLA+ A  +     T  + T  Y AP+    S K 
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 224 TEKSDVFSFGVMLLELITG 242
           +   D++S G +  E++ G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQL------L 116
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 172
Query: 213 LAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
            APE     K  +   D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 110/255 (43%), Gaps = 51/255 (20%)
Query: 37  EELARATDGFSDANLLGQGGFGYVHRGVLPNGKEV----------AIKQLKAGSGQGERE 86
           +E+    + F    ++G+G FG V    + N + +           +K+ +    + ER+
Sbjct: 67  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 126
Query: 87  F--QAEVEIISRVHH-----KHLVSLVGYYTAGSQRMLVYEF---VPNNTLEFHLHGKGR 136
                + + I+ +H+      HL  ++ YY  G    L+ +F   +P +   F++     
Sbjct: 127 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYI----- 181
Query: 137 PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
                   + +A+ S   L Y         +HRDIK  N+LLD     ++ADFG     +
Sbjct: 182 ------GEMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMN 226
Query: 197 DVNTHVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDSTHT 251
           D  T  S+  +GT  Y++PE   +     GK   + D +S GV + E++ G  P      
Sbjct: 227 DDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP------ 280
Query: 252 FVEDSLVDWARPLLN 266
           F  +SLV+    ++N
Sbjct: 281 FYAESLVETYGKIMN 295

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 110/255 (43%), Gaps = 51/255 (20%)
Query: 37  EELARATDGFSDANLLGQGGFGYVHRGVLPNGKEV----------AIKQLKAGSGQGERE 86
           +E+    + F    ++G+G FG V    + N + +           +K+ +    + ER+
Sbjct: 83  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 142
Query: 87  F--QAEVEIISRVHH-----KHLVSLVGYYTAGSQRMLVYEF---VPNNTLEFHLHGKGR 136
                + + I+ +H+      HL  ++ YY  G    L+ +F   +P +   F++     
Sbjct: 143 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYI----- 197
Query: 137 PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
                   + +A+ S   L Y         +HRDIK  N+LLD     ++ADFG     +
Sbjct: 198 ------GEMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMN 242
Query: 197 DVNTHVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDSTHT 251
           D  T  S+  +GT  Y++PE   +     GK   + D +S GV + E++ G  P      
Sbjct: 243 DDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP------ 296
Query: 252 FVEDSLVDWARPLLN 266
           F  +SLV+    ++N
Sbjct: 297 FYAESLVETYGKIMN 311

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQL------L 113
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 114 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 169
Query: 213 LAPEYASSGKLTEKS-DVFSFGVMLLELITGR 243
            APE     K    + D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQL------L 115
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 116 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 171
Query: 213 LAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
            APE     K  +   D++S G +  E++T R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQA--EVEIISRVH 98
           AT  +     +G G +G V++   P +G  VA+K ++  +G+         EV ++ R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 99  ---HKHLVSLVGYY-TAGSQR----MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
              H ++V L+    T+ + R     LV+E V +  L  +L     P +   T   +   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
             +GL +LH +C   I+HRD+K  NIL+      K+ADFGLA+I S         V+ T 
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALFPVVVTL 175
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
            Y APE           D++S G +  E+   R+P+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQL---KAGSGQGEREFQAEVEIISRVHHKHLVSLVGY 108
           +G+G +G V++     G+  A+K++   K   G      + E+ I+  + H ++V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
                + +LV+E +  +  +     +G   ++ +T     L    G+AY H+    +++H
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR---RVLH 123
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-YASSGKLTEKS 227
           RD+K  N+L++ + E K+ADFGLA+ A  +     T  + T  Y AP+    S K +   
Sbjct: 124 RDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTI 182
Query: 228 DVFSFGVMLLELITG 242
           D++S G +  E++ G
Sbjct: 183 DIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 99/199 (49%), Gaps = 19/199 (9%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQA-------EVEIISRVHHKHLVS 104
           +G+G +G V++     G+  A+K+++      E+E +        E+ I+  + H ++V 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL-----EKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L        + +LV+E +  +  +     +G   ++ +T     L    G+AY H+    
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR--- 119
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-YASSGKL 223
           +++HRD+K  N+L++ + E K+ADFGLA+ A  +     T  + T  Y AP+    S K 
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 224 TEKSDVFSFGVMLLELITG 242
           +   D++S G +  E++ G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 102/207 (49%), Gaps = 15/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHL 102
           +++ + +G+G +G V       N   VAIK++     Q   +R  + E++I+ R  H+++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
           + +     A +   +   ++  + +E   + L      + D +      +   +GL Y+H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKYIH 145
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAPEY 217
                 ++HRD+K +N+LL+   + K+ DFGLA++A   + H       + T  Y APE 
Sbjct: 146 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 202
Query: 218 ASSGK-LTEKSDVFSFGVMLLELITGR 243
             + K  T+  D++S G +L E+++ R
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 102/207 (49%), Gaps = 15/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHL 102
           +++ + +G+G +G V       N   VAIK++     Q   +R  + E++I+ R  H+++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 88
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
           + +     A +   +   ++  + +E   + L      + D +      +   +GL Y+H
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKYIH 146
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAPEY 217
                 ++HRD+K +N+LL+   + K+ DFGLA++A   + H       + T  Y APE 
Sbjct: 147 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 203
Query: 218 ASSGK-LTEKSDVFSFGVMLLELITGR 243
             + K  T+  D++S G +L E+++ R
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------L 113
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 169
Query: 213 LAPEYASSGKLTEKS-DVFSFGVMLLELITGR 243
            APE     K    + D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------L 113
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 169
Query: 213 LAPEYASSGKLTEKS-DVFSFGVMLLELITGR 243
            APE     K    + D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQL------L 116
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 117 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 172
Query: 213 LAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
            APE     K  +   D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------L 116
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 172
Query: 213 LAPEYASSGKLTEKS-DVFSFGVMLLELITGR 243
            APE     K    + D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------L 115
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 116 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 171
Query: 213 LAPEYASSGKLTEKS-DVFSFGVMLLELITGR 243
            APE     K    + D++S G +  E++T R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------L 113
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 169
Query: 213 LAPEYASSGKLTEKS-DVFSFGVMLLELITGR 243
            APE     K    + D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------L 115
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 116 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 171
Query: 213 LAPEYASSGKLTEKS-DVFSFGVMLLELITGR 243
            APE     K    + D++S G +  E++T R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------L 114
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 115 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 170
Query: 213 LAPEYASSGKLTEKS-DVFSFGVMLLELITGR 243
            APE     K    + D++S G +  E++T R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 44  DGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHH 99
           + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  ++H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSAKG 154
            ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       +G
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------LQG 114
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y A
Sbjct: 115 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRA 170
Query: 215 PEYASSGKLTEKS-DVFSFGVMLLELITGR 243
           PE     K    + D++S G +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------L 115
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 116 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 171
Query: 213 LAPEYASSGKLTEKS-DVFSFGVMLLELITGR 243
            APE     K    + D++S G +  E++T R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 44  DGFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQL---KAGSGQGEREFQAE---VEIISR 96
           + FS   ++G+GGFG V+     + GK  A+K L   +    QGE     E   + ++S 
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHL--HGKGRPTMDWLTRLKIALGSAKG 154
                +V +   +    +   + + +    L +HL  HG            +I LG    
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG---- 303
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           L ++H      +++RD+K ANILLD     +++D GLA   S    H S   +GT GY+A
Sbjct: 304 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 357
Query: 215 PEYASSGKLTEKS-DVFSFGVMLLELITGRRP 245
           PE    G   + S D FS G ML +L+ G  P
Sbjct: 358 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQL------L 114
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 115 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 170
Query: 213 LAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
            APE     K  +   D++S G +  E++T R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------L 116
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 172
Query: 213 LAPEYASSGKLTEKS-DVFSFGVMLLELITGR 243
            APE     K    + D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------L 117
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 118 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 173
Query: 213 LAPEYASSGKLTEKS-DVFSFGVMLLELITGR 243
            APE     K    + D++S G +  E++T R
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------L 113
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 169
Query: 213 LAPEYASSGKLTEKS-DVFSFGVMLLELITGR 243
            APE     K    + D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 52  LGQGGFGYVHRGVLP----NGKEVAIKQLKAGSGQG-EREFQAEVEIISRVHHKHLVSLV 106
           LG G F  V   VL      GK  A+K +   + +G E   + E+ ++ ++ H+++V+L 
Sbjct: 30  LGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALE 86
Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPT-MDWLTRLKIALGSAKGLAYLHEDCHPK 165
             Y + +   LV + V    L   +  KG  T  D  T ++  L +   + YLH      
Sbjct: 87  DIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDA---VYYLH---RMG 140
Query: 166 IIHRDIKAANILL---DFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK 222
           I+HRD+K  N+L    D + +  ++DFGL+K+       V +   GT GY+APE  +   
Sbjct: 141 IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEG--KGDVMSTACGTPGYVAPEVLAQKP 198
Query: 223 LTEKSDVFSFGVMLLELITGRRP 245
            ++  D +S GV+   L+ G  P
Sbjct: 199 YSKAVDCWSIGVIAYILLCGYPP 221

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 44  DGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHH 99
           + F     +G+G +G V+  R  L  G+ VA+ +++  +        A  E+ ++  ++H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSAKG 154
            ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       +G
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------LQG 115
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V     T  + T  Y A
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 171
Query: 215 PEYASSGKLTEKS-DVFSFGVMLLELITGR 243
           PE     K    + D++S G +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 44  DGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHH 99
           + F     +G+G +G V+  R  L  G+ VA+ +++  +        A  E+ ++  ++H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSAKG 154
            ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       +G
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------LQG 114
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V     T  + T  Y A
Sbjct: 115 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 170
Query: 215 PEYASSGKLTEKS-DVFSFGVMLLELITGR 243
           PE     K    + D++S G +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------L 114
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 115 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 170
Query: 213 LAPEYASSGKLTEKS-DVFSFGVMLLELITGR 243
            APE     K    + D++S G +  E++T R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 44  DGFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQL---KAGSGQGEREFQAE---VEIISR 96
           + FS   ++G+GGFG V+     + GK  A+K L   +    QGE     E   + ++S 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHL--HGKGRPTMDWLTRLKIALGSAKG 154
                +V +   +    +   + + +    L +HL  HG            +I LG    
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG---- 304
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           L ++H      +++RD+K ANILLD     +++D GLA   S    H S   +GT GY+A
Sbjct: 305 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 358
Query: 215 PEYASSGKLTEKS-DVFSFGVMLLELITGRRP 245
           PE    G   + S D FS G ML +L+ G  P
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G+G +G V  G    G++VA+K         E  +  E EI   V  +H  +++G+  A
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRH-ENILGFIAA 99
Query: 112 -------GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC-- 162
                   +Q  L+ ++  N +L  +L      T+D  + LK+A  S  GL +LH +   
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 163 ---HPKIIHRDIKAANILLDFKFEAKVADFGLA-KIASD---VNTHVSTRVMGTFGYLAP 215
               P I HRD+K+ NIL+       +AD GLA K  SD   V+   +TRV GT  Y+ P
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYMPP 215
Query: 216 EYASSG------KLTEKSDVFSFGVMLLELITGRRPV 246
           E           +    +D++SFG++L E+   RR V
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCV 250

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 44  DGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHH 99
           + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  ++H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSAKG 154
            ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       +G
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------LQG 114
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y A
Sbjct: 115 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRA 170
Query: 215 PEYASSGKLTEKS-DVFSFGVMLLELITGR 243
           PE     K    + D++S G +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYY 109
           LG+G  G V   V    +E VA+K +         E  + E+ I   ++H+++V   G+ 
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G+ + L  E+     L   +    G P  D   R    L +  G+ YLH      I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMA--GVVYLH---GIGITH 127
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL-TEK 226
           RDIK  N+LLD +   K++DFGLA +    N   +  ++ GT  Y+APE     +   E 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 227 SDVFSFGVMLLELITGRRPVDS 248
            DV+S G++L  ++ G  P D 
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 44  DGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHH 99
           + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  ++H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSAKG 154
            ++V L+      ++  LV+EF+  +  +F     L G   P +  +L +L       +G
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------LQG 116
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y A
Sbjct: 117 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRA 172
Query: 215 PEYASSGKLTEKS-DVFSFGVMLLELITGR 243
           PE     K    + D++S G +  E++T R
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 38/221 (17%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLK---AGSGQGEREFQAEVEIISRVH-HKHLVSLV 106
           LG+G +G V + +    G+ VA+K++      S   +R F+ E+ I++ +  H+++V+L+
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 107 GYYTAGSQR--MLVYEFVPNNTLEFHLHGKGRPT-MDWLTRLKIALGSAKGLAYLHEDCH 163
               A + R   LV+++     +E  LH   R   ++ + +  +     K + YLH    
Sbjct: 76  NVLRADNDRDVYLVFDY-----METDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG-- 128
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAK-----------IASDVNTH---------VS 203
             ++HRD+K +NILL+ +   KVADFGL++           I   +N +         + 
Sbjct: 129 -GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 204 TRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLELITGR 243
           T  + T  Y APE    S K T+  D++S G +L E++ G+
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 46/229 (20%)
Query: 44  DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEI--ISRVHHKH 101
           D      L+G+G +G V++G L + + VA+K     + Q    F  E  I  +  + H +
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDN 68
Query: 102 LVSLVGYYTAGSQR---------MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA 152
               +  +  G +R         +LV E+ PN +L  +L      T DW++  ++A    
Sbjct: 69  ----IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVT 121
Query: 153 KGLAYLHEDC------HPKIIHRDIKAANILLDFKFEAKVADFGLA---------KIASD 197
           +GLAYLH +        P I HRD+ + N+L+       ++DFGL+         +   +
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 198 VNTHVSTRVMGTFGYLAPEYASSG-------KLTEKSDVFSFGVMLLEL 239
            N  +S   +GT  Y+APE               ++ D+++ G++  E+
Sbjct: 182 DNAAISE--VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGCLLKYIRKIGS-FDETCTRFYTA-EIVSALEY 147
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 148 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 204
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +    ++ SD+++ G ++ +L+ G  P
Sbjct: 205 LLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 46  FSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHK 100
           +++ + +G+G +G V   +  V  N   VAIK++     Q   +R  + E++I+    H+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHE 83
Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +++ +     A +   +   ++  + +E   + L      + D +      +   +GL Y
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKY 141
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAP 215
           +H      ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y AP
Sbjct: 142 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 216 EYASSGK-LTEKSDVFSFGVMLLELITGR 243
           E   + K  T+  D++S G +L E+++ R
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 27/227 (11%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQL--KAGSGQGEREFQ 88
           S F      + +D +     LG+G F  V R V    G E A K +  K  S +  ++ +
Sbjct: 17  SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE 76
Query: 89  AEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL-------EFHLHGKGRPTMDW 141
            E  I  ++ H ++V L       S   LV++ V    L       EF+        +  
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ 136
Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDV 198
           +          + +AY H +    I+HR++K  N+LL  K +    K+ADFGLA   +D 
Sbjct: 137 IL---------ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND- 183
Query: 199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
            +       GT GYL+PE       ++  D+++ GV+L  L+ G  P
Sbjct: 184 -SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +H  LV L   +   S+   V E+V    L FH+  + R   +   R   A  S   L Y
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISL-ALNY 168
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
           LHE     II+RD+K  N+LLD +   K+ D+G+ K         ST   GT  Y+APE 
Sbjct: 169 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEI 224
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
                     D ++ GV++ E++ GR P D
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 52  LGQGGFGYVHRGVLP--------NGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHL 102
           LGQG F  + +GV          +  EV +K L KA     E  F+A   ++S++ HKHL
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA-ASMMSKLSHKHL 74
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           V   G    G + +LV EFV   +L+ +L  K +  ++ L +L++A   A  + +L E+ 
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFLEEN- 132
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAPEYA 218
              +IH ++ A NILL  + + K  +    K+ SD    ++      +     ++ PE  
Sbjct: 133 --TLIHGNVCAKNILLIREEDRKTGNPPFIKL-SDPGISITVLPKDILQERIPWVPPECI 189
Query: 219 SSGK-LTEKSDVFSFGVMLLELITG 242
            + K L   +D +SFG  L E+ +G
Sbjct: 190 ENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 44  DGFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQL---KAGSGQGEREFQAE---VEIISR 96
           + FS   ++G+GGFG V+     + GK  A+K L   +    QGE     E   + ++S 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHL--HGKGRPTMDWLTRLKIALGSAKG 154
                +V +   +    +   + + +    L +HL  HG            +I LG    
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG---- 304
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           L ++H   +  +++RD+K ANILLD     +++D GLA   S    H S   +GT GY+A
Sbjct: 305 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 358
Query: 215 PEYASSGKLTEKS-DVFSFGVMLLELITGRRP 245
           PE    G   + S D FS G ML +L+ G  P
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 44  DGFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQL---KAGSGQGEREFQAE---VEIISR 96
           + FS   ++G+GGFG V+     + GK  A+K L   +    QGE     E   + ++S 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHL--HGKGRPTMDWLTRLKIALGSAKG 154
                +V +   +    +   + + +    L +HL  HG            +I LG    
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG---- 304
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           L ++H   +  +++RD+K ANILLD     +++D GLA   S    H S   +GT GY+A
Sbjct: 305 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 358
Query: 215 PEYASSGKLTEKS-DVFSFGVMLLELITGRRP 245
           PE    G   + S D FS G ML +L+ G  P
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+EF+  +   F     L G   P +  +L +L       
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQL------L 116
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 172
Query: 213 LAPEYASSGKLTEKS-DVFSFGVMLLELITGR 243
            APE     K    + D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 22/222 (9%)
Query: 40  ARATDGFSDANLLGQGGFGYV----HRGVLPNGKEV--AIKQLKAGS---GQGEREFQAE 90
           A+ +D F    ++G+G FG V    H+      +EV  A+K L+  +    + E+   +E
Sbjct: 35  AKPSD-FHFLKVIGKGSFGKVLLARHKA-----EEVFYAVKVLQKKAILKKKEEKHIMSE 88
Query: 91  VEIISR-VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIAL 149
             ++ + V H  LV L   +    +   V +++    L +HL  + R  ++   R   A 
Sbjct: 89  RNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARF-YAA 146
Query: 150 GSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
             A  L YLH      I++RD+K  NILLD +    + DFGL K   + N+  ST   GT
Sbjct: 147 EIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGT 202
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHT 251
             YLAPE           D +  G +L E++ G  P  S +T
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 244

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 104/238 (43%), Gaps = 53/238 (22%)
Query: 41  RATDGFSDANLLGQGGFGYV--HRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH 98
           R    F +  +LGQG FG V   R  L + +  AIK+++  + +      +EV +++ ++
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNAL-DSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60
Query: 99  HKHLVSLVGYYTAGSQR----------------MLVYEFVPNNTLEFHLHGKG-RPTMDW 141
           H+++V    YY A  +R                 +  E+  N TL   +H +      D 
Sbjct: 61  HQYVVR---YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE 117
Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH 201
             RL   +  A  L+Y+H      IIHRD+K  NI +D     K+ DFGLAK     N H
Sbjct: 118 YWRLFRQILEA--LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK-----NVH 167
Query: 202 VS------------------TRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELI 240
            S                  T  +GT  Y+A E    +G   EK D++S G++  E+I
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 70  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEY 125
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 126 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 182
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +     + SD+++ G ++ +L+ G  P
Sbjct: 183 LLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 69  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEY 124
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 125 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 181
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +     + SD+++ G ++ +L+ G  P
Sbjct: 182 LLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 39/217 (17%)
Query: 46  FSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEV---------EIIS 95
           + D   +G G +G V   V    G +VAIK+L        R FQ+E+          ++ 
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELRLLK 79
Query: 96  RVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIA 148
            + H++++ L+  +T        +   LV  F+  +  +   H K G   + +L    + 
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML- 138
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA-SDVNTHVSTRVM 207
               KGL Y+H      IIHRD+K  N+ ++   E K+ DFGLA+ A S++   V TR  
Sbjct: 139 ----KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR-- 189
Query: 208 GTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 243
               Y APE   +  + T+  D++S G ++ E+ITG+
Sbjct: 190 ---WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 113/251 (45%), Gaps = 29/251 (11%)
Query: 49  ANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-HKHLVSLV 106
           + LLG+G +  V   V L NGKE A+K ++  +G        EVE + +   +K+++ L+
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
            ++   ++  LV+E +   ++  H+  +        +R  +    A  L +LH      I
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASR--VVRDVAAALDFLHTK---GI 132
Query: 167 IHRDIKAANILLDFKFE---AKVADFGLA------KIASDVNTHVSTRVMGTFGYLAPE- 216
            HRD+K  NIL +   +    K+ DF L          + + T   T   G+  Y+APE 
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEV 192
Query: 217 ---YASSGKLTEK-SDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD--WARPLLNRAIE 270
              +       +K  D++S GV+L  +++G  P      FV     D  W R  + R  +
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP------FVGHCGADCGWDRGEVCRVCQ 246
Query: 271 DGNFDTLVDPK 281
           +  F+++ + K
Sbjct: 247 NKLFESIQEGK 257

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 46  FSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHK 100
           +++ + +G+G +G V   +  V  N   VAIK++     Q   +R  + E++I+    H+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHE 83
Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLE---FHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +++ +     A +   +   ++  + +E   + L      + D +      +   +GL Y
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--LRGLKY 141
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAP 215
           +H      ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y AP
Sbjct: 142 IHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 216 EYASSGK-LTEKSDVFSFGVMLLELITGR 243
           E   + K  T+  D++S G +L E+++ R
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 67  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEY 122
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 123 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 179
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +     + SD+++ G ++ +L+ G  P
Sbjct: 180 LLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 104/238 (43%), Gaps = 53/238 (22%)
Query: 41  RATDGFSDANLLGQGGFGYV--HRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH 98
           R    F +  +LGQG FG V   R  L + +  AIK+++  + +      +EV +++ ++
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNAL-DSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60
Query: 99  HKHLVSLVGYYTAGSQR----------------MLVYEFVPNNTLEFHLHGKG-RPTMDW 141
           H+++V    YY A  +R                 +  E+  N TL   +H +      D 
Sbjct: 61  HQYVVR---YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH 201
             RL   +  A  L+Y+H      IIHRD+K  NI +D     K+ DFGLAK     N H
Sbjct: 118 YWRLFRQILEA--LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK-----NVH 167
Query: 202 VS------------------TRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELI 240
            S                  T  +GT  Y+A E    +G   EK D++S G++  E+I
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 18/216 (8%)
Query: 40  ARATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQLKAGSGQGEREFQA---EVEIIS 95
            + TD F+   +LG+G FG V        +E+ AIK LK      + + +    E  +++
Sbjct: 16  VKLTD-FNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLA 74
Query: 96  RVHHK-HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLH--GKGRPTMDWLTRLKIALGSA 152
            +     L  L   +    +   V E+V    L +H+   GK +         +I++G  
Sbjct: 75  LLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIG-- 132
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR-VMGTFG 211
             L +LH+     II+RD+K  N++LD +   K+ADFG+ K    +   V+TR   GT  
Sbjct: 133 --LFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPD 185
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
           Y+APE  +     +  D +++GV+L E++ G+ P D
Sbjct: 186 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 68  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEY 123
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 124 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 180
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +     + SD+++ G ++ +L+ G  P
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEY 147
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 148 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +     + SD+++ G ++ +L+ G  P
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 14/217 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 93  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEY 148
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 149 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 205
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFV 253
             +     + SD+++ G ++ +L+ G  P  + + ++
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 242

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 90  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEY 145
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 146 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +     + SD+++ G ++ +L+ G  P
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 93  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEY 148
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 149 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 205
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +     + SD+++ G ++ +L+ G  P
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 35/217 (16%)
Query: 46  FSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHK 100
           +++ + +G+G +G V   +  V  N   VAIK++     Q   +R  + E++I+ R  H+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHE 101
Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS--------- 151
           +++ +     A +      E + +  L  HL G      D    LK    S         
Sbjct: 102 NIIGINDIIRAPT-----IEQMKDVYLVTHLMGA-----DLYKLLKTQHLSNDHICYFLY 151
Query: 152 --AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVM 207
              +GL Y+H      ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  +
Sbjct: 152 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 208 GTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
            T  Y APE   + K  T+  D++S G +L E+++ R
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRFYTA-EIVSALEY 147
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 148 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +     + SD+++ G ++ +L+ G  P
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVH--RGVLPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRV 97
           + + F     +G+G +G V+  R  L  G+ VA+K+++  +        A  E+ ++  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH----LHGKGRPTM-DWLTRLKIALGSA 152
           +H ++V L+      ++  LV+E V  +  +F     L G   P +  +L +L       
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQL------L 116
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           +GLA+ H     +++HRD+K  N+L++ +   K+ADFGLA+ A  V        + T  Y
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 172
Query: 213 LAPEYASSGKLTEKS-DVFSFGVMLLELITGR 243
            APE     K    + D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 10/215 (4%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
              V L   +    +      +  N  L  ++   G    +  TR   A      L YLH
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEYLH 154
Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPEYA 218
                 IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE  
Sbjct: 155 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 211
Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFV 253
           +     + SD+++ G ++ +L+ G  P  + + ++
Sbjct: 212 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 246

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 90  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRFYTA-EIVSALEY 145
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 146 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +     + SD+++ G ++ +L+ G  P
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 43  TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKH 101
           +D F   + LG+G    V+R       K  A+K LK    +  +  + E+ ++ R+ H +
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG----RPTMDWLTRLKIALGSAKGLAY 157
           ++ L   +   ++  LV E V    L   +  KG    R   D + ++       + +AY
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI------LEAVAY 163
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           LHE+    I+HRD+K  N+L          K+ADFGL+KI    +  +   V GT GY A
Sbjct: 164 LHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCA 218
Query: 215 PEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           PE         + D++S G++   L+ G  P
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 14/217 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 95  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEY 150
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 151 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFV 253
             +     + SD+++ G ++ +L+ G  P  + + ++
Sbjct: 208 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 244

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRFYTA-EIVSALEY 147
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 148 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +     + SD+++ G ++ +L+ G  P
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 90  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEY 145
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 146 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE 202
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +     + SD+++ G ++ +L+ G  P
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 74  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRFYTA-EIVSALEY 129
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 130 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 186
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +     + SD+++ G ++ +L+ G  P
Sbjct: 187 LLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 41  RATDGFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQ-LKAGSGQGEREFQA-EVEIISRV 97
           ++ + + +  L+G+G +G V +    + G+ VAIK+ L++   +  ++    E++++ ++
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLE-FHLHGKGRPTMDWLTRLKIALGSAKGLA 156
            H++LV+L+       +  LV+EFV +  L+   L   G   +D+    K       G+ 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIG 138
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE 216
           + H      IIHRDIK  NIL+      K+ DFG A+  +     V    + T  Y APE
Sbjct: 139 FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVATRWYRAPE 194
Query: 217 -YASSGKLTEKSDVFSFGVMLLELITG 242
                 K  +  DV++ G ++ E+  G
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEY 147
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 148 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +     + SD+++ G ++ +L+ G  P
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 89  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRFYTA-EIVSALEY 144
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 145 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 201
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +     + SD+++ G ++ +L+ G  P
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 30/219 (13%)
Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQLK-AGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG+  FG V++G L         + VAIK LK    G    EF+ E  + +R+ H ++V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 105 LVGYYTAGSQRMLVYEFVPNNTL-EFHL----HGKGRPTMDWLTRLKIALGS-------- 151
           L+G  T      +++ +  +  L EF +    H     T D  T +K AL          
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT-VKSALEPPDFVHLVA 152
Query: 152 --AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVM 207
             A G+ YL       ++H+D+   N+L+  K   K++D GL +   A+D    +   ++
Sbjct: 153 QIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 209
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
               ++APE    GK +  SD++S+GV+L E+ + G +P
Sbjct: 210 -PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 89  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRFYTA-EIVSALEY 144
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 145 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 201
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +     + SD+++ G ++ +L+ G  P
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 108/229 (47%), Gaps = 21/229 (9%)
Query: 34  FTYEELARATDGFSDANLLGQGGFGYVHRGVLP----NGKEVAIKQL---KAGSGQGERE 86
           F     A  +D +    +LG+G FG V   +L      G+E A+K +   +      +  
Sbjct: 22  FVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKES 78
Query: 87  FQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK 146
              EV+++ ++ H +++ L  ++       LV E      L   +  + R     +   +
Sbjct: 79  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAAR 136
Query: 147 IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVS 203
           I      G+ Y+H++   KI+HRD+K  N+LL+ K +    ++ DFGL+    + +  + 
Sbjct: 137 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS-THFEASKKMK 192
Query: 204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTF 252
            ++ GT  Y+APE    G   EK DV+S GV+L  L++G  P +  + +
Sbjct: 193 DKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEY 239

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 21/219 (9%)
Query: 42  ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQA-----EVEIIS 95
           AT  +     +G G +G V++   P +G  VA+K ++  +G G           EV ++ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 96  RVH---HKHLVSLVGYY-TAGSQR----MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKI 147
           R+    H ++V L+    T+ + R     LV+E V +  L  +L     P +   T   +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDL 125
Query: 148 ALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM 207
                +GL +LH +C   I+HRD+K  NIL+      K+ADFGLA+I S       T V+
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALTPVV 180
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPV 246
            T  Y APE           D++S G +  E+   R+P+
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 86/177 (48%), Gaps = 13/177 (7%)
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL-----EFHLHGKGRPTMD 140
           +F+ E++II+ + +++ ++  G  T   +  ++YE++ N+++      F +  K      
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 141 WLTRLKIALGSA-KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +  +K  + S     +Y+H +    I HRD+K +NIL+D     K++DFG ++   D  
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 200 THVSTRVMGTFGYLAPEYAS--SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE 254
              S    GT+ ++ PE+ S  S     K D++S G+ L  +     P     + VE
Sbjct: 207 IKGSR---GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHL 102
           F   +LLG+G +G V      P G+ VAIK+++         R  + E++I+    H+++
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENI 71
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIAL-GSAKGLAYLHED 161
           +++       S       ++    ++  LH      M     ++  +  + + +  LH  
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS---------TRVMGTFGY 212
               +IHRD+K +N+L++   + KV DFGLA+I  +     S         T  + T  Y
Sbjct: 132 ---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWY 188
Query: 213 LAPEYA-SSGKLTEKSDVFSFGVMLLELITGRRPV 246
            APE   +S K +   DV+S G +L EL   RRP+
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 52  LGQGGFGYVHRGVLP--------NGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHL 102
           LGQG F  + +GV          +  EV +K L KA     E  F+A   ++S++ HKHL
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA-ASMMSKLSHKHL 74
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           V   G    G + +LV EFV   +L+ +L  K +  ++ L +L++A   A  + +L E+ 
Sbjct: 75  VLNYGVCFCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAWAMHFLEEN- 132
Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAPEYA 218
              +IH ++ A NILL  + + K  +    K+ SD    ++      +     ++ PE  
Sbjct: 133 --TLIHGNVCAKNILLIREEDRKTGNPPFIKL-SDPGISITVLPKDILQERIPWVPPECI 189
Query: 219 SSGK-LTEKSDVFSFGVMLLELITG 242
            + K L   +D +SFG  L E+ +G
Sbjct: 190 ENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 16/210 (7%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAG-SGQGEREFQAEVEIISR-VHHKHLVSLVGY 108
           LG+G +G V +   +P+G+  A+K+++A  + Q ++    +++I  R V     V+  G 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 109 YTAGSQRMLVYEFVPNNTLEFH--LHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
                   +  E    +  +F+  +  KG+ T+      KIA+   K L +LH      +
Sbjct: 102 LFREGDVWICXELXDTSLDKFYKQVIDKGQ-TIPEDILGKIAVSIVKALEHLHSKL--SV 158
Query: 167 IHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVMGTFGYLAPEYA----SSG 221
           IHRD+K +N+L++   + K  DFG++  +  DV   +     G   Y APE      +  
Sbjct: 159 IHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA---GCKPYXAPERINPELNQK 215
Query: 222 KLTEKSDVFSFGVMLLELITGRRPVDSTHT 251
             + KSD++S G+  +EL   R P DS  T
Sbjct: 216 GYSVKSDIWSLGITXIELAILRFPYDSWGT 245

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHL 102
           F   +LLG+G +G V      P G+ VAIK+++         R  + E++I+    H+++
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENI 71
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIAL-GSAKGLAYLHED 161
           +++       S       ++    ++  LH      M     ++  +  + + +  LH  
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS---------TRVMGTFGY 212
               +IHRD+K +N+L++   + KV DFGLA+I  +     S         T  + T  Y
Sbjct: 132 ---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWY 188
Query: 213 LAPEYA-SSGKLTEKSDVFSFGVMLLELITGRRPV 246
            APE   +S K +   DV+S G +L EL   RRP+
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 53/231 (22%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH------ 98
           +   +++G+G    V R V    G E A+K ++  + +   E   EV   +R        
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 99  ---HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAK-- 153
              H H+++L+  Y + S   LV++ +    L            D+LT  K+AL   +  
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGEL-----------FDYLTE-KVALSEKETR 203
Query: 154 --------GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST- 204
                    +++LH +    I+HRD+K  NILLD   + +++DFG +        H+   
Sbjct: 204 SIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFS-------CHLEPG 253
Query: 205 ----RVMGTFGYLAPEYASSGK------LTEKSDVFSFGVMLLELITGRRP 245
                + GT GYLAPE              ++ D+++ GV+L  L+ G  P
Sbjct: 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQL--KAGSGQGEREFQAEVEIISRVHH 99
           +D +     LG+G F  V R V    G E A K +  K  S +  ++ + E  I  ++ H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-------EFHLHGKGRPTMDWLTRLKIALGSA 152
            ++V L       S   LV++ V    L       EF+        +  +          
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL--------- 114
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMGT 209
           + +AY H +    I+HR++K  N+LL  K +    K+ADFGLA   +D  +       GT
Sbjct: 115 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGT 169
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
            GYL+PE       ++  D+++ GV+L  L+ G  P
Sbjct: 170 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQL--KAGSGQGEREFQAEVEIISRVHH 99
           +D +     LG+G F  V R V    G E A K +  K  S +  ++ + E  I  ++ H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-------EFHLHGKGRPTMDWLTRLKIALGSA 152
            ++V L       S   LV++ V    L       EF+        +  +          
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL--------- 115
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMGT 209
           + +AY H +    I+HR++K  N+LL  K +    K+ADFGLA   +D  +       GT
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGT 170
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
            GYL+PE       ++  D+++ GV+L  L+ G  P
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 107/234 (45%), Gaps = 31/234 (13%)
Query: 34  FTYEELARATDGFSDANLLGQGGFGYVHRGVLP----NGKEVAIKQL---KAGSGQGERE 86
           F     A  +D +    +LG+G FG V   +L      G+E A+K +   +      +  
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKES 72
Query: 87  FQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK 146
              EV+++ ++ H +++ L  ++       LV E      L   +  + R +   +   +
Sbjct: 73  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE--VDAAR 130
Query: 147 IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVS 203
           I      G+ Y+H++   KI+HRD+K  N+LL+ K +    ++ DFGL+       TH  
Sbjct: 131 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFE 180
Query: 204 TR-----VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTF 252
                   +GT  Y+APE    G   EK DV+S GV+L  L++G  P +  + +
Sbjct: 181 ASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEY 233

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 30/219 (13%)
Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQLK-AGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG+  FG V++G L         + VAIK LK    G    EF+ E  + +R+ H ++V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 105 LVGYYTAGSQRMLVYEFVPNNTL-EFHL----HGKGRPTMDWLTRLKIALGS-------- 151
           L+G  T      +++ +  +  L EF +    H     T D  T +K AL          
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT-VKSALEPPDFVHLVA 135
Query: 152 --AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVM 207
             A G+ YL       ++H+D+   N+L+  K   K++D GL +   A+D    +   ++
Sbjct: 136 QIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
               ++APE    GK +  SD++S+GV+L E+ + G +P
Sbjct: 193 -PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGY-VHRGVLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F   V    L   +E AIK L+      E +      E +++SR+ H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 90  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEY 145
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 146 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +     + SD+++ G ++ +L+ G  P
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQL--KAGSGQGEREFQAEVEIISRVHH 99
           +D +     LG+G F  V R V    G E A K +  K  S +  ++ + E  I  ++ H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-------EFHLHGKGRPTMDWLTRLKIALGSA 152
            ++V L       S   LV++ V    L       EF+        +  +          
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL--------- 115
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMGT 209
           + +AY H +    I+HR++K  N+LL  K +    K+ADFGLA   +D  +       GT
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGT 170
Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
            GYL+PE       ++  D+++ GV+L  L+ G  P
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 111/232 (47%), Gaps = 27/232 (11%)
Query: 34  FTYEELARATDGFSDANLLGQGGFGYVHRGVLP----NGKEVAIKQLKAGSGQGEREFQA 89
           F     A  +D +    +LG+G FG V   +L      G+E A+K +     + + + ++
Sbjct: 39  FVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKES 95
Query: 90  ---EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK 146
              EV+++ ++ H +++ L  ++       LV E      L   +  + R     +   +
Sbjct: 96  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAAR 153
Query: 147 IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVS 203
           I      G+ Y+H++   KI+HRD+K  N+LL+ K +    ++ DFGL+      +   S
Sbjct: 154 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS-----THFEAS 205
Query: 204 TRV---MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTF 252
            ++   +GT  Y+APE    G   EK DV+S GV+L  L++G  P +  + +
Sbjct: 206 KKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGANEY 256

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHH 99
           + F    +LG+G F  V     L   +E AIK L+      E +      E +++SR+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 100 KHLVSLVGYYTAGSQRMLVY--EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
              V L  Y+T      L +   +  N  L  ++   G    +  TR   A      L Y
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTA-EIVSALEY 147
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPE 216
           LH      IIHRD+K  NILL+     ++ DFG AK+ S  +    +   +GT  Y++PE
Sbjct: 148 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             +     + SD+++ G ++ +L+ G  P
Sbjct: 205 LLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 108/232 (46%), Gaps = 27/232 (11%)
Query: 34  FTYEELARATDGFSDANLLGQGGFGYVHRGVLP----NGKEVAIKQL---KAGSGQGERE 86
           F     A  +D +    +LG+G FG V   +L      G+E A+K +   +      +  
Sbjct: 40  FVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKES 96
Query: 87  FQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK 146
              EV+++ ++ H +++ L  ++       LV E      L   +  + R     +   +
Sbjct: 97  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAAR 154
Query: 147 IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVS 203
           I      G+ Y+H++   KI+HRD+K  N+LL+ K +    ++ DFGL+      +   S
Sbjct: 155 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS-----THFEAS 206
Query: 204 TRV---MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTF 252
            ++   +GT  Y+APE    G   EK DV+S GV+L  L++G  P +  + +
Sbjct: 207 KKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGANEY 257

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +ELA+      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 1   RPTFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-------R 53
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 54  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 108
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 109 LNNIVKCAKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 165
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 166 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 46  FSDANLLGQGGFGYVHRGVLPNGKE-VAIKQLKAG----SGQG-EREFQAEVEIISRVHH 99
           +   + LG+G F  V++    N  + VAIK++K G    +  G  R    E++++  + H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKI---ALGSAKGLA 156
            +++ L+  +   S   LV++F     +E  L    +     LT   I    L + +GL 
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE 216
           YLH+     I+HRD+K  N+LLD     K+ADFGLAK     N     +V+ T  Y APE
Sbjct: 127 YLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRWYRAPE 182
Query: 217 YASSGKLT-EKSDVFSFGVMLLELI 240
                ++     D+++ G +L EL+
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELL 207

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 105/248 (42%), Gaps = 51/248 (20%)
Query: 44  DGFSDANLLGQGGFGYVHRGVLPNGKEV----------AIKQLKAGSGQGEREF--QAEV 91
           + F    ++G+G FG V    L N  +V           +K+ +    + ER+     + 
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 92  EIISRVHH-----KHLVSLVGYYTAGSQRMLVYEF---VPNNTLEFHLHGKGRPTMDWLT 143
           + I+ +H+      +L  ++ YY  G    L+ +F   +P     F+L            
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL-----------A 182
Query: 144 RLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS 203
            + IA+ S   L Y         +HRDIK  NIL+D     ++ADFG      +  T  S
Sbjct: 183 EMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233
Query: 204 TRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV 258
           +  +GT  Y++PE   +     G+   + D +S GV + E++ G  P      F  +SLV
Sbjct: 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP------FYAESLV 287
Query: 259 DWARPLLN 266
           +    ++N
Sbjct: 288 ETYGKIMN 295

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 69/150 (46%), Gaps = 6/150 (4%)
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +H  LV L   +   S+   V E+V    L FH+  + R   +   R   A  S   L Y
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISL-ALNY 136
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
           LHE     II+RD+K  N+LLD +   K+ D+G+ K         S    GT  Y+APE 
Sbjct: 137 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSX-FCGTPNYIAPEI 192
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
                     D ++ GV++ E++ GR P D
Sbjct: 193 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 87/207 (42%), Gaps = 15/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVH 98
           F    LLG+G FG V   +L      G+  A+K LK      + E      E  ++    
Sbjct: 153 FEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 209
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
           H  L +L   +    +   V E+     L FHL  +   + D        + SA  L YL
Sbjct: 210 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYL 267
Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           H +    +++RD+K  N++LD     K+ DFGL K        + T   GT  YLAPE  
Sbjct: 268 HSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVL 324
Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
                    D +  GV++ E++ GR P
Sbjct: 325 EDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 108/244 (44%), Gaps = 25/244 (10%)
Query: 44  DGFSDANLLGQGGFGYVHR-GVLPNGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKH 101
           D F     LG G FG VH      +G E  IK +     Q   E  +AE+E++  + H +
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHL---HGKGRPTMD-WLTRLKIALGSAKGLAY 157
           ++ +   +       +V E      L   +     +G+   + ++  L   + +A  LAY
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA--LAY 139
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
            H      ++H+D+K  NIL          K+ DFGLA++    + H ST   GT  Y+A
Sbjct: 140 FHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEH-STNAAGTALYMA 194
Query: 215 PEYASSGKLTEKSDVFSFGVMLLELITGRRP--------VDSTHTFVEDSLVDWARPLLN 266
           PE      +T K D++S GV++  L+TG  P        V    T+ E +     RPL  
Sbjct: 195 PEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTP 253
Query: 267 RAIE 270
           +A++
Sbjct: 254 QAVD 257

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 87/207 (42%), Gaps = 15/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVH 98
           F    LLG+G FG V   +L      G+  A+K LK      + E      E  ++    
Sbjct: 150 FEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
           H  L +L   +    +   V E+     L FHL  +   + D        + SA  L YL
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYL 264
Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           H +    +++RD+K  N++LD     K+ DFGL K        + T   GT  YLAPE  
Sbjct: 265 HSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVL 321
Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
                    D +  GV++ E++ GR P
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 47  SDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           S   +LG G FG VH+      G ++A K +K    + + E + E+ +++++ H +L+ L
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIAL---GSAKGLAYLHEDC 162
              + + +  +LV E+V    L   +  +       LT L   L      +G+ ++H+  
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYN----LTELDTILFMKQICEGIRHMHQ-- 205
Query: 163 HPKIIHRDIKAANILL---DFKFEAKVADFGLAKIASDVNTHVSTRV-MGTFGYLAPEYA 218
              I+H D+K  NIL    D K + K+ DFGLA+           +V  GT  +LAPE  
Sbjct: 206 -MYILHLDLKPENILCVNRDAK-QIKIIDFGLAR---RYKPREKLKVNFGTPEFLAPEVV 260
Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
           +   ++  +D++S GV+   L++G  P
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +H  LV L   +   S+   V E+V    L FH+  + R   +   R   A  S   L Y
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISL-ALNY 125
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
           LHE     II+RD+K  N+LLD +   K+ D+G+ K         ++   GT  Y+APE 
Sbjct: 126 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSXFCGTPNYIAPEI 181
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
                     D ++ GV++ E++ GR P D
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 52  LGQGGFGYVHRGVLPNGK----EVAIKQLK--AGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG G +G V   +L   K    E AIK ++  + S     +   EV ++  + H +++ L
Sbjct: 45  LGSGAYGEV---LLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 106 VGYYTAGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
             ++       LV E      L +  +H      +D    +K  L    G+ YLH+    
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS---GVTYLHK---H 155
Query: 165 KIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
            I+HRD+K  N+LL+ K +    K+ DFGL+ +    N       +GT  Y+APE     
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPEVLRK- 212
Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
           K  EK DV+S GV+L  L+ G  P
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPP 236

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +H  LV L   +   S+   V E+V    L FH+  + R   +   R   A  S   L Y
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISL-ALNY 121
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
           LHE     II+RD+K  N+LLD +   K+ D+G+ K         ++   GT  Y+APE 
Sbjct: 122 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSXFCGTPNYIAPEI 177
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
                     D ++ GV++ E++ GR P D
Sbjct: 178 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 13/216 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRV 97
           D +    ++G+G F  V R +    G++ A+K     +  +  G    + + E  I   +
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
            H H+V L+  Y++     +V+EF+    L F +    R    ++    +A    + +  
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSEAVASHYMRQILE 143
Query: 158 LHEDCHP-KIIHRDIKAANILLDFK---FEAKVADFGLAKIASDVNTHVSTRVMGTFGYL 213
               CH   IIHRD+K   +LL  K      K+  FG+A    +       RV GT  ++
Sbjct: 144 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFM 202
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST 249
           APE        +  DV+  GV+L  L++G  P   T
Sbjct: 203 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 238

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 37/230 (16%)
Query: 41  RATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-FQAEVEIISRVH 98
           R    F     LG+GGFG V       +    AIK+++  + +  RE    EV+ ++++ 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNT-----LEFHLHGK--------GRPTMDWLTR- 144
           H     +V Y+ A  ++    +  P++      ++  L  K        GR T++   R 
Sbjct: 62  HP---GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 145 --LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV 202
             L I L  A+ + +LH      ++HRD+K +NI        KV DFGL   A D +   
Sbjct: 119 VCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVT-AMDQDEEE 174
Query: 203 STRV------------MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 240
            T +            +GT  Y++PE       + K D+FS G++L EL+
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 51  LLGQGGFGYVHRGVLPN----GKEVAIKQLKA-GSGQGE-REFQAEVEIISRVHHKHLVS 104
           +LG+G FG V  G L        +VA+K +K   S Q E  EF +E   +    H +++ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 105 LVGYYTAGSQR-----MLVYEFVPNNTLEFHLH----GKGRPTMDWLTRLKIALGSAKGL 155
           L+G     S +     M++  F+    L  +L       G   +   T LK  +  A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT-FGYLA 214
            YL    +   +HRD+ A N +L       VADFGL+K     + +   R+      ++A
Sbjct: 161 EYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 215 PEYASSGKLTEKSDVFSFGVMLLELIT 241
            E  +    T KSDV++FGV + E+ T
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHL 102
           F   +LLG+G +G V      P G+ VAIK+++         R  + E++I+    H+++
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENI 71
Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIAL-GSAKGLAYLHED 161
           +++       S       ++    ++  LH      M     ++  +  + + +  LH  
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS---------TRVMGTFGY 212
               +IHRD+K +N+L++   + KV DFGLA+I  +     S            + T  Y
Sbjct: 132 ---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 213 LAPEYA-SSGKLTEKSDVFSFGVMLLELITGRRPV 246
            APE   +S K +   DV+S G +L EL   RRP+
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 13/216 (6%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRV 97
           D +    ++G+G F  V R +    G++ A+K     +  +  G    + + E  I   +
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
            H H+V L+  Y++     +V+EF+    L F +    R    ++    +A    + +  
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSEAVASHYMRQILE 141
Query: 158 LHEDCHP-KIIHRDIKAANILLDFK---FEAKVADFGLAKIASDVNTHVSTRVMGTFGYL 213
               CH   IIHRD+K   +LL  K      K+  FG+A    +       RV GT  ++
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFM 200
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST 249
           APE        +  DV+  GV+L  L++G  P   T
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 51  LLGQGGFGYVHRGVLPNGKEV-AIKQLKAGSGQGEREFQAEVEIISRV-----HHKHLVS 104
           +LG+G FG V         E+ A+K LK      + + +  + +  RV         L  
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM-VEKRVLALPGKPPFLTQ 406
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L   +    +   V E+V    L +H+   GR        +  A   A GL +L      
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSK--- 461
Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR-VMGTFGYLAPEYASSGKL 223
            II+RD+K  N++LD +   K+ADFG+ K   ++   V+T+   GT  Y+APE  +    
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIAYQPY 519
Query: 224 TEKSDVFSFGVMLLELITGRRPVD 247
            +  D ++FGV+L E++ G+ P +
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 52  LGQGGFGYVHRG-VLPNGKEVAIKQLKA---GSGQGEREFQAEVEIISRVHHKHLVSLVG 107
           +G+G F  V+R   L +G  VA+K+++       +   +   E++++ +++H +++    
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLH--GKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
            +   ++  +V E      L   +    K +  +   T  K  +     L ++H     +
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---R 156
Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           ++HRDIK AN+ +      K+ D GL +  S   T   + V GT  Y++PE         
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNF 215
Query: 226 KSDVFSFGVMLLELITGRRP 245
           KSD++S G +L E+   + P
Sbjct: 216 KSDIWSLGCLLYEMAALQSP 235

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 91/215 (42%), Gaps = 16/215 (7%)
Query: 39  LARAT-DGFSDANLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGEREFQ---AE 90
           +AR T + F    LLG+G FG V   +L      G+  A+K LK      + E      E
Sbjct: 3   MARVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 59
Query: 91  VEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
             ++    H  L +L   +    +   V E+     L FHL  +   + D        + 
Sbjct: 60  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 119
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
           SA  L YLH +    +++RD+K  N++LD     K+ DFGL K     +        GT 
Sbjct: 120 SA--LDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKXFCGTP 174
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
            YLAPE           D +  GV++ E++ GR P
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   ++    +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMTGYVATR-----WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 41  RATDGFSDANLLGQGGFGYVHRGVLPNGKEV-AIKQLKAGSGQGEREFQAEVEIISRV-- 97
           + TD F+   +LG+G FG V         E+ A+K LK      + + +  + +  RV  
Sbjct: 18  KLTD-FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM-VEKRVLA 75
Query: 98  ---HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKG 154
                  L  L   +    +   V E+V    L +H+   GR        +  A   A G
Sbjct: 76  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIG 133
Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR-VMGTFGYL 213
           L +L       II+RD+K  N++LD +   K+ADFG+ K   ++   V+T+   GT  Y+
Sbjct: 134 LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYI 188
Query: 214 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
           APE  +     +  D ++FGV+L E++ G+ P +
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 102/238 (42%), Gaps = 53/238 (22%)
Query: 41  RATDGFSDANLLGQGGFGYV--HRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH 98
           R    F +  +LGQG FG V   R  L + +  AIK+++  + +      +EV +++ ++
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNAL-DSRYYAIKKIR-HTEEKLSTILSEVXLLASLN 60
Query: 99  HKHLVSLVGYYTAGSQR----------------MLVYEFVPNNTLEFHLHGKG-RPTMDW 141
           H+++V    YY A  +R                 +  E+  N TL   +H +      D 
Sbjct: 61  HQYVVR---YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE 117
Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH 201
             RL   +  A  L+Y+H      IIHR++K  NI +D     K+ DFGLAK     N H
Sbjct: 118 YWRLFRQILEA--LSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAK-----NVH 167
Query: 202 VS------------------TRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELI 240
            S                  T  +GT  Y+A E    +G   EK D +S G++  E I
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 86/207 (41%), Gaps = 16/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVH 98
           F    LLG+G FG V   +L      G+  A+K L+      + E      E  ++    
Sbjct: 10  FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 66
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
           H  L +L   +    +   V E+     L FHL  +   T +        + SA  L YL
Sbjct: 67  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYL 124
Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           H      +++RDIK  N++LD     K+ DFGL K        + T   GT  YLAPE  
Sbjct: 125 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVL 180
Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
                    D +  GV++ E++ GR P
Sbjct: 181 EDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 86/207 (41%), Gaps = 16/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVH 98
           F    LLG+G FG V   +L      G+  A+K L+      + E      E  ++    
Sbjct: 7   FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
           H  L +L   +    +   V E+     L FHL  +   T +        + SA  L YL
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYL 121
Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           H      +++RDIK  N++LD     K+ DFGL K        + T   GT  YLAPE  
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVL 177
Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
                    D +  GV++ E++ GR P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 108/234 (46%), Gaps = 31/234 (13%)
Query: 34  FTYEELARATDGFSDANLLGQGGFGYVHRGVLP----NGKEVAIKQLKAGSGQGEREFQA 89
           F     A  +D +    +LG+G FG V   +L      G+E A+K +     + + + ++
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKES 72
Query: 90  ---EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK 146
              EV+++ ++ H ++  L  ++       LV E      L   +  + R +   +   +
Sbjct: 73  LLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE--VDAAR 130
Query: 147 IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVS 203
           I      G+ Y H++   KI+HRD+K  N+LL+ K +    ++ DFGL+       TH  
Sbjct: 131 IIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFE 180
Query: 204 TR-----VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTF 252
                   +GT  Y+APE    G   EK DV+S GV+L  L++G  P +  + +
Sbjct: 181 ASKKXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEY 233

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 86/207 (41%), Gaps = 16/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVH 98
           F    LLG+G FG V   +L      G+  A+K L+      + E      E  ++    
Sbjct: 7   FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
           H  L +L   +    +   V E+     L FHL  +   T +        + SA  L YL
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYL 121
Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           H      +++RDIK  N++LD     K+ DFGL K        + T   GT  YLAPE  
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVL 177
Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
                    D +  GV++ E++ GR P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 98/196 (50%), Gaps = 11/196 (5%)
Query: 52  LGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQA-EVEIISRVHHKHLVSLVGYY 109
           LG+G +  V++G        VA+K+++    +G       EV ++  + H ++V+L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA-KGLAYLHEDCHPKIIH 168
                  LV+E++ +  L+ +L   G   +  +  +K+ L    +GLAY H     K++H
Sbjct: 70  HTEKSLTLVFEYL-DKDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQ---KVLH 123
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-YASSGKLTEKS 227
           RD+K  N+L++ + E K+ADFGLA+ A  + T      + T  Y  P+    S   + + 
Sbjct: 124 RDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQI 182
Query: 228 DVFSFGVMLLELITGR 243
           D++  G +  E+ TGR
Sbjct: 183 DMWGVGCIFYEMATGR 198

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 12  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 64
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 65  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 119
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 120 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 176
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+  +D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 177 GLARHTADEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 12  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 64
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 65  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 119
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 120 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 176
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+  +D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 177 GLARHTADEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 12  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 64
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 65  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 119
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 120 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 176
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+  +D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 177 GLARHTADEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGS-GQGERE-FQAEVEIISRVHHKHLVSLVGY 108
           +G+G F  V++G+      EVA  +L+     + ER+ F+ E E +  + H ++V     
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 109 YTAGSQ----RMLVYEFVPNNTLEFHLH----GKGRPTMDWLTRLKIALGSAKGLAYLHE 160
           + +  +     +LV E   + TL+ +L      K +    W  ++       KGL +LH 
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGLQFLHT 147
Query: 161 DCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
              P IIHRD+K  NI +       K+ D GLA +        +  V+GT  + APE   
Sbjct: 148 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFXAPEXYE 203
Query: 220 SGKLTEKSDVFSFGVMLLELITGRRP 245
             K  E  DV++FG   LE  T   P
Sbjct: 204 E-KYDESVDVYAFGXCXLEXATSEYP 228

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 24  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-------R 76
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 77  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 131
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 132 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 188
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 189 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 25  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-------R 77
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 78  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 132
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 133 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 189
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 190 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 92/218 (42%), Gaps = 21/218 (9%)
Query: 46  FSDANLLGQGGFGYVHRGVLPNGK----EVAIKQLKAG--SGQGEREFQAEVEIISRVHH 99
           F+   +LG+G FG V    L        +VA+K LKA   +     EF  E   +    H
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 100 KHLVSLVGYYTAGSQR------MLVYEFVPNNTLEFHLH----GKGRPTMDWLTRLKIAL 149
            H+  LVG       +      M++  F+ +  L   L     G+    +   T ++  +
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 150 GSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVMG 208
             A G+ YL        IHRD+ A N +L       VADFGL+ KI S            
Sbjct: 145 DIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
              +LA E  +    T  SDV++FGV + E++T G+ P
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 7   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 59
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 60  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 114
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 115 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 171
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 172 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 17  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 69
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 70  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 124
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 125 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 181
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 182 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 17  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 69
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 70  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 124
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 125 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 181
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 182 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 7   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 59
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 60  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 114
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 115 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 171
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 172 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 12  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 64
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 65  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 119
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 120 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 176
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 177 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 25  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 77
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 78  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 132
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 133 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 189
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 190 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 10  RPTFYRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 62
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 63  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 117
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 118 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDF 174
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 175 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 24  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 76
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 77  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 131
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 132 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 188
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 189 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 110/236 (46%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + +   + +G G +G V     + +G ++A+K+L        R
Sbjct: 34  RPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLS-------R 86
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T  +    + EF  N+  L  HL G  
Sbjct: 87  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATS---LEEF--NDVYLVTHLMGAD 141
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 142 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 198
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +        D++S G ++ EL+TGR
Sbjct: 199 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 28  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 80
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 81  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 135
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 136 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 192
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 193 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 11  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-------R 63
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 64  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 118
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 119 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 175
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 176 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 16  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 68
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 69  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 123
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 124 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 180
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 181 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 10  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 62
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 63  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 117
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 118 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 174
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 175 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 10/199 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGEREFQA--EVEIISRVHHKHLVSLVGY 108
           +G+G +G V +       E VA+K+++           A  E+ ++  + HK++V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             +  +  LV+EF   +  ++     G    + +      L   KGL + H      ++H
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL--LKGLGFCHSR---NVLH 124
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS- 227
           RD+K  N+L++   E K+ADFGLA+ A  +     +  + T  Y  P+     KL   S 
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLAR-AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 228 DVFSFGVMLLELITGRRPV 246
           D++S G +  EL    RP+
Sbjct: 184 DMWSAGCIFAELANAARPL 202

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 7   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 59
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 60  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 114
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 115 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 171
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 172 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 4   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 56
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 57  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 111
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 112 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 168
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 169 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 1   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-------R 53
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 54  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 108
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 109 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 165
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 166 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLK------AGSGQGE 84
           STF  E++    D +     LG G F  V +      GKE A K +K      +  G   
Sbjct: 3   STFRQEDVE---DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSR 59
Query: 85  REFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR 144
            E + EV I+  + H ++++L   +   +  +L+ E V    L   L  K   T D  T+
Sbjct: 60  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 119
Query: 145 -LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF----EAKVADFGLAKIASDVN 199
            LK  L    G+ YLH     +I H D+K  NI+L  K       K+ DFG+A      N
Sbjct: 120 FLKQILD---GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 173
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
                 + GT  ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 174 EF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 11  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 63
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 64  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 118
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 119 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 175
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 176 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 16  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 68
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 69  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 123
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 124 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDF 180
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 181 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 2   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 54
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 55  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 109
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 110 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 166
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 167 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 10  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 62
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 63  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 117
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 118 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 174
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 175 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 2   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 54
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 55  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 109
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 110 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 166
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 167 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 10  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 62
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 63  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 117
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 118 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDF 174
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 175 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 11  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 63
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 64  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 118
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 119 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 175
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 176 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 108/230 (46%), Gaps = 31/230 (13%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLK---AGSGQ 82
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L         
Sbjct: 17  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIH 76
Query: 83  GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKGRPTMDW 141
            +R ++ E+ ++  + H++++ L+  +T       + EF  N+  L  HL G     +  
Sbjct: 77  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGADLNNIVK 130
Query: 142 LTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA 195
             +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DFGLA+  
Sbjct: 131 CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 187
Query: 196 SDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
            D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 188 DDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 1   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 53
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 54  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 108
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 109 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 165
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 166 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 3   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 55
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 56  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 110
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 111 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 167
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 168 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 113 LNNIVKXQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 105/267 (39%), Gaps = 82/267 (30%)
Query: 52  LGQGGFGYVHRGVL------PNGKEVAIKQLKAGSGQGE-REFQAEVEIISRV-HHKHLV 103
           LG+G FG V +         P  + VA+K LK G+   E +    E++I++ + HH ++V
Sbjct: 35  LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVV 94
Query: 104 SLVGYYTA-GSQRMLVYE-----------------FVPNNTLEFHLHGKG---------- 135
           +L+G  T  G   M++ E                 F  N     H+  K           
Sbjct: 95  NLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHMEPKKEKMEPGLEQG 154
Query: 136 -RPTMDWLTR-------------------------------------LKIALGSAKGLAY 157
            +P +D +T                                      +  +   A+G+ +
Sbjct: 155 KKPRLDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMEDLISYSFQVARGMEF 214
Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV---STRVMGTFGYLA 214
           L      K IHRD+ A NILL      K+ DFGLA+       +V    TR+     ++A
Sbjct: 215 LSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL--PLKWMA 269
Query: 215 PEYASSGKLTEKSDVFSFGVMLLELIT 241
           PE       + KSDV+S+GV+L E+ +
Sbjct: 270 PESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 7   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 59
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 60  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 114
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 115 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDF 171
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 172 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 86/207 (41%), Gaps = 15/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVH 98
           F    LLG+G FG V   +L      G+  A+K LK      + E      E  ++    
Sbjct: 10  FEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 66
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
           H  L +L   +    +   V E+     L FHL  +   + D        + SA  L YL
Sbjct: 67  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYL 124
Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           H +    +++RD+K  N++LD     K+ DFGL K     +        GT  YLAPE  
Sbjct: 125 HSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKXFCGTPEYLAPEVL 181
Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
                    D +  GV++ E++ GR P
Sbjct: 182 EDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 86/207 (41%), Gaps = 15/207 (7%)
Query: 46  FSDANLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVH 98
           F    LLG+G FG V   +L      G+  A+K LK      + E      E  ++    
Sbjct: 12  FEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 68
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
           H  L +L   +    +   V E+     L FHL  +   + D        + SA  L YL
Sbjct: 69  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYL 126
Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           H +    +++RD+K  N++LD     K+ DFGL K     +        GT  YLAPE  
Sbjct: 127 HSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKXFCGTPEYLAPEVL 183
Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
                    D +  GV++ E++ GR P
Sbjct: 184 EDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + +   +G G +G V        G  VA+K+L        R
Sbjct: 15  RPTFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLS-------R 67
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 68  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 122
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 123 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 179
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 180 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 46  FSDANLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVH 98
           F    LLG+G FG V   +L      G+  A+K L+      + E      E  ++    
Sbjct: 12  FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 68
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
           H  L +L   +    +   V E+     L FHL  +   T +        + SA  L YL
Sbjct: 69  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYL 126
Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA-SDVNTHVSTRVMGTFGYLAPEY 217
           H      +++RDIK  N++LD     K+ DFGL K   SD  T       GT  YLAPE 
Sbjct: 127 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEV 181
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRP 245
                     D +  GV++ E++ GR P
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 46  FSDANLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVH 98
           F    LLG+G FG V   +L      G+  A+K L+      + E      E  ++    
Sbjct: 7   FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
           H  L +L   +    +   V E+     L FHL  +   T +        + SA  L YL
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYL 121
Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA-SDVNTHVSTRVMGTFGYLAPEY 217
           H      +++RDIK  N++LD     K+ DFGL K   SD  T       GT  YLAPE 
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEV 176
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRP 245
                     D +  GV++ E++ GR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 46  FSDANLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVH 98
           F    LLG+G FG V   +L      G+  A+K L+      + E      E  ++    
Sbjct: 7   FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
           H  L +L   +    +   V E+     L FHL  +   T +        + SA  L YL
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYL 121
Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA-SDVNTHVSTRVMGTFGYLAPEY 217
           H      +++RDIK  N++LD     K+ DFGL K   SD  T       GT  YLAPE 
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEV 176
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRP 245
                     D +  GV++ E++ GR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 86/208 (41%), Gaps = 18/208 (8%)
Query: 46  FSDANLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVH 98
           F    LLG+G FG V   +L      G+  A+K L+      + E      E  ++    
Sbjct: 7   FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
           H  L +L   +    +   V E+     L FHL  + R   +   R   A      L YL
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGA-EIVSALEYL 121
Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA-SDVNTHVSTRVMGTFGYLAPEY 217
           H      +++RDIK  N++LD     K+ DFGL K   SD  T       GT  YLAPE 
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEV 176
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRP 245
                     D +  GV++ E++ GR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 14/210 (6%)
Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQL--KAGSGQGEREFQAEVEIISRVHH 99
           TD +     LG+G F  V R + +P G+E A K +  K  S +  ++ + E  I   + H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
            ++V L    +      LV++ V    L   +  +     ++ +    +    + L  ++
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILESVN 117
Query: 160 EDCHPK-IIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
             CH   I+HRD+K  N+LL  K +    K+ADFGLA I    +        GT GYL+P
Sbjct: 118 H-CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSP 175
Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           E        +  D+++ GV+L  L+ G  P
Sbjct: 176 EVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 28  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 80
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 81  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 135
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 136 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 192
Query: 190 GLAKIASD-VNTHVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D +  +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 193 GLARHTDDEMXGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 113 LNNIVKXQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDF 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 11  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 63
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 64  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 118
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 119 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDF 175
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 176 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 28/217 (12%)
Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQL--KAGSGQGEREFQAEVEIISRVHH 99
           TD +     +G+G F  V R V L  G E A K +  K  S +  ++ + E  I   + H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTL-------EFHLHGKGRPTMDWLTRLKIALGSA 152
            ++V L    +      LV++ V    L       E++        +  +          
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE-------- 114
Query: 153 KGLAYLHEDCHPK-IIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMG 208
              A LH  CH   ++HRD+K  N+LL  K +    K+ADFGLA I    +        G
Sbjct: 115 ---AVLH--CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAG 168
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T GYL+PE        +  D+++ GV+L  L+ G  P
Sbjct: 169 TPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     +G G FG V               +L   K V +KQ++            E 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   KVADFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 14/210 (6%)
Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQL--KAGSGQGEREFQAEVEIISRVHH 99
           TD +     LG+G F  V R + +P G+E A K +  K  S +  ++ + E  I   + H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
            ++V L    +      LV++ V    L   +  +     ++ +    +    + L  ++
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILESVN 117
Query: 160 EDCHPK-IIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
             CH   I+HRD+K  N+LL  K +    K+ADFGLA I    +        GT GYL+P
Sbjct: 118 H-CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSP 175
Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           E        +  D+++ GV+L  L+ G  P
Sbjct: 176 EVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 52  LGQGGFGYVHRGVLP-NGKEVAIKQLK------AGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G F  V +      GKE A K +K      +  G    E + EV I+  + H ++++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-LKIALGSAKGLAYLHEDCH 163
           L   +   +  +L+ E V    L   L  K   T D  T+ LK  L    G+ YLH    
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHS--- 126
Query: 164 PKIIHRDIKAANILLDFKF----EAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
            +I H D+K  NI+L  K       K+ DFG+A      N      + GT  ++APE  +
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEIVN 184
Query: 220 SGKLTEKSDVFSFGVMLLELITGRRP 245
              L  ++D++S GV+   L++G  P
Sbjct: 185 YEPLGLEADMWSIGVITYILLSGASP 210

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ D+
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDY 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 105/250 (42%), Gaps = 39/250 (15%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSG--------QGEREFQ-AEVEI 93
           + +    +LG+G    V R +  P  KE A+K +    G        Q  RE    EV+I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 94  ISRVH-HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA 152
           + +V  H +++ L   Y   +   LV++ +    L  +L  K   T+      KI     
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALL 134
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           + +  LH+     I+HRD+K  NILLD     K+ DFG +    D    + + V GT  Y
Sbjct: 135 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLRS-VCGTPSY 189
Query: 213 LAPEYASSGK------LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP--L 264
           LAPE              ++ D++S GV++  L+ G  P              W R   L
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-------------WHRKQML 236
Query: 265 LNRAIEDGNF 274
           + R I  GN+
Sbjct: 237 MLRMIMSGNY 246

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 32/207 (15%)
Query: 52  LGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEV---------EIISRVHHKH 101
           +G G +G V   +   +G++VAIK+L        R FQ+E+          ++  + H++
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 102 LVSLVGYYTAGSQRMLVYEF---VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
           ++ L+  +T  S     Y+F   +P    +       + + + +  L   +   KGL Y+
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM--LKGLKYI 142
Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA-SDVNTHVSTRVMGTFGYLAPEY 217
           H      ++HRD+K  N+ ++   E K+ DFGLA+ A +++  +V TR      Y APE 
Sbjct: 143 HS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEV 194
Query: 218 ASSGK-LTEKSDVFSFGVMLLELITGR 243
             S     +  D++S G ++ E++TG+
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T  V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMTGXVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 52  LGQGGFGYVHRGVLP-NGKEVAIKQLK------AGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G F  V +      GKE A K +K      +  G    E + EV I+  + H ++++
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-LKIALGSAKGLAYLHEDCH 163
           L   +   +  +L+ E V    L   L  K   T D  T+ LK  L    G+ YLH    
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL---DGVHYLHS--- 147
Query: 164 PKIIHRDIKAANILLDFKF----EAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
            +I H D+K  NI+L  K       K+ DFG+A      N      + GT  ++APE  +
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEIVN 205
Query: 220 SGKLTEKSDVFSFGVMLLELITGRRP 245
              L  ++D++S GV+   L++G  P
Sbjct: 206 YEPLGLEADMWSIGVITYILLSGASP 231

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 105/251 (41%), Gaps = 41/251 (16%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSG--------QGEREFQ-AEVEI 93
           + +    +LG+G    V R +  P  KE A+K +    G        Q  RE    EV+I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 94  ISRVH-HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA 152
           + +V  H +++ L   Y   +   LV++ +    L  +L  K   T+      KI     
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALL 134
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR-VMGTFG 211
           + +  LH+     I+HRD+K  NILLD     K+ DFG    +  ++     R V GT  
Sbjct: 135 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF---SCQLDPGEKLREVCGTPS 188
Query: 212 YLAPEYASSGK------LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP-- 263
           YLAPE              ++ D++S GV++  L+ G  P              W R   
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-------------WHRKQM 235
Query: 264 LLNRAIEDGNF 274
           L+ R I  GN+
Sbjct: 236 LMLRMIMSGNY 246

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 25  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-------R 77
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 78  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 132
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 133 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 189
Query: 190 GLAKIASD-VNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 243
           GLA+   D +   V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 190 GLARHTDDEMXGXVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 28/208 (13%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQL--KAGSGQGEREFQAEVEIISRVHHKHLVSLVGY 108
           LG+G F  V R V +  G+E A K +  K  S +  ++ + E  I   + H ++V L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 109 YTAGSQRMLVYEFVPNNTL-------EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
            +      L+++ V    L       E++        +  +             A LH  
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE-----------AVLH-- 136
Query: 162 CHPK-IIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
           CH   ++HRD+K  N+LL  K +    K+ADFGLA I  +          GT GYL+PE 
Sbjct: 137 CHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPEV 195
Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRP 245
                  +  D+++ GV+L  L+ G  P
Sbjct: 196 LRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 105/251 (41%), Gaps = 41/251 (16%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSG--------QGEREFQ-AEVEI 93
           + +    +LG+G    V R +  P  KE A+K +    G        Q  RE    EV+I
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 94  ISRVH-HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA 152
           + +V  H +++ L   Y   +   LV++ +    L  +L  K   T+      KI     
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALL 121
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR-VMGTFG 211
           + +  LH+     I+HRD+K  NILLD     K+ DFG    +  ++     R V GT  
Sbjct: 122 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF---SCQLDPGEKLREVCGTPS 175
Query: 212 YLAPEYASSGK------LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP-- 263
           YLAPE              ++ D++S GV++  L+ G  P              W R   
Sbjct: 176 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-------------WHRKQM 222
Query: 264 LLNRAIEDGNF 274
           L+ R I  GN+
Sbjct: 223 LMLRMIMSGNY 233

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 97/213 (45%), Gaps = 21/213 (9%)
Query: 43  TDGFSDANLLGQGGFGYV--HRGVLPNGKEVAIKQLKAGSGQGEREFQA---EVEIISRV 97
           +D +     LG G +G V   +  L  G E AIK +K  S        A   EV ++ ++
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTL--EFHLHGKGRPTMDWLTRLKIALGSAKGL 155
            H +++ L  ++       LV E      L  E  L  K    +D    +K  L    G 
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKF-SEVDAAVIMKQVLS---GT 134
Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMGTFGY 212
            YLH+     I+HRD+K  N+LL+ K      K+ DFGL+    +V   +  R +GT  Y
Sbjct: 135 TYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSA-HFEVGGKMKER-LGTAYY 189
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           +APE     K  EK DV+S GV+L  L+ G  P
Sbjct: 190 IAPEVLRK-KYDEKCDVWSCGVILYILLCGYPP 221

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 26/240 (10%)
Query: 46  FSDANLLGQGGFGYVHRGVLPNG-KEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           + D   LG GG G V   V  +  K VAIK++     Q  +    E++II R+ H ++V 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 105 L--------------VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
           +              VG  T  +   +V E++  +       G   P ++   RL     
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG---PLLEEHARL-FMYQ 128
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAKIASDVNTHVSTRVMG- 208
             +GL Y+H      ++HRD+K AN+ ++ +    K+ DFGLA+I     +H      G 
Sbjct: 129 LLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 209 -TFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN 266
            T  Y +P    S    T+  D+++ G +  E++TG+      H   +  L+  + P+++
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 88/209 (42%), Gaps = 19/209 (9%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHH 99
           D F     LG G FG V     +  G   A+K L        +E +    E  I+  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIALGSAKGLA 156
             LV L   +   S   +V E+ P   +  HL   GR   P   +    +I L       
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA-QIVLT----FE 155
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE 216
           YLH      +I+RD+K  N+++D +   KV DFGLAK         +  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG----RTWXLCGTPEYLAPE 208
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
              S    +  D ++ GV++ E+  G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 97/213 (45%), Gaps = 21/213 (9%)
Query: 43  TDGFSDANLLGQGGFGYV--HRGVLPNGKEVAIKQLKAGSGQGEREFQA---EVEIISRV 97
           +D +     LG G +G V   +  L  G E AIK +K  S        A   EV ++ ++
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTL--EFHLHGKGRPTMDWLTRLKIALGSAKGL 155
            H +++ L  ++       LV E      L  E  L  K    +D    +K  L    G 
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKF-SEVDAAVIMKQVLS---GT 117
Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMGTFGY 212
            YLH+     I+HRD+K  N+LL+ K      K+ DFGL+    +V   +  R +GT  Y
Sbjct: 118 TYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSA-HFEVGGKMKER-LGTAYY 172
Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           +APE     K  EK DV+S GV+L  L+ G  P
Sbjct: 173 IAPEVLRK-KYDEKCDVWSCGVILYILLCGYPP 204

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 108/266 (40%), Gaps = 38/266 (14%)
Query: 32  STFT----YEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLK---AGSGQGE 84
           STFT    Y++L     G        QG        VL  G  VA+K+L          +
Sbjct: 16  STFTVLKRYQQLKPIGSG-------AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAK 66
Query: 85  REFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPT 138
           R ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +          
Sbjct: 67  RAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHER 125
Query: 139 MDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV 198
           M +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ AS  
Sbjct: 126 MSYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAS-- 175
Query: 199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV 258
              + T  + T  Y APE        E  D++S G ++ EL+ G      T     D + 
Sbjct: 176 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT-----DHID 230
Query: 259 DWARPLLNRAIEDGNFDTLVDPKLHN 284
            W + +         F   + P + N
Sbjct: 231 QWNKVIEQLGTPSAEFMAALQPTVRN 256

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 54/218 (24%)
Query: 52  LGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEV---------EIISRVHHKH 101
           +G G +G V   +   +G++VAIK+L        R FQ+E+          ++  + H++
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS---------- 151
           ++ L+  +T  S           N  +F+L     P M   T L+  +G           
Sbjct: 103 VIGLLDVFTPASSL--------RNFYDFYL---VMPFMQ--TDLQKIMGMEFSEEKIQYL 149
Query: 152 ----AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA-SDVNTHVSTRV 206
                KGL Y+H      ++HRD+K  N+ ++   E K+ DFGLA+ A +++  +V TR 
Sbjct: 150 VYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR- 205
Query: 207 MGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
                Y APE   S     +  D++S G ++ E++TG+
Sbjct: 206 ----WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 25/223 (11%)
Query: 52  LGQGGFGYVHRGVLPN-GKEVAIKQLKAGS-GQGER-EFQAEVEIISRVHH-KHLVSLVG 107
           LG+G F  V + +  + G+E A K LK    GQ  R E   E+ ++        +++L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTM----DWLTRLKIALGSAKGLAYLHEDCH 163
            Y   S+ +L+ E+     + F L       M    D +  +K  L   +G+ YLH++  
Sbjct: 97  VYENTSEIILILEYAAGGEI-FSLCLPELAEMVSENDVIRLIKQIL---EGVYYLHQN-- 150
Query: 164 PKIIHRDIKAANILLDFKF---EAKVADFGLA-KIASDVNTHVSTRVMGTFGYLAPEYAS 219
             I+H D+K  NILL   +   + K+ DFG++ KI           +MGT  YLAPE  +
Sbjct: 151 -NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---EIMGTPEYLAPEILN 206
Query: 220 SGKLTEKSDVFSFGVMLLELITGRRPV---DSTHTFVEDSLVD 259
              +T  +D+++ G++   L+T   P    D+  T++  S V+
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN 249

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 169
Query: 190 GLAKIASD-VNTHVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D +   V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMAGFVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 44  DGFSDANLLGQGGFG--YVHRGVL--PNGKEVAIKQLKAGS----GQGEREFQAEVEIIS 95
           + F    +LG G +G  ++ R +     GK  A+K LK  +     +     + E +++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 96  RVHHK-HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS-AK 153
            +     LV+L   +   ++  L+ +++    L  HL  + R T      ++I +G    
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYVGEIVL 170
Query: 154 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL 213
            L +LH+     II+RDIK  NILLD      + DFGL+K      T  +    GT  Y+
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 214 APEYASSGKL--TEKSDVFSFGVMLLELITGRRP 245
           AP+    G     +  D +S GV++ EL+TG  P
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 169
Query: 190 GLAKIASD-VNTHVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D +   V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMAGFVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 93
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-QIV 152
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 153 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 201
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 93
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-QIV 152
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 153 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 201
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 93
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-QIV 152
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 153 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 201
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     +G G FG V               +L   K V +KQ++            E 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E++P   +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   KVADFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     +G G FG V               +L   K V +KQ++            E 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E++P   +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   KVADFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 85
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA-QIV 144
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 145 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 193
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 85
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-QIV 144
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 145 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 193
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 1   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-------R 53
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 54  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 108
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 109 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 165
Query: 190 GLAKIASD-VNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 243
           GLA+   D +   V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 166 GLARHTDDEMAGFVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V               +L   K V +KQ++            E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 93
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-QIV 152
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK    V     T + G
Sbjct: 153 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWT-LCG 201
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 37/241 (15%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  VL   + VAIK+L          +R
Sbjct: 56  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKR 107
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +          M
Sbjct: 108 AYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 166
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 167 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 216
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI------TGRRPVDSTHTFV 253
           + + T  + T  Y APE        E  D++S G ++ E++       GR  +D  +  +
Sbjct: 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 276
Query: 254 E 254
           E
Sbjct: 277 E 277

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 113
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 114 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-QIV 172
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 173 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 221
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 10/199 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGEREFQA--EVEIISRVHHKHLVSLVGY 108
           +G+G +G V +       E VA+K+++           A  E+ ++  + HK++V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             +  +  LV+EF   +  ++     G    + +      L   KGL + H      ++H
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL--LKGLGFCHSR---NVLH 124
Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS- 227
           RD+K  N+L++   E K+A+FGLA+ A  +     +  + T  Y  P+     KL   S 
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 228 DVFSFGVMLLELITGRRPV 246
           D++S G +  EL    RP+
Sbjct: 184 DMWSAGCIFAELANAGRPL 202

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V               +L   K V +KQ++            E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 93
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-QIV 152
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 153 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 201
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V               +L   K V +KQ++            E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V               +L   K V +KQ++            E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V               +L   K V +KQ++            E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V               +L   K V +KQ++            E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V               +L   K V +KQ++            E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 93
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA-QIV 152
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 153 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 201
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V               +L   K V +KQ++            E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 37/241 (15%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  VL   + VAIK+L          +R
Sbjct: 18  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKR 69
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +          M
Sbjct: 70  AYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 128
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 129 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 178
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI------TGRRPVDSTHTFV 253
           + + T  + T  Y APE        E  D++S G ++ E++       GR  +D  +  +
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238
Query: 254 E 254
           E
Sbjct: 239 E 239

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 88/209 (42%), Gaps = 19/209 (9%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHH 99
           D F     LG G FG V     +  G   A+K L        +E +    E  I+  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIALGSAKGLA 156
             LV L   +   S   +V E+ P   +  HL   GR   P   +    +I L       
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA-QIVLT----FE 155
Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE 216
           YLH      +I+RD+K  N+++D +   +V DFGLAK         +  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG----RTWXLCGTPEYLAPE 208
Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
              S    +  D ++ GV++ E+  G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V               +L   K V +KQ++            E 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 78
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+VP   +  HL   GR   P   +    +I 
Sbjct: 79  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA-QIV 137
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK    V     T + G
Sbjct: 138 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWT-LCG 186
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 187 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
            LA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 YLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 93
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I   V+   LV L   +   S   +V E+ P   +  HL   GR   P   +    +I 
Sbjct: 94  RIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAA-QIV 152
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   KVADFG AK         +  + G
Sbjct: 153 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCG 201
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 37/241 (15%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  VL   + VAIK+L          +R
Sbjct: 19  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKR 70
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +          M
Sbjct: 71  AYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 129
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 130 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 179
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI------TGRRPVDSTHTFV 253
           + + T  + T  Y APE        E  D++S G ++ E++       GR  +D  +  +
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 239
Query: 254 E 254
           E
Sbjct: 240 E 240

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+  F
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGF 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 37/241 (15%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  VL   + VAIK+L          +R
Sbjct: 19  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKR 70
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +          M
Sbjct: 71  AYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 129
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 130 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 179
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI------TGRRPVDSTHTFV 253
           + + T  + T  Y APE        E  D++S G ++ E++       GR  +D  +  +
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 239
Query: 254 E 254
           E
Sbjct: 240 E 240

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 28/217 (12%)
Query: 49  ANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA-EVEIISRVHHKHLVSLV 106
           +++LGQG    V RG     G   AIK     S     + Q  E E++ +++HK++V L 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 107 GYY--TAGSQRMLVYEFVPNNTLEFHL----HGKGRPTMDWLTRLKIALGSAKGLAYLHE 160
                T    ++L+ EF P  +L   L    +  G P  ++L  L+  +G   G+ +L E
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG---GMNHLRE 130
Query: 161 DCHPKIIHRDIKAANILL----DFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE 216
           +    I+HR+IK  NI+     D +   K+ DFG A+   D    VS  + GT  YL P+
Sbjct: 131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPD 185
Query: 217 YASSGKLTE--------KSDVFSFGVMLLELITGRRP 245
                 L +          D++S GV      TG  P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 37/241 (15%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  VL   + VAIK+L          +R
Sbjct: 56  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKR 107
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +          M
Sbjct: 108 AYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 166
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 167 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 216
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI------TGRRPVDSTHTFV 253
           + + T  + T  Y APE        E  D++S G ++ E++       GR  +D  +  +
Sbjct: 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 276
Query: 254 E 254
           E
Sbjct: 277 E 277

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ DF
Sbjct: 113 LNNIVKSQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDF 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GL +   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLCRHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 37/241 (15%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  VL   + VAIK+L          +R
Sbjct: 18  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKR 69
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +          M
Sbjct: 70  AYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 128
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 129 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 178
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI------TGRRPVDSTHTFV 253
           + + T  + T  Y APE        E  D++S G ++ E++       GR  +D  +  +
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238
Query: 254 E 254
           E
Sbjct: 239 E 239

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 37/241 (15%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  VL   + VAIK+L          +R
Sbjct: 17  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKR 68
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +          M
Sbjct: 69  AYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 127
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 128 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 177
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI------TGRRPVDSTHTFV 253
           + + T  + T  Y APE        E  D++S G ++ E++       GR  +D  +  +
Sbjct: 178 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 237
Query: 254 E 254
           E
Sbjct: 238 E 238

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 37/241 (15%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT          + +   +G G  G V   +  VL   + VAIK+L          +R
Sbjct: 11  STFT------VLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKR 62
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +          M
Sbjct: 63  AYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 121
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 122 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 171
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI------TGRRPVDSTHTFV 253
           + + T  + T  Y APE        E  D++S G ++ E++       GR  +D  +  +
Sbjct: 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231
Query: 254 E 254
           E
Sbjct: 232 E 232

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 37/241 (15%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT          + +   +G G  G V   +  VL   + VAIK+L          +R
Sbjct: 12  STFT------VLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKR 63
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +          M
Sbjct: 64  AYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 122
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 123 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 172
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI------TGRRPVDSTHTFV 253
           + + T  + T  Y APE        E  D++S G ++ E++       GR  +D  +  +
Sbjct: 173 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 232
Query: 254 E 254
           E
Sbjct: 233 E 233

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ D 
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDA 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 37/241 (15%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  VL   + VAIK+L          +R
Sbjct: 12  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKR 63
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +          M
Sbjct: 64  AYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 122
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 123 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 172
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI------TGRRPVDSTHTFV 253
           + + T  + T  Y APE        E  D++S G ++ E++       GR  +D  +  +
Sbjct: 173 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 232
Query: 254 E 254
           E
Sbjct: 233 E 233

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 110/238 (46%), Gaps = 45/238 (18%)
Query: 36  YEELARATDGFSDANLLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREFQA-- 89
           YE+LA+          +GQG FG V    HR     G++VA+K++   + +      A  
Sbjct: 20  YEKLAK----------IGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPITALR 66
Query: 90  EVEIISRVHHKHLVSLV--------GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW 141
           E++I+  + H+++V+L+         Y    +   LV++F  ++      +   + T+  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSE 126
Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH 201
           + R+   L    GL Y+H +   KI+HRD+KAAN+L+      K+ADFGLA+  S     
Sbjct: 127 IKRVMQML--LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 202 VSTRVMG---TFGYLAPEYASSGKLTEKS-----DVFSFGVMLLELITGRRPVDSTHT 251
              R      T  Y  PE      L E+      D++  G ++ E+ T R P+   +T
Sbjct: 182 QPNRYXNRVVTLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNT 234

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 86/179 (48%), Gaps = 31/179 (17%)
Query: 81  GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD 140
           G  E+ +Q E+ I+ ++ H ++V LV      ++  L         + F L  +G P M+
Sbjct: 78  GPIEQVYQ-EIAILKKLDHPNVVKLVEVLDDPNEDHL--------YMVFELVNQG-PVME 127
Query: 141 WLTRLKIALGSA--------KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 192
             T   ++   A        KG+ YLH   + KIIHRDIK +N+L+      K+ADFG++
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 193 KIASDVNTHVSTRVMGTFGYLAPEYAS------SGKLTEKSDVFSFGVMLLELITGRRP 245
                 +  +S  V GT  ++APE  S      SGK     DV++ GV L   + G+ P
Sbjct: 185 NEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKAL---DVWAMGVTLYCFVFGQCP 239

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 37/241 (15%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT          + +   +G G  G V   +  VL   + VAIK+L          +R
Sbjct: 18  STFT------VLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKR 69
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +          M
Sbjct: 70  AYR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 128
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 129 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG--T 178
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI------TGRRPVDSTHTFV 253
           + + T  + T  Y APE        E  D++S G ++ E++       GR  +D  +  +
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238
Query: 254 E 254
           E
Sbjct: 239 E 239

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 31/229 (13%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLK--------AGSGQGEREFQAEVEII 94
           D +  +  LG G  G V         K+VAIK +         A         + E+EI+
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
            +++H  ++ +  ++ A     +V E +    L   + G  R        +  ++ +A+ 
Sbjct: 76  KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV- 133
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVM 207
                 YLHE+    IIHRD+K  N+LL  + E    K+ DFG +KI  +  T +   + 
Sbjct: 134 -----QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLC 183
Query: 208 GTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFV 253
           GT  YLAPE   S          D +S GV+L   ++G  P     T V
Sbjct: 184 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 232

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTF 210
           AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +           
Sbjct: 208 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 264
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            ++APE       T +SDV+SFGV+L E+ +
Sbjct: 265 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 31/229 (13%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLK--------AGSGQGEREFQAEVEII 94
           D +  +  LG G  G V         K+VAIK +         A         + E+EI+
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
            +++H  ++ +  ++ A     +V E +    L   + G  R        +  ++ +A+ 
Sbjct: 70  KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV- 127
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVM 207
                 YLHE+    IIHRD+K  N+LL  + E    K+ DFG +KI  +  T +   + 
Sbjct: 128 -----QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLC 177
Query: 208 GTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFV 253
           GT  YLAPE   S          D +S GV+L   ++G  P     T V
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 31/229 (13%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLK--------AGSGQGEREFQAEVEII 94
           D +  +  LG G  G V         K+VAIK +         A         + E+EI+
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
            +++H  ++ +  ++ A     +V E +    L   + G  R        +  ++ +A+ 
Sbjct: 70  KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV- 127
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVM 207
                 YLHE+    IIHRD+K  N+LL  + E    K+ DFG +KI  +  T +   + 
Sbjct: 128 -----QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLC 177
Query: 208 GTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFV 253
           GT  YLAPE   S          D +S GV+L   ++G  P     T V
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 31/229 (13%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLK--------AGSGQGEREFQAEVEII 94
           D +  +  LG G  G V         K+VAIK +         A         + E+EI+
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
            +++H  ++ +  ++ A     +V E +    L   + G  R        +  ++ +A+ 
Sbjct: 69  KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV- 126
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVM 207
                 YLHE+    IIHRD+K  N+LL  + E    K+ DFG +KI  +  T +   + 
Sbjct: 127 -----QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLC 176
Query: 208 GTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFV 253
           GT  YLAPE   S          D +S GV+L   ++G  P     T V
Sbjct: 177 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 225

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 31/229 (13%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLK--------AGSGQGEREFQAEVEII 94
           D +  +  LG G  G V         K+VAIK +         A         + E+EI+
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR----PTMDWLTRLKIALG 150
            +++H  ++ +  ++ A     +V E +    L   + G  R        +  ++ +A+ 
Sbjct: 70  KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV- 127
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVM 207
                 YLHE+    IIHRD+K  N+LL  + E    K+ DFG +KI  +  T +   + 
Sbjct: 128 -----QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLC 177
Query: 208 GTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFV 253
           GT  YLAPE   S          D +S GV+L   ++G  P     T V
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ D 
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDR 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTF 210
           AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +           
Sbjct: 203 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            ++APE       T +SDV+SFGV+L E+ +
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 93
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+ P   +  HL   GR   P   +    +I 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA-QIV 152
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+++D +   KV DFG AK         +  + G
Sbjct: 153 LT----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCG 201
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTF 210
           AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +           
Sbjct: 210 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 266
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            ++APE       T +SDV+SFGV+L E+ +
Sbjct: 267 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 109/238 (45%), Gaps = 45/238 (18%)
Query: 36  YEELARATDGFSDANLLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREFQA-- 89
           YE+LA+          +GQG FG V    HR     G++VA+K++   + +      A  
Sbjct: 20  YEKLAK----------IGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPITALR 66
Query: 90  EVEIISRVHHKHLVSLV--------GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW 141
           E++I+  + H+++V+L+         Y        LV++F  ++      +   + T+  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 126
Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH 201
           + R+   L    GL Y+H +   KI+HRD+KAAN+L+      K+ADFGLA+  S     
Sbjct: 127 IKRVMQML--LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 202 VSTRVMG---TFGYLAPEYASSGKLTEKS-----DVFSFGVMLLELITGRRPVDSTHT 251
              R      T  Y  PE      L E+      D++  G ++ E+ T R P+   +T
Sbjct: 182 QPNRYXNRVVTLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNT 234

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTF 210
           AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +           
Sbjct: 201 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 257
Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
            ++APE       T +SDV+SFGV+L E+ +
Sbjct: 258 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 46  FSDANLLGQGGFG-YVHRGVLPNGKEVAIKQ-LKAGSGQGEREFQAEVEIISRVHHKHLV 103
           F   ++LG G  G  V+RG+  N ++VA+K+ L       +RE Q     + R   +H  
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDN-RDVAVKRILPECFSFADREVQ-----LLRESDEH-P 78
Query: 104 SLVGYYTAGSQRMLVYEFV--PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
           +++ Y+     R   Y  +     TL+ ++  K    +  L  + +   +  GLA+LH  
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLG-LEPITLLQQTTSGLAHLHS- 136
Query: 162 CHPKIIHRDIKAANILLDF-----KFEAKVADFGLAKIASDVNTHVSTR---VMGTFGYL 213
               I+HRD+K  NIL+       K +A ++DFGL K  + V  H  +R   V GT G++
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA-VGRHSFSRRSGVPGTEGWI 193
Query: 214 APEYASSG---KLTEKSDVFSFGVMLLELIT 241
           APE  S       T   D+FS G +   +I+
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 37/241 (15%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  VL   + VAIK+L          +R
Sbjct: 18  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKR 69
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +          M
Sbjct: 70  AYR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERM 128
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 129 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG--T 178
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI------TGRRPVDSTHTFV 253
           + + T  + T  Y APE        E  D++S G ++ E++       GR  +D  +  +
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238
Query: 254 E 254
           E
Sbjct: 239 E 239

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 34/218 (15%)
Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHK 100
           TDG+     +G G +    R +      E A+K +     + +R+   E+EI+ R   H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEILLRYGQHP 76
Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK---------IALGS 151
           ++++L   Y  G    +V E +           KG   +D + R K         +    
Sbjct: 77  NIITLKDVYDDGKYVYVVTELM-----------KGGELLDKILRQKFFSEREASAVLFTI 125
Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKF----EAKVADFGLAKIASDVNTHVSTRVM 207
            K + YLH      ++HRD+K +NIL   +       ++ DFG AK     N  + T   
Sbjct: 126 TKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY 182
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
            T  ++APE           D++S GV+L  ++TG  P
Sbjct: 183 -TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 28/221 (12%)
Query: 39  LARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVA--IKQLKAGSGQGEREFQAEVEIIS 95
             R T+ +     LG+G F  V R V +  G+E A  I   K  S +  ++ + E  I  
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 96  RVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL-------EFHLHGKGRPTMDWLTRLKIA 148
            + H ++V L    +      L+++ V    L       E++        +  +      
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE---- 121
Query: 149 LGSAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVST 204
                  A LH  CH   ++HR++K  N+LL  K +    K+ADFGLA I  +       
Sbjct: 122 -------AVLH--CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWF 171
Query: 205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
              GT GYL+PE        +  D+++ GV+L  L+ G  P
Sbjct: 172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 43/236 (18%)
Query: 31  KSTFTYEELARAT----DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER 85
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L        R
Sbjct: 5   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------R 57
Query: 86  EFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT-LEFHLHGKG 135
            FQ+         E+ ++  + H++++ L+  +T       + EF  N+  L  HL G  
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEF--NDVYLVTHLMGAD 112
Query: 136 RPTMDWLTRLK------IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
              +    +L       +     +GL Y+H      IIHRD+K +N+ ++   E K+ D 
Sbjct: 113 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDG 169
Query: 190 GLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           GLA+   D  T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 170 GLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 41  RATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER------EFQAEVEI 93
           +  D +     LG G F  V +      G E A K +K    +  R      E + EV I
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 94  ISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSA 152
           + +V H ++++L   Y   +  +L+ E V    L +F    +     +  + +K  L   
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD-- 126
Query: 153 KGLAYLHEDCHPKIIHRDIKAANI-LLDFKF---EAKVADFGLAKIASDVNTHVSTR-VM 207
            G+ YLH     KI H D+K  NI LLD        K+ DFGLA    ++   V  + + 
Sbjct: 127 -GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIF 179
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           GT  ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGS-GQGEREFQAEVEIISR 96
           D +     LG G F  V +      G+    K +  ++ K+   G    + + EV I+  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-LKIALGSAKGL 155
           + H ++++L   Y   +  +L+ E V    L   L  K   T +  T  LK  L    G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GV 127
Query: 156 AYLHEDCHPKIIHRDIKAANI-LLDF---KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
            YLH     +I H D+K  NI LLD    K   K+ DFGLA      N      + GT  
Sbjct: 128 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPA 182
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 32/226 (14%)
Query: 51  LLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGEREFQ------AEVEIISRVH----H 99
           LLG+GGFG V  G  L +  +VAIK +      G            EV ++ +V     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 100 KHLVSLVGYYTAGSQRMLVYE-FVPNNTLEFHLHGKGR----PTMDWLTRLKIALGSAKG 154
             ++ L+ ++      MLV E  +P   L  ++  KG     P+  +  ++  A+     
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI----- 152
Query: 155 LAYLHEDCHPK-IIHRDIKAANILLDFKF-EAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
                + CH + ++HRDIK  NIL+D +   AK+ DFG   +  D      T   GT  Y
Sbjct: 153 -----QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTDFDGTRVY 204
Query: 213 LAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL 257
             PE+ S  +     + V+S G++L +++ G  P +     +E  L
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL 250

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 87/217 (40%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V               +L   K V +KQ++            E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+ P   +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+++D +   KV DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 29/228 (12%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLK--------AGSGQGEREFQAEVEII 94
           D +  +  LG G  G V         K+VAI+ +         A         + E+EI+
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKG 154
            +++H  ++ +  ++ A     +V E +    L   + G  R     L      L   + 
Sbjct: 195 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKR-----LKEATCKLYFYQM 248
Query: 155 L---AYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMG 208
           L    YLHE+    IIHRD+K  N+LL  + E    K+ DFG +KI  +  T +   + G
Sbjct: 249 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCG 303
Query: 209 TFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFV 253
           T  YLAPE   S          D +S GV+L   ++G  P     T V
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 109/238 (45%), Gaps = 45/238 (18%)
Query: 36  YEELARATDGFSDANLLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREFQA-- 89
           YE+LA+          +GQG FG V    HR     G++VA+K++   + +      A  
Sbjct: 20  YEKLAK----------IGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPITALR 66
Query: 90  EVEIISRVHHKHLVSLV--------GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW 141
           E++I+  + H+++V+L+         Y        LV++F  ++      +   + T+  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 126
Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH 201
           + R+   L    GL Y+H +   KI+HRD+KAAN+L+      K+ADFGLA+  S     
Sbjct: 127 IKRVMQML--LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 202 VSTRVMG---TFGYLAPEYASSGKLTEKS-----DVFSFGVMLLELITGRRPVDSTHT 251
              R      T  Y  PE      L E+      D++  G ++ E+ T R P+   +T
Sbjct: 182 QPNRYXNRVVTLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNT 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 87/217 (40%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V               +L   K V +KQ++            E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+ P   +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+++D +   KV DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 109/238 (45%), Gaps = 45/238 (18%)
Query: 36  YEELARATDGFSDANLLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREFQA-- 89
           YE+LA+          +GQG FG V    HR     G++VA+K++   + +      A  
Sbjct: 19  YEKLAK----------IGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPITALR 65
Query: 90  EVEIISRVHHKHLVSLV--------GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW 141
           E++I+  + H+++V+L+         Y        LV++F  ++      +   + T+  
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 125
Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH 201
           + R+   L    GL Y+H +   KI+HRD+KAAN+L+      K+ADFGLA+  S     
Sbjct: 126 IKRVMQML--LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 202 VSTRVMG---TFGYLAPEYASSGKLTEKS-----DVFSFGVMLLELITGRRPVDSTHT 251
              R      T  Y  PE      L E+      D++  G ++ E+ T R P+   +T
Sbjct: 181 QPNRYXNRVVTLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNT 233

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 29/228 (12%)
Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLK--------AGSGQGEREFQAEVEII 94
           D +  +  LG G  G V         K+VAI+ +         A         + E+EI+
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKG 154
            +++H  ++ +  ++ A     +V E +    L   + G  R     L      L   + 
Sbjct: 209 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKR-----LKEATCKLYFYQM 262
Query: 155 L---AYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMG 208
           L    YLHE+    IIHRD+K  N+LL  + E    K+ DFG +KI  +  T +   + G
Sbjct: 263 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCG 317
Query: 209 TFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFV 253
           T  YLAPE   S          D +S GV+L   ++G  P     T V
Sbjct: 318 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 365

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG+GGF YV     L +G   A+K++     Q   E Q E ++    +H +++ LV Y  
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 111 ----AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR---LKIALGSAKGLAYLHEDCH 163
               A  +  L+  F    TL   +  + +   ++LT    L + LG  +GL  +H   +
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIE-RLKDKGNFLTEDQILWLLLGICRGLEAIHAKGY 155
Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM---------GTFGYLA 214
               HRD+K  NILL  + +  + D G    A  ++   S + +          T  Y A
Sbjct: 156 A---HRDLKPTNILLGDEGQPVLMDLGSMNQAC-IHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 215 PEY---ASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
           PE     S   + E++DV+S G +L  ++ G  P D
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 37/241 (15%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  VL   + VAIK+L          +R
Sbjct: 18  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKR 69
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +          M
Sbjct: 70  AYR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERM 128
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 129 SYLLYQMLX-----GIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG--T 178
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI------TGRRPVDSTHTFV 253
           + + T  + T  Y APE        E  D++S G ++ E++       GR  +D  +  +
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238
Query: 254 E 254
           E
Sbjct: 239 E 239

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 26/220 (11%)
Query: 39  LARATDGFSDANLLGQGGFGYVHRGV--LPNGKEVA-IKQLKAGSGQGEREFQAEVEIIS 95
             R TD +     LG+G F  V R V   P  +  A I   K  S +  ++ + E  I  
Sbjct: 26  CTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICR 85
Query: 96  RVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL-------EFHLHGKGRPTMDWLTRLKIA 148
            + H ++V L    +      LV++ V    L       E++        +  +      
Sbjct: 86  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQIL----- 140
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTR 205
               + + ++H+     I+HRD+K  N+LL  K +    K+ADFGLA I           
Sbjct: 141 ----ESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFG 192
Query: 206 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
             GT GYL+PE        +  D+++ GV+L  L+ G  P
Sbjct: 193 FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 99/243 (40%), Gaps = 37/243 (15%)
Query: 36  YEELARATDG-------FSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGERE-- 86
           YE++ +   G       +    ++G+G FG V        ++V   +L +     +R   
Sbjct: 60  YEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDS 119
Query: 87  --FQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW--- 141
             F  E +I++  +   +V L   +       +V E++P   L   +     P   W   
Sbjct: 120 AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKF 178
Query: 142 -LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KIASDVN 199
               + +AL +   +          +IHRD+K  N+LLD     K+ADFG   K+     
Sbjct: 179 YTAEVVLALDAIHSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 229
Query: 200 THVSTRVMGTFGYLAPEYASS----GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED 255
            H  T V GT  Y++PE   S    G    + D +S GV L E++ G  P      F  D
Sbjct: 230 VHCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP------FYAD 282
Query: 256 SLV 258
           SLV
Sbjct: 283 SLV 285

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 28/217 (12%)
Query: 49  ANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA-EVEIISRVHHKHLVSLV 106
           +++LGQG    V RG     G   AIK     S     + Q  E E++ +++HK++V L 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 107 GYY--TAGSQRMLVYEFVPNNTLEFHL----HGKGRPTMDWLTRLKIALGSAKGLAYLHE 160
                T    ++L+ EF P  +L   L    +  G P  ++L  L+  +G   G+ +L E
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG---GMNHLRE 130
Query: 161 DCHPKIIHRDIKAANILL----DFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE 216
           +    I+HR+IK  NI+     D +   K+ DFG A+   D    V   + GT  YL P+
Sbjct: 131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX--LYGTEEYLHPD 185
Query: 217 YASSGKLTE--------KSDVFSFGVMLLELITGRRP 245
                 L +          D++S GV      TG  P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGS-GQGEREFQAEVEIISR 96
           D +     LG G F  V +      G+    K +  ++ K+   G    + + EV I+  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-LKIALGSAKGL 155
           + H ++++L   Y   +  +L+ E V    L   L  K   T +  T  LK  L    G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GV 127
Query: 156 AYLHEDCHPKIIHRDIKAANI-LLDF---KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
            YLH     +I H D+K  NI LLD    K   K+ DFGLA      N      + GT  
Sbjct: 128 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPE 182
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 37/241 (15%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  VL   + VAIK+L          +R
Sbjct: 18  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKR 69
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +          M
Sbjct: 70  AYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERM 128
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 129 SYLLYQMLX-----GIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG--T 178
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI------TGRRPVDSTHTFV 253
           + + T  + T  Y APE        E  D++S G ++ E++       GR  +D  +  +
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238
Query: 254 E 254
           E
Sbjct: 239 E 239

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 113
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 114 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIV 172
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 173 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----ATWTLCG 221
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 37/241 (15%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT          + +   +G G  G V   +  VL   + VAIK+L          +R
Sbjct: 11  STFT------VLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKR 62
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +          M
Sbjct: 63  AYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERM 121
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 122 SYLLYQMLX-----GIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG--T 171
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI------TGRRPVDSTHTFV 253
           + + T  + T  Y APE        E  D++S G ++ E++       GR  +D  +  +
Sbjct: 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231
Query: 254 E 254
           E
Sbjct: 232 E 232

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGS-GQGEREFQAEVEIISR 96
           D +     LG G F  V +      G+    K +  ++ K+   G    + + EV I+  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-LKIALGSAKGL 155
           + H ++++L   Y   +  +L+ E V    L   L  K   T +  T  LK  L    G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GV 127
Query: 156 AYLHEDCHPKIIHRDIKAANI-LLDF---KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
            YLH     +I H D+K  NI LLD    K   K+ DFGLA      N      + GT  
Sbjct: 128 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPE 182
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 38/220 (17%)
Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHK 100
           +DG+     +G G +    R V      E A+K +     + +R+   E+EI+ R   H 
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVID----KSKRDPSEEIEILLRYGQHP 81
Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK---------IALGS 151
           ++++L   Y  G    LV E +           +G   +D + R K         +    
Sbjct: 82  NIITLKDVYDDGKHVYLVTELM-----------RGGELLDKILRQKFFSEREASFVLHTI 130
Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA------KVADFGLAKIASDVNTHVSTR 205
            K + YLH      ++HRD+K +NIL  +  E+      ++ DFG AK     N  + T 
Sbjct: 131 GKTVEYLHSQ---GVVHRDLKPSNIL--YVDESGNPECLRICDFGFAKQLRAENGLLMTP 185
Query: 206 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
              T  ++APE        E  D++S G++L  ++ G  P
Sbjct: 186 CY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGS-GQGEREFQAEVEIISR 96
           D +     LG G F  V +      G+    K +  ++ K+   G    + + EV I+  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-LKIALGSAKGL 155
           + H ++++L   Y   +  +L+ E V    L   L  K   T +  T  LK  L    G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GV 126
Query: 156 AYLHEDCHPKIIHRDIKAANI-LLDF---KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
            YLH     +I H D+K  NI LLD    K   K+ DFGLA      N      + GT  
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPE 181
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 38/220 (17%)
Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHK 100
           +DG+     +G G +    R V      E A+K +     + +R+   E+EI+ R   H 
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVID----KSKRDPSEEIEILLRYGQHP 81
Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK---------IALGS 151
           ++++L   Y  G    LV E +           +G   +D + R K         +    
Sbjct: 82  NIITLKDVYDDGKHVYLVTELM-----------RGGELLDKILRQKFFSEREASFVLHTI 130
Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA------KVADFGLAKIASDVNTHVSTR 205
            K + YLH      ++HRD+K +NIL  +  E+      ++ DFG AK     N  + T 
Sbjct: 131 GKTVEYLHSQ---GVVHRDLKPSNIL--YVDESGNPECLRICDFGFAKQLRAENGLLMTP 185
Query: 206 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
              T  ++APE        E  D++S G++L  ++ G  P
Sbjct: 186 CY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 41  RATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGER------EFQAEVEI 93
           +  D +     LG G F  V +      G E A K +K    +  R      E + EV I
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 94  ISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSA 152
           + +V H ++++L   Y   +  +L+ E V    L +F    +     +  + +K  L   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD-- 126
Query: 153 KGLAYLHEDCHPKIIHRDIKAANI-LLDFKF---EAKVADFGLAKIASDVNTHVSTR-VM 207
            G+ YLH     KI H D+K  NI LLD        K+ DFGLA    ++   V  + + 
Sbjct: 127 -GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIF 179
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           GT  ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGS-GQGEREFQAEVEIISR 96
           D +     LG G F  V +      G+    K +  ++ K+   G    + + EV I+  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-LKIALGSAKGL 155
           + H ++++L   Y   +  +L+ E V    L   L  K   T +  T  LK  L    G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GV 126
Query: 156 AYLHEDCHPKIIHRDIKAANI-LLDF---KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
            YLH     +I H D+K  NI LLD    K   K+ DFGLA      N      + GT  
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPE 181
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 41  RATDGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGER------EFQAEVEI 93
           +  D +     LG G F  V +      G E A K +K    +  R      E + EV I
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 94  ISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSA 152
           + +V H ++++L   Y   +  +L+ E V    L +F    +     +  + +K  L   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD-- 126
Query: 153 KGLAYLHEDCHPKIIHRDIKAANI-LLDFKF---EAKVADFGLAKIASDVNTHVSTR-VM 207
            G+ YLH     KI H D+K  NI LLD        K+ DFGLA    ++   V  + + 
Sbjct: 127 -GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIF 179
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           GT  ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 41  RATDGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGER------EFQAEVEI 93
           +  D +     LG G F  V +      G E A K +K    +  R      E + EV I
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 94  ISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSA 152
           + +V H ++++L   Y   +  +L+ E V    L +F    +     +  + +K  L   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD-- 126
Query: 153 KGLAYLHEDCHPKIIHRDIKAANI-LLDFKF---EAKVADFGLAKIASDVNTHVSTR-VM 207
            G+ YLH     KI H D+K  NI LLD        K+ DFGLA    ++   V  + + 
Sbjct: 127 -GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIF 179
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           GT  ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGS-GQGEREFQAEVEIISR 96
           D +     LG G F  V +      G+    K +  ++ K+   G    + + EV I+  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-LKIALGSAKGL 155
           + H ++++L   Y   +  +L+ E V    L   L  K   T +  T  LK  L    G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GV 127
Query: 156 AYLHEDCHPKIIHRDIKAANI-LLDF---KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
            YLH     +I H D+K  NI LLD    K   K+ DFGLA      N      + GT  
Sbjct: 128 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPE 182
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 41  RATDGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGER------EFQAEVEI 93
           +  D +     LG G F  V +      G E A K +K    +  R      E + EV I
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 94  ISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSA 152
           + +V H ++++L   Y   +  +L+ E V    L +F    +     +  + +K  L   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD-- 126
Query: 153 KGLAYLHEDCHPKIIHRDIKAANI-LLDFKF---EAKVADFGLAKIASDVNTHVSTR-VM 207
            G+ YLH     KI H D+K  NI LLD        K+ DFGLA    ++   V  + + 
Sbjct: 127 -GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIF 179
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           GT  ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 34/218 (15%)
Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHK 100
           TDG+     +G G +    R +      E A+K +     + +R+   E+EI+ R   H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIID----KSKRDPTEEIEILLRYGQHP 76
Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK---------IALGS 151
           ++++L   Y  G    +V E             KG   +D + R K         +    
Sbjct: 77  NIITLKDVYDDGKYVYVVTELX-----------KGGELLDKILRQKFFSEREASAVLFTI 125
Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKF----EAKVADFGLAKIASDVNTHVSTRVM 207
            K + YLH      ++HRD+K +NIL   +       ++ DFG AK     N  + T   
Sbjct: 126 TKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY 182
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
            T  ++APE           D++S GV+L   +TG  P
Sbjct: 183 -TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGS-GQGEREFQAEVEIISR 96
           D +     LG G F  V +      G+    K +  ++ K+   G    + + EV I+  
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-LKIALGSAKGL 155
           + H ++++L   Y   +  +L+ E V    L   L  K   T +  T  LK  L    G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GV 127
Query: 156 AYLHEDCHPKIIHRDIKAANI-LLDF---KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
            YLH     +I H D+K  NI LLD    K   K+ DFGLA      N      + GT  
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPE 182
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHHKHLVSLVGY 108
           +G+G +G V +      G+ VAIK+          +  A  E+ ++ ++ H +LV+L+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 109 YTAGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHE-DCHPKI 166
           +    +  LV+E+  +  L E   + +G P  + L +  I   + + + + H+ +C    
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGVP--EHLVK-SITWQTLQAVNFCHKHNC---- 123
Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-YASSGKLTE 225
           IHRD+K  NIL+      K+ DFG A++ +  + +    V  T  Y +PE      +   
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATRWYRSPELLVGDTQYGP 182
Query: 226 KSDVFSFGVMLLELITG 242
             DV++ G +  EL++G
Sbjct: 183 PVDVWAIGCVFAELLSG 199

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 41  RATDGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGER------EFQAEVEI 93
           +  D +     LG G F  V +      G E A K +K    +  R      E + EV I
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 94  ISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIALGSA 152
           + +V H ++++L   Y   +  +L+ E V    L +F    +     +  + +K  L   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD-- 126
Query: 153 KGLAYLHEDCHPKIIHRDIKAANI-LLDFKF---EAKVADFGLAKIASDVNTHVSTR-VM 207
            G+ YLH     KI H D+K  NI LLD        K+ DFGLA    ++   V  + + 
Sbjct: 127 -GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIF 179
Query: 208 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           GT  ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGS-GQGEREFQAEVEIISR 96
           D +     LG G F  V +      G+    K +  ++ K+   G    + + EV I+  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-LKIALGSAKGL 155
           + H ++++L   Y   +  +L+ E V    L   L  K   T +  T  LK  L    G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GV 127
Query: 156 AYLHEDCHPKIIHRDIKAANI-LLDF---KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
            YLH     +I H D+K  NI LLD    K   K+ DFGLA      N      + GT  
Sbjct: 128 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPE 182
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 41  RATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHH 99
           +  D F    + GQG FG V  G     G  VAIK++        RE Q  ++ ++ +HH
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHH 78
Query: 100 KHLVSLVGY-YTAGSQRM------LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS- 151
            ++V L  Y YT G +        +V E+VP+       +   R        +K+ L   
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA----KVADFGLAKIASDVNTHVSTRVM 207
            + +  LH      + HRDIK  N+L++   EA    K+ DFG AK  S    +V+   +
Sbjct: 139 IRSIGCLHLP-SVNVCHRDIKPHNVLVN---EADGTLKLCDFGSAKKLSPSEPNVA--YI 192
Query: 208 GTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITG 242
            +  Y APE     +  T   D++S G +  E++ G
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGS-GQGEREFQAEVEIISR 96
           D +     LG G F  V +      G+    K +  ++ K+   G    + + EV I+  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-LKIALGSAKGL 155
           + H ++++L   Y   +  +L+ E V    L   L  K   T +  T  LK  L    G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GV 127
Query: 156 AYLHEDCHPKIIHRDIKAANI-LLDF---KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
            YLH     +I H D+K  NI LLD    K   K+ DFGLA      N      + GT  
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPE 182
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 87/217 (40%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V               +L   K V +KQ++            E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+ P   +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+++D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 106/266 (39%), Gaps = 38/266 (14%)
Query: 32  STFT----YEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLK---AGSGQGE 84
           STFT    Y++L     G        QG        VL  G  VA+K+L          +
Sbjct: 18  STFTVLKRYQQLKPIGSG-------AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAK 68
Query: 85  REFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPT 138
           R ++ E+ ++  V+HK+++SL+  +T            LV E +  N  +          
Sbjct: 69  RAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHER 127
Query: 139 MDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV 198
           M +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A   
Sbjct: 128 MSYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC-- 177
Query: 199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV 258
              + T  + T  Y APE           D++S G ++ EL+ G      T     D + 
Sbjct: 178 TNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGT-----DHID 232
Query: 259 DWARPLLNRAIEDGNFDTLVDPKLHN 284
            W + +         F   + P + N
Sbjct: 233 QWNKVIEQLGTPSAEFMAALQPTVRN 258

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGS-GQGEREFQAEVEIISR 96
           D +     LG G F  V +      G+    K +  ++ K+   G    + + EV I+  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-LKIALGSAKGL 155
           + H ++++L   Y   +  +L+ E V    L   L  K   T +  T  LK  L    G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GV 127
Query: 156 AYLHEDCHPKIIHRDIKAANI-LLDF---KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
            YLH     +I H D+K  NI LLD    K   K+ DFGLA      N      + GT  
Sbjct: 128 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPE 182
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  +L   + VAIK+L          +R
Sbjct: 19  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKR 70
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQR------MLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++ L+  +T            +V E +  N  +          M
Sbjct: 71  AYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 129
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 130 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 179
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG 242
           + + T  + T  Y APE        E  D++S G ++ E+I G
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  +L   + VAIK+L          +R
Sbjct: 18  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKR 69
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQR------MLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++ L+  +T            +V E +  N  +          M
Sbjct: 70  AYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 129 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 178
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG 242
           + + T  + T  Y APE        E  D++S G ++ E+I G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGS-GQGEREFQAEVEIISR 96
           D +     LG G F  V +      G+    K +  ++ K+   G    + + EV I+  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-LKIALGSAKGL 155
           + H ++++L   Y   +  +L+ E V    L   L  K   T +  T  LK  L    G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GV 127
Query: 156 AYLHEDCHPKIIHRDIKAANI-LLDF---KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
            YLH     +I H D+K  NI LLD    K   K+ DFGLA      N      + GT  
Sbjct: 128 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPE 182
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  +L   + VAIK+L          +R
Sbjct: 18  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKR 69
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQR------MLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++ L+  +T            +V E +  N  +          M
Sbjct: 70  AYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 129 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 178
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG 242
           + + T  + T  Y APE        E  D++S G ++ E+I G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 106/229 (46%), Gaps = 30/229 (13%)
Query: 42  ATDGFS---------DANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEV 91
           +TD FS           ++LG+G    V   + L   +E A+K ++   G        EV
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 92  EIISRVH-HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
           E++ +   H++++ L+ ++    +  LV+E +   ++  H+H   R   + L    +   
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH--KRRHFNELEASVVVQD 119
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLA---KIASDVNTHVST 204
            A  L +LH   +  I HRD+K  NIL +   +    K+ DFGL    K+  D +   + 
Sbjct: 120 VASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTP 176
Query: 205 RVMGTFG---YLAPE----YASSGKLTEK-SDVFSFGVMLLELITGRRP 245
            ++   G   Y+APE    ++    + +K  D++S GV+L  L++G  P
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 93
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIV 152
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 153 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 201
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 87
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 88  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA-QIV 146
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 147 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 195
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 196 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGS-GQGEREFQAEVEIISR 96
           D +     LG G F  V +      G+    K +  ++ K+   G    + + EV I+  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-LKIALGSAKGL 155
           + H ++++L   Y   +  +L+ E V    L   L  K   T +  T  LK  L    G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GV 127
Query: 156 AYLHEDCHPKIIHRDIKAANI-LLDF---KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
            YLH     +I H D+K  NI LLD    K   K+ DFGLA      N      + GT  
Sbjct: 128 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPE 182
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 86/217 (39%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V               +L   K V +KQ++            E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 93
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   L  L   +   S   +V E+ P   +  HL   GR   P   +    +I 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA-QIV 152
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+++D +   KV DFG AK         +  + G
Sbjct: 153 LT----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCG 201
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGS-GQGEREFQAEVEIISR 96
           D +     LG G F  V +      G+    K +  ++ K+   G    + + EV I+  
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-LKIALGSAKGL 155
           + H ++++L   Y   +  +L+ E V    L   L  K   T +  T  LK  L    G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GV 127
Query: 156 AYLHEDCHPKIIHRDIKAANI-LLDF---KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
            YLH     +I H D+K  NI LLD    K   K+ DFGLA      N      + GT  
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPE 182
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 12/201 (5%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-HKHLVSLVGYYT 110
           LG+G F    + V  + K      +K  S + E   Q E+  +     H ++V L   + 
Sbjct: 19  LGEGSFSICRKCV--HKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 LV E +    L   +  K   +    + +   L SA  ++++H+     ++HRD
Sbjct: 77  DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSA--VSHMHD---VGVVHRD 131
Query: 171 IKAANILL---DFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS 227
           +K  N+L    +   E K+ DFG A++    N  + T    T  Y APE  +     E  
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELLNQNGYDESC 190
Query: 228 DVFSFGVMLLELITGRRPVDS 248
           D++S GV+L  +++G+ P  S
Sbjct: 191 DLWSLGVILYTMLSGQVPFQS 211

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 86/217 (39%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V               +L   K V +KQ++            E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 93
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   L  L   +   S   +V E+ P   +  HL   GR   P   +    +I 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA-QIV 152
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+++D +   KV DFG AK         +  + G
Sbjct: 153 LT----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCG 201
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 86/217 (39%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V               +L   K V +KQ++            E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 93
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   L  L   +   S   +V E+ P   +  HL   GR   P   +    +I 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAA-QIV 152
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+++D +   KV DFG AK         +  + G
Sbjct: 153 LT----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCG 201
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK        ++    G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA----G 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 113
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 114 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA-QIV 172
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 173 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 221
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 46/96 (47%)
Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS 227
           HRD+K  NIL+     A + DFG+A   +D         +GT  Y APE  S    T ++
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 228 DVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP 263
           D+++   +L E +TG  P       V  + ++ A P
Sbjct: 217 DIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAIP 252

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 79
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 80  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIV 138
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 139 LT----FEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG----RTWXLCG 187
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 188 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  +L   + VAIK+L          +R
Sbjct: 18  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKR 69
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQR------MLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++ L+  +T            +V E +  N  +          M
Sbjct: 70  AYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 129 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 178
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG 242
           + + T  + T  Y APE        E  D++S G ++ E+I G
Sbjct: 179 SFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLXG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 30/234 (12%)
Query: 38  ELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGERE----FQAEVEI 93
           +L    + +    ++G+G FG V      + ++V   +L +     +R     F  E +I
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 94  ISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW----LTRLKIAL 149
           ++  +   +V L   +       +V E++P   L   +     P   W       + +AL
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLAL 186
Query: 150 GSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVMG 208
            +   + +         IHRD+K  N+LLD     K+ADFG   K+  +      T V G
Sbjct: 187 DAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 236
Query: 209 TFGYLAPEYASS----GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV 258
           T  Y++PE   S    G    + D +S GV L E++ G  P      F  DSLV
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP------FYADSLV 284

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 30/234 (12%)
Query: 38  ELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGERE----FQAEVEI 93
           +L    + +    ++G+G FG V      + ++V   +L +     +R     F  E +I
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 94  ISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW----LTRLKIAL 149
           ++  +   +V L   +       +V E++P   L   +     P   W       + +AL
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLAL 181
Query: 150 GSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVMG 208
            +   + +         IHRD+K  N+LLD     K+ADFG   K+  +      T V G
Sbjct: 182 DAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 231
Query: 209 TFGYLAPEYASS----GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV 258
           T  Y++PE   S    G    + D +S GV L E++ G  P      F  DSLV
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP------FYADSLV 279

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 44  DGFSDANLLGQGGFGYVHR------GVLPNGKEVAIKQLKAGS-GQGEREFQAEVEIISR 96
           D +     LG G F  V +      G+    K +  ++ K+   G    + + EV I+  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-LKIALGSAKGL 155
           + H ++++L   Y   +  +L+ E V    L   L  K   T +  T  LK  L    G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILN---GV 127
Query: 156 AYLHEDCHPKIIHRDIKAANI-LLDF---KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
            YLH     +I H D+K  NI LLD    K   K+ DFGLA      N      + GT  
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPE 182
Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           ++APE  +   L  ++D++S GV+   L++G  P
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 87/217 (40%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYVH------------RGVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V               +L   K V +KQ++            E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+++D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 30/234 (12%)
Query: 38  ELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGERE----FQAEVEI 93
           +L    + +    ++G+G FG V      + ++V   +L +     +R     F  E +I
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 94  ISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW----LTRLKIAL 149
           ++  +   +V L   +       +V E++P   L   +     P   W       + +AL
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLAL 186
Query: 150 GSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVMG 208
            +   + +         IHRD+K  N+LLD     K+ADFG   K+  +      T V G
Sbjct: 187 DAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 236
Query: 209 TFGYLAPEYASS----GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV 258
           T  Y++PE   S    G    + D +S GV L E++ G  P      F  DSLV
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP------FYADSLV 284

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  +L   + VAIK+L          +R
Sbjct: 18  STFTV--LKR----YQNLKPIGSGAQGIVVAAYDAIL--ERNVAIKKLSRPFQNQTHAKR 69
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++ L+  +T            +V E +  N  +          M
Sbjct: 70  AYR-ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 129 SYLLYQMLV-----GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--T 178
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG 242
           + + T  + T  Y APE        E  D++S GV++ E+I G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  +L   + VAIK+L          +R
Sbjct: 18  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKR 69
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++ L+  +T            +V E +  N  +          M
Sbjct: 70  AYR-ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 129 SYLLYQMLV-----GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--T 178
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG 242
           + + T  + T  Y APE        E  D++S GV++ E+I G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAPE   S    +  D ++ GV++ ++  G  P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  +L   + VAIK+L          +R
Sbjct: 20  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKR 71
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQR------MLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++ L+  +T            +V E +  N  +          M
Sbjct: 72  AYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 130
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 131 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 180
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG 242
           + +    + T  Y APE        E  D++S G ++ E+I G
Sbjct: 181 SFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 105/241 (43%), Gaps = 37/241 (15%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  +L   + VAIK+L          +R
Sbjct: 23  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKR 74
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQR------MLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++ L+  +T            +V E +  N  +          M
Sbjct: 75  AYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 133
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 134 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 183
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT------GRRPVDSTHTFV 253
           + + T  + T  Y APE        E  D++S G ++ E++       GR  +D  +  +
Sbjct: 184 SFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 243
Query: 254 E 254
           E
Sbjct: 244 E 244

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  +L   + VAIK+L          +R
Sbjct: 18  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKR 69
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQR------MLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++ L+  +T            +V E +  N  +          M
Sbjct: 70  AYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 129 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 178
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG 242
           + + T  + T  Y APE        E  D++S G ++ E+I G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/204 (21%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG+G FG VHR V  + K+  + +     G  +   + E+ I++   H++++ L   + +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP------- 164
             + ++++EF+            G    + +      L   + ++Y+H+ C         
Sbjct: 73  MEELVMIFEFIS-----------GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 165 KIIHRDIKAANILLDFKFEA--KVADFGLAKIASDVNTHVSTRVMGTF-GYLAPEYASSG 221
            I H DI+  NI+   +  +  K+ +FG A+    +    + R++ T   Y APE     
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
            ++  +D++S G ++  L++G  P
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINP 202

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 105/241 (43%), Gaps = 37/241 (15%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  +L   + VAIK+L          +R
Sbjct: 12  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKR 63
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQR------MLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++ L+  +T            +V E +  N  +          M
Sbjct: 64  AYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 122
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 123 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--T 172
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT------GRRPVDSTHTFV 253
           + + T  + T  Y APE        E  D++S G ++ E++       GR  +D  +  +
Sbjct: 173 SFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 232
Query: 254 E 254
           E
Sbjct: 233 E 233

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG+G FG VHR      G + A+K+++    + E     E+   + +    +V L G   
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYGAVR 136
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA-KGLAYLHEDCHPKIIHR 169
            G    +  E +   +L   +  +G    D   R    LG A +GL YLH     +I+H 
Sbjct: 137 EGPWVNIFMELLEGGSLGQLVKEQGCLPED---RALYYLGQALEGLEYLHSR---RILHG 190
Query: 170 DIKAANILLDFK-FEAKVADFGLA------KIASDVNTHVSTRVMGTFGYLAPEYASSGK 222
           D+KA N+LL      A + DFG A       +  D+ T     + GT  ++APE      
Sbjct: 191 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLT--GDYIPGTETHMAPEVVLGRS 248
Query: 223 LTEKSDVFSFGVMLLELITGRRP 245
              K DV+S   M+L ++ G  P
Sbjct: 249 CDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  +L   + VAIK+L          +R
Sbjct: 18  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKR 69
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQR------MLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++ L+  +T            +V E +  N  +          M
Sbjct: 70  AYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 129 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAG--T 178
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG 242
           + + T  + T  Y APE        E  D++S G ++ E+I G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  +L   + VAIK+L          +R
Sbjct: 18  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKR 69
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQR------MLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++ L+  +T            +V E +  N  +          M
Sbjct: 70  AYR-ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 129 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAG--T 178
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG 242
           + + T  + T  Y APE        E  D++S G ++ E+I G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T  YLAP    S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 23/182 (12%)
Query: 83  GEREFQAEVEIISRVHHKHLVSLVG-YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW 141
           GE   + E++++ R+ HK+++ LV   Y    Q+M +        +E+ + G  +  +D 
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM-------VMEYCVCGM-QEMLDS 100
Query: 142 LTRLKIALGSA--------KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 193
           +   +  +  A         GL YLH      I+H+DIK  N+LL      K++  G+A+
Sbjct: 101 VPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157
Query: 194 IASDVNTHVSTRV-MGTFGYLAPEYASSGKLTE--KSDVFSFGVMLLELITGRRPVDSTH 250
                    + R   G+  +  PE A+        K D++S GV L  + TG  P +  +
Sbjct: 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217
Query: 251 TF 252
            +
Sbjct: 218 IY 219

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 105/229 (45%), Gaps = 30/229 (13%)
Query: 42  ATDGFS---------DANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEV 91
           +TD FS           ++LG+G    V   + L   +E A+K ++   G        EV
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 92  EIISRVH-HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
           E++ +   H++++ L+ ++    +  LV+E +   ++  H+H   R   + L    +   
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH--KRRHFNELEASVVVQD 119
Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLA---KIASDVNTHVST 204
            A  L +LH   +  I HRD+K  NIL +   +    K+ DF L    K+  D +   + 
Sbjct: 120 VASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 205 RVMGTFG---YLAPE----YASSGKLTEK-SDVFSFGVMLLELITGRRP 245
            ++   G   Y+APE    ++    + +K  D++S GV+L  L++G  P
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  +L   + VAIK+L          +R
Sbjct: 18  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKR 69
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++ L+  +T            +V E +  N  +          M
Sbjct: 70  AYR-ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 129 SYLLYQMLV-----GIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAG--T 178
Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG 242
           + + T  + T  Y APE        E  D++S G ++ E+I G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 106/222 (47%), Gaps = 20/222 (9%)
Query: 38  ELARATDGFS-DANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQG-EREFQAEVEIIS 95
           E  R  D F  +   +G+G +G+V++    +GK+     LK   G G       E+ ++ 
Sbjct: 14  ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLR 73
Query: 96  RVHHKHLVSLVGYYTAGSQR--MLVYEFVPNN---TLEFHLHGKGRPTMDWLTR--LKIA 148
            + H +++SL   + + + R   L++++  ++    ++FH   K       L R  +K  
Sbjct: 74  ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 149 LGSA-KGLAYLHEDCHPKIIHRDIKAANILL----DFKFEAKVADFGLAKIASDVNTHVS 203
           L     G+ YLH +    ++HRD+K ANIL+      +   K+AD G A++ +     ++
Sbjct: 134 LYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190
Query: 204 --TRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITG 242
               V+ TF Y APE     +  T+  D+++ G +  EL+T 
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 104/244 (42%), Gaps = 43/244 (17%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  +L   + VAIK+L          +R
Sbjct: 18  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKR 69
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQR------MLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++ L+  +T            +V E +  N  +          M
Sbjct: 70  AYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD-- 197
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 129 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180
Query: 198 -VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT------GRRPVDSTH 250
            +   V TR      Y APE        E  D++S G ++ E++       GR  +D  +
Sbjct: 181 MMEPEVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWN 235
Query: 251 TFVE 254
             +E
Sbjct: 236 KVIE 239

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT-HVSTRVMGTFG 211
           +GL Y+H      IIHRD+K +N+ ++   E ++ DFGLA+ A +  T +V+TR      
Sbjct: 134 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----W 185
Query: 212 YLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           Y APE   +     +  D++S G ++ EL+ G+
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 115/282 (40%), Gaps = 68/282 (24%)
Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREF--------QAEVEIISRVHHKHLV 103
           +GQG +G V   +    +  AI+ +K  +    R+         + EV ++ ++HH ++ 
Sbjct: 34  IGQGSYGVVRVAI--ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 104 SLVGYYTAGSQRMLVYE-------------FVPNNT----------------------LE 128
            L   Y       LV E             F+ ++T                      + 
Sbjct: 92  RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 129 FHLHGKGRPTMDWLTRLKIALGSAK----GLAYLHEDCHPKIIHRDIKAANILL--DFKF 182
             +HG  R ++D++ R K+     +     L YLH      I HRDIK  N L   +  F
Sbjct: 152 GSIHG-FRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSF 207
Query: 183 EAKVADFGLAKIASDVNT---HVSTRVMGTFGYLAPEYASSGKLT--EKSDVFSFGVMLL 237
           E K+ DFGL+K    +N    +  T   GT  ++APE  ++   +   K D +S GV+L 
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
Query: 238 ELITGRRPVDSTHTFVEDSLVDWARPLLNR--AIEDGNFDTL 277
            L+ G  P       V D+  D    +LN+    E+ N++ L
Sbjct: 268 LLLMGAVPFPG----VNDA--DTISQVLNKKLCFENPNYNVL 303

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 86/201 (42%), Gaps = 18/201 (8%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG+G FG VHR      G + A+K+++    + E     E+   + +    +V L G   
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYGAVR 155
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA-KGLAYLHEDCHPKIIHR 169
            G    +  E +   +L   +  +G    D   R    LG A +GL YLH     +I+H 
Sbjct: 156 EGPWVNIFMELLEGGSLGQLVKEQGCLPED---RALYYLGQALEGLEYLHSR---RILHG 209
Query: 170 DIKAANILLDFK-FEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAPEYASSGKLT 224
           D+KA N+LL      A + DFG A          S      + GT  ++APE        
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCD 269
Query: 225 EKSDVFSFGVMLLELITGRRP 245
            K DV+S   M+L ++ G  P
Sbjct: 270 AKVDVWSSCCMMLHMLNGCHP 290

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 7/96 (7%)
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK---IASDVNTHVSTRVMGT 209
           +GL Y+H     ++IHRD+K +N+L++   E K+ DFG+A+    +   + +  T  + T
Sbjct: 170 RGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 210 FGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGRR 244
             Y APE   S  + T+  D++S G +  E++  R+
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT-HVSTRVMGTFG 211
           +GL Y+H      IIHRD+K +N+ ++   E ++ DFGLA+ A +  T +V+TR      
Sbjct: 142 RGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----W 193
Query: 212 YLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           Y APE   +     +  D++S G ++ EL+ G+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT-HVSTRVMGTFG 211
           +GL Y+H      IIHRD+K +N+ ++   E ++ DFGLA+ A +  T +V+TR      
Sbjct: 142 RGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----W 193
Query: 212 YLAPEYASSGK-LTEKSDVFSFGVMLLELITGR 243
           Y APE   +     +  D++S G ++ EL+ G+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 7/96 (7%)
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK---IASDVNTHVSTRVMGT 209
           +GL Y+H     ++IHRD+K +N+L++   E K+ DFG+A+    +   + +  T  + T
Sbjct: 169 RGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 210 FGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGRR 244
             Y APE   S  + T+  D++S G +  E++  R+
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 104/244 (42%), Gaps = 43/244 (17%)
Query: 32  STFTYEELARATDGFSDANLLGQGGFGYV---HRGVLPNGKEVAIKQLK---AGSGQGER 85
           STFT   L R    + +   +G G  G V   +  +L   + VAIK+L          +R
Sbjct: 18  STFTV--LKR----YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKR 69
Query: 86  EFQAEVEIISRVHHKHLVSLVGYYTAGSQR------MLVYEFVPNNTLEFHLHGKGRPTM 139
            ++ E+ ++  V+HK+++ L+  +T            +V E +  N  +          M
Sbjct: 70  AYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD-- 197
            +L    +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 129 SYLLYQMLC-----GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180
Query: 198 -VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT------GRRPVDSTH 250
            +   V TR      Y APE        E  D++S G ++ E++       GR  +D  +
Sbjct: 181 MMEPEVVTRY-----YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWN 235
Query: 251 TFVE 254
             +E
Sbjct: 236 KVIE 239

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 55/125 (44%), Gaps = 28/125 (22%)
Query: 140 DWLTR------------LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA 187
           DW+ R            L I +  A+ + +LH      ++HRD+K +NI        KV 
Sbjct: 150 DWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 206
Query: 188 DFGLAKIASDVNTHVSTRV------------MGTFGYLAPEYASSGKLTEKSDVFSFGVM 235
           DFGL   A D +    T +            +GT  Y++PE       + K D+FS G++
Sbjct: 207 DFGLVT-AMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLI 265
Query: 236 LLELI 240
           L EL+
Sbjct: 266 LFELL 270

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 44  DGFSDANLLGQGGFGYV----HR--------GVLPNGKEVAIKQLKAGSGQGEREFQAEV 91
           D F     LG G FG V    H+         +L   K V +KQ++            E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------EK 92
Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTRLKIA 148
            I+  V+   LV L   +   S   +V E+V    +  HL   GR   P   +    +I 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIV 151
Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
           L       YLH      +I+RD+K  N+L+D +   +V DFG AK         +  + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCG 200
Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           T   LAPE   S    +  D ++ GV++ E+  G  P
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 51  LLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           L+G+G FG V+ G       + +  ++  +    + F+ EV    +  H+++V  +G   
Sbjct: 40  LIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
           +     ++       TL + +    +  +D     +IA    KG+ YLH      I+H+D
Sbjct: 100 SPPHLAIITSLCKGRTL-YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKD 155
Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNT---HVSTRVM-GTFGYLAPEY-------AS 219
           +K+ N+  D   +  + DFGL  I+  +         R+  G   +LAPE          
Sbjct: 156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 220 SGKL--TEKSDVFSFGVMLLEL 239
             KL  ++ SDVF+ G +  EL
Sbjct: 215 EDKLPFSKHSDVFALGTIWYEL 236

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 76  VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 122
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 123 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 179
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 118 VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 164
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 165 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 221
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 75  VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 121
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 122 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 178
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 76  VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 122
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 123 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 179
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 90  VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 136
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 137 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 193
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 34/216 (15%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 102 LVSLVGYYTAGSQRMLVYEFV-PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHE 160
           ++ L+ ++      +L+ E + P   L            D++T  + AL      ++  +
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDL-----------FDFITE-RGALQEELARSFFWQ 122
Query: 161 ------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
                  CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  Y
Sbjct: 123 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVY 179
Query: 213 LAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
             PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 90  VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 136
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 137 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 193
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 91  VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 137
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 138 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 194
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 103 VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 149
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 150 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 206
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 104 VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 150
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 151 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 207
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 71  VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 117
Query: 160 E------DCHPK-IIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 118 QVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 174
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 91  VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 137
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 138 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 194
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 104 VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 150
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 151 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 207
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 103 VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 149
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 150 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 206
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 103 VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 149
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 150 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 206
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 74  VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 120
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 121 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 177
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 178 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 214

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 104 VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 150
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 151 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 207
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 103 VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 149
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 150 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 206
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 76  VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 122
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 123 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 179
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 104 VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 150
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 151 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 207
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 110 VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 156
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 213
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 13/169 (7%)
Query: 90  EVEIISRVHH-KHLVSLVGYYT---AGSQRML-VYEFVPNNTLEFHLHGKGRPTMDWLTR 144
           EVE+  R     H+V +V  Y    AG + +L V E +    L   +  +G         
Sbjct: 74  EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 133
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTH 201
            +I     + + YLH      I HRD+K  N+L   K      K+ DFG AK  +  N+ 
Sbjct: 134 SEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 189
Query: 202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
           ++T     + Y+APE     K  +  D++S GV++  L+ G  P  S H
Sbjct: 190 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 237

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 13/169 (7%)
Query: 90  EVEIISRVHH-KHLVSLVGYYT---AGSQRML-VYEFVPNNTLEFHLHGKGRPTMDWLTR 144
           EVE+  R     H+V +V  Y    AG + +L V E +    L   +  +G         
Sbjct: 66  EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 125
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTH 201
            +I     + + YLH      I HRD+K  N+L   K      K+ DFG AK  +  N+ 
Sbjct: 126 SEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 181
Query: 202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
           ++T     + Y+APE     K  +  D++S GV++  L+ G  P  S H
Sbjct: 182 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 229

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 71  VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 117
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 174
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 71  VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 117
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 174
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 91  VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 137
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 138 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 194
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 89/231 (38%), Gaps = 34/231 (14%)
Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQ--------AEVEIISR 96
           +S  + LG G FG+V   V     KEV +K +K      +   +         E+ I+SR
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWL---TRLKIALGS-- 151
           V H +++ ++  +       LV E           HG G     ++    RL   L S  
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVME----------KHGSGLDLFAFIDRHPRLDEPLASYI 135
Query: 152 ----AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM 207
                  + YL       IIHRDIK  NI++   F  K+ DFG A         +     
Sbjct: 136 FRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE--RGKLFYTFC 190
Query: 208 GTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL 257
           GT  Y APE          + +++S GV L  L+    P       VE ++
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAI 241

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 97
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 98  VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 144
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 145 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 201
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 202 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 238

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 118 VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 164
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 165 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 221
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 73/169 (43%), Gaps = 13/169 (7%)
Query: 90  EVEIISRVHH-KHLVSLVGYYT---AGSQRML-VYEFVPNNTLEFHLHGKGRPTMDWLTR 144
           EVE+  R     H+V +V  Y    AG + +L V E +    L   +  +G         
Sbjct: 58  EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 117
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTH 201
            +I     + + YLH      I HRD+K  N+L   K      K+ DFG AK  +  N+ 
Sbjct: 118 SEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 173
Query: 202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
             T    T  Y+APE     K  +  D++S GV++  L+ G  P  S H
Sbjct: 174 -LTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 221

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGE----REFQAEVEIISRVH--HKH 101
           LLG GGFG V+ G+ + +   VAIK ++    S  GE         EV ++ +V      
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL--KIALGSAKGLAYLH 159
           ++ L+ ++      +L+ E             +  P  D    +  + AL      ++  
Sbjct: 123 VIRLLDWFERPDSFVLILE-------------RPEPVQDLFDFITERGALQEELARSFFW 169
Query: 160 E------DCH-PKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           +       CH   ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  
Sbjct: 170 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV 226
Query: 212 YLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPVD 247
           Y  PE+    +   +S  V+S G++L +++ G  P +
Sbjct: 227 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 263

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 73/169 (43%), Gaps = 13/169 (7%)
Query: 90  EVEIISRVHH-KHLVSLVGYYT---AGSQRML-VYEFVPNNTLEFHLHGKGRPTMDWLTR 144
           EVE+  R     H+V +V  Y    AG + +L V E +    L   +  +G         
Sbjct: 64  EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 123
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTH 201
            +I     + + YLH      I HRD+K  N+L   K      K+ DFG AK  +  N+ 
Sbjct: 124 SEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 179
Query: 202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
             T    T  Y+APE     K  +  D++S GV++  L+ G  P  S H
Sbjct: 180 -LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 227

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 16/209 (7%)
Query: 43  TDGFSDANLLGQGGFGYVHRGVLPNGKE-VAIKQLKAGSGQGEREFQAEVEIISR--VHH 99
           +D +     +G G FG          KE VA+K ++ G+   E     + EII+   + H
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE---NVQREIINHRSLRH 75
Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
            ++V         +   ++ E+     L   +   GR + D        L S  G++Y H
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS--GVSYCH 133
Query: 160 EDCHPKIIHRDIKAANILLD--FKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
                +I HRD+K  N LLD       K+ DFG +K  S V        +GT  Y+APE 
Sbjct: 134 SM---QICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEV 188
Query: 218 ASSGKLTEK-SDVFSFGVMLLELITGRRP 245
               +   K +DV+S GV L  ++ G  P
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 13/169 (7%)
Query: 90  EVEIISRVHH-KHLVSLVGYYT---AGSQRML-VYEFVPNNTLEFHLHGKGRPTMDWLTR 144
           EVE+  R     H+V +V  Y    AG + +L V E +    L   +  +G         
Sbjct: 65  EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 124
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTH 201
            +I     + + YLH      I HRD+K  N+L   K      K+ DFG AK  +  N+ 
Sbjct: 125 SEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 180
Query: 202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
           ++T     + Y+APE     K  +  D++S GV++  L+ G  P  S H
Sbjct: 181 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 228

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 13/169 (7%)
Query: 90  EVEIISRVHH-KHLVSLVGYYT---AGSQRML-VYEFVPNNTLEFHLHGKGRPTMDWLTR 144
           EVE+  R     H+V +V  Y    AG + +L V E +    L   +  +G         
Sbjct: 110 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 169
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTH 201
            +I     + + YLH      I HRD+K  N+L   K      K+ DFG AK  +  N+ 
Sbjct: 170 SEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 225
Query: 202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
           ++T     + Y+APE     K  +  D++S GV++  L+ G  P  S H
Sbjct: 226 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 273

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 13/169 (7%)
Query: 90  EVEIISRVHH-KHLVSLVGYYT---AGSQRML-VYEFVPNNTLEFHLHGKGRPTMDWLTR 144
           EVE+  R     H+V +V  Y    AG + +L V E +    L   +  +G         
Sbjct: 104 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 163
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTH 201
            +I     + + YLH      I HRD+K  N+L   K      K+ DFG AK  +  N+ 
Sbjct: 164 SEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 219
Query: 202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
           ++T     + Y+APE     K  +  D++S GV++  L+ G  P  S H
Sbjct: 220 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 13/169 (7%)
Query: 90  EVEIISRVHH-KHLVSLVGYYT---AGSQRML-VYEFVPNNTLEFHLHGKGRPTMDWLTR 144
           EVE+  R     H+V +V  Y    AG + +L V E +    L   +  +G         
Sbjct: 60  EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 119
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTH 201
            +I     + + YLH      I HRD+K  N+L   K      K+ DFG AK  +  N+ 
Sbjct: 120 SEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 175
Query: 202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
           ++T     + Y+APE     K  +  D++S GV++  L+ G  P  S H
Sbjct: 176 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 223

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 13/169 (7%)
Query: 90  EVEIISRVHH-KHLVSLVGYYT---AGSQRML-VYEFVPNNTLEFHLHGKGRPTMDWLTR 144
           EVE+  R     H+V +V  Y    AG + +L V E +    L   +  +G         
Sbjct: 58  EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 117
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTH 201
            +I     + + YLH      I HRD+K  N+L   K      K+ DFG AK  +  N+ 
Sbjct: 118 SEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 173
Query: 202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
           ++T     + Y+APE     K  +  D++S GV++  L+ G  P  S H
Sbjct: 174 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 221

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 85/201 (42%), Gaps = 18/201 (8%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG+G FG VHR      G + A+K+++    + E     E+   + +    +V L G   
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVR 134
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA-KGLAYLHEDCHPKIIHR 169
            G    +  E +   +L   +   G    D   R    LG A +GL YLH     +I+H 
Sbjct: 135 EGPWVNIFMELLEGGSLGQLIKQMGCLPED---RALYYLGQALEGLEYLHTR---RILHG 188
Query: 170 DIKAANILLDFK-FEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAPEYASSGKLT 224
           D+KA N+LL      A + DFG A          S      + GT  ++APE        
Sbjct: 189 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 248
Query: 225 EKSDVFSFGVMLLELITGRRP 245
            K D++S   M+L ++ G  P
Sbjct: 249 AKVDIWSSCCMMLHMLNGCHP 269

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 13/169 (7%)
Query: 90  EVEIISRVHH-KHLVSLVGYYT---AGSQRML-VYEFVPNNTLEFHLHGKGRPTMDWLTR 144
           EVE+  R     H+V +V  Y    AG + +L V E +    L   +  +G         
Sbjct: 60  EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 119
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTH 201
            +I     + + YLH      I HRD+K  N+L   K      K+ DFG AK  +  N+ 
Sbjct: 120 SEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 175
Query: 202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
           ++T     + Y+APE     K  +  D++S GV++  L+ G  P  S H
Sbjct: 176 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 223

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 13/169 (7%)
Query: 90  EVEIISRVHH-KHLVSLVGYYT---AGSQRML-VYEFVPNNTLEFHLHGKGRPTMDWLTR 144
           EVE+  R     H+V +V  Y    AG + +L V E +    L   +  +G         
Sbjct: 59  EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 118
Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTH 201
            +I     + + YLH      I HRD+K  N+L   K      K+ DFG AK  +  N+ 
Sbjct: 119 SEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 174
Query: 202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
           ++T     + Y+APE     K  +  D++S GV++  L+ G  P  S H
Sbjct: 175 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 222

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 79/181 (43%), Gaps = 33/181 (18%)
Query: 40  ARATDGFSDANLLGQGGFGYVHRGVLPNG-KEVAIKQLKAGSGQ--GEREFQAEVEIISR 96
            +  D +   +L+G+G +GYV+     N  K VAIK++          +    E+ I++R
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNR 83
Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEF-HLH----------GKGRPTMDWLTRL 145
           +   +++ L                +P + L+F  L+           K   T  +LT  
Sbjct: 84  LKSDYIIRLHDL------------IIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQ 131
Query: 146 ---KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTH 201
               I      G  ++HE     IIHRD+K AN LL+     K+ DFGLA+ I SD + H
Sbjct: 132 HVKTILYNLLLGEKFIHES---GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIH 188
Query: 202 V 202
           +
Sbjct: 189 I 189

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 81/201 (40%), Gaps = 50/201 (24%)
Query: 62  RGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF 121
           R VL NG    I QL          FQ E          +L  ++ YY  G    L+ +F
Sbjct: 112 RDVLVNGDRRWITQLHFA-------FQDE---------NYLYLVMEYYVGGDLLTLLSKF 155
Query: 122 ---VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL 178
              +P     F+L             + +A+ S   L Y         +HRDIK  NILL
Sbjct: 156 GERIPAEMARFYL-----------AEIVMAIDSVHRLGY---------VHRDIKPDNILL 195
Query: 179 DFKFEAKVADFG-LAKIASDVNTHVSTRVMGTFGYLAPEYASS-------GKLTEKSDVF 230
           D     ++ADFG   K+ +D  T  S   +GT  YL+PE   +       G    + D +
Sbjct: 196 DRCGHIRLADFGSCLKLRAD-GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWW 254
Query: 231 SFGVMLLELITGRRP--VDST 249
           + GV   E+  G+ P   DST
Sbjct: 255 ALGVFAYEMFYGQTPFYADST 275

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 24/223 (10%)
Query: 35  TYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQ--LKAGSGQGEREFQAEVE 92
            YE L     GF D   +    +        P G+ V +++  L+A S +     Q E+ 
Sbjct: 26  CYELLTVIGKGFEDLMTVNLARYK-------PTGEYVTVRRINLEACSNEMVTFLQGELH 78
Query: 93  IISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA 152
           +    +H ++V     + A ++  +V  F+   + +  +       M+ L    I  G  
Sbjct: 79  VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF-- 210
           K L Y+H   H   +HR +KA++IL+    + KV   GL    S ++     RV+  F  
Sbjct: 139 KALDYIH---HMGYVHRSVKASHILI--SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193
Query: 211 ------GYLAPEYASSG--KLTEKSDVFSFGVMLLELITGRRP 245
                  +L+PE           KSD++S G+   EL  G  P
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 24/223 (10%)
Query: 35  TYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQ--LKAGSGQGEREFQAEVE 92
            YE L     GF D   +    +        P G+ V +++  L+A S +     Q E+ 
Sbjct: 10  CYELLTVIGKGFEDLMTVNLARYK-------PTGEYVTVRRINLEACSNEMVTFLQGELH 62
Query: 93  IISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA 152
           +    +H ++V     + A ++  +V  F+   + +  +       M+ L    I  G  
Sbjct: 63  VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 122
Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF-- 210
           K L Y+H   H   +HR +KA++IL+    + KV   GL    S ++     RV+  F  
Sbjct: 123 KALDYIH---HMGYVHRSVKASHILI--SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 177
Query: 211 ------GYLAPEYASSG--KLTEKSDVFSFGVMLLELITGRRP 245
                  +L+PE           KSD++S G+   EL  G  P
Sbjct: 178 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 220

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 85/201 (42%), Gaps = 18/201 (8%)
Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +G+G FG VHR      G + A+K+++    + E     E+   + +    +V L G   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVR 120
Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA-KGLAYLHEDCHPKIIHR 169
            G    +  E +   +L   +   G    D   R    LG A +GL YLH     +I+H 
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPED---RALYYLGQALEGLEYLHTR---RILHG 174
Query: 170 DIKAANILLDFK-FEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAPEYASSGKLT 224
           D+KA N+LL      A + DFG A          S      + GT  ++APE        
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 225 EKSDVFSFGVMLLELITGRRP 245
            K D++S   M+L ++ G  P
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHP 255
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	416
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	0.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	0.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-174
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-93
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-70
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-66
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-65
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-64
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-62
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-62
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-61
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-60
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-60
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-58
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-56
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-56
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-55
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-52
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-46
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-44
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-43
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-43
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-43
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-43
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-43
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-42
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-42
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-42
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-42
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-42
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-42
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-42
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-41
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-41
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-41
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-41
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-41
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-41
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-41
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-41
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-41
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-40
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-40
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-40
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-40
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-40
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-40
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-40
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-40
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-40
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-39
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-39
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-39
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-38
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-38
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-38
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-38
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-37
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-37
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-37
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-37
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-36
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-36
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-36
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-36
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-35
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-35
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-34
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-34
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-34
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-34
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-33
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-33
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-33
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-33
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-32
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-32
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-32
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-32
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-31
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-31
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-31
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-29
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-25
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-25
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-24
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-22
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-21
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-20
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-20
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-20
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-19
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-18
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-18
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-16
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-13
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	9e-12
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	9e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  558 bits (1441), Expect = 0.0
 Identities = 147/317 (46%), Positives = 203/317 (64%), Gaps = 10/317 (3%)

Query: 20  PPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAG 79
              P + LG  K  F+  EL  A+D FS+ N+LG+GGFG V++G L +G  VA+K+LK  
Sbjct: 7   EEDPEVHLGQLK-RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE 65

Query: 80  SGQG-EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGK--GR 136
             QG E +FQ EVE+IS   H++L+ L G+    ++R+LVY ++ N ++   L  +   +
Sbjct: 66  RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125

Query: 137 PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
           P +DW  R +IALGSA+GLAYLH+ C PKIIHRD+KAANILLD +FEA V DFGLAK+  
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185

Query: 197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDS 256
             +THV+T V GT G++APEY S+GK +EK+DVF +GVMLLELITG+R  D      +D 
Sbjct: 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245

Query: 257 --LVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQ 314
             L+DW + LL    ++   + LVD  L   Y   E+ +++  A  C + S   RP+MS+
Sbjct: 246 VMLLDWVKGLL----KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301

Query: 315 IVRALEGDASLADLNEG 331
           +VR LEGD       E 
Sbjct: 302 VVRMLEGDGLAERWEEW 318

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  523 bits (1350), Expect = 0.0
 Identities = 121/324 (37%), Positives = 181/324 (55%), Gaps = 11/324 (3%)

Query: 8   GSNYS-GSEAPLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLP 66
           GS YS  + +     S    + F        +L  AT+ F    L+G G FG V++GVL 
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61

Query: 67  NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT 126
           +G +VA+K+    S QG  EF+ E+E +S   H HLVSL+G+    ++ +L+Y+++ N  
Sbjct: 62  DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121

Query: 127 LEFHLHGKGRPT--MDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA 184
           L+ HL+G   PT  M W  RL+I +G+A+GL YLH      IIHRD+K+ NILLD  F  
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP 178

Query: 185 KVADFGLAKIASDV-NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 243
           K+ DFG++K  +++  TH+ST V GT GY+ PEY   G+LTEKSDV+SFGV+L E++  R
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

Query: 244 RPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVR 303
             +  +      +L +WA    N     G  + +VDP L ++     + +    A  C+ 
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNN----GQLEQIVDPNLADKIRPESLRKFGDTAVKCLA 294

Query: 304 HSARRRPRMSQIVRALEGDASLAD 327
            S+  RP M  ++  LE    L +
Sbjct: 295 LSSEDRPSMGDVLWKLEYALRLQE 318

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  488 bits (1260), Expect = e-174
 Identities = 104/304 (34%), Positives = 177/304 (58%), Gaps = 23/304 (7%)

Query: 33  TFTYEELARATDGFSD------ANLLGQGGFGYVHRGVLPNGKEVAIKQLKAG----SGQ 82
           +F++ EL   T+ F +       N +G+GGFG V++G + N   VA+K+L A     + +
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72

Query: 83  GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG-KGRPTMDW 141
            +++F  E++++++  H++LV L+G+ + G    LVY ++PN +L   L    G P + W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132

Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA-SDVNT 200
             R KIA G+A G+ +LHE+     IHRDIK+ANILLD  F AK++DFGLA+ +     T
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189

Query: 201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDW 260
            +++R++GT  Y+APE    G++T KSD++SFGV+LLE+ITG   VD         L+D 
Sbjct: 190 VMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDI 246

Query: 261 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
              + +   E+   +  +D K+ N+ +   +  M + A+ C+     +RP + ++ + L+
Sbjct: 247 KEEIED---EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

Query: 321 GDAS 324
              +
Sbjct: 303 EMTA 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  281 bits (721), Expect = 7e-93
 Identities = 74/319 (23%), Positives = 117/319 (36%), Gaps = 26/319 (8%)

Query: 30  SKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQA 89
           S      E L   +       +  +G FG V +      + VA+K       Q   + + 
Sbjct: 10  SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW-QNEY 67

Query: 90  EVEIISRVHHKHLVSLVGYYTAGS----QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRL 145
           EV  +  + H++++  +G    G+       L+  F    +L   L       + W    
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELC 124

Query: 146 KIALGSAKGLAYLHED-------CHPKIIHRDIKAANILLDFKFEAKVADFGLAKI-ASD 197
            IA   A+GLAYLHED         P I HRDIK+ N+LL     A +ADFGLA    + 
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184

Query: 198 VNTHVSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVMLLELITGRRPVDSTHTF 252
            +   +   +GT  Y+APE              + D+++ G++L EL +     D     
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

Query: 253 VEDSLVD--WARPLLNRAIEDGNFDTLVDPKLHNEY-NHNEMARMVACAAACVRHSARRR 309
                 +     P L    E         P L + +  H  MA +      C  H A  R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHK-KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303

Query: 310 PRMSQIVRALEGDASLADL 328
                +   +     L ++
Sbjct: 304 LSAGCVGERITQMQRLTNI 322

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  225 bits (574), Expect = 1e-70
 Identities = 65/342 (19%), Positives = 126/342 (36%), Gaps = 49/342 (14%)

Query: 34  FTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEI 93
               E +   D      L+G+G +G V++G L + + VA+K     +    + F  E  I
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNI 58

Query: 94  --ISRVHHKHLVSLVGYYTAGS-----QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK 146
             +  + H ++   +      +     + +LV E+ PN +L  +L      T DW++  +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115

Query: 147 IALGSAKGLAYLHED------CHPKIIHRDIKAANILLDFKFEAKVADFGLAKI------ 194
           +A    +GLAYLH +        P I HRD+ + N+L+       ++DFGL+        
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 195 -ASDVNTHVSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELITGRRPV 246
                  + +   +GT  Y+APE               ++ D+++ G++  E+       
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC--- 232

Query: 247 DSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD--------PKLHNEYNHNE--MARMVA 296
             T  F  +S+ ++             F+ +          PK    +  N   +  +  
Sbjct: 233 --TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290

Query: 297 CAAACVRHSARRRPRMSQIVRALEGDASLADLNEGIRPGQSS 338
               C    A  R         +     + + N+ + P    
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  212 bits (542), Expect = 4e-66
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 29/274 (10%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
           +G G FG VHR    +G +VA+K L       +   EF  EV I+ R+ H ++V  +G  
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKG-RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
           T      +V E++   +L   LH  G R  +D   RL +A   AKG+ YLH   +P I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162

Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 228
           R++K+ N+L+D K+  KV DFGL+++ +      S    GT  ++APE        EKSD
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKAS-TFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 221

Query: 229 VFSFGVMLLELITGRRPVDSTHTF--VEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEY 286
           V+SFGV+L EL T ++P  + +    V        R  +              P      
Sbjct: 222 VYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI--------------P----RN 263

Query: 287 NHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
            + ++A ++     C  +   +RP  + I+  L 
Sbjct: 264 LNPQVAAII---EGCWTNEPWKRPSFATIMDLLR 294

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  209 bits (535), Expect = 2e-65
 Identities = 86/292 (29%), Positives = 136/292 (46%), Gaps = 56/292 (19%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE-------REFQAEVEIISRVHHKHLV 103
           +G+GGFG VH+G  + +   VAIK L  G  +GE       +EFQ EV I+S ++H ++V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            L G     +   +V EFVP   L   L  K  P + W  +L++ L  A G+ Y+  + +
Sbjct: 87  KLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQ-NQN 142

Query: 164 PKIIHRDIKAANILLD-----FKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-- 216
           P I+HRD+++ NI L          AKVADFGL++     + H  + ++G F ++APE  
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPETI 198

Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP--------VDSTHTFVEDSLVDWARPLLNRA 268
            A     TEK+D +SF ++L  ++TG  P        +   +   E+ L    RP +   
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL----RPTIPED 254

Query: 269 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
                                 +  ++     C     ++RP  S IV+ L 
Sbjct: 255 C------------------PPRLRNVI---ELCWSGDPKKRPHFSYIVKELS 285

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  207 bits (528), Expect = 4e-64
 Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 35/274 (12%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G+G FG V +      K+VAIKQ++  S    + F  E+  +SRV+H ++V L G    
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACL- 71

Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGR-PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
            +   LV E+    +L   LHG    P       +   L  ++G+AYLH      +IHRD
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 171 IKAANILLDFKFE-AKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           +K  N+LL       K+ DFG A           T   G+  ++APE       +EK DV
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDV 186

Query: 230 FSFGVMLLELITGRRP---VDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEY 286
           FS+G++L E+IT R+P   +      +  ++ +  RP L               K     
Sbjct: 187 FSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL--------------IK----N 228

Query: 287 NHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
               +  ++     C      +RP M +IV+ + 
Sbjct: 229 LPKPIESLM---TRCWSKDPSQRPSMEEIVKIMT 259

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  200 bits (512), Expect = 3e-62
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 19/206 (9%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAG----SGQGEREFQAEVEIISRVHHKHLVSLVG 107
           +G GGFG V+R     G EVA+K  +        Q     + E ++ + + H ++++L G
Sbjct: 15  IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
                    LV EF     L   L GK    +     +  A+  A+G+ YLH++    II
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPII 130

Query: 168 HRDIKAANILLDFKFE--------AKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
           HRD+K++NIL+  K E         K+ DFGLA+      T   +   G + ++APE   
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAA-GAYAWMAPEVIR 187

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRP 245
           +   ++ SDV+S+GV+L EL+TG  P
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVP 213

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  200 bits (511), Expect = 5e-62
 Identities = 56/278 (20%), Positives = 108/278 (38%), Gaps = 38/278 (13%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
           L +   G + +G    G ++ +K LK    S +  R+F  E   +    H +++ ++G  
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 110 TA--GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
            +       L+  ++P  +L   LH      +D    +K AL  A+G+A+LH    P I 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135

Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE---YASSGKLT 224
              + + ++++D    A+++   +           S   M    ++APE           
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPEDTNR 189

Query: 225 EKSDVFSFGVMLLELITGRRPVD--STHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL 282
             +D++SF V+L EL+T   P    S         ++  RP +              P  
Sbjct: 190 RSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI--------------P-- 233

Query: 283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
                   +++++     C+     +RP+   IV  LE
Sbjct: 234 --PGISPHVSKLM---KICMNEDPAKRPKFDMIVPILE 266

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  199 bits (508), Expect = 4e-61
 Identities = 68/283 (24%), Positives = 109/283 (38%), Gaps = 36/283 (12%)

Query: 52  LGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG+G FG   +      G+ + +K+L     + +R F  EV+++  + H +++  +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
              +   + E++   TL   +         W  R+  A   A G+AYLH      IIHRD
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHS---MNIIHRD 133

Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTH-------------VSTRVMGTFGYLAPEY 217
           + + N L+       VADFGLA++  D  T                  V+G   ++APE 
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193

Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL 277
            +     EK DVFSFG++L E+I              D  ++  R  L+R          
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRGFLDRYCPPN----- 247

Query: 278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
             P                    C      +RP   ++   LE
Sbjct: 248 CPPSFFP------------ITVRCCDLDPEKRPSFVKLEHWLE 278

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  197 bits (502), Expect = 1e-60
 Identities = 74/278 (26%), Positives = 132/278 (47%), Gaps = 34/278 (12%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
           +G G FG V++G   +G +VA+K L     + Q  + F+ EV ++ +  H +++  +GY 
Sbjct: 32  IGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
           T   Q  +V ++   ++L  HLH       +    + IA  +A+G+ YLH      IIHR
Sbjct: 90  T-APQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHA---KSIIHR 144

Query: 170 DIKAANILLDFKFEAKVADFGLAKI-ASDVNTHVSTRVMGTFGYLAPE---YASSGKLTE 225
           D+K+ NI L      K+ DFGLA   +    +H   ++ G+  ++APE      S   + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204

Query: 226 KSDVFSFGVMLLELITGRRP---VDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL 282
           +SDV++FG++L EL+TG+ P   +++    +E        P L++   +         ++
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN------CPKRM 258

Query: 283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
                   MA        C++     RP   +I+  +E
Sbjct: 259 -----KRLMAE-------CLKKKRDERPSFPRILAEIE 284

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  192 bits (489), Expect = 3e-58
 Identities = 61/291 (20%), Positives = 110/291 (37%), Gaps = 51/291 (17%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSLVG 107
            L+G+G FG V+ G   +G EVAI+ +     +    + F+ EV    +  H+++V  +G
Sbjct: 39  ELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
              +     ++       TL   +    +  +D     +IA    KG+ YLH      I+
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152

Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM----GTFGYLAPEYASSGKL 223
           H+D+K+ N+  D   +  + DFGL  I+  +        +    G   +LAPE       
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211

Query: 224 ---------TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA-----RPLLNRAI 269
                    ++ SDVF+ G +  EL     P  +         + W      +P L++  
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----IIWQMGTGMKPNLSQIG 267

Query: 270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
                  +                ++ C A         RP  ++++  LE
Sbjct: 268 MGKEISDI----------------LLFCWAF----EQEERPTFTKLMDMLE 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  186 bits (474), Expect = 8e-56
 Identities = 64/300 (21%), Positives = 121/300 (40%), Gaps = 44/300 (14%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEI--ISRVHHKHLVSLVG 107
             +G+G +G V  G    G++VA+K         E  +  E EI     + H++++  + 
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98

Query: 108 YYTAGS----QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED-- 161
               G+    Q  L+ ++  N +L  +L      T+D  + LK+A  S  GL +LH +  
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 162 ---CHPKIIHRDIKAANILLDFKFEAKVADFGLAKI---ASDVNTHVSTRVMGTFGYLAP 215
                P I HRD+K+ NIL+       +AD GLA      ++         +GT  Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

Query: 216 E------YASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAI 269
           E        +  +    +D++SFG++L E+                 + ++  P  +   
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS--------GGIVEEYQLPYHDLVP 267

Query: 270 EDGNFDTLVD--------PKLHNEY-NHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
            D +++ + +        P   N + +   + +M      C  H+   R    ++ + L 
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  185 bits (471), Expect = 9e-56
 Identities = 65/300 (21%), Positives = 123/300 (41%), Gaps = 44/300 (14%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEI--ISRVHHKHLVSLVG 107
             +G+G +G V RG    G+ VA+K   +   + E+ +  E E+     + H++++  + 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 108 YYTAGS----QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED-- 161
                     Q  L+  +    +L  +L      T+D ++ L+I L  A GLA+LH +  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 162 ---CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV---STRVMGTFGYLAP 215
                P I HRD+K+ NIL+    +  +AD GLA + S     +   +   +GT  Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 216 E------YASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAI 269
           E              ++ D+++FG++L E+                 + D+  P  +   
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS--------NGIVEDYKPPFYDVVP 238

Query: 270 EDGNFDTLVD--------PKLHNEY-NHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
            D +F+ +          P + N + +   +  +      C   +   R    +I + L 
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  177 bits (451), Expect = 2e-52
 Identities = 68/300 (22%), Positives = 123/300 (41%), Gaps = 44/300 (14%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEI--ISRVHHKHLVSLVG 107
             +G+G FG V RG    G+EVA+K   +   + ER +  E EI     + H++++  + 
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103

Query: 108 ----YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED-- 161
                    +Q  LV ++  + +L  +L+   R T+     +K+AL +A GLA+LH +  
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 162 ---CHPKIIHRDIKAANILLDFKFEAKVADFGLAKI---ASDVNTHVSTRVMGTFGYLAP 215
                P I HRD+K+ NIL+       +AD GLA     A+D         +GT  Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 216 E------YASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAI 269
           E           +  +++D+++ G++  E+            +          P  +   
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY--------QLPYYDLVP 272

Query: 270 EDGNFDTLVD--------PKLHNEY-NHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
            D + + +          P + N + +   +  M      C   +   R    +I + L 
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  163 bits (415), Expect = 1e-46
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 10/199 (5%)

Query: 52  LGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLVGYY 109
           +G+G FG V  G L  +   VA+K  +       + +F  E  I+ +  H ++V L+G  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
           T      +V E V        L  +G   +   T L++   +A G+ YL        IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESK---CCIHR 237

Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY--LAPEYASSGKLTEKS 227
           D+ A N L+  K   K++DFG+++  +D   + ++  +        APE  + G+ + +S
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEAD-GVYAASGGLRQVPVKWTAPEALNYGRYSSES 296

Query: 228 DVFSFGVMLLELIT-GRRP 245
           DV+SFG++L E  + G  P
Sbjct: 297 DVWSFGILLWETFSLGASP 315

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  156 bits (397), Expect = 1e-44
 Identities = 83/321 (25%), Positives = 134/321 (41%), Gaps = 42/321 (13%)

Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G  VA+KQL+      +R+FQ E++I+  +H   +V   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 107 G--YYTAGSQRMLVYEFVPN-NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           G  Y        LV E++P+    +F    + R     L  L  +    KG+ YL     
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL--LLYSSQICKGMEYLGSR-- 146

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASSG 221
            + +HRD+ A NIL++ +   K+ADFGLAK+      +   R  G     + APE  S  
Sbjct: 147 -RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205

Query: 222 KLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP 280
             + +SDV+SFGV+L EL T   +    +  F+     +   P L+R +E          
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE---------- 255

Query: 281 KLHNEYNHNEMARMVACAAA-------CVRHSARRRPRMSQIVRALEGDASLADLNEGIR 333
            L        +    AC A        C   S + RP  S +   L+       L  G R
Sbjct: 256 LLEEGQ---RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD------MLWSGSR 306

Query: 334 PGQSSVYGSYGSSDYDTMQYN 354
             ++  + ++    + ++ ++
Sbjct: 307 GCETHAFTAHPEGKHHSLSFS 327

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  152 bits (387), Expect = 4e-43
 Identities = 69/204 (33%), Positives = 110/204 (53%), Gaps = 15/204 (7%)

Query: 52  LGQGGFGYVHRGVL--PNGKE---VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSL 105
           +G G FG V++G+L   +GK+   VAIK LKAG  + +R +F  E  I+ +  H +++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHL-HGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
            G  +     M++ E++ N  L+  L    G  ++  L  + +  G A G+ YL  + + 
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL--VGMLRGIAAGMKYL-ANMN- 167

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY--LAPEYASSGK 222
             +HRD+ A NIL++     KV+DFGL+++  D      T   G       APE  S  K
Sbjct: 168 -YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226

Query: 223 LTEKSDVFSFGVMLLELIT-GRRP 245
            T  SDV+SFG+++ E++T G RP
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERP 250

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  151 bits (384), Expect = 4e-43
 Identities = 63/201 (31%), Positives = 106/201 (52%), Gaps = 12/201 (5%)

Query: 52  LGQGGFGYVHRGVLPNGKE---VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLVG 107
           LG G FG V +GV    K+   VAIK LK G+ + +  E   E +I+ ++ + ++V L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
                   MLV E      L   L GK    +      ++    + G+ YL E+ +   +
Sbjct: 78  VCQ-AEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYL-EEKN--FV 132

Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASSGKLTE 225
           HRD+ A N+LL  +  AK++DFGL+K     +++ + R  G +   + APE  +  K + 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192

Query: 226 KSDVFSFGVMLLELIT-GRRP 245
           +SDV+S+GV + E ++ G++P
Sbjct: 193 RSDVWSYGVTMWEALSYGQKP 213

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  152 bits (386), Expect = 5e-43
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 13/202 (6%)

Query: 52  LGQGGFGYVHRGVLPNGKE-----VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSL 105
           LG G FG V++G+     E     VAIK+L+  +      E   E  +++ V + H+  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G     S   L+ + +P   L  ++  + +  +     L   +  AKG+ YL +    +
Sbjct: 83  LGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
           ++HRD+ A N+L+      K+ DFGLAK + ++   + +        ++A E       T
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197

Query: 225 EKSDVFSFGVMLLELIT-GRRP 245
            +SDV+S+GV + EL+T G +P
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKP 219

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  151 bits (384), Expect = 6e-43
 Identities = 68/291 (23%), Positives = 114/291 (39%), Gaps = 43/291 (14%)

Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSL 105
           LG+G FG V            G++VA+K LK  SG     + + E+EI+  ++H+++V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 106 VG--YYTAGSQRMLVYEFVPN-NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
            G      G+   L+ EF+P+ +  E+    K +  +     LK A+   KG+ YL    
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ--LKYAVQICKGMDYLGSR- 145

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASS 220
             + +HRD+ A N+L++ + + K+ DFGL K       + + +        + APE    
Sbjct: 146 --QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203

Query: 221 GKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLV---DWARPLLNRAIEDGNFDT 276
            K    SDV+SFGV L EL+T           F++             L   +++G    
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG---- 259

Query: 277 LVDPKLHNEYNHNEMARMVACAAA-------CVRHSARRRPRMSQIVRALE 320
                         +     C          C       R     ++   E
Sbjct: 260 ------------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  150 bits (382), Expect = 8e-43
 Identities = 68/290 (23%), Positives = 118/290 (40%), Gaps = 41/290 (14%)

Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 107 GYYTAGSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G   +  +R   L+ E++P  +L  +L  K +  +D +  L+      KG+ YL      
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 133

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASSGK 222
           + IHRD+   NIL++ +   K+ DFGL K+          +  G     + APE  +  K
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193

Query: 223 LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL-----VDWARPLLNRAIEDGNFDTL 277
            +  SDV+SFGV+L EL T      S        +            L   +++      
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN----- 248

Query: 278 VDPKLHNEYNHNEMARMVACAAA-------CVRHSARRRPRMSQIVRALE 320
                        + R   C          C  ++  +RP    +   ++
Sbjct: 249 -----------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  149 bits (379), Expect = 2e-42
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 14/202 (6%)

Query: 52  LGQGGFGYVHRGVLPNGK---EVAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG G FG V +G     K    VA+K LK        + E  AE  ++ ++ + ++V ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
           G        MLV E      L  +L          +  +++    + G+ YL E+ +   
Sbjct: 85  GICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVSMGMKYL-EESN--F 138

Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASSGKLT 224
           +HRD+ A N+LL  +  AK++DFGL+K       +   +  G +   + APE  +  K +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198

Query: 225 EKSDVFSFGVMLLELIT-GRRP 245
            KSDV+SFGV++ E  + G++P
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKP 220

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  151 bits (384), Expect = 3e-42
 Identities = 68/202 (33%), Positives = 103/202 (50%), Gaps = 12/202 (5%)

Query: 52  LGQGGFGYVHRGVL--PNGKE--VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLV 106
           +G G FG V  G L  P+ KE  VAIK LK G  + +R +F  E  I+ +  H +++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
           G  T     M+V E++ N +L+  L  K       +  + +  G A G+ YL  D     
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL-SDMG--Y 168

Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL--APEYASSGKLT 224
           +HRD+ A NIL++     KV+DFGL ++  D      T   G       +PE  +  K T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228

Query: 225 EKSDVFSFGVMLLELIT-GRRP 245
             SDV+S+G++L E+++ G RP
Sbjct: 229 SASDVWSYGIVLWEVMSYGERP 250

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  150 bits (381), Expect = 3e-42
 Identities = 67/290 (23%), Positives = 121/290 (41%), Gaps = 41/290 (14%)

Query: 52  LGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V            G+ VA+K+L+  + +  R+F+ E+EI+  + H ++V   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 107 GYYTAGSQR--MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           G   +  +R   L+ E++P  +L  +L  K +  +D +  L+      KG+ YL      
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 164

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASSGK 222
           + IHRD+   NIL++ +   K+ DFGL K+      +   +  G     + APE  +  K
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224

Query: 223 LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN-----RAIEDGNFDTL 277
            +  SDV+SFGV+L EL T      S        + +  +  +        +++      
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN----- 279

Query: 278 VDPKLHNEYNHNEMARMVACAAA-------CVRHSARRRPRMSQIVRALE 320
                        + R   C          C  ++  +RP    +   ++
Sbjct: 280 -----------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  148 bits (375), Expect = 4e-42
 Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 14/199 (7%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G G FG VH G   N  +VAIK ++ G+   E +F  E E++ ++ H  LV L G    
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74

Query: 112 GSQRMLVYEFVPN-NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
            +   LV EF+ +    ++    +G    + L  L + L   +G+AYL E     +IHRD
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETL--LGMCLDVCEGMAYLEEA---CVIHRD 129

Query: 171 IKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGY--LAPEYASSGKLTEKS 227
           + A N L+      KV+DFG+ + +  D  T   +     F     +PE  S  + + KS
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYT---SSTGTKFPVKWASPEVFSFSRYSSKS 186

Query: 228 DVFSFGVMLLELIT-GRRP 245
           DV+SFGV++ E+ + G+ P
Sbjct: 187 DVWSFGVLMWEVFSEGKIP 205

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  149 bits (379), Expect = 6e-42
 Identities = 67/203 (33%), Positives = 103/203 (50%), Gaps = 14/203 (6%)

Query: 52  LGQGGFGYVHRGVL--PNGKE--VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLV 106
           +G G  G V  G L  P  ++  VAIK LKAG  + +R +F +E  I+ +  H +++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 107 GYYTAGSQRMLVYEFVPN-NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           G  T G   M+V E++ N +   F     G+ T+  L  + +  G   G+ YL  D    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL--VGMLRGVGAGMRYL-SDLG-- 171

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL--APEYASSGKL 223
            +HRD+ A N+L+D     KV+DFGL+++  D      T   G       APE  +    
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231

Query: 224 TEKSDVFSFGVMLLELIT-GRRP 245
           +  SDV+SFGV++ E++  G RP
Sbjct: 232 SSASDVWSFGVVMWEVLAYGERP 254

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  148 bits (376), Expect = 6e-42
 Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 17/234 (7%)

Query: 16  APLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQ 75
            PL   +   + G    ++   E+       +    LG G FG V  G      +VAIK 
Sbjct: 1   GPLGSKNAPSTAGLGYGSW---EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM 55

Query: 76  LKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPN-NTLEFHLHGK 134
           +K GS   E EF  E +++  + H+ LV L G  T      ++ E++ N   L +    +
Sbjct: 56  IKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR 114

Query: 135 GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI 194
            R     L  L++     + + YL E      +HRD+ A N L++ +   KV+DFGL++ 
Sbjct: 115 HRFQTQQL--LEMCKDVCEAMEYL-ESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRY 169

Query: 195 ASDVNTHVSTRVMGTFGY--LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
             D     ++ V   F      PE     K + KSD+++FGV++ E+ + G+ P
Sbjct: 170 VLD--DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  149 bits (378), Expect = 7e-42
 Identities = 80/287 (27%), Positives = 119/287 (41%), Gaps = 37/287 (12%)

Query: 52  LGQGGFGYVHRGVLPNGKE-----VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSL 105
           LG+G FG V         +     VA+K LKA +G   R  ++ E++I+  ++H+H++  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 106 VG--YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            G       +   LV E+VP  +L  +L  +    +  L  L  A    +G+AYLH    
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSIGLAQL--LLFAQQICEGMAYLHAQ-- 153

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF--GYLAPEYASSG 221
              IHRD+ A N+LLD     K+ DFGLAK   + + +   R  G     + APE     
Sbjct: 154 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212

Query: 222 KLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP 280
           K    SDV+SFGV L EL+T           F+E   +   +  + R  E          
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE---------- 262

Query: 281 KLHNEYNHNEMARMVACAAA-------CVRHSARRRPRMSQIVRALE 320
            L        + R   C A        C    A  RP    ++  L+
Sbjct: 263 LLERGE---RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  147 bits (374), Expect = 1e-41
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 23/207 (11%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQ--LKAGSGQGEREFQAEVEIISRVHHKHLVSLVG 107
            +G+G F  V++G+      EVA  +   +  +    + F+ E E++  + H ++V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 108 YYTAGSQRM----LVYEFVPNNTLEFHLHGKGRPTMD----WLTRLKIALGSAKGLAYLH 159
            + +  +      LV E + + TL+ +L       +     W  ++       KGL +LH
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI------LKGLQFLH 146

Query: 160 EDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
               P IIHRD+K  NI +       K+ D GLA +        +  V+GT  ++APE  
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPEMY 202

Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
                 E  DV++FG+ +LE+ T   P
Sbjct: 203 EEK-YDESVDVYAFGMCMLEMATSEYP 228

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  147 bits (373), Expect = 1e-41
 Identities = 63/204 (30%), Positives = 92/204 (45%), Gaps = 15/204 (7%)

Query: 52  LGQGGFGYVHRGVL--PNGKE--VAIKQLKAG---SGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V RG    P+GK   VA+K LK       +   +F  EV  +  + H++L+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L G         +V E  P  +L   L  K +      T  + A+  A+G+ YL E    
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYL-ESKR- 141

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY--LAPEYASSGK 222
             IHRD+ A N+LL  +   K+ DFGL +     + H   +      +   APE   +  
Sbjct: 142 -FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200

Query: 223 LTEKSDVFSFGVMLLELIT-GRRP 245
            +  SD + FGV L E+ T G+ P
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEP 224

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  146 bits (372), Expect = 2e-41
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)

Query: 52  LGQGGFGYVHRGVL--PNGKE--VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLV 106
           +G+G FG VH+G+   P      VAIK  K  +    R +F  E   + +  H H+V L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
           G  T  +   ++ E      L   L    + ++D  + +  A   +  LAYL      + 
Sbjct: 83  GVIT-ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESK---RF 137

Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEK 226
           +HRDI A N+L+      K+ DFGL++   D   + +++      ++APE  +  + T  
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197

Query: 227 SDVFSFGVMLLELIT-GRRP 245
           SDV+ FGV + E++  G +P
Sbjct: 198 SDVWMFGVCMWEILMHGVKP 217

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  146 bits (371), Expect = 2e-41
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
             +G+G FG V  G    G +VA+K +K  +    + F AE  +++++ H +LV L+G  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 110 TAGSQR-MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
                   +V E++   +L  +L  +GR  +     LK +L   + + YL  +     +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 140

Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY--LAPEYASSGKLTEK 226
           RD+ A N+L+     AKV+DFGL K   + ++   T+  G       APE     K + K
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK---EASS---TQDTGKLPVKWTAPEALREKKFSTK 194

Query: 227 SDVFSFGVMLLELIT-GRRP 245
           SDV+SFG++L E+ + GR P
Sbjct: 195 SDVWSFGILLWEIYSFGRVP 214

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  151 bits (382), Expect = 3e-41
 Identities = 69/197 (35%), Positives = 98/197 (49%), Gaps = 6/197 (3%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
             LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
           +      +V E++   +L   L G+    +     + +A   A G+AY+        +HR
Sbjct: 249 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304

Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364

Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 365 WSFGILLTELTTKGRVP 381

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  146 bits (370), Expect = 3e-41
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 14/199 (7%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K +K GS   E EF  E + + ++ H  LV   G  + 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74

Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGR-PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                +V E++ N  L  +L   G+      L  L++     +G+A+L      + IHRD
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL--LEMCYDVCEGMAFLESH---QFIHRD 129

Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT---FGYLAPEYASSGKLTEKS 227
           + A N L+D     KV+DFG+ +   D         +GT     + APE     K + KS
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLD---DQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186

Query: 228 DVFSFGVMLLELIT-GRRP 245
           DV++FG+++ E+ + G+ P
Sbjct: 187 DVWAFGILMWEVFSLGKMP 205

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  146 bits (371), Expect = 3e-41
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 13/201 (6%)

Query: 52  LGQGGFGYVHRGVL--PNGKE--VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLV 106
           LG+G FG V+ GV     G++  VA+K  K       + +F +E  I+  + H H+V L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHL-HGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           G         ++ E  P   L  +L   K    +  L  +  +L   K +AYL E  +  
Sbjct: 80  GIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTL--VLYSLQICKAMAYL-ESIN-- 133

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
            +HRDI   NIL+      K+ DFGL++   D + + ++       +++PE  +  + T 
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 193

Query: 226 KSDVFSFGVMLLELIT-GRRP 245
            SDV+ F V + E+++ G++P
Sbjct: 194 ASDVWMFAVCMWEILSFGKQP 214

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  150 bits (381), Expect = 4e-41
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 16/198 (8%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           +G+G FG V  G    G +VA+K +K  +    + F AE  +++++ H +LV L+G    
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 112 GSQR-MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 +V E++   +L  +L  +GR  +     LK +L   + + YL  +     +HRD
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 314

Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY--LAPEYASSGKLTEKSD 228
           + A N+L+     AKV+DFGL K   + ++   T+  G       APE     K + KSD
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK---EASS---TQDTGKLPVKWTAPEALREKKFSTKSD 368

Query: 229 VFSFGVMLLELIT-GRRP 245
           V+SFG++L E+ + GR P
Sbjct: 369 VWSFGILLWEIYSFGRVP 386

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  151 bits (382), Expect = 5e-41
 Identities = 60/198 (30%), Positives = 95/198 (47%), Gaps = 6/198 (3%)

Query: 50  NLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGY 108
           + LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 284

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
            T      ++ EF+    L  +L    R  +  +  L +A   +  + YL +      IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 341

Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 228
           R++ A N L+      KVADFGL+++ +               + APE  +  K + KSD
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401

Query: 229 VFSFGVMLLELIT-GRRP 245
           V++FGV+L E+ T G  P
Sbjct: 402 VWAFGVLLWEIATYGMSP 419

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  145 bits (369), Expect = 8e-41
 Identities = 71/210 (33%), Positives = 104/210 (49%), Gaps = 22/210 (10%)

Query: 50  NLLGQGGFGYVHRGVL--PNGKE--VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
            ++G+G FG V+ G L   +GK+   A+K L   +  GE  +F  E  I+    H +++S
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 105 LVGYYTAG-SQRMLVYEFVPN-NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           L+G         ++V  ++ + +   F  +    PT+  L  +   L  AKG+ YL    
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMKYLASK- 147

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL------APE 216
             K +HRD+ A N +LD KF  KVADFGLA+   D+       V    G        A E
Sbjct: 148 --KFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKWMALE 202

Query: 217 YASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
              + K T KSDV+SFGV+L EL+T G  P
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  145 bits (367), Expect = 1e-40
 Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 31/214 (14%)

Query: 52  LGQGGFGYVHRGVL--------PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
           LGQG F  + +GV          +  EV +K L          F     ++S++ HKHLV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 104 SLVGYYTAGSQRMLVYEFVPN-NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
              G    G + +LV EFV   +   +    K    + W   L++A   A  + +L E+ 
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFL-EEN 132

Query: 163 HPKIIHRDIKAANILLDFKFE--------AKVADFGLAK-IASDVNTHVSTRVMGTFGYL 213
              +IH ++ A NILL  + +         K++D G++  +            +      
Sbjct: 133 T--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV------ 184

Query: 214 APEYASSGKL-TEKSDVFSFGVMLLELIT-GRRP 245
            PE   + K     +D +SFG  L E+ + G +P
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  144 bits (365), Expect = 2e-40
 Identities = 68/198 (34%), Positives = 101/198 (51%), Gaps = 12/198 (6%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA 111
           LG G FG V  G      +VA+K LK GS   +  F AE  ++ ++ H+ LV L    T 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT- 78

Query: 112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDI 171
                ++ E++ N +L   L       +     L +A   A+G+A++ E      IHRD+
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135

Query: 172 KAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT---FGYLAPEYASSGKLTEKSD 228
           +AANIL+      K+ADFGLA+    +  +  T   G      + APE  + G  T KSD
Sbjct: 136 RAANILVSDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192

Query: 229 VFSFGVMLLELIT-GRRP 245
           V+SFG++L E++T GR P
Sbjct: 193 VWSFGILLTEIVTHGRIP 210

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  145 bits (369), Expect = 2e-40
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 13/202 (6%)

Query: 52  LGQGGFGYVHRGVLPNGKE-----VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSL 105
           LG G FG V++G+     E     VAIK+L+  +      E   E  +++ V + H+  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G     S   L+ + +P   L  ++  + +  +     L   +  AKG+ YL +    +
Sbjct: 83  LGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
           ++HRD+ A N+L+      K+ DFGLAK + ++   + +        ++A E       T
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197

Query: 225 EKSDVFSFGVMLLELIT-GRRP 245
            +SDV+S+GV + EL+T G +P
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKP 219

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  144 bits (366), Expect = 2e-40
 Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 16/201 (7%)

Query: 52  LGQGGFGYVHRGVLPNGK-EVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G +G V+ GV       VA+K LK  + + E EF  E  ++  + H +LV L+G  T
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79

Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
                 ++ EF+    L  +L    R  +  +  L +A   +  + YL +      IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136

Query: 171 IKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL-----APEYASSGKLTE 225
           + A N L+      KVADFGL+++ +       T              APE  +  K + 
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-----DTYTAHAGAKFPIKWTAPESLAYNKFSI 191

Query: 226 KSDVFSFGVMLLELIT-GRRP 245
           KSDV++FGV+L E+ T G  P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  144 bits (366), Expect = 2e-40
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 9/199 (4%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE---REFQAEVEIISRVHHKHLVSLV 106
            LG GG   V+         +VAIK +     + E   + F+ EV   S++ H+++VS++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
                     LV E++   TL  ++   G   +   T +        G+ + H+    +I
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM---RI 132

Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEK 226
           +HRDIK  NIL+D     K+ DFG+AK  S+ +   +  V+GT  Y +PE A      E 
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192

Query: 227 SDVFSFGVMLLELITGRRP 245
           +D++S G++L E++ G  P
Sbjct: 193 TDIYSIGIVLYEMLVGEPP 211

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  144 bits (366), Expect = 4e-40
 Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 13/202 (6%)

Query: 52  LGQGGFGYVHRGVLPNGKE-----VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSL 105
           LG G FG VH+GV     E     V IK ++  SG+         +  I  + H H+V L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G    GS   LV +++P  +L  H+  + R  +     L   +  AKG+ YL E     
Sbjct: 81  LGLCP-GSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEH---G 135

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
           ++HR++ A N+LL    + +VADFG+A  +  D    + +       ++A E    GK T
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195

Query: 225 EKSDVFSFGVMLLELIT-GRRP 245
            +SDV+S+GV + EL+T G  P
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEP 217

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  148 bits (376), Expect = 4e-40
 Identities = 69/197 (35%), Positives = 98/197 (49%), Gaps = 6/197 (3%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
             LGQG FG V  G       VAIK LK G+   E  F  E +++ ++ H+ LV L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
           +      +V E++   +L   L G+    +     + +A   A G+AY+        +HR
Sbjct: 332 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 387

Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      KVADFGLA++  D              + APE A  G+ T KSDV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447

Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L EL T GR P
Sbjct: 448 WSFGILLTELTTKGRVP 464

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  143 bits (363), Expect = 6e-40
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 22/210 (10%)

Query: 50  NLLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
            ++G+G FG V+ G   +  +     AIK L   +   +   F  E  ++  ++H ++++
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 105 LVGYYTAGS-QRMLVYEFVPN-NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           L+G          ++  ++ + + L+F    +  PT+  L  +   L  A+G+ YL E  
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL--ISFGLQVARGMEYLAEQ- 143

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL------APE 216
             K +HRD+ A N +LD  F  KVADFGLA+   D+       V             A E
Sbjct: 144 --KFVHRDLAARNCMLDESFTVKVADFGLAR---DILDREYYSVQQHRHARLPVKWTALE 198

Query: 217 YASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
              + + T KSDV+SFGV+L EL+T G  P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  149 bits (377), Expect = 8e-40
 Identities = 63/201 (31%), Positives = 106/201 (52%), Gaps = 12/201 (5%)

Query: 52  LGQGGFGYVHRGVLPNGKE---VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLVG 107
           LG G FG V +GV    K+   VAIK LK G+ + +  E   E +I+ ++ + ++V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
                   MLV E      L   L GK R  +      ++    + G+ YL E+ +   +
Sbjct: 404 VCQ-AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL-EEKN--FV 458

Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY--LAPEYASSGKLTE 225
           HR++ A N+LL  +  AK++DFGL+K     +++ + R  G +     APE  +  K + 
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518

Query: 226 KSDVFSFGVMLLELIT-GRRP 245
           +SDV+S+GV + E ++ G++P
Sbjct: 519 RSDVWSYGVTMWEALSYGQKP 539

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  146 bits (371), Expect = 1e-39
 Identities = 62/197 (31%), Positives = 93/197 (47%), Gaps = 6/197 (3%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
             LG G FG V         +VA+K +K GS      F AE  ++  + H  LV L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
           T      ++ EF+   +L   L             +  +   A+G+A++ +      IHR
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 308

Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368

Query: 230 FSFGVMLLELIT-GRRP 245
           +SFG++L+E++T GR P
Sbjct: 369 WSFGILLMEIVTYGRIP 385

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  149 bits (377), Expect = 1e-39
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)

Query: 52  LGQGGFGYVHRGVL--PNGKE--VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVSLV 106
           +G+G FG VH+G+   P      VAIK  K  +    R +F  E   + +  H H+V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
           G  T  +   ++ E      L   L    + ++D  + +  A   +  LAYL      + 
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESK---RF 512

Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEK 226
           +HRDI A N+L+      K+ DFGL++   D   + +++      ++APE  +  + T  
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572

Query: 227 SDVFSFGVMLLELIT-GRRP 245
           SDV+ FGV + E++  G +P
Sbjct: 573 SDVWMFGVCMWEILMHGVKP 592

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  140 bits (356), Expect = 6e-39
 Identities = 65/220 (29%), Positives = 98/220 (44%), Gaps = 33/220 (15%)

Query: 52  LGQGGFGYVHRGVLPNGKE------VAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG V      N         VA+K LK  +    ++FQ E E+++ + H+H+V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR--------------LKIALGS 151
            G    G   ++V+E++ +  L   L   G   M  +                L IA   
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
           A G+ YL        +HRD+   N L+      K+ DFG+++   DV +    RV G   
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR---DVYSTDYYRVGGH-T 195

Query: 212 YL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
            L      PE     K T +SDV+SFGV+L E+ T G++P
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  140 bits (354), Expect = 1e-38
 Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 15/205 (7%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLK---AGSGQGEREFQAEVEIISRVHHKHLVSL- 105
           +LG GG   VH    L + ++VA+K L+   A        F+ E +  + ++H  +V++ 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 106 -VGYYTAGSQRM--LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
             G     +  +  +V E+V   TL   +H +G   M     +++   + + L + H++ 
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN- 135

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV--STRVMGTFGYLAPEYASS 220
              IIHRD+K ANI++      KV DFG+A+  +D    V  +  V+GT  YL+PE A  
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 221 GKLTEKSDVFSFGVMLLELITGRRP 245
             +  +SDV+S G +L E++TG  P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  141 bits (357), Expect = 2e-38
 Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 22/210 (10%)

Query: 50  NLLGQGGFGYVHRGVL--PNGKE--VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
            ++G+G FG V+ G L   +GK+   A+K L   +  GE  +F  E  I+    H +++S
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 105 LVGYYT-AGSQRMLVYEFVPN-NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           L+G    +    ++V  ++ + +   F  +    PT+  L  +   L  AKG+ +L    
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--IGFGLQVAKGMKFLASK- 211

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL------APE 216
             K +HRD+ A N +LD KF  KVADFGLA+   D+       V    G        A E
Sbjct: 212 --KFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEFDSVHNKTGAKLPVKWMALE 266

Query: 217 YASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
              + K T KSDV+SFGV+L EL+T G  P
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  139 bits (353), Expect = 3e-38
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 28/215 (13%)

Query: 52  LGQGGFGYVHRGVLPNGKE------VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
           LGQG FG V+ GV     +      VAIK +   +   ER EF  E  ++   +  H+V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHL-----HGKGRPTMDWLTR---LKIALGSAKGLA 156
           L+G  + G   +++ E +    L+ +L          P +   +    +++A   A G+A
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL--- 213
           YL+ +   K +HRD+ A N ++   F  K+ DFG+ +   D+      R  G  G L   
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYR-KGGKGLLPVR 205

Query: 214 --APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
             +PE    G  T  SDV+SFGV+L E+ T   +P
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  139 bits (352), Expect = 4e-38
 Identities = 64/219 (29%), Positives = 97/219 (44%), Gaps = 32/219 (14%)

Query: 52  LGQGGFGYVHRGVLPNGKE------VAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG V      N         VA+K LK  S    ++FQ E E+++ + H+H+V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-------------LKIALGSA 152
            G  T G   ++V+E++ +  L   L   G                      L +A   A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
            G+ YL        +HRD+   N L+      K+ DFG+++   D+ +    RV G    
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR---DIYSTDYYRVGGR-TM 221

Query: 213 L-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
           L      PE     K T +SDV+SFGV+L E+ T G++P
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  137 bits (348), Expect = 2e-37
 Identities = 64/215 (29%), Positives = 94/215 (43%), Gaps = 28/215 (13%)

Query: 52  LGQGGFGYVHRGVLPNGK------EVAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
           LG G FG V+ G +          +VA+K L     + +  +F  E  IIS+ +H+++V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHL-----HGKGRPTMDWLTRLKIALGSAKGLAYLH 159
            +G       R ++ E +    L+  L           ++  L  L +A   A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 160 EDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMGTFGYL--- 213
           E+     IHRDI A N LL        AK+ DFG+A+   D+      R  G    L   
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---DIYRASYYR-KGGCAMLPVK 210

Query: 214 --APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
              PE    G  T K+D +SFGV+L E+ + G  P
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  136 bits (345), Expect = 2e-37
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 11/201 (5%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
           +LG+G +G V+ G  L N   +AIK++     +  +    E+ +   + HK++V  +G +
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGK-GR-PTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
           +      +  E VP  +L   L  K G     +            +GL YLH++   +I+
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHDN---QIV 144

Query: 168 HRDIKAANILLDFKF-EAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE--YASSGKLT 224
           HRDIK  N+L++      K++DFG +K  + +N    T   GT  Y+APE          
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYG 203

Query: 225 EKSDVFSFGVMLLELITGRRP 245
           + +D++S G  ++E+ TG+ P
Sbjct: 204 KAADIWSLGCTIIEMATGKPP 224

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  135 bits (343), Expect = 3e-37
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 34/221 (15%)

Query: 52  LGQGGFGYVHRGVLPNGKE------VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
           LG+  FG V++G L           VAIK LK  +    R EF+ E  + +R+ H ++V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR--------------LKIALG 150
           L+G  T      +++ +  +  L   L  +   +    T               + +   
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
            A G+ YL       ++H+D+   N+L+  K   K++D GL +   +V      +++G  
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR---EVYAADYYKLLGN- 189

Query: 211 GYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
             L     APE    GK +  SD++S+GV+L E+ + G +P
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  136 bits (344), Expect = 4e-37
 Identities = 50/202 (24%), Positives = 80/202 (39%), Gaps = 15/202 (7%)

Query: 51  LLGQGGFGYVHRG---VLPNGKEVAIKQLKAGSGQGE---REFQAEVEIISRVHHKHLVS 104
           L+G+GG G V+     V    + VA+K +              Q E     R+   H+V 
Sbjct: 41  LVGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           +  +     Q  +    +    L   L  +G   +     + I       L   H     
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAA--- 153

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKL 223
              HRD+K  NIL+     A + DFG+A   +D   T +    +GT  Y+APE  S    
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESHA 212

Query: 224 TEKSDVFSFGVMLLELITGRRP 245
           T ++D+++   +L E +TG  P
Sbjct: 213 TYRADIYALTCVLYECLTGSPP 234

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  134 bits (339), Expect = 2e-36
 Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 28/215 (13%)

Query: 52  LGQGGFGYVHRGVLPNGKE----VAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG V  G L         VA+K +K    S +   EF +E   +    H +++ L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 106 VG-----YYTAGSQRMLVYEFVPN-NTLEFHLHGKGRPTMDWLTR---LKIALGSAKGLA 156
           +G           + M++  F+   +   + L+ +       +     LK  +  A G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL--- 213
           YL        +HRD+ A N +L       VADFGL+K    + +    R  G    +   
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK---KIYSGDYYRQ-GRIAKMPVK 214

Query: 214 --APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
             A E  +    T KSDV++FGV + E+ T G  P
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  135 bits (341), Expect = 3e-36
 Identities = 62/277 (22%), Positives = 119/277 (42%), Gaps = 41/277 (14%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA---EVEIISRVHHKHLVSLV 106
            +G+G FG         +G++  IK++   S    +E +    EV +++ + H ++V   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINI-SRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHG-KGRP-----TMDWLTRLKIALGSAKGLAYLHE 160
             +       +V ++     L   ++  KG        +DW  ++         L ++H+
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI------CLALKHVHD 143

Query: 161 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS 220
               KI+HRDIK+ NI L      ++ DFG+A++ +         + GT  YL+PE   +
Sbjct: 144 ---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICEN 199

Query: 221 GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP 280
                KSD+++ G +L EL T +        F   S+ +     L   I  G+F     P
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHA------FEAGSMKN-----LVLKIISGSF-----P 243

Query: 281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
            +   Y+  ++  +V   +   + + R RP ++ I+ 
Sbjct: 244 PVSLHYS-YDLRSLV---SQLFKRNPRDRPSVNSILE 276

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  133 bits (337), Expect = 3e-36
 Identities = 47/251 (18%), Positives = 93/251 (37%), Gaps = 32/251 (12%)

Query: 7   SGSNYSGSEAPLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGV-L 65
           S            P           +   +               +G+G F  V+R   L
Sbjct: 5   SQGMQGPPVPQFQPQKALRPDMGYNTLANFRIE----------KKIGRGQFSEVYRAACL 54

Query: 66  PNGKEVAIKQLKAGSGQGEREFQA---EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV 122
            +G  VA+K+++       +       E++++ +++H +++     +   ++  +V E  
Sbjct: 55  LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA 114

Query: 123 PNNTLEFHLHGKGRPT--------MDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAA 174
               L   +    +            +  +L         L ++H     +++HRDIK A
Sbjct: 115 DAGDLSRMIKHFKKQKRLIPERTVWKYFVQL------CSALEHMHSR---RVMHRDIKPA 165

Query: 175 NILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 234
           N+ +      K+ D GL +  S   T   + V GT  Y++PE         KSD++S G 
Sbjct: 166 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGC 224

Query: 235 MLLELITGRRP 245
           +L E+   + P
Sbjct: 225 LLYEMAALQSP 235

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  135 bits (341), Expect = 3e-36
 Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 30/216 (13%)

Query: 52  LGQGGFGYVHRGVLPNGK------EVAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
           LG G FG V+ G +          +VA+K L     + +  +F  E  IIS+ +H+++V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD---WLTR---LKIALGSAKGLAYL 158
            +G       R ++ E +    L+  L  + RP       L     L +A   A G  YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 159 HEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMGTFGYL-- 213
            E+     IHRDI A N LL        AK+ DFG+A+   D+      R  G    L  
Sbjct: 198 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---DIYRAGYYR-KGGCAMLPV 250

Query: 214 ---APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
               PE    G  T K+D +SFGV+L E+ + G  P
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  134 bits (338), Expect = 4e-36
 Identities = 54/213 (25%), Positives = 83/213 (38%), Gaps = 21/213 (9%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
            LG+GGF YV     L +G   A+K++     Q   E Q E ++    +H +++ LV Y 
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 110 TAGSQRM----LVYEFVPNNTLEFHL--HGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
                      L+  F    TL   +         +     L + LG  +GL  +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM--------GTFGYLAP 215
               HRD+K  NILL  + +  + D G    A          +          T  Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 216 E---YASSGKLTEKSDVFSFGVMLLELITGRRP 245
           E     S   + E++DV+S G +L  ++ G  P
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  132 bits (335), Expect = 5e-36
 Identities = 69/285 (24%), Positives = 120/285 (42%), Gaps = 51/285 (17%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGY 108
            L+G GGFG V +     +GK   IK++K        + + EV+ ++++ H ++V   G 
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 109 Y-------------TAGSQRMLVY---EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA 152
           +             ++ S+   ++   EF    TLE  +  +    +D +  L++     
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132

Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           KG+ Y+H     K+I+RD+K +NI L    + K+ DFGL       N    TR  GT  Y
Sbjct: 133 KGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK--NDGKRTRSKGTLRY 187

Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDG 272
           ++PE  SS    ++ D+++ G++L EL+        T  F  D             + DG
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD-------------LRDG 234

Query: 273 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
               + D K            ++      +      RP  S+I+R
Sbjct: 235 IISDIFDKKEKT---------LL---QKLLSKKPEDRPNTSEILR 267

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  133 bits (336), Expect = 7e-36
 Identities = 59/216 (27%), Positives = 88/216 (40%), Gaps = 29/216 (13%)

Query: 52  LGQGGFGYVHRGVLPNGKE----VAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSL 105
           LG+G FG V    L         VA+K LKA   +     EF  E   +    H H+  L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 106 VG------YYTAGSQRMLVYEFVPN-NTLEF---HLHGKGRPTMDWLTRLKIALGSAKGL 155
           VG              M++  F+ + +   F      G+    +   T ++  +  A G+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL-- 213
            YL        IHRD+ A N +L       VADFGL++    + +    R  G    L  
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSR---KIYSGDYYRQ-GCASKLPV 203

Query: 214 ---APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
              A E  +    T  SDV++FGV + E++T G+ P
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  131 bits (332), Expect = 9e-36
 Identities = 65/282 (23%), Positives = 114/282 (40%), Gaps = 42/282 (14%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQL-KAGSGQGEREF-QAEVEIISRVHHKHLVSLVG 107
            +G G +G   +     +GK +  K+L      + E++   +EV ++  + H ++V    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 108 YYTAGSQRML--VYEFVPNNTLEFHLHGKGRPT--------MDWLTRLKIALGSAKGLAY 157
                +   L  V E+     L   +    +          +  +T+L         L  
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL------TLALKE 126

Query: 158 LHE--DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
            H   D    ++HRD+K AN+ LD K   K+ DFGLA+I +   +   T V GT  Y++P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSP 185

Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD 275
           E  +     EKSD++S G +L EL     P      F   S  +     L   I +G F 
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPP------FTAFSQKE-----LAGKIREGKF- 233

Query: 276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
                ++   Y+ +E+  ++      +      RP + +I+ 
Sbjct: 234 ----RRIPYRYS-DELNEII---TRMLNLKDYHRPSVEEILE 267

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  132 bits (335), Expect = 1e-35
 Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 33/220 (15%)

Query: 50  NLLGQGGFGYVHRGVLPNGKE---VAIKQLKAGSGQGER-EFQAEVEIISRV-HHKHLVS 104
           +++G+G FG V +  +         AIK++K  + + +  +F  E+E++ ++ HH ++++
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 105 LVGYYTAGSQRMLVYEFVPN-NTLEF----------HLHGKGRPTMDWLTR---LKIALG 150
           L+G         L  E+ P+ N L+F                  T   L+    L  A  
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRV---- 206
            A+G+ YL +    + IHRD+ A NIL+   + AK+ADFGL++           R+    
Sbjct: 151 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 207

Query: 207 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
           M      A E  +    T  SDV+S+GV+L E+++ G  P
Sbjct: 208 M------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  132 bits (333), Expect = 1e-35
 Identities = 66/307 (21%), Positives = 109/307 (35%), Gaps = 57/307 (18%)

Query: 40  ARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-FQAEVEIISRV 97
            R    F     LG+GGFG V       +    AIK+++  + +  RE    EV+ ++++
Sbjct: 1   GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 60

Query: 98  HHKHLVSLVGYYTA------------GSQRMLVY---EFVPNNTL-EFHLHGKGRPTMDW 141
            H  +V    Y+ A             S ++ +Y   +      L ++          + 
Sbjct: 61  EHPGIV---RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117

Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI------- 194
              L I L  A+ + +LH      ++HRD+K +NI        KV DFGL          
Sbjct: 118 SVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174

Query: 195 ----ASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
                        T  +GT  Y++PE       + K D+FS G++L EL+         +
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---------Y 225

Query: 251 TFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP 310
            F         R      + +  F     P L  +  +     MV      +  S   RP
Sbjct: 226 PFSTQME----RVRTLTDVRNLKF-----PPLFTQK-YPCEYVMV---QDMLSPSPMERP 272

Query: 311 RMSQIVR 317
               I+ 
Sbjct: 273 EAINIIE 279

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  129 bits (327), Expect = 6e-35
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 14/204 (6%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLK----AGSGQGEREFQAEVEIISRVHHKHLVS 104
             LG+G FG V+      +   +A+K L       +G   +  + EVEI S + H +++ 
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L GY+   ++  L+ E+ P  T+   L    +   +  T   I    A  L+Y H     
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-EQRTATYITE-LANALSYCHSK--- 128

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
           ++IHRDIK  N+LL    E K+ADFG +  A            GT  YL PE        
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYLPPEMIEGRMHD 185

Query: 225 EKSDVFSFGVMLLELITGRRPVDS 248
           EK D++S GV+  E + G+ P ++
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEA 209

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  135 bits (342), Expect = 7e-35
 Identities = 43/208 (20%), Positives = 81/208 (38%), Gaps = 22/208 (10%)

Query: 51  LLGQGGFGYVHRGV--LPNGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL-- 105
            +  GG G+++  +    NG+ V +K L        +    AE + ++ V H  +V +  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 106 VGYYTAGSQRMLVY---EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
              +T      + Y   E+V   +L+     K    +     +   L     L+YLH   
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHSI- 201

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK 222
              +++ D+K  NI+L  + + K+ D G     +         + GT G+ APE      
Sbjct: 202 --GLVYNDLKPENIMLT-EEQLKLIDLGAVSRINSFGY-----LYGTPGFQAPEIVR-TG 252

Query: 223 LTEKSDVFSFGVMLLELITGRRPVDSTH 250
            T  +D+++ G  L  L       +  +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRNGRY 280

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  129 bits (326), Expect = 1e-34
 Identities = 53/236 (22%), Positives = 98/236 (41%), Gaps = 45/236 (19%)

Query: 41  RATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHH 99
           R    F +  +LGQG FG V +     + +  AIK+++    +      +EV +++ ++H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNH 61

Query: 100 KHLVSLVGYYTAGSQRM-------------LVYEFVPNNTLEFHLHGKGRPT-----MDW 141
           +++V     +      +             +  E+  N TL   +H +            
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI------- 194
             ++       + L+Y+H      IIHRD+K  NI +D     K+ DFGLAK        
Sbjct: 122 FRQI------LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172

Query: 195 -------ASDVNTHVSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITG 242
                      + ++++ + GT  Y+A E    +G   EK D++S G++  E+I  
Sbjct: 173 LKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  130 bits (328), Expect = 2e-34
 Identities = 50/212 (23%), Positives = 85/212 (40%), Gaps = 23/212 (10%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQ--LKAGSGQGEREFQAEVEIISRV--HHKHLVSL 105
             +G GG   V + +    +  AIK   L+    Q    ++ E+  ++++  H   ++ L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
             Y        +V E   N  L   L  K              +   + +  +H+     
Sbjct: 75  YDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQH---G 128

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPE-------- 216
           I+H D+K AN L+      K+ DFG+A  +  D  + V    +GT  Y+ PE        
Sbjct: 129 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187

Query: 217 ---YASSGKLTEKSDVFSFGVMLLELITGRRP 245
                S  K++ KSDV+S G +L  +  G+ P
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  128 bits (325), Expect = 2e-34
 Identities = 49/212 (23%), Positives = 84/212 (39%), Gaps = 23/212 (10%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQ--LKAGSGQGEREFQAEVEIISRVHHK--HLVSL 105
             +G GG   V + +    +  AIK   L+    Q    ++ E+  ++++      ++ L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
             Y        +V E   N  L   L  K              +   + +  +H+     
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQH---G 147

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPE-------- 216
           I+H D+K AN L+      K+ DFG+A  +  D  + V    +GT  Y+ PE        
Sbjct: 148 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206

Query: 217 ---YASSGKLTEKSDVFSFGVMLLELITGRRP 245
                S  K++ KSDV+S G +L  +  G+ P
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  127 bits (322), Expect = 3e-34
 Identities = 64/204 (31%), Positives = 93/204 (45%), Gaps = 16/204 (7%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLK----AGSGQGEREFQAEVEIISRVHHKHLVSL 105
            LG+G FG V+      N   +A+K L        G   +  + E+EI S + H +++ +
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRM 79

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYLHEDCHP 164
             Y+    +  L+ EF P   L   L   GR   +  +   +  L  A  L Y HE    
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD-EQRSATFMEELADA--LHYCHER--- 133

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
           K+IHRDIK  N+L+ +K E K+ADFG +  A  +         GT  YL PE        
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTHD 190

Query: 225 EKSDVFSFGVMLLELITGRRPVDS 248
           EK D++  GV+  E + G  P DS
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDS 214

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  128 bits (324), Expect = 6e-34
 Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 42/229 (18%)

Query: 52  LGQGGFGYVHRGVLPNGKE------VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
           +G+G FG V +   P          VA+K LK  +    + +FQ E  +++   + ++V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR-------------------- 144
           L+G    G    L++E++    L   L      T+  L+                     
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 145 --LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV 202
             L IA   A G+AYL E    K +HRD+   N L+      K+ADFGL++   ++ +  
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR---NIYSAD 228

Query: 203 STRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
             +       +      PE     + T +SDV+++GV+L E+ + G +P
Sbjct: 229 YYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  127 bits (322), Expect = 7e-34
 Identities = 60/244 (24%), Positives = 91/244 (37%), Gaps = 36/244 (14%)

Query: 14  SEAPLPPPSPGLSLGFSKSTFT--YEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKE 70
            EA     SPG      +S F   ++ L          + LG G +G V +     +G+ 
Sbjct: 35  GEASETLQSPGYDPSRPESFFQQSFQRL----------SRLGHGSYGEVFKVRSKEDGRL 84

Query: 71  VAIKQLKAGSGQGEREFQ---AEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNT 126
            A+K+  +   +G ++     AEV    +V  H   V L   +  G    L  E     +
Sbjct: 85  YAVKRSMS-PFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPS 142

Query: 127 LEFHLHGKGRP-----TMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK 181
           L+ H    G          +L            LA+LH      ++H D+K ANI L  +
Sbjct: 143 LQQHCEAWGASLPEAQVWGYLRDT------LLALAHLHSQ---GLVHLDVKPANIFLGPR 193

Query: 182 FEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 241
              K+ DFGL             +  G   Y+APE    G     +DVFS G+ +LE+  
Sbjct: 194 GRCKLGDFGLLVELGT-AGAGEVQE-GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVAC 250

Query: 242 GRRP 245
               
Sbjct: 251 NMEL 254

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  127 bits (322), Expect = 7e-34
 Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 42/229 (18%)

Query: 52  LGQGGFGYVHRGVLPNGKE------VAIKQLKAGSGQGER-EFQAEVEIISRVHHKHLVS 104
           LG+G FG V +    + K       VA+K LK  +   E  +  +E  ++ +V+H H++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 105 LVGYYTAGSQRMLVYEFVPN-NTLEF------------------HLHGKGRPTMDWLTR- 144
           L G  +     +L+ E+    +   F                  +      P    LT  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 145 --LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV 202
             +  A   ++G+ YL E    K++HRD+ A NIL+    + K++DFGL++   DV    
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSR---DVYEE- 203

Query: 203 STRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
            + V  + G +     A E       T +SDV+SFGV+L E++T G  P
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  129 bits (325), Expect = 8e-34
 Identities = 56/260 (21%), Positives = 97/260 (37%), Gaps = 23/260 (8%)

Query: 2   SSSGGSGSNYSGSEAPLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVH 61
            S     +        +  P  G       S+   E ++     +S    +G GG   V 
Sbjct: 14  GSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVF 73

Query: 62  RGVLPNGKEVAIKQ--LKAGSGQGEREFQAEVEIISRVHHK--HLVSLVGYYTAGSQRML 117
           + +    +  AIK   L+    Q    ++ E+  ++++      ++ L  Y        +
Sbjct: 74  QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133

Query: 118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANIL 177
           V E   N  L   L  K    +D   R        + +  +H+     I+H D+K AN L
Sbjct: 134 VMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFL 187

Query: 178 LDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPE-----------YASSGKLTE 225
           +      K+ DFG+A  +  D  + V    +G   Y+ PE             S  K++ 
Sbjct: 188 IV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISP 246

Query: 226 KSDVFSFGVMLLELITGRRP 245
           KSDV+S G +L  +  G+ P
Sbjct: 247 KSDVWSLGCILYYMTYGKTP 266

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  127 bits (322), Expect = 8e-34
 Identities = 51/207 (24%), Positives = 81/207 (39%), Gaps = 26/207 (12%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGY 108
             +G+G FG VHR      G + A+K+++      E     E+   + +    +V L G 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVEELVACAGLSSPRIVPLYGA 118

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGR---PTMDWLTR--LKIALGSAKGLAYLHEDCH 163
              G    +  E +   +L   +   G        +     L+       GL YLH    
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE-------GLEYLHTR-- 169

Query: 164 PKIIHRDIKAANILLDFK-FEAKVADFGLAKIASDVNTHVSTR----VMGTFGYLAPEYA 218
            +I+H D+KA N+LL      A + DFG A          S      + GT  ++APE  
Sbjct: 170 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228

Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
                  K D++S   M+L ++ G  P
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  127 bits (322), Expect = 1e-33
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 25/218 (11%)

Query: 50  NLLGQGGFGYVHRGVL------PNGKEVAIKQLKAGSGQGER-EFQAEVEIISRV-HHKH 101
             LG G FG V               +VA+K LK+ +   E+    +E++I+S +  H++
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR------------LKIAL 149
           +V+L+G  T G   +++ E+     L   L  K R                    L  + 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 150 GSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVMG 208
             A+G+A+L        IHRD+ A N+LL     AK+ DFGLA  I +D N  V      
Sbjct: 172 QVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228

Query: 209 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
              ++APE       T +SDV+S+G++L E+ + G  P
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  128 bits (322), Expect = 1e-33
 Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 13/253 (5%)

Query: 44  DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREF-QAEVEIISRVHHKH 101
           D F   + LG G  G V +    P+G  +A K +        R     E++++   +  +
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
           +V   G + +  +  +  E +   +L+  L   GR     L   K+++   KGL YL E 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG--KVSIAVIKGLTYLREK 150

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTFGYLAPEYAS 219
              KI+HRD+K +NIL++ + E K+ DFG++   I S  N+ V     GT  Y++PE   
Sbjct: 151 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQ 203

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD 279
               + +SD++S G+ L+E+  GR P+        + +                      
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263

Query: 280 PKLHNEYNHNEMA 292
                  +   MA
Sbjct: 264 LNKFGMDSRPPMA 276

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  125 bits (317), Expect = 1e-33
 Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 15/207 (7%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           LLG+G F  V+R   +  G EVAIK      +   +G  +R  Q EV+I  ++ H  ++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-AGMVQR-VQNEVKIHCQLKHPSILE 75

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYLHEDCH 163
           L  Y+   +   LV E   N  +  +L  + +P  +   R  +  +    G+ YLH    
Sbjct: 76  LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI--ITGMLYLHSH-- 131

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
             I+HRD+  +N+LL      K+ADFGLA      +    T + GT  Y++PE A+    
Sbjct: 132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAH 189

Query: 224 TEKSDVFSFGVMLLELITGRRPVDSTH 250
             +SDV+S G M   L+ GR P D+  
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDT 216

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  131 bits (331), Expect = 2e-33
 Identities = 69/213 (32%), Positives = 96/213 (45%), Gaps = 25/213 (11%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLV--- 106
           LG GGFGYV R +    G++VAIKQ +       RE +  E++I+ +++H ++VS     
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 107 ---GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-----LGSAKGLAYL 158
                       +L  E+     L  +L+         L    I      + SA  L YL
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG--LKEGPIRTLLSDISSA--LRYL 137

Query: 159 HEDCHPKIIHRDIKAANILLDFKFEA---KVADFGLAKIASDVNTHVSTRVMGTFGYLAP 215
           HE+   +IIHRD+K  NI+L    +    K+ D G AK         +  V GT  YLAP
Sbjct: 138 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-GELCTEFV-GTLQYLAP 192

Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRPVDS 248
           E     K T   D +SFG +  E ITG RP   
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  126 bits (318), Expect = 3e-33
 Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 37/224 (16%)

Query: 52  LGQGGFGYVHRGVLPNGKE------VAIKQLKAGSGQGER-EFQAEVEIISRV-HHKHLV 103
           LG G FG V         +      VA+K LK  +   ER    +E++++S + +H ++V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 104 SLVGYYTAGSQRMLVYEFVPN-NTLEF------------HLHGKGRPTMDWLTR---LKI 147
           +L+G  T G   +++ E+    + L F                        L     L  
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 148 ALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM 207
           +   AKG+A+L        IHRD+ A NILL      K+ DFGLA+   D+    +  V 
Sbjct: 151 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLAR---DIKNDSNYVVK 204

Query: 208 GTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
           G    L     APE   +   T +SDV+S+G+ L EL + G  P
Sbjct: 205 GN-ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  126 bits (318), Expect = 3e-33
 Identities = 68/223 (30%), Positives = 99/223 (44%), Gaps = 36/223 (16%)

Query: 52  LGQGGFGYVHRGVLPNGKE------VAIKQLKAGSGQGER-EFQAEVEIISRV-HHKHLV 103
           LG+G FG V         +      VA+K LK G+   E     +E++I+  + HH ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 104 SLVGYYT-AGSQRMLVYEFVPN-NTLEF----------HLHGKGRPTMDWLTR---LKIA 148
           +L+G  T  G   M++ EF    N   +          +         D+LT    +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
              AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+   D+       V  
Sbjct: 155 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKD-PDYVRK 207

Query: 209 TFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
               L     APE       T +SDV+SFGV+L E+ + G  P
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  126 bits (317), Expect = 3e-33
 Identities = 55/214 (25%), Positives = 82/214 (38%), Gaps = 26/214 (12%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVSLVGY 108
           +LGQG    V RG     G   AIK        +       E E++ +++HK++V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 109 YTAGSQRM--LVYEFVPNNTLEFHLHGKGRPTMDWLTR---LKIALGSAKGLAYLHEDCH 163
               + R   L+ EF P  +L   L          L     L +      G+ +L E+  
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLREN-- 131

Query: 164 PKIIHRDIKAANILLDFKFEA----KVADFGLAKIASDVNTHVSTRVMGTFGYLAPE--- 216
             I+HR+IK  NI+     +     K+ DFG A+   D +    +   GT  YL P+   
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY-GTEEYLHPDMYE 188

Query: 217 -----YASSGKLTEKSDVFSFGVMLLELITGRRP 245
                     K     D++S GV      TG  P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  126 bits (318), Expect = 3e-33
 Identities = 76/352 (21%), Positives = 139/352 (39%), Gaps = 49/352 (13%)

Query: 20  PPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKA 78
           P S G + G  +S F  + +           +L +GGF +V+    + +G+E A+K+L +
Sbjct: 4   PGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS 63

Query: 79  GSGQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQR--------MLVYEFVPNNTLEF 129
              +  R    EV  + ++  H ++V      + G +         +L+ E      +EF
Sbjct: 64  NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEF 123

Query: 130 HLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 189
               + R  +   T LKI   + + + ++H    P IIHRD+K  N+LL  +   K+ DF
Sbjct: 124 LKKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDF 182

Query: 190 GLAKIASDVNTHVSTRVM-----------GTFGYLAPE---YASSGKLTEKSDVFSFGVM 235
           G A   S    +  +               T  Y  PE     S+  + EK D+++ G +
Sbjct: 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242

Query: 236 LLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMV 295
           L  L   + P      F ED             I +G +     P    +Y       ++
Sbjct: 243 LYLLCFRQHP------F-EDGAK--------LRIVNGKYS---IPPHDTQY--TVFHSLI 282

Query: 296 ACAAACVRHSARRRPRMSQIVRALEGDASLADLN-EGIRPGQSSVYGSYGSS 346
                 ++ +   R  ++++V  L+  A+  ++N +          G YGS+
Sbjct: 283 RA---MLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSA 331

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  125 bits (315), Expect = 5e-33
 Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 15/210 (7%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLV 103
           F+    +G+G FG V +G+     K VAIK +     + E E  Q E+ ++S+    ++ 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIAL---GSAKGLAYLHE 160
              G Y   ++  ++ E++   +    L          L   +IA       KGL YLH 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLHS 137

Query: 161 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS 220
           +   K IHRDIKAAN+LL    E K+ADFG+A   +D     +T  +GT  ++APE    
Sbjct: 138 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQ 193

Query: 221 GKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
                K+D++S G+  +EL  G  P    H
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELH 223

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  125 bits (316), Expect = 6e-33
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 37/224 (16%)

Query: 52  LGQGGFGYVHRGVLPNGKE--------VAIKQLKAGSGQGER-EFQAEVEIISRV-HHKH 101
           LG+G FG V         +        VA+K LK  + + +  +  +E+E++  +  HK+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 102 LVSLVGYYTAGSQRMLVYEFVPN-NTLEF----------HLHGKGRPTMDWLTR---LKI 147
           +++L+G  T      ++ E+    N  E+          + +   R   + +T    +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 148 ALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM 207
               A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+   D+N     +  
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR---DINNIDYYKK- 215

Query: 208 GTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
            T G L     APE       T +SDV+SFGV++ E+ T G  P
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  125 bits (315), Expect = 1e-32
 Identities = 48/229 (20%), Positives = 94/229 (41%), Gaps = 33/229 (14%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQL-----------------KAGSGQGEREFQAEVEII 94
           L QG F  +      + K  A+K+                  K        +F+ E++II
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 95  SRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS--- 151
           + + +++ ++  G  T   +  ++YE++ N+++            ++   + I +     
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 152 ---AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG 208
                  +Y+H      I HRD+K +NIL+D     K++DFG ++   D     S    G
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---RG 212

Query: 209 TFGYLAPEYASSGKLT---EKSDVFSFGVMLLELITGRRPVDSTHTFVE 254
           T+ ++ PE   S + +    K D++S G+ L  +     P     + VE
Sbjct: 213 TYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  126 bits (317), Expect = 1e-32
 Identities = 55/214 (25%), Positives = 82/214 (38%), Gaps = 26/214 (12%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVSLVGY 108
           +LGQG    V RG     G   AIK        +       E E++ +++HK++V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 109 YTAGSQRM--LVYEFVPNNTLEFHLHGKGRPTMDWLTR---LKIALGSAKGLAYLHEDCH 163
               + R   L+ EF P  +L   L          L     L +      G+ +L E+  
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG--LPESEFLIVLRDVVGGMNHLREN-- 131

Query: 164 PKIIHRDIKAANILLDFKFEA----KVADFGLAKIASDVNTHVSTRVMGTFGYLAPE--- 216
             I+HR+IK  NI+     +     K+ DFG A+   D +    +   GT  YL P+   
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY-GTEEYLHPDMYE 188

Query: 217 -----YASSGKLTEKSDVFSFGVMLLELITGRRP 245
                     K     D++S GV      TG  P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  124 bits (314), Expect = 2e-32
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 37/224 (16%)

Query: 52  LGQGGFGYVHRGVLPNGKE--------VAIKQLKAGSGQGER-EFQAEVEIISRV-HHKH 101
           LG+G FG V         +        VA+K LK  + + +  +  +E+E++  +  HK+
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 102 LVSLVGYYTAGSQRMLVYEFVPN-NTLEF----------HLHGKGRPTMDWLTR---LKI 147
           +++L+G  T      ++ E+    N  E+          + +   R   + +T    +  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 148 ALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM 207
               A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+   D+N     +  
Sbjct: 209 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR---DINNIDYYKK- 261

Query: 208 GTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
            T G L     APE       T +SDV+SFGV++ E+ T G  P
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  122 bits (309), Expect = 3e-32
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 14/204 (6%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           ++    +GQG  G V+  + +  G+EVAI+Q+       +     E+ ++    + ++V+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIAL---GSAKGLAYLHED 161
            +  Y  G +  +V E++   +L   +          +   +IA       + L +LH +
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLHSN 135

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
              ++IHRDIK+ NILL      K+ DFG     +   +  ST V GT  ++APE  +  
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191

Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
               K D++S G+M +E+I G  P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  123 bits (311), Expect = 3e-32
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 14/206 (6%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQL---KAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
            LG+GGF            +  A K +            +   E+ I   + H+H+V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
           G++       +V E     +L   LH + +   +   R         G  YLH +   ++
Sbjct: 108 GFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---RV 162

Query: 167 IHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVM-GTFGYLAPEYASSGKLT 224
           IHRD+K  N+ L+   E K+ DFGLA K+  D       +V+ GT  Y+APE  S    +
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGHS 219

Query: 225 EKSDVFSFGVMLLELITGRRPVDSTH 250
            + DV+S G ++  L+ G+ P +++ 
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSC 245

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  122 bits (308), Expect = 4e-32
 Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 28/231 (12%)

Query: 36  YEELARATD---GFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEV 91
           YE + R  D    +     LG G FG V++      G   A K ++  S +   ++  E+
Sbjct: 8   YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI 67

Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIAL-- 149
           EI++   H ++V L+G Y    +  ++ EF P   ++  +    R     LT  +I +  
Sbjct: 68  EILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVC 123

Query: 150 -GSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG----LAKIASDVNTHVST 204
               + L +LH     +IIHRD+KA N+L+  + + ++ADFG      K     ++ +  
Sbjct: 124 RQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-- 178

Query: 205 RVMGTFGYLAPEYASSGKLTE-----KSDVFSFGVMLLELITGRRPVDSTH 250
              GT  ++APE      + +     K+D++S G+ L+E+     P    +
Sbjct: 179 ---GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  122 bits (308), Expect = 5e-32
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 14/207 (6%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQL---KAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
            LG+GGF            +  A K +            +   E+ I   + H+H+V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
           G++       +V E     +L   LH + +   +   R         G  YLH +   ++
Sbjct: 82  GFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---RV 136

Query: 167 IHRDIKAANILLDFKFEAKVADFGLA-KIASDVNTHVSTRVM-GTFGYLAPEYASSGKLT 224
           IHRD+K  N+ L+   E K+ DFGLA K+  D       +V+ GT  Y+APE  S    +
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGHS 193

Query: 225 EKSDVFSFGVMLLELITGRRPVDSTHT 251
            + DV+S G ++  L+ G+ P +++  
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCL 220

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  121 bits (307), Expect = 6e-32
 Identities = 63/269 (23%), Positives = 118/269 (43%), Gaps = 34/269 (12%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-FQAEVEIISR-VHHKHLVSLVGY 108
           LG+G +G V +   +P+G+ +A+K+++A     E++    +++I  R V     V+  G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 109 YTAGSQRMLVYEFVP---NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
                   +  E +    +   +  +        D L   KIA+   K L +LH      
Sbjct: 75  LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG--KIAVSIVKALEHLHSKL--S 130

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE----YASSG 221
           +IHRD+K +N+L++   + K+ DFG++     V+        G   Y+APE      +  
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAPERINPELNQK 188

Query: 222 KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK 281
             + KSD++S G+ ++EL   R P DS  T  +          L + +E+        P+
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ---------QLKQVVEEP------SPQ 233

Query: 282 LHNEYNHNEMARMVACAAACVRHSARRRP 310
           L  +    E     +    C++ +++ RP
Sbjct: 234 LPADKFSAEFVDFTSQ---CLKKNSKERP 259

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  122 bits (309), Expect = 6e-32
 Identities = 61/229 (26%), Positives = 102/229 (44%), Gaps = 42/229 (18%)

Query: 52  LGQGGFGYVHRGVLPNGKE------VAIKQLKAGSGQGER-EFQAEVEIISRV-HHKHLV 103
           LG G FG V         +      VA+K LK  +   ER    +E+++++++  H+++V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 104 SLVGYYTAGSQRMLVYEFVPN-NTLEF-----------------HLHGKGRPTMDWLTR- 144
           +L+G  T      L++E+    + L +                     +    ++ LT  
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 145 --LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV 202
             L  A   AKG+ +L        +HRD+ A N+L+      K+ DFGLA+   D+ +  
Sbjct: 173 DLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR---DIMSDS 226

Query: 203 STRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
           +  V G    L     APE    G  T KSDV+S+G++L E+ + G  P
Sbjct: 227 NYVVRGN-ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  121 bits (306), Expect = 1e-31
 Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 14/204 (6%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           F     LG+G +G V++ +    G+ VAIKQ+        +E   E+ I+ +    H+V 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIAL---GSAKGLAYLHED 161
             G Y   +   +V E+    ++   +  + +     LT  +IA     + KGL YLH  
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT----LTEDEIATILQSTLKGLEYLHFM 144

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
              + IHRDIKA NILL+ +  AK+ADFG+A   +D     +T + GT  ++APE     
Sbjct: 145 ---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEI 200

Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
                +D++S G+  +E+  G+ P
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPP 224

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  121 bits (306), Expect = 1e-31
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 17/214 (7%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-FQAEVEIISR-VHHKHLVSLVGY 108
           +G+G +G V++ V  P+G+ +A+K++++   + E++    +++++ R     ++V   G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 109 YTAGSQRMLVYEF----VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
                   +  E             +         + L   KI L + K L +L E+   
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG--KITLATVKALNHLKENL-- 145

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE----YASS 220
           KIIHRDIK +NILLD     K+ DFG++     V++   TR  G   Y+APE     AS 
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPSASR 203

Query: 221 GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE 254
                +SDV+S G+ L EL TGR P    ++  +
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  121 bits (305), Expect = 1e-31
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 16/215 (7%)

Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKH 101
           D +    ++G G    V      P  ++VAIK++     Q   +    E++ +S+ HH +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 102 LVSLVGYYTAGSQRMLVYEFVPN---NTLEFHLHGKGRPTMDWLTRLKIAL---GSAKGL 155
           +VS    +    +  LV + +       +  H+  KG      L    IA       +GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF-G--- 211
            YLH++     IHRD+KA NILL      ++ADFG++   +        +V  TF G   
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 212 YLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRP 245
           ++APE     +    K+D++SFG+  +EL TG  P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  122 bits (307), Expect = 1e-31
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 23/215 (10%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHHKH 101
           FSD   +G G FG V+    + N + VAIK++     Q   ++     EV  + ++ H +
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIAL---GSAKGLAYL 158
            +   G Y       LV E+   +  +     K       L  ++IA    G+ +GLAYL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLAYL 170

Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           H      +IHRD+KA NILL      K+ DFG A I +  N+      +GT  ++APE  
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVI 222

Query: 219 SSGKLTE---KSDVFSFGVMLLELITGRRPVDSTH 250
            +    +   K DV+S G+  +EL   + P+ + +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  122 bits (307), Expect = 2e-31
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 37/224 (16%)

Query: 52  LGQGGFGYVHRGVLPNGK--------EVAIKQLKAGSGQGER-EFQAEVEIISRV-HHKH 101
           LG+G FG V                 +VA+K LK+ + + +  +  +E+E++  +  HK+
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR--------------LKI 147
           +++L+G  T      ++ E+     L  +L  +  P +++                 +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 148 ALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM 207
           A   A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+   D++     +  
Sbjct: 197 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR---DIHHIDYYKK- 249

Query: 208 GTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
            T G L     APE       T +SDV+SFGV+L E+ T G  P
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  120 bits (303), Expect = 3e-31
 Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 24/209 (11%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
                 +G+G  G V       +G++VA+K +     Q       EV I+    H ++V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK--------IALGSAKGLA 156
           +   Y  G +  ++ EF+    L            D +++++        +     + LA
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGAL-----------TDIVSQVRLNEEQIATVCEAVLQALA 155

Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE 216
           YLH      +IHRDIK+ +ILL      K++DFG     S       + V GT  ++APE
Sbjct: 156 YLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPE 211

Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
             S      + D++S G+M++E++ G  P
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  118 bits (298), Expect = 2e-30
 Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 14/211 (6%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-FQAEVEIISR-VHHKHLVSLVGY 108
           +G G  G V +      G  +A+KQ++    + E +    +++++ +     ++V   G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
           +   +   +  E +     +     +G      L   K+ +   K L YL E     +IH
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG--KMTVAIVKALYYLKEK--HGVIH 148

Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-----YASSGKL 223
           RD+K +NILLD + + K+ DFG++     V+     R  G   Y+APE       +    
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206

Query: 224 TEKSDVFSFGVMLLELITGRRPVDSTHTFVE 254
             ++DV+S G+ L+EL TG+ P  +  T  E
Sbjct: 207 DIRADVWSLGISLVELATGQFPYKNCKTDFE 237

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  114 bits (288), Expect = 2e-29
 Identities = 45/237 (18%), Positives = 80/237 (33%), Gaps = 46/237 (19%)

Query: 41  RATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLK-AGSGQGEREFQ-AEVEIISRV 97
           R T  F +   +G G FG V + V   +G   AIK+ K   +G  + +    EV   + +
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 98  -HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHL--HGKGRPTMDWLTRLKIALGSAKG 154
             H H+V     +      ++  E+    +L   +  + +            + L   +G
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 155 LAYLHEDCHPKIIHRDIKAANILLD-------------------FKFEAKVADFGLAKIA 195
           L Y+H      ++H DIK +NI +                     K   K+ D G     
Sbjct: 128 LRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 196 SDVNTHVSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELITGRRP 245
           S           G   +LA E       +        K+D+F+  + ++        
Sbjct: 185 SSPQVEE-----GDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAEPL 230

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  117 bits (295), Expect = 3e-29
 Identities = 68/347 (19%), Positives = 124/347 (35%), Gaps = 59/347 (17%)

Query: 46  FSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVS 104
           F   ++LG G  G +    + + ++VA+K++     +       EV+++     H +++ 
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIR 82

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
                     + +  E     TL+ ++  K    +       +   +  GLA+LH     
Sbjct: 83  YFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHSL--- 137

Query: 165 KIIHRDIKAANILLDFKFE-----AKVADFGLAKIASDVNTHVSTR--VMGTFGYLAPEY 217
            I+HRD+K  NIL+          A ++DFGL K  +      S R  V GT G++APE 
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 218 ---ASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN 273
                    T   D+FS G +   +I+ G  P   +            +   N  +   +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-----------QRQANILLGACS 246

Query: 274 FDTLVDPKLHNEYNHNEMARMVA-------CAAACVRH----------------SAR--R 308
            D L   K  +      + +M+A        A   ++H                S R  +
Sbjct: 247 LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEK 306

Query: 309 RPRMSQIVRALEGDAS---LADLNEGIRPGQSSVYGSYGSSDYDTMQ 352
                 IV+ LE         D  E I     +    + +    +++
Sbjct: 307 ESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVR 353

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  114 bits (287), Expect = 1e-28
 Identities = 43/223 (19%), Positives = 82/223 (36%), Gaps = 30/223 (13%)

Query: 43  TDGFSDANLLGQG--GFGYVHRGV-LPNGKEVAIKQ--LKAGSGQGEREFQAEVEIISRV 97
              +    ++G+G      V+     P G+ V +++  L+A S +     Q E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPN----NTLEFHLHGKGRPTMDWLTRLKIAL---G 150
           +H ++V     + A ++  +V  F+      + +  H           +  L IA    G
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-------MNELAIAYILQG 136

Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG----LAKIASDVNTHVSTRV 206
             K L Y+H       +HR +KA++IL+    +  ++       +               
Sbjct: 137 VLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193

Query: 207 M--GTFGYLAPEYASSGKL--TEKSDVFSFGVMLLELITGRRP 245
                  +L+PE           KSD++S G+   EL  G  P
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  112 bits (283), Expect = 2e-28
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 26/222 (11%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLV 103
           F    L+G G +G V++G  +  G+  AIK +   +G  E E + E+ ++ +  HH+++ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 84

Query: 104 SLVGYYTAGSQRM------LVYEFVPNNTL-EFHLHGKGRPTMDWLTRLKIAL---GSAK 153
           +  G +   +         LV EF    ++ +   + KG      L    IA       +
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT----LKEEWIAYICREILR 140

Query: 154 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL 213
           GL++LH+    K+IHRDIK  N+LL    E K+ DFG++          +T  +GT  ++
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWM 196

Query: 214 APEYASSGKLTE-----KSDVFSFGVMLLELITGRRPVDSTH 250
           APE  +  +  +     KSD++S G+  +E+  G  P+   H
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  113 bits (285), Expect = 2e-28
 Identities = 21/231 (9%), Positives = 47/231 (20%), Gaps = 43/231 (18%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQL---KAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
            L  G    V     +   ++ A+K        S              +R+  +      
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 107 GYY--------------------------TAGSQRMLVYEFVPNNTLE----FHLHGKGR 136
                                         A +  +L+      +              R
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 137 PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
                L    +     +  A L       ++H      N+ +       + D        
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

Query: 197 DVNTHVSTRVMGTFGYLAPEYASSGKL--TEKSDVFSFGVMLLELITGRRP 245
                          Y   E+ ++     T   + +  G+ +  +     P
Sbjct: 246 T----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  114 bits (287), Expect = 6e-28
 Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 16/234 (6%)

Query: 19  PPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQL- 76
                   L  +   F   +    ++ +     LG G +G V          E AIK + 
Sbjct: 12  ENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR 71

Query: 77  KAGSGQGERE-FQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG 135
           K             EV ++  + H +++ L  ++       LV E      L   +  + 
Sbjct: 72  KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM 131

Query: 136 RPT-MDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA---KVADFGL 191
           +   +D    +K  L    G+ YLH+     I+HRD+K  N+LL+ K +    K+ DFGL
Sbjct: 132 KFNEVDAAVIIKQVLS---GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGL 185

Query: 192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           + +  +         +GT  Y+APE     K  EK DV+S GV+L  L+ G  P
Sbjct: 186 SAVFEN--QKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  112 bits (282), Expect = 8e-28
 Identities = 30/260 (11%), Positives = 68/260 (26%), Gaps = 49/260 (18%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE---REFQAEVEIISR---------- 96
           +LGQ              G+   +              ++ + EV  +            
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 97  ------------VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHL---------HGKG 135
                       V       ++          ++  F     ++ +L         H   
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 136 RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA 195
             ++    RL++ L   + LA LH   H  ++H  ++  +I+LD +    +  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 196 SDVNTHVSTRVMGTFGYLAPE-----YASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH 250
                    R        A             +T   D ++ G+ +  +     P     
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----- 316

Query: 251 TFVEDSLVDWARPLLNRAIE 270
              +D+ +  +  +      
Sbjct: 317 -NTDDAALGGSEWIFRSCKN 335

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  111 bits (280), Expect = 9e-28
 Identities = 37/220 (16%), Positives = 69/220 (31%), Gaps = 30/220 (13%)

Query: 50  NLLGQGGFGYVHRGV------LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV 103
           +LLG+G F  V+           N ++  +K  K  +          +E +        +
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPT---MDWLTRLKIALGSAKGLAYLHE 160
                +   +  +LV E     TL   ++         M     +  A+     +  +H+
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190

Query: 161 DCHPKIIHRDIKAANILLDFKFEA-----------KVADFGLAKIASDVNTHVSTRVM-- 207
               +IIH DIK  N +L   F              + D G +    D+       +   
Sbjct: 191 C---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI---DMKLFPKGTIFTA 244

Query: 208 --GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
              T G+   E  S+     + D F     +  ++ G   
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  111 bits (280), Expect = 4e-27
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 15/233 (6%)

Query: 20  PPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQL-- 76
           P S    L  +   F     A  +D +    +LG+G FG V        G+E A+K +  
Sbjct: 2   PGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK 61

Query: 77  -KAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG 135
            +      +     EV+++ ++ H +++ L  ++       LV E      L   +  + 
Sbjct: 62  RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK 121

Query: 136 RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA---KVADFGLA 192
           R +     R+   + S   + Y+H++   KI+HRD+K  N+LL+ K +    ++ DFGL+
Sbjct: 122 RFSEVDAARIIRQVLSG--ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176

Query: 193 KIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
                  +      +GT  Y+APE    G   EK DV+S GV+L  L++G  P
Sbjct: 177 THFEA--SKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  108 bits (273), Expect = 4e-27
 Identities = 58/242 (23%), Positives = 100/242 (41%), Gaps = 49/242 (20%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
           +LG G F  V        GK  A+K +K      +   + E+ ++ ++ H+++V+L   Y
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS-------------AKGLA 156
            + +   LV + V    L F          D +    +  G                 + 
Sbjct: 76  ESTTHYYLVMQLVSGGEL-F----------DRI----LERGVYTEKDASLVIQQVLSAVK 120

Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA---KVADFGLAKIASDVNTHVSTRVMGTFGYL 213
           YLHE+    I+HRD+K  N+L     E     + DFGL+K+       + +   GT GY+
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYV 174

Query: 214 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN 273
           APE  +    ++  D +S GV+   L+ G  P      F E++        L   I++G 
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPP------FYEET-----ESKLFEKIKEGY 223

Query: 274 FD 275
           ++
Sbjct: 224 YE 225

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  110 bits (278), Expect = 1e-26
 Identities = 58/252 (23%), Positives = 97/252 (38%), Gaps = 31/252 (12%)

Query: 14  SEAPLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVA 72
             +          +  +   +  ++  +  + +     LG G +G V          E A
Sbjct: 6   HHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKA 65

Query: 73  IKQLK-------------AGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY 119
           IK +K                 +   E   E+ ++  + H +++ L   +       LV 
Sbjct: 66  IKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVT 125

Query: 120 EFVPNNTLEFHLHGKGRPT---MDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANI 176
           EF     L   +  + +        + + +I      G+ YLH+     I+HRDIK  NI
Sbjct: 126 EFYEGGELFEQIINRHKFDECDAANIMK-QIL----SGICYLHKH---NIVHRDIKPENI 177

Query: 177 LLDFKFEA---KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFG 233
           LL+ K      K+ DFGL+   S    +     +GT  Y+APE     K  EK DV+S G
Sbjct: 178 LLENKNSLLNIKIVDFGLSSFFSK--DYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCG 234

Query: 234 VMLLELITGRRP 245
           V++  L+ G  P
Sbjct: 235 VIMYILLCGYPP 246

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  107 bits (268), Expect = 4e-26
 Identities = 31/263 (11%), Positives = 71/263 (26%), Gaps = 60/263 (22%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE----------------------- 86
           +LGQ              G+   +                                    
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 87  -----FQAEVEIISRVHHKHLVSLVGYYTAGSQRM--LVYEFVPNNTLEF----HLHGKG 135
                F    +++     K ++ +              +Y  + +N   F      H   
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 136 RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA 195
             ++    RL++ L   + LA LH   H  ++H  ++  +I+LD +    +  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 196 SDVNTHVSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVMLLELITGRR 244
                        + G+  PE  +              +T   D ++ G+++  +     
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311

Query: 245 PVDSTHTFVEDSLVDWARPLLNR 267
           P        +D+ +  +  +   
Sbjct: 312 P------ITKDAALGGSEWIFRS 328

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  107 bits (270), Expect = 5e-26
 Identities = 50/226 (22%), Positives = 88/226 (38%), Gaps = 37/226 (16%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGY 108
            +LG G  G V       G+ VA+K++             E+++++    H +++     
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCS 77

Query: 109 YTAGSQRMLVYEFVPNNTLEF----HLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
            T      +  E    N  +     ++  +          + +    A G+A+LH     
Sbjct: 78  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL--- 134

Query: 165 KIIHRDIKAANILLDFK-------------FEAKVADFGLAKI----ASDVNTHVSTRVM 207
           KIIHRD+K  NIL+                    ++DFGL K      S   T+++    
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS- 193

Query: 208 GTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
           GT G+ APE         +  +LT   D+FS G +   +++ G+ P
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  105 bits (265), Expect = 1e-25
 Identities = 68/267 (25%), Positives = 112/267 (41%), Gaps = 26/267 (9%)

Query: 16  APLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIK 74
            P      G       S F      + +D +     LG+G F  V R V    G E A K
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60

Query: 75  QL--KAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLH 132
            +  K  S +  ++ + E  I  ++ H ++V L       S   LV++ V    L   + 
Sbjct: 61  IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120

Query: 133 GKGRPT-MDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA---KVAD 188
            +   +  D    ++  L   + +AY H +    I+HR++K  N+LL  K +    K+AD
Sbjct: 121 AREFYSEADASHCIQQIL---ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLAD 174

Query: 189 FGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDS 248
           FGLA   +D  +       GT GYL+PE       ++  D+++ GV+L  L+ G  P   
Sbjct: 175 FGLAIEVND--SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP--- 229

Query: 249 THTFVEDSLVDWARPLLNRAIEDGNFD 275
              F ++      +  L   I+ G +D
Sbjct: 230 ---FWDED-----QHRLYAQIKAGAYD 248

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  105 bits (264), Expect = 2e-25
 Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 25/240 (10%)

Query: 22  SPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIK-----Q 75
           SPG+S G        ++     D +    ++G+G F  V R +    G++ A+K     +
Sbjct: 2   SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61

Query: 76  LKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG 135
             +  G    + + E  I   + H H+V L+  Y++     +V+EF+    L F +  + 
Sbjct: 62  FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121

Query: 136 RPTMDW-------LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA---K 185
                +         R +I     + L Y H++    IIHRD+K   +LL  K  +   K
Sbjct: 122 DAGFVYSEAVASHYMR-QIL----EALRYCHDN---NIIHRDVKPHCVLLASKENSAPVK 173

Query: 186 VADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           +  FG+A    +       RV GT  ++APE        +  DV+  GV+L  L++G  P
Sbjct: 174 LGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  104 bits (262), Expect = 2e-25
 Identities = 47/250 (18%), Positives = 84/250 (33%), Gaps = 37/250 (14%)

Query: 80  SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL-EFHLHGKGRPT 138
           S         ++  +     K+ V  +   +      +  +      L ++         
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160

Query: 139 MDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI---- 194
            +    L I +  A+ + +LH      ++HRD+K +NI        KV DFGL       
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217

Query: 195 -------ASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD 247
                           T  +GT  Y++PE       + K D+FS G++L EL+       
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS--- 274

Query: 248 STHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSAR 307
              T +E       R  +   + +  F     P L  +  + +   MV      +  S  
Sbjct: 275 ---TQME-------RVRIITDVRNLKF-----PLLFTQK-YPQEHMMV---QDMLSPSPT 315

Query: 308 RRPRMSQIVR 317
            RP  + I+ 
Sbjct: 316 ERPEATDIIE 325

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  104 bits (261), Expect = 3e-25
 Identities = 54/275 (19%), Positives = 86/275 (31%), Gaps = 65/275 (23%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           +GQG +G V   +        AIK     +++  + +     + EV ++ ++HH ++  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAK------------ 153
              Y       LV E      L   L+     +        +                  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 154 --------------------------GLAYLHEDCHPKIIHRDIKAANILLDFKFEA--K 185
                                      L YLH      I HRDIK  N L         K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210

Query: 186 VADFGLAKIASDVNTHVSTRVM---GTFGYLAPE--YASSGKLTEKSDVFSFGVMLLELI 240
           + DFGL+K    +N      +    GT  ++APE    ++     K D +S GV+L  L+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270

Query: 241 TGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD 275
            G  P      F   +  D         + +    
Sbjct: 271 MGAVP------FPGVNDAD-----TISQVLNKKLC 294

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  106 bits (266), Expect = 3e-25
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 16/201 (7%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQL-KAGSGQGERE-FQAEVEIISRVHHKHLVSLVGY 108
           LG+G FG V +       +E A+K + KA +   +      EVE++ ++ H +++ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPT-MDWLTRLKIALGSAKGLAYLHEDCHPKII 167
               S   +V E      L   +  + R +  D    +K       G+ Y+H+     I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS---GITYMHKH---NIV 143

Query: 168 HRDIKAANILLDFKFEA---KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
           HRD+K  NILL+ K +    K+ DFGL+              +GT  Y+APE    G   
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIGTAYYIAPE-VLRGTYD 200

Query: 225 EKSDVFSFGVMLLELITGRRP 245
           EK DV+S GV+L  L++G  P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  103 bits (259), Expect = 4e-25
 Identities = 65/239 (27%), Positives = 97/239 (40%), Gaps = 17/239 (7%)

Query: 15  EAPLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAI 73
           +     P PG                R  D F    +LG+G F  V         +E AI
Sbjct: 2   DGTAAEPRPGAGSLQHAQPPPQPRKKRPED-FKFGKILGEGSFSTVVLARELATSREYAI 60

Query: 74  KQLKAGSGQGEREFQ---AEVEIISRVHHKHLVSLVGYYTAGSQRML--VYEFVPNNTLE 128
           K L+      E +      E +++SR+ H   V L  Y+T      L     +  N  L 
Sbjct: 61  KILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELL 118

Query: 129 FHLHGKGRPTMDWLTRLKIA-LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA 187
            ++   G       TR   A + SA  L YLH      IIHRD+K  NILL+     ++ 
Sbjct: 119 KYIRKIGSFDET-CTRFYTAEIVSA--LEYLHGK---GIIHRDLKPENILLNEDMHIQIT 172

Query: 188 DFGLAKIASDVNTHVSTRVM-GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           DFG AK+ S  +         GT  Y++PE  +     + SD+++ G ++ +L+ G  P
Sbjct: 173 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  102 bits (256), Expect = 7e-25
 Identities = 58/248 (23%), Positives = 97/248 (39%), Gaps = 46/248 (18%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQL-KAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
           LG G FG VH      +G E  IK + K  S     + +AE+E++  + H +++ +   +
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS-------------AKGLA 156
                  +V E      L           ++ +   +    +                LA
Sbjct: 90  EDYHNMYIVMETCEGGEL-----------LERIVSAQARGKALSEGYVAELMKQMMNALA 138

Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEA---KVADFGLAKIASDVNTHVSTRVMGTFGYL 213
           Y H      ++H+D+K  NIL          K+ DFGLA++        ST   GT  Y+
Sbjct: 139 YFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAAGTALYM 193

Query: 214 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN 273
           APE      +T K D++S GV++  L+TG  P      F   SL +     + +      
Sbjct: 194 APEVF-KRDVTFKCDIWSAGVVMYFLLTGCLP------FTGTSLEE-----VQQKATYKE 241

Query: 274 FDTLVDPK 281
            +  V+ +
Sbjct: 242 PNYAVECR 249

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  103 bits (259), Expect = 1e-24
 Identities = 63/279 (22%), Positives = 105/279 (37%), Gaps = 63/279 (22%)

Query: 29  FSKSTFTYEELARATDGFSD----ANLLGQGGFGYVHRGV-LPNGKEVAIKQL--KAGSG 81
           F     T ++ +       D    +  LG G  G V         K+VAI+ +  +  + 
Sbjct: 116 FVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAI 175

Query: 82  QGERE------FQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG 135
              RE       + E+EI+ +++H  ++ +  ++ A     +V E +    L        
Sbjct: 176 GSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGEL-------- 226

Query: 136 RPTMDWLTRLKIALGS-------------AKGLAYLHEDCHPKIIHRDIKAANILLDFKF 182
               D +    +                    + YLHE+    IIHRD+K  N+LL  + 
Sbjct: 227 ---FDKV----VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE 276

Query: 183 EA---KVADFGLAKIASDVNTHVSTRVMGTFGYLAPE---YASSGKLTEKSDVFSFGVML 236
           E    K+ DFG +KI  +  + + T   GT  YLAPE      +       D +S GV+L
Sbjct: 277 EDCLIKITDFGHSKILGE-TSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

Query: 237 LELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD 275
              ++G  P      F E       +  L   I  G ++
Sbjct: 335 FICLSGYPP------FSEHR----TQVSLKDQITSGKYN 363

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  104 bits (262), Expect = 1e-24
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 25/212 (11%)

Query: 46  FSDANLLGQGGFGYV----HRGVLPNGKEVAIKQLKAG---SGQGEREFQAEVEIISRVH 98
           F    +LG+GGFG V     R     GK  A K+L+       +GE     E +I+ +V+
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242

Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK-----IALGSAK 153
            + +VSL   Y       LV   +    L+FH++  G+       R       I  G   
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYAAEICCG--- 298

Query: 154 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL 213
            L  LH +   +I++RD+K  NILLD     +++D GLA    +    +  RV GT GY+
Sbjct: 299 -LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQTIKGRV-GTVGYM 352

Query: 214 APEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           APE   + + T   D ++ G +L E+I G+ P
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  101 bits (253), Expect = 2e-24
 Identities = 57/242 (23%), Positives = 94/242 (38%), Gaps = 41/242 (16%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLK----AGSGQGEREFQAEVEIISRVHHKHLVSL 105
           LLG+G +G V   +        A+K LK         GE   + E++++ R+ HK+++ L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 106 VGYYTAGSQRM--LVYEFVPNNTLE-FHLHGKGRPTMDWLTRLKIALGSAK------GLA 156
           V       ++   +V E+      E      + R          +            GL 
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--------FPVCQAHGYFCQLIDGLE 123

Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV--NTHVSTRVMGTFGYLA 214
           YLH      I+H+DIK  N+LL      K++  G+A+       +    T   G+  +  
Sbjct: 124 YLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQP 179

Query: 215 PEYASSGKLTE--KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDG 272
           PE A+        K D++S GV L  + TG  P      F  D++       L   I  G
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP------FEGDNI-----YKLFENIGKG 228

Query: 273 NF 274
           ++
Sbjct: 229 SY 230

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  100 bits (251), Expect = 3e-24
 Identities = 54/230 (23%), Positives = 88/230 (38%), Gaps = 27/230 (11%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +G+G +G V   V        A K++     +    F+ E+EI+  + H +++ L   + 
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 111 AGSQRMLVYEFVPNNTLEFH-LHGKGRPT-MDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             +   LV E      L F  +  K      D    +K  L     +AY H+     + H
Sbjct: 77  DNTDIYLVMELCTGGEL-FERVVHKRVFRESDAARIMKDVL---SAVAYCHKL---NVAH 129

Query: 169 RDIKAANILLDFKFEA---KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           RD+K  N L          K+ DFGLA         +    +GT  Y++P+    G    
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGTPYYVSPQ-VLEGLYGP 186

Query: 226 KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD 275
           + D +S GVM+  L+ G  P      F   +        +   I +G F 
Sbjct: 187 ECDEWSAGVMMYVLLCGYPP------FSAPT-----DSEVMLKIREGTFT 225

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  100 bits (251), Expect = 3e-24
 Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 24/230 (10%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQL--KAGSGQGEREFQAEVEIISRVHHKHLVSLVGY 108
           LG+G F  V R V    G E A K +  K  S +  ++ + E  I  ++ H ++V L   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
               S   LV++ V    L   +  +   +    +     +   + +AY H +    I+H
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI--LESIAYCHSN---GIVH 128

Query: 169 RDIKAANILLDFKFEA---KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           R++K  N+LL  K +    K+ADFGLA   +D +        GT GYL+PE       ++
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVND-SEAWHGFA-GTPGYLSPEVLKKDPYSK 186

Query: 226 KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD 275
             D+++ GV+L  L+ G  P      F ++      +  L   I+ G +D
Sbjct: 187 PVDIWACGVILYILLVGYPP------FWDED-----QHRLYAQIKAGAYD 225

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  100 bits (251), Expect = 4e-24
 Identities = 65/232 (28%), Positives = 105/232 (45%), Gaps = 29/232 (12%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQL--KAGSGQGEREFQAEVEIISRVHHKHLVSLVGY 108
           LG+G FG V +       +E A+K +   +   +       EVE++ ++ H +++ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 109 YTAGSQRMLVYEFVPNNTLEFH-LHGKGRPT-MDWLTRLKIALGSAKGLAYLHEDCHPKI 166
               S   +V E      L F  +  + R +  D    +K       G+ Y+H+     I
Sbjct: 90  LEDSSSFYIVGELYTGGEL-FDEIIKRKRFSEHDAARIIKQVFS---GITYMHKH---NI 142

Query: 167 IHRDIKAANILLDFKFEA---KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
           +HRD+K  NILL+ K +    K+ DFGL+      NT +  R+ GT  Y+APE    G  
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRI-GTAYYIAPEVL-RGTY 199

Query: 224 TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD 275
            EK DV+S GV+L  L++G  P      F   +  D     + + +E G + 
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP------FYGKNEYD-----ILKRVETGKYA 240

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  101 bits (253), Expect = 5e-24
 Identities = 64/265 (24%), Positives = 103/265 (38%), Gaps = 43/265 (16%)

Query: 2   SSSGGSGSNYSGSEAPLPPPSPGLSLGFSKSTFTYEELARATDGFSDA----NLLGQGGF 57
            SSG      +     +   +   + G +     Y       D  SD     + LG+G  
Sbjct: 7   HSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGAT 66

Query: 58  GYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM 116
             V+R       K  A+K LK      ++  + E+ ++ R+ H +++ L   +   ++  
Sbjct: 67  SIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124

Query: 117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS-------------AKGLAYLHEDCH 163
           LV E V    L F          D +    +  G               + +AYLHE+  
Sbjct: 125 LVLELVTGGEL-F----------DRI----VEKGYYSERDAADAVKQILEAVAYLHEN-- 167

Query: 164 PKIIHRDIKAANILLDFKFEA---KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS 220
             I+HRD+K  N+L          K+ADFGL+KI       + T   GT GY APE    
Sbjct: 168 -GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-QVLMKTVC-GTPGYCAPEILRG 224

Query: 221 GKLTEKSDVFSFGVMLLELITGRRP 245
                + D++S G++   L+ G  P
Sbjct: 225 CAYGPEVDMWSVGIITYILLCGFEP 249

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  101 bits (253), Expect = 7e-24
 Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 29/207 (14%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G FG VHR V    G+    K +       +   + E+ I++++HH  L++L   + 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118

Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAK----------GLAYLHE 160
              + +L+ EF+            G    D +      +  A+          GL ++HE
Sbjct: 119 DKYEMVLILEFL-----------SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167

Query: 161 DCHPKIIHRDIKAANILLDFKFEA--KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
                I+H DIK  NI+ + K  +  K+ DFGLA   +     +      T  + APE  
Sbjct: 168 H---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIV 222

Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
               +   +D+++ GV+   L++G  P
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSP 249

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  102 bits (256), Expect = 8e-24
 Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 24/215 (11%)

Query: 44  DGFSDANLLGQGGFGYV----HRGVLPNGKEVAIKQLKAG---SGQGEREFQAEVEIISR 96
           D F D  +LG+GGFG V     +     GK  A K+L        +G +    E +I+++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241

Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDW-LTRLK-----IALG 150
           VH + +VSL   +   +   LV   +    + +H++        +   R       I  G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301

Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
               L +LH+     II+RD+K  N+LLD     +++D GLA       T       GT 
Sbjct: 302 ----LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTP 353

Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           G++APE     +     D F+ GV L E+I  R P
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  103 bits (257), Expect = 8e-24
 Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 26/213 (12%)

Query: 46  FSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAG---SGQGEREFQAEVEIISRVH--- 98
           FS   ++G+GGFG V+       GK  A+K L        QGE     E  ++S V    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250

Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK-----IALGSAK 153
              +V +   +    +   + + +    L +HL   G  +      ++     I LG   
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILG--- 304

Query: 154 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYL 213
            L ++H      +++RD+K ANILLD     +++D GLA   S    H    V GT GY+
Sbjct: 305 -LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYM 357

Query: 214 APEYASSGKLTEKS-DVFSFGVMLLELITGRRP 245
           APE    G   + S D FS G ML +L+ G  P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  100 bits (250), Expect = 9e-24
 Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 30/232 (12%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQL---KAGSGQGEREFQAEVEIISRVHHKHLVSLVG 107
           +G+G F  V     +  G+EVAIK +   +      ++ F+ EV I+  ++H ++V L  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKL-- 79

Query: 108 YYTAGSQRM--LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +    +++   L+ E+     +  +L   GR            + SA  + Y H+     
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA--VQYCHQKR--- 134

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           I+HRD+KA N+LLD     K+ADFG +   +     +     G   Y APE    GK  +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFC-GAPPYAAPELF-QGKKYD 191

Query: 226 --KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD 275
             + DV+S GV+L  L++G  P      F   +L       L   +  G + 
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLP------FDGQNL-----KELRERVLRGKYR 232

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 68/257 (26%), Positives = 106/257 (41%), Gaps = 41/257 (15%)

Query: 41  RATDGFSDA----NLLGQGGFGYVHRGV-LPNGKEVAIK--------QLKAGSGQGERE- 86
            +T GF +      +LG+G    V R +  P  KE A+K           A   Q  RE 
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 87  FQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFH-LHGKGRPTMDWLTR 144
              EV+I+ +V  H +++ L   Y   +   LV++ +    L F  L  K   +     +
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-FDYLTEKVTLSEKETRK 128

Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST 204
           +  AL   + +  LH+     I+HRD+K  NILLD     K+ DFG +         +  
Sbjct: 129 IMRAL--LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLRE 182

Query: 205 RVMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV 258
              GT  YLAPE        +     ++ D++S GV++  L+ G  P      F      
Sbjct: 183 VC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP------FWHRK-- 233

Query: 259 DWARPLLNRAIEDGNFD 275
              + L+ R I  GN+ 
Sbjct: 234 ---QMLMLRMIMSGNYQ 247

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 62/208 (29%), Positives = 91/208 (43%), Gaps = 26/208 (12%)

Query: 51  LLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHHKHLV 103
            +G+G FG V            K  A+K +         E +    E++I+  + H  LV
Sbjct: 22  AIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78

Query: 104 SLVGYYT-AGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYLHE 160
           +L  +Y+    + M +V + +    L +HL        +   +L I  L  A  L YL  
Sbjct: 79  NL--WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-VKLFICELVMA--LDYLQN 133

Query: 161 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS 220
               +IIHRD+K  NILLD      + DF +A +        +  + GT  Y+APE  SS
Sbjct: 134 Q---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSS 188

Query: 221 GKLTEKS---DVFSFGVMLLELITGRRP 245
            K    S   D +S GV   EL+ GRRP
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  101 bits (252), Expect = 3e-23
 Identities = 49/207 (23%), Positives = 83/207 (40%), Gaps = 29/207 (14%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG G FG VHR      G   A K +       +   + E++ +S + H  LV+L   + 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAK----------GLAYLHE 160
             ++ +++YEF+            G    + +      +   +          GL ++HE
Sbjct: 225 DDNEMVMIYEFM-----------SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273

Query: 161 DCHPKIIHRDIKAANILLDFKFEA--KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           +     +H D+K  NI+   K     K+ DFGL                GT  + APE A
Sbjct: 274 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--PKQSVKVTTGTAEFAAPEVA 328

Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
               +   +D++S GV+   L++G  P
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSP 355

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 97.7 bits (244), Expect = 4e-23
 Identities = 58/256 (22%), Positives = 100/256 (39%), Gaps = 50/256 (19%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGSGQGEREFQA--------------- 89
            +G+G +G V       +    A+K     +L   +G   R                   
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 90  ------EVEIISRVHHKHLVSLVGYYTAGSQRML--VYEFVPNNTLEFHLHGKGRPTMDW 141
                 E+ I+ ++ H ++V LV      ++  L  V+E V    +   +      + D 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-MEVPTLKPLSEDQ 138

Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH 201
                  L    G+ YLH     KIIHRDIK +N+L+      K+ADFG++      +  
Sbjct: 139 ARFYFQDLIK--GIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193

Query: 202 VSTRVMGTFGYLAPEYASSGKLT---EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV 258
           +S  V GT  ++APE  S  +     +  DV++ GV L   + G+ P      F+++ + 
Sbjct: 194 LSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP------FMDERI- 245

Query: 259 DWARPLLNRAIEDGNF 274
                 L+  I+    
Sbjct: 246 ----MCLHSKIKSQAL 257

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 99.3 bits (248), Expect = 6e-23
 Identities = 56/231 (24%), Positives = 98/231 (42%), Gaps = 25/231 (10%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQL--KAGSGQGEREFQAEVEIISRVHHKHLVSLVGY 108
           LG+G F  V R V +  G+E A   +  K  S +  ++ + E  I   + H ++V L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPT-MDWLTRLKIALGSAKGLAYLHEDCHPKII 167
            +      L+++ V    L   +  +   +  D    ++  L     + + H+     ++
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE---AVLHCHQM---GVV 132

Query: 168 HRDIKAANILLDFKFEA---KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
           HR++K  N+LL  K +    K+ADFGLA               GT GYL+PE        
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRKDPYG 191

Query: 225 EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD 275
           +  D+++ GV+L  L+ G  P      F ++         L + I+ G +D
Sbjct: 192 KPVDLWACGVILYILLVGYPP------FWDEDQHR-----LYQQIKAGAYD 231

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 97.0 bits (242), Expect = 9e-23
 Identities = 61/252 (24%), Positives = 97/252 (38%), Gaps = 59/252 (23%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQL--KAGSGQGERE------FQAEVEIISRVHHKHL 102
           LG G  G V         K+VAIK +  +  +    RE       + E+EI+ +++H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS----------- 151
           + +  ++ A     +V E +    L            D +    +               
Sbjct: 78  IKIKNFFDA-EDYYIVLELMEGGEL-----------FDKV----VGNKRLKEATCKLYFY 121

Query: 152 --AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA---KVADFGLAKIASDVNTHVSTRV 206
                + YLHE+    IIHRD+K  N+LL  + E    K+ DFG +KI  +  + + T  
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLC 177

Query: 207 MGTFGYLAPE---YASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP 263
            GT  YLAPE      +       D +S GV+L   ++G  P     T V          
Sbjct: 178 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--------- 227

Query: 264 LLNRAIEDGNFD 275
            L   I  G ++
Sbjct: 228 -LKDQITSGKYN 238

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 58/260 (22%), Positives = 103/260 (39%), Gaps = 39/260 (15%)

Query: 1   MSSSGGSGSNYSGSEAPLPPPSPGLSLGFSKSTFT--YEELARATDGFSDANLLGQGGFG 58
           M       S  +      P P     +   +      Y          S   +LG G FG
Sbjct: 52  MPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYT--------VSKTEILGGGRFG 103

Query: 59  YVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 117
            VH+      G ++A K +K    + + E + E+ +++++ H +L+ L   + + +  +L
Sbjct: 104 QVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163

Query: 118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAK----------GLAYLHEDCHPKII 167
           V E+V    L F          D +      L              G+ ++H+     I+
Sbjct: 164 VMEYVDGGEL-F----------DRIIDESYNLTELDTILFMKQICEGIRHMHQM---YIL 209

Query: 168 HRDIKAANILLDFKFEA--KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           H D+K  NIL   +     K+ DFGLA+        +     GT  +LAPE  +   ++ 
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKP-REKLKVNF-GTPEFLAPEVVNYDFVSF 267

Query: 226 KSDVFSFGVMLLELITGRRP 245
            +D++S GV+   L++G  P
Sbjct: 268 PTDMWSVGVIAYMLLSGLSP 287

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 95.6 bits (238), Expect = 2e-22
 Identities = 32/290 (11%), Positives = 80/290 (27%), Gaps = 58/290 (20%)

Query: 51  LLGQGGFGYVHRG---VLPNGKEVAIKQLKAGSGQGE---REFQAEVEIISRVHHKHLVS 104
             G        +     L   ++VA+  +       +   +E  +    +SR+    +  
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           ++      +  ++V E++   +L+        P    +  ++     A      H     
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADAAHRA--- 148

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
            +       + +         V+  G   +A                 +           
Sbjct: 149 GVALSIDHPSRVR--------VSIDGDVVLA-------------YPATMPDA-------N 180

Query: 225 EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHN 284
            + D+   G  L  L+  R P        E  +     P              ++P   +
Sbjct: 181 PQDDIRGIGASLYALLVNRWP------LPEAGVRSGLAPAERDTAGQ-----PIEPADID 229

Query: 285 EYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDASLADLNEGIRP 334
                +++ + A +         R    S ++  ++   ++AD  E + P
Sbjct: 230 RDIPFQISAVAARSVQ--GDGGIRSA--STLLNLMQQATAVADRTEVLGP 275

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 70/296 (23%), Positives = 118/296 (39%), Gaps = 41/296 (13%)

Query: 2   SSSGGSGSNYSGSEAPLPPPSPGLSLGFSKSTFTYEEL-ARATDGFSDA----NLLGQGG 56
             S  +       +     P    +L F       E     A   F       +++G+G 
Sbjct: 47  DPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGV 106

Query: 57  FGYVHRGV-LPNGKEVAIK-------QLKAGSGQGERE-FQAEVEIISRVH-HKHLVSLV 106
              V R V    G E A+K       +L     +  RE  + E  I+ +V  H H+++L+
Sbjct: 107 SSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFH-LHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
             Y + S   LV++ +    L F  L  K   +      +  +L  A  +++LH +    
Sbjct: 167 DSYESSSFMFLVFDLMRKGEL-FDYLTEKVALSEKETRSIMRSLLEA--VSFLHAN---N 220

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE------YAS 219
           I+HRD+K  NILLD   + +++DFG +         +     GT GYLAPE        +
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-GEKLRELC-GTPGYLAPEILKCSMDET 278

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD 275
                ++ D+++ GV+L  L+ G  P      F         + L+ R I +G + 
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPP------FWHRR-----QILMLRMIMEGQYQ 323

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 95.3 bits (238), Expect = 2e-22
 Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 22/207 (10%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGSGQGERE-FQAEVEIISRVHHKHLVS 104
           LG G F  V +      GKE A K     +L +      RE  + EV I+  + H ++++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFH-LHGKGRPT-MDWLTRLKIALGSAKGLAYLHEDC 162
           L   +   +  +L+ E V    L F  L  K   T  +    LK  L    G+ YLH   
Sbjct: 73  LHDIFENKTDVVLILELVSGGEL-FDFLAEKESLTEDEATQFLKQILD---GVHYLHSK- 127

Query: 163 HPKIIHRDIKAANILLDFKFEA----KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
             +I H D+K  NI+L  K       K+ DFG+A               GT  ++APE  
Sbjct: 128 --RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA-GNEFKNIF-GTPEFVAPEIV 183

Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
           +   L  ++D++S GV+   L++G  P
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASP 210

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 55/245 (22%), Positives = 107/245 (43%), Gaps = 25/245 (10%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGY 108
           +LG+G    V   + L   +E A+K ++   G        EVE++ +   H++++ L+ +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
           +    +  LV+E +   ++  H+H +        + +   + SA  L +LH      I H
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA--LDFLHN---KGIAH 134

Query: 169 RDIKAANILLDFKFEA---KVADFGLAKI------ASDVNTHVSTRVMGTFGYLAPE--- 216
           RD+K  NIL +   +    K+ DF L          S ++T       G+  Y+APE   
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194

Query: 217 --YASSGKLTEKSDVFSFGVMLLELITGRRP----VDSTHTFVEDSLVDWARPLLNRAIE 270
                +    ++ D++S GV+L  L++G  P      S   +         + +L  +I+
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ 254

Query: 271 DGNFD 275
           +G ++
Sbjct: 255 EGKYE 259

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 96.6 bits (241), Expect = 3e-22
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 42/219 (19%)

Query: 46  FSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSL 105
           +++  ++G G FG V +  L    EVAIK++     Q +R    E++I+  V H ++V L
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL----QDKRFKNRELQIMRIVKHPNVVDL 97

Query: 106 VGYYTAGSQRM------LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA------- 152
             ++ +   +       LV E+VP       ++           +LK  +          
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPET-----VY----RASRHYAKLKQTMPMLLIKLYMY 148

Query: 153 ---KGLAYLHEDCHPKIIHRDIKAANILLD-FKFEAKVADFGLAK--IASDVNTH-VSTR 205
              + LAY+H      I HRDIK  N+LLD      K+ DFG AK  IA + N   + +R
Sbjct: 149 QLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR 205

Query: 206 VMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 243
                 Y APE    +   T   D++S G ++ EL+ G+
Sbjct: 206 Y-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 95.6 bits (238), Expect = 4e-22
 Identities = 57/219 (26%), Positives = 81/219 (36%), Gaps = 42/219 (19%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGSGQGEREFQA---EVEIISRVHHKHL 102
           LG G FG+V   V     KEV +K     ++       + +      E+ I+SRV H ++
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNT---LEFHLHGKGRPTMDWL---TRLKIALGSAK--- 153
           + +              +   N     L    HG G     ++    RL   L S     
Sbjct: 92  IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138

Query: 154 ---GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
               + YL       IIHRDIK  NI++   F  K+ DFG A           T   GT 
Sbjct: 139 LVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLFYTFC-GTI 193

Query: 211 GYLAPEYASSGKLTE--KSDVFSFGVMLLELITGRRPVD 247
            Y APE    G      + +++S GV L  L+    P  
Sbjct: 194 EYCAPEVL-MGNPYRGPELEMWSLGVTLYTLVFEENPFC 231

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 95.4 bits (238), Expect = 4e-22
 Identities = 51/234 (21%), Positives = 97/234 (41%), Gaps = 25/234 (10%)

Query: 26  SLGFSKSTFTYEELARATDGFS-DANLLGQGGFGYVHRGV-LPNGKEVAIKQL-KAGSGQ 82
            +        ++ +    + +   +  LG+G F  V + +    G+E A K L K   GQ
Sbjct: 10  GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69

Query: 83  GERE-FQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD 140
             R     E+ ++        +++L   Y   S+ +L+ E+     + F          +
Sbjct: 70  DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI-FS-----LCLPE 123

Query: 141 WLTRL--KIALGSAK----GLAYLHEDCHPKIIHRDIKAANILLDFKFEA---KVADFGL 191
               +     +   K    G+ YLH++    I+H D+K  NILL   +     K+ DFG+
Sbjct: 124 LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180

Query: 192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           ++        +   + GT  YLAPE  +   +T  +D+++ G++   L+T   P
Sbjct: 181 SRKIGH-ACELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 95.0 bits (237), Expect = 5e-22
 Identities = 44/204 (21%), Positives = 90/204 (44%), Gaps = 24/204 (11%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           LG+G FG VHR V   + K    K +K   G  +   + E+ I++   H++++ L   + 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 111 AGSQRMLVYEFVPNNTL-------EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           +  + ++++EF+    +        F L+ +     + ++ +       + L +LH    
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAFELNER-----EIVSYVHQVC---EALQFLHSH-- 121

Query: 164 PKIIHRDIKAANILLDFKFEA--KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
             I H DI+  NI+   +  +  K+ +FG A+       +          Y APE     
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRLLF-TAPEYYAPEVHQHD 178

Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
            ++  +D++S G ++  L++G  P
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINP 202

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 95.0 bits (237), Expect = 5e-22
 Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 20/206 (9%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGSGQGERE-FQAEVEIISRVHHKHLVS 104
           LG G F  V +      G E A K     Q +A      RE  + EV I+ +V H ++++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPT-MDWLTRLKIALGSAKGLAYLHEDCH 163
           L   Y   +  +L+ E V    L   L  K   +  +  + +K  L    G+ YLH    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNYLHTK-- 134

Query: 164 PKIIHRDIKAANILLDFKFEA----KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
            KI H D+K  NI+L  K       K+ DFGLA    D          GT  ++APE  +
Sbjct: 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-GVEFKNIF-GTPEFVAPEIVN 191

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRP 245
              L  ++D++S GV+   L++G  P
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASP 217

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 93.8 bits (234), Expect = 5e-22
 Identities = 72/232 (31%), Positives = 104/232 (44%), Gaps = 29/232 (12%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQL---KAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
            LG G FG V  G     G +VA+K L   K  S     + + E++ +    H H++ L 
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76

Query: 107 GYYTAGSQRM--LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
            Y    +     +V E+V    L  ++   GR       RL   + SA  + Y H     
Sbjct: 77  -YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA--VDYCHRH--- 130

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
            ++HRD+K  N+LLD    AK+ADFGL+ + SD    + T   G+  Y APE   SG+L 
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC-GSPNYAAPEVI-SGRLY 187

Query: 225 E--KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF 274
              + D++S GV+L  L+ G  P D  H            P L + I  G F
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHV-----------PTLFKKIRGGVF 228

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 94.7 bits (236), Expect = 7e-22
 Identities = 53/230 (23%), Positives = 99/230 (43%), Gaps = 20/230 (8%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQL-KAGSGQGEREFQAEVEIISRV-HHKHLVSLVGY 108
           LG+G F    + V   + +  A+K + K      ++E    +  +     H ++V L   
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKE----ITALKLCEGHPNIVKLHEV 74

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
           +       LV E +    L   +  K   +    + +   L SA  ++++H+     ++H
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSA--VSHMHDV---GVVH 129

Query: 169 RDIKAANILLDFKFEA---KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           RD+K  N+L   + +    K+ DFG A++    N  + T    T  Y APE  +     E
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNGYDE 188

Query: 226 KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD 275
             D++S GV+L  +++G+ P  S       SL   +   + + I+ G+F 
Sbjct: 189 SCDLWSLGVILYTMLSGQVPFQSHD----RSLTCTSAVEIMKKIKKGDFS 234

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 93.8 bits (234), Expect = 7e-22
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 21/207 (10%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
            LG+G +G V   V     + VA+K     +        ++E    + I   ++H+++V 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
             G+   G+ + L  E+     L   +            R    L +   + YLH     
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHGI--- 124

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT--HVSTRVMGTFGYLAPEYASSGK 222
            I HRDIK  N+LLD +   K++DFGLA +    N    ++    GT  Y+APE     +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-KRR 182

Query: 223 L--TEKSDVFSFGVMLLELITGRRPVD 247
               E  DV+S G++L  ++ G  P D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWD 209

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 35/224 (15%)

Query: 38  ELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE---FQA--EV 91
           ++      +   + LG+G F  V++       + VAIK++K G     ++     A  E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRP-TMD----WLTRLK 146
           +++  + H +++ L+  +   S   LV++F+  + LE  +       T      ++    
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMT- 121

Query: 147 IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRV 206
                 +GL YLH+     I+HRD+K  N+LLD     K+ADFGLAK     N   + +V
Sbjct: 122 -----LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 173

Query: 207 MGTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELITGR 243
           + T  Y APE       Y          D+++ G +L EL+   
Sbjct: 174 V-TRWYRAPELLFGARMYGVG------VDMWAVGCILAELLLRV 210

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 22/207 (10%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGSGQGERE-FQAEVEIISRVHHKHLVS 104
           LG G F  V +      G E A K     Q +A      RE  + EV I+ +V H ++++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEF-HLHGKGRPT-MDWLTRLKIALGSAKGLAYLHEDC 162
           L   Y   +  +L+ E V    L F  L  K   +  +  + +K  L    G+ YLH   
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL-FDFLAQKESLSEEEATSFIKQILD---GVNYLHTK- 134

Query: 163 HPKIIHRDIKAANILLDFKFEA----KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
             KI H D+K  NI+L  K       K+ DFGLA    D        + GT  ++APE  
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTPEFVAPEIV 190

Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
           +   L  ++D++S GV+   L++G  P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 93.0 bits (232), Expect = 2e-21
 Identities = 60/237 (25%), Positives = 110/237 (46%), Gaps = 37/237 (15%)

Query: 19  PPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKA 78
              S   +L F      Y++L +          +G+G +G V++     G+ VA+K+++ 
Sbjct: 6   HHSSGRENLYFQGLMEKYQKLEK----------VGEGTYGVVYKAKDSQGRIVALKRIRL 55

Query: 79  GSGQGERE---FQA--EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHG 133
            +   E E     A  E+ ++  +HH ++VSL+    +     LV+EF+  + L+  L  
Sbjct: 56  DA---EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDE 111

Query: 134 KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 193
                 D   +        +G+A+ H+    +I+HRD+K  N+L++     K+ADFGLA+
Sbjct: 112 NKTGLQDSQIK-IYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR 167

Query: 194 IASDVNTHVSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELITGR 243
                    +  V+ T  Y AP+       Y++S       D++S G +  E+ITG+
Sbjct: 168 AFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTS------VDIWSIGCIFAEMITGK 217

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 62/244 (25%), Positives = 99/244 (40%), Gaps = 39/244 (15%)

Query: 23  PGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG 81
           PG  +  + +    E   +  D F    + GQG FG V  G     G  VAIK++     
Sbjct: 2   PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61

Query: 82  QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQR-------MLVYEFVPNNTLEFHLHGK 134
              RE Q  ++ ++ +HH ++V L  Y+    +R        +V E+VP+      LH  
Sbjct: 62  FRNRELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-----LH-- 113

Query: 135 GRPTMDWLTRLKIALGSA----------KGLAYLHEDCHPKIIHRDIKAANILLDFK-FE 183
                    R ++A              + +  LH      + HRDIK  N+L++     
Sbjct: 114 --RCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGT 170

Query: 184 AKVADFGLAKIAS--DVNTH-VSTRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLEL 239
            K+ DFG AK  S  + N   + +R      Y APE    +   T   D++S G +  E+
Sbjct: 171 LKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEM 225

Query: 240 ITGR 243
           + G 
Sbjct: 226 MLGE 229

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 92.6 bits (231), Expect = 2e-21
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE---FQA--EVEIISRVHHKHLVSL 105
           +G+G +G V +       + VA+K+++      + E     A  E+ ++  + HK++V L
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVRL 66

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
                +  +  LV+EF   + L+ +        +D            KGL + H      
Sbjct: 67  HDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSR---N 121

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-------YA 218
           ++HRD+K  N+L++   E K+A+FGLA+         S  V+ T  Y  P+       Y+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 180

Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
           +S       D++S G +  EL    RP
Sbjct: 181 TS------IDMWSAGCIFAELANAGRP 201

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 92.0 bits (229), Expect = 5e-21
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 21/207 (10%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
            LG+G +G V   V     + VA+K     +        ++E    + I   ++H+++V 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
             G+   G+ + L  E+     L   +            R    L +   + YLH     
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHGI--- 124

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT--HVSTRVMGTFGYLAPEYASSGK 222
            I HRDIK  N+LLD +   K++DFGLA +    N    ++    GT  Y+APE     +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-KRR 182

Query: 223 L--TEKSDVFSFGVMLLELITGRRPVD 247
               E  DV+S G++L  ++ G  P D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWD 209

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 93.2 bits (232), Expect = 5e-21
 Identities = 69/275 (25%), Positives = 113/275 (41%), Gaps = 53/275 (19%)

Query: 1   MSSSGGSGSNYSGSEAPLPPPSPGLSLGFSKSTFTYEELARATDG----------FSDAN 50
           MS    + S     +    P + G          +      AT G          ++D  
Sbjct: 1   MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK 60

Query: 51  LLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
           ++G G FG V++  L  +G+ VAIK++     Q +R    E++I+ ++ H ++V L  ++
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFF 116

Query: 110 TAGSQRM------LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA----------K 153
            +  ++       LV ++VP       ++          +R K  L             +
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPET-----VY----RVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 154 GLAYLHEDCHPKIIHRDIKAANILLD-FKFEAKVADFGLAKIAS--DVNTH-VSTRVMGT 209
            LAY+H      I HRDIK  N+LLD      K+ DFG AK     + N   + +R    
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 221

Query: 210 FGYLAPEY-ASSGKLTEKSDVFSFGVMLLELITGR 243
             Y APE    +   T   DV+S G +L EL+ G+
Sbjct: 222 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 92.0 bits (229), Expect = 6e-21
 Identities = 53/239 (22%), Positives = 90/239 (37%), Gaps = 37/239 (15%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGY 108
           +LG G  G V        G++ A+K L         + + EV+   +     H+V ++  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILDV 90

Query: 109 Y-TAGSQRMLVY---EFVPNNTLEFHLHGKGRPTMD-----WLTRLKIALGSAKGLAYLH 159
           Y      +  +    E +    L   +  +G           + R  I       + +LH
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR-DIG----TAIQFLH 145

Query: 160 EDCHPKIIHRDIKAANILLDFKFEA---KVADFGLAKIASDVNTHVSTRVMGTFGYLAPE 216
                 I HRD+K  N+L   K +    K+ DFG AK  +     + T    T  Y+APE
Sbjct: 146 SH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT--QNALQTPC-YTPYYVAPE 199

Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD 275
                K  +  D++S GV++  L+ G  P      F  ++    +  +  R I  G + 
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPP------FYSNTGQAISPGMKRR-IRLGQYG 251

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 91.9 bits (229), Expect = 6e-21
 Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 22/207 (10%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGSGQGERE-FQAEVEIISRVHHKHLVS 104
           LG G F  V +      G + A K     + K+      RE  + EV I+  + H ++++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFH-LHGKGRPT-MDWLTRLKIALGSAKGLAYLHEDC 162
           L   Y   +  +L+ E V    L F  L  K   T  +    LK  L    G+ YLH   
Sbjct: 79  LHEVYENKTDVILILELVAGGEL-FDFLAEKESLTEEEATEFLKQILN---GVYYLHSL- 133

Query: 163 HPKIIHRDIKAANILLDFKFEA----KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
             +I H D+K  NI+L  +       K+ DFGLA      N      + GT  ++APE  
Sbjct: 134 --QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIV 189

Query: 219 SSGKLTEKSDVFSFGVMLLELITGRRP 245
           +   L  ++D++S GV+   L++G  P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 92.0 bits (229), Expect = 8e-21
 Identities = 53/249 (21%), Positives = 96/249 (38%), Gaps = 28/249 (11%)

Query: 37  EELARATDGFSDA----NLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEV 91
           ++L R +  F+D       +G G +    R +      E A+K +         E    +
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----I 66

Query: 92  EIISR-VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
           EI+ R   H ++++L   Y  G    +V E +    L   +  +   +    + +   + 
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT 126

Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA----KVADFGLAKIASDVNTHVSTRV 206
               + YLH      ++HRD+K +NIL   +       ++ DFG AK     N  + T  
Sbjct: 127 KT--VEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181

Query: 207 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN 266
             T  ++APE           D++S GV+L  ++TG  P  +      + ++        
Sbjct: 182 -YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA------- 233

Query: 267 RAIEDGNFD 275
             I  G F 
Sbjct: 234 -RIGSGKFS 241

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 71/238 (29%), Positives = 102/238 (42%), Gaps = 41/238 (17%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQL---KAGSGQGEREFQAEVEIISRVHHKHLVSLV 106
            LG G FG V  G     G +VA+K L   K  S     + + E++ +    H H++ L 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL- 81

Query: 107 GYYTAGSQRM--LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAK------GLAYL 158
            Y    +     +V E+V    L  ++   GR        L              G+ Y 
Sbjct: 82  -YQVISTPSDIFMVMEYVSGGELFDYICKNGR--------LDEKESRRLFQQILSGVDYC 132

Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           H      ++HRD+K  N+LLD    AK+ADFGL+ + SD    + T   G+  Y APE  
Sbjct: 133 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC-GSPNYAAPEVI 187

Query: 219 SSGKLTE--KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF 274
            SG+L    + D++S GV+L  L+ G  P D  H            P L + I DG F
Sbjct: 188 -SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----------PTLFKKICDGIF 233

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 50/261 (19%), Positives = 102/261 (39%), Gaps = 44/261 (16%)

Query: 1   MSSSGGSGSNYSGSEAPLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYV 60
           M+           ++   P      +   + S   Y  + +          LG+G +G V
Sbjct: 1   MAHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITK----------LGEGTYGEV 50

Query: 61  HRGV-LPNGKEVAIKQLKAGSGQGERE---FQA--EVEIISRVHHKHLVSLVGYYTAGSQ 114
           ++ +     + VAIK+++      E E     A  EV ++  + H++++ L        +
Sbjct: 51  YKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107

Query: 115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAA 174
             L++E+  N+ L+ ++      +M  +      L    G+ + H     + +HRD+K  
Sbjct: 108 LHLIFEYAEND-LKKYMDKNPDVSMRVIKSFLYQL--INGVNFCH---SRRCLHRDLKPQ 161

Query: 175 NILLDFKFEA-----KVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-------YASSGK 222
           N+LL     +     K+ DFGLA+         +  ++ T  Y  PE       Y++S  
Sbjct: 162 NLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTS-- 218

Query: 223 LTEKSDVFSFGVMLLELITGR 243
                D++S   +  E++   
Sbjct: 219 ----VDIWSIACIWAEMLMKT 235

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 55/234 (23%), Positives = 94/234 (40%), Gaps = 31/234 (13%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
            +G G FG           + VA+K ++ G+   E   Q E+     + H ++V      
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRF--KE 83

Query: 110 TAGSQRML--VYEFVPNNTLEFHLHGKGRPTMD---WLTRLKIALGSAKGLAYLHEDCHP 164
              +   L  + E+     L   +   GR + D   +  +  ++     G++Y H     
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-----GVSYCHSM--- 135

Query: 165 KIIHRDIKAANILLDFKFEA--KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK 222
           +I HRD+K  N LLD       K+ DFG +K +   ++   + V GT  Y+APE     +
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTV-GTPAYIAPEVL-LRQ 192

Query: 223 LTE--KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF 274
             +   +DV+S GV L  ++ G  P      F +       R  + R I    +
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYP------FEDPEEPRDYRKTIQR-ILSVKY 239

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 90.2 bits (224), Expect = 4e-20
 Identities = 65/289 (22%), Positives = 110/289 (38%), Gaps = 36/289 (12%)

Query: 1   MSSSGGSGSNYSGSEAPLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYV 60
                 + +       P PPP         KS    ++ A   D    + +LG G  G V
Sbjct: 19  PPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKV 78

Query: 61  HRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYY-TAGSQRML 117
            +       ++ A+K L+        + + EVE+  R     H+V +V  Y    + R  
Sbjct: 79  LQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133

Query: 118 VY---EFVPNNTLEFHLHGKGRPTMD-----WLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
           +    E +    L   +  +G           + +  I     + + YLH      I HR
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK-SIG----EAIQYLHSI---NIAHR 185

Query: 170 DIKAANILLDFKFEA---KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEK 226
           D+K  N+L   K      K+ DFG AK  +  N+ ++T    T  Y+APE     K  + 
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPEVLGPEKYDKS 243

Query: 227 SDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD 275
            D++S GV++  L+ G  P      F  +  +  +  +  R I  G ++
Sbjct: 244 CDMWSLGVIMYILLCGYPP------FYSNHGLAISPGMKTR-IRMGQYE 285

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 89.3 bits (222), Expect = 5e-20
 Identities = 61/262 (23%), Positives = 103/262 (39%), Gaps = 21/262 (8%)

Query: 1   MSSSGGSGSNYSGSEAPLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYV 60
           M SS     + SG        +P   L  +K     E+       +    LLG GGFG V
Sbjct: 1   MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEK-EPLESQYQVGPLLGSGGFGSV 59

Query: 61  HRGV-LPNGKEVAIKQL------KAGSGQGEREFQAEVEIISRVHHK--HLVSLVGYYTA 111
           + G+ + +   VAIK +        G          EV ++ +V      ++ L+ ++  
Sbjct: 60  YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119

Query: 112 GSQRMLVYEFV-PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD 170
               +L+ E   P   L   +  +G    + L R        + + + H      ++HRD
Sbjct: 120 PDSFVLILERPEPVQDLFDFITERGALQEE-LAR-SFFWQVLEAVRHCHNC---GVLHRD 174

Query: 171 IKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT-EKSD 228
           IK  NIL+D  + E K+ DFG   +  D          GT  Y  PE+    +     + 
Sbjct: 175 IKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWIRYHRYHGRSAA 231

Query: 229 VFSFGVMLLELITGRRPVDSTH 250
           V+S G++L +++ G  P +   
Sbjct: 232 VWSLGILLYDMVCGDIPFEHDE 253

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 18/204 (8%)

Query: 51  LLGQGGFGYV----HRGVLPNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVS 104
           +LGQG FG V            +  A+K LK  +   +     + E +I+  V+H  +V 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 105 LVGYYTAGSQRML--VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYLHED 161
           L  +Y   ++  L  + +F+    L   L  +   T +   +  +A L  A  L +LH  
Sbjct: 91  L--HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-VKFYLAELALA--LDHLHSL 145

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
               II+RD+K  NILLD +   K+ DFGL+K + D      +   GT  Y+APE  +  
Sbjct: 146 ---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRR 201

Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
             T+ +D +SFGV++ E++TG  P
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLP 225

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 87.2 bits (217), Expect = 2e-19
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 38/226 (16%)

Query: 41  RATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEV------EI 93
            AT  +     +G G +G V++     +G  VA+K ++  +          +      E+
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---GGGGGGGLPISTVREV 62

Query: 94  -----ISRVHHKHLVSL----VGYYTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLT 143
                +    H ++V L        T    ++ LV+E V  + L  +L     P +   T
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAET 121

Query: 144 RLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS 203
              +     +GL +LH +    I+HRD+K  NIL+      K+ADFGLA+        ++
Sbjct: 122 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALT 177

Query: 204 TRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELITGR 243
             V+ T  Y APE      YA+        D++S G +  E+   +
Sbjct: 178 PVVV-TLWYRAPEVLLQSTYATP------VDMWSVGCIFAEMFRRK 216

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 87.2 bits (217), Expect = 2e-19
 Identities = 49/204 (24%), Positives = 97/204 (47%), Gaps = 27/204 (13%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGERE---FQA--EVEIISRVHHKHLVSLV 106
           +G+G +G V++     G+  A+K+++      E E        E+ I+  + H ++V L 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
                  + +LV+E +  + L+  L       ++ +T     L    G+AY H+    ++
Sbjct: 67  DVIHTKKRLVLVFEHLDQD-LKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDR---RV 121

Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-------YAS 219
           +HRD+K  N+L++ + E K+ADFGLA+         +  ++ T  Y AP+       Y++
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYST 180

Query: 220 SGKLTEKSDVFSFGVMLLELITGR 243
           +       D++S G +  E++ G 
Sbjct: 181 T------IDIWSVGCIFAEMVNGT 198

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 64/242 (26%), Positives = 99/242 (40%), Gaps = 50/242 (20%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIK-----QLKAGS--GQGEREFQAEVEIISRVHHKHL 102
            LG+G FG V         ++VA+K      LK      + ERE    +  +  + H H+
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRHPHI 71

Query: 103 VSLVGYYTAGSQRM--LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAK------G 154
           + L  Y    +     +V E+     L  ++  K R        +    G          
Sbjct: 72  IKL--YDVITTPTDIVMVIEYA-GGELFDYIVEKKR--------MTEDEGRRFFQQIICA 120

Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLA 214
           + Y H     KI+HRD+K  N+LLD     K+ADFGL+ I +D    + T   G+  Y A
Sbjct: 121 IEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTSC-GSPNYAA 175

Query: 215 PEYASSGKLTE--KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDG 272
           PE   +GKL    + DV+S G++L  ++ GR P D               P L + +   
Sbjct: 176 PEVI-NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI-----------PNLFKKVNSC 223

Query: 273 NF 274
            +
Sbjct: 224 VY 225

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 86.1 bits (214), Expect = 4e-19
 Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 36/209 (17%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE---FQA--EVEIISRVHHKHLVSL 105
           +G+G +G V +      G+ VAIK+        +       A  E+ ++ ++ H +LV+L
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQLKHPNLVNL 67

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +  +    +  LV+E+  +  +   L    R   + L +  I   + + + + H+  H  
Sbjct: 68  LEVFRRKRRLHLVFEYCDHT-VLHELDRYQRGVPEHLVK-SITWQTLQAVNFCHK--H-N 122

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAK---IASDVNTH-VSTRVMGTFGYLAPE----- 216
            IHRD+K  NIL+      K+ DFG A+     SD     V+TR      Y +PE     
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPELLVGD 177

Query: 217 --YASSGKLTEKSDVFSFGVMLLELITGR 243
             Y          DV++ G +  EL++G 
Sbjct: 178 TQYGPP------VDVWAIGCVFAELLSGV 200

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 85.7 bits (213), Expect = 7e-19
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 29/213 (13%)

Query: 44  DGFSDANLLGQGGFGYVHRG-VLPNGKEVAIKQLKAGSGQGE-----REFQAEVEIISRV 97
           + +   + LG+G +  V++G        VA+K+++    +G      RE    V ++  +
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57

Query: 98  HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
            H ++V+L           LV+E++  + L+ +L   G   ++            +GLAY
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNI-INMHNVKLFLFQLLRGLAY 115

Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE- 216
            H     K++HRD+K  N+L++ + E K+ADFGLA+  S         V+ T  Y  P+ 
Sbjct: 116 CH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDI 171

Query: 217 ------YASSGKLTEKSDVFSFGVMLLELITGR 243
                 Y++        D++  G +  E+ TGR
Sbjct: 172 LLGSTDYSTQ------IDMWGVGCIFYEMATGR 198

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 87.1 bits (216), Expect = 8e-19
 Identities = 59/203 (29%), Positives = 88/203 (43%), Gaps = 17/203 (8%)

Query: 51  LLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHHKHLV 103
           LLG+G FG V     +     G+  A+K LK      + E      E  ++    H  L 
Sbjct: 155 LLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYLHEDC 162
           +L   +    +   V E+     L FHL  +   + D   R   A + SA  L YLH + 
Sbjct: 212 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGAEIVSA--LDYLHSEK 268

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK 222
           +  +++RD+K  N++LD     K+ DFGL K        + T   GT  YLAPE      
Sbjct: 269 N--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDND 325

Query: 223 LTEKSDVFSFGVMLLELITGRRP 245
                D +  GV++ E++ GR P
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLP 348

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 58/208 (27%), Positives = 85/208 (40%), Gaps = 17/208 (8%)

Query: 44  DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHH 99
           D F     LG G FG V       +G   A+K L        ++ +    E  I+  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYL 158
             LV L   +   S   +V E+V    +  HL   GR +     R   A +       YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT--FEYL 157

Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAPEY 217
           H      +I+RD+K  N+L+D +   +V DFG AK          T  + GT   LAPE 
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEI 209

Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRP 245
             S    +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 22/211 (10%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQL------KAGSGQGEREFQAEVEIISRVH----H 99
           LLG+GGFG V  G  L +  +VAIK +                   EV ++ +V     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 100 KHLVSLVGYYTAGSQRMLVYEF-VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
             ++ L+ ++      MLV E  +P   L  ++  KG       +R          + + 
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG-PSR-CFFGQVVAAIQHC 155

Query: 159 HEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEY 217
           H      ++HRDIK  NIL+D +   AK+ DFG   +  D          GT  Y  PE+
Sbjct: 156 HSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTRVYSPPEW 209

Query: 218 ASSGKLT-EKSDVFSFGVMLLELITGRRPVD 247
            S  +     + V+S G++L +++ G  P +
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFE 240

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 23/209 (11%)

Query: 51  LLGQGGFGYV----HRGVLPNGKEVAIKQLKAGS--GQGERE-FQAEVEIISRVHHKHLV 103
           ++G+G FG V     +      K  A+K L       + E   F+ E +++     K + 
Sbjct: 81  VIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWIT 137

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIA-LGSAKGLAYLHED 161
           +L   +   +   LV ++     L   L   + R   +   R  +A +  A  +  +H+ 
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLAEMVIA--IDSVHQL 194

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE----- 216
                +HRDIK  NIL+D     ++ADFG      +  T  S+  +GT  Y++PE     
Sbjct: 195 ---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251

Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRP 245
               G+   + D +S GV + E++ G  P
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 36/224 (16%)

Query: 41  RATDGFSDANLLGQGGFGYVHRG--VLPNGKEVAIKQLKAGSGQGERE---FQAEVEI-- 93
           RA   +     +G+G +G V +   +   G+ VA+K+++  +     E        E+  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAV 64

Query: 94  ---ISRVHHKHLVSL----VGYYTAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRL 145
              +    H ++V L        T    ++ LV+E V  + L  +L     P +   T  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIK 123

Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR 205
            +     +GL +LH     +++HRD+K  NIL+    + K+ADFGLA+        +++ 
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSV 179

Query: 206 VMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELITGR 243
           V+ T  Y APE      YA+        D++S G +  E+   +
Sbjct: 180 VV-TLWYRAPEVLLQSSYATP------VDLWSVGCIFAEMFRRK 216

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 42/239 (17%)

Query: 22  SPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGS 80
           S G+ LG     F      ++ + + +  L+G+G +G V +      G+ VAIK+     
Sbjct: 9   SSGVDLGTENLYF------QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD 62

Query: 81  GQGERE---FQA--EVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG 135
              + +     A  E++++ ++ H++LV+L+       +  LV+EFV +  +   L    
Sbjct: 63  ---DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDLELFP 118

Query: 136 RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-- 193
                 + + K       G+ + H   H  IIHRDIK  NIL+      K+ DFG A+  
Sbjct: 119 NGLDYQVVQ-KYLFQIINGIGFCHS--H-NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174

Query: 194 -IASDVNTH-VSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELITGR 243
               +V    V+TR      Y APE       Y  +       DV++ G ++ E+  G 
Sbjct: 175 AAPGEVYDDEVATR-----WYRAPELLVGDVKYGKA------VDVWAIGCLVTEMFMGE 222

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 84.1 bits (209), Expect = 3e-18
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 20/206 (9%)

Query: 51  LLGQGGFGYV----HRGVLPNGKEVAIKQL-KAGSGQGEREF---QAEVEIISRVHHKHL 102
           +LG+GG+G V           GK  A+K L KA   +  ++    +AE  I+  V H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 103 VSLVGYYTAGSQRML--VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYLH 159
           V L   Y   +   L  + E++    L   L  +G    D      +A +  A  L +LH
Sbjct: 84  VDL--IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT-ACFYLAEISMA--LGHLH 138

Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
           +     II+RD+K  NI+L+ +   K+ DFGL K +    T   T   GT  Y+APE   
Sbjct: 139 QK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMAPEILM 194

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRP 245
                   D +S G ++ +++TG  P
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPP 220

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 83.0 bits (206), Expect = 6e-18
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 30/208 (14%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE-----REFQAEVEIISRVHHKHLVSL 105
           LG G +  V++G+    G  VA+K++K  S +G      RE    + ++  + H+++V L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKHENIVRL 68

Query: 106 VGYYTAGSQRMLVYEFVPN---NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
                  ++  LV+EF+ N     ++    G     ++            +GLA+ HE+ 
Sbjct: 69  YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN- 127

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE------ 216
             KI+HRD+K  N+L++ + + K+ DFGLA+         S+ V+ T  Y AP+      
Sbjct: 128 --KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGSR 184

Query: 217 -YASSGKLTEKSDVFSFGVMLLELITGR 243
            Y++S       D++S G +L E+ITG+
Sbjct: 185 TYSTS------IDIWSCGCILAEMITGK 206

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 83.4 bits (206), Expect = 8e-18
 Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 5/167 (2%)

Query: 81  GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD 140
           G   R+ +  V  I     + L S+    ++ S   +  + + +   E       +  + 
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191

Query: 141 WLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVN 199
               +  +   AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+ I  D +
Sbjct: 192 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248

Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 245
                       ++APE       T +SDV+SFGV+L E+ + G  P
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 27/212 (12%)

Query: 51  LLGQGGFGYV----HRGVLPNGKEVAIKQLKAGS--GQGERE-FQAEVEIISRVHHKHLV 103
           ++G+G F  V     +     G+  A+K +       +GE   F+ E +++     + + 
Sbjct: 68  VIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124

Query: 104 SLVGYYTAGSQRML--VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYLHE 160
            L  ++    +  L  V E+     L   L   G      + R  +A +  A  +  +H 
Sbjct: 125 QL--HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA--IDSVHR 180

Query: 161 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE---- 216
                 +HRDIK  NILLD     ++ADFG         T  S   +GT  YL+PE    
Sbjct: 181 L---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237

Query: 217 ---YASSGKLTEKSDVFSFGVMLLELITGRRP 245
                 +G    + D ++ GV   E+  G+ P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 81.8 bits (203), Expect = 2e-17
 Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 23/204 (11%)

Query: 51  LLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSGQGEREFQ---AEVEIISRVHHKHLV 103
            LG G FG VH   L     NG+  A+K LK       ++ +    E  ++S V H  ++
Sbjct: 13  TLGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 69

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYLHEDC 162
            + G +    Q  ++ +++    L   L    R     + +   A +  A  L YLH   
Sbjct: 70  RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-VAKFYAAEVCLA--LEYLHSK- 125

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAPEYASSG 221
              II+RD+K  NILLD     K+ DFG AK   DV     T  + GT  Y+APE  S+ 
Sbjct: 126 --DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTK 178

Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
              +  D +SFG+++ E++ G  P
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTP 202

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 57/210 (27%), Positives = 84/210 (40%), Gaps = 28/210 (13%)

Query: 51  LLGQGGFGYV----HRGVLPNGKEVAIKQLK----AGSGQGEREFQAEVEIISRVHHKHL 102
           ++G+G FG V    H+      K  A+K L              F  E +I++  +   +
Sbjct: 76  VIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWV 131

Query: 103 VSLVGYYTAGSQRML--VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYLH 159
           V L  +Y     R L  V E++P   L  +L         W  R   A +  A  L  +H
Sbjct: 132 VQL--FYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKW-ARFYTAEVVLA--LDAIH 185

Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE--- 216
                  IHRD+K  N+LLD     K+ADFG     +          +GT  Y++PE   
Sbjct: 186 SM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242

Query: 217 -YASSGKLTEKSDVFSFGVMLLELITGRRP 245
                G    + D +S GV L E++ G  P
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 48/227 (21%), Positives = 83/227 (36%), Gaps = 42/227 (18%)

Query: 43  TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQL--KAGSGQGEREFQA---------EV 91
              ++    +  G +G V  GV   G  VAIK++      G+                E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 92  EIISRVHHKHLVSLVGYYTAGSQRM-----LVYEFVPNNTLEFHLHGKGRPTMDWLTRLK 146
            +++  HH +++ L   +    +       LV E      +   L          ++   
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVISPQH 135

Query: 147 I------ALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT 200
           I       L    GL  LHE     ++HRD+   NILL    +  + DF LA+  +    
Sbjct: 136 IQYFMYHIL---LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189

Query: 201 ---HVSTRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLELITGR 243
              +V+ R      Y APE        T+  D++S G ++ E+   +
Sbjct: 190 KTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 20/204 (9%)

Query: 51  LLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRVHHKHLV 103
           LLG+G FG V     +     G+  A+K L+      + E      E  ++    H  L 
Sbjct: 12  LLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYLHEDC 162
           +L   +    +   V E+     L FHL  +   T +   R   A + SA  L YLH   
Sbjct: 69  ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER-ARFYGAEIVSA--LEYLHSR- 124

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAPEYASSG 221
              +++RDIK  N++LD     K+ DFGL K    ++   + +   GT  YLAPE     
Sbjct: 125 --DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
                 D +  GV++ E++ GR P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 81.4 bits (201), Expect = 4e-17
 Identities = 52/222 (23%), Positives = 101/222 (45%), Gaps = 47/222 (21%)

Query: 52  LGQGGFGYVHRGV---LPNGKEVAIKQLKAGSGQGEREFQA--EVEIISRVHHKHLVSLV 106
           +G+G +G+V++       + K+ A+KQ++           A  E+ ++  + H +++SL 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQ 84

Query: 107 GYYTAGSQR--MLVYEFVPN---NTLEFHLHGKGRPTMDWLTRLKIA------LGSAKGL 155
             + + + R   L++++  +   + ++FH   K       L R  +       L    G+
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL---DGI 141

Query: 156 AYLHEDCHPKIIHRDIKAANILLDFKFEA----KVADFGLAKIASD---VNTHVSTRVMG 208
            YLH +    ++HRD+K ANIL+  +       K+AD G A++ +        +   V+ 
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 197

Query: 209 TFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELITGR 243
           TF Y APE       Y      T+  D+++ G +  EL+T  
Sbjct: 198 TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 65/259 (25%), Positives = 107/259 (41%), Gaps = 76/259 (29%)

Query: 23  PGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSG 81
             +   F      YE+LA+          +GQG FG V +      G++VA+K++   + 
Sbjct: 6   DSVECPFCDEVSKYEKLAK----------IGQGTFGEVFKARHRKTGQKVALKKVLMEN- 54

Query: 82  QGERE---FQA--EVEIISRVHHKHLVSLVG--------YYTAGSQRMLVYEFVPNNTLE 128
             E+E     A  E++I+  + H+++V+L+         Y        LV++F      E
Sbjct: 55  --EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CE 107

Query: 129 FHLHGKGRPTMDWLTRLKIALGSA----------KGLAYLHEDCHPKIIHRDIKAANILL 178
             L G        L+ + +    +           GL Y+H +   KI+HRD+KAAN+L+
Sbjct: 108 HDLAG-------LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLI 157

Query: 179 DFKFEAKVADFGLAKIASDVN-------THVSTRVMGTFGYLAPE-------YASSGKLT 224
                 K+ADFGLA+  S          T+   RV+ T  Y  PE       Y       
Sbjct: 158 TRDGVLKLADFGLARAFSLAKNSQPNRYTN---RVV-TLWYRPPELLLGERDY------G 207

Query: 225 EKSDVFSFGVMLLELITGR 243
              D++  G ++ E+ T  
Sbjct: 208 PPIDLWGAGCIMAEMWTRS 226

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 66/246 (26%), Positives = 108/246 (43%), Gaps = 29/246 (11%)

Query: 12  SGSEAPLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYV----HRGVLPN 67
             +  P PPP+P   +    S+      A+ +D F    ++G+G FG V    H+     
Sbjct: 10  LMNANPAPPPAPSQQINLGPSS---NPHAKPSD-FHFLKVIGKGSFGKVLLARHKA---E 62

Query: 68  GKEVAIKQLKAGSGQGEREF---QAEVEIISR-VHHKHLVSLVGYYTAGSQRML--VYEF 121
               A+K L+  +   ++E     +E  ++ + V H  LV L  +++  +   L  V ++
Sbjct: 63  EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL--HFSFQTADKLYFVLDY 120

Query: 122 VPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYLHEDCHPKIIHRDIKAANILLDF 180
           +    L +HL  +         R   A + SA  L YLH      I++RD+K  NILLD 
Sbjct: 121 INGGELFYHLQRERCFLEPR-ARFYAAEIASA--LGYLHSL---NIVYRDLKPENILLDS 174

Query: 181 KFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 239
           +    + DFGL K   ++  + +T    GT  YLAPE           D +  G +L E+
Sbjct: 175 QGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEM 232

Query: 240 ITGRRP 245
           + G  P
Sbjct: 233 LYGLPP 238

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 56/264 (21%), Positives = 98/264 (37%), Gaps = 73/264 (27%)

Query: 28  GFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE 86
           G   S+  Y               LG G FG V     + +GK  A+K++       +  
Sbjct: 1   GLETSSKKYSLG----------KTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPR 45

Query: 87  FQA-EVEIISRVHHKHLVSLVGYYTAGSQRM----------------------------- 116
           ++  E++I+  + H +++ LV Y+                                    
Sbjct: 46  YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIV 105

Query: 117 ---------LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS---AKGLAYLHEDCHP 164
                    ++ E+VP+ TL   L    R     +    I++      + + ++H     
Sbjct: 106 NPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRS-IPMNLISIYIYQLFRAVGFIH---SL 160

Query: 165 KIIHRDIKAANILLDFK-FEAKVADFGLAKIAS--DVNTH-VSTRVMGTFGYLAPE-YAS 219
            I HRDIK  N+L++ K    K+ DFG AK     + +   + +R      Y APE    
Sbjct: 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLG 215

Query: 220 SGKLTEKSDVFSFGVMLLELITGR 243
           + + T   D++S G +  ELI G+
Sbjct: 216 ATEYTPSIDLWSIGCVFGELILGK 239

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 50/217 (23%), Positives = 92/217 (42%), Gaps = 35/217 (16%)

Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHK 100
            D +     LG+G +  V   + + N ++V +K LK      +++ + E++I+  +    
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91

Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA------LGSAKG 154
           ++++L         R     F   N  +F            LT   I       L   K 
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQL------YQTLTDYDIRFYMYEIL---KA 142

Query: 155 LAYLHEDCHPK-IIHRDIKAANILLDFKF-EAKVADFGLAKIASDV---NTHVSTRVMGT 209
           L Y    CH   I+HRD+K  N+++D +  + ++ D+GLA+        N  V++R    
Sbjct: 143 LDY----CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY--- 195

Query: 210 FGYLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRP 245
             +  PE     ++ + S D++S G ML  +I  + P
Sbjct: 196 --FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 52/218 (23%), Positives = 85/218 (38%), Gaps = 36/218 (16%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEI-------------ISR 96
            LG G F  V     + N   VA+K ++      E    AE EI                
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNTKEDS 82

Query: 97  VHHKHLVSLVGY-YTAGSQRM---LVYEFVPNNTLEFHLHGKGRP-TMDWLTRLKIALGS 151
           +   H++ L+ +    G   +   +V+E +  N L      + R   +    + +I+   
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI-YVK-QISKQL 140

Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLD------FKFEAKVADFGLAKIASDVNTHVSTR 205
             GL Y+H  C   IIH DIK  N+L++         + K+AD G    A   + H +  
Sbjct: 141 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLG---NACWYDEHYTNS 195

Query: 206 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 243
           +     Y +PE          +D++S   ++ ELITG 
Sbjct: 196 IQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 42/221 (19%)

Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA---------EVE 92
              +     +G G +G V   +   +G++VAIK+L        R FQ+         E+ 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEIFAKRAYRELL 75

Query: 93  IISRVHHKHLVSLVGYYTAGSQRM------LVYEFVPNNTLEFHLHG--KGRPTMDWLTR 144
           ++  + H++++ L+  +T  S         LV  F     ++  L      + + + +  
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEEKIQY 130

Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH-VS 203
           L   +   KGL Y+H      ++HRD+K  N+ ++   E K+ DFGLA+ A    T  V 
Sbjct: 131 LVYQM--LKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV 185

Query: 204 TRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGR 243
           TR      Y APE   S     +  D++S G ++ E++TG+
Sbjct: 186 TRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 78.9 bits (194), Expect = 6e-16
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 19/204 (9%)

Query: 51  LLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRV-HHKHL 102
           +LG+G FG V     +G     +  A+K LK      + +      E  +++       L
Sbjct: 348 VLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
             L   +    +   V E+V    L +H+   GR           A   A GL +L    
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-HAVFYAA-EIAIGLFFLQSK- 461

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAPEYASSG 221
              II+RD+K  N++LD +   K+ADFG+ K   ++   V+T+   GT  Y+APE  +  
Sbjct: 462 --GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQ 517

Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
              +  D ++FGV+L E++ G+ P
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAP 541

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 77.8 bits (192), Expect = 6e-16
 Identities = 69/252 (27%), Positives = 109/252 (43%), Gaps = 59/252 (23%)

Query: 19  PPPSPGLSLGFSKSTF---TYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIK 74
           PPP+     GF +       +E  A     + D   +G G +G V   V    G +VAIK
Sbjct: 4   PPPARS---GFYRQEVTKTAWEVRAV----YRDLQPVGSGAYGAVCSAVDGRTGAKVAIK 56

Query: 75  QLKAGSGQGEREFQA---------EVEIISRVHHKHLVSLVGYYTAGSQRM------LVY 119
           +L        R FQ+         E+ ++  + H++++ L+  +T            LV 
Sbjct: 57  KL-------YRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 109

Query: 120 EFVPNNTLEFHLHGKGRPTMDWLTRLKI------ALGSAKGLAYLHEDCHPKIIHRDIKA 173
            F     +   L    +   + L   +I       L   KGL Y+H      IIHRD+K 
Sbjct: 110 PF-----MGTDLGKLMK--HEKLGEDRIQFLVYQML---KGLRYIHA---AGIIHRDLKP 156

Query: 174 ANILLDFKFEAKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFS 231
            N+ ++   E K+ DFGLA+ A    T +V TR      Y APE   +  + T+  D++S
Sbjct: 157 GNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWS 211

Query: 232 FGVMLLELITGR 243
            G ++ E+ITG+
Sbjct: 212 VGCIMAEMITGK 223

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 77.3 bits (191), Expect = 8e-16
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 21/205 (10%)

Query: 51  LLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRV-HHKHL 102
           +LG+G FG V     +G     +  A+K LK      + +      E  +++       L
Sbjct: 27  VLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYLHED 161
             L   +    +   V E+V    L +H+   GR           A +     L +L   
Sbjct: 84  TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH-AVFYAAEIAIG--LFFLQSK 140

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAPEYASS 220
               II+RD+K  N++LD +   K+ADFG+ K   ++   V+T+   GT  Y+APE  + 
Sbjct: 141 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAY 195

Query: 221 GKLTEKSDVFSFGVMLLELITGRRP 245
               +  D ++FGV+L E++ G+ P
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAP 220

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 26/211 (12%)

Query: 51  LLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREF----QAEVEIISRV-HHKH 101
           +LG G +G V           GK  A+K LK  +   + +     + E +++  +     
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 102 LVSLVGYYTAGSQRML--VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYL 158
           LV+L  +Y   ++  L  + +++    L  HL  + R T     ++ +  +  A  L +L
Sbjct: 121 LVTL--HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-VQIYVGEIVLA--LEHL 175

Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE-- 216
           H+     II+RDIK  NILLD      + DFGL+K      T  +    GT  Y+AP+  
Sbjct: 176 HKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232

Query: 217 -YASSGKLTEKS-DVFSFGVMLLELITGRRP 245
               SG   +K+ D +S GV++ EL+TG  P
Sbjct: 233 RGGDSGH--DKAVDWWSLGVLMYELLTGASP 261

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 59/229 (25%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA---------EVEIIS 95
           +++ + +G+G +G V       N   VAIK++          F+          E++I+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIKILL 80

Query: 96  RVHHKHLVSLVGYYTAGSQRM-----LVYEFVPNNTLEFHLHG--KGRPTMDWLTRLKI- 147
           R  H++++ +     A +        +V +      +E  L+   K +     L+   I 
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQH----LSNDHIC 131

Query: 148 -----ALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH- 201
                 L   +GL Y+H      ++HRD+K +N+LL+   + K+ DFGLA++A   + H 
Sbjct: 132 YFLYQIL---RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

Query: 202 ------VSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGR 243
                 V+TR      Y APE   +S   T+  D++S G +L E+++ R
Sbjct: 186 GFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 21/205 (10%)

Query: 51  LLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRV-HHKHL 102
           ++G+G +  V     +      +  A+K +K      + +    Q E  +  +  +H  L
Sbjct: 16  VIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYLHED 161
           V L   +   S+   V E+V    L FH+  + +   +   R   A +  A  L YLHE 
Sbjct: 73  VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAEISLA--LNYLHER 129

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAPEYASS 220
               II+RD+K  N+LLD +   K+ D+G+ K    +    +T    GT  Y+APE    
Sbjct: 130 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRG 184

Query: 221 GKLTEKSDVFSFGVMLLELITGRRP 245
                  D ++ GV++ E++ GR P
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSP 209

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 39/214 (18%)

Query: 51  LLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRV-HHKHL 102
           +LG+G FG V     +      +  AIK LK      + +      E  ++S    H  L
Sbjct: 24  MLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLK-----IALGSAKGLAY 157
             +   +        V E++    L +H+    +  +    R       I LG    L +
Sbjct: 81  THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---RATFYAAEIILG----LQF 133

Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--IASDVNTHVSTRVMGTF-G--- 211
           LH      I++RD+K  NILLD     K+ADFG+ K  +  D  T+       TF G   
Sbjct: 134 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN-------TFCGTPD 183

Query: 212 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           Y+APE     K     D +SFGV+L E++ G+ P
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 61/252 (24%), Positives = 104/252 (41%), Gaps = 26/252 (10%)

Query: 9   SNYSGSEAPLPPPSPGLSLGFSKSTFTYEELARATDGFS--DANLL---GQGGFGYV--- 60
            +   +E      + G  +   K      E  +A+      D +LL   G+G +  V   
Sbjct: 12  YDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLV 71

Query: 61  -HRGVLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRV-HHKHLVSLVGYYTAGSQR 115
             +      +  A++ +K      + +    Q E  +  +  +H  LV L   +   S+ 
Sbjct: 72  RLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128

Query: 116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYLHEDCHPKIIHRDIKAA 174
             V E+V    L FH+  + +   +   R   A +  A  L YLHE     II+RD+K  
Sbjct: 129 FFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAEISLA--LNYLHER---GIIYRDLKLD 182

Query: 175 NILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAPEYASSGKLTEKSDVFSFG 233
           N+LLD +   K+ D+G+ K    +    +T    GT  Y+APE           D ++ G
Sbjct: 183 NVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG 240

Query: 234 VMLLELITGRRP 245
           V++ E++ GR P
Sbjct: 241 VLMFEMMAGRSP 252

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 75.7 bits (186), Expect = 4e-15
 Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 39/220 (17%)

Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA---------EVE 92
              + +   +G G  G V         + VAIK+L        R FQ          E+ 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELV 113

Query: 93  IISRVHHKHLVSLVGYYTAGSQRM------LVYEFVPNNTLEFHLHGKGRPTMDWLTRLK 146
           ++  V+HK+++SL+  +T            LV E      ++ +L    +  +D      
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMELDHERMSY 168

Query: 147 IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT---HVS 203
           +      G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A        +V 
Sbjct: 169 LLYQMLCGIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 225

Query: 204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 243
           TR      Y APE        E  D++S G ++ E++  +
Sbjct: 226 TRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 62/205 (30%), Positives = 90/205 (43%), Gaps = 21/205 (10%)

Query: 51  LLGQGGFGYV----HRGVLPNGKEVAIKQLKAGSGQGEREF---QAEVEIISRV-HHKHL 102
           +LG+G FG V     +     G   A+K LK      + +      E  I+S   +H  L
Sbjct: 30  VLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIA-LGSAKGLAYLHED 161
             L   +    +   V EFV    L FH+    R       R   A + SA  L +LH+ 
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR-ARFYAAEIISA--LMFLHDK 143

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVM-GTFGYLAPEYASS 220
               II+RD+K  N+LLD +   K+ADFG+ K    +   V+T    GT  Y+APE    
Sbjct: 144 ---GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQE 198

Query: 221 GKLTEKSDVFSFGVMLLELITGRRP 245
                  D ++ GV+L E++ G  P
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGHAP 223

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 74.3 bits (183), Expect = 9e-15
 Identities = 54/227 (23%), Positives = 89/227 (39%), Gaps = 59/227 (25%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA---------EVEIIS 95
           + +   +G G  G V         + VAIK+L        R FQ          E+ ++ 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-------SRPFQNQTHAKRAYRELVLMK 79

Query: 96  RVHHKHLVSLVGYYTAGSQRM------LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIAL 149
            V+HK+++ L+  +T            +V E      ++ +L             +++ L
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-----MDANLC----------QVIQMEL 124

Query: 150 GSA----------KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
                         G+ +LH      IIHRD+K +NI++      K+ DFGLA+ A    
Sbjct: 125 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181

Query: 200 T---HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 243
               +V TR      Y APE        E  D++S G ++ E+I G 
Sbjct: 182 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 53/227 (23%)

Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA---------EVE 92
            + + + + +G G +G V        G  VA+K+L        R FQ+         E+ 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80

Query: 93  IISRVHHKHLVSLVGYYTAGSQRM------LVYEFVPNNTLEFHLHG--KGRPTMDWLTR 144
           ++  + H++++ L+  +T            LV        +   L+   K +     LT 
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQK----LTD 131

Query: 145 LKIA------LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV 198
             +       L   +GL Y+H      IIHRD+K +N+ ++   E K+ DFGLA+  +D 
Sbjct: 132 DHVQFLIYQIL---RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185

Query: 199 NT-HVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGR 243
            T +V+TR      Y APE   +     +  D++S G ++ EL+TGR
Sbjct: 186 MTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 48/230 (20%), Positives = 89/230 (38%), Gaps = 46/230 (20%)

Query: 51  LLGQGGFGYVHRGVLPNGK------EVAIKQLKAGSGQGEREFQ-----AEVEIISRVHH 99
            +GQGGFG ++   + + +         +K   + +G    E +     A+ E I +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 100 KHLVSLVG---YYTAGSQ-------RMLVYEFV-PNNTLEFHLHGKGRPTMDWLTRLKIA 148
              +  +G   Y+ +G         R ++ +    +  L+       +      T L+++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSD--LQKIYEANAK-RFSRKTVLQLS 158

Query: 149 LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV--ADFGLAKIASDVNTHV---- 202
           L     L Y+HE      +H DIKA+N+LL++K   +V   D+GLA        H     
Sbjct: 159 LRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215

Query: 203 --STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRP 245
                  GT      E+ S         + + D+   G  +++ +TG  P
Sbjct: 216 DPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 56/283 (19%), Positives = 92/283 (32%), Gaps = 92/283 (32%)

Query: 21  PSPGLSLGFSKSTFT--YEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLK 77
           P     L   K+     Y+  ++         +LG G  G V +       ++ A+K L+
Sbjct: 2   PHVKSGLQIKKNAIIDDYKVTSQ---------VLGLGINGKVLQIFNKRTQEKFALKMLQ 52

Query: 78  AGSGQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR 136
                   + + EVE+  R     H+V +V           VYE +        +     
Sbjct: 53  D-----CPKARREVELHWRASQCPHIVRIVD----------VYENLYAGRKCLLI----- 92

Query: 137 PTMDWLT------RLKIALGS---------------AKGLAYLHEDCHPKIIHRDIKAAN 175
             M+ L       R+    G                 + + YLH      I HRD+K  N
Sbjct: 93  -VMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPEN 147

Query: 176 ILLDFKFEA---KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSF 232
           +L   K      K+ DFG AK              G   Y            +  D++S 
Sbjct: 148 LLYTSKRPNAILKLTDFGFAKE-----------TTGE-KY-----------DKSCDMWSL 184

Query: 233 GVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD 275
           GV++  L+ G  P      F  +  +  +  +  R I  G ++
Sbjct: 185 GVIMYILLCGYPP------FYSNHGLAISPGMKTR-IRMGQYE 220

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.5 bits (176), Expect = 6e-14
 Identities = 58/239 (24%), Positives = 97/239 (40%), Gaps = 66/239 (27%)

Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA---------EVE 92
           +  F   +LLG+G +G V      P G+ VAIK+++         F           E++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61

Query: 93  IISRVHHKHLVSLVGYYTAGSQRM-----LVYEFVPNNTLEFHLHG--KGRPTMDWLTRL 145
           I+    H++++++       S        ++ E      ++  LH     +     L+  
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQM----LSDD 112

Query: 146 KIA------LGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
            I       L   + +  LH      +IHRD+K +N+L++   + KV DFGLA+I  +  
Sbjct: 113 HIQYFIYQTL---RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166

Query: 200 T--------------HVSTRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLELITGR 243
                           V+TR      Y APE   +S K +   DV+S G +L EL   R
Sbjct: 167 ADNSEPTGQQSGMVEFVATR-----WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.8 bits (174), Expect = 9e-14
 Identities = 51/232 (21%), Positives = 89/232 (38%), Gaps = 56/232 (24%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA---------EVEIIS 95
           + D   LG GG G V   V     K VAIK++                      E++II 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIKIIR 63

Query: 96  RVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA--- 152
           R+ H ++V +         ++             ++    +  M+  T L   L      
Sbjct: 64  RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYI---VQEYME--TDLANVLEQGPLL 118

Query: 153 ------------KGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKIASDVN 199
                       +GL Y+H      ++HRD+K AN+ ++ +    K+ DFGLA+I     
Sbjct: 119 EEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175

Query: 200 TH-------VSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 243
           +H       + T+      Y +P    S    T+  D+++ G +  E++TG+
Sbjct: 176 SHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 43/229 (18%), Positives = 85/229 (37%), Gaps = 46/229 (20%)

Query: 52  LGQGGFGYVHRGV---------LPNGKEVAIKQLKAGSGQGEREF--------QAEVEII 94
             +   G ++             P  ++ ++K L A  G+   E           +V   
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 95  SRVHHKHLVSLVGYYTAGSQ----RMLVYEFV-PNNTLEFHLHGKGRPTMDWLTRLKIAL 149
            +++   L+++      G      R LV   +  +  L+  L    +  +   + L++A 
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRS--LQSALDVSPKHVLSERSVLQVAC 166

Query: 150 GSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV--ADFGLAKIASDVNTHVSTR-- 205
                L +LHE+     +H ++ A NI +D + +++V  A +G A        HV+    
Sbjct: 167 RLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223

Query: 206 ----VMGTFGYLAPEYAS----SGK-LTEKSDVFSFGVMLLELITGRRP 245
                 G       E+ S     G   + +SD+ S G  +L+ + G  P
Sbjct: 224 SRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 28/207 (13%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREF--QA--EVEIISRVHHK----- 100
           ++G+G FG V +       + VA+K ++      E+ F  QA  E+ I+  +  +     
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 101 -HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
            +++ ++  +T  +   + +E +  N  E     K +     L R K A    + L  LH
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVR-KFAHSILQCLDALH 217

Query: 160 EDCHPKIIHRDIKAANILL--DFKFEAKVADFGLAKIASD-VNTHVSTRVMGTFGYLAPE 216
           +    +IIH D+K  NILL    +   KV DFG +      V T++ +R    F Y APE
Sbjct: 218 K---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR----F-YRAPE 269

Query: 217 YASSGKLTEKSDVFSFGVMLLELITGR 243
                +     D++S G +L EL+TG 
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGY 296

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 54/228 (23%), Positives = 90/228 (39%), Gaps = 45/228 (19%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLK---AGSGQGEREFQ-----AEVEIISRVHHKH 101
            +G GGFG ++        ++ A   +K     +G    E +     A+ + I +   + 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 102 LVSLVG---YYTAGSQ-------RMLVYE-FVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
            +  +G   +Y +G         R +V E    +  L+      G       T L++ + 
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID--LQKISGQNGTFKKS--TVLQLGIR 159

Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV--ADFGLAKIASDVNTHV------ 202
               L Y+HE+     +H DIKAAN+LL +K   +V  AD+GL+        H       
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216

Query: 203 STRVMGTFGYLAPEYAS----SGK-LTEKSDVFSFGVMLLELITGRRP 245
                GT      E+ S     G  L+ +SDV   G  +L  + G+ P
Sbjct: 217 RKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 24/207 (11%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA---EVEIISRV------HH 99
           +L+G+G FG V +       + VAIK +K      +        EV ++  +        
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
            ++V L  ++   +   LV+E +  N  +   +   R     LTR K A      L +L 
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTR-KFAQQMCTALLFLA 174

Query: 160 EDCHPKIIHRDIKAANILL--DFKFEAKVADFGLAKIASD-VNTHVSTRVMGTFGYLAPE 216
                 IIH D+K  NILL    +   K+ DFG +      +  ++ +R    F Y +PE
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR----F-YRSPE 228

Query: 217 YASSGKLTEKSDVFSFGVMLLELITGR 243
                      D++S G +L+E+ TG 
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 49/209 (23%), Positives = 78/209 (37%), Gaps = 49/209 (23%)

Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA---------EVE 92
            D +   +L+G+G +GYV+        K VAIK++        R F+          E+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-------NRMFEDLIDCKRILREIT 77

Query: 93  IISRVHHKHLVSLVGYYTAGSQRM-----LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKI 147
           I++R+   +++ L                +V E       +  L          L +  I
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-----ADSDLKK--------LFKTPI 124

Query: 148 ALGSA----------KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KIAS 196
            L              G  ++HE     IIHRD+K AN LL+     KV DFGLA  I S
Sbjct: 125 FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181

Query: 197 DVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           + +T++   +               +LT 
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTS 210

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 65.6 bits (160), Expect = 9e-12
 Identities = 50/255 (19%), Positives = 84/255 (32%), Gaps = 54/255 (21%)

Query: 2   SSSGGSGSNYSGSEAPLPPPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVH 61
             + G+    SGS+          S   + S        +  D +   +L+G G +G+V 
Sbjct: 11  QHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVC 70

Query: 62  RGV-LPNGKEVAIKQLKAGSGQGEREFQA---------EVEIISRVHHKHLVSLVGYYTA 111
                   + VAIK++        R F+          E+ I++R++H H+V ++     
Sbjct: 71  EAYDKLEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIP 123

Query: 112 GSQRM-----LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA----------KGLA 156
                     +V E       +             L R  + L              G+ 
Sbjct: 124 KDVEKFDELYVVLEI-----ADSDFKK--------LFRTPVYLTELHIKTLLYNLLVGVK 170

Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG------TF 210
           Y+H      I+HRD+K AN L++     KV DFGLA+         S   +         
Sbjct: 171 YVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227

Query: 211 GYLAPEYASSGKLTE 225
                      +LT 
Sbjct: 228 VTFPHTKNLKRQLTG 242

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 55/257 (21%), Positives = 85/257 (33%), Gaps = 72/257 (28%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH--------HKHL 102
           LG G F  V     +   K VA+K +K+     E     E+ ++  V          + +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103

Query: 103 VSLVGYYT----AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
           V L+  +      G+   +V+E + ++ L++ +    +       + KI     +GL YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK-KIIQQVLQGLDYL 162

Query: 159 HEDCHPKIIHRDIKAANILLDF-------------------------------------- 180
           H  C   IIH DIK  NILL                                        
Sbjct: 163 HTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220

Query: 181 -----------KFEAKVADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSD 228
                      K + K+AD G A       T  + TR      Y + E          +D
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPAD 275

Query: 229 VFSFGVMLLELITGRRP 245
           ++S   M  EL TG   
Sbjct: 276 IWSTACMAFELATGDYL 292

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 49/213 (23%), Positives = 84/213 (39%), Gaps = 32/213 (15%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQ--LKAGSGQGEREFQAEVEIISRVHHKHLVSLVGY 108
           +G+G FG +  G  L N ++VAIK    ++ + Q   E++             + ++  +
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT---YKLLAGCTGIPNVYYF 74

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
              G   +LV + +  + LE  L   GR      T    A      +  +HE     +++
Sbjct: 75  GQEGLHNVLVIDLLGPS-LEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS---LVY 129

Query: 169 RDIKAANILLDFKFEAK-----VADFGLAKIASDVNT--HVSTR----VMGTFGYLAPEY 217
           RDIK  N L+            V DFG+ K   D  T  H+  R    + GT       Y
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT-----ARY 184

Query: 218 AS----SGK-LTEKSDVFSFGVMLLELITGRRP 245
            S     G+  + + D+ + G + +  + G  P
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 52/212 (24%), Positives = 80/212 (37%), Gaps = 30/212 (14%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT 110
           +G G FG +  G  L   + VAIK     S   +   +             +  +  +  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-YKQLGSGDGIPQVYYFGP 75

Query: 111 AGSQRMLVYEFV-PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            G    +V E + P+  LE       R T    T L IA+     + Y+H      +I+R
Sbjct: 76  CGKYNAMVLELLGPS--LEDLFDLCDR-TFSLKTVLMIAIQLISRMEYVHSKN---LIYR 129

Query: 170 DIKAANILL---DFKFEAKV--ADFGLAKIASDVNT--HVSTR----VMGTFGYLAPEYA 218
           D+K  N L+     K +  +   DF LAK   D  T  H+  R    + GT       Y 
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT-----ARYM 184

Query: 219 S----SGK-LTEKSDVFSFGVMLLELITGRRP 245
           S     GK  + + D+ + G M +  + G  P
Sbjct: 185 SINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 52/240 (21%), Positives = 98/240 (40%), Gaps = 64/240 (26%)

Query: 46  FSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA---------EVEIIS 95
           +     LG+G +G V + +    G+ VA+K++          FQ          E+ I++
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILT 63

Query: 96  RVH-HKHLVSLVGYYTAGSQR--MLVYEFVPNNTLEFHLHG--KGRPTMDWLTRLKI--- 147
            +  H+++V+L+    A + R   LV+++     +E  LH   +       L  +     
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDVYLVFDY-----METDLHAVIRANI----LEPVHKQYV 114

Query: 148 ---ALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST 204
               +   K + YLH      ++HRD+K +NILL+ +   KVADFGL++   ++    + 
Sbjct: 115 VYQLI---KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168

Query: 205 RVMGTFGYLAPEYASSGKLTE--------------------KS-DVFSFGVMLLELITGR 243
             +               LT+                    K  D++S G +L E++ G+
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.9 bits (144), Expect = 4e-10
 Identities = 48/320 (15%), Positives = 80/320 (25%), Gaps = 79/320 (24%)

Query: 30  SKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQL--------KAGSG 81
            K    +      T+       +G+G FG V + +  +   VAIK +             
Sbjct: 7   QKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQ 64

Query: 82  QGEREFQAEVEIISRVHH--------------------------KHLVSLVGYYTA---- 111
           +   E   E+ I   +                              L+    +Y +    
Sbjct: 65  KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124

Query: 112 ---------GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
                      Q  +V EF         L           T   I       LA      
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASL 181

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAP--EYASS 220
                HRD+   N+LL      K+      K          +  + + G      +Y  S
Sbjct: 182 R--FEHRDLHWGNVLLKKTSLKKLHYTLNGK----------SSTIPSCGLQVSIIDYTLS 229

Query: 221 GKLTEKSDVFSFGVMLLELITGRRP-------------VDSTHTFVEDSLVDWARPLLNR 267
               +   VF    M  +L TG                 +    +   S V W   L ++
Sbjct: 230 RLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDK 289

Query: 268 AIEDGNFDTLVDPKLHNEYN 287
            ++   F T  +     +  
Sbjct: 290 MLKQMTFKTKCNTPAMKQIK 309

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 22/207 (10%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHH-KHLVSLVGYY 109
           +G G FG ++ G  +  G+EVAIK     +     +   E +I   +     + ++    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 110 TAGSQRMLVYEFV-PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
             G   ++V E + P+  LE   +   R      T L +A      + Y+H       IH
Sbjct: 75  AEGDYNVMVMELLGPS--LEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN---FIH 128

Query: 169 RDIKAANILLDFKFEAK---VADFGLAK--IASDVNTHVSTR----VMGTFGYLAPEYAS 219
           RD+K  N L+    +     + DFGLAK    +  + H+  R    + GT  Y A     
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-ASINTH 187

Query: 220 SGK-LTEKSDVFSFGVMLLELITGRRP 245
            G   + + D+ S G +L+    G  P
Sbjct: 188 LGIEQSRRDDLESLGYVLMYFNLGSLP 214

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 51/229 (22%), Positives = 83/229 (36%), Gaps = 56/229 (24%)

Query: 51  LLGQGGFGYVHRGV--LPNGKEVAIKQLKAGSGQGEREFQA---EVEIISRVHHK----- 100
            LG+G FG V   +       +VA+K ++       +  +A   E+ ++ ++  K     
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENK 81

Query: 101 -HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
              V +  ++       + +E +  NT EF      +P      R  +A      L +LH
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR-HMAYQLCHALRFLH 140

Query: 160 EDCHPKIIHRDIKAANILL-------------------DFKFEAKVADFGLAKIASD-VN 199
           E    ++ H D+K  NIL                          +VADFG A    +   
Sbjct: 141 E---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHT 197

Query: 200 THVSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELITG 242
           T V+TR      Y  PE      +       +  DV+S G +L E   G
Sbjct: 198 TIVATRH-----YRPPEVILELGW------AQPCDVWSIGCILFEYYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 55.7 bits (135), Expect = 9e-09
 Identities = 56/232 (24%), Positives = 92/232 (39%), Gaps = 62/232 (26%)

Query: 51  LLGQGGFGYV-----HRGVLPNGKEVAIKQLKAGSGQGEREFQA---EVEIISRVHHK-- 100
            LG+G FG V     H+     G+ VA+K +K      +R  +A   E++++  ++    
Sbjct: 21  TLGEGAFGKVVECIDHKA---GGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDP 73

Query: 101 ----HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLA 156
                 V ++ ++       +V+E +  +T +F       P      R K+A    K + 
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIR-KMAYQICKSVN 132

Query: 157 YLHEDCHPKIIHRDIKAANILLD-------------------FKFEAKVADFGLAKIASD 197
           +LH     K+ H D+K  NIL                        + KV DFG A    +
Sbjct: 133 FLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189

Query: 198 -VNTHVSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELITG 242
             +T VSTR      Y APE      +      ++  DV+S G +L+E   G
Sbjct: 190 HHSTLVSTRH-----YRAPEVILALGW------SQPCDVWSIGCILIEYYLG 230

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 20/206 (9%)

Query: 52  LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY- 109
           +G G FG ++ G  +   +EVAIK     +     +   E +I   +     +  V ++ 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
             G   +LV + +  + LE   +   R  +   T L +A      + ++H       +HR
Sbjct: 73  VEGDYNVLVMDLLGPS-LEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS---FLHR 127

Query: 170 DIKAANILLDFKFEAK---VADFGLAKIASDVNT--HVSTR----VMGTFGYLAPEYASS 220
           DIK  N L+     A    + DFGLAK   D +T  H+  R    + GT  Y A      
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASVNTHL 186

Query: 221 GK-LTEKSDVFSFGVMLLELITGRRP 245
           G   + + D+ S G +L+  + G  P
Sbjct: 187 GIEQSRRDDLESLGYVLMYFLRGSLP 212

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 50/233 (21%), Positives = 85/233 (36%), Gaps = 60/233 (25%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQA---EVEIISRV-----HHKH 101
            +G G FG V     + N K  A+K ++      ++  ++   E +I+ ++     ++ +
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNN 97

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
           +V   G +       L++E +  +  E               +    +   K L YL + 
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIK-LYCIEILKALNYLRKM 156

Query: 162 CHPKIIHRDIKAANILL-------------------------DFKFEAKVADFGLAKIAS 196
               + H D+K  NILL                               K+ DFG A   S
Sbjct: 157 ---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213

Query: 197 D-VNTHVSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELITG 242
           D   + ++TR      Y APE      +         SD++SFG +L EL TG
Sbjct: 214 DYHGSIINTR----Q-YRAPEVILNLGW------DVSSDMWSFGCVLAELYTG 255

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 3e-05
 Identities = 48/381 (12%), Positives = 101/381 (26%), Gaps = 97/381 (25%)

Query: 29  FSKSTFT----YEELARATDGFSDANLL---GQGGFGYVHRGVLPNGKEV-AIKQLKAGS 80
           F+K   +    Y +L +A      A  +   G  G G          K   A+    +  
Sbjct: 126 FAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG----------KTWVALDVCLSYK 175

Query: 81  GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMD 140
            Q + +F+        +          +    +             L + +        D
Sbjct: 176 VQCKMDFK--------IF---------WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD 218

Query: 141 WLTRLKIALGSAKG--LAYLHEDCHPK--IIHRDIKAANILLDFKFEAKVADFGLAKIAS 196
             + +K+ + S +      L    +    ++  +++ A     F    K+    L     
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI----L----- 269

Query: 197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSF--GVMLLELITGRRPVDSTHTFVE 254
                ++TR      +L+    +   L   S   +      LL      RP D      E
Sbjct: 270 -----LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR---E 321

Query: 255 DSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQ 314
               +   P     +      +++   + +     +  + V C    +         +  
Sbjct: 322 VLTTN---PR---RL------SIIAESIRDGLATWDNWKHVNCDK--LTTI------IES 361

Query: 315 IVRALEGD------ASLADLNEGIR-PGQSSVYGSY--GSSDYDTMQYNEDLKKFRKMAL 365
            +  LE          L+        P  + +           D M     + K  K +L
Sbjct: 362 SLNVLEPAEYRKMFDRLSVFPPSAHIP--TILLSLIWFDVIKSDVM---VVVNKLHKYSL 416

Query: 366 NSQEYSASSEYSRPTSEYGLY 386
             ++    S  S       +Y
Sbjct: 417 -VEKQPKESTISI----PSIY 432

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	416
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.7
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.44
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.12
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.1
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.8
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.75
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.72
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.64
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.55
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.45
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.23
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.2
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.03
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.94
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.91
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.88
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.74
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.5
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.49
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.49
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.32
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.31
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.08
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.07
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.88
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.62
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.13
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.65
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.86
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.63

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.1e-56  Score=429.29  Aligned_cols=256  Identities=25%  Similarity=0.419  Sum_probs=214.3

Q ss_pred             CCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ++|.+.+.||+|+||.||+|.+.      +++.||||+++.......++|.+|+.++++++|||||+++++|.+....+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56788899999999999999863      478899999987766666789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEE
Q 014904          118 VYEFVPNNTLEFHLHGKG-----------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV  186 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl  186 (416)
                      ||||+++|+|.++|+..+           ...++|..++.|+.|+|.||+|||+.   +||||||||+||||+.++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence            999999999999997532           34699999999999999999999999   9999999999999999999999


Q ss_pred             eecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHH
Q 014904          187 ADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPL  264 (416)
Q Consensus       187 ~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~  264 (416)
                      +|||+++........ ......||+.|+|||++.++.++.++|||||||+||||+| |+.||.....   ..+.      
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~------  240 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVI------  240 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHH------
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH------
Confidence            999999866543332 2334679999999999999999999999999999999999 9999976442   1111      


Q ss_pred             hHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          265 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       265 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                        ..+..+....         .+..++..+.+++.+||+.+|++||+|.||++.|+..
T Consensus       241 --~~i~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          241 --ECITQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             --HHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              1222333211         1223446789999999999999999999999999854

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.7e-55  Score=431.10  Aligned_cols=256  Identities=27%  Similarity=0.422  Sum_probs=207.5

Q ss_pred             CCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ++|.+.+.||+|+||.||+|.+.      +++.||||+++.......++|.+|+.++++++|||||+++++|.+....+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46777889999999999999864      478999999987766666789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCce
Q 014904          118 VYEFVPNNTLEFHLHGKG-------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA  184 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~  184 (416)
                      ||||+++|+|.++++...             ...++|.+++.|+.|+|.||+|||+.   +||||||||+||||+.++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence            999999999999997542             23599999999999999999999998   99999999999999999999


Q ss_pred             EEeecccceeccCCC-cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhh
Q 014904          185 KVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWAR  262 (416)
Q Consensus       185 kl~DFGla~~~~~~~-~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~  262 (416)
                      ||+|||+++...... ....+...||+.|+|||++.+..++.++|||||||+||||+| |+.||.....   ..+.    
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~----  270 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAI----  270 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHH----
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHH----
Confidence            999999998764433 233355789999999999999999999999999999999999 9999976442   1111    


Q ss_pred             HHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          263 PLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       263 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                          ..+..+.-     +    ..+..++..+.+|+.+||+.||++||+|.||++.|+..
T Consensus       271 ----~~i~~g~~-----~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l  317 (329)
T 4aoj_A          271 ----DCITQGRE-----L----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL  317 (329)
T ss_dssp             ----HHHHHTCC-----C----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----HHHHcCCC-----C----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence                11222321     1    11223446789999999999999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.1e-56  Score=430.52  Aligned_cols=254  Identities=25%  Similarity=0.403  Sum_probs=211.4

Q ss_pred             CCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      .+++.+.||+|+||.||+|.+.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+....+|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4566789999999999999862      46899999997543 3345789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc
Q 014904          118 VYEFVPNNTLEFHLHGKG--------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE  183 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~  183 (416)
                      ||||+++|+|.++|+...              ...++|..++.|+.|+|.||+|||+.   +||||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence            999999999999996532              23589999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccceeccCCC-cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhh
Q 014904          184 AKVADFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWA  261 (416)
Q Consensus       184 ~kl~DFGla~~~~~~~-~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~  261 (416)
                      +||+|||+++...... ....+...||+.|+|||++.++.++.++|||||||+||||+| |+.||.....   ..+.   
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~---  257 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVV---  257 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHH---
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHH---
Confidence            9999999998664432 233455689999999999999999999999999999999999 8999976543   1222   


Q ss_pred             hHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          262 RPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       262 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                           ..+..+...         ..+.+++..+.+++.+||+.+|.+||+|.||++.|+.
T Consensus       258 -----~~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          258 -----EMIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             -----HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             -----HHHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                 222333321         1223345678999999999999999999999999984

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-54  Score=418.73  Aligned_cols=257  Identities=29%  Similarity=0.493  Sum_probs=204.1

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .++|.+.+.||+|+||+||+|.+.+  .||||+++....  ...+.|.+|+.++++++|||||+++++|.+ +..+||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            4678888999999999999999743  599999975432  334679999999999999999999999865 56899999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC-
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN-  199 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~-  199 (416)
                      |+++|+|.++|+.... .++|..++.|+.|+|.||+|||+.   +||||||||+||||+.++.+||+|||+|+...... 
T Consensus       112 y~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          112 WCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CCSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             cCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            9999999999976543 699999999999999999999998   99999999999999999999999999998765432 


Q ss_pred             cceeecccccccccChhhhcc---CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          200 THVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~---~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      ........||+.|+|||++.+   +.++.++|||||||+||||+||+.||......  ..+        ...+..+.   
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~--------~~~~~~~~---  254 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQI--------IFMVGRGY---  254 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHH--------HHHHHTTC---
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHH--------HHHHhcCC---
Confidence            233455789999999999963   46999999999999999999999999764431  111        11112221   


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                       ..|.+ ...+.+++..+.+|+.+||+.+|++||+|.||++.|+.
T Consensus       255 -~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~  297 (307)
T 3omv_A          255 -ASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL  297 (307)
T ss_dssp             -CCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred             -CCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence             11211 12233455688999999999999999999999999874

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.8e-54  Score=422.59  Aligned_cols=251  Identities=21%  Similarity=0.357  Sum_probs=206.6

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++.....  ...+.+.+|+.++++++|||||++++++.+....||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            37899999999999999999995 5799999999986543  23457899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++|+|.++|.......+++..++.|+.|++.||.|||+.   +||||||||+||||+.++.+||+|||+++......
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            999999999999876666789999999999999999999999   99999999999999999999999999998764322


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                       ...+..+||+.|+|||++.+..++.++|||||||+||||+||+.||.....      .+.    + ..+..+.+..   
T Consensus       180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~----~-~~i~~~~~~~---  244 (350)
T 4b9d_A          180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNL----V-LKIISGSFPP---  244 (350)
T ss_dssp             -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHH----H-HHHHHTCCCC---
T ss_pred             -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHH----H-HHHHcCCCCC---
Confidence             223456899999999999999999999999999999999999999976543      111    1 1122333221   


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                        +..    .....+.+|+.+||+.||++||++.|+++
T Consensus       245 --~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          245 --VSL----HYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             --CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCc----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              112    23357889999999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.7e-53  Score=416.65  Aligned_cols=249  Identities=23%  Similarity=0.359  Sum_probs=210.2

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      ..|...+.||+|+||.||+|.+ .+|+.||||++........+.+.+|+.+++.++|||||++++++.+.+..||||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            4699999999999999999996 479999999998665555567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++|+|.+++...   .+++..+..|+.|++.||+|||+.   +||||||||+||||+.++.+||+|||+++........ 
T Consensus       154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-  226 (346)
T 4fih_A          154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-  226 (346)
T ss_dssp             TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-
T ss_pred             CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-
Confidence            999999999753   589999999999999999999999   9999999999999999999999999999977554332 


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      .+..+||+.|+|||++.+..|+.++|||||||+||||++|+.||......   .+.        ..+..+....+     
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~--------~~i~~~~~~~~-----  290 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAM--------KMIRDNLPPRL-----  290 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH--------HHHHHSSCCCC-----
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHH--------HHHHcCCCCCC-----
Confidence            34578999999999999999999999999999999999999999765431   111        11112211111     


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                        .........+.+|+.+||+.||++||++.|+++
T Consensus       291 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          291 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              111223457889999999999999999999886

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.6e-54  Score=415.31  Aligned_cols=270  Identities=23%  Similarity=0.325  Sum_probs=204.8

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCC----eEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGS----QRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~  119 (416)
                      ++|.+.+.||+|+||.||+|.+ +|+.||||+++.... ....+..|+.++.+++|||||+++++|.+..    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4677889999999999999998 689999999975321 1122334666667889999999999998753    579999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC-----HPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-----~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      ||+++|+|.++++..   .++|..+++|+.|++.||+|||+.+     .++||||||||+||||+.++.+||+|||+++.
T Consensus        81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            999999999999764   5999999999999999999999863     45899999999999999999999999999987


Q ss_pred             ccCCCcce---eecccccccccChhhhccC------CCCchhhhHhHHHHHHHHHhCCCCCCCCCcc----cchhhhhhh
Q 014904          195 ASDVNTHV---STRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVMLLELITGRRPVDSTHTF----VEDSLVDWA  261 (416)
Q Consensus       195 ~~~~~~~~---~~~~~gt~~YlaPE~~~~~------~~t~ksDV~SlGvvL~elltG~~pf~~~~~~----~~~~l~~~~  261 (416)
                      ........   ....+||+.|+|||++.+.      .++.++|||||||+||||+||+.||......    .+.....+.
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            75543322   2346799999999999754      4678999999999999999999887643321    111111111


Q ss_pred             hHHhHHhhhcCCcccccCccccCcC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          262 RPLLNRAIEDGNFDTLVDPKLHNEY-NHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       262 ~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      ...+...+..+.    .+|.+.... +.+.+..+.+++.+||+.||++||||.||++.|+..
T Consensus       238 ~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          238 VEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             HHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            111112222222    233333222 345677899999999999999999999999999753

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.6e-53  Score=411.02  Aligned_cols=247  Identities=23%  Similarity=0.343  Sum_probs=209.0

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.++||+|+||+||+|.. .+|+.||||++....   ....+.+.+|+.++++++|||||++++++.+....||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999995 579999999997532   233467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++|+|.+++...+  .+++..+..++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+|+......
T Consensus       112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            9999999999997654  599999999999999999999999   99999999999999999999999999999875433


Q ss_pred             c-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          200 T-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       200 ~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      . ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.   ..        +...+..+.+.   
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~--------~~~~i~~~~~~---  252 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GL--------IFAKIIKLEYD---  252 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------HHHHHHHTCCC---
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HH--------HHHHHHcCCCC---
Confidence            2 334567899999999999999999999999999999999999999976442   11        11122233321   


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIV  316 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv  316 (416)
                         +...    ....+.+|+.+||+.||.+||++.|++
T Consensus       253 ---~p~~----~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          253 ---FPEK----FFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ---CCTT----CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ---CCcc----cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence               1122    234688999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.9e-52  Score=418.17  Aligned_cols=249  Identities=23%  Similarity=0.353  Sum_probs=211.0

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      +.|...+.||+|+||.||+|.+ .+|+.||||++........+.+.+|+.+++.++|||||++++++.+.+..|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            4699999999999999999996 469999999998766666667899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++|+|.+++...   .+++..+..|+.|++.||+|||+.   +||||||||+||||+.++.+||+|||+++........ 
T Consensus       231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-  303 (423)
T 4fie_A          231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-  303 (423)
T ss_dssp             TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-
T ss_pred             CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-
Confidence            999999999754   489999999999999999999999   9999999999999999999999999999877554332 


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.......   +.        ..+..+....+.    
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~--------~~i~~~~~~~~~----  368 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AM--------KMIRDNLPPRLK----  368 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH--------HHHHHSCCCCCS----
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HH--------HHHHcCCCCCCc----
Confidence            345789999999999999999999999999999999999999997654311   11        111222111111    


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                         ........+.+|+.+||+.||++||++.|+++
T Consensus       369 ---~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 ---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             ---CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               11123357889999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.4e-53  Score=412.24  Aligned_cols=252  Identities=21%  Similarity=0.233  Sum_probs=206.2

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ..+.|.+.++||+|+||.||+|.+ .+|+.||||+++....     +.+|+.++++++|||||++++++.++...+||||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            345678888999999999999995 4699999999986432     2469999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC-ceEEeecccceeccCCC
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKIASDVN  199 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~-~~kl~DFGla~~~~~~~  199 (416)
                      |+++++|.+++...+  .+++..+..++.|++.||+|||+.   +||||||||+||||+.++ .+||+|||+++......
T Consensus       131 y~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          131 LLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             ccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999999999997654  599999999999999999999999   999999999999999987 59999999998765432


Q ss_pred             cc----eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          200 TH----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       200 ~~----~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ..    ....++||+.|+|||++.+..++.++|||||||+||||+||+.||........          +. .+..+...
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----------~~-~i~~~~~~  274 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL----------CL-KIASEPPP  274 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC----------HH-HHHHSCCG
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----------HH-HHHcCCCC
Confidence            21    12346799999999999999999999999999999999999999976543111          11 11111110


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                             ....+......+.+++.+||+.||.+||++.||++.|..
T Consensus       275 -------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          275 -------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             -------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence                   011223344678899999999999999999999998864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.7e-53  Score=415.48  Aligned_cols=264  Identities=27%  Similarity=0.383  Sum_probs=214.6

Q ss_pred             HHHHHhhCCCCcCceecccCcEEEEEEEeCC------CcEEEEEEeecCCccc-HHHHHHHHHHHHhcCC-CcccceEEE
Q 014904           37 EELARATDGFSDANLLGQGGFGYVHRGVLPN------GKEVAIKQLKAGSGQG-EREFQAEVEIISRVHH-KHLVSLVGY  108 (416)
Q Consensus        37 ~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h-~niv~l~~~  108 (416)
                      .+.+--.++|.+.+.||+|+||.||+|.+..      ++.||||+++...... .+.|.+|+.++.++.| ||||+++++
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            3334456789999999999999999998532      3689999998654433 4579999999999965 999999999


Q ss_pred             EEeC-CeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccC
Q 014904          109 YTAG-SQRMLVYEFVPNNTLEFHLHGKG--------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKA  173 (416)
Q Consensus       109 ~~~~-~~~~lV~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp  173 (416)
                      |.+. ...+|||||+++|+|.++|+...              ...++|..++.|+.|+|+||+|||+.   +||||||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~  213 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA  213 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCc
Confidence            9764 56899999999999999997532              23589999999999999999999999   999999999


Q ss_pred             CcEEECCCCceEEeecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCc
Q 014904          174 ANILLDFKFEAKVADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHT  251 (416)
Q Consensus       174 ~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~  251 (416)
                      +||||+.++.+||+|||+|+........ ..+...||+.|+|||++.++.++.++|||||||+||||+| |+.||.....
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999976544333 3455789999999999999999999999999999999998 9999976442


Q ss_pred             ccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          252 FVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       252 ~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      .  ..        +...+..|.-     +.    .+..++..+.+++.+||+.||++||+|.||++.|+..
T Consensus       294 ~--~~--------~~~~i~~g~~-----~~----~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          294 D--EE--------FCRRLKEGTR-----MR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             S--HH--------HHHHHHHTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H--HH--------HHHHHHcCCC-----CC----CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            1  11        1122223321     11    1222345788999999999999999999999999753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.8e-52  Score=402.27  Aligned_cols=244  Identities=25%  Similarity=0.392  Sum_probs=197.0

Q ss_pred             CcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEe----CCeEEEEE
Q 014904           47 SDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTA----GSQRMLVY  119 (416)
Q Consensus        47 ~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~  119 (416)
                      ...+.||+|+||.||+|.+ .+++.||||++....  ....+.|.+|+.++++++|||||+++++|.+    ....+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            5567899999999999995 468999999997543  2334579999999999999999999999875    34579999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeecccCCcEEECC-CCceEEeecccceecc
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK--IIHRDIKAANILLDF-KFEAKVADFGLAKIAS  196 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--iiHrDIkp~NILl~~-~~~~kl~DFGla~~~~  196 (416)
                      ||+++|+|.+++....  .+++..+..|+.|++.||+|||+.   +  ||||||||+||||+. ++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999997644  589999999999999999999998   6  999999999999985 7899999999998643


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      ..   .....+||+.|+|||++. ++++.++|||||||+||||+||+.||......  ..        +...+..+....
T Consensus       184 ~~---~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~--------~~~~i~~~~~~~  249 (290)
T 3fpq_A          184 AS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQ--------IYRRVTSGVKPA  249 (290)
T ss_dssp             TT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HH--------HHHHHTTTCCCG
T ss_pred             CC---ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HH--------HHHHHHcCCCCC
Confidence            32   234578999999999886 47999999999999999999999999754321  11        111222222111


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                          .+...    ....+.+|+.+||+.||++||++.|+++
T Consensus       250 ----~~~~~----~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 ----SFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----GGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----CCCcc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                11111    2246889999999999999999999985

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.5e-51  Score=392.85  Aligned_cols=245  Identities=25%  Similarity=0.374  Sum_probs=192.1

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++.....   .....+.+|+.++++++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999995 5799999999975432   23457899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+ +|+|.+++...+  .+++..+..++.|++.||+|||+.   +|+||||||+||||+.++.+||+|||+|+......
T Consensus        93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            999 678888887654  599999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cceeecccccccccChhhhccCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~-t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                        .....+||+.|+|||++.+..+ +.++|||||||+||||+||+.||.....      ..     +.+.+..+.+.   
T Consensus       167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~-----~~~~i~~~~~~---  230 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PV-----LFKNISNGVYT---  230 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-----HHHHHHHTCCC---
T ss_pred             --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HH-----HHHHHHcCCCC---
Confidence              2344689999999999988775 5899999999999999999999976432      11     11222233221   


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                         +..    .....+.+++.+||+.||++|||+.|+++
T Consensus       231 ---~p~----~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          231 ---LPK----FLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ---CCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---CCC----CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence               111    22356889999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.4e-51  Score=398.30  Aligned_cols=242  Identities=25%  Similarity=0.297  Sum_probs=194.9

Q ss_pred             CCCCcCceecccCcEEEEEEEeC----CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP----NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ++|++.+.||+|+||.||+|...    +++.||||+++....  .....+.+|+.++++++|||||++++++.+....+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999852    478999999975422  223468889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+++|+|.+++...+  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+|+....
T Consensus       104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            999999999999997654  599999999999999999999999   999999999999999999999999999986544


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      ... .....+||+.|+|||++.+..++.++|||||||+||||+||+.||......   .+       + ..+..+.+.  
T Consensus       179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~-------~-~~i~~~~~~--  244 (304)
T 3ubd_A          179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ET-------M-TMILKAKLG--  244 (304)
T ss_dssp             --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH-------H-HHHHHCCCC--
T ss_pred             CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HH-------H-HHHHcCCCC--
Confidence            332 234478999999999999999999999999999999999999999765431   11       1 112222211  


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRM  312 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  312 (416)
                              ++......+.+|+.+||+.||++||++
T Consensus       245 --------~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          245 --------MPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             --------CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             --------CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence                    112234578899999999999999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=9.1e-50  Score=388.42  Aligned_cols=290  Identities=48%  Similarity=0.819  Sum_probs=251.4

Q ss_pred             ccccCHHHHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEE
Q 014904           31 KSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYY  109 (416)
Q Consensus        31 ~~~f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~  109 (416)
                      ...|++.++..++++|.+.++||+|+||.||+|...+|+.||||++...... ....+.+|+.+++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            4579999999999999999999999999999999888999999999765322 223689999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEe
Q 014904          110 TAGSQRMLVYEFVPNNTLEFHLHGKG--RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA  187 (416)
Q Consensus       110 ~~~~~~~lV~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~  187 (416)
                      ......++||||+.+++|.+++....  ...+++..++.|+.+++.||+|||+.+.++|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999997653  3359999999999999999999999988899999999999999999999999


Q ss_pred             ecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCC--cccchhhhhhhhHHh
Q 014904          188 DFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH--TFVEDSLVDWARPLL  265 (416)
Q Consensus       188 DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~--~~~~~~l~~~~~~~~  265 (416)
                      |||+++..............||+.|+|||++.++.++.++||||||+++|+|++|+.||+...  ......+.+|...  
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--  254 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG--  254 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT--
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH--
Confidence            999999877666666666779999999999998999999999999999999999999996321  1123344455433  


Q ss_pred             HHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 014904          266 NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDAS  324 (416)
Q Consensus       266 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~~  324 (416)
                        .........+.+..+...+...+...+.+++.+||+.+|.+||++.||++.|++...
T Consensus       255 --~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          255 --LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             --TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             --HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence              334567778888888888999999999999999999999999999999999997643

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.6e-49  Score=386.34  Aligned_cols=286  Identities=39%  Similarity=0.687  Sum_probs=249.6

Q ss_pred             ccccCHHHHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEE
Q 014904           31 KSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT  110 (416)
Q Consensus        31 ~~~f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  110 (416)
                      ...+++.++..++++|...++||+|+||.||+|.+.+++.||||++........+.+.+|+.++++++||||+++++++.
T Consensus        26 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           26 SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             ----CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             ceeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            44577778889999999999999999999999998889999999998776666678999999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEee
Q 014904          111 AGSQRMLVYEFVPNNTLEFHLHGKGR--PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD  188 (416)
Q Consensus       111 ~~~~~~lV~e~~~~~sL~~~l~~~~~--~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~D  188 (416)
                      +....++||||+++++|.+++.....  ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D  182 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITD  182 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECC
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEee
Confidence            99999999999999999999975542  3589999999999999999999999   999999999999999999999999


Q ss_pred             cccceeccCCC-cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHH
Q 014904          189 FGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNR  267 (416)
Q Consensus       189 FGla~~~~~~~-~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~  267 (416)
                      ||+++...... ........||+.|+|||++.++.++.++||||||+++|||++|+.||....+.....+..|....   
T Consensus       183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~---  259 (321)
T 2qkw_B          183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES---  259 (321)
T ss_dssp             CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH---
T ss_pred             cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc---
Confidence            99998754322 22334467899999999999999999999999999999999999999887766666666665433   


Q ss_pred             hhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          268 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       268 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                       ...+.+..++++.+...........+.+++.+||+.+|++||++.||++.|+...
T Consensus       260 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          260 -HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             -HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence             3456777888888888888899999999999999999999999999999998653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.6e-50  Score=385.58  Aligned_cols=249  Identities=23%  Similarity=0.389  Sum_probs=189.8

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCC--------
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGS--------  113 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  113 (416)
                      ++|.+.+.||+|+||.||+|.. .+|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4588999999999999999995 47999999999765433 3357899999999999999999999987544        


Q ss_pred             ----eEEEEEEecCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEee
Q 014904          114 ----QRMLVYEFVPNNTLEFHLHGKGR-PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD  188 (416)
Q Consensus       114 ----~~~lV~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~D  188 (416)
                          ..++||||+++++|.+++..... ...++..++.|+.|++.||+|||+.   +||||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999986543 2456778899999999999999999   999999999999999999999999


Q ss_pred             cccceeccCCCcc-----------eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhh
Q 014904          189 FGLAKIASDVNTH-----------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL  257 (416)
Q Consensus       189 FGla~~~~~~~~~-----------~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l  257 (416)
                      ||+|+........           ..+..+||+.|+|||++.+..++.++|||||||+||||++   ||....    +..
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~~  234 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ERV  234 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HHH
Confidence            9999876543221           1233579999999999999999999999999999999996   664311    000


Q ss_pred             hhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .     .+ ..+....+...         .......+.+++.+||+.||.+||++.||++
T Consensus       235 ~-----~~-~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          235 R-----TL-TDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             H-----HH-HHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H-----HH-HHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0     01 11122222111         1122345678999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=383.16  Aligned_cols=261  Identities=20%  Similarity=0.306  Sum_probs=201.2

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEe------CC
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTA------GS  113 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  113 (416)
                      .++|.+.+.||+|+||.||+|.+ .+|+.||||+++....  ...+.+.+|+.+|++++|||||++++++..      ..
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            36799999999999999999995 5799999999975432  223568899999999999999999999764      35


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ..||||||+. |+|.+++...+  .+++..+..++.|++.||.|||+.   +||||||||+|||++.++.+||+|||+++
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence            7899999995 67888886544  699999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCC---cceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhh
Q 014904          194 IASDVN---THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAI  269 (416)
Q Consensus       194 ~~~~~~---~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~  269 (416)
                      .+....   .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+  ..     . 
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I--~~-----~-  278 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI--MM-----V-  278 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH--HH-----H-
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH--HH-----h-
Confidence            664322   2233457899999999998775 5799999999999999999999999875532111111  00     0 


Q ss_pred             hcCCcccc----------------cCccccC---cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          270 EDGNFDTL----------------VDPKLHN---EYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       270 ~~~~~~~~----------------~d~~l~~---~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                       .|.....                ..+....   .........+.+|+.+||+.||.+|||+.|+++.
T Consensus       279 -~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          279 -LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             -HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence             0100000                0000000   0001123467899999999999999999998863

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.8e-47  Score=374.97  Aligned_cols=205  Identities=23%  Similarity=0.373  Sum_probs=175.8

Q ss_pred             HHHHHHhhCCCCcCceecccCcEEEEEEEeC----CCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEEEE
Q 014904           36 YEELARATDGFSDANLLGQGGFGYVHRGVLP----NGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYYT  110 (416)
Q Consensus        36 ~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  110 (416)
                      |+.+-...++|.+.++||+|+||.||+|..+    +++.||||++....  ...++.+|+.++..+ +|||||++++++.
T Consensus        13 ~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~   90 (361)
T 4f9c_A           13 YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR   90 (361)
T ss_dssp             HHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred             HHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence            3444557789999999999999999999853    46889999987543  345788999999998 6999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC-CceEEeec
Q 014904          111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADF  189 (416)
Q Consensus       111 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~-~~~kl~DF  189 (416)
                      +.++.++||||+++++|.+++.     .+++..+..++.|++.||+|||+.   +|+||||||+||||+.+ +.+||+||
T Consensus        91 ~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           91 KNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             ETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             ECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcC
Confidence            9999999999999999999984     489999999999999999999999   99999999999999877 79999999


Q ss_pred             ccceeccCCCcc---------------------------eeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHh
Q 014904          190 GLAKIASDVNTH---------------------------VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIT  241 (416)
Q Consensus       190 Gla~~~~~~~~~---------------------------~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~ellt  241 (416)
                      |+|+...+....                           ..+..+||+.|+|||++.+. .++.++||||+||++|||++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            999865432211                           12335799999999999875 58999999999999999999


Q ss_pred             CCCCCCCCC
Q 014904          242 GRRPVDSTH  250 (416)
Q Consensus       242 G~~pf~~~~  250 (416)
                      |+.||....
T Consensus       243 G~~Pf~~~~  251 (361)
T 4f9c_A          243 GRYPFYKAS  251 (361)
T ss_dssp             TCSSSSCCS
T ss_pred             CCCCCCCCC
Confidence            999996544

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.9e-46  Score=392.80  Aligned_cols=252  Identities=23%  Similarity=0.333  Sum_probs=210.3

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++..........+.+|+.+|+.++|||||++++++.+....+|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            46899999999999999999995 47999999999876655567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC--CceEEeecccceeccCCC
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK--FEAKVADFGLAKIASDVN  199 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~--~~~kl~DFGla~~~~~~~  199 (416)
                      +.+|+|.+++..... .+++..+..++.|++.||.|||+.   +|+||||||+||||+.+  +.+||+|||+++......
T Consensus       236 ~~gg~L~~~i~~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          236 MSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCCBHHHHHTCTTS-CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             cCCCcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            999999998865433 699999999999999999999999   99999999999999854  889999999999875433


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                        .....+||+.|+|||++.+..++.++|||||||+||||++|+.||......   ..        ...+..+.+. + .
T Consensus       312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~--------~~~i~~~~~~-~-~  376 (573)
T 3uto_A          312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ET--------LRNVKSCDWN-M-D  376 (573)
T ss_dssp             --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH--------HHHHHTTCCC-C-C
T ss_pred             --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HH--------HHHHHhCCCC-C-C
Confidence              234467999999999999999999999999999999999999999765431   11        1112222211 1 1


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      +....    .....+.+|+.+||+.||.+||++.|+++
T Consensus       377 ~~~~~----~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          377 DSAFS----GISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             SGGGT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccccc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111    22346789999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.4e-46  Score=360.94  Aligned_cols=259  Identities=26%  Similarity=0.402  Sum_probs=212.8

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      .++|.+.++||+|+||.||+|.+ .+++.||+|++........+.|.+|+.++.+++||||+++++++.++...++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            36788999999999999999996 46899999999776666667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.+++..... .+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus        89 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           89 IKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CTTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            999999999986433 699999999999999999999999   9999999999999999999999999999876543322


Q ss_pred             ee-------------ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHh
Q 014904          202 VS-------------TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRA  268 (416)
Q Consensus       202 ~~-------------~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~  268 (416)
                      ..             ....||+.|+|||++.+..++.++||||||+++|||++|..|+............. .....   
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~~---  240 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRGFL---  240 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHHHH---
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhccc---
Confidence            11             14579999999999999999999999999999999999999987644322111110 00000   


Q ss_pred             hhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          269 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       269 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                                +..    .+...+..+.+++.+||+.+|++||++.+|++.|+...
T Consensus       241 ----------~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          241 ----------DRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             ----------HHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------ccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                      000    11122346889999999999999999999999998543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.2e-44  Score=349.10  Aligned_cols=281  Identities=36%  Similarity=0.666  Sum_probs=230.7

Q ss_pred             ccccCHHHHHHhhCCCCcC------ceecccCcEEEEEEEeCCCcEEEEEEeecCC----cccHHHHHHHHHHHHhcCCC
Q 014904           31 KSTFTYEELARATDGFSDA------NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGS----GQGEREFQAEVEIISRVHHK  100 (416)
Q Consensus        31 ~~~f~~~el~~~t~~f~~~------~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~  100 (416)
                      ...|++.++.+++++|...      +.||+|+||.||+|.. +++.||||++....    ......+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4679999999999999988      8999999999999997 68899999987532    22346789999999999999


Q ss_pred             cccceEEEEEeCCeEEEEEEecCCCCHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC
Q 014904          101 HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGK-GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD  179 (416)
Q Consensus       101 niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~  179 (416)
                      ||+++++++.+....++||||+++++|.+++... ....+++..++.|+.+++.||.|||+.   +|+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence            9999999999999999999999999999998643 234699999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhh
Q 014904          180 FKFEAKVADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV  258 (416)
Q Consensus       180 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~  258 (416)
                      .++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||......  ..+.
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~  244 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLL  244 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS--SBTT
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch--HHHH
Confidence            9999999999999876543322 2344679999999998864 6899999999999999999999999865432  1122


Q ss_pred             hhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          259 DWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      .+.....   .....+...+++.+ ...+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus       245 ~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          245 DIKEEIE---DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             HHHHHHH---TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHhh---hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            2211110   01222333444443 345667788999999999999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1e-44  Score=353.35  Aligned_cols=263  Identities=22%  Similarity=0.335  Sum_probs=219.1

Q ss_pred             ccccCHHHHHHhhCC----------CCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCC
Q 014904           31 KSTFTYEELARATDG----------FSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHH   99 (416)
Q Consensus        31 ~~~f~~~el~~~t~~----------f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h   99 (416)
                      ...|+++++..+++.          |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            346899999999986          667789999999999999965 799999999987776667789999999999999


Q ss_pred             CcccceEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC
Q 014904          100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD  179 (416)
Q Consensus       100 ~niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~  179 (416)
                      |||+++++++......++||||+++++|.+++...   .+++..++.++.|++.||.|||+.   +|+||||||+|||++
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~  175 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT  175 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC
Confidence            99999999999999999999999999999998643   589999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhh
Q 014904          180 FKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD  259 (416)
Q Consensus       180 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~  259 (416)
                      .++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......   ... 
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~-  250 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAM-  250 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH-
T ss_pred             CCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH-
Confidence            9999999999999876543322 24467999999999999999999999999999999999999999764431   111 


Q ss_pred             hhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          260 WARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                             ..+.......+.       ........+.+++.+||+.+|++||++.||++.
T Consensus       251 -------~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          251 -------KRLRDSPPPKLK-------NSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             -------HHHHHSSCCCCT-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -------HHHhcCCCCCcC-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   111111111110       111223568899999999999999999999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.2e-45  Score=387.72  Aligned_cols=249  Identities=24%  Similarity=0.334  Sum_probs=200.5

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHH---HHHHHHhcCCCcccceEEEEEeCCeE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQA---EVEIISRVHHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~  115 (416)
                      .++|.+.++||+|+||.||+|.. .+|+.||||++.+..   ......+.+   ++.+++.++|||||++++++.+....
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            36799999999999999999995 469999999997432   122233333   45666778999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ||||||++||+|..+|...+  .+++..+..++.||+.||.|||+.   +||||||||+||||+.+|.+||+|||+|+..
T Consensus       268 ylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999997654  599999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ....   ....+||+.|+|||++.. ..++.++|||||||+||||++|+.||..........+.        ..+....+
T Consensus       343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~--------~~i~~~~~  411 (689)
T 3v5w_A          343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------RMTLTMAV  411 (689)
T ss_dssp             SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH--------HHHHHCCC
T ss_pred             CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--------HhhcCCCC
Confidence            5433   234689999999999975 47999999999999999999999999754332111111        11111111


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR-----MSQIVR  317 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evv~  317 (416)
                            .    ++......+.+|+.+||+.||.+|++     +.||++
T Consensus       412 ------~----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          412 ------E----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ------C----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ------C----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                  1    12223457889999999999999998     677764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.3e-44  Score=348.58  Aligned_cols=251  Identities=23%  Similarity=0.386  Sum_probs=211.1

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++..........+.+|+.++++++||||+++++++......++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46899999999999999999994 57899999999876666667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +.+++|.+++...   .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.........
T Consensus        99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (297)
T 3fxz_A           99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (297)
T ss_dssp             CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence            9999999999764   489999999999999999999999   9999999999999999999999999999876544332


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                       .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .+.        .....+. ..+    
T Consensus       173 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~--------~~~~~~~-~~~----  236 (297)
T 3fxz_A          173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALY--------LIATNGT-PEL----  236 (297)
T ss_dssp             -BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH--------HHHHHCS-CCC----
T ss_pred             -cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHH--------HHHhCCC-CCC----
Confidence             334679999999999999999999999999999999999999997654311  110        0111111 111    


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                         ..+......+.+++.+||+.||++||++.|+++.
T Consensus       237 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          237 ---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             ---SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence               1112234578899999999999999999999863

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-45  Score=357.23  Aligned_cols=263  Identities=31%  Similarity=0.454  Sum_probs=205.2

Q ss_pred             HHHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCccc--HHHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           37 EELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQG--EREFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        37 ~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      .++....++|++.+.||+|+||.||+|.. +|+.||||++.......  ...+.+|+.++++++||||+++++++.+...
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            33444567899999999999999999987 68899999997654332  3578899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeecccCCcEEECCCCceEEeeccc
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGR-PTMDWLTRLKIALGSAKGLAYLHEDCHPK--IIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                      .++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.   +  |+||||||+|||++.++.+||+|||+
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            9999999999999999976532 2489999999999999999999998   8  99999999999999999999999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhc
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIED  271 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~  271 (416)
                      ++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......   ......       ...
T Consensus       186 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~~-------~~~  254 (309)
T 3p86_A          186 SRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVAAV-------GFK  254 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHHH-------HHS
T ss_pred             Ccccccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH-------Hhc
Confidence            986543221 223467999999999999999999999999999999999999999765431   111100       001


Q ss_pred             CCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          272 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       272 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      ...         ...+......+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       255 ~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~  297 (309)
T 3p86_A          255 CKR---------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI  297 (309)
T ss_dssp             CCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            110         1112223357899999999999999999999999998654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.8e-45  Score=347.14  Aligned_cols=255  Identities=30%  Similarity=0.452  Sum_probs=212.8

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      .++|.+.+.||+|+||.||+|.+.+++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            36788999999999999999998889999999998654 34567999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++++|.+++..... .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        88 ~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           88 EHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             TTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCCcHHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence            99999999975443 689999999999999999999999   99999999999999999999999999998665433333


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                      .....+|+.|+|||++.+..++.++||||||+++++|++ |+.||......   .+.        ..+..+.  ...   
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~--------~~~~~~~--~~~---  227 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVV--------EDISTGF--RLY---  227 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH--------HHHHTTC--CCC---
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHH--------HHHhcCc--cCC---
Confidence            334567888999999999999999999999999999999 99999764431   111        1111211  011   


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                          .+......+.+++.+||+.+|++||++.|+++.|+..
T Consensus       228 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          228 ----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence                1111235788999999999999999999999999854

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.1e-45  Score=361.62  Aligned_cols=258  Identities=26%  Similarity=0.409  Sum_probs=211.8

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC--------CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhc-CCCcccceEEEEEeC
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP--------NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRV-HHKHLVSLVGYYTAG  112 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  112 (416)
                      .++|.+.+.||+|+||.||+|.+.        ++..||||+++..... ....+.+|+.++.++ +||||++++++|.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467889999999999999999852        3567999999865432 235789999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE
Q 014904          113 SQRMLVYEFVPNNTLEFHLHGKGR--------------PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL  178 (416)
Q Consensus       113 ~~~~lV~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl  178 (416)
                      ...++||||+++++|.+++.....              ..+++..++.++.|++.||.|||+.   +|+||||||+||||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence            999999999999999999976432              3589999999999999999999999   99999999999999


Q ss_pred             CCCCceEEeecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchh
Q 014904          179 DFKFEAKVADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDS  256 (416)
Q Consensus       179 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~  256 (416)
                      +.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....   ..
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---~~  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GG
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---HH
Confidence            99999999999999876543322 2233567889999999999999999999999999999999 9999976442   11


Q ss_pred             hhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          257 LVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       257 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      +.        ..+..+...         ..+......+.+++.+||+.+|.+||++.||++.|+...
T Consensus       314 ~~--------~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          314 LF--------KLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             HH--------HHHHTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HH--------HHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11        111222211         112233457899999999999999999999999998653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.4e-45  Score=365.45  Aligned_cols=257  Identities=28%  Similarity=0.458  Sum_probs=199.6

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC----CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP----NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      .++|.+.++||+|+||.||+|.+.    ++..||||+++.... ...+.|.+|+.++.+++||||+++++++.+....++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            358999999999999999999964    577899999986532 334679999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+++++|.+++.... ..+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       124 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            999999999999997654 3699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCccee--ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          198 VNTHVS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       198 ~~~~~~--~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ......  ....+++.|+|||++.+..++.++|||||||++|||++ |+.||.....   ..+.        ..+..+. 
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~--------~~i~~~~-  267 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVI--------KAVDEGY-  267 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHH--------HHHHTTE-
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHH--------HHHHcCC-
Confidence            332221  22345778999999999999999999999999999998 9999976432   1111        1111111 


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                              ....+...+..+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       268 --------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          268 --------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             --------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence                    01112234467899999999999999999999999998653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=357.25  Aligned_cols=256  Identities=29%  Similarity=0.444  Sum_probs=207.6

Q ss_pred             CCCCcCceecccCcEEEEEEEeC----CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP----NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ++|.+.++||+|+||.||+|.+.    .+..||||+++.... ...+.|.+|+.++++++||||+++++++.+....++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            46778899999999999999964    345699999986533 3345789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+++++|.+++..... .+++..++.|+.+++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       129 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EECCTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             eeCCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            999999999999975533 699999999999999999999999   9999999999999999999999999999877543


Q ss_pred             Ccce--eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          199 NTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       199 ~~~~--~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ....  .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......   .+.        ..+..+.. 
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~--------~~~~~~~~-  272 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVI--------SSVEEGYR-  272 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH--------HHHHTTCC-
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHH--------HHHHcCCC-
Confidence            3222  223456788999999999999999999999999999999 99999764431   111        11112210 


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                              ...+......+.+++.+||+.+|.+||++.||++.|+...
T Consensus       273 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          273 --------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                    1112233457899999999999999999999999998653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6.1e-45  Score=344.34  Aligned_cols=257  Identities=27%  Similarity=0.416  Sum_probs=214.3

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ..++|.+.+.||+|+||.||+|...++..||||+++.... ...++.+|+.++.+++||||+++++++.+....++||||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            3468999999999999999999988888999999986543 356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.+++..... .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.........
T Consensus        85 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             CTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            999999999975432 589999999999999999999999   9999999999999999999999999999877654444


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                      ......+|+.|+|||.+.+..++.++||||||+++++|++ |+.||.......   .        ...+..+..  ...+
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~--------~~~~~~~~~--~~~~  227 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---V--------VLKVSQGHR--LYRP  227 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---H--------HHHHHTTCC--CCCC
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---H--------HHHHHcCCC--CCCC
Confidence            3344556788999999998899999999999999999999 999997654311   0        011111211  1111


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                             ......+.+++.+||+.+|.+||++.||++.|+...
T Consensus       228 -------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          228 -------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             -------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             -------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                   112346889999999999999999999999998643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.6e-44  Score=344.96  Aligned_cols=260  Identities=23%  Similarity=0.369  Sum_probs=207.8

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCccc---HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQG---EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++.......   .+.+.+|+.++.+++||||+++++++.+....++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            47899999999999999999995 468999999986543333   35788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+++++|.+++...+  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            99999999999997654  589999999999999999999999   9999999999999999999999999999876554


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      .........||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......          .....+.. ...   
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~----------~~~~~~~~-~~~---  230 (294)
T 4eqm_A          165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS----------IAIKHIQD-SVP---  230 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH----------HHHHHHSS-CCC---
T ss_pred             cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH----------HHHHHhhc-cCC---
Confidence            4344445679999999999999999999999999999999999999997654310          01111111 111   


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHhcccc
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRP-RMSQIVRALEGDA  323 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~evv~~L~~~~  323 (416)
                        ..........+..+.+++.+|++.+|.+|| ++.++.+.|+...
T Consensus       231 --~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          231 --NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             --CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             --CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence              111112223345789999999999999999 9999999998643

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.7e-44  Score=351.67  Aligned_cols=272  Identities=25%  Similarity=0.339  Sum_probs=209.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCC----eEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGS----QRML  117 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l  117 (416)
                      ..++|.+.++||+|+||.||+|... ++.||||++.... .....+..|+.++.+++||||+++++++....    ..++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            3478999999999999999999974 7999999997543 22345567888999999999999999998744    4799


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeeeecccCCcEEECCCCceEEeecc
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC-------HPKIIHRDIKAANILLDFKFEAKVADFG  190 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-------~~~iiHrDIkp~NILl~~~~~~kl~DFG  190 (416)
                      ||||+++++|.+++...   .+++..++.|+.|++.||+|||+.+       .++|+||||||+|||++.++.+||+|||
T Consensus       100 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            99999999999999764   4999999999999999999999862       3479999999999999999999999999


Q ss_pred             cceeccCCCcc-eeecccccccccChhhhccC-----CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhh---
Q 014904          191 LAKIASDVNTH-VSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA---  261 (416)
Q Consensus       191 la~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~-----~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~---  261 (416)
                      +++........ ......||+.|+|||++.+.     .++.++|||||||++|||++|+.||...............   
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  256 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH  256 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred             cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence            99876543332 22336799999999999863     5567899999999999999999999765432211111110   


Q ss_pred             --hHHhHHhhhcCCcccccCccccCc-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          262 --RPLLNRAIEDGNFDTLVDPKLHNE-YNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       262 --~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                        ...+.........    .+.+... .....+..+.+++.+||+.||++||++.||++.|+..
T Consensus       257 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          257 PSLEDMQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             CCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CchhhhhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              0011111111111    1111111 1234567799999999999999999999999999854

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.6e-45  Score=347.96  Aligned_cols=256  Identities=25%  Similarity=0.372  Sum_probs=209.8

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ..++|.+.+.||+|+||.||+|.+.++..||||+++... ....++.+|+.++.+++|+||+++++++.+....++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            356899999999999999999999888899999998654 3456799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.+++..... .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus       101 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  176 (283)
T 3gen_A          101 MANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  176 (283)
T ss_dssp             CTTCBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred             cCCCcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence            999999999976332 599999999999999999999999   9999999999999999999999999999866543322


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                      ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......   ...        ..+..+..     .
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~--------~~~~~~~~-----~  240 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETA--------EHIAQGLR-----L  240 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHH--------HHHHTTCC-----C
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHH--------HHHhcccC-----C
Confidence            2333456788999999999999999999999999999998 99999765431   111        11111110     0


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      .    .+......+.+++.+||+.+|.+||++.||++.|+..
T Consensus       241 ~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          241 Y----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             C----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C----CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            1    1111235788999999999999999999999999753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.5e-44  Score=351.07  Aligned_cols=251  Identities=24%  Similarity=0.339  Sum_probs=209.2

Q ss_pred             HHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           40 ARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        40 ~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      ....++|.+.+.||+|+||.||+|.+ .+|+.||||++....  ......+.+|+.+++.++||||+++++++......+
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence            34567899999999999999999996 679999999997543  233456889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +||||+++++|.+++...+  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        91 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            9999999999999987654  589999999999999999999999   99999999999999999999999999998665


Q ss_pred             CCCcceeecccccccccChhhhccCCCC-chhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t-~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ...  ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||......      .     +...+..+.+.
T Consensus       166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~-----~~~~i~~~~~~  232 (328)
T 3fe3_A          166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------E-----LRERVLRGKYR  232 (328)
T ss_dssp             SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-----HHHHHHHCCCC
T ss_pred             CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------H-----HHHHHHhCCCC
Confidence            432  23446799999999999888765 8999999999999999999999765431      1     11112223221


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                                .+......+.+++.+||+.||.+||++.|+++.
T Consensus       233 ----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          233 ----------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ----------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ----------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                      111223468899999999999999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.1e-45  Score=358.77  Aligned_cols=268  Identities=27%  Similarity=0.385  Sum_probs=215.6

Q ss_pred             ccCHHHHHHhhCCCCcCceecccCcEEEEEEEe------CCCcEEEEEEeecCCcc-cHHHHHHHHHHHHhc-CCCcccc
Q 014904           33 TFTYEELARATDGFSDANLLGQGGFGYVHRGVL------PNGKEVAIKQLKAGSGQ-GEREFQAEVEIISRV-HHKHLVS  104 (416)
Q Consensus        33 ~f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~h~niv~  104 (416)
                      .+...+..-..++|.+.+.||+|+||.||+|.+      .+++.||||+++..... ..+.+.+|+.++.++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            345556666789999999999999999999973      24689999999865433 335789999999999 7999999


Q ss_pred             eEEEEEeCCe-EEEEEEecCCCCHHHHhhcCCC-----------------------------------------------
Q 014904          105 LVGYYTAGSQ-RMLVYEFVPNNTLEFHLHGKGR-----------------------------------------------  136 (416)
Q Consensus       105 l~~~~~~~~~-~~lV~e~~~~~sL~~~l~~~~~-----------------------------------------------  136 (416)
                      +++++.+... .++||||+++++|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            9999987554 8999999999999999976532                                               


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          137 -----------------PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       137 -----------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                                       ..+++..++.|+.|++.||+|||+.   +|+||||||+||||+.++.+||+|||+++......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                             1289999999999999999999999   99999999999999999999999999998664433


Q ss_pred             c-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          200 T-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       200 ~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      . .......||+.|+|||++.+..++.++|||||||++|||++ |+.||......  ..+        ...+..+.... 
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~--------~~~~~~~~~~~-  316 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF--------CRRLKEGTRMR-  316 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHH--------HHHHHHTCCCC-
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--HHH--------HHHHHcCCCCC-
Confidence            2 23345678999999999999999999999999999999998 99999765431  111        11112221111 


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                              .+......+.+++.+||+.+|.+||++.||++.|+..
T Consensus       317 --------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          317 --------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence                    1112235788999999999999999999999999854

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-44  Score=352.97  Aligned_cols=265  Identities=25%  Similarity=0.401  Sum_probs=216.2

Q ss_pred             HHHHHHhhCCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEE
Q 014904           36 YEELARATDGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGY  108 (416)
Q Consensus        36 ~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~  108 (416)
                      +.++.-..++|.+.+.||+|+||.||+|...      +++.||||+++..... ....+.+|+.++++++||||++++++
T Consensus        39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3445556789999999999999999999964      3489999999865432 34578999999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 014904          109 YTAGSQRMLVYEFVPNNTLEFHLHGKG----------------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKI  166 (416)
Q Consensus       109 ~~~~~~~~lV~e~~~~~sL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i  166 (416)
                      +.+....++||||+++++|.+++....                      ...+++..++.|+.|++.||.|||+.   +|
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~i  195 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF  195 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            999999999999999999999997642                      14689999999999999999999999   99


Q ss_pred             eeecccCCcEEECCCCceEEeecccceeccCCCc-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCC
Q 014904          167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRR  244 (416)
Q Consensus       167 iHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~  244 (416)
                      +||||||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999986543222 22234568999999999999999999999999999999999 999


Q ss_pred             CCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          245 PVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       245 pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      ||.....   ..+        ...+..+....         .+...+..+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       276 p~~~~~~---~~~--------~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~  334 (343)
T 1luf_A          276 PYYGMAH---EEV--------IYYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  334 (343)
T ss_dssp             TTTTSCH---HHH--------HHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cCCCCCh---HHH--------HHHHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence            9976432   111        11222333211         11223457899999999999999999999999998754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7.9e-45  Score=374.87  Aligned_cols=258  Identities=26%  Similarity=0.376  Sum_probs=216.3

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCC-CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ...+|.+.+.||+|+||.||+|.+.. +..||||+++... ....+|.+|+.++++++||||++++++|......++|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            45678889999999999999999754 8899999998654 346789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|.+++.......+++..++.|+.|++.||+|||+.   +|+||||||+||||+.++.+||+|||+++.......
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            99999999999876666799999999999999999999999   999999999999999999999999999987654333


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                      .......++..|+|||++.++.++.++|||||||+||||++ |+.||......   .+.        ..+..+.      
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~--------~~~~~~~------  436 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVY--------ELLEKDY------  436 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHH--------HHHHTTC------
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHH--------HHHHcCC------
Confidence            32333456789999999999999999999999999999999 99999765431   111        1111111      


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                         ....+..++..+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       437 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          437 ---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence               11122234467899999999999999999999999998643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.8e-45  Score=349.55  Aligned_cols=267  Identities=24%  Similarity=0.355  Sum_probs=207.2

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-----CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEe--CCeE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-----PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA--GSQR  115 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  115 (416)
                      .++|++.+.||+|+||.||+|..     .+++.||||++........+.+.+|+.++.+++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46889999999999999999984     3688999999987665556789999999999999999999999865  3568


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++||||+++++|.+++..... .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            999999999999999976543 589999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCcc--eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchh-----hhhhhhHHhHHh
Q 014904          196 SDVNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDS-----LVDWARPLLNRA  268 (416)
Q Consensus       196 ~~~~~~--~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~-----l~~~~~~~~~~~  268 (416)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||++|..|+..........     ...+....+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  244 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence            543322  2233457788999999999999999999999999999999999986532100000     000000011111


Q ss_pred             hhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          269 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       269 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      +..+.         ....+...+..+.+++.+||+.+|++||++.||++.|+..
T Consensus       245 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          245 LKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            11111         1112223446799999999999999999999999999853

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.1e-45  Score=347.70  Aligned_cols=258  Identities=27%  Similarity=0.380  Sum_probs=217.7

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ...++|.+.+.||+|+||.||+|.+. +++.||||++.... .....+.+|+.++++++||||+++++++.+....++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            35678999999999999999999965 48899999997543 34567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+.+++|.+++.......+++..++.++.+++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            999999999999876666799999999999999999999999   99999999999999999999999999998776554


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......   .+..        .+..+.     
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~--------~~~~~~-----  229 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE--------LLEKDY-----  229 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH--------HHHTTC-----
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--------HHhccC-----
Confidence            444455667889999999999999999999999999999999 99999765431   1111        111111     


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                          ....+...+..+.+++.+||+.+|.+||++.||++.|+..
T Consensus       230 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          230 ----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence                0111222345789999999999999999999999999754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.6e-45  Score=371.43  Aligned_cols=259  Identities=28%  Similarity=0.435  Sum_probs=214.4

Q ss_pred             HHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           40 ARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        40 ~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ....++|.+.+.||+|+||.||+|.+.+++.||||+++... ...+.|.+|+.++++++||||+++++++. ....++||
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence            44567899999999999999999999888999999998654 45678999999999999999999999986 56789999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++.......+++..++.++.|++.||+|||+.   +|+||||||+||||+.++.+||+|||+++......
T Consensus       262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            999999999999765444688999999999999999999999   99999999999999999999999999998764422


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      ........+|..|+|||++..+.++.++|||||||+||||++ |+.||.....   ..+.        ..+..+..  + 
T Consensus       339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~--------~~i~~~~~--~-  404 (454)
T 1qcf_A          339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVI--------RALERGYR--M-  404 (454)
T ss_dssp             HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHH--------HHHHHTCC--C-
T ss_pred             eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHH--------HHHHcCCC--C-
Confidence            222233456788999999999999999999999999999999 9999976432   1111        11222210  1 


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                            ..+..++..+.+++.+||+.+|++||++.+|++.|+...
T Consensus       405 ------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          405 ------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence                  112234467899999999999999999999999999654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.3e-44  Score=342.07  Aligned_cols=260  Identities=24%  Similarity=0.385  Sum_probs=204.5

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHh--cCCCcccceEEEEEe----CCeE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISR--VHHKHLVSLVGYYTA----GSQR  115 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~  115 (416)
                      ..++|.+.+.||+|+||.||+|.. +++.||||++...   ....+..|.+++..  ++||||+++++++..    ....
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            457899999999999999999998 7899999998653   34566677777777  799999999999765    2458


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeecccCCcEEECCCCceEEe
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH--------EDCHPKIIHRDIKAANILLDFKFEAKVA  187 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH--------~~~~~~iiHrDIkp~NILl~~~~~~kl~  187 (416)
                      ++||||+++++|.++++..   .+++..++.|+.|++.||+|||        +.   +|+||||||+|||++.++.+||+
T Consensus        82 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred             EEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence            9999999999999999543   5999999999999999999999        66   99999999999999999999999


Q ss_pred             ecccceeccCCCcce---eecccccccccChhhhccC------CCCchhhhHhHHHHHHHHHhC----------CCCCCC
Q 014904          188 DFGLAKIASDVNTHV---STRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVMLLELITG----------RRPVDS  248 (416)
Q Consensus       188 DFGla~~~~~~~~~~---~~~~~gt~~YlaPE~~~~~------~~t~ksDV~SlGvvL~elltG----------~~pf~~  248 (416)
                      |||+++.........   .....||+.|+|||++.+.      .++.++|||||||++|||++|          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            999998765544332   2234799999999999876      455799999999999999999          777755


Q ss_pred             CCcccchhhhhhhhHHhHHhhhcCCcccccCcccc-CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          249 THTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLH-NEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       249 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                      ...... .....     ........    ..+.+. ..........+.+++.+||+.+|.+||++.||++.|+.
T Consensus       236 ~~~~~~-~~~~~-----~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          236 VVPNDP-SFEDM-----RKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TSCSSC-CHHHH-----HHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCCCc-chhhh-----hHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            332111 11111     01111111    111111 11234567889999999999999999999999999974

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.7e-44  Score=352.35  Aligned_cols=256  Identities=25%  Similarity=0.401  Sum_probs=202.1

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcE----EEEEEeecC-CcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKE----VAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~----vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      .++|.+.++||+|+||.||+|.+. +++.    ||+|.+... .....++|.+|+.++++++||||++++++|.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            367999999999999999999953 4443    588887643 2344578999999999999999999999998765 77


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +|++|+.+++|.+++..... .+++..++.|+.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            89999999999999976543 699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          197 DVNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       197 ~~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ...... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......   +.        ..+..+..
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~--------~~~~~~~~  237 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS--------SILEKGER  237 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH--------HHHHTTCC
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HH--------HHHHcCCC
Confidence            433322 233557889999999999999999999999999999999 999997654311   11        11122211


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                               ...+......+..++.+||+.+|.+||++.||++.|+...
T Consensus       238 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~  277 (327)
T 3poz_A          238 ---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             ---------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred             ---------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                     1112223457889999999999999999999999998643

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-43  Score=340.54  Aligned_cols=275  Identities=22%  Similarity=0.260  Sum_probs=216.1

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCC--eEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGS--QRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV  118 (416)
                      .++|.+.++||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            467999999999999999999965 58999999997543 233567889999999999999999999998755  78999


Q ss_pred             EEecCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE----CCCCceEEeecccce
Q 014904          119 YEFVPNNTLEFHLHGKGR-PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL----DFKFEAKVADFGLAK  193 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl----~~~~~~kl~DFGla~  193 (416)
                      |||+++++|.+++..... ..+++..++.|+.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976432 2499999999999999999999999   99999999999999    888889999999998


Q ss_pred             eccCCCcceeecccccccccChhhhc--------cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHh
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYAS--------SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLL  265 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~--------~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~  265 (416)
                      ........  ....||+.|+|||++.        +..++.++|||||||++|||++|+.||........  ..+.....+
T Consensus       165 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~  240 (319)
T 4euu_A          165 ELEDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKII  240 (319)
T ss_dssp             ECCTTCCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHHH
T ss_pred             ecCCCCce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHh
Confidence            76553322  3356999999999986        57889999999999999999999999975432111  111111111


Q ss_pred             HHh----------hhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 014904          266 NRA----------IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDAS  324 (416)
Q Consensus       266 ~~~----------~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~~  324 (416)
                      ...          ...+.+....+..............+.+++.+||+.||++||++.|+++...++..
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            100          00000100001112234556778889999999999999999999999999987653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=350.68  Aligned_cols=244  Identities=22%  Similarity=0.316  Sum_probs=193.8

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc--cHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|++.++||+|+||+||+|.+. +|+.||||++......  ....+..|+..+.++ +|+||++++++|.++...++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            68999999999999999999965 7999999998754322  223455566665555 8999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+ +++|.+++..... .+++..++.|+.|++.||+|||+.   +|+||||||+||||+.++.+||+|||++.......
T Consensus       137 e~~-~~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGA-SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             ecc-CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            999 6788888765443 699999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                        ......||++|+|||++.+ .++.++|||||||++|||++|..|+.....        |      ..+..+...    
T Consensus       212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~------~~~~~~~~~----  270 (311)
T 3p1a_A          212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------W------QQLRQGYLP----  270 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------H------HHHTTTCCC----
T ss_pred             --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------H------HHHhccCCC----
Confidence              2234569999999998875 799999999999999999999877643211        1      111111111    


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      +.+..    .....+.+++.+||+.+|++||++.||++
T Consensus       271 ~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          271 PEFTA----GLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            11111    22357899999999999999999999985

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1e-43  Score=362.23  Aligned_cols=251  Identities=29%  Similarity=0.424  Sum_probs=208.7

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCC-eEEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGS-QRMLVYE  120 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e  120 (416)
                      ..++|.+.+.||+|+||.||+|.+ .|+.||||+++...  ..+.|.+|+.++++++||||+++++++.... ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            456888899999999999999998 47899999998654  3467999999999999999999999988765 7899999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|.+++...+...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  343 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  343 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence            99999999999876655689999999999999999999999   99999999999999999999999999998543321 


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                         ....++..|+|||++.+..++.++|||||||++|||++ |+.||......   .+.        ..+..+..     
T Consensus       344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~--------~~i~~~~~-----  404 (450)
T 1k9a_A          344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV--------PRVEKGYK-----  404 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT---THH--------HHHHTTCC-----
T ss_pred             ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH--------HHHHcCCC-----
Confidence               22357889999999999999999999999999999999 99999765431   111        11222211     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                          ...+..++..+.+++.+||+.+|.+||++.+|++.|+..
T Consensus       405 ----~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          405 ----MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                112223446789999999999999999999999999853

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.6e-44  Score=349.14  Aligned_cols=253  Identities=24%  Similarity=0.372  Sum_probs=204.7

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .++|.+.+.||+|+||.||+|... +++.||||++...... ....+.+|+.+++.++||||+++++++.++...++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999965 7899999999754432 23568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           86 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            999999999986543  589999999999999999999999   999999999999999999999999999986643322


Q ss_pred             -ceeecccccccccChhhhccCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          201 -HVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       201 -~~~~~~~gt~~YlaPE~~~~~~~-t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                       .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... ......|..        ....   .
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~--------~~~~---~  228 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKE--------KKTY---L  228 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT-SHHHHHHHT--------TCTT---S
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHhc--------cccc---C
Confidence             22345679999999999987765 78999999999999999999999765431 111222211        1110   0


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .+      .......+.+++.+||+.+|.+||++.||++.
T Consensus       229 ~~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          229 NP------WKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             Cc------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            00      11223567899999999999999999998764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.1e-43  Score=345.93  Aligned_cols=252  Identities=25%  Similarity=0.349  Sum_probs=208.1

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc------cHHHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ------GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      ..++|.+.+.||+|+||.||+|... +|+.||||+++.....      ....+.+|+.++.+++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            5678999999999999999999964 6899999999865322      34678999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC----ceEEeecc
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF----EAKVADFG  190 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~----~~kl~DFG  190 (416)
                      .++||||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++    .+||+|||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999996543  699999999999999999999999   999999999999998877    79999999


Q ss_pred             cceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh
Q 014904          191 LAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       191 la~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~  270 (416)
                      +++.......  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......   .+.        ..+.
T Consensus       165 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~--------~~i~  231 (361)
T 2yab_A          165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETL--------ANIT  231 (361)
T ss_dssp             SCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH--------HHHH
T ss_pred             CceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHH--------HHHH
Confidence            9987654322  23467999999999999989999999999999999999999999764421   111        1111


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .+.+.  .++....    .....+.+++.+||+.||.+||++.|+++
T Consensus       232 ~~~~~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          232 AVSYD--FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             TTCCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcCCC--CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            22211  0111111    12346889999999999999999999885

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-44  Score=360.89  Aligned_cols=257  Identities=26%  Similarity=0.368  Sum_probs=209.5

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||+++..... ....|.+|+.++++++||||++++++|......++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3467888999999999999999975 7899999999854322 2346889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++...+. .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       192 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             ECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             EcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            99999999999975432 589999999999999999999999   99999999999999999999999999998654322


Q ss_pred             ccee-ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          200 THVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       200 ~~~~-~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      .... ....++..|+|||.+.++.++.++|||||||++|||++ |+.||.....   ....        ..+..+..  +
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~--------~~~~~~~~--~  334 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTR--------EFVEKGGR--L  334 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHH--------HHHHTTCC--C
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHH--------HHHHcCCC--C
Confidence            1111 12345778999999999999999999999999999999 9999976442   1111        11222211  1


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                             ..+..++..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       335 -------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          335 -------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence                   11222345788999999999999999999999999753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.4e-44  Score=337.61  Aligned_cols=253  Identities=26%  Similarity=0.430  Sum_probs=196.5

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCc----ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSG----QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .++|.+.++||+|+||.||+|.+ .++.||||+++....    ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            46899999999999999999997 488999999875432    2246788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC--------CCceEEeecc
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF--------KFEAKVADFG  190 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~--------~~~~kl~DFG  190 (416)
                      |||+++++|.+++...   .+++..++.++.|++.||.|||+....+|+||||||+|||++.        ++.+||+|||
T Consensus        85 ~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999999998643   6899999999999999999999992222999999999999986        6789999999


Q ss_pred             cceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh
Q 014904          191 LAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       191 la~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~  270 (416)
                      +++.......   ....||+.|+|||++.+..++.++||||||+++++|++|+.||.......   .       . ....
T Consensus       162 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~-------~-~~~~  227 (271)
T 3dtc_A          162 LAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---V-------A-YGVA  227 (271)
T ss_dssp             C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---H-------H-HHHH
T ss_pred             cccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H-------H-Hhhh
Confidence            9986543322   23568999999999999999999999999999999999999997644211   0       0 0011


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                      .+...        ...+......+.+++.+||+.+|.+||++.||++.|+.
T Consensus       228 ~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          228 MNKLA--------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             TSCCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             cCCCC--------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            11111        11122334578999999999999999999999999974

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.7e-44  Score=356.28  Aligned_cols=259  Identities=26%  Similarity=0.402  Sum_probs=212.5

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC--------CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhc-CCCcccceEEEEEe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP--------NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRV-HHKHLVSLVGYYTA  111 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  111 (416)
                      ..++|.+.+.||+|+||.||+|...        .+..||||+++..... ....+.+|+.++.++ +||||++++++|..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            3478999999999999999999952        2357999999865432 336788999999999 99999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEE
Q 014904          112 GSQRMLVYEFVPNNTLEFHLHGKG--------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANIL  177 (416)
Q Consensus       112 ~~~~~lV~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NIL  177 (416)
                      ....++||||+++++|.+++....              ...+++..++.|+.|++.||.|||+.   +|+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence            999999999999999999997643              23589999999999999999999999   9999999999999


Q ss_pred             ECCCCceEEeecccceeccCCCc-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccch
Q 014904          178 LDFKFEAKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVED  255 (416)
Q Consensus       178 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~  255 (416)
                      |+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....   .
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---~  300 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---E  300 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---H
Confidence            99999999999999987654332 22234567889999999999999999999999999999999 9999976442   1


Q ss_pred             hhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          256 SLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       256 ~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      .+.        ..+..+....         .+......+.+++.+||+.+|++||++.||++.|+...
T Consensus       301 ~~~--------~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          301 ELF--------KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             HHH--------HHHHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH--------HHHHcCCCCC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111        1122222111         11123357899999999999999999999999998654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.2e-44  Score=344.99  Aligned_cols=260  Identities=28%  Similarity=0.397  Sum_probs=213.2

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe------CCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhc-CCCcccceEEEEEeCC
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL------PNGKEVAIKQLKAGSG-QGEREFQAEVEIISRV-HHKHLVSLVGYYTAGS  113 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  113 (416)
                      ..++|.+.+.||+|+||.||+|.+      .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++....
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            346899999999999999999984      3568999999986543 2346789999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEE
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGR----------------PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANIL  177 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NIL  177 (416)
                      ..++||||+++++|.+++.....                ..+++..++.++.|++.||.|||+.   +|+||||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence            99999999999999999976542                2489999999999999999999999   9999999999999


Q ss_pred             ECCCCceEEeecccceeccCCCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccch
Q 014904          178 LDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVED  255 (416)
Q Consensus       178 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~  255 (416)
                      ++.++.+||+|||+++......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......  .
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~  255 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--S  255 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--H
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch--h
Confidence            9999999999999998765543322 234567889999999999999999999999999999999 99999765431  1


Q ss_pred             hhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          256 SLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       256 ~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      .+..        .+..+. .    +    ..+......+.+++.+||+.+|.+||++.||++.|+...
T Consensus       256 ~~~~--------~~~~~~-~----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          256 KFYK--------MIKEGF-R----M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             HHHH--------HHHHTC-C----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHH--------HhccCC-C----C----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            1111        111111 1    0    111123457899999999999999999999999998643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-44  Score=349.79  Aligned_cols=260  Identities=24%  Similarity=0.385  Sum_probs=210.8

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe------CCCcEEEEEEeecCC-cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCC
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL------PNGKEVAIKQLKAGS-GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGS  113 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  113 (416)
                      ..++|.+.+.||+|+||.||+|..      .+++.||||++.... ......+.+|+.++.++ +||||+++++++....
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            457899999999999999999995      245689999997543 22336789999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccc
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGR---------------------PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIK  172 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIk  172 (416)
                      ..++||||+++++|.+++.....                     ..+++..++.++.|++.||.|||+.   +|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence            99999999999999999976532                     2479999999999999999999999   99999999


Q ss_pred             CCcEEECCCCceEEeecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCC
Q 014904          173 AANILLDFKFEAKVADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTH  250 (416)
Q Consensus       173 p~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~  250 (416)
                      |+|||++.++.+||+|||++......... ......||+.|+|||.+.++.++.++||||||+++|+|+| |+.||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999999999999999999876544332 2344567889999999999999999999999999999998 999997654


Q ss_pred             cccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          251 TFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       251 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      ..  ..+.        ..+..+..         ...+......+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       280 ~~--~~~~--------~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  333 (344)
T 1rjb_A          280 VD--ANFY--------KLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL  333 (344)
T ss_dssp             CS--HHHH--------HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cH--HHHH--------HHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            31  1111        11112210         1111223457899999999999999999999999998643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.4e-43  Score=342.01  Aligned_cols=266  Identities=21%  Similarity=0.291  Sum_probs=202.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ..++|.+.+.||+|+||.||+|...+|+.||||++......  ....+.+|+.++++++||||+++++++.+....++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            45899999999999999999999988999999999754322  2357889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        99 e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           99 EFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             ECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             cCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            99975 7777776543 3589999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhH------------
Q 014904          200 THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN------------  266 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~------------  266 (416)
                      .. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  .+..... .+.            
T Consensus       174 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~-~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          174 RS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD--QLPKIFS-ILGTPNPREWPQVQE  249 (311)
T ss_dssp             C----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT--HHHHHHH-HHCCCCTTTSGGGTT
T ss_pred             cc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH-HHCCCChHHhhhhhc
Confidence            22 233578999999999876 568999999999999999999999997654321  1111110 000            


Q ss_pred             -HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          267 -RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       267 -~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                       .......+.. .+..............+.+++.+||+.||.+||++.|+++
T Consensus       250 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          250 LPLWKQRTFQV-FEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             SHHHHSCCCCC-CCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cchhhhccccc-ccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             0000001100 0000000001112347889999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.6e-44  Score=344.92  Aligned_cols=258  Identities=26%  Similarity=0.397  Sum_probs=212.3

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe------CCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL------PNGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      ..++|.+.+.||+|+||.||+|..      .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            357899999999999999999985      2458899999976432 334678899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccc
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGR----------------------PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIK  172 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIk  172 (416)
                      .++||||+++++|.+++.....                      ..+++..++.++.|++.||.|||+.   +|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence            9999999999999999976432                      2489999999999999999999999   99999999


Q ss_pred             CCcEEECCCCceEEeecccceeccCCCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCC
Q 014904          173 AANILLDFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTH  250 (416)
Q Consensus       173 p~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~  250 (416)
                      |+|||++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999998765443322 233457889999999999899999999999999999999 999997654


Q ss_pred             cccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          251 TFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       251 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      ..   .+.        ..+..+...         ..+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus       258 ~~---~~~--------~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          258 PE---RLF--------NLLKTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             GG---GHH--------HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH---HHH--------HHhhcCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            31   111        111222211         11122345789999999999999999999999999854

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=9.4e-44  Score=350.74  Aligned_cols=254  Identities=24%  Similarity=0.331  Sum_probs=193.3

Q ss_pred             HHhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           40 ARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        40 ~~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ..+.++|.+.+.||+|+||.||+|... +++.||||+++...  ..+.+.+|+.++.+++||||+++++++......++|
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            446788999999999999999999965 58899999998543  345688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC---CCceEEeecccceec
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFGLAKIA  195 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~---~~~~kl~DFGla~~~  195 (416)
                      |||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++..
T Consensus       127 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             ECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99999999999987543  589999999999999999999999   9999999999999975   889999999999866


Q ss_pred             cCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  ..+        ...+..+...
T Consensus       202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~--------~~~i~~~~~~  269 (349)
T 2w4o_A          202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFM--------FRRILNCEYY  269 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHH--------HHHHHTTCCC
T ss_pred             Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHH--------HHHHHhCCCc
Confidence            4322  223467999999999999999999999999999999999999999754431  111        1111122211


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                       ...+     ........+.+++.+||+.||++||++.|+++.
T Consensus       270 -~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          270 -FISP-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             -CCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -cCCc-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             1111     112234578899999999999999999999863

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3e-44  Score=341.55  Aligned_cols=257  Identities=29%  Similarity=0.435  Sum_probs=212.3

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ..++|.+.+.||+|+||.||+|...+++.||||++.... .....+.+|+.++++++||||+++++++.. ...++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            457889999999999999999998888899999997654 345689999999999999999999999864 568899999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            9999999999754333689999999999999999999999   9999999999999999999999999999877654333


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                      ......++..|+|||.+.++.++.++||||||++++||++ |+.||.....   ..+.        ..+..+..     .
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~--------~~~~~~~~-----~  229 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVI--------QNLERGYR-----M  229 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHH--------HHHHTTCC-----C
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHH--------HHHhcccC-----C
Confidence            3334567889999999998899999999999999999999 9999876432   1111        11112210     1


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                          ..+......+.+++.+|++.+|++||++.+|++.|+...
T Consensus       230 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          230 ----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence                111223457899999999999999999999999998643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3e-43  Score=345.79  Aligned_cols=249  Identities=23%  Similarity=0.334  Sum_probs=206.6

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecC---CcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAG---SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .++|.+.+.||+|+||.||+|... +|+.||||+++..   .......+..|+.++..++||||+++++++......++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            468999999999999999999964 6899999999753   223345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+++++|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            99999999999987543  589999999999999999999999   9999999999999999999999999999864332


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      .. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+   .     ..+..+..    
T Consensus       159 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~---~-----~~i~~~~~----  222 (337)
T 1o6l_A          159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERL---F-----ELILMEEI----  222 (337)
T ss_dssp             TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---H-----HHHHHCCC----
T ss_pred             CC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---HHH---H-----HHHHcCCC----
Confidence            22 23446799999999999999999999999999999999999999976432   111   1     11111211    


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRP-----RMSQIVRA  318 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~~  318 (416)
                        .    ++......+.+++.+||+.+|.+||     ++.||++.
T Consensus       223 --~----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          223 --R----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             --C----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --C----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence              1    1122335788999999999999999     89998864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.1e-44  Score=367.57  Aligned_cols=257  Identities=30%  Similarity=0.418  Sum_probs=207.8

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ..++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++||||+++++++.+ ...++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            457889999999999999999999888899999998654 345689999999999999999999999876 678999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.+++.......+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  336 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  336 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence            9999999999754444689999999999999999999999   9999999999999999999999999999876543333


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                      ......++..|+|||++.++.++.++|||||||+||||++ |+.||......   .+        ...+..+..      
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~--------~~~i~~~~~------  399 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV--------LDQVERGYR------  399 (452)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH--------HHHHHTTCC------
T ss_pred             cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HH--------HHHHHcCCC------
Confidence            3334557889999999999999999999999999999999 99999764321   11        111222211      


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                         ...+..++..+.+++.+||+.+|++||++.+|++.|+...
T Consensus       400 ---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          400 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence               1112234467899999999999999999999999998654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.3e-43  Score=344.37  Aligned_cols=260  Identities=19%  Similarity=0.214  Sum_probs=209.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||++......  ..+..|+.+++++ +|+||+++++++......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            347899999999999999999995 57899999998755332  3688999999999 9999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc-----eEEeeccccee
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE-----AKVADFGLAKI  194 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~-----~kl~DFGla~~  194 (416)
                      ||+ +++|.+++.... ..+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.     +||+|||+++.
T Consensus        85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             ECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            999 999999997643 3699999999999999999999999   9999999999999998887     99999999987


Q ss_pred             ccCCCcce------eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHh
Q 014904          195 ASDVNTHV------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRA  268 (416)
Q Consensus       195 ~~~~~~~~------~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~  268 (416)
                      ........      .....||+.|+|||++.+..++.++|||||||++|||++|+.||................   ...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~---~~~  236 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG---DTK  236 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH---HHH
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH---hhh
Confidence            65433321      235679999999999999999999999999999999999999998754322211111110   000


Q ss_pred             hhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          269 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       269 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      .. -..     ..+..    ..+ .+.+++..|++.+|.+||++.+|++.|+..
T Consensus       237 ~~-~~~-----~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          237 RA-TPI-----EVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             HH-SCH-----HHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             cc-CCH-----HHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            00 000     00001    112 789999999999999999999999999743

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5e-44  Score=337.37  Aligned_cols=255  Identities=30%  Similarity=0.440  Sum_probs=211.9

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      .++|.+.+.||+|+||.||+|...+++.||||++..... ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            367889999999999999999988889999999986543 4568999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++++|.+++..... .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        86 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  161 (267)
T 3t9t_A           86 EHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  161 (267)
T ss_dssp             TTCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCCcHHHHHhhCcc-cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence            99999999976533 689999999999999999999999   99999999999999999999999999998664432222


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....   ..+.        ..+..+..  ..   
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~--------~~i~~~~~--~~---  225 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVV--------EDISTGFR--LY---  225 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH--------HHHHTTCC--CC---
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHHH--------HHHhcCCc--CC---
Confidence            233567888999999998999999999999999999999 8999876432   1111        11112211  00   


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                          .+......+.+++.+||+.+|.+||++.++++.|+..
T Consensus       226 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          226 ----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                1112235788999999999999999999999999854

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.1e-43  Score=336.35  Aligned_cols=261  Identities=18%  Similarity=0.207  Sum_probs=211.7

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||++.....  ...+.+|+.++.++ +|+|++++++++.+....++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            346899999999999999999995 5799999999875432  23678899999999 7999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc-----eEEeeccccee
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE-----AKVADFGLAKI  194 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~-----~kl~DFGla~~  194 (416)
                      ||+ +++|.+++...+. .+++..++.|+.|++.||.|||+.   +|+||||||+|||++.++.     +||+|||+++.
T Consensus        86 e~~-~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             ECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             Eec-CCCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            999 9999999986543 599999999999999999999999   9999999999999987776     99999999987


Q ss_pred             ccCCCcc------eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHh
Q 014904          195 ASDVNTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRA  268 (416)
Q Consensus       195 ~~~~~~~------~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~  268 (416)
                      .......      ......||+.|+|||++.+..++.++||||||+++|||++|+.||..................    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~----  236 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK----  236 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH----
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh----
Confidence            6554332      224467999999999999999999999999999999999999999875443222222111100    


Q ss_pred             hhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          269 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       269 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      ......     +.+..    ..+..+.+++.+||+.+|.+||++.+|++.|+..
T Consensus       237 ~~~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          237 KQSTPL-----RELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             HHHSCH-----HHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             ccCccH-----HHHHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            000000     00111    1235789999999999999999999999999854

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.3e-44  Score=367.53  Aligned_cols=265  Identities=20%  Similarity=0.242  Sum_probs=213.8

Q ss_pred             cCHHHHHHhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEE
Q 014904           34 FTYEELARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYY  109 (416)
Q Consensus        34 f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~  109 (416)
                      +.+.++...+++|.+.++||+|+||.||+|.+. +++.||||+++....   .....+.+|..++..++||||++++++|
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            445667777899999999999999999999965 578999999975321   1122488999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeec
Q 014904          110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF  189 (416)
Q Consensus       110 ~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DF  189 (416)
                      .+....+|||||+++++|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+||||+.++.+||+||
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence            99999999999999999999997643 2699999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccCCCcceeecccccccccChhhhc-----cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH
Q 014904          190 GLAKIASDVNTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL  264 (416)
Q Consensus       190 Gla~~~~~~~~~~~~~~~gt~~YlaPE~~~-----~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~  264 (416)
                      |+++.............+||+.|+|||++.     .+.++.++|||||||++|||++|+.||.......   .   ....
T Consensus       220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~---~---~~~i  293 (437)
T 4aw2_A          220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---T---YGKI  293 (437)
T ss_dssp             TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHH
T ss_pred             hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH---H---HHhh
Confidence            999877665555555578999999999987     5678999999999999999999999998654311   1   1111


Q ss_pred             hHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 014904          265 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARR--RPRMSQIVRA  318 (416)
Q Consensus       265 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evv~~  318 (416)
                      +... ..-.     -|.....    ....+.+++.+||+.+|++  ||++.||++.
T Consensus       294 ~~~~-~~~~-----~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          294 MNHK-ERFQ-----FPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HTHH-HHCC-----CCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hhcc-cccc-----CCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            1000 0001     1111111    2346888999999888888  9999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-43  Score=344.06  Aligned_cols=253  Identities=18%  Similarity=0.301  Sum_probs=208.4

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++..++||||+++++++.+....++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            4678999999999999999999964 68899999987543 334578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC--CCceEEeecccceeccCC
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF--KFEAKVADFGLAKIASDV  198 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~--~~~~kl~DFGla~~~~~~  198 (416)
                      |+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.  ++.+||+|||+++.....
T Consensus        82 ~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           82 FISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             eCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999997543 3689999999999999999999999   9999999999999987  789999999999877543


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ..+.        ..+..+.+..  
T Consensus       158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~--------~~i~~~~~~~--  222 (321)
T 1tki_A          158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQII--------ENIMNAEYTF--  222 (321)
T ss_dssp             C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHH--------HHHHHTCCCC--
T ss_pred             C--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---HHHH--------HHHHcCCCCC--
Confidence            2  23446799999999999988899999999999999999999999976443   1111        1111222110  


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ++....    .....+.+++.+||+.+|.+||++.|+++.
T Consensus       223 ~~~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          223 DEEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             Chhhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            000001    123578899999999999999999999974

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=359.25  Aligned_cols=259  Identities=28%  Similarity=0.406  Sum_probs=209.8

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  115 (416)
                      .++|.+.+.||+|+||.||+|.+.      +++.||||+++... ......+..|+.++++++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            367889999999999999999943      46789999997543 33445788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC---ceEEe
Q 014904          116 MLVYEFVPNNTLEFHLHGKG-----RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF---EAKVA  187 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~-----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~---~~kl~  187 (416)
                      ++||||+++++|.+++....     ...+++..++.|+.|++.||+|||+.   +|+||||||+||||+.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997532     23589999999999999999999999   999999999999999554   59999


Q ss_pred             ecccceeccCCC-cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHh
Q 014904          188 DFGLAKIASDVN-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLL  265 (416)
Q Consensus       188 DFGla~~~~~~~-~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~  265 (416)
                      |||+++...... ........||+.|+|||++.++.++.++|||||||++|||++ |+.||.....   ..+.       
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~-------  296 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVL-------  296 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHH-------
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHH-------
Confidence            999997543222 222344678999999999999999999999999999999998 9999976543   1111       


Q ss_pred             HHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 014904          266 NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDAS  324 (416)
Q Consensus       266 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~~  324 (416)
                       ..+..+...         ..+......+.+++.+||+.+|.+||++.+|++.|+....
T Consensus       297 -~~i~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          297 -EFVTSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             -HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHcCCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence             111222211         1112234578899999999999999999999999986543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=342.37  Aligned_cols=253  Identities=23%  Similarity=0.345  Sum_probs=207.2

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc------cHHHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ------GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      ..++|.+.+.||+|+||.||+|... +|+.||||++......      ....+.+|+.++++++||||+++++++.+...
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3467999999999999999999964 6899999999764322      35679999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC----ceEEeecc
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF----EAKVADFG  190 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~----~~kl~DFG  190 (416)
                      .++||||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++    .+||+|||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999996543  699999999999999999999999   999999999999999887    79999999


Q ss_pred             cceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh
Q 014904          191 LAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       191 la~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~  270 (416)
                      +++.......  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......  ..+.         .+.
T Consensus       164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~---------~~~  230 (326)
T 2y0a_A          164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLA---------NVS  230 (326)
T ss_dssp             TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHH---------HHH
T ss_pred             CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHH---------HHH
Confidence            9987654322  23457999999999999999999999999999999999999999764321  1110         011


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ..... + .+....    .....+.+++.+||+.+|.+||++.|+++.
T Consensus       231 ~~~~~-~-~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          231 AVNYE-F-EDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HTCCC-C-CHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hcCCC-c-Cccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11110 0 000001    123568899999999999999999999863

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.4e-44  Score=339.75  Aligned_cols=256  Identities=25%  Similarity=0.401  Sum_probs=197.6

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCC----CcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPN----GKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      ..++|.+.+.||+|+||.||+|....    +..||||++..... ...+.+.+|+.++++++||||+++++++. ....+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            45789999999999999999999643    45799999876433 23457899999999999999999999984 46788


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccC
Confidence            9999999999999997653 3689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ...........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......   .+.        ..+..+...
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~--------~~i~~~~~~  236 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVI--------GRIENGERL  236 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHH--------HHHHTTCCC
T ss_pred             cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHH--------HHHHcCCCC
Confidence            544333344567889999999999999999999999999999997 99999765431   111        111222211


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                           .    .+...+..+.+++.+||+.+|.+||++.||++.|+..
T Consensus       237 -----~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          237 -----P----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             -----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----C----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                 1    1223345788999999999999999999999999854

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.9e-43  Score=348.60  Aligned_cols=213  Identities=25%  Similarity=0.314  Sum_probs=187.9

Q ss_pred             CccccCHHHHHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-----CCccc
Q 014904           30 SKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-----HKHLV  103 (416)
Q Consensus        30 ~~~~f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv  103 (416)
                      ....|++.+.....++|.+.++||+|+||.||+|.. .+++.||||+++.. ......+..|+.++..+.     ||||+
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            345577777778899999999999999999999996 57899999999743 233456788999999996     99999


Q ss_pred             ceEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC---
Q 014904          104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF---  180 (416)
Q Consensus       104 ~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~---  180 (416)
                      ++++++......++||||+ +++|.+++.......+++..++.++.|++.||+|||+.   +|+||||||+||||+.   
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence            9999999999999999999 99999999876655799999999999999999999999   9999999999999975   


Q ss_pred             ----------------------CCceEEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHH
Q 014904          181 ----------------------KFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLE  238 (416)
Q Consensus       181 ----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~e  238 (416)
                                            ++.+||+|||+++......    ....||+.|+|||++.+..++.++|||||||++|+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                  7889999999998754422    34578999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 014904          239 LITGRRPVDSTHT  251 (416)
Q Consensus       239 lltG~~pf~~~~~  251 (416)
                      |++|+.||.....
T Consensus       252 ll~g~~pf~~~~~  264 (360)
T 3llt_A          252 LYTGSLLFRTHEH  264 (360)
T ss_dssp             HHHSSCSCCCSSH
T ss_pred             HHHCCCCCCCCcH
Confidence            9999999986543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.2e-44  Score=358.11  Aligned_cols=254  Identities=23%  Similarity=0.332  Sum_probs=194.9

Q ss_pred             hhCCCCcC-ceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHh-cCCCcccceEEEEEe----CCe
Q 014904           42 ATDGFSDA-NLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISR-VHHKHLVSLVGYYTA----GSQ  114 (416)
Q Consensus        42 ~t~~f~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~  114 (416)
                      ..++|.+. ++||+|+||.||+|.+. +|+.||||+++..     ..+.+|+.++.+ .+||||+++++++..    ...
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            34566665 68999999999999964 6899999999632     356788888754 589999999999876    567


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC---CCceEEeeccc
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFGL  191 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~---~~~~kl~DFGl  191 (416)
                      .+|||||+++++|.+++.......+++..++.|+.|++.||.|||+.   +|+||||||+||||+.   ++.+||+|||+
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence            89999999999999999876656799999999999999999999999   9999999999999998   78899999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhc
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIED  271 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~  271 (416)
                      ++.......  .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........       .....+..
T Consensus       211 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-------~~~~~i~~  281 (400)
T 1nxk_A          211 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GMKTRIRM  281 (400)
T ss_dssp             CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-------SHHHHHHH
T ss_pred             ccccCCCCc--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-------HHHHHHHc
Confidence            986653222  234678999999999999999999999999999999999999997654321100       00111122


Q ss_pred             CCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          272 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       272 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      +.+. +..+.     .......+.+++.+||+.||.+||++.||++.
T Consensus       282 ~~~~-~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          282 GQYE-FPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TCCC-CCTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             Cccc-CCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            2221 11111     11233578899999999999999999999975

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=348.43  Aligned_cols=252  Identities=22%  Similarity=0.356  Sum_probs=198.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCC--CcccceEEEEEeCCeEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHH--KHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l  117 (416)
                      ..++|.+.+.||+|+||.||++...+++.||||++.....  .....+.+|+.++.+++|  +||+++++++......++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            3567999999999999999999988899999999976533  233578999999999976  999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||| +.+++|.+++....  .+++..+..|+.|++.||.|||+.   +|+||||||+|||++ ++.+||+|||+++....
T Consensus        87 v~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEC-CCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             EEe-CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            999 56889999997654  589999999999999999999999   999999999999997 67899999999987654


Q ss_pred             CCcc-eeecccccccccChhhhcc-----------CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHh
Q 014904          198 VNTH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLL  265 (416)
Q Consensus       198 ~~~~-~~~~~~gt~~YlaPE~~~~-----------~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~  265 (416)
                      .... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||......    ...     +
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~-----~  230 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----ISK-----L  230 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----HHH-----H
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----HHH-----H
Confidence            3332 2345679999999999865           67899999999999999999999999753321    100     0


Q ss_pred             HHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          266 NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       266 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ..         ++++.....++......+.+++.+||+.+|.+||++.||++.
T Consensus       231 ~~---------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          231 HA---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HH---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HH---------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            01         111111122222233578899999999999999999999865

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8e-44  Score=336.04  Aligned_cols=251  Identities=20%  Similarity=0.315  Sum_probs=206.3

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeC--CeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAG--SQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV  118 (416)
                      .++|.+.+.||+|+||.||+|.+ +++.||||+++....  ...+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            46899999999999999999998 488999999986542  3345789999999999999999999999886  778999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeecccCCcEEECCCCceEEeecccceecc
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK--IIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      |||+++++|.+++.......+++..++.|+.|++.||.|||+.   +  |+||||||+||+++.++.++|+|||+.....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            9999999999999877666799999999999999999999998   7  9999999999999999999999998875432


Q ss_pred             CCCcceeecccccccccChhhhccCCCCc---hhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLTE---KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t~---ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      .      ....||+.|+|||.+.+...+.   ++||||||+++|||++|+.||.......          ........+.
T Consensus       165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------~~~~~~~~~~  228 (271)
T 3kmu_A          165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME----------IGMKVALEGL  228 (271)
T ss_dssp             C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH----------HHHHHHHSCC
T ss_pred             c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH----------HHHHHHhcCC
Confidence            2      2346899999999998765444   8999999999999999999997644211          0111111111


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                           .+.    .+......+.+++.+||+.+|++||++.||++.|+..
T Consensus       229 -----~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          229 -----RPT----IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             -----CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                 111    1222345789999999999999999999999999853

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.7e-43  Score=349.41  Aligned_cols=272  Identities=17%  Similarity=0.261  Sum_probs=206.4

Q ss_pred             hhCCCCcCceeccc--CcEEEEEEEeC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           42 ATDGFSDANLLGQG--GFGYVHRGVLP-NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        42 ~t~~f~~~~~LG~G--~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      ..++|.+.++||+|  +||.||+|... +|+.||||++.....  .....+.+|+.++++++||||+++++++.+....+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            34689999999999  99999999965 799999999975432  22356888999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +||||+++++|.+++.......+++..++.|+.|++.||+|||+.   +|+||||||+||||+.++.+||+|||++....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999999876555799999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCCc------ceeecccccccccChhhhcc--CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHh
Q 014904          197 DVNT------HVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRA  268 (416)
Q Consensus       197 ~~~~------~~~~~~~gt~~YlaPE~~~~--~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~  268 (416)
                      ....      .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.......  .+.......+...
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~  257 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCL  257 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--HHHHC--------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcCCCCcc
Confidence            2211      11122478999999999987  579999999999999999999999997644311  1111000000000


Q ss_pred             hh------------------cCCcccccC---c------cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          269 IE------------------DGNFDTLVD---P------KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       269 ~~------------------~~~~~~~~d---~------~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ..                  .......+.   +      .....+.......+.+|+.+||+.||.+||++.|+++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            00                  000000000   0      00001222334578999999999999999999999854

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.5e-43  Score=334.58  Aligned_cols=267  Identities=19%  Similarity=0.264  Sum_probs=201.4

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ++|.+.+.||+|+||+||+|... +++.||||++......  ....+.+|+.++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999964 6899999999865432  23678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+.++.+..+....  ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             cCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence            99865444444322  2599999999999999999999999   999999999999999999999999999987653322


Q ss_pred             ceeecccccccccChhhhccCC-CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhH-------HhhhcC
Q 014904          201 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN-------RAIEDG  272 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~-~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~-------~~~~~~  272 (416)
                       ......||+.|+|||++.+.. ++.++|||||||++++|++|+.||..... ..+.+.........       ......
T Consensus       157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-HHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHHhCCCChhhhhhhcccc
Confidence             223457899999999998765 89999999999999999999888644332 11111111110000       000000


Q ss_pred             Ccc---cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          273 NFD---TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       273 ~~~---~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .+.   ..................+.+++.+||+.||++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            000   000000011112234457889999999999999999999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-43  Score=348.78  Aligned_cols=254  Identities=21%  Similarity=0.329  Sum_probs=209.7

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|++..........+.+|+.++..++||||+++++++.+....++|||
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            3578999999999999999999964 689999999987665556688999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC--CCceEEeecccceeccCC
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF--KFEAKVADFGLAKIASDV  198 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~--~~~~kl~DFGla~~~~~~  198 (416)
                      |+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.  ++.+||+|||+++.....
T Consensus       129 ~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          129 FLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             cCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999999987543 3689999999999999999999999   9999999999999974  477999999999876543


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      ..  .....||+.|+|||++.+..++.++|||||||++|||++|+.||......   ...        ..+..+.+.  .
T Consensus       205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~--------~~i~~~~~~--~  269 (387)
T 1kob_A          205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETL--------QNVKRCDWE--F  269 (387)
T ss_dssp             SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH--------HHHHHCCCC--C
T ss_pred             cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHH--------HHHHhCCCC--C
Confidence            32  23457999999999999999999999999999999999999999764421   111        111111111  1


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ++..    .......+.+++.+||+.+|.+||++.|+++.
T Consensus       270 ~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          270 DEDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CSST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             Cccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            1111    11234578899999999999999999999864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.9e-43  Score=334.59  Aligned_cols=252  Identities=33%  Similarity=0.581  Sum_probs=203.8

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccH-------HHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGE-------REFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      .++|.+.+.||+|+||.||+|.+ .+++.||||++........       +.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            37899999999999999999996 5789999999875433221       57889999999999999999999987655 


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeecccCCcEEECCCCc-----eEEe
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK--IIHRDIKAANILLDFKFE-----AKVA  187 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--iiHrDIkp~NILl~~~~~-----~kl~  187 (416)
                       ++||||+++++|.+.+..... .+++..++.++.|++.||+|||+.   +  |+||||||+|||++.++.     +||+
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             -eEEEEecCCCCHHHHHhcccC-CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence             699999999999888865543 699999999999999999999998   8  999999999999988776     9999


Q ss_pred             ecccceeccCCCcceeecccccccccChhhh--ccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHh
Q 014904          188 DFGLAKIASDVNTHVSTRVMGTFGYLAPEYA--SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLL  265 (416)
Q Consensus       188 DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~--~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~  265 (416)
                      |||+++....    ......||+.|+|||++  ....++.++||||||+++|||++|+.||........ .....     
T Consensus       172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~-----  241 (287)
T 4f0f_A          172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINM-----  241 (287)
T ss_dssp             CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHH-----
T ss_pred             CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHH-----
Confidence            9999975433    23346799999999998  445678999999999999999999999976543111 11110     


Q ss_pred             HHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          266 NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       266 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                         ......        ....+......+.+++.+||+.+|.+||++.||++.|+.
T Consensus       242 ---~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          242 ---IREEGL--------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             ---HHHSCC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             ---HhccCC--------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence               111111        111222334578999999999999999999999999974

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.8e-43  Score=347.54  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=208.4

Q ss_pred             HHhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           40 ARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        40 ~~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      ....++|.+.+.||+|+||.||+|... +|+.||||++......  ....+.+|+.++++++||||+++++++.+....+
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            345678999999999999999999964 6899999999865432  2356889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC---ceEEeecccce
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF---EAKVADFGLAK  193 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~---~~kl~DFGla~  193 (416)
                      +||||+++++|.+.+....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++   .+||+|||++.
T Consensus       105 lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            9999999999999886543  589999999999999999999999   999999999999998654   59999999998


Q ss_pred             eccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      .......  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ..+.        ..+..+.
T Consensus       180 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~--------~~i~~~~  246 (362)
T 2bdw_A          180 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLY--------AQIKAGA  246 (362)
T ss_dssp             CCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH--------HHHHHTC
T ss_pred             EecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH--------HHHHhCC
Confidence            7654322  2346799999999999998999999999999999999999999976432   1111        1122232


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      +.. ..+.     .......+.+++.+||+.+|.+||++.|+++.
T Consensus       247 ~~~-~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          247 YDY-PSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CCC-CTTG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCC-Cccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            211 1111     01223578899999999999999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8e-43  Score=335.36  Aligned_cols=250  Identities=21%  Similarity=0.293  Sum_probs=198.4

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc--------------------------cHHHHHHHHHHH
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ--------------------------GEREFQAEVEII   94 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--------------------------~~~~~~~E~~~l   94 (416)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||++......                          ....+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            357899999999999999999995 46899999999754321                          124688999999


Q ss_pred             HhcCCCcccceEEEEEe--CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccc
Q 014904           95 SRVHHKHLVSLVGYYTA--GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIK  172 (416)
Q Consensus        95 ~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIk  172 (416)
                      ++++||||+++++++.+  ....++||||+++++|.+++..   ..+++..++.++.|++.||+|||+.   +|+|||||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk  164 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK  164 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence            99999999999999987  6689999999999999876543   3699999999999999999999999   99999999


Q ss_pred             CCcEEECCCCceEEeecccceeccCCCcceeecccccccccChhhhccCC---CCchhhhHhHHHHHHHHHhCCCCCCCC
Q 014904          173 AANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELITGRRPVDST  249 (416)
Q Consensus       173 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~---~t~ksDV~SlGvvL~elltG~~pf~~~  249 (416)
                      |+|||++.++.+||+|||+++....... ......||+.|+|||.+.+..   .+.++|||||||++|+|++|+.||...
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            9999999999999999999987654332 233467999999999997665   378999999999999999999999754


Q ss_pred             CcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          250 HTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       250 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..      ..+.     ..+..+....   + ...    .....+.+++.+||+.+|++||++.||++
T Consensus       244 ~~------~~~~-----~~~~~~~~~~---~-~~~----~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          244 RI------MCLH-----SKIKSQALEF---P-DQP----DIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SH------HHHH-----HHHHHCCCCC---C-SSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cH------HHHH-----HHHhcccCCC---C-Ccc----ccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            32      1111     1111121110   0 011    12347899999999999999999999874

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=9.2e-44  Score=358.41  Aligned_cols=260  Identities=22%  Similarity=0.277  Sum_probs=210.2

Q ss_pred             HHHHHHhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEe
Q 014904           36 YEELARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTA  111 (416)
Q Consensus        36 ~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  111 (416)
                      +.++....++|.+.++||+|+||.||+|... +++.||+|+++...   ......+.+|+.++..++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3455566789999999999999999999965 58999999997521   1112357899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       112 ~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                      ....++||||+++++|.+++...   .+++..+..++.+++.||.|||+.   +|+||||||+||||+.++.+||+|||+
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence            99999999999999999999754   489999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccCC----CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHH
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNR  267 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~----~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~  267 (416)
                      ++.............+||+.|+|||++.+..    ++.++|||||||++|||++|+.||......      .....++..
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~  288 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNH  288 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTH
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHHhc
Confidence            9877654444445678999999999997655    789999999999999999999999765431      111111100


Q ss_pred             hhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 014904          268 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARR--RPRMSQIVRA  318 (416)
Q Consensus       268 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evv~~  318 (416)
                      .. .-.+     |. ..    .....+.+++.+||+.+|.+  ||++.||++.
T Consensus       289 ~~-~~~~-----p~-~~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          289 KN-SLTF-----PD-DN----DISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HH-HCCC-----CT-TC----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             cc-cccC-----CC-cc----cccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            00 0000     10 01    12347889999999999998  9999999975

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=6.7e-43  Score=347.88  Aligned_cols=246  Identities=23%  Similarity=0.341  Sum_probs=198.0

Q ss_pred             CceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCH
Q 014904           49 ANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTL  127 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL  127 (416)
                      .++||+|+||.||+|.. .+|+.||||+++.........+.+|+.++.+++||||+++++++.+....+|||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56899999999999995 56899999999876656667899999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE--CCCCceEEeecccceeccCCCcceeec
Q 014904          128 EFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL--DFKFEAKVADFGLAKIASDVNTHVSTR  205 (416)
Q Consensus       128 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~~~  205 (416)
                      .+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||+  +.++.+||+|||+++.......  ...
T Consensus       174 ~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~  247 (373)
T 2x4f_A          174 FDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV  247 (373)
T ss_dssp             HHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence            98886543 2589999999999999999999999   99999999999999  6678899999999987654332  233


Q ss_pred             ccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCc
Q 014904          206 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNE  285 (416)
Q Consensus       206 ~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~  285 (416)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......  ..+..    .     ....+. +.. .... 
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~----i-----~~~~~~-~~~-~~~~-  313 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLNN----I-----LACRWD-LED-EEFQ-  313 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH----H-----HHTCCC-SCS-GGGT-
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH----H-----HhccCC-CCh-hhhc-
Confidence            56999999999999999999999999999999999999999765431  11111    1     111111 001 1111 


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          286 YNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       286 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                         .....+.+++.+||+.+|.+||++.|+++
T Consensus       314 ---~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          314 ---DISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             ---TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               12357899999999999999999999997

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6e-43  Score=334.81  Aligned_cols=266  Identities=21%  Similarity=0.324  Sum_probs=200.7

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ++|.+.+.||+|+||.||+|...+|+.||||++......  ....+.+|+.++++++||||+++++++......++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            578999999999999999999988999999999754322  235788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +.+ +|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (288)
T ss_dssp             CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence            975 8888886543 3689999999999999999999999   999999999999999999999999999986543222 


Q ss_pred             eeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHh-------HHhhhcCC
Q 014904          202 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLL-------NRAIEDGN  273 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~-------~~~~~~~~  273 (416)
                      ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......  +.+.......-       ....+...
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHCCCChhhchhhhcccc
Confidence            22335689999999999764 5899999999999999999999999765431  11111110000       00000000


Q ss_pred             ccc---ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          274 FDT---LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       274 ~~~---~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      +..   ...+.............+.+++.+||+.||++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000   00000001111223457889999999999999999999985

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.6e-43  Score=343.78  Aligned_cols=263  Identities=25%  Similarity=0.361  Sum_probs=196.3

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEEeCC-Cc---EEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEe
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGVLPN-GK---EVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTA  111 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~-g~---~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  111 (416)
                      ++....++|.+.+.||+|+||.||+|.+.. ++   .||||+++...  ....+.+.+|+.++++++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            333456789999999999999999999644 32   79999997652  3334679999999999999999999999987


Q ss_pred             CCeE------EEEEEecCCCCHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC
Q 014904          112 GSQR------MLVYEFVPNNTLEFHLHGKG----RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK  181 (416)
Q Consensus       112 ~~~~------~lV~e~~~~~sL~~~l~~~~----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~  181 (416)
                      ....      ++|+||+.+++|.+++....    ...+++..++.|+.|++.||+|||+.   +|+||||||+|||++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED  173 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence            6655      99999999999999885422    22589999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhh
Q 014904          182 FEAKVADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVD  259 (416)
Q Consensus       182 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~  259 (416)
                      +.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......   .+. 
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~-  249 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIY-  249 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHH-
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHH-
Confidence            99999999999866443322 2233457889999999999999999999999999999999 99999765431   111 


Q ss_pred             hhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          260 WARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                             ..+..+...         ..+......+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       250 -------~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          250 -------NYLIGGNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             -------HHHHTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------HHHhcCCCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                   111111111         111223457899999999999999999999999998643

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.6e-43  Score=349.00  Aligned_cols=266  Identities=18%  Similarity=0.217  Sum_probs=205.7

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCC------CcEEEEEEeecCCcccH-----------HHHHHHHHHHHhcCCCcccc
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPN------GKEVAIKQLKAGSGQGE-----------REFQAEVEIISRVHHKHLVS  104 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~  104 (416)
                      ..++|.+.++||+|+||.||+|.+..      ++.||||++........           ..+..|+..+..++|+||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            46799999999999999999999754      47899999886543211           12334556677788999999


Q ss_pred             eEEEEEeC----CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC-
Q 014904          105 LVGYYTAG----SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD-  179 (416)
Q Consensus       105 l~~~~~~~----~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~-  179 (416)
                      +++++...    ...++||||+ +++|.+++.... ..+++..++.|+.|++.||+|||+.   +|+||||||+||||+ 
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence            99998774    4589999999 999999997643 3699999999999999999999999   999999999999999 


Q ss_pred             -CCCceEEeecccceeccCCCcce------eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcc
Q 014904          180 -FKFEAKVADFGLAKIASDVNTHV------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTF  252 (416)
Q Consensus       180 -~~~~~kl~DFGla~~~~~~~~~~------~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~  252 (416)
                       .++.+||+|||+++.........      .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... 
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~-  266 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK-  266 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT-
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc-
Confidence             88999999999998765432221      1334599999999999999999999999999999999999999975322 


Q ss_pred             cchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          253 VEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       253 ~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                       ......+.....     ...+..++++.+..   ...+..+.+++..||+.+|.+||++.+|++.|+..
T Consensus       267 -~~~~~~~~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          267 -DPKYVRDSKIRY-----RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             -CHHHHHHHHHHH-----HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             -CHHHHHHHHHHh-----hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence             122222211111     11122222222211   12235789999999999999999999999999854

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.1e-43  Score=347.86  Aligned_cols=248  Identities=27%  Similarity=0.365  Sum_probs=200.7

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  117 (416)
                      .++|.+.++||+|+||.||+|... +|+.||||+++...   ......+..|..++..+ +||||+++++++.+....++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999964 68999999997532   22335678899999988 79999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+++++|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++....
T Consensus       102 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            999999999999997654  589999999999999999999999   999999999999999999999999999985432


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      .. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+       + ..+..+.+   
T Consensus       177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~-------~-~~i~~~~~---  241 (353)
T 3txo_A          177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DL-------F-EAILNDEV---  241 (353)
T ss_dssp             ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH-------H-HHHHHCCC---
T ss_pred             CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HH-------H-HHHHcCCC---
Confidence            22 2234467999999999999889999999999999999999999999765431   11       1 11112221   


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRM------SQIVR  317 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~------~evv~  317 (416)
                             .++......+.+++.+||+.+|.+||++      .||++
T Consensus       242 -------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 -------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                   1112233568899999999999999998      66664

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.2e-44  Score=346.72  Aligned_cols=257  Identities=27%  Similarity=0.410  Sum_probs=203.5

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcE----EEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKE----VAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      .++|.+.++||+|+||.||+|.+. +++.    ||+|++.... ......+.+|+.++.+++||||+++++++.. ...+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence            357889999999999999999954 4554    7888775433 2223467789999999999999999999864 5688


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +|+||+.+++|.+++.... ..+++..++.|+.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        91 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            9999999999999997643 2688999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          197 DVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       197 ~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ..... ......||..|+|||++.++.++.++|||||||++|+|++ |+.||.......   +.        ..+..+..
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~--------~~~~~~~~  235 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VP--------DLLEKGER  235 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HH--------HHHHTTCB
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HH--------HHHHcCCC
Confidence            44332 2344678889999999999999999999999999999999 999998654311   11        11122211


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDAS  324 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~~  324 (416)
                      .  ..+       ......+.+++.+||+.+|.+||++.||++.|+....
T Consensus       236 ~--~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          236 L--AQP-------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             C--CCC-------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             C--CCC-------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            1  111       1122357889999999999999999999999986543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=344.52  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=201.1

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcE----EEEEEeecC-CcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKE----VAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~----vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      .++|.+.++||+|+||.||+|.+. +++.    ||+|.+... .......+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            468999999999999999999953 4554    577777543 3345678999999999999999999999998765 78


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +|++++.+++|.+++..... .+++..++.|+.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            89999999999999976543 699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          197 DVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       197 ~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ..... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......   +.        ..+..+..
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~--------~~~~~~~~  237 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS--------SILEKGER  237 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH--------HHHHTTCC
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH--------HHHHcCCC
Confidence            43322 2233456888999999999999999999999999999999 999997654311   11        11122211


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      .         ..+......+.+++.+||+.+|.+||++.||++.|+...
T Consensus       238 ~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          238 L---------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             C---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            1         111223447889999999999999999999999998654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7.2e-43  Score=339.13  Aligned_cols=251  Identities=21%  Similarity=0.341  Sum_probs=199.8

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCC------
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGS------  113 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  113 (416)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3567999999999999999999975 799999999985443 34467999999999999999999999986643      


Q ss_pred             ---------------------------------------------------eEEEEEEecCCCCHHHHhhcCCC-CCCCH
Q 014904          114 ---------------------------------------------------QRMLVYEFVPNNTLEFHLHGKGR-PTMDW  141 (416)
Q Consensus       114 ---------------------------------------------------~~~lV~e~~~~~sL~~~l~~~~~-~~l~~  141 (416)
                                                                         ..++||||+++++|.+++..... ...++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               37999999999999999976543 34677


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc-----------ceeecccccc
Q 014904          142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT-----------HVSTRVMGTF  210 (416)
Q Consensus       142 ~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~  210 (416)
                      ..++.++.|++.||+|||+.   +|+||||||+||||+.++.+||+|||+++.......           .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            78899999999999999999   999999999999999999999999999987655422           1123357999


Q ss_pred             cccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHH
Q 014904          211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNE  290 (416)
Q Consensus       211 ~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  290 (416)
                      .|+|||++.+..++.++|||||||++|||++|..|+..        ...     .......+.+..         .....
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~-----~~~~~~~~~~~~---------~~~~~  298 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVR-----IITDVRNLKFPL---------LFTQK  298 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHH-----HHHHHHTTCCCH---------HHHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHH-----HHHHhhccCCCc---------ccccC
Confidence            99999999999999999999999999999998765321        000     011111111111         11233


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          291 MARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       291 ~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ...+.+++.+||+.+|.+||++.|+++
T Consensus       299 ~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          299 YPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             CHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             ChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            456789999999999999999999986

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.1e-43  Score=344.61  Aligned_cols=253  Identities=23%  Similarity=0.380  Sum_probs=205.5

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecC-----CcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAG-----SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++...     .....+.+.+|+.++..++||||+++++++.+....+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46799999999999999999995 46899999998642     1224568999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc---eEEeeccc
Q 014904          117 LVYEFVPNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGL  191 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~---~kl~DFGl  191 (416)
                      +||||+++++|.+.+...  ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998777542  233589999999999999999999999   9999999999999987655   99999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhc
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIED  271 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~  271 (416)
                      ++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....    .+.        ..+..
T Consensus       180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~--------~~i~~  246 (351)
T 3c0i_A          180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLF--------EGIIK  246 (351)
T ss_dssp             CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHH--------HHHHH
T ss_pred             eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHH--------HHHHc
Confidence            987755332 23346799999999999999999999999999999999999999976321    111        11112


Q ss_pred             CCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          272 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       272 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      +.+..  .+.....    ....+.+++.+||+.||.+||++.|+++
T Consensus       247 ~~~~~--~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          247 GKYKM--NPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             TCCCC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCC--Ccccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            22110  1111111    2357889999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.3e-42  Score=335.46  Aligned_cols=261  Identities=20%  Similarity=0.336  Sum_probs=200.2

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ..++|.+.+.||+|+||.||+|.. .+|+.||||++.....   .....+.+|+.++++++||||+++++++......++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            446899999999999999999995 5789999999985432   234578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          118 VYEFVPNNTLEFHLHG--KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ||||+.+++|.+++..  .....+++..++.++.+++.||.|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999998864  2234689999999999999999999999   9999999999999999999999999999866


Q ss_pred             cCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ..... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||......    ...+     ...+..+.+.
T Consensus       187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~-----~~~~~~~~~~  256 (310)
T 2wqm_A          187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-----CKKIEQCDYP  256 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHH-----HHHHHTTCSC
T ss_pred             cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHH-----HHHhhcccCC
Confidence            54322 223457899999999999999999999999999999999999999754321    1111     1122233322


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      .+..        ......+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       257 ~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~  296 (310)
T 2wqm_A          257 PLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH  296 (310)
T ss_dssp             CCCT--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcc--------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            2111        122357889999999999999999999999998543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.8e-43  Score=338.46  Aligned_cols=265  Identities=26%  Similarity=0.376  Sum_probs=207.0

Q ss_pred             CCCCcCceecccCcEEEEEEEe-----CCCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeC--CeE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-----PNGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAG--SQR  115 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  115 (416)
                      ++|++.+.||+|+||.||+|.+     .+++.||||++.... ......+.+|+.++.+++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            5688899999999999999983     468999999997543 33446789999999999999999999999876  668


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++||||+++++|.+++..... .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence            999999999999999965433 589999999999999999999999   9999999999999999999999999999877


Q ss_pred             cCCCcc--eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchh----hhhhhhHHhHHhh
Q 014904          196 SDVNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDS----LVDWARPLLNRAI  269 (416)
Q Consensus       196 ~~~~~~--~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~----l~~~~~~~~~~~~  269 (416)
                      ......  ......||..|+|||++.+..++.++||||||+++|+|++|+.|+..........    ...+....+...+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence            654332  2234568888999999999999999999999999999999999864321100000    0000001111111


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                      ..+.         ....+......+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       257 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          257 KEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             hccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            1211         111222344678999999999999999999999999974

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=353.09  Aligned_cols=255  Identities=21%  Similarity=0.303  Sum_probs=208.0

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ...++|.+.+.||+|+||.||+|.. .+|+.+|+|++......  ....+.+|+.++++++||||+++++++.+....++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            4567899999999999999999995 57899999999865432  23568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC---CCCceEEeeccccee
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD---FKFEAKVADFGLAKI  194 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~---~~~~~kl~DFGla~~  194 (416)
                      ||||+.+++|.+.+....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++   .++.+||+|||++..
T Consensus        88 v~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999999887654  599999999999999999999999   999999999999998   467899999999987


Q ss_pred             ccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          195 ASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       195 ~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ..        +...+..+.+
T Consensus       163 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~--------~~~~i~~~~~  230 (444)
T 3soa_A          163 VEGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HR--------LYQQIKAGAY  230 (444)
T ss_dssp             CCTTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HH--------HHHHHHHTCC
T ss_pred             ecCCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HH--------HHHHHHhCCC
Confidence            6543322 2346799999999999998999999999999999999999999976442   11        1112223332


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .. ..+.+     ......+.+++.+||+.||.+||++.|+++.
T Consensus       231 ~~-~~~~~-----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          231 DF-PSPEW-----DTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CC-CTTTT-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CC-Ccccc-----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11 11111     1223578899999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.2e-43  Score=341.02  Aligned_cols=268  Identities=27%  Similarity=0.393  Sum_probs=216.3

Q ss_pred             ccCHHHHHHhhCCCCcCceecccCcEEEEEEEe------CCCcEEEEEEeecCCcc-cHHHHHHHHHHHHhc-CCCcccc
Q 014904           33 TFTYEELARATDGFSDANLLGQGGFGYVHRGVL------PNGKEVAIKQLKAGSGQ-GEREFQAEVEIISRV-HHKHLVS  104 (416)
Q Consensus        33 ~f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~h~niv~  104 (416)
                      .+...+..-..++|.+.+.||+|+||.||+|.+      .+++.||||+++..... ..+.+.+|+.++.++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            345556666788999999999999999999984      35689999999865433 335788999999999 7999999


Q ss_pred             eEEEEEeCC-eEEEEEEecCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeee
Q 014904          105 LVGYYTAGS-QRMLVYEFVPNNTLEFHLHGKGR--------------PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR  169 (416)
Q Consensus       105 l~~~~~~~~-~~~lV~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHr  169 (416)
                      +++++.... ..++|+||+++++|.+++.....              ..+++..++.++.|++.||.|||+.   +|+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence            999988754 48999999999999999976543              1288999999999999999999999   99999


Q ss_pred             cccCCcEEECCCCceEEeecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCC
Q 014904          170 DIKAANILLDFKFEAKVADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD  247 (416)
Q Consensus       170 DIkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~  247 (416)
                      ||||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            99999999999999999999999876543332 2344668899999999999999999999999999999998 999997


Q ss_pred             CCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          248 STHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       248 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      .....  ..+.        ..+..+...     ..    +......+.+++.+||+.+|.+||++.||++.|+..
T Consensus       253 ~~~~~--~~~~--------~~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          253 GVKID--EEFC--------RRLKEGTRM-----RA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             TCCCS--HHHH--------HHHHHTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccchh--HHHH--------HHhccCccC-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            64421  1111        111122111     11    112235788999999999999999999999999854

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.8e-43  Score=335.51  Aligned_cols=256  Identities=25%  Similarity=0.387  Sum_probs=204.3

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCC----CcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPN----GKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      ..++|.+.+.||+|+||.||+|...+    +..||||++..... ...+.+.+|+.++++++||||+++++++.+ ...+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            45789999999999999999998543    34699999986532 334678999999999999999999999865 4568


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +|+||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        89 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            9999999999999997543 2589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ...........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......   ....        .+..+...
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~--------~~~~~~~~  233 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIG--------VLEKGDRL  233 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHH--------HHHHTCCC
T ss_pred             cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHH--------HHhcCCCC
Confidence            544333344567889999999999999999999999999999998 99999754331   1111        11122111


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                           .    .+......+.+++.+||+.+|.+||++.||++.|+..
T Consensus       234 -----~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          234 -----P----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             -----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----C----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence                 0    1112235789999999999999999999999999854

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.5e-44  Score=371.94  Aligned_cols=258  Identities=29%  Similarity=0.424  Sum_probs=212.9

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ...++|.+.++||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++|+||+++++++.+ ...+||||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            3457889999999999999999999888899999998654 345689999999999999999999999876 67899999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+.+++|.+++.......+++..++.|+.|++.||+|||+.   +|+||||||+||||+.++.+||+|||+++.......
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            99999999999754334689999999999999999999999   999999999999999999999999999986643222


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                      .......++..|+|||++.++.++.++|||||||+||||++ |+.||.....   ..+.        ..+..+..     
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~--------~~i~~~~~-----  482 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVL--------DQVERGYR-----  482 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHH--------HHHHTTCC-----
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHH--------HHHHcCCC-----
Confidence            22233456788999999999999999999999999999999 9999976432   1111        11222211     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                          ...+..+...+.+++.+||+.+|++||++.+|++.|+...
T Consensus       483 ----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          483 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                1112233457899999999999999999999999998654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.9e-43  Score=344.41  Aligned_cols=267  Identities=28%  Similarity=0.351  Sum_probs=212.5

Q ss_pred             CCCCcCceecccCcEEEEEEEe-----CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEE--eCCeEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-----PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT--AGSQRM  116 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  116 (416)
                      ++|++.+.||+|+||.||+|.+     .+++.||||++........+.+.+|+.++++++|+||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            6889999999999999999983     468899999998776666677999999999999999999999987  456789


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +||||+++++|.+++..... .+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            99999999999999975332 589999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCCcc--eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhh-----hHHhHHhh
Q 014904          197 DVNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA-----RPLLNRAI  269 (416)
Q Consensus       197 ~~~~~--~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~-----~~~~~~~~  269 (416)
                      .....  ......||..|+|||++.+..++.++||||||+++|+|++|+.||......... ...+.     ...+...+
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVPALSRLLELL  257 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----CCHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccccccHHHHHHHh
Confidence            43332  223356888899999999999999999999999999999999998653210000 00000     00111111


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDAS  324 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~~  324 (416)
                      ..+.         ....+......+.+++.+||+.+|.+||++.||++.|+....
T Consensus       258 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          258 EEGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             hccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            1111         112223345678999999999999999999999999987543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.5e-42  Score=332.17  Aligned_cols=258  Identities=29%  Similarity=0.510  Sum_probs=196.9

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .++|.+.++||+|+||.||+|...  ..||||+++....  ...+.|.+|+.++++++|+||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            478999999999999999999864  3599999976543  2335789999999999999999999966 4556899999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC-
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN-  199 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~-  199 (416)
                      |+.+++|.+++.... ..+++..++.|+.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A          100 WCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             ecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            999999999996544 3699999999999999999999999   99999999999999999999999999997654322 


Q ss_pred             cceeecccccccccChhhhc---cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          200 THVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~---~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      ........||+.|+|||.+.   +..++.++||||||+++|+|++|+.||.....  ...+.        ..+..+....
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~--------~~~~~~~~~~  245 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQII--------EMVGRGSLSP  245 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHH--------HHHHHTSCCC
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHH--------HHhcccccCc
Confidence            22234467999999999986   66789999999999999999999999976443  11111        1112222211


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      ..     .......+..+.+++.+||+.+|.+||++.+|++.|+..
T Consensus       246 ~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l  286 (289)
T 3og7_A          246 DL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL  286 (289)
T ss_dssp             CT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             ch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            11     111223346899999999999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.9e-43  Score=341.65  Aligned_cols=269  Identities=24%  Similarity=0.424  Sum_probs=218.2

Q ss_pred             cccCHHHHHHhhCCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccc
Q 014904           32 STFTYEELARATDGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVS  104 (416)
Q Consensus        32 ~~f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~  104 (416)
                      ..|..++...+.++|.+.+.||+|+||.||+|.+.      +++.||||++..... .....+.+|+.+++.++|+||++
T Consensus        13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~   92 (322)
T 1p4o_A           13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR   92 (322)
T ss_dssp             SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred             cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence            34555666778899999999999999999999854      378899999975433 23356889999999999999999


Q ss_pred             eEEEEEeCCeEEEEEEecCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcE
Q 014904          105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG--------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANI  176 (416)
Q Consensus       105 l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NI  176 (416)
                      +++++.+....++||||+++++|.+++....        ...+++..++.++.|++.||.|||+.   +|+||||||+||
T Consensus        93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NI  169 (322)
T 1p4o_A           93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC  169 (322)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGE
T ss_pred             eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceE
Confidence            9999999999999999999999999986421        13579999999999999999999999   999999999999


Q ss_pred             EECCCCceEEeecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccc
Q 014904          177 LLDFKFEAKVADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVE  254 (416)
Q Consensus       177 Ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~  254 (416)
                      +++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....   
T Consensus       170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---  246 (322)
T 1p4o_A          170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---  246 (322)
T ss_dssp             EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---
T ss_pred             EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---
Confidence            9999999999999999865443222 1233467889999999999999999999999999999999 8999876432   


Q ss_pred             hhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          255 DSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       255 ~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      ..+.        ..+..+....         .+......+.+++.+||+.+|.+||++.||++.|+...
T Consensus       247 ~~~~--------~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          247 EQVL--------RFVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             HHHH--------HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHH--------HHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            1111        1112222111         11223457889999999999999999999999998754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-42  Score=337.37  Aligned_cols=246  Identities=25%  Similarity=0.352  Sum_probs=205.5

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .++|.+.+.||+|+||.||+|... +|+.||||+++...   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467999999999999999999964 78999999997532   22345678999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+++++|.+++....  .+++..+..++.+++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            99999999999997654  589999999999999999999999   9999999999999999999999999999876442


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                          .....||+.|+|||++.+..++.++|||||||++|||++|+.||......      ....     .+..+.+    
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~-----~i~~~~~----  220 (318)
T 1fot_A          160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYE-----KILNAEL----  220 (318)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH-----HHHHCCC----
T ss_pred             ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHH-----HHHhCCC----
Confidence                23467999999999999999999999999999999999999999764421      1111     1112211    


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRP-----RMSQIVRA  318 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~~  318 (416)
                        .    ++......+.+++.+||+.+|.+||     ++.||++.
T Consensus       221 --~----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          221 --R----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             --C----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --C----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence              1    1112235788999999999999999     88888743

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.6e-43  Score=350.44  Aligned_cols=250  Identities=22%  Similarity=0.329  Sum_probs=197.9

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcC--CCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVH--HKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.+.||+|+||.||+|...+++.||||++.....  .....+.+|+.++.+++  |+||+++++++......++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            45999999999999999999988899999999976532  33467899999999996  599999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      | +.+++|.+++....  .+++..++.|+.|++.||.|||+.   +|+||||||+||||+ ++.+||+|||+++......
T Consensus       136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            9 56889999997654  688999999999999999999999   999999999999995 5789999999998765433


Q ss_pred             cc-eeecccccccccChhhhcc-----------CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHH
Q 014904          200 TH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNR  267 (416)
Q Consensus       200 ~~-~~~~~~gt~~YlaPE~~~~-----------~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~  267 (416)
                      .. ......||+.|+|||++.+           ..++.++|||||||+||||++|+.||......    . ..    +..
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~-~~----~~~  279 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----I-SK----LHA  279 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----H-HH----HHH
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH----H-HH----HHH
Confidence            22 2345679999999999865           46899999999999999999999999754321    0 00    111


Q ss_pred             hhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          268 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       268 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      . ...        .....++......+.+++.+||+.+|.+||++.||++.
T Consensus       280 ~-~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          280 I-IDP--------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             H-HCT--------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             H-hCc--------cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            1 111        11111111123578899999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.3e-42  Score=348.31  Aligned_cols=250  Identities=22%  Similarity=0.337  Sum_probs=200.9

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCccc---HHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQG---EREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  117 (416)
                      .++|.+.++||+|+||.||+|... +++.||||+++......   ...+..|..++.++ +||||+++++++.+....++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            468999999999999999999964 68899999998643222   23578899999887 89999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+++++|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++....
T Consensus       131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            999999999999987644  599999999999999999999999   999999999999999999999999999986332


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc--hhhhhhhhHHhHHhhhcCCcc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE--DSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      .. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........  ....++    +.+.+..+.+ 
T Consensus       206 ~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~----~~~~i~~~~~-  279 (396)
T 4dc2_A          206 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY----LFQVILEKQI-  279 (396)
T ss_dssp             TT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHH----HHHHHHHCCC-
T ss_pred             CC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHH----HHHHHhcccc-
Confidence            22 223456899999999999999999999999999999999999999975332111  111111    1111222221 


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRM  312 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  312 (416)
                               .++......+.+++.+||+.+|.+||++
T Consensus       280 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          280 ---------RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ---------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                     1122234578899999999999999996

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.3e-43  Score=343.05  Aligned_cols=258  Identities=26%  Similarity=0.410  Sum_probs=210.6

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC--------CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhc-CCCcccceEEEEEeC
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP--------NGKEVAIKQLKAGSG-QGEREFQAEVEIISRV-HHKHLVSLVGYYTAG  112 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  112 (416)
                      .++|.+.+.||+|+||.||+|.+.        +++.||||+++.... .....+.+|+.++.++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            478999999999999999999863        467899999986543 2345788999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE
Q 014904          113 SQRMLVYEFVPNNTLEFHLHGKGR--------------PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL  178 (416)
Q Consensus       113 ~~~~lV~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl  178 (416)
                      ...++||||+++++|.+++.....              ..+++..++.++.|++.||.|||+.   +|+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence            999999999999999999976432              2489999999999999999999999   99999999999999


Q ss_pred             CCCCceEEeecccceeccCCCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchh
Q 014904          179 DFKFEAKVADFGLAKIASDVNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDS  256 (416)
Q Consensus       179 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~  256 (416)
                      +.++.+||+|||+++......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....   ..
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---HH
Confidence            999999999999998765433222 233457889999999998899999999999999999999 9999976432   11


Q ss_pred             hhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          257 LVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       257 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      +.        ..+..+...     .    .+......+.+++.+||+.+|.+||++.||++.|+...
T Consensus       268 ~~--------~~~~~~~~~-----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          268 LF--------KLLKEGHRM-----D----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             HH--------HHHHHTCCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HH--------HHHhcCCCC-----C----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11        111222111     1    11223457899999999999999999999999998654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.1e-44  Score=358.64  Aligned_cols=264  Identities=20%  Similarity=0.222  Sum_probs=210.9

Q ss_pred             cCHHHHHHhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc---cHHHHHHHHHHHHhcCCCcccceEEEE
Q 014904           34 FTYEELARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ---GEREFQAEVEIISRVHHKHLVSLVGYY  109 (416)
Q Consensus        34 f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~  109 (416)
                      +.++++....++|.+.++||+|+||.||++... +|+.||||+++.....   ....+.+|..++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            345666777899999999999999999999964 7999999999753211   123478899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeec
Q 014904          110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF  189 (416)
Q Consensus       110 ~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DF  189 (416)
                      .+....+|||||+++++|..++...+. .+++..+..++.+++.||.|||+.   +|+||||||+||||+.++.+||+||
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence            999999999999999999999975432 689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccCCCcceeecccccccccChhhhc-------cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh
Q 014904          190 GLAKIASDVNTHVSTRVMGTFGYLAPEYAS-------SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR  262 (416)
Q Consensus       190 Gla~~~~~~~~~~~~~~~gt~~YlaPE~~~-------~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~  262 (416)
                      |+++.............+||+.|+|||++.       .+.++.++|||||||++|||++|+.||.......   .   ..
T Consensus       207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~---~~  280 (412)
T 2vd5_A          207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE---T---YG  280 (412)
T ss_dssp             TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HH
T ss_pred             hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH---H---HH
Confidence            999877654444444568999999999987       4578999999999999999999999997654311   0   11


Q ss_pred             HHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 014904          263 PLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRR---PRMSQIVRA  318 (416)
Q Consensus       263 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R---Pt~~evv~~  318 (416)
                      .++... ..     +.-|....    .....+.+++.+||+ +|.+|   |++.||++.
T Consensus       281 ~i~~~~-~~-----~~~p~~~~----~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          281 KIVHYK-EH-----LSLPLVDE----GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHHTHH-HH-----CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHHhcc-cC-----cCCCcccc----CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            111000 00     00111111    223578899999999 99998   588888754

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-43  Score=341.72  Aligned_cols=255  Identities=30%  Similarity=0.466  Sum_probs=199.9

Q ss_pred             CCCcCceecccCcEEEEEEEeCC-----CcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLPN-----GKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      +|...++||+|+||.||+|....     +..||||+++.... .....+.+|+.++.+++||||+++++++......++|
T Consensus        45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  124 (333)
T 1mqb_A           45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII  124 (333)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence            44457899999999999999543     23699999986533 2335788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+++++|.+++..... .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       125 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          125 TEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EECCTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EeCCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            999999999999976433 699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             Ccce--eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          199 NTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       199 ~~~~--~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ....  .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....   ..+        ...+..+.. 
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~--------~~~~~~~~~-  268 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEV--------MKAINDGFR-  268 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH--------HHHHHTTCC-
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHH--------HHHHHCCCc-
Confidence            2221  122346788999999999999999999999999999999 9999975432   111        111222211 


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                       .       ..+......+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       269 -~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          269 -L-------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             -C-------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -C-------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             0       111223457899999999999999999999999998643

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=346.91  Aligned_cols=250  Identities=26%  Similarity=0.331  Sum_probs=205.7

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .++|.+.+.||+|+||.||++... +++.||||++....   ....+.+.+|+.++..++||||+++++++.+....++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            368999999999999999999954 68899999987432   23346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+.+++|..++....  .+++..+..++.+++.||.|||+.   +|+||||||+||||+.++.+||+|||+++.....
T Consensus        94 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999999997644  599999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeecccccccccChhhhcc---CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~---~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      .  ......||+.|+|||++..   ..++.++|||||||++|||++|+.||..........+....        ....  
T Consensus       169 ~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--------~~~~--  236 (384)
T 4fr4_A          169 T--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--------ETTV--  236 (384)
T ss_dssp             C--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--------HHCC--
T ss_pred             C--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--------hhcc--
Confidence            2  2344679999999999864   45899999999999999999999999765432222222211        1111  


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR-MSQIVR  317 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~evv~  317 (416)
                              ..++......+.+++.+||+.+|.+||+ +.+|++
T Consensus       237 --------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 --------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                    1112223457899999999999999998 666654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-43  Score=370.91  Aligned_cols=247  Identities=28%  Similarity=0.414  Sum_probs=200.2

Q ss_pred             eecccCcEEEEEEEeC---CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCC
Q 014904           51 LLGQGGFGYVHRGVLP---NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNT  126 (416)
Q Consensus        51 ~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~s  126 (416)
                      .||+|+||.||+|.+.   ++..||||+++.... ...++|.+|+.++++++|||||+++++|.. ...++||||+++++
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999863   466899999986533 345789999999999999999999999976 56899999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee--e
Q 014904          127 LEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--T  204 (416)
Q Consensus       127 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~--~  204 (416)
                      |.+++.... ..+++..++.|+.|++.||+|||+.   +|+||||||+||||+.++.+||+|||+++..........  .
T Consensus       422 L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  497 (613)
T 2ozo_A          422 LHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  497 (613)
T ss_dssp             HHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred             HHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence            999997543 3699999999999999999999999   999999999999999999999999999987654332222  2


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcccc
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLH  283 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~  283 (416)
                      ...+|+.|+|||++.++.++.++|||||||+||||++ |+.||......   .+.        ..+..+..         
T Consensus       498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~--------~~i~~~~~---------  557 (613)
T 2ozo_A          498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM--------AFIEQGKR---------  557 (613)
T ss_dssp             ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHH--------HHHHTTCC---------
T ss_pred             CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHH--------HHHHcCCC---------
Confidence            2345689999999999999999999999999999998 99999765431   111        12223321         


Q ss_pred             CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          284 NEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       284 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      ...+..++..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       558 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          558 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            112223456899999999999999999999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-43  Score=345.58  Aligned_cols=261  Identities=23%  Similarity=0.283  Sum_probs=204.5

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecC-----CcccHHHHHHHHHHHHhcCCCcccceEEEEEe
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAG-----SGQGEREFQAEVEIISRVHHKHLVSLVGYYTA  111 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  111 (416)
                      ++..+.++|.+.+.||+|+||.||+|.. .+++.||||++...     .......+.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            4667889999999999999999999995 46889999998643     23344678999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhcCC--------------------------------------CCCCCHHHHHHHHHHHHH
Q 014904          112 GSQRMLVYEFVPNNTLEFHLHGKG--------------------------------------RPTMDWLTRLKIALGSAK  153 (416)
Q Consensus       112 ~~~~~lV~e~~~~~sL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~ia~  153 (416)
                      ....++||||+++++|.+++....                                      ...+++..++.|+.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            999999999999999999885210                                      112357778899999999


Q ss_pred             HHHHHHhcCCCCeeeecccCCcEEECCCC--ceEEeecccceeccCCCcc---eeecccccccccChhhhcc--CCCCch
Q 014904          154 GLAYLHEDCHPKIIHRDIKAANILLDFKF--EAKVADFGLAKIASDVNTH---VSTRVMGTFGYLAPEYASS--GKLTEK  226 (416)
Q Consensus       154 aL~~LH~~~~~~iiHrDIkp~NILl~~~~--~~kl~DFGla~~~~~~~~~---~~~~~~gt~~YlaPE~~~~--~~~t~k  226 (416)
                      ||+|||+.   +|+||||||+|||++.++  .+||+|||+++........   ......||+.|+|||++.+  ..++.+
T Consensus       180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            99999999   999999999999998776  8999999999876442221   2344679999999999975  678999


Q ss_pred             hhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCC
Q 014904          227 SDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSA  306 (416)
Q Consensus       227 sDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p  306 (416)
                      +|||||||++|||++|+.||......  +.+        ...+ .+... +..+..     ......+.+++.+||+.+|
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~--~~~--------~~~~-~~~~~-~~~~~~-----~~~~~~~~~li~~~l~~~p  319 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDA--DTI--------SQVL-NKKLC-FENPNY-----NVLSPLARDLLSNLLNRNV  319 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHH--HHH--------HHHH-HCCCC-TTSGGG-----GGSCHHHHHHHHHHSCSCT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChH--HHH--------HHHH-hcccc-cCCccc-----ccCCHHHHHHHHHHcCCCh
Confidence            99999999999999999999765431  111        1111 11110 111111     1123578899999999999


Q ss_pred             CCCCCHHHHHHH
Q 014904          307 RRRPRMSQIVRA  318 (416)
Q Consensus       307 ~~RPt~~evv~~  318 (416)
                      .+||++.|+++.
T Consensus       320 ~~Rps~~~~l~h  331 (345)
T 3hko_A          320 DERFDAMRALQH  331 (345)
T ss_dssp             TTSCCHHHHHHS
T ss_pred             hHCCCHHHHhcC
Confidence            999999999863

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.1e-43  Score=344.49  Aligned_cols=259  Identities=27%  Similarity=0.388  Sum_probs=210.1

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCC-C-----cEEEEEEeecCCc-ccHHHHHHHHHHHHhc-CCCcccceEEEEEeCC
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPN-G-----KEVAIKQLKAGSG-QGEREFQAEVEIISRV-HHKHLVSLVGYYTAGS  113 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~-g-----~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  113 (416)
                      ..++|.+.+.||+|+||.||+|.... +     +.||||++..... .....+.+|+.++.++ +||||+++++++.+..
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            45789999999999999999999642 2     4799999986543 2345789999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKG------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK  181 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~  181 (416)
                      ..++||||+++++|.+++....            ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence            9999999999999999986431            23589999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhh
Q 014904          182 FEAKVADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVD  259 (416)
Q Consensus       182 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~  259 (416)
                      +.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......  ..+..
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~  278 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--SKFYK  278 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--HHHHH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--HHHHH
Confidence            99999999999866543332 2234567889999999999999999999999999999999 99999764421  11111


Q ss_pred             hhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          260 WARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                              ....+..     .    ..+......+.+++.+||+.+|.+||++.||++.|+..
T Consensus       279 --------~~~~~~~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          279 --------LVKDGYQ-----M----AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             --------HHHHTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------HHhcCCC-----C----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence                    1111110     0    01112235788999999999999999999999999854

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.6e-42  Score=334.46  Aligned_cols=265  Identities=22%  Similarity=0.316  Sum_probs=190.0

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ..++|.+.+.||+|+||.||+|.. .+|+.||||+++.... .....+.+|+.++++++||||+++++++......++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            357899999999999999999995 4689999999976542 23367889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          120 EFVPNNTLEFHLHGK----GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       120 e~~~~~sL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ||+. ++|.+++...    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9998 5888887542    223589999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH-------hHH
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL-------LNR  267 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~-------~~~  267 (416)
                      ...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......  .+.......       +..
T Consensus       159 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          159 GIPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE--QLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             TSCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCTTTCGG
T ss_pred             CCCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChhHhhh
Confidence            533222 233578999999999976 468999999999999999999999997654311  111100000       000


Q ss_pred             hhhcCC------------cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          268 AIEDGN------------FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       268 ~~~~~~------------~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ......            +.+.+.+.....    ....+.+++.+||+.||++||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEP----LDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSC----CCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhcccccccccchhHHHhhccccccc----CCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            000000            000111111111    2347899999999999999999999885

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.9e-43  Score=332.94  Aligned_cols=256  Identities=27%  Similarity=0.407  Sum_probs=208.9

Q ss_pred             hCCCCcCc-eecccCcEEEEEEEeC---CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           43 TDGFSDAN-LLGQGGFGYVHRGVLP---NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        43 t~~f~~~~-~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      .++|.+.+ .||+|+||.||+|...   +++.||||+++.... ...+.+.+|+.++.+++||||+++++++ .....++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            35666666 9999999999999853   578899999986533 3346789999999999999999999999 5567899


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999999997543 3699999999999999999999999   999999999999999999999999999987754


Q ss_pred             CCccee--ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          198 VNTHVS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       198 ~~~~~~--~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ......  ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....   ..+.        ..+..+..
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~--------~~i~~~~~  231 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVM--------AFIEQGKR  231 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHH--------HHHHTTCC
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHH--------HHHhcCCc
Confidence            333222  23456889999999998899999999999999999999 9999976543   1111        11222221


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      .         ..+......+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       232 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          232 M---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             C---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C---------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1         112233457899999999999999999999999998643

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=333.68  Aligned_cols=266  Identities=23%  Similarity=0.291  Sum_probs=201.7

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-----ccHHHHHHHHHHHHhcC---CCcccceEEEEEeC
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG-----QGEREFQAEVEIISRVH---HKHLVSLVGYYTAG  112 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  112 (416)
                      ++++|.+.+.||+|+||.||+|.. .+++.||||++.....     .....+.+|+.+++++.   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            568999999999999999999995 5789999999874321     11245677787777764   99999999999876


Q ss_pred             C-----eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEe
Q 014904          113 S-----QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA  187 (416)
Q Consensus       113 ~-----~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~  187 (416)
                      .     ..++||||+. ++|.+++.......+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence            5     5799999996 5999999877666699999999999999999999999   99999999999999999999999


Q ss_pred             ecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHH
Q 014904          188 DFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNR  267 (416)
Q Consensus       188 DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~  267 (416)
                      |||+++.......  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......  ..+..... .+..
T Consensus       163 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~-~~~~  237 (308)
T 3g33_A          163 DFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGKIFD-LIGL  237 (308)
T ss_dssp             SCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH--HHHHHHHH-HHCC
T ss_pred             eCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH-HhCC
Confidence            9999986643222  24567999999999999999999999999999999999999999765431  11111110 0000


Q ss_pred             hhhcCCccc---ccCcccc-------CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          268 AIEDGNFDT---LVDPKLH-------NEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       268 ~~~~~~~~~---~~d~~l~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                       .....+..   +....+.       ..........+.+++.+||+.||.+||++.|+++
T Consensus       238 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          238 -PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             -CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence             00000000   0000000       0001123357889999999999999999999985

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.2e-42  Score=333.48  Aligned_cols=260  Identities=21%  Similarity=0.273  Sum_probs=200.7

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCccc---HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQG---EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      ...++|.+.+.||+|+||.||+|... +++.||||++.......   ...+.+|+.++.+++||||+++++++......+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            34589999999999999999999964 68999999997543322   357889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +|+||+++++|.+++....  .+++..++.++.+++.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       111 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            9999999999999997543  589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      ...........|++.|+|||++.+..++.++||||||+++|+|++|+.||......   .        +...+.... ..
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~--------~~~~~~~~~-~~  253 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---V--------MGAHINQAI-PR  253 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---H--------HHHHHHSCC-CC
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---H--------HHHHhccCC-CC
Confidence            54433334567999999999999999999999999999999999999999764321   1        111111111 00


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHhcccc
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRP-RMSQIVRALEGDA  323 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~evv~~L~~~~  323 (416)
                         +   .......+..+.+++.+||+.+|++|| ++.++++.|+...
T Consensus       254 ---~---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l  295 (309)
T 2h34_A          254 ---P---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL  295 (309)
T ss_dssp             ---G---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred             ---c---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence               0   011122334788999999999999999 9999999998654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.3e-43  Score=345.75  Aligned_cols=264  Identities=19%  Similarity=0.231  Sum_probs=200.4

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC----CCcEEEEEEeecCCccc-----------HHHHHHHHHHHHhcCCCcccceEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP----NGKEVAIKQLKAGSGQG-----------EREFQAEVEIISRVHHKHLVSLVG  107 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~  107 (416)
                      .++|.+.+.||+|+||.||+|...    ++..+|||++.......           ...+..|+.++..++|+||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            478999999999999999999965    57899999998654321           123667888999999999999999


Q ss_pred             EEEe----CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC-
Q 014904          108 YYTA----GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-  182 (416)
Q Consensus       108 ~~~~----~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~-  182 (416)
                      ++..    ....++||||+ +++|.+++....  .+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++ 
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSST
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCC
Confidence            9988    77899999999 999999997654  699999999999999999999999   999999999999998887 


Q ss_pred             -ceEEeecccceeccCCCcce------eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch
Q 014904          183 -EAKVADFGLAKIASDVNTHV------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED  255 (416)
Q Consensus       183 -~~kl~DFGla~~~~~~~~~~------~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~  255 (416)
                       .+||+|||+++.........      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~  268 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP-V  268 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-H
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-H
Confidence             99999999998764332211      134579999999999999999999999999999999999999996422111 1


Q ss_pred             hhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          256 SLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       256 ~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      .+. ......    . ..+...+.....   ....+..+.+++.+||+.+|.+||++.+|++.|+..
T Consensus       269 ~~~-~~~~~~----~-~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          269 AVQ-TAKTNL----L-DELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHH-HHHHHH----H-HTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHH-HHHHhh----c-ccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            111 110000    0 000000000000   012335789999999999999999999999999864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-42  Score=333.91  Aligned_cols=272  Identities=25%  Similarity=0.360  Sum_probs=206.6

Q ss_pred             CHHHHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhc--CCCcccceEEEEEeC
Q 014904           35 TYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV--HHKHLVSLVGYYTAG  112 (416)
Q Consensus        35 ~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~  112 (416)
                      ....-....++|.+.++||+|+||.||+|... ++.||||++...   ....+..|.+++..+  +||||+++++++...
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            34445556789999999999999999999984 899999998643   234555666666655  899999999999987


Q ss_pred             ----CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeecccCCcEEECCCCc
Q 014904          113 ----SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC-----HPKIIHRDIKAANILLDFKFE  183 (416)
Q Consensus       113 ----~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-----~~~iiHrDIkp~NILl~~~~~  183 (416)
                          ...++||||+++++|.+++...   .+++..++.++.+++.||+|||+.+     .++|+||||||+|||++.++.
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence                7899999999999999999754   5999999999999999999999763     348999999999999999999


Q ss_pred             eEEeecccceeccCCCcce---eecccccccccChhhhccCCCCch------hhhHhHHHHHHHHHhC----------CC
Q 014904          184 AKVADFGLAKIASDVNTHV---STRVMGTFGYLAPEYASSGKLTEK------SDVFSFGVMLLELITG----------RR  244 (416)
Q Consensus       184 ~kl~DFGla~~~~~~~~~~---~~~~~gt~~YlaPE~~~~~~~t~k------sDV~SlGvvL~elltG----------~~  244 (416)
                      +||+|||+++.........   .....||+.|+|||++.+.....+      +|||||||++|||++|          +.
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            9999999998665433221   124579999999999987766665      9999999999999999          55


Q ss_pred             CCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          245 PVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEY-NHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       245 pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      ||........ ....     +........    ..+.+...+ ...+...+.+++.+||+.+|.+||++.||++.|+...
T Consensus       261 p~~~~~~~~~-~~~~-----~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          261 PYHDLVPSDP-SYED-----MREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             TTTTTSCSSC-CHHH-----HHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cHhhhcCCCC-chhh-----hHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence            5543222110 1111     111111111    111111111 2367788999999999999999999999999998643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.1e-42  Score=341.45  Aligned_cols=246  Identities=24%  Similarity=0.288  Sum_probs=206.0

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....   ......+.+|+.++..++||||+++++++.+....++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            368999999999999999999964 68999999997532   23345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+++++|.+++...+  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       120 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999999997644  589999999999999999999999   9999999999999999999999999999876542


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                          .....||+.|+|||++.+..++.++|||||||++|||++|+.||......      +.     ...+..+.+    
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~-----~~~i~~~~~----  255 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QI-----YEKIVSGKV----  255 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-----HHHHHHCCC----
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HH-----HHHHHcCCC----
Confidence                23457999999999999999999999999999999999999999765421      11     111222221    


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPR-----MSQIVRA  318 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evv~~  318 (416)
                        .+    +......+.+++.+||+.+|.+||+     +.||++.
T Consensus       256 --~~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          256 --RF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             --CC----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CC----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence              11    1123357889999999999999998     7777753

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.9e-42  Score=325.42  Aligned_cols=251  Identities=22%  Similarity=0.276  Sum_probs=206.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ..++|.+.+.||+|+||.||+|... ++..||+|++..........+.+|+.++++++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            4578999999999999999999964 578999999987666667789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE---CCCCceEEeecccceeccC
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL---DFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl---~~~~~~kl~DFGla~~~~~  197 (416)
                      |+++++|.+++....  .+++..++.|+.+++.||.|||+.   +|+||||||+||++   +.++.+||+|||++.....
T Consensus        87 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           87 LCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             ccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            999999998886543  589999999999999999999999   99999999999999   7889999999999987654


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      ...  .....||+.|+|||++.+ .++.++||||||+++++|++|+.||......   ..        ...+..+.... 
T Consensus       162 ~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~--------~~~~~~~~~~~-  226 (277)
T 3f3z_A          162 GKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EV--------MLKIREGTFTF-  226 (277)
T ss_dssp             TSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HH--------HHHHHHCCCCC-
T ss_pred             ccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH---HH--------HHHHHhCCCCC-
Confidence            332  234569999999999865 5999999999999999999999999764421   11        11112222110 


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ... ...    .....+.+++.+||+.+|.+||++.|+++
T Consensus       227 ~~~-~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          227 PEK-DWL----NVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             CHH-HHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             Cch-hhh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000 000    12357889999999999999999999985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.8e-42  Score=326.92  Aligned_cols=253  Identities=25%  Similarity=0.366  Sum_probs=206.8

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++.....  .....+.+|+.++++++||||+++++++......++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            4689999999999999999999964 689999999975432  2335788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc---eEEeecccceec
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIA  195 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~---~kl~DFGla~~~  195 (416)
                      |||+++++|.+.+....  .+++..++.++.+++.||.|||+.   +|+||||||+||+++.++.   +||+|||++...
T Consensus        84 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           84 FDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999988886543  589999999999999999999999   9999999999999987655   999999999876


Q ss_pred             cCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      .....  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......   .+        ...+..+...
T Consensus       159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~--------~~~~~~~~~~  225 (284)
T 3kk8_A          159 NDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RL--------YAQIKAGAYD  225 (284)
T ss_dssp             CSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH--------HHHHHHTCCC
T ss_pred             ccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HH--------HHHHHhcccc
Confidence            54332  23457999999999999999999999999999999999999999764431   11        1111222211


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      . ..+.     .......+.+++.+||+.+|.+||++.|+++.
T Consensus       226 ~-~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          226 Y-PSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             C-CTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             C-Cchh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            1 1111     11223568899999999999999999999873

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.1e-43  Score=345.68  Aligned_cols=254  Identities=20%  Similarity=0.264  Sum_probs=195.5

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ..++|.+.+.||+|+||.||++... +++.||||++...... ...+.+|+.+++.++||||+++++++.+....++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            3578999999999999999999965 7899999999865433 3568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc--eEEeecccceeccCC
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE--AKVADFGLAKIASDV  198 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~--~kl~DFGla~~~~~~  198 (416)
                      |+.+++|..++...+  .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.  +||+|||+++.....
T Consensus        97 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           97 YASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             eCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999999986544  589999999999999999999999   9999999999999987765  999999998743322


Q ss_pred             CcceeecccccccccChhhhccCCCCch-hhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEK-SDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~k-sDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      .  ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........  ......    . +...... +
T Consensus       172 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~----~-~~~~~~~-~  241 (361)
T 3uc3_A          172 S--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQ----R-ILSVKYS-I  241 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHH----H-HHTTCCC-C
T ss_pred             C--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHH----H-HhcCCCC-C
Confidence            1  2234579999999999988887666 8999999999999999999976443111  111111    1 1111110 0


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .       ........+.+++.+||+.+|.+||++.|+++.
T Consensus       242 ~-------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          242 P-------DDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             C-------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             C-------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            0       001123578899999999999999999999864

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.7e-42  Score=338.55  Aligned_cols=249  Identities=24%  Similarity=0.344  Sum_probs=195.9

Q ss_pred             hCCCCcCceecccCcEEEEEEEe----CCCcEEEEEEeecCCc----ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGSG----QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      .++|.+.++||+|+||.||++..    .+++.||||+++....    .....+.+|+.+++.++||||+++++++.....
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46899999999999999999996    4789999999986432    223467889999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      .++||||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            999999999999999987543  588999999999999999999999   999999999999999999999999999875


Q ss_pred             ccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          195 ASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       195 ~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......   ..   ..     .+..+..
T Consensus       171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~---~~-----~i~~~~~  238 (327)
T 3a62_A          171 SIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KT---ID-----KILKCKL  238 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH---HH-----HHHHTCC
T ss_pred             cccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HH---HH-----HHHhCCC
Confidence            433222 234467999999999999999999999999999999999999999764421   11   11     1111111


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP-----RMSQIVRA  318 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~~  318 (416)
                            .    ++......+.+++.+||+.+|.+||     ++.|+++.
T Consensus       239 ------~----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          239 ------N----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ------C----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ------C----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                  1    1112335788999999999999999     66777653

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2e-42  Score=336.31  Aligned_cols=261  Identities=30%  Similarity=0.394  Sum_probs=207.8

Q ss_pred             CCcCceecccCcEEEEEEEeC-----CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEe--CCeEEE
Q 014904           46 FSDANLLGQGGFGYVHRGVLP-----NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTA--GSQRML  117 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  117 (416)
                      |.+.+.||+|+||.||++...     +++.||||+++.... .....+.+|+.++++++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488999999999999988642     688999999986543 334578999999999999999999999988  467899


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+++++|.+++...   .+++..++.|+.+++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            99999999999999764   389999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCcc--eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhh-----hHHhHHhhh
Q 014904          198 VNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA-----RPLLNRAIE  270 (416)
Q Consensus       198 ~~~~--~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~-----~~~~~~~~~  270 (416)
                      ....  ......+|..|+|||++.+..++.++||||||+++|+|++|+.||...... ...+..+.     ...+...+.
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-FLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-HHHHHCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-hhhhhcccccchhHHHHHHHHh
Confidence            4332  223456788899999999989999999999999999999999998653210 00111110     011111122


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      .+.         ....+......+.+++.+||+.+|.+||++.||++.|+..
T Consensus       266 ~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          266 RGE---------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccc---------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            221         1122233446899999999999999999999999999854

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.4e-42  Score=327.95  Aligned_cols=262  Identities=21%  Similarity=0.274  Sum_probs=203.4

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEE-EeCCeEEEE
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY-TAGSQRMLV  118 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV  118 (416)
                      ...++|.+.+.||+|+||.||+|.. .+++.||||++......  ..+..|+.++..++|++++..+..+ ......++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            3568999999999999999999995 67899999987654322  3578899999999988877666655 677888999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE---CCCCceEEeecccceec
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL---DFKFEAKVADFGLAKIA  195 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl---~~~~~~kl~DFGla~~~  195 (416)
                      |||+ +++|.+++..... .+++..++.++.|++.||.|||+.   +|+||||||+|||+   +.++.+||+|||+++..
T Consensus        84 ~e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEcc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            9999 9999999875433 599999999999999999999999   99999999999999   78899999999999876


Q ss_pred             cCCCcc------eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhh
Q 014904          196 SDVNTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAI  269 (416)
Q Consensus       196 ~~~~~~------~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~  269 (416)
                      ......      ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.................   ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~  235 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---KKM  235 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH---HHH
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc---ccc
Confidence            554331      12346799999999999999999999999999999999999999986543222222111100   000


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                       ....     +.+...    .+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       236 -~~~~-----~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          236 -STPI-----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             -HSCH-----HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             -cchh-----hhhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence             0000     001111    135789999999999999999999999999854

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4e-42  Score=332.03  Aligned_cols=270  Identities=19%  Similarity=0.291  Sum_probs=201.3

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCccc--HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQG--EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.......  .+.+.+|+.++.+++||||+++++++......++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            468999999999999999999964 58999999987554322  356789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|..++....  .+++..+..++.+++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        82 e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           82 EYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             ECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            9999999998886543  589999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhh-h---HHhHHhhhcCCc
Q 014904          200 THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA-R---PLLNRAIEDGNF  274 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~-~---~~~~~~~~~~~~  274 (416)
                      .. .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||............... .   +...........
T Consensus       157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          157 DY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             cc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence            22 234578999999999876 67899999999999999999999999775542211111100 0   000000000000


Q ss_pred             ---ccccCccccCc---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          275 ---DTLVDPKLHNE---YNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       275 ---~~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                         ..+.++.....   ........+.+++.+||+.+|.+||++.||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence               01111110000   001234568899999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.7e-42  Score=330.90  Aligned_cols=252  Identities=26%  Similarity=0.380  Sum_probs=204.4

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CC-------cEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NG-------KEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      .++|.+.+.||+|+||.||+|... ++       ..||+|++..........+.+|+.++++++||||+++++++.+...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            467889999999999999999954 33       4799999987666666789999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc--------eEE
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE--------AKV  186 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~--------~kl  186 (416)
                      .++||||+++++|.+++..... .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.        +||
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CEEEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence            9999999999999999976542 489999999999999999999999   9999999999999998887        999


Q ss_pred             eecccceeccCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHh
Q 014904          187 ADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLL  265 (416)
Q Consensus       187 ~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~  265 (416)
                      +|||++......     ....||+.|+|||++.+ ..++.++||||||+++|||++|..|+.....  ......      
T Consensus       163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~~~~~------  229 (289)
T 4fvq_A          163 SDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD--SQRKLQ------  229 (289)
T ss_dssp             CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHH------
T ss_pred             ccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc--hHHHHH------
Confidence            999998654321     23568999999999987 6799999999999999999996555433221  111110      


Q ss_pred             HHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 014904          266 NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDAS  324 (416)
Q Consensus       266 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~~  324 (416)
                        ......       .+...    ....+.+++.+||+.+|.+||++.||++.|+....
T Consensus       230 --~~~~~~-------~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          230 --FYEDRH-------QLPAP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             --HHHTTC-------CCCCC----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             --HhhccC-------CCCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence              001100       01111    12357899999999999999999999999997654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.4e-43  Score=342.52  Aligned_cols=248  Identities=23%  Similarity=0.314  Sum_probs=202.8

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ..++|.+.+.||+|+||.||+|.+ .+++.||||++....   ......+.+|+.+++.++||||+++++++......++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            347899999999999999999995 578999999987431   1223578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+ +++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        87 v~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             EECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            99999 678887776543  589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcceeecccccccccChhhhccCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~-t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      ...  .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......   +        ...+..+.   
T Consensus       161 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~--------~~~i~~~~---  224 (336)
T 3h4j_B          161 GNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---L--------FKKVNSCV---  224 (336)
T ss_dssp             SBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---C--------BCCCCSSC---
T ss_pred             Ccc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---H--------HHHHHcCC---
Confidence            322  234579999999999987765 789999999999999999999997643210   0        00000110   


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                             ...+......+.+++.+||+.||.+||++.||++.
T Consensus       225 -------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          225 -------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             -------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             -------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                   01122233578899999999999999999999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=329.15  Aligned_cols=251  Identities=27%  Similarity=0.386  Sum_probs=186.1

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      ...++|.+.+.||+|+||.||+|.. .+|+.||||++....   ......+.+|+.++.+++||||+++++++.+....+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (278)
T 3cok_A            8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY   87 (278)
T ss_dssp             SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred             cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence            3457899999999999999999996 578999999997432   122367899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +|+||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        88 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            9999999999999997543 3689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      ..... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........  +        .. ....    
T Consensus       164 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~--------~~-~~~~----  227 (278)
T 3cok_A          164 MPHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--L--------NK-VVLA----  227 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------CCSS----
T ss_pred             CCCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--H--------HH-Hhhc----
Confidence            32222 2335789999999999988999999999999999999999999976443110  0        00 0000    


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                        +..    .+......+.+++.+||+.+|++||++.+|++
T Consensus       228 --~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          228 --DYE----MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             --CCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --ccC----CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence              111    11223357889999999999999999999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-41  Score=331.14  Aligned_cols=253  Identities=25%  Similarity=0.351  Sum_probs=208.0

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc------cHHHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ------GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      ..++|.+.+.||+|+||.||+|... +|+.||||++......      ....+.+|+.++.+++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            4577999999999999999999964 6899999999764322      35679999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC----ceEEeecc
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF----EAKVADFG  190 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~----~~kl~DFG  190 (416)
                      .++||||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++    .+||+|||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999997643  589999999999999999999999   999999999999999887    79999999


Q ss_pred             cceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh
Q 014904          191 LAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       191 la~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~  270 (416)
                      +++.......  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......   ...        ..+.
T Consensus       165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~--------~~i~  231 (321)
T 2a2a_A          165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETL--------ANIT  231 (321)
T ss_dssp             TCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH--------HHHH
T ss_pred             cceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHH--------HHHH
Confidence            9987654322  23456999999999999999999999999999999999999999764321   111        1111


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .+...  .++.....    ....+.+++.+||+.+|.+||++.|+++.
T Consensus       232 ~~~~~--~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          232 SVSYD--FDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             TTCCC--CCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             hcccc--cChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11110  01111111    23468899999999999999999999863

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-42  Score=343.01  Aligned_cols=250  Identities=25%  Similarity=0.350  Sum_probs=204.5

Q ss_pred             HHhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCe
Q 014904           40 ARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        40 ~~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  114 (416)
                      ....++|.+.++||+|+||.||+|... +|+.||||+++...   ......+..|..++..+ +||||+++++++.+...
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345689999999999999999999964 68999999997532   22345678899999887 99999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      .++||||+++++|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            999999999999999997643  589999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          195 ASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       195 ~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+.        ..+..+. 
T Consensus       168 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~--------~~i~~~~-  234 (345)
T 1xjd_A          168 NMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELF--------HSIRMDN-  234 (345)
T ss_dssp             CCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH--------HHHHHCC-
T ss_pred             cccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHHH--------HHHHhCC-
Confidence            432222 23456899999999999999999999999999999999999999976442   1111        1111221 


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMS-QIV  316 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-evv  316 (416)
                           +.+    +......+.+++.+||+.+|.+||++. +|+
T Consensus       235 -----~~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 -----PFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -----CCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -----CCC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                 111    112335788999999999999999997 655

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.2e-43  Score=339.40  Aligned_cols=265  Identities=26%  Similarity=0.361  Sum_probs=201.0

Q ss_pred             CHHHHHHhhCCCCcCceecccCcEEEEEEEeC----CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEE
Q 014904           35 TYEELARATDGFSDANLLGQGGFGYVHRGVLP----NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGY  108 (416)
Q Consensus        35 ~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~  108 (416)
                      .++++....++|.+.+.||+|+||.||+|...    +++.||||+++....  .....+.+|+.++++++||||++++++
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  104 (313)
T 3brb_A           25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV  104 (313)
T ss_dssp             CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence            34455556678888899999999999999853    345899999975532  233578899999999999999999999


Q ss_pred             EEeCC-----eEEEEEEecCCCCHHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC
Q 014904          109 YTAGS-----QRMLVYEFVPNNTLEFHLHG----KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD  179 (416)
Q Consensus       109 ~~~~~-----~~~lV~e~~~~~sL~~~l~~----~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~  179 (416)
                      +.+..     ..++|+||+++++|..++..    .....+++..++.|+.|++.||.|||+.   +|+||||||+|||++
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~  181 (313)
T 3brb_A          105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLR  181 (313)
T ss_dssp             EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEEC
T ss_pred             EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEc
Confidence            98754     35999999999999999843    2334699999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhh
Q 014904          180 FKFEAKVADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSL  257 (416)
Q Consensus       180 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l  257 (416)
                      .++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......   .+
T Consensus       182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~  258 (313)
T 3brb_A          182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EM  258 (313)
T ss_dssp             TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GH
T ss_pred             CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HH
Confidence            9999999999999866443222 2233567889999999999999999999999999999999 88998765431   11


Q ss_pred             hhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      ..        .+..+...     ..    +......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus       259 ~~--------~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          259 YD--------YLLHGHRL-----KQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             HH--------HHHTTCCC-----CC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH--------HHHcCCCC-----CC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11        11122111     11    122335789999999999999999999999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9.8e-43  Score=354.39  Aligned_cols=250  Identities=23%  Similarity=0.331  Sum_probs=197.2

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecC---CcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAG---SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ..++|.+.++||+|+||.||+|.. .+|+.||||+++..   .......+..|+.++..++||||+++++++......++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            346899999999999999999995 46899999999753   22333567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHE-DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      ||||+++++|..++....  .+++..+..++.|++.||+|||+ .   +|+||||||+||||+.++.+||+|||+++...
T Consensus       226 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999999987543  58999999999999999999998 7   89999999999999999999999999998643


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      .... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.....   ..+.        ..+..+..  
T Consensus       301 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~--------~~i~~~~~--  366 (446)
T 4ejn_A          301 KDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLF--------ELILMEEI--  366 (446)
T ss_dssp             C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH--------HHHHHCCC--
T ss_pred             CCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHH--------HHHHhCCC--
Confidence            3222 23446799999999999999999999999999999999999999976443   1111        11111111  


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRP-----RMSQIVRA  318 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~~  318 (416)
                          .    ++......+.+++.+||+.||.+||     ++.|+++.
T Consensus       367 ----~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          367 ----R----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             ----C----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----C----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                1    1112335788999999999999999     99999863

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=336.89  Aligned_cols=253  Identities=30%  Similarity=0.472  Sum_probs=198.7

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      ++|.+.++||+|+||.||+|.. .++.||||++...  ...+.|.+|+.++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            5788899999999999999998 4789999998743  334678999999999999999999998874  4789999999


Q ss_pred             CCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc-eEEeecccceeccCCCcc
Q 014904          124 NNTLEFHLHGKGR-PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE-AKVADFGLAKIASDVNTH  201 (416)
Q Consensus       124 ~~sL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~-~kl~DFGla~~~~~~~~~  201 (416)
                      +++|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.....   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999986543 35789999999999999999999943338999999999999988876 799999999755432   


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                       .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......  ....|       ....+..     +.
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~-------~~~~~~~-----~~  224 (307)
T 2eva_A          160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIMW-------AVHNGTR-----PP  224 (307)
T ss_dssp             ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--HHHHH-------HHHTTCC-----CC
T ss_pred             -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--HHHHH-------HHhcCCC-----CC
Confidence             123468999999999999999999999999999999999999997543211  11111       1112211     11


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      ....    .+..+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       225 ~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          225 LIKN----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             CBTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             cccc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            1122    2346889999999999999999999999998643

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.7e-41  Score=324.76  Aligned_cols=261  Identities=20%  Similarity=0.263  Sum_probs=207.6

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEE-EeCCeEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY-TAGSQRMLVY  119 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~  119 (416)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||++......  ..+..|+.++..++|++++..+.++ ......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            467899999999999999999995 67999999998765433  3688999999999988866665555 6678889999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE---CCCCceEEeecccceecc
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL---DFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl---~~~~~~kl~DFGla~~~~  196 (416)
                      ||+ +++|.+++..... .+++..++.++.|++.||.|||+.   +|+||||||+|||+   +.++.+||+|||+++...
T Consensus        85 e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             Eec-CCCHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            999 9999999974433 699999999999999999999999   99999999999999   488899999999998766


Q ss_pred             CCCcc------eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh
Q 014904          197 DVNTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       197 ~~~~~------~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~  270 (416)
                      .....      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.................   ....
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~  236 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---KKMS  236 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH---HHHH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc---cccC
Confidence            54332      12446799999999999999999999999999999999999999986543222221111110   0000


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                       ..     .+.+...    .+..+.+++.+||+.+|.+||++.+|++.|+..
T Consensus       237 -~~-----~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          237 -TP-----IEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             -SC-----HHHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             -Cc-----hHHHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence             00     0001111    235789999999999999999999999999854

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.6e-42  Score=329.65  Aligned_cols=248  Identities=26%  Similarity=0.428  Sum_probs=206.1

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEe---------
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA---------  111 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  111 (416)
                      ..++|.+.+.||+|+||.||+|... +++.||||++....    ..+.+|+.++.+++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4567999999999999999999975 79999999998654    356789999999999999999998864         


Q ss_pred             -------CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCce
Q 014904          112 -------GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA  184 (416)
Q Consensus       112 -------~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~  184 (416)
                             ....++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence                   34579999999999999999765445799999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH
Q 014904          185 KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL  264 (416)
Q Consensus       185 kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~  264 (416)
                      ||+|||++........  .....||+.|+|||++.+..++.++||||||+++|+|++|..|+...        ..+    
T Consensus       162 kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~----  227 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKF----  227 (284)
T ss_dssp             EECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHH----
T ss_pred             EECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHH----
Confidence            9999999987654332  23456899999999999999999999999999999999999885321        011    


Q ss_pred             hHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          265 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       265 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                       ...+..+.+        ...+    ...+.+++.+||+.+|.+||++.||++.|+...
T Consensus       228 -~~~~~~~~~--------~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          228 -FTDLRDGII--------SDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             -HHHHHTTCC--------CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             -HHHhhcccc--------cccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence             111122221        1122    246789999999999999999999999997543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.4e-41  Score=332.27  Aligned_cols=268  Identities=24%  Similarity=0.346  Sum_probs=212.6

Q ss_pred             CHHHHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHh--cCCCcccceEEEEEeC
Q 014904           35 TYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISR--VHHKHLVSLVGYYTAG  112 (416)
Q Consensus        35 ~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~  112 (416)
                      ...--....++|.+.+.||+|+||.||+|.. +|+.||||++...   ....+..|++++..  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3444456678999999999999999999998 5899999998643   34677889999888  7899999999999887


Q ss_pred             C----eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeecccCCcEEECC
Q 014904          113 S----QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH--------EDCHPKIIHRDIKAANILLDF  180 (416)
Q Consensus       113 ~----~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH--------~~~~~~iiHrDIkp~NILl~~  180 (416)
                      .    ..++||||+++++|.+++...   .+++..++.++.+++.||.|||        +.   +|+||||||+||||+.
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK  182 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence            6    789999999999999999754   5899999999999999999999        66   9999999999999999


Q ss_pred             CCceEEeecccceeccCCCcc---eeecccccccccChhhhccCC------CCchhhhHhHHHHHHHHHhC---------
Q 014904          181 KFEAKVADFGLAKIASDVNTH---VSTRVMGTFGYLAPEYASSGK------LTEKSDVFSFGVMLLELITG---------  242 (416)
Q Consensus       181 ~~~~kl~DFGla~~~~~~~~~---~~~~~~gt~~YlaPE~~~~~~------~t~ksDV~SlGvvL~elltG---------  242 (416)
                      ++.+||+|||+++........   ......||+.|+|||++.+..      ++.++|||||||++|||++|         
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~  262 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  262 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence            999999999999876554332   123457999999999997652      33789999999999999999         


Q ss_pred             -CCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCc-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          243 -RRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNE-YNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       243 -~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                       +.||...... ......+..     .+..+.    ..+.+... ........+.+++.+||+.+|.+||++.||++.|+
T Consensus       263 ~~~p~~~~~~~-~~~~~~~~~-----~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          263 YQLPYYDLVPS-DPSVEEMRK-----VVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             CCCTTTTTSCS-SCCHHHHHH-----HHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             cccCccccCcC-cccHHHHHH-----HHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence             6677554321 111111111     111111    11222211 23467788999999999999999999999999998


Q ss_pred             cc
Q 014904          321 GD  322 (416)
Q Consensus       321 ~~  322 (416)
                      ..
T Consensus       333 ~i  334 (342)
T 1b6c_B          333 QL  334 (342)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.3e-42  Score=336.31  Aligned_cols=257  Identities=26%  Similarity=0.413  Sum_probs=197.3

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCccc---HHHHHHHHHHHHhcCCCcccceEEEEEeCC----
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQG---EREFQAEVEIISRVHHKHLVSLVGYYTAGS----  113 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  113 (416)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||+++......   ...+.+|+.++.+++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            457899999999999999999995 578999999998654333   346889999999999999999999987644    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             ccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            3499999999999999997544  589999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCcc--eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhc
Q 014904          194 IASDVNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIED  271 (416)
Q Consensus       194 ~~~~~~~~--~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~  271 (416)
                      ........  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......  .        .......
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~--~--------~~~~~~~  234 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--V--------AYQHVRE  234 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H--------HHHHHHC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--H--------HHHHhcC
Confidence            76543222  2234679999999999999999999999999999999999999997654311  0        0111111


Q ss_pred             CCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH-Hhc
Q 014904          272 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR-ALE  320 (416)
Q Consensus       272 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~-~L~  320 (416)
                      .....   .....    .....+.+++.+||+.+|.+||++.++++ .|.
T Consensus       235 ~~~~~---~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  277 (311)
T 3ork_A          235 DPIPP---SARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLV  277 (311)
T ss_dssp             CCCCH---HHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CCCCc---ccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence            11100   00011    12357889999999999999997666554 443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.1e-42  Score=336.25  Aligned_cols=250  Identities=23%  Similarity=0.332  Sum_probs=201.1

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc---cHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ---GEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  117 (416)
                      .++|.+.+.||+|+||.||+|... +++.||||+++.....   ....+..|..++.++ +||||+++++++.+....++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            367999999999999999999964 6899999999865322   234678899999988 89999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+++++|..++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        88 v~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            999999999999987543  589999999999999999999999   999999999999999999999999999986433


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch--hhhhhhhHHhHHhhhcCCcc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED--SLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~--~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ....    .+...+..+.. 
T Consensus       163 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----~~~~~i~~~~~-  236 (345)
T 3a8x_A          163 PGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED----YLFQVILEKQI-  236 (345)
T ss_dssp             TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHH----HHHHHHHHCCC-
T ss_pred             CCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHH----HHHHHHHcCCC-
Confidence            222 234468999999999999999999999999999999999999999753221110  1111    11111222221 


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRM  312 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  312 (416)
                           .    ++......+.+++.+||+.+|.+||++
T Consensus       237 -----~----~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          237 -----R----IPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -----C----CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -----C----CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                 1    122233578899999999999999996

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.8e-43  Score=340.53  Aligned_cols=267  Identities=24%  Similarity=0.346  Sum_probs=210.1

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-----CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCC--eE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-----PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGS--QR  115 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  115 (416)
                      .++|.+.+.||+|+||.||+|..     .+++.||||++........+.+.+|+.++++++||||+++++++....  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35788999999999999999983     368999999998766555678999999999999999999999987643  67


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++|+||+++++|.+++..... .+++..++.++.+++.||.|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTT-SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEECCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            999999999999999976543 589999999999999999999999   9999999999999999999999999999877


Q ss_pred             cCCCcce--eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch-----hhhhhhhHHhHHh
Q 014904          196 SDVNTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED-----SLVDWARPLLNRA  268 (416)
Q Consensus       196 ~~~~~~~--~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~-----~l~~~~~~~~~~~  268 (416)
                      .......  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.........     ....+....+...
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence            5543321  22345778899999999888999999999999999999999987642110000     0000000111111


Q ss_pred             hhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          269 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       269 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      +..+..         ...+...+..+.+++.+||+.+|.+||++.||++.|+..
T Consensus       276 ~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          276 LKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcCCC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            122111         111223346789999999999999999999999999854

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-42  Score=342.79  Aligned_cols=247  Identities=26%  Similarity=0.395  Sum_probs=200.5

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCccc---HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQG---EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .+.|...+.||+|+||.||+|.. .+++.||||++.......   ...+.+|+.++++++||||+++++++......++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            35688999999999999999995 578999999997654322   24688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+. ++|.+++.... ..+++..++.++.+++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       133 ~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             EECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            99997 57777765332 3689999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CcceeecccccccccChhhhc---cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          199 NTHVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~---~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                           ....||+.|+|||++.   .+.++.++|||||||++|||++|+.||......  ..+        .... .+...
T Consensus       208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~~~--------~~~~-~~~~~  271 (348)
T 1u5q_A          208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SAL--------YHIA-QNESP  271 (348)
T ss_dssp             -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHH--------HHHH-HSCCC
T ss_pred             -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHH--------HHHH-hcCCC
Confidence                 2357999999999984   567899999999999999999999999764321  111        1111 11111


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .+..    .    .....+.+++.+||+.+|++||++.+|++.
T Consensus       272 ~~~~----~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          272 ALQS----G----HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CCCC----T----TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCC----C----CCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            1111    1    223468899999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.8e-43  Score=337.89  Aligned_cols=261  Identities=23%  Similarity=0.309  Sum_probs=205.1

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEe----CCeEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA----GSQRM  116 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  116 (416)
                      ..++|.+.+.||+|+||.||++.. .+++.||||++..........+.+|+.+++.++||||+++++++..    ....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            357899999999999999999996 6789999999977665566789999999999999999999999873    34789


Q ss_pred             EEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          117 LVYEFVPNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      +|+||+.+++|.+++...  ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            999999999999988652  234699999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCCcc--------eeecccccccccChhhhccCC---CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH
Q 014904          195 ASDVNTH--------VSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP  263 (416)
Q Consensus       195 ~~~~~~~--------~~~~~~gt~~YlaPE~~~~~~---~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~  263 (416)
                      .......        ......||+.|+|||++....   ++.++||||||+++|+|++|+.||....... ..+.     
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~-----  257 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVA-----  257 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHH-----
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhh-----
Confidence            5321111        012245799999999987553   6899999999999999999999985321100 0010     


Q ss_pred             HhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          264 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       264 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                         ..... .. .+       .........+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       258 ---~~~~~-~~-~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          258 ---LAVQN-QL-SI-------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             ---HHHHC-C---C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             ---HHhhc-cC-CC-------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence               00111 10 00       011122357899999999999999999999999998643

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.2e-43  Score=333.12  Aligned_cols=250  Identities=29%  Similarity=0.425  Sum_probs=199.8

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeC-CeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAG-SQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~  121 (416)
                      .++|.+.+.||+|+||.||+|.. +|+.||||+++...  ..+.+.+|+.++++++||||+++++++.+. ...++|+||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            57899999999999999999987 58899999997543  346789999999999999999999997654 468999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++++|.+++.......+++..++.++.+++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......  
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  171 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence            9999999999765433488999999999999999999999   99999999999999999999999999987654322  


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                        ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......   .+.        ..+..+..     +
T Consensus       172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~--------~~~~~~~~-----~  233 (278)
T 1byg_A          172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV--------PRVEKGYK-----M  233 (278)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHH--------HHHTTTCC-----C
T ss_pred             --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH--------HHHhcCCC-----C
Confidence              22457889999999999999999999999999999998 99999764321   111        11112211     1


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                          ..+......+.+++.+||+.+|.+||++.||++.|+..
T Consensus       234 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          234 ----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence                11222345789999999999999999999999999853

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=7.1e-43  Score=347.83  Aligned_cols=252  Identities=24%  Similarity=0.308  Sum_probs=197.5

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc---cHHHHHHHHHH-HHhcCCCcccceEEEEEeCCeEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ---GEREFQAEVEI-ISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      ..++|.+.++||+|+||.||+|... +++.||||+++.....   ....+..|..+ ++.++||||+++++++.+....+
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            3468999999999999999999964 5889999999764322   22355667666 56789999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +||||+++++|..++....  .+++..+..++.+++.||.|||+.   +|+||||||+||||+.++.+||+|||+++...
T Consensus       116 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999987643  588999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      ... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......      +...     .+..+.+  
T Consensus       191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~-----~i~~~~~--  256 (373)
T 2r5t_A          191 EHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYD-----NILNKPL--  256 (373)
T ss_dssp             CCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHH-----HHHHSCC--
T ss_pred             cCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHH-----HHHhccc--
Confidence            322 2234568999999999999999999999999999999999999999764321      1111     1111211  


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                          .+    +......+.+++.+||+.+|.+||++.+.++.+.
T Consensus       257 ----~~----~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~  292 (373)
T 2r5t_A          257 ----QL----KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK  292 (373)
T ss_dssp             ----CC----CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred             ----CC----CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence                11    1122346889999999999999999875554443

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-42  Score=329.48  Aligned_cols=256  Identities=25%  Similarity=0.324  Sum_probs=201.7

Q ss_pred             CCCcCceecccCcEEEEEEEeC-CC---cEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeE-EEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP-NG---KEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQR-MLV  118 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lV  118 (416)
                      .|...++||+|+||.||+|.+. ++   ..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.... ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            3445688999999999999853 23   3799999875443 3346788999999999999999999999876554 999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      +||+.+++|.+++.... ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            99999999999997643 3689999999999999999999999   9999999999999999999999999999865432


Q ss_pred             Cc---ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          199 NT---HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       199 ~~---~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ..   .......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+.....  ...+..        .+..+...
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~--------~~~~~~~~  247 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTH--------FLAQGRRL  247 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHH--------HHHTTCCC
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHH--------HhhcCCCC
Confidence            21   122335678999999999999999999999999999999996665433222  111111        11122110


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                               ..+......+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       248 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  286 (298)
T 3pls_A          248 ---------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV  286 (298)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                     111122357899999999999999999999999998643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.2e-42  Score=339.77  Aligned_cols=249  Identities=25%  Similarity=0.345  Sum_probs=204.0

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  116 (416)
                      ..++|.+.++||+|+||.||+|... +++.||||+++...   ......+..|..++..+ +||||+++++++.+....+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3578999999999999999999965 48899999997532   23345678899999988 8999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +||||+++++|..++...+  .+++..++.++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++...
T Consensus        98 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            9999999999999997644  589999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      .... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+   .     ..+..+.+  
T Consensus       173 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~---~-----~~i~~~~~--  238 (353)
T 2i0e_A          173 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DEL---F-----QSIMEHNV--  238 (353)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---H-----HHHHHCCC--
T ss_pred             cCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---HHH---H-----HHHHhCCC--
Confidence            2222 23446799999999999999999999999999999999999999976432   111   1     11112221  


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR-----MSQIVR  317 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evv~  317 (416)
                          .    ++......+.+++.+||+.+|.+||+     +.+|++
T Consensus       239 ----~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 ----A----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ----C----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ----C----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                1    11223457889999999999999996     466654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.2e-42  Score=332.99  Aligned_cols=255  Identities=25%  Similarity=0.368  Sum_probs=205.7

Q ss_pred             hhCCCCcCc-eecccCcEEEEEEEe---CCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeE
Q 014904           42 ATDGFSDAN-LLGQGGFGYVHRGVL---PNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        42 ~t~~f~~~~-~LG~G~~g~Vy~~~~---~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  115 (416)
                      ..++|.+.+ .||+|+||.||+|..   .+++.||||+++.....  ..+++.+|+.+++.++||||+++++++ .....
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            446788877 999999999999963   34789999999765322  246789999999999999999999999 56778


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++|+||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            99999999999999997653  589999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCccee--ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcC
Q 014904          196 SDVNTHVS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDG  272 (416)
Q Consensus       196 ~~~~~~~~--~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~  272 (416)
                      ........  ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.....   ..+.        ..+..+
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~--------~~~~~~  236 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVT--------AMLEKG  236 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHH--------HHHHTT
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHH--------HHHHcC
Confidence            55433322  22346788999999998889999999999999999999 9999976543   1111        112222


Q ss_pred             CcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          273 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       273 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      ...         ..+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus       237 ~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          237 ERM---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             CCC---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            211         11223345789999999999999999999999999854

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.8e-42  Score=326.64  Aligned_cols=248  Identities=27%  Similarity=0.419  Sum_probs=202.7

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      +.++|.+.+.||+|+||.||+|... +++.||||++....   ......+.+|+.++++++||||+++++++.+....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            4678999999999999999999954 57899999986432   1224578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+++++|.+++....  .+++..++.++.+++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        87 v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            999999999999987543  589999999999999999999998   999999999999999999999999999865433


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      .   ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......   ..        ..+.....   
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~--------~~~~~~~~---  224 (279)
T 3fdn_A          162 S---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TY--------KRISRVEF---  224 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH--------HHHHHTCC---
T ss_pred             c---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH---HH--------HHHHhCCC---
Confidence            2   2234578999999999999999999999999999999999999997644211   00        11111111   


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                             .++......+.+++.+||+.+|.+||++.||++.
T Consensus       225 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          225 -------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             -------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             -------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                   1112233578899999999999999999999964

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.7e-42  Score=335.58  Aligned_cols=250  Identities=20%  Similarity=0.332  Sum_probs=206.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ..++|.+.++||+|+||.||++... +++.||+|++.....   .....+..|+.+++.++|+||+++++++.+....++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            4578999999999999999999964 588999999875432   234578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+.+++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       119 v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             EECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999999886543  589999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      ... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......      +..     ..+..+.+   
T Consensus       194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~-----~~~~~~~~---  258 (335)
T 2owb_A          194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETY-----LRIKKNEY---  258 (335)
T ss_dssp             TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH-----HHHHHTCC---
T ss_pred             Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHH-----HHHhcCCC---
Confidence            322 223467999999999999989999999999999999999999999764421      110     01111211   


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                         .+...    ....+.+++.+||+.+|++||++.||++.
T Consensus       259 ---~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          259 ---SIPKH----INPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ---CCCTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---CCCcc----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               11112    23468899999999999999999999863

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.9e-42  Score=338.17  Aligned_cols=267  Identities=18%  Similarity=0.250  Sum_probs=195.0

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCccc--HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQG--EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ..++|.+.++||+|+||.||+|.. .+++.||||+++......  ...+.+|+.++++++||||+++++++.+....++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            457899999999999999999995 478999999997554322  34678999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE-----CCCCceEEeecccce
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL-----DFKFEAKVADFGLAK  193 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl-----~~~~~~kl~DFGla~  193 (416)
                      |||+.+ +|.+++....  .+++..++.|+.|++.||.|||+.   +|+||||||+|||+     +.++.+||+|||+++
T Consensus       112 ~e~~~~-~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EECCSE-EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EecCCC-CHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            999975 8988887654  589999999999999999999999   99999999999999     455569999999998


Q ss_pred             eccCCCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhH------
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN------  266 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~------  266 (416)
                      ....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......  +.+.......-.      
T Consensus       186 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          186 AFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--DQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTS
T ss_pred             ccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--HHHHHHHHHhCCCchhhh
Confidence            7653322 22345689999999999875 4899999999999999999999999765431  111111100000      


Q ss_pred             -Hhhh----cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          267 -RAIE----DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       267 -~~~~----~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                       ....    ...+.......+...........+.+++.+||+.||.+||++.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence             0000    00000000000000001112357889999999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.1e-41  Score=329.56  Aligned_cols=265  Identities=21%  Similarity=0.341  Sum_probs=202.0

Q ss_pred             hCCCCcC-ceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEE
Q 014904           43 TDGFSDA-NLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        43 t~~f~~~-~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      .+.|.+. ++||+|+||.||+|.. .+++.||||++..........+.+|+.++.++ +||||+++++++.+....++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4678874 7899999999999994 57899999999877666677899999999985 7999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc---eEEeecccceecc
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKIAS  196 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~---~kl~DFGla~~~~  196 (416)
                      ||+++++|.+++....  .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.   +||+|||++....
T Consensus        91 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             EcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            9999999999997643  589999999999999999999999   9999999999999998776   9999999987653


Q ss_pred             CCCc------ceeecccccccccChhhhcc-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch----hhhhhh
Q 014904          197 DVNT------HVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED----SLVDWA  261 (416)
Q Consensus       197 ~~~~------~~~~~~~gt~~YlaPE~~~~-----~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~----~l~~~~  261 (416)
                      ....      .......||+.|+|||++..     ..++.++|||||||++|||++|+.||.........    ....-.
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            2211      11223569999999999875     56889999999999999999999999765432100    000000


Q ss_pred             hHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          262 RPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       262 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ...+...+..+.+. +... ...    .....+.+++.+||+.||.+||++.|+++.
T Consensus       246 ~~~~~~~i~~~~~~-~~~~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          246 QNMLFESIQEGKYE-FPDK-DWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHCCCC-CCHH-HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHhccCcc-cCch-hcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            01111222222211 0000 001    123578899999999999999999999873

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.6e-41  Score=330.48  Aligned_cols=261  Identities=21%  Similarity=0.305  Sum_probs=202.7

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-CCcccceEEEEEe--CCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-HKHLVSLVGYYTA--GSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV  118 (416)
                      .++|.+.++||+|+||.||+|.. .+++.||||+++..   ....+.+|+.++.+++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36799999999999999999995 57899999999743   3467899999999997 9999999999998  6778999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC-ceEEeecccceeccC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKIASD  197 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~-~~kl~DFGla~~~~~  197 (416)
                      |||+.+++|..++.     .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++ .+||+|||+++....
T Consensus       112 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999999999885     388999999999999999999999   999999999999999776 899999999987654


Q ss_pred             CCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH----HhHHhhhcC
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP----LLNRAIEDG  272 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~----~~~~~~~~~  272 (416)
                      ...  .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .+.+......    .+...+...
T Consensus       184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHhcCCchhhhHHHHh
Confidence            332  233578999999999977 67999999999999999999999999654331 1122211110    000111111


Q ss_pred             Ccc--------------cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          273 NFD--------------TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       273 ~~~--------------~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ...              ..................+.+++.+||+.||.+||++.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            100              000000111111223467899999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.4e-42  Score=328.17  Aligned_cols=257  Identities=23%  Similarity=0.342  Sum_probs=208.0

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEe--CCeEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTA--GSQRM  116 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  116 (416)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++.....  .....+.+|+.++++++||||+++++++.+  ....+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            3578999999999999999999964 789999999986542  234578899999999999999999998864  56899


Q ss_pred             EEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eeeecccCCcEEECCCCceEEeec
Q 014904          117 LVYEFVPNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDCHPK-----IIHRDIKAANILLDFKFEAKVADF  189 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~-----iiHrDIkp~NILl~~~~~~kl~DF  189 (416)
                      +||||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +     |+||||||+||+++.++.+||+||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            999999999999998643  234599999999999999999999999   7     999999999999999999999999


Q ss_pred             ccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhh
Q 014904          190 GLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAI  269 (416)
Q Consensus       190 Gla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~  269 (416)
                      |+++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....   ..+        ...+
T Consensus       161 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~--------~~~i  228 (279)
T 2w5a_A          161 GLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KEL--------AGKI  228 (279)
T ss_dssp             CHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH--------HHHH
T ss_pred             chheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHH--------HHHH
Confidence            99986644322 22345789999999999999999999999999999999999999976542   111        1122


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      ..+....+         +......+.+++.+||+.+|.+||++.||++.+...
T Consensus       229 ~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          229 REGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             HHTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             hhcccccC---------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence            23332211         112335789999999999999999999999988654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-41  Score=325.29  Aligned_cols=251  Identities=24%  Similarity=0.332  Sum_probs=198.7

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .++|.+.+.||+|+||.||+|.. .+++.+|+|++.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            47899999999999999999995 468999999997653 3345789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE---CCCCceEEeecccceec
Q 014904          121 FVPNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL---DFKFEAKVADFGLAKIA  195 (416)
Q Consensus       121 ~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl---~~~~~~kl~DFGla~~~  195 (416)
                      |+++++|.+++...  ....+++..++.|+.|++.||.|||+.   +|+||||||+|||+   +.++.+||+|||+++..
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999888542  224699999999999999999999999   99999999999999   45678999999999866


Q ss_pred             cCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      .....  .....||+.|+|||++. +.++.++||||||+++++|++|+.||......   .+..        ........
T Consensus       178 ~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---~~~~--------~~~~~~~~  243 (285)
T 3is5_A          178 KSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---EVQQ--------KATYKEPN  243 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH--------HHHHCCCC
T ss_pred             CCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---HHHh--------hhccCCcc
Confidence            54322  23467899999999886 57899999999999999999999999765421   1111        01111110


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ....   ...    ....+.+++.+||+.+|++||++.||++
T Consensus       244 ~~~~---~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          244 YAVE---CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCC-----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cccc---cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000   011    2346889999999999999999999985

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.1e-42  Score=328.25  Aligned_cols=252  Identities=25%  Similarity=0.401  Sum_probs=200.9

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      ++|....+||+|+||.||+|.. .+++.||||++..........+.+|+.+++.++||||+++++++......++|+||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            4556666999999999999995 568899999998766555678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC-CCceEEeecccceeccCCCc
Q 014904          123 PNNTLEFHLHGKG-RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       123 ~~~sL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~-~~~~kl~DFGla~~~~~~~~  200 (416)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++. ++.+||+|||+++.......
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            9999999997653 33578999999999999999999999   9999999999999987 89999999999987654322


Q ss_pred             ceeecccccccccChhhhccCC--CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~--~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      . .....||+.|+|||++.++.  ++.++||||||+++|+|++|+.||....... ...  +      ......     .
T Consensus       179 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~--~------~~~~~~-----~  243 (295)
T 2clq_A          179 C-TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-AAM--F------KVGMFK-----V  243 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-HHH--H------HHHHHC-----C
T ss_pred             c-ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-HHH--H------hhcccc-----c
Confidence            2 23457899999999997654  8899999999999999999999996432211 000  0      000000     0


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .+.+    +......+.+++.+||+.+|++||++.++++
T Consensus       244 ~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          244 HPEI----PESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCC----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1112    2223457889999999999999999999985

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.9e-42  Score=336.72  Aligned_cols=250  Identities=23%  Similarity=0.336  Sum_probs=181.9

Q ss_pred             CceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-CCcccceEEEEEeCCeEEEEEEecCCCC
Q 014904           49 ANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVYEFVPNNT  126 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~~s  126 (416)
                      .++||+|+||.||+|.+. +++.||||++...   ....+..|+.++.++. ||||+++++++.+....++||||+++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999964 6899999999743   3467889999999997 9999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC---ceEEeecccceeccCCCccee
Q 014904          127 LEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF---EAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       127 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~---~~kl~DFGla~~~~~~~~~~~  203 (416)
                      |.+++....  .+++..++.|+.|++.||.|||+.   +|+||||||+|||++.++   .+||+|||+++........ .
T Consensus        93 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-~  166 (325)
T 3kn6_A           93 LFERIKKKK--HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-L  166 (325)
T ss_dssp             HHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-c
Confidence            999997653  699999999999999999999999   999999999999997665   7999999999876543322 3


Q ss_pred             ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc-hhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE-DSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ....+     +...+..+.+..      
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-----~~~~i~~~~~~~------  235 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-----IMKKIKKGDFSF------  235 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-----HHHHHTTTCCCC------
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-----HHHHHHcCCCCC------
Confidence            345789999999999999999999999999999999999999976443111 11111     112222332210      


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ...........+.+++.+||+.+|.+||++.||++.
T Consensus       236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            010011234578999999999999999999998743

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-42  Score=338.23  Aligned_cols=262  Identities=15%  Similarity=0.208  Sum_probs=207.8

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCC---------CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccc---------
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPN---------GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVS---------  104 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  104 (416)
                      .++|.+.+.||+|+||.||+|....         ++.||||++...     ..+.+|+.++.+++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3789999999999999999999653         789999999754     36789999999999999987         


Q ss_pred             ------eEEEEEe-CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEE
Q 014904          105 ------LVGYYTA-GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANIL  177 (416)
Q Consensus       105 ------l~~~~~~-~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NIL  177 (416)
                            +++++.. ....++||||+ +++|.+++.......+++..++.|+.|++.||.|||+.   +|+||||||+|||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence                  6788876 78899999999 99999999866445799999999999999999999999   9999999999999


Q ss_pred             ECCCC--ceEEeecccceeccCCCcc------eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCC
Q 014904          178 LDFKF--EAKVADFGLAKIASDVNTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDST  249 (416)
Q Consensus       178 l~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~  249 (416)
                      ++.++  .+||+|||+++........      ......||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  8999999999876543221      113357999999999999999999999999999999999999999765


Q ss_pred             CcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          250 HTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       250 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      ... ...+..+....      ......+.+.....   ......+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       272 ~~~-~~~~~~~~~~~------~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          272 LPN-TEDIMKQKQKF------VDKPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             TTC-HHHHHHHHHHH------HHSCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             CcC-HHHHHHHHHhc------cCChhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            421 11122111111      11111222211110   112357899999999999999999999999998643

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.3e-42  Score=329.77  Aligned_cols=256  Identities=28%  Similarity=0.378  Sum_probs=201.3

Q ss_pred             CCCCcCceecccCcEEEEEEEeCC----CcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEe-CCeEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPN----GKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTA-GSQRML  117 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  117 (416)
                      .+|.+.++||+|+||.||+|.+.+    ...+|||.+...... ....+.+|+.++++++||||+++++++.. ....++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            467888999999999999999543    236899998764432 33578899999999999999999999654 567899


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+++++|.+++.... ..+++..++.|+.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence            999999999999997543 3689999999999999999999999   999999999999999999999999999986644


Q ss_pred             CCcc---eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          198 VNTH---VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       198 ~~~~---~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      ....   ......+|+.|+|||.+.+..++.++||||||+++++|++ |..||.......   +..        .+..+.
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~--------~~~~~~  249 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV--------YLLQGR  249 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHH--------HHHTTC
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHH--------HHhcCC
Confidence            3221   2233567889999999999999999999999999999999 555555433211   111        111111


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      ..  ..       +......+.+++.+||+.+|.+||++.||++.|+...
T Consensus       250 ~~--~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  290 (298)
T 3f66_A          250 RL--LQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  290 (298)
T ss_dssp             CC--CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC--CC-------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            10  01       1112347899999999999999999999999998643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7.3e-42  Score=329.59  Aligned_cols=251  Identities=22%  Similarity=0.377  Sum_probs=205.0

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ..++|.+.+.||+|+||.||+|... +|+.||||+++.........+.+|+.++.+++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            4578999999999999999999964 789999999987655455678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE---CCCCceEEeecccceeccC
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL---DFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl---~~~~~~kl~DFGla~~~~~  197 (416)
                      |+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+||++   +.++.+||+|||+++....
T Consensus        87 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           87 LVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             cCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            999999999886543  589999999999999999999999   99999999999999   7889999999999876543


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      .   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....   ..+        ...+..+.+. +
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~--------~~~i~~~~~~-~  226 (304)
T 2jam_A          162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKL--------FEKIKEGYYE-F  226 (304)
T ss_dssp             B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH--------HHHHHHCCCC-C
T ss_pred             C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH--------HHHHHcCCCC-C
Confidence            2   12335689999999999999999999999999999999999999976432   111        1112222211 1


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                       .    ..........+.+++.+||+.+|.+||++.|+++
T Consensus       227 -~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          227 -E----SPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             -C----TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             -C----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             0    1111223457899999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=343.99  Aligned_cols=274  Identities=22%  Similarity=0.264  Sum_probs=213.3

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCC--eEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGS--QRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV  118 (416)
                      .++|.+.++||+|+||.||+|.+. +|+.||||++.... ......+.+|+.++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            467999999999999999999965 58999999997543 233467889999999999999999999998755  78999


Q ss_pred             EEecCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE----CCCCceEEeecccce
Q 014904          119 YEFVPNNTLEFHLHGKGR-PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL----DFKFEAKVADFGLAK  193 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl----~~~~~~kl~DFGla~  193 (416)
                      |||+++++|.+++..... ..+++..++.++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999976432 2499999999999999999999999   99999999999999    788889999999998


Q ss_pred             eccCCCcceeecccccccccChhhhcc--------CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHh
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYASS--------GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLL  265 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~~--------~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~  265 (416)
                      .......  .....||+.|+|||++.+        ..++.++|||||||++|||++|+.||.........  .+.....+
T Consensus       165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~  240 (396)
T 4eut_A          165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKII  240 (396)
T ss_dssp             ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHH
T ss_pred             EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHh
Confidence            7654332  233569999999999865        56788999999999999999999999754321110  11111111


Q ss_pred             HHh----------hhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          266 NRA----------IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       266 ~~~----------~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      ...          ...+.+...-+..............+..++.+||+.||++||++.|+++.|+...
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence            000          0011111000111223445677888999999999999999999999999997543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.9e-42  Score=335.98  Aligned_cols=254  Identities=28%  Similarity=0.427  Sum_probs=203.8

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEE--EEEEeecCC-cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEV--AIKQLKAGS-GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~v--avK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ++|.+.+.||+|+||.||+|... ++..+  |||.++... ....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            68899999999999999999954 56644  999987532 23345789999999999 899999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCce
Q 014904          119 YEFVPNNTLEFHLHGKG--------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA  184 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~  184 (416)
                      |||+++++|.+++....              ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence            99999999999997643              24689999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhH
Q 014904          185 KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARP  263 (416)
Q Consensus       185 kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~  263 (416)
                      ||+|||+++......  ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......   .+      
T Consensus       182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~------  250 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---EL------  250 (327)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH------
T ss_pred             EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HH------
Confidence            999999987433211  1233457889999999998889999999999999999998 99999765421   11      


Q ss_pred             HhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          264 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       264 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                        ...+..+..         ...+......+.+++.+||+.+|.+||++.|+++.|+..
T Consensus       251 --~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          251 --YEKLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             --HHHGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHhhcCCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              111112210         111122345789999999999999999999999999854

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=336.76  Aligned_cols=254  Identities=16%  Similarity=0.141  Sum_probs=206.1

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEE------eCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC---CCcccceEEE
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGV------LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH---HKHLVSLVGY  108 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~  108 (416)
                      ++....++|.+.++||+|+||.||+|+      ..+++.||||+++...   ..++..|+.++.+++   |+||++++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            334456789999999999999999994      4568999999997543   457888888888887   8999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC-----
Q 014904          109 YTAGSQRMLVYEFVPNNTLEFHLHGK---GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF-----  180 (416)
Q Consensus       109 ~~~~~~~~lV~e~~~~~sL~~~l~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~-----  180 (416)
                      +......++||||+++++|.+++...   ....+++..++.|+.|++.||+|||+.   +|+||||||+||||+.     
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence            99999999999999999999999642   234699999999999999999999998   9999999999999998     


Q ss_pred             ------CCceEEeecccceeccCC-CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccc
Q 014904          181 ------KFEAKVADFGLAKIASDV-NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFV  253 (416)
Q Consensus       181 ------~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~  253 (416)
                            ++.+||+|||+++..... .........||++|+|||++.+..++.++|||||||++|||+||+.||...... 
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-  291 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG-  291 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC-
Confidence                  899999999999865422 233345578999999999999999999999999999999999999998543220 


Q ss_pred             chhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHhccc
Q 014904          254 EDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRR-PRMSQIVRALEGD  322 (416)
Q Consensus       254 ~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R-Pt~~evv~~L~~~  322 (416)
                           .|                .+...+....   ....+.+++..|++.+|.+| |++.++.+.|+..
T Consensus       292 -----~~----------------~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          292 -----EC----------------KPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             -----EE----------------EECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             -----ce----------------eechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence                 00                0011111111   13467789999999999998 5788888888754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=338.66  Aligned_cols=243  Identities=24%  Similarity=0.336  Sum_probs=203.2

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc--------cHHHHHHHHHHHHhcCCCcccceEEEEEeC
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ--------GEREFQAEVEIISRVHHKHLVSLVGYYTAG  112 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  112 (416)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||++......        ....+..|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            457899999999999999999994 57899999999865321        123577899999999999999999999999


Q ss_pred             CeEEEEEEecCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          113 SQRMLVYEFVPNN-TLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       113 ~~~~lV~e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                      ...++||||+.++ +|..++....  .+++..++.|+.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            9999999998776 9999987654  599999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~-t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~  270 (416)
                      ++.......  .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......                . 
T Consensus       177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------~-  237 (335)
T 3dls_A          177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------V-  237 (335)
T ss_dssp             CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------T-
T ss_pred             ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------H-
Confidence            987654332  234679999999999988776 88999999999999999999999652210                0 


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ...    ..+  ..    .....+.+++.+||+.+|.+||++.||++.
T Consensus       238 ~~~----~~~--~~----~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 EAA----IHP--PY----LVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             TTC----CCC--SS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             hhc----cCC--Cc----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000    000  01    123468899999999999999999999874

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-42  Score=340.89  Aligned_cols=255  Identities=25%  Similarity=0.338  Sum_probs=206.6

Q ss_pred             hCCCCcCceecccCcEEEEEEEe----CCCcEEEEEEeecCC----cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCC
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL----PNGKEVAIKQLKAGS----GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGS  113 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  113 (416)
                      .++|.+.++||+|+||.||+|..    .+++.||||+++...    ......+..|+.++.++ +|+||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            47899999999999999999996    378999999987432    12234577899999999 6999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            9999999999999999997543  589999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCcceeecccccccccChhhhccC--CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhc
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIED  271 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~~~--~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~  271 (416)
                      ..............||+.|+|||++.++  .++.++|||||||+||||++|+.||.......  ....+.....     .
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~-----~  280 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRIL-----K  280 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHH-----H
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHh-----c
Confidence            7655444444557899999999999863  47899999999999999999999997544321  1111111111     1


Q ss_pred             CCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHh
Q 014904          272 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP-----RMSQIVRAL  319 (416)
Q Consensus       272 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~~L  319 (416)
                      ..      +.    ++......+.+++.+||+.+|.+||     ++.|+++..
T Consensus       281 ~~------~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          281 SE------PP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             CC------CC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             cC------CC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            11      11    1222335788999999999999999     999998764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.2e-41  Score=324.07  Aligned_cols=251  Identities=25%  Similarity=0.366  Sum_probs=203.2

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc------ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG------QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  115 (416)
                      .++|.+.+.||+|+||.||+|... +++.||||+++....      .....+.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467899999999999999999965 689999999975432      2356899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC----ceEEeeccc
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF----EAKVADFGL  191 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~----~~kl~DFGl  191 (416)
                      ++||||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++    .+||+|||+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            99999999999999997543  589999999999999999999999   999999999999998877    799999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhc
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIED  271 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~  271 (416)
                      +........  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......  ..+.         .+..
T Consensus       159 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~---------~~~~  225 (283)
T 3bhy_A          159 AHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETLT---------NISA  225 (283)
T ss_dssp             CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH---------HHHT
T ss_pred             ceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHHH---------HhHh
Confidence            987654322  23456899999999999999999999999999999999999999764421  1111         1111


Q ss_pred             CCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          272 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       272 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ....  .++....    .....+.+++.+||+.+|.+||++.|+++
T Consensus       226 ~~~~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          226 VNYD--FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             TCCC--CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cccC--Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            1110  0011111    12346889999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.7e-42  Score=326.13  Aligned_cols=253  Identities=24%  Similarity=0.359  Sum_probs=206.1

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ..++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++.+....++|+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3568999999999999999999964 789999999975432 33467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        85 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             ECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999999886543  589999999999999999999999   99999999999999999999999999998664332


Q ss_pred             c-ceeecccccccccChhhhccCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          200 T-HVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       200 ~-~~~~~~~gt~~YlaPE~~~~~~~-t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      . .......||+.|+|||.+.+..+ +.++||||||+++++|++|+.||...... ...+..|..        ....   
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~--------~~~~---  227 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKE--------KKTY---  227 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT-SHHHHHHHT--------TCTT---
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHhhh--------cccc---
Confidence            2 22344678999999999987665 78999999999999999999999765431 112222211        1000   


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..      ........+.+++.+||+.+|.+||++.||++
T Consensus       228 ~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 LN------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ST------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cC------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            00      01122346889999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-42  Score=333.68  Aligned_cols=260  Identities=25%  Similarity=0.400  Sum_probs=203.5

Q ss_pred             cCHHHHHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEEEEe
Q 014904           34 FTYEELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYYTA  111 (416)
Q Consensus        34 f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  111 (416)
                      +++.++....++|.+.+.||+|+||.||+|.+ .+++.||||++.... .....+.+|+.++.++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            45556667889999999999999999999996 578999999997543 3346789999999999 89999999999987


Q ss_pred             ------CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceE
Q 014904          112 ------GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAK  185 (416)
Q Consensus       112 ------~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~k  185 (416)
                            ....++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence                  46889999999999999999865545789999999999999999999999   999999999999999999999


Q ss_pred             EeecccceeccCCCcceeecccccccccChhhhc-----cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhh
Q 014904          186 VADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDW  260 (416)
Q Consensus       186 l~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~-----~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~  260 (416)
                      |+|||++........ ......||+.|+|||++.     +..++.++|||||||++|+|++|+.||.......  .+.  
T Consensus       170 l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~--  244 (326)
T 2x7f_A          170 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--ALF--  244 (326)
T ss_dssp             ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH--
T ss_pred             EeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHH--
Confidence            999999886543222 223457899999999987     5678999999999999999999999997644311  110  


Q ss_pred             hhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          261 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                            . +..+....+..    .    .....+.+++.+||+.+|.+||++.+|++
T Consensus       245 ------~-~~~~~~~~~~~----~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          245 ------L-IPRNPAPRLKS----K----KWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             ------H-HHHSCCCCCSC----S----CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ------H-hhcCccccCCc----c----ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                  0 11111111111    1    12347889999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.7e-42  Score=329.47  Aligned_cols=249  Identities=28%  Similarity=0.444  Sum_probs=208.0

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .+.|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            36799999999999999999995 468999999997654 3345789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|.+++...   .+++..++.++.+++.||.|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus       101 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          101 YLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             CCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             eCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            99999999998643   589999999999999999999999   999999999999999999999999999987654332


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCc
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP  280 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~  280 (416)
                      . .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......   ....        .+..+..     +
T Consensus       175 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~--------~~~~~~~-----~  237 (303)
T 3a7i_A          175 K-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLF--------LIPKNNP-----P  237 (303)
T ss_dssp             C-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH--------HHHHSCC-----C
T ss_pred             c-cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHH--------HhhcCCC-----C
Confidence            2 23457899999999999999999999999999999999999999764431   1111        1111211     1


Q ss_pred             cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       281 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .+...+    ...+.+++.+||+.+|.+||++.||++.
T Consensus       238 ~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          238 TLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CCCSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CCcccc----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            122222    3468899999999999999999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.7e-42  Score=335.26  Aligned_cols=268  Identities=22%  Similarity=0.367  Sum_probs=202.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCccc--HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQG--EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ..++|.+.++||+|+||.||+|... +|+.||||++.......  .+.+.+|+.++++++||||+++++++.+....++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            3478999999999999999999964 58999999987654332  34678999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+.+++|..++....  .+++..++.++.+++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       103 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999999998876544  589999999999999999999999   9999999999999999999999999999865443


Q ss_pred             CcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh------HHhHHhh-h
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR------PLLNRAI-E  270 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~------~~~~~~~-~  270 (416)
                      .. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......  .+.....      +...... .
T Consensus       178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHH
T ss_pred             cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhhHhhh
Confidence            22 22345689999999999875 78999999999999999999999997754321  1111110      0000000 0


Q ss_pred             cCCcccccCccccCcCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          271 DGNFDTLVDPKLHNEYN-----HNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ...+.....+.+....+     ......+.+++.+||+.+|.+||++.||++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            11111111111111111     123467899999999999999999999885

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.7e-42  Score=324.45  Aligned_cols=245  Identities=20%  Similarity=0.286  Sum_probs=200.5

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG--QGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  117 (416)
                      .+++|.+.+.||+|+||.||+|... +++.||||++.....  ....++.+|+.++..+ +||||+++++++.+....++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4578999999999999999999965 799999999986432  3346788999999999 99999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC--------------
Q 014904          118 VYEFVPNNTLEFHLHGKG--RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK--------------  181 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~--------------  181 (416)
                      ||||+++++|.+++....  ...+++..++.|+.|++.||.|||+.   +|+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999997542  13689999999999999999999999   99999999999999844              


Q ss_pred             -----CceEEeecccceeccCCCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch
Q 014904          182 -----FEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED  255 (416)
Q Consensus       182 -----~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~  255 (416)
                           ..+||+|||++........     ..||+.|+|||++.+. .++.++|||||||++++|++|+.++.....    
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred             ccCCceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence                 4799999999987654322     3589999999999866 567899999999999999999887643211    


Q ss_pred             hhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          256 SLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       256 ~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                       .         ..+..+....     +...    ....+.+++.+||+.+|.+||++.|+++
T Consensus       237 -~---------~~~~~~~~~~-----~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 -W---------HEIRQGRLPR-----IPQV----LSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -H---------HHHHTTCCCC-----CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -H---------HHHHcCCCCC-----CCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence             1         1112222211     1122    2357899999999999999999999985

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.4e-42  Score=336.80  Aligned_cols=287  Identities=20%  Similarity=0.270  Sum_probs=207.5

Q ss_pred             cCHHHHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcc-----------cHHHHHHHHHHHHhcCCCcc
Q 014904           34 FTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQ-----------GEREFQAEVEIISRVHHKHL  102 (416)
Q Consensus        34 f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~ni  102 (416)
                      ....++..+.++|.+.+.||+|+||.||+|...+|+.||||++......           ..+.+.+|+.++.+++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            4567899999999999999999999999999888999999998643221           12678999999999999999


Q ss_pred             cceEEEEEe-----CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEE
Q 014904          103 VSLVGYYTA-----GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANIL  177 (416)
Q Consensus       103 v~l~~~~~~-----~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NIL  177 (416)
                      +++++++..     ....++||||+. ++|.+.+.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL  166 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence            999999865     336899999997 57777776443 3699999999999999999999999   9999999999999


Q ss_pred             ECCCCceEEeecccceeccCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch-
Q 014904          178 LDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED-  255 (416)
Q Consensus       178 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~-  255 (416)
                      ++.++.+||+|||+++.......  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... 
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  244 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN  244 (362)
T ss_dssp             ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EcCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999975443222  234578999999999877 67999999999999999999999999865431110 


Q ss_pred             hhhh------------hhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hcc
Q 014904          256 SLVD------------WARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA--LEG  321 (416)
Q Consensus       256 ~l~~------------~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~--L~~  321 (416)
                      .+..            +..+.....+. .......... ...........+.+++.+||+.+|.+||++.|+++.  ++.
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  322 (362)
T 3pg1_A          245 KIVEVVGTPKIEDVVMFSSPSARDYLR-NSLSNVPARA-WTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES  322 (362)
T ss_dssp             HHHHHHCCCCHHHHHHTSCHHHHHHTT-TCCCCCCCCC-HHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHHHcCCCChHHhhhccchhhhHHHH-hhcccCChhh-HHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhh
Confidence            0000            00000111110 0111110000 001111223568899999999999999999999964  444


Q ss_pred             ccCccccc
Q 014904          322 DASLADLN  329 (416)
Q Consensus       322 ~~~~~~~~  329 (416)
                      .....++.
T Consensus       323 ~~~~~~~~  330 (362)
T 3pg1_A          323 LFDPLDLT  330 (362)
T ss_dssp             TCCGGGGT
T ss_pred             ccCccccc
Confidence            43333333

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.3e-43  Score=340.80  Aligned_cols=255  Identities=23%  Similarity=0.340  Sum_probs=188.2

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-CCcccceEEEEEe--------
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-HKHLVSLVGYYTA--------  111 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--------  111 (416)
                      ...+|++.++||+|+||.||+|.+ .+++.||||++........+.+.+|+.++.++. ||||+++++++..        
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            346899999999999999999995 478999999997766555678899999999996 9999999999953        


Q ss_pred             CCeEEEEEEecCCCCHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeecccCCcEEECCCCceEEee
Q 014904          112 GSQRMLVYEFVPNNTLEFHLHG-KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK--IIHRDIKAANILLDFKFEAKVAD  188 (416)
Q Consensus       112 ~~~~~lV~e~~~~~sL~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--iiHrDIkp~NILl~~~~~~kl~D  188 (416)
                      ....++|+||+. ++|.+++.. .....+++..++.|+.|++.||.|||+.   +  |+||||||+||||+.++.+||+|
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence            345799999995 688877754 2233699999999999999999999998   7  99999999999999999999999


Q ss_pred             cccceeccCCCcce-----------eecccccccccChhhh---ccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc
Q 014904          189 FGLAKIASDVNTHV-----------STRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE  254 (416)
Q Consensus       189 FGla~~~~~~~~~~-----------~~~~~gt~~YlaPE~~---~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~  254 (416)
                      ||+++.........           .....||+.|+|||++   .+..++.++|||||||++|+|++|+.||......  
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--  259 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--  259 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--
Confidence            99998765432211           1134689999999998   5667899999999999999999999999653321  


Q ss_pred             hhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          255 DSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       255 ~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                       .+            ..+....        .........+.+++.+||+.+|.+||++.||++.|+...
T Consensus       260 -~~------------~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          260 -RI------------VNGKYSI--------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             -------------------CCC--------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -Hh------------hcCcccC--------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             00            0111110        001111234788999999999999999999999998543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-41  Score=348.83  Aligned_cols=247  Identities=27%  Similarity=0.397  Sum_probs=206.4

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++....   ......+.+|+.+++.++||||+++++++......++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            478999999999999999999965 79999999997532   12345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+++++|.+++...+  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        95 ~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            99999999999997543  589999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeecccccccccChhhhccCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~-t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      .  ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......   .        +...+..+.+.  
T Consensus       170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~--------~~~~i~~~~~~--  234 (476)
T 2y94_A          170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---T--------LFKKICDGIFY--  234 (476)
T ss_dssp             C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---H--------HHHHHHTTCCC--
T ss_pred             c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---H--------HHHHHhcCCcC--
Confidence            2  2234579999999999988765 78999999999999999999999764431   1        11122223221  


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                          ...    .....+.+++.+||+.||.+||++.||++
T Consensus       235 ----~p~----~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          235 ----TPQ----YLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ----CCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----CCc----cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                111    12346889999999999999999999996

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=8.7e-42  Score=356.17  Aligned_cols=254  Identities=26%  Similarity=0.401  Sum_probs=210.0

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ..++|.+.++||+|+||.||+|... +|+.||||++....   ......+.+|+.++..++||||+++++++.+....++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3467999999999999999999964 79999999997532   2334568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+++++|..++...+...+++..++.++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++....
T Consensus       262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999999876655699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc-hhhhhhhhHHhHHhhhcCCccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE-DSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      ...  .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+..        .+....   
T Consensus       339 ~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~--------~i~~~~---  405 (576)
T 2acx_A          339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER--------LVKEVP---  405 (576)
T ss_dssp             TCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH--------HHHHCC---
T ss_pred             Ccc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH--------Hhhccc---
Confidence            332  2345799999999999998999999999999999999999999987543211 11111        111111   


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRP-----RMSQIVRA  318 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~~  318 (416)
                             ..++......+.+++.+||+.||.+||     ++.||++.
T Consensus       406 -------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          406 -------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                   111222335789999999999999999     67888753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.9e-42  Score=332.79  Aligned_cols=259  Identities=21%  Similarity=0.307  Sum_probs=206.7

Q ss_pred             HHHHhhCCCCcC-ceecccCcEEEEEEEeC-CCcEEEEEEeecCC--cccHHHHHHHHHHHHhc-CCCcccceEEEEEeC
Q 014904           38 ELARATDGFSDA-NLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS--GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAG  112 (416)
Q Consensus        38 el~~~t~~f~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  112 (416)
                      ......++|.+. +.||+|+||.||+|... +++.||||+++...  ......+.+|+.++.++ +||||+++++++.+.
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~  101 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT  101 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence            344566788887 89999999999999964 68999999997542  33457889999999999 569999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC---CCceEEeec
Q 014904          113 SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADF  189 (416)
Q Consensus       113 ~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~---~~~~kl~DF  189 (416)
                      ...++||||+.+++|.+++.......+++..++.++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+||
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            9999999999999999998766556799999999999999999999999   9999999999999988   789999999


Q ss_pred             ccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhh
Q 014904          190 GLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAI  269 (416)
Q Consensus       190 Gla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~  269 (416)
                      |+++.......  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......  .+.         .+
T Consensus       179 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~---------~i  245 (327)
T 3lm5_A          179 GMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--TYL---------NI  245 (327)
T ss_dssp             GGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH---------HH
T ss_pred             ccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHH---------HH
Confidence            99987654322  234579999999999999999999999999999999999999997654311  110         01


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ......      ............+.+++.+||+.+|.+||++.|+++.
T Consensus       246 ~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          246 SQVNVD------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHTCCC------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             Hhcccc------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            111110      1111112234578899999999999999999999854

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.9e-42  Score=337.35  Aligned_cols=266  Identities=28%  Similarity=0.416  Sum_probs=208.9

Q ss_pred             CHHHHHH-hhCCCCcCceecccCcEEEEEEEe------CCCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceE
Q 014904           35 TYEELAR-ATDGFSDANLLGQGGFGYVHRGVL------PNGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLV  106 (416)
Q Consensus        35 ~~~el~~-~t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~  106 (416)
                      +..++.. ..++|.+.+.||+|+||.||+|.+      .+++.||||++.... ......+.+|+.++++++||||++++
T Consensus        20 s~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   99 (327)
T 2yfx_A           20 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCI   99 (327)
T ss_dssp             CGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             chhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEE
Confidence            3444432 357999999999999999999983      357789999997543 33345788999999999999999999


Q ss_pred             EEEEeCCeEEEEEEecCCCCHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC-
Q 014904          107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGR-----PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF-  180 (416)
Q Consensus       107 ~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~-----~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~-  180 (416)
                      +++.+....++||||+++++|.+++.....     ..+++..++.++.|++.||.|||+.   +|+||||||+|||++. 
T Consensus       100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~  176 (327)
T 2yfx_A          100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP  176 (327)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCS
T ss_pred             EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecC
Confidence            999999999999999999999999976532     3589999999999999999999999   9999999999999984 


Q ss_pred             --CCceEEeecccceeccCCCc-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchh
Q 014904          181 --KFEAKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDS  256 (416)
Q Consensus       181 --~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~  256 (416)
                        +..+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.....   ..
T Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~  253 (327)
T 2yfx_A          177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QE  253 (327)
T ss_dssp             STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred             CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HH
Confidence              45699999999975543222 22334578999999999999999999999999999999998 9999876432   11


Q ss_pred             hhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          257 LVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       257 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      +..        .+..+...     .    .+......+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       254 ~~~--------~~~~~~~~-----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          254 VLE--------FVTSGGRM-----D----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HHH--------HHHTTCCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH--------HHhcCCCC-----C----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            111        11222111     1    11223357889999999999999999999999998644

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-42  Score=343.62  Aligned_cols=255  Identities=29%  Similarity=0.408  Sum_probs=193.9

Q ss_pred             CCCcCceecccCcEEEEEEEeC--CC--cEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEe-CCeEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVLP--NG--KEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTA-GSQRMLV  118 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~--~g--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV  118 (416)
                      .|...++||+|+||.||+|.+.  ++  ..||||.++.... ...+.|.+|+.++++++||||++++++|.. ....++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3556689999999999999953  22  3689999875432 334679999999999999999999999764 4578999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+++++|.+++..... .+++..++.++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++.....
T Consensus       170 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EECCCCCCHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence            999999999999975443 689999999999999999999999   9999999999999999999999999999865433


Q ss_pred             Ccc---eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          199 NTH---VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       199 ~~~---~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ...   ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.......   +..        .+..+..
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~--------~~~~~~~  314 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV--------YLLQGRR  314 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHH--------HHHTTCC
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHH--------HHHcCCC
Confidence            221   1233567889999999999999999999999999999999 677776543311   111        1112211


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                        ...       +...+..+.+++.+||+.+|++||++.||++.|+...
T Consensus       315 --~~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          315 --LLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             --CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              111       1123357899999999999999999999999998643

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.7e-42  Score=331.11  Aligned_cols=258  Identities=24%  Similarity=0.408  Sum_probs=187.6

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||++.... .....++.+|+.++.+++||||+++++++......++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            457899999999999999999994 478999999987543 233457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          120 EFVPNNTLEFHLHG------KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       120 e~~~~~sL~~~l~~------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ||+++++|.+++..      .....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999998863      1234689999999999999999999999   99999999999999999999999999987


Q ss_pred             eccCCCc----ceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHh
Q 014904          194 IASDVNT----HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRA  268 (416)
Q Consensus       194 ~~~~~~~----~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~  268 (416)
                      .......    .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........  +.        ..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~--------~~  239 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LM--------LT  239 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HH--------HH
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HH--------HH
Confidence            6543221    11234578999999999876 5689999999999999999999999977543211  00        00


Q ss_pred             hhcCCccc----ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          269 IEDGNFDT----LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       269 ~~~~~~~~----~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      . .+....    ..++.....+    ...+.+++.+||+.+|.+||++.||++
T Consensus       240 ~-~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          240 L-QNDPPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             H-TSSCCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             h-ccCCCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1 111111    1111122222    347889999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3e-41  Score=324.76  Aligned_cols=253  Identities=22%  Similarity=0.317  Sum_probs=201.0

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC----cccHHHHHHHHHHHHhcCCCcccceEEEEE--eCC
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS----GQGEREFQAEVEIISRVHHKHLVSLVGYYT--AGS  113 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~  113 (416)
                      +..++|.+.+.||+|+||.||+|.. .+++.||||+++...    ......+.+|+.++++++|+||+++++++.  +..
T Consensus         2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred             ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence            3568999999999999999999996 468999999997532    233467899999999999999999999984  456


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ..++||||+.++ |.+++.......+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence            789999999877 76777655555799999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCC-cceeecccccccccChhhhccCC--CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh
Q 014904          194 IASDVN-THVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       194 ~~~~~~-~~~~~~~~gt~~YlaPE~~~~~~--~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~  270 (416)
                      ...... ........||+.|+|||++.+..  .+.++||||||+++|+|++|+.||.....      ...     ...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~-----~~~i~  226 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKL-----FENIG  226 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHH-----HHHHH
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHH-----HHHHh
Confidence            765322 22234457899999999997654  37899999999999999999999976432      111     11122


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .+..      .+..    .....+.+++.+||+.+|.+||++.|+++.
T Consensus       227 ~~~~------~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          227 KGSY------AIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HCCC------CCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             cCCC------CCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            2221      1111    233578899999999999999999999964

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3e-41  Score=336.06  Aligned_cols=267  Identities=23%  Similarity=0.290  Sum_probs=204.1

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC--------CCcccceEEEEE---
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH--------HKHLVSLVGYYT---  110 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  110 (416)
                      .++|.+.++||+|+||.||+|.. .+++.||||+++... .....+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            47899999999999999999995 468899999997532 33457889999999985        788999999987   


Q ss_pred             -eCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC-------
Q 014904          111 -AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-------  182 (416)
Q Consensus       111 -~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~-------  182 (416)
                       .....++||||+ +++|.+.+.......+++..++.|+.|++.||.|||+.+  +|+||||||+||||+.++       
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence             456789999999 555555555444446999999999999999999999975  899999999999999775       


Q ss_pred             ------------------------------------------ceEEeecccceeccCCCcceeecccccccccChhhhcc
Q 014904          183 ------------------------------------------EAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS  220 (416)
Q Consensus       183 ------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~  220 (416)
                                                                .+||+|||+++.....    .....||+.|+|||++.+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence                                                      7999999999876543    233578999999999999


Q ss_pred             CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHh-------HHhhh-----------cCCcccccCccc
Q 014904          221 GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLL-------NRAIE-----------DGNFDTLVDPKL  282 (416)
Q Consensus       221 ~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~-------~~~~~-----------~~~~~~~~d~~l  282 (416)
                      ..++.++|||||||+||||++|+.||..........-.+......       ...+.           .+....+.+...
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence            999999999999999999999999998654321111000000000       00000           111111111000


Q ss_pred             ---------cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          283 ---------HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       283 ---------~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                               ....+......+.+|+.+||+.||++||++.||++
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                     11345677788999999999999999999999985

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-41  Score=338.21  Aligned_cols=204  Identities=25%  Similarity=0.441  Sum_probs=165.1

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcC-CCcccceEEEEEeCC--e
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVH-HKHLVSLVGYYTAGS--Q  114 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  114 (416)
                      ...++|.+.+.||+|+||.||+|.+ .+|+.||||++....  ......+.+|+.++..+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            4568999999999999999999995 578999999986432  233456788999999997 999999999998644  6


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      .++||||+. ++|..++...   .+++..+..++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++.
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            899999997 5888888753   589999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCC--------------------CcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCc
Q 014904          195 ASDV--------------------NTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHT  251 (416)
Q Consensus       195 ~~~~--------------------~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~  251 (416)
                      ....                    .....+...||+.|+|||++.+ ..++.++|||||||+++||++|+.||.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            5331                    1112244679999999999976 6799999999999999999999999987543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.1e-41  Score=327.41  Aligned_cols=253  Identities=23%  Similarity=0.371  Sum_probs=200.7

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++..........+..|+.++..++||||+++++++......++|+|
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            4578999999999999999999965 589999999987666667789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|..++..... .+++..++.++.+++.||.|||+.   +|+||||||+||+++.++.+||+|||++....... 
T Consensus        97 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             CCTTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             eCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            9999999998865332 589999999999999999999999   99999999999999999999999999975432211 


Q ss_pred             ceeecccccccccChhhh-----ccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          201 HVSTRVMGTFGYLAPEYA-----SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~-----~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      .......||+.|+|||++     ....++.++||||||+++|+|++|+.||......  ..+        .. +..+...
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~--------~~-~~~~~~~  240 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVL--------LK-IAKSDPP  240 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHH--------HH-HHHSCCC
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHH--------HH-HhccCCc
Confidence            112335689999999998     3667899999999999999999999999765431  111        11 1112211


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ....       +......+.+++.+||+.+|.+||++.+|++
T Consensus       241 ~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          241 TLLT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CCSS-------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ccCC-------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1111       1122357889999999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.2e-41  Score=324.48  Aligned_cols=249  Identities=20%  Similarity=0.342  Sum_probs=206.4

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG---QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.....   .....+.+|+.+++.++|+||+++++++.+....++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            468899999999999999999965 588999999875432   2345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        94 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            99999999999886543  589999999999999999999999   9999999999999999999999999999876533


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      .. ......||+.|+|||++.+..++.++||||||+++++|++|+.||......  +..         ..+..+..    
T Consensus       169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~---------~~~~~~~~----  232 (294)
T 2rku_A          169 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETY---------LRIKKNEY----  232 (294)
T ss_dssp             TC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH---------HHHHTTCC----
T ss_pred             cc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH---------HHHhhccC----
Confidence            22 223457899999999999889999999999999999999999999764421  110         01111211    


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                        .+..    .....+.+++.+||+.+|++||++.|+++.
T Consensus       233 --~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          233 --SIPK----HINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             --CCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             --CCcc----ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence              1111    223468899999999999999999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.4e-42  Score=364.29  Aligned_cols=246  Identities=27%  Similarity=0.389  Sum_probs=198.9

Q ss_pred             ceecccCcEEEEEEEe---CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVL---PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~---~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      +.||+|+||.||+|.+   ..++.||||+++....  ...+++.+|+.++.+++|||||+++++|.. ...++||||+.+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            3799999999999974   3468899999986432  335789999999999999999999999965 558899999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc--e
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH--V  202 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~--~  202 (416)
                      ++|.+++....  .+++..++.|+.|++.||+|||+.   +|+||||||+||||+.++.+||+|||+++........  .
T Consensus       454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            99999997543  589999999999999999999999   9999999999999999999999999999876543322  2


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                      .....+|+.|+|||++.+..++.++|||||||+||||++ |+.||......   .        +...+..+...      
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~--------~~~~i~~~~~~------  591 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---E--------VTAMLEKGERM------  591 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H--------HHHHHHTTCCC------
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---H--------HHHHHHcCCCC------
Confidence            233457889999999999999999999999999999998 99999765431   1        11122222211      


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                         ..+..++..+.+++..||+.+|++||++.+|++.|+.
T Consensus       592 ---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          592 ---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence               1222344678999999999999999999999999984

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.5e-41  Score=323.51  Aligned_cols=252  Identities=27%  Similarity=0.391  Sum_probs=201.5

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ...++|.+.+.||+|+||.||+|... +|+.||||++....  ....+.+|+.++.+++||||+++++++......++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34578999999999999999999965 58999999998643  2357889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++.... ..+++..++.++.+++.||.|||+.   +|+|+||||+||+++.++.+||+|||++.......
T Consensus       104 e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          104 EYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             ECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            9999999999986432 3689999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                      .. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........  +        . .+..+....+..
T Consensus       180 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~--------~-~~~~~~~~~~~~  247 (314)
T 3com_A          180 AK-RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA--I--------F-MIPTNPPPTFRK  247 (314)
T ss_dssp             SC-BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H--------H-HHHHSCCCCCSS
T ss_pred             cc-cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--H--------H-HHhcCCCcccCC
Confidence            22 2345789999999999999999999999999999999999999976443110  0        0 011111111111


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                             +......+.+++.+||+.+|.+||++.++++
T Consensus       248 -------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          248 -------PELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                   1122357889999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.3e-41  Score=334.81  Aligned_cols=253  Identities=22%  Similarity=0.342  Sum_probs=203.8

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ..++|.+.+.||+|+||.||+|... +|+.||||++......    +.+|++++.++ +||||+++++++.+....++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4578999999999999999999964 6899999999865432    34678888887 7999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC----CceEEeecccceec
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK----FEAKVADFGLAKIA  195 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~----~~~kl~DFGla~~~  195 (416)
                      ||+++++|.+++....  .+++..+..++.+++.||.|||+.   +|+||||||+|||+..+    +.+||+|||+++..
T Consensus        96 E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            9999999999987654  589999999999999999999999   99999999999998543    34999999999876


Q ss_pred             cCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+.        ..+..+.+.
T Consensus       171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--------~~i~~~~~~  241 (342)
T 2qr7_A          171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL--------ARIGSGKFS  241 (342)
T ss_dssp             BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH--------HHHHHCCCC
T ss_pred             cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH--------HHHccCCcc
Confidence            54332 233467899999999998888999999999999999999999999764322211111        122233322


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .      ...+.......+.+++.+||+.||++||++.||++.
T Consensus       242 ~------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          242 L------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             C------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             c------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1      111112234578899999999999999999998853

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.7e-41  Score=331.47  Aligned_cols=259  Identities=23%  Similarity=0.395  Sum_probs=209.2

Q ss_pred             CHHHHHHhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc--------cHHHHHHHHHHHHhc-CCCcccc
Q 014904           35 TYEELARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ--------GEREFQAEVEIISRV-HHKHLVS  104 (416)
Q Consensus        35 ~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~  104 (416)
                      .++......++|.+.+.||+|+||.||+|.+. +|+.||||++......        ..+.+..|+.++.++ +||||++
T Consensus        85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~  164 (365)
T 2y7j_A           85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT  164 (365)
T ss_dssp             HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            44555667788999999999999999999975 7999999999765421        134578899999999 7999999


Q ss_pred             eEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCce
Q 014904          105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA  184 (416)
Q Consensus       105 l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~  184 (416)
                      +++++......++||||+++++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus       165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             EEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             EEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence            9999999999999999999999999987543  589999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeccCCCcceeecccccccccChhhhcc------CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhh
Q 014904          185 KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS------GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV  258 (416)
Q Consensus       185 kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~------~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~  258 (416)
                      ||+|||++........  .....||+.|+|||++.+      ..++.++|||||||++|+|++|+.||......   ...
T Consensus       240 kl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~  314 (365)
T 2y7j_A          240 RLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LML  314 (365)
T ss_dssp             EECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH
T ss_pred             EEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHH
Confidence            9999999987654322  234679999999999863      35889999999999999999999999764321   111


Q ss_pred             hhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          259 DWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                              ..+..+.+.. ..+.+ ..    ....+.+++.+||+.+|.+||++.|+++
T Consensus       315 --------~~i~~~~~~~-~~~~~-~~----~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          315 --------RMIMEGQYQF-SSPEW-DD----RSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             --------HHHHHTCCCC-CHHHH-SS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --------HHHHhCCCCC-CCccc-cc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                    1111222110 00000 11    2346889999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=331.59  Aligned_cols=270  Identities=22%  Similarity=0.365  Sum_probs=200.3

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHH--HHhcCCCcccceEEEEEe-----CCeE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEI--ISRVHHKHLVSLVGYYTA-----GSQR  115 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~  115 (416)
                      .++|.+.++||+|+||.||+|.. +++.||||++....   ...+..|.++  +..++|+||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            47899999999999999999987 78999999997532   3445555555  445899999999987653     2356


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeeecccCCcEEECCCCceEEeec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC------HPKIIHRDIKAANILLDFKFEAKVADF  189 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~------~~~iiHrDIkp~NILl~~~~~~kl~DF  189 (416)
                      ++||||+++++|.+++...   .+++..++.|+.|++.||.|||+.+      .++|+||||||+||||+.++.+||+||
T Consensus        88 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF  164 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF  164 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred             EEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence            8999999999999999765   3589999999999999999999874      338999999999999999999999999


Q ss_pred             ccceeccCCCc-------ceeecccccccccChhhhcc-------CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccch
Q 014904          190 GLAKIASDVNT-------HVSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVED  255 (416)
Q Consensus       190 Gla~~~~~~~~-------~~~~~~~gt~~YlaPE~~~~-------~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~  255 (416)
                      |+++.......       .......||+.|+|||++.+       ..++.++|||||||++|||++|+.||.........
T Consensus       165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  244 (336)
T 3g2f_A          165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY  244 (336)
T ss_dssp             TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred             cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence            99987654221       11234579999999999976       35677999999999999999998876543321111


Q ss_pred             hhhhh----hh---HHhHHhhhcCCcccccCccccCc--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          256 SLVDW----AR---PLLNRAIEDGNFDTLVDPKLHNE--YNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       256 ~l~~~----~~---~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      ...-.    ..   ..+.........    .+.+...  ........+.+++.+||+.+|++||++.||++.|+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          245 QMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            00000    00   000000111111    1111111  12346678999999999999999999999999998654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.3e-41  Score=322.68  Aligned_cols=246  Identities=28%  Similarity=0.404  Sum_probs=205.0

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .++|.+.+.||+|+||.||+|... +++.||||++....   ......+.+|+.++++++||||+++++++.+....++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            368999999999999999999964 67899999986432   22346789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      +||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        93 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            99999999999987654  589999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      .   .....|++.|+|||++.+..++.++||||||+++|+|++|+.||.......      ..     ..+.....    
T Consensus       168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~-----~~~~~~~~----  229 (284)
T 2vgo_A          168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------TH-----RRIVNVDL----  229 (284)
T ss_dssp             C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-----HHHHTTCC----
T ss_pred             c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HH-----HHHhcccc----
Confidence            2   234578999999999999999999999999999999999999997644211      00     11111111    


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                        .+    +......+.+++.+||+.+|.+||++.||++
T Consensus       230 --~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 --KF----PPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             --CC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --CC----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence              11    1222357889999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.3e-42  Score=345.67  Aligned_cols=241  Identities=13%  Similarity=0.157  Sum_probs=190.2

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecC---CcccHHHHHHHH---HHHHhcCCCcccceE-------EE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAG---SGQGEREFQAEV---EIISRVHHKHLVSLV-------GY  108 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  108 (416)
                      .++|.+.+.||+|+||.||+|.+ .+|+.||||++...   .....+.+.+|+   .++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788889999999999999995 57999999999743   233446788999   455556899999998       77


Q ss_pred             EEeCC-----------------eEEEEEEecCCCCHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 014904          109 YTAGS-----------------QRMLVYEFVPNNTLEFHLHGKGR-----PTMDWLTRLKIALGSAKGLAYLHEDCHPKI  166 (416)
Q Consensus       109 ~~~~~-----------------~~~lV~e~~~~~sL~~~l~~~~~-----~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i  166 (416)
                      +...+                 ..++||||+ +++|.+++.....     ..+++..++.|+.|++.||+|||+.   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            76553                 278999999 6899999875321     2344688899999999999999999   99


Q ss_pred             eeecccCCcEEECCCCceEEeecccceeccCCCcceeecccccccccChhhhccC-----------CCCchhhhHhHHHH
Q 014904          167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG-----------KLTEKSDVFSFGVM  235 (416)
Q Consensus       167 iHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~-----------~~t~ksDV~SlGvv  235 (416)
                      +||||||+||||+.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999986432    2344567 999999999887           89999999999999


Q ss_pred             HHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 014904          236 LLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQI  315 (416)
Q Consensus       236 L~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev  315 (416)
                      +|||++|+.||........                   ...+...  ...    ....+.+++.+||+.+|++||++.|+
T Consensus       303 l~elltg~~Pf~~~~~~~~-------------------~~~~~~~--~~~----~~~~~~~li~~~L~~dp~~Rpt~~e~  357 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGG-------------------SEWIFRS--CKN----IPQPVRALLEGFLRYPKEDRLLPLQA  357 (377)
T ss_dssp             HHHHHHSSCCC------CC-------------------SGGGGSS--CCC----CCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred             HHHHHHCCCCCcccccccc-------------------hhhhhhh--ccC----CCHHHHHHHHHHcCCCchhCCCHHHH
Confidence            9999999999975432110                   0000000  011    23578899999999999999999999


Q ss_pred             HH
Q 014904          316 VR  317 (416)
Q Consensus       316 v~  317 (416)
                      ++
T Consensus       358 l~  359 (377)
T 3byv_A          358 ME  359 (377)
T ss_dssp             HT
T ss_pred             hh
Confidence            85

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.8e-41  Score=342.84  Aligned_cols=195  Identities=26%  Similarity=0.368  Sum_probs=155.0

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeC-----C
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAG-----S  113 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  113 (416)
                      ..++|.+.++||+|+||.||+|.+. +++.||||++.....  ...+.+.+|+.++++++||||+++++++...     .
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            4578999999999999999999954 789999999975432  2345788999999999999999999999543     5


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ..++||||+ +++|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             eEEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence            689999998 578888886543  599999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCc--------------------------ceeecccccccccChhhh-ccCCCCchhhhHhHHHHHHHHHhC
Q 014904          194 IASDVNT--------------------------HVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITG  242 (416)
Q Consensus       194 ~~~~~~~--------------------------~~~~~~~gt~~YlaPE~~-~~~~~t~ksDV~SlGvvL~elltG  242 (416)
                      .......                          ...+..+||+.|+|||++ ....++.++|||||||+||||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            7643211                          122446789999999986 456799999999999999999993

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.5e-41  Score=335.33  Aligned_cols=261  Identities=22%  Similarity=0.324  Sum_probs=204.6

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++.+++||||+++++++.+....++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357999999999999999999964 689999999986532 334578999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|.+++....  .+++..+..|+.+++.||.|||+.+  +|+||||||+|||++.++.+||+|||++......  
T Consensus       112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999997654  5899999999999999999999843  7999999999999999999999999998755322  


Q ss_pred             ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhh-------------------
Q 014904          201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA-------------------  261 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~-------------------  261 (416)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...............                   
T Consensus       186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence             223457899999999999999999999999999999999999999764431111000000                   


Q ss_pred             ------------hHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          262 ------------RPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       262 ------------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                                  .......+..+...        ..........+.+++.+||+.+|.+||++.|+++.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPP--------KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCC--------CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccccCCCCcccchhhhhHHhccCCC--------CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                        00000000011100        00111123578999999999999999999999853

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-41  Score=331.94  Aligned_cols=271  Identities=24%  Similarity=0.311  Sum_probs=198.2

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCccc-----HHHHHHHHHHHHhcCCCcccceEEEEEe
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQG-----EREFQAEVEIISRVHHKHLVSLVGYYTA  111 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~  111 (416)
                      ++....++|.+.++||+|+||.||+|... +|+.||||++.......     .+.+.+|+.++.+++||||+++++++.+
T Consensus         4 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (346)
T 1ua2_A            4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH   83 (346)
T ss_dssp             ---------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             hhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence            34556789999999999999999999964 68999999997543221     1367899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       112 ~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                      ....++||||+.+ +|..++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        84 ~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (346)
T 1ua2_A           84 KSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL  158 (346)
T ss_dssp             TTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred             CCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccc
Confidence            9999999999976 7888876543 3588889999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~  270 (416)
                      ++....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||......  +.+.........  ..
T Consensus       159 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~~~~i~~~~~~--~~  233 (346)
T 1ua2_A          159 AKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGT--PT  233 (346)
T ss_dssp             GSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCC--CC
T ss_pred             ceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHcCC--CC
Confidence            987654332 22345789999999999764 5899999999999999999999998765431  111111100000  00


Q ss_pred             cCCc---ccccCc---cccCcCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          271 DGNF---DTLVDP---KLHNEYN-----HNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       271 ~~~~---~~~~d~---~l~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ...+   ..+.+.   ......+     ......+.+++.+||+.+|.+||++.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0000   000000   0000001     1233678999999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.4e-41  Score=319.74  Aligned_cols=249  Identities=25%  Similarity=0.386  Sum_probs=198.0

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ..++|.+.+.||+|+||.||+|... +|+.||||++....   ......+.+|+.+++.++||||+++++++......++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            3478999999999999999999965 79999999997532   2334578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      |+||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++.....
T Consensus        89 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            999999999999997543  589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcceeecccccccccChhhhccCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~-t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      ...  .....||+.|+|||.+.+..+ +.++||||||+++++|++|+.||.....   ..+        ...+..+... 
T Consensus       164 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~--------~~~~~~~~~~-  229 (276)
T 2h6d_A          164 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PTL--------FKKIRGGVFY-  229 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH--------HHHHHHCCCC-
T ss_pred             Ccc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHH--------HHHhhcCccc-
Confidence            322  234568999999999987765 6899999999999999999999976432   111        1111222110 


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                           +..    .....+.+++.+||+.+|.+||++.||++.
T Consensus       230 -----~~~----~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          230 -----IPE----YLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -----CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -----Cch----hcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                 111    123468899999999999999999999974

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.3e-41  Score=325.41  Aligned_cols=246  Identities=24%  Similarity=0.386  Sum_probs=197.6

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEe----CCeEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTA----GSQRML  117 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  117 (416)
                      .|.+.+.||+|+||.||+|.. .++..||+|++....  ......+.+|+.++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            367777899999999999995 468899999987543  2334578899999999999999999999876    456899


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeecccCCcEEEC-CCCceEEeeccccee
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK--IIHRDIKAANILLD-FKFEAKVADFGLAKI  194 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--iiHrDIkp~NILl~-~~~~~kl~DFGla~~  194 (416)
                      ||||+++++|.+++....  .+++..++.|+.+++.||.|||+.   +  |+||||||+|||++ .++.+||+|||++..
T Consensus       107 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            999999999999997543  589999999999999999999998   7  99999999999997 789999999999975


Q ss_pred             ccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          195 ASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       195 ~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ....   ......||+.|+|||++. +.++.++||||||+++|+|++|+.||......  ..+.        ..+..+..
T Consensus       182 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~--------~~~~~~~~  247 (290)
T 1t4h_A          182 KRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIY--------RRVTSGVK  247 (290)
T ss_dssp             CCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHH--------HHHTTTCC
T ss_pred             cccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HHHH--------HHHhccCC
Confidence            4432   223457999999999886 56999999999999999999999999764331  1111        11111211


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..    ....    .....+.+++.+||+.+|.+||++.||++
T Consensus       248 ~~----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          248 PA----SFDK----VAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CG----GGGG----CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cc----ccCC----CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11    1111    12246899999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.6e-41  Score=348.12  Aligned_cols=254  Identities=25%  Similarity=0.351  Sum_probs=204.3

Q ss_pred             HHhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-------------ccHHHHHHHHHHHHhcCCCcccce
Q 014904           40 ARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG-------------QGEREFQAEVEIISRVHHKHLVSL  105 (416)
Q Consensus        40 ~~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l  105 (416)
                      ....++|.+.++||+|+||.||+|... +++.||||++.....             ...+.+.+|+.++++++||||+++
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            346789999999999999999999964 688999999975432             224578899999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC---
Q 014904          106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF---  182 (416)
Q Consensus       106 ~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~---  182 (416)
                      ++++.+....++||||+++++|.+++....  .+++..++.|+.|++.||.|||+.   +|+||||||+|||++.++   
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence            999999999999999999999998886543  599999999999999999999999   999999999999998776   


Q ss_pred             ceEEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh
Q 014904          183 EAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR  262 (416)
Q Consensus       183 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~  262 (416)
                      .+||+|||+++.......  .....||+.|+|||++. +.++.++|||||||++|+|++|+.||......   .      
T Consensus       187 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~------  254 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---D------  254 (504)
T ss_dssp             SEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H------
T ss_pred             cEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---H------
Confidence            699999999987654322  23457999999999987 57999999999999999999999999865431   1      


Q ss_pred             HHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          263 PLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       263 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                        +...+..+.+..  +.....    .....+.+++.+||+.+|.+||++.|+++.
T Consensus       255 --~~~~i~~~~~~~--~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          255 --IIKKVEKGKYYF--DFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             --HHHHHHHCCCCC--CHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --HHHHHHcCCCCC--CccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence              111222232211  000001    123578899999999999999999999853

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3e-41  Score=345.44  Aligned_cols=265  Identities=22%  Similarity=0.290  Sum_probs=196.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecC--CcccHHHHHHHHHHHHhcCCCcccceEEEEEeC------
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAG------  112 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  112 (416)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            467899999999999999999995 46899999999754  223345788999999999999999999999654      


Q ss_pred             CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccc
Q 014904          113 SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA  192 (416)
Q Consensus       113 ~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla  192 (416)
                      ...++||||+.++ |...+..    .+++..+..++.|++.||+|||+.   +|+||||||+||||+.++.+||+|||++
T Consensus       140 ~~~~lv~E~~~~~-l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          140 QDVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             CEEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             CeEEEEEeCCCCC-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            4579999999765 5555543    389999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh----------
Q 014904          193 KIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR----------  262 (416)
Q Consensus       193 ~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~----------  262 (416)
                      +.....  ...+...||+.|+|||++.+..++.++|||||||+|+||++|+.||........  +.....          
T Consensus       212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~--~~~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          212 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCPEFM  287 (464)
T ss_dssp             -----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHHH
T ss_pred             eecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHH
Confidence            876542  223456899999999999999999999999999999999999999987543111  111000          


Q ss_pred             ----HHhHHhhhcC-Cccc-----ccCcccc---CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          263 ----PLLNRAIEDG-NFDT-----LVDPKLH---NEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       263 ----~~~~~~~~~~-~~~~-----~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                          +.....++.. ....     +....+.   ..........+.+|+.+||+.||.+||++.|+++.
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                0000111100 0000     0000000   00111225678999999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.3e-41  Score=343.57  Aligned_cols=254  Identities=25%  Similarity=0.380  Sum_probs=194.8

Q ss_pred             HHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--------ccHHHHHHHHHHHHhcCCCcccceEEEEE
Q 014904           40 ARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG--------QGEREFQAEVEIISRVHHKHLVSLVGYYT  110 (416)
Q Consensus        40 ~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~  110 (416)
                      ....++|.+.+.||+|+||.||+|.. .+++.||||++.....        .....+.+|+.++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            34678999999999999999999995 4689999999875321        11224789999999999999999999985


Q ss_pred             eCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC---ceEEe
Q 014904          111 AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF---EAKVA  187 (416)
Q Consensus       111 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~---~~kl~  187 (416)
                      . ...++||||+++++|.+++....  .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++   .+||+
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             c-CceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence            4 56899999999999998886543  599999999999999999999999   999999999999997544   59999


Q ss_pred             ecccceeccCCCcceeecccccccccChhhhcc---CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH
Q 014904          188 DFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL  264 (416)
Q Consensus       188 DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~---~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~  264 (416)
                      |||+++.....  .......||+.|+|||++.+   ..++.++|||||||++|+|++|+.||.......  .+.      
T Consensus       285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~------  354 (419)
T 3i6u_A          285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLK------  354 (419)
T ss_dssp             CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHH------
T ss_pred             ecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHH------
Confidence            99999876542  22344679999999999853   678899999999999999999999997643311  111      


Q ss_pred             hHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          265 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       265 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                        ..+..+.+...  +....    .....+.+++.+||+.+|.+||++.|+++
T Consensus       355 --~~i~~~~~~~~--~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          355 --DQITSGKYNFI--PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             --HHHHTTCCCCC--HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --HHHhcCCCCCC--chhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence              11122222111  11111    12357889999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.2e-41  Score=343.06  Aligned_cols=201  Identities=22%  Similarity=0.310  Sum_probs=175.7

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhc------CCCcccceEEEEEeCCe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRV------HHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~  114 (416)
                      ...+|.+.++||+|+||.||+|... +++.||||+++... .....+..|+.++..+      +|+||+++++++.....
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            4568999999999999999999854 58999999997532 2335677888888887      57799999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc--eEEeecccc
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE--AKVADFGLA  192 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~--~kl~DFGla  192 (416)
                      .++||||+. ++|.+++.......+++..++.|+.|++.||+|||+.   +|+||||||+||||+.++.  +||+|||++
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999996 6888888776655799999999999999999999999   9999999999999999987  999999999


Q ss_pred             eeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCc
Q 014904          193 KIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHT  251 (416)
Q Consensus       193 ~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~  251 (416)
                      +.....    .....||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus       250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          250 CYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             EETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             eecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            765432    2335789999999999999999999999999999999999999977543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.8e-42  Score=329.41  Aligned_cols=257  Identities=26%  Similarity=0.394  Sum_probs=197.9

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC--CCc--EEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP--NGK--EVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~--~g~--~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  115 (416)
                      .++|.+.+.||+|+||.||+|.+.  +++  .||||+++...   ......+.+|+.++.+++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            368999999999999999999853  333  68999987542   233467889999999999999999999998765 8


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++|+||+++++|.+++.... ..+++..++.++.+++.||.|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence            89999999999999987543 2589999999999999999999999   9999999999999999999999999999877


Q ss_pred             cCCCcce--eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcC
Q 014904          196 SDVNTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDG  272 (416)
Q Consensus       196 ~~~~~~~--~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~  272 (416)
                      .......  .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....   ..+..       . +...
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~-------~-~~~~  240 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILH-------K-IDKE  240 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH-------H-HHTS
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHHH-------H-HHcc
Confidence            5543322  233567889999999998889999999999999999999 9999976542   11111       1 1111


Q ss_pred             CcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          273 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       273 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      ...    .    ..+......+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       241 ~~~----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          241 GER----L----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             CCC----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCC----C----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence            110    0    111223457899999999999999999999999998643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-42  Score=334.95  Aligned_cols=264  Identities=22%  Similarity=0.340  Sum_probs=194.6

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccH-HHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ++|.+.+.||+|+||.||+|... +++.||||++........ ..+.+|+.++++++||||+++++++......++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999965 789999999975432221 2455799999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +. ++|.+++..... .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        82 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  155 (324)
T ss_dssp             CS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence            97 588888765543 689999999999999999999999   999999999999999999999999999986543322 


Q ss_pred             eeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc--
Q 014904          202 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV--  278 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~--  278 (416)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  .+. .....+.. .....+....  
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~-~i~~~~~~-~~~~~~~~~~~~  231 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--QLH-FIFRILGT-PTEETWPGILSN  231 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH-HHHHHHCC-CCTTTSTTGGGC
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHH-HHHHHhCC-CChHhchhhhcc
Confidence            2234568999999999876 568999999999999999999999998754321  111 11000000 0000000000  


Q ss_pred             -------CccccCc----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          279 -------DPKLHNE----YNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       279 -------d~~l~~~----~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                             .+.....    ........+.+++.+||+.||.+||++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                   0000000    00112356789999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.1e-42  Score=335.88  Aligned_cols=258  Identities=21%  Similarity=0.303  Sum_probs=207.1

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCccc-----------------HHHHHHHHHHHHhcCCCcccce
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQG-----------------EREFQAEVEIISRVHHKHLVSL  105 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l  105 (416)
                      .++|.+.+.||+|+||.||+|.. +++.||||++.......                 ...+.+|+.++.+++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            57899999999999999999999 99999999997432111                 1688999999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCCHHHH------hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeecccCCcEEE
Q 014904          106 VGYYTAGSQRMLVYEFVPNNTLEFH------LHGKGRPTMDWLTRLKIALGSAKGLAYLHE-DCHPKIIHRDIKAANILL  178 (416)
Q Consensus       106 ~~~~~~~~~~~lV~e~~~~~sL~~~------l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiHrDIkp~NILl  178 (416)
                      ++++.+....++||||+++++|.++      +.......+++..++.++.|++.||.|||+ .   +|+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence            9999999999999999999999998      655445679999999999999999999999 7   99999999999999


Q ss_pred             CCCCceEEeecccceeccCCCcceeecccccccccChhhhccC-CCCc-hhhhHhHHHHHHHHHhCCCCCCCCCcccchh
Q 014904          179 DFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG-KLTE-KSDVFSFGVMLLELITGRRPVDSTHTFVEDS  256 (416)
Q Consensus       179 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~-~~t~-ksDV~SlGvvL~elltG~~pf~~~~~~~~~~  256 (416)
                      +.++.+||+|||++......   ......||..|+|||.+.+. .++. ++||||||+++|||++|+.||......  ..
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~  260 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VE  260 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HH
T ss_pred             cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH
Confidence            99999999999999876443   33446799999999999877 6666 999999999999999999999865431  11


Q ss_pred             hhhhhhHHhHHhhhcCCcccccC------ccc---cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          257 LVDWARPLLNRAIEDGNFDTLVD------PKL---HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       257 l~~~~~~~~~~~~~~~~~~~~~d------~~l---~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      +..        .+..+......+      +..   ...........+.+++.+||+.+|.+||++.|+++
T Consensus       261 ~~~--------~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 LFN--------NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHH--------HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHH--------HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111        111221110000      000   00011223457899999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6.2e-41  Score=326.11  Aligned_cols=268  Identities=19%  Similarity=0.306  Sum_probs=206.4

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe--CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCC------cccceEEEEEeCC
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL--PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHK------HLVSLVGYYTAGS  113 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~  113 (416)
                      ..++|.+.+.||+|+||.||+|..  .+++.||||+++... .....+.+|+.++..++|+      +++++++++....
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            347899999999999999999986  368899999997532 3345788899999998765      4999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC-------------
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF-------------  180 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~-------------  180 (416)
                      ..++||||+ +++|.+++.......+++..++.++.|++.||+|||+.   +|+||||||+|||++.             
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999999 88999999877656789999999999999999999999   9999999999999987             


Q ss_pred             ------CCceEEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc
Q 014904          181 ------KFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE  254 (416)
Q Consensus       181 ------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~  254 (416)
                            ++.+||+|||+++......    ....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             ccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                  6689999999998754322    335789999999999999999999999999999999999999986543211


Q ss_pred             hhhhhhh-hH---HhHHhhhcCCc--------c----------cccCcc-ccCcCCHHHHHHHHHHHHHhhccCCCCCCC
Q 014904          255 DSLVDWA-RP---LLNRAIEDGNF--------D----------TLVDPK-LHNEYNHNEMARMVACAAACVRHSARRRPR  311 (416)
Q Consensus       255 ~~l~~~~-~~---~~~~~~~~~~~--------~----------~~~d~~-l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt  311 (416)
                      ....... .+   .+........+        .          ....+. -...........+.+++.+||+.||.+||+
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            1111000 00   00000000000        0          000000 001123355678999999999999999999


Q ss_pred             HHHHHHH
Q 014904          312 MSQIVRA  318 (416)
Q Consensus       312 ~~evv~~  318 (416)
                      +.||++.
T Consensus       323 ~~ell~h  329 (339)
T 1z57_A          323 LREALKH  329 (339)
T ss_dssp             HHHHTTS
T ss_pred             HHHHhcC
Confidence            9999853

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.9e-42  Score=326.56  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=187.4

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCccc-H-HHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQG-E-REFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ..++|++.+.||+|+||.||+|.. .+|+.||||+++...... . +.+.++...++.++||||+++++++.+....++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            357899999999999999999995 578999999997653222 2 2344555568888999999999999999999999


Q ss_pred             EEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          119 YEFVPNNTLEFHLHG--KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      |||+++ +|.+++..  .....+++..++.|+.|++.||.|||+.+  +|+||||||+||+++.++.+||+|||+++...
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            999974 77766643  12346999999999999999999999864  89999999999999999999999999998765


Q ss_pred             CCCcceeecccccccccChhhh----ccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcC
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYA----SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDG  272 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~----~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~  272 (416)
                      ....  .....||+.|+|||++    .+..++.++||||||+++|+|++|+.||..... ....+        .......
T Consensus       162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~--------~~~~~~~  230 (290)
T 3fme_A          162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-PFQQL--------KQVVEEP  230 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-HHHHH--------HHHHHSC
T ss_pred             cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-hHHHH--------HHHhccC
Confidence            4322  2334689999999996    566789999999999999999999999975332 11111        1111111


Q ss_pred             CcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          273 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       273 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      . ....        .......+.+++.+||+.+|++||++.||++
T Consensus       231 ~-~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 S-PQLP--------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             C-CCCC--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C-CCcc--------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            1 1111        1122357899999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.5e-41  Score=343.39  Aligned_cols=261  Identities=20%  Similarity=0.271  Sum_probs=209.2

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCC-CcccceEEEEEeCCeEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHH-KHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~  119 (416)
                      ..++|.+.++||+|+||.||+|.+ .+++.||||++......  .++..|+.++..++| +++..+..++......+|||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            357899999999999999999995 57899999998755432  357889999999976 66667777778889999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE---CCCCceEEeecccceecc
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL---DFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl---~~~~~~kl~DFGla~~~~  196 (416)
                      ||+ +++|.+++..... .+++..++.|+.|++.||.|||+.   +||||||||+||||   +.++.+||+|||+++...
T Consensus        83 e~~-g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             ECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ECC-CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            999 9999999975433 699999999999999999999999   99999999999999   688999999999998776


Q ss_pred             CCCcce------eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh
Q 014904          197 DVNTHV------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       197 ~~~~~~------~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~  270 (416)
                      ......      .....||+.|+|||++.+..++.++|||||||+||||++|+.||..................   .+ 
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~---~~-  233 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---KV-  233 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH---HH-
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc---cc-
Confidence            543321      22567999999999999999999999999999999999999999875543222222211110   00 


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      ......     +...    .+..+.+++..||+.+|++||++.+|++.|+..
T Consensus       234 ~~~~~~-----l~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          234 ATSIEA-----LCRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HSCHHH-----HHTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cccHHH-----HhcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            000000     1111    235789999999999999999999999998753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.2e-41  Score=346.49  Aligned_cols=252  Identities=23%  Similarity=0.373  Sum_probs=207.3

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ..++|.+.++||+|+||.||+|... +|+.||||++....   ......+.+|+.++++++||||+++++++.+....++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3568999999999999999999965 78999999997543   3345789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE---CCCCceEEeeccccee
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL---DFKFEAKVADFGLAKI  194 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl---~~~~~~kl~DFGla~~  194 (416)
                      |+||+.+++|.+.+....  .+++..++.|+.|++.||.|||+.   +|+||||||+|||+   +.++.+||+|||+++.
T Consensus       104 v~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             EECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            999999999999887654  589999999999999999999999   99999999999999   5678899999999987


Q ss_pred             ccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          195 ASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       195 ~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ......  .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||......   .+        ...+..+.+
T Consensus       179 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~--------~~~i~~~~~  244 (484)
T 3nyv_A          179 FEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DI--------LKKVEKGKY  244 (484)
T ss_dssp             BCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH--------HHHHHHCCC
T ss_pred             cccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HH--------HHHHHcCCC
Confidence            654322  234579999999999875 7999999999999999999999999865431   11        112223322


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ..- .+.     .......+.+++.+||+.+|.+||++.|+++.
T Consensus       245 ~~~-~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          245 TFE-LPQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             CCC-SGG-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCC-Ccc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            110 011     11233578899999999999999999999853

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.6e-42  Score=332.33  Aligned_cols=261  Identities=22%  Similarity=0.345  Sum_probs=201.0

Q ss_pred             ccCHHHHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcC--CCcccceEEE
Q 014904           33 TFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVH--HKHLVSLVGY  108 (416)
Q Consensus        33 ~f~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~  108 (416)
                      .+.+..+....++|.+.+.||+|+||.||++...+++.||||++.....  .....+.+|+.++.+++  |+||++++++
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            3444455556788999999999999999999988899999999975432  23467899999999997  5999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEee
Q 014904          109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD  188 (416)
Q Consensus       109 ~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~D  188 (416)
                      +......++||| +.+++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||+++ +.+||+|
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~D  169 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLID  169 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECC
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEee
Confidence            999999999999 56889999997654  589999999999999999999999   9999999999999964 7999999


Q ss_pred             cccceeccCCCcc-eeecccccccccChhhhcc-----------CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchh
Q 014904          189 FGLAKIASDVNTH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDS  256 (416)
Q Consensus       189 FGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~-----------~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~  256 (416)
                      ||+++........ ......||+.|+|||++.+           ..++.++||||||+++|+|++|+.||......    
T Consensus       170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----  245 (313)
T 3cek_A          170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----  245 (313)
T ss_dssp             CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----
T ss_pred             ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH----
Confidence            9999876543322 2234578999999999875           47889999999999999999999999754321    


Q ss_pred             hhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          257 LVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       257 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ...     +....         ++.....++......+.+++.+||+.+|.+||++.||++.
T Consensus       246 ~~~-----~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          246 ISK-----LHAII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHH-----HHHHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHH-----HHHHH---------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            000     11111         1111111111223578899999999999999999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-41  Score=336.14  Aligned_cols=267  Identities=22%  Similarity=0.303  Sum_probs=198.5

Q ss_pred             HHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEe------
Q 014904           39 LARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA------  111 (416)
Q Consensus        39 l~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  111 (416)
                      +....++|.+.+.||+|+||.||+|.. .+|+.||||++.....    ...+|+.+++.++||||+++++++..      
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            445678999999999999999999995 5799999999875432    23469999999999999999999854      


Q ss_pred             --------------------------------CCeEEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHH
Q 014904          112 --------------------------------GSQRMLVYEFVPNNTLEFHLHG--KGRPTMDWLTRLKIALGSAKGLAY  157 (416)
Q Consensus       112 --------------------------------~~~~~lV~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~  157 (416)
                                                      ....++||||+++ +|...+..  .....+++..+..++.|++.||+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            3348899999984 77666643  223469999999999999999999


Q ss_pred             HHhcCCCCeeeecccCCcEEEC-CCCceEEeecccceeccCCCcceeecccccccccChhhhccC-CCCchhhhHhHHHH
Q 014904          158 LHEDCHPKIIHRDIKAANILLD-FKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVM  235 (416)
Q Consensus       158 LH~~~~~~iiHrDIkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvv  235 (416)
                      ||+.   +|+||||||+|||++ .++.+||+|||+++........  ....||+.|+|||++.+. .++.++|||||||+
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC--CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC--cCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9999   999999999999997 6889999999999876543332  345689999999998765 48999999999999


Q ss_pred             HHHHHhCCCCCCCCCcccchhhhhhhhHH----hHHhh-hcCCccc-----ccCccccCcCCHHHHHHHHHHHHHhhccC
Q 014904          236 LLELITGRRPVDSTHTFVEDSLVDWARPL----LNRAI-EDGNFDT-----LVDPKLHNEYNHNEMARMVACAAACVRHS  305 (416)
Q Consensus       236 L~elltG~~pf~~~~~~~~~~l~~~~~~~----~~~~~-~~~~~~~-----~~d~~l~~~~~~~~~~~l~~l~~~cl~~~  305 (416)
                      +|||++|+.||......  +.+.......    ..... ....+..     +....+...++......+.+++.+||+.+
T Consensus       232 l~ell~g~~pf~~~~~~--~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          232 FGELILGKPLFSGETSI--DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            99999999999875431  2222211100    00000 0111111     11111111223334457899999999999


Q ss_pred             CCCCCCHHHHHH
Q 014904          306 ARRRPRMSQIVR  317 (416)
Q Consensus       306 p~~RPt~~evv~  317 (416)
                      |.+||++.|+++
T Consensus       310 P~~R~t~~e~l~  321 (383)
T 3eb0_A          310 PDLRINPYEAMA  321 (383)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999984

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.3e-41  Score=346.01  Aligned_cols=251  Identities=25%  Similarity=0.391  Sum_probs=200.8

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ..++|.+.+.||+|+||.||+|... ++..||||++....  ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4567999999999999999999964 68999999997643  23346789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC---CceEEeecccceec
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK---FEAKVADFGLAKIA  195 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~---~~~kl~DFGla~~~  195 (416)
                      |||+++++|.+.+....  .+++..++.|+.|++.||.|||+.   +|+||||||+|||++.+   +.+||+|||+++..
T Consensus       115 ~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          115 MECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999999988886543  589999999999999999999999   99999999999999764   45999999999877


Q ss_pred             cCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      .....  .....||+.|+|||++. +.++.++|||||||++|+|++|+.||......   .+        ...+..+.+.
T Consensus       190 ~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~--------~~~i~~~~~~  255 (494)
T 3lij_A          190 ENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EI--------LRKVEKGKYT  255 (494)
T ss_dssp             BTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH--------HHHHHHTCCC
T ss_pred             CCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HH--------HHHHHhCCCC
Confidence            54322  23467999999999986 57999999999999999999999999765431   11        1112222221


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                       +..+.+ .    .....+.+++.+||+.+|.+||++.|+++
T Consensus       256 -~~~~~~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          256 -FDSPEW-K----NVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -CCSGGG-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -CCchhc-c----cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence             111111 1    12356889999999999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.6e-41  Score=328.41  Aligned_cols=267  Identities=21%  Similarity=0.266  Sum_probs=199.9

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEe--------
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTA--------  111 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  111 (416)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++......  ....+.+|+.++.+++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            47899999999999999999996 57899999998654322  23578899999999999999999999987        


Q ss_pred             CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       112 ~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                      ....++||||+.+ +|...+..... .+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCC-CHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence            4568999999975 66666654332 599999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCc---ceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHH
Q 014904          192 AKIASDVNT---HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNR  267 (416)
Q Consensus       192 a~~~~~~~~---~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~  267 (416)
                      ++.......   .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.   .... 
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~-  246 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS---QLCG-  246 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHC-
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---HHhC-
Confidence            987653222   22244678999999999876 458999999999999999999999998754321111110   0000 


Q ss_pred             hhhcCCccccc--------CccccCcCC-HHH------HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          268 AIEDGNFDTLV--------DPKLHNEYN-HNE------MARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       268 ~~~~~~~~~~~--------d~~l~~~~~-~~~------~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ......+....        ......... ...      ...+.+++.+||+.||.+||++.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            00000000000        000000000 011      2457899999999999999999999863

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1e-40  Score=343.16  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=204.1

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ..++|.+.++||+|+||.||+|... +++.||||++....  ......+.+|+.++++++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4578999999999999999999964 78999999986432  23456789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC---CCCceEEeecccceec
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD---FKFEAKVADFGLAKIA  195 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~---~~~~~kl~DFGla~~~  195 (416)
                      +||+.+++|.+.+....  .+++..++.|+.|++.||.|||+.   +|+||||||+|||++   .++.+||+|||+++..
T Consensus       100 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            99999999998886543  589999999999999999999999   999999999999995   4567999999999866


Q ss_pred             cCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ....  ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......   .+        ...+..+.+.
T Consensus       175 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~--------~~~i~~~~~~  240 (486)
T 3mwu_A          175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DI--------LKRVETGKYA  240 (486)
T ss_dssp             CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH--------HHHHHHTCCC
T ss_pred             CCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH--------HHHHHhCCCC
Confidence            4432  2234579999999999875 6999999999999999999999999765431   11        1112223221


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .- .+.     .......+.+++.+||+.+|.+||++.|+++.
T Consensus       241 ~~-~~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          241 FD-LPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             SC-SGG-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CC-Ccc-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            10 011     11223578899999999999999999999874

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.1e-40  Score=319.68  Aligned_cols=253  Identities=25%  Similarity=0.338  Sum_probs=205.5

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc---------ccHHHHHHHHHHHHhcC-CCcccceEEEE
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG---------QGEREFQAEVEIISRVH-HKHLVSLVGYY  109 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~  109 (416)
                      ...++|.+.+.||+|+||.||+|... +|+.||||++.....         ...+.+.+|+.++.++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            35689999999999999999999964 689999999976431         11346789999999995 99999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeec
Q 014904          110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF  189 (416)
Q Consensus       110 ~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DF  189 (416)
                      ......++||||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.+||+||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999997543  589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccCCCcceeecccccccccChhhhc------cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH
Q 014904          190 GLAKIASDVNTHVSTRVMGTFGYLAPEYAS------SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP  263 (416)
Q Consensus       190 Gla~~~~~~~~~~~~~~~gt~~YlaPE~~~------~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~  263 (416)
                      |++........  .....|++.|+|||++.      ...++.++||||||+++++|++|+.||......   ..      
T Consensus       169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~------  237 (298)
T 1phk_A          169 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LM------  237 (298)
T ss_dssp             TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH------
T ss_pred             cchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HH------
Confidence            99987654322  23457899999999985      456899999999999999999999999764321   11      


Q ss_pred             HhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          264 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       264 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                        ...+..+.... ..+     ........+.+++.+||+.+|.+||++.|+++
T Consensus       238 --~~~~~~~~~~~-~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          238 --LRMIMSGNYQF-GSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             --HHHHHHTCCCC-CTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --HHHHhcCCccc-Ccc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence              11112222211 111     11123457899999999999999999999985

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=8.5e-42  Score=338.95  Aligned_cols=254  Identities=11%  Similarity=0.052  Sum_probs=184.2

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc---cHHHHHHHHHHHHhc--CCCcccceE-------EEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ---GEREFQAEVEIISRV--HHKHLVSLV-------GYY  109 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l--~h~niv~l~-------~~~  109 (416)
                      ...|...+.||+|+||.||+|.+. +|+.||||++......   ....+.+|+.++..+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345889999999999999999954 7899999999876532   234677885555555  699987754       555


Q ss_pred             EeC-----------------CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCe
Q 014904          110 TAG-----------------SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR------LKIALGSAKGLAYLHEDCHPKI  166 (416)
Q Consensus       110 ~~~-----------------~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~------~~i~~~ia~aL~~LH~~~~~~i  166 (416)
                      ...                 ...++||||++ ++|.+++...+. .+.+..+      +.++.|++.||+|||+.   +|
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~i  215 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK---GL  215 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CC
Confidence            443                 33799999998 899999975432 3455566      78889999999999999   99


Q ss_pred             eeecccCCcEEECCCCceEEeecccceeccCCCcceeecccccccccChhhhcc--CCCCchhhhHhHHHHHHHHHhCCC
Q 014904          167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRR  244 (416)
Q Consensus       167 iHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~--~~~t~ksDV~SlGvvL~elltG~~  244 (416)
                      +||||||+||||+.++.+||+|||+++.....    .....+|+.|+|||++.+  ..++.++|||||||+||||++|+.
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999876432    224567899999999987  679999999999999999999999


Q ss_pred             CCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          245 PVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       245 pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ||....+.....   |..         ..........+...........+.+++.+||+.+|++||++.|+++
T Consensus       292 Pf~~~~~~~~~~---~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKGS---WKR---------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTTC---CCB---------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCcccccc---hhh---------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            998754321111   100         0000000111111111233467899999999999999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-41  Score=336.85  Aligned_cols=263  Identities=23%  Similarity=0.324  Sum_probs=197.7

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCC-----
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGS-----  113 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  113 (416)
                      ..++|.+.+.||+|+||.||+|.. .+|+.||||++.....  ...+.+.+|+.+++.++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            568999999999999999999996 5799999999965432  22357889999999999999999999997653     


Q ss_pred             -eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccc
Q 014904          114 -QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA  192 (416)
Q Consensus       114 -~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla  192 (416)
                       ..++||||+ +++|..++...   .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence             459999999 88999998763   589999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh------HHh
Q 014904          193 KIASDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR------PLL  265 (416)
Q Consensus       193 ~~~~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~------~~~  265 (416)
                      +.....    .+...||+.|+|||++.+ ..++.++|||||||+++||++|+.||........  +.....      ..+
T Consensus       176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~  249 (367)
T 1cm8_A          176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPAEF  249 (367)
T ss_dssp             EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHH
T ss_pred             cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHH
Confidence            876542    234578999999999887 6899999999999999999999999986543111  110000      000


Q ss_pred             HHhhhcC-------CcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          266 NRAIEDG-------NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       266 ~~~~~~~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ...+...       .+.......+ ..........+.+++.+||+.||.+||++.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0000000       0000000111 11112234578899999999999999999999874

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.6e-41  Score=348.15  Aligned_cols=249  Identities=26%  Similarity=0.381  Sum_probs=204.5

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .++|...++||+|+||.||+|... +|+.||||++....   ......+..|+.++.+++||||+++++++......++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367888999999999999999964 69999999997532   22345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          119 YEFVPNNTLEFHLHGKG--RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      |||+++++|..++....  ...+++..++.++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999987643  44699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      ..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........  ...+...     +..+..  
T Consensus       341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~-----i~~~~~--  410 (543)
T 3c4z_A          341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQR-----VLEQAV--  410 (543)
T ss_dssp             TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHH-----HHHCCC--
T ss_pred             CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHH-----Hhhccc--
Confidence            43322 2345799999999999999999999999999999999999999976542111  1111111     111111  


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRM  312 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  312 (416)
                              .++......+.+++.+||+.+|.+||++
T Consensus       411 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          411 --------TYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             --------CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             --------CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence                    1122234578899999999999999976

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.7e-41  Score=325.29  Aligned_cols=271  Identities=23%  Similarity=0.306  Sum_probs=204.6

Q ss_pred             HHHhhCCCCcCceecccCcEEEEEEEe--CCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhc---CCCcccceEEEEE-
Q 014904           39 LARATDGFSDANLLGQGGFGYVHRGVL--PNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRV---HHKHLVSLVGYYT-  110 (416)
Q Consensus        39 l~~~t~~f~~~~~LG~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~-  110 (416)
                      +..+.++|.+.+.||+|+||.||+|..  .+|+.||||++......  ....+.+|+.+++.+   +||||+++++++. 
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A            6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             ccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            345678999999999999999999997  46889999998743221  123566777777766   8999999999987 


Q ss_pred             ----eCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEE
Q 014904          111 ----AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV  186 (416)
Q Consensus       111 ----~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl  186 (416)
                          .....++|+||+. ++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl  161 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL  161 (326)
T ss_dssp             EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEE
Confidence                4567899999997 6999998876655699999999999999999999999   9999999999999999999999


Q ss_pred             eecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHh-
Q 014904          187 ADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLL-  265 (416)
Q Consensus       187 ~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~-  265 (416)
                      +|||+++......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  .+.......- 
T Consensus       162 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~  237 (326)
T 1blx_A          162 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGL  237 (326)
T ss_dssp             CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCC
T ss_pred             ecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCC
Confidence            9999998664322  2234578999999999999999999999999999999999999998654311  1111000000 


Q ss_pred             --HHhhh-cCCcc-ccc---CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          266 --NRAIE-DGNFD-TLV---DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       266 --~~~~~-~~~~~-~~~---d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                        ...+. ..... ...   .......+.......+.+++.+||+.+|.+||++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              00000 00000 000   000001122233457889999999999999999999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.4e-41  Score=331.27  Aligned_cols=274  Identities=21%  Similarity=0.285  Sum_probs=193.9

Q ss_pred             HHHHHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           36 YEELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        36 ~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      -++.....++|.+.++||+|+||.||+|.. .+|+.||||++...... ...+..++..+..++||||+++++++.....
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            356778889999999999999999999996 46899999998754322 2356778888999999999999999976433


Q ss_pred             -------EEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeeeecccCCcEEECC-CC
Q 014904          115 -------RMLVYEFVPNNTLEFHLHG--KGRPTMDWLTRLKIALGSAKGLAYLH--EDCHPKIIHRDIKAANILLDF-KF  182 (416)
Q Consensus       115 -------~~lV~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH--~~~~~~iiHrDIkp~NILl~~-~~  182 (416)
                             .++||||+.++ |...+..  .....+++..+..++.+++.||.|||  +.   +|+||||||+||||+. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence                   78999999865 4333321  23346899999999999999999999  77   9999999999999996 89


Q ss_pred             ceEEeecccceeccCCCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhh
Q 014904          183 EAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA  261 (416)
Q Consensus       183 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~  261 (416)
                      .+||+|||+++........  ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......  ..+....
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~~  245 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEPN--VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHEIV  245 (360)
T ss_dssp             EEEECCCTTCBCCCTTSCC--CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH
T ss_pred             cEEEeeCCCceecCCCCCc--ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHHHH
Confidence            9999999999876543322  345789999999998665 4899999999999999999999999875431  1111111


Q ss_pred             hHH------hHHhhhcCCc-ccccC------ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          262 RPL------LNRAIEDGNF-DTLVD------PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       262 ~~~------~~~~~~~~~~-~~~~d------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ...      ....+..... ..+.+      ..............+.+++.+||+.||.+||++.||++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            100      0000000000 00000      000111222245689999999999999999999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=328.27  Aligned_cols=246  Identities=25%  Similarity=0.382  Sum_probs=192.9

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCccc------HHHHHHHHHHHHhc----CCCcccceE
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQG------EREFQAEVEIISRV----HHKHLVSLV  106 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~------~~~~~~E~~~l~~l----~h~niv~l~  106 (416)
                      +.....++|.+.+.||+|+||.||+|.. .+++.||||++.......      ...+..|+.++.++    +|+||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            4455678999999999999999999995 578999999997654321      22456799999998    899999999


Q ss_pred             EEEEeCCeEEEEEEe-cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC-CCCce
Q 014904          107 GYYTAGSQRMLVYEF-VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD-FKFEA  184 (416)
Q Consensus       107 ~~~~~~~~~~lV~e~-~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~-~~~~~  184 (416)
                      +++......++|+|+ +.+++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+||+++ .++.+
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence            999998999999999 78999999997643  589999999999999999999999   999999999999999 88999


Q ss_pred             EEeecccceeccCCCcceeecccccccccChhhhccCCCC-chhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH
Q 014904          185 KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP  263 (416)
Q Consensus       185 kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t-~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~  263 (416)
                      ||+|||+++......   .....||..|+|||++.+..+. .++||||||+++|+|++|+.||.....     .      
T Consensus       180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~------  245 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----I------  245 (312)
T ss_dssp             EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H------
T ss_pred             EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----H------
Confidence            999999998765432   2345689999999999877664 599999999999999999999864211     0      


Q ss_pred             HhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          264 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       264 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                       .     ....      .    ++......+.+++.+||+.+|++||++.||++.
T Consensus       246 -~-----~~~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          246 -L-----EAEL------H----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             -H-----HTCC------C----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -h-----hhcc------C----CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0     1110      0    111223478899999999999999999999974

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7e-41  Score=335.59  Aligned_cols=265  Identities=25%  Similarity=0.342  Sum_probs=198.7

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCe------EE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ------RM  116 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~  116 (416)
                      ..+|.+.++||+|+||.||+|.+..+..||+|++......    ..+|+.+++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            4579999999999999999999877777999988754322    2368999999999999999999965433      78


Q ss_pred             EEEEecCCCCHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC-CCCceEEeeccccee
Q 014904          117 LVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD-FKFEAKVADFGLAKI  194 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~-~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~-~~~~~kl~DFGla~~  194 (416)
                      +||||++++.+..... ......+++..+..++.|++.||+|||+.   +|+||||||+||||+ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999998765544432 12234699999999999999999999999   999999999999999 789999999999987


Q ss_pred             ccCCCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH-------hH
Q 014904          195 ASDVNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL-------LN  266 (416)
Q Consensus       195 ~~~~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~-------~~  266 (416)
                      .......  ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.....  .+.+......+       +.
T Consensus       192 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          192 LIAGEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG--IDQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CCTTCCC--CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHHH
T ss_pred             ccCCCCC--cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHHH
Confidence            6543322  345789999999998765 589999999999999999999999987543  12222211100       00


Q ss_pred             ---HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          267 ---RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       267 ---~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                         .......+..+....+...+.......+.+++.+||+.+|.+||++.|+++.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence               0000111111111111111222244578999999999999999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9.7e-41  Score=324.55  Aligned_cols=252  Identities=26%  Similarity=0.398  Sum_probs=198.6

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--------ccHHHHHHHHHHHHhcCCCcccceEEEEEeC
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG--------QGEREFQAEVEIISRVHHKHLVSLVGYYTAG  112 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  112 (416)
                      ..++|.+.+.||+|+||.||+|... +++.||||++.....        .....+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4578999999999999999999964 689999999875421        1123578999999999999999999998765


Q ss_pred             CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc---eEEeec
Q 014904          113 SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADF  189 (416)
Q Consensus       113 ~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~---~kl~DF  189 (416)
                      . .++||||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.   +||+||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            5 899999999999999886543  689999999999999999999999   9999999999999987665   999999


Q ss_pred             ccceeccCCCcceeecccccccccChhhhc---cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhH
Q 014904          190 GLAKIASDVNTHVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN  266 (416)
Q Consensus       190 Gla~~~~~~~~~~~~~~~gt~~YlaPE~~~---~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~  266 (416)
                      |+++......  ......||+.|+|||++.   ...++.++|||||||++|+|++|+.||.......  .+..       
T Consensus       162 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~-------  230 (322)
T 2ycf_A          162 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKD-------  230 (322)
T ss_dssp             TTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHH-------
T ss_pred             ccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHH-------
Confidence            9998765322  223467999999999974   5678999999999999999999999997644311  1111       


Q ss_pred             HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          267 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       267 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                       .+..+.....  +....    .....+.+++.+||+.+|.+||++.++++
T Consensus       231 -~~~~~~~~~~--~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          231 -QITSGKYNFI--PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -HHHHTCCCCC--HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HHHhCccccC--chhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             1112221110  11111    12357889999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.6e-40  Score=336.85  Aligned_cols=200  Identities=26%  Similarity=0.328  Sum_probs=168.0

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeC-----C
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAG-----S  113 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  113 (416)
                      ..++|.+.++||+|+||.||+|.. .+++.||||++....  ....+.+.+|+.++++++|+||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            468999999999999999999995 468899999997543  22346788999999999999999999999776     5


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ..++||||+. ++|..++....  .+++..++.++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            7899999986 59999887543  599999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCcc---------------------eeecccccccccChhhh-ccCCCCchhhhHhHHHHHHHHHhCCCCCC
Q 014904          194 IASDVNTH---------------------VSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGRRPVD  247 (416)
Q Consensus       194 ~~~~~~~~---------------------~~~~~~gt~~YlaPE~~-~~~~~t~ksDV~SlGvvL~elltG~~pf~  247 (416)
                      ........                     ..+..+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            76543211                     22456899999999986 55679999999999999999998655543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.2e-40  Score=328.19  Aligned_cols=210  Identities=24%  Similarity=0.271  Sum_probs=177.5

Q ss_pred             CHHHHHHhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-CC-----cccceEE
Q 014904           35 TYEELARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-HK-----HLVSLVG  107 (416)
Q Consensus        35 ~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~  107 (416)
                      ...+.....++|.+.++||+|+||.||+|... +++.||||+++... ....++..|+.++..++ |+     +|+++++
T Consensus        45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            33445567789999999999999999999954 68899999997432 23456778899988885 54     4999999


Q ss_pred             EEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC--CCCceE
Q 014904          108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD--FKFEAK  185 (416)
Q Consensus       108 ~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~--~~~~~k  185 (416)
                      ++......++||||+. ++|.+++.......+++..+..++.|++.||.|||.. ..+|+||||||+||||+  .++.+|
T Consensus       124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~k  201 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK  201 (382)
T ss_dssp             EEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEE
T ss_pred             eeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEE
Confidence            9999999999999996 5999988876555699999999999999999999942 12899999999999994  477899


Q ss_pred             EeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCc
Q 014904          186 VADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHT  251 (416)
Q Consensus       186 l~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~  251 (416)
                      |+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       202 L~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          202 IVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             ECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999876542    2346789999999999999999999999999999999999999986543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=327.21  Aligned_cols=261  Identities=23%  Similarity=0.336  Sum_probs=203.2

Q ss_pred             HHHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           37 EELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        37 ~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      .+..-..++|.+.+.||+|+||.||+|....  .+|+|+++....  ...+.+.+|+.++.+++|+||+++++++.+...
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            3444456899999999999999999999743  499999875432  223467789999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      .++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+.   +|+||||||+|||++ ++.+||+|||+++.
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             eEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            999999999999999997643 3689999999999999999999999   999999999999998 67999999999875


Q ss_pred             ccCCC----cceeecccccccccChhhhcc---------CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhh
Q 014904          195 ASDVN----THVSTRVMGTFGYLAPEYASS---------GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA  261 (416)
Q Consensus       195 ~~~~~----~~~~~~~~gt~~YlaPE~~~~---------~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~  261 (416)
                      .....    ........||+.|+|||++..         ..++.++||||||+++|||++|+.||......   .+.   
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~---  252 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AII---  252 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHH---
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---
Confidence            53211    112233468999999999864         45789999999999999999999999764421   111   


Q ss_pred             hHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          262 RPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       262 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                           ..+..+....+...    .    ....+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       253 -----~~~~~~~~~~~~~~----~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~  301 (319)
T 2y4i_B          253 -----WQMGTGMKPNLSQI----G----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP  301 (319)
T ss_dssp             -----HHHHTTCCCCCCCS----S----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred             -----HHhccCCCCCCCcC----C----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence                 11122221111111    1    2235889999999999999999999999998654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.7e-40  Score=326.36  Aligned_cols=271  Identities=21%  Similarity=0.304  Sum_probs=203.3

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeC-----C
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAG-----S  113 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  113 (416)
                      ...++|.+.++||+|+||.||+|... +++.||||++...... ....+.+|+.++.+++||||+++++++...     .
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            45679999999999999999999954 6889999999754433 235788999999999999999999999764     3


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ..++|+||+. ++|..++...   .+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            6899999997 5888888654   589999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCCcce--eecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhh-hhhhhHHhHHhh
Q 014904          194 IASDVNTHV--STRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSL-VDWARPLLNRAI  269 (416)
Q Consensus       194 ~~~~~~~~~--~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l-~~~~~~~~~~~~  269 (416)
                      .........  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... ...........+
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            765433222  244679999999998754 4589999999999999999999999977553221111 000000000000


Q ss_pred             hc------CC-cccccCccc--cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          270 ED------GN-FDTLVDPKL--HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       270 ~~------~~-~~~~~d~~l--~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ..      .. ...+..+..  ...........+.+++.+||+.||.+||++.|+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00      00 000000000  000011223568899999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=334.18  Aligned_cols=203  Identities=23%  Similarity=0.352  Sum_probs=156.2

Q ss_pred             hhCCCCc-CceecccCcEEEEEEEeC---CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEe--CCeE
Q 014904           42 ATDGFSD-ANLLGQGGFGYVHRGVLP---NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA--GSQR  115 (416)
Q Consensus        42 ~t~~f~~-~~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  115 (416)
                      ..+.|.+ .++||+|+||.||+|.+.   +++.||||++.....  ...+.+|+.++++++||||+++++++..  ....
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            3445665 448999999999999965   578999999975432  2468899999999999999999999965  6789


Q ss_pred             EEEEEecCCCCHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE----CCCCce
Q 014904          116 MLVYEFVPNNTLEFHLHGK-------GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL----DFKFEA  184 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~-------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl----~~~~~~  184 (416)
                      ++||||+.+ +|.+++...       ....+++..++.|+.|++.||+|||+.   +|+||||||+||||    +.++.+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcE
Confidence            999999965 666666421       122589999999999999999999999   99999999999999    778899


Q ss_pred             EEeecccceeccCCCc--ceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCC
Q 014904          185 KVADFGLAKIASDVNT--HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTH  250 (416)
Q Consensus       185 kl~DFGla~~~~~~~~--~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~  250 (416)
                      ||+|||+++.......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            9999999987654322  222446799999999999874 59999999999999999999999997644

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.5e-40  Score=328.70  Aligned_cols=265  Identities=22%  Similarity=0.292  Sum_probs=194.5

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCC-----
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGS-----  113 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  113 (416)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||++.....  .....+.+|+.+++.++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            457999999999999999999995 4689999999975432  23356889999999999999999999997654     


Q ss_pred             -eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccc
Q 014904          114 -QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA  192 (416)
Q Consensus       114 -~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla  192 (416)
                       ..++||||+.+ +|.+.+..    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             cceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence             78999999975 67777753    488999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhh-----------
Q 014904          193 KIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA-----------  261 (416)
Q Consensus       193 ~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~-----------  261 (416)
                      +......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........  +....           
T Consensus       175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHC-CCCCCHHHH
T ss_pred             ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHH
Confidence            8654322  22346789999999999999999999999999999999999999976543111  00000           


Q ss_pred             ---hHHhHHhhhcC-Cc-----ccccCcccc---CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          262 ---RPLLNRAIEDG-NF-----DTLVDPKLH---NEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       262 ---~~~~~~~~~~~-~~-----~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                         .+.+....... .+     ..+......   ..........+.+++.+||+.||.+||++.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence               00000000000 00     000000000   00112235678999999999999999999999874

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8.4e-41  Score=337.80  Aligned_cols=263  Identities=25%  Similarity=0.335  Sum_probs=196.8

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeC------CeEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAG------SQRM  116 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  116 (416)
                      .+|.+.++||+|+||.||+|.+. +|+.||||++.....    .+.+|+.++++++|+||++++++|...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            36889999999999999999964 689999999875432    234699999999999999999998642      2367


Q ss_pred             EEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC-CceEEeecccce
Q 014904          117 LVYEFVPNNTLEFHLHG--KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAK  193 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~-~~~kl~DFGla~  193 (416)
                      +||||+++ +|...+..  .....+++..++.++.|+++||.|||+.   +|+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999976 55544432  2234699999999999999999999998   99999999999999965 568999999998


Q ss_pred             eccCCCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH---hHHhh
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL---LNRAI  269 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~---~~~~~  269 (416)
                      .......  .....||+.|+|||++.+. .++.++|||||||+||||++|+.||.....  .+.+......+   ....+
T Consensus       206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCSCCHHHH
T ss_pred             hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHH
Confidence            7654332  2345789999999999765 799999999999999999999999987543  22222222110   00000


Q ss_pred             --hcCCcccccCccccC-----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          270 --EDGNFDTLVDPKLHN-----EYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       270 --~~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                        ....+..+..+.+..     .+.......+.+|+.+||+.+|.+||++.|+++.
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence              011222222222111     1222334678999999999999999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-40  Score=355.76  Aligned_cols=249  Identities=25%  Similarity=0.353  Sum_probs=204.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC---cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS---GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  116 (416)
                      ..++|.+.++||+|+||.||+|... +++.||||+++...   ......+..|..++..+ +|+||+++++++.+....+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3568999999999999999999954 68899999997531   22335678899999987 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      |||||+++++|..++...+  .+++..++.++.|++.||.|||+.   +||||||||+||||+.++.+||+|||+++...
T Consensus       419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            9999999999999997654  589999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      .... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.....   ..+       + ..+..+.+  
T Consensus       494 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~~-------~-~~i~~~~~--  559 (674)
T 3pfq_A          494 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DEL-------F-QSIMEHNV--  559 (674)
T ss_dssp             CTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH-------H-HHHHSSCC--
T ss_pred             cCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---HHH-------H-HHHHhCCC--
Confidence            3222 23457899999999999999999999999999999999999999976543   111       1 11122221  


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRM-----SQIVR  317 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~-----~evv~  317 (416)
                              .++......+.+|+.+||+.+|.+||++     .||++
T Consensus       560 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                    1222334578999999999999999997     56654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.5e-40  Score=325.86  Aligned_cols=254  Identities=21%  Similarity=0.279  Sum_probs=176.5

Q ss_pred             hhCCCCcCc-eecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEe----CCeE
Q 014904           42 ATDGFSDAN-LLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA----GSQR  115 (416)
Q Consensus        42 ~t~~f~~~~-~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  115 (416)
                      ..++|.+.+ +||+|+||.||+|... +|+.||||++...    ..........+..+.|+||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            567899855 6999999999999965 6899999999753    2222333344667799999999999876    4458


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC---CCceEEeecccc
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFGLA  192 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~---~~~~kl~DFGla  192 (416)
                      ++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            9999999999999999877666799999999999999999999999   9999999999999976   455999999999


Q ss_pred             eeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcC
Q 014904          193 KIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDG  272 (416)
Q Consensus       193 ~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~  272 (416)
                      +......   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.........  ..     ....+..+
T Consensus       179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~-----~~~~~~~~  248 (336)
T 3fhr_A          179 KETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--PG-----MKRRIRLG  248 (336)
T ss_dssp             EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             eeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--hh-----HHHhhhcc
Confidence            8654322   23457899999999998889999999999999999999999999764331100  00     00000111


Q ss_pred             CcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          273 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       273 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ..      .............+.+++.+||+.+|.+||++.|+++.
T Consensus       249 ~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          249 QY------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cc------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            10      00111111234578899999999999999999999973

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.8e-41  Score=324.60  Aligned_cols=266  Identities=21%  Similarity=0.301  Sum_probs=195.4

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEE----------
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT----------  110 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------  110 (416)
                      ..++|.+.+.||+|+||.||+|... +++.||||++........+.+.+|+.++++++||||+++++++.          
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            3578999999999999999999965 58999999998766555678899999999999999999999873          


Q ss_pred             ----eCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC-CCCceE
Q 014904          111 ----AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD-FKFEAK  185 (416)
Q Consensus       111 ----~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~-~~~~~k  185 (416)
                          +....++||||+. ++|.+++...   .+++..++.++.|++.||+|||+.   +|+||||||+|||++ .++.+|
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence                4467899999997 5899988642   589999999999999999999999   999999999999997 567999


Q ss_pred             EeecccceeccCCCcc--eeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh
Q 014904          186 VADFGLAKIASDVNTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR  262 (416)
Q Consensus       186 l~DFGla~~~~~~~~~--~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~  262 (416)
                      |+|||+++........  ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||........  +.....
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~  239 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLILE  239 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence            9999999876432221  1234567999999998865 6799999999999999999999999987543111  110000


Q ss_pred             HH------hHHhhhcCCccccc-----Ccccc-CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          263 PL------LNRAIEDGNFDTLV-----DPKLH-NEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       263 ~~------~~~~~~~~~~~~~~-----d~~l~-~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..      ....+. ..+...+     .+... ..........+.+++.+||+.+|.+||++.|+++
T Consensus       240 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          240 SIPVVHEEDRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HSCCCCHHHHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hcCCCchhhhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            00      000000 0000000     00000 0001123457899999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.2e-40  Score=317.24  Aligned_cols=253  Identities=24%  Similarity=0.381  Sum_probs=195.3

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEe---------
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA---------  111 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  111 (416)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            457899999999999999999996 47899999999643 2334578899999999999999999999865         


Q ss_pred             ----CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEe
Q 014904          112 ----GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA  187 (416)
Q Consensus       112 ----~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~  187 (416)
                          ....++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence                356799999999999999997543 3578899999999999999999999   99999999999999999999999


Q ss_pred             ecccceeccCCC-------------cceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCccc
Q 014904          188 DFGLAKIASDVN-------------THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFV  253 (416)
Q Consensus       188 DFGla~~~~~~~-------------~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~  253 (416)
                      |||++.......             ........||+.|+|||++.+. .++.++|||||||++|+|++   ||....   
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---  232 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---  232 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---
Confidence            999998654321             1122345789999999999764 78999999999999999998   443211   


Q ss_pred             chhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          254 EDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       254 ~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                        .....     ...+....      ..+...++......+.+++.+||+.||.+||++.++++.
T Consensus       233 --~~~~~-----~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          233 --ERVNI-----LKKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             --HHHHH-----HHHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --hHHHH-----HHhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence              11111     11111211      112223344445678999999999999999999999863

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.1e-40  Score=325.66  Aligned_cols=268  Identities=21%  Similarity=0.326  Sum_probs=203.6

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-----------CCcccceEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-----------HKHLVSLVGYYT  110 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  110 (416)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+.+|+.++.+++           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            46899999999999999999995 578999999997432 33457888999999886           899999999998


Q ss_pred             eCC----eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC------C
Q 014904          111 AGS----QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD------F  180 (416)
Q Consensus       111 ~~~----~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~------~  180 (416)
                      ...    ..++|||++ +++|.+++.......+++..++.|+.|++.||.|||+.+  +|+||||||+||||+      .
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence            644    789999999 899999998765556999999999999999999999964  899999999999994      4


Q ss_pred             CCceEEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCccc----chh
Q 014904          181 KFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFV----EDS  256 (416)
Q Consensus       181 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~----~~~  256 (416)
                      .+.+||+|||+++......    ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    ...
T Consensus       174 ~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  249 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  249 (373)
T ss_dssp             EEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence            4579999999998765432    33578999999999999999999999999999999999999998654211    111


Q ss_pred             hhhhhh---HHhHHhhhcC-----------CcccccCcc---------ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 014904          257 LVDWAR---PLLNRAIEDG-----------NFDTLVDPK---------LHNEYNHNEMARMVACAAACVRHSARRRPRMS  313 (416)
Q Consensus       257 l~~~~~---~~~~~~~~~~-----------~~~~~~d~~---------l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~  313 (416)
                      +.....   ..-...+..+           .+..+....         ....++......+.+++.+||+.||.+||++.
T Consensus       250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  329 (373)
T 1q8y_A          250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  329 (373)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence            111100   0000000000           000000000         01234567788999999999999999999999


Q ss_pred             HHHHH
Q 014904          314 QIVRA  318 (416)
Q Consensus       314 evv~~  318 (416)
                      ||++.
T Consensus       330 ell~h  334 (373)
T 1q8y_A          330 GLVNH  334 (373)
T ss_dssp             HHHTC
T ss_pred             HHhhC
Confidence            99863

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.3e-39  Score=311.29  Aligned_cols=253  Identities=24%  Similarity=0.362  Sum_probs=204.9

Q ss_pred             HHhhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           40 ARATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        40 ~~~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      ....++|.+.+.||+|+||.||+|... +++.||||++....  ......+.+|+.++++++||||+++++++.+....+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            345678999999999999999999965 78999999987542  234568899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC---CceEEeecccce
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK---FEAKVADFGLAK  193 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~---~~~kl~DFGla~  193 (416)
                      +|+||+++++|.+.+....  .+++..++.++.+++.||.|||+.   +|+||||||+||+++.+   +.+||+|||++.
T Consensus        98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            9999999999988886543  589999999999999999999999   99999999999999764   469999999998


Q ss_pred             eccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      .......  .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||......   .+        ...+..+.
T Consensus       173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~--------~~~~~~~~  238 (287)
T 2wei_A          173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DI--------LKRVETGK  238 (287)
T ss_dssp             TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH--------HHHHHHCC
T ss_pred             eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HH--------HHHHHcCC
Confidence            6644322  233468999999999875 5899999999999999999999999765421   11        11122232


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      +... .+ ...    .....+.+++.+||+.+|.+||++.|+++
T Consensus       239 ~~~~-~~-~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          239 YAFD-LP-QWR----TISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCCC-SG-GGT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCC-ch-hhh----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            2110 00 001    12347889999999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.4e-40  Score=322.45  Aligned_cols=267  Identities=18%  Similarity=0.268  Sum_probs=201.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CC-cEEEEEEeecCCcccHHHHHHHHHHHHhcCCCc------ccceEEEEEeCC
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NG-KEVAIKQLKAGSGQGEREFQAEVEIISRVHHKH------LVSLVGYYTAGS  113 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~  113 (416)
                      ..++|.+.+.||+|+||.||+|... ++ +.||||+++... .....+..|+.++++++|++      ++.+++++....
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            3579999999999999999999964 44 689999997532 33457888999999997665      899999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEE---------------
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILL---------------  178 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl---------------  178 (416)
                      ..++||||+ ++++.+.+.......+++..++.++.|++.||.|||+.   +|+||||||+|||+               
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence            999999999 56666666655545799999999999999999999999   99999999999999               


Q ss_pred             ----CCCCceEEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc
Q 014904          179 ----DFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE  254 (416)
Q Consensus       179 ----~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~  254 (416)
                          +.++.+||+|||+++......    ....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                567899999999998754322    335799999999999999999999999999999999999999986543211


Q ss_pred             hhhhhhh-hHHhHHhhhcCC-cccccCc---------------------cccCcCCHHHHHHHHHHHHHhhccCCCCCCC
Q 014904          255 DSLVDWA-RPLLNRAIEDGN-FDTLVDP---------------------KLHNEYNHNEMARMVACAAACVRHSARRRPR  311 (416)
Q Consensus       255 ~~l~~~~-~~~~~~~~~~~~-~~~~~d~---------------------~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt  311 (416)
                      ....... .+.....+.... .......                     .........+...+.+++.+||+.||.+||+
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  327 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT  327 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence            1110000 000000000000 0000000                     0001122345568999999999999999999


Q ss_pred             HHHHHH
Q 014904          312 MSQIVR  317 (416)
Q Consensus       312 ~~evv~  317 (416)
                      +.||++
T Consensus       328 ~~e~l~  333 (355)
T 2eu9_A          328 LAEALL  333 (355)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999984

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8e-41  Score=355.83  Aligned_cols=256  Identities=25%  Similarity=0.409  Sum_probs=204.5

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCC----CcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPN----GKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      ..++|.+.+.||+|+||.||+|.+..    +..||||+++.... ...+.+.+|+.++++++||||+++++++.+ ...+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence            44678888999999999999999642    45799999876433 233678999999999999999999999854 5689


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       467 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            9999999999999997543 3589999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....   ..+.        ..+..+...
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~--------~~i~~~~~~  611 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVI--------GRIENGERL  611 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH--------HHHHHTCCC
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHH--------HHHHcCCCC
Confidence            544433344567889999999999999999999999999999997 9999976443   1111        111222211


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                               ..+...+..+.+++.+||+.+|.+||++.+|++.|+..
T Consensus       612 ---------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          612 ---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                     11223345789999999999999999999999999854

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.8e-40  Score=321.73  Aligned_cols=255  Identities=26%  Similarity=0.431  Sum_probs=179.2

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-ccHHHHHHHHH-HHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG-QGEREFQAEVE-IISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      .++|...+.||+|+||.||+|.. .+|+.||||++..... ....++..|+. +++.++||||+++++++......++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            37889999999999999999996 4789999999986532 22345555665 677789999999999999999999999


Q ss_pred             EecCCCCHHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          120 EFVPNNTLEFHLHG---KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       120 e~~~~~sL~~~l~~---~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      ||+.+ +|.+++..   .....+++..+..++.+++.||.|||+..  +|+||||||+|||++.++.+||+|||+++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            99975 77766642   22346899999999999999999999964  79999999999999999999999999998665


Q ss_pred             CCCcceeecccccccccChhhh----ccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcC
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYA----SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDG  272 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~----~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~  272 (416)
                      ....  .....||+.|+|||++    .+..++.++||||||+++|+|++|+.||.......+ .+.         .+..+
T Consensus       178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~---------~~~~~  245 (327)
T 3aln_A          178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-QLT---------QVVKG  245 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------C---------CCCCS
T ss_pred             cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-HHH---------HHhcC
Confidence            4322  2334689999999998    456789999999999999999999999975432100 000         00111


Q ss_pred             CcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          273 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       273 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..     +.+...........+.+++.+||+.+|.+||++.+|++
T Consensus       246 ~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          246 DP-----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CC-----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC-----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            11     11111111223457899999999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2e-40  Score=325.68  Aligned_cols=266  Identities=20%  Similarity=0.288  Sum_probs=200.4

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeC-----Ce
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAG-----SQ  114 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  114 (416)
                      ..++|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|+.++++++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            5689999999999999999999964 689999999975432 2235688999999999999999999998764     67


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      .++|+||+. ++|..++...   .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            899999997 5888888753   589999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCcce---------eecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH
Q 014904          195 ASDVNTHV---------STRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL  264 (416)
Q Consensus       195 ~~~~~~~~---------~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~  264 (416)
                      ........         .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  .+.... ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~-~~  238 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH--QLLLIF-GI  238 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH-HH
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHH-HH
Confidence            65322211         123578999999998764 679999999999999999999999998654311  111000 00


Q ss_pred             hHHhhhcCCcccc---------------cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          265 LNRAIEDGNFDTL---------------VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       265 ~~~~~~~~~~~~~---------------~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ............+               ....+. .........+.+++.+||+.||.+||++.||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000000000000               000000 0011234578899999999999999999999873

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.9e-40  Score=326.00  Aligned_cols=260  Identities=21%  Similarity=0.316  Sum_probs=197.2

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeE---
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQR---  115 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  115 (416)
                      ..++|.+.+.||+|+||.||+|.. .+|+.||||++......  ....+.+|+.+++.++||||+++++++......   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            568999999999999999999995 46899999999764332  235788999999999999999999999876654   


Q ss_pred             ---EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccc
Q 014904          116 ---MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA  192 (416)
Q Consensus       116 ---~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla  192 (416)
                         ++||||+. ++|...+..    .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence               99999997 578777633    489999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH--------
Q 014904          193 KIASDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP--------  263 (416)
Q Consensus       193 ~~~~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~--------  263 (416)
                      +.....    .....||+.|+|||++.+ ..++.++|||||||++++|++|+.||......  +.+......        
T Consensus       192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~  265 (371)
T 4exu_A          192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGTEF  265 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCHHH
T ss_pred             cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCcHHH
Confidence            865432    233578999999999987 68999999999999999999999999865431  111111000        


Q ss_pred             -------HhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          264 -------LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       264 -------~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                             ........  +.......+ ..........+.+++.+||+.+|.+||++.|+++.
T Consensus       266 ~~~~~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          266 VQKLNDKAAKSYIQS--LPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HTTCSCHHHHHHHHH--SCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHhhhhhhhhhhhc--cCCCcchhH-HHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                   00000000  000000000 00011224578999999999999999999999865

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.4e-40  Score=330.49  Aligned_cols=264  Identities=22%  Similarity=0.313  Sum_probs=185.0

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeC-----
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAG-----  112 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  112 (416)
                      ...++|.+.+.||+|+||.||+|.. .+|+.||||++.....  .....+.+|+.+++.++||||+++++++...     
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            3568999999999999999999994 5789999999975432  2345788999999999999999999998754     


Q ss_pred             -CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          113 -SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       113 -~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                       ...++|+|++ +++|..++..   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             CCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence             5679999998 7888888864   2599999999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH------
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL------  264 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~------  264 (416)
                      ++.....    .+...||+.|+|||++.+ ..++.++|||||||+++||++|+.||........  +.......      
T Consensus       179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~  252 (367)
T 2fst_X          179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTPGAE  252 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHH
T ss_pred             ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence            9865432    234678999999999877 6799999999999999999999999977543111  11100000      


Q ss_pred             hHHhhhcC-------CcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          265 LNRAIEDG-------NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       265 ~~~~~~~~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ....+...       .+.......+. .........+.+|+.+||+.||.+||++.|+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          253 LLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHTTCCCHHHHHHHHTSCCCCCCCHH-HHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhhhHHHHHHHhccCCCCCCCHH-HHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            00000000       00000000000 0001123568899999999999999999999864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2e-39  Score=329.12  Aligned_cols=251  Identities=22%  Similarity=0.324  Sum_probs=189.4

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEEEec
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      +.|...++||+|+||+||.+...+|+.||||++...   ....+.+|+.++.++ +||||+++++++.+....++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            344556889999999998777778999999998753   235678899999886 8999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCC-----CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC-------------Cce
Q 014904          123 PNNTLEFHLHGKGRPT-----MDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK-------------FEA  184 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~-----l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~-------------~~~  184 (416)
                      . ++|.+++.......     .++..++.|+.|++.||+|||+.   +|+||||||+||||+.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 69999997654311     13334578999999999999999   99999999999999654             489


Q ss_pred             EEeecccceeccCCCcce---eecccccccccChhhhcc-------CCCCchhhhHhHHHHHHHHHh-CCCCCCCCCccc
Q 014904          185 KVADFGLAKIASDVNTHV---STRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFV  253 (416)
Q Consensus       185 kl~DFGla~~~~~~~~~~---~~~~~gt~~YlaPE~~~~-------~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~  253 (416)
                      ||+|||+++.........   .....||++|+|||++.+       ..++.++|||||||++|||++ |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            999999998775543221   234579999999999975       678999999999999999999 999997543211


Q ss_pred             chhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          254 EDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       254 ~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                       ..+       +     .+...   .+.+....+......+.+++.+||+.+|.+||++.||++
T Consensus       248 -~~i-------~-----~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 -SNI-------I-----RGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             -HHH-------H-----HTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHH-------h-----cCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence             111       0     11111   011112224456678999999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.3e-39  Score=311.20  Aligned_cols=253  Identities=23%  Similarity=0.368  Sum_probs=181.8

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCccc-H-HHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQG-E-REFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ..++|.+.+.||+|+||.||+|... +|+.||||++....... . +.+.++..++..++||||+++++++.+....++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3578999999999999999999964 78999999998654322 2 3344555678888999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+ ++.+..+.... ...+++..++.++.+++.||.|||+.+  +|+||||||+||+++.++.+||+|||++......
T Consensus       103 ~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             ECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             Eecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9999 55666555432 236899999999999999999999832  8999999999999999999999999999765443


Q ss_pred             CcceeecccccccccChhhhc-----cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          199 NTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~-----~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      ..  .....||+.|+|||++.     ...++.++||||||+++|+|++|+.||......  ..       .+.... .+.
T Consensus       179 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~-------~~~~~~-~~~  246 (318)
T 2dyl_A          179 KA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FE-------VLTKVL-QEE  246 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HH-------HHHHHH-HSC
T ss_pred             cc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HH-------HHHHHh-ccC
Confidence            22  23457899999999994     567899999999999999999999999763321  11       111111 111


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ...+..   ..    .....+.+++.+||+.+|.+||++.||++
T Consensus       247 ~~~~~~---~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          247 PPLLPG---HM----GFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCCCCS---SS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCCc---cC----CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            111110   01    12347889999999999999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.6e-40  Score=323.29  Aligned_cols=248  Identities=22%  Similarity=0.351  Sum_probs=201.0

Q ss_pred             HHHHHHhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc------cHHHHHHHHHHHHhcC--CCcccceE
Q 014904           36 YEELARATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ------GEREFQAEVEIISRVH--HKHLVSLV  106 (416)
Q Consensus        36 ~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~  106 (416)
                      ..+.....++|.+.++||+|+||.||+|.. .+++.||||++......      ....+..|+.++.+++  |+||++++
T Consensus        35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~  114 (320)
T 3a99_A           35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL  114 (320)
T ss_dssp             -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence            345556778999999999999999999995 57899999999754322      1235678999999996  59999999


Q ss_pred             EEEEeCCeEEEEEEecCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC-CCCce
Q 014904          107 GYYTAGSQRMLVYEFVPN-NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD-FKFEA  184 (416)
Q Consensus       107 ~~~~~~~~~~lV~e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~-~~~~~  184 (416)
                      +++......++|+|++.+ ++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++ .++.+
T Consensus       115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~  189 (320)
T 3a99_A          115 DWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGEL  189 (320)
T ss_dssp             EEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEE
T ss_pred             EEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCE
Confidence            999999999999999976 89999987543  589999999999999999999999   999999999999999 78899


Q ss_pred             EEeecccceeccCCCcceeecccccccccChhhhccCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH
Q 014904          185 KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP  263 (416)
Q Consensus       185 kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~-t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~  263 (416)
                      ||+|||+++......   .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....     .      
T Consensus       190 kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~------  255 (320)
T 3a99_A          190 KLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I------  255 (320)
T ss_dssp             EECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H------
T ss_pred             EEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----h------
Confidence            999999998765432   233568999999999987765 6889999999999999999999864211     0      


Q ss_pred             HhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          264 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       264 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                       .     .+..      .....    ....+.+++.+||+.+|++||++.||++.
T Consensus       256 -~-----~~~~------~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          256 -I-----RGQV------FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             -H-----HCCC------CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -h-----cccc------ccccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0     1110      01112    23478899999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=320.24  Aligned_cols=262  Identities=21%  Similarity=0.307  Sum_probs=197.1

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEeCCe----
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ----  114 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  114 (416)
                      ..++|...+.||+|+||.||+|.. .+|+.||||++......  ....+.+|+.+++.++||||+++++++.....    
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            457899999999999999999996 46899999999764322  23578899999999999999999999987654    


Q ss_pred             --EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccc
Q 014904          115 --RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA  192 (416)
Q Consensus       115 --~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla  192 (416)
                        .++||||+. ++|..++..    .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence              499999997 577776642    489999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH------Hh
Q 014904          193 KIASDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP------LL  265 (416)
Q Consensus       193 ~~~~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~------~~  265 (416)
                      +.....    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  .+......      .+
T Consensus       174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~  247 (353)
T 3coi_A          174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGTEF  247 (353)
T ss_dssp             TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHHHHHHCBCCHHH
T ss_pred             cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHH
Confidence            765432    233578999999999877 678999999999999999999999997654311  11110000      00


Q ss_pred             HHhhhc-------CCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          266 NRAIED-------GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       266 ~~~~~~-------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ...+..       ..+.....+.+ ..........+.+++.+||+.+|.+||++.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          248 VQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000000       00000000111 11122345678999999999999999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.2e-39  Score=325.41  Aligned_cols=250  Identities=23%  Similarity=0.325  Sum_probs=188.7

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ...+|...++||+|+||+|+.....+|+.||||++......   .+.+|+.+++.+ +||||+++++++.+....++|||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            34568899999999999976555668999999999764432   356799999999 79999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC-----CCceEEeecccceec
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF-----KFEAKVADFGLAKIA  195 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~-----~~~~kl~DFGla~~~  195 (416)
                      |+. ++|.+++..... .+.+..++.++.|++.||.|||+.   +|+||||||+||||+.     ...+||+|||+++..
T Consensus        99 ~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           99 LCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            996 599998876543 344445678999999999999999   9999999999999943     345889999999876


Q ss_pred             cCCCc--ceeecccccccccChhhhc---cCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhh
Q 014904          196 SDVNT--HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAI  269 (416)
Q Consensus       196 ~~~~~--~~~~~~~gt~~YlaPE~~~---~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~  269 (416)
                      .....  .......||++|+|||++.   ...++.++|||||||++|||++ |+.||.......   .        ....
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~---~--------~~~~  242 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---A--------NILL  242 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH---H--------HHHT
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH---H--------HHHh
Confidence            54322  1224467999999999997   4577889999999999999999 999986533210   0        0001


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ....... .      .........+.+++.+||+.+|.+||++.||++
T Consensus       243 ~~~~~~~-~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          243 GACSLDC-L------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TCCCCTT-S------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCCccc-c------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1111111 1      112234556789999999999999999999983

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.1e-38  Score=306.06  Aligned_cols=233  Identities=12%  Similarity=0.117  Sum_probs=185.0

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCccc---HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQG---EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ..++|.+.+.||+|+||.||+|... +++.||||++.......   .+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            3478999999999999999999965 58999999998654332   3578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+++++|.+++...    ........|+.|++.||.|||+.   +|+||||||+||||+.++.+||+++        
T Consensus       109 v~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~--------  173 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP--------  173 (286)
T ss_dssp             EEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSC--------
T ss_pred             EEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEec--------
Confidence            99999999999999542    34556788999999999999999   9999999999999999999999743        


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                                   +|++       .++.++|||||||++|||++|+.||...........   +.    .. ..+..   
T Consensus       174 -------------~~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~----~~-~~~~~---  222 (286)
T 3uqc_A          174 -------------ATMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AE----RD-TAGQP---  222 (286)
T ss_dssp             -------------CCCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CC----BC-TTSCB---
T ss_pred             -------------cccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HH----HH-hccCC---
Confidence                         3443       368999999999999999999999987554211000   00    00 00000   


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccccC
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDAS  324 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~~  324 (416)
                      ..+   ..........+.+++.+||+.||++| ++.|+++.|+....
T Consensus       223 ~~~---~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          223 IEP---ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             CCH---HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             CCh---hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            000   01112234578999999999999999 99999999986543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-38  Score=340.17  Aligned_cols=239  Identities=20%  Similarity=0.316  Sum_probs=193.5

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC--CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCe----
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP--NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ----  114 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  114 (416)
                      ..++|.+.++||+|+||.||+|.+.  +|+.||||++..... .....+..|+.++.+++||||+++++++.....    
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            3478999999999999999999965  689999999875432 334578899999999999999999999987655    


Q ss_pred             -EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          115 -RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       115 -~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                       .+|||||+++++|.+++..    .+++..++.|+.|++.||.|||+.   +||||||||+||||+.+ .+||+|||+++
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence             7999999999999887654    599999999999999999999999   99999999999999886 89999999998


Q ss_pred             eccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      .....     ....||++|+|||++.++. +.++|||||||+|++|++|..||......                   + 
T Consensus       230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------------~-  283 (681)
T 2pzi_A          230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-------------------G-  283 (681)
T ss_dssp             ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-------------------S-
T ss_pred             hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-------------------c-
Confidence            76543     3357999999999997654 89999999999999999998887542110                   0 


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHhcc
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR-MSQIVRALEG  321 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~evv~~L~~  321 (416)
                         +.    ...........+..++.+||+.+|.+||+ +.++...|.+
T Consensus       284 ---~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          284 ---LP----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ---CC----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ---cc----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence               00    00001122357889999999999999995 6666666654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-37  Score=299.62  Aligned_cols=229  Identities=22%  Similarity=0.318  Sum_probs=182.0

Q ss_pred             hhCCCCcC-ceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHH-HhcCCCcccceEEEEEe----CCe
Q 014904           42 ATDGFSDA-NLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEII-SRVHHKHLVSLVGYYTA----GSQ  114 (416)
Q Consensus        42 ~t~~f~~~-~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~  114 (416)
                      ..++|.+. ++||+|+||.||+|.. .+++.||||+++..     ..+.+|+.++ +.++||||+++++++..    ...
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            44678777 7899999999999996 57899999999642     4667888888 55699999999999987    677


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC---CCceEEeeccc
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFGL  191 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~---~~~~kl~DFGl  191 (416)
                      .++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            89999999999999999877666799999999999999999999999   9999999999999998   78899999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhc
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIED  271 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~  271 (416)
                      +....                       +..++.++|||||||++|||++|+.||.........               .
T Consensus       167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---------------~  208 (299)
T 3m2w_A          167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------------P  208 (299)
T ss_dssp             CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------------C
T ss_pred             ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh---------------H
Confidence            86543                       134678999999999999999999999764321100               0


Q ss_pred             CCcccccCccccCcCC----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          272 GNFDTLVDPKLHNEYN----HNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       272 ~~~~~~~d~~l~~~~~----~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .....+....  ...+    ......+.+++.+||+.+|.+||++.|+++.
T Consensus       209 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          209 GMKTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CSCCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            0000000000  0111    1224578999999999999999999999963

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8e-39  Score=337.70  Aligned_cols=261  Identities=27%  Similarity=0.366  Sum_probs=201.0

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC-cccHHHHHHHHHHHHhcCCCcccceEEEEEe------CCeE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS-GQGEREFQAEVEIISRVHHKHLVSLVGYYTA------GSQR  115 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~  115 (416)
                      ++|.+.+.||+|+||.||+|.+ .+|+.||||++.... ......+.+|+.++.+++||||+++++++..      ....
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6899999999999999999996 468999999987643 3334578999999999999999999998755      6778


Q ss_pred             EEEEEecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc---eEEeeccc
Q 014904          116 MLVYEFVPNNTLEFHLHGKG-RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGL  191 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~---~kl~DFGl  191 (416)
                      ++||||+++++|.+++.... ...+++..++.|+.+++.||+|||+.   +|+||||||+||+++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            99999999999999997643 23588899999999999999999999   9999999999999987665   89999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh-
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE-  270 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~-  270 (416)
                      +........  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....     ...|.......... 
T Consensus       171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~~  243 (676)
T 3qa8_A          171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNEH  243 (676)
T ss_dssp             CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC------
T ss_pred             ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccchh
Confidence            987654332  2446799999999999999999999999999999999999999975421     22332211111000 


Q ss_pred             -------cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 014904          271 -------DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQ  314 (416)
Q Consensus       271 -------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~e  314 (416)
                             .+.+...................+.+++.+||+.||++||++.|
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence                   11111000111123344557788999999999999999999987

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.9e-38  Score=318.57  Aligned_cols=242  Identities=14%  Similarity=0.138  Sum_probs=181.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCccc---HHHHHHHHHHHHhcCC-Ccc---------cceE-
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQG---EREFQAEVEIISRVHH-KHL---------VSLV-  106 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h-~ni---------v~l~-  106 (416)
                      .++.|...++||+|+||.||+|.+ .+|+.||||++.......   .+.|.+|+.++..++| +|.         +... 
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            445678889999999999999994 579999999988443222   4678999999999977 321         1111 


Q ss_pred             -----------EEEEe-----CCeEEEEEEecCCCCHHHHhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 014904          107 -----------GYYTA-----GSQRMLVYEFVPNNTLEFHLH-----GKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK  165 (416)
Q Consensus       107 -----------~~~~~-----~~~~~lV~e~~~~~sL~~~l~-----~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~  165 (416)
                                 .++..     ....+++|++. +++|.+++.     ......+++..++.|+.|++.||+|||+.   +
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence                       11111     22356777755 788988884     22334688999999999999999999999   9


Q ss_pred             eeeecccCCcEEECCCCceEEeecccceeccCCCcceeecccccccccChhhh----------ccCCCCchhhhHhHHHH
Q 014904          166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA----------SSGKLTEKSDVFSFGVM  235 (416)
Q Consensus       166 iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~----------~~~~~t~ksDV~SlGvv  235 (416)
                      |+||||||+||||+.++.+||+|||+++.....    .....| +.|+|||++          ....++.++|||||||+
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            999999999999999999999999999865432    344567 999999999          55568899999999999


Q ss_pred             HHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 014904          236 LLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQI  315 (416)
Q Consensus       236 L~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev  315 (416)
                      +|||++|+.||........                   ...+...  ...+    +..+.+++.+||+.+|++||++.++
T Consensus       307 l~elltg~~Pf~~~~~~~~-------------------~~~~~~~--~~~~----~~~~~~li~~~l~~dP~~Rpt~~~~  361 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGG-------------------SEWIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQA  361 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSC-------------------SGGGGSS--CCCC----CHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHCCCCCCCcchhhh-------------------HHHHHhh--cccC----CHHHHHHHHHHccCChhhCcCHHHH
Confidence            9999999999976442110                   0001110  0112    2578999999999999999998887


Q ss_pred             HH
Q 014904          316 VR  317 (416)
Q Consensus       316 v~  317 (416)
                      ++
T Consensus       362 l~  363 (413)
T 3dzo_A          362 ME  363 (413)
T ss_dssp             TT
T ss_pred             Hh
Confidence            53

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.1e-37  Score=300.88  Aligned_cols=242  Identities=17%  Similarity=0.190  Sum_probs=187.1

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCc--------ccHHHHHHHHHHHHhcC---------CCcccce
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSG--------QGEREFQAEVEIISRVH---------HKHLVSL  105 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~---------h~niv~l  105 (416)
                      .++|.+.+.||+|+||.||+|.. +|+.||||++.....        ...+.+.+|+.+++.++         |+||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46788999999999999999998 789999999986532        22367889999998885         8888888


Q ss_pred             EEEEE------------------------------eCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 014904          106 VGYYT------------------------------AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGL  155 (416)
Q Consensus       106 ~~~~~------------------------------~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL  155 (416)
                      .+.+.                              .....++||||++++++.+.+..   ..+++..++.|+.|++.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence            77653                              26789999999999976555533   3589999999999999999


Q ss_pred             HHHH-hcCCCCeeeecccCCcEEECCCC--------------------ceEEeecccceeccCCCcceeecccccccccC
Q 014904          156 AYLH-EDCHPKIIHRDIKAANILLDFKF--------------------EAKVADFGLAKIASDVNTHVSTRVMGTFGYLA  214 (416)
Q Consensus       156 ~~LH-~~~~~~iiHrDIkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~Yla  214 (416)
                      +||| +.   +|+||||||+||||+.++                    .+||+|||+++.....      ...||+.|+|
T Consensus       175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a  245 (336)
T 2vuw_A          175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD  245 (336)
T ss_dssp             HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred             HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence            9999 88   999999999999999887                    8999999999876542      2479999999


Q ss_pred             hhhhccCCCCchhhhHhHHHH-HHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHH
Q 014904          215 PEYASSGKLTEKSDVFSFGVM-LLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMAR  293 (416)
Q Consensus       215 PE~~~~~~~t~ksDV~SlGvv-L~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  293 (416)
                      ||++.+.. +.++|||||+++ .+++++|..||..         ..|................    .............
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~s~~  311 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDKMLKQMTFKT----KCNTPAMKQIKRK  311 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHHHHHTCCCSS----CCCSHHHHHHHHH
T ss_pred             hhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHhhhhhhccCc----ccchhhhhhcCHH
Confidence            99998665 999999998777 7778889888732         1222222222111111111    1111223456778


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHH
Q 014904          294 MVACAAACVRHSARRRPRMSQIV  316 (416)
Q Consensus       294 l~~l~~~cl~~~p~~RPt~~evv  316 (416)
                      +.+|+.+||+.+     ++.|++
T Consensus       312 ~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHhccC-----CHHHHH
Confidence            999999999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=3.4e-31  Score=277.17  Aligned_cols=184  Identities=17%  Similarity=0.126  Sum_probs=130.4

Q ss_pred             ecccCcEEEEEEE-eCCCcEEEEEEeecCCc----------ccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEEE
Q 014904           52 LGQGGFGYVHRGV-LPNGKEVAIKQLKAGSG----------QGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        52 LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++.|++|.+..+. .-.|+.++||++...-.          ...++|.+|+++|+++ .|+||++++++++++...||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4556666665544 33588999999975421          1124699999999999 7999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||++|++|.++|...+  .++..   .|+.||+.||+|||+.   +||||||||+||||+.++.+||+|||+++......
T Consensus       322 Eyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             ECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             ecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            9999999999998654  45543   4889999999999999   99999999999999999999999999998765543


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP  245 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~p  245 (416)
                      .. .+..+||++|+|||++.+ .+..++|+|++|+++++|.++..+
T Consensus       394 ~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          394 SW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             cc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            32 345789999999999874 678899999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=9.9e-28  Score=249.53  Aligned_cols=187  Identities=17%  Similarity=0.199  Sum_probs=147.0

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCccc--------HHHHHHHHHHHHhcCCCcccceEEEEEeCCeE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQG--------EREFQAEVEIISRVHHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  115 (416)
                      ..+...++||+|+||.||+|.. .++.+++|+........        .+.+.+|+.++++++||||+++..++......
T Consensus       336 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~  414 (540)
T 3en9_A          336 KRKIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK  414 (540)
T ss_dssp             ------------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT
T ss_pred             ccCCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc
Confidence            3345567999999999999954 67889999875533221        23578999999999999999777777788888


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      +|||||+++++|.+++..          ++.|+.|+++||.|||+.   +|+||||||+|||++.  .+||+|||+++..
T Consensus       415 ~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~  479 (540)
T 3en9_A          415 RIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKIS  479 (540)
T ss_dssp             EEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred             EEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence            999999999999999865          458999999999999999   9999999999999998  9999999999987


Q ss_pred             cCCCcce------eecccccccccChhhhcc--CCCCchhhhHhHHHHHHHHHhCCCCC
Q 014904          196 SDVNTHV------STRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPV  246 (416)
Q Consensus       196 ~~~~~~~------~~~~~gt~~YlaPE~~~~--~~~t~ksDV~SlGvvL~elltG~~pf  246 (416)
                      .......      .....||+.|+|||++..  ..|+..+|+|+..+-.++-+.++.++
T Consensus       480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            6532221      235789999999999976  56788999999999888888777664

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=5.1e-24  Score=203.73  Aligned_cols=151  Identities=16%  Similarity=0.110  Sum_probs=120.5

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcc------------------cHHHHHHHHHHHHhcCC
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQ------------------GEREFQAEVEIISRVHH   99 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~------------------~~~~~~~E~~~l~~l~h   99 (416)
                      .+......|.+.+.||+|+||.||+|...+|+.||||+++.....                  ....+.+|+.++++++ 
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence            334445566677999999999999999977999999999753221                  2346889999999999 


Q ss_pred             CcccceEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC
Q 014904          100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD  179 (416)
Q Consensus       100 ~niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~  179 (416)
                       | +++.+++.. +..++||||+++++|.+ +..        .....++.|++.||.|||+.   +|+||||||+|||++
T Consensus       163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~  227 (282)
T 1zar_A          163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS  227 (282)
T ss_dssp             -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred             -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE
Confidence             5 666665544 45699999999999988 421        12346999999999999999   999999999999999


Q ss_pred             CCCceEEeecccceeccCCCcceeecccccccccChhhhc
Q 014904          180 FKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS  219 (416)
Q Consensus       180 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~  219 (416)
                       ++.+||+|||+++.              +..+.|||++.
T Consensus       228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             -TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             -CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence             99999999999863              34478899875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=3.5e-20  Score=174.67  Aligned_cols=136  Identities=18%  Similarity=0.151  Sum_probs=106.2

Q ss_pred             CCcCceecccCcEEEEEEEe-CCCcE--EEEEEeecCCcc------------------------cHHHHHHHHHHHHhcC
Q 014904           46 FSDANLLGQGGFGYVHRGVL-PNGKE--VAIKQLKAGSGQ------------------------GEREFQAEVEIISRVH   98 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~   98 (416)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+..|+.++.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999997 78999  999997643211                        0135788999999998


Q ss_pred             CCcc--cceEEEEEeCCeEEEEEEecCC-C----CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeeec
Q 014904           99 HKHL--VSLVGYYTAGSQRMLVYEFVPN-N----TLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH-EDCHPKIIHRD  170 (416)
Q Consensus        99 h~ni--v~l~~~~~~~~~~~lV~e~~~~-~----sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH-~~~~~~iiHrD  170 (416)
                      |+++  ..++.+    ...+|||||+.+ +    .|.++...     .++..+..++.|++.+|.||| +.   +|+|||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence            8864  344432    256899999942 3    67666432     223456789999999999999 77   999999


Q ss_pred             ccCCcEEECCCCceEEeecccceec
Q 014904          171 IKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       171 Ikp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      |||.|||++.  .++|+|||++...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999988  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.70  E-value=3e-17  Score=162.52  Aligned_cols=146  Identities=14%  Similarity=0.089  Sum_probs=106.2

Q ss_pred             HHHHHHhhCC---CCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCc-----c---------cHH--------HHHHH
Q 014904           36 YEELARATDG---FSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSG-----Q---------GER--------EFQAE   90 (416)
Q Consensus        36 ~~el~~~t~~---f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-----~---------~~~--------~~~~E   90 (416)
                      |--|.+..++   |++.+.||+|+||.||+|...+|+.||||+++....     .         ...        ....|
T Consensus        84 ~LAL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE  163 (397)
T 4gyi_A           84 YLALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKE  163 (397)
T ss_dssp             HHHHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHH
Confidence            3345555555   888999999999999999998999999999864211     0         001        12346


Q ss_pred             HHHHHhcCCCcccceEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeec
Q 014904           91 VEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRD  170 (416)
Q Consensus        91 ~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrD  170 (416)
                      +..|.++++.++....-+....  .+|||||+.+..|..+...        .....++.|++.+|.+||+.   +|||||
T Consensus       164 ~~nL~rL~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrD  230 (397)
T 4gyi_A          164 FAFMKALYEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGD  230 (397)
T ss_dssp             HHHHHHHHHTTCSCCCEEEEET--TEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHHHHHHhcCCCCCeeeeccC--ceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCC
Confidence            7777777655543322222222  3699999999888655321        12346789999999999998   999999


Q ss_pred             ccCCcEEECCCCc----------eEEeeccccee
Q 014904          171 IKAANILLDFKFE----------AKVADFGLAKI  194 (416)
Q Consensus       171 Ikp~NILl~~~~~----------~kl~DFGla~~  194 (416)
                      |||.||||++++.          +.|+||+-+-.
T Consensus       231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            9999999988763          89999997654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.44  E-value=5.1e-13  Score=125.06  Aligned_cols=148  Identities=11%  Similarity=0.025  Sum_probs=116.4

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-CCcccceEEEEEeCCeEE
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-HKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  116 (416)
                      .+.....+|.....++.|+.+.||+.... ++.+++|+...........+.+|+.++..+. +..+.++++++.+....+
T Consensus         8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A            8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            34566778988888898889999999864 6899999987532122346889999999985 677889999999999999


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC----------------------------------  162 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~----------------------------------  162 (416)
                      +|||+++|.+|...+..       ......++.+++++|+.||+..                                  
T Consensus        87 lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            99999999999876421       1123468889999999999810                                  


Q ss_pred             ----------------------CCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          163 ----------------------HPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       163 ----------------------~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                                            .+.++|+|+++.|||++.+..+.|+||+.+.
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  1359999999999999876556799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.30  E-value=4.3e-12  Score=117.81  Aligned_cols=139  Identities=17%  Similarity=0.084  Sum_probs=101.8

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCc--ccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKH--LVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e  120 (416)
                      ..++.+..+.+.|..+.||+....+|+.++||+.....   ...+..|+.++..+.+.+  +.++++++..++..++|||
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            34555433333455699999987778889999976542   235778999999986544  4568888888788999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC--------------------------------------  162 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~--------------------------------------  162 (416)
                      |++|.+|.  ...     ..   ...++.++++.|+.||...                                      
T Consensus        96 ~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           96 EVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             CCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             ecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            99998884  211     12   2356777888888888642                                      


Q ss_pred             -----------------CCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          163 -----------------HPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       163 -----------------~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                                       ...++|+|++|.|||++.+..+.|+||+.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                             12399999999999998776667999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.12  E-value=6.1e-11  Score=113.62  Aligned_cols=185  Identities=19%  Similarity=0.210  Sum_probs=123.0

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-CCc--ccceEEEEEeCC---eEEEEEEec
Q 014904           49 ANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-HKH--LVSLVGYYTAGS---QRMLVYEFV  122 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~e~~  122 (416)
                      .+.|+.|....||+..    ..+++|+....  .....+..|+.++..+. +..  +.+++.......   ..++||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4578999999999853    56899986532  33467889999999884 333  345555443332   347899999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED-----------------------------------------  161 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-----------------------------------------  161 (416)
                      +|..+......    .++...+..++.+++..|+.||..                                         
T Consensus        99 ~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           99 KGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             CCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            99888653321    367777788888888888888861                                         


Q ss_pred             --------------CCCCeeeecccCCcEEECC--CCceEEeecccceeccCCCcceee--------------ccccccc
Q 014904          162 --------------CHPKIIHRDIKAANILLDF--KFEAKVADFGLAKIASDVNTHVST--------------RVMGTFG  211 (416)
Q Consensus       162 --------------~~~~iiHrDIkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~--------------~~~gt~~  211 (416)
                                    ..+.++|+|+++.||+++.  +..+.|+||+.+...... .....              .+....+
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHcC
Confidence                          1245899999999999988  456789999998754221 10000              0111112


Q ss_pred             ccC-hhhhccCCCCchhhhHhHHHHHHHHHhCCCCC
Q 014904          212 YLA-PEYASSGKLTEKSDVFSFGVMLLELITGRRPV  246 (416)
Q Consensus       212 Yla-PE~~~~~~~t~ksDV~SlGvvL~elltG~~pf  246 (416)
                      ... |++...  .....+.|+++++++.+.+|..+|
T Consensus       254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            222 332221  122368999999999999997764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.10  E-value=2.9e-10  Score=111.44  Aligned_cols=143  Identities=15%  Similarity=0.169  Sum_probs=107.5

Q ss_pred             CcCceecccCcEEEEEEEeCCCcEEEEEEee--cCCc-ccHHHHHHHHHHHHhcCC--CcccceEEEEEeC---CeEEEE
Q 014904           47 SDANLLGQGGFGYVHRGVLPNGKEVAIKQLK--AGSG-QGEREFQAEVEIISRVHH--KHLVSLVGYYTAG---SQRMLV  118 (416)
Q Consensus        47 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~--~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lV  118 (416)
                      ...+.|+.|.++.||+....+ ..+++|+..  .... .....+..|+.+++.+..  ..+.+++.++.+.   +..++|
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            346688999999999988754 678888876  3321 223568889999999974  5578899988776   447899


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC------------------------------------  162 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~------------------------------------  162 (416)
                      |||++|..+.+..    ...++...+..++.++++.|+.||...                                    
T Consensus       120 me~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          120 MEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            9999998774321    124678888899999999999999731                                    


Q ss_pred             -------------------CCCeeeecccCCcEEECCCCc--eEEeeccccee
Q 014904          163 -------------------HPKIIHRDIKAANILLDFKFE--AKVADFGLAKI  194 (416)
Q Consensus       163 -------------------~~~iiHrDIkp~NILl~~~~~--~kl~DFGla~~  194 (416)
                                         .+.++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               257999999999999987753  68999999864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.64  E-value=3.6e-07  Score=87.50  Aligned_cols=137  Identities=20%  Similarity=0.235  Sum_probs=95.0

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCC---cccceEEEEE-eCCeEEEEEEecCC
Q 014904           49 ANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHK---HLVSLVGYYT-AGSQRMLVYEFVPN  124 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~e~~~~  124 (416)
                      .+.++.|....||+.    |+.++||+..  .......+..|+.++..+.+.   .+.+++.++. ..+..++||++++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            346778888899987    5778999853  223345788999999999753   3567777775 34567899999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED-------------------------------------------  161 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-------------------------------------------  161 (416)
                      ..+....-.    .++...+..++.++++.|+.||..                                           
T Consensus        98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            888753211    234444555555555555555542                                           


Q ss_pred             --------------CCCCeeeecccCCcEEECC---CCc-eEEeecccceec
Q 014904          162 --------------CHPKIIHRDIKAANILLDF---KFE-AKVADFGLAKIA  195 (416)
Q Consensus       162 --------------~~~~iiHrDIkp~NILl~~---~~~-~kl~DFGla~~~  195 (416)
                                    ..+.++|+|+++.||+++.   ++. +.|+||+.+...
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                          2335799999999999987   455 489999987653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.55  E-value=5.7e-07  Score=83.90  Aligned_cols=143  Identities=18%  Similarity=0.103  Sum_probs=99.4

Q ss_pred             hhCCCCcCceecccCcE-EEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-CCcccceEEEEEeCCeEEEE
Q 014904           42 ATDGFSDANLLGQGGFG-YVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV  118 (416)
                      ...+|+. ..+..|..+ .||+.... ++..++||+-...   ....+..|..+|+.+. +--+.+++.++.+.+..++|
T Consensus        23 ~l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv   98 (272)
T 4gkh_A           23 DLYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL   98 (272)
T ss_dssp             HHTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             cccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence            3344543 234445444 68988754 5678999986643   2457888999999884 33467889999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED-------------------------------------  161 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-------------------------------------  161 (416)
                      ||++++.++.+......      .....++.+++..|+.||..                                     
T Consensus        99 me~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (272)
T 4gkh_A           99 TTAIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN  172 (272)
T ss_dssp             EECCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred             EEeeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence            99999988876553211      12234555666666666641                                     


Q ss_pred             ------------------CCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          162 ------------------CHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       162 ------------------~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                                        ..+.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                              112379999999999999877677999998754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.45  E-value=3.2e-07  Score=89.34  Aligned_cols=80  Identities=10%  Similarity=0.017  Sum_probs=55.9

Q ss_pred             Ccee-cccCcEEEEEEEeC-------CCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCC---CcccceEEEEEeC--
Q 014904           49 ANLL-GQGGFGYVHRGVLP-------NGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHH---KHLVSLVGYYTAG--  112 (416)
Q Consensus        49 ~~~L-G~G~~g~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~--  112 (416)
                      .+.| +.|....+|+....       +++.+++|+.....   ......+..|+.++..+..   -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 77888899988764       26789999865432   1112456788888888843   3567788887665  


Q ss_pred             -CeEEEEEEecCCCCHH
Q 014904          113 -SQRMLVYEFVPNNTLE  128 (416)
Q Consensus       113 -~~~~lV~e~~~~~sL~  128 (416)
                       ...++|||+++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.23  E-value=1e-05  Score=80.01  Aligned_cols=75  Identities=16%  Similarity=0.127  Sum_probs=49.9

Q ss_pred             CceecccCcEEEEEEEeC-CCcEEEEEEeecCCc-------ccHHHHHHHHHHHHhcCC--Cc-ccceEEEEEeCCeEEE
Q 014904           49 ANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG-------QGEREFQAEVEIISRVHH--KH-LVSLVGYYTAGSQRML  117 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l  117 (416)
                      .+.||.|..+.||++... +++.++||.......       .....+..|++++..+..  +. +.+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            567999999999999754 568899998653221       122356778888888742  43 3455544  3455689


Q ss_pred             EEEecCCC
Q 014904          118 VYEFVPNN  125 (416)
Q Consensus       118 V~e~~~~~  125 (416)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.20  E-value=7.5e-06  Score=78.59  Aligned_cols=139  Identities=16%  Similarity=0.225  Sum_probs=80.6

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCC--CcccceEE------EEEeCCeEEEEEEe
Q 014904           50 NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHH--KHLVSLVG------YYTAGSQRMLVYEF  121 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lV~e~  121 (416)
                      ..|+.|..+.||+....+| .+++|+....    ..++..|+.++..+..  -.+.+++.      +....+..++|++|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3465566889999987555 5899998752    2344456666665531  12333332      12346778999999


Q ss_pred             cCCCCHH--------------HHhhc--C-C--C-------CCCCHHHHH------------------------------
Q 014904          122 VPNNTLE--------------FHLHG--K-G--R-------PTMDWLTRL------------------------------  145 (416)
Q Consensus       122 ~~~~sL~--------------~~l~~--~-~--~-------~~l~~~~~~------------------------------  145 (416)
                      ++|..+.              ..+|.  . .  .       ....|...+                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              11221  1 0  0       012343211                              


Q ss_pred             -HHHHHHHHHHHHHHh----------cCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          146 -KIALGSAKGLAYLHE----------DCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       146 -~i~~~ia~aL~~LH~----------~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                       .+...+..++.+|++          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             011123345666663          124589999999999999888889999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.03  E-value=4e-05  Score=73.57  Aligned_cols=138  Identities=15%  Similarity=0.126  Sum_probs=93.1

Q ss_pred             cCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC---CCcccceEEEEEeCCeEEEEEEecCC
Q 014904           48 DANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH---HKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        48 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ..+.|+.|....+|+... +++.++||+....   ....+..|+..|+.+.   ...+.+++.++......++|||++++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            345789999999999886 5678999987643   3457889999998884   35678899998888889999999998


Q ss_pred             CCHH--------H---HhhcCCC-C-------------------CCCHHHHH---HHH--HHH-----------HHHHH-
Q 014904          125 NTLE--------F---HLHGKGR-P-------------------TMDWLTRL---KIA--LGS-----------AKGLA-  156 (416)
Q Consensus       125 ~sL~--------~---~l~~~~~-~-------------------~l~~~~~~---~i~--~~i-----------a~aL~-  156 (416)
                      ..+.        .   .||.... .                   .-+|...+   ++.  .+.           ...++ 
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            7541        1   2232211 0                   12454322   111  111           11222 


Q ss_pred             ---HHHh-cCCCCeeeecccCCcEEECCCCceEEeecc
Q 014904          157 ---YLHE-DCHPKIIHRDIKAANILLDFKFEAKVADFG  190 (416)
Q Consensus       157 ---~LH~-~~~~~iiHrDIkp~NILl~~~~~~kl~DFG  190 (416)
                         .|.. ...+.++|+|+.+.||+++.++ +.|+||.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence               2321 2256799999999999999887 8899974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.94  E-value=4.2e-05  Score=72.12  Aligned_cols=79  Identities=18%  Similarity=0.193  Sum_probs=58.5

Q ss_pred             CCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCC---cccceEEEEEeCCeEEEEEEe
Q 014904           45 GFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHK---HLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ....+..+|.|..+.||+..+.+|+.|+||+...........|..|+..|+.+.-.   .+.++++.  ..  .++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEe
Confidence            45556789999999999999999999999987655544445688999999988532   23455543  22  3689999


Q ss_pred             cCCCCH
Q 014904          122 VPNNTL  127 (416)
Q Consensus       122 ~~~~sL  127 (416)
                      +.+...
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.91  E-value=6.9e-05  Score=71.52  Aligned_cols=158  Identities=11%  Similarity=0.059  Sum_probs=92.7

Q ss_pred             ccCHHHHHHhhCCCCcC-----ceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCc--ccce
Q 014904           33 TFTYEELARATDGFSDA-----NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKH--LVSL  105 (416)
Q Consensus        33 ~f~~~el~~~t~~f~~~-----~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l  105 (416)
                      .++-+++......|...     +.|+.|....+|+....+| .+++|+.....  ....+..|+.++..+...+  +.++
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            46778888888888652     3466677789999987655 68899887521  1235566777777764222  2233


Q ss_pred             EE------EEEeCCeEEEEEEecCCCCHHH--------------HhhcC----CCCC------CCHHHHHHH--------
Q 014904          106 VG------YYTAGSQRMLVYEFVPNNTLEF--------------HLHGK----GRPT------MDWLTRLKI--------  147 (416)
Q Consensus       106 ~~------~~~~~~~~~lV~e~~~~~sL~~--------------~l~~~----~~~~------l~~~~~~~i--------  147 (416)
                      +.      +....+..++|++|++|..+..              .+|..    ....      ..|...+.-        
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            31      1223466789999999865311              11211    1110      123321110        


Q ss_pred             ----HHHHHHHHHHHHhc----CCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          148 ----ALGSAKGLAYLHED----CHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       148 ----~~~ia~aL~~LH~~----~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                          ...+...+..+++.    ....++|+|+++.|||++.+..+.|+||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                11234455666542    13479999999999999877556899998764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.88  E-value=6.5e-05  Score=74.89  Aligned_cols=77  Identities=12%  Similarity=0.154  Sum_probs=47.5

Q ss_pred             CCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceeecccc--cccccChhhhccC---CCCchhhhHhHHHHHH
Q 014904          163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMG--TFGYLAPEYASSG---KLTEKSDVFSFGVMLL  237 (416)
Q Consensus       163 ~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~YlaPE~~~~~---~~t~ksDV~SlGvvL~  237 (416)
                      .+.++|+|+++.|||++.++ ++|+||+.+........ .. ....  ...|++|++....   .-....++..+...+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            45799999999999998876 99999998875432100 00 0111  1345666655311   1122355567777777


Q ss_pred             HHHhC
Q 014904          238 ELITG  242 (416)
Q Consensus       238 elltG  242 (416)
                      +.+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.74  E-value=0.00061  Score=65.00  Aligned_cols=159  Identities=15%  Similarity=0.107  Sum_probs=93.9

Q ss_pred             cccCHHHHHHhhCCCCc-----CceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCc--ccc
Q 014904           32 STFTYEELARATDGFSD-----ANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKH--LVS  104 (416)
Q Consensus        32 ~~f~~~el~~~t~~f~~-----~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~  104 (416)
                      ...+-+++..+...|..     ...|+ |....||+....+|+.+++|+..... .....+..|+.++..+....  +++
T Consensus         9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~   86 (328)
T 1zyl_A            9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA   86 (328)
T ss_dssp             CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred             CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecc
Confidence            34566677766665533     23566 77789999887778789999987432 23456777888888874222  334


Q ss_pred             eEEE-----EEeCCeEEEEEEecCCCCHH-----H------H---hhc----CC---CCCCCHHHH----HHH-------
Q 014904          105 LVGY-----YTAGSQRMLVYEFVPNNTLE-----F------H---LHG----KG---RPTMDWLTR----LKI-------  147 (416)
Q Consensus       105 l~~~-----~~~~~~~~lV~e~~~~~sL~-----~------~---l~~----~~---~~~l~~~~~----~~i-------  147 (416)
                      ++..     ....+..++|+++++|..+.     .      .   +|.    ..   ....++...    ..+       
T Consensus        87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  166 (328)
T 1zyl_A           87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI  166 (328)
T ss_dssp             CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred             eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence            4332     22355678899999875431     1      0   111    00   112232211    000       


Q ss_pred             --------HHHHHHHHHHHHhc----CCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          148 --------ALGSAKGLAYLHED----CHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       148 --------~~~ia~aL~~LH~~----~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                              ...+...+..+...    ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                    01111223333322    234689999999999998 4 899999987653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.50  E-value=0.00038  Score=65.91  Aligned_cols=140  Identities=12%  Similarity=0.117  Sum_probs=77.3

Q ss_pred             CCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcc-cceEEEEEeCCeEEEEEEec-C
Q 014904           46 FSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVYEFV-P  123 (416)
Q Consensus        46 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~-~  123 (416)
                      +.-.+.|+.|....+|+.     +.+++|+........ .....|+.++..+...++ .+++.+  +...-++|+||+ +
T Consensus        20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~   91 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG   91 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred             ccceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence            334678888989999998     568999876532111 123467877777753333 455554  333456899999 6


Q ss_pred             CCCHHH------------------HhhcCCCC---CCCHHHH-HHHHH--------------HHHHHHHHHH----h-cC
Q 014904          124 NNTLEF------------------HLHGKGRP---TMDWLTR-LKIAL--------------GSAKGLAYLH----E-DC  162 (416)
Q Consensus       124 ~~sL~~------------------~l~~~~~~---~l~~~~~-~~i~~--------------~ia~aL~~LH----~-~~  162 (416)
                      +.++..                  .+|.....   ....... ..+..              .+...+..|.    . ..
T Consensus        92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~  171 (301)
T 3dxq_A           92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL  171 (301)
T ss_dssp             CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred             CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence            654421                  11211110   0111111 11100              0111111111    1 12


Q ss_pred             CCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       163 ~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      ...++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            345899999999999 5566789999988764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.49  E-value=0.00021  Score=71.58  Aligned_cols=73  Identities=19%  Similarity=0.278  Sum_probs=49.7

Q ss_pred             CceecccCcEEEEEEEeCC--------CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcc-cceEEEEEeCCeEEEEE
Q 014904           49 ANLLGQGGFGYVHRGVLPN--------GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~  119 (416)
                      .+.|+.|--..||+....+        ++.+++|+....  .....+..|+.++..+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4567777789999998753        578999988432  122455679999888854444 567765532    2899


Q ss_pred             EecCCCCH
Q 014904          120 EFVPNNTL  127 (416)
Q Consensus       120 e~~~~~sL  127 (416)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986443

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.49  E-value=0.00067  Score=65.03  Aligned_cols=141  Identities=17%  Similarity=0.133  Sum_probs=74.2

Q ss_pred             ceecccCcEE-EEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCC--CcccceEEEEEeCCeEEEEEEecCCCC
Q 014904           50 NLLGQGGFGY-VHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHH--KHLVSLVGYYTAGSQRMLVYEFVPNNT  126 (416)
Q Consensus        50 ~~LG~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~~s  126 (416)
                      +.|+.|.... +|+....+++.+++|.......   ..+..|+.++..+..  -.+.+++.+.....  ++|||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4565554444 6676654477788886554321   234456777776642  23556776643333  68999997766


Q ss_pred             HHHHhhc---------------------CCC---CCCCHHHHH---------H-----------HHHHHHHHHHHHHh--
Q 014904          127 LEFHLHG---------------------KGR---PTMDWLTRL---------K-----------IALGSAKGLAYLHE--  160 (416)
Q Consensus       127 L~~~l~~---------------------~~~---~~l~~~~~~---------~-----------i~~~ia~aL~~LH~--  160 (416)
                      +...+..                     ...   +.++.....         .           ....+...+..|.+  
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            6443321                     110   111111000         0           00011222333321  


Q ss_pred             -cCCCCeeeecccCCcEEECCC----CceEEeecccceec
Q 014904          161 -DCHPKIIHRDIKAANILLDFK----FEAKVADFGLAKIA  195 (416)
Q Consensus       161 -~~~~~iiHrDIkp~NILl~~~----~~~kl~DFGla~~~  195 (416)
                       .....++|+|+.+.|||++.+    ..+.|+||+.+...
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence             124479999999999999874    67899999988653

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.32  E-value=0.00067  Score=66.75  Aligned_cols=139  Identities=19%  Similarity=0.225  Sum_probs=81.1

Q ss_pred             ceecccCcEEEEEEEeC--------CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCc-ccceEEEEEeCCeEEEEEE
Q 014904           50 NLLGQGGFGYVHRGVLP--------NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKH-LVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e  120 (416)
                      +.|..|--..+|+....        +++.+++|+.... ......+.+|..+++.+.-.+ ..++++++.+    .+|+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            45655666789998864        2578999986432 223456678999998885333 3566666543    28999


Q ss_pred             ecCCCCHHH-----------------HhhcCC---CCCCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 014904          121 FVPNNTLEF-----------------HLHGKG---RPTMD--WLTRLKIALGSA-------------------KGLAYLH  159 (416)
Q Consensus       121 ~~~~~sL~~-----------------~l~~~~---~~~l~--~~~~~~i~~~ia-------------------~aL~~LH  159 (416)
                      |++|..|..                 -||...   .....  |.+..++..++.                   ..+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            999865421                 012211   11122  334444443321                   1233333


Q ss_pred             h----c-CCCCeeeecccCCcEEECCC----CceEEeecccce
Q 014904          160 E----D-CHPKIIHRDIKAANILLDFK----FEAKVADFGLAK  193 (416)
Q Consensus       160 ~----~-~~~~iiHrDIkp~NILl~~~----~~~kl~DFGla~  193 (416)
                      +    . ....++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            2    1 23368999999999999876    689999998875

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.31  E-value=0.00078  Score=68.01  Aligned_cols=73  Identities=12%  Similarity=0.113  Sum_probs=46.9

Q ss_pred             ceecccCcEEEEEEEeCC-CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcc-cceEEEEEeCCeEEEEEEecCCCCH
Q 014904           50 NLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVYEFVPNNTL  127 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~~sL  127 (416)
                      +.|+.|--..+|+....+ +..+++|+........ -....|+.++..+...++ .++++++.  +  .+|+||++|..|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            456667778999988765 5789999875432111 112578889998875555 46777662  2  259999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.08  E-value=0.0039  Score=60.11  Aligned_cols=32  Identities=22%  Similarity=0.308  Sum_probs=27.8

Q ss_pred             CCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       163 ~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      ...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            34699999999999999888899999987754

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.07  E-value=0.001  Score=64.84  Aligned_cols=73  Identities=10%  Similarity=0.068  Sum_probs=44.0

Q ss_pred             CceecccCcEEEEEEEeCC---------CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcc-cceEEEEEeCCeEEEE
Q 014904           49 ANLLGQGGFGYVHRGVLPN---------GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLV  118 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV  118 (416)
                      ...|+.|-...+|+....+         ++.+++|+....... ......|..++..+...++ .++++.+  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3466777778999988654         268899987643211 1123578888888754343 4666544  2  2689


Q ss_pred             EEecCCCC
Q 014904          119 YEFVPNNT  126 (416)
Q Consensus       119 ~e~~~~~s  126 (416)
                      ++|++|..
T Consensus       113 ~e~i~G~~  120 (369)
T 3c5i_A          113 EEWLYGDP  120 (369)
T ss_dssp             EECCCSEE
T ss_pred             EEEecCCc
Confidence            99998754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.88  E-value=0.0048  Score=55.56  Aligned_cols=99  Identities=15%  Similarity=0.070  Sum_probs=65.5

Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcceee
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVST  204 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  204 (416)
                      -+|.++|...+. +++..++|.++.|.+++|.-+-.... . ..+=+.|..|+|..+|.+-+.+ ..+.           
T Consensus        33 vSL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence            378898886665 79999999999999998877632111 1 1233457999999999887753 1110           


Q ss_pred             cccccccccChhhhccCCCCchhhhHhHHHHHHHHHh
Q 014904          205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT  241 (416)
Q Consensus       205 ~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt  241 (416)
                        .....+.+||... ...+.+.=|||||++||.-+-
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence              0122356888764 355789999999999998885

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.13  E-value=0.053  Score=53.91  Aligned_cols=73  Identities=10%  Similarity=0.151  Sum_probs=46.0

Q ss_pred             ceecccCcEEEEEEEeCC--------CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcc-cceEEEEEeCCeEEEEEE
Q 014904           50 NLLGQGGFGYVHRGVLPN--------GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e  120 (416)
                      +.|..|--..+|+....+        ++.+++|+....... .-...+|..+++.+.-.++ .++++.+  .  -++|++
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence            456556667899988753        588999987543211 1123567888887753333 4566533  2  268999


Q ss_pred             ecCCCCH
Q 014904          121 FVPNNTL  127 (416)
Q Consensus       121 ~~~~~sL  127 (416)
                      |++|..|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.65  E-value=0.29  Score=47.93  Aligned_cols=29  Identities=31%  Similarity=0.401  Sum_probs=24.3

Q ss_pred             CeeeecccCCcEEE------CCCCceEEeecccce
Q 014904          165 KIIHRDIKAANILL------DFKFEAKVADFGLAK  193 (416)
Q Consensus       165 ~iiHrDIkp~NILl------~~~~~~kl~DFGla~  193 (416)
                      .++|+|+.+.|||+      +++..++|+||..+.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            36799999999999      455679999998875

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.86  E-value=1.1  Score=40.04  Aligned_cols=82  Identities=10%  Similarity=0.100  Sum_probs=60.1

Q ss_pred             CCCcccceEEEEEeCCeEEEEEEecCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeeeecccCCc
Q 014904           98 HHKHLVSLVGYYTAGSQRMLVYEFVPNN-TLEFHLHGKGRPTMDWLTRLKIALGSAKGLA-YLHEDCHPKIIHRDIKAAN  175 (416)
Q Consensus        98 ~h~niv~l~~~~~~~~~~~lV~e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~-~LH~~~~~~iiHrDIkp~N  175 (416)
                      .||++  -..+-.+.+...+.|+.-++. ++.. +.     .++...+++++.+++.... +++     .-+|--|.|.|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i~-----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-IR-----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-HH-----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-HH-----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCce
Confidence            68888  445557777777777765333 4443 32     4788899999999887655 444     34778899999


Q ss_pred             EEECCCCceEEeecccc
Q 014904          176 ILLDFKFEAKVADFGLA  192 (416)
Q Consensus       176 ILl~~~~~~kl~DFGla  192 (416)
                      |+++.++.++|.-.|+-
T Consensus       115 L~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             EEECTTCCEEESCCEET
T ss_pred             EEEeCCCcEEEEEcCCc
Confidence            99999999999877764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.63  E-value=0.85  Score=40.68  Aligned_cols=115  Identities=8%  Similarity=0.098  Sum_probs=77.2

Q ss_pred             CCCcccceEEEEEeCCeEEEEEEecC-CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcE
Q 014904           98 HHKHLVSLVGYYTAGSQRMLVYEFVP-NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANI  176 (416)
Q Consensus        98 ~h~niv~l~~~~~~~~~~~lV~e~~~-~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NI  176 (416)
                      .||+++.. .+-.+.+...+.|+.-+ ..++.. +.     .++...+++++.+++....+++.     =+|--|.|.||
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence            68888877 56666677666666443 223333 22     47888999999999987755543     36888999999


Q ss_pred             EECCCCceEEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCC
Q 014904          177 LLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD  247 (416)
Q Consensus       177 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~  247 (416)
                      +++.++.+++.-.|+....                  +|.     .+++..=+-.+=+++..+++++..|+
T Consensus       111 ~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999877763221                  221     11222223356678888999888764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	416
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-74
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-70
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-67
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-66
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-66
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-66
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-65
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-64
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-62
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-62
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-61
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-60
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-59
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-59
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-59
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-58
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-58
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-54
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-54
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-47
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-45
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-45
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-45
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-44
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-42
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-39
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-38
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-37
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-36
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-22

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (586), Expect = 9e-74
 Identities = 75/277 (27%), Positives = 130/277 (46%), Gaps = 28/277 (10%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQLK--AGSGQGEREFQAEVEIISRVHHKHLVSLVG 107
             +G G FG V++G      +VA+K L   A + Q  + F+ EV ++ +  H +++  +G
Sbjct: 14  QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
           Y T   Q  +V ++   ++L  HLH       + +  + IA  +A+G+ YLH      II
Sbjct: 72  YST-APQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSII 126

Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDV-NTHVSTRVMGTFGYLAPEYA---SSGKL 223
           HRD+K+ NI L      K+ DFGLA + S    +H   ++ G+  ++APE          
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186

Query: 224 TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLH 283
           + +SDV++FG++L EL+TG+ P      +   +  D    ++ R     +          
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLP------YSNINNRDQIIFMVGRGYLSPDLS-------- 232

Query: 284 NEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
            +   N    M    A C++     RP   QI+ ++E
Sbjct: 233 -KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 2e-70
 Identities = 77/271 (28%), Positives = 115/271 (42%), Gaps = 24/271 (8%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
             LG G FG V  G      +VA+K LK GS      F AE  ++ ++ H+ LV L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
           T      ++ E++ N +L   L       +     L +A   A+G+A++ E      IHR
Sbjct: 78  TQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133

Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D++AANIL+      K+ADFGLA++  D              + APE  + G  T KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193

Query: 230 FSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHN 289
           +SFG++L E++T  R      T  E          + + +E G    +V P        N
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPE----------VIQNLERGY--RMVRPD-------N 234

Query: 290 EMARMVACAAACVRHSARRRPRMSQIVRALE 320
               +      C +     RP    +   LE
Sbjct: 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 3e-67
 Identities = 74/271 (27%), Positives = 116/271 (42%), Gaps = 24/271 (8%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
             +G G FG VH G   N  +VAIK ++ G+   E +F  E E++ ++ H  LV L G  
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
              +   LV+EF+ +  L        R      T L + L   +G+AYL       +IHR
Sbjct: 70  LEQAPICLVFEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHR 125

Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D+ A N L+      KV+DFG+ +   D     ST       + +PE  S  + + KSDV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185

Query: 230 FSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHN 289
           +SFGV++ E+ +  +      +  E          +   I  G    L  P+L +     
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSNSE----------VVEDISTGF--RLYKPRLAST---- 229

Query: 290 EMARMVACAAACVRHSARRRPRMSQIVRALE 320
               +      C +     RP  S+++R L 
Sbjct: 230 ---HVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  212 bits (540), Expect = 1e-66
 Identities = 74/307 (24%), Positives = 129/307 (42%), Gaps = 43/307 (14%)

Query: 33  TFTYEELARATDGFSDA---------NLLGQGGFGYVHRGVLPNGKE----VAIKQLKAG 79
            FT+E+   A   F+            ++G G FG V  G L    +    VAIK LK+G
Sbjct: 6   PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65

Query: 80  -SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPT 138
            + +  R+F +E  I+ +  H +++ L G  T  +  M++ EF+ N +L+  L       
Sbjct: 66  YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ- 124

Query: 139 MDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV 198
              +  + +  G A G+ YL        +HRD+ A NIL++     KV+DFGL++   D 
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 199 NTHVSTR----VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFV 253
            +  +            + APE     K T  SDV+S+G+++ E+++ G RP      + 
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP------YW 235

Query: 254 EDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMS 313
           + +  D                  ++         +  + +      C +     RP+  
Sbjct: 236 DMTNQDVIN--------------AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281

Query: 314 QIVRALE 320
           QIV  L+
Sbjct: 282 QIVNTLD 288

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 2e-66
 Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 9/210 (4%)

Query: 42  ATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHH 99
             D F   + LG G  G V +    P+G  +A K +        R     E++++   + 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
            ++V   G + +  +  +  E +   +L+  L   GR  +      K+++   KGL YL 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR 121

Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
           E    KI+HRD+K +NIL++ + E K+ DFG++    D    ++   +GT  Y++PE   
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQ 176

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRPVDST 249
               + +SD++S G+ L+E+  GR P+   
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 2e-66
 Identities = 78/301 (25%), Positives = 117/301 (38%), Gaps = 33/301 (10%)

Query: 20  PPSPGLSLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAG 79
           P + GL+          +      +       LGQG FG V  G       VAIK LK G
Sbjct: 2   PQTQGLA---------KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG 52

Query: 80  SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTM 139
           +      F  E +++ ++ H+ LV L    +      +V E++   +L   L G+    +
Sbjct: 53  T-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYL 110

Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
                + +A   A G+AY+        +HRD++AANIL+      KVADFGLA++  D  
Sbjct: 111 RLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167

Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVD 259
                       + APE A  G+ T KSDV+SFG++L EL T  R         E     
Sbjct: 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----- 222

Query: 260 WARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRAL 319
               +L++          V+              +      C R     RP    +   L
Sbjct: 223 ----VLDQ----------VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

Query: 320 E 320
           E
Sbjct: 269 E 269

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 3e-65
 Identities = 67/292 (22%), Positives = 125/292 (42%), Gaps = 32/292 (10%)

Query: 52  LGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYT- 110
           +G+G FG V RG    G+EVA+K   +   +     +AE+     + H++++  +     
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 111 ---AGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC----- 162
                +Q  LV ++  + +L  +L+   R T+     +K+AL +A GLA+LH +      
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKI---ASDVNTHVSTRVMGTFGYLAPEYAS 219
            P I HRD+K+ NIL+       +AD GLA     A+D         +GT  Y+APE   
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185

Query: 220 S------GKLTEKSDVFSFGVMLLELITGRRP----VDSTHTFVEDSLVDWARPLLNRAI 269
                   +  +++D+++ G++  E+           D    + +    D +   + + +
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245

Query: 270 EDGNFDTLVDPKLHNEYNHNEMARMVA-CAAACVRHSARRRPRMSQIVRALE 320
            +        P + N +   E  R++A     C   +   R    +I + L 
Sbjct: 246 CEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 9e-65
 Identities = 62/271 (22%), Positives = 107/271 (39%), Gaps = 24/271 (8%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
             LG G FG V  G      +VAIK +K GS   E EF  E +++  + H+ LV L G  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
           T      ++ E++ N  L  +L             L++     + + YL      + +HR
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 124

Query: 170 DIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 229
           D+ A N L++ +   KV+DFGL++   D     S        +  PE     K + KSD+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184

Query: 230 FSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHN 289
           ++FGV++ E+ +  +       +   +  + A                +   L     H 
Sbjct: 185 WAFGVLMWEIYSLGKM-----PYERFTNSETAE--------------HIAQGLRLYRPHL 225

Query: 290 EMARMVACAAACVRHSARRRPRMSQIVRALE 320
              ++     +C    A  RP    ++  + 
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  205 bits (523), Expect = 3e-64
 Identities = 72/300 (24%), Positives = 124/300 (41%), Gaps = 27/300 (9%)

Query: 32  STFTYEELARATDGFSDANLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQGEREFQAE 90
           S+  Y++        +  + LG G +G V+ GV       VA+K LK  + + E EF  E
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 63

Query: 91  VEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALG 150
             ++  + H +LV L+G  T      ++ EF+    L  +L    R  +  +  L +A  
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123

Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
            +  + YL +      IHRD+ A N L+      KVADFGL+++ +              
Sbjct: 124 ISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180

Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE 270
            + APE  +  K + KSDV++FGV+L E+ T            +                
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------- 224

Query: 271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG---DASLAD 327
                 L++     E       ++     AC + +   RP  ++I +A E    ++S++D
Sbjct: 225 ---VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 2e-62
 Identities = 68/290 (23%), Positives = 121/290 (41%), Gaps = 31/290 (10%)

Query: 46  FSDANLLGQGGFGYVHRGVLPNGKE-----VAIKQLKAGSGQGER-EFQAEVEIISRVHH 99
            +   ++G G FG V++G+L          VAIK LKAG  + +R +F  E  I+ +  H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
            +++ L G  +     M++ E++ N         +       L  + +  G A G+ YL 
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127

Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD--VNTHVSTRVMGTFGYLAPEY 217
              +   +HRD+ A NIL++     KV+DFGL+++  D    T+ ++       + APE 
Sbjct: 128 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL 277
            S  K T  SDV+SFG+++ E++T         +                   +      
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------------------NHEVMKA 225

Query: 278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDASLAD 327
           ++         +  + +      C +    RRP+ + IV  L+      D
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 4e-62
 Identities = 70/272 (25%), Positives = 112/272 (41%), Gaps = 30/272 (11%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
             +G+G FG V  G    G +VA+K +K  +    + F AE  +++++ H +LV L+G  
Sbjct: 13  QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 110 TAGSQRM-LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
                 + +V E++   +L  +L  +GR  +     LK +L   + + YL        +H
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126

Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 228
           RD+ A N+L+     AKV+DFGL K AS               + APE     K + KSD
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALREKKFSTKSD 182

Query: 229 VFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNH 288
           V+SFG++L E+ +  R         +          +   +E G      D         
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKD----------VVPRVEKGYKMDAPD--------- 223

Query: 289 NEMARMVACAAACVRHSARRRPRMSQIVRALE 320
                +      C    A  RP   Q+   LE
Sbjct: 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 3e-61
 Identities = 76/280 (27%), Positives = 118/280 (42%), Gaps = 32/280 (11%)

Query: 50  NLLGQGGFGYVHRGVLPNGK----EVAIKQLKAGSGQGE-REFQAEVEIISRVHHKHLVS 104
            ++G+G FG V+ G L +        A+K L   +  GE  +F  E  I+    H +++S
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 105 LVGY-YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
           L+G    +    ++V  ++ +  L  +              +   L  AKG+        
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN---THVSTRVMGTFGYLAPEYASS 220
            K +HRD+ A N +LD KF  KVADFGLA+   D      H  T       ++A E   +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

Query: 221 GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP 280
            K T KSDV+SFGV+L EL+T   P      + + +  D    LL           L+ P
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQG-------RRLLQP 256

Query: 281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
               EY  + +  +      C    A  RP  S++V  + 
Sbjct: 257 ----EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRIS 289

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 9e-61
 Identities = 76/300 (25%), Positives = 115/300 (38%), Gaps = 46/300 (15%)

Query: 50  NLLGQGGFGYVHRGVL------PNGKEVAIKQLKAGSGQGERE-FQAEVEIISRV-HHKH 101
             LG G FG V                VA+K LK  +   ERE   +E++++S + +H +
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKG----------------RPTMDWLTRL 145
           +V+L+G  T G   +++ E+     L   L  K                    +D    L
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVST 204
             +   AKG+A+L        IHRD+ A NILL      K+ DFGLA+ I +D N  V  
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 205 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL 264
                  ++APE   +   T +SDV+S+G+ L EL +                       
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP------------- 252

Query: 265 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDAS 324
                 D  F  ++          +  A M      C      +RP   QIV+ +E   S
Sbjct: 253 -----VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (500), Expect = 1e-60
 Identities = 68/315 (21%), Positives = 110/315 (34%), Gaps = 52/315 (16%)

Query: 36  YEELARATDGFSDANLLGQGGFGYVHRGVLPN------GKEVAIKQLK-AGSGQGEREFQ 88
              L    +       +G+G FG V +   P          VA+K LK   S   + +FQ
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 89  AEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR------------ 136
            E  +++   + ++V L+G    G    L++E++    L   L                 
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 137 ----------PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV 186
                     P +    +L IA   A G+AYL      K +HRD+   N L+      K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI 181

Query: 187 ADFGLAK-IASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           ADFGL++ I S               ++ PE     + T +SDV+++GV+L E+ +    
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 246 VDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHS 305
                   E          +   + DGN     +         N    +      C    
Sbjct: 242 PYYGMAHEE----------VIYYVRDGNILACPE---------NCPLELYNLMRLCWSKL 282

Query: 306 ARRRPRMSQIVRALE 320
              RP    I R L+
Sbjct: 283 PADRPSFCSIHRILQ 297

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 1e-59
 Identities = 70/287 (24%), Positives = 121/287 (42%), Gaps = 31/287 (10%)

Query: 40  ARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGS--GQGEREFQAEVEIISR 96
           +RA D +     +G G +G   +     +GK +  K+L  GS     ++   +EV ++  
Sbjct: 1   SRAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 59

Query: 97  VHHKHLVSLVGYYTAGSQRML--VYEFVPNNTLEFHLH--GKGRPTMDWLTRLKIALGSA 152
           + H ++V         +   L  V E+     L   +    K R  +D    L++     
Sbjct: 60  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119

Query: 153 KGLAYLHE--DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
             L   H   D    ++HRD+K AN+ LD K   K+ DFGLA+I +  +T  +   +GT 
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTP 178

Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE 270
            Y++PE  +     EKSD++S G +L EL     P      F   S  +     L   I 
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP------FTAFSQKE-----LAGKIR 227

Query: 271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
           +G F      ++   Y+ +E+  ++      +      RP + +I+ 
Sbjct: 228 EGKF-----RRIPYRYS-DELNEII---TRMLNLKDYHRPSVEEILE 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 2e-59
 Identities = 63/274 (22%), Positives = 113/274 (41%), Gaps = 33/274 (12%)

Query: 52  LGQGGFGYVHRGVLP-NGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSLVGY 108
           +G+G F  V++G+      EVA  +L+    +    + F+ E E++  + H ++V     
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 109 YTAGSQR----MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           + +  +     +LV E + + TL+ +L       M             KGL +LH    P
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHT-RTP 133

Query: 165 KIIHRDIKAANILLDFK-FEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
            IIHRD+K  NI +       K+ D GLA +        +  V+GT  ++APE     K 
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPEMYE-EKY 189

Query: 224 TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLH 283
            E  DV++FG+ +LE+ T   P      + E          +   ++  +FD +  P++ 
Sbjct: 190 DESVDVYAFGMCMLEMATSEYP------YSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243

Query: 284 NEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
                            C+R +   R  +  ++ 
Sbjct: 244 E------------IIEGCIRQNKDERYSIKDLLN 265

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 2e-59
 Identities = 64/280 (22%), Positives = 106/280 (37%), Gaps = 32/280 (11%)

Query: 48  DANLLGQGGFGYVHRGVLPN---GKEVAIKQLKAGSGQGE--REFQAEVEIISRVHHKHL 102
           +   LG G FG V +G        K VA+K LK  +       E  AE  ++ ++ + ++
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC 162
           V ++G   A S  MLV E      L  +L       +     +++    + G+ YL    
Sbjct: 71  VRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE--- 124

Query: 163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGTFGYLAPEYASS 220
               +HRD+ A N+LL  +  AK++DFGL+K       +   +        + APE  + 
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 221 GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDP 280
            K + KSDV+SFGV++ E  +  +         E          +   +E G        
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------VTAMLEKGE------- 227

Query: 281 KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
                        M      C  +    RP  + +   L 
Sbjct: 228 --RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  193 bits (492), Expect = 2e-59
 Identities = 69/282 (24%), Positives = 116/282 (41%), Gaps = 36/282 (12%)

Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE---REFQAEVEIISRVH 98
              FSD   +G G FG V+    + N + VAIK++     Q     ++   EV  + ++ 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 99  HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
           H + +   G Y       LV E+   +  +     K    +  +    +  G+ +GLAYL
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYL 131

Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYA 218
           H      +IHRD+KA NILL      K+ DFG A I +  N+ V     GT  ++APE  
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVI 183

Query: 219 SS---GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD 275
            +   G+   K DV+S G+  +EL   + P          + +      L    ++    
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPP------LFNMNAMS----ALYHIAQNE--- 230

Query: 276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
               P L + +        V    +C++   + RP    +++
Sbjct: 231 ---SPALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 3e-59
 Identities = 70/291 (24%), Positives = 120/291 (41%), Gaps = 31/291 (10%)

Query: 37  EELARATDGFSDANL-LGQGGFGYVHRGVL---PNGKEVAIKQLKAGSGQGERE-FQAEV 91
           ++L    D    A++ LG G FG V +GV        +VAIK LK G+ + + E    E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS 151
           +I+ ++ + ++V L+G        MLV E      L   L GK    +      ++    
Sbjct: 61  QIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQV 118

Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR--VMGT 209
           + G+ YL        +HRD+ A N+LL  +  AK++DFGL+K     +++ + R      
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAI 269
             + APE  +  K + +SDV+S+GV + E ++  +         E          +   I
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----------VMAFI 225

Query: 270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
           E G            E        + A  + C  +    RP    + + + 
Sbjct: 226 EQGK---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 9e-59
 Identities = 64/291 (21%), Positives = 117/291 (40%), Gaps = 32/291 (10%)

Query: 36  YEELAR---ATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEV 91
           YE + R     D +     LG G FG V++          A K +   S +   ++  E+
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS 151
           +I++   H ++V L+  +   +   ++ EF     ++  +    RP +       +   +
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQT 119

Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFG 211
              L YLH+    KIIHRD+KA NIL     + K+ADFG++   +       + + GT  
Sbjct: 120 LDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPY 175

Query: 212 YLAPEYA-----SSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN 266
           ++APE              K+DV+S G+ L+E+     P        E + +      + 
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP------HHELNPMR-----VL 224

Query: 267 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
             I      TL  P   +    + + +       C+  +   R   SQ+++
Sbjct: 225 LKIAKSEPPTLAQPSRWSSNFKDFLKK-------CLEKNVDARWTTSQLLQ 268

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 4e-58
 Identities = 70/300 (23%), Positives = 116/300 (38%), Gaps = 51/300 (17%)

Query: 51  LLGQGGFGYVHRGVLPN------GKEVAIKQLKAGSGQGERE-FQAEVEIISRV-HHKHL 102
           +LG G FG V               +VA+K LK  +   ERE   +E+++++++  H+++
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRP---------------------TMDW 141
           V+L+G  T      L++E+     L  +L  K                         + +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 142 LTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNT 200
              L  A   AKG+ +L        +HRD+ A N+L+      K+ DFGLA+ I SD N 
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDW 260
            V         ++APE    G  T KSDV+S+G++L E+ +                   
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP--------- 271

Query: 261 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
                     D NF  L+      +        +     +C    +R+RP    +   L 
Sbjct: 272 ---------VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 6e-58
 Identities = 66/272 (24%), Positives = 112/272 (41%), Gaps = 33/272 (12%)

Query: 50  NLLGQGGFGYVHRGVLP-NGKEVAIKQLK---AGSGQGEREFQAEVEIISRVHHKHLVSL 105
             LG+G FG V+      +   +A+K L          E + + EVEI S + H +++ L
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
            GY+   ++  L+ E+ P  T+   L    +   D           A  L+Y H     +
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHS---KR 126

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           +IHRDIK  N+LL    E K+ADFG +  A          + GT  YL PE        E
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRMHDE 183

Query: 226 KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNE 285
           K D++S GV+  E + G+ P      F  ++  +  + +      +  F   V     + 
Sbjct: 184 KVDLWSLGVLCYEFLVGKPP------FEANTYQETYKRISR---VEFTFPDFVTEGARD- 233

Query: 286 YNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
                        +  ++H+  +RP + +++ 
Sbjct: 234 -----------LISRLLKHNPSQRPMLREVLE 254

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 3e-56
 Identities = 63/290 (21%), Positives = 120/290 (41%), Gaps = 32/290 (11%)

Query: 38  ELARATDGFSDANLLGQGGFGYVHRGV-LPNGKE----VAIKQLK-AGSGQGEREFQAEV 91
            + + T+ F    +LG G FG V++G+ +P G++    VAIK+L+ A S +  +E   E 
Sbjct: 4   RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62

Query: 92  EIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGS 151
            +++ V + H+  L+G     +   L+ + +P   L  ++       +     L   +  
Sbjct: 63  YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQI 120

Query: 152 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTF 210
           AKG+ YL      +++HRD+ A N+L+      K+ DFGLAK + ++   + +       
Sbjct: 121 AKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE 270
            ++A E       T +SDV+S+GV + EL+T            E                
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------------- 221

Query: 271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
                ++++              +      C    A  RP+  +++    
Sbjct: 222 ---ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 5e-56
 Identities = 64/275 (23%), Positives = 112/275 (40%), Gaps = 29/275 (10%)

Query: 51  LLGQGGFGYVHRGVLPNGKE----VAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSL 105
            +G+G FG VH+G+  + +     VAIK  K  +    RE F  E   + +  H H+V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
           +G  T      ++ E      L        + ++D  + +  A   +  LAYL      +
Sbjct: 74  IGVITEN-PVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLES---KR 128

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
            +HRDI A N+L+      K+ DFGL++   D   + +++      ++APE  +  + T 
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188

Query: 226 KSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNE 285
            SDV+ FGV + E++             +          +   IE+G    +  P     
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNND----------VIGRIENGERLPM-PPNCPPT 237

Query: 286 YNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
                   + +    C  +   RRPR +++   L 
Sbjct: 238 --------LYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 1e-55
 Identities = 67/290 (23%), Positives = 116/290 (40%), Gaps = 43/290 (14%)

Query: 50  NLLGQGGFGYVHRGVLPNG---KEVAIKQLK-AGSGQGEREFQAEVEIISRV-HHKHLVS 104
           +++G+G FG V +  +       + AIK++K   S    R+F  E+E++ ++ HH ++++
Sbjct: 16  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGK--------------GRPTMDWLTRLKIALG 150
           L+G         L  E+ P+  L   L                    T+     L  A  
Sbjct: 76  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135

Query: 151 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTF 210
            A+G+ YL +    + IHRD+ A NIL+   + AK+ADFGL++          T      
Sbjct: 136 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPV 190

Query: 211 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE 270
            ++A E  +    T  SDV+S+GV+L E+++          +   +  +    L      
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEKLPQ---- 241

Query: 271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
                         E   N    +      C R     RP  +QI+ +L 
Sbjct: 242 ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-54
 Identities = 59/278 (21%), Positives = 105/278 (37%), Gaps = 27/278 (9%)

Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKH 101
           + +     LG+G +G V   V     + VA+K +         E  + E+ I   ++H++
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
           +V   G+   G+ + L  E+     L   +       M      +       G+ YLH  
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH-- 120

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAK-IASDVNTHVSTRVMGTFGYLAPEYASS 220
               I HRDIK  N+LLD +   K++DFGLA     +    +  ++ GT  Y+APE    
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 221 GKL-TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD 279
            +   E  DV+S G++L  ++ G  P D      +               ++        
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ----------EYSDWKEKKTYLNPW 229

Query: 280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
            K+ +          +A     +  +   R  +  I +
Sbjct: 230 KKIDSA--------PLALLHKILVENPSARITIPDIKK 259

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (459), Expect = 1e-54
 Identities = 60/269 (22%), Positives = 113/269 (42%), Gaps = 26/269 (9%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGY 108
             +GQG  G V+  + +  G+EVAI+Q+       +     E+ ++    + ++V+ +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
           Y  G +  +V E++   +L   +       MD      +     + L +LH +   ++IH
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN---QVIH 139

Query: 169 RDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 228
           RDIK+ NILL      K+ DFG     +   +  ST V GT  ++APE  +      K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198

Query: 229 VFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNH 288
           ++S G+M +E+I G  P      ++ ++ +      L     +G  +     KL      
Sbjct: 199 IWSLGIMAIEMIEGEPP------YLNENPLR----ALYLIATNGTPELQNPEKLSAI--- 245

Query: 289 NEMARMVACAAACVRHSARRRPRMSQIVR 317
                       C+     +R    ++++
Sbjct: 246 -----FRDFLNRCLDMDVEKRGSAKELLQ 269

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-54
 Identities = 63/278 (22%), Positives = 99/278 (35%), Gaps = 32/278 (11%)

Query: 52  LGQGGFGYVHRGVLP----NGKEVAIKQLK---AGSGQGEREFQAEVEIISRVHHKHLVS 104
           LG G FG V RG           VA+K LK       +   +F  EV  +  + H++L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           L G       +M V E  P  +L      K +      T  + A+  A+G+ YL      
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSL-LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---K 130

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH--VSTRVMGTFGYLAPEYASSGK 222
           + IHRD+ A N+LL  +   K+ DFGL +     + H  +       F + APE   +  
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190

Query: 223 LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL 282
            +  SD + FGV L E+ T  +       ++  +                    +     
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQI-------------LHKIDKEGE 232

Query: 283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
                 +    +      C  H    RP    +   L 
Sbjct: 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 7e-52
 Identities = 75/295 (25%), Positives = 114/295 (38%), Gaps = 45/295 (15%)

Query: 50  NLLGQGGFGYVHRGV------LPNGKEVAIKQLKAGSGQGE-REFQAEVEIISR-VHHKH 101
             LG+G FG V              + VA+K LK G+   E R   +E++I+    HH +
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 102 LVSLVGYYT-AGSQRMLVYEFVPNNTLEFHLHGKG--------------RPTMDWLTRLK 146
           +V+L+G  T  G   M++ EF     L  +L  K               +  +     + 
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 147 IALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV-STR 205
            +   AKG+ +L      K IHRD+ A NILL  K   K+ DFGLA+       +V    
Sbjct: 139 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 206 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLL 265
                 ++APE       T +SDV+SFGV+L E+ +            E+          
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---------F 246

Query: 266 NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
            R +++G      D              M      C      +RP  S++V  L 
Sbjct: 247 CRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 1e-51
 Identities = 68/301 (22%), Positives = 120/301 (39%), Gaps = 47/301 (15%)

Query: 50  NLLGQGGFGYVHRGVLP--------NGKEVAIKQLKAGSGQGE-REFQAEVEIISRV-HH 99
             LG+G FG V                 +VA+K LK+ + + +  +  +E+E++  +  H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRP--------------TMDWLTRL 145
           K++++L+G  T      ++ E+     L  +L  +  P               +     +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 146 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTR 205
             A   A+G+ YL      K IHRD+ A N+L+      K+ADFGLA+    ++ +  T 
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 206 VM-GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL 264
                  ++APE       T +SDV+SFGV+L E+ T            E          
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 245

Query: 265 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDAS 324
           L + +++G+           +   N    +      C      +RP   Q+V  L+   +
Sbjct: 246 LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296

Query: 325 L 325
           L
Sbjct: 297 L 297

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 4e-51
 Identities = 65/289 (22%), Positives = 117/289 (40%), Gaps = 38/289 (13%)

Query: 50  NLLGQGGFGYVHRGVLPN------GKEVAIKQLKAGSGQGER-EFQAEVEIISRVHHKHL 102
             LGQG FG V+ GV            VAIK +   +   ER EF  E  ++   +  H+
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 103 VSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGR--------PTMDWLTRLKIALGSAKG 154
           V L+G  + G   +++ E +    L+ +L                     +++A   A G
Sbjct: 86  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145

Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN-THVSTRVMGTFGYL 213
           +AYL      K +HRD+ A N ++   F  K+ DFG+ +   + +      + +    ++
Sbjct: 146 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202

Query: 214 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN 273
           +PE    G  T  SDV+SFGV+L E+ T         +  +          + R + +G 
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ----------VLRFVMEGG 252

Query: 274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD 322
                D         N    +      C +++ + RP   +I+ +++ +
Sbjct: 253 LLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  173 bits (439), Expect = 4e-51
 Identities = 60/268 (22%), Positives = 104/268 (38%), Gaps = 26/268 (9%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
            LG G FG VHR      G   A K +       +   + E++ +S + H  LV+L   +
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
              ++ +++YEF+    L   +  +    M     ++      KGL ++HE+     +H 
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN---YVHL 148

Query: 170 DIKAANILLDFKF--EAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS 227
           D+K  NI+   K   E K+ DFGL        +   T   GT  + APE A    +   +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYT 206

Query: 228 DVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYN 287
           D++S GV+   L++G  P      F  ++  +  R + +    D N D      +  +  
Sbjct: 207 DMWSVGVLSYILLSGLSP------FGGENDDETLRNVKS---CDWNMDDSAFSGISED-- 255

Query: 288 HNEMARMVACAAACVRHSARRRPRMSQI 315
                         +      R  + Q 
Sbjct: 256 ------GKDFIRKLLLADPNTRMTIHQA 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 1e-50
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 10/210 (4%)

Query: 41  RATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLK---AGSGQGEREFQAEVEIISR 96
           +  + F    +LG+G F  V     L   +E AIK L+               E +++SR
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 97  VHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLA 156
           + H   V L   +    +      +  N  L  ++   G               +A+ ++
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVS 119

Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS-DVNTHVSTRVMGTFGYLAP 215
            L       IIHRD+K  NILL+     ++ DFG AK+ S +     +   +GT  Y++P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

Query: 216 EYASSGKLTEKSDVFSFGVMLLELITGRRP 245
           E  +     + SD+++ G ++ +L+ G  P
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  168 bits (426), Expect = 3e-49
 Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 9/203 (4%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
            LG G FG VHR V    G+    K +       +   + E+ I++++HH  L++L   +
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
               + +L+ EF+    L   +  +    M     +     + +GL ++HE     I+H 
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE---HSIVHL 151

Query: 170 DIKAANILLDFKF--EAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS 227
           DIK  NI+ + K     K+ DFGLA   +     +      T  + APE      +   +
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVDREPVGFYT 209

Query: 228 DVFSFGVMLLELITGRRPVDSTH 250
           D+++ GV+   L++G  P     
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGED 232

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  162 bits (410), Expect = 1e-47
 Identities = 75/289 (25%), Positives = 127/289 (43%), Gaps = 33/289 (11%)

Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGE---REFQAEVEIISRVH 98
           +D +    +LG GG   VH    L   ++VA+K L+A   +       F+ E +  + ++
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 99  HKHLVSLVGYY----TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKG 154
           H  +V++         AG    +V E+V   TL   +H +G   M     +++   + + 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 123

Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV--STRVMGTFGY 212
           L + H+     IIHRD+K ANI++      KV DFG+A+  +D    V  +  V+GT  Y
Sbjct: 124 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDG 272
           L+PE A    +  +SDV+S G +L E++TG  P      F  DS V  A   +    ED 
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP------FTGDSPVSVAYQHVR---EDP 231

Query: 273 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR-MSQIVRALE 320
              +     L  +        + A     +  +   R +  +++   L 
Sbjct: 232 IPPSARHEGLSAD--------LDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (405), Expect = 1e-46
 Identities = 59/273 (21%), Positives = 109/273 (39%), Gaps = 29/273 (10%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHKHLVSLVG 107
           ++LG G F  V         K VAIK +   + +G+    + E+ ++ ++ H ++V+L  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
            Y +G    L+ + V    L   +  KG          ++       + YLH+     I+
Sbjct: 75  IYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLG---IV 129

Query: 168 HRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
           HRD+K  N+L     E     ++DFGL+K+       V +   GT GY+APE  +    +
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVLAQKPYS 187

Query: 225 EKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHN 284
           +  D +S GV+   L+ G  P      F +++       +L     +  FD+     + +
Sbjct: 188 KAVDCWSIGVIAYILLCGYPP------FYDENDAKLFEQILK---AEYEFDSPYWDDISD 238

Query: 285 EYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
                            +     +R    Q ++
Sbjct: 239 S--------AKDFIRHLMEKDPEKRFTCEQALQ 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  161 bits (408), Expect = 2e-46
 Identities = 60/212 (28%), Positives = 90/212 (42%), Gaps = 16/212 (7%)

Query: 44  DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLK---AGSGQGEREFQAEVEIISRVH- 98
           + FS   ++G+GGFG V+       GK  A+K L        QGE     E  ++S V  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 99  --HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLA 156
                +V +   +    +   + + +    L +HL   G            A     GL 
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLE 121

Query: 157 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE 216
           ++H      +++RD+K ANILLD     +++D GLA   S    H     +GT GY+APE
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPE 175

Query: 217 YASSGK-LTEKSDVFSFGVMLLELITGRRPVD 247
               G      +D FS G ML +L+ G  P  
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  159 bits (404), Expect = 2e-46
 Identities = 55/200 (27%), Positives = 83/200 (41%), Gaps = 13/200 (6%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLK---AGSGQGEREFQAEVEIISRVHHKHLVSL 105
             LG G FG VH      NG+  A+K LK       +       E  ++S V H  ++ +
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 106 VGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
            G +    Q  ++ +++    L   L    R            +        L       
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALEYLHSKD 124

Query: 166 IIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTE 225
           II+RD+K  NILLD     K+ DFG AK   DV       + GT  Y+APE  S+    +
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKPYNK 180

Query: 226 KSDVFSFGVMLLELITGRRP 245
             D +SFG+++ E++ G  P
Sbjct: 181 SIDWWSFGILIYEMLAGYTP 200

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 4e-46
 Identities = 49/270 (18%), Positives = 109/270 (40%), Gaps = 27/270 (10%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
            LG+G FG VHR V   + K    K +K   G  +   + E+ I++   H++++ L   +
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 110 TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHR 169
            +  + ++++EF+    +   ++      ++    +       + L +LH      I H 
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS---HNIGHF 126

Query: 170 DIKAANILLDFKFEA--KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS 227
           DI+  NI+   +  +  K+ +FG A+     +      +     Y APE      ++  +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 228 DVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYN 287
           D++S G ++  L++G  P      F+ ++       ++N    +  FD     ++  E  
Sbjct: 185 DMWSLGTLVYVLLSGINP------FLAETNQQIIENIMN---AEYTFDEEAFKEISIE-- 233

Query: 288 HNEMARMVACAAACVRHSARRRPRMSQIVR 317
                  +      +    + R   S+ ++
Sbjct: 234 ------AMDFVDRLLVKERKSRMTASEALQ 257

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  155 bits (393), Expect = 3e-45
 Identities = 60/289 (20%), Positives = 107/289 (37%), Gaps = 41/289 (14%)

Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSG---------QGEREFQAEVEI 93
           + +    +LG+G    V R +  P  KE A+K +    G         +       EV+I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 94  ISRVH-HKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSA 152
           + +V  H +++ L   Y   +   LV++ +    L  +L  K    +      KI     
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALL 120

Query: 153 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGY 212
           + +  LH+     I+HRD+K  NILLD     K+ DFG +             V GT  Y
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPSY 175

Query: 213 LAPEYASSG------KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN 266
           LAPE              ++ D++S GV++  L+ G  P      F     +   R +++
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP------FWHRKQMLMLRMIMS 229

Query: 267 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQI 315
               +  F +       +         +    +  +    ++R    + 
Sbjct: 230 ---GNYQFGSPEWDDYSDT--------VKDLVSRFLVVQPQKRYTAEEA 267

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 5e-45
 Identities = 62/298 (20%), Positives = 111/298 (37%), Gaps = 34/298 (11%)

Query: 41  RATDGFSDANLLGQGGFGYVHRG--VLPNGKEVAIKQLKAGSGQGEREFQAEVEI----- 93
           RA   +     +G+G +G V +   +   G+ VA+K+++  +G+         E+     
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 94  ISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLE----FHLHGKGRPTMDWLTRLKIAL 149
           +    H ++V L    T           +    ++     +L     P +   T   +  
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 150 GSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGT 209
              +GL +LH     +++HRD+K  NIL+    + K+ADFGLA+I S       T V+ T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVT 178

Query: 210 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAI 269
             Y APE           D++S G +  E+   +        F   S VD    +L+   
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL------FRGSSDVDQLGKILDVIG 232

Query: 270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSAR------------RRPRMSQI 315
             G  D   D  L  +  H++ A+ +      +    +            +R      
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 9e-45
 Identities = 42/205 (20%), Positives = 90/205 (43%), Gaps = 7/205 (3%)

Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHHK 100
           + F     +G+G +G V++      G+ VA+K+++    +         E+ ++  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHE 160
           ++V L+      ++  LV+EF+  +  +F +       +             +GLA+ H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKF-MDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 161 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS 220
                ++HRD+K  N+L++ +   K+ADFGLA+         +  V+  +          
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 221 GKLTEKSDVFSFGVMLLELITGRRP 245
              +   D++S G +  E++T R  
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRAL 202

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 4e-44
 Identities = 59/287 (20%), Positives = 111/287 (38%), Gaps = 25/287 (8%)

Query: 46  FSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVS 104
           ++D  ++G G FG V++  L  +G+ VAIK++     Q +R    E++I+ ++ H ++V 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77

Query: 105 LVGYYTAGSQRM------LVYEFVPNNTLEFHLH-GKGRPTMDWLTRLKIALGSAKGLAY 157
           L  ++ +  ++       LV ++VP        H  + + T+  +          + LAY
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 158 LHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPE 216
           +H      I HRDIK  N+LLD      K+ DFG AK          + +   +      
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSYICSRYYRAPEL 193

Query: 217 YASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTF--------VEDSLVDWARPLLNRA 268
              +   T   DV+S G +L EL+ G+                 V  +        +N  
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 269 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQI 315
             +  F  +        +        +A  +  + ++   R    + 
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  153 bits (386), Expect = 4e-44
 Identities = 48/278 (17%), Positives = 108/278 (38%), Gaps = 15/278 (5%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQLK--AGSGQGEREFQAEVEIISRVHHKHLVSLVG 107
             +G+G +G V++     G+  A+K+++              E+ I+  + H ++V L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 108 YYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKII 167
                 + +LV+E +  +  +     +G   ++ +T     L    G+AY H+    +++
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD---RRVL 122

Query: 168 HRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKS 227
           HRD+K  N+L++ + E K+ADFGLA+         +  ++  +         S K +   
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182

Query: 228 DVFSFGVMLLELITGRRPVDSTHTF--------VEDSLVDWARPLLNRAIEDGNFDTLVD 279
           D++S G +  E++ G                  +  +      P +    +     T+ +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242

Query: 280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
           P     +        +   +  ++    +R    Q + 
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (386), Expect = 6e-44
 Identities = 51/281 (18%), Positives = 94/281 (33%), Gaps = 31/281 (11%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYY 109
            +G G FG ++ G  +  G+EVAIK     +     +   E +I   +     +  + + 
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 110 -TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
              G   ++V E +  +  +       + ++     L +A      + Y+H       IH
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKT--VLLLADQMISRIEYIHS---KNFIH 126

Query: 169 RDIKAANIL---LDFKFEAKVADFGLAKIASDVNTHV------STRVMGTFGYLAPEYAS 219
           RD+K  N L           + DFGLAK   D  TH       +  + GT  Y +     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD 279
             + + + D+ S G +L+    G  P               A     +            
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQ----------GLKAATKRQKYERISEKKMSTP 236

Query: 280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
            ++  +   +E A  +     C       +P  S + +   
Sbjct: 237 IEVLCKGYPSEFATYLNF---CRSLRFDDKPDYSYLRQLFR 274

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 1e-43
 Identities = 57/201 (28%), Positives = 85/201 (42%), Gaps = 11/201 (5%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE---FQAEVEIISRV-HHKHLVS 104
            +LG+G FG V         +  AIK LK      + +      E  ++S    H  L  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 105 LVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           +   +        V E++    L +H+    +   D       A     GL +LH     
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHS---K 122

Query: 165 KIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLT 224
            I++RD+K  NILLD     K+ADFG+ K     +   +T   GT  Y+APE     K  
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKYN 181

Query: 225 EKSDVFSFGVMLLELITGRRP 245
              D +SFGV+L E++ G+ P
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSP 202

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 1e-43
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 13/203 (6%)

Query: 50  NLLGQGGFGYVHRGVLPN-GKEVAIKQLKAGSGQG-----EREFQAEVEIISRVHHKHLV 103
           + LG+G F  V++    N  + VAIK++K G          R    E++++  + H +++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 104 SLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCH 163
            L+  +   S   LV++F+  +            T          L + +GL YLH+   
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSH--IKAYMLMTLQGLEYLHQHW- 120

Query: 164 PKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL 223
             I+HRD+K  N+LLD     K+ADFGLAK          T  + T  Y APE     ++
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGARM 177

Query: 224 -TEKSDVFSFGVMLLELITGRRP 245
                D+++ G +L EL+     
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPF 200

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 2e-43
 Identities = 59/276 (21%), Positives = 107/276 (38%), Gaps = 32/276 (11%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGY 108
           +LG G  G V +       ++ A+K L+        + + EVE+  R     H+V +V  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73

Query: 109 Y----TAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHP 164
           Y          ++V E +    L   +  +G          +I     + + YLH     
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 130

Query: 165 KIIHRDIKAANILLDFKFE---AKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
            I HRD+K  N+L   K      K+ DFG AK  +  N+  +     T  Y+APE     
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPE 188

Query: 222 KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK 281
           K  +  D++S GV++  L+ G  P      F  +  +  +  +  R I  G ++    P 
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPP------FYSNHGLAISPGMKTR-IRMGQYEF---PN 238

Query: 282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
                   E+  ++      ++    +R  +++ + 
Sbjct: 239 PEWSEVSEEVKMLIRN---LLKTEPTQRMTITEFMN 271

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 1e-42
 Identities = 57/293 (19%), Positives = 114/293 (38%), Gaps = 23/293 (7%)

Query: 43  TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE-FQAEVEIISRVHHK 100
              +++ + +G+G +G V       N   VAIK++     Q   +    E++I+ R  H+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 101 HLVSLVGYYTAGSQRMLVYEFVPN---NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAY 157
           +++ +     A +   +   ++         + L       +             +GL Y
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKY 124

Query: 158 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS--TRVMGTFGYLAP 215
           +H      ++HRD+K +N+LL+   + K+ DFGLA++A   + H    T  + T  Y AP
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 216 EYASSGKL-TEKSDVFSFGVMLLELITGRRPVDSTH----------TFVEDSLVDWARPL 264
           E   + K  T+  D++S G +L E+++ R      H               S  D    +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241

Query: 265 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
             +A          +    N    N  ++ +      +  +  +R  + Q + 
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 2e-42
 Identities = 64/297 (21%), Positives = 114/297 (38%), Gaps = 38/297 (12%)

Query: 32  STFTYEELARATDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLK------AGSGQGE 84
           + F  E +    D +     LG G F  V +      G + A K +K      +  G   
Sbjct: 1   TVFRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 57

Query: 85  REFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTR 144
            + + EV I+  + H ++++L   Y   +  +L+ E V    L   L  K   T +  T 
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117

Query: 145 LKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD----FKFEAKVADFGLAKIASDVNT 200
                   + L  ++     +I H D+K  NI+L      K   K+ DFGLA      N 
Sbjct: 118 F-----LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172

Query: 201 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDW 260
                + GT  ++APE  +   L  ++D++S GV+   L++G  P      F+ D+  + 
Sbjct: 173 F--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP------FLGDTKQET 224

Query: 261 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR 317
              +             V+ +  +EY  N  A         +    ++R  +   ++
Sbjct: 225 LANVSA-----------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  147 bits (371), Expect = 7e-42
 Identities = 46/283 (16%), Positives = 87/283 (30%), Gaps = 33/283 (11%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGY 108
            +G+G FG +  G  L N ++VAIK           + + E      +     + ++  +
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH 168
              G   +LV + +  +  E  L   GR      T    A      +  +HE     +++
Sbjct: 70  GQEGLHNVLVIDLLGPSL-EDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHE---KSLVY 124

Query: 169 RDIKAANILLDFKFE-----AKVADFGLAKIASD------VNTHVSTRVMGTFGYLAPEY 217
           RDIK  N L+            V DFG+ K   D      +       + GT  Y++   
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 218 ASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL 277
               + + + D+ + G + +  + G  P               A     +    G     
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK----------AATNKQKYERIGEKKQS 234

Query: 278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE 320
              +        E  + +         +    P    +     
Sbjct: 235 TPLRELCAGFPEEFYKYMHY---ARNLAFDATPDYDYLQGLFS 274

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 1e-40
 Identities = 41/208 (19%), Positives = 84/208 (40%), Gaps = 8/208 (3%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSLV 106
             +G+G +G V +       + VA+K+++              E+ ++  + HK++V L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 107 GYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKI 166
               +  +  LV+EF   +  ++     G    + +          + L  L       +
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCHSRNV 122

Query: 167 IHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEK 226
           +HRD+K  N+L++   E K+A+FGLA+         S  V+  +         +   +  
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182

Query: 227 SDVFSFGVMLLELITGRRPVDSTHTFVE 254
            D++S G +  EL    RP+   +   +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDD 210

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-40
 Identities = 51/237 (21%), Positives = 93/237 (39%), Gaps = 24/237 (10%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE------FQAEVEIISRVHHKH-- 101
           LLG GGFG V+ G+ + +   VAIK ++        E         EV ++ +V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 102 LVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
           ++ L+ ++      +L+ E        F    +    +             + + + H  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHN- 128

Query: 162 CHPKIIHRDIKAANILLDF-KFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS 220
               ++HRDIK  NIL+D  + E K+ DFG   +  D    V T   GT  Y  PE+   
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIRY 183

Query: 221 GKL-TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV------DWARPLLNRAIE 270
            +     + V+S G++L +++ G  P +     +   +          + L+   + 
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 240

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 5e-40
 Identities = 52/206 (25%), Positives = 80/206 (38%), Gaps = 10/206 (4%)

Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLK---AGSGQGEREFQAEVEIISRVHH 99
           + F    LLG+G FG V        G+  A+K L+     +         E  ++    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
             L +L   +    +   V E+     L FHL  +   T +           A+ ++ L 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----GAEIVSALE 119

Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
                 +++RDIK  N++LD     K+ DFGL K              GT  YLAPE   
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLE 178

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRP 245
                   D +  GV++ E++ GR P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 3e-39
 Identities = 55/292 (18%), Positives = 107/292 (36%), Gaps = 31/292 (10%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQG--EREFQAEVEIISRVHHKHLVSLV 106
             +GQG FG V +      G++VA+K++   + +         E++I+  + H+++V+L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 107 GYYTAGSQRM--------LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYL 158
                 +           LV++F  ++      +   + T+  + R+   L     L  L
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-----LNGL 130

Query: 159 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT---HVSTRVMGTFGYLAP 215
           +     KI+HRD+KAAN+L+      K+ADFGLA+  S       +  T  + T  Y  P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

Query: 216 EYASSGKL-TEKSDVFSFGVMLLELITGRRPVDSTHTF-----VEDSLVDWARPLLNRAI 269
           E     +      D++  G ++ E+ T    +           +          +     
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250

Query: 270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAA------CVRHSARRRPRMSQI 315
               ++ L   K       + +   V    A       +     +R      
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 4e-38
 Identities = 50/228 (21%), Positives = 96/228 (42%), Gaps = 23/228 (10%)

Query: 31  KSTFTYEELARATDGFSDA----NLLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQG 83
           +S F  +E+ +              +G G +G V   V    G +VAIK+L     S   
Sbjct: 1   RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60

Query: 84  EREFQAEVEIISRVHHKHLVSLVGYYTAGSQR------MLVYEFVPNNTLEFHLHGKGRP 137
            +    E+ ++  + H++++ L+  +T            LV  F+  +  +   H K   
Sbjct: 61  AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--- 117

Query: 138 TMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD 197
            +       +     KGL Y+H        HRD+K  N+ ++   E K+ DFGLA+    
Sbjct: 118 -LGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQ--- 170

Query: 198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
            ++ ++  V+  +        +  + T+  D++S G ++ E+ITG+  
Sbjct: 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (342), Expect = 4e-37
 Identities = 56/206 (27%), Positives = 81/206 (39%), Gaps = 13/206 (6%)

Query: 44  DGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGERE---FQAEVEIISRVHH 99
           D F     LG G FG V       +G   A+K L        ++      E  I+  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
             LV L   +   S   +V E+V    +  HL   GR           A        YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158

Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYAS 219
                 +I+RD+K  N+L+D +   +V DFG AK         +  + GT   LAPE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIIL 211

Query: 220 SGKLTEKSDVFSFGVMLLELITGRRP 245
           S    +  D ++ GV++ E+  G  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 5e-36
 Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 16/207 (7%)

Query: 50  NLLGQGGFGYVHRGVL----PNGKEVAIKQLK----AGSGQGEREFQAEVEIISRV-HHK 100
            +LG G +G V           GK  A+K LK        +     + E +++  +    
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 101 HLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHE 160
            LV+L   +   ++  L+ +++    L  HL  + R T        + +   + +  L  
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEIVLALEH 144

Query: 161 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASS 220
                II+RDIK  NILLD      + DFGL+K      T  +    GT  Y+AP+    
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204

Query: 221 GK--LTEKSDVFSFGVMLLELITGRRP 245
           G     +  D +S GV++ EL+TG  P
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASP 231

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 4e-32
 Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 19/204 (9%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSLVG 107
            +G G  G V         + VAIK+L     +    +    E+ ++  V+HK+++SL+ 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 108 YYTA------GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED 161
            +T            LV E +  N  +          +D      +      G+ +LH  
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 138

Query: 162 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSG 221
                IHRD+K +NI++      K+ DFGLA+ A    + + T  + T  Y APE     
Sbjct: 139 GI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGM 193

Query: 222 KLTEKSDVFSFGVMLLELITGRRP 245
              E  D++S G ++ E++  +  
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKIL 217

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  119 bits (299), Expect = 3e-31
 Identities = 44/211 (20%), Positives = 88/211 (41%), Gaps = 19/211 (9%)

Query: 50  NLLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVG 107
             LG+G +  V   + + N ++V +K LK      +++ + E++I+  +    ++++L  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 97

Query: 108 YYTAGSQRM--LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK 165
                  R   LV+E V N   +         T+             K L Y H      
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS---MG 149

Query: 166 IIHRDIKAANILLDFKF-EAKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKL- 223
           I+HRD+K  N+++D +  + ++ D+GLA+       +     + +  +  PE     ++ 
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMY 207

Query: 224 TEKSDVFSFGVMLLELITGRRPVDSTHTFVE 254
               D++S G ML  +I  + P    H   +
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 7e-31
 Identities = 43/226 (19%), Positives = 91/226 (40%), Gaps = 19/226 (8%)

Query: 31  KSTFTYEELARA----TDGFSDANLLGQGGFGYVHRGV-LPNGKEVAIKQLKAG--SGQG 83
           + TF  +EL +      + + + + +G G +G V        G  VA+K+L     S   
Sbjct: 1   RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 60

Query: 84  EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM----LVYEFVPNNTLEFHLHGKGRPTM 139
            +    E+ ++  + H++++ L+  +T          +            ++    +  +
Sbjct: 61  AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--L 118

Query: 140 DWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
                  +     +GL Y+H        HRD+K +N+ ++   E K+ DFGLA+     +
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARH---TD 172

Query: 200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 245
             ++  V   +        +     +  D++S G ++ EL+TGR  
Sbjct: 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  116 bits (291), Expect = 8e-30
 Identities = 47/228 (20%), Positives = 87/228 (38%), Gaps = 22/228 (9%)

Query: 51  LLGQGGFGYVHRGV-LPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHH---------- 99
            LG G F  V     + N   VA+K ++      E   + E++++ RV+           
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMG 78

Query: 100 -KHLVSLVGYYTA----GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKG 154
             H++ L+ ++      G   ++V+E +  N L      + R  +  +   +I+     G
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG-IPLIYVKQISKQLLLG 137

Query: 155 LAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAKIASDVNTHVSTR-VMGTFGY 212
           L Y+H      IIH DIK  N+L++       +    +A + +           + T  Y
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 213 LAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDW 260
            +PE          +D++S   ++ ELITG    +           D 
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 91.0 bits (225), Expect = 4e-22
 Identities = 27/160 (16%), Positives = 49/160 (30%), Gaps = 19/160 (11%)

Query: 50  NLLGQGGFGYVHRGVLPNGKEVAIKQLKAGS----------GQGEREFQAEVEIISRVHH 99
            L+G+G    V         E  +K  K G             G+  F       +R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 100 KHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLH 159
           + L  L G          VY +  N  L   +  K    +      ++     + +A  +
Sbjct: 66  RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 160 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN 199
                 I+H D+   N+L+  +    + DF  +    +  
Sbjct: 121 HRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG 156

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	416
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.76
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.32
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.7
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.63
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.89
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.81

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-54  Score=407.62  Aligned_cols=254  Identities=30%  Similarity=0.464  Sum_probs=201.0

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      ++|.+.+.||+|+||.||+|.+.+++.||||+++... ...++|.+|+.++++++|||||+++++|......++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5788899999999999999999888999999998644 446789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      +++|.+++.... ..++|..++.|+.|+|.||.|||+.   +|+||||||+||||+.++.+||+|||+++..........
T Consensus        84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~  159 (263)
T d1sm2a_          84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  159 (263)
T ss_dssp             TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence            999999987654 3689999999999999999999999   999999999999999999999999999987766555444


Q ss_pred             ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCC-CCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRR-PVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~-pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      ....||+.|+|||++.+..++.++|||||||+||||+|+.. ||.....   ..+..        .+..+.  ....|  
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~--------~i~~~~--~~~~p--  224 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVE--------DISTGF--RLYKP--  224 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHH--------HHHHTC--CCCCC--
T ss_pred             cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHH--------HHHhcC--CCCCc--
Confidence            55679999999999999999999999999999999999544 4443221   11111        112221  11111  


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                           ..+...+.+++.+||+.+|++||+|.||++.|+..
T Consensus       225 -----~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         225 -----RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                 22345789999999999999999999999999853

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-54  Score=408.88  Aligned_cols=255  Identities=29%  Similarity=0.423  Sum_probs=212.0

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      .++|++.+.||+|+||.||+|.+.+++.||||+++... ...+.|.+|+.++++++|||||++++++.+ ...++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            46788899999999999999999888999999997654 445689999999999999999999998865 5678999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++|+|.+++.......++|..++.|+.|+++||.|||+.   +|+||||||+||||+.++.+||+|||+++.........
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~  166 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA  166 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence            999999988765545699999999999999999999998   99999999999999999999999999999876655544


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      .....||+.|+|||++.++.++.++|||||||+||||+||..|+.....  ...+.        ..+..+..     +. 
T Consensus       167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~--------~~i~~~~~-----~~-  230 (272)
T d1qpca_         167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVI--------QNLERGYR-----MV-  230 (272)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHH--------HHHHTTCC-----CC-
T ss_pred             ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHH--------HHHHhcCC-----CC-
Confidence            5557799999999999999999999999999999999996665443222  11111        11222211     11 


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                         .+...+..+.+++.+||+.+|++||||.||++.|+.
T Consensus       231 ---~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         231 ---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence               112234578999999999999999999999999974

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-54  Score=412.80  Aligned_cols=257  Identities=26%  Similarity=0.352  Sum_probs=217.0

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||+++... ...++|.+|+.++++++|||||+++++|.++...++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            467888999999999999999965 58899999997654 4456899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +++|+|..++.......+++..++.|+.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++........
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~  171 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  171 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence            9999999999876666899999999999999999999999   9999999999999999999999999999987665555


Q ss_pred             eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          202 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                      ......||+.|+|||++.++.++.++|||||||++|||++|..|+.....  ...+.        +.+..+.        
T Consensus       172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~--------~~i~~~~--------  233 (287)
T d1opja_         172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVY--------ELLEKDY--------  233 (287)
T ss_dssp             EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHH--------HHHHTTC--------
T ss_pred             eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHH--------HHHhcCC--------
Confidence            55556789999999999999999999999999999999997777644322  11111        1122221        


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                       ....+...+..+.+|+.+||+.+|++||+|.||++.|+..
T Consensus       234 -~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         234 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             -CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             1112223445789999999999999999999999999754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.2e-54  Score=412.42  Aligned_cols=267  Identities=29%  Similarity=0.473  Sum_probs=206.6

Q ss_pred             cccCHHHHHHhhCCCC---------cCceecccCcEEEEEEEeC-CCc---EEEEEEeecCCc-ccHHHHHHHHHHHHhc
Q 014904           32 STFTYEELARATDGFS---------DANLLGQGGFGYVHRGVLP-NGK---EVAIKQLKAGSG-QGEREFQAEVEIISRV   97 (416)
Q Consensus        32 ~~f~~~el~~~t~~f~---------~~~~LG~G~~g~Vy~~~~~-~g~---~vavK~l~~~~~-~~~~~~~~E~~~l~~l   97 (416)
                      ..|||+++..++.+|.         +.++||+|+||+||+|.+. +++   .||||++..... ...++|.+|+.+++++
T Consensus         5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l   84 (299)
T d1jpaa_           5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF   84 (299)
T ss_dssp             CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred             CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence            3578888888876654         4578999999999999964 332   588998875433 3346799999999999


Q ss_pred             CCCcccceEEEEEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEE
Q 014904           98 HHKHLVSLVGYYTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANIL  177 (416)
Q Consensus        98 ~h~niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NIL  177 (416)
                      +|||||+++++|.+....++||||+++++|.+++..... .++|..++.|+.|+|+||.|||+.   +|+||||||+|||
T Consensus        85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NIL  160 (299)
T d1jpaa_          85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNIL  160 (299)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred             CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEE
Confidence            999999999999999999999999999999998876443 699999999999999999999998   9999999999999


Q ss_pred             ECCCCceEEeecccceeccCCCcce----eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcc
Q 014904          178 LDFKFEAKVADFGLAKIASDVNTHV----STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF  252 (416)
Q Consensus       178 l~~~~~~kl~DFGla~~~~~~~~~~----~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~  252 (416)
                      |+.++.+||+|||+++.........    .....||+.|+|||++.++.++.++|||||||+||||+| |+.||..... 
T Consensus       161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-  239 (299)
T d1jpaa_         161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-  239 (299)
T ss_dssp             ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred             ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-
Confidence            9999999999999998765433221    122467999999999999999999999999999999998 8999976443 


Q ss_pred             cchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          253 VEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       253 ~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                        ..+.        ..+..+..         ...+.+.+..+.+++.+||+.+|++||+|.||++.|+..
T Consensus       240 --~~~~--------~~i~~~~~---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         240 --QDVI--------NAIEQDYR---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             --HHHH--------HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --HHHH--------HHHHcCCC---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              1111        11222211         112223456789999999999999999999999999854

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-52  Score=395.97  Aligned_cols=258  Identities=29%  Similarity=0.495  Sum_probs=204.2

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecC--CcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAG--SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .++|.+.+.||+|+||.||+|.+.  ..||||+++..  .....+.|.+|+.++++++|||||++++++.+ ...++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            468999999999999999999864  36999999754  33445689999999999999999999999865 56899999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|.+++..... .+++..++.|+.|+|+||+|||+.   +||||||||+||||+.++.+||+|||+++.......
T Consensus        84 y~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          84 WCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             CCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             cCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            9999999999975543 699999999999999999999999   999999999999999999999999999987654332


Q ss_pred             -ceeecccccccccChhhhcc---CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          201 -HVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       201 -~~~~~~~gt~~YlaPE~~~~---~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                       .......||+.|+|||++.+   +.++.++|||||||+||||+||+.||.......  .+        ...+..+... 
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~--------~~~~~~~~~~-  228 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QI--------IFMVGRGYLS-  228 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HH--------HHHHHHTSCC-
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HH--------HHHHhcCCCC-
Confidence             33355789999999999864   458999999999999999999999997654311  11        1111222111 


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                         |.+ ...+.+++..+.+++.+||+.+|.+||||.||++.|+..
T Consensus       229 ---p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         229 ---PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             ---CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               111 112233446789999999999999999999999999843

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=394.01  Aligned_cols=253  Identities=26%  Similarity=0.407  Sum_probs=215.8

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecC
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVP  123 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  123 (416)
                      ++|.+.++||+|+||+||+|.+.+++.||||+++... ...++|++|+.++++++||||++++++|.+....++||||+.
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            6899999999999999999999888899999998654 345789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee
Q 014904          124 NNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS  203 (416)
Q Consensus       124 ~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  203 (416)
                      +|+|..++..... .+++..+++|+.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++..........
T Consensus        83 ~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  158 (258)
T d1k2pa_          83 NGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS  158 (258)
T ss_dssp             TEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred             CCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence            9999998765443 689999999999999999999999   999999999999999999999999999987665555444


Q ss_pred             ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          204 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       204 ~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      ....||+.|+|||++.++.++.|+|||||||++|||+| |+.||......   .+        ...+..+.  .+..|  
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~--------~~~i~~~~--~~~~p--  223 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ET--------AEHIAQGL--RLYRP--  223 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HH--------HHHHHTTC--CCCCC--
T ss_pred             cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HH--------HHHHHhCC--CCCCc--
Confidence            55679999999999999999999999999999999998 89999765431   11        11222222  11112  


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                           ......+.+++.+||+.+|++||++.||++.|.+
T Consensus       224 -----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         224 -----HLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -----ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                 2233578999999999999999999999999853

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=393.48  Aligned_cols=249  Identities=23%  Similarity=0.384  Sum_probs=210.3

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      ++|.+.+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4799999999999999999995 579999999998766566678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++++|.+++...   .+++..+..++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++....... .
T Consensus       100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  172 (293)
T ss_dssp             TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred             CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence            999999988654   589999999999999999999999   999999999999999999999999999987754333 2


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      .....||+.|+|||++.++.++.++|||||||++|||++|+.||......  ..+        ......+.. .+     
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~--------~~~~~~~~~-~~-----  236 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RAL--------YLIATNGTP-EL-----  236 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHH--------HHHHHHCSC-CC-----
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--HHH--------HHHHhCCCC-CC-----
Confidence            34567999999999999999999999999999999999999999764431  111        111112211 11     


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                        ..+......+.+++.+||+.||.+||++.|+++
T Consensus       237 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             --SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              111223457889999999999999999999875

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=397.18  Aligned_cols=252  Identities=24%  Similarity=0.352  Sum_probs=204.4

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++..... ...+.+.+|+.++++++|||||++++++.+....+||||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            46799999999999999999996 4689999999976532 234568999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++.......
T Consensus        84 y~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          84 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             ccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            999999999986543  699999999999999999999999   999999999999999999999999999987654332


Q ss_pred             -ceeecccccccccChhhhccCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          201 -HVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       201 -~~~~~~~gt~~YlaPE~~~~~~~-t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                       ...+..+||+.|+|||++.+..+ +.++|||||||+||||++|+.||....... ..+..+         .......  
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~~~---------~~~~~~~--  226 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW---------KEKKTYL--  226 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-HHHHHH---------HTTCTTS--
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-HHHHHH---------hcCCCCC--
Confidence             23455789999999999988775 678999999999999999999997654311 111111         1111000  


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                            .........+.+++.+||+.||++||++.||++
T Consensus       227 ------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 ------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  001122356788999999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=389.28  Aligned_cols=245  Identities=27%  Similarity=0.430  Sum_probs=206.9

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecC---CcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAG---SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.+.||+|+||.||+|... +++.||||++...   .......+.+|+.++++++|||||++++++.+....++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57899999999999999999964 6899999998643   2233567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++....  .+++..+..++.|++.||+|||+.   +|+||||||+||||+.++.+||+|||+++......
T Consensus        86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            9999999999997544  599999999999999999999999   99999999999999999999999999998665432


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                         .....||+.|+|||++.+..++.++|||||||+||||++|+.||......   .+        ...+..+.+     
T Consensus       161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~--------~~~i~~~~~-----  221 (263)
T d2j4za1         161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ET--------YKRISRVEF-----  221 (263)
T ss_dssp             ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HH--------HHHHHTTCC-----
T ss_pred             ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HH--------HHHHHcCCC-----
Confidence               23467999999999999999999999999999999999999999764431   11        111122221     


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                       .    ++......+.+++.+||+.||.+|||+.||++
T Consensus       222 -~----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 -T----FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -C----CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence             1    11223357889999999999999999999985

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=399.26  Aligned_cols=257  Identities=29%  Similarity=0.408  Sum_probs=206.3

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      .++|++.+.||+|+||.||+|.+.+++.||||+++... ...+.|.+|+.++++++|+|||+++++|.+ ...++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            46899999999999999999999888899999997544 456789999999999999999999999855 5678999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++|+|..++.......++|..++.|+.|++.||+|||+.   +|+||||||+||||+.++.+||+|||+++.........
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence            999999988765545699999999999999999999999   99999999999999999999999999998776544444


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCccc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKL  282 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l  282 (416)
                      .....||+.|+|||++..+.++.++|||||||+||||++|..|+.....  ...+..+        +..+..        
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~--------i~~~~~--------  232 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQ--------VERGYR--------  232 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHH--------HHTTCC--------
T ss_pred             eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHH--------HHhcCC--------
Confidence            4556799999999999999999999999999999999997766544332  1112111        111211        


Q ss_pred             cCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          283 HNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                       ...+....+.+.+++.+||+.+|++||+|.+|+++|+...
T Consensus       233 -~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         233 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             -CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence             1122233457899999999999999999999999998644

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=392.15  Aligned_cols=253  Identities=28%  Similarity=0.422  Sum_probs=207.9

Q ss_pred             CCCCcCce-ecccCcEEEEEEEeC---CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           44 DGFSDANL-LGQGGFGYVHRGVLP---NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        44 ~~f~~~~~-LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ++|.+.+. ||+|+||.||+|.+.   ++..||||+++.... ...++|.+|+.++++++|||||+++++|.. +..+||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            56667774 999999999999853   355799999976543 334679999999999999999999999975 568999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+++|+|.+++.... ..+++..++.|+.|++.||+|||+.   +|+||||||+||||+.++.+||+|||+++.....
T Consensus        87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            99999999999886543 3699999999999999999999999   9999999999999999999999999999977654


Q ss_pred             Ccce--eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          199 NTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       199 ~~~~--~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ....  .....||+.|+|||++.++.++.++|||||||++|||+| |+.||.....   ..+        ...+..|...
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~--------~~~i~~~~~~  231 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEV--------MAFIEQGKRM  231 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHH--------HHHHHTTCCC
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHH--------HHHHHcCCCC
Confidence            3322  234568999999999999999999999999999999998 9999976443   111        1222333211


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                               ..+...+..+.+++.+||+.+|++||+|.+|++.|+.
T Consensus       232 ---------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         232 ---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             ---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                     1222344678899999999999999999999999974

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-52  Score=396.35  Aligned_cols=257  Identities=28%  Similarity=0.431  Sum_probs=201.8

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCC-----cEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNG-----KEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g-----~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      ..|+..++||+|+||.||+|.+...     ..||||++...... ...+|.+|+.++++++|||||+++++|.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            5688889999999999999996532     37999999765433 33578999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+.++++.+++..... .++|..++.++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++....
T Consensus        87 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEecccCcchhhhhcccc-cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            9999999999988765443 699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCc--ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          198 VNT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       198 ~~~--~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ...  .......||+.|+|||++.++.++.++|||||||+||||++|..|+.....  ...+.        ..+..+.  
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~--------~~i~~~~--  230 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVM--------KAINDGF--  230 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHH--------HHHHTTC--
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHH--------HHHhccC--
Confidence            322  222345689999999999999999999999999999999997666543322  11111        1122221  


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                             ....+.+.+..+.+++.+||+.+|++||+|.||++.|+...
T Consensus       231 -------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         231 -------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             -------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence                   11222234567899999999999999999999999998643

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=393.58  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=207.9

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      +.|++.+.||+|+||.||+|.+ .+|+.||||++........+.+.+|+.++++++|||||++++++.+....++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4689999999999999999995 478999999998766666678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++++|..++....+ .+++..+..++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++....... .
T Consensus        92 ~~g~L~~~~~~~~~-~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~  166 (288)
T d2jfla1          92 AGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R  166 (288)
T ss_dssp             TTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-H
T ss_pred             CCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-c
Confidence            99999998765432 699999999999999999999999   999999999999999999999999999976543221 2


Q ss_pred             eecccccccccChhhhc-----cCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          203 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~-----~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                      .....||+.|+|||++.     ...++.++|||||||+||||+||+.||.......  .+        .. +..+....+
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~--------~~-i~~~~~~~~  235 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VL--------LK-IAKSEPPTL  235 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HH--------HH-HHHSCCCCC
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HH--------HH-HHcCCCCCC
Confidence            23467999999999984     4568999999999999999999999997654311  11        11 112222221


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..       +......+.+|+.+||+.||.+|||+.|+++
T Consensus       236 ~~-------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         236 AQ-------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             SS-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             Cc-------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11       1223457889999999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=391.49  Aligned_cols=253  Identities=23%  Similarity=0.364  Sum_probs=195.6

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEe--CCeEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTA--GSQRMLV  118 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV  118 (416)
                      ++|.+.+.||+|+||.||+|.. .+|+.||||++......  ..+.+.+|+.++++++|||||++++++.+  ....++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            6799999999999999999995 57899999999765432  23568899999999999999999999865  4568999


Q ss_pred             EEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          119 YEFVPNNTLEFHLHGK--GRPTMDWLTRLKIALGSAKGLAYLHEDC--HPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      |||+++++|.+++...  .+..+++..++.++.|++.||.|||+..  ..+||||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998642  2347999999999999999999999872  12499999999999999999999999999987


Q ss_pred             ccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          195 ASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       195 ~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....   ..+        ...+..+.+
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~--------~~~i~~~~~  231 (269)
T d2java1         164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KEL--------AGKIREGKF  231 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH--------HHHHHHTCC
T ss_pred             cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHH--------HHHHHcCCC
Confidence            654322 33457899999999999999999999999999999999999999976432   111        112233433


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..+     ...    ....+.+++.+||+.||.+||++.||++
T Consensus       232 ~~~-----~~~----~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 RRI-----PYR----YSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CCC-----CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC-----Ccc----cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            221     122    2347889999999999999999999974

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=401.82  Aligned_cols=255  Identities=25%  Similarity=0.402  Sum_probs=207.8

Q ss_pred             CCCCcCceecccCcEEEEEEEeCC-C-----cEEEEEEeecCC-cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPN-G-----KEVAIKQLKAGS-GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~-g-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  115 (416)
                      ++|.+.++||+|+||.||+|.+.. +     ..||||++.... ......+.+|+.++.++ +|||||+++++|.+....
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            678899999999999999999542 2     369999986543 23335789999999998 899999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCC
Q 014904          116 MLVYEFVPNNTLEFHLHGKGR---------------------PTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAA  174 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~  174 (416)
                      ++||||+++|+|.++|+....                     ..+++..++.|+.|+++||+|||+.   +||||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence            999999999999999975432                     3589999999999999999999999   9999999999


Q ss_pred             cEEECCCCceEEeecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcc
Q 014904          175 NILLDFKFEAKVADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTF  252 (416)
Q Consensus       175 NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~  252 (416)
                      |||++.++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||+||||+| |+.||......
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999876554433 2345678999999999999999999999999999999998 89999764431


Q ss_pred             cchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhc
Q 014904          253 VEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALE  320 (416)
Q Consensus       253 ~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~  320 (416)
                        ..+.        +.+..+.         ....+...+..+.+|+.+||+.+|++||||.||++.|.
T Consensus       274 --~~~~--------~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 --ANFY--------KLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             --HHHH--------HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --HHHH--------HHHhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence              1111        1122221         11122233457899999999999999999999999985

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-51  Score=389.20  Aligned_cols=246  Identities=27%  Similarity=0.392  Sum_probs=199.9

Q ss_pred             ceecccCcEEEEEEEeC---CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEecCC
Q 014904           50 NLLGQGGFGYVHRGVLP---NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFVPN  124 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  124 (416)
                      ++||+|+||.||+|.+.   .++.||||+++....  ...++|.+|+.++++++|||||+++++|.. ...+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            47999999999999854   356899999975432  234679999999999999999999999965 457899999999


Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCccee-
Q 014904          125 NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHVS-  203 (416)
Q Consensus       125 ~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-  203 (416)
                      |+|.+++....  .+++..++.|+.|++.||+|||+.   +|+||||||+||||+.++.+||+|||+++.......... 
T Consensus        92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            99999997654  599999999999999999999999   999999999999999999999999999987655433322 


Q ss_pred             -ecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          204 -TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       204 -~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                       ....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.....   ..+        ...+..+...      
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~--------~~~i~~~~~~------  229 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEV--------TAMLEKGERM------  229 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHH--------HHHHHTTCCC------
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHH--------HHHHHcCCCC------
Confidence             34578999999999999999999999999999999998 8999976442   111        1122233211      


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                         ..+...+..+.+++.+||+.+|++||+|.+|++.|+.
T Consensus       230 ---~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         230 ---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ---CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence               1222334578899999999999999999999998864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.4e-50  Score=392.76  Aligned_cols=253  Identities=23%  Similarity=0.330  Sum_probs=210.5

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++|||||++++++.+....++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46899999999999999999995 57999999999876655567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC--CCceEEeecccceeccCCC
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF--KFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~--~~~~kl~DFGla~~~~~~~  199 (416)
                      +++++|.+++..... .+++..+..|+.|++.||.|||+.   +||||||||+||||+.  ++.+||+|||+++......
T Consensus       105 ~~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         105 MSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CCSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            999999999865433 599999999999999999999999   9999999999999954  5789999999998776543


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                      .  .....||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+       + ..+..+...  ..
T Consensus       181 ~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~-------~-~~i~~~~~~--~~  245 (350)
T d1koaa2         181 S--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ET-------L-RNVKSCDWN--MD  245 (350)
T ss_dssp             C--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH-------H-HHHHHTCCC--SC
T ss_pred             c--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HH-------H-HHHHhCCCC--CC
Confidence            3  34467999999999999999999999999999999999999999764321   11       1 111122211  01


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      +.    ........+.+|+.+||+.||++|||+.|+++.
T Consensus       246 ~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         246 DS----AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CG----GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             cc----cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11    111223578899999999999999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=393.65  Aligned_cols=202  Identities=27%  Similarity=0.445  Sum_probs=179.0

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ..++|.+.++||+|+||+||+|.. .+|+.||||+++.... .....+.+|+.++++++|||||+++++|.+..+.++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            357899999999999999999995 5789999999976533 33467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++...+  .+++..+..++.|++.||.|||+.+  +|+||||||+||||+.++.+||+|||+|+...+. 
T Consensus        84 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             ECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            9999999999997654  5899999999999999999999732  8999999999999999999999999999865432 


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTH  250 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~  250 (416)
                        ..+..+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence              2234689999999999999999999999999999999999999997654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=383.76  Aligned_cols=246  Identities=25%  Similarity=0.401  Sum_probs=197.4

Q ss_pred             CC-CcCceecccCcEEEEEEEeC-CCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEe----CCeEE
Q 014904           45 GF-SDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTA----GSQRM  116 (416)
Q Consensus        45 ~f-~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  116 (416)
                      +| +..+.||+|+||+||+|.+. +++.||+|++....  ....+.|.+|++++++++|||||++++++.+    ....+
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            44 55668999999999999964 68899999987543  2334578999999999999999999999875    34679


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeecccCCcEEEC-CCCceEEeecccce
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPK--IIHRDIKAANILLD-FKFEAKVADFGLAK  193 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--iiHrDIkp~NILl~-~~~~~kl~DFGla~  193 (416)
                      +||||+++++|.+++....  .+++..++.++.|+++||+|||+.   +  |+||||||+||||+ .++.+||+|||+++
T Consensus        89 ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            9999999999999997643  589999999999999999999998   6  99999999999996 57899999999998


Q ss_pred             eccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          194 IASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       194 ~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      .....   ......||+.|+|||++.+ +++.++|||||||+||||++|+.||......  ..+        .+.+..+.
T Consensus       164 ~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~--------~~~i~~~~  229 (270)
T d1t4ha_         164 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQI--------YRRVTSGV  229 (270)
T ss_dssp             GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHH--------HHHHTTTC
T ss_pred             eccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHH--------HHHHHcCC
Confidence            65432   2234689999999998864 6999999999999999999999999754321  111        11122222


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ...    .+...    ....+.+++.+||+.+|++|||+.|+++
T Consensus       230 ~~~----~~~~~----~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         230 KPA----SFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CCG----GGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCc----ccCcc----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            111    11111    2346889999999999999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=388.16  Aligned_cols=248  Identities=23%  Similarity=0.349  Sum_probs=204.8

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.++||+|+||+||+|.. .+|+.||||++....   ......+.+|+.++++++||||+++++++.+....++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999996 579999999987432   233467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+++++|.+++...+  .+++..+..++.|++.||+|||+.   +|+||||||+||||+.++.+||+|||+++......
T Consensus        88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            9999999999887654  599999999999999999999999   99999999999999999999999999999775433


Q ss_pred             -cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          200 -THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       200 -~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                       ........||+.|+|||++.+..++.++|||||||+||||++|+.||......   .        +...+..+.+.   
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~--------~~~~i~~~~~~---  228 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---L--------IFQKIIKLEYD---  228 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---H--------HHHHHHTTCCC---
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---H--------HHHHHHcCCCC---
Confidence             22334568999999999999999999999999999999999999999865431   1        11112223221   


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                         +..    .....+.+|+.+||+.||.+|||+.|++.
T Consensus       229 ---~p~----~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         229 ---FPE----KFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ---CCT----TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ---CCc----cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence               112    22346889999999999999999999753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-50  Score=387.61  Aligned_cols=253  Identities=23%  Similarity=0.355  Sum_probs=193.2

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ..+.|.+.++||+|+||+||+|... +|+.||||++...... ....+.+|+.++++++|||||++++++.++...+|||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4577999999999999999999964 6899999999765432 2346789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC---CCCceEEeecccceecc
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD---FKFEAKVADFGLAKIAS  196 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~---~~~~~kl~DFGla~~~~  196 (416)
                      ||+++++|.+++...+  .+++..+..++.|++.||+|||+.   +|+||||||+|||+.   .++.+||+|||+++...
T Consensus        87 E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          87 QLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             eccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999999997654  599999999999999999999999   999999999999994   57889999999998765


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          197 DVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       197 ~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      ...  .....+||+.|+|||++.+..++.++|||||||+||||++|+.||.....   ..+.        ..+..+... 
T Consensus       162 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~--------~~i~~~~~~-  227 (307)
T d1a06a_         162 PGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKLF--------EQILKAEYE-  227 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH--------HHHHTTCCC-
T ss_pred             CCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---HHHH--------HHHhccCCC-
Confidence            432  22346799999999999999999999999999999999999999976442   1111        111222211 


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                           ............+.+++.+||+.||.+||++.|+++.
T Consensus       228 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         228 -----FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             -----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -----CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                 1111112234578999999999999999999999863

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1e-49  Score=391.60  Aligned_cols=253  Identities=21%  Similarity=0.340  Sum_probs=211.6

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      .++|++.+.||+|+||.||+|.. .+|+.||||+++.........+.+|+.++++++|||||++++++.+....+|||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46799999999999999999995 57999999999876655566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC--CCCceEEeecccceeccCCC
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD--FKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~--~~~~~kl~DFGla~~~~~~~  199 (416)
                      +++++|.+++..... .+++..++.|+.|++.||.|||+.   +|+||||||+||||+  .++.+||+|||+++......
T Consensus       108 ~~gg~L~~~~~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         108 LSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCCBHHHHTTCTTC-CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCCChHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            999999988765443 599999999999999999999999   999999999999998  57899999999998876533


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                        ......||+.|+|||++.+..++.++|||||||+||||+||+.||......   .+       + ..+..+.+.    
T Consensus       184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~-------~-~~i~~~~~~----  246 (352)
T d1koba_         184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ET-------L-QNVKRCDWE----  246 (352)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH-------H-HHHHHCCCC----
T ss_pred             --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HH-------H-HHHHhCCCC----
Confidence              234567999999999999999999999999999999999999999765431   11       1 112222221    


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                        ............+.+|+.+||+.||.+||++.|+++.
T Consensus       247 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         247 --FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             --CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             --CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              1111222334578899999999999999999999863

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-50  Score=390.31  Aligned_cols=244  Identities=27%  Similarity=0.418  Sum_probs=201.9

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccH---HHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGE---REFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .|+..+.||+|+||.||+|.. .+|+.||||++........   +.+.+|+.++++++|||||++++++.+....++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            489999999999999999995 5789999999986543332   468899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+.+++|..++....  .+++..++.++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++.....  
T Consensus        96 ~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--  168 (309)
T d1u5ra_          96 YCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (309)
T ss_dssp             CCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence            999999987665443  699999999999999999999999   9999999999999999999999999999865432  


Q ss_pred             ceeecccccccccChhhhcc---CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccc
Q 014904          201 HVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTL  277 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~---~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  277 (416)
                         ....||+.|+|||++.+   +.++.++|||||||++|||++|+.||......  .        .+.. +..+....+
T Consensus       169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--~--------~~~~-i~~~~~~~~  234 (309)
T d1u5ra_         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--S--------ALYH-IAQNESPAL  234 (309)
T ss_dssp             ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--H--------HHHH-HHHSCCCCC
T ss_pred             ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--H--------HHHH-HHhCCCCCC
Confidence               33579999999999854   46899999999999999999999999754321  1        1111 112222111


Q ss_pred             cCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          278 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       278 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..    .    .....+.+|+.+||+.||.+|||+.|+++
T Consensus       235 ~~----~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         235 QS----G----HWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             SC----T----TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC----C----CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            11    1    22357889999999999999999999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-50  Score=388.44  Aligned_cols=254  Identities=25%  Similarity=0.399  Sum_probs=202.8

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCc----EEEEEEeecC-CcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGK----EVAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      .+|++.++||+|+||+||+|.+. +|+    .||||+++.. .....++|.+|+.++++++|||||+++++|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999954 454    5899988653 344567899999999999999999999999875 5678


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      |+|++.+++|.+++..... .+++..++.|+.|+|.||+|||+.   +||||||||+||||+.++.+||+|||+++....
T Consensus        88 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEeccCCccccccccccc-CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            8899999999988876543 699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc
Q 014904          198 VNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD  275 (416)
Q Consensus       198 ~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  275 (416)
                      ..... .....||+.|+|||++.++.++.++|||||||+||||+| |+.||+.....   .+.        ..+..+.. 
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~--------~~i~~~~~-  231 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EIS--------SILEKGER-  231 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHH--------HHHHHTCC-
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHH--------HHHHcCCC-
Confidence            43332 344578999999999999999999999999999999999 78888765431   111        11222221 


Q ss_pred             cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          276 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       276 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                              ...+..++..+.+++.+||+.+|.+||++.||++.|+..
T Consensus       232 --------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         232 --------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             --------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence                    112223446789999999999999999999999998753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-50  Score=381.13  Aligned_cols=254  Identities=26%  Similarity=0.418  Sum_probs=197.3

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCC----CcEEEEEEeecCCccc-HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPN----GKEVAIKQLKAGSGQG-EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRML  117 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  117 (416)
                      .++|.+.+.||+|+||.||+|++..    +..||||+++...... ...|.+|+.++++++|||||++++++.+ +..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            3678899999999999999999643    3468899887544333 4579999999999999999999999964 67899


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccC
Q 014904          118 VYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASD  197 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~  197 (416)
                      ||||+++++|..++..... .+++..++.++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        85 v~E~~~~g~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTT-TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEeccCCcHHhhhhccCC-CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence            9999999999988765443 689999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccc
Q 014904          198 VNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDT  276 (416)
Q Consensus       198 ~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  276 (416)
                      ..........||+.|+|||++.++.++.++|||||||++|||+| |+.||......   .+.        ..+..+... 
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~--------~~i~~~~~~-  228 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVI--------GRIENGERL-  228 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHH--------HHHHTTCCC-
T ss_pred             CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHH--------HHHHcCCCC-
Confidence            55555566778999999999999999999999999999999998 89998765431   111        112233211 


Q ss_pred             ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          277 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       277 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                              ..+.+.+..+.+++.+||+.+|++||++.||++.|+.
T Consensus       229 --------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         229 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                    1122344678999999999999999999999999874

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=381.66  Aligned_cols=249  Identities=29%  Similarity=0.436  Sum_probs=199.1

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEe-CCeEEEEEEec
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTA-GSQRMLVYEFV  122 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~  122 (416)
                      ++|.+.+.||+|+||.||+|.+ .|+.||||+++...  ..+.|.+|+.++++++||||++++++|.+ ....++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            4678889999999999999998 57899999997543  34679999999999999999999999965 45689999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      ++|+|.+++.......++|..++.|+.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......   
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~---  157 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  157 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence            999999999765444689999999999999999999999   99999999999999999999999999998654322   


Q ss_pred             eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccCcc
Q 014904          203 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPK  281 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~  281 (416)
                       ....+|..|+|||++.++.++.++|||||||++|||+| |+.||.....   ..+..+        +..+.     .+ 
T Consensus       158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~--------i~~~~-----~~-  219 (262)
T d1byga_         158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR--------VEKGY-----KM-  219 (262)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHH--------HTTTC-----CC-
T ss_pred             -ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHH--------HHcCC-----CC-
Confidence             23467899999999999999999999999999999998 6777765432   222222        12221     11 


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          282 LHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       282 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                         ..+......+.+++.+||+.||.+||+|.+|++.|+..
T Consensus       220 ---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         220 ---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence               12223345788999999999999999999999999753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=378.56  Aligned_cols=252  Identities=24%  Similarity=0.346  Sum_probs=207.6

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc------ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCe
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG------QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQ  114 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  114 (416)
                      ..++|.+.+.||+|+||+||+|.. .+|+.||||+++....      ...+.|.+|+.++++++|||||++++++.+...
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            347899999999999999999996 5799999999975422      235679999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC----ceEEeecc
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF----EAKVADFG  190 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~----~~kl~DFG  190 (416)
                      .++||||+++++|.+++...+  .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++    .+||+|||
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence            999999999999999997654  599999999999999999999999   999999999999998776    49999999


Q ss_pred             cceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh
Q 014904          191 LAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       191 la~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~  270 (416)
                      +++.......  .....||+.|+|||++.+..++.++|||||||+||||++|+.||......   ..       + ..+.
T Consensus       163 ~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~-------~-~~i~  229 (293)
T d1jksa_         163 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ET-------L-ANVS  229 (293)
T ss_dssp             TCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH-------H-HHHH
T ss_pred             hhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---HH-------H-HHHH
Confidence            9987754332  23467899999999999999999999999999999999999999865431   11       1 1111


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .+...      ............+.+++.+||+.||.+||++.||++
T Consensus       230 ~~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         230 AVNYE------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             TTCCC------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hcCCC------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            22211      000011122356889999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-49  Score=382.76  Aligned_cols=262  Identities=25%  Similarity=0.409  Sum_probs=213.2

Q ss_pred             HHHHhhCCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCccc-HHHHHHHHHHHHhcCCCcccceEEEEE
Q 014904           38 ELARATDGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSGQG-EREFQAEVEIISRVHHKHLVSLVGYYT  110 (416)
Q Consensus        38 el~~~t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~  110 (416)
                      +++--+++|.+.+.||+|+||.||+|...      +++.||||+++...... .++|.+|+.++++++||||++++++|.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            44445788999999999999999999853      35789999997654333 457999999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 014904          111 AGSQRMLVYEFVPNNTLEFHLHGKG----------------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIH  168 (416)
Q Consensus       111 ~~~~~~lV~e~~~~~sL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH  168 (416)
                      .....++|+||+++++|.+++....                      ...+++..++.|+.|++.||+|||+.   +|||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence            9999999999999999999986432                      23589999999999999999999999   9999


Q ss_pred             ecccCCcEEECCCCceEEeecccceeccCCCc-ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCC-CCC
Q 014904          169 RDIKAANILLDFKFEAKVADFGLAKIASDVNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR-RPV  246 (416)
Q Consensus       169 rDIkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~-~pf  246 (416)
                      |||||+||||+.++.+||+|||+++....... ...+...||+.|+|||++.+..++.++|||||||++|||++|. .||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            99999999999999999999999986544332 2334567899999999999999999999999999999999986 566


Q ss_pred             CCCCcccchhhhhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          247 DSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       247 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      .....   ..+.        ..+..+....         .+...+..+.+|+.+||+.+|.+||||.||++.|+..
T Consensus       244 ~~~~~---~e~~--------~~v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         244 YGMAH---EEVI--------YYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TTSCH---HHHH--------HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCH---HHHH--------HHHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            65433   1111        1223333211         1223345789999999999999999999999999853

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=382.26  Aligned_cols=269  Identities=23%  Similarity=0.342  Sum_probs=204.5

Q ss_pred             hCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHH--HHHHHHHhcCCCcccceEEEEEeCC----eEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQ--AEVEIISRVHHKHLVSLVGYYTAGS----QRM  116 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~--~E~~~l~~l~h~niv~l~~~~~~~~----~~~  116 (416)
                      .+.|.+.+.||+|+||.||+|++ +|+.||||+++...   .+.+.  .|+..+..++|||||+++++|.+..    ..+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            35677889999999999999997 68999999986432   33433  4555556789999999999998643    679


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDC-----HPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-----~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                      +||||+++++|..+++..   .++|..++.++.++|.||+|||..+     ..+|+||||||+||||+.++.+||+|||+
T Consensus        78 lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            999999999999999865   5999999999999999999999742     24899999999999999999999999999


Q ss_pred             ceeccCCCcce---eecccccccccChhhhccCC------CCchhhhHhHHHHHHHHHhCCCCCCCCCcc----cchhhh
Q 014904          192 AKIASDVNTHV---STRVMGTFGYLAPEYASSGK------LTEKSDVFSFGVMLLELITGRRPVDSTHTF----VEDSLV  258 (416)
Q Consensus       192 a~~~~~~~~~~---~~~~~gt~~YlaPE~~~~~~------~t~ksDV~SlGvvL~elltG~~pf~~~~~~----~~~~l~  258 (416)
                      ++.........   .....||+.|+|||++....      ++.|+|||||||+||||+||..||......    ......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            98775544322   24568999999999987542      577999999999999999999887543321    111111


Q ss_pred             hhhhHHhHHhhhcCCcccccCccccCcC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          259 DWARPLLNRAIEDGNFDTLVDPKLHNEY-NHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      .+....+......+    ..+|.+...+ +.+.+..+.+++.+||+.||++||+|.||++.|+..
T Consensus       235 ~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         235 DPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             SCCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            11111111211122    2233333222 334667799999999999999999999999999743

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.2e-48  Score=371.64  Aligned_cols=258  Identities=25%  Similarity=0.398  Sum_probs=203.1

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCccc---HHHHHHHHHHHHhcCCCcccceEEEEEeCC----
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQG---EREFQAEVEIISRVHHKHLVSLVGYYTAGS----  113 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  113 (416)
                      ..++|.+.+.||+|+||.||+|.. .+|+.||||+++......   ...|.+|+.+++.++|||||++++++....    
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            457899999999999999999995 579999999998654332   346899999999999999999999987643    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                      ..+|||||+++++|..++...+  .+++..++.|+.|++.||+|||+.   +|+||||||+||||+.++..+|+|||.++
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             eEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence            3789999999999998887654  589999999999999999999999   99999999999999999999999999987


Q ss_pred             eccCCCc--ceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhc
Q 014904          194 IASDVNT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIED  271 (416)
Q Consensus       194 ~~~~~~~--~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~  271 (416)
                      .......  .......||+.|+|||++.+..++.++|||||||++|||+||+.||......      +    .+...+..
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~----~~~~~~~~  229 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------S----VAYQHVRE  229 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------H----HHHHHHHC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------H----HHHHHHhc
Confidence            6543322  2334568999999999999999999999999999999999999999765431      1    11112222


Q ss_pred             CCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHhcc
Q 014904          272 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP-RMSQIVRALEG  321 (416)
Q Consensus       272 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~evv~~L~~  321 (416)
                      +...       ......+.+..+.+++.+||+.||.+|| ++.++++.|..
T Consensus       230 ~~~~-------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         230 DPIP-------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CCCC-------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCCC-------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            2111       0111122335788999999999999999 89999988864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=376.62  Aligned_cols=251  Identities=28%  Similarity=0.406  Sum_probs=201.9

Q ss_pred             CceecccCcEEEEEEEeCCC----cEEEEEEeecC-CcccHHHHHHHHHHHHhcCCCcccceEEEEEe-CCeEEEEEEec
Q 014904           49 ANLLGQGGFGYVHRGVLPNG----KEVAIKQLKAG-SGQGEREFQAEVEIISRVHHKHLVSLVGYYTA-GSQRMLVYEFV  122 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~~g----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~  122 (416)
                      .++||+|+||+||+|.+.++    ..||||+++.. +....++|.+|++++++++||||++++++|.. ....++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999996432    26899999754 33344679999999999999999999999876 46889999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc-
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH-  201 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~-  201 (416)
                      ++++|.+++..... .+++..++.++.|+++||.|||+.   +|+||||||+||||+.++.+||+|||+++........ 
T Consensus       112 ~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         112 KHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             TTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             ecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            99999999876543 688999999999999999999999   9999999999999999999999999999876543322 


Q ss_pred             --eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          202 --VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       202 --~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                        ......||+.|+|||++.++.++.++||||||+++|||+||+.||.....  ...+..+        +..|.  ....
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~--------i~~g~--~~~~  255 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVY--------LLQGR--RLLQ  255 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH--------HHTTC--CCCC
T ss_pred             ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHH--------HHcCC--CCCC
Confidence              22335789999999999999999999999999999999998888765332  1111111        12232  1111


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      |       ...+..+.+++.+||+.+|++||+|.||++.|+..
T Consensus       256 p-------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         256 P-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             c-------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            1       12345788999999999999999999999999854

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-49  Score=381.35  Aligned_cols=257  Identities=27%  Similarity=0.390  Sum_probs=210.6

Q ss_pred             CCCCcCceecccCcEEEEEEEe------CCCcEEEEEEeecCCcc-cHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL------PNGKEVAIKQLKAGSGQ-GEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  115 (416)
                      ++|.+.++||+|+||.||+|++      .+++.||||+++..... ...+|.+|+.+++.+ +|||||+++++|.+....
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            6888899999999999999985      24678999999865433 335789999999999 699999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC
Q 014904          116 MLVYEFVPNNTLEFHLHGKG----------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD  179 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~  179 (416)
                      ++||||+++++|.++++...                ...+++..++.++.|++.||+|||+.   +|+||||||+|||++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence            99999999999999997543                23589999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCC-CCCCCcccchhh
Q 014904          180 FKFEAKVADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP-VDSTHTFVEDSL  257 (416)
Q Consensus       180 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~p-f~~~~~~~~~~l  257 (416)
                      .++.+||+|||+++........ ..+...||+.|+|||++.++.++.++|||||||++|||+|++.| |.....  ...+
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~--~~~~  257 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--DSKF  257 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS--SHHH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH--HHHH
Confidence            9999999999999987654443 33457899999999999999999999999999999999995555 444332  1111


Q ss_pred             hhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      .        +.+..+.         ....+...+..+.+|+.+||+.||++||+|.||+++|+..
T Consensus       258 ~--------~~i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         258 Y--------KMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             H--------HHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H--------HHHhcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            1        1112221         1111222345789999999999999999999999999864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.1e-48  Score=376.94  Aligned_cols=245  Identities=25%  Similarity=0.358  Sum_probs=206.2

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecC---CcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAG---SGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|++.+.||+|+||.||+|.. .+|+.||||+++..   .....+.+.+|+.++++++|||||++++++.+....++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5799999999999999999996 56999999999743   2233467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+.+++|..++....  .+++..+..++.|++.||+|||+.   +|+||||||+||||+.++.+||+|||+++......
T Consensus        84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~  158 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT  158 (316)
T ss_dssp             CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred             eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence            9999999999887655  478888899999999999999999   99999999999999999999999999998875432


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                          ....||+.|+|||++.+..++.++|||||||+||||++|+.||......      +    .+ ..+..+...    
T Consensus       159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~----~~-~~i~~~~~~----  219 (316)
T d1fota_         159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------K----TY-EKILNAELR----  219 (316)
T ss_dssp             ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------H----HH-HHHHHCCCC----
T ss_pred             ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------H----HH-HHHHcCCCC----
Confidence                3467999999999999999999999999999999999999999765431      1    11 112222211    


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRP-----RMSQIVRA  318 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~~  318 (416)
                            ++......+.+++.+||+.+|.+||     ++.+|++.
T Consensus       220 ------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         220 ------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                  1122235688999999999999996     88888763

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-48  Score=379.21  Aligned_cols=248  Identities=23%  Similarity=0.328  Sum_probs=207.9

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||+++...   ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            36799999999999999999995 579999999997532   23346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+++++|..++...+  .+++..+..++.|++.||.|||+.   +||||||||+||||+.++.+||+|||+++.....
T Consensus        84 ~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            99999999999987654  588999999999999999999999   9999999999999999999999999999866443


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      .. .....+||+.|+|||++.+..++.++|||||||+||||++|+.||.....   ..+        .+.+..+.+    
T Consensus       159 ~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~--------~~~i~~~~~----  222 (337)
T d1o6la_         159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERL--------FELILMEEI----  222 (337)
T ss_dssp             TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHH--------HHHHHHCCC----
T ss_pred             Cc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHH--------HHHHhcCCC----
Confidence            22 23457899999999999999999999999999999999999999987543   111        112222221    


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPR-----MSQIVR  317 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evv~  317 (416)
                        .+    +......+.+|+.+||+.||.+||+     +.||++
T Consensus       223 --~~----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 --RF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --CC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CC----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence              11    1223346789999999999999995     777775

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=379.60  Aligned_cols=258  Identities=28%  Similarity=0.387  Sum_probs=198.0

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhc-CCCcccceEEEEEeC-C
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSG-QGEREFQAEVEIISRV-HHKHLVSLVGYYTAG-S  113 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  113 (416)
                      .++|.+.++||+|+||.||+|.+.      +++.||||+++.... ...+.+..|..++.++ +|+||+.+++++... .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            367999999999999999999953      346899999975443 3345678888888777 689999999998764 4


Q ss_pred             eEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKG--------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD  179 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~  179 (416)
                      ..++||||+++++|.++++...              ...+++..++.++.|+++||.|||+.   +||||||||+||||+
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence            6899999999999999997542              23589999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCC-CCCCCCCcccchhh
Q 014904          180 FKFEAKVADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR-RPVDSTHTFVEDSL  257 (416)
Q Consensus       180 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~-~pf~~~~~~~~~~l  257 (416)
                      .++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+||. .||......  ..+
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~~  246 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF  246 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence            9999999999999876544333 234567999999999999999999999999999999999975 567554321  111


Q ss_pred             hhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                              ...+..+...     ..    +......+.+++.+||+.+|++||||.||++.|+..
T Consensus       247 --------~~~~~~~~~~-----~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         247 --------CRRLKEGTRM-----RA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             --------HHHHHHTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------HHHHhcCCCC-----CC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                    1122233211     11    122345789999999999999999999999999753

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=376.55  Aligned_cols=254  Identities=26%  Similarity=0.389  Sum_probs=196.3

Q ss_pred             CCCCcCceecccCcEEEEEEEeC--CC--cEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP--NG--KEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRM  116 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~--~g--~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  116 (416)
                      ++|++.+.||+|+||.||+|.+.  ++  ..||||+++...   ....++|.+|+.++++++|||||+++++|.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56889999999999999999853  23  378999987542   2334579999999999999999999999976 4678


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceecc
Q 014904          117 LVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIAS  196 (416)
Q Consensus       117 lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~  196 (416)
                      +||||++++++.+.+..... .+++..++.++.|+|.||.|||+.   +|+||||||+||||+.++.+||+|||+++...
T Consensus        87 lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            99999999999988765433 599999999999999999999998   99999999999999999999999999999775


Q ss_pred             CCCcce--eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhhhhhhhHHhHHhhhcCC
Q 014904          197 DVNTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSLVDWARPLLNRAIEDGN  273 (416)
Q Consensus       197 ~~~~~~--~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  273 (416)
                      ......  .....|+..|+|||++.+..++.++|||||||++|||+| |+.||.....   ..+..+       ....+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~~~~~~-------i~~~~~  232 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHK-------IDKEGE  232 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHH-------HHTSCC
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---HHHHHH-------HHhCCC
Confidence            543332  234568889999999999999999999999999999998 8999975432   112111       112221


Q ss_pred             cccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcc
Q 014904          274 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEG  321 (416)
Q Consensus       274 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~  321 (416)
                      .     +    ..+...+..+.+++.+||+.+|++||+|.||++.|+.
T Consensus       233 ~-----~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         233 R-----L----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             C-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C-----C----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            1     1    1112233578899999999999999999999999874

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=378.01  Aligned_cols=254  Identities=27%  Similarity=0.422  Sum_probs=204.1

Q ss_pred             CCCCcCceecccCcEEEEEEEeC-CCc--EEEEEEeecCC-cccHHHHHHHHHHHHhc-CCCcccceEEEEEeCCeEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP-NGK--EVAIKQLKAGS-GQGEREFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ++|++.++||+|+||.||+|.+. +|.  .||||+++... ....+.|.+|+.+++++ +|||||+++++|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            68888999999999999999964 444  57888876443 33445799999999998 799999999999999999999


Q ss_pred             EEecCCCCHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCce
Q 014904          119 YEFVPNNTLEFHLHGK--------------GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA  184 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~  184 (416)
                      |||+++|+|.++++..              ....+++..++.++.|+|.||.|||+.   +|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            9999999999999754              234799999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCC-CCCCCCcccchhhhhhhhH
Q 014904          185 KVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRR-PVDSTHTFVEDSLVDWARP  263 (416)
Q Consensus       185 kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~-pf~~~~~~~~~~l~~~~~~  263 (416)
                      ||+|||+++........  ....||..|+|||.+.++.++.++|||||||++|||++|.. ||.....   ..+..    
T Consensus       167 kl~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~----  237 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYE----  237 (309)
T ss_dssp             EECCTTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH----
T ss_pred             EEccccccccccccccc--cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHH----
Confidence            99999999865433222  23568999999999999999999999999999999999765 5654332   11111    


Q ss_pred             HhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          264 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       264 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                          .+..+.-     +    ..+...+..+.+|+.+||+.+|++||+|.||++.|+..
T Consensus       238 ----~i~~~~~-----~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         238 ----KLPQGYR-----L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             ----HGGGTCC-----C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HHHhcCC-----C----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                1222211     1    12223446799999999999999999999999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-49  Score=376.80  Aligned_cols=257  Identities=26%  Similarity=0.402  Sum_probs=206.5

Q ss_pred             CCCCcCceecccCcEEEEEEEeCC--------CcEEEEEEeecCCcc-cHHHHHHHHHHHHhc-CCCcccceEEEEEeCC
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPN--------GKEVAIKQLKAGSGQ-GEREFQAEVEIISRV-HHKHLVSLVGYYTAGS  113 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  113 (416)
                      ++|.+.+.||+|+||.||+|....        +..||||+++..... ...++.+|+..+.++ +|||||+++++|.+..
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            578888999999999999998422        247999999865543 336788999999888 8999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEEC
Q 014904          114 QRMLVYEFVPNNTLEFHLHGKG--------------RPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLD  179 (416)
Q Consensus       114 ~~~lV~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~  179 (416)
                      ..++||||+.+|+|.+++....              ...+++.+++.++.|++.||.|||+.   +||||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence            9999999999999999997543              23589999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccceeccCCCcc-eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCcccchhh
Q 014904          180 FKFEAKVADFGLAKIASDVNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDSTHTFVEDSL  257 (416)
Q Consensus       180 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~ellt-G~~pf~~~~~~~~~~l  257 (416)
                      .++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||++ |+.||.....   ..+
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~~~  246 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EEL  246 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHH
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---HHH
Confidence            9999999999999877554333 2344678999999999999999999999999999999998 6888865442   111


Q ss_pred             hhhhhHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          258 VDWARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                      .        ..+..+...     .    .+...+..+.+++.+||+.+|++||||.||++.|+...
T Consensus       247 ~--------~~i~~~~~~-----~----~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         247 F--------KLLKEGHRM-----D----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             H--------HHHHTTCCC-----C----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H--------HHHHcCCCC-----C----CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            1        122233211     1    12223457899999999999999999999999998653

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.1e-48  Score=366.01  Aligned_cols=250  Identities=25%  Similarity=0.364  Sum_probs=206.1

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCccc---------HHHHHHHHHHHHhcC-CCcccceEEEEEeC
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQG---------EREFQAEVEIISRVH-HKHLVSLVGYYTAG  112 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  112 (416)
                      ++|.+.+.||+|+||+||+|.. .+|+.||||++.......         ...+.+|+.++++++ ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6899999999999999999995 578999999997653211         235788999999997 99999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccc
Q 014904          113 SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA  192 (416)
Q Consensus       113 ~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla  192 (416)
                      ...+|||||+++++|.+++...+  .+++..++.++.|+++||+|||+.   +|+||||||+||||+.++.+||+|||++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence            99999999999999999997654  599999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCcceeecccccccccChhhhcc------CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhH
Q 014904          193 KIASDVNTHVSTRVMGTFGYLAPEYASS------GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLN  266 (416)
Q Consensus       193 ~~~~~~~~~~~~~~~gt~~YlaPE~~~~------~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~  266 (416)
                      +......  ..+...||+.|+|||++.+      ..++.++|||||||+||||++|+.||.......           ..
T Consensus       158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-----------~~  224 (277)
T d1phka_         158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-----------ML  224 (277)
T ss_dssp             EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------HH
T ss_pred             eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-----------HH
Confidence            9876532  2344679999999999853      357889999999999999999999998654311           11


Q ss_pred             HhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          267 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       267 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..+..+... .     ...........+.+++.+||+.+|.+||++.||++
T Consensus       225 ~~i~~~~~~-~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         225 RMIMSGNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHTCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHhCCCC-C-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            112223221 1     11111223457899999999999999999999875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-47  Score=376.48  Aligned_cols=244  Identities=24%  Similarity=0.293  Sum_probs=205.6

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  119 (416)
                      ++|.+.+.||+|+||.||+|.+ .+|+.||||++....   ......+.+|+.+++.++|||||++++++.+....++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5799999999999999999996 479999999986432   233457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVN  199 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~  199 (416)
                      ||+.+++|..++...+  .+++..+..++.|++.||.|||+.   +||||||||+||||+.++.+||+|||+++......
T Consensus       121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~  195 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred             ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence            9999999999987654  589999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcccccC
Q 014904          200 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLVD  279 (416)
Q Consensus       200 ~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d  279 (416)
                          ....||+.|+|||++.+..++.++|||||||+||||+||+.||......   .        +...+..+.+.    
T Consensus       196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~--------~~~~i~~~~~~----  256 (350)
T d1rdqe_         196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---Q--------IYEKIVSGKVR----  256 (350)
T ss_dssp             ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H--------HHHHHHHCCCC----
T ss_pred             ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---H--------HHHHHhcCCCC----
Confidence                3467999999999999999999999999999999999999999764421   1        11112222211    


Q ss_pred             ccccCcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014904          280 PKLHNEYNHNEMARMVACAAACVRHSARRRP-----RMSQIVR  317 (416)
Q Consensus       280 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evv~  317 (416)
                        .    +......+.+++.+||+.||.+|+     ++.||++
T Consensus       257 --~----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 --F----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --C----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --C----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence              1    112335788999999999999994     8888875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=372.46  Aligned_cols=252  Identities=19%  Similarity=0.311  Sum_probs=207.2

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ..++|.+.+.||+|+||+||+|.+. +|+.||||+++... .....+.+|+.+|++++|||||++++++.+....++|||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            4578999999999999999999964 68999999997654 334568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC--CceEEeecccceeccCC
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK--FEAKVADFGLAKIASDV  198 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~--~~~kl~DFGla~~~~~~  198 (416)
                      |+++++|.+++...+. .+++..++.|+.|++.||.|||+.   +|+||||||+|||++.+  ..+||+|||+++.....
T Consensus        82 ~~~gg~L~~~i~~~~~-~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          82 FISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCCBHHHHHTSSSC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             cCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            9999999999976542 589999999999999999999999   99999999999999854  57999999999876543


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      .  ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||......   .+       + ..+..+.+. + 
T Consensus       158 ~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~-------~-~~i~~~~~~-~-  222 (321)
T d1tkia_         158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QI-------I-ENIMNAEYT-F-  222 (321)
T ss_dssp             C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HH-------H-HHHHHTCCC-C-
T ss_pred             C--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HH-------H-HHHHhCCCC-C-
Confidence            2  234467899999999999999999999999999999999999999765431   11       1 111122211 0 


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      +......    ....+.+++.+||+.||.+||++.|+++
T Consensus       223 ~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         223 DEEAFKE----ISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ChhhccC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000011    2346889999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=370.59  Aligned_cols=258  Identities=24%  Similarity=0.405  Sum_probs=210.6

Q ss_pred             hCCCCcCceecccCcEEEEEEEeC------CCcEEEEEEeecCCc-ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVLP------NGKEVAIKQLKAGSG-QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  115 (416)
                      .++|.+.+.||+|+||.||+|.+.      +++.||||+++.... .....|.+|+.++++++|||||+++++|......
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            367888899999999999999863      357899999975433 2334689999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEe
Q 014904          116 MLVYEFVPNNTLEFHLHGK--------GRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA  187 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~--------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~  187 (416)
                      ++||||+++|+|.+++...        ....+++..+..++.++|+||.|||+.   +|+||||||+||||+.++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence            9999999999999988642        223579999999999999999999999   99999999999999999999999


Q ss_pred             ecccceeccCCCcce-eecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCC-CCCCCCCcccchhhhhhhhHHh
Q 014904          188 DFGLAKIASDVNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR-RPVDSTHTFVEDSLVDWARPLL  265 (416)
Q Consensus       188 DFGla~~~~~~~~~~-~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~-~pf~~~~~~~~~~l~~~~~~~~  265 (416)
                      |||+++......... .....||+.|+|||.+.++.++.++||||||++||||+||+ .||.....      .++.    
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~----  245 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVL----  245 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHH----
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHH----
Confidence            999998765443332 34457899999999999999999999999999999999985 56654322      1111    


Q ss_pred             HHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhcccc
Q 014904          266 NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGDA  323 (416)
Q Consensus       266 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~~  323 (416)
                       ..+..+....         .+...+..+.+++.+||+.+|++||+|.||++.|+...
T Consensus       246 -~~i~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         246 -RFVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             -HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             -HHHHhCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence             1222332211         11223457999999999999999999999999998754

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=374.81  Aligned_cols=253  Identities=23%  Similarity=0.321  Sum_probs=201.6

Q ss_pred             hhCCCCcCc-eecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhc-CCCcccceEEEEEe----CCe
Q 014904           42 ATDGFSDAN-LLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRV-HHKHLVSLVGYYTA----GSQ  114 (416)
Q Consensus        42 ~t~~f~~~~-~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  114 (416)
                      ..++|.+.+ +||+|+||.||+|.+ .+++.||||+++..     ..+.+|+.++.++ +|||||++++++.+    ...
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            457898875 699999999999995 57999999998642     4677899987655 89999999999875    456


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC---CCceEEeeccc
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFGL  191 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~---~~~~kl~DFGl  191 (416)
                      .++||||++||+|.+++...+...+++..+..|+.|++.||+|||+.   +|+||||||+|||++.   ++.+||+|||+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence            89999999999999999876656799999999999999999999999   9999999999999986   45699999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhc
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIED  271 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~  271 (416)
                      ++.......  .....||+.|+|||++.+..++.++|||||||+||+|+||+.||..........       .+...+..
T Consensus       161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~-------~~~~~i~~  231 (335)
T d2ozaa1         161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GMKTRIRM  231 (335)
T ss_dssp             CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCS
T ss_pred             eeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH-------HHHHHHhc
Confidence            987655333  244679999999999999999999999999999999999999997544311000       00001111


Q ss_pred             CCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          272 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       272 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      +.+      .+...........+.+|+.+||+.||.+||++.|+++
T Consensus       232 ~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         232 GQY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CSS------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            111      0111111233467899999999999999999999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-47  Score=377.94  Aligned_cols=249  Identities=25%  Similarity=0.351  Sum_probs=199.9

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHH---HHHHHhcCCCcccceEEEEEeCCeE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAE---VEIISRVHHKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~  115 (416)
                      .++|.+.++||+|+||.||+|.. .+|+.||||++....   ......+..|   +.+++.++|||||++++++.+....
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            36899999999999999999996 469999999986432   1222334444   6667777899999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      ++||||+++++|..++....  .+++..++.++.|++.||.|||+.   +||||||||+||||+.++.+||+|||+++..
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999997654  588999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCc
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNF  274 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  274 (416)
                      ....   .....||+.|+|||++..+ .++.++|||||||+||||+||+.||..........+..        ...... 
T Consensus       158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~--------~~~~~~-  225 (364)
T d1omwa3         158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--------MTLTMA-  225 (364)
T ss_dssp             SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH--------HSSSCC-
T ss_pred             CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hcccCC-
Confidence            5432   2346799999999999754 68999999999999999999999998654322111111        111111 


Q ss_pred             ccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014904          275 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR-----MSQIVR  317 (416)
Q Consensus       275 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evv~  317 (416)
                           +.+    +......+.+|+.+||+.||.+||+     +.||++
T Consensus       226 -----~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         226 -----VEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -----CCC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -----CCC----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                 111    1123356889999999999999999     577764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=366.05  Aligned_cols=263  Identities=23%  Similarity=0.286  Sum_probs=196.5

Q ss_pred             CceecccCcEEEEEEEe-CCCcEEEEEEeecCCccc-----HHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEec
Q 014904           49 ANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQG-----EREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEFV  122 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  122 (416)
                      +++||+|+||+||+|.. .+|+.||||+++......     .+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            57899999999999995 569999999997543221     236889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcce
Q 014904          123 PNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTHV  202 (416)
Q Consensus       123 ~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~~  202 (416)
                      .++++..++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus        83 ~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-  156 (299)
T d1ua2a_          83 ETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-  156 (299)
T ss_dssp             SEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred             cchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc-
Confidence            988777666433  3588889999999999999999999   9999999999999999999999999999876543332 


Q ss_pred             eecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCcc---ccc
Q 014904          203 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFD---TLV  278 (416)
Q Consensus       203 ~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~---~~~  278 (416)
                      .....||+.|+|||++..+ .++.++|||||||++|||++|+.||.......  .+..... .+.. .....+.   ...
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i~~-~~~~-~~~~~~~~~~~~~  232 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFE-TLGT-PTEEQWPDMCSLP  232 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCC-CCTTTSSSTTSST
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHHHH-hcCC-CChhhccchhccc
Confidence            2335799999999998755 57999999999999999999999997654311  1111100 0000 0000000   000


Q ss_pred             C---ccccCcCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hcc
Q 014904          279 D---PKLHNEYN-----HNEMARMVACAAACVRHSARRRPRMSQIVRA--LEG  321 (416)
Q Consensus       279 d---~~l~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~--L~~  321 (416)
                      .   -......+     ......+.+|+.+||+.||++|||+.|+++.  |..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence            0   00000011     1123578899999999999999999999863  553

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=371.84  Aligned_cols=247  Identities=25%  Similarity=0.331  Sum_probs=203.3

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC---cccHHHHHHHHHHHH-hcCCCcccceEEEEEeCCeEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS---GQGEREFQAEVEIIS-RVHHKHLVSLVGYYTAGSQRMLV  118 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV  118 (416)
                      ++|.+.+.||+|+||+||+|+. .+|+.||||+++...   ....+.+..|..++. .++|||||++++++.++...++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            6799999999999999999996 479999999997432   223345666777665 68999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCC
Q 014904          119 YEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDV  198 (416)
Q Consensus       119 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~  198 (416)
                      |||+++|+|..++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            99999999999997654  488999999999999999999999   9999999999999999999999999999865543


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcCCccccc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDGNFDTLV  278 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  278 (416)
                      .. ..+...||+.|+|||++.+..++.++|||||||++|||++|+.||......   .        +...+..+.+    
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~--------~~~~i~~~~~----  220 (320)
T d1xjda_         157 DA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---E--------LFHSIRMDNP----  220 (320)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H--------HHHHHHHCCC----
T ss_pred             cc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---H--------HHHHHHcCCC----
Confidence            32 234467999999999999999999999999999999999999999765431   1        1112222221    


Q ss_pred             CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 014904          279 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMS-QIVR  317 (416)
Q Consensus       279 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-evv~  317 (416)
                        .+    +......+.+|+.+||+.||.+||++. ||++
T Consensus       221 --~~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 --FY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             --CC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             --CC----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence              11    122335688999999999999999996 6653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-47  Score=365.03  Aligned_cols=268  Identities=19%  Similarity=0.292  Sum_probs=200.0

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ++|.+.++||+|+||+||+|.+ .+|+.||||+++....  .....+.+|+.++++++|||||++++++.+....++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            6899999999999999999995 5799999999975432  224578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      |+.++.+. ++.......+++..+..++.|++.||.|||+.   +||||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~~~~-~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          82 FLHQDLKK-FMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             CCSEEHHH-HHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             ecCCchhh-hhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            99765444 44434444799999999999999999999999   999999999999999999999999999987654332


Q ss_pred             ceeecccccccccChhhhccCC-CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH-------hHHhhhcC
Q 014904          201 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL-------LNRAIEDG  272 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~-~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~-------~~~~~~~~  272 (416)
                       ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+..  +.+.......       ........
T Consensus       158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--HHHHHHHHhcCCCchhhcccccccc
Confidence             233457999999999876655 589999999999999999999999765431  1111100000       00000000


Q ss_pred             CcccccCccccCc---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          273 NFDTLVDPKLHNE---YNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       273 ~~~~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .............   ........+.+++.+||+.||++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0000000000000   001123577899999999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.1e-47  Score=360.73  Aligned_cols=266  Identities=21%  Similarity=0.322  Sum_probs=202.1

Q ss_pred             CCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEEe
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYEF  121 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  121 (416)
                      ++|.+.+.||+|+||+||+|.+.+|+.||||+++....  .....+.+|+.++++++||||+++++++.+....++|+|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            68999999999999999999998999999999976532  2246789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCcc
Q 014904          122 VPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNTH  201 (416)
Q Consensus       122 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~~  201 (416)
                      +.++.+..+....  ..+++..+..++.|++.||.|||+.   +||||||||+||||+.++.+||+|||++........ 
T Consensus        82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (286)
T ss_dssp             CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence            9887777766544  3699999999999999999999998   999999999999999999999999999987654322 


Q ss_pred             eeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHH-------hHHhhhcCC
Q 014904          202 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPL-------LNRAIEDGN  273 (416)
Q Consensus       202 ~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~-------~~~~~~~~~  273 (416)
                      ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||......  +.+.......       +........
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCChhhccchhhhhh
Confidence            2233568999999999865 45799999999999999999999999765431  1111110000       000000000


Q ss_pred             cc---cccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          274 FD---TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       274 ~~---~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..   ....+.............+.+++.+||+.||++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00   000111111112223357889999999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-47  Score=360.61  Aligned_cols=240  Identities=23%  Similarity=0.374  Sum_probs=196.5

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc------cHHHHHHHHHHHHhcC--CCcccceEEEEEeCC
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ------GEREFQAEVEIISRVH--HKHLVSLVGYYTAGS  113 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  113 (416)
                      .++|.+.++||+|+||.||+|.. .+|+.||||++......      ...++.+|+.++++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            46899999999999999999995 57899999998753211      1134678999999996  899999999999999


Q ss_pred             eEEEEEEecCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCC-CceEEeeccc
Q 014904          114 QRMLVYEFVPN-NTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGL  191 (416)
Q Consensus       114 ~~~lV~e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~-~~~kl~DFGl  191 (416)
                      ..++||||+.+ +++.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.+ +.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             eEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence            99999999976 57777776543  589999999999999999999999   99999999999999854 7899999999


Q ss_pred             ceeccCCCcceeecccccccccChhhhccCCC-CchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhh
Q 014904          192 AKIASDVNTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIE  270 (416)
Q Consensus       192 a~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~-t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~  270 (416)
                      ++.....   ..+...||+.|+|||++.+..+ +.++|||||||+||||++|+.||.....     +            .
T Consensus       158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i------------~  217 (273)
T d1xwsa_         158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I------------I  217 (273)
T ss_dssp             CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H------------H
T ss_pred             ceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H------------h
Confidence            9875432   2344679999999999987765 5779999999999999999999965211     1            1


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .+..      .+...+    ...+.+++.+||+.||++|||+.|+++
T Consensus       218 ~~~~------~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         218 RGQV------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HCCC------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hccc------CCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1111      111222    346889999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-46  Score=358.43  Aligned_cols=268  Identities=22%  Similarity=0.290  Sum_probs=197.8

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CC-CcEEEEEEeecCCc--ccHHHHHHHHHHHHhc---CCCcccceEEEEEe---
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PN-GKEVAIKQLKAGSG--QGEREFQAEVEIISRV---HHKHLVSLVGYYTA---  111 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---  111 (416)
                      ..++|.+.+.||+|+||+||+|.+ .+ ++.||||+++....  .....+.+|+.+++.+   +||||++++++|..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            347899999999999999999996 34 56799999865322  1123456777777665   89999999999863   


Q ss_pred             --CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeec
Q 014904          112 --GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF  189 (416)
Q Consensus       112 --~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DF  189 (416)
                        ....++++|++.++.+...... ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             ccCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence              3468999999988877655443 334689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHh---H
Q 014904          190 GLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLL---N  266 (416)
Q Consensus       190 Gla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~---~  266 (416)
                      |+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .+........   .
T Consensus       161 g~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~~  236 (305)
T d1blxa_         161 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPGE  236 (305)
T ss_dssp             CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCG
T ss_pred             hhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCCCch
Confidence            9988654322  2345679999999999999999999999999999999999999998654311  1111100000   0


Q ss_pred             Hhhh-cCCccc----ccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          267 RAIE-DGNFDT----LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       267 ~~~~-~~~~~~----~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ..+. ......    .........+.......+.+|+.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000 000000    00000011122223456788999999999999999999875

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-45  Score=356.38  Aligned_cols=262  Identities=24%  Similarity=0.330  Sum_probs=196.1

Q ss_pred             CCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcccceEEEEEeC------CeEEE
Q 014904           45 GFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYYTAG------SQRML  117 (416)
Q Consensus        45 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  117 (416)
                      .|+..++||+|+||+||+|.+ .+|+.||||+++....    .+.+|+.++++++|+||++++++|...      .+.+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            577889999999999999996 4699999999976542    234699999999999999999998643      35789


Q ss_pred             EEEecCCCCHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC-ceEEeecccceec
Q 014904          118 VYEFVPNNTLEFHLHG-KGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKIA  195 (416)
Q Consensus       118 V~e~~~~~sL~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~-~~kl~DFGla~~~  195 (416)
                      ||||++++.+..+.+. .....+++..+..|+.|++.||+|||+.   +|+||||||+||||+.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987755544431 2334699999999999999999999998   999999999999999775 8999999999876


Q ss_pred             cCCCcceeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh-------HHhHH
Q 014904          196 SDVNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR-------PLLNR  267 (416)
Q Consensus       196 ~~~~~~~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~-------~~~~~  267 (416)
                      ......  ....||..|+|||.+.+ ..++.++|||||||++|||++|+.||......  +.+.....       ..+..
T Consensus       174 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~--~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         174 VRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHH
T ss_pred             cCCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH--HHHHHHHHHhCCChHHhhhh
Confidence            543332  33579999999998865 46899999999999999999999999765432  12211110       00000


Q ss_pred             h---hhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          268 A---IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       268 ~---~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .   .....+.......+...........+.+|+.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0   0011111111111111122233457889999999999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=345.08  Aligned_cols=267  Identities=19%  Similarity=0.270  Sum_probs=205.1

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCCeEEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  120 (416)
                      ++|++.+.||+|+||+||+|++ .+++.||||+++....  .....+.+|+.+++.++||||+++++++.+....++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5899999999999999999995 5789999999976543  234678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceeccCCCc
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIASDVNT  200 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~~~~~~  200 (416)
                      ++.++++..++....  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||.++.......
T Consensus        82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          82 FCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             ecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            999999988876554  588999999999999999999999   999999999999999999999999999987754333


Q ss_pred             ceeecccccccccChhhhccCC-CCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhh----------HHhHHhh
Q 014904          201 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWAR----------PLLNRAI  269 (416)
Q Consensus       201 ~~~~~~~gt~~YlaPE~~~~~~-~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~----------~~~~~~~  269 (416)
                      . .....+++.|.|||.+.... ++.++|||||||+++||++|+.||.......+ .+.....          +......
T Consensus       157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             C-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             c-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH-HHHHHHhhcCCCChhhhhhhhhcc
Confidence            2 23345788899999987665 69999999999999999999999754332111 1110000          0000000


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      ........................+.+|+.+||+.||.+|||+.||++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000111110111111122233456889999999999999999999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-44  Score=346.15  Aligned_cols=259  Identities=20%  Similarity=0.253  Sum_probs=198.7

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCccc-ceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHLV-SLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e  120 (416)
                      -++|++.+.||+|+||.||+|.+ .+|+.||||++......  .++..|++++++++|+|++ .+..++.++...++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            36799999999999999999995 56899999998765432  3578899999999876654 55566678889999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC---CCceEEeecccceeccC
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFGLAKIASD  197 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~---~~~~kl~DFGla~~~~~  197 (416)
                      |+ ++++...+..... .+++..++.++.|++.||+|||+.   +||||||||+|||++.   +..+||+|||+++....
T Consensus        84 ~~-~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          84 LL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             Ec-CCchhhhhhhccC-CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            99 4556555544332 699999999999999999999999   9999999999999853   55799999999998765


Q ss_pred             CCcc------eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhh-hhhhHHhHHhhh
Q 014904          198 VNTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV-DWARPLLNRAIE  270 (416)
Q Consensus       198 ~~~~------~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~-~~~~~~~~~~~~  270 (416)
                      ....      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............ .+.....     
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-----  233 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-----  233 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-----
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-----
Confidence            4332      223467999999999999999999999999999999999999999765432221111 1111100     


Q ss_pred             cCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          271 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       271 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      ...     .+.+..    ..+..+.+++..|++.+|++||++.+|.+.|+..
T Consensus       234 ~~~-----~~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         234 STP-----IEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HSC-----HHHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             CCC-----hhHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            000     011111    2235788999999999999999999999888753

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=350.36  Aligned_cols=271  Identities=20%  Similarity=0.237  Sum_probs=195.7

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCC--cccHHHHHHHHHHHHhcCCCcccceEEEEEe--------
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGS--GQGEREFQAEVEIISRVHHKHLVSLVGYYTA--------  111 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  111 (416)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++....  ......+.+|+.++++++|+||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            48999999999999999999996 579999999986442  2334678899999999999999999999855        


Q ss_pred             CCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccc
Q 014904          112 GSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL  191 (416)
Q Consensus       112 ~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGl  191 (416)
                      ....++||||+.++.+.......  ..++...+..|+.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~--~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhhhcc--cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecce
Confidence            34679999999887776554333  3688899999999999999999999   999999999999999999999999999


Q ss_pred             ceeccCCCcc---eeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhH-HhH
Q 014904          192 AKIASDVNTH---VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARP-LLN  266 (416)
Q Consensus       192 a~~~~~~~~~---~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~-~~~  266 (416)
                      ++........   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||................. ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9866543221   22335799999999998765 689999999999999999999999976543211111110000 000


Q ss_pred             Hhhhc---CCc-ccccCccccCcCCHH------HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          267 RAIED---GNF-DTLVDPKLHNEYNHN------EMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       267 ~~~~~---~~~-~~~~d~~l~~~~~~~------~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      .....   ... ..+............      ....+.+|+.+||+.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            00000   000 000000000000011      12356789999999999999999999864

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.5e-44  Score=342.71  Aligned_cols=260  Identities=18%  Similarity=0.205  Sum_probs=207.1

Q ss_pred             hCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCC-CcccceEEEEEeCCeEEEEEE
Q 014904           43 TDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHH-KHLVSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        43 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e  120 (416)
                      .++|.+.++||+|+||.||+|++ .+|+.||||++.....  ...+.+|++++..+.| +|++.+++++..+...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            46899999999999999999995 4689999999865432  2357789999999965 899999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECC-----CCceEEeecccceec
Q 014904          121 FVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDF-----KFEAKVADFGLAKIA  195 (416)
Q Consensus       121 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~-----~~~~kl~DFGla~~~  195 (416)
                      |+ +++|.+++...+. .+++.++..++.|++.||.|||+.   +|+||||||+|||++.     ++.+||+|||+++..
T Consensus        82 ~~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          82 LL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             ec-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            98 7899888876544 689999999999999999999999   9999999999999974     567999999999976


Q ss_pred             cCCCcc------eeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhh
Q 014904          196 SDVNTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAI  269 (416)
Q Consensus       196 ~~~~~~------~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~  269 (416)
                      .+....      ......||+.|+|||.+.+..++.++|||||||++|||+||+.||..................    .
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~----~  232 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK----K  232 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH----H
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc----c
Confidence            543221      123467999999999999999999999999999999999999999865443222221111100    0


Q ss_pred             hcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHhccc
Q 014904          270 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRALEGD  322 (416)
Q Consensus       270 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~L~~~  322 (416)
                      ......     .+...    .+..+.+++..|++.+|++||++..+.+.|+..
T Consensus       233 ~~~~~~-----~l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         233 QSTPLR-----ELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HHSCHH-----HHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             CCCChH-----HhcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            000111     11112    234688999999999999999999998888753

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-44  Score=351.05  Aligned_cols=271  Identities=20%  Similarity=0.283  Sum_probs=198.1

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc-cHHHHHHHHHHHHhcCCCcccceEEEEEeCC----eE
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ-GEREFQAEVEIISRVHHKHLVSLVGYYTAGS----QR  115 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  115 (416)
                      .+.+|.+.++||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+.+|++++||||+++++++....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            567899999999999999999995 58999999999765432 2357889999999999999999999997643    23


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccceec
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKIA  195 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~~  195 (416)
                      +++++++.+++|.+++...   .+++..+..++.|++.||+|||+.   +||||||||+||||+.++.+||+|||+++..
T Consensus        86 ~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            4455667799999999754   589999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCcc--eeecccccccccChhhhcc-CCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcC
Q 014904          196 SDVNTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDG  272 (416)
Q Consensus       196 ~~~~~~--~~~~~~gt~~YlaPE~~~~-~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~  272 (416)
                      ......  .....+||+.|+|||++.. ..++.++||||+||+++||++|+.||..........................
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            543322  2344679999999999844 5678999999999999999999999976543211111100000000000000


Q ss_pred             Ccc----c--ccCccccC----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          273 NFD----T--LVDPKLHN----EYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       273 ~~~----~--~~d~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                      ...    .  ...+....    .........+.+++.+||+.||.+||++.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000    0  00000000    0001112468899999999999999999999864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-44  Score=351.34  Aligned_cols=267  Identities=23%  Similarity=0.303  Sum_probs=196.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEeCC-----
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTAGS-----  113 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  113 (416)
                      ..++|++.++||+|+||+||+|.. .+|+.||||+++....  ...+.+.+|+.+|++++|||||+++++|....     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            468999999999999999999995 5699999999975432  22356889999999999999999999997654     


Q ss_pred             -eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccc
Q 014904          114 -QRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA  192 (416)
Q Consensus       114 -~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla  192 (416)
                       ..++||||+ +.+|..++...   .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|++|||++
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence             469999999 66787777543   599999999999999999999999   9999999999999999999999999999


Q ss_pred             eeccCCCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhh----------
Q 014904          193 KIASDVNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA----------  261 (416)
Q Consensus       193 ~~~~~~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~----------  261 (416)
                      +......    +...||+.|+|||.+.+. .++.++|||||||++|||++|+.||...............          
T Consensus       169 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         169 RQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             EECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             eccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            8765432    346799999999998764 5799999999999999999999999775432111100000          


Q ss_pred             --hHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--hcc
Q 014904          262 --RPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA--LEG  321 (416)
Q Consensus       262 --~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~--L~~  321 (416)
                        ..........+ ........+ ..........+.+|+.+||+.||.+|||+.|+++.  |+.
T Consensus       245 ~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~  306 (346)
T d1cm8a_         245 RLQSDEAKNYMKG-LPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  306 (346)
T ss_dssp             TCSCHHHHHHHHH-SCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             hhcchhhhhhhcc-CCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence              00000000000 000000000 01111223467899999999999999999999974  553

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5e-43  Score=340.33  Aligned_cols=261  Identities=20%  Similarity=0.300  Sum_probs=198.0

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-CCcccceEEEEEe--CCeEEEEE
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-HKHLVSLVGYYTA--GSQRMLVY  119 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV~  119 (416)
                      ++|++.++||+|+||+||+|.. .+|+.||||+++...   .+++.+|+.+|..+. ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            6799999999999999999996 579999999997533   467889999999995 9999999999985  45689999


Q ss_pred             EecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCC-ceEEeecccceeccCC
Q 014904          120 EFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKIASDV  198 (416)
Q Consensus       120 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~-~~kl~DFGla~~~~~~  198 (416)
                      ||+.+++|..+..     .++...+..++.|++.||.|||+.   +|+||||||+||||+.++ .+||+|||+++.....
T Consensus       112 e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         112 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             ECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            9999999876642     589999999999999999999999   999999999999998655 6899999999876543


Q ss_pred             CcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchh--hhhhh-hHHhHHhhhcCCc
Q 014904          199 NTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDS--LVDWA-RPLLNRAIEDGNF  274 (416)
Q Consensus       199 ~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~--l~~~~-~~~~~~~~~~~~~  274 (416)
                      ..  .....||+.|+|||.+.+. .++.++|||||||+++||++|+.||.......+..  +.... .+...........
T Consensus       184 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         184 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             Cc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            32  2446789999999998765 47999999999999999999999997654321110  00000 0000000000000


Q ss_pred             c------ccc--------CccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          275 D------TLV--------DPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       275 ~------~~~--------d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                      .      ...        ...............+.+|+.+||+.||++|||+.|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0      000        000111111223356889999999999999999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-44  Score=345.49  Aligned_cols=252  Identities=25%  Similarity=0.326  Sum_probs=202.9

Q ss_pred             CCCCcCceecccCcEEEEEEEeC----CCcEEEEEEeecCC----cccHHHHHHHHHHHHhcCC-CcccceEEEEEeCCe
Q 014904           44 DGFSDANLLGQGGFGYVHRGVLP----NGKEVAIKQLKAGS----GQGEREFQAEVEIISRVHH-KHLVSLVGYYTAGSQ  114 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  114 (416)
                      ++|++.+.||+|+||+||+|...    +|+.||||+++...    ....+.+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999842    47899999986432    1223567899999999966 899999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          115 RMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       115 ~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      .++|+||+.+++|..++....  .+.......++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence            999999999999999997655  467788889999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCcceeecccccccccChhhhccC--CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhhhHHhHHhhhcC
Q 014904          195 ASDVNTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWARPLLNRAIEDG  272 (416)
Q Consensus       195 ~~~~~~~~~~~~~gt~~YlaPE~~~~~--~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~  272 (416)
                      .............|++.|+|||.+.+.  .++.++|||||||+||||++|+.||........  .....     ......
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~--~~~i~-----~~~~~~  251 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEIS-----RRILKS  251 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHH-----HHHHHC
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-----HhcccC
Confidence            765555445567899999999999764  478899999999999999999999977543211  11111     101111


Q ss_pred             CcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014904          273 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR-----MSQIVR  317 (416)
Q Consensus       273 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evv~  317 (416)
                      .      +    ..+......+.+++.+||+.+|.+||+     +.|+++
T Consensus       252 ~------~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 E------P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             C------C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             C------C----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            1      1    112233468899999999999999994     788875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=341.39  Aligned_cols=267  Identities=22%  Similarity=0.291  Sum_probs=192.9

Q ss_pred             hhCCCCcCceecccCcEEEEEEEeC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHHhcCCCcccceEEEEEe------C
Q 014904           42 ATDGFSDANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAGSG--QGEREFQAEVEIISRVHHKHLVSLVGYYTA------G  112 (416)
Q Consensus        42 ~t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~  112 (416)
                      +.++|++.++||+|+||+||+|.+. +|+.||||++.....  ....++.+|+.++++++|||||++++++..      .
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            3478999999999999999999964 699999999986532  233568899999999999999999999963      4


Q ss_pred             CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccc
Q 014904          113 SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA  192 (416)
Q Consensus       113 ~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla  192 (416)
                      .+.|+||||+.++.+..+ ..    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|++|||++
T Consensus        95 ~~~~iv~Ey~~~~l~~~~-~~----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          95 QDVYLVMELMDANLCQVI-QM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             CEEEEEEECCSEEHHHHH-TS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             ceeEEEEeccchHHHHhh-hc----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence            688999999976655544 32    489999999999999999999999   9999999999999999999999999998


Q ss_pred             eeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhh---------hhh--
Q 014904          193 KIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLV---------DWA--  261 (416)
Q Consensus       193 ~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~---------~~~--  261 (416)
                      +.....  ...+...||+.|+|||++.+..++.++||||+||+++||++|+.||...........+         ++.  
T Consensus       167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            866542  2334567999999999999999999999999999999999999999765421110000         000  


Q ss_pred             -hHHhHHhhhcC-Ccc-----cccCcccc---CcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014904          262 -RPLLNRAIEDG-NFD-----TLVDPKLH---NEYNHNEMARMVACAAACVRHSARRRPRMSQIVRA  318 (416)
Q Consensus       262 -~~~~~~~~~~~-~~~-----~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~~  318 (416)
                       ........... ...     .+......   ..........+.+|+.+||+.||++|||+.||++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence             00001111110 000     00000010   11123345678999999999999999999999854

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-43  Score=342.54  Aligned_cols=264  Identities=20%  Similarity=0.292  Sum_probs=196.0

Q ss_pred             HhhCCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcc--cHHHHHHHHHHHHhcCCCcccceEEEEEeC-----
Q 014904           41 RATDGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQ--GEREFQAEVEIISRVHHKHLVSLVGYYTAG-----  112 (416)
Q Consensus        41 ~~t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  112 (416)
                      ...++|++.++||+|+||+||+|.. .+|+.||||+++.....  ..+.+.+|+.+|++++|||+|++++++...     
T Consensus        15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred             cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence            3578999999999999999999995 57999999999765432  235688999999999999999999998642     


Q ss_pred             CeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEeecccc
Q 014904          113 SQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA  192 (416)
Q Consensus       113 ~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla  192 (416)
                      ...++|++++.+++|.+++...   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++|||++
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             CceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence            3346667788899999998643   599999999999999999999999   9999999999999999999999999998


Q ss_pred             eeccCCCcceeecccccccccChhhhccC-CCCchhhhHhHHHHHHHHHhCCCCCCCCCcccchhhhhhh----------
Q 014904          193 KIASDVNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDSTHTFVEDSLVDWA----------  261 (416)
Q Consensus       193 ~~~~~~~~~~~~~~~gt~~YlaPE~~~~~-~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~~~l~~~~----------  261 (416)
                      ......    .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+...          
T Consensus       169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            765432    2335789999999987665 5689999999999999999999999765432111110000          


Q ss_pred             ---hHHhHHhhhcCCcccccCccccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014904          262 ---RPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRMSQIVR  317 (416)
Q Consensus       262 ---~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evv~  317 (416)
                         ........  ..........+.. ........+.+|+.+||+.||.+|||+.|+++
T Consensus       245 ~~~~~~~~~~~--~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         245 KISSESARNYI--QSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TCCCHHHHHHH--TTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhhhhh--hhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence               00000000  0000000000000 00112346789999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-38  Score=311.16  Aligned_cols=271  Identities=21%  Similarity=0.291  Sum_probs=194.5

Q ss_pred             CCCCcCceecccCcEEEEEEEe-CCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-----------CCcccceEEEEEe
Q 014904           44 DGFSDANLLGQGGFGYVHRGVL-PNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-----------HKHLVSLVGYYTA  111 (416)
Q Consensus        44 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  111 (416)
                      ++|.+.++||+|+||+||+|+. .+|+.||||+++.... ....+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            3599999999999999999996 5799999999985432 2356788999888875           5789999988764


Q ss_pred             --CCeEEEEEEecCCCC-HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCc-----
Q 014904          112 --GSQRMLVYEFVPNNT-LEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE-----  183 (416)
Q Consensus       112 --~~~~~lV~e~~~~~s-L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~-----  183 (416)
                        ....++|+++..... ............+++..+..++.|++.||.|||+..  +|+||||||+||||+.++.     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccc
Confidence              455667777665543 333334444557899999999999999999999832  8999999999999986653     


Q ss_pred             -eEEeecccceeccCCCcceeecccccccccChhhhccCCCCchhhhHhHHHHHHHHHhCCCCCCCCCcccc----hhhh
Q 014904          184 -AKVADFGLAKIASDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDSTHTFVE----DSLV  258 (416)
Q Consensus       184 -~kl~DFGla~~~~~~~~~~~~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL~elltG~~pf~~~~~~~~----~~l~  258 (416)
                       ++++|||.+.......    ...+||+.|+|||++....++.++|||||||++++|++|+.||........    +.+.
T Consensus       170 ~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         170 QIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence             8999999998654422    346799999999999999999999999999999999999999976433211    1111


Q ss_pred             hhhhHH---hHHhhhcCC-----------cccccCc---------cccCcCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 014904          259 DWARPL---LNRAIEDGN-----------FDTLVDP---------KLHNEYNHNEMARMVACAAACVRHSARRRPRMSQI  315 (416)
Q Consensus       259 ~~~~~~---~~~~~~~~~-----------~~~~~d~---------~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev  315 (416)
                      .++..+   .......+.           ...+...         .............+.+|+.+||+.||.+|||+.|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            111000   000000000           0000000         01223446677889999999999999999999999


Q ss_pred             HHH--hcc
Q 014904          316 VRA--LEG  321 (416)
Q Consensus       316 v~~--L~~  321 (416)
                      ++.  |..
T Consensus       326 L~Hp~f~~  333 (362)
T d1q8ya_         326 VNHPWLKD  333 (362)
T ss_dssp             HTCGGGTT
T ss_pred             hcCcccCC
Confidence            874  553

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=3.1e-24  Score=191.09  Aligned_cols=168  Identities=15%  Similarity=0.115  Sum_probs=120.7

Q ss_pred             CcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcc------------------cHHHHHHHHHHHHhcCCCcccceEEE
Q 014904           47 SDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQ------------------GEREFQAEVEIISRVHHKHLVSLVGY  108 (416)
Q Consensus        47 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~l~~~  108 (416)
                      .+.++||+|+||.||+|.+.+|+.||||+++.....                  ....+..|+..+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            456899999999999999889999999987642110                  01234568889999999999988765


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecccCCcEEECCCCceEEee
Q 014904          109 YTAGSQRMLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD  188 (416)
Q Consensus       109 ~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDIkp~NILl~~~~~~kl~D  188 (416)
                      ..    .++||||+++..+..         ++......++.|++.+|+|||+.   +|+||||||+|||++++ .++|+|
T Consensus        83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred             cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence            32    369999998866543         23334567899999999999999   99999999999999865 589999


Q ss_pred             cccceeccCCCccee-ecccccccccChhhhccCCCCchhhhHhHHHHH
Q 014904          189 FGLAKIASDVNTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVML  236 (416)
Q Consensus       189 FGla~~~~~~~~~~~-~~~~gt~~YlaPE~~~~~~~t~ksDV~SlGvvL  236 (416)
                      ||+|........... .+.+..    -.+++ ..++..++||||..--+
T Consensus       146 FG~a~~~~~~~~~~~l~rd~~~----~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWREILERDVRN----IITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHHHHHHHHHHH----HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcHHHHHHHHHH----HHHHH-cCCCCCcccHHHHHHHH
Confidence            999976543322110 000000    01222 35678899999965443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.76  E-value=2.5e-08  Score=90.57  Aligned_cols=150  Identities=11%  Similarity=0.034  Sum_probs=104.2

Q ss_pred             HHHHHhhCCCCcCceecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcC-CCcccceEEEEEeCCeE
Q 014904           37 EELARATDGFSDANLLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVH-HKHLVSLVGYYTAGSQR  115 (416)
Q Consensus        37 ~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  115 (416)
                      .||.+....|++....+-+..+.||+... +++.++||+...........+.+|+.++..+. +--+.+++.++.+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            47888888888776644344568998875 56678888876544333345778888888774 43467888888889999


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 014904          116 MLVYEFVPNNTLEFHLHGKGRPTMDWLTRLKIALGSAKGLAYLHED----------------------------------  161 (416)
Q Consensus       116 ~lV~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~----------------------------------  161 (416)
                      ++||+++++.++.......    ..   ...++.++++.++.||+.                                  
T Consensus        86 ~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            9999999998886544211    11   223444555555555531                                  


Q ss_pred             -------------------C---CCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          162 -------------------C---HPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       162 -------------------~---~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                                         .   ...++|+|+.+.|||++++..+-|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                               0   12378999999999998776667999998753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.32  E-value=1.1e-06  Score=78.94  Aligned_cols=141  Identities=19%  Similarity=0.127  Sum_probs=86.4

Q ss_pred             eecccCc-EEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCC--CcccceEEEEEeCCeEEEEEEecCCCCH
Q 014904           51 LLGQGGF-GYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHH--KHLVSLVGYYTAGSQRMLVYEFVPNNTL  127 (416)
Q Consensus        51 ~LG~G~~-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~~sL  127 (416)
                      .+..|.. +.||+....++..+++|........   .+..|+..++.+..  -.+.+++.++.+.+..++||++++|..+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455553 6899999888888999987655432   46778888877743  3356788888888889999999987655


Q ss_pred             HHH-----------------hhcCC--CCCC--CHHHHHHHHH--------------------HHHHHHHHHHhcC----
Q 014904          128 EFH-----------------LHGKG--RPTM--DWLTRLKIAL--------------------GSAKGLAYLHEDC----  162 (416)
Q Consensus       128 ~~~-----------------l~~~~--~~~l--~~~~~~~i~~--------------------~ia~aL~~LH~~~----  162 (416)
                      ...                 ||...  ...+  .+.....-..                    .....+..+.+..    
T Consensus        94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  173 (255)
T d1nd4a_          94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE  173 (255)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred             ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence            221                 11100  0000  1110000000                    0112233333321    


Q ss_pred             CCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          163 HPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       163 ~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                      .+.++|+|+.|.|||++.+..+-|+||+.+..
T Consensus       174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            22389999999999998876678999998753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.70  E-value=8.9e-05  Score=70.99  Aligned_cols=76  Identities=16%  Similarity=0.109  Sum_probs=48.3

Q ss_pred             CceecccCcEEEEEEEeC-CCcEEEEEEeecC-----C--cccHHHHHHHHHHHHhcC-C-C-cccceEEEEEeCCeEEE
Q 014904           49 ANLLGQGGFGYVHRGVLP-NGKEVAIKQLKAG-----S--GQGEREFQAEVEIISRVH-H-K-HLVSLVGYYTAGSQRML  117 (416)
Q Consensus        49 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~-----~--~~~~~~~~~E~~~l~~l~-h-~-niv~l~~~~~~~~~~~l  117 (416)
                      .+.||.|....||+.... +++.++||.-.+.     .  .....+...|++.|..+. + | .+.+++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            347899999999999865 4678999975431     1  112234556888887763 2 3 34555544  4556679


Q ss_pred             EEEecCCCC
Q 014904          118 VYEFVPNNT  126 (416)
Q Consensus       118 V~e~~~~~s  126 (416)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.63  E-value=0.00032  Score=65.09  Aligned_cols=163  Identities=15%  Similarity=0.107  Sum_probs=95.1

Q ss_pred             CCCccccCHHHHHHhhCCCCc---Cc--eecccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcc
Q 014904           28 GFSKSTFTYEELARATDGFSD---AN--LLGQGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHL  102 (416)
Q Consensus        28 ~~~~~~f~~~el~~~t~~f~~---~~--~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni  102 (416)
                      +++...+|-+.|..|...+-.   ..  .|+ +.--.||+....+|+.+++|+..+.. ...+++..|...+..|...++
T Consensus         2 ~~~f~~L~pd~i~~al~~~g~~~~~~~~~L~-s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gi   79 (325)
T d1zyla1           2 AFTFQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEV   79 (325)
T ss_dssp             CCCCCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTC
T ss_pred             CCCccccCHHHHHHHHHHcCCCCCcCccccc-cccceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCC
Confidence            456667777777666654421   11  132 22358999999999999999987653 455678889888888753222


Q ss_pred             c--ceE-----EEEEeCCeEEEEEEecCCCCHH-----H------H---hh----cC---CCCCCCHHH-----------
Q 014904          103 V--SLV-----GYYTAGSQRMLVYEFVPNNTLE-----F------H---LH----GK---GRPTMDWLT-----------  143 (416)
Q Consensus       103 v--~l~-----~~~~~~~~~~lV~e~~~~~sL~-----~------~---l~----~~---~~~~l~~~~-----------  143 (416)
                      .  ..+     ..+..+...+.|+++++|..+.     .      .   +|    ..   .+..+++..           
T Consensus        80 pv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~  159 (325)
T d1zyla1          80 PVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFED  159 (325)
T ss_dssp             SBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHT
T ss_pred             CCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHH
Confidence            1  111     1234567788999999764321     0      0   11    11   111222211           


Q ss_pred             --------HHHHHHHHHHHHHHHHh----cCCCCeeeecccCCcEEECCCCceEEeeccccee
Q 014904          144 --------RLKIALGSAKGLAYLHE----DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKI  194 (416)
Q Consensus       144 --------~~~i~~~ia~aL~~LH~----~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~~  194 (416)
                              +..+...+...+..+..    ....++||+|+.+.|||++++  ..++||+-++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         160 ATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             cCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence                    11112222233333332    224578999999999999754  46899998753

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.89  E-value=0.0043  Score=56.48  Aligned_cols=157  Identities=13%  Similarity=0.007  Sum_probs=85.1

Q ss_pred             cCHHHHHHhhCCCCcCceec-----ccCcEEEEEEEeCCCcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcc-----c
Q 014904           34 FTYEELARATDGFSDANLLG-----QGGFGYVHRGVLPNGKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHL-----V  103 (416)
Q Consensus        34 f~~~el~~~t~~f~~~~~LG-----~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-----v  103 (416)
                      .+-+||.....+|.+.++..     .|---+.|+....+| .+++|+......  ..++..|+.++..+...++     +
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence            57789999999998765544     344467899887665 589999865322  2355566777777643222     1


Q ss_pred             ce---EEEEEeCCeEEEEEEecCCCCHHH--------------Hhhc----CCC----CCCCH-H---------------
Q 014904          104 SL---VGYYTAGSQRMLVYEFVPNNTLEF--------------HLHG----KGR----PTMDW-L---------------  142 (416)
Q Consensus       104 ~l---~~~~~~~~~~~lV~e~~~~~sL~~--------------~l~~----~~~----~~l~~-~---------------  142 (416)
                      ..   ..+..-......++.++.+.....              .++.    ...    ....+ .               
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            11   001223455667777776543210              0010    000    00000 0               


Q ss_pred             -HHHHHHHHHHHHHHHHHh-cCCCCeeeecccCCcEEECCCCceEEeecccce
Q 014904          143 -TRLKIALGSAKGLAYLHE-DCHPKIIHRDIKAANILLDFKFEAKVADFGLAK  193 (416)
Q Consensus       143 -~~~~i~~~ia~aL~~LH~-~~~~~iiHrDIkp~NILl~~~~~~kl~DFGla~  193 (416)
                       .....+......+...+. ....++||+|+.+.||+++.+...-|+||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence             001111111222222221 224479999999999999988777899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.81  E-value=0.0025  Score=60.40  Aligned_cols=72  Identities=19%  Similarity=0.286  Sum_probs=48.5

Q ss_pred             ceecccCcEEEEEEEeCC--------CcEEEEEEeecCCcccHHHHHHHHHHHHhcCCCcc-cceEEEEEeCCeEEEEEE
Q 014904           50 NLLGQGGFGYVHRGVLPN--------GKEVAIKQLKAGSGQGEREFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVYE  120 (416)
Q Consensus        50 ~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e  120 (416)
                      +.|+-|---.+|+...++        .+.|++++....  .......+|..+++.+.-.++ .++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            467767777999988654        356777776532  233455678888888854444 477777643    47999


Q ss_pred             ecCCCCH
Q 014904          121 FVPNNTL  127 (416)
Q Consensus       121 ~~~~~sL  127 (416)
                      |+++..+
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544